Citrus Sinensis ID: 013092
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 449 | 2.2.26 [Sep-21-2011] | |||||||
| P42158 | 450 | Casein kinase I isoform d | yes | no | 0.908 | 0.906 | 0.743 | 0.0 | |
| Q5ZLL1 | 416 | Casein kinase I isoform e | yes | no | 0.670 | 0.723 | 0.653 | 1e-127 | |
| Q06486 | 415 | Casein kinase I isoform d | yes | no | 0.576 | 0.624 | 0.776 | 1e-127 | |
| Q9DC28 | 415 | Casein kinase I isoform d | yes | no | 0.576 | 0.624 | 0.776 | 1e-127 | |
| P48730 | 415 | Casein kinase I isoform d | yes | no | 0.576 | 0.624 | 0.776 | 1e-127 | |
| P35508 | 415 | Casein kinase I isoform d | yes | no | 0.576 | 0.624 | 0.776 | 1e-127 | |
| Q5BP74 | 415 | Casein kinase I isoform d | N/A | no | 0.576 | 0.624 | 0.772 | 1e-127 | |
| Q6P647 | 415 | Casein kinase I isoform d | yes | no | 0.570 | 0.616 | 0.777 | 1e-127 | |
| Q9JMK2 | 416 | Casein kinase I isoform e | no | no | 0.639 | 0.689 | 0.670 | 1e-127 | |
| Q6P3K7 | 409 | Casein kinase I isoform d | yes | no | 0.681 | 0.748 | 0.643 | 1e-127 |
| >sp|P42158|KC1D_ARATH Casein kinase I isoform delta-like OS=Arabidopsis thaliana GN=At4g26100 PE=2 SV=2 | Back alignment and function desciption |
|---|
Score = 645 bits (1663), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 327/440 (74%), Positives = 362/440 (82%), Gaps = 32/440 (7%)
Query: 12 ENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRK 71
ENVKTKHPQLLYESKLYRILQGGTG+PNV+WFGVEGDYNVLVMDLLGPSLEDLFNFCSRK
Sbjct: 40 ENVKTKHPQLLYESKLYRILQGGTGVPNVKWFGVEGDYNVLVMDLLGPSLEDLFNFCSRK 99
Query: 72 LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 131
LSLK+VLMLADQMINRVEF HSKSFLHRD+KPDNFLMGLGRRANQVYIIDFGLAKKYRD+
Sbjct: 100 LSLKSVLMLADQMINRVEFFHSKSFLHRDLKPDNFLMGLGRRANQVYIIDFGLAKKYRDS 159
Query: 132 STHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 191
+THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGY+LMYFL+GSLPWQGLKAG
Sbjct: 160 TTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYILMYFLKGSLPWQGLKAG 219
Query: 192 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIR 251
TKKQKYE+ISEKKVSTSIEALCRGYP+EFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIR
Sbjct: 220 TKKQKYERISEKKVSTSIEALCRGYPSEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIR 279
Query: 252 EGFQFDYVFDWTILKYQQSQLATPPARALVPGAGTSGA-PPAIASGDRQTGGGEEGRPAG 310
EGFQFDYVFDWTILKYQQSQL PP+RAL P GTS A PP I++ DR T G EEGRP
Sbjct: 280 EGFQFDYVFDWTILKYQQSQLTAPPSRALNPAVGTSAALPPGISNIDRYT-GEEEGRP-- 336
Query: 311 LSSMDSSRRRMSGPVINSGSFSKQKSPVVNEPTMT--KDTMLSSSNFLGRSGGGSSRRAA 368
M+SSRRR+SG + NSG+ S N+PT + +D+M+ SS+ +S GSSRR
Sbjct: 337 --HMESSRRRVSGALDNSGNIS-------NQPTSSSARDSMIPSSSLFAQS-AGSSRRVT 386
Query: 369 AVSSSRDAFVGSETEPQRSRTTEASPGAMHRISSGPRGSPIGSSDPKRSSSGRNTTHIKT 428
AVS SRD F GSE QRSRT + S G + PR SP +G++T +
Sbjct: 387 AVSGSRDNFPGSEELLQRSRTGDVSRGVI------PRNSP--------GEAGKSTR--RH 430
Query: 429 YETTLKGIESLHFDTDERVH 448
YE+ +KGI++L + H
Sbjct: 431 YESVVKGIDNLQVSDEHHPH 450
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. It can phosphorylate a large number of proteins. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q5ZLL1|KC1E_CHICK Casein kinase I isoform epsilon OS=Gallus gallus GN=CSNK1E PE=2 SV=2 | Back alignment and function description |
|---|
Score = 457 bits (1175), Expect = e-127, Method: Compositional matrix adjust.
Identities = 217/332 (65%), Positives = 261/332 (78%), Gaps = 31/332 (9%)
Query: 12 ENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRK 71
E VKTKHPQL ESK Y+++QGG GIP+++W G EGDYNV+VM+LLGPSLEDLFNFCSRK
Sbjct: 40 ECVKTKHPQLHIESKFYKMMQGGVGIPSIKWCGAEGDYNVMVMELLGPSLEDLFNFCSRK 99
Query: 72 LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 131
SLKTVL+LADQMI+R+E++HSK+F+HRD+KPDNFLMGLG++ N VYIIDFGLAKKYRD
Sbjct: 100 FSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 159
Query: 132 STHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 191
THQHIPYRENKNLTGTARYAS+NTHLGIEQSRRDDLESLGYVLMYF GSLPWQGLKA
Sbjct: 160 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAA 219
Query: 192 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIR 251
TK+QKYE+ISEKK+ST IE LC+GYP+EF++Y ++CRSLRFDDKPDY+YL+++FR+LF R
Sbjct: 220 TKRQKYERISEKKMSTPIEVLCKGYPSEFSTYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279
Query: 252 EGFQFDYVFDWTILKY--------------------QQSQLATPPARALVPGAGTSGAPP 291
+GF +DYVFDW +LK+ + QL RAL PG PP
Sbjct: 280 QGFSYDYVFDWNMLKFGAARNPEDMDRERREHEREERMGQLRGSATRALPPG------PP 333
Query: 292 AIASGDRQTGGGEEGRPAGLSSMDSSRRRMSG 323
A A+G+R E ++S +SR + SG
Sbjct: 334 AGATGNRLRNVAEP-----MASTPTSRIQQSG 360
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Can phosphorylate a large number of proteins. Participates in Wnt signaling. Phosphorylates DVL1. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating PER1 and PER2. Retains PER1 in the cytoplasm. Gallus gallus (taxid: 9031) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q06486|KC1D_RAT Casein kinase I isoform delta OS=Rattus norvegicus GN=Csnk1d PE=1 SV=2 | Back alignment and function description |
|---|
Score = 455 bits (1170), Expect = e-127, Method: Compositional matrix adjust.
Identities = 201/259 (77%), Positives = 236/259 (91%)
Query: 12 ENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRK 71
E VKTKHPQL ESK+Y+++QGG GIP +RW G EGDYNV+VM+LLGPSLEDLFNFCSRK
Sbjct: 40 ECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK 99
Query: 72 LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 131
SLKTVL+LADQMI+R+E++HSK+F+HRD+KPDNFLMGLG++ N VYIIDFGLAKKYRD
Sbjct: 100 FSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 159
Query: 132 STHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 191
THQHIPYRENKNLTGTARYAS+NTHLGIEQSRRDDLESLGYVLMYF GSLPWQGLKA
Sbjct: 160 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAA 219
Query: 192 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIR 251
TK+QKYE+ISEKK+ST IE LC+GYP+EFA+Y ++CRSLRFDDKPDY+YL+++FR+LF R
Sbjct: 220 TKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279
Query: 252 EGFQFDYVFDWTILKYQQS 270
+GF +DYVFDW +LK+ S
Sbjct: 280 QGFSYDYVFDWNMLKFGAS 298
|
Essential serine/threonine-protein kinase that regulates diverse cellular growth and survival processes including Wnt signaling, DNA repair and circadian rhythms. It can phosphorylate a large number of proteins. Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Phosphorylates connexin-43/GJA1, MAP1A, SNAPIN, MAPT/TAU, TOP2A, DCK, HIF1A, EIF6, p53/TP53, DVL2, DVL3, ESR1, AIB1/NCOA3, DNMT1, PKD2, YAP1, PER1 and PER2. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating PER1 and PER2, leading to retain PER1 in the cytoplasm. YAP1 phosphorylation promotes its SCF(beta-TRCP) E3 ubiquitin ligase-mediated ubiquitination and subsequent degradation. DNMT1 phosphorylation reduces its DNA-binding activity. Phosphorylation of ESR1 and AIB1/NCOA3 stimulates their activity and coactivation. Phosphorylation of DVL2 and DVL3 regulates WNT3A signaling pathway that controls neurite outgrowth. EIF6 phosphorylation promotes its nuclear export. Triggers down-regulation of dopamine receptors in the forebrain. Activates DCK in vitro by phosphorylation. TOP2A phosphorylation favors DNA cleavable complex formation. May regulate the formation of the mitotic spindle apparatus in extravillous trophoblast. Modulates connexin-43/GJA1 gap junction assembly by phosphorylation. Probably involved in lymphocyte physiology. Regulates fast synaptic transmission mediated by glutamate. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 6 |
| >sp|Q9DC28|KC1D_MOUSE Casein kinase I isoform delta OS=Mus musculus GN=Csnk1d PE=1 SV=2 | Back alignment and function description |
|---|
Score = 455 bits (1170), Expect = e-127, Method: Compositional matrix adjust.
Identities = 201/259 (77%), Positives = 236/259 (91%)
Query: 12 ENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRK 71
E VKTKHPQL ESK+Y+++QGG GIP +RW G EGDYNV+VM+LLGPSLEDLFNFCSRK
Sbjct: 40 ECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK 99
Query: 72 LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 131
SLKTVL+LADQMI+R+E++HSK+F+HRD+KPDNFLMGLG++ N VYIIDFGLAKKYRD
Sbjct: 100 FSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 159
Query: 132 STHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 191
THQHIPYRENKNLTGTARYAS+NTHLGIEQSRRDDLESLGYVLMYF GSLPWQGLKA
Sbjct: 160 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAA 219
Query: 192 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIR 251
TK+QKYE+ISEKK+ST IE LC+GYP+EFA+Y ++CRSLRFDDKPDY+YL+++FR+LF R
Sbjct: 220 TKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279
Query: 252 EGFQFDYVFDWTILKYQQS 270
+GF +DYVFDW +LK+ S
Sbjct: 280 QGFSYDYVFDWNMLKFGAS 298
|
Essential serine/threonine-protein kinase that regulates diverse cellular growth and survival processes including Wnt signaling, DNA repair and circadian rhythms. It can phosphorylate a large number of proteins. Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Phosphorylates connexin-43/GJA1, MAP1A, SNAPIN, MAPT/TAU, TOP2A, DCK, HIF1A, EIF6, p53/TP53, DVL2, DVL3, ESR1, AIB1/NCOA3, DNMT1, PKD2, YAP1, PER1 and PER2. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating PER1 and PER2, leading to retain PER1 in the cytoplasm. YAP1 phosphorylation promotes its SCF(beta-TRCP) E3 ubiquitin ligase-mediated ubiquitination and subsequent degradation. DNMT1 phosphorylation reduces its DNA-binding activity. Phosphorylation of ESR1 and AIB1/NCOA3 stimulates their activity and coactivation. Phosphorylation of DVL2 and DVL3 regulates WNT3A signaling pathway that controls neurite outgrowth. EIF6 phosphorylation promotes its nuclear export. Triggers down-regulation of dopamine receptors in the forebrain. Activates DCK in vitro by phosphorylation. TOP2A phosphorylation favors DNA cleavable complex formation. May regulate the formation of the mitotic spindle apparatus in extravillous trophoblast. Modulates connexin-43/GJA1 gap junction assembly by phosphorylation. Probably involved in lymphocyte physiology. Regulates fast synaptic transmission mediated by glutamate. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 6 |
| >sp|P48730|KC1D_HUMAN Casein kinase I isoform delta OS=Homo sapiens GN=CSNK1D PE=1 SV=2 | Back alignment and function description |
|---|
Score = 454 bits (1169), Expect = e-127, Method: Compositional matrix adjust.
Identities = 201/259 (77%), Positives = 236/259 (91%)
Query: 12 ENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRK 71
E VKTKHPQL ESK+Y+++QGG GIP +RW G EGDYNV+VM+LLGPSLEDLFNFCSRK
Sbjct: 40 ECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK 99
Query: 72 LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 131
SLKTVL+LADQMI+R+E++HSK+F+HRD+KPDNFLMGLG++ N VYIIDFGLAKKYRD
Sbjct: 100 FSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 159
Query: 132 STHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 191
THQHIPYRENKNLTGTARYAS+NTHLGIEQSRRDDLESLGYVLMYF GSLPWQGLKA
Sbjct: 160 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAA 219
Query: 192 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIR 251
TK+QKYE+ISEKK+ST IE LC+GYP+EFA+Y ++CRSLRFDDKPDY+YL+++FR+LF R
Sbjct: 220 TKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279
Query: 252 EGFQFDYVFDWTILKYQQS 270
+GF +DYVFDW +LK+ S
Sbjct: 280 QGFSYDYVFDWNMLKFGAS 298
|
Essential serine/threonine-protein kinase that regulates diverse cellular growth and survival processes including Wnt signaling, DNA repair and circadian rhythms. It can phosphorylate a large number of proteins. Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Phosphorylates connexin-43/GJA1, MAP1A, SNAPIN, MAPT/TAU, TOP2A, DCK, HIF1A, EIF6, p53/TP53, DVL2, DVL3, ESR1, AIB1/NCOA3, DNMT1, PKD2, YAP1, PER1 and PER2. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating PER1 and PER2, leading to retain PER1 in the cytoplasm. YAP1 phosphorylation promotes its SCF(beta-TRCP) E3 ubiquitin ligase-mediated ubiquitination and subsequent degradation. DNMT1 phosphorylation reduces its DNA-binding activity. Phosphorylation of ESR1 and AIB1/NCOA3 stimulates their activity and coactivation. Phosphorylation of DVL2 and DVL3 regulates WNT3A signaling pathway that controls neurite outgrowth. EIF6 phosphorylation promotes its nuclear export. Triggers down-regulation of dopamine receptors in the forebrain. Activates DCK in vitro by phosphorylation. TOP2A phosphorylation favors DNA cleavable complex formation. May regulate the formation of the mitotic spindle apparatus in extravillous trophoblast. Modulates connexin-43/GJA1 gap junction assembly by phosphorylation. Probably involved in lymphocyte physiology. Regulates fast synaptic transmission mediated by glutamate. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 6 |
| >sp|P35508|KC1D_BOVIN Casein kinase I isoform delta OS=Bos taurus GN=CSNK1D PE=2 SV=2 | Back alignment and function description |
|---|
Score = 454 bits (1169), Expect = e-127, Method: Compositional matrix adjust.
Identities = 201/259 (77%), Positives = 236/259 (91%)
Query: 12 ENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRK 71
E VKTKHPQL ESK+Y+++QGG GIP +RW G EGDYNV+VM+LLGPSLEDLFNFCSRK
Sbjct: 40 ECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK 99
Query: 72 LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 131
SLKTVL+LADQMI+R+E++HSK+F+HRD+KPDNFLMGLG++ N VYIIDFGLAKKYRD
Sbjct: 100 FSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 159
Query: 132 STHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 191
THQHIPYRENKNLTGTARYAS+NTHLGIEQSRRDDLESLGYVLMYF GSLPWQGLKA
Sbjct: 160 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAA 219
Query: 192 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIR 251
TK+QKYE+ISEKK+ST IE LC+GYP+EFA+Y ++CRSLRFDDKPDY+YL+++FR+LF R
Sbjct: 220 TKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279
Query: 252 EGFQFDYVFDWTILKYQQS 270
+GF +DYVFDW +LK+ S
Sbjct: 280 QGFSYDYVFDWNMLKFGAS 298
|
Essential serine/threonine-protein kinase that regulates diverse cellular growth and survival processes including Wnt signaling, DNA repair and circadian rhythms. It can phosphorylate a large number of proteins. Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Phosphorylates connexin-43/GJA1, MAP1A, SNAPIN, MAPT/TAU, TOP2A, DCK, HIF1A, EIF6, p53/TP53, DVL2, DVL3, ESR1, AIB1/NCOA3, DNMT1, PKD2, YAP1, PER1 and PER2. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating PER1 and PER2, leading to retain PER1 in the cytoplasm. YAP1 phosphorylation promotes its SCF(beta-TRCP) E3 ubiquitin ligase-mediated ubiquitination and subsequent degradation. DNMT1 phosphorylation reduces its DNA-binding activity. Phosphorylation of ESR1 and AIB1/NCOA3 stimulates their activity and coactivation. Phosphorylation of DVL2 and DVL3 regulates WNT3A signaling pathway that controls neurite outgrowth. EIF6 phosphorylation promotes its nuclear export. Triggers down-regulation of dopamine receptors in the forebrain. Activates DCK in vitro by phosphorylation. TOP2A phosphorylation favors DNA cleavable complex formation. May regulate the formation of the mitotic spindle apparatus in extravillous trophoblast. Modulates connexin-43/GJA1 gap junction assembly by phosphorylation. Probably involved in lymphocyte physiology. Regulates fast synaptic transmission mediated by glutamate. Bos taurus (taxid: 9913) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 6 |
| >sp|Q5BP74|KC1D_XENLA Casein kinase I isoform delta OS=Xenopus laevis GN=csnk1d PE=1 SV=2 | Back alignment and function description |
|---|
Score = 454 bits (1169), Expect = e-127, Method: Compositional matrix adjust.
Identities = 200/259 (77%), Positives = 236/259 (91%)
Query: 12 ENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRK 71
E VKTKHPQL ESK+Y+++QGG GIP ++W G EGDYNV+VM+LLGPSLEDLFNFCSRK
Sbjct: 40 ECVKTKHPQLHIESKIYKMMQGGVGIPTIKWCGAEGDYNVMVMELLGPSLEDLFNFCSRK 99
Query: 72 LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 131
SLKTVL+LADQMI+R+E++HSK+F+HRD+KPDNFLMGLG++ N VYIIDFGLAKKYRD
Sbjct: 100 FSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 159
Query: 132 STHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 191
THQHIPYRENKNLTGTARYAS+NTHLGIEQSRRDDLESLGYVLMYF GSLPWQGLKA
Sbjct: 160 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAA 219
Query: 192 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIR 251
TK+QKYE+ISEKK+ST IE LC+GYP+EFA+Y ++CRSLRFDDKPDY+YL+++FR+LF R
Sbjct: 220 TKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279
Query: 252 EGFQFDYVFDWTILKYQQS 270
+GF +DYVFDW +LK+ S
Sbjct: 280 QGFSYDYVFDWNMLKFGAS 298
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Isoform 1 can phosphorylate a large number of proteins. Isoform 2 has no kinase activity. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating per1 and per2, which may lead to their degradation. Participates in wnt signaling. Xenopus laevis (taxid: 8355) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q6P647|KC1D_XENTR Casein kinase I isoform delta OS=Xenopus tropicalis GN=csnk1d PE=2 SV=1 | Back alignment and function description |
|---|
Score = 454 bits (1167), Expect = e-127, Method: Compositional matrix adjust.
Identities = 199/256 (77%), Positives = 235/256 (91%)
Query: 12 ENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRK 71
E VKTKHPQL ESK+Y+++QGG GIP ++W G EGDYNV+VM+LLGPSLEDLFNFCSRK
Sbjct: 40 ECVKTKHPQLHIESKIYKMMQGGVGIPTIKWCGAEGDYNVMVMELLGPSLEDLFNFCSRK 99
Query: 72 LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 131
SLKTVL+LADQMI+R+E++HSK+F+HRD+KPDNFLMGLG++ N VYIIDFGLAKKYRD
Sbjct: 100 FSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 159
Query: 132 STHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 191
THQHIPYRENKNLTGTARYAS+NTHLGIEQSRRDDLESLGYVLMYF GSLPWQGLKA
Sbjct: 160 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAA 219
Query: 192 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIR 251
TK+QKYE+ISEKK+ST IE LC+GYP+EFA+Y ++CRSLRFDDKPDY+YL+++FR+LF R
Sbjct: 220 TKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279
Query: 252 EGFQFDYVFDWTILKY 267
+GF +DYVFDW +LK+
Sbjct: 280 QGFSYDYVFDWNMLKF 295
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating per1 and per2, which may lead to their degradation. Participates in wnt signaling. Xenopus tropicalis (taxid: 8364) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9JMK2|KC1E_MOUSE Casein kinase I isoform epsilon OS=Mus musculus GN=Csnk1e PE=1 SV=2 | Back alignment and function description |
|---|
Score = 454 bits (1167), Expect = e-127, Method: Compositional matrix adjust.
Identities = 210/313 (67%), Positives = 250/313 (79%), Gaps = 26/313 (8%)
Query: 12 ENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRK 71
E VKTKHPQL ESK Y+++QGG GIP+++W G EGDYNV+VM+LLGPSLEDLFNFCSRK
Sbjct: 40 ECVKTKHPQLHIESKFYKMMQGGVGIPSIKWCGAEGDYNVMVMELLGPSLEDLFNFCSRK 99
Query: 72 LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 131
SLKTVL+LADQMI+R+E++HSK+F+HRD+KPDNFLMGLG++ N VYIIDFGLAKKYRD
Sbjct: 100 FSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 159
Query: 132 STHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 191
THQHIPYRENKNLTGTARYAS+NTHLGIEQSRRDDLESLGYVLMYF GSLPWQGLKA
Sbjct: 160 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAA 219
Query: 192 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIR 251
TK+QKYE+ISEKK+ST IE LC+GYP+EF++Y ++CRSLRFDDKPDY+YL+++FR+LF R
Sbjct: 220 TKRQKYERISEKKMSTPIEVLCKGYPSEFSTYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279
Query: 252 EGFQFDYVFDWTILKY--------------------QQSQLATPPARALVPGAGTSGAPP 291
+GF +DYVFDW +LK+ + QL RAL PG PP
Sbjct: 280 QGFSYDYVFDWNMLKFGAARNPEDVDRERREHEREERMGQLRGSATRALPPG------PP 333
Query: 292 AIASGDRQTGGGE 304
A+ +R E
Sbjct: 334 TGATANRLRSAAE 346
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Can phosphorylate a large number of proteins. Participates in Wnt signaling. Phosphorylates DVL1. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating PER1 and PER2. Retains PER1 in the cytoplasm. Inhibits cytokine-induced granuloytic differentiation. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q6P3K7|KC1DB_DANRE Casein kinase I isoform delta-B OS=Danio rerio GN=csnk1db PE=2 SV=1 | Back alignment and function description |
|---|
Score = 454 bits (1167), Expect = e-127, Method: Compositional matrix adjust.
Identities = 213/331 (64%), Positives = 258/331 (77%), Gaps = 25/331 (7%)
Query: 12 ENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRK 71
E VKTKHPQL ESK+Y+++QGG GIP ++W G EGDYNV+VM+LLGPSLEDLFNFCSRK
Sbjct: 40 ECVKTKHPQLHIESKIYKMMQGGVGIPTIKWCGAEGDYNVMVMELLGPSLEDLFNFCSRK 99
Query: 72 LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 131
SLKTVL+LADQMI+R+E++HSK+F+HRD+KPDNFLMGLG++ N VYIIDFGLAKKYRD
Sbjct: 100 FSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 159
Query: 132 STHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 191
THQHIPYRENKNLTGTARYAS+NTHLGIEQSRRDDLESLGYVLMYF GSLPWQGLKA
Sbjct: 160 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAA 219
Query: 192 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIR 251
TK+QKYE+ISEKK+ST IE LC+GYP+EFA+Y ++CRSLRFDDKPDY+YL+++FR+LF R
Sbjct: 220 TKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279
Query: 252 EGFQFDYVFDWTILKYQQSQLA------------------TPPARALVPGAG-----TSG 288
+GF +DYVFDW +LK+ ++ A P AR + +G G
Sbjct: 280 QGFSYDYVFDWNMLKFGANRTAEEADRERRERDERMRHSRNPAARGIPAASGRPRPTQDG 339
Query: 289 APPAIASGDRQTGGGEEGRPAGLSSMDSSRR 319
APP + T RP ++ M+ R+
Sbjct: 340 APPTPLTPTSHTANTSSPRP--VTGMERERK 368
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating per1 and per2, which may lead to their degradation. Participates in wnt signaling. Danio rerio (taxid: 7955) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 449 | ||||||
| 224122454 | 475 | predicted protein [Populus trichocarpa] | 0.968 | 0.915 | 0.865 | 0.0 | |
| 255546141 | 446 | casein kinase, putative [Ricinus communi | 0.988 | 0.995 | 0.847 | 0.0 | |
| 224091248 | 475 | predicted protein [Populus trichocarpa] | 0.968 | 0.915 | 0.867 | 0.0 | |
| 359484471 | 474 | PREDICTED: casein kinase I isoform delta | 0.962 | 0.911 | 0.841 | 0.0 | |
| 359482807 | 471 | PREDICTED: casein kinase I isoform delta | 0.955 | 0.910 | 0.827 | 0.0 | |
| 255560729 | 472 | casein kinase, putative [Ricinus communi | 0.959 | 0.913 | 0.829 | 0.0 | |
| 121501708 | 473 | casein kinase [Beta vulgaris] | 0.959 | 0.911 | 0.827 | 0.0 | |
| 356547889 | 483 | PREDICTED: casein kinase I isoform delta | 0.966 | 0.898 | 0.816 | 0.0 | |
| 449446600 | 479 | PREDICTED: casein kinase I isoform delta | 0.968 | 0.908 | 0.826 | 0.0 | |
| 413915514 | 479 | Caesin kinase I isoform delta like prote | 0.968 | 0.908 | 0.823 | 0.0 |
| >gi|224122454|ref|XP_002330485.1| predicted protein [Populus trichocarpa] gi|222872419|gb|EEF09550.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 786 bits (2029), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 380/439 (86%), Positives = 405/439 (92%), Gaps = 4/439 (0%)
Query: 12 ENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRK 71
EN+KTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRK
Sbjct: 40 ENIKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRK 99
Query: 72 LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 131
LSLK+VLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD+
Sbjct: 100 LSLKSVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDS 159
Query: 132 STHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 191
STHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG
Sbjct: 160 STHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 219
Query: 192 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIR 251
TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIR
Sbjct: 220 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIR 279
Query: 252 EGFQFDYVFDWTILKYQQSQLATPPARALVPGAGTSGAPPAIASGDRQTGGGEEGRPAGL 311
EGFQFDYVFDWTILKYQQSQLA PP R + PG GTS P I S DRQTG GEEGR G
Sbjct: 280 EGFQFDYVFDWTILKYQQSQLANPPTRGIGPGVGTSSGMPPIVSADRQTGSGEEGRAVG- 338
Query: 312 SSMDSSRRRMSGPVINSGSFSKQKSPVVNEPTMTKDTMLSSSNFLGRSGGGSSRRAAAVS 371
SMDSSR R+SGP++N+GS+SKQKSPV N+ +TKD +L SS FLGRS GS+RRAA VS
Sbjct: 339 QSMDSSRHRLSGPILNAGSYSKQKSPVANDYPITKDAVLPSSTFLGRS-SGSARRAAGVS 397
Query: 372 SSRDAF-VGSETEPQRSRTTEASPGAMHRISSGPRGSPIGSSDPKRSSSGRNTTHIKTYE 430
SSRD F SE++PQ SR T+ASPGA+H+ISSGPR SP+GSSDP+R+SS RNTTH+KTYE
Sbjct: 398 SSRDVFAAASESDPQWSRITDASPGAIHKISSGPR-SPLGSSDPRRTSSSRNTTHMKTYE 456
Query: 431 TTLKGIESLHFDTDERVHY 449
TTLKGIESL+FD+DE+VHY
Sbjct: 457 TTLKGIESLNFDSDEKVHY 475
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255546141|ref|XP_002514130.1| casein kinase, putative [Ricinus communis] gi|223546586|gb|EEF48084.1| casein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 784 bits (2025), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 382/451 (84%), Positives = 415/451 (92%), Gaps = 7/451 (1%)
Query: 1 MYEILTVFSVQENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPS 60
M ++++ F QENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPS
Sbjct: 1 MLKLVSDF--QENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPS 58
Query: 61 LEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYII 120
LEDLFNFCSRKLSLK+VLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVY+I
Sbjct: 59 LEDLFNFCSRKLSLKSVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYMI 118
Query: 121 DFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR 180
DFGLAKKYRD+STHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR
Sbjct: 119 DFGLAKKYRDSSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR 178
Query: 181 GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAY 240
GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAY
Sbjct: 179 GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAY 238
Query: 241 LKRIFRDLFIREGFQFDYVFDWTILKYQQSQLATPPARALVPGAGT-SGAPPAIASGDRQ 299
LKRIFRDLFIREGFQFDYVFDWTILKYQQSQLA PPARAL PG GT SG PPAI S DRQ
Sbjct: 239 LKRIFRDLFIREGFQFDYVFDWTILKYQQSQLANPPARALGPGIGTSSGMPPAIGSADRQ 298
Query: 300 TGGGEEGRPAGLSSMDSSRRRMSGPVINSGSFSKQKSPVVNEPTMTKDTMLSSSNFLGRS 359
T GGEE R AG SMDS+RRR+SGP++N+GSF+KQKSPV N+ ++KD +L SS F+GRS
Sbjct: 299 T-GGEEARQAG-QSMDSARRRLSGPILNTGSFAKQKSPVANDSPVSKDPILPSSTFMGRS 356
Query: 360 GGGSSRRAAAVSSSRDAFVGSETEPQRSRTTEASPGAMHRISSGPRG-SPIGSSDPKRSS 418
SSR+AAAVSSSRD ++GSE +PQR+RTT+ASPGAMH+I SG R P+GSSDP+RSS
Sbjct: 357 -SRSSRQAAAVSSSRDVYLGSEADPQRTRTTDASPGAMHKIPSGQRSPPPLGSSDPRRSS 415
Query: 419 SGRNTTHIKTYETTLKGIESLHFDTDERVHY 449
S RN TH+KTYE+ LKGIE L+FD+D++VHY
Sbjct: 416 SARNATHMKTYESALKGIEGLNFDSDDKVHY 446
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224091248|ref|XP_002309212.1| predicted protein [Populus trichocarpa] gi|222855188|gb|EEE92735.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 777 bits (2007), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 381/439 (86%), Positives = 403/439 (91%), Gaps = 4/439 (0%)
Query: 12 ENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRK 71
ENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRK
Sbjct: 40 ENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRK 99
Query: 72 LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 131
LSLK+VLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD+
Sbjct: 100 LSLKSVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDS 159
Query: 132 STHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 191
STHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG
Sbjct: 160 STHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 219
Query: 192 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIR 251
TKKQKYEKISEKKVSTSIEAL RGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIR
Sbjct: 220 TKKQKYEKISEKKVSTSIEALSRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIR 279
Query: 252 EGFQFDYVFDWTILKYQQSQLATPPARALVPGAGT-SGAPPAIASGDRQTGGGEEGRPAG 310
EGFQFDYVFDWTILKYQQSQLA PP R L G GT SG PP I S DRQT GGEE R AG
Sbjct: 280 EGFQFDYVFDWTILKYQQSQLANPPTRGLGLGVGTSSGMPPPIVSADRQT-GGEEVRAAG 338
Query: 311 LSSMDSSRRRMSGPVINSGSFSKQKSPVVNEPTMTKDTMLSSSNFLGRSGGGSSRRAAAV 370
+M+SSRRR+SG +IN+GS SKQKS V NE +TKD ML +S FLGRS GSSRRAAAV
Sbjct: 339 -QTMESSRRRLSGQIINAGSSSKQKSLVANESPITKDAMLPNSTFLGRS-SGSSRRAAAV 396
Query: 371 SSSRDAFVGSETEPQRSRTTEASPGAMHRISSGPRGSPIGSSDPKRSSSGRNTTHIKTYE 430
SSSRD FVGSE++PQRS TTEASPGA+H+ISSG R P+GSSDP+R+SS RNT+H+KTYE
Sbjct: 397 SSSRDVFVGSESDPQRSCTTEASPGAIHKISSGQRSPPLGSSDPRRTSSSRNTSHMKTYE 456
Query: 431 TTLKGIESLHFDTDERVHY 449
TTLKG ESL+FD+DE+ H+
Sbjct: 457 TTLKGFESLNFDSDEKAHH 475
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359484471|ref|XP_002281345.2| PREDICTED: casein kinase I isoform delta-like [Vitis vinifera] gi|147859066|emb|CAN80417.1| hypothetical protein VITISV_024542 [Vitis vinifera] gi|297738643|emb|CBI27888.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 751 bits (1938), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 371/441 (84%), Positives = 400/441 (90%), Gaps = 9/441 (2%)
Query: 12 ENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRK 71
ENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEG+YNVLVMDLLGPSLEDLFNFCSRK
Sbjct: 40 ENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGEYNVLVMDLLGPSLEDLFNFCSRK 99
Query: 72 LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 131
LSLK+VLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT
Sbjct: 100 LSLKSVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159
Query: 132 STHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 191
+THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG
Sbjct: 160 ATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 219
Query: 192 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIR 251
TKKQKYEKISE+KVSTSIE LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIR
Sbjct: 220 TKKQKYEKISERKVSTSIEVLCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIR 279
Query: 252 EGFQFDYVFDWTILKYQQSQLATPPARALVPGAGTSGA--PPAIASGDRQTGGGEEGRPA 309
EGFQFDYVFDWTILKYQQSQLATPP+R L PGAGTS PPA+A+ DRQ+ GEEGRPA
Sbjct: 280 EGFQFDYVFDWTILKYQQSQLATPPSRVLGPGAGTSSGLPPPAVANADRQS--GEEGRPA 337
Query: 310 GLSSMDSSRRRMSGPVINSGSFSKQKSPVVNEPTMTKDTMLSSSNFLGRSGGGSSRRAAA 369
GLSSMD SRRR+SG + G SKQKSPV ++ ++KD MLSSS+FLGRS G S R A +
Sbjct: 338 GLSSMDPSRRRISG---DGGGLSKQKSPVASDLAVSKDAMLSSSHFLGRSSGSSRRAAVS 394
Query: 370 VSSSRDAFVGSETEPQRSRTTEASPG-AMHRISSGPRGSPIGSSDPKRSSSGRNTTHIKT 428
S A +GSE++P R+ TTEASPG A+ RISSG R SP+GSSDPKR+SSGRN T+IK
Sbjct: 395 SSRDA-AIMGSESDPSRAHTTEASPGAAVRRISSGQRSSPVGSSDPKRTSSGRNITNIKN 453
Query: 429 YETTLKGIESLHFDTDERVHY 449
YE+T++GIE+L+FD DERVHY
Sbjct: 454 YESTIRGIENLNFDNDERVHY 474
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359482807|ref|XP_002277513.2| PREDICTED: casein kinase I isoform delta-like [Vitis vinifera] gi|297743045|emb|CBI35912.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 730 bits (1885), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 365/441 (82%), Positives = 396/441 (89%), Gaps = 12/441 (2%)
Query: 12 ENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRK 71
ENVKTKHPQLLYESKLY+ILQGGTGIPNV+WFGVEGDYNVLVMDLLGPSLEDLFNFCSRK
Sbjct: 40 ENVKTKHPQLLYESKLYKILQGGTGIPNVKWFGVEGDYNVLVMDLLGPSLEDLFNFCSRK 99
Query: 72 LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 131
LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVY+IDFGLAKKYRD+
Sbjct: 100 LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYVIDFGLAKKYRDS 159
Query: 132 STHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 191
STHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG
Sbjct: 160 STHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 219
Query: 192 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIR 251
TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIR
Sbjct: 220 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIR 279
Query: 252 EGFQFDYVFDWTILKYQQSQLATPPARALVPGAGTS-GAPPAIASGDRQTGGGEEGRPAG 310
EGFQFDYVFDWTILKYQQSQ++ PP+RAL PGAG S G PPA+A+ DRQ+ GGE+GRP+G
Sbjct: 280 EGFQFDYVFDWTILKYQQSQISGPPSRALGPGAGPSHGIPPAVANMDRQS-GGEDGRPSG 338
Query: 311 LSSMDSSRRRMSGPVINSGSFSKQKSPVVNEPTMTKDTMLSSSNFLGRSGGGSSRRAAAV 370
SS D SRRR + P +N GS KQKSPV N+ TM KD++ S+N GSSRR AV
Sbjct: 339 WSSADPSRRRTTVPALNLGSL-KQKSPVANDSTMAKDSL--SANV---RASGSSRR-GAV 391
Query: 371 SSSRDA-FVGSETEPQRSRTTEASPGAMHRISSGPRGSPIGSSDPKRSSSGRNT-THIKT 428
SSSRDA VG E++P RSR +ASPGA+ +ISSG RGSP+ SS+ KR SSGRNT ++IK
Sbjct: 392 SSSRDAVIVGGESDPSRSR-ADASPGALRKISSGQRGSPVHSSEHKRISSGRNTSSNIKN 450
Query: 429 YETTLKGIESLHFDTDERVHY 449
+E+TLKGIESLHF+ +ERV Y
Sbjct: 451 FESTLKGIESLHFNNEERVQY 471
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255560729|ref|XP_002521378.1| casein kinase, putative [Ricinus communis] gi|223539456|gb|EEF41046.1| casein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 729 bits (1882), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 365/440 (82%), Positives = 393/440 (89%), Gaps = 9/440 (2%)
Query: 12 ENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRK 71
ENVKTKHPQLLYESKLY+ILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRK
Sbjct: 40 ENVKTKHPQLLYESKLYKILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRK 99
Query: 72 LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 131
LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT
Sbjct: 100 LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159
Query: 132 STHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 191
STHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG
Sbjct: 160 STHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 219
Query: 192 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIR 251
TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR+FRDLFIR
Sbjct: 220 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 279
Query: 252 EGFQFDYVFDWTILKYQQSQLATPPARALVPGAG-TSGAPPAIASGDRQTGGGEEGRPAG 310
EGFQFDYVFDWTILKYQQSQ+A PP RAL PGAG +SG PP+ A+ DRQ GGEEGRP
Sbjct: 280 EGFQFDYVFDWTILKYQQSQIANPPTRALGPGAGPSSGMPPSGANIDRQP-GGEEGRPT- 337
Query: 311 LSSMDSSRRRMSGPVINSGSFSKQKSPVVNEPTMTKDTMLSSSNFLGRSGGGSSRRAAAV 370
SMD +RRR SGP+ +S +FSKQK PV N+ ++KD LSS+NFL S G+SRR A+
Sbjct: 338 WPSMDPTRRRNSGPITSSVNFSKQKGPVANDLPLSKDAKLSSTNFLRSS--GTSRR-PAI 394
Query: 371 SSSRD-AFVGSETEPQRSRTTEASPGAMHRISSGPRGSPIGSSDPKRSSSGRNTTHIKTY 429
SSSRD A G+E++P SRTT+ASP +IS G R SPI S++ K SSGRNTT+IKT+
Sbjct: 395 SSSRDAALTGNESDPTWSRTTDASPAV--KISGGQRSSPIVSAEQKHLSSGRNTTNIKTF 452
Query: 430 ETTLKGIESLHFDTDERVHY 449
E+TL+GIESLHF+ DERV Y
Sbjct: 453 ESTLRGIESLHFNNDERVQY 472
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|121501708|gb|ABM55249.1| casein kinase [Beta vulgaris] | Back alignment and taxonomy information |
|---|
Score = 728 bits (1879), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 364/440 (82%), Positives = 388/440 (88%), Gaps = 9/440 (2%)
Query: 12 ENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRK 71
ENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRK
Sbjct: 40 ENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRK 99
Query: 72 LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 131
SLKTVLMLADQMINR+EFVHSKSFLHRDIKPDNFLMGLGRRANQVY+IDFGLAKKYRDT
Sbjct: 100 FSLKTVLMLADQMINRIEFVHSKSFLHRDIKPDNFLMGLGRRANQVYVIDFGLAKKYRDT 159
Query: 132 STHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 191
+THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG
Sbjct: 160 TTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 219
Query: 192 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIR 251
TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRI+RDLFIR
Sbjct: 220 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIYRDLFIR 279
Query: 252 EGFQFDYVFDWTILKYQQSQLATPPARALVPGAGTS-GAP-PAIASGDRQTGGGEEGRPA 309
EGFQFDYVFDWTILKYQQSQLA PPAR GAGTS G P P +A+ +R+ G EEGR
Sbjct: 280 EGFQFDYVFDWTILKYQQSQLAAPPARTGA-GAGTSAGVPTPPVANPERKL-GEEEGRAG 337
Query: 310 GLSSMDSSRRRMSGPVINSGSFSKQKSPVVNEPTMTKDTMLSSSNFLGRSGGGSSRRAAA 369
GLS+ D RRRMSG ++NSGS KQKSP+ N+PT++KD LSS+N GRS G R AA
Sbjct: 338 GLSTGDGLRRRMSGSLLNSGSLLKQKSPLANDPTVSKDPTLSSTNLTGRSSGFLKR--AA 395
Query: 370 VSSSRDAFV-GSETEPQRSRTTEASPGAMHRISSGPRGSPIGSSDPKRSSSGRNTTHIKT 428
+ SSR+A G+E++P RSRT EASP M R SSG R SP+GSSD K+ SSGR T IK
Sbjct: 396 IPSSREAVTGGNESDPSRSRTAEASPSTMQRFSSGQRSSPVGSSDAKQQSSGR-ITSIKN 454
Query: 429 YETTLKGIESLHFDTDERVH 448
YE+TLKGIESLHFD DERVH
Sbjct: 455 YESTLKGIESLHFD-DERVH 473
|
Source: Beta vulgaris Species: Beta vulgaris Genus: Beta Family: Amaranthaceae Order: Caryophyllales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356547889|ref|XP_003542337.1| PREDICTED: casein kinase I isoform delta-like isoform 2 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 728 bits (1878), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 366/448 (81%), Positives = 390/448 (87%), Gaps = 14/448 (3%)
Query: 12 ENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRK 71
ENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRK
Sbjct: 40 ENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRK 99
Query: 72 LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 131
LSLKTVLMLADQMINRVEF+HSKSFLHRDIKPDNFLMGLGRRANQVY IDFGLAKKYRD+
Sbjct: 100 LSLKTVLMLADQMINRVEFIHSKSFLHRDIKPDNFLMGLGRRANQVYAIDFGLAKKYRDS 159
Query: 132 STHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 191
STHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG
Sbjct: 160 STHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 219
Query: 192 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIR 251
TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIR
Sbjct: 220 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIR 279
Query: 252 EGFQFDYVFDWTILKYQQSQLATPPARALVPGAGT-SGAPPAIASGDRQTGGGEEGRPAG 310
EGFQFDYVFDWTILKYQQSQLATPP RA+ P AGT SG PPA+ + DR T GGEEGRP
Sbjct: 280 EGFQFDYVFDWTILKYQQSQLATPPTRAIGPSAGTSSGMPPAVTNADRHT-GGEEGRPPA 338
Query: 311 LSSMDSSRRRMSGPVINSGSFSKQKSPVVNEPTMTKDTMLSSS--------NFLGRSGGG 362
L S+DSSRRRMSGP++N+ SFSK K + N D+++SSS N LG+S G
Sbjct: 339 LVSVDSSRRRMSGPILNTVSFSKPKKLITNFSFTFSDSIISSSMNMQLSSANALGQSSGS 398
Query: 363 SSRRAAAVSSSRDAFVGSETEPQRSRTTEASPGAMHRISSGPRGSPIGSSDPKR-SSSGR 421
S AVSSSRDAFVG+E++ R+RT EASPGA HR SG R SPIGSSDPKR SSGR
Sbjct: 399 SR--RVAVSSSRDAFVGAESDI-RTRTAEASPGAAHRALSGQRSSPIGSSDPKRVVSSGR 455
Query: 422 NTTHIKTYETTLKGIESLHFDTDERVHY 449
N +H+K Y+T L+G+E L + DER HY
Sbjct: 456 NASHVKNYDTALRGMEGLQLENDERTHY 483
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449446600|ref|XP_004141059.1| PREDICTED: casein kinase I isoform delta-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 726 bits (1873), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 366/443 (82%), Positives = 392/443 (88%), Gaps = 8/443 (1%)
Query: 12 ENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRK 71
ENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRK
Sbjct: 40 ENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRK 99
Query: 72 LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 131
LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD+
Sbjct: 100 LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDS 159
Query: 132 STHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 191
STHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG
Sbjct: 160 STHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 219
Query: 192 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIR 251
TKKQKYEKISEKKVSTSIEALCRGYP+EFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIR
Sbjct: 220 TKKQKYEKISEKKVSTSIEALCRGYPSEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIR 279
Query: 252 EGFQFDYVFDWTILKYQQSQLATPPARALVPGAGT-SGAPPAIASGDRQTGGGEEGRPAG 310
EGFQFDYVFDWTILKYQQSQLATPP RAL GAGT SG PP IA+ DRQT GGEE + AG
Sbjct: 280 EGFQFDYVFDWTILKYQQSQLATPPTRALGAGAGTSSGIPPGIANPDRQT-GGEEAQLAG 338
Query: 311 LSSMDSSRRRMSGPVINSGSFSKQKSPVVNE-PTMTKDTMLSSSNFLGRSGGGSSRRAAA 369
+S MDSSRRR SG +NSG+F+KQKSP+ N+ + KD + S N +GRS G S AA
Sbjct: 339 MSLMDSSRRRASGLTMNSGTFAKQKSPIANDTAAVPKDGVFSGPNIVGRSSGSSR--RAA 396
Query: 370 VSSSRDAFVGSETEPQR-SRTTEASPGAMHRISSGPRGSPIGSSDPKRSSSGRNT--THI 426
VSSSRD +VGSE +P R SRT +ASPGA+H+ S R P+G +DPKRS+SGR+T H+
Sbjct: 397 VSSSRDPYVGSEADPHRSSRTRDASPGALHKSMSAQRSPPVGPADPKRSASGRHTGHGHV 456
Query: 427 KTYETTLKGIESLHFDTDERVHY 449
K Y++ LKGIE L + DERVHY
Sbjct: 457 KNYDSALKGIEGLQLENDERVHY 479
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|413915514|emb|CCM43976.1| Caesin kinase I isoform delta like protein [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 724 bits (1870), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 365/443 (82%), Positives = 392/443 (88%), Gaps = 8/443 (1%)
Query: 12 ENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRK 71
ENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRK
Sbjct: 40 ENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRK 99
Query: 72 LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 131
LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD+
Sbjct: 100 LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDS 159
Query: 132 STHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 191
STHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLE+LGYVLMYFLRGSLPWQGLKAG
Sbjct: 160 STHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLETLGYVLMYFLRGSLPWQGLKAG 219
Query: 192 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIR 251
TKKQKYEKISEKKVSTSIEALCRGYP+EFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIR
Sbjct: 220 TKKQKYEKISEKKVSTSIEALCRGYPSEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIR 279
Query: 252 EGFQFDYVFDWTILKYQQSQLATPPARALVPGAGT-SGAPPAIASGDRQTGGGEEGRPAG 310
EGFQFDYVFDWTILKYQQSQLATPP RAL GAGT SG PP IA+ DRQT GGEE + AG
Sbjct: 280 EGFQFDYVFDWTILKYQQSQLATPPTRALGAGAGTSSGIPPGIANPDRQT-GGEEAQLAG 338
Query: 311 LSSMDSSRRRMSGPVINSGSFSKQKSPVVNE-PTMTKDTMLSSSNFLGRSGGGSSRRAAA 369
+S MDSSRRR SG +NSG+F+KQKSP+ N+ + KD + S N +GRS G S AA
Sbjct: 339 MSLMDSSRRRASGLTMNSGTFAKQKSPIANDTAAVPKDGVFSGPNIVGRSSGSSR--RAA 396
Query: 370 VSSSRDAFVGSETEPQR-SRTTEASPGAMHRISSGPRGSPIGSSDPKRSSSGRNT--THI 426
VSSSRD +VGSE +P R SRT +ASPGA+H+ S R P+G +DPKRS+SGR+T H+
Sbjct: 397 VSSSRDPYVGSEADPHRSSRTRDASPGALHKSMSAQRSPPVGPADPKRSASGRHTGHGHV 456
Query: 427 KTYETTLKGIESLHFDTDERVHY 449
K Y++ LKGIE L + DERVHY
Sbjct: 457 KNYDSALKGIEGLQLENDERVHY 479
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 449 | ||||||
| TAIR|locus:2030170 | 465 | CKL2 "casein kinase 1-like pro | 0.944 | 0.911 | 0.671 | 3.7e-151 | |
| TAIR|locus:2120765 | 450 | CK1 "casein kinase 1" [Arabido | 0.830 | 0.828 | 0.724 | 3.3e-147 | |
| TAIR|locus:504954933 | 435 | ckl12 "casein kinase I-like 12 | 0.719 | 0.742 | 0.784 | 2.4e-142 | |
| TAIR|locus:2050409 | 433 | ckl5 "casein kinase I-like 5" | 0.641 | 0.665 | 0.768 | 3.4e-126 | |
| TAIR|locus:2167634 | 476 | ckl7 "casein kinase I-like 7" | 0.574 | 0.542 | 0.806 | 8.8e-118 | |
| TAIR|locus:2024147 | 471 | ADK1 "dual specificity kinase | 0.574 | 0.547 | 0.798 | 1.3e-116 | |
| TAIR|locus:2121338 | 479 | CKL6 "casein kinase I-like 6" | 0.576 | 0.540 | 0.779 | 7.7e-116 | |
| TAIR|locus:2090875 | 442 | ckl10 "casein kinase I-like 10 | 0.603 | 0.613 | 0.756 | 1.5e-115 | |
| UNIPROTKB|Q6K9N1 | 463 | OJ1234_B11.27 "Os02g0622100 pr | 0.561 | 0.544 | 0.781 | 1.1e-112 | |
| TAIR|locus:2129640 | 457 | CKI1 "casein kinase I" [Arabid | 0.663 | 0.652 | 0.692 | 2.9e-112 |
| TAIR|locus:2030170 CKL2 "casein kinase 1-like protein 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1475 (524.3 bits), Expect = 3.7e-151, P = 3.7e-151
Identities = 290/432 (67%), Positives = 323/432 (74%)
Query: 12 ENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRK 71
ENVKTKHPQLLYESKLY++LQGGTG+PNV+W+GVEGDYNVLV+DLLGPSLEDLFNFCSRK
Sbjct: 40 ENVKTKHPQLLYESKLYKVLQGGTGVPNVKWYGVEGDYNVLVIDLLGPSLEDLFNFCSRK 99
Query: 72 LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 131
LSLKTVLMLADQMINR+EFVH KSFLHRDIKPDNFLMGLGRRANQVY+IDFGLAKKYRD
Sbjct: 100 LSLKTVLMLADQMINRIEFVHQKSFLHRDIKPDNFLMGLGRRANQVYVIDFGLAKKYRD- 158
Query: 132 STHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 191
S HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLG+VLMYFL+GSLPWQGLKAG
Sbjct: 159 SNHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGFVLMYFLKGSLPWQGLKAG 218
Query: 192 TXXXXXXXXXXXXVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIR 251
VSTSIEALCRGYP+EFASYFHYCRSLRFDDKPDYAYLKR+FRDLFIR
Sbjct: 219 NKKQKYEKISEKKVSTSIEALCRGYPSEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 278
Query: 252 EGFQFDYVFDWTILKYQQSQLATPPARALVPGAGTSGA-PPAIASGDRQTGGGEEGRPAG 310
EGFQFDYVFDWTILKYQQSQ++TPP R P G S A PPAI S +R +GG +E RP+G
Sbjct: 279 EGFQFDYVFDWTILKYQQSQISTPPPRHHGPVVGPSSALPPAITSAERPSGG-DEARPSG 337
Query: 311 LXXXXXXXXXXXGPVINSGSFSKQKSPVVNEPTMTKDTMLXXXXXXXXXXXXXXXXXXXX 370
G + NSGS +KQK+PV ++P ++KD +L
Sbjct: 338 WSSGIPRRNS--GQIFNSGSLAKQKAPVSSDPAISKDVVLSSSSFLRATGSSRRAAVSSS 395
Query: 371 XXXXXXFVGSETEPQRSRTTEASPGAMHXXXXXXXXXXXXXXDPKRSSSGRNTTHI-KTY 429
+G+++EP + EA G+ K SS R TT + K Y
Sbjct: 396 REAAV--LGTDSEPSNPQIVEAGSGSNSKIPVSRNSPIVSSEINKLSSPSRATTSVMKNY 453
Query: 430 ETTLKGIESLHF 441
E LKGIESLHF
Sbjct: 454 EANLKGIESLHF 465
|
|
| TAIR|locus:2120765 CK1 "casein kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1406 (500.0 bits), Expect = 3.3e-147, Sum P(2) = 3.3e-147
Identities = 282/389 (72%), Positives = 303/389 (77%)
Query: 12 ENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRK 71
ENVKTKHPQLLYESKLYRILQGGTG+PNV+WFGVEGDYNVLVMDLLGPSLEDLFNFCSRK
Sbjct: 40 ENVKTKHPQLLYESKLYRILQGGTGVPNVKWFGVEGDYNVLVMDLLGPSLEDLFNFCSRK 99
Query: 72 LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 131
LSLK+VLMLADQMINRVEF HSKSFLHRD+KPDNFLMGLGRRANQVYIIDFGLAKKYRD+
Sbjct: 100 LSLKSVLMLADQMINRVEFFHSKSFLHRDLKPDNFLMGLGRRANQVYIIDFGLAKKYRDS 159
Query: 132 STHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 191
+THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGY+LMYFL+GSLPWQGLKAG
Sbjct: 160 TTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYILMYFLKGSLPWQGLKAG 219
Query: 192 TXXXXXXXXXXXXVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIR 251
T VSTSIEALCRGYP+EFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIR
Sbjct: 220 TKKQKYERISEKKVSTSIEALCRGYPSEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIR 279
Query: 252 EGFQFDYVFDWTILKYQQSQLATPPARALVPGAGTSGA-PPAIASGDRQTGGGEEGRPAG 310
EGFQFDYVFDWTILKYQQSQL PP+RAL P GTS A PP I++ DR TG EEGRP
Sbjct: 280 EGFQFDYVFDWTILKYQQSQLTAPPSRALNPAVGTSAALPPGISNIDRYTGE-EEGRP-- 336
Query: 311 LXXXXXXXXXXXGPVINSGSFSKQKSPVVNEPTMT--KDTMLXXXXXXXXXXXXXXXXXX 368
G + NSG+ S N+PT + +D+M+
Sbjct: 337 --HMESSRRRVSGALDNSGNIS-------NQPTSSSARDSMIPSSSLFAQSAGSSRRVTA 387
Query: 369 XXXXXXXXFVGSETEPQRSRTTEASPGAM 397
F GSE QRSRT + S G +
Sbjct: 388 VSGSRDN-FPGSEELLQRSRTGDVSRGVI 415
|
|
| TAIR|locus:504954933 ckl12 "casein kinase I-like 12" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1349 (479.9 bits), Expect = 2.4e-142, Sum P(2) = 2.4e-142
Identities = 259/330 (78%), Positives = 278/330 (84%)
Query: 12 ENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRK 71
ENVKTKHPQLLYESKLYRILQGGTG+PN++WFGVEGDYN LVMDLLGPSLEDLFNFCSRK
Sbjct: 40 ENVKTKHPQLLYESKLYRILQGGTGVPNIKWFGVEGDYNTLVMDLLGPSLEDLFNFCSRK 99
Query: 72 LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 131
LSLK+VLMLADQMINRVE+ HSKSFLHRD+KPDNFLMGLGRRANQV+IIDFGLAKKYRD
Sbjct: 100 LSLKSVLMLADQMINRVEYFHSKSFLHRDLKPDNFLMGLGRRANQVHIIDFGLAKKYRDN 159
Query: 132 STHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 191
+THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGY+LMYFL+GSLPWQGLKAG
Sbjct: 160 TTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYILMYFLKGSLPWQGLKAG 219
Query: 192 TXXXXXXXXXXXXVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIR 251
T VSTSIE+LCRGYP+EFASYFHYCRSLRFDDKPDY YLKRIFRDLFIR
Sbjct: 220 TKKQKYERISEKKVSTSIESLCRGYPSEFASYFHYCRSLRFDDKPDYGYLKRIFRDLFIR 279
Query: 252 EGFQFDYVFDWTILKYQQSQLATPPARALV-PGAGTS-GAPPAIASGDRQTGGGEEGRPA 309
EGFQFDYVFDWTILKYQQSQL PP+R LV P GTS G PP + S DR G E GRP
Sbjct: 280 EGFQFDYVFDWTILKYQQSQLTAPPSRGLVSPAVGTSAGLPPGLTSIDRYGGEEEGGRPP 339
Query: 310 GLXXXXXXXXXXXGPVINSGSFSKQKSPVV 339
G + NSG+ S + P++
Sbjct: 340 ----MDSSRRRMSGALENSGNLSS-RGPMM 364
|
|
| TAIR|locus:2050409 ckl5 "casein kinase I-like 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1216 (433.1 bits), Expect = 3.4e-126, Sum P(2) = 3.4e-126
Identities = 222/289 (76%), Positives = 253/289 (87%)
Query: 12 ENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRK 71
E+VKT HPQL YES++YR+LQGGTGIPN++W+GVEGDYNVLVMDLLGPSLEDLF++C R+
Sbjct: 40 ESVKTAHPQLSYESRIYRVLQGGTGIPNMKWYGVEGDYNVLVMDLLGPSLEDLFSYCKRQ 99
Query: 72 LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 131
SLKTVLMLADQMINR+EF+HSKS+LHRDIKPDNFLMGLGRRANQVYIID+GLAKKYRD+
Sbjct: 100 FSLKTVLMLADQMINRLEFIHSKSYLHRDIKPDNFLMGLGRRANQVYIIDYGLAKKYRDS 159
Query: 132 STHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 191
STH+HIPYRENK+L GT RYAS+NTHLGIEQSRRDD+ESLGY+LMYFL+GSLPWQGLKAG
Sbjct: 160 STHRHIPYRENKSLIGTPRYASLNTHLGIEQSRRDDIESLGYILMYFLKGSLPWQGLKAG 219
Query: 192 TXXXXXXXXXXXXVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIR 251
VSTSIE LCRG+PTEFASYFHYCRSLRFDDKPDYAYLKR+FR+LFIR
Sbjct: 220 NKKQKYDKISEKKVSTSIETLCRGHPTEFASYFHYCRSLRFDDKPDYAYLKRLFRNLFIR 279
Query: 252 EGFQFDYVFDWTILKYQQSQLATPPARALVPGAGTS-GAPPAIASGDRQ 299
EGFQFD+VFDWT+ KYQQSQ P R G GTS G PA+ + +++
Sbjct: 280 EGFQFDFVFDWTVYKYQQSQSGNPQPRPHDGGVGTSSGLNPAVGNSEKR 328
|
|
| TAIR|locus:2167634 ckl7 "casein kinase I-like 7" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1160 (413.4 bits), Expect = 8.8e-118, P = 8.8e-118
Identities = 208/258 (80%), Positives = 234/258 (90%)
Query: 12 ENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRK 71
ENVKTKHPQL YESKLY +LQGG+GIPN++WFGVEGDY+V+V+DLLGPSLEDLFN+C+RK
Sbjct: 40 ENVKTKHPQLHYESKLYMLLQGGSGIPNIKWFGVEGDYSVMVIDLLGPSLEDLFNYCNRK 99
Query: 72 LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 131
L+LKTVLMLADQ++NRVEF+H++ FLHRDIKPDNFLMGLGR+ANQVYIIDFGL KKYRD
Sbjct: 100 LTLKTVLMLADQLLNRVEFMHTRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLGKKYRDL 159
Query: 132 STHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 191
TH+HIPYRENKNLTGTARYAS+NTHLG+EQSRRDDLESLGYVLMYFL+GSLPWQGLKAG
Sbjct: 160 QTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLKGSLPWQGLKAG 219
Query: 192 TXXXXXXXXXXXXVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIR 251
T VST IE LC+ P+EF SYFHYCRSLRFDDKPDY+YLKR+FRDLFIR
Sbjct: 220 TKKQKYDRISEKKVSTPIEVLCKNQPSEFVSYFHYCRSLRFDDKPDYSYLKRLFRDLFIR 279
Query: 252 EGFQFDYVFDWTILKYQQ 269
EG+QFDYVFDWT+LKY Q
Sbjct: 280 EGYQFDYVFDWTVLKYPQ 297
|
|
| TAIR|locus:2024147 ADK1 "dual specificity kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1149 (409.5 bits), Expect = 1.3e-116, P = 1.3e-116
Identities = 206/258 (79%), Positives = 233/258 (90%)
Query: 12 ENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRK 71
E+VKTKHPQL YESKLY +LQGGTG+PN++W+GVEGDYNV+V+DLLGPSLEDLFN+C+RK
Sbjct: 40 ESVKTKHPQLHYESKLYMLLQGGTGVPNLKWYGVEGDYNVMVIDLLGPSLEDLFNYCNRK 99
Query: 72 LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 131
LSLKTVLMLADQ+INRVEF+H++ FLHRDIKPDNFLMGLGR+ANQVYIIDFGL KKYRD
Sbjct: 100 LSLKTVLMLADQLINRVEFMHTRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLGKKYRDL 159
Query: 132 STHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 191
TH+HIPYRENKNLTGTARYAS+NTHLG+EQSRRDDLE+LGYVLMYFL+GSLPWQGLKAG
Sbjct: 160 QTHRHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLEALGYVLMYFLKGSLPWQGLKAG 219
Query: 192 TXXXXXXXXXXXXVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIR 251
T V+T IE LC+ P+EF SYF YCRSLRFDDKPDY+YLKR+FRDLFIR
Sbjct: 220 TKKQKYDRISEKKVATPIEVLCKNQPSEFVSYFRYCRSLRFDDKPDYSYLKRLFRDLFIR 279
Query: 252 EGFQFDYVFDWTILKYQQ 269
EG+QFDYVFDWT+LKY Q
Sbjct: 280 EGYQFDYVFDWTVLKYPQ 297
|
|
| TAIR|locus:2121338 CKL6 "casein kinase I-like 6" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1122 (400.0 bits), Expect = 7.7e-116, Sum P(2) = 7.7e-116
Identities = 202/259 (77%), Positives = 230/259 (88%)
Query: 12 ENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRK 71
E KTKHPQL YESK+Y +LQGG+GIP+++WFGV+GDYN +V+DLLGPSLEDLFN+C+R+
Sbjct: 44 EPAKTKHPQLHYESKIYMLLQGGSGIPSLKWFGVQGDYNAMVIDLLGPSLEDLFNYCNRR 103
Query: 72 LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 131
L+LK VLMLADQ+I+RVE++HS+ FLHRDIKPDNFLMGLGR+ANQVYIIDFGLAKKYRD
Sbjct: 104 LTLKAVLMLADQLISRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDL 163
Query: 132 STHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 191
TH+HIPYRENKNLTGTARYAS+NTHLG+EQSRRDDLESLGYVLMYFLRGSLPWQGLKAG
Sbjct: 164 QTHRHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 223
Query: 192 TXXXXXXXXXXXXVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIR 251
T VST IE LC+ YP EF SYF YCRSLRF+DKPDY+YLKR+FRDLFIR
Sbjct: 224 TKKQKYDRISEKKVSTPIEVLCKSYPPEFVSYFQYCRSLRFEDKPDYSYLKRLFRDLFIR 283
Query: 252 EGFQFDYVFDWTILKYQQS 270
EG+QFDYVFDWT LK+ QS
Sbjct: 284 EGYQFDYVFDWTALKHPQS 302
|
|
| TAIR|locus:2090875 ckl10 "casein kinase I-like 10" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1139 (406.0 bits), Expect = 1.5e-115, P = 1.5e-115
Identities = 208/275 (75%), Positives = 238/275 (86%)
Query: 12 ENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRK 71
E VKTKHPQL YESK+Y +LQGGTG+P+++WFGVEG+YN + +DLLGPSLEDLFN+C+R
Sbjct: 40 EPVKTKHPQLHYESKVYMLLQGGTGVPHIKWFGVEGNYNCMAIDLLGPSLEDLFNYCTRS 99
Query: 72 LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 131
SLKTVLMLADQ+INRVE++HS+ FLHRDIKPDNFLMGLGR+ANQVYIID+GLAKKYRD
Sbjct: 100 FSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDL 159
Query: 132 STHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 191
TH+HIPYRENKNLTGTARYAS+NTHLGIEQSRRDDLESLGYVLMYF+RGSLPWQGLKAG
Sbjct: 160 QTHKHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFIRGSLPWQGLKAG 219
Query: 192 TXXXXXXXXXXXXVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIR 251
T + T +E LC+ YP+EF SYFHYCRSLRF+DKPDY+YLKR+FRDLFIR
Sbjct: 220 TKKQKYEKISEKKMLTPVEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIR 279
Query: 252 EGFQFDYVFDWTILKYQQS-QLATP---PARALVP 282
EG+QFDYVFDWTILKY QS ++ P P AL P
Sbjct: 280 EGYQFDYVFDWTILKYPQSGSISKPRPNPKPALDP 314
|
|
| UNIPROTKB|Q6K9N1 OJ1234_B11.27 "Os02g0622100 protein" [Oryza sativa Japonica Group (taxid:39947)] | Back alignment and assigned GO terms |
|---|
Score = 1112 (396.5 bits), Expect = 1.1e-112, P = 1.1e-112
Identities = 197/252 (78%), Positives = 228/252 (90%)
Query: 12 ENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRK 71
E+VK++HPQL YESKLY +LQGGTGIP+++WFGVEG+YNV+V+DLLGPSLEDLFN+C+RK
Sbjct: 40 ESVKSRHPQLHYESKLYMLLQGGTGIPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRK 99
Query: 72 LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 131
SLKTVLMLADQMINRVE++H++ FLHRDIKPDNFLMGLGR+A+QVY+ID+GLAKKYRD
Sbjct: 100 FSLKTVLMLADQMINRVEYMHTRGFLHRDIKPDNFLMGLGRKASQVYVIDYGLAKKYRDL 159
Query: 132 STHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 191
TH+HIPYRENKNLTGTARYAS+NTHLG+EQSRRDDLESLGYVLMYFLRGSLPWQGLKAG
Sbjct: 160 QTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 219
Query: 192 TXXXXXXXXXXXXVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIR 251
T + T +E LC+ YPTEF SYFHYCRSLRF+DKPDY+YLKR+FRDLFIR
Sbjct: 220 TKKQKYDKISEKKMLTPVEVLCKSYPTEFISYFHYCRSLRFEDKPDYSYLKRLFRDLFIR 279
Query: 252 EGFQFDYVFDWT 263
EG+Q DY+FDWT
Sbjct: 280 EGYQLDYIFDWT 291
|
|
| TAIR|locus:2129640 CKI1 "casein kinase I" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1108 (395.1 bits), Expect = 2.9e-112, P = 2.9e-112
Identities = 207/299 (69%), Positives = 239/299 (79%)
Query: 12 ENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRK 71
E VKT+HPQL YESK+Y LQGGTG+P+++WFGVEG+Y+ +V+DLLGPSLEDLFN+C R
Sbjct: 46 EPVKTRHPQLQYESKIYMFLQGGTGVPHLKWFGVEGEYSCMVIDLLGPSLEDLFNYCKRI 105
Query: 72 LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 131
SLK+VLMLADQ+I RVE++HS+ FLHRDIKPDNFLMGLGRRANQVYIID+GLAKKY+D
Sbjct: 106 FSLKSVLMLADQLICRVEYMHSRGFLHRDIKPDNFLMGLGRRANQVYIIDYGLAKKYKDL 165
Query: 132 STHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 191
T +HIPYRENKNLTGTARYAS+NTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG
Sbjct: 166 QTQKHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 225
Query: 192 TXXXXXXXXXXXXVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIR 251
T + TS+E LC+ YP+EF SYFHYCRSLRF+DKPDY+YL+R+FRDLFIR
Sbjct: 226 TKKQKYDKISEKKMLTSVETLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLRRLFRDLFIR 285
Query: 252 EGFQFDYVFDWTILKYQQSQLATPPARALVPGAGTSGAPPAIASGDRQTGGGEEGRPAG 310
EG+Q DYVFDWTI KY Q ++ P P G PPA + G GR G
Sbjct: 286 EGYQLDYVFDWTISKYPQIGSSSRPRPTPRPALDPPG-PPAERAEKPTVGQDLRGRFTG 343
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
ID ![]() | Name ![]() | Annotated EC number ![]() | Identity ![]() | Query coverage ![]() | Hit coverage ![]() | RBH(Q2H) ![]() | RBH(H2Q) ![]() |
| P42158 | KC1D_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7431 | 0.9086 | 0.9066 | yes | no |
| Q556Y4 | KC1_DICDI | 2, ., 7, ., 1, 1, ., 1 | 0.7019 | 0.5679 | 0.5985 | yes | no |
| P48730 | KC1D_HUMAN | 2, ., 7, ., 1, 1, ., 2, 6 | 0.7760 | 0.5768 | 0.6240 | yes | no |
| P35508 | KC1D_BOVIN | 2, ., 7, ., 1, 1, ., 2, 6 | 0.7760 | 0.5768 | 0.6240 | yes | no |
| Q6P647 | KC1D_XENTR | 2, ., 7, ., 1, 1, ., 1 | 0.7773 | 0.5701 | 0.6168 | yes | no |
| Q6P3K7 | KC1DB_DANRE | 2, ., 7, ., 1, 1, ., 1 | 0.6435 | 0.6815 | 0.7481 | yes | no |
| P42168 | KC1A_CAEEL | 2, ., 7, ., 1, 1, ., 1 | 0.6791 | 0.6280 | 0.8269 | yes | no |
| Q9DC28 | KC1D_MOUSE | 2, ., 7, ., 1, 1, ., 2, 6 | 0.7760 | 0.5768 | 0.6240 | yes | no |
| Q5RC72 | KC1D_PONAB | 2, ., 7, ., 1, 1, ., 2, 6 | 0.7683 | 0.5768 | 0.6240 | yes | no |
| P40235 | HHP1_SCHPO | 2, ., 7, ., 1, 1, ., 1 | 0.7865 | 0.5634 | 0.6931 | yes | no |
| Q06486 | KC1D_RAT | 2, ., 7, ., 1, 1, ., 2, 6 | 0.7760 | 0.5768 | 0.6240 | yes | no |
| O76324 | DCO_DROME | 2, ., 7, ., 1, 1, ., 1 | 0.7070 | 0.5701 | 0.5818 | yes | no |
| Q5ZLL1 | KC1E_CHICK | 2, ., 7, ., 1, 1, ., 1 | 0.6536 | 0.6703 | 0.7235 | yes | no |
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
| Your Input: | |||||||||||
| gw1.145.30.1 | hypothetical protein (475 aa) | ||||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 449 | |||
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 6e-34 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 6e-26 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-23 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 7e-19 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-15 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-12 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 5e-12 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-11 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 3e-11 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-11 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 4e-11 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-10 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 5e-10 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 6e-10 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-09 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 3e-09 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 8e-09 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-08 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-08 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 7e-08 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-07 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-07 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-07 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-07 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 3e-07 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 4e-07 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 5e-07 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 6e-07 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-06 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-06 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-06 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-06 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-06 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-06 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 3e-06 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-06 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 4e-06 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 6e-06 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 7e-06 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 7e-06 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 7e-06 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 7e-06 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 8e-06 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-05 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-05 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-05 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-05 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-05 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-05 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-05 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-05 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-05 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-05 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 3e-05 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 4e-05 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 4e-05 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 5e-05 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 5e-05 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 5e-05 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 5e-05 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 5e-05 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 6e-05 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 6e-05 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 7e-05 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 8e-05 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-04 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 1e-04 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-04 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-04 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-04 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-04 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-04 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-04 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-04 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-04 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-04 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-04 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-04 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-04 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-04 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-04 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-04 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 3e-04 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 3e-04 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-04 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-04 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 4e-04 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 4e-04 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 4e-04 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 4e-04 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 4e-04 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 5e-04 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 6e-04 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 6e-04 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 6e-04 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 7e-04 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 7e-04 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 7e-04 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 8e-04 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 9e-04 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 9e-04 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 0.001 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 0.001 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 0.001 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 0.001 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 0.001 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 0.001 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 0.001 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 0.001 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 0.001 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 0.001 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 0.001 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 0.001 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 0.001 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 0.001 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 0.002 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 0.002 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 0.002 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 0.002 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 0.002 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 0.002 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 0.002 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 0.002 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 0.002 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 0.002 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 0.002 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 0.002 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 0.002 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 0.003 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 0.003 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 0.003 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 0.003 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 0.003 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 0.003 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 0.003 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 0.003 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 0.004 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 0.004 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 0.004 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 0.004 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 6e-34
Identities = 58/230 (25%), Positives = 87/230 (37%), Gaps = 19/230 (8%)
Query: 7 VFSVQENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFN 66
+ + K E ++ R L + + F + D+ LVM+ DLF+
Sbjct: 31 ILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDAF-EDKDHLYLVMEYCEGG--DLFD 87
Query: 67 FCSRK--LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGL 124
+ SR LS +A Q++ +E++HS +HRD+KP+N L+ V I DFGL
Sbjct: 88 YLSRGGPLSEDEAKKIALQILRGLEYLHSNGIIHRDLKPENILLD---ENGVVKIADFGL 144
Query: 125 AKKYRDTSTHQHIPYRENKNLTGTARYASMNTHL-GIEQSRRDDLESLGYVLMYFLRGSL 183
AKK GT Y + L G + D+ SLG +L L G
Sbjct: 145 AKK-------LLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKP 197
Query: 184 PWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFD 233
P+ G + Q +I + G E C L D
Sbjct: 198 PFSGENILDQLQLIRRILGPPLEFDEPKWSSGSE-EAKDLIKKC--LNKD 244
|
Length = 260 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 108 bits (269), Expect = 6e-26
Identities = 64/204 (31%), Positives = 97/204 (47%), Gaps = 9/204 (4%)
Query: 12 ENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSR 70
E+ + + L E ++ L I + F + LVM+ + G SLEDL R
Sbjct: 35 ESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGR 94
Query: 71 --KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 128
LS L + Q+++ +E++HSK +HRDIKP+N L L R V +IDFGLAK
Sbjct: 95 KGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENIL--LDRDGRVVKLIDFGLAKLL 152
Query: 129 RDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQ---SRRDDLESLGYVLMYFLRGSLPW 185
D + IP + ++ GT Y + LG+ S D+ SLG L L G P+
Sbjct: 153 PDPGSTSSIPALPSTSV-GTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPF 211
Query: 186 QGLKAGTKKQKYEKISEKKVSTSI 209
+G K + + KI + + S+
Sbjct: 212 EGEKNSSATSQTLKIILELPTPSL 235
|
Length = 384 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 97.7 bits (244), Expect = 1e-23
Identities = 54/174 (31%), Positives = 87/174 (50%), Gaps = 19/174 (10%)
Query: 11 QENVKTKHPQLLYESKLYRILQGGTGIPN-VRWFGV--EGDYNVLVMDLL-GPSLEDLFN 66
+E+ + +LL E ++ + L PN V+ +GV + ++ LVM+ G SL+DL
Sbjct: 28 KEDSSSLLEELLREIEILKKLNH----PNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLK 83
Query: 67 FCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 126
KLS +L + Q++ +E++HS +HRD+KP+N L L +V + DFGL+K
Sbjct: 84 ENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENIL--LDSDNGKVKLADFGLSK 141
Query: 127 KYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFL 179
K + GT Y + LG S + D+ SLG V++Y L
Sbjct: 142 LLTSDK-------SLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLG-VILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 86.5 bits (214), Expect = 7e-19
Identities = 61/208 (29%), Positives = 102/208 (49%), Gaps = 26/208 (12%)
Query: 49 YNVLVMDLLGPSLEDLFN--FCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNF 106
Y ++++ L + +++F C K +K ++ M+ +E++H H DIKP+N
Sbjct: 101 YRFILLEKLVENTKEIFKRIKCKNKKLIKNIMK---DMLTTLEYIHEHGISHGDIKPENI 157
Query: 107 LMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPY-RENKNL-TGTARYASMNTHLGIEQSR 164
++ R YIID+G+A + +HI Y +E K+L GT YA ++ H G +R
Sbjct: 158 MVDGNNRG---YIIDYGIASHF--IIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTR 212
Query: 165 RDDLESLGYVLMYFLRGSLPWQGLKAGT------KKQKYEKISEKKVSTSIEALCRGYPT 218
R DLESLGY ++ + LPW+G K +++ E K+
Sbjct: 213 RGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKCDFIKRLHEGKIKIK-------NAN 265
Query: 219 EFASYFHYCRS-LRFDDKPDYAYLKRIF 245
+F F C + L +++KPDY L +IF
Sbjct: 266 KFIYDFIECVTKLSYEEKPDYDALIKIF 293
|
Length = 294 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 74.9 bits (185), Expect = 3e-15
Identities = 51/174 (29%), Positives = 78/174 (44%), Gaps = 20/174 (11%)
Query: 38 PN-VRWFGV--EGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 93
PN VR + V + D LVM+ G L DL +LS Q+++ +E++HS
Sbjct: 57 PNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKR-GRLSEDEARFYLRQILSALEYLHS 115
Query: 94 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYAS 153
K +HRD+KP+N L+ V + DFGLA++ GT Y +
Sbjct: 116 KGIVHRDLKPENILLD---EDGHVKLADFGLARQLDPGEKL--------TTFVGTPEYMA 164
Query: 154 MNTHLGIEQSRRDDLESLGYVLMY-FLRGSLPWQGLKAGTKKQKYEKISEKKVS 206
LG + D+ SLG V++Y L G P+ G + ++KI + K
Sbjct: 165 PEVLLGKGYGKAVDIWSLG-VILYELLTGKPPFPG--DDQLLELFKKIGKPKPP 215
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 67.6 bits (166), Expect = 1e-12
Identities = 45/205 (21%), Positives = 77/205 (37%), Gaps = 33/205 (16%)
Query: 52 LVMDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMG 109
V++ G L+ + + S L K A +++ +E++HSK +HRD+KP+N L+
Sbjct: 79 FVLEYAPNGELLQYIRKYGS--LDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLD 136
Query: 110 LGRRANQVYIIDFGLAK-------------KYRDTSTHQHIPYRENKNLTGTARYASMNT 156
+ + I DFG AK + + R + GTA Y S
Sbjct: 137 ---KDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPEL 193
Query: 157 HLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE----------KKVS 206
+ DL +LG ++ L G P++G + ++KI +
Sbjct: 194 LNEKPAGKSSDLWALGCIIYQMLTGKPPFRG---SNEYLTFQKILKLEYSFPPNFPPDAK 250
Query: 207 TSIEALCRGYPTEFASYFHYCRSLR 231
IE L P + L+
Sbjct: 251 DLIEKLLVLDPQDRLGVNEGYDELK 275
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 65.4 bits (160), Expect = 5e-12
Identities = 51/186 (27%), Positives = 85/186 (45%), Gaps = 20/186 (10%)
Query: 11 QENVKTKHPQLLYESKLYRILQGGTGIPN-VRWFGVE-GDYNVLV-MDLL-GPSLEDLFN 66
Q+N ++ E K+ +L+ PN V+++GVE V + M+ G +LE+L
Sbjct: 36 QDNDPKTIKEIADEMKVLELLKH----PNLVKYYGVEVHREKVYIFMEYCSGGTLEELLE 91
Query: 67 FCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 126
R L + + Q++ + ++HS +HRDIKP N + + + DFG A
Sbjct: 92 H-GRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLD---HNGVIKLGDFGCAV 147
Query: 127 KYRDTSTHQHIPYREN-KNLTGTARYASMNTHLGIEQS---RRDDLESLGYVLMYFLRGS 182
K ++ +T E ++L GT Y + G + R D+ SLG V++ G
Sbjct: 148 KLKNNTT----TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGK 203
Query: 183 LPWQGL 188
PW L
Sbjct: 204 RPWSEL 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.7 bits (156), Expect = 2e-11
Identities = 25/86 (29%), Positives = 40/86 (46%), Gaps = 6/86 (6%)
Query: 52 LVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 111
LV + L+ + LS + + Q++ + + HS LHRD+KP N L+
Sbjct: 75 LVFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILIN-- 132
Query: 112 RRANQVYIIDFGLAKKYR---DTSTH 134
R + + DFGLA+ + T TH
Sbjct: 133 -RDGVLKLADFGLARAFGIPLRTYTH 157
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 3e-11
Identities = 49/168 (29%), Positives = 74/168 (44%), Gaps = 37/168 (22%)
Query: 71 KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK---- 126
K S+ L + ++ +E+VHSK LHRD+KPDN L+GL +V I+D+G A
Sbjct: 109 KTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGL---FGEVVILDWGAAIFKKL 165
Query: 127 --------KYRDTSTHQH---IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVL 175
+ + IP + + GT Y + LG+ S D+ +LG +L
Sbjct: 166 EEEDLLDIDVDERNICYSSMTIPGK----IVGTPDYMAPERLLGVPASESTDIYALGVIL 221
Query: 176 MYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASY 223
L S P+ +++K KIS + V S P E A Y
Sbjct: 222 YQMLTLSFPY-------RRKKGRKISYRDVILS--------PIEVAPY 254
|
Length = 932 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 3e-11
Identities = 50/175 (28%), Positives = 72/175 (41%), Gaps = 27/175 (15%)
Query: 47 GDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDN 105
DY LVM+ L G L L +++ VE +H + +HRDIKP+N
Sbjct: 69 KDYLYLVMEYLNGGDCASLIKTLG-GLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPEN 127
Query: 106 FLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRR 165
L+ + + + DFGL++ ENK GT Y + T LG+ +
Sbjct: 128 LLID---QTGHLKLTDFGLSRN-----------GLENKKFVGTPDYLAPETILGVGDDKM 173
Query: 166 DDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI--------SEKKVSTSIEAL 212
D SLG V+ FL G P+ A T ++ I E K S EA+
Sbjct: 174 SDWWSLGCVIFEFLFGYPPFH---AETPDAVFDNILSRRINWPEEVKEFCSPEAV 225
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.9 bits (154), Expect = 4e-11
Identities = 46/162 (28%), Positives = 77/162 (47%), Gaps = 27/162 (16%)
Query: 52 LVMDLL--GPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFL 107
LV++ G +LF+ S+ + S + A +++ +E++HS ++RD+KP+N L
Sbjct: 70 LVLEYAPGG----ELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENIL 125
Query: 108 MGLGRRANQVYIIDFGLAKK--YRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRR 165
L + + + DFGLAK+ + T+ GT Y + LG +
Sbjct: 126 --LDADGH-IKLTDFGLAKELSSEGSRTNT---------FCGTPEYLAPEVLLGKGYGKA 173
Query: 166 DDLESLGYVLMY-FLRGSLPWQGLKAGTKKQKYEKISEKKVS 206
D SLG VL+Y L G P+ A +K+ YEKI + +
Sbjct: 174 VDWWSLG-VLLYEMLTGKPPFY---AEDRKEIYEKILKDPLR 211
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 61.1 bits (149), Expect = 2e-10
Identities = 46/188 (24%), Positives = 75/188 (39%), Gaps = 42/188 (22%)
Query: 1 MYEILTVFSVQENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPS 60
+ EI + + Q HP ++ KL + G+G VLVM+ +
Sbjct: 47 LREIKALQACQ------HPYVV---KLLDVFPHGSGF-------------VLVMEYMPSD 84
Query: 61 LEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYII 120
L ++ R L V ++ V ++H+ +HRD+KP N L+ + I
Sbjct: 85 LSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLIS---ADGVLKIA 141
Query: 121 DFGLAKKY----RDTSTHQHIP--YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYV 174
DFGLA+ + +HQ YR + L G +Y G+ DL ++G +
Sbjct: 142 DFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDP-----GV------DLWAVGCI 190
Query: 175 LMYFLRGS 182
L GS
Sbjct: 191 FAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 59.6 bits (145), Expect = 5e-10
Identities = 38/151 (25%), Positives = 59/151 (39%), Gaps = 28/151 (18%)
Query: 83 QMINRVEFVHSKSFLHRDIKPDNFLMGL-GRRANQVYIIDFGLAKK-YRDTSTHQHIPYR 140
++ E++H++ ++RD+KP+N L+ G V ++DFG AKK T
Sbjct: 101 CVVLAFEYLHNRGIIYRDLKPENLLLDSNGY----VKLVDFGFAKKLKSGQKTW------ 150
Query: 141 ENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMY-FLRGSLPWQGLKA--------- 190
GT Y + L D SLG +L+Y L G P+
Sbjct: 151 ---TFCGTPEYVAPEIILNKGYDFSVDYWSLG-ILLYELLTGRPPFGEDDEDPMEIYNDI 206
Query: 191 --GTKKQKYEKISEKKVSTSIEALCRGYPTE 219
G K ++ +K I+ L R P E
Sbjct: 207 LKGNGKLEFPNYIDKAAKDLIKQLLRRNPEE 237
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 59.1 bits (144), Expect = 6e-10
Identities = 28/103 (27%), Positives = 52/103 (50%), Gaps = 12/103 (11%)
Query: 52 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL 110
+VM+ G SL+DL ++ L+ + + +++ +E++HS +HRDIK N L+
Sbjct: 74 IVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLT- 132
Query: 111 GRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYAS 153
+V +IDFGL+ + DT + + GT + +
Sbjct: 133 --SDGEVKLIDFGLSAQLSDT--------KARNTMVGTPYWMA 165
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 58.7 bits (143), Expect = 1e-09
Identities = 27/94 (28%), Positives = 44/94 (46%), Gaps = 20/94 (21%)
Query: 52 LVMDLLGPSLEDLFNFCSRKLSLKTVLMLAD------QMINRVEFVHSKSFLHRDIKPDN 105
LV + + LE + VL AD + +E++HS LHRD+KP+N
Sbjct: 79 LVFEFMETDLEKVIK------DKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNN 132
Query: 106 FLMGLGRRAN-QVYIIDFGLAKKYRDTS---THQ 135
L+ ++ + + DFGLA+ + + THQ
Sbjct: 133 LLIA----SDGVLKLADFGLARSFGSPNRKMTHQ 162
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 3e-09
Identities = 46/180 (25%), Positives = 67/180 (37%), Gaps = 34/180 (18%)
Query: 52 LVMDLLGPSLEDLFNFCSRK--LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMG 109
LVM+ + DL N RK +T +++ ++ VH F+HRDIKPDN L+
Sbjct: 78 LVMEYMPGG--DLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILID 135
Query: 110 LGRRANQVYIIDFGLAKKYRD-----------------TSTHQHIPYRENKN-----LTG 147
+ + DFGL KK + + + G
Sbjct: 136 ---ADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVG 192
Query: 148 TARYASMNTHLGIEQSRRDDLESLGYVLMY-FLRGSLPWQGLKAGTKKQKYEKISEKKVS 206
T Y + G D SLG V++Y L G P + T ++ Y KI K S
Sbjct: 193 TPDYIAPEVLRGTPYGLECDWWSLG-VILYEMLYGFPP---FYSDTLQETYNKIINWKES 248
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.1 bits (136), Expect = 8e-09
Identities = 24/61 (39%), Positives = 34/61 (55%), Gaps = 3/61 (4%)
Query: 72 LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 131
L +T+ L Q++ V+F+HS +HRD+KP N L+ QV I DFGLA+ Y
Sbjct: 104 LPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVT---SDGQVKIADFGLARIYSFE 160
Query: 132 S 132
Sbjct: 161 M 161
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 55.3 bits (134), Expect = 1e-08
Identities = 37/124 (29%), Positives = 63/124 (50%), Gaps = 7/124 (5%)
Query: 83 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK-YRDTSTHQHIPYRE 141
+++ +E++HS +HRD+KPDN L+ + + DFGL+K + + +E
Sbjct: 101 EIVLALEYLHSNGIIHRDLKPDNILID---SNGHLKLTDFGLSKVGLVRRQINLNDDEKE 157
Query: 142 NKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKIS 201
+K + GT Y + LG S+ D SLG +L FL G P+ G T ++ ++ I
Sbjct: 158 DKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHG---ETPEEIFQNIL 214
Query: 202 EKKV 205
K+
Sbjct: 215 NGKI 218
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 2e-08
Identities = 33/98 (33%), Positives = 55/98 (56%), Gaps = 11/98 (11%)
Query: 38 PN-VRWFG--VEGDYNVLVMDLL-GPSLEDLFNFCSRK---LSLKTVLMLADQMINRVEF 90
PN VR++ +E D +VMDL+ G L + FN K + + + + QM+ + +
Sbjct: 69 PNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRY 128
Query: 91 VH-SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 127
+H K +HRD+ P+N ++G ++V I DFGLAK+
Sbjct: 129 LHKEKRIVHRDLTPNNIMLG---EDDKVTITDFGLAKQ 163
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.3 bits (129), Expect = 7e-08
Identities = 49/187 (26%), Positives = 78/187 (41%), Gaps = 38/187 (20%)
Query: 71 KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 130
K + + Q++ ++++HS LHRDIK N L+ + + DFGLA+ Y
Sbjct: 96 KFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILIN---NDGVLKLADFGLARPYTK 152
Query: 131 TSTHQHIP------YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 184
++ + YR + L G RY + D+ S+G +L G
Sbjct: 153 RNSADYTNRVITLWYRPPELLLGATRYGP-----EV------DMWSVGCILAELFLGKPI 201
Query: 185 WQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRF--DDKPDYAYLK 242
+QG T+ ++ EKI E LC G PT+ + L + + KP Y K
Sbjct: 202 FQG---STELEQLEKIFE---------LC-GSPTD--ENWPGVSKLPWFENLKPKKPY-K 245
Query: 243 RIFRDLF 249
R R+ F
Sbjct: 246 RRLREFF 252
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 52.2 bits (126), Expect = 1e-07
Identities = 48/174 (27%), Positives = 74/174 (42%), Gaps = 23/174 (13%)
Query: 20 QLLYESKLYRILQGGTGIPN-VRWFGVEGD-----YNVLVMDLL-GPSLEDLF-NFCSRK 71
L E ++ LQ PN VR++G E D N + ++ + G SL L F K
Sbjct: 45 ALEREIRILSSLQH----PNIVRYYGSERDEEKNTLN-IFLEYVSGGSLSSLLKKF--GK 97
Query: 72 LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 131
L + Q++ + ++HS +HRDIK N L+ + DFG AK+ D
Sbjct: 98 LPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVK---LADFGCAKRLGDI 154
Query: 132 STHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPW 185
T + ++ GT + + G E R D+ SLG ++ G PW
Sbjct: 155 ETGE-----GTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPW 203
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 2e-07
Identities = 27/76 (35%), Positives = 43/76 (56%), Gaps = 7/76 (9%)
Query: 83 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR---DTSTHQHIP- 138
Q++ + + HS LHRD+KP N L + RR N + + DFGLA+ + T TH+ +
Sbjct: 110 QILRGIAYCHSHRVLHRDLKPQNLL--IDRRTNALKLADFGLARAFGIPVRTFTHEVVTL 167
Query: 139 -YRENKNLTGTARYAS 153
YR + L G+ Y++
Sbjct: 168 WYRAPEILLGSRHYST 183
|
Length = 294 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.9 bits (125), Expect = 2e-07
Identities = 25/88 (28%), Positives = 38/88 (43%), Gaps = 6/88 (6%)
Query: 51 VLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL 110
LV + + L L R L + Q++ + F HS LHRD+KP+N L+
Sbjct: 74 YLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLI-- 131
Query: 111 GRRANQVYIIDFGLAKKYR---DTSTHQ 135
+ + DFGLA+ + TH
Sbjct: 132 -NTEGVLKLADFGLARSFGSPVRPYTHY 158
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 3e-07
Identities = 34/119 (28%), Positives = 54/119 (45%), Gaps = 11/119 (9%)
Query: 58 GPSLEDLFN-FCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQ 116
G +L + C+ L T+L Q++ + VH+K LHRD+K N L+ +
Sbjct: 83 GGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILL--DKHKMV 140
Query: 117 VYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVL 175
V I DFG++K S + + GT Y S G +++ D+ +LG VL
Sbjct: 141 VKIGDFGISKILSSKS--------KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVL 191
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 51.0 bits (123), Expect = 3e-07
Identities = 25/80 (31%), Positives = 42/80 (52%), Gaps = 8/80 (10%)
Query: 50 NVLVMDLL-GPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNF 106
+VL+MD + DLF+ KLS V + Q++ + +H + +H DIK +N
Sbjct: 84 HVLIMDYIKDG---DLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENV 140
Query: 107 LMGLGRRANQVYIIDFGLAK 126
L R +++Y+ D+GL K
Sbjct: 141 L--YDRAKDRIYLCDYGLCK 158
|
Length = 267 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 4e-07
Identities = 34/109 (31%), Positives = 54/109 (49%), Gaps = 20/109 (18%)
Query: 45 VEGDYNVLVMDLLGPSLEDLFNFCSRKLSL----KTVLMLADQMINRVEFVHSKSFLHRD 100
VEGD+ LVMD++ L+ + + RK+ L ++L Q++N + +H F+HRD
Sbjct: 90 VEGDFINLVMDIMASDLKKVVD---RKIRLTESQVKCILL--QILNGLNVLHKWYFMHRD 144
Query: 101 IKPDN-FLMGLGRRANQVYIIDFGLAKKY------RDTSTHQHIPYREN 142
+ P N F+ G I DFGLA++Y S + + RE
Sbjct: 145 LSPANIFINSKG----ICKIADFGLARRYGYPPYSDTLSKDETMQRREE 189
|
Length = 335 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 5e-07
Identities = 57/207 (27%), Positives = 94/207 (45%), Gaps = 22/207 (10%)
Query: 2 YEILTVFSVQENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSL 61
Y L V ++ E ++ K Q ++ K R+L+ + +R F E D L M +
Sbjct: 28 YYALKVMAIPEVIRLKQEQHVHNEK--RVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPG 85
Query: 62 EDLFNF--CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYI 119
+LF++ S + S T L A +++ +E++HSK ++RD+KP+N L+ + + +
Sbjct: 86 GELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLD---KEGHIKL 142
Query: 120 IDFGLAKKYRD-TSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYF 178
DFG AKK RD T T L GT Y + ++ D +LG ++
Sbjct: 143 TDFGFAKKLRDRTWT-----------LCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEM 191
Query: 179 LRGSLPWQGLKAGTKKQKYEKISEKKV 205
L G P+ YEKI K+
Sbjct: 192 LVGYPPFFD---DNPFGIYEKILAGKL 215
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 6e-07
Identities = 27/101 (26%), Positives = 48/101 (47%), Gaps = 10/101 (9%)
Query: 75 KTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 134
+ VL Q+++ V ++H LHRDIK N + +A + + DFG++K +
Sbjct: 101 EMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFL---TKAGLIKLGDFGISKILGSEYSM 157
Query: 135 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVL 175
+ + GT Y S G++ + + D+ +LG VL
Sbjct: 158 A-------ETVVGTPYYMSPELCQGVKYNFKSDIWALGCVL 191
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 49.6 bits (119), Expect = 1e-06
Identities = 45/148 (30%), Positives = 64/148 (43%), Gaps = 23/148 (15%)
Query: 46 EGDYNVLVMDLLGPSLEDLFNFCSRKLSLK--TVLMLADQMINRVEFVHSKSFLHRDIKP 103
+ + LV+DLL DL S+K+ V +++ +E++HSK +HRDIKP
Sbjct: 71 DEENMYLVVDLLLGG--DLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKP 128
Query: 104 DNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLT---GTARYASMNTHLGI 160
DN L+ V+I DF +A K + T GT Y +
Sbjct: 129 DNILLD---EQGHVHITDFNIATKVTP-----------DTLTTSTSGTPGYMAPEVLCRQ 174
Query: 161 EQSRRDDLESLGYVLMY-FLRGSLPWQG 187
S D SLG V Y LRG P++G
Sbjct: 175 GYSVAVDWWSLG-VTAYECLRGKRPYRG 201
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 49.5 bits (119), Expect = 1e-06
Identities = 23/77 (29%), Positives = 37/77 (48%), Gaps = 3/77 (3%)
Query: 52 LVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 111
+VM+ + L+ L + V L Q+++ V +H LHRD+K N L+
Sbjct: 83 MVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLL--- 139
Query: 112 RRANQVYIIDFGLAKKY 128
+ I DFGLA++Y
Sbjct: 140 NNRGILKICDFGLAREY 156
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.2 bits (118), Expect = 2e-06
Identities = 21/49 (42%), Positives = 29/49 (59%), Gaps = 1/49 (2%)
Query: 83 QMINRVEFVHSKSFLHRDIKPDN-FLMGLGRRANQVYIIDFGLAKKYRD 130
Q++N V ++HS LHRD+KP N +MG G V I D GLA+ +
Sbjct: 116 QILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNA 164
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 60/214 (28%), Positives = 96/214 (44%), Gaps = 24/214 (11%)
Query: 40 VRWFGV-EGDYNVLVMDL--LGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 96
VR GV +G+ +LVM+L LGP L+ L R++ + + LA Q+ + ++ SK F
Sbjct: 59 VRLIGVCKGEPLMLVMELAPLGPLLKYLKK--RREIPVSDLKELAHQVAMGMAYLESKHF 116
Query: 97 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTAR-YASMN 155
+HRD+ N L L R +Q I DFG+++ S + YR + YA
Sbjct: 117 VHRDLAARNVL--LVNR-HQAKISDFGMSRALGAGSDY----YRATTAGRWPLKWYAPEC 169
Query: 156 THLGIEQSRRDDLESLGYVLMY--FLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 213
+ G S + D+ S G V ++ F G+ P+ +K + + E C
Sbjct: 170 INYGK-FSSKSDVWSYG-VTLWEAFSYGAKPYGEMKG----AEVIAMLESGERLPRPEEC 223
Query: 214 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRD 247
P E S C R +D+P ++ L+ FR
Sbjct: 224 ---PQEIYSIMLSCWKYRPEDRPTFSELESTFRR 254
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.7 bits (117), Expect = 2e-06
Identities = 19/60 (31%), Positives = 31/60 (51%), Gaps = 3/60 (5%)
Query: 70 RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 129
+ S + + Q++ + +H F HRD+KP+N L+ V I DFGLA++ R
Sbjct: 94 KPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLV---SGPEVVKIADFGLAREIR 150
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 2e-06
Identities = 32/108 (29%), Positives = 51/108 (47%), Gaps = 7/108 (6%)
Query: 83 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYREN 142
Q++ VE++HS +HRDIK N L A V + DFG +K+ + +
Sbjct: 112 QILEGVEYLHSNMIVHRDIKGANILRDS---AGNVKLGDFGASKRLQTICSSG----TGM 164
Query: 143 KNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 190
K++TGT + S G R+ D+ S+G ++ L PW +A
Sbjct: 165 KSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA 212
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 3e-06
Identities = 24/117 (20%), Positives = 47/117 (40%), Gaps = 16/117 (13%)
Query: 17 KHPQLLYESKLYRILQG-GTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSL 74
K E + ++L G +P V G ++ L+M+ + G +L+ ++S
Sbjct: 34 KGADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLD--------EVSE 85
Query: 75 KTVLMLADQMINRVEFVHS---KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 128
+ +A+Q+ + +H H D+ P N L+ + IID+ A
Sbjct: 86 EEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILV---DDGKILGIIDWEYAGYG 139
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 48.5 bits (116), Expect = 3e-06
Identities = 21/72 (29%), Positives = 33/72 (45%), Gaps = 8/72 (11%)
Query: 83 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYREN 142
Q++ + ++H LHRDIK N L+ + I DFGLA+ Y P +
Sbjct: 123 QLLEGINYLHENHILHRDIKAANILID---NQGILKIADFGLARPYDGP-----PPNPKG 174
Query: 143 KNLTGTARYASM 154
GT +Y ++
Sbjct: 175 GGGGGTRKYTNL 186
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 4e-06
Identities = 23/66 (34%), Positives = 37/66 (56%), Gaps = 4/66 (6%)
Query: 61 LEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYII 120
L+DL + + L V Q++ +EF HS + +HRDIKP+N L+ ++ V +
Sbjct: 87 LDDLEKYPN-GLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVS---QSGVVKLC 142
Query: 121 DFGLAK 126
DFG A+
Sbjct: 143 DFGFAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 6e-06
Identities = 41/135 (30%), Positives = 60/135 (44%), Gaps = 41/135 (30%)
Query: 50 NVL-VMDLLGPSLEDLFNFCSRKLSLKTVLMLAD---------------------QMINR 87
NVL +D+L P D F ++ + T LM +D Q++
Sbjct: 60 NVLSALDILQPPHIDPF----EEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRG 115
Query: 88 VEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAKKYR-DTSTH-------QHIP 138
++++HS LHRDIKP N L+ +N + I DFGLA+ D S H Q+
Sbjct: 116 LKYLHSAGILHRDIKPGNLLVN----SNCVLKICDFGLARVEEPDESKHMTQEVVTQY-- 169
Query: 139 YRENKNLTGTARYAS 153
YR + L G+ Y S
Sbjct: 170 YRAPEILMGSRHYTS 184
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 7e-06
Identities = 45/168 (26%), Positives = 81/168 (48%), Gaps = 19/168 (11%)
Query: 52 LVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 111
LVM+L+ +L + + +L + + L QM+ ++ +HS +HRD+KP N ++
Sbjct: 103 LVMELMDANLCQVIHM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV--- 156
Query: 112 RRANQVYIIDFGLAKKYRDTSTH-QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLES 170
+ + I+DFGLA R T+ PY T Y + LG+ D+ S
Sbjct: 157 KSDCTLKILDFGLA---RTACTNFMMTPY------VVTRYYRAPEVILGMGYKENVDIWS 207
Query: 171 LGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPT 218
+G ++ ++GS+ +QG ++ K+ E+ + S E + R PT
Sbjct: 208 VGCIMGELVKGSVIFQGTD---HIDQWNKVIEQLGTPSAEFMNRLQPT 252
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 47.1 bits (113), Expect = 7e-06
Identities = 23/67 (34%), Positives = 32/67 (47%), Gaps = 12/67 (17%)
Query: 88 VEFVHSKSFLHRDIKPDN-FLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLT 146
++++HS+ LHRDIKP N FL V + DFG++K T K +
Sbjct: 116 LKYLHSRKILHRDIKPQNIFLT----SNGLVKLGDFGISKVLSSTVDL-------AKTVV 164
Query: 147 GTARYAS 153
GT Y S
Sbjct: 165 GTPYYLS 171
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.3 bits (113), Expect = 7e-06
Identities = 26/77 (33%), Positives = 43/77 (55%), Gaps = 10/77 (12%)
Query: 83 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY----RDTSTHQHIP 138
Q++ + + HS LHRD+KP N L+ R + + DFGLA+ + R T TH+ +
Sbjct: 107 QLLQGIAYCHSHRVLHRDLKPQNLLID---REGALKLADFGLARAFGVPVR-TYTHEVVT 162
Query: 139 --YRENKNLTGTARYAS 153
YR + L G+ +Y++
Sbjct: 163 LWYRAPEILLGSRQYST 179
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 7e-06
Identities = 22/57 (38%), Positives = 35/57 (61%), Gaps = 3/57 (5%)
Query: 72 LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 128
L +T+ L Q + ++F+H+ +HRD+KP+N L+ G QV + DFGLA+ Y
Sbjct: 105 LPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSG---GQVKLADFGLARIY 158
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 8e-06
Identities = 59/227 (25%), Positives = 99/227 (43%), Gaps = 46/227 (20%)
Query: 40 VRWFGV-EGDYNVLVMDL--LGPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVHSK 94
VR G+ E + +LVM+L LGP L F ++ ++ K + L Q+ ++++
Sbjct: 59 VRMIGICEAESWMLVMELAELGP----LNKFLQKNKHVTEKNITELVHQVSMGMKYLEET 114
Query: 95 SFLHRDIKPDNFLMGLGRRANQVY--IIDFGLAK------KYRDTSTHQHIPYRENKNLT 146
+F+HRD+ N L+ Q Y I DFGL+K Y TH P +
Sbjct: 115 NFVHRDLAARNVLL-----VTQHYAKISDFGLSKALGADENYYKAKTHGKWPVK------ 163
Query: 147 GTARYAS--MNTHLGIEQSRRDDLESLGYVLMY--FLRGSLPWQGLKAGTKKQKYEKISE 202
YA MN + + S + D+ S G VLM+ F G P++G+K Q E
Sbjct: 164 ---WYAPECMNYY---KFSSKSDVWSFG-VLMWEAFSYGQKPYKGMKGNEVTQMIES--G 214
Query: 203 KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLF 249
+++ + P E C + D++P +A ++ R+ +
Sbjct: 215 ERMECP-----QRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNYY 256
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 1e-05
Identities = 30/107 (28%), Positives = 53/107 (49%), Gaps = 8/107 (7%)
Query: 52 LVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 111
LV + L L+ + C +S+ V + Q++ + + H + LHRD+KP N L+
Sbjct: 80 LVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLIN-- 137
Query: 112 RRANQVYIIDFGLAK-KYRDTSTHQH----IPYRENKNLTGTARYAS 153
++ + DFGLA+ K T T+ + + YR L G+ Y++
Sbjct: 138 -EKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYST 183
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 1e-05
Identities = 27/82 (32%), Positives = 47/82 (57%), Gaps = 5/82 (6%)
Query: 52 LVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 111
LV +L+G L ++ +KLS + V L Q++ ++++HS +HRD+KP N +
Sbjct: 97 LVTNLMGADLNNIVKC--QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVN-- 152
Query: 112 RRANQVYIIDFGLAKKYRDTST 133
++ I+DFGLA++ D T
Sbjct: 153 -EDCELRILDFGLARQADDEMT 173
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 1e-05
Identities = 25/76 (32%), Positives = 43/76 (56%), Gaps = 6/76 (7%)
Query: 52 LVMDLLGPSLEDLFNFCSR-KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL 110
L+M+ + L L ++ + KL+L +L+ A Q+ + ++HS+ ++HRD+ N L+
Sbjct: 85 LIMEYV--PLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLL-- 140
Query: 111 GRRANQVYIIDFGLAK 126
V I DFGLAK
Sbjct: 141 -DNDRLVKIGDFGLAK 155
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 1e-05
Identities = 27/75 (36%), Positives = 39/75 (52%), Gaps = 9/75 (12%)
Query: 83 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS----THQHIP 138
Q++ + + H K+FLHRDIK N L+ Q+ + DFGLA+ Y T++ I
Sbjct: 124 QLLEGLNYCHKKNFLHRDIKCSNILLN---NKGQIKLADFGLARLYNSEESRPYTNKVIT 180
Query: 139 --YRENKNLTGTARY 151
YR + L G RY
Sbjct: 181 LWYRPPELLLGEERY 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 1e-05
Identities = 23/77 (29%), Positives = 41/77 (53%), Gaps = 3/77 (3%)
Query: 52 LVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 111
LV + L+ F+ C+ + + V Q++ + F HS + LHRD+KP N L+
Sbjct: 76 LVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLI--- 132
Query: 112 RRANQVYIIDFGLAKKY 128
+ ++ + DFGLA+ +
Sbjct: 133 NKNGELKLADFGLARAF 149
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 46.1 bits (110), Expect = 2e-05
Identities = 25/90 (27%), Positives = 42/90 (46%), Gaps = 9/90 (10%)
Query: 52 LVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 111
LV +L+ +L +L R L K V Q++ ++ +H HRDIKP+N L+
Sbjct: 77 LVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILI--- 133
Query: 112 RRANQVYIIDFGLAKKYRDTSTHQHIPYRE 141
+ + + + DFG + + PY E
Sbjct: 134 -KDDILKLADFGSCR-----GIYSKPPYTE 157
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 2e-05
Identities = 30/107 (28%), Positives = 54/107 (50%), Gaps = 8/107 (7%)
Query: 52 LVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 111
LV + L L+ + C +S+ V + Q++ + + H + LHRD+KP N L+
Sbjct: 81 LVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLIN-- 138
Query: 112 RRANQVYIIDFGLAK-KYRDTSTHQH----IPYRENKNLTGTARYAS 153
++ + DFGLA+ K T T+ + + YR L G++ Y++
Sbjct: 139 -ERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYST 184
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 45.7 bits (109), Expect = 2e-05
Identities = 27/89 (30%), Positives = 42/89 (47%), Gaps = 22/89 (24%)
Query: 47 GDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRV--------EFVHSKSFL 97
GD +VM+ + G SL D+ +++ + I V E++HS++ +
Sbjct: 87 GDELWVVMEYMDGGSLTDIITQNFVRMN--------EPQIAYVCREVLQGLEYLHSQNVI 138
Query: 98 HRDIKPDNFLMGL-GRRANQVYIIDFGLA 125
HRDIK DN L+ G V + DFG A
Sbjct: 139 HRDIKSDNILLSKDGS----VKLADFGFA 163
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 45.2 bits (108), Expect = 3e-05
Identities = 36/111 (32%), Positives = 53/111 (47%), Gaps = 11/111 (9%)
Query: 38 PN-VRWFGV--EGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 93
PN V+ GV E + +VM+ + G L KLSL +L A Q+ +E++ S
Sbjct: 61 PNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLES 120
Query: 94 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT----STHQHIPYR 140
K+F+HRD+ N L+G V I DFGL++ D +P R
Sbjct: 121 KNFIHRDLAARNCLVGEN---LVVKISDFGLSRDLYDDDYYRKRGGKLPIR 168
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 44.9 bits (107), Expect = 3e-05
Identities = 40/140 (28%), Positives = 61/140 (43%), Gaps = 14/140 (10%)
Query: 54 MDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS-FLHRDIKPDNFLMGLGR 112
MD G SL DL K+ + +A Q++ ++++H+K +HRDIKP N L+
Sbjct: 81 MD--GGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLIN--- 134
Query: 113 RANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLG 172
+V I DFG++K +T + GT Y S G S D+ SLG
Sbjct: 135 SKGEVKIADFGISKVLENTLD-------QCNTFVGTVTYMSPERIQGESYSYAADIWSLG 187
Query: 173 YVLMYFLRGSLPWQGLKAGT 192
L+ G P+ +
Sbjct: 188 LTLLECALGKFPFLPPGQPS 207
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 3e-05
Identities = 30/113 (26%), Positives = 54/113 (47%), Gaps = 21/113 (18%)
Query: 88 VEFVHSKSFLHRDIKPDNFLM-GLGRRANQVYIIDFGLAK------------KYRDTSTH 134
+E++H+ +HRD+KPDN L+ +G + + DFGL+K + + T
Sbjct: 114 LEYLHNYGIVHRDLKPDNLLITSMG----HIKLTDFGLSKIGLMSLTTNLYEGHIEKDTR 169
Query: 135 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 187
+ + +K + GT Y + L + D ++G +L FL G +P+ G
Sbjct: 170 EFL----DKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFG 218
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 4e-05
Identities = 16/44 (36%), Positives = 26/44 (59%), Gaps = 3/44 (6%)
Query: 83 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 126
Q + V F H + +HRD+KP+N L+ + Q+ + DFG A+
Sbjct: 108 QTLQAVNFCHKHNCIHRDVKPENILI---TKQGQIKLCDFGFAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.6 bits (106), Expect = 4e-05
Identities = 21/75 (28%), Positives = 37/75 (49%), Gaps = 3/75 (4%)
Query: 52 LVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 111
LV + + +L +L L V Q++ + + HS + +HRDIKP+N L+
Sbjct: 77 LVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILV--- 133
Query: 112 RRANQVYIIDFGLAK 126
+ + + DFG A+
Sbjct: 134 SESGVLKLCDFGFAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 5e-05
Identities = 24/77 (31%), Positives = 43/77 (55%), Gaps = 7/77 (9%)
Query: 52 LVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 111
LV L+G L ++ +KLS + L Q++ ++++HS +HRD+KP N +
Sbjct: 97 LVTHLMGADLNNIVK--CQKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSN----IA 150
Query: 112 RRAN-QVYIIDFGLAKK 127
+ ++ I+DFGLA+
Sbjct: 151 VNEDCELKILDFGLARH 167
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 5e-05
Identities = 29/107 (27%), Positives = 53/107 (49%), Gaps = 8/107 (7%)
Query: 52 LVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 111
LV + L L+ + C +++ V + Q++ + + H + LHRD+KP N L+
Sbjct: 81 LVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLIN-- 138
Query: 112 RRANQVYIIDFGLAK-KYRDTSTHQH----IPYRENKNLTGTARYAS 153
++ + DFGLA+ K T T+ + + YR L G+ Y++
Sbjct: 139 -ERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYST 184
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 5e-05
Identities = 30/109 (27%), Positives = 51/109 (46%), Gaps = 10/109 (9%)
Query: 40 VRWFGVEGDYNV-LVMDL--LGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 96
+R +GV + + +V +L LG L+ L + T+ A Q+ N + ++ SK F
Sbjct: 59 IRLYGVVLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRF 118
Query: 97 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNL 145
+HRD+ N L+ ++V I DFGL + H Y ++L
Sbjct: 119 IHRDLAARNILLA---SDDKVKIGDFGLMRALPQNEDH----YVMEEHL 160
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 5e-05
Identities = 33/115 (28%), Positives = 54/115 (46%), Gaps = 14/115 (12%)
Query: 80 LADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPY 139
+Q++ + ++HSK LHRD+K DN L+ I DFG++KK D +
Sbjct: 113 FTEQVLEGLAYLHSKGILHRDLKADNLLVDA---DGICKISDFGISKKSDDIYDND---- 165
Query: 140 RENKNLTGT----ARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 190
+N ++ G+ A + G S + D+ SLG V++ G PW +A
Sbjct: 166 -QNMSMQGSVFWMAPEVIHSYSQGY--SAKVDIWSLGCVVLEMFAGRRPWSDEEA 217
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 5e-05
Identities = 25/76 (32%), Positives = 41/76 (53%), Gaps = 5/76 (6%)
Query: 52 LVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 111
LVM +G L L KLS + L QM+ ++++H+ +HRD+KP N +
Sbjct: 97 LVMPFMGTDLGKLMKH--EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVN-- 152
Query: 112 RRANQVYIIDFGLAKK 127
++ I+DFGLA++
Sbjct: 153 -EDCELKILDFGLARQ 167
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 6e-05
Identities = 33/112 (29%), Positives = 52/112 (46%), Gaps = 19/112 (16%)
Query: 80 LADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPY 139
+A Q+++ + ++H + +HRDIKP N L+ + V I DFG+++ T P
Sbjct: 173 VARQILSGIAYLHRRHIVHRDIKPSNLLINSAKN---VKIADFGVSRILAQTMD----PC 225
Query: 140 RENKNLTGTARYAS---MNTHLGIEQSRRD----DLESLGYVLMYFLRGSLP 184
+ GT Y S +NT L D D+ SLG ++ F G P
Sbjct: 226 NSS---VGTIAYMSPERINTDL--NHGAYDGYAGDIWSLGVSILEFYLGRFP 272
|
Length = 353 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 6e-05
Identities = 25/67 (37%), Positives = 33/67 (49%), Gaps = 9/67 (13%)
Query: 88 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTG 147
+E VH F+HRDIKPDN L+ R + + DFGL +R TH Y++
Sbjct: 114 IESVHKMGFIHRDIKPDNILID---RDGHIKLTDFGLCTGFR--WTHDSKYYQKG----D 164
Query: 148 TARYASM 154
R SM
Sbjct: 165 HHRQDSM 171
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 7e-05
Identities = 24/76 (31%), Positives = 43/76 (56%), Gaps = 4/76 (5%)
Query: 52 LVMDLLGP-SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL 110
L+M+ L SL D +++LK +L+ + Q+ ++++ S+ ++HRD+ N L+
Sbjct: 85 LIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILV-- 142
Query: 111 GRRANQVYIIDFGLAK 126
+ V I DFGLAK
Sbjct: 143 -ESEDLVKISDFGLAK 157
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 8e-05
Identities = 30/108 (27%), Positives = 49/108 (45%), Gaps = 9/108 (8%)
Query: 52 LVMDLLGPSLEDLFNFCSRK-LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL 110
LV + L L+ + + L + Q++ + F HS LHRD+KP N L+
Sbjct: 76 LVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLIN- 134
Query: 111 GRRANQVYIIDFGLAKKY---RDTSTHQHIP--YRENKNLTGTARYAS 153
+ + DFGLA+ + T TH+ + YR + L G Y++
Sbjct: 135 --TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYST 180
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 43.7 bits (104), Expect = 1e-04
Identities = 58/203 (28%), Positives = 85/203 (41%), Gaps = 45/203 (22%)
Query: 20 QLLYESKLYRILQGGTGIPN-VRWFGV--EGDYNVLVM------DLLG---PSLEDLFNF 67
L E+++ + L G PN VR GV E + LV+ DLL S +
Sbjct: 42 DFLKEARVMKKL----GHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSP 97
Query: 68 CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 127
LSLK +L A Q+ +E++ SK F+HRD+ N L+G V I DFGL++
Sbjct: 98 EKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVG---EDLVVKISDFGLSRD 154
Query: 128 -----YRDTSTHQHIPYR----ENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMY- 177
Y T +P R E S+ + +S D+ S G VL++
Sbjct: 155 VYDDDYYRKKTGGKLPIRWMAPE-----------SLKDGIFTSKS---DVWSFG-VLLWE 199
Query: 178 -FLRGSLPWQGLKAGTKKQKYEK 199
F G+ P+ GL + K
Sbjct: 200 IFTLGATPYPGLSNEEVLEYLRK 222
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 21/49 (42%), Positives = 28/49 (57%), Gaps = 3/49 (6%)
Query: 83 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 131
++ VE VH F+HRDIKPDN L+ R + + DFGL +R T
Sbjct: 109 ELTCAVESVHKMGFIHRDIKPDNILID---RDGHIKLTDFGLCTGFRWT 154
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 1e-04
Identities = 25/68 (36%), Positives = 38/68 (55%), Gaps = 7/68 (10%)
Query: 63 DLFNFCSRK----LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVY 118
DL NF RK L+L+ +L + Q+ + F+ SK+ +HRD+ N L+ G+
Sbjct: 125 DLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVK--- 181
Query: 119 IIDFGLAK 126
I DFGLA+
Sbjct: 182 ICDFGLAR 189
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 43.3 bits (103), Expect = 1e-04
Identities = 27/85 (31%), Positives = 38/85 (44%), Gaps = 20/85 (23%)
Query: 60 SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYI 119
SL DL +F L +A M E++ SK+F+HRD+ N L+G V I
Sbjct: 101 SLSDLLSFA---------LQIARGM----EYLESKNFIHRDLAARNCLVGEN---LVVKI 144
Query: 120 IDFGLAKKYRD----TSTHQHIPYR 140
DFGL++ D +P R
Sbjct: 145 SDFGLSRDLYDDDYYKVKGGKLPIR 169
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 43.7 bits (104), Expect = 1e-04
Identities = 45/167 (26%), Positives = 69/167 (41%), Gaps = 38/167 (22%)
Query: 69 SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 128
S + A Q++ +E++HS ++RD+KP+N L+ + I DFG AK+
Sbjct: 95 SGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLL---DSDGYIKITDFGFAKRV 151
Query: 129 RD-TSTHQHIPYRENKNLTGTARYAS--MNTHLGIEQSRRDDLESLGYVLMY-FLRGSLP 184
+ T T L GT Y + + G ++ D +LG +L+Y L G P
Sbjct: 152 KGRTYT-----------LCGTPEYLAPEIILSKGYGKAV--DWWALG-ILIYEMLAGYPP 197
Query: 185 WQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHY-CRSL 230
+ Q YEKI E KV F S+F + L
Sbjct: 198 F---FDDNPIQIYEKILEGKV-------------RFPSFFSPDAKDL 228
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 1e-04
Identities = 36/118 (30%), Positives = 55/118 (46%), Gaps = 18/118 (15%)
Query: 89 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD-TSTHQHIPYRENKNLTG 147
E++HSK ++RD+KP+N L L + + V + DFG AKK D T T L G
Sbjct: 132 EYLHSKDIIYRDLKPENLL--LDNKGH-VKVTDFGFAKKVPDRTFT-----------LCG 177
Query: 148 TARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 205
T Y + + D ++G +L F+ G P+ T + YEKI ++
Sbjct: 178 TPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFD---DTPFRIYEKILAGRL 232
|
Length = 329 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 43.7 bits (104), Expect = 1e-04
Identities = 21/78 (26%), Positives = 39/78 (50%), Gaps = 10/78 (12%)
Query: 52 LVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 111
+V +L+ L + + L+ + Q++ ++++HS + +HRD+KP N L
Sbjct: 81 IVTELMETDLHKVIK-SPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNIL---- 135
Query: 112 RRAN---QVYIIDFGLAK 126
N + I DFGLA+
Sbjct: 136 --VNSNCDLKICDFGLAR 151
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 43.4 bits (103), Expect = 1e-04
Identities = 34/117 (29%), Positives = 46/117 (39%), Gaps = 19/117 (16%)
Query: 93 SKSFLHRDIKPDN-FLMGLGRRANQVYIIDFGLAKKYRDTS--THQHIPYRENKNLTGTA 149
+ LHRD+KP N FL N V + DFGLAK S ++ GT
Sbjct: 128 GNTVLHRDLKPANIFLDA----NNNVKLGDFGLAKILGHDSSFAKTYV---------GTP 174
Query: 150 RYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 206
Y S + + D+ SLG ++ S P+ A + Q KI E K
Sbjct: 175 YYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFT---ARNQLQLASKIKEGKFR 228
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 1e-04
Identities = 34/122 (27%), Positives = 55/122 (45%), Gaps = 16/122 (13%)
Query: 69 SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 128
S + A ++I ++F+H K ++RD+K DN L+ + + I DFG+ K
Sbjct: 90 SGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLD---KDGHIKIADFGMCK-- 144
Query: 129 RDTSTHQHIPYRENKNLT--GTARYASMNTHLGIEQSRRDDLESLGYVLMY-FLRGSLPW 185
+++ E K T GT Y + G + + D S G VL+Y L G P+
Sbjct: 145 ------ENM-NGEGKASTFCGTPDYIAPEILKGQKYNESVDWWSFG-VLLYEMLIGQSPF 196
Query: 186 QG 187
G
Sbjct: 197 HG 198
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 30/105 (28%), Positives = 50/105 (47%), Gaps = 13/105 (12%)
Query: 83 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYREN 142
+M V+ +H ++HRD+KP+NFL+ + + + DFGL+K T+ +
Sbjct: 109 EMFEAVDALHELGYIHRDLKPENFLID---ASGHIKLTDFGLSK---GIVTYAN------ 156
Query: 143 KNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 187
++ G+ Y + G D SLG +L FL G P+ G
Sbjct: 157 -SVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSG 200
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 1e-04
Identities = 26/82 (31%), Positives = 44/82 (53%), Gaps = 5/82 (6%)
Query: 52 LVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 111
LV L+G L ++ +KL+ V L Q++ ++++HS +HRD+KP N +
Sbjct: 99 LVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN-- 154
Query: 112 RRANQVYIIDFGLAKKYRDTST 133
++ I+DFGLA+ D T
Sbjct: 155 -EDCELKILDFGLARHTDDEMT 175
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 1e-04
Identities = 25/75 (33%), Positives = 40/75 (53%), Gaps = 8/75 (10%)
Query: 83 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR---DTSTHQHIP- 138
Q++ + F HS+ LHRD+KP N L+ + + DFGLA+ + TH+ +
Sbjct: 109 QILQGILFCHSRRVLHRDLKPQNLLID---NKGVIKLADFGLARAFGIPVRVYTHEVVTL 165
Query: 139 -YRENKNLTGTARYA 152
YR + L G+ RY+
Sbjct: 166 WYRAPEVLLGSPRYS 180
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 1e-04
Identities = 26/75 (34%), Positives = 39/75 (52%), Gaps = 5/75 (6%)
Query: 52 LVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 111
V +LLG L L SR L + + Q++ +++VHS +HRD+KP N L+
Sbjct: 87 FVTELLGTDLHRLLT--SRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILIN-- 142
Query: 112 RRANQVYIIDFGLAK 126
+ I DFGLA+
Sbjct: 143 -ENCDLKICDFGLAR 156
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 2e-04
Identities = 30/98 (30%), Positives = 46/98 (46%), Gaps = 10/98 (10%)
Query: 47 GDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDN 105
GD +VM+ L G SL D+ + + + + + +EF+HS +HRDIK DN
Sbjct: 88 GDELWVVMEYLAGGSLTDVVTETC--MDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDN 145
Query: 106 FLMGLGRRANQVYIIDFG----LAKKYRDTSTHQHIPY 139
L+G+ V + DFG + + ST PY
Sbjct: 146 ILLGMD---GSVKLTDFGFCAQITPEQSKRSTMVGTPY 180
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 24/88 (27%), Positives = 47/88 (53%), Gaps = 11/88 (12%)
Query: 52 LVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 111
+VMDL+ L + + L+ + + Q++ ++++HS + +HRD+KP N L+
Sbjct: 85 VVMDLMESDLHHII-HSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLV--- 140
Query: 112 RRANQ---VYIIDFGLAKKYRDTSTHQH 136
N+ + I DFG+A+ +S +H
Sbjct: 141 ---NEDCELRIGDFGMARGL-SSSPTEH 164
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 2e-04
Identities = 30/109 (27%), Positives = 53/109 (48%), Gaps = 14/109 (12%)
Query: 81 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYR 140
A +++ ++F+HSK ++RD+K DN ++ R + I DFG+ K+ +
Sbjct: 102 AAEIVCGLQFLHSKGIIYRDLKLDNVMLD---RDGHIKIADFGMCKEN---------VFG 149
Query: 141 ENKNLT--GTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 187
+N+ T GT Y + G++ + D S G +L L G P+ G
Sbjct: 150 DNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHG 198
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 2e-04
Identities = 45/169 (26%), Positives = 69/169 (40%), Gaps = 19/169 (11%)
Query: 43 FGVEGDYNV-LVMDL-LGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRD 100
+ + + N+ LVMD +G L L + +L +M+ ++ VH ++HRD
Sbjct: 68 YAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRD 127
Query: 101 IKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI 160
IKPDN LM + + + DFG K + T Q + GT Y S +
Sbjct: 128 IKPDNILMDMN---GHIRLADFGSCLKLMEDGTVQ------SSVAVGTPDYISPEILQAM 178
Query: 161 EQSR-----RDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 204
E + D SLG + L G P+ A + + Y KI K
Sbjct: 179 EDGKGKYGPECDWWSLGVCMYEMLYGETPFY---AESLVETYGKIMNHK 224
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 3e-04
Identities = 20/49 (40%), Positives = 28/49 (57%), Gaps = 3/49 (6%)
Query: 88 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQH 136
+E VH F+HRDIKPDN L+ L + + DFGL +R T ++
Sbjct: 114 IESVHKMGFIHRDIKPDNILIDLD---GHIKLTDFGLCTGFRWTHNSKY 159
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 3e-04
Identities = 14/39 (35%), Positives = 22/39 (56%), Gaps = 3/39 (7%)
Query: 88 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 126
++ +H ++HRDIKPDN L+ + + DFGL
Sbjct: 114 IDSIHKLGYIHRDIKPDNLLL---DAKGHIKLSDFGLCT 149
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 3e-04
Identities = 59/228 (25%), Positives = 97/228 (42%), Gaps = 53/228 (23%)
Query: 40 VRWFGV-EGDYNVLVMDLL--GPSLEDLFNFCSRK---LSLKTVLMLADQMINRVEFVHS 93
VR GV E + +LVM++ GP L F S K +++ V+ L Q+ ++++
Sbjct: 58 VRMIGVCEAEALMLVMEMASGGP----LNKFLSGKKDEITVSNVVELMHQVSMGMKYLEG 113
Query: 94 KSFLHRDIKPDNFLMGLGRRANQVY--IIDFGLAK------KYRDTSTHQHIPYRENKNL 145
K+F+HRD+ N L+ NQ Y I DFGL+K Y + P +
Sbjct: 114 KNFVHRDLAARNVLL-----VNQHYAKISDFGLSKALGADDSYYKARSAGKWPLK----- 163
Query: 146 TGTARYAS--MNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK 203
YA +N + S R D+ S G + W+ G K Y+K+
Sbjct: 164 ----WYAPECINFR---KFSSRSDVWSYGITM---------WEAFSYGQK--PYKKMKGP 205
Query: 204 KVSTSIEALCR-----GYPTEFASYFHYCRSLRFDDKPDYAYLKRIFR 246
+V + IE R P E + C +++D+P++A ++ R
Sbjct: 206 EVMSFIEQGKRLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMR 253
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 3e-04
Identities = 32/117 (27%), Positives = 51/117 (43%), Gaps = 10/117 (8%)
Query: 71 KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 130
K L A ++I ++F+HSK ++RD+K DN L+ + I DFG+ K+
Sbjct: 92 KFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLD---TDGHIKIADFGMCKE--- 145
Query: 131 TSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 187
+ + GT Y + LG + + D S G +L L G P+ G
Sbjct: 146 ----NMLGDAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHG 198
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 41.5 bits (98), Expect = 4e-04
Identities = 35/146 (23%), Positives = 67/146 (45%), Gaps = 17/146 (11%)
Query: 43 FGVEGDYNVLV--MDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK-SFLHR 99
F GD ++ + MD G SL+ + ++ + + +A ++ + ++H K +HR
Sbjct: 68 FYNNGDISICMEYMD--GGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHR 125
Query: 100 DIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG 159
D+KP N L+ Q+ + DFG++ + ++ K GT+ Y + G
Sbjct: 126 DVKPSNILVN---SRGQIKLCDFGVSGQLVNSLA---------KTFVGTSSYMAPERIQG 173
Query: 160 IEQSRRDDLESLGYVLMYFLRGSLPW 185
+ S + D+ SLG L+ G P+
Sbjct: 174 NDYSVKSDIWSLGLSLIELATGRFPY 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 4e-04
Identities = 30/110 (27%), Positives = 52/110 (47%), Gaps = 12/110 (10%)
Query: 75 KTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 134
K + +A+ ++ + ++HS+ +HRDIKP N L+ R QV + DFG++ + ++
Sbjct: 105 KVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILL---TRKGQVKLCDFGVSGELVNSLA- 160
Query: 135 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 184
TGT+ Y + G S D+ SLG L+ + P
Sbjct: 161 --------GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFP 202
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 4e-04
Identities = 33/125 (26%), Positives = 58/125 (46%), Gaps = 15/125 (12%)
Query: 83 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR----DTSTHQHIP 138
Q++ + ++H++ +HRDIK N L+ + I DFG++KK T T+ P
Sbjct: 114 QILKGLNYLHNRGIIHRDIKGANILVD---NKGGIKISDFGISKKLEANSLSTKTNGARP 170
Query: 139 YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYE 198
+L G+ + + +R+ D+ SLG +++ L G P+ T+ Q
Sbjct: 171 -----SLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDC---TQLQAIF 222
Query: 199 KISEK 203
KI E
Sbjct: 223 KIGEN 227
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 4e-04
Identities = 20/77 (25%), Positives = 38/77 (49%), Gaps = 3/77 (3%)
Query: 52 LVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 111
LV + L L + + K +L + + ++N + ++H LHRD+K N L+
Sbjct: 96 LVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILI--- 152
Query: 112 RRANQVYIIDFGLAKKY 128
+ + + DFGLA+ +
Sbjct: 153 TKDGILKLADFGLARAF 169
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 4e-04
Identities = 18/46 (39%), Positives = 29/46 (63%), Gaps = 3/46 (6%)
Query: 83 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 128
Q++ ++F+HS +HRD+KP N L+ Q+ + DFGLA+ Y
Sbjct: 118 QLLRGLDFLHSHRVVHRDLKPQNILVTSS---GQIKLADFGLARIY 160
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 5e-04
Identities = 28/108 (25%), Positives = 51/108 (47%), Gaps = 11/108 (10%)
Query: 83 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYREN 142
Q++ + ++H + LHRD+KP N L+ ++ + DFGLA+ + +P
Sbjct: 111 QLLRGLSYIHQRYILHRDLKPQNLLIS---DTGELKLADFGLARA-------KSVPSHTY 160
Query: 143 KNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLK 189
N T Y + LG E S D+ +G + + ++G + G+K
Sbjct: 161 SNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMK 208
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 41.1 bits (97), Expect = 6e-04
Identities = 26/96 (27%), Positives = 49/96 (51%), Gaps = 8/96 (8%)
Query: 40 VRWFG---VEGDYNVLVMDLLGP-SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 95
V+++G D +VM+ G S+ D+ ++ L+ + + + Q + +E++HS
Sbjct: 61 VKYYGSYFKNTDL-WIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNK 119
Query: 96 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 131
+HRDIK N L+ Q + DFG++ + DT
Sbjct: 120 KIHRDIKAGNILLN---EEGQAKLADFGVSGQLTDT 152
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 6e-04
Identities = 35/116 (30%), Positives = 55/116 (47%), Gaps = 22/116 (18%)
Query: 79 MLADQMINRVEFVHSKSFLHRDIKPDN-FLMGLGRRANQVYIIDFGLAKKYRDT------ 131
+L Q++ ++ VHS+ +HRD+K N FLM G + + DFG +K+Y D+
Sbjct: 173 LLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTG----IIKLGDFGFSKQYSDSVSLDVA 228
Query: 132 STHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 187
S+ PY L RY S++ D+ SLG +L L P++G
Sbjct: 229 SSFCGTPYYLAPELWERKRY-----------SKKADMWSLGVILYELLTLHRPFKG 273
|
Length = 478 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 6e-04
Identities = 19/45 (42%), Positives = 30/45 (66%), Gaps = 5/45 (11%)
Query: 83 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAK 126
Q++ ++++HS + LHRD+KP N L+ AN + I DFGLA+
Sbjct: 116 QLLRGLKYIHSANVLHRDLKPSNLLLN----ANCDLKICDFGLAR 156
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 7e-04
Identities = 34/123 (27%), Positives = 51/123 (41%), Gaps = 13/123 (10%)
Query: 72 LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 131
S + A ++I +E +H++ ++RD+KP N L+ V I D GLA +
Sbjct: 94 FSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLD---EHGHVRISDLGLACDFSKK 150
Query: 132 STHQHIPYRENKNLTGTARY-ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 190
H + GT Y A G+ D SLG +L LRG P++ K
Sbjct: 151 KPHASV---------GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 201
Query: 191 GTK 193
K
Sbjct: 202 KDK 204
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 7e-04
Identities = 47/184 (25%), Positives = 75/184 (40%), Gaps = 20/184 (10%)
Query: 70 RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDN-FLMGLGRRANQVYIIDFGLAKKY 128
R + +TV Q+ + VE +HS+ +HRDIKP N F+ G V + D GL + +
Sbjct: 101 RLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATG----VVKLGDLGLGRFF 156
Query: 129 RDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGL 188
+T H +L GT Y S + + D+ SLG +L P+ G
Sbjct: 157 SSKTTAAH-------SLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209
Query: 189 KAG--TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFR 246
K + QK E+ + T Y + C D +PD Y+ +I +
Sbjct: 210 KMNLFSLCQKIEQCDYPPLPT------EHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAK 263
Query: 247 DLFI 250
+ +
Sbjct: 264 QMHV 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 7e-04
Identities = 27/104 (25%), Positives = 45/104 (43%), Gaps = 7/104 (6%)
Query: 83 QMINRVEFVHSKSFLHRDIKPDNFLM-GLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRE 141
Q++ + ++H +HRD+K N L+ G+R + I DFG A + T
Sbjct: 111 QLLRGLSYLHENQIIHRDVKGANLLIDSTGQR---LRIADFGAAARLAAKGTGAG---EF 164
Query: 142 NKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPW 185
L GT + + G + R D+ S+G V++ PW
Sbjct: 165 QGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPW 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 8e-04
Identities = 17/49 (34%), Positives = 27/49 (55%), Gaps = 3/49 (6%)
Query: 83 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 131
QM+ + F+HS +HRD+K N L+ V + DFG++ K + T
Sbjct: 111 QMLEALNFLHSHKVIHRDLKAGNILL---TLDGDVKLADFGVSAKNKST 156
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 9e-04
Identities = 22/64 (34%), Positives = 34/64 (53%), Gaps = 3/64 (4%)
Query: 63 DLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDF 122
DL LS V L QM+ ++++HS +HRD+KP N + ++ I+DF
Sbjct: 105 DLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVN---EDCELKILDF 161
Query: 123 GLAK 126
GLA+
Sbjct: 162 GLAR 165
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 9e-04
Identities = 28/94 (29%), Positives = 42/94 (44%), Gaps = 11/94 (11%)
Query: 83 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVY-IIDFGLAKKYRDTSTHQHIPYRE 141
Q+I + + H +HRDIKP+N L+ N V + DFG A+ + S + Y
Sbjct: 108 QLIKAIHWCHKNDIVHRDIKPENLLIS----HNDVLKLCDFGFARNLSEGSNANYTEY-- 161
Query: 142 NKNLTGTARYASMNTHLGIEQSRRDDLESLGYVL 175
T Y S LG + D+ S+G +L
Sbjct: 162 ----VATRWYRSPELLLGAPYGKAVDMWSVGCIL 191
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.9 bits (94), Expect = 0.001
Identities = 27/109 (24%), Positives = 54/109 (49%), Gaps = 13/109 (11%)
Query: 24 ESK-LYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLA 81
E++ + R + G +P V + E ++VM+ + G L+DL N S + +
Sbjct: 49 EARIMSRARKAGVNVPAVYFVDPENF--IIVMEYIEGEPLKDLIN--SNGMEELELSREI 104
Query: 82 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 130
+++ ++ HS +H D+ N ++ ++Y+IDFGLA+ +D
Sbjct: 105 GRLVGKL---HSAGIIHGDLTTSNMIL----SGGKIYLIDFGLAEFSKD 146
|
Length = 211 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.001
Identities = 34/100 (34%), Positives = 47/100 (47%), Gaps = 15/100 (15%)
Query: 83 QMINRVEFVHSKSFLHRDIKPDNFLM---GLGRRANQVYIIDFGLAKKYRDTSTHQHIPY 139
Q++ V VHSK +HRDIK N L+ GL V + DFG +K Y T +
Sbjct: 151 QVLLAVHHVHSKHMIHRDIKSANILLCSNGL------VKLGDFGFSKMYAATVSDD---- 200
Query: 140 RENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFL 179
+ GT Y + S++ D+ SLG VL+Y L
Sbjct: 201 -VGRTFCGTPYYVAPEIWRRKPYSKKADMFSLG-VLLYEL 238
|
Length = 496 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.001
Identities = 17/46 (36%), Positives = 30/46 (65%), Gaps = 3/46 (6%)
Query: 83 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 128
Q++ ++++HS + LHRD+KP N L+ ++ I DFGLA+ +
Sbjct: 113 QILCGLKYIHSANVLHRDLKPGNLLVNAD---CELKICDFGLARGF 155
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 40.5 bits (94), Expect = 0.001
Identities = 37/142 (26%), Positives = 63/142 (44%), Gaps = 17/142 (11%)
Query: 47 GDYNVLVMDLL-GPSLEDLFN-FCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPD 104
GD +VM+ L G SL D+ C + + V + + +EF+H+ +HRDIK D
Sbjct: 88 GDELFVVMEYLAGGSLTDVVTETCMDEAQIAAV---CRECLQALEFLHANQVIHRDIKSD 144
Query: 105 NFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKN-LTGTARYASMNTHLGIEQS 163
N L+G+ V + DFG Q P + ++ + GT + +
Sbjct: 145 NVLLGM---DGSVKLTDFGFCA--------QITPEQSKRSTMVGTPYWMAPEVVTRKAYG 193
Query: 164 RRDDLESLGYVLMYFLRGSLPW 185
+ D+ SLG + + + G P+
Sbjct: 194 PKVDIWSLGIMAIEMVEGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.001
Identities = 35/140 (25%), Positives = 61/140 (43%), Gaps = 17/140 (12%)
Query: 83 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYREN 142
Q+I+ +E +H + ++RD+KP+N L+ V I D GLA + +D + +
Sbjct: 105 QIISGLEHLHQRRIIYRDLKPENVLLD---NDGNVRISDLGLAVELKDGQS-------KT 154
Query: 143 KNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFL--RGSLPWQGLKAGTKKQKYEKI 200
K GT + + G E D +LG L + RG +G K K+ K +
Sbjct: 155 KGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRIL 214
Query: 201 SE-----KKVSTSIEALCRG 215
++ K S + ++ C
Sbjct: 215 NDSVTYPDKFSPASKSFCEA 234
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 0.001
Identities = 24/80 (30%), Positives = 37/80 (46%), Gaps = 9/80 (11%)
Query: 52 LVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM--- 108
LVM+ L L + S V L Q++ ++++H +HRD+K N L+
Sbjct: 85 LVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDK 144
Query: 109 GLGRRANQVYIIDFGLAKKY 128
G + I DFGLA+ Y
Sbjct: 145 GC------LKIADFGLARTY 158
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.001
Identities = 40/186 (21%), Positives = 79/186 (42%), Gaps = 42/186 (22%)
Query: 70 RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 129
+ L + +++ +A Q+ + ++ ++ +HRD+ N L+G + DFGLA+ +
Sbjct: 99 QVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCK---VADFGLARLIK 155
Query: 130 DT--STHQH-IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMY--FLRGSLP 184
+ + IPY+ TA A+ + S + D+ S G +L+Y F G +P
Sbjct: 156 EDVYLSSDKKIPYK------WTAPEAASHGTF----STKSDVWSFG-ILLYEMFTYGQVP 204
Query: 185 WQGLKAGTKKQKYEKISEKKVSTSIEALCRGY--------PTEFASYFHYCRSLRFDDKP 236
+ G+ + Y++I+ GY P E C + +D+P
Sbjct: 205 YPGM---NNHEVYDQIT------------AGYRMPCPAKCPQEIYKIMLECWAAEPEDRP 249
Query: 237 DYAYLK 242
+ L+
Sbjct: 250 SFKALR 255
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.001
Identities = 20/55 (36%), Positives = 33/55 (60%), Gaps = 10/55 (18%)
Query: 83 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN---QVYIIDFGLAK-KYRDTST 133
Q++ ++++H+ + HRD+KP N L AN ++ I DFGLA+ + DT T
Sbjct: 111 QLLRALKYIHTANVFHRDLKPKNIL------ANADCKLKICDFGLARVAFNDTPT 159
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.001
Identities = 19/59 (32%), Positives = 30/59 (50%), Gaps = 3/59 (5%)
Query: 70 RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 128
L TV Q++ + F H LHRD+KP N L+ + ++ + DFGLA+ +
Sbjct: 95 GALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLIN---KRGELKLADFGLARAF 150
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 40.0 bits (94), Expect = 0.001
Identities = 19/61 (31%), Positives = 34/61 (55%), Gaps = 3/61 (4%)
Query: 70 RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 129
+KL L ++ +A Q+ + ++ S++++HRD+ N L+G I DFGLA+
Sbjct: 98 KKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGEN---LVCKIADFGLARLIE 154
Query: 130 D 130
D
Sbjct: 155 D 155
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 40.5 bits (94), Expect = 0.001
Identities = 36/141 (25%), Positives = 62/141 (43%), Gaps = 15/141 (10%)
Query: 47 GDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDN 105
GD +VM+ L G SL D+ + + + + + +EF+HS +HRDIK DN
Sbjct: 89 GDELWVVMEYLAGGSLTDVVT--ETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDN 146
Query: 106 FLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKN-LTGTARYASMNTHLGIEQSR 164
L+G+ V + DFG Q P + ++ + GT + +
Sbjct: 147 ILLGMD---GSVKLTDFGFCA--------QITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 195
Query: 165 RDDLESLGYVLMYFLRGSLPW 185
+ D+ SLG + + + G P+
Sbjct: 196 KVDIWSLGIMAIEMIEGEPPY 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.001
Identities = 38/144 (26%), Positives = 56/144 (38%), Gaps = 15/144 (10%)
Query: 48 DYNVLVMDL-LGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNF 106
+Y LVMD +G L L + +L +M+ + +H ++HRDIKPDN
Sbjct: 74 NYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNV 133
Query: 107 LMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRD 166
L+ + + + DFG K T Q + GT Y S +E
Sbjct: 134 LLDMN---GHIRLADFGSCLKMNQDGTVQ------SSVAVGTPDYISPEILQAMEDGMGK 184
Query: 167 -----DLESLGYVLMYFLRGSLPW 185
D SLG + L G P+
Sbjct: 185 YGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 40.3 bits (95), Expect = 0.001
Identities = 16/44 (36%), Positives = 29/44 (65%), Gaps = 3/44 (6%)
Query: 83 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 126
Q++ ++++HS + +HRD+KP N L+ +V + DFGLA+
Sbjct: 115 QLLKALKYIHSGNVIHRDLKPSNILLN---SDCRVKLADFGLAR 155
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.001
Identities = 40/173 (23%), Positives = 70/173 (40%), Gaps = 23/173 (13%)
Query: 52 LVMDLL-GPSLE-DLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMG 109
LVM L+ G L+ ++N + A Q+I +E +H + ++RD+KP+N L+
Sbjct: 70 LVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLD 129
Query: 110 LGRRANQVYIIDFGLAKKYRD-TSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDL 168
V I D GLA + + GT Y + G D
Sbjct: 130 ---DHGNVRISDLGLAVELKGGKKIKGRA---------GTPGYMAPEVLQGEVYDFSVDW 177
Query: 169 ESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFA 221
+LG L + G P++ Q+ EK+ ++++ + YP +F+
Sbjct: 178 FALGCTLYEMIAGRSPFR--------QRKEKVEKEELKRRTLEMAVEYPDKFS 222
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.002
Identities = 23/62 (37%), Positives = 32/62 (51%), Gaps = 7/62 (11%)
Query: 88 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTG 147
+E VH F+HRDIKPDN L+ R + + DFGL+ + H Y+ K L G
Sbjct: 114 IEAVHKLGFIHRDIKPDNILID---RGGHIKLSDFGLSTGFH--KQHDSAYYQ--KLLQG 166
Query: 148 TA 149
+
Sbjct: 167 KS 168
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.0 bits (94), Expect = 0.002
Identities = 20/55 (36%), Positives = 31/55 (56%), Gaps = 7/55 (12%)
Query: 83 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAKKYRDTSTHQH 136
Q++ ++++HS + LHRD+KP N L+ N + I DFGLA+ H H
Sbjct: 114 QILRGLKYIHSANVLHRDLKPSNLLLN----TNCDLKICDFGLARI--ADPEHDH 162
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.002
Identities = 23/76 (30%), Positives = 41/76 (53%), Gaps = 6/76 (7%)
Query: 52 LVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 111
LVM+L+ +L + L + + L QM+ ++ +HS +HRD+KP N ++
Sbjct: 98 LVMELMDANLCQVIQ---MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV--- 151
Query: 112 RRANQVYIIDFGLAKK 127
+ + I+DFGLA+
Sbjct: 152 KSDCTLKILDFGLART 167
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.002
Identities = 30/102 (29%), Positives = 47/102 (46%), Gaps = 12/102 (11%)
Query: 75 KTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAKKYRDTST 133
+T+ Q+ + +E +HSK +HRDIKP N + A V + D GL + + +T
Sbjct: 106 RTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFIT----ATGVVKLGDLGLGRFFSSKTT 161
Query: 134 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVL 175
H +L GT Y S + + D+ SLG +L
Sbjct: 162 AAH-------SLVGTPYYMSPERIHENGYNFKSDIWSLGCLL 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.002
Identities = 25/80 (31%), Positives = 42/80 (52%), Gaps = 4/80 (5%)
Query: 52 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL 110
L+M+ L SL++ K++LK L A Q+ ++++ S+ ++HRD+ N L+
Sbjct: 85 LIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLV-- 142
Query: 111 GRRANQVYIIDFGLAKKYRD 130
+QV I DFGL K
Sbjct: 143 -ESEHQVKIGDFGLTKAIET 161
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.002
Identities = 39/129 (30%), Positives = 61/129 (47%), Gaps = 23/129 (17%)
Query: 69 SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK- 127
L+ K ++ A Q+ +EF+ SK +HRD+ N L+ + + I DFGLA+
Sbjct: 126 EETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTED---HVMKIADFGLARDI 182
Query: 128 -----YRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMY--FLR 180
YR T T+ +P K + A + + TH QS D+ S G VL++ F
Sbjct: 183 HHIDYYRKT-TNGRLPV---KWMAPEALFDRVYTH----QS---DVWSFG-VLLWEIFTL 230
Query: 181 GSLPWQGLK 189
G P+ G+
Sbjct: 231 GGSPYPGIP 239
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.002
Identities = 48/201 (23%), Positives = 87/201 (43%), Gaps = 32/201 (15%)
Query: 52 LVMDLLGPSLEDLFNFCSRK---LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM 108
+VM+L+ D +F +K L K ++ A + ++ SK+ +HRD+ N L+
Sbjct: 69 IVMELVPGG--DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLV 126
Query: 109 GLGRRANQVYIIDFGLAKKYRD----TSTHQHIPYR-ENKNLTGTARYASMNTHLGIEQS 163
G N + I DFG++++ D +S + IP + RY+S
Sbjct: 127 G---ENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSS---------- 173
Query: 164 RRDDLESLGYVLM-YFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFAS 222
D+ S G +L F G P+ G+ T +Q E++ EK S C P +
Sbjct: 174 -ESDVWSYGILLWETFSLGVCPYPGM---TNQQAREQV-EKGYRMSCPQKC---PDDVYK 225
Query: 223 YFHYCRSLRFDDKPDYAYLKR 243
C + +++P ++ L++
Sbjct: 226 VMQRCWDYKPENRPKFSELQK 246
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.002
Identities = 28/77 (36%), Positives = 42/77 (54%), Gaps = 6/77 (7%)
Query: 52 LVMDLLGP--SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMG 109
LVM+ L P SL D +L + +L+ A Q+ +E++ SK ++HRD+ N L+
Sbjct: 84 LVMEYL-PYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILV- 141
Query: 110 LGRRANQVYIIDFGLAK 126
N+V I DFGL K
Sbjct: 142 --ESENRVKIGDFGLTK 156
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.002
Identities = 32/101 (31%), Positives = 51/101 (50%), Gaps = 12/101 (11%)
Query: 88 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTG 147
++ +HS ++RD+KP+N L+ + + DFGL+K+ D H+ Y + G
Sbjct: 111 LDHLHSLGIIYRDLKPENILLD---EEGHIKLTDFGLSKESID---HEKKAY----SFCG 160
Query: 148 TARYASMNTHLGIEQSRRDDLESLGYVLMY-FLRGSLPWQG 187
T Y + ++ D S G VLM+ L GSLP+QG
Sbjct: 161 TVEYMAPEVVNRRGHTQSADWWSFG-VLMFEMLTGSLPFQG 200
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.002
Identities = 27/94 (28%), Positives = 42/94 (44%), Gaps = 15/94 (15%)
Query: 69 SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA--- 125
R L KT+ Q++ V H +HRD+KP N L + ++ + I D GL
Sbjct: 104 GRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLL--VDKQKGLLKIADLGLGRAF 161
Query: 126 ----KKYRDTSTHQHIP--YRENKNLTGTARYAS 153
K Y TH+ + YR + L G+ Y++
Sbjct: 162 SIPVKSY----THEIVTLWYRAPEVLLGSTHYST 191
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 39.4 bits (93), Expect = 0.002
Identities = 34/106 (32%), Positives = 55/106 (51%), Gaps = 15/106 (14%)
Query: 38 PN-VRWFGV--EGDYNVLVMDL--LGPSLEDLFNF---CSRKLSLKTVLMLADQMINRVE 89
PN VR GV +G+ +V + G DL +F KL+LK +L +A Q+ +E
Sbjct: 61 PNIVRLLGVCTQGEPLYIVTEYMPGG----DLLDFLRKHGEKLTLKDLLQMALQIAKGME 116
Query: 90 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ 135
++ SK+F+HRD+ N L+ V I DFGL++ + ++
Sbjct: 117 YLESKNFVHRDLAARNCLVT---ENLVVKISDFGLSRDIYEDDYYR 159
|
Length = 258 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 0.002
Identities = 34/110 (30%), Positives = 48/110 (43%), Gaps = 15/110 (13%)
Query: 45 VEGDYNVLVMDLL-GPSLEDLFNFCSRK-----LSLKTVLMLADQMINRVEFVHSKSFLH 98
V GD LVM L G SL D+ + + TVL +++ +E++HS +H
Sbjct: 69 VVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVL---KEVLKGLEYLHSNGQIH 125
Query: 99 RDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGT 148
RDIK N L+G V I DFG++ D + K GT
Sbjct: 126 RDIKAGNILLG---EDGSVKIADFGVSASLADGGDRTR---KVRKTFVGT 169
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.002
Identities = 36/121 (29%), Positives = 54/121 (44%), Gaps = 12/121 (9%)
Query: 70 RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDN-FLMGLGRRANQVYIIDFGLAKKY 128
R + KTV Q+ + +E +HS+ +HRDIKP N F+ G V + D GL + +
Sbjct: 101 RLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATG----VVKLGDLGLGRFF 156
Query: 129 RDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGL 188
+T H +L GT Y S + + D+ SLG +L P+ G
Sbjct: 157 SSKTTAAH-------SLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209
Query: 189 K 189
K
Sbjct: 210 K 210
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.003
Identities = 25/80 (31%), Positives = 39/80 (48%), Gaps = 6/80 (7%)
Query: 88 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRE-NKNLT 146
++ +H F+HRDIKPDN L+ V + DFGL + H+ YR N +L
Sbjct: 114 IDSIHQLGFIHRDIKPDNLLLD---SKGHVKLSDFGLCTGLK--KAHRTEFYRNLNHSLP 168
Query: 147 GTARYASMNTHLGIEQSRRD 166
+ +MN+ E +R+
Sbjct: 169 SDFTFQNMNSKRKAETWKRN 188
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.003
Identities = 17/58 (29%), Positives = 33/58 (56%), Gaps = 3/58 (5%)
Query: 70 RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 127
R L+ + ++ QM+ ++++HS +HRD+K N L+ L + + DFG++ K
Sbjct: 105 RGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLD---GDIKLADFGVSAK 159
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.003
Identities = 34/135 (25%), Positives = 66/135 (48%), Gaps = 12/135 (8%)
Query: 51 VLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL 110
VL+ L G +L D+ + +L+ + + + + ++ + ++HS+ +HRDIK D+ L+ L
Sbjct: 95 VLMEFLQGGALTDIVS--QTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTL 152
Query: 111 GRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLES 170
R V + DFG + + +P R K+L GT + + D+ S
Sbjct: 153 DGR---VKLSDFGFCAQ-----ISKDVPKR--KSLVGTPYWMAPEVISRTPYGTEVDIWS 202
Query: 171 LGYVLMYFLRGSLPW 185
LG +++ + G P+
Sbjct: 203 LGIMVIEMVDGEPPY 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 38.9 bits (91), Expect = 0.003
Identities = 36/122 (29%), Positives = 58/122 (47%), Gaps = 18/122 (14%)
Query: 11 QENVKTKHPQLLYESKLYRILQGGTGIPN-VRWFGV---EGDYNVLVMDLLGPSLEDLF- 65
QE VK QL E L LQ PN V++ G E + + + + G SL L
Sbjct: 43 QEAVK----QLEQEIALLSKLQH----PNIVQYLGTEREEDNLYIFLELVPGGSLAKLLK 94
Query: 66 NFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 125
+ S + + + Q++ +E++H ++ +HRDIK N L+ V + DFG+A
Sbjct: 95 KYGSFPEPV--IRLYTRQILLGLEYLHDRNTVHRDIKGANILV---DTNGVVKLADFGMA 149
Query: 126 KK 127
K+
Sbjct: 150 KQ 151
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.003
Identities = 15/49 (30%), Positives = 30/49 (61%), Gaps = 3/49 (6%)
Query: 63 DLFNFCSRK---LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM 108
DL+ + + L L V +A Q+++ ++++H + +HRDIK +N L+
Sbjct: 245 DLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLV 293
|
Length = 461 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.003
Identities = 36/137 (26%), Positives = 59/137 (43%), Gaps = 20/137 (14%)
Query: 52 LVMDLLGPSLEDLFNFCSRK---LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM 108
+VM+ + ++ +R L L V + + Q+ + ++HSK HRD+KP N L
Sbjct: 144 VVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLL- 202
Query: 109 GLGRRANQVYIIDFGLAKKY----RDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSR 164
+ + + + DFG AK R S YR + + G Y TH+
Sbjct: 203 -IDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYT---THI------ 252
Query: 165 RDDLESLGYVLMYFLRG 181
DL SLG ++ + G
Sbjct: 253 --DLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 39.3 bits (91), Expect = 0.003
Identities = 18/47 (38%), Positives = 29/47 (61%), Gaps = 1/47 (2%)
Query: 83 QMINRVEFVHSKSFLHRDIKPDNFL-MGLGRRANQVYIIDFGLAKKY 128
Q+++ + ++H+ LHRD+KP N L MG G +V I D G A+ +
Sbjct: 116 QILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 38.7 bits (90), Expect = 0.003
Identities = 20/61 (32%), Positives = 35/61 (57%), Gaps = 4/61 (6%)
Query: 76 TVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR-DTSTH 134
+L +A Q+ + +E++ K+F+HRD+ N L+G + V + DFGL++ DT T
Sbjct: 105 VLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTA 161
Query: 135 Q 135
Sbjct: 162 H 162
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 38.9 bits (90), Expect = 0.004
Identities = 21/59 (35%), Positives = 33/59 (55%), Gaps = 1/59 (1%)
Query: 71 KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFL-MGLGRRANQVYIIDFGLAKKY 128
+L V L Q+++ + ++H+ LHRD+KP N L MG G +V I D G A+ +
Sbjct: 104 QLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 38.9 bits (90), Expect = 0.004
Identities = 34/136 (25%), Positives = 64/136 (47%), Gaps = 14/136 (10%)
Query: 52 LVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 111
LVM+L+ +L + +L + + L QM+ ++ +HS +HRD+KP N ++
Sbjct: 99 LVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV--- 152
Query: 112 RRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESL 171
+ + I+DFGLA+ ++ PY T Y + LG+ D+ S+
Sbjct: 153 KSDCTLKILDFGLART--AGTSFMMTPY------VVTRYYRAPEVILGMGYKENVDIWSV 204
Query: 172 GYVLMYFLRGSLPWQG 187
G ++ +R + + G
Sbjct: 205 GCIMGEMVRHKILFPG 220
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 38.4 bits (90), Expect = 0.004
Identities = 17/54 (31%), Positives = 27/54 (50%), Gaps = 3/54 (5%)
Query: 83 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQH 136
Q++ + ++H + +HRDIK N L + V + DFG+A K D S
Sbjct: 107 QVLQGLAYLHEQGVIHRDIKAANILTT---KDGVVKLADFGVATKLNDVSKDDA 157
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 38.5 bits (89), Expect = 0.004
Identities = 45/202 (22%), Positives = 82/202 (40%), Gaps = 35/202 (17%)
Query: 58 GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQV 117
G L+ L + L L ++ +A Q+ + + +V +++HRD++ N L+G N V
Sbjct: 85 GSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG----ENLV 140
Query: 118 -YIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLM 176
+ DFGLA+ D Y + ++ + L + + D+ S G +L
Sbjct: 141 CKVADFGLARLIEDNE------YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLT 194
Query: 177 YF-LRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGY----PTEFASYFH----YC 227
+G +P+ G+ ++V +E RGY P E H C
Sbjct: 195 ELTTKGRVPYPGM------------VNREVLDQVE---RGYRMPCPPECPESLHDLMCQC 239
Query: 228 RSLRFDDKPDYAYLKRIFRDLF 249
+++P + YL+ D F
Sbjct: 240 WRKEPEERPTFEYLQAFLEDYF 261
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 449 | |||
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 100.0 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.98 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.98 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.98 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.98 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.98 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.98 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.98 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.98 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.98 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.98 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.98 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.98 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.98 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.98 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.98 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.98 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.98 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.98 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.97 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.97 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.96 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.96 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.96 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.96 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.96 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.96 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.95 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.95 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.94 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.94 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.94 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.94 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.94 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.94 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.93 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.93 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.93 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.93 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.92 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.92 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.91 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.9 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.88 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.88 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.84 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.84 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.81 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.8 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.79 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.79 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.76 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.76 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.72 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.72 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.71 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.71 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.69 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.68 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.66 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.65 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.59 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.57 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.48 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.48 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.47 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.45 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.37 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.36 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.27 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.26 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.24 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.17 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.11 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.09 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 98.99 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.98 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 98.96 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.96 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.93 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.81 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.79 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.75 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.63 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 98.61 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.61 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.57 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.53 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.47 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.2 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.03 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.01 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.97 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.87 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 97.87 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.7 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 97.59 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.58 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.55 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.46 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.44 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.37 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.21 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.15 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.84 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.74 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 96.49 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 96.46 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.41 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.34 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.29 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.29 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 96.17 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 96.04 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 95.98 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 95.88 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 95.55 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 95.2 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 95.12 | |
| PLN02236 | 344 | choline kinase | 94.98 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 94.63 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 94.51 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 94.2 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 93.35 | |
| PTZ00384 | 383 | choline kinase; Provisional | 92.69 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 92.3 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 92.16 | |
| PHA03111 | 444 | Ser/Thr kinase; Provisional | 90.29 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 89.55 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 89.1 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 88.69 | |
| PF05445 | 434 | Pox_ser-thr_kin: Poxvirus serine/threonine protein | 88.42 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 86.62 | |
| smart00587 | 196 | CHK ZnF_C4 abd HLH domain containing kinases domai | 86.48 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 86.15 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 86.09 |
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-52 Score=381.77 Aligned_cols=268 Identities=71% Similarity=1.229 Sum_probs=261.7
Q ss_pred EEEEeeecccCCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHH
Q 013092 5 LTVFSVQENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQM 84 (449)
Q Consensus 5 ikV~~k~~~~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~~~~i~~qi 84 (449)
.+|++|++..+..++++.+|.++++.|++..+|+.+.+++.+..+.+||||++|++|+++++.|.+.|+..++++++.|+
T Consensus 41 e~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLLGPsLEdLfnfC~R~ftmkTvLMLaDQm 120 (341)
T KOG1163|consen 41 EEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQM 120 (341)
T ss_pred ceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeeeccCccHHHHHHHHhhhhhHHhHHHHHHHH
Confidence 57999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCCh
Q 013092 85 INRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSR 164 (449)
Q Consensus 85 ~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~ 164 (449)
+..|+|+|.+++|||||||+|||++++...+.++|+||||++++.+..+..|+||++...+.||.+|++-..+.+.++++
T Consensus 121 l~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSR 200 (341)
T KOG1163|consen 121 LSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSR 200 (341)
T ss_pred HHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred hhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHH
Q 013092 165 RDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRI 244 (449)
Q Consensus 165 ~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~ 244 (449)
++|+.|+|++|+++..|.+||+++.+.++.|+|++|.++++..+++.+|+++|.||.-++.+|..+.+++.|+|..|.++
T Consensus 201 RDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrql 280 (341)
T KOG1163|consen 201 RDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQL 280 (341)
T ss_pred hhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHcCCCCCCcccchhhhhhhccC
Q 013092 245 FRDLFIREGFQFDYVFDWTILKYQQSQL 272 (449)
Q Consensus 245 L~~~~~~~~~~~~~~~dw~~~~~~~~~~ 272 (449)
|+-++...+++.|..+||+.++.+..+.
T Consensus 281 FriLfr~ln~~~d~iyDW~~lkqk~~q~ 308 (341)
T KOG1163|consen 281 FRILFRTLNHQYDYIYDWTMLKQKSQQS 308 (341)
T ss_pred HHHHHhhccccCCeEeeHHHHHHHhhcc
Confidence 9999999999999999999998665443
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-49 Score=373.07 Aligned_cols=265 Identities=60% Similarity=1.003 Sum_probs=255.4
Q ss_pred ccEEEEEeeecccCCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHH
Q 013092 2 YEILTVFSVQENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLA 81 (449)
Q Consensus 2 ~~aikV~~k~~~~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~~~~i~ 81 (449)
|.-.-|++|++..+.+.++|..|.+.|+.|.+.++|+.+++||.++.+..||||++|++|+|+++.|+++|+.+++++++
T Consensus 51 ~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLLGPSLEDLFD~CgR~FSvKTV~miA 130 (449)
T KOG1165|consen 51 YNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLLGPSLEDLFDLCGRRFSVKTVAMIA 130 (449)
T ss_pred ccCceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhhCcCHHHHHHHhcCcccHHhHHHHH
Confidence 34456899999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHCCceecCCCCCcEEEee--cCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhC
Q 013092 82 DQMINRVEFVHSKSFLHRDIKPDNFLMGL--GRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG 159 (449)
Q Consensus 82 ~qi~~aL~yLH~~givHRDLKP~NiLl~~--~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~ 159 (449)
.|++..|+|+|++.+|+|||||+||||+. ....+.|.|+|||+|+.+.+..+..|+||++.+.+.||.+||+-..|+|
T Consensus 131 ~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlG 210 (449)
T KOG1165|consen 131 KQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLG 210 (449)
T ss_pred HHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCccccccCccccccccccceeeeEeecccc
Confidence 99999999999999999999999999974 2344679999999999999999999999999999999999999999999
Q ss_pred CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHH
Q 013092 160 IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYA 239 (449)
Q Consensus 160 ~~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~ 239 (449)
.++++++|+.|||=|++++|.|.+||+++++.+.+++|++|.+.+-.++++.||.++|.||..++++...+++++-|+|+
T Consensus 211 rEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYd 290 (449)
T KOG1165|consen 211 REQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYD 290 (449)
T ss_pred chhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHcCCCCCCcccchhhh
Q 013092 240 YLKRIFRDLFIREGFQFDYVFDWTILK 266 (449)
Q Consensus 240 ~l~~~L~~~~~~~~~~~~~~~dw~~~~ 266 (449)
.+..+|.+++.+.|..+|+.+||..+.
T Consensus 291 ylr~Lf~dvldr~g~t~Dg~yDW~~ln 317 (449)
T KOG1165|consen 291 YLRKLFDDVLDRLGETDDGEYDWMGLN 317 (449)
T ss_pred HHHHHHHHHHHhcCCcccccccccccC
Confidence 999999999999999999999999765
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-45 Score=365.31 Aligned_cols=244 Identities=23% Similarity=0.332 Sum_probs=210.9
Q ss_pred EEEEEeeecccCC-ChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHH
Q 013092 4 ILTVFSVQENVKT-KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLA 81 (449)
Q Consensus 4 aikV~~k~~~~~~-~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~ 81 (449)
||||+.|....++ +.+-+..|..+|.+|.+||+|++|+..|++...+|+|+||+ +|+|.++|++. +.|++.++..++
T Consensus 102 AiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe~A~nGdll~~i~K~-Gsfde~caR~YA 180 (604)
T KOG0592|consen 102 AIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLEYAPNGDLLDLIKKY-GSFDETCARFYA 180 (604)
T ss_pred eHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEEecCCCcHHHHHHHh-CcchHHHHHHHH
Confidence 6788877776654 45567899999999999999999999999999999999999 99999999974 679999999999
Q ss_pred HHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccc----ccc--CCCCccCccccchh
Q 013092 82 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIP----YRE--NKNLTGTARYASMN 155 (449)
Q Consensus 82 ~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~----~~~--~~~~~gT~~Y~aPE 155 (449)
.||+.||+|||++|||||||||+|||| +.+++++|+|||.|+.+.........+ +.. ...++||..|.+||
T Consensus 181 AeIldAleylH~~GIIHRDlKPENILL---d~dmhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPE 257 (604)
T KOG0592|consen 181 AEILDALEYLHSNGIIHRDLKPENILL---DKDGHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPE 257 (604)
T ss_pred HHHHHHHHHHHhcCceeccCChhheeE---cCCCcEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHH
Confidence 999999999999999999999999999 799999999999999887654331111 111 25699999999999
Q ss_pred hhhCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCC
Q 013092 156 THLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDK 235 (449)
Q Consensus 156 ~~~~~~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~R 235 (449)
++.....++.+|||+||||||+|+.|.+||.+. +....+++|..... .+++++|+...+||.++|..||.+|
T Consensus 258 lL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~---NeyliFqkI~~l~y-----~fp~~fp~~a~dLv~KLLv~dp~~R 329 (604)
T KOG0592|consen 258 LLNDSPAGPSSDLWALGCILYQMLAGQPPFRAA---NEYLIFQKIQALDY-----EFPEGFPEDARDLIKKLLVRDPSDR 329 (604)
T ss_pred HhcCCCCCcccchHHHHHHHHHHhcCCCCCccc---cHHHHHHHHHHhcc-----cCCCCCCHHHHHHHHHHHccCcccc
Confidence 999999999999999999999999999999884 44566666666544 3567899999999999999999999
Q ss_pred CCHHHHHHHHHHHHHHcCCCCCCcccchhhhhhh
Q 013092 236 PDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQ 269 (449)
Q Consensus 236 Pt~~~l~~~L~~~~~~~~~~~~~~~dw~~~~~~~ 269 (449)
++.++|++ ++|+..+||+.+..+.
T Consensus 330 lt~~qIk~----------HpFF~~Vdw~nlw~~~ 353 (604)
T KOG0592|consen 330 LTSQQIKA----------HPFFEGVDWENLWQQT 353 (604)
T ss_pred ccHHHHhh----------CcccccCChhhhhhcC
Confidence 99988865 5899999999876543
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-44 Score=345.64 Aligned_cols=246 Identities=20% Similarity=0.224 Sum_probs=208.4
Q ss_pred EEEEEeeecccCC-ChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHH
Q 013092 4 ILTVFSVQENVKT-KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLA 81 (449)
Q Consensus 4 aikV~~k~~~~~~-~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~ 81 (449)
|+||++|...++. +....+.|..||..+ +||.||++++.|++.+.+|||+||+ ||.|...+++ ++.|+++.+..++
T Consensus 54 AmKvl~K~~iv~~~e~~~~~~Er~IL~~v-~hPFiv~l~ysFQt~~kLylVld~~~GGeLf~hL~~-eg~F~E~~arfYl 131 (357)
T KOG0598|consen 54 AMKVLKKKKIVEKKEVRHTKAERNILSKI-KHPFIVKLIYSFQTEEKLYLVLDYLNGGELFYHLQR-EGRFSEDRARFYL 131 (357)
T ss_pred ehhhhhhhHhhhhhhHHHHHHHHHHHHhC-CCCcEeeeEEecccCCeEEEEEeccCCccHHHHHHh-cCCcchhHHHHHH
Confidence 7888888887764 567799999999998 9999999999999999999999999 9999999986 6789999999999
Q ss_pred HHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCC
Q 013092 82 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIE 161 (449)
Q Consensus 82 ~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~ 161 (449)
.+|+.||.|||++|||||||||+|||| +..|+|+|+||||++..-.... ...+++||+.|||||++.+..
T Consensus 132 aEi~lAL~~LH~~gIiyRDlKPENILL---d~~GHi~LtDFgL~k~~~~~~~-------~t~tfcGT~eYmAPEil~~~g 201 (357)
T KOG0598|consen 132 AEIVLALGYLHSKGIIYRDLKPENILL---DEQGHIKLTDFGLCKEDLKDGD-------ATRTFCGTPEYMAPEILLGKG 201 (357)
T ss_pred HHHHHHHHHHHhCCeeeccCCHHHeee---cCCCcEEEeccccchhcccCCC-------ccccccCCccccChHHHhcCC
Confidence 999999999999999999999999999 7999999999999985544322 124689999999999999999
Q ss_pred CChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHH
Q 013092 162 QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYL 241 (449)
Q Consensus 162 ~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l 241 (449)
|+..+|+||||+++|||++|..||.+ .+..+.+++|...+... .+..++.+.++++..++..+|++|..
T Consensus 202 y~~~vDWWsLGillYeML~G~pPF~~---~~~~~~~~~I~~~k~~~----~p~~ls~~ardll~~LL~rdp~~RLg---- 270 (357)
T KOG0598|consen 202 YDKAVDWWSLGILLYEMLTGKPPFYA---EDVKKMYDKILKGKLPL----PPGYLSEEARDLLKKLLKRDPRQRLG---- 270 (357)
T ss_pred CCcccchHhHHHHHHHHhhCCCCCcC---ccHHHHHHHHhcCcCCC----CCccCCHHHHHHHHHHhccCHHHhcC----
Confidence 99999999999999999999999987 45577788887776321 22337899999999999999999953
Q ss_pred HHHHHHHHHHcCCCCCCcccchhhhhhhccCCC
Q 013092 242 KRIFRDLFIREGFQFDYVFDWTILKYQQSQLAT 274 (449)
Q Consensus 242 ~~~L~~~~~~~~~~~~~~~dw~~~~~~~~~~~~ 274 (449)
...+...-..++++..++|+.+...+..++.
T Consensus 271 --~~~d~~~ik~HpfF~~inW~~l~~k~l~PpF 301 (357)
T KOG0598|consen 271 --GPGDAEEIKRHPFFKGINWEKLLAKKLSPPF 301 (357)
T ss_pred --CCCChHHhhcCcccccCCHHHHHhcCCCCCe
Confidence 0111112245688899999998776655433
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=342.89 Aligned_cols=220 Identities=22% Similarity=0.314 Sum_probs=189.8
Q ss_pred EEEEEeeecccCCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCC-EEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHH
Q 013092 4 ILTVFSVQENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGD-YNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLA 81 (449)
Q Consensus 4 aikV~~k~~~~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~-~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~ 81 (449)
|+|++ .+....+..+|+.+|++|++.+ .||+||.+++.|...+ ..+|+|||| ||+|.++++. .+++++.....++
T Consensus 108 AlK~I-~~~~~~~~~~Qi~rEl~il~~~-~spyIV~~ygaF~~~~~~isI~mEYMDgGSLd~~~k~-~g~i~E~~L~~ia 184 (364)
T KOG0581|consen 108 ALKVI-LLNIDPALQKQILRELEILRSC-QSPYIVGFYGAFYSNGEEISICMEYMDGGSLDDILKR-VGRIPEPVLGKIA 184 (364)
T ss_pred EEEee-cccCCHHHHHHHHHHHHHHhhC-CCCCeeeEeEEEEeCCceEEeehhhcCCCCHHHHHhh-cCCCCHHHHHHHH
Confidence 44554 3344556778899999999999 9999999999999988 599999999 9999999986 3679999999999
Q ss_pred HHHHHHHHHHHH-CCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCC
Q 013092 82 DQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI 160 (449)
Q Consensus 82 ~qi~~aL~yLH~-~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~ 160 (449)
.+|+.||.|||+ ++||||||||.|||+ ...|.|||||||.++.+.+.. +.+++||..|||||.+.+.
T Consensus 185 ~~VL~GL~YLh~~~~IIHRDIKPsNlLv---NskGeVKicDFGVS~~lvnS~---------a~tfvGT~~YMsPERi~g~ 252 (364)
T KOG0581|consen 185 RAVLRGLSYLHEERKIIHRDIKPSNLLV---NSKGEVKICDFGVSGILVNSI---------ANTFVGTSAYMSPERISGE 252 (364)
T ss_pred HHHHHHHHHHhhccCeeeccCCHHHeee---ccCCCEEeccccccHHhhhhh---------cccccccccccChhhhcCC
Confidence 999999999995 999999999999999 689999999999998876642 4688999999999999999
Q ss_pred CCChhhHHHHHHHHHHHHHhCCCCCCCC--CcCCHHHHHHHHHhhcccchHHHhhcC-CcHHHHHHHHHHhcCCCCCCCC
Q 013092 161 EQSRRDDLESLGYVLMYFLRGSLPWQGL--KAGTKKQKYEKISEKKVSTSIEALCRG-YPTEFASYFHYCRSLRFDDKPD 237 (449)
Q Consensus 161 ~~s~~~DiwSlG~il~elltG~~Pf~~~--~~~~~~~~~~~i~~~~~~~~~~~l~~~-~p~el~~li~~cl~~~p~~RPt 237 (449)
.|+.++||||||++++||++|+.||... ......+.+..|.... .+.++.. |++||++||..||++||.+||+
T Consensus 253 ~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~p----pP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s 328 (364)
T KOG0581|consen 253 SYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEP----PPRLPEGEFSPEFRSFVSCCLRKDPSERPS 328 (364)
T ss_pred cCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCC----CCCCCcccCCHHHHHHHHHHhcCCcccCCC
Confidence 9999999999999999999999999874 2234455566665543 3345554 9999999999999999999999
Q ss_pred HHHHH
Q 013092 238 YAYLK 242 (449)
Q Consensus 238 ~~~l~ 242 (449)
+.+|.
T Consensus 329 ~~qLl 333 (364)
T KOG0581|consen 329 AKQLL 333 (364)
T ss_pred HHHHh
Confidence 87764
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-43 Score=329.19 Aligned_cols=253 Identities=21% Similarity=0.301 Sum_probs=218.3
Q ss_pred ccEEEEEeeecccCCC-hhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHH
Q 013092 2 YEILTVFSVQENVKTK-HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLM 79 (449)
Q Consensus 2 ~~aikV~~k~~~~~~~-~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~ 79 (449)
|=|+||+.|.+.++.+ .++..+|..||+.+ .||.+++|++.+.+..++||||||+ ||.|..+++++ ++|++..++.
T Consensus 71 yYAmKvL~k~~vVklKQveH~~nEk~vL~~v-~~PFlv~l~~t~~d~~~lymvmeyv~GGElFS~Lrk~-~rF~e~~arF 148 (355)
T KOG0616|consen 71 YYAMKVLDKQKVVKLKQVEHTHNEKRVLKAV-SHPFLVKLYGTFKDNSNLYMVMEYVPGGELFSYLRKS-GRFSEPHARF 148 (355)
T ss_pred eeehhhcCHHHHHHHHHHHHHhhHHHHHhhc-cCceeEEEEEeeccCCeEEEEEeccCCccHHHHHHhc-CCCCchhHHH
Confidence 5689999999888754 45688999999999 7999999999999999999999999 99999999974 5799999999
Q ss_pred HHHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhC
Q 013092 80 LADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG 159 (449)
Q Consensus 80 i~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~ 159 (449)
++.||+.||+|||+++|++|||||+|||| +..|.+||+|||+|+..... ..+.+|||.|+|||.+..
T Consensus 149 YAAeivlAleylH~~~iiYRDLKPENiLl---D~~G~iKitDFGFAK~v~~r----------T~TlCGTPeYLAPEii~s 215 (355)
T KOG0616|consen 149 YAAEIVLALEYLHSLDIIYRDLKPENLLL---DQNGHIKITDFGFAKRVSGR----------TWTLCGTPEYLAPEIIQS 215 (355)
T ss_pred HHHHHHHHHHHHHhcCeeeccCChHHeee---ccCCcEEEEeccceEEecCc----------EEEecCCccccChHHhhc
Confidence 99999999999999999999999999999 79999999999999987654 246799999999999999
Q ss_pred CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHH
Q 013092 160 IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYA 239 (449)
Q Consensus 160 ~~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~ 239 (449)
.+|+..+|+|+||+++|||+.|.+||... +..+.|++|.+.++. ++..+++++.+|+..+++.|-.+| +.
T Consensus 216 k~ynkavDWWalGVLIYEMlaG~pPF~~~---~~~~iY~KI~~~~v~-----fP~~fs~~~kdLl~~LL~vD~t~R--~g 285 (355)
T KOG0616|consen 216 KGYNKAVDWWALGVLIYEMLAGYPPFYDD---NPIQIYEKILEGKVK-----FPSYFSSDAKDLLKKLLQVDLTKR--FG 285 (355)
T ss_pred CCCCcchhHHHHHHHHHHHHcCCCCCcCC---ChHHHHHHHHhCccc-----CCcccCHHHHHHHHHHHhhhhHhh--hc
Confidence 99999999999999999999999999874 458899999998774 455688999999999999998888 22
Q ss_pred HHHHHHHHHHHHcCCCCCCcccchhhhhhhccCCCCCCccCCC
Q 013092 240 YLKRIFRDLFIREGFQFDYVFDWTILKYQQSQLATPPARALVP 282 (449)
Q Consensus 240 ~l~~~L~~~~~~~~~~~~~~~dw~~~~~~~~~~~~~p~~~~~p 282 (449)
-++.=.+++ .+++++..++|.....+..++|..|+.-..+
T Consensus 286 nlknG~~dI---k~H~wF~~v~W~~i~~r~ie~P~~pp~~~~~ 325 (355)
T KOG0616|consen 286 NLKNGVEDI---KNHPWFKGVDWEAILQRKIEPPFEPPNIHGP 325 (355)
T ss_pred CcCCCcccc---ccCcccccccHHHHhhccccCCCCCccccCC
Confidence 222222222 4568888999999988888877776444333
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=343.12 Aligned_cols=227 Identities=22% Similarity=0.270 Sum_probs=189.4
Q ss_pred cEEEEEeeecccCCC-----hhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHH
Q 013092 3 EILTVFSVQENVKTK-----HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKT 76 (449)
Q Consensus 3 ~aikV~~k~~~~~~~-----~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~ 76 (449)
.|||++.|.+..... ...+.+|++||+.| +|||||++++++...++.||||||+ ||+|.+.+-. ++.+.++.
T Consensus 200 vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL-~HP~IV~~~d~f~~~ds~YmVlE~v~GGeLfd~vv~-nk~l~ed~ 277 (475)
T KOG0615|consen 200 VAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKL-SHPNIVRIKDFFEVPDSSYMVLEYVEGGELFDKVVA-NKYLREDL 277 (475)
T ss_pred EEeeeeehhhcccccccccchhhhHHHHHHHHhc-CCCCEEEEeeeeecCCceEEEEEEecCccHHHHHHh-ccccccch
Confidence 477888777755422 23356999999999 9999999999999999999999999 9999999874 56788899
Q ss_pred HHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhh
Q 013092 77 VLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNT 156 (449)
Q Consensus 77 ~~~i~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~ 156 (449)
...++.|++.||.|||++||+||||||+|||+..+..+..+||+|||+|+..+... ...+++||+.|.|||+
T Consensus 278 ~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g~~s--------fm~TlCGTpsYvAPEV 349 (475)
T KOG0615|consen 278 GKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVSGEGS--------FMKTLCGTPSYVAPEV 349 (475)
T ss_pred hHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhccccce--------ehhhhcCCccccChhh
Confidence 99999999999999999999999999999999877777899999999999876432 3578999999999999
Q ss_pred hhCCCC---ChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCC
Q 013092 157 HLGIEQ---SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFD 233 (449)
Q Consensus 157 ~~~~~~---s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~ 233 (449)
+.+..+ ..++||||||||||-+|+|.+||.+..... -.++.|....... .+..+..++++..+||..||..||+
T Consensus 350 l~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~--sl~eQI~~G~y~f-~p~~w~~Iseea~dlI~~mL~VdP~ 426 (475)
T KOG0615|consen 350 LASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP--SLKEQILKGRYAF-GPLQWDRISEEALDLINWMLVVDPE 426 (475)
T ss_pred eecCCeecccchheeeeccceEEEEeccCCCcccccCCc--cHHHHHhcCcccc-cChhhhhhhHHHHHHHHHhhEeCcc
Confidence 987543 348899999999999999999998754432 1345555555533 2234567899999999999999999
Q ss_pred CCCCHHHHH
Q 013092 234 DKPDYAYLK 242 (449)
Q Consensus 234 ~RPt~~~l~ 242 (449)
.||+..+++
T Consensus 427 ~R~s~~eaL 435 (475)
T KOG0615|consen 427 NRPSADEAL 435 (475)
T ss_pred cCcCHHHHh
Confidence 999977654
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=341.71 Aligned_cols=233 Identities=21% Similarity=0.312 Sum_probs=193.3
Q ss_pred EEEEEeeecccCCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCC-EEEEEEecC-CCCHHHHHHH-cCCCCCHHHHHHH
Q 013092 4 ILTVFSVQENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGD-YNVLVMDLL-GPSLEDLFNF-CSRKLSLKTVLML 80 (449)
Q Consensus 4 aikV~~k~~~~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~-~~~lVmE~~-g~sL~~ll~~-~~~~ls~~~~~~i 80 (449)
|+|++...+........|.+|+.+|..| +|||||.+++++.+.. ..+|||||+ +|+|.+++.. .++.+++..++.|
T Consensus 69 avK~~~~~~~~~~~~~~f~~E~~il~~l-~HpNIV~f~G~~~~~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~ 147 (362)
T KOG0192|consen 69 AVKIISDPDFDDESRKAFRREASLLSRL-RHPNIVQFYGACTSPPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRI 147 (362)
T ss_pred EEEEecchhcChHHHHHHHHHHHHHHhC-CCCCeeeEEEEEcCCCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHH
Confidence 3444443332322356899999999999 9999999999999887 799999999 9999999986 3678999999999
Q ss_pred HHHHHHHHHHHHHCC-ceecCCCCCcEEEeecCCCC-eEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhh
Q 013092 81 ADQMINRVEFVHSKS-FLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHL 158 (449)
Q Consensus 81 ~~qi~~aL~yLH~~g-ivHRDLKP~NiLl~~~~~~~-~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~ 158 (449)
+.||+.||+|||+++ ||||||||+|||+ +..+ ++||+|||+++....... ......||+.|||||++.
T Consensus 148 aldiArGm~YLH~~~~iIHrDLK~~NiLv---~~~~~~~KI~DFGlsr~~~~~~~-------~~~~~~GT~~wMAPEv~~ 217 (362)
T KOG0192|consen 148 ALDIARGMEYLHSEGPIIHRDLKSDNILV---DLKGKTLKIADFGLSREKVISKT-------SMTSVAGTYRWMAPEVLR 217 (362)
T ss_pred HHHHHHHHHHHhcCCCeeecccChhhEEE---cCCCCEEEECCCccceeeccccc-------cccCCCCCccccChhhhc
Confidence 999999999999999 9999999999999 5675 999999999987765321 123468999999999999
Q ss_pred --CCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCC
Q 013092 159 --GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKP 236 (449)
Q Consensus 159 --~~~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RP 236 (449)
...|+.++||||||++||||++|..||.++.. .+....+...... +.++..+|+.+..+|..||..+|+.||
T Consensus 218 ~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~---~~~~~~v~~~~~R---p~~p~~~~~~l~~l~~~CW~~dp~~RP 291 (362)
T KOG0192|consen 218 GEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP---VQVASAVVVGGLR---PPIPKECPPHLSSLMERCWLVDPSRRP 291 (362)
T ss_pred CCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH---HHHHHHHHhcCCC---CCCCccCCHHHHHHHHHhCCCCCCcCC
Confidence 56899999999999999999999999998654 3333333333222 234455999999999999999999999
Q ss_pred CHHHHHHHHHHHHHHcC
Q 013092 237 DYAYLKRIFRDLFIREG 253 (449)
Q Consensus 237 t~~~l~~~L~~~~~~~~ 253 (449)
++.+|...|+.+.....
T Consensus 292 ~f~ei~~~l~~~~~~~~ 308 (362)
T KOG0192|consen 292 SFLEIVSRLESIMSHIS 308 (362)
T ss_pred CHHHHHHHHHHHHHhhc
Confidence 99999999998876443
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=335.75 Aligned_cols=224 Identities=21% Similarity=0.285 Sum_probs=185.8
Q ss_pred ccEEEEEeeecccCCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHH
Q 013092 2 YEILTVFSVQENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLML 80 (449)
Q Consensus 2 ~~aikV~~k~~~~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i 80 (449)
++|||.+.|....+...+.+..|++||+.| +|||||.++++..+++++||||||| ||+|.++++. .+.+++.++..+
T Consensus 37 ~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel-~H~nIV~l~d~~~~~~~i~lVMEyC~gGDLs~yi~~-~~~l~e~t~r~F 114 (429)
T KOG0595|consen 37 EVAIKCIAKKKLNKKLVELLLSEIKILKEL-KHPNIVRLLDCIEDDDFIYLVMEYCNGGDLSDYIRR-RGRLPEATARHF 114 (429)
T ss_pred eEEeeeehhhccCHHHHHHHHHHHHHHHhc-CCcceeeEEEEEecCCeEEEEEEeCCCCCHHHHHHH-cCCCCHHHHHHH
Confidence 456666666655556677789999999999 7999999999999999999999999 9999999996 457999999999
Q ss_pred HHHHHHHHHHHHHCCceecCCCCCcEEEeecCCC---CeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhh
Q 013092 81 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRA---NQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTH 157 (449)
Q Consensus 81 ~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~---~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~ 157 (449)
+.||+.||++||+++||||||||+||||+..... -.+||+|||+|+.+..... ..+.+|++.|||||++
T Consensus 115 m~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~~~--------a~tlcGSplYMAPEV~ 186 (429)
T KOG0595|consen 115 MQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPGSM--------AETLCGSPLYMAPEVI 186 (429)
T ss_pred HHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCchhH--------HHHhhCCccccCHHHH
Confidence 9999999999999999999999999999754233 5799999999998875432 4678999999999999
Q ss_pred hCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCC
Q 013092 158 LGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPD 237 (449)
Q Consensus 158 ~~~~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt 237 (449)
....|+.|+|+||+|+|||+|++|+.||...+. .+.+..+... ...++.+...+...+.+++...+..++.+|-+
T Consensus 187 ~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~---~eL~~~~~k~--~~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~ 261 (429)
T KOG0595|consen 187 MSQQYDAKADLWSIGTILYQCLTGKPPFDAETP---KELLLYIKKG--NEIVPVLPAELSNPLRELLISLLQRNPKDRIS 261 (429)
T ss_pred HhccccchhhHHHHHHHHHHHHhCCCCccccCH---HHHHHHHhcc--ccccCchhhhccCchhhhhhHHHhcCccccCc
Confidence 999999999999999999999999999987443 4444433332 22233333445666778888899999999987
Q ss_pred HHH
Q 013092 238 YAY 240 (449)
Q Consensus 238 ~~~ 240 (449)
+.+
T Consensus 262 ~~~ 264 (429)
T KOG0595|consen 262 FED 264 (429)
T ss_pred hHH
Confidence 643
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-42 Score=347.10 Aligned_cols=220 Identities=23% Similarity=0.300 Sum_probs=193.1
Q ss_pred cEEEEEeeecccC-CChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHH
Q 013092 3 EILTVFSVQENVK-TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLML 80 (449)
Q Consensus 3 ~aikV~~k~~~~~-~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i 80 (449)
.|+||+-|....+ ...+.+.+|++|.+.| .|||||+++.+|++.++.|||.|+| .++|..+++. .+.+++.+++.+
T Consensus 46 ~A~KvVpk~~l~k~~~reKv~~EIeIHr~L-~HpnIV~f~~~FEDs~nVYivLELC~~~sL~el~Kr-rk~ltEpEary~ 123 (592)
T KOG0575|consen 46 VAVKVVPKKLLKKPKQREKVLNEIEIHRSL-KHPNIVQFYHFFEDSNNVYIVLELCHRGSLMELLKR-RKPLTEPEARYF 123 (592)
T ss_pred EEEEEeehHHhcCcchHHHHHHHHHHHHhc-CCCcEEeeeeEeecCCceEEEEEecCCccHHHHHHh-cCCCCcHHHHHH
Confidence 3566665544444 4566699999999999 9999999999999999999999999 9999999984 678999999999
Q ss_pred HHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCC
Q 013092 81 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI 160 (449)
Q Consensus 81 ~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~ 160 (449)
+.||+.||.|||+++|||||||..|++| +++.+|||+|||||..+..+.- ...+++|||.|.|||++...
T Consensus 124 l~QIv~GlkYLH~~~IiHRDLKLGNlfL---~~~~~VKIgDFGLAt~le~~~E-------rk~TlCGTPNYIAPEVl~k~ 193 (592)
T KOG0575|consen 124 LRQIVEGLKYLHSLGIIHRDLKLGNLFL---NENMNVKIGDFGLATQLEYDGE-------RKKTLCGTPNYIAPEVLNKS 193 (592)
T ss_pred HHHHHHHHHHHHhcCceecccchhheee---cCcCcEEecccceeeeecCccc-------ccceecCCCcccChhHhccC
Confidence 9999999999999999999999999999 6888999999999998875432 23678999999999999999
Q ss_pred CCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHH
Q 013092 161 EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAY 240 (449)
Q Consensus 161 ~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~ 240 (449)
..+..+||||+|||||-||.|++||.. .+.++.|.+|...... ++..++.+..+||..+|+.+|.+||++++
T Consensus 194 gHsfEvDiWSlGcvmYtLL~G~PPFet---k~vkety~~Ik~~~Y~-----~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~ 265 (592)
T KOG0575|consen 194 GHSFEVDIWSLGCVMYTLLVGRPPFET---KTVKETYNKIKLNEYS-----MPSHLSAEAKDLIRKLLRPNPSERPSLDE 265 (592)
T ss_pred CCCCchhhhhhhhHHHhhhhCCCCccc---chHHHHHHHHHhcCcc-----cccccCHHHHHHHHHHhcCCcccCCCHHH
Confidence 999999999999999999999999976 4567888888776553 23467899999999999999999999776
Q ss_pred HH
Q 013092 241 LK 242 (449)
Q Consensus 241 l~ 242 (449)
|+
T Consensus 266 vL 267 (592)
T KOG0575|consen 266 VL 267 (592)
T ss_pred Hh
Confidence 63
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-41 Score=335.21 Aligned_cols=247 Identities=19% Similarity=0.284 Sum_probs=203.1
Q ss_pred ccEEEEEeeeccc-CCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHH
Q 013092 2 YEILTVFSVQENV-KTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLM 79 (449)
Q Consensus 2 ~~aikV~~k~~~~-~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~ 79 (449)
|-|+|+++|-+.. +.+...++.|..||... ++|+||+|++.|++.+++||||||+ ||++..+|.+ .+.|+++.+.+
T Consensus 168 iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~-ds~~vVKLyYsFQD~~~LYLiMEylPGGD~mTLL~~-~~~L~e~~arf 245 (550)
T KOG0605|consen 168 IYAMKILKKSEMLKKNQVEHVRAERDILAEV-DSPWVVKLYYSFQDKEYLYLIMEYLPGGDMMTLLMR-KDTLTEDWARF 245 (550)
T ss_pred EEeeecccHHHHHhhhhHHHHHHHHHHhhhc-CCCcEEEEEEEecCCCeeEEEEEecCCccHHHHHHh-cCcCchHHHHH
Confidence 3588999998865 46778899999999996 9999999999999999999999999 9999999986 56899999999
Q ss_pred HHHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCC------------------Cccccc--
Q 013092 80 LADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST------------------HQHIPY-- 139 (449)
Q Consensus 80 i~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~------------------~~~~~~-- 139 (449)
++.+++.||+.||+.|||||||||+|+|| +..|++||+||||+..+..... ....+.
T Consensus 246 YiaE~vlAI~~iH~~gyIHRDIKPdNlLi---D~~GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (550)
T KOG0605|consen 246 YIAETVLAIESIHQLGYIHRDIKPDNLLI---DAKGHIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFN 322 (550)
T ss_pred HHHHHHHHHHHHHHcCcccccCChhheee---cCCCCEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccc
Confidence 99999999999999999999999999999 7999999999999864422100 000000
Q ss_pred --c------------------cCCCCccCccccchhhhhCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHH
Q 013092 140 --R------------------ENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEK 199 (449)
Q Consensus 140 --~------------------~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~ 199 (449)
+ .....+|||.|||||++.+..|+..+|+||||||+||||.|.+||.+ .+..+.+.+
T Consensus 323 ~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ImyEmLvGyPPF~s---~tp~~T~rk 399 (550)
T KOG0605|consen 323 TPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIMYEMLVGYPPFCS---ETPQETYRK 399 (550)
T ss_pred cccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHHHHHHHhCCCCCCC---CCHHHHHHH
Confidence 0 11246799999999999999999999999999999999999999988 455677777
Q ss_pred HHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCC---HHHHHHHHHHHHHHcCCCCCCcccchhhhhh
Q 013092 200 ISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPD---YAYLKRIFRDLFIREGFQFDYVFDWTILKYQ 268 (449)
Q Consensus 200 i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt---~~~l~~~L~~~~~~~~~~~~~~~dw~~~~~~ 268 (449)
|.........+. ...++.+..+||.+|+. ||+.|.. ++|| ..++|+..+||+.+...
T Consensus 400 I~nwr~~l~fP~-~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EI----------K~HPfF~~v~W~~l~~~ 459 (550)
T KOG0605|consen 400 IVNWRETLKFPE-EVDLSDEAKDLITRLLC-DPENRLGSKGAEEI----------KKHPFFKGVDWDHLREM 459 (550)
T ss_pred HHHHhhhccCCC-cCcccHHHHHHHHHHhc-CHHHhcCcccHHHH----------hcCCccccCCcchhhcC
Confidence 776653222211 12466899999999999 9999975 4444 34689999999987544
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=331.27 Aligned_cols=230 Identities=20% Similarity=0.292 Sum_probs=192.9
Q ss_pred EEEeeecccCC-ChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHH-cCCCCCHHHHHHHHH
Q 013092 6 TVFSVQENVKT-KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNF-CSRKLSLKTVLMLAD 82 (449)
Q Consensus 6 kV~~k~~~~~~-~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~-~~~~ls~~~~~~i~~ 82 (449)
+|++|...... ....|.+|++||+.| .|++||++++++..++.+||||||| .|+|.++++. .+..+.....+.++.
T Consensus 232 ~vavk~ik~~~m~~~~f~~Ea~iMk~L-~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~ 310 (468)
T KOG0197|consen 232 KVAVKTIKEGSMSPEAFLREAQIMKKL-RHEKLVKLYGVCTKQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAA 310 (468)
T ss_pred cccceEEeccccChhHHHHHHHHHHhC-cccCeEEEEEEEecCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHH
Confidence 44555544433 346799999999999 9999999999999999999999999 9999999986 356799999999999
Q ss_pred HHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCC
Q 013092 83 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQ 162 (449)
Q Consensus 83 qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~ 162 (449)
|||+|++||+++++|||||-..|||+ +.+..|||+|||||+...++.. .......-...|.|||.+....+
T Consensus 311 qIaeGM~YLes~~~IHRDLAARNiLV---~~~~~vKIsDFGLAr~~~d~~Y------~~~~~~kfPIkWtAPEa~~~~~F 381 (468)
T KOG0197|consen 311 QIAEGMAYLESKNYIHRDLAARNILV---DEDLVVKISDFGLARLIGDDEY------TASEGGKFPIKWTAPEALNYGKF 381 (468)
T ss_pred HHHHHHHHHHhCCccchhhhhhheee---ccCceEEEcccccccccCCCce------eecCCCCCCceecCHHHHhhCCc
Confidence 99999999999999999999999999 5888999999999996555443 22233344678999999999999
Q ss_pred ChhhHHHHHHHHHHHHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHH
Q 013092 163 SRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYL 241 (449)
Q Consensus 163 s~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l 241 (449)
+.++||||||++||||+| |+.||.+++.. +.++.+.+.... .-++.||+++.++|..||..+|++||||+.|
T Consensus 382 S~kSDVWSFGVlL~E~fT~G~~py~~msn~---ev~~~le~GyRl----p~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L 454 (468)
T KOG0197|consen 382 SSKSDVWSFGVLLWELFTYGRVPYPGMSNE---EVLELLERGYRL----PRPEGCPDEVYELMKSCWHEDPEDRPTFETL 454 (468)
T ss_pred ccccceeehhhhHHHHhccCCCCCCCCCHH---HHHHHHhccCcC----CCCCCCCHHHHHHHHHHhhCCcccCCCHHHH
Confidence 999999999999999998 99999986553 344444433221 1246799999999999999999999999999
Q ss_pred HHHHHHHHHHc
Q 013092 242 KRIFRDLFIRE 252 (449)
Q Consensus 242 ~~~L~~~~~~~ 252 (449)
...|++++...
T Consensus 455 ~~~l~~~~~~~ 465 (468)
T KOG0197|consen 455 REVLEDFFTST 465 (468)
T ss_pred HHHHHHhhhcc
Confidence 99999886543
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=311.36 Aligned_cols=205 Identities=23% Similarity=0.293 Sum_probs=176.2
Q ss_pred ChhHHHHHHHHHHHhcCCCCCceEEE-EeE-eCCEEEEEEecC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHH
Q 013092 17 KHPQLLYESKLYRILQGGTGIPNVRW-FGV-EGDYNVLVMDLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEF 90 (449)
Q Consensus 17 ~~~~~~~E~~il~~l~~hp~Iv~l~~-~~~-~~~~~~lVmE~~-g~sL~~ll~~~---~~~ls~~~~~~i~~qi~~aL~y 90 (449)
..+.+..|+.+|++| +|||||+.+. .+. +...++|||||| +|+|.++++.. .+.+++.++++++.|++.||..
T Consensus 61 ~rq~~v~Ei~lLkQL-~HpNIVqYy~~~f~~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~ 139 (375)
T KOG0591|consen 61 ARQDCVKEISLLKQL-NHPNIVQYYAHSFIEDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYH 139 (375)
T ss_pred HHHHHHHHHHHHHhc-CCchHHHHHHHhhhccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHH
Confidence 455689999999999 9999999987 344 444589999999 99999998743 4569999999999999999999
Q ss_pred HHH--CC--ceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhh
Q 013092 91 VHS--KS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRD 166 (449)
Q Consensus 91 LH~--~g--ivHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~ 166 (449)
||. .. |+||||||.||+| +.+|.|||.||||++.+....+ ....++|||.||+||.+.+.+|++++
T Consensus 140 cH~~~~r~~VmHRDIKPaNIFl---~~~gvvKLGDfGL~r~l~s~~t-------fA~S~VGTPyYMSPE~i~~~~Y~~kS 209 (375)
T KOG0591|consen 140 CHSKIPRGTVMHRDIKPANIFL---TANGVVKLGDFGLGRFLSSKTT-------FAHSLVGTPYYMSPERIHESGYNFKS 209 (375)
T ss_pred HhccccccceeeccCcchheEE---cCCCceeeccchhHhHhcchhH-------HHHhhcCCCcccCHHHHhcCCCCcch
Confidence 999 45 9999999999999 6899999999999998876543 23568999999999999999999999
Q ss_pred HHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCH
Q 013092 167 DLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDY 238 (449)
Q Consensus 167 DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~ 238 (449)
||||+||++|||+.-+.||.+. +..+...+|.+...++... ..++.++..||..|+..|++.||+.
T Consensus 210 DiWslGCllyEMcaL~~PF~g~---n~~~L~~KI~qgd~~~~p~---~~YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 210 DIWSLGCLLYEMCALQSPFYGD---NLLSLCKKIEQGDYPPLPD---EHYSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred hHHHHHHHHHHHHhcCCCcccc---cHHHHHHHHHcCCCCCCcH---HHhhhHHHHHHHHHccCCcccCCCc
Confidence 9999999999999999999984 5566667777765543221 4578999999999999999999983
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=329.03 Aligned_cols=220 Identities=18% Similarity=0.250 Sum_probs=193.7
Q ss_pred cEEEEEeee-cccCCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHH
Q 013092 3 EILTVFSVQ-ENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLML 80 (449)
Q Consensus 3 ~aikV~~k~-~~~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i 80 (449)
.|||++.|. +........+.+|+.||+.| .||||+.+++.+++..++|+|.||+ ||.|++++-. ++++++.++.++
T Consensus 40 aaiKii~k~~~~s~s~~~~IerEIviMkLi-~HpnVl~LydVwe~~~~lylvlEyv~gGELFdylv~-kG~l~e~eaa~f 117 (786)
T KOG0588|consen 40 AAIKIIPKRSELSSSQPAGIEREIVIMKLI-EHPNVLRLYDVWENKQHLYLVLEYVPGGELFDYLVR-KGPLPEREAAHF 117 (786)
T ss_pred eEEEeeccccccccccccchhhhhHHHHHh-cCCCeeeeeeeeccCceEEEEEEecCCchhHHHHHh-hCCCCCHHHHHH
Confidence 467777777 33445566699999999999 9999999999999999999999999 9999999875 678999999999
Q ss_pred HHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCC
Q 013092 81 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI 160 (449)
Q Consensus 81 ~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~ 160 (449)
+.||+.|+.|||..+|+||||||+|+|| +..++|||+|||+|..-..+.. -.+.||.+.|++||++.|.
T Consensus 118 f~QIi~gv~yCH~~~icHRDLKpENlLL---d~~~nIKIADFGMAsLe~~gkl--------LeTSCGSPHYA~PEIV~G~ 186 (786)
T KOG0588|consen 118 FRQILDGVSYCHAFNICHRDLKPENLLL---DVKNNIKIADFGMASLEVPGKL--------LETSCGSPHYAAPEIVSGR 186 (786)
T ss_pred HHHHHHHHHHHhhhcceeccCCchhhhh---hcccCEeeeccceeecccCCcc--------ccccCCCcccCCchhhcCC
Confidence 9999999999999999999999999999 5667799999999976544332 3577999999999999999
Q ss_pred CC-ChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHH
Q 013092 161 EQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYA 239 (449)
Q Consensus 161 ~~-s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~ 239 (449)
+| +.++||||.|||||-||+|++||.+ ++....+.|++...+. ++..++.+.++|+.+|+..||+.|.+.+
T Consensus 187 pYdG~~sDVWSCGVILfALLtG~LPFdD---dNir~LLlKV~~G~f~-----MPs~Is~eaQdLLr~ml~VDp~~RiT~~ 258 (786)
T KOG0588|consen 187 PYDGRPSDVWSCGVILFALLTGKLPFDD---DNIRVLLLKVQRGVFE-----MPSNISSEAQDLLRRMLDVDPSTRITTE 258 (786)
T ss_pred CCCCCccccchhHHHHHHHHhCCCCCCC---ccHHHHHHHHHcCccc-----CCCcCCHHHHHHHHHHhccCccccccHH
Confidence 98 6899999999999999999999975 6677888888887664 4577999999999999999999999977
Q ss_pred HHHH
Q 013092 240 YLKR 243 (449)
Q Consensus 240 ~l~~ 243 (449)
+|.+
T Consensus 259 eI~k 262 (786)
T KOG0588|consen 259 EILK 262 (786)
T ss_pred HHhh
Confidence 7643
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=321.33 Aligned_cols=220 Identities=21% Similarity=0.259 Sum_probs=184.9
Q ss_pred cEEEEEeeeccc-C--CChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHH
Q 013092 3 EILTVFSVQENV-K--TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVL 78 (449)
Q Consensus 3 ~aikV~~k~~~~-~--~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~ 78 (449)
+|+|+..+.... . ...+.+.+|+.+++.+..||||++++.+.......||||||| ||+|.+++.. .+++.+.++.
T Consensus 45 vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar 123 (370)
T KOG0583|consen 45 VAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIYIVMEYCSGGDLFDYIVN-KGRLKEDEAR 123 (370)
T ss_pred EEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEEEEEecCCccHHHHHHH-cCCCChHHHH
Confidence 456644443211 1 345567789999999977999999999999999999999999 9999999997 7889999999
Q ss_pred HHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCCC-CeEEEeecCcceeec-CCCCCcccccccCCCCccCccccchhh
Q 013092 79 MLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRA-NQVYIIDFGLAKKYR-DTSTHQHIPYRENKNLTGTARYASMNT 156 (449)
Q Consensus 79 ~i~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~-~~vkL~DFGla~~~~-~~~~~~~~~~~~~~~~~gT~~Y~aPE~ 156 (449)
.++.|++.||+|||++||+||||||+|||+ +.+ +.+||+|||++.... .. ....+.+||+.|+|||+
T Consensus 124 ~~F~Qlisav~y~H~~gi~HRDLK~ENill---d~~~~~~Kl~DFG~s~~~~~~~--------~~l~t~cGsp~Y~aPEv 192 (370)
T KOG0583|consen 124 KYFRQLISAVAYCHSRGIVHRDLKPENILL---DGNEGNLKLSDFGLSAISPGED--------GLLKTFCGSPAYAAPEV 192 (370)
T ss_pred HHHHHHHHHHHHHHhCCEeeCCCCHHHEEe---cCCCCCEEEeccccccccCCCC--------CcccCCCCCcccCCHHH
Confidence 999999999999999999999999999999 466 999999999998874 21 12467899999999999
Q ss_pred hhCCC-C-ChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCC-cHHHHHHHHHHhcCCCC
Q 013092 157 HLGIE-Q-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGY-PTEFASYFHYCRSLRFD 233 (449)
Q Consensus 157 ~~~~~-~-s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~-p~el~~li~~cl~~~p~ 233 (449)
+.+.. | +.++||||+|++||.|++|..||.. .+....+.+|...... ++..+ ++++..++..|+..+|.
T Consensus 193 l~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d---~~~~~l~~ki~~~~~~-----~p~~~~S~~~~~Li~~mL~~~P~ 264 (370)
T KOG0583|consen 193 LSGKGTYSGKAADVWSLGVILYVLLCGRLPFDD---SNVPNLYRKIRKGEFK-----IPSYLLSPEARSLIEKMLVPDPS 264 (370)
T ss_pred hCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCC---ccHHHHHHHHhcCCcc-----CCCCcCCHHHHHHHHHHcCCCcc
Confidence 99987 8 4899999999999999999999987 3444556666555442 23345 89999999999999999
Q ss_pred CCCCHHHHH
Q 013092 234 DKPDYAYLK 242 (449)
Q Consensus 234 ~RPt~~~l~ 242 (449)
.|+++.+|.
T Consensus 265 ~R~t~~~i~ 273 (370)
T KOG0583|consen 265 TRITLLEIL 273 (370)
T ss_pred cCCCHHHHh
Confidence 999987775
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=330.89 Aligned_cols=246 Identities=19% Similarity=0.278 Sum_probs=211.2
Q ss_pred ccEEEEEeeeccc-CCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHH
Q 013092 2 YEILTVFSVQENV-KTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLM 79 (449)
Q Consensus 2 ~~aikV~~k~~~~-~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~ 79 (449)
|=||||++|-... ....+.+..|.+|+.....||.+++++.++++.+++|+||||+ ||+|..+++ .+.|++..+..
T Consensus 395 ~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey~~Ggdm~~~~~--~~~F~e~rarf 472 (694)
T KOG0694|consen 395 YYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEYVAGGDLMHHIH--TDVFSEPRARF 472 (694)
T ss_pred EEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEecCCCcEEEEEe--cccccHHHHHH
Confidence 3489999998855 4677889999999999989999999999999999999999999 888665555 56899999999
Q ss_pred HHHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhC
Q 013092 80 LADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG 159 (449)
Q Consensus 80 i~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~ 159 (449)
|++.|+.||.|||++||||||||.+|||| +..|++||+|||+++...... ....+++|||.|||||++.+
T Consensus 473 yaAev~l~L~fLH~~~IIYRDlKLdNiLL---D~eGh~kiADFGlcKe~m~~g-------~~TsTfCGTpey~aPEil~e 542 (694)
T KOG0694|consen 473 YAAEVVLGLQFLHENGIIYRDLKLDNLLL---DTEGHVKIADFGLCKEGMGQG-------DRTSTFCGTPEFLAPEVLTE 542 (694)
T ss_pred HHHHHHHHHHHHHhcCceeeecchhheEE---cccCcEEecccccccccCCCC-------CccccccCChhhcChhhhcc
Confidence 99999999999999999999999999999 799999999999998644222 22468999999999999999
Q ss_pred CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCH-
Q 013092 160 IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDY- 238 (449)
Q Consensus 160 ~~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~- 238 (449)
..|+..+|+|+|||+|||||.|..||++ ++..+.++.|...... ++..++.|...+|++++..+|++|...
T Consensus 543 ~~Yt~aVDWW~lGVLlyeML~Gq~PF~g---ddEee~FdsI~~d~~~-----yP~~ls~ea~~il~~ll~k~p~kRLG~~ 614 (694)
T KOG0694|consen 543 QSYTRAVDWWGLGVLLYEMLVGESPFPG---DDEEEVFDSIVNDEVR-----YPRFLSKEAIAIMRRLLRKNPEKRLGSG 614 (694)
T ss_pred CcccchhhHHHHHHHHHHHHcCCCCCCC---CCHHHHHHHHhcCCCC-----CCCcccHHHHHHHHHHhccCcccccCCC
Confidence 9999999999999999999999999998 4456667777665443 345689999999999999999999765
Q ss_pred ----HHHHHHHHHHHHHcCCCCCCcccchhhhhhhccCCCCCC
Q 013092 239 ----AYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQLATPPA 277 (449)
Q Consensus 239 ----~~l~~~L~~~~~~~~~~~~~~~dw~~~~~~~~~~~~~p~ 277 (449)
.+| ...+|+..+||+.+...+..+|..|.
T Consensus 615 e~d~~~i----------~~hpFFr~i~w~~L~~r~i~PPf~P~ 647 (694)
T KOG0694|consen 615 ERDAEDI----------KKHPFFRSIDWDDLLNRRIKPPFVPT 647 (694)
T ss_pred CCCchhh----------hhCCccccCCHHHHhhccCCCCCCcc
Confidence 223 23578889999999998887766654
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=315.17 Aligned_cols=213 Identities=24% Similarity=0.336 Sum_probs=174.6
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeCC--EEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEGD--YNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 94 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~--~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~ 94 (449)
.+.+.+|+.+|..|+ |||||+.++...... .++|+|||+ +|+|.+++...+++|++..+..++.||+.||+|||++
T Consensus 58 ~~~l~~Ei~iL~~l~-~p~IV~~~G~~~~~~~~~~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~ 136 (313)
T KOG0198|consen 58 SESLEREIRILSRLN-HPNIVQYYGSSSSRENDEYNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSK 136 (313)
T ss_pred HHHHHHHHHHHHhCC-CCCEEeeCCccccccCeeeEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 566999999999995 999999999755444 799999999 9999999997655899999999999999999999999
Q ss_pred CceecCCCCCcEEEeecCC-CCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhC-CCCChhhHHHHHH
Q 013092 95 SFLHRDIKPDNFLMGLGRR-ANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLG 172 (449)
Q Consensus 95 givHRDLKP~NiLl~~~~~-~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~-~~~s~~~DiwSlG 172 (449)
|||||||||+|||+ +. ++.+||+|||+++........ ........||+.|||||++.. ....+.+||||||
T Consensus 137 g~vH~DiK~~NiLl---~~~~~~~KlaDFG~a~~~~~~~~~----~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlG 209 (313)
T KOG0198|consen 137 GIVHCDIKPANILL---DPSNGDVKLADFGLAKKLESKGTK----SDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLG 209 (313)
T ss_pred CEeccCcccceEEE---eCCCCeEEeccCcccccccccccc----ccccccccCCccccCchhhcCCCcCCccchhhhcC
Confidence 99999999999999 46 689999999999877641111 122346789999999999995 3445699999999
Q ss_pred HHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 173 YVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 173 ~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
|++.||+||..||... ......+.++.... ..+.++..++++..+|+..|+..+|+.|||+.+|++
T Consensus 210 CtVvEM~Tg~~PW~~~--~~~~~~~~~ig~~~---~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~ 275 (313)
T KOG0198|consen 210 CTVVEMLTGKPPWSEF--FEEAEALLLIGRED---SLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLE 275 (313)
T ss_pred CEEEeccCCCCcchhh--cchHHHHHHHhccC---CCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 9999999999999873 11122222333222 233667789999999999999999999999888754
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=308.31 Aligned_cols=232 Identities=16% Similarity=0.237 Sum_probs=188.7
Q ss_pred ccEEEEEeeecccCCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHc-CCCCCHHHHHH
Q 013092 2 YEILTVFSVQENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFC-SRKLSLKTVLM 79 (449)
Q Consensus 2 ~~aikV~~k~~~~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~-~~~ls~~~~~~ 79 (449)
|+|||++..-.+ .+....+.+|+..|..+ +||||+..+..|..+..+|+||.|| +|++.++++.. ...|++..+..
T Consensus 53 ~VAIK~inLEkc-~~~ld~l~kE~~~msl~-~HPNIv~~~~sFvv~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~ 130 (516)
T KOG0582|consen 53 VVAIKIINLEKC-NNDLDALRKEVQTMSLI-DHPNIVTYHCSFVVDSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIAT 130 (516)
T ss_pred EEEEEEeehhhh-hhhHHHHHHHHHHhhhc-CCCCcceEEEEEEecceeEEeehhhcCCcHHHHHHHHccccccHHHHHH
Confidence 456665554333 33467899999999999 9999999999999999999999999 99999999754 45599999999
Q ss_pred HHHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhC
Q 013092 80 LADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG 159 (449)
Q Consensus 80 i~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~ 159 (449)
|+.+++.||.|||.+|.||||||+.|||| +.+|.|||+|||..-.+.+... ...++. .+++||++|||||++..
T Consensus 131 iLre~LkaL~YLH~~G~IHRdvKAgnILi---~~dG~VkLadFgvsa~l~~~G~--R~~~rf-~tfvgtp~wmAPEvl~q 204 (516)
T KOG0582|consen 131 ILREVLKALDYLHQNGHIHRDVKAGNILI---DSDGTVKLADFGVSASLFDSGD--RQVTRF-NTFVGTPCWMAPEVLMQ 204 (516)
T ss_pred HHHHHHHHHHHHHhcCceecccccccEEE---cCCCcEEEcCceeeeeecccCc--eeeEee-ccccCcccccChHHhhh
Confidence 99999999999999999999999999999 6999999999998877766542 223344 78999999999999653
Q ss_pred --CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccc----hHHHhhcCCcHHHHHHHHHHhcCCCC
Q 013092 160 --IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST----SIEALCRGYPTEFASYFHYCRSLRFD 233 (449)
Q Consensus 160 --~~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~----~~~~l~~~~p~el~~li~~cl~~~p~ 233 (449)
..|+.|+||||||++..||.+|..||..+.+. +..+.++....... .-.+-.+.++..|..+|..|+..||.
T Consensus 205 ~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPm--kvLl~tLqn~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~ 282 (516)
T KOG0582|consen 205 QLHGYDFKADIWSFGITACELAHGHAPFSKYPPM--KVLLLTLQNDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPS 282 (516)
T ss_pred cccCccchhhhhhhhHHHHHHhcCCCCcccCChH--HHHHHHhcCCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcc
Confidence 46999999999999999999999999987552 33333443332211 11122356788999999999999999
Q ss_pred CCCCHHHHHH
Q 013092 234 DKPDYAYLKR 243 (449)
Q Consensus 234 ~RPt~~~l~~ 243 (449)
+||++++|++
T Consensus 283 kRptAskLlk 292 (516)
T KOG0582|consen 283 KRPTASKLLK 292 (516)
T ss_pred cCCCHHHHhc
Confidence 9999988753
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=316.57 Aligned_cols=221 Identities=19% Similarity=0.233 Sum_probs=192.4
Q ss_pred ccEEEEEeeecccCCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHH
Q 013092 2 YEILTVFSVQENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLA 81 (449)
Q Consensus 2 ~~aikV~~k~~~~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~~~~i~ 81 (449)
++|||++-|....+.+-..+.+|++|++.| .||||+.++..|+...+.|+|.|||-|+|..++.. ++.++++.+..++
T Consensus 29 ~vAik~i~K~gr~~k~l~~l~~ev~i~r~l-kHpniv~m~esfEt~~~~~vVte~a~g~L~~il~~-d~~lpEe~v~~~a 106 (808)
T KOG0597|consen 29 VVAIKFIDKSGRNEKELKNLRQEVRILRSL-KHPNIVEMLESFETSAHLWVVTEYAVGDLFTILEQ-DGKLPEEQVRAIA 106 (808)
T ss_pred EEEEEEehhcCCchHHHHHHHHHHHHHHhc-CCcchhhHHHhhcccceEEEEehhhhhhHHHHHHh-ccCCCHHHHHHHH
Confidence 467888887777777777899999999999 99999999999999999999999995599999986 6789999999999
Q ss_pred HHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCC
Q 013092 82 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIE 161 (449)
Q Consensus 82 ~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~ 161 (449)
+|++.||.|||+.+|+|||+||+|||+ +.++.+|+||||+|+.+..+.. ......|||-|||||+..+.+
T Consensus 107 ~~LVsaL~yLhs~rilhrd~kPqniLl---~~~~~~KlcdFg~Ar~m~~~t~-------vltsikGtPlYmAPElv~e~p 176 (808)
T KOG0597|consen 107 YDLVSALYYLHSNRILHRDMKPQNILL---EKGGTLKLCDFGLARAMSTNTS-------VLTSIKGTPLYMAPELVEEQP 176 (808)
T ss_pred HHHHHHHHHHHhcCcccccCCcceeee---cCCCceeechhhhhhhcccCce-------eeeeccCcccccCHHHHcCCC
Confidence 999999999999999999999999999 6899999999999998766422 124568999999999999999
Q ss_pred CChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHH
Q 013092 162 QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYL 241 (449)
Q Consensus 162 ~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l 241 (449)
|+..+|+||||||+|||+.|++||.. ....+..+.|....... +...+.+|..|++..+..||..|.+..+|
T Consensus 177 yd~~sDlWslGcilYE~~~G~PPF~a---~si~~Lv~~I~~d~v~~-----p~~~S~~f~nfl~gLL~kdP~~RltW~~L 248 (808)
T KOG0597|consen 177 YDHTSDLWSLGCILYELYVGQPPFYA---RSITQLVKSILKDPVKP-----PSTASSSFVNFLQGLLIKDPAQRLTWTDL 248 (808)
T ss_pred ccchhhHHHHHHHHHHHhcCCCCchH---HHHHHHHHHHhcCCCCC-----cccccHHHHHHHHHHhhcChhhcccHHHH
Confidence 99999999999999999999999975 34455555555544332 23578899999999999999999998776
Q ss_pred H
Q 013092 242 K 242 (449)
Q Consensus 242 ~ 242 (449)
.
T Consensus 249 l 249 (808)
T KOG0597|consen 249 L 249 (808)
T ss_pred h
Confidence 4
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=312.54 Aligned_cols=209 Identities=22% Similarity=0.279 Sum_probs=180.1
Q ss_pred HHHHHHHHHHhcCCCCCceEEEEeEeCC-EEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q 013092 21 LLYESKLYRILQGGTGIPNVRWFGVEGD-YNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHR 99 (449)
Q Consensus 21 ~~~E~~il~~l~~hp~Iv~l~~~~~~~~-~~~lVmE~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~givHR 99 (449)
=++|++.|++|..||||++|+.++.+.+ .+|+|||||..+|+++++..++.|++..+..|+.||+.||+|+|++||.||
T Consensus 55 nLREvksL~kln~hpniikL~Evi~d~~~~L~fVfE~Md~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHR 134 (538)
T KOG0661|consen 55 NLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVFEFMDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHR 134 (538)
T ss_pred HHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeHHhhhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccc
Confidence 3689999999966999999999998887 999999999999999999878889999999999999999999999999999
Q ss_pred CCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhC-CCCChhhHHHHHHHHHHHH
Q 013092 100 DIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYF 178 (449)
Q Consensus 100 DLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~-~~~s~~~DiwSlG~il~el 178 (449)
||||+|||+ .....|||+|||||+....... | ..++.|.+|.|||+++. .-|+.+.|||++|||++|+
T Consensus 135 DlKPENiLi---~~~~~iKiaDFGLARev~SkpP-----Y---TeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl 203 (538)
T KOG0661|consen 135 DLKPENILI---SGNDVIKIADFGLAREVRSKPP-----Y---TEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAEL 203 (538)
T ss_pred cCChhheEe---cccceeEecccccccccccCCC-----c---chhhhcccccchHHhhhccccCCchHHHHHHHHHHHH
Confidence 999999999 4688999999999998766443 3 46789999999999885 5689999999999999999
Q ss_pred HhCCCCCCCCCcCCHHHHHHHHHhhc-------------------------ccchHHHhhcCCcHHHHHHHHHHhcCCCC
Q 013092 179 LRGSLPWQGLKAGTKKQKYEKISEKK-------------------------VSTSIEALCRGYPTEFASYFHYCRSLRFD 233 (449)
Q Consensus 179 ltG~~Pf~~~~~~~~~~~~~~i~~~~-------------------------~~~~~~~l~~~~p~el~~li~~cl~~~p~ 233 (449)
.+-++.|+|... .+.+.+|++.. ....+..+...++.++.++|..|+.+||+
T Consensus 204 ~sLrPLFPG~sE---~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~ 280 (538)
T KOG0661|consen 204 YSLRPLFPGASE---IDQIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPD 280 (538)
T ss_pred HHhcccCCCCcH---HHHHHHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCc
Confidence 999999998543 33334454421 22344455667899999999999999999
Q ss_pred CCCCHHHHHH
Q 013092 234 DKPDYAYLKR 243 (449)
Q Consensus 234 ~RPt~~~l~~ 243 (449)
+|||+.+.++
T Consensus 281 kRpTA~~al~ 290 (538)
T KOG0661|consen 281 KRPTASQALQ 290 (538)
T ss_pred cCccHHHHhc
Confidence 9999988765
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=305.69 Aligned_cols=247 Identities=19% Similarity=0.273 Sum_probs=202.0
Q ss_pred ccEEEEEeeeccc-CCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHc-CCCCCHHHHH
Q 013092 2 YEILTVFSVQENV-KTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFC-SRKLSLKTVL 78 (449)
Q Consensus 2 ~~aikV~~k~~~~-~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~-~~~ls~~~~~ 78 (449)
+-|+||+-|.... ..+......|.+||..+ +||.++.||..++.+++.||||||| ||+|..++++. ++.|++..+.
T Consensus 104 ~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~l-DHPFlPTLYa~fet~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aR 182 (459)
T KOG0610|consen 104 LFAMKVMDKESLASRKKLKRAQTEREILSLL-DHPFLPTLYASFETDKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAAR 182 (459)
T ss_pred eEEEEEecHHHHhhhhHHHHHHHHHHHHHhc-CCCccchhhheeeccceeEEEEecCCCccHHHHHhhCCCCccchhhHH
Confidence 3488999888865 45666788899999999 9999999999999999999999999 99999999765 5669999999
Q ss_pred HHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCc-----------------------
Q 013092 79 MLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ----------------------- 135 (449)
Q Consensus 79 ~i~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~----------------------- 135 (449)
+++.+++.||+|||-.|||+|||||+|||| ..+|+|.|+||.|+....-..+..
T Consensus 183 FYaAEvl~ALEYLHmlGivYRDLKPENILv---redGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~ 259 (459)
T KOG0610|consen 183 FYAAEVLLALEYLHMLGIVYRDLKPENILV---REDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFS 259 (459)
T ss_pred HHHHHHHHHHHHHHhhceeeccCCcceeEE---ecCCcEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccc
Confidence 999999999999999999999999999999 699999999999976542110000
Q ss_pred -------c------------------cc-cccCCCCccCccccchhhhhCCCCChhhHHHHHHHHHHHHHhCCCCCCCCC
Q 013092 136 -------H------------------IP-YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLK 189 (449)
Q Consensus 136 -------~------------------~~-~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il~elltG~~Pf~~~~ 189 (449)
. .| ......++||..|+|||++.|...+..+|+|.||++|||||.|..||.+.+
T Consensus 260 ~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~ 339 (459)
T KOG0610|consen 260 PRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSN 339 (459)
T ss_pred cchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCC
Confidence 0 00 012235789999999999999999999999999999999999999999854
Q ss_pred cCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCC----HHHHHHHHHHHHHHcCCCCCCcccchhh
Q 013092 190 AGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPD----YAYLKRIFRDLFIREGFQFDYVFDWTIL 265 (449)
Q Consensus 190 ~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt----~~~l~~~L~~~~~~~~~~~~~~~dw~~~ 265 (449)
..+.+..|..+....+-. ..++..+.+||+++|.+||.+|.. +.+|+ .++|+..++|...
T Consensus 340 ---~~~Tl~NIv~~~l~Fp~~---~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK----------~HpFF~gVnWaLi 403 (459)
T KOG0610|consen 340 ---NKETLRNIVGQPLKFPEE---PEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIK----------RHPFFEGVNWALI 403 (459)
T ss_pred ---chhhHHHHhcCCCcCCCC---CcchhHHHHHHHHHhccChhhhhccccchHHhh----------cCccccCCChhhe
Confidence 456666666554432111 145689999999999999999987 45554 4689999999966
Q ss_pred hhh
Q 013092 266 KYQ 268 (449)
Q Consensus 266 ~~~ 268 (449)
+..
T Consensus 404 r~~ 406 (459)
T KOG0610|consen 404 RCA 406 (459)
T ss_pred ecc
Confidence 543
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=310.07 Aligned_cols=219 Identities=17% Similarity=0.276 Sum_probs=177.1
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEe-CCEEEEEEecC-CCCHHHHHHHcC--------------------------
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVE-GDYNVLVMDLL-GPSLEDLFNFCS-------------------------- 69 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~-~~~~~lVmE~~-g~sL~~ll~~~~-------------------------- 69 (449)
...+.+|+.++..+.+||||+.+++++.. ....|+||||+ +++|.+++....
T Consensus 54 ~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 133 (338)
T cd05102 54 HKALMSELKILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRV 133 (338)
T ss_pred HHHHHHHHHHHHHhccCcceeeEEeEecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhcc
Confidence 35688999999999899999999998775 44689999999 999999987421
Q ss_pred -----------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCCC
Q 013092 70 -----------------------------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRA 114 (449)
Q Consensus 70 -----------------------------------~~ls~~~~~~i~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~ 114 (449)
..+++..++.++.||+.||+|||++||+||||||+|||+ +.+
T Consensus 134 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~---~~~ 210 (338)
T cd05102 134 DRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILL---SEN 210 (338)
T ss_pred ccccccccCCccccccccccCcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEE---cCC
Confidence 247888999999999999999999999999999999999 577
Q ss_pred CeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCCH
Q 013092 115 NQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTK 193 (449)
Q Consensus 115 ~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~ 193 (449)
+.+||+|||+++........ .......++..|+|||++.+..++.++|||||||+||||++ |..||.+.....
T Consensus 211 ~~~kl~DfG~a~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~- 284 (338)
T cd05102 211 NVVKICDFGLARDIYKDPDY-----VRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE- 284 (338)
T ss_pred CcEEEeecccccccccCcch-----hcccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH-
Confidence 89999999999865432211 11233456788999999999999999999999999999997 999998754321
Q ss_pred HHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 013092 194 KQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFI 250 (449)
Q Consensus 194 ~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~L~~~~~ 250 (449)
.....+..... ...+..+++++.+++..||+.+|++||++.+|.+.|++++.
T Consensus 285 -~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 285 -EFCQRLKDGTR----MRAPENATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred -HHHHHHhcCCC----CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 12222222111 12345678999999999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=317.58 Aligned_cols=210 Identities=20% Similarity=0.308 Sum_probs=179.6
Q ss_pred CChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC
Q 013092 16 TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 94 (449)
Q Consensus 16 ~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~ 94 (449)
.+.+-+++|+.+|+-+ +|+|||+++..+..++.+|+||||+ ||+|.|++.. ..+++.++..|+.+++.||+|||.+
T Consensus 312 ~~keLilnEi~Vm~~~-~H~NiVnfl~Sylv~deLWVVMEym~ggsLTDvVt~--~~~~E~qIA~Icre~l~aL~fLH~~ 388 (550)
T KOG0578|consen 312 PKKELLLNEILVMRDL-HHPNIVNFLDSYLVGDELWVVMEYMEGGSLTDVVTK--TRMTEGQIAAICREILQGLKFLHAR 388 (550)
T ss_pred CchhhhHHHHHHHHhc-cchHHHHHHHHhcccceeEEEEeecCCCchhhhhhc--ccccHHHHHHHHHHHHHHHHHHHhc
Confidence 3445588999999999 9999999999999889999999999 9999999984 4599999999999999999999999
Q ss_pred CceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHH
Q 013092 95 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYV 174 (449)
Q Consensus 95 givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~i 174 (449)
||+|||||.+|||+ ..++.+||+|||++..+...... ..+.+||+.|||||+.....|+++.||||||+|
T Consensus 389 gIiHrDIKSDnILL---~~~g~vKltDFGFcaqi~~~~~K-------R~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIM 458 (550)
T KOG0578|consen 389 GIIHRDIKSDNILL---TMDGSVKLTDFGFCAQISEEQSK-------RSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIM 458 (550)
T ss_pred ceeeeccccceeEe---ccCCcEEEeeeeeeeccccccCc-------cccccCCCCccchhhhhhcccCccccchhhhhH
Confidence 99999999999999 58888999999999888765542 357899999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 175 LMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 175 l~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
++||+.|.+||-.. +..+.+..|..... +.-..++.++++|.+|+.+||..|+++|+++.+|++
T Consensus 459 aIEMveGEPPYlnE---~PlrAlyLIa~ng~--P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 459 AIEMVEGEPPYLNE---NPLRALYLIATNGT--PKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred HHHHhcCCCCccCC---ChHHHHHHHhhcCC--CCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 99999999999763 33333333332211 111234678999999999999999999999887753
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=306.99 Aligned_cols=238 Identities=19% Similarity=0.259 Sum_probs=189.0
Q ss_pred cEEEEEeeecccC-CChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHH
Q 013092 3 EILTVFSVQENVK-TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLML 80 (449)
Q Consensus 3 ~aikV~~k~~~~~-~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i 80 (449)
.|+|++.+..... .....+.+|+.+++.+ +||||+++++.+.+++..|+||||+ |++|.+++.. ...+++..+..+
T Consensus 46 ~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~ 123 (329)
T PTZ00263 46 YAIKCLKKREILKMKQVQHVAQEKSILMEL-SHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRK-AGRFPNDVAKFY 123 (329)
T ss_pred EEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-CCCCCCcEEEEEEcCCEEEEEEcCCCCChHHHHHHH-cCCCCHHHHHHH
Confidence 4566665543222 3445688999999999 9999999999999999999999999 9999999875 457899999999
Q ss_pred HHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCC
Q 013092 81 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI 160 (449)
Q Consensus 81 ~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~ 160 (449)
+.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++...... ....||+.|+|||++.+.
T Consensus 124 ~~qi~~aL~~LH~~~ivH~dlkp~NIll---~~~~~~kl~Dfg~~~~~~~~~----------~~~~gt~~y~aPE~~~~~ 190 (329)
T PTZ00263 124 HAELVLAFEYLHSKDIIYRDLKPENLLL---DNKGHVKVTDFGFAKKVPDRT----------FTLCGTPEYLAPEVIQSK 190 (329)
T ss_pred HHHHHHHHHHHHHCCeeecCCCHHHEEE---CCCCCEEEeeccCceEcCCCc----------ceecCChhhcCHHHHcCC
Confidence 9999999999999999999999999999 678899999999998764322 235799999999999999
Q ss_pred CCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHH
Q 013092 161 EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAY 240 (449)
Q Consensus 161 ~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~ 240 (449)
.++.++|||||||++|+|++|..||.+. ...+.+..+..... .++..++.++.+||..||+.||.+||+.
T Consensus 191 ~~~~~~DiwslG~il~elltg~~pf~~~---~~~~~~~~i~~~~~-----~~p~~~~~~~~~li~~~L~~dP~~R~~~-- 260 (329)
T PTZ00263 191 GHGKAVDWWTMGVLLYEFIAGYPPFFDD---TPFRIYEKILAGRL-----KFPNWFDGRARDLVKGLLQTDHTKRLGT-- 260 (329)
T ss_pred CCCCcceeechHHHHHHHHcCCCCCCCC---CHHHHHHHHhcCCc-----CCCCCCCHHHHHHHHHHhhcCHHHcCCC--
Confidence 9999999999999999999999999763 33455555554432 1334578899999999999999999972
Q ss_pred HHHHHHHHHHHcCCCCCCcccchhhhhh
Q 013092 241 LKRIFRDLFIREGFQFDYVFDWTILKYQ 268 (449)
Q Consensus 241 l~~~L~~~~~~~~~~~~~~~dw~~~~~~ 268 (449)
+...+.++ ..+++....+|......
T Consensus 261 ~~~~~~~l---l~hp~f~~~~~~~~~~~ 285 (329)
T PTZ00263 261 LKGGVADV---KNHPYFHGANWDKLYAR 285 (329)
T ss_pred CCCCHHHH---hcCCccCCCCHHHHHhC
Confidence 11111222 12344555678866443
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=308.17 Aligned_cols=236 Identities=18% Similarity=0.245 Sum_probs=188.8
Q ss_pred cEEEEEeeeccc-CCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHH
Q 013092 3 EILTVFSVQENV-KTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLML 80 (449)
Q Consensus 3 ~aikV~~k~~~~-~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i 80 (449)
.|||++.+.... ......+.+|+.+++.+ +||||+.+++.+...+..||||||+ +++|.+++.. .+.+++..+..+
T Consensus 23 ~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~ 100 (323)
T cd05571 23 YAMKILKKEVIIAKDEVAHTLTESRVLQNT-RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSR-ERVFSEDRARFY 100 (323)
T ss_pred EEEEEEEHHHhhhhHHHHHHHHHHHHHHhC-CCCCCCCEEEEEEcCCEEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHH
Confidence 455655543322 23345678999999999 8999999999999999999999999 9999999875 567999999999
Q ss_pred HHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCC
Q 013092 81 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI 160 (449)
Q Consensus 81 ~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~ 160 (449)
+.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++....... ......||+.|+|||++.+.
T Consensus 101 ~~qi~~~L~~lH~~~ivHrDlkp~NIll---~~~~~~kl~DfG~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~ 170 (323)
T cd05571 101 GAEIVSALGYLHSCDVVYRDLKLENLML---DKDGHIKITDFGLCKEGISDGA-------TMKTFCGTPEYLAPEVLEDN 170 (323)
T ss_pred HHHHHHHHHHHHhCCeEeCCCCHHHEEE---CCCCCEEEeeCCCCcccccCCC-------cccceecCccccChhhhcCC
Confidence 9999999999999999999999999999 5788999999999875432211 12345799999999999999
Q ss_pred CCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCC----
Q 013092 161 EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKP---- 236 (449)
Q Consensus 161 ~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RP---- 236 (449)
.++.++|||||||++|||++|..||... +....+..+..... .++..+++++.++|..||..||++||
T Consensus 171 ~~~~~~DiwSlG~il~elltg~~Pf~~~---~~~~~~~~~~~~~~-----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~ 242 (323)
T cd05571 171 DYGRAVDWWGLGVVMYEMMCGRLPFYNQ---DHEKLFELILMEEI-----RFPRTLSPEAKSLLAGLLKKDPKQRLGGGP 242 (323)
T ss_pred CCCccccCcccchhhhhhhcCCCCCCCC---CHHHHHHHHHcCCC-----CCCCCCCHHHHHHHHHHccCCHHHcCCCCC
Confidence 9999999999999999999999999763 23333443333222 23456889999999999999999999
Q ss_pred -CHHHHHHHHHHHHHHcCCCCCCcccchhhhhh
Q 013092 237 -DYAYLKRIFRDLFIREGFQFDYVFDWTILKYQ 268 (449)
Q Consensus 237 -t~~~l~~~L~~~~~~~~~~~~~~~dw~~~~~~ 268 (449)
++.+|++ +++....+|......
T Consensus 243 ~~~~~ll~----------h~~f~~~~~~~~~~~ 265 (323)
T cd05571 243 EDAKEIME----------HRFFASINWQDVVQK 265 (323)
T ss_pred CCHHHHHc----------CCCcCCCCHHHHHhC
Confidence 6666532 355666788766443
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=296.55 Aligned_cols=212 Identities=18% Similarity=0.257 Sum_probs=174.1
Q ss_pred HHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q 013092 20 QLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHR 99 (449)
Q Consensus 20 ~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~givHR 99 (449)
-.++|+++|++| .|+|+|.|+.+|......+||+|||.-++.+.+......++.+.+..+++|++.|+.|+|++++|||
T Consensus 47 IAlREIrmLKqL-kH~NLVnLiEVFrrkrklhLVFE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHR 125 (396)
T KOG0593|consen 47 IALREIRMLKQL-KHENLVNLIEVFRRKRKLHLVFEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHR 125 (396)
T ss_pred HHHHHHHHHHhc-ccchHHHHHHHHHhcceeEEEeeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecc
Confidence 367999999999 9999999999999999999999999888887787666679999999999999999999999999999
Q ss_pred CCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhC-CCCChhhHHHHHHHHHHHH
Q 013092 100 DIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYF 178 (449)
Q Consensus 100 DLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~-~~~s~~~DiwSlG~il~el 178 (449)
||||+|||| ...+.+||||||+|+.+..+.. ....++.|.+|.|||.+.| .+|+..+|||++||++.||
T Consensus 126 DIKPENILi---t~~gvvKLCDFGFAR~L~~pgd-------~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl 195 (396)
T KOG0593|consen 126 DIKPENILI---TQNGVVKLCDFGFARTLSAPGD-------NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAEL 195 (396)
T ss_pred cCChhheEE---ecCCcEEeccchhhHhhcCCcc-------hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHH
Confidence 999999999 5899999999999998764322 2245788999999999998 7899999999999999999
Q ss_pred HhCCCCCCCCCcCCHHHHHHHHHhh-----------------------cccchHHHhhcCCcHHHHHHHHHHhcCCCCCC
Q 013092 179 LRGSLPWQGLKAGTKKQKYEKISEK-----------------------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDK 235 (449)
Q Consensus 179 ltG~~Pf~~~~~~~~~~~~~~i~~~-----------------------~~~~~~~~l~~~~p~el~~li~~cl~~~p~~R 235 (449)
++|.+.|++..+-+..-.+.+.... .-..+++.-.+++..-+.+|++.|++.||++|
T Consensus 196 ~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R 275 (396)
T KOG0593|consen 196 LTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDR 275 (396)
T ss_pred hcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCcccc
Confidence 9999999996543322222211100 00111222223445678999999999999999
Q ss_pred CCHHHHH
Q 013092 236 PDYAYLK 242 (449)
Q Consensus 236 Pt~~~l~ 242 (449)
++.+++.
T Consensus 276 ~sc~qll 282 (396)
T KOG0593|consen 276 LSCEQLL 282 (396)
T ss_pred ccHHHHh
Confidence 9988875
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=297.94 Aligned_cols=210 Identities=21% Similarity=0.212 Sum_probs=176.6
Q ss_pred hHHHHHHHHHHHhcCCCCCceEEEEeEe----CCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH
Q 013092 19 PQLLYESKLYRILQGGTGIPNVRWFGVE----GDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 93 (449)
Q Consensus 19 ~~~~~E~~il~~l~~hp~Iv~l~~~~~~----~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~ 93 (449)
+.+.+|+.+|.++ .||||+++++++.+ ....+|||||+ +++|.+++.. ...+++...+.++.|++.||.|||+
T Consensus 63 ~~~~~E~~~l~~l-~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lH~ 140 (283)
T PHA02988 63 DITENEIKNLRRI-DSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDK-EKDLSFKTKLDMAIDCCKGLYNLYK 140 (283)
T ss_pred HHHHHHHHHHHhc-CCCCEEEEeeeEEecccCCCceEEEEEeCCCCcHHHHHhh-CCCCChhHHHHHHHHHHHHHHHHHh
Confidence 5677999999999 89999999999876 45789999999 9999999985 4578999999999999999999998
Q ss_pred -CCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhC--CCCChhhHHHH
Q 013092 94 -KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG--IEQSRRDDLES 170 (449)
Q Consensus 94 -~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~--~~~s~~~DiwS 170 (449)
.+++||||||+|||+ +.++.+||+|||+++.+.... ....||..|+|||++.+ ..++.++||||
T Consensus 141 ~~~~~Hrdlkp~nill---~~~~~~kl~dfg~~~~~~~~~----------~~~~~~~~y~aPE~~~~~~~~~~~k~Di~S 207 (283)
T PHA02988 141 YTNKPYKNLTSVSFLV---TENYKLKIICHGLEKILSSPP----------FKNVNFMVYFSYKMLNDIFSEYTIKDDIYS 207 (283)
T ss_pred cCCCCCCcCChhhEEE---CCCCcEEEcccchHhhhcccc----------ccccCcccccCHHHhhhccccccchhhhhH
Confidence 499999999999999 578899999999998654322 23468899999999976 67899999999
Q ss_pred HHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 013092 171 LGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLF 249 (449)
Q Consensus 171 lG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~L~~~~ 249 (449)
|||++|||++|..||.+.+ ..+.+..+....... .++..+|+++.+|+.+||+.+|++||++.+|...|+.+.
T Consensus 208 lGvil~el~~g~~Pf~~~~---~~~~~~~i~~~~~~~---~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 208 LGVVLWEIFTGKIPFENLT---TKEIYDLIINKNNSL---KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred HHHHHHHHHHCCCCCCCCC---HHHHHHHHHhcCCCC---CCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 9999999999999998753 334444443332222 133468999999999999999999999999999988763
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=298.86 Aligned_cols=231 Identities=16% Similarity=0.203 Sum_probs=184.5
Q ss_pred hHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 013092 19 PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSF 96 (449)
Q Consensus 19 ~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~-~~~ls~~~~~~i~~qi~~aL~yLH~~gi 96 (449)
..+.+|++++..+ +|++|+.+.+.+.+.+..|+||||+ +++|.+++... ...+++..++.++.|++.||+|||++||
T Consensus 45 ~~~~~E~~il~~l-~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i 123 (285)
T cd05631 45 AMALNEKRILEKV-NSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERI 123 (285)
T ss_pred HHHHHHHHHHHhc-CCCcEEEEEEEEccCCeEEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCE
Confidence 4578999999999 9999999999999999999999999 89998887643 3468999999999999999999999999
Q ss_pred eecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHHHH
Q 013092 97 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLM 176 (449)
Q Consensus 97 vHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il~ 176 (449)
+||||||+|||+ +.++.++|+|||++........ .....||..|+|||++.+..++.++|||||||++|
T Consensus 124 iH~dikp~Nill---~~~~~~kl~Dfg~~~~~~~~~~--------~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~ 192 (285)
T cd05631 124 VYRDLKPENILL---DDRGHIRISDLGLAVQIPEGET--------VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIY 192 (285)
T ss_pred EeCCCCHHHEEE---CCCCCEEEeeCCCcEEcCCCCe--------ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHH
Confidence 999999999999 5788999999999987543221 12457899999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCC-----HHHHHHHHHHHHHH
Q 013092 177 YFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPD-----YAYLKRIFRDLFIR 251 (449)
Q Consensus 177 elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt-----~~~l~~~L~~~~~~ 251 (449)
+|++|+.||.+.......+.+.... ......+...++.++.+|+..||+.+|++||+ ++++++
T Consensus 193 el~~g~~pf~~~~~~~~~~~~~~~~----~~~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~-------- 260 (285)
T cd05631 193 EMIQGQSPFRKRKERVKREEVDRRV----KEDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ-------- 260 (285)
T ss_pred HHHhCCCCCCCCCcchhHHHHHHHh----hcccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc--------
Confidence 9999999998754432222222111 11122344568999999999999999999997 454432
Q ss_pred cCCCCCCcccchhhhhhhccCCCC
Q 013092 252 EGFQFDYVFDWTILKYQQSQLATP 275 (449)
Q Consensus 252 ~~~~~~~~~dw~~~~~~~~~~~~~ 275 (449)
.++...++|..++.....++..
T Consensus 261 --h~~~~~~~~~~~~~~~~~~~~~ 282 (285)
T cd05631 261 --HPIFKNINFKRLEANMLEPPFC 282 (285)
T ss_pred --CHhhcCCCHHHHHhCcCCcCCC
Confidence 3445667888877665444433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=305.00 Aligned_cols=215 Identities=22% Similarity=0.258 Sum_probs=179.8
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeC--CEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEG--DYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 95 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~--~~~~lVmE~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~g 95 (449)
.....+||.||++| +||||++|.+...+. ..+|||+|||..+|.-++....-+|++.++..|+.|++.||+|||.+|
T Consensus 160 ~~t~~REI~ILr~l-~HpNIikL~eivt~~~~~siYlVFeYMdhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~g 238 (560)
T KOG0600|consen 160 PITAIREIKILRRL-DHPNIIKLEEIVTSKLSGSIYLVFEYMDHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRG 238 (560)
T ss_pred hHHHHHHHHHHHhc-CCCcccceeeEEEecCCceEEEEEecccchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcC
Confidence 34467999999999 999999999888765 789999999999999999865668999999999999999999999999
Q ss_pred ceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCC-CCChhhHHHHHHHH
Q 013092 96 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYV 174 (449)
Q Consensus 96 ivHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~-~~s~~~DiwSlG~i 174 (449)
|+|||||..|||| +..|.+||+|||||+.+...... .....+-|.+|.+||.++|. .|+...|+||.|||
T Consensus 239 vlHRDIK~SNiLi---dn~G~LKiaDFGLAr~y~~~~~~------~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCI 309 (560)
T KOG0600|consen 239 VLHRDIKGSNILI---DNNGVLKIADFGLARFYTPSGSA------PYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCI 309 (560)
T ss_pred eeeccccccceEE---cCCCCEEeccccceeeccCCCCc------ccccceEEeeccChHHhcCCcccccceeehhhhHH
Confidence 9999999999999 79999999999999988765432 13566789999999999984 69999999999999
Q ss_pred HHHHHhCCCCCCCCCcCCHHHHHHHHHhhc---------------------ccchHHHhhcCCcHHHHHHHHHHhcCCCC
Q 013092 175 LMYFLRGSLPWQGLKAGTKKQKYEKISEKK---------------------VSTSIEALCRGYPTEFASYFHYCRSLRFD 233 (449)
Q Consensus 175 l~elltG~~Pf~~~~~~~~~~~~~~i~~~~---------------------~~~~~~~l~~~~p~el~~li~~cl~~~p~ 233 (449)
|.||+.|++.|++.+.-+...++.+++... ....+.+....+|+...+|+..+|.+||+
T Consensus 310 l~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~ 389 (560)
T KOG0600|consen 310 LAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPD 389 (560)
T ss_pred HHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCcc
Confidence 999999999999965544444444443211 01112233466789999999999999999
Q ss_pred CCCCHHHHH
Q 013092 234 DKPDYAYLK 242 (449)
Q Consensus 234 ~RPt~~~l~ 242 (449)
+|.++.+.+
T Consensus 390 kR~tA~~aL 398 (560)
T KOG0600|consen 390 KRGTASSAL 398 (560)
T ss_pred ccccHHHHh
Confidence 999987654
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=301.22 Aligned_cols=217 Identities=22% Similarity=0.324 Sum_probs=181.4
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 96 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gi 96 (449)
.+.+.+|+.+++.+ +||||+++++++.+++..||||||+ +++|.+++.. .+.+++..++.++.||+.||+|||++||
T Consensus 45 ~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i 122 (291)
T cd05612 45 EQHVHNEKRVLKEV-SHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRN-SGRFSNSTGLFYASEIVCALEYLHSKEI 122 (291)
T ss_pred HHHHHHHHHHHHhC-CCCcHhhhHhhhccCCeEEEEEeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 45688999999999 8999999999999999999999999 9999999975 4579999999999999999999999999
Q ss_pred eecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHHHH
Q 013092 97 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLM 176 (449)
Q Consensus 97 vHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il~ 176 (449)
+||||||+|||+ +.++.+||+|||+++...... ....||+.|+|||++.+..++.++|||||||++|
T Consensus 123 ~H~dlkp~NIli---~~~~~~kl~Dfg~~~~~~~~~----------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ 189 (291)
T cd05612 123 VYRDLKPENILL---DKEGHIKLTDFGFAKKLRDRT----------WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIY 189 (291)
T ss_pred eecCCCHHHeEE---CCCCCEEEEecCcchhccCCc----------ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHH
Confidence 999999999999 578899999999998654321 2357899999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCC-----HHHHHHHHHHHHHH
Q 013092 177 YFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPD-----YAYLKRIFRDLFIR 251 (449)
Q Consensus 177 elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt-----~~~l~~~L~~~~~~ 251 (449)
+|++|..||.+.. ..+.+..+..... .+...++.++.++|..||+.||.+||+ +.+++
T Consensus 190 ~l~~g~~pf~~~~---~~~~~~~i~~~~~-----~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l--------- 252 (291)
T cd05612 190 EMLVGYPPFFDDN---PFGIYEKILAGKL-----EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVK--------- 252 (291)
T ss_pred HHHhCCCCCCCCC---HHHHHHHHHhCCc-----CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHh---------
Confidence 9999999998743 3444555544332 233457889999999999999999995 55443
Q ss_pred cCCCCCCcccchhhhh
Q 013092 252 EGFQFDYVFDWTILKY 267 (449)
Q Consensus 252 ~~~~~~~~~dw~~~~~ 267 (449)
..++...++|.....
T Consensus 253 -~h~~~~~~~~~~~~~ 267 (291)
T cd05612 253 -NHRWFKSVDWDDVPQ 267 (291)
T ss_pred -cCccccCCCHHHHhc
Confidence 235556678876543
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=303.05 Aligned_cols=238 Identities=18% Similarity=0.263 Sum_probs=188.4
Q ss_pred EEEEEeeecc-cCCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHH
Q 013092 4 ILTVFSVQEN-VKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLA 81 (449)
Q Consensus 4 aikV~~k~~~-~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~ 81 (449)
|+|++.+... .......+..|+.++..+ +||||+++++.+.+.+..||||||+ +++|.+++.. ...+++..+..++
T Consensus 22 aiK~i~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~ 99 (312)
T cd05585 22 ALKTIRKAHIVSRSEVTHTLAERTVLAQV-NCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQR-EGRFDLSRARFYT 99 (312)
T ss_pred EEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCcEeceeeEEecCCeEEEEEcCCCCCcHHHHHHh-cCCCCHHHHHHHH
Confidence 4555443322 223345678999999999 9999999999999999999999999 9999999875 5679999999999
Q ss_pred HHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCC
Q 013092 82 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIE 161 (449)
Q Consensus 82 ~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~ 161 (449)
.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++....... ......||+.|+|||++.+..
T Consensus 100 ~qi~~~l~~lH~~~i~HrDlkp~Nili---~~~~~~kl~Dfg~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~ 169 (312)
T cd05585 100 AELLCALENLHKFNVIYRDLKPENILL---DYQGHIALCDFGLCKLNMKDDD-------KTNTFCGTPEYLAPELLLGHG 169 (312)
T ss_pred HHHHHHHHHHHhCCeEeCCCCHHHeEE---CCCCcEEEEECcccccCccCCC-------ccccccCCcccCCHHHHcCCC
Confidence 999999999999999999999999999 6788999999999975432211 123457999999999999999
Q ss_pred CChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHH
Q 013092 162 QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYL 241 (449)
Q Consensus 162 ~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l 241 (449)
++.++|||||||++|+|++|..||.+. ...+.+..+..... .++..+++++.++|..||..+|++||++..+
T Consensus 170 ~~~~~DvwslGvil~el~tg~~pf~~~---~~~~~~~~~~~~~~-----~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~ 241 (312)
T cd05585 170 YTKAVDWWTLGVLLYEMLTGLPPFYDE---NVNEMYRKILQEPL-----RFPDGFDRDAKDLLIGLLSRDPTRRLGYNGA 241 (312)
T ss_pred CCCccceechhHHHHHHHhCCCCcCCC---CHHHHHHHHHcCCC-----CCCCcCCHHHHHHHHHHcCCCHHHcCCCCCH
Confidence 999999999999999999999999864 33444444443322 2345688999999999999999999976555
Q ss_pred HHHHHHHHHHcCCCCCCcccchhhhhh
Q 013092 242 KRIFRDLFIREGFQFDYVFDWTILKYQ 268 (449)
Q Consensus 242 ~~~L~~~~~~~~~~~~~~~dw~~~~~~ 268 (449)
.++|.. ++....+|......
T Consensus 242 ~e~l~h-------p~~~~~~~~~~~~~ 261 (312)
T cd05585 242 QEIKNH-------PFFSQLSWKKLLMK 261 (312)
T ss_pred HHHHcC-------CCcCCCCHHHHHhC
Confidence 555433 33344466655433
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=305.81 Aligned_cols=220 Identities=19% Similarity=0.269 Sum_probs=184.7
Q ss_pred ChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 013092 17 KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 95 (449)
Q Consensus 17 ~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~g 95 (449)
....+.+|+.+++.+ +||||+++++++.+.+..||||||+ +++|.+++.. ...+++..+..++.||+.||+|||++|
T Consensus 74 ~~~~~~~E~~~l~~l-~hp~Iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ 151 (340)
T PTZ00426 74 QVDHVFSERKILNYI-NHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRR-NKRFPNDVGCFYAAQIVLIFEYLQSLN 151 (340)
T ss_pred hHHHHHHHHHHHHhC-CCCCCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 445688999999999 8999999999999999999999999 9999999975 457999999999999999999999999
Q ss_pred ceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHHH
Q 013092 96 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVL 175 (449)
Q Consensus 96 ivHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il 175 (449)
|+||||||+|||+ +.++.+||+|||+++...... ....||+.|+|||++.+..++.++|||||||++
T Consensus 152 ivHrDLkp~NILl---~~~~~ikL~DFG~a~~~~~~~----------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 218 (340)
T PTZ00426 152 IVYRDLKPENLLL---DKDGFIKMTDFGFAKVVDTRT----------YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFI 218 (340)
T ss_pred eEccCCCHHHEEE---CCCCCEEEecCCCCeecCCCc----------ceecCChhhcCHHHHhCCCCCccccccchhhHH
Confidence 9999999999999 578899999999998654321 245799999999999998899999999999999
Q ss_pred HHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCC-----CHHHHHHHHHHHHH
Q 013092 176 MYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKP-----DYAYLKRIFRDLFI 250 (449)
Q Consensus 176 ~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RP-----t~~~l~~~L~~~~~ 250 (449)
|||++|..||.+. +....+..+..... .++..+++++.++|..|++.+|++|+ ++++|+
T Consensus 219 ~ell~G~~Pf~~~---~~~~~~~~i~~~~~-----~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~-------- 282 (340)
T PTZ00426 219 YEILVGCPPFYAN---EPLLIYQKILEGII-----YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVK-------- 282 (340)
T ss_pred HHHhcCCCCCCCC---CHHHHHHHHhcCCC-----CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHH--------
Confidence 9999999999864 33444555544332 23456788999999999999999996 555553
Q ss_pred HcCCCCCCcccchhhhhhh
Q 013092 251 REGFQFDYVFDWTILKYQQ 269 (449)
Q Consensus 251 ~~~~~~~~~~dw~~~~~~~ 269 (449)
..++...++|.......
T Consensus 283 --~hp~f~~~~~~~~~~~~ 299 (340)
T PTZ00426 283 --EHPWFGNIDWVSLLHKN 299 (340)
T ss_pred --cCCCcCCCCHHHHHhCC
Confidence 34666778898765443
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=300.74 Aligned_cols=235 Identities=18% Similarity=0.256 Sum_probs=187.0
Q ss_pred cEEEEEeeeccc-CCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHH
Q 013092 3 EILTVFSVQENV-KTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLML 80 (449)
Q Consensus 3 ~aikV~~k~~~~-~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i 80 (449)
.|+|++.+.... ......+.+|+++++.+ +||||+.+++.+...+..||||||+ +++|.+++.. ...+++..++.+
T Consensus 23 ~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~-~~~l~~~~~~~~ 100 (328)
T cd05593 23 YAMKILKKEVIIAKDEVAHTLTESRVLKNT-RHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSR-ERVFSEDRTRFY 100 (328)
T ss_pred EEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCcceEEEEEcCCEEEEEEeCCCCCCHHHHHHh-cCCCCHHHHHHH
Confidence 456665543322 23445688999999999 9999999999999999999999999 9999988875 457999999999
Q ss_pred HHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCC
Q 013092 81 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI 160 (449)
Q Consensus 81 ~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~ 160 (449)
+.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++....... ......||+.|+|||++.+.
T Consensus 101 ~~qi~~aL~~LH~~~ivHrDikp~NIll---~~~~~~kL~DfG~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~ 170 (328)
T cd05593 101 GAEIVSALDYLHSGKIVYRDLKLENLML---DKDGHIKITDFGLCKEGITDAA-------TMKTFCGTPEYLAPEVLEDN 170 (328)
T ss_pred HHHHHHHHHHHHhCCeEecccCHHHeEE---CCCCcEEEecCcCCccCCCccc-------ccccccCCcCccChhhhcCC
Confidence 9999999999999999999999999999 5788999999999875432211 12345799999999999998
Q ss_pred CCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCC----
Q 013092 161 EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKP---- 236 (449)
Q Consensus 161 ~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RP---- 236 (449)
.++.++|||||||++|+|++|..||...+. .+.+..+..... .++..++.++.++|..||..+|++|+
T Consensus 171 ~~~~~~DiwslGvil~elltG~~Pf~~~~~---~~~~~~~~~~~~-----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~ 242 (328)
T cd05593 171 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---EKLFELILMEDI-----KFPRTLSADAKSLLSGLLIKDPNKRLGGGP 242 (328)
T ss_pred CCCccCCccccchHHHHHhhCCCCCCCCCH---HHHHHHhccCCc-----cCCCCCCHHHHHHHHHHcCCCHHHcCCCCC
Confidence 999999999999999999999999976432 233333322211 23456889999999999999999997
Q ss_pred -CHHHHHHHHHHHHHHcCCCCCCcccchhhhh
Q 013092 237 -DYAYLKRIFRDLFIREGFQFDYVFDWTILKY 267 (449)
Q Consensus 237 -t~~~l~~~L~~~~~~~~~~~~~~~dw~~~~~ 267 (449)
++.+|.+ ..+....+|.....
T Consensus 243 ~~~~~il~----------h~~~~~~~~~~~~~ 264 (328)
T cd05593 243 DDAKEIMR----------HSFFTGVNWQDVYD 264 (328)
T ss_pred CCHHHHhc----------CCCcCCCCHHHHHh
Confidence 6666543 34556678876544
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=298.69 Aligned_cols=220 Identities=17% Similarity=0.238 Sum_probs=173.9
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcC------------------CCCCHHHHH
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCS------------------RKLSLKTVL 78 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~------------------~~ls~~~~~ 78 (449)
...|.+|++++..+ .||||+++++++.+.+..||||||+ +++|.+++.... ..+++..++
T Consensus 63 ~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 141 (304)
T cd05096 63 RNDFLKEVKILSRL-KDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLL 141 (304)
T ss_pred HHHHHHHHHHHhhc-CCCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHH
Confidence 45689999999999 9999999999999999999999999 999999986421 236788899
Q ss_pred HHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhh
Q 013092 79 MLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHL 158 (449)
Q Consensus 79 ~i~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~ 158 (449)
.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||+++.+..... +.......++..|+|||++.
T Consensus 142 ~i~~~i~~al~~lH~~~ivH~dlkp~Nill---~~~~~~kl~DfG~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~ 213 (304)
T cd05096 142 HVALQIASGMKYLSSLNFVHRDLATRNCLV---GENLTIKIADFGMSRNLYAGDY-----YRIQGRAVLPIRWMAWECIL 213 (304)
T ss_pred HHHHHHHHHHHHHHHCCccccCcchhheEE---cCCccEEECCCccceecccCce-----eEecCcCCCCccccCHHHHh
Confidence 999999999999999999999999999999 5778999999999986543321 11123345678999999999
Q ss_pred CCCCChhhHHHHHHHHHHHHHh--CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCC
Q 013092 159 GIEQSRRDDLESLGYVLMYFLR--GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKP 236 (449)
Q Consensus 159 ~~~~s~~~DiwSlG~il~ellt--G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RP 236 (449)
+..++.++|||||||++|||++ +..||..............................+|..+.+||..||+.+|++||
T Consensus 214 ~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP 293 (304)
T cd05096 214 MGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERP 293 (304)
T ss_pred cCCCCchhhhHHHHHHHHHHHHccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCc
Confidence 8899999999999999999986 67888775432222211111111111111112346789999999999999999999
Q ss_pred CHHHHHHHHH
Q 013092 237 DYAYLKRIFR 246 (449)
Q Consensus 237 t~~~l~~~L~ 246 (449)
++.+|...|+
T Consensus 294 s~~~i~~~l~ 303 (304)
T cd05096 294 SFSDIHAFLT 303 (304)
T ss_pred CHHHHHHHHh
Confidence 9999988775
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=301.06 Aligned_cols=243 Identities=17% Similarity=0.206 Sum_probs=190.1
Q ss_pred EEEEEeeeccc-CCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHH
Q 013092 4 ILTVFSVQENV-KTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLA 81 (449)
Q Consensus 4 aikV~~k~~~~-~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~ 81 (449)
|+|++.+.... ......+..|.+++..+.+||||+++++++.+.+..||||||+ +++|.+++.. ...+++..++.++
T Consensus 24 aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g~L~~~i~~-~~~l~~~~~~~~~ 102 (320)
T cd05590 24 AVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQK-SRRFDEARARFYA 102 (320)
T ss_pred EEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCCchHHHHHHH-cCCCCHHHHHHHH
Confidence 45555443222 2344567889999998878999999999999999999999999 9999998875 4579999999999
Q ss_pred HHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCC
Q 013092 82 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIE 161 (449)
Q Consensus 82 ~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~ 161 (449)
.|++.||+|||++||+||||||+|||+ +.++.+||+|||+++....... ......||+.|+|||++.+..
T Consensus 103 ~ql~~~L~~lH~~~ivH~dlkp~NIli---~~~~~~kL~DfG~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~ 172 (320)
T cd05590 103 AEITSALMFLHDKGIIYRDLKLDNVLL---DHEGHCKLADFGMCKEGIFNGK-------TTSTFCGTPDYIAPEILQEML 172 (320)
T ss_pred HHHHHHHHHHHHCCeEeCCCCHHHeEE---CCCCcEEEeeCCCCeecCcCCC-------cccccccCccccCHHHHcCCC
Confidence 999999999999999999999999999 6788999999999875432211 123457999999999999999
Q ss_pred CChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHH
Q 013092 162 QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYL 241 (449)
Q Consensus 162 ~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l 241 (449)
++.++|||||||++|+|++|..||.+.+ ..+.+..+..... .++..++.++.+++..||+.||++||+..++
T Consensus 173 ~~~~~DiwslG~il~el~~g~~Pf~~~~---~~~~~~~i~~~~~-----~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~ 244 (320)
T cd05590 173 YGPSVDWWAMGVLLYEMLCGHAPFEAEN---EDDLFEAILNDEV-----VYPTWLSQDAVDILKAFMTKNPTMRLGSLTL 244 (320)
T ss_pred CCCccchhhhHHHHHHHhhCCCCCCCCC---HHHHHHHHhcCCC-----CCCCCCCHHHHHHHHHHcccCHHHCCCCCCC
Confidence 9999999999999999999999998743 3444555544322 1234578999999999999999999997432
Q ss_pred HHHHHHHHHHcCCCCCCcccchhhhhhh
Q 013092 242 KRIFRDLFIREGFQFDYVFDWTILKYQQ 269 (449)
Q Consensus 242 ~~~L~~~~~~~~~~~~~~~dw~~~~~~~ 269 (449)
. -.+++ ..+++...++|......+
T Consensus 245 ~-~~~~~---~~h~~f~~~~~~~~~~~~ 268 (320)
T cd05590 245 G-GEEAI---LRHPFFKELDWEKLNRRQ 268 (320)
T ss_pred C-CHHHH---HcCCCcCCCCHHHHHhCC
Confidence 1 11111 234566677888765443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=300.58 Aligned_cols=236 Identities=18% Similarity=0.225 Sum_probs=188.3
Q ss_pred EEEEEeeeccc-CCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHH
Q 013092 4 ILTVFSVQENV-KTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLA 81 (449)
Q Consensus 4 aikV~~k~~~~-~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~ 81 (449)
|+|++.+.... ......+..|.+++..+.+||||+.+++++.+.+..||||||+ +++|.+++.. .+.+++..+..++
T Consensus 24 aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~-~~~~~~~~~~~~~ 102 (321)
T cd05591 24 AIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQR-SRKFDEPRSRFYA 102 (321)
T ss_pred EEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHH
Confidence 45555443222 2334557789999998879999999999999999999999999 9999998875 4579999999999
Q ss_pred HHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCC
Q 013092 82 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIE 161 (449)
Q Consensus 82 ~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~ 161 (449)
.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++....... ......||+.|+|||++.+..
T Consensus 103 ~qi~~aL~~LH~~~ivHrDikp~Nill---~~~~~~kL~Dfg~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~ 172 (321)
T cd05591 103 AEVTLALMFLHRHGVIYRDLKLDNILL---DAEGHCKLADFGMCKEGILNGV-------TTTTFCGTPDYIAPEILQELE 172 (321)
T ss_pred HHHHHHHHHHHHCCeeccCCCHHHeEE---CCCCCEEEeecccceecccCCc-------cccccccCccccCHHHHcCCC
Confidence 999999999999999999999999999 6788999999999976433221 123457999999999999999
Q ss_pred CChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCC-----
Q 013092 162 QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKP----- 236 (449)
Q Consensus 162 ~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RP----- 236 (449)
++.++|||||||++|+|++|..||.... ..+.+..+...... ++..++.++.+++..||+.+|++||
T Consensus 173 ~~~~~DvwslG~il~el~tg~~Pf~~~~---~~~~~~~i~~~~~~-----~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~ 244 (321)
T cd05591 173 YGPSVDWWALGVLMYEMMAGQPPFEADN---EDDLFESILHDDVL-----YPVWLSKEAVSILKAFMTKNPNKRLGCVAS 244 (321)
T ss_pred CCCccceechhHHHHHHhcCCCCCCCCC---HHHHHHHHHcCCCC-----CCCCCCHHHHHHHHHHhccCHHHcCCCCCC
Confidence 9999999999999999999999998643 34445555443321 2234789999999999999999999
Q ss_pred --CHHHHHHHHHHHHHHcCCCCCCcccchhhhhh
Q 013092 237 --DYAYLKRIFRDLFIREGFQFDYVFDWTILKYQ 268 (449)
Q Consensus 237 --t~~~l~~~L~~~~~~~~~~~~~~~dw~~~~~~ 268 (449)
+..+++ .+++...++|......
T Consensus 245 ~~~~~~~~----------~hp~~~~~~~~~~~~~ 268 (321)
T cd05591 245 QGGEDAIK----------QHPFFKEIDWVLLEQR 268 (321)
T ss_pred CCCHHHHh----------cCCccCCCCHHHHHhC
Confidence 444443 2456667889876543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=298.27 Aligned_cols=237 Identities=18% Similarity=0.240 Sum_probs=188.0
Q ss_pred cEEEEEeeeccc-CCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHH
Q 013092 3 EILTVFSVQENV-KTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLML 80 (449)
Q Consensus 3 ~aikV~~k~~~~-~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i 80 (449)
.|+|++++.... ......+..|..++..+.+||||+++++.+..++..||||||+ |++|.+++.. ...+++..+..+
T Consensus 23 vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg~L~~~~~~-~~~~~~~~~~~~ 101 (316)
T cd05592 23 FAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQS-SGRFDEARARFY 101 (316)
T ss_pred EEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCCcHHHHHHH-cCCCCHHHHHHH
Confidence 456666543322 2344556778888887779999999999999999999999999 9999999875 457999999999
Q ss_pred HHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCC
Q 013092 81 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI 160 (449)
Q Consensus 81 ~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~ 160 (449)
+.|++.||+|||++||+||||||+|||+ +.++.+||+|||+++....... ......||+.|+|||++.+.
T Consensus 102 ~~qi~~al~~LH~~~ivH~dlkp~Nill---~~~~~~kL~Dfg~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~ 171 (316)
T cd05592 102 AAEIICGLQFLHKKGIIYRDLKLDNVLL---DKDGHIKIADFGMCKENMNGEG-------KASTFCGTPDYIAPEILKGQ 171 (316)
T ss_pred HHHHHHHHHHHHHCCEEeCCCCHHHeEE---CCCCCEEEccCcCCeECCCCCC-------ccccccCCccccCHHHHcCC
Confidence 9999999999999999999999999999 5788999999999976433221 12345799999999999999
Q ss_pred CCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHH-
Q 013092 161 EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYA- 239 (449)
Q Consensus 161 ~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~- 239 (449)
.++.++|||||||++|+|++|..||.+.+. .+.+..+.... ..+...++.++.+++..||+.+|++||+..
T Consensus 172 ~~~~~~DvwslG~il~ell~G~~Pf~~~~~---~~~~~~i~~~~-----~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~ 243 (316)
T cd05592 172 KYNESVDWWSFGVLLYEMLIGQSPFHGEDE---DELFDSILNDR-----PHFPRWISKEAKDCLSKLFERDPTKRLGVDG 243 (316)
T ss_pred CCCCcccchhHHHHHHHHHhCCCCCCCCCH---HHHHHHHHcCC-----CCCCCCCCHHHHHHHHHHccCCHHHcCCChH
Confidence 999999999999999999999999987433 33444443321 123456789999999999999999999863
Q ss_pred HHHHHHHHHHHHcCCCCCCcccchhhhhh
Q 013092 240 YLKRIFRDLFIREGFQFDYVFDWTILKYQ 268 (449)
Q Consensus 240 ~l~~~L~~~~~~~~~~~~~~~dw~~~~~~ 268 (449)
+++. +++....+|......
T Consensus 244 ~l~~----------h~~~~~~~~~~~~~~ 262 (316)
T cd05592 244 DIRQ----------HPFFRGIDWERLEKR 262 (316)
T ss_pred HHHc----------CcccCCCCHHHHHhC
Confidence 3322 355566788766543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=298.32 Aligned_cols=235 Identities=18% Similarity=0.257 Sum_probs=186.0
Q ss_pred cEEEEEeeeccc-CCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHH
Q 013092 3 EILTVFSVQENV-KTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLML 80 (449)
Q Consensus 3 ~aikV~~k~~~~-~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i 80 (449)
.|+|++.+.... +.....+..|+++++.+ +||||+.+++.+...+..||||||+ +++|.+++.. ...+++..++.+
T Consensus 23 vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~-~~~~~~~~~~~~ 100 (323)
T cd05595 23 YAMKILRKEVIIAKDEVAHTVTESRVLQNT-RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSR-ERVFTEERARFY 100 (323)
T ss_pred EEEEEEEHHHhhhhHHHHHHHHHHHHHHhC-CCCCCcceeeEEecCCEEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHH
Confidence 355555543222 23345678899999999 9999999999999999999999999 9999988875 457999999999
Q ss_pred HHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCC
Q 013092 81 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI 160 (449)
Q Consensus 81 ~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~ 160 (449)
+.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++....... ......||+.|+|||++.+.
T Consensus 101 ~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~Dfg~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~ 170 (323)
T cd05595 101 GAEIVSALEYLHSRDVVYRDIKLENLML---DKDGHIKITDFGLCKEGISDGA-------TMKTFCGTPEYLAPEVLEDN 170 (323)
T ss_pred HHHHHHHHHHHHHCCeEecCCCHHHEEE---cCCCCEEecccHHhccccCCCC-------ccccccCCcCcCCcccccCC
Confidence 9999999999999999999999999999 5788999999999875432211 12345799999999999999
Q ss_pred CCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCC----
Q 013092 161 EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKP---- 236 (449)
Q Consensus 161 ~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RP---- 236 (449)
.++.++|||||||++|+|++|..||...+. ...+..+..... .++..+++++.++|..||..+|++|+
T Consensus 171 ~~~~~~DiwSlGvil~ell~g~~Pf~~~~~---~~~~~~~~~~~~-----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~ 242 (323)
T cd05595 171 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---ERLFELILMEEI-----RFPRTLSPEAKSLLAGLLKKDPKQRLGGGP 242 (323)
T ss_pred CCCchhchhhhHHHHHHHHhCCCCCCCCCH---HHHHHHHhcCCC-----CCCCCCCHHHHHHHHHHccCCHHHhCCCCC
Confidence 999999999999999999999999976432 333333333222 23456899999999999999999998
Q ss_pred -CHHHHHHHHHHHHHHcCCCCCCcccchhhhh
Q 013092 237 -DYAYLKRIFRDLFIREGFQFDYVFDWTILKY 267 (449)
Q Consensus 237 -t~~~l~~~L~~~~~~~~~~~~~~~dw~~~~~ 267 (449)
++.++.+ .++...++|.....
T Consensus 243 ~~~~~~l~----------h~~~~~~~~~~~~~ 264 (323)
T cd05595 243 SDAKEVME----------HRFFLSINWQDVVQ 264 (323)
T ss_pred CCHHHHHc----------CCCcCCCCHHHHHh
Confidence 5555432 34555677876543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=303.34 Aligned_cols=238 Identities=19% Similarity=0.259 Sum_probs=189.1
Q ss_pred EEEEEeeecccCCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHH
Q 013092 4 ILTVFSVQENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLAD 82 (449)
Q Consensus 4 aikV~~k~~~~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~ 82 (449)
|+|++.+..........+..|+++++.+ +||||+++++++.+.+..||||||+ +++|.+++.. ...+++..++.++.
T Consensus 28 aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~ 105 (318)
T cd05582 28 AMKVLKKATLKVRDRVRTKMERDILAEV-NHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSK-EVMFTEEDVKFYLA 105 (318)
T ss_pred EEEEEEHHHhhhhhHHHHHHHHHHHHhC-CCCCcccEEEEEEcCCEEEEEEcCCCCCcHHHHHHH-cCCCCHHHHHHHHH
Confidence 4555544332233445678899999999 8999999999999999999999999 9999999875 45699999999999
Q ss_pred HHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCC
Q 013092 83 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQ 162 (449)
Q Consensus 83 qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~ 162 (449)
||+.||+|||++||+||||||+|||+ +.++.+||+|||+++....... ......||+.|+|||++.+..+
T Consensus 106 qi~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kL~Dfg~~~~~~~~~~-------~~~~~~g~~~y~aPE~~~~~~~ 175 (318)
T cd05582 106 ELALALDHLHSLGIIYRDLKPENILL---DEEGHIKLTDFGLSKESIDHEK-------KAYSFCGTVEYMAPEVVNRRGH 175 (318)
T ss_pred HHHHHHHHHHHCCEecCCCCHHHeEE---CCCCcEEEeeccCCcccCCCCC-------ceecccCChhhcCHHHHcCCCC
Confidence 99999999999999999999999999 5788999999999876543211 1234579999999999999889
Q ss_pred ChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHH--
Q 013092 163 SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAY-- 240 (449)
Q Consensus 163 s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~-- 240 (449)
+.++|||||||++|+|++|+.||... +..+.+..+..... .++..+++++.++|..||+.+|++||++.+
T Consensus 176 ~~~~DiwslG~il~el~tg~~p~~~~---~~~~~~~~i~~~~~-----~~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~ 247 (318)
T cd05582 176 TQSADWWSFGVLMFEMLTGSLPFQGK---DRKETMTMILKAKL-----GMPQFLSPEAQSLLRALFKRNPANRLGAGPDG 247 (318)
T ss_pred CCccceeccceEeeeeccCCCCCCCC---CHHHHHHHHHcCCC-----CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCC
Confidence 99999999999999999999999764 33344444443322 133567899999999999999999999655
Q ss_pred HHHHHHHHHHHcCCCCCCcccchhhhhh
Q 013092 241 LKRIFRDLFIREGFQFDYVFDWTILKYQ 268 (449)
Q Consensus 241 l~~~L~~~~~~~~~~~~~~~dw~~~~~~ 268 (449)
+.+++ ...+...++|......
T Consensus 248 ~~~~~-------~~~~~~~~~~~~~~~~ 268 (318)
T cd05582 248 VEEIK-------RHPFFSTIDWNKLYRR 268 (318)
T ss_pred HHHHh-------CCCCcCCCCHHHHHhc
Confidence 33333 2344555678765543
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=302.51 Aligned_cols=246 Identities=16% Similarity=0.238 Sum_probs=187.6
Q ss_pred cEEEEEeeecccC-CChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHH
Q 013092 3 EILTVFSVQENVK-TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLML 80 (449)
Q Consensus 3 ~aikV~~k~~~~~-~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i 80 (449)
.|+|++++..... .....+..|..++..+.+||||+.+++++.+.+..||||||| |++|.+++.. .+.+++..++.+
T Consensus 23 ~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~-~~~l~~~~~~~~ 101 (329)
T cd05588 23 YAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQR-QRKLPEEHARFY 101 (329)
T ss_pred EEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCCCCHHHHHHH-cCCCCHHHHHHH
Confidence 3555555433222 234457899999999989999999999999999999999999 9999998875 567999999999
Q ss_pred HHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCC
Q 013092 81 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI 160 (449)
Q Consensus 81 ~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~ 160 (449)
+.||+.||+|||++||+||||||+|||+ +..+.+||+|||+++....... ......||+.|+|||++.+.
T Consensus 102 ~~qi~~~l~~lH~~~ivH~dlkp~Nili---~~~~~~kL~Dfg~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~ 171 (329)
T cd05588 102 SAEISLALNFLHERGIIYRDLKLDNVLL---DAEGHIKLTDYGMCKEGIRPGD-------TTSTFCGTPNYIAPEILRGE 171 (329)
T ss_pred HHHHHHHHHHHHHCCeEecCCCHHHeEE---CCCCCEEECcCccccccccCCC-------ccccccCCccccCHHHHcCC
Confidence 9999999999999999999999999999 5788999999999874322111 12346799999999999999
Q ss_pred CCChhhHHHHHHHHHHHHHhCCCCCCCCCcCC------HHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCC
Q 013092 161 EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT------KKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDD 234 (449)
Q Consensus 161 ~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~------~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~ 234 (449)
.++.++|||||||++|+|++|..||....... ....+..+..... .++..++.++.++|..||..+|.+
T Consensus 172 ~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~p~~~~~~~~~li~~~L~~dP~~ 246 (329)
T cd05588 172 DYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI-----RIPRSLSVKASSVLKGFLNKDPKE 246 (329)
T ss_pred CCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC-----CCCCCCCHHHHHHHHHHhccCHHH
Confidence 99999999999999999999999996432111 1112222322221 234568899999999999999999
Q ss_pred CCCHHHHHHHHHHHHHHcCCCCCCcccchhhhhh
Q 013092 235 KPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQ 268 (449)
Q Consensus 235 RPt~~~l~~~L~~~~~~~~~~~~~~~dw~~~~~~ 268 (449)
|++.... ..+.++ ..+++...++|......
T Consensus 247 R~~~~~~-~~~~~i---~~hp~~~~~~~~~~~~~ 276 (329)
T cd05588 247 RLGCHPQ-TGFRDI---KSHPFFRNIDWDLLEQK 276 (329)
T ss_pred cCCCCCC-CCHHHH---hcCCCCCCCCHHHHHhC
Confidence 9984211 011222 23455667789876543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=319.89 Aligned_cols=232 Identities=22% Similarity=0.280 Sum_probs=196.0
Q ss_pred EEEEeeecccCC---ChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcC---------CC
Q 013092 5 LTVFSVQENVKT---KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCS---------RK 71 (449)
Q Consensus 5 ikV~~k~~~~~~---~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~---------~~ 71 (449)
+-|++|.-+.+. ..++|.+|++++..| +|||||+|++.|.+++..|||+||| .|+|.+++..+. ..
T Consensus 517 ~lVAVK~LKd~a~~~~~~dF~REaeLla~l-~H~nIVrLlGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~ 595 (774)
T KOG1026|consen 517 QLVAVKALKDKAENQARQDFRREAELLAEL-QHPNIVRLLGVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQD 595 (774)
T ss_pred eehhHhhhcccccHHHHHHHHHHHHHHHhc-cCCCeEEEEEEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCC
Confidence 345555444432 456799999999999 9999999999999999999999999 999999997431 12
Q ss_pred ----CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCcc
Q 013092 72 ----LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTG 147 (449)
Q Consensus 72 ----ls~~~~~~i~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~g 147 (449)
++..+.+.|+.|||.|++||-++.||||||-.+|+|| .....|||+||||++....... |+....-.-
T Consensus 596 ~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLV---ge~l~VKIsDfGLsRdiYssDY-----Yk~~~~t~l 667 (774)
T KOG1026|consen 596 TPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLV---GENLVVKISDFGLSRDIYSSDY-----YKVRGNTLL 667 (774)
T ss_pred CCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhcee---ccceEEEecccccchhhhhhhh-----hcccCCcee
Confidence 7888999999999999999999999999999999999 4888999999999998766554 233334455
Q ss_pred CccccchhhhhCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHH
Q 013092 148 TARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHY 226 (449)
Q Consensus 148 T~~Y~aPE~~~~~~~s~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~ 226 (449)
..+||+||.++..+++.++|||||||+|||+++ |..||.++.. .+.++.|..... -..+++||.++++||..
T Consensus 668 PIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn---~EVIe~i~~g~l----L~~Pe~CP~~vY~LM~~ 740 (774)
T KOG1026|consen 668 PIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN---QEVIECIRAGQL----LSCPENCPTEVYSLMLE 740 (774)
T ss_pred eeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccch---HHHHHHHHcCCc----ccCCCCCCHHHHHHHHH
Confidence 789999999999999999999999999999998 9999999765 344555555544 23457899999999999
Q ss_pred HhcCCCCCCCCHHHHHHHHHHHHHHc
Q 013092 227 CRSLRFDDKPDYAYLKRIFRDLFIRE 252 (449)
Q Consensus 227 cl~~~p~~RPt~~~l~~~L~~~~~~~ 252 (449)
||+.+|.+||+|.+|...|++.....
T Consensus 741 CW~~~P~~RPsF~eI~~~L~~~~~~s 766 (774)
T KOG1026|consen 741 CWNENPKRRPSFKEIHSRLQAWAQAS 766 (774)
T ss_pred HhhcCcccCCCHHHHHHHHHHHHhcC
Confidence 99999999999999999999876544
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=301.19 Aligned_cols=249 Identities=17% Similarity=0.230 Sum_probs=190.8
Q ss_pred cEEEEEeeecccC-CChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHH
Q 013092 3 EILTVFSVQENVK-TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLML 80 (449)
Q Consensus 3 ~aikV~~k~~~~~-~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i 80 (449)
.|+|++.+..... .....+..|+.++..+.+|++|+.+++++.+.+..||||||+ |++|.+++.. .+.+++..++.+
T Consensus 23 ~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~l~~~~~~~~ 101 (327)
T cd05617 23 YAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQR-QRKLPEEHARFY 101 (327)
T ss_pred EEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHH
Confidence 3455555433222 234457899999999988999999999999999999999999 9999998875 457999999999
Q ss_pred HHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCC
Q 013092 81 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI 160 (449)
Q Consensus 81 ~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~ 160 (449)
+.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++....... ......||+.|+|||++.+.
T Consensus 102 ~~qi~~al~~lH~~~ivHrDlkp~Nili---~~~~~~kl~Dfg~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~ 171 (327)
T cd05617 102 AAEICIALNFLHERGIIYRDLKLDNVLL---DADGHIKLTDYGMCKEGLGPGD-------TTSTFCGTPNYIAPEILRGE 171 (327)
T ss_pred HHHHHHHHHHHHHCCeeccCCCHHHEEE---eCCCCEEEeccccceeccCCCC-------ceecccCCcccCCHHHHCCC
Confidence 9999999999999999999999999999 5788999999999875332211 12346799999999999999
Q ss_pred CCChhhHHHHHHHHHHHHHhCCCCCCCCCcC----CHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCC
Q 013092 161 EQSRRDDLESLGYVLMYFLRGSLPWQGLKAG----TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKP 236 (449)
Q Consensus 161 ~~s~~~DiwSlG~il~elltG~~Pf~~~~~~----~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RP 236 (449)
.++.++|||||||++|+|++|..||...... .....+..+..... .++..++.++.+++..||..+|.+|+
T Consensus 172 ~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-----~~p~~~~~~~~~li~~~L~~dP~~R~ 246 (327)
T cd05617 172 EYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPI-----RIPRFLSVKASHVLKGFLNKDPKERL 246 (327)
T ss_pred CCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCC-----CCCCCCCHHHHHHHHHHhccCHHHcC
Confidence 9999999999999999999999999653321 11222233322211 23456789999999999999999999
Q ss_pred CHHHHHHHHHHHHHHcCCCCCCcccchhhhhhhcc
Q 013092 237 DYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQ 271 (449)
Q Consensus 237 t~~~l~~~L~~~~~~~~~~~~~~~dw~~~~~~~~~ 271 (449)
+.... ..+.++ ..+++...++|+.....+..
T Consensus 247 ~~~~~-~~~~~i---~~h~~f~~~~~~~~~~~~~~ 277 (327)
T cd05617 247 GCQPQ-TGFSDI---KSHTFFRSIDWDLLEKKQVT 277 (327)
T ss_pred CCCCC-CCHHHH---HcCCCCCCCCHHHHHhCCCC
Confidence 85321 011111 24577778899987655433
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=300.22 Aligned_cols=240 Identities=18% Similarity=0.221 Sum_probs=184.9
Q ss_pred cEEEEEeeecccC--CChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHH
Q 013092 3 EILTVFSVQENVK--TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLM 79 (449)
Q Consensus 3 ~aikV~~k~~~~~--~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~ 79 (449)
.|+|++.+..... .....+..|+.+++.+.+|++|+.+++.+...+..||||||+ +++|.+++.. ...+++..+..
T Consensus 31 ~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~ 109 (332)
T cd05614 31 YAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQ-RDNFSEDEVRF 109 (332)
T ss_pred EEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHH
Confidence 3555555433221 234457889999999988999999999999999999999999 9999999875 45699999999
Q ss_pred HHHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhC
Q 013092 80 LADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG 159 (449)
Q Consensus 80 i~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~ 159 (449)
++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.+...... ......||+.|+|||++.+
T Consensus 110 ~~~qi~~~l~~lH~~~ivHrDlkp~Nili---~~~~~~kl~DfG~~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~ 180 (332)
T cd05614 110 YSGEIILALEHLHKLGIVYRDIKLENILL---DSEGHVVLTDFGLSKEFLSEEKE------RTYSFCGTIEYMAPEIIRG 180 (332)
T ss_pred HHHHHHHHHHHHHHCCcEecCCCHHHeEE---CCCCCEEEeeCcCCccccccCCC------ccccccCCccccCHHHhcC
Confidence 99999999999999999999999999999 57789999999999865433221 1124579999999999987
Q ss_pred C-CCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHH-HHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCC-
Q 013092 160 I-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKK-QKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKP- 236 (449)
Q Consensus 160 ~-~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~-~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RP- 236 (449)
. .++.++|||||||++|||++|..||......... .....+.... ..+...++.++.+++..||+.+|++||
T Consensus 181 ~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~li~~~l~~dp~~R~~ 255 (332)
T cd05614 181 KGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCD-----PPFPSFIGPEAQDLLHKLLRKDPKKRLG 255 (332)
T ss_pred CCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCC-----CCCCCCCCHHHHHHHHHHcCCCHHHcCC
Confidence 5 4788999999999999999999999764332222 2222222211 123356789999999999999999999
Q ss_pred ----CHHHHHHHHHHHHHHcCCCCCCcccchhhhh
Q 013092 237 ----DYAYLKRIFRDLFIREGFQFDYVFDWTILKY 267 (449)
Q Consensus 237 ----t~~~l~~~L~~~~~~~~~~~~~~~dw~~~~~ 267 (449)
+++++++ +++....+|.....
T Consensus 256 ~~~~~~~~~l~----------h~~~~~~~~~~~~~ 280 (332)
T cd05614 256 AGPQGASEIKE----------HPFFKGLDWEALAL 280 (332)
T ss_pred CCCCCHHHHHc----------CCCcCCCCHHHHHh
Confidence 4444432 34555567776543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=297.05 Aligned_cols=236 Identities=19% Similarity=0.262 Sum_probs=186.1
Q ss_pred EEEEEeeeccc-CCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHH
Q 013092 4 ILTVFSVQENV-KTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLA 81 (449)
Q Consensus 4 aikV~~k~~~~-~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~ 81 (449)
|+|++++.... ......+..|..++..+.+||+|+++++++.+.++.||||||+ +++|.+++.. ...+++..+..++
T Consensus 24 avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~-~~~~~~~~~~~~~ 102 (316)
T cd05620 24 AVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQD-KGRFDLYRATFYA 102 (316)
T ss_pred EEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCCCcHHHHHHH-cCCCCHHHHHHHH
Confidence 45555443221 2344567788889887779999999999999999999999999 9999999875 4579999999999
Q ss_pred HHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCC
Q 013092 82 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIE 161 (449)
Q Consensus 82 ~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~ 161 (449)
.|++.||+|||++||+||||||+|||+ +.++.++|+|||+++....... ......||+.|+|||++.+..
T Consensus 103 ~qi~~~l~~lH~~~ivHrDlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~ 172 (316)
T cd05620 103 AEIVCGLQFLHSKGIIYRDLKLDNVML---DRDGHIKIADFGMCKENVFGDN-------RASTFCGTPDYIAPEILQGLK 172 (316)
T ss_pred HHHHHHHHHHHHCCeEecCCCHHHeEE---CCCCCEEeCccCCCeecccCCC-------ceeccCCCcCccCHHHHcCCC
Confidence 999999999999999999999999999 5788999999999875322111 123467999999999999999
Q ss_pred CChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHH-H
Q 013092 162 QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYA-Y 240 (449)
Q Consensus 162 ~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~-~ 240 (449)
++.++|||||||++|||++|..||.+.. ..+.++.+.... ..++..++.++.++|..||+.||++||+.. +
T Consensus 173 ~~~~~DiwslGvil~el~~g~~Pf~~~~---~~~~~~~~~~~~-----~~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~ 244 (316)
T cd05620 173 YTFSVDWWSFGVLLYEMLIGQSPFHGDD---EDELFESIRVDT-----PHYPRWITKESKDILEKLFERDPTRRLGVVGN 244 (316)
T ss_pred CCcccchhhhHHHHHHHHhCCCCCCCCC---HHHHHHHHHhCC-----CCCCCCCCHHHHHHHHHHccCCHHHcCCChHH
Confidence 9999999999999999999999997643 233343333221 123345788999999999999999999863 3
Q ss_pred HHHHHHHHHHHcCCCCCCcccchhhhhh
Q 013092 241 LKRIFRDLFIREGFQFDYVFDWTILKYQ 268 (449)
Q Consensus 241 l~~~L~~~~~~~~~~~~~~~dw~~~~~~ 268 (449)
|+ .+++...++|......
T Consensus 245 ~~----------~h~~f~~~~~~~~~~~ 262 (316)
T cd05620 245 IR----------GHPFFKTINWTALEKR 262 (316)
T ss_pred HH----------cCCCcCCCCHHHHHhC
Confidence 32 2456667788865443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=302.15 Aligned_cols=236 Identities=20% Similarity=0.269 Sum_probs=186.6
Q ss_pred cEEEEEeeeccc-CCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHH
Q 013092 3 EILTVFSVQENV-KTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLML 80 (449)
Q Consensus 3 ~aikV~~k~~~~-~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i 80 (449)
+|||++.+.... ......+..|++++..+ +||||+++++.+.+++..||||||+ |++|.+++.. ...+++..+..+
T Consensus 29 vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~-~~~l~~~~~~~~ 106 (333)
T cd05600 29 VALKRMKKSLLFKLNEVRHVLTERDILTTT-KSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNN-LGVLSEDHARFY 106 (333)
T ss_pred EEEEEEEHHHHhhhhHHHHHHHHHHHHHhC-CCCCCccEEEEEEcCCEEEEEEeCCCCCCHHHHHHH-cCCCCHHHHHHH
Confidence 355555543322 23445688999999999 7999999999999999999999999 9999999975 457899999999
Q ss_pred HHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCC
Q 013092 81 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI 160 (449)
Q Consensus 81 ~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~ 160 (449)
+.||+.||.|||++||+||||||+|||+ +..+.+||+|||+++..... .....||+.|+|||++.+.
T Consensus 107 ~~qi~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kL~Dfg~a~~~~~~----------~~~~~gt~~y~aPE~~~~~ 173 (333)
T cd05600 107 MAEMFEAVDALHELGYIHRDLKPENFLI---DASGHIKLTDFGLSKGIVTY----------ANSVVGSPDYMAPEVLRGK 173 (333)
T ss_pred HHHHHHHHHHHHHCCccccCCCHHHEEE---CCCCCEEEEeCcCCcccccc----------cCCcccCccccChhHhcCC
Confidence 9999999999999999999999999999 57889999999999765431 2345799999999999999
Q ss_pred CCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhccc---chHHHhhcCCcHHHHHHHHHHhcCCCCCCCC
Q 013092 161 EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS---TSIEALCRGYPTEFASYFHYCRSLRFDDKPD 237 (449)
Q Consensus 161 ~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~---~~~~~l~~~~p~el~~li~~cl~~~p~~RPt 237 (449)
.++.++|||||||++|||++|..||.+... .+.+..+...... +........++.++.++|..||..+|++||+
T Consensus 174 ~~~~~~DvwslG~il~ell~g~~pf~~~~~---~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s 250 (333)
T cd05600 174 GYDFTVDYWSLGCMLYEFLCGFPPFSGSTP---NETWENLKYWKETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGS 250 (333)
T ss_pred CCCCccceecchHHHhhhhhCCCCCCCCCH---HHHHHHHHhccccccCCCCCccccccCHHHHHHHHHHhhChhhhcCC
Confidence 999999999999999999999999987433 3333333322111 1111111256899999999999999999999
Q ss_pred HHHHHHHHHHHHHHcCCCCCCcccchhhh
Q 013092 238 YAYLKRIFRDLFIREGFQFDYVFDWTILK 266 (449)
Q Consensus 238 ~~~l~~~L~~~~~~~~~~~~~~~dw~~~~ 266 (449)
+.+|++ .++...++|....
T Consensus 251 ~~~ll~----------h~~~~~~~~~~~~ 269 (333)
T cd05600 251 LEDIKN----------HPFFKEVDWNELR 269 (333)
T ss_pred HHHHHh----------CcccCCCCHHHHh
Confidence 777754 2444556776543
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=298.11 Aligned_cols=242 Identities=18% Similarity=0.218 Sum_probs=188.7
Q ss_pred cEEEEEeeeccc-CCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHH
Q 013092 3 EILTVFSVQENV-KTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLML 80 (449)
Q Consensus 3 ~aikV~~k~~~~-~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i 80 (449)
.|+|++.+.... ......+..|++++..+.+|++|+.+++++.+.+..||||||+ |++|.+++.. ...+++..++.+
T Consensus 28 ~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~-~~~~~~~~~~~~ 106 (324)
T cd05587 28 YAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQ-VGKFKEPHAVFY 106 (324)
T ss_pred EEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcCCCCCcHHHHHHH-cCCCCHHHHHHH
Confidence 355555543322 2344568889999999977788999999999999999999999 9999999875 457899999999
Q ss_pred HHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCC
Q 013092 81 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI 160 (449)
Q Consensus 81 ~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~ 160 (449)
+.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++....... ......||+.|+|||++.+.
T Consensus 107 ~~qi~~al~~lH~~~ivH~dlkp~Nill---~~~~~~kL~Dfg~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~ 176 (324)
T cd05587 107 AAEIAIGLFFLHSKGIIYRDLKLDNVML---DAEGHIKIADFGMCKENIFGGK-------TTRTFCGTPDYIAPEIIAYQ 176 (324)
T ss_pred HHHHHHHHHHHHHCCeEecCCCHHHeEE---cCCCCEEEeecCcceecCCCCC-------ceeeecCCccccChhhhcCC
Confidence 9999999999999999999999999999 5788999999999875322111 12345799999999999999
Q ss_pred CCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHH
Q 013092 161 EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAY 240 (449)
Q Consensus 161 ~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~ 240 (449)
.++.++|||||||++|+|++|+.||.+.+ ..+.+..+..... .++..+++++.+++..||..+|.+|++...
T Consensus 177 ~~~~~~DiwslGvil~elltG~~pf~~~~---~~~~~~~i~~~~~-----~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ 248 (324)
T cd05587 177 PYGKSVDWWAFGVLLYEMLAGQPPFDGED---EDELFQSIMEHNV-----SYPKSLSKEAVSICKGLLTKHPAKRLGCGP 248 (324)
T ss_pred CCCcccchhhhHHHHHHHHhCCCCCCCCC---HHHHHHHHHcCCC-----CCCCCCCHHHHHHHHHHhhcCHHHcCCCCC
Confidence 99999999999999999999999997643 3444555544332 234568899999999999999999997521
Q ss_pred HHHHHHHHHHHcCCCCCCcccchhhhhh
Q 013092 241 LKRIFRDLFIREGFQFDYVFDWTILKYQ 268 (449)
Q Consensus 241 l~~~L~~~~~~~~~~~~~~~dw~~~~~~ 268 (449)
. ..+++ ..+++...++|......
T Consensus 249 ~--~~~~~---~~hp~~~~~~~~~~~~~ 271 (324)
T cd05587 249 T--GERDI---REHAFFRRIDWEKLERR 271 (324)
T ss_pred C--CHHHH---hcCCCcCCCCHHHHHhC
Confidence 0 01111 23456677889876544
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=291.59 Aligned_cols=230 Identities=18% Similarity=0.203 Sum_probs=176.2
Q ss_pred EEEEEeeecccCCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHH
Q 013092 4 ILTVFSVQENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQ 83 (449)
Q Consensus 4 aikV~~k~~~~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~~~~i~~q 83 (449)
|+|+..+........+.+.+|+.+++.+ +|+||+++++++...+..||||||+.+.+.+.+......+++..++.++.|
T Consensus 30 avK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~q 108 (287)
T cd07848 30 AIKKFKDSEENEEVKETTLRELKMLRTL-KQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQ 108 (287)
T ss_pred EEEEEecccccccchhhHHHHHHHHHhC-CCccccchhhhEecCCEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHH
Confidence 4555554443444556788999999999 899999999999999999999999944455555544567999999999999
Q ss_pred HHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCC
Q 013092 84 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQS 163 (449)
Q Consensus 84 i~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s 163 (449)
++.||.|||+.||+||||||+||++ +.++.+||+|||+++........ ......||..|+|||++.+..++
T Consensus 109 i~~~L~~lH~~~i~H~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~ 179 (287)
T cd07848 109 LIKAIHWCHKNDIVHRDIKPENLLI---SHNDVLKLCDFGFARNLSEGSNA------NYTEYVATRWYRSPELLLGAPYG 179 (287)
T ss_pred HHHHHHHHHHCCeecCCCCHHHEEE---cCCCcEEEeeccCcccccccccc------cccccccccccCCcHHHcCCCCC
Confidence 9999999999999999999999999 57889999999999876432211 11245789999999999998899
Q ss_pred hhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhc----------------c--------cchHHHhhcCCcHH
Q 013092 164 RRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK----------------V--------STSIEALCRGYPTE 219 (449)
Q Consensus 164 ~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~----------------~--------~~~~~~l~~~~p~e 219 (449)
.++|||||||++|||++|+.||.+.........+..+.... . ..........++.+
T Consensus 180 ~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 259 (287)
T cd07848 180 KAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGV 259 (287)
T ss_pred CchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHH
Confidence 99999999999999999999998754322111111110000 0 00001112346888
Q ss_pred HHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 220 FASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 220 l~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
+.+||..||+.+|++||++.++++
T Consensus 260 ~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 260 LLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred HHHHHHHHccCCcccCCCHHHHhc
Confidence 999999999999999999887753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=304.69 Aligned_cols=218 Identities=20% Similarity=0.308 Sum_probs=176.9
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcC---------------------------
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCS--------------------------- 69 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~--------------------------- 69 (449)
...+.+|+.+++.+.+|+||+++++.+.+.+..||||||| +++|.+++....
T Consensus 85 ~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (374)
T cd05106 85 REALMSELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEK 164 (374)
T ss_pred HHHHHHHHHHHHhhccCCceeeEeeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhc
Confidence 3468899999999988999999999999999999999999 999999985421
Q ss_pred ------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEE
Q 013092 70 ------------------------------------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFL 107 (449)
Q Consensus 70 ------------------------------------------~~ls~~~~~~i~~qi~~aL~yLH~~givHRDLKP~NiL 107 (449)
.++++..++.++.||+.||+|||++||+||||||+|||
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil 244 (374)
T cd05106 165 KYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVL 244 (374)
T ss_pred ccccccccccccccccccccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEE
Confidence 24788899999999999999999999999999999999
Q ss_pred EeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHHHHHHHh-CCCCCC
Q 013092 108 MGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQ 186 (449)
Q Consensus 108 l~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il~ellt-G~~Pf~ 186 (449)
+ +.++.+||+|||+++.+...... .......++..|+|||++.+..++.++|||||||++|+|++ |..||.
T Consensus 245 ~---~~~~~~kL~DfGla~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~ 316 (374)
T cd05106 245 L---TDGRVAKICDFGLARDIMNDSNY-----VVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYP 316 (374)
T ss_pred E---eCCCeEEEeeceeeeeccCCcce-----eeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCc
Confidence 9 57789999999999866443211 11123345678999999998899999999999999999997 999998
Q ss_pred CCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 013092 187 GLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLF 249 (449)
Q Consensus 187 ~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~L~~~~ 249 (449)
...... .+..+....... .....+|+++.++|..||+.+|++||++.+|.+.|++++
T Consensus 317 ~~~~~~---~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 317 GILVNS---KFYKMVKRGYQM---SRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred cccccH---HHHHHHHcccCc---cCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 754321 222222211111 122346899999999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=280.00 Aligned_cols=212 Identities=22% Similarity=0.258 Sum_probs=185.5
Q ss_pred CChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC
Q 013092 16 TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 94 (449)
Q Consensus 16 ~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~ 94 (449)
...+++.+|++|.+.| .||||+.|.....+..+.|||+|++ |++|..-|-. ...+++..+-.++.||+.+|.|+|.+
T Consensus 52 ~~~e~l~rEarIC~~L-qHP~IvrL~~ti~~~~~~ylvFe~m~G~dl~~eIV~-R~~ySEa~aSH~~rQiLeal~yCH~n 129 (355)
T KOG0033|consen 52 RDFQKLEREARICRKL-QHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVA-REFYSEADASHCIQQILEALAYCHSN 129 (355)
T ss_pred ccHHHHHHHHHHHHhc-CCCcEeehhhhhcccceeEEEEecccchHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHHhc
Confidence 4678899999999999 9999999999999999999999999 9888554432 24589999999999999999999999
Q ss_pred CceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHH
Q 013092 95 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYV 174 (449)
Q Consensus 95 givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~i 174 (449)
||||||+||+|+|+...+...-+||+|||+|..+.+... ...++|||.|||||++...+|+..+|||+.|+|
T Consensus 130 ~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~~--------~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGVi 201 (355)
T KOG0033|consen 130 GIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGEA--------WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVI 201 (355)
T ss_pred CceeccCChhheeeeeccCCCceeecccceEEEeCCccc--------cccccCCCcccCHHHhhcCCCCCcchhhhhhHH
Confidence 999999999999998666777899999999998874332 346799999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHH
Q 013092 175 LMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYL 241 (449)
Q Consensus 175 l~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l 241 (449)
||-||.|.+||.+ ++....|+.|.......+-+ .++.+.++..+|+++||..||.+|.++.+.
T Consensus 202 LfiLL~G~~PF~~---~~~~rlye~I~~g~yd~~~~-~w~~is~~Ak~LvrrML~~dP~kRIta~EA 264 (355)
T KOG0033|consen 202 LYILLVGYPPFWD---EDQHRLYEQIKAGAYDYPSP-EWDTVTPEAKSLIRRMLTVNPKKRITADEA 264 (355)
T ss_pred HHHHHhCCCCCCC---ccHHHHHHHHhccccCCCCc-ccCcCCHHHHHHHHHHhccChhhhccHHHH
Confidence 9999999999988 45567888888877654433 346788999999999999999999997654
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=298.53 Aligned_cols=234 Identities=20% Similarity=0.248 Sum_probs=185.2
Q ss_pred cEEEEEeeecccC--CChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHH
Q 013092 3 EILTVFSVQENVK--TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLM 79 (449)
Q Consensus 3 ~aikV~~k~~~~~--~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~ 79 (449)
.|+|++.+..... .....+..|+.+|+.+ +||||+++++.+..++..||||||+ +++|.+++.. .+.+++..+..
T Consensus 27 ~avK~~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~ 104 (323)
T cd05584 27 FAMKVLKKATIVRNQKDTAHTKAERNILEAV-KHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLER-EGIFMEDTACF 104 (323)
T ss_pred EEEEEEEHHHHHhhhhhHHHHHHHHHHHHhC-CCCchhceeeEEecCCeEEEEEeCCCCchHHHHHHH-cCCCCHHHHHH
Confidence 3555555433221 2334578899999999 8999999999999999999999999 9999999875 45688999999
Q ss_pred HHHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhC
Q 013092 80 LADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG 159 (449)
Q Consensus 80 i~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~ 159 (449)
++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++....... ......||+.|+|||++.+
T Consensus 105 ~~~qi~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~ 174 (323)
T cd05584 105 YLSEISLALEHLHQQGIIYRDLKPENILL---DAQGHVKLTDFGLCKESIHEGT-------VTHTFCGTIEYMAPEILMR 174 (323)
T ss_pred HHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCCEEEeeCcCCeecccCCC-------cccccCCCccccChhhccC
Confidence 99999999999999999999999999999 5788999999999875433221 1234579999999999999
Q ss_pred CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCC---
Q 013092 160 IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKP--- 236 (449)
Q Consensus 160 ~~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RP--- 236 (449)
..++.++|||||||++|||++|+.||.... ..+.+..+..... .++..+++++.++|..||+.+|++||
T Consensus 175 ~~~~~~~DiwslG~il~ell~G~~pf~~~~---~~~~~~~~~~~~~-----~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 246 (323)
T cd05584 175 SGHGKAVDWWSLGALMYDMLTGAPPFTAEN---RKKTIDKILKGKL-----NLPPYLTPEARDLLKKLLKRNPSSRLGAG 246 (323)
T ss_pred CCCCCcceecccHHHHHHHhcCCCCCCCCC---HHHHHHHHHcCCC-----CCCCCCCHHHHHHHHHHcccCHhHcCCCC
Confidence 889999999999999999999999997643 3334444443322 23456789999999999999999999
Q ss_pred --CHHHHHHHHHHHHHHcCCCCCCcccchhhh
Q 013092 237 --DYAYLKRIFRDLFIREGFQFDYVFDWTILK 266 (449)
Q Consensus 237 --t~~~l~~~L~~~~~~~~~~~~~~~dw~~~~ 266 (449)
+..+++. .++....+|....
T Consensus 247 ~~~~~~l~~----------h~~~~~~~~~~~~ 268 (323)
T cd05584 247 PGDAAEVQS----------HPFFRHVNWDDLL 268 (323)
T ss_pred CCCHHHHhc----------CCCcCCCCHHHHh
Confidence 6665543 2444445676543
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=287.63 Aligned_cols=214 Identities=11% Similarity=0.196 Sum_probs=177.2
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 96 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gi 96 (449)
...+.+|+.+++.+ +||||+++++++..++..||||||+ +++|.+++......+++..++.++.|++.||+|||++|+
T Consensus 50 ~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i 128 (266)
T cd05064 50 RRGFLAEALTLGQF-DHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGY 128 (266)
T ss_pred HHHHHHHHHHHhcC-CCCCcCeEEEEEecCCCcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCE
Confidence 34688999999999 8999999999999999999999999 889999998655679999999999999999999999999
Q ss_pred eecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHHHH
Q 013092 97 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLM 176 (449)
Q Consensus 97 vHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il~ 176 (449)
+||||||+|||+ +.++.++|+|||++........ .......++..|+|||++.+..++.++|||||||++|
T Consensus 129 iH~dikp~nili---~~~~~~~l~dfg~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ 199 (266)
T cd05064 129 VHKGLAAHKVLV---NSDLVCKISGFRRLQEDKSEAI------YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMW 199 (266)
T ss_pred eeccccHhhEEE---cCCCcEEECCCcccccccccch------hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHH
Confidence 999999999999 5788999999998765432211 0112334567899999999999999999999999999
Q ss_pred HHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 013092 177 YFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDL 248 (449)
Q Consensus 177 ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~L~~~ 248 (449)
|+++ |..||.+... ......+.+.... ..+..+|..+.+++..||+.+|++||++.+|.+.|..+
T Consensus 200 ell~~g~~p~~~~~~---~~~~~~~~~~~~~----~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 200 EVMSYGERPYWDMSG---QDVIKAVEDGFRL----PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred HHhcCCCCCcCcCCH---HHHHHHHHCCCCC----CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 9875 9999987543 2333333332211 23456899999999999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=298.03 Aligned_cols=247 Identities=17% Similarity=0.243 Sum_probs=188.2
Q ss_pred cEEEEEeeeccc-CCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHH
Q 013092 3 EILTVFSVQENV-KTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLML 80 (449)
Q Consensus 3 ~aikV~~k~~~~-~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i 80 (449)
.|+|++++.... ......+..|+.++..+.+||||+.+++++.+.+..||||||+ +++|.+++.. ...+++..++.+
T Consensus 23 ~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~-~~~l~~~~~~~i 101 (329)
T cd05618 23 YAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQR-QRKLPEEHARFY 101 (329)
T ss_pred EEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCCCCHHHHHHH-cCCCCHHHHHHH
Confidence 355555543322 2233457789999988879999999999999999999999999 9999988875 467999999999
Q ss_pred HHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCC
Q 013092 81 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI 160 (449)
Q Consensus 81 ~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~ 160 (449)
+.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++....... ......||+.|+|||++.+.
T Consensus 102 ~~qi~~~l~~lH~~~ivH~Dikp~Nili---~~~~~~kL~DfG~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~ 171 (329)
T cd05618 102 SAEISLALNYLHERGIIYRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRPGD-------TTSTFCGTPNYIAPEILRGE 171 (329)
T ss_pred HHHHHHHHHHHHHCCeeeCCCCHHHEEE---CCCCCEEEeeCCccccccCCCC-------ccccccCCccccCHHHHcCC
Confidence 9999999999999999999999999999 5788999999999875322111 12346799999999999999
Q ss_pred CCChhhHHHHHHHHHHHHHhCCCCCCCCCcC------CHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCC
Q 013092 161 EQSRRDDLESLGYVLMYFLRGSLPWQGLKAG------TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDD 234 (449)
Q Consensus 161 ~~s~~~DiwSlG~il~elltG~~Pf~~~~~~------~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~ 234 (449)
.++.++|||||||++|+|++|..||...... .....+..+..... .++..++.++.++|..||..+|++
T Consensus 172 ~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~-----~~p~~~~~~~~~ll~~~L~~dP~~ 246 (329)
T cd05618 172 DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-----RIPRSLSVKAASVLKSFLNKDPKE 246 (329)
T ss_pred CCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC-----CCCCCCCHHHHHHHHHHhcCCHHH
Confidence 9999999999999999999999999642211 11112222322221 244567899999999999999999
Q ss_pred CCCHHHHHHHHHHHHHHcCCCCCCcccchhhhhhh
Q 013092 235 KPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQ 269 (449)
Q Consensus 235 RPt~~~l~~~L~~~~~~~~~~~~~~~dw~~~~~~~ 269 (449)
||+...+. .+.++ ..+++...++|......+
T Consensus 247 R~~~~~~~-~~~~i---~~hp~f~~~~~~~~~~~~ 277 (329)
T cd05618 247 RLGCHPQT-GFADI---QGHPFFRNVDWDLMEQKQ 277 (329)
T ss_pred cCCCCCCC-CHHHH---hcCCCCCCCCHHHHHcCC
Confidence 99842110 01111 235667778998776543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=290.20 Aligned_cols=227 Identities=17% Similarity=0.224 Sum_probs=178.0
Q ss_pred hHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHC
Q 013092 19 PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSK 94 (449)
Q Consensus 19 ~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~---~~~ls~~~~~~i~~qi~~aL~yLH~~ 94 (449)
..+..|+++++.+ +|+||+.+.+++......||||||+ +++|.+++... +..+++..++.++.||+.||+|||++
T Consensus 38 ~~~~~E~~il~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~ 116 (280)
T cd05608 38 EGAMVEKRILAKV-HSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR 116 (280)
T ss_pred HHHHHHHHHHHhC-CCCcEeeeeEEEcCCCeEEEEEeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 4577899999999 9999999999999999999999999 99998887432 34689999999999999999999999
Q ss_pred CceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHH
Q 013092 95 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYV 174 (449)
Q Consensus 95 givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~i 174 (449)
||+||||||+||++ +.++.++|+|||++..+..... ......||+.|+|||++.+..++.++|||||||+
T Consensus 117 ~i~H~dlkp~Nili---~~~~~~~l~dfg~~~~~~~~~~-------~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~i 186 (280)
T cd05608 117 RIIYRDLKPENVLL---DNDGNVRISDLGLAVELKDGQS-------KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVT 186 (280)
T ss_pred CcccCCCCHHHEEE---CCCCCEEEeeCccceecCCCCc-------cccccCCCcCccCHHHhcCCCCCccccHHHHHHH
Confidence 99999999999999 5788999999999987654322 1234578999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCCcCCHH-HHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHH--HHHHHHHHHHH
Q 013092 175 LMYFLRGSLPWQGLKAGTKK-QKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAY--LKRIFRDLFIR 251 (449)
Q Consensus 175 l~elltG~~Pf~~~~~~~~~-~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~--l~~~L~~~~~~ 251 (449)
+|+|++|+.||......... .....+... ...+...++.++.+++..||+.+|++||++.+ +.+++.
T Consensus 187 l~el~~g~~pf~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~----- 256 (280)
T cd05608 187 LYEMIAARGPFRARGEKVENKELKQRILND-----SVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT----- 256 (280)
T ss_pred HHHHHhCCCCCCCCCcchhHHHHHHhhccc-----CCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc-----
Confidence 99999999999764332211 111111111 11234568999999999999999999995432 222222
Q ss_pred cCCCCCCcccchhhhhh
Q 013092 252 EGFQFDYVFDWTILKYQ 268 (449)
Q Consensus 252 ~~~~~~~~~dw~~~~~~ 268 (449)
+++...++|......
T Consensus 257 --h~~~~~~~~~~~~~~ 271 (280)
T cd05608 257 --HPLFRDLNWRQLEAG 271 (280)
T ss_pred --ChhhhcCCHhHHhhc
Confidence 244445678765433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=297.01 Aligned_cols=218 Identities=17% Similarity=0.239 Sum_probs=169.5
Q ss_pred ChhHHHHHHHHHHHhcCCCCCceEEEEeEeC-----CEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHH
Q 013092 17 KHPQLLYESKLYRILQGGTGIPNVRWFGVEG-----DYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 91 (449)
Q Consensus 17 ~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~-----~~~~lVmE~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yL 91 (449)
....+.+|+++++.+ +||||+++++++... ...|||||||+++|.+++.. ...+++..+..++.||+.||.||
T Consensus 42 ~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~L 119 (338)
T cd07859 42 DATRILREIKLLRLL-RHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKA-NDDLTPEHHQFFLYQLLRALKYI 119 (338)
T ss_pred hHHHHHHHHHHHHhC-CCCCEeeecceEeccCCCCCceEEEEEecCCCCHHHHHHh-cccCCHHHHHHHHHHHHHHHHHH
Confidence 344688999999999 899999999887543 35899999998899999875 45699999999999999999999
Q ss_pred HHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhC--CCCChhhHHH
Q 013092 92 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG--IEQSRRDDLE 169 (449)
Q Consensus 92 H~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~--~~~s~~~Diw 169 (449)
|++||+||||||+|||+ +.++.+||+|||+++......... .......||+.|+|||++.+ ..++.++|||
T Consensus 120 H~~~ivH~dlkp~NIll---~~~~~~kL~Dfg~~~~~~~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~~Dvw 192 (338)
T cd07859 120 HTANVFHRDLKPKNILA---NADCKLKICDFGLARVAFNDTPTA----IFWTDYVATRWYRAPELCGSFFSKYTPAIDIW 192 (338)
T ss_pred HHCCeecCCCCHHHeEE---CCCCcEEEccCccccccccccCcc----ccccCCCCCCCcCCHHHHhccccccCchhHHH
Confidence 99999999999999999 688899999999998654322111 11134579999999999876 5789999999
Q ss_pred HHHHHHHHHHhCCCCCCCCCcCCHHHHH------------HHHH-----------hhcccchHHHhhcCCcHHHHHHHHH
Q 013092 170 SLGYVLMYFLRGSLPWQGLKAGTKKQKY------------EKIS-----------EKKVSTSIEALCRGYPTEFASYFHY 226 (449)
Q Consensus 170 SlG~il~elltG~~Pf~~~~~~~~~~~~------------~~i~-----------~~~~~~~~~~l~~~~p~el~~li~~ 226 (449)
||||++|+|++|+.||.+.........+ ..+. ............+.+++++.+++..
T Consensus 193 SlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 272 (338)
T cd07859 193 SIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLER 272 (338)
T ss_pred HHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHH
Confidence 9999999999999999774321111110 1110 0111122223335678899999999
Q ss_pred HhcCCCCCCCCHHHHHH
Q 013092 227 CRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 227 cl~~~p~~RPt~~~l~~ 243 (449)
||+.+|++||++.+++.
T Consensus 273 ~l~~~P~~Rpt~~e~l~ 289 (338)
T cd07859 273 LLAFDPKDRPTAEEALA 289 (338)
T ss_pred HcCcCcccCCCHHHHhc
Confidence 99999999999887754
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=296.65 Aligned_cols=245 Identities=18% Similarity=0.228 Sum_probs=191.1
Q ss_pred cEEEEEeeeccc-CCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHH
Q 013092 3 EILTVFSVQENV-KTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLML 80 (449)
Q Consensus 3 ~aikV~~k~~~~-~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i 80 (449)
.|+|++.+.... ......+..|..++..+.+|++|+.+++++.+.+..||||||+ +++|.+++.. ...+++..++.+
T Consensus 28 ~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~-~~~~~~~~~~~~ 106 (323)
T cd05616 28 YAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQ-VGRFKEPHAVFY 106 (323)
T ss_pred EEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcCCCCCCHHHHHHH-cCCCCHHHHHHH
Confidence 355555543322 2233457788999988878999999999999999999999999 9999999875 457999999999
Q ss_pred HHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCC
Q 013092 81 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI 160 (449)
Q Consensus 81 ~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~ 160 (449)
+.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++....... ......||+.|+|||++.+.
T Consensus 107 ~~qi~~aL~~LH~~~ivHrDlkp~Nill---~~~~~~kL~DfG~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~ 176 (323)
T cd05616 107 AAEIAIGLFFLHSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKENMWDGV-------TTKTFCGTPDYIAPEIIAYQ 176 (323)
T ss_pred HHHHHHHHHHHHHCCEEecCCCHHHeEE---CCCCcEEEccCCCceecCCCCC-------ccccCCCChhhcCHHHhcCC
Confidence 9999999999999999999999999999 6788999999999975432211 12345799999999999999
Q ss_pred CCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHH
Q 013092 161 EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAY 240 (449)
Q Consensus 161 ~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~ 240 (449)
.++.++|||||||++|||++|..||.+.. ....+..+..... .++..++.++.+++..|++.+|++|++...
T Consensus 177 ~~~~~~DiwSlGvil~elltg~~Pf~~~~---~~~~~~~i~~~~~-----~~p~~~s~~~~~li~~~l~~~p~~R~~~~~ 248 (323)
T cd05616 177 PYGKSVDWWAFGVLLYEMLAGQAPFEGED---EDELFQSIMEHNV-----AYPKSMSKEAVAICKGLMTKHPGKRLGCGP 248 (323)
T ss_pred CCCCccchhchhHHHHHHHhCCCCCCCCC---HHHHHHHHHhCCC-----CCCCcCCHHHHHHHHHHcccCHHhcCCCCC
Confidence 99999999999999999999999998643 3444555554432 234568899999999999999999998521
Q ss_pred HHHHHHHHHHHcCCCCCCcccchhhhhhhcc
Q 013092 241 LKRIFRDLFIREGFQFDYVFDWTILKYQQSQ 271 (449)
Q Consensus 241 l~~~L~~~~~~~~~~~~~~~dw~~~~~~~~~ 271 (449)
. ...++ ...++...+||........+
T Consensus 249 ~--~~~~i---~~h~~~~~~~~~~~~~~~~~ 274 (323)
T cd05616 249 E--GERDI---KEHAFFRYIDWEKLERKEVQ 274 (323)
T ss_pred C--CHHHH---hcCCCcCCCCHHHHHhCCCC
Confidence 0 01111 13355666799887655443
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=288.87 Aligned_cols=226 Identities=19% Similarity=0.221 Sum_probs=177.3
Q ss_pred EEEEEeeecccCCChhHHHHHHHHHHHhc--CCCCCceEEEEeE-----eCCEEEEEEecCCCCHHHHHHHc-CCCCCHH
Q 013092 4 ILTVFSVQENVKTKHPQLLYESKLYRILQ--GGTGIPNVRWFGV-----EGDYNVLVMDLLGPSLEDLFNFC-SRKLSLK 75 (449)
Q Consensus 4 aikV~~k~~~~~~~~~~~~~E~~il~~l~--~hp~Iv~l~~~~~-----~~~~~~lVmE~~g~sL~~ll~~~-~~~ls~~ 75 (449)
|+|++............+.+|+.+++.+. .||||+++++++. .....++||||++++|.+++... ...+++.
T Consensus 31 avK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~ 110 (290)
T cd07862 31 ALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTE 110 (290)
T ss_pred EEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCCcEEEEEccCCCCHHHHHHhCCCCCCCHH
Confidence 44444433333334456788999998875 6999999999875 34568999999988999998754 3458999
Q ss_pred HHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchh
Q 013092 76 TVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMN 155 (449)
Q Consensus 76 ~~~~i~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE 155 (449)
.++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++...... ......||+.|+|||
T Consensus 111 ~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~--------~~~~~~~~~~y~aPE 179 (290)
T cd07862 111 TIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILV---TSSGQIKLADFGLARIYSFQM--------ALTSVVVTLWYRAPE 179 (290)
T ss_pred HHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEE---cCCCCEEEccccceEeccCCc--------ccccccccccccChH
Confidence 999999999999999999999999999999999 578899999999998764331 123457899999999
Q ss_pred hhhCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhc----------------------ccchHHHhh
Q 013092 156 THLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK----------------------VSTSIEALC 213 (449)
Q Consensus 156 ~~~~~~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~----------------------~~~~~~~l~ 213 (449)
++.+..++.++|||||||++|||++|..||.+... .+.+.++.... ....++.+.
T Consensus 180 ~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~---~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (290)
T cd07862 180 VLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD---VDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFV 256 (290)
T ss_pred HHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCH---HHHHHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHc
Confidence 99998999999999999999999999999987543 23333332211 111233444
Q ss_pred cCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 214 RGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 214 ~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
+.+++.+.+++..||+.+|++||++.++++
T Consensus 257 ~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 257 TDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred cCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 567889999999999999999999887753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=290.29 Aligned_cols=213 Identities=19% Similarity=0.244 Sum_probs=171.6
Q ss_pred ChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 013092 17 KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 96 (449)
Q Consensus 17 ~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gi 96 (449)
....+.+|+.+++.+ +||||+++++++.+.+..|+||||+.++|.+++......+++..+..++.||+.||+|||++||
T Consensus 46 ~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i 124 (288)
T cd07871 46 APCTAIREVSLLKNL-KHANIVTLHDIIHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKI 124 (288)
T ss_pred cchhHHHHHHHHHhC-CCCCEeeEEEEEcCCCeEEEEEeCCCcCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence 345688999999999 9999999999999999999999999779999988656668999999999999999999999999
Q ss_pred eecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhC-CCCChhhHHHHHHHHH
Q 013092 97 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVL 175 (449)
Q Consensus 97 vHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~-~~~s~~~DiwSlG~il 175 (449)
+||||||+|||+ +.++.+||+|||+++....... ......+++.|+|||++.+ ..++.++|||||||++
T Consensus 125 vH~dlkp~Nil~---~~~~~~kl~DfG~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l 194 (288)
T cd07871 125 LHRDLKPQNLLI---NEKGELKLADFGLARAKSVPTK-------TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCIL 194 (288)
T ss_pred ccCCCCHHHEEE---CCCCCEEECcCcceeeccCCCc-------cccCceecccccChHHhcCCcccCcHHHHHHHHHHH
Confidence 999999999999 5788999999999976543211 1234568999999999876 5689999999999999
Q ss_pred HHHHhCCCCCCCCCcCCHHHHHHHHHhhccc-------------------------chHHHhhcCCcHHHHHHHHHHhcC
Q 013092 176 MYFLRGSLPWQGLKAGTKKQKYEKISEKKVS-------------------------TSIEALCRGYPTEFASYFHYCRSL 230 (449)
Q Consensus 176 ~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~-------------------------~~~~~l~~~~p~el~~li~~cl~~ 230 (449)
|+|++|+.||.+.... +.+..+...... .........++.++.+||..|+..
T Consensus 195 ~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~ 271 (288)
T cd07871 195 YEMATGRPMFPGSTVK---EELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLY 271 (288)
T ss_pred HHHHhCCCCCCCCCHH---HHHHHHHHHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCc
Confidence 9999999999875432 222222111000 001112235678999999999999
Q ss_pred CCCCCCCHHHHHH
Q 013092 231 RFDDKPDYAYLKR 243 (449)
Q Consensus 231 ~p~~RPt~~~l~~ 243 (449)
||.+||++.++++
T Consensus 272 dp~~R~t~~~~l~ 284 (288)
T cd07871 272 ETKSRISAEAALR 284 (288)
T ss_pred CcccCCCHHHHhc
Confidence 9999999888753
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=295.53 Aligned_cols=240 Identities=19% Similarity=0.232 Sum_probs=187.0
Q ss_pred EEEEEeeeccc-CCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHH
Q 013092 4 ILTVFSVQENV-KTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLA 81 (449)
Q Consensus 4 aikV~~k~~~~-~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~ 81 (449)
|+|++.+.... ......+..|.+++..+.+||||+++++++.+.+..|+||||+ |++|.+++.. ...+++..+..++
T Consensus 24 aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~l~~~~~~~~~ 102 (318)
T cd05570 24 AVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQR-SGRFDEPRARFYA 102 (318)
T ss_pred EEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHH-cCCCCHHHHHHHH
Confidence 45555543322 2334557889999999888999999999999999999999999 9999998875 4579999999999
Q ss_pred HHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCC
Q 013092 82 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIE 161 (449)
Q Consensus 82 ~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~ 161 (449)
.|++.||.|||++||+||||||+|||+ +.++.++|+|||+++....... ......||+.|+|||++.+..
T Consensus 103 ~qi~~~l~~LH~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~-------~~~~~~g~~~y~aPE~~~~~~ 172 (318)
T cd05570 103 AEIVLGLQFLHERGIIYRDLKLDNVLL---DSEGHIKIADFGMCKEGILGGV-------TTSTFCGTPDYIAPEILSYQP 172 (318)
T ss_pred HHHHHHHHHHHhCCeEccCCCHHHeEE---CCCCcEEecccCCCeecCcCCC-------cccceecCccccCHHHhcCCC
Confidence 999999999999999999999999999 5788999999999875322211 123456899999999999999
Q ss_pred CChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHH
Q 013092 162 QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYL 241 (449)
Q Consensus 162 ~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l 241 (449)
++.++|||||||++|+|++|..||.+.. ..+.+..+..... .++..++.++.+||..||..+|++||++.+
T Consensus 173 ~~~~~DiwslGvil~~l~~G~~pf~~~~---~~~~~~~i~~~~~-----~~~~~~~~~~~~li~~~l~~dP~~R~s~~~- 243 (318)
T cd05570 173 YGPAVDWWALGVLLYEMLAGQSPFEGDD---EDELFQSILEDEV-----RYPRWLSKEAKSILKSFLTKNPEKRLGCLP- 243 (318)
T ss_pred CCcchhhhhHHHHHHHHhhCCCCCCCCC---HHHHHHHHHcCCC-----CCCCcCCHHHHHHHHHHccCCHHHcCCCCC-
Confidence 9999999999999999999999997643 3334444443322 133567899999999999999999999822
Q ss_pred HHHHHHHHHHcCCCCCCcccchhhhh
Q 013092 242 KRIFRDLFIREGFQFDYVFDWTILKY 267 (449)
Q Consensus 242 ~~~L~~~~~~~~~~~~~~~dw~~~~~ 267 (449)
..+.++ ...++...++|.....
T Consensus 244 -~~~~~l---l~~~~~~~~~~~~~~~ 265 (318)
T cd05570 244 -TGEQDI---KGHPFFREIDWDKLER 265 (318)
T ss_pred -CCHHHH---hcCCCcCCCCHHHHHh
Confidence 111111 1234555678876543
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=290.53 Aligned_cols=227 Identities=17% Similarity=0.201 Sum_probs=181.7
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKS 95 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~-~~~ls~~~~~~i~~qi~~aL~yLH~~g 95 (449)
...+.+|+.+++.+ +|+||+.+++.+.+++..|+||||+ +++|.+++... ...+++..+..++.|++.||.|||+.|
T Consensus 44 ~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ 122 (285)
T cd05605 44 EAMALNEKQILEKV-NSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER 122 (285)
T ss_pred HHHHHHHHHHHHhc-CCCCEeeeeeeecCCCeEEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 34578899999999 8999999999999999999999999 89999888643 346999999999999999999999999
Q ss_pred ceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHHH
Q 013092 96 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVL 175 (449)
Q Consensus 96 ivHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il 175 (449)
|+||||||+||++ +.++.++|+|||++........ .....|++.|+|||++.+..++.++|||||||++
T Consensus 123 ivH~dlkp~Nil~---~~~~~~~l~Dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l 191 (285)
T cd05605 123 IVYRDLKPENILL---DDYGHIRISDLGLAVEIPEGET--------IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLI 191 (285)
T ss_pred cEecCCCHHHEEE---CCCCCEEEeeCCCceecCCCCc--------cccccCCCCccCcHHhcCCCCCccccchhHHHHH
Confidence 9999999999999 5778999999999987543221 1234789999999999998999999999999999
Q ss_pred HHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCC-----CHHHHHHHHHHHHH
Q 013092 176 MYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKP-----DYAYLKRIFRDLFI 250 (449)
Q Consensus 176 ~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RP-----t~~~l~~~L~~~~~ 250 (449)
|+|++|..||.+.+.....+.+..... .....++..++..+.+||..||..||++|| ++.+|+.
T Consensus 192 ~el~~g~~pf~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~------- 260 (285)
T cd05605 192 YEMIEGKSPFRQRKEKVKREEVERRVK----EDQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA------- 260 (285)
T ss_pred HHHHHCCCCCCCCchhhHHHHHHHHhh----hcccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc-------
Confidence 999999999987543222111111111 111223456889999999999999999999 5555532
Q ss_pred HcCCCCCCcccchhhhhhhc
Q 013092 251 REGFQFDYVFDWTILKYQQS 270 (449)
Q Consensus 251 ~~~~~~~~~~dw~~~~~~~~ 270 (449)
.++...++|...+..+.
T Consensus 261 ---~~~~~~~~~~~~~~~~~ 277 (285)
T cd05605 261 ---HPFFRTANFKRLEAGML 277 (285)
T ss_pred ---CcCccCCCHHHHhhCCC
Confidence 35556678887765443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=298.57 Aligned_cols=234 Identities=19% Similarity=0.249 Sum_probs=185.0
Q ss_pred cEEEEEeeeccc-CCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHH
Q 013092 3 EILTVFSVQENV-KTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLML 80 (449)
Q Consensus 3 ~aikV~~k~~~~-~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i 80 (449)
.|+|++.+.... ......+..|+++++.+ +||||+.+++.+.+.+..||||||+ +++|.+++.. ...+++..+..+
T Consensus 23 ~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~-~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~-~~~l~~~~~~~~ 100 (325)
T cd05594 23 YAMKILKKEVIVAKDEVAHTLTENRVLQNS-RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSR-ERVFSEDRARFY 100 (325)
T ss_pred EEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCCceEEEEEcCCEEEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHH
Confidence 455665543322 23345678899999998 9999999999999999999999999 9999988875 457999999999
Q ss_pred HHHHHHHHHHHHH-CCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhC
Q 013092 81 ADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG 159 (449)
Q Consensus 81 ~~qi~~aL~yLH~-~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~ 159 (449)
+.||+.||+|||+ +||+||||||+|||+ +.++.+||+|||+++....... ......||+.|+|||++.+
T Consensus 101 ~~qi~~aL~~lH~~~~ivHrDikp~NIll---~~~~~~kL~Dfg~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~ 170 (325)
T cd05594 101 GAEIVSALDYLHSEKNVVYRDLKLENLML---DKDGHIKITDFGLCKEGIKDGA-------TMKTFCGTPEYLAPEVLED 170 (325)
T ss_pred HHHHHHHHHHHHhcCCEEecCCCCCeEEE---CCCCCEEEecCCCCeecCCCCc-------ccccccCCcccCCHHHHcc
Confidence 9999999999997 799999999999999 6788999999999875432211 1234579999999999999
Q ss_pred CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCC---
Q 013092 160 IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKP--- 236 (449)
Q Consensus 160 ~~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RP--- 236 (449)
..++.++|||||||++|+|++|..||.+... .+.+..+..... .++..+++++.++|..||+.||++|+
T Consensus 171 ~~~~~~~DiwslG~il~el~tG~~Pf~~~~~---~~~~~~i~~~~~-----~~p~~~~~~~~~li~~~L~~dP~~R~~~~ 242 (325)
T cd05594 171 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---EKLFELILMEEI-----RFPRTLSPEAKSLLSGLLKKDPKQRLGGG 242 (325)
T ss_pred CCCCCccccccccceeeeeccCCCCCCCCCH---HHHHHHHhcCCC-----CCCCCCCHHHHHHHHHHhhcCHHHhCCCC
Confidence 9999999999999999999999999976432 333333332222 23456889999999999999999997
Q ss_pred --CHHHHHHHHHHHHHHcCCCCCCcccchhhh
Q 013092 237 --DYAYLKRIFRDLFIREGFQFDYVFDWTILK 266 (449)
Q Consensus 237 --t~~~l~~~L~~~~~~~~~~~~~~~dw~~~~ 266 (449)
++.++.+ .++...++|....
T Consensus 243 ~~~~~~il~----------h~~~~~~~~~~~~ 264 (325)
T cd05594 243 PDDAKEIMQ----------HKFFAGIVWQDVY 264 (325)
T ss_pred CCCHHHHhc----------CCCcCCCCHHHHH
Confidence 6666543 3455556777543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=293.69 Aligned_cols=216 Identities=18% Similarity=0.238 Sum_probs=174.4
Q ss_pred cEEEEEeeeccc-CCChhHHHHHHHHHHHhc--CCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHH
Q 013092 3 EILTVFSVQENV-KTKHPQLLYESKLYRILQ--GGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVL 78 (449)
Q Consensus 3 ~aikV~~k~~~~-~~~~~~~~~E~~il~~l~--~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~ 78 (449)
.|||++.+.... ......+..|++++..++ +||||+++++++.+++..||||||+ |++|..++. ...+++..++
T Consensus 27 ~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~~~--~~~l~~~~~~ 104 (324)
T cd05589 27 YAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIH--TDVFSEPRAV 104 (324)
T ss_pred EEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEEcCCCCCcHHHHhh--cCCCCHHHHH
Confidence 355655543322 233456888888876553 6999999999999999999999999 999998886 4579999999
Q ss_pred HHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhh
Q 013092 79 MLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHL 158 (449)
Q Consensus 79 ~i~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~ 158 (449)
.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++....... ......||+.|+|||++.
T Consensus 105 ~~~~qi~~al~~lH~~~ivHrdlkp~Nill---~~~~~~kL~Dfg~~~~~~~~~~-------~~~~~~g~~~y~aPE~~~ 174 (324)
T cd05589 105 FYAACVVLGLQYLHENKIVYRDLKLDNLLL---DTEGFVKIADFGLCKEGMGFGD-------RTSTFCGTPEFLAPEVLT 174 (324)
T ss_pred HHHHHHHHHHHHHHhCCeEecCCCHHHeEE---CCCCcEEeCcccCCccCCCCCC-------cccccccCccccCHhHhc
Confidence 999999999999999999999999999999 6788999999999875332211 123567999999999999
Q ss_pred CCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCH
Q 013092 159 GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDY 238 (449)
Q Consensus 159 ~~~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~ 238 (449)
+..++.++|||||||++|+|++|..||.+.+ ..+.+..+..... .++..++.++.++|.+||..+|++||+.
T Consensus 175 ~~~~~~~~DiwslG~il~el~~G~~pf~~~~---~~~~~~~i~~~~~-----~~p~~~~~~~~~li~~~L~~dP~~R~~~ 246 (324)
T cd05589 175 ETSYTRAVDWWGLGVLIYEMLVGESPFPGDD---EEEVFDSIVNDEV-----RYPRFLSREAISIMRRLLRRNPERRLGS 246 (324)
T ss_pred CCCCCcccchhhHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhCCC-----CCCCCCCHHHHHHHHHHhhcCHhHcCCC
Confidence 9999999999999999999999999997643 3344444443322 1335688999999999999999999954
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=293.26 Aligned_cols=237 Identities=19% Similarity=0.249 Sum_probs=186.3
Q ss_pred cEEEEEeeecc-cCCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHH
Q 013092 3 EILTVFSVQEN-VKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLML 80 (449)
Q Consensus 3 ~aikV~~k~~~-~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i 80 (449)
.|+|++.+... .......+..|..++..+.+||||+++++++.+.+..||||||+ |++|.+++.. ...+++..+..+
T Consensus 23 vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~-~~~~~~~~~~~~ 101 (316)
T cd05619 23 FAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQS-CHKFDLPRATFY 101 (316)
T ss_pred EEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHH
Confidence 35555544322 12344567788888887769999999999999999999999999 9999999975 456899999999
Q ss_pred HHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCC
Q 013092 81 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI 160 (449)
Q Consensus 81 ~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~ 160 (449)
+.|++.||+|||++||+||||||+|||+ +.++.+||+|||+++....... ......||+.|+|||++.+.
T Consensus 102 ~~qi~~al~~LH~~~ivHrdikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~ 171 (316)
T cd05619 102 AAEIICGLQFLHSKGIVYRDLKLDNILL---DTDGHIKIADFGMCKENMLGDA-------KTCTFCGTPDYIAPEILLGQ 171 (316)
T ss_pred HHHHHHHHHHHHhCCeEeCCCCHHHEEE---CCCCCEEEccCCcceECCCCCC-------ceeeecCCccccCHHHHcCC
Confidence 9999999999999999999999999999 5788999999999875432111 12345789999999999999
Q ss_pred CCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHH-
Q 013092 161 EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYA- 239 (449)
Q Consensus 161 ~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~- 239 (449)
.++.++|||||||++|+|++|..||.+.+ ..+.+..+..... .+...++.++.+++..||..+|++||++.
T Consensus 172 ~~~~~~DvwslG~il~el~~G~~pf~~~~---~~~~~~~i~~~~~-----~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ 243 (316)
T cd05619 172 KYNTSVDWWSFGVLLYEMLIGQSPFHGHD---EEELFQSIRMDNP-----CYPRWLTREAKDILVKLFVREPERRLGVKG 243 (316)
T ss_pred CCCchhhhhhHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhCCC-----CCCccCCHHHHHHHHHHhccCHhhcCCChH
Confidence 99999999999999999999999998743 2333443332211 12345788999999999999999999975
Q ss_pred HHHHHHHHHHHHcCCCCCCcccchhhhhh
Q 013092 240 YLKRIFRDLFIREGFQFDYVFDWTILKYQ 268 (449)
Q Consensus 240 ~l~~~L~~~~~~~~~~~~~~~dw~~~~~~ 268 (449)
+|+ ..++...++|......
T Consensus 244 ~l~----------~h~~~~~~~~~~~~~~ 262 (316)
T cd05619 244 DIR----------QHPFFREIDWSALEER 262 (316)
T ss_pred HHH----------cCcccCCCCHHHHHhC
Confidence 332 2355566788765443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=294.02 Aligned_cols=241 Identities=19% Similarity=0.248 Sum_probs=185.5
Q ss_pred cEEEEEeeeccc-CCChhHHHHHHHHH-HHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHH
Q 013092 3 EILTVFSVQENV-KTKHPQLLYESKLY-RILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLM 79 (449)
Q Consensus 3 ~aikV~~k~~~~-~~~~~~~~~E~~il-~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~ 79 (449)
.|+|++.+.... ......+..|..++ +.+ +||||+++++.+.+.+..||||||+ +++|.+++.. ...+++..+..
T Consensus 23 vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~ 100 (323)
T cd05575 23 YAVKVLQKKAILKKKEQKHIMAERNVLLKNV-KHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQR-ERSFPEPRARF 100 (323)
T ss_pred EEEEEEEHHHHhhhhHHHHHHHHHHHHHhhC-CCCCCCCeeEEEEeCCEEEEEEcCCCCCCHHHHHHh-cCCCCHHHHHH
Confidence 345554433221 22334566666654 556 9999999999999999999999999 9999998875 56799999999
Q ss_pred HHHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhC
Q 013092 80 LADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG 159 (449)
Q Consensus 80 i~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~ 159 (449)
++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++....... ......||+.|+|||++.+
T Consensus 101 ~~~qi~~~l~~lH~~givH~dikp~NIll---~~~~~~kl~Dfg~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~ 170 (323)
T cd05575 101 YAAEIASALGYLHSLNIIYRDLKPENILL---DSQGHVVLTDFGLCKEGIEHSK-------TTSTFCGTPEYLAPEVLRK 170 (323)
T ss_pred HHHHHHHHHHHHHHCCeEeCCCCHHHeEE---CCCCcEEEeccCCCcccccCCC-------ccccccCChhhcChhhhcC
Confidence 99999999999999999999999999999 6788999999999875432211 1234579999999999999
Q ss_pred CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHH
Q 013092 160 IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYA 239 (449)
Q Consensus 160 ~~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~ 239 (449)
..++.++|||||||++|+|++|..||... +..+.+..+..... .+...++.++.++|..||+.+|.+||+..
T Consensus 171 ~~~~~~~DvwslG~il~ell~g~~pf~~~---~~~~~~~~i~~~~~-----~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 171 QPYDRTVDWWCLGAVLYEMLYGLPPFYSR---DTAEMYDNILNKPL-----RLKPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CCCCccccccccchhhhhhhcCCCCCCCC---CHHHHHHHHHcCCC-----CCCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 99999999999999999999999999764 33444555544322 23456799999999999999999999864
Q ss_pred HHHHHHHHHHHHcCCCCCCcccchhhhhhh
Q 013092 240 YLKRIFRDLFIREGFQFDYVFDWTILKYQQ 269 (449)
Q Consensus 240 ~l~~~L~~~~~~~~~~~~~~~dw~~~~~~~ 269 (449)
. .+.++ ...++...++|......+
T Consensus 243 ~---~~~~i---l~~~~~~~~~~~~~~~~~ 266 (323)
T cd05575 243 D---DFLEI---KNHVFFSSINWDDLVNKK 266 (323)
T ss_pred C---CHHHH---HcCCCcCCCCHHHHhhcc
Confidence 2 12222 234555667887665443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=289.10 Aligned_cols=229 Identities=19% Similarity=0.220 Sum_probs=180.6
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKS 95 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~-~~~ls~~~~~~i~~qi~~aL~yLH~~g 95 (449)
...+..|+++++.+ +||||+++.+.+.++.+.||||||+ |++|.+++... ...+++..++.++.|++.||+|||+.|
T Consensus 37 ~~~~~~E~~il~~l-~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ 115 (277)
T cd05607 37 EKMALLEKEILEKV-NSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD 115 (277)
T ss_pred hHHHHHHHHHHHhc-CCCcEEEEEEEEecCCeEEEEEecCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 34566799999999 9999999999999999999999999 99999888643 345899999999999999999999999
Q ss_pred ceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHHH
Q 013092 96 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVL 175 (449)
Q Consensus 96 ivHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il 175 (449)
|+||||||+||++ +.++.++|+|||++........ .....|+..|+|||++.+..++.++|||||||++
T Consensus 116 ivH~dikp~Nili---~~~~~~~l~Dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l 184 (277)
T cd05607 116 IVYRDMKPENVLL---DDQGNCRLSDLGLAVELKDGKT--------ITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSI 184 (277)
T ss_pred EEEccCChHhEEE---cCCCCEEEeeceeeeecCCCce--------eeccCCCCCccCHHHHccCCCCCchhHHHHHHHH
Confidence 9999999999999 5788999999999987654321 1234689999999999998899999999999999
Q ss_pred HHHHhCCCCCCCCCcC-CHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCC
Q 013092 176 MYFLRGSLPWQGLKAG-TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGF 254 (449)
Q Consensus 176 ~elltG~~Pf~~~~~~-~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~L~~~~~~~~~ 254 (449)
|+|++|..||...... ...+....+.... .......++.++.+++..||+.+|++||++.++.+. .+ .+
T Consensus 185 ~el~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~---~~---~h 254 (277)
T cd05607 185 YEMVAGRTPFKDHKEKVAKEELKRRTLEDE----VKFEHQNFTEESKDICRLFLAKKPEDRLGSREKNDD---PR---KH 254 (277)
T ss_pred HHHHhCCCCCCCCcchhhHHHHHHHhhccc----cccccccCCHHHHHHHHHHhccCHhhCCCCccchhh---hh---cC
Confidence 9999999999764322 1112222222211 111224688999999999999999999998665422 21 24
Q ss_pred CCCCcccchhhhhh
Q 013092 255 QFDYVFDWTILKYQ 268 (449)
Q Consensus 255 ~~~~~~dw~~~~~~ 268 (449)
++...++|...+..
T Consensus 255 ~~f~~~~~~~~~~~ 268 (277)
T cd05607 255 EFFKTINFPRLEAG 268 (277)
T ss_pred hhhcCCCHHHHhcC
Confidence 55566788766543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=308.60 Aligned_cols=235 Identities=17% Similarity=0.262 Sum_probs=198.1
Q ss_pred cEEEEEeeecccCCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHH
Q 013092 3 EILTVFSVQENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLA 81 (449)
Q Consensus 3 ~aikV~~k~~~~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~ 81 (449)
+|||++.......++-+.|++|+.+|+.- .|.||+-+.+++..... .||..+| |.+|+.+++....+|.+.+.+.|+
T Consensus 417 VAVK~Lnv~~pt~~qlqaFKnEVa~lkkT-RH~NIlLFMG~~~~p~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIA 494 (678)
T KOG0193|consen 417 VAVKLLNVDDPTPEQLQAFKNEVAVLKKT-RHENILLFMGACMNPPL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIA 494 (678)
T ss_pred eEEEEEecCCCCHHHHHHHHHHHHHHhhc-chhhheeeehhhcCCce-eeeehhccCchhhhhccchhhhhhHHHHHHHH
Confidence 57787777777777788899999999999 99999999999998887 9999999 999999998767789999999999
Q ss_pred HHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhC--
Q 013092 82 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG-- 159 (449)
Q Consensus 82 ~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~-- 159 (449)
.||+.|+.|||.++|||||||..||+| .+++.|||.||||+..-..-... .......|...|||||++..
T Consensus 495 qQiaqGM~YLHAK~IIHrDLKSnNIFl---~~~~kVkIgDFGLatvk~~w~g~-----~q~~qp~gsilwmAPEvIRmqd 566 (678)
T KOG0193|consen 495 QQIAQGMDYLHAKNIIHRDLKSNNIFL---HEDLKVKIGDFGLATVKTRWSGE-----QQLEQPHGSLLWMAPEVIRMQD 566 (678)
T ss_pred HHHHHhhhhhhhhhhhhhhccccceEE---ccCCcEEEecccceeeeeeeccc-----cccCCCccchhhhcHHHHhhcc
Confidence 999999999999999999999999999 57799999999998643221110 11234568899999999985
Q ss_pred -CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCH
Q 013092 160 -IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDY 238 (449)
Q Consensus 160 -~~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~ 238 (449)
.+|++.+|||||||++|||++|.+||.. ....+++..+-........-....++|.++.+|+..||..++++||.|
T Consensus 567 ~nPfS~qSDVYaFGiV~YELltg~lPysi---~~~dqIifmVGrG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F 643 (678)
T KOG0193|consen 567 DNPFSFQSDVYAFGIVWYELLTGELPYSI---QNRDQIIFMVGRGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLF 643 (678)
T ss_pred cCCCCcccchhhhhHHHHHHHhCcCCcCC---CChhheEEEecccccCccchhhhccCHHHHHHHHHHHHhcCcccCccH
Confidence 4589999999999999999999999984 334455555555545555666778899999999999999999999999
Q ss_pred HHHHHHHHHHHH
Q 013092 239 AYLKRIFRDLFI 250 (449)
Q Consensus 239 ~~l~~~L~~~~~ 250 (449)
.+|...|++++.
T Consensus 644 ~~il~~l~~l~~ 655 (678)
T KOG0193|consen 644 PQLLSKLEELLP 655 (678)
T ss_pred HHHHHHHHHhhh
Confidence 999998877754
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=299.50 Aligned_cols=245 Identities=18% Similarity=0.257 Sum_probs=186.4
Q ss_pred cEEEEEeeeccc-CCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHH
Q 013092 3 EILTVFSVQENV-KTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLML 80 (449)
Q Consensus 3 ~aikV~~k~~~~-~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i 80 (449)
.|||++.+.... ......+..|+.++..+ +|++|+++++.+.+....||||||| |++|.+++.. .+.+++..+..+
T Consensus 29 ~aiK~~~~~~~~~~~~~~~~~~E~~il~~~-~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~-~~~l~~~~~~~~ 106 (363)
T cd05628 29 YAMKILRKADMLEKEQVGHIRAERDILVEA-DSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMK-KDTLTEEETQFY 106 (363)
T ss_pred EEEEEEEHHHHHHhhHHHHHHHHHHHHHhC-CCCCcceEEEEEecCCeEEEEEcCCCCCcHHHHHHh-cCCCCHHHHHHH
Confidence 456666544322 23345688899999999 9999999999999999999999999 9999999975 467999999999
Q ss_pred HHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCc-------ccc---------------
Q 013092 81 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ-------HIP--------------- 138 (449)
Q Consensus 81 ~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~-------~~~--------------- 138 (449)
+.|++.||+|||++||+||||||+|||| +.++.+||+|||+++.+....... ..+
T Consensus 107 ~~qi~~aL~~lH~~givHrDlKp~NILi---~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 183 (363)
T cd05628 107 IAETVLAIDSIHQLGFIHRDIKPDNLLL---DSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAE 183 (363)
T ss_pred HHHHHHHHHHHHhCCeEecCCCHHHeEE---CCCCCEEEeeccCcccccccccccccccccccccccccccccccccccc
Confidence 9999999999999999999999999999 578899999999997654211000 000
Q ss_pred ------cccCCCCccCccccchhhhhCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHh
Q 013092 139 ------YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 212 (449)
Q Consensus 139 ------~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 212 (449)
.......+||+.|+|||++.+..++.++|||||||++|||++|..||.+.. ..+.+.++........++.
T Consensus 184 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~~---~~~~~~~i~~~~~~~~~p~- 259 (363)
T cd05628 184 TWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSET---PQETYKKVMNWKETLIFPP- 259 (363)
T ss_pred hhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCCC---HHHHHHHHHcCcCcccCCC-
Confidence 000124579999999999999999999999999999999999999998643 3445555554322211111
Q ss_pred hcCCcHHHHHHHHHHhcCCCC---CCCCHHHHHHHHHHHHHHcCCCCCCcccchhhhh
Q 013092 213 CRGYPTEFASYFHYCRSLRFD---DKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKY 267 (449)
Q Consensus 213 ~~~~p~el~~li~~cl~~~p~---~RPt~~~l~~~L~~~~~~~~~~~~~~~dw~~~~~ 267 (449)
...+++++.++|..++. ++. .||++++|++ .++...++|.....
T Consensus 260 ~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~----------hp~f~~~~~~~~~~ 306 (363)
T cd05628 260 EVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKT----------NPFFEGVDWEHIRE 306 (363)
T ss_pred cCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhC----------CCCCCCCCHHHHHh
Confidence 12367899999988654 344 4578777743 46777889987644
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=283.47 Aligned_cols=214 Identities=20% Similarity=0.322 Sum_probs=175.1
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 96 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gi 96 (449)
...+..|+.+++.+ +|+||+++++++. .+..++||||+ +++|.+++.. ...+++..++.++.|++.||+|||++||
T Consensus 40 ~~~~~~e~~~l~~l-~h~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~i 116 (257)
T cd05116 40 KDELLREANVMQQL-DNPYIVRMIGICE-AESWMLVMELAELGPLNKFLQK-NKHVTEKNITELVHQVSMGMKYLEETNF 116 (257)
T ss_pred HHHHHHHHHHHHhC-CCCCcceEEEEEc-CCCcEEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCE
Confidence 45688999999999 9999999998875 45679999999 8899999975 4579999999999999999999999999
Q ss_pred eecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHHHH
Q 013092 97 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLM 176 (449)
Q Consensus 97 vHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il~ 176 (449)
+||||||.||++ +.++.+||+|||+++.+...... +.......++..|+|||.+....++.++|||||||++|
T Consensus 117 ~H~dlkp~nill---~~~~~~kl~Dfg~~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ 189 (257)
T cd05116 117 VHRDLAARNVLL---VTQHYAKISDFGLSKALGADENY----YKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMW 189 (257)
T ss_pred eecccchhhEEE---cCCCeEEECCCccccccCCCCCe----eeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHH
Confidence 999999999999 57789999999999876543221 11112234467899999998888999999999999999
Q ss_pred HHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 013092 177 YFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDL 248 (449)
Q Consensus 177 ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~L~~~ 248 (449)
||++ |..||..... ......+..... ..++..+++++.++|..||+.+|++||++.+|.+.|++.
T Consensus 190 el~t~g~~p~~~~~~---~~~~~~i~~~~~----~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 190 EAFSYGQKPYKGMKG---NEVTQMIESGER----MECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred HHHhCCCCCCCCCCH---HHHHHHHHCCCC----CCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 9998 9999976433 233333433221 123456899999999999999999999999999888764
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=285.27 Aligned_cols=214 Identities=20% Similarity=0.283 Sum_probs=178.8
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcC---------------CCCCHHHHHHHH
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCS---------------RKLSLKTVLMLA 81 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~---------------~~ls~~~~~~i~ 81 (449)
...|.+|+.++..+ +||||+++++++.+.+..|++|||+ +++|.+++.... ..+++..++.++
T Consensus 52 ~~~~~~ei~~l~~l-~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 130 (283)
T cd05048 52 QQEFRQEAELMSDL-QHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIA 130 (283)
T ss_pred HHHHHHHHHHHHhc-CCcccceEEEEEcCCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHH
Confidence 34588999999999 8999999999999999999999999 899999997531 457889999999
Q ss_pred HHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCC
Q 013092 82 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIE 161 (449)
Q Consensus 82 ~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~ 161 (449)
.|++.||.|||++|++|+||||+||++ +.++.++|+|||+++....... +.......+++.|+|||.+.+..
T Consensus 131 ~~l~~al~~lH~~~i~H~dlkp~Nil~---~~~~~~~L~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~ 202 (283)
T cd05048 131 IQIAAGMEYLSSHHFVHRDLAARNCLV---GEGLTVKISDFGLSRDIYSADY-----YRVQSKSLLPVRWMPPEAILYGK 202 (283)
T ss_pred HHHHHHHHHHHhCCeeccccccceEEE---cCCCcEEECCCcceeecccccc-----ccccCCCcccccccCHHHhccCc
Confidence 999999999999999999999999999 5778999999999986543221 11223446788999999999888
Q ss_pred CChhhHHHHHHHHHHHHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHH
Q 013092 162 QSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAY 240 (449)
Q Consensus 162 ~s~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~ 240 (449)
++.++|||||||++|||++ |..||.+... .+.+..+..... ...+..+|.++.+|+..||+.+|++||++.+
T Consensus 203 ~~~~sDv~slG~il~el~~~g~~p~~~~~~---~~~~~~i~~~~~----~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~ 275 (283)
T cd05048 203 FTTESDIWSFGVVLWEIFSYGLQPYYGFSN---QEVIEMIRSRQL----LPCPEDCPARVYALMIECWNEIPARRPRFKD 275 (283)
T ss_pred CchhhhHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHHcCCc----CCCcccCCHHHHHHHHHHccCChhhCcCHHH
Confidence 9999999999999999998 9999987543 334444443322 2234678999999999999999999999999
Q ss_pred HHHHHHH
Q 013092 241 LKRIFRD 247 (449)
Q Consensus 241 l~~~L~~ 247 (449)
|.+.|+.
T Consensus 276 i~~~l~~ 282 (283)
T cd05048 276 IHTRLRS 282 (283)
T ss_pred HHHHHhc
Confidence 9988764
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=297.44 Aligned_cols=239 Identities=19% Similarity=0.257 Sum_probs=186.9
Q ss_pred cEEEEEeeeccc-CCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHH
Q 013092 3 EILTVFSVQENV-KTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLML 80 (449)
Q Consensus 3 ~aikV~~k~~~~-~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i 80 (449)
.|+|++.+.... ......+..|+.+++.+ +|+||+.+++.+.+.+..||||||+ +++|.+++......+++..+..+
T Consensus 29 ~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~ 107 (330)
T cd05601 29 YAMKVMKKSVLLAQETVSFFEEERDILSIS-NSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFY 107 (330)
T ss_pred EEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCcceeeEEecCCeEEEEECCCCCCCHHHHHHHhcCCCCHHHHHHH
Confidence 355555543321 23445578899999988 9999999999999999999999999 99999999876567999999999
Q ss_pred HHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhh--
Q 013092 81 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHL-- 158 (449)
Q Consensus 81 ~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~-- 158 (449)
+.||+.||+|||++||+||||||+|||+ +..+.+||+|||++..+...... ......||+.|+|||++.
T Consensus 108 ~~qi~~aL~~lH~~~i~H~Dlkp~NIll---~~~~~~kL~Dfg~a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~ 178 (330)
T cd05601 108 LAELVLAIHSVHQMGYVHRDIKPENVLI---DRTGHIKLADFGSAARLTANKMV------NSKLPVGTPDYIAPEVLTTM 178 (330)
T ss_pred HHHHHHHHHHHHHCCeEcccCchHheEE---CCCCCEEeccCCCCeECCCCCce------eeecccCCccccCHHHhccc
Confidence 9999999999999999999999999999 68889999999999876543221 112347899999999987
Q ss_pred ----CCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCC
Q 013092 159 ----GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDD 234 (449)
Q Consensus 159 ----~~~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~ 234 (449)
...++.++|||||||++|+|++|..||.... ....+.++.........+ ....++.++.+|+..|+. +|.+
T Consensus 179 ~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~---~~~~~~~i~~~~~~~~~~-~~~~~~~~~~~li~~ll~-~p~~ 253 (330)
T cd05601 179 NGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGT---SAKTYNNIMNFQRFLKFP-EDPKVSSDFLDLIQSLLC-GQKE 253 (330)
T ss_pred cccccCCCCCcceeecccceeeeeccCCCCCCCCC---HHHHHHHHHcCCCccCCC-CCCCCCHHHHHHHHHHcc-Chhh
Confidence 4567889999999999999999999997643 334444444322111111 113578999999999998 9999
Q ss_pred CCCHHHHHHHHHHHHHHcCCCCCCcccchhhh
Q 013092 235 KPDYAYLKRIFRDLFIREGFQFDYVFDWTILK 266 (449)
Q Consensus 235 RPt~~~l~~~L~~~~~~~~~~~~~~~dw~~~~ 266 (449)
||++.+++. .++....+|....
T Consensus 254 R~t~~~l~~----------h~~~~~~~~~~~~ 275 (330)
T cd05601 254 RLGYEGLCC----------HPFFSKIDWNNIR 275 (330)
T ss_pred CCCHHHHhC----------CCCcCCCCHHHHh
Confidence 999887642 3555567887654
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=295.17 Aligned_cols=239 Identities=18% Similarity=0.240 Sum_probs=184.9
Q ss_pred cEEEEEeeecccC-CChhHHHHHHHH-HHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHH
Q 013092 3 EILTVFSVQENVK-TKHPQLLYESKL-YRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLM 79 (449)
Q Consensus 3 ~aikV~~k~~~~~-~~~~~~~~E~~i-l~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~ 79 (449)
.|+|++.+..... .....+..|..+ ++.+ +|+||+++++.+.+.+..||||||+ +++|.+++.. ...+++..+..
T Consensus 23 ~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-~h~~Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~ 100 (325)
T cd05602 23 YAVKVLQKKAILKKKEEKHIMSERNVLLKNV-KHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQR-ERCFLEPRARF 100 (325)
T ss_pred EEEEEEEHHHHHhhhHHHHHHHHHHHHHHhC-CCCCCCceeEEEEcCCeEEEEEeCCCCCcHHHHHHh-cCCCCHHHHHH
Confidence 3555555433222 223345556554 4556 9999999999999999999999999 9999999875 45688999999
Q ss_pred HHHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhC
Q 013092 80 LADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG 159 (449)
Q Consensus 80 i~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~ 159 (449)
++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++....... ......||+.|+|||++.+
T Consensus 101 ~~~qi~~~L~~lH~~giiHrDlkp~Nili---~~~~~~kl~DfG~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~ 170 (325)
T cd05602 101 YAAEIASALGYLHSLNIVYRDLKPENILL---DSQGHIVLTDFGLCKENIEHNG-------TTSTFCGTPEYLAPEVLHK 170 (325)
T ss_pred HHHHHHHHHHHHHHCCeEecCCCHHHeEE---CCCCCEEEccCCCCcccccCCC-------CcccccCCccccCHHHHcC
Confidence 99999999999999999999999999999 5788999999999975432211 1234579999999999999
Q ss_pred CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHH
Q 013092 160 IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYA 239 (449)
Q Consensus 160 ~~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~ 239 (449)
..++.++|||||||++|+|++|..||.+.. ..+.+..+..... .+...++.++.++|..|++.+|.+||+..
T Consensus 171 ~~~~~~~DiwslG~il~el~~g~~pf~~~~---~~~~~~~i~~~~~-----~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (325)
T cd05602 171 QPYDRTVDWWCLGAVLYEMLYGLPPFYSRN---TAEMYDNILNKPL-----QLKPNITNSARHLLEGLLQKDRTKRLGAK 242 (325)
T ss_pred CCCCCccccccccHHHHHHhcCCCCCCCCC---HHHHHHHHHhCCc-----CCCCCCCHHHHHHHHHHcccCHHHCCCCC
Confidence 999999999999999999999999998643 3444454444322 23356889999999999999999999865
Q ss_pred HHHHHHHHHHHHcCCCCCCcccchhhhh
Q 013092 240 YLKRIFRDLFIREGFQFDYVFDWTILKY 267 (449)
Q Consensus 240 ~l~~~L~~~~~~~~~~~~~~~dw~~~~~ 267 (449)
+. +.++ ....+...++|+....
T Consensus 243 ~~---~~~i---~~~~~~~~~~~~~~~~ 264 (325)
T cd05602 243 DD---FMEI---KNHIFFSPINWDDLIN 264 (325)
T ss_pred CC---HHHH---hcCcccCCCCHHHHHh
Confidence 32 2222 2345566788987643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=305.96 Aligned_cols=205 Identities=20% Similarity=0.314 Sum_probs=177.2
Q ss_pred HHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecC
Q 013092 22 LYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRD 100 (449)
Q Consensus 22 ~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~givHRD 100 (449)
..+|+-|++| .|+||+.+.++|.....+||||||| .|-|.++++. .++++......|..+|+.|+.|||.+.|||||
T Consensus 160 ETdIKHLRkL-kH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~VLka-~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRD 237 (904)
T KOG4721|consen 160 ETDIKHLRKL-KHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEVLKA-GRPITPSLLVDWSKGIAGGMNYLHLHKIIHRD 237 (904)
T ss_pred hhhHHHHHhc-cCcceeeEeeeecCCceeEEeeeccccccHHHHHhc-cCccCHHHHHHHHHHhhhhhHHHHHhhHhhhc
Confidence 4588889999 9999999999999999999999999 9999999985 67799999999999999999999999999999
Q ss_pred CCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHHHHHHHh
Q 013092 101 IKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR 180 (449)
Q Consensus 101 LKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il~ellt 180 (449)
||.-||||+ .+..|||+|||..+...+..+ .-.+.||..|||||++...+.+.++||||||||||||||
T Consensus 238 LKSPNiLIs---~~d~VKIsDFGTS~e~~~~ST--------kMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT 306 (904)
T KOG4721|consen 238 LKSPNILIS---YDDVVKISDFGTSKELSDKST--------KMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLT 306 (904)
T ss_pred cCCCceEee---ccceEEeccccchHhhhhhhh--------hhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHh
Confidence 999999994 778899999999987766543 246899999999999999999999999999999999999
Q ss_pred CCCCCCCCCcCCHHHHHHHHHhhcccchH-HHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 013092 181 GSLPWQGLKAGTKKQKYEKISEKKVSTSI-EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFR 246 (449)
Q Consensus 181 G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~-~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~L~ 246 (449)
|..||.+.+.. .|........+ -..+..||+.|.-||+.||+..|..||+|.+|+..|.
T Consensus 307 ~EiPYkdVdss-------AIIwGVGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~Hld 366 (904)
T KOG4721|consen 307 GEIPYKDVDSS-------AIIWGVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLD 366 (904)
T ss_pred cCCCccccchh-------eeEEeccCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHh
Confidence 99999875432 12222222111 1234678999999999999999999999999976653
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=287.42 Aligned_cols=212 Identities=19% Similarity=0.227 Sum_probs=168.6
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFL 97 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~giv 97 (449)
...+.+|+.+++.+ +||||+++++++.+....|+||||++++|.+++......++...+..++.|++.||+|||++||+
T Consensus 47 ~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iv 125 (303)
T cd07869 47 PFTAIREASLLKGL-KHANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYIL 125 (303)
T ss_pred chhHHHHHHHHhhC-CCCCcCeEEEEEecCCeEEEEEECCCcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 34678999999999 99999999999999999999999998899998876556799999999999999999999999999
Q ss_pred ecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhC-CCCChhhHHHHHHHHHH
Q 013092 98 HRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLM 176 (449)
Q Consensus 98 HRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~-~~~s~~~DiwSlG~il~ 176 (449)
||||||+|||+ +..+.+||+|||+++....... ......||+.|+|||++.+ ..++.++|||||||++|
T Consensus 126 H~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ 195 (303)
T cd07869 126 HRDLKPQNLLI---SDTGELKLADFGLARAKSVPSH-------TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFV 195 (303)
T ss_pred cCCCCHHHEEE---CCCCCEEECCCCcceeccCCCc-------cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHH
Confidence 99999999999 5788999999999975433211 1234568999999999876 45789999999999999
Q ss_pred HHHhCCCCCCCCCcCCHHHHHHHHHhhccc-------------------------chHHHhh--cCCcHHHHHHHHHHhc
Q 013092 177 YFLRGSLPWQGLKAGTKKQKYEKISEKKVS-------------------------TSIEALC--RGYPTEFASYFHYCRS 229 (449)
Q Consensus 177 elltG~~Pf~~~~~~~~~~~~~~i~~~~~~-------------------------~~~~~l~--~~~p~el~~li~~cl~ 229 (449)
+|++|..||.+... ....+..+...... ..+.... ..++.++.+|+..|++
T Consensus 196 ~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~ 273 (303)
T cd07869 196 EMIQGVAAFPGMKD--IQDQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQ 273 (303)
T ss_pred HHHhCCCCCCCCcc--HHHHHHHHHHHhCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhc
Confidence 99999999987533 22222222111000 0000111 1245789999999999
Q ss_pred CCCCCCCCHHHHH
Q 013092 230 LRFDDKPDYAYLK 242 (449)
Q Consensus 230 ~~p~~RPt~~~l~ 242 (449)
.||.+||++.+++
T Consensus 274 ~dp~~R~s~~~~l 286 (303)
T cd07869 274 CFPKNRLSAQAAL 286 (303)
T ss_pred cCchhccCHHHHh
Confidence 9999999987764
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=300.69 Aligned_cols=244 Identities=22% Similarity=0.276 Sum_probs=190.8
Q ss_pred cEEEEEeeecccC-CChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHH
Q 013092 3 EILTVFSVQENVK-TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLML 80 (449)
Q Consensus 3 ~aikV~~k~~~~~-~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i 80 (449)
.|||++.+..... .....+..|++++..+ +|+||+++++.+.++++.||||||+ +++|.+++.. ...+++..++.+
T Consensus 29 ~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i 106 (350)
T cd05573 29 YAMKVLRKSDMIKRNQIAHVRAERDILADA-DSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIR-KDVFPEETARFY 106 (350)
T ss_pred EEEEEEEHHHHhhccHHHHHHHHHHHHHhc-CCCCccchhhheecCCeEEEEEcCCCCCCHHHHHHH-cCCCCHHHHHHH
Confidence 4566655544332 4455688999999999 8999999999999999999999999 9999999986 367999999999
Q ss_pred HHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcc----------------------cc
Q 013092 81 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQH----------------------IP 138 (449)
Q Consensus 81 ~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~----------------------~~ 138 (449)
+.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.+........ ..
T Consensus 107 ~~qi~~aL~~LH~~giiH~Dlkp~NIll---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 183 (350)
T cd05573 107 IAELVLALDSVHKLGFIHRDIKPDNILI---DADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQR 183 (350)
T ss_pred HHHHHHHHHHHHHCCeeccCCCHHHeEE---CCCCCEEeecCCCCccCcccCcccccccccccccccccccccccccccc
Confidence 9999999999999999999999999999 6888999999999987654320000 00
Q ss_pred cccCCCCccCccccchhhhhCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcH
Q 013092 139 YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPT 218 (449)
Q Consensus 139 ~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~ 218 (449)
........||+.|+|||++.+..++.++|||||||++|||++|..||.... ....+.++........++. ...+++
T Consensus 184 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~---~~~~~~~i~~~~~~~~~p~-~~~~~~ 259 (350)
T cd05573 184 RVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT---LQETYNKIINWKESLRFPP-DPPVSP 259 (350)
T ss_pred cccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC---HHHHHHHHhccCCcccCCC-CCCCCH
Confidence 011234579999999999999999999999999999999999999998744 3344444444211111111 123689
Q ss_pred HHHHHHHHHhcCCCCCCCC-HHHHHHHHHHHHHHcCCCCCCcccchhhh
Q 013092 219 EFASYFHYCRSLRFDDKPD-YAYLKRIFRDLFIREGFQFDYVFDWTILK 266 (449)
Q Consensus 219 el~~li~~cl~~~p~~RPt-~~~l~~~L~~~~~~~~~~~~~~~dw~~~~ 266 (449)
++.++|..|+. +|.+||+ +.+++. .++...++|....
T Consensus 260 ~~~~li~~ll~-dp~~R~~s~~~ll~----------hp~~~~~~~~~~~ 297 (350)
T cd05573 260 EAIDLICRLLC-DPEDRLGSFEEIKS----------HPFFKGIDWENLR 297 (350)
T ss_pred HHHHHHHHHcc-ChhhcCCCHHHHhc----------CCCcCCCCHHHHh
Confidence 99999999997 9999999 888754 3555667887554
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=291.93 Aligned_cols=241 Identities=20% Similarity=0.240 Sum_probs=186.2
Q ss_pred cEEEEEeeeccc-CCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHH
Q 013092 3 EILTVFSVQENV-KTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLML 80 (449)
Q Consensus 3 ~aikV~~k~~~~-~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i 80 (449)
.|+|++.+.+.. ......+..|+.++..+ +|+||+.+++++.++++.||||||+ |++|.+++......+++..+..+
T Consensus 29 ~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~ 107 (331)
T cd05597 29 YAMKILNKWEMLKRAETACFREERDVLVNG-DRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFY 107 (331)
T ss_pred EEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-CCCCCCceEEEEecCCeEEEEEecCCCCcHHHHHHHhcCCCCHHHHHHH
Confidence 456666543322 23445688899999998 9999999999999999999999999 99999999865667999999999
Q ss_pred HHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhC-
Q 013092 81 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG- 159 (449)
Q Consensus 81 ~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~- 159 (449)
+.||+.||+|||++||+||||||+|||+ +.++.+||+|||++..+...... ......||+.|+|||++..
T Consensus 108 ~~qi~~~l~~lH~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~ 178 (331)
T cd05597 108 LAEMVLAIDSVHQLGYVHRDIKPDNVLL---DKNGHIRLADFGSCLRLLADGTV------QSNVAVGTPDYISPEILQAM 178 (331)
T ss_pred HHHHHHHHHHHHhCCeEECCCCHHHEEE---CCCCCEEEEECCceeecCCCCCc------cccceeccccccCHHHHhhc
Confidence 9999999999999999999999999999 57889999999999776543221 1123469999999999973
Q ss_pred ----CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCC--
Q 013092 160 ----IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFD-- 233 (449)
Q Consensus 160 ----~~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~-- 233 (449)
..++.++|||||||++|+|++|+.||.+. ...+.+.++........++.....++.++.++|..|+..+++
T Consensus 179 ~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~---~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~ll~~~~~r~ 255 (331)
T cd05597 179 EDGKGRYGPECDWWSLGVCMYEMLYGETPFYAE---SLVETYGKIMNHKEHFQFPPDVTDVSEEAKDLIRRLICSPETRL 255 (331)
T ss_pred cccccCCCCcceeehhhhHHHHHhhCCCCCCCC---CHHHHHHHHHcCCCcccCCCccCCCCHHHHHHHHHHccCccccc
Confidence 34688999999999999999999999763 334445555443322222233345789999999998865333
Q ss_pred CCCCHHHHHHHHHHHHHHcCCCCCCcccchhhh
Q 013092 234 DKPDYAYLKRIFRDLFIREGFQFDYVFDWTILK 266 (449)
Q Consensus 234 ~RPt~~~l~~~L~~~~~~~~~~~~~~~dw~~~~ 266 (449)
.|+++.++++ +++...++|....
T Consensus 256 ~r~~~~~~l~----------hp~~~~~~~~~~~ 278 (331)
T cd05597 256 GRNGLQDFKD----------HPFFEGIDWDNIR 278 (331)
T ss_pred CCCCHHHHhc----------CCCCCCCCHHHHh
Confidence 2667655533 3666677888764
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=301.68 Aligned_cols=217 Identities=20% Similarity=0.275 Sum_probs=175.8
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcC---------------------------
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCS--------------------------- 69 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~--------------------------- 69 (449)
.+.+.+|+++|..+.+||||+++++++.+++..|+||||| +|+|.+++....
T Consensus 82 ~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (375)
T cd05104 82 REALMSELKVLSYLGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMS 161 (375)
T ss_pred HHHHHHHHHHHHHhcCCcceeeeeeeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhccc
Confidence 4568899999999988999999999999999999999999 999999986421
Q ss_pred -----------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCC
Q 013092 70 -----------------------------------------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIK 102 (449)
Q Consensus 70 -----------------------------------------------~~ls~~~~~~i~~qi~~aL~yLH~~givHRDLK 102 (449)
..+++..++.++.||+.||+|||++||+|||||
T Consensus 162 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlk 241 (375)
T cd05104 162 CDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLA 241 (375)
T ss_pred chhhhhhhhcCCCcccccccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCc
Confidence 147888999999999999999999999999999
Q ss_pred CCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHHHHHHHh-C
Q 013092 103 PDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-G 181 (449)
Q Consensus 103 P~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il~ellt-G 181 (449)
|+|||+ +.++.+||+|||+++........ .......++..|+|||++.+..++.++|||||||++|||++ |
T Consensus 242 p~Nill---~~~~~~kl~DfG~a~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g 313 (375)
T cd05104 242 ARNILL---THGRITKICDFGLARDIRNDSNY-----VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLG 313 (375)
T ss_pred hhhEEE---ECCCcEEEecCccceeccCcccc-----cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcC
Confidence 999999 46788999999999876543221 11223345678999999999999999999999999999998 9
Q ss_pred CCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 013092 182 SLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDL 248 (449)
Q Consensus 182 ~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~L~~~ 248 (449)
..||....... ..+..+..... . ..+...|.++.+||..||+.+|++||++.+|.+.|++.
T Consensus 314 ~~p~~~~~~~~--~~~~~~~~~~~-~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 314 SSPYPGMPVDS--KFYKMIKEGYR-M---LSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred CCCCCCCCchH--HHHHHHHhCcc-C---CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 99997754321 22222222111 1 12234688999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=278.77 Aligned_cols=206 Identities=21% Similarity=0.236 Sum_probs=178.8
Q ss_pred HHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q 013092 21 LLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHR 99 (449)
Q Consensus 21 ~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~givHR 99 (449)
-..|+.||+++.+||+|+++.++++.....|+|+|+| .|.|+|++.. .-.++++....|+.|+..|++|||.++||||
T Consensus 69 T~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlVFdl~prGELFDyLts-~VtlSEK~tR~iMrqlfegVeylHa~~IVHR 147 (411)
T KOG0599|consen 69 TRQEISILRQVMGHPYIIDLQDVYESDAFVFLVFDLMPRGELFDYLTS-KVTLSEKETRRIMRQLFEGVEYLHARNIVHR 147 (411)
T ss_pred HHHHHHHHHHhcCCCcEEEeeeeccCcchhhhhhhhcccchHHHHhhh-heeecHHHHHHHHHHHHHHHHHHHHhhhhhc
Confidence 4679999999999999999999999999999999999 9999999985 4569999999999999999999999999999
Q ss_pred CCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhC------CCCChhhHHHHHHH
Q 013092 100 DIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG------IEQSRRDDLESLGY 173 (449)
Q Consensus 100 DLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~------~~~s~~~DiwSlG~ 173 (449)
||||+|||+ +++.+++|+|||++..+...... ...+|||+|+|||.+.- ..|+...|+|++|+
T Consensus 148 DLKpENILl---ddn~~i~isDFGFa~~l~~GekL--------relCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GV 216 (411)
T KOG0599|consen 148 DLKPENILL---DDNMNIKISDFGFACQLEPGEKL--------RELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGV 216 (411)
T ss_pred ccChhheee---ccccceEEeccceeeccCCchhH--------HHhcCCCcccChhheeeecccCCCCccchhhHHHHHH
Confidence 999999999 68899999999999988765432 35799999999998762 35889999999999
Q ss_pred HHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 013092 174 VLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 242 (449)
Q Consensus 174 il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~ 242 (449)
|+|.||.|.+||..-+ ....+..|++.+....-+ -+.+++.+..+||.+|++.||.+|.+..+.+
T Consensus 217 ImyTLLaGcpPFwHRk---QmlMLR~ImeGkyqF~sp-eWadis~~~KdLIsrlLqVdp~~Ritake~L 281 (411)
T KOG0599|consen 217 IMYTLLAGCPPFWHRK---QMLMLRMIMEGKYQFRSP-EWADISATVKDLISRLLQVDPTKRITAKEAL 281 (411)
T ss_pred HHHHHHcCCCchhHHH---HHHHHHHHHhcccccCCc-chhhccccHHHHHHHHHeeCchhcccHHHHh
Confidence 9999999999997632 233456677777644333 3467889999999999999999999987765
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=293.20 Aligned_cols=243 Identities=17% Similarity=0.222 Sum_probs=190.8
Q ss_pred cEEEEEeeeccc-CCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHH
Q 013092 3 EILTVFSVQENV-KTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLML 80 (449)
Q Consensus 3 ~aikV~~k~~~~-~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i 80 (449)
.|+|++.+.... ......+..|..++..+.+|++|++++.++.+.+..||||||+ |++|.+++.. ...+++..++.+
T Consensus 28 vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~-~~~l~~~~~~~i 106 (323)
T cd05615 28 YAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQ-VGKFKEPQAVFY 106 (323)
T ss_pred EEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcCCCCCcHHHHHHH-cCCCCHHHHHHH
Confidence 355655543322 2334567889999999878899999999999999999999999 9999999875 457999999999
Q ss_pred HHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCC
Q 013092 81 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI 160 (449)
Q Consensus 81 ~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~ 160 (449)
+.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++....... ......||+.|+|||++.+.
T Consensus 107 ~~qi~~al~~lH~~~ivHrDikp~Nill---~~~~~ikL~Dfg~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~ 176 (323)
T cd05615 107 AAEISVGLFFLHRRGIIYRDLKLDNVML---DSEGHIKIADFGMCKEHMVDGV-------TTRTFCGTPDYIAPEIIAYQ 176 (323)
T ss_pred HHHHHHHHHHHHHCCeeccCCCHHHeEE---CCCCCEEEeccccccccCCCCc-------cccCccCCccccCHHHHcCC
Confidence 9999999999999999999999999999 5788999999999875432211 12345699999999999999
Q ss_pred CCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHH
Q 013092 161 EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAY 240 (449)
Q Consensus 161 ~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~ 240 (449)
.++.++|||||||++|+|++|..||.+.. ..+.+..+..... .++..++.++.+++..||+.+|.+|++..+
T Consensus 177 ~~~~~~DiwslGvil~elltG~~pf~~~~---~~~~~~~i~~~~~-----~~p~~~~~~~~~li~~~l~~~p~~R~~~~~ 248 (323)
T cd05615 177 PYGKSVDWWAYGVLLYEMLAGQPPFDGED---EDELFQSIMEHNV-----SYPKSLSKEAVSICKGLMTKHPSKRLGCGP 248 (323)
T ss_pred CCCCccchhhhHHHHHHHHhCCCCCCCCC---HHHHHHHHHhCCC-----CCCccCCHHHHHHHHHHcccCHhhCCCCCC
Confidence 99999999999999999999999998743 3444555544332 234567899999999999999999998532
Q ss_pred HHHHHHHHHHHcCCCCCCcccchhhhhhh
Q 013092 241 LKRIFRDLFIREGFQFDYVFDWTILKYQQ 269 (449)
Q Consensus 241 l~~~L~~~~~~~~~~~~~~~dw~~~~~~~ 269 (449)
. ..+++ ..+++...++|.......
T Consensus 249 ~--~~~~i---~~h~~f~~~~~~~~~~~~ 272 (323)
T cd05615 249 E--GERDI---REHAFFRRIDWDKLENRE 272 (323)
T ss_pred C--CHHHH---hcCcccCCCCHHHHhcCC
Confidence 1 11122 234566778998776544
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=297.14 Aligned_cols=228 Identities=17% Similarity=0.212 Sum_probs=181.4
Q ss_pred ccEEEEEeeecccCCC------------hhHHHHHHHHHHHhcCCCCCceEEEEeE--eCCEEEEEEecC-CCCHHHHHH
Q 013092 2 YEILTVFSVQENVKTK------------HPQLLYESKLYRILQGGTGIPNVRWFGV--EGDYNVLVMDLL-GPSLEDLFN 66 (449)
Q Consensus 2 ~~aikV~~k~~~~~~~------------~~~~~~E~~il~~l~~hp~Iv~l~~~~~--~~~~~~lVmE~~-g~sL~~ll~ 66 (449)
+.||||+-|.+..+.. .+...+|+.||++| +|||||+|+.+-. ..+.+|||+||| .|.+...-.
T Consensus 124 l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl-~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p~ 202 (576)
T KOG0585|consen 124 LYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKL-HHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCPP 202 (576)
T ss_pred EEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhc-CCcCeeEEEEeecCcccCceEEEEEeccCCccccCCC
Confidence 4689998888765432 24788999999999 9999999998875 457899999999 665543221
Q ss_pred HcCCC-CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCC
Q 013092 67 FCSRK-LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNL 145 (449)
Q Consensus 67 ~~~~~-ls~~~~~~i~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~ 145 (449)
... +++.++++|+.+++.||+|||.+|||||||||.|+|| +.+++|||+|||.+..+........ -......
T Consensus 203 --d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl---~~~g~VKIsDFGVs~~~~~~~~~~~--d~~L~~t 275 (576)
T KOG0585|consen 203 --DKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLL---SSDGTVKISDFGVSNEFPQGSDEGS--DDQLSRT 275 (576)
T ss_pred --CcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEE---cCCCcEEeeccceeeecccCCcccc--HHHHhhc
Confidence 344 8999999999999999999999999999999999999 5779999999999987633311100 0112236
Q ss_pred ccCccccchhhhhCCC----CChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHH
Q 013092 146 TGTARYASMNTHLGIE----QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFA 221 (449)
Q Consensus 146 ~gT~~Y~aPE~~~~~~----~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~ 221 (449)
+|||.|+|||...+.. .+.+.||||+||+||.|+.|++||.+ ....+.+++|....+..+.. +.+.+++.
T Consensus 276 vGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~---~~~~~l~~KIvn~pL~fP~~---pe~~e~~k 349 (576)
T KOG0585|consen 276 VGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFD---DFELELFDKIVNDPLEFPEN---PEINEDLK 349 (576)
T ss_pred CCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCccc---chHHHHHHHHhcCcccCCCc---ccccHHHH
Confidence 8999999999998733 36788999999999999999999976 45677888888765532221 23567899
Q ss_pred HHHHHHhcCCCCCCCCHHHHHH
Q 013092 222 SYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 222 ~li~~cl~~~p~~RPt~~~l~~ 243 (449)
+||.++|.+||+.|.+..+|+.
T Consensus 350 Dli~~lL~KdP~~Ri~l~~ik~ 371 (576)
T KOG0585|consen 350 DLIKRLLEKDPEQRITLPDIKL 371 (576)
T ss_pred HHHHHHhhcChhheeehhhhee
Confidence 9999999999999999777754
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=308.76 Aligned_cols=209 Identities=20% Similarity=0.202 Sum_probs=175.1
Q ss_pred hHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHC
Q 013092 19 PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSK 94 (449)
Q Consensus 19 ~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~---~~~ls~~~~~~i~~qi~~aL~yLH~~ 94 (449)
..+..|+.++..+ +||||+++++++..++..||||||+ |++|.+++... ...+++..+..++.||+.||+|||++
T Consensus 110 ~~~~~E~~~l~~l-~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~ 188 (478)
T PTZ00267 110 AYARSELHCLAAC-DHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR 188 (478)
T ss_pred HHHHHHHHHHHhC-CCCCEeEEEEEEEECCEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 4577899999999 9999999999999999999999999 99999988532 34689999999999999999999999
Q ss_pred CceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHH
Q 013092 95 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYV 174 (449)
Q Consensus 95 givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~i 174 (449)
||+||||||+|||+ +..+.+||+|||+++.+...... ......+||+.|+|||++.+..++.++|||||||+
T Consensus 189 ~ivHrDlkp~NIll---~~~~~~kL~DFgla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~ 260 (478)
T PTZ00267 189 KMMHRDLKSANIFL---MPTGIIKLGDFGFSKQYSDSVSL-----DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVI 260 (478)
T ss_pred CEEECCcCHHhEEE---CCCCcEEEEeCcCceecCCcccc-----ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHH
Confidence 99999999999999 57889999999999876543211 12345679999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 175 LMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 175 l~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
+|+|++|..||.+.. ..+.+..+...... .+...++.++.++|..||..+|++||++.+++.
T Consensus 261 l~el~tg~~Pf~~~~---~~~~~~~~~~~~~~----~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 261 LYELLTLHRPFKGPS---QREIMQQVLYGKYD----PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred HHHHHhCCCCCCCCC---HHHHHHHHHhCCCC----CCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 999999999997633 33344444333221 233467899999999999999999999988753
|
|
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=282.51 Aligned_cols=216 Identities=19% Similarity=0.316 Sum_probs=175.8
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 96 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gi 96 (449)
.+.+.+|+.+++.+ +|+||+++++++. ....|+||||+ +++|.+++......+++..++.++.|++.||+|||++|+
T Consensus 39 ~~~~~~E~~~l~~l-~h~~ii~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i 116 (257)
T cd05115 39 RDEMMREAEIMHQL-DNPYIVRMIGVCE-AEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNF 116 (257)
T ss_pred HHHHHHHHHHHHhc-CCCCeEEEEEEEc-CCCeEEEEEeCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCe
Confidence 45688999999999 9999999998875 45789999999 999999987555679999999999999999999999999
Q ss_pred eecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHHHH
Q 013092 97 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLM 176 (449)
Q Consensus 97 vHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il~ 176 (449)
+||||||+|||+ +.++.+||+|||+++.+...... +.......++..|+|||++.+..++.++|||||||++|
T Consensus 117 ~H~dlkp~nil~---~~~~~~kl~dfg~~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ 189 (257)
T cd05115 117 VHRDLAARNVLL---VNQHYAKISDFGLSKALGADDSY----YKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMW 189 (257)
T ss_pred eecccchheEEE---cCCCcEEeccCCccccccCCccc----eeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHH
Confidence 999999999999 57789999999999865433221 11112223467899999999888999999999999999
Q ss_pred HHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 013092 177 YFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLF 249 (449)
Q Consensus 177 ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~L~~~~ 249 (449)
++++ |..||...... .....+..... ......+++++.++|..||..+|++||++.+|.+.|+.++
T Consensus 190 el~~~g~~p~~~~~~~---~~~~~~~~~~~----~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~~ 256 (257)
T cd05115 190 EAFSYGQKPYKKMKGP---EVMSFIEQGKR----LDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTYY 256 (257)
T ss_pred HHhcCCCCCcCcCCHH---HHHHHHHCCCC----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhhc
Confidence 9996 99999875442 22233322211 1234567899999999999999999999999999988763
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=299.74 Aligned_cols=211 Identities=22% Similarity=0.231 Sum_probs=186.3
Q ss_pred CChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCE-EEEEEecC-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHH
Q 013092 16 TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDY-NVLVMDLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVH 92 (449)
Q Consensus 16 ~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~-~~lVmE~~-g~sL~~ll~~~~-~~ls~~~~~~i~~qi~~aL~yLH 92 (449)
......+.|+.++.++ .|||||..++.+++++. .||||+|| ||+|.+.++..+ .-|+++.++.|+.|++.||.|||
T Consensus 45 ~~r~~A~~E~~lis~~-~hP~iv~y~ds~~~~~~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH 123 (426)
T KOG0589|consen 45 PERRSAIQEMDLLSKL-LHPNIVEYKDSFEEDGQLLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLH 123 (426)
T ss_pred hhhHHHHHHHHHHHhc-cCCCeeeeccchhcCCceEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH
Confidence 3444678999999998 99999999999998877 99999999 999999998654 56899999999999999999999
Q ss_pred HCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHH
Q 013092 93 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLG 172 (449)
Q Consensus 93 ~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG 172 (449)
+++|+|||||+.||++ .+++.|+|.|||+|+.+..... ...+.+||+.||+||.+.+.+|+.++||||||
T Consensus 124 ~~~iLHRDlK~~Nifl---tk~~~VkLgDfGlaK~l~~~~~-------~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLG 193 (426)
T KOG0589|consen 124 ENRVLHRDLKCANIFL---TKDKKVKLGDFGLAKILNPEDS-------LASTVVGTPYYMCPEILSDIPYNEKSDIWSLG 193 (426)
T ss_pred hhhhhcccchhhhhhc---cccCceeecchhhhhhcCCchh-------hhheecCCCcccCHHHhCCCCCCccCcchhhc
Confidence 9999999999999999 5888899999999999877542 24578999999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHH
Q 013092 173 YVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRI 244 (449)
Q Consensus 173 ~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~ 244 (449)
|++|||++-+.+|.. .+......+|.+..+. .++..++.++..+|..|+..+|+.||++.+|+..
T Consensus 194 C~~yEm~~lk~aF~a---~~m~~Li~ki~~~~~~----Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 194 CCLYEMCTLKPAFKA---SNMSELILKINRGLYS----PLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred chHHHHHhcccccCc---cchHHHHHHHhhccCC----CCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 999999999999987 4455666677666543 3567789999999999999999999999888754
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=299.16 Aligned_cols=244 Identities=19% Similarity=0.258 Sum_probs=183.0
Q ss_pred cEEEEEeeeccc-CCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHH
Q 013092 3 EILTVFSVQENV-KTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLML 80 (449)
Q Consensus 3 ~aikV~~k~~~~-~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i 80 (449)
.|||++.+.... ......+.+|+++++.+ +||||+++++++.+..+.||||||+ |++|.+++.. .+.+++..+..+
T Consensus 29 ~aiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~ 106 (377)
T cd05629 29 YAMKTLLKSEMFKKDQLAHVKAERDVLAES-DSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIK-YDTFSEDVTRFY 106 (377)
T ss_pred EEEEEEEHHHHHHhHHHHHHHHHHHHHHhC-CCCCcceEEEEEEcCCeeEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHH
Confidence 356665554322 23345688899999999 9999999999999999999999999 9999999875 467999999999
Q ss_pred HHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCc-----------ccc-----------
Q 013092 81 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ-----------HIP----------- 138 (449)
Q Consensus 81 ~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~-----------~~~----------- 138 (449)
+.|++.||+|||++||+||||||+|||+ +.++.+||+|||+++.+....... ..+
T Consensus 107 ~~ql~~aL~~LH~~givHrDlkp~NIll---~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 183 (377)
T cd05629 107 MAECVLAIEAVHKLGFIHRDIKPDNILI---DRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDS 183 (377)
T ss_pred HHHHHHHHHHHHhCCeeccCCCHHHEEE---CCCCCEEEeeccccccccccccccccccccccccccccccccccccccc
Confidence 9999999999999999999999999999 578899999999997442211000 000
Q ss_pred ------------------cccCCCCccCccccchhhhhCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHH
Q 013092 139 ------------------YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI 200 (449)
Q Consensus 139 ------------------~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i 200 (449)
.......+||+.|+|||++.+..++.++|||||||++|||++|..||.+... ...+..+
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~---~~~~~~i 260 (377)
T cd05629 184 INLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLIGWPPFCSENS---HETYRKI 260 (377)
T ss_pred ccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhhhhhhcCCCCCCCCCH---HHHHHHH
Confidence 0000125799999999999999999999999999999999999999976432 3344444
Q ss_pred HhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCC---CHHHHHHHHHHHHHHcCCCCCCcccchhhh
Q 013092 201 SEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKP---DYAYLKRIFRDLFIREGFQFDYVFDWTILK 266 (449)
Q Consensus 201 ~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RP---t~~~l~~~L~~~~~~~~~~~~~~~dw~~~~ 266 (449)
........++. ...++.++.+||..|+. +|.+|+ ++.+++. .++...++|+...
T Consensus 261 ~~~~~~~~~p~-~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~----------hp~~~~~~~~~~~ 317 (377)
T cd05629 261 INWRETLYFPD-DIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKS----------HPFFRGVDWDTIR 317 (377)
T ss_pred HccCCccCCCC-CCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhc----------CCCcCCCCHHHHc
Confidence 43211111110 12468899999999997 777764 7666543 3555567887653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=273.86 Aligned_cols=226 Identities=18% Similarity=0.183 Sum_probs=184.8
Q ss_pred EEEEEeeecccCCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHH
Q 013092 4 ILTVFSVQENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQ 83 (449)
Q Consensus 4 aikV~~k~~~~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~~~~i~~q 83 (449)
|||.++.-+....-....++|++.|+.+ +|+||+.+++++......-||+||+..+|+.+++.....++...+..|+.+
T Consensus 31 AIKKIkl~~~kdGi~~talREIK~Lqel-~h~nIi~LiD~F~~~~~l~lVfEfm~tdLe~vIkd~~i~l~pa~iK~y~~m 109 (318)
T KOG0659|consen 31 AIKKIKLGNAKDGINRTALREIKLLQEL-KHPNIIELIDVFPHKSNLSLVFEFMPTDLEVVIKDKNIILSPADIKSYMLM 109 (318)
T ss_pred EEEEeeccccccCccHHHHHHHHHHHHc-cCcchhhhhhhccCCCceEEEEEeccccHHHHhcccccccCHHHHHHHHHH
Confidence 4444444433334466789999999999 899999999999999999999999999999999977778999999999999
Q ss_pred HHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCC-CC
Q 013092 84 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI-EQ 162 (449)
Q Consensus 84 i~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~-~~ 162 (449)
++.||+|||.+.|+||||||.|+|| ..+|.+||+|||+|+.+....... ...+-|.+|.|||.+.|. .|
T Consensus 110 ~LkGl~y~H~~~IlHRDlKPnNLLi---s~~g~lKiADFGLAr~f~~p~~~~-------~~~V~TRWYRAPELLfGsr~Y 179 (318)
T KOG0659|consen 110 TLKGLAYCHSKWILHRDLKPNNLLI---SSDGQLKIADFGLARFFGSPNRIQ-------THQVVTRWYRAPELLFGSRQY 179 (318)
T ss_pred HHHHHHHHHhhhhhcccCCccceEE---cCCCcEEeecccchhccCCCCccc-------ccceeeeeccChHHhccchhc
Confidence 9999999999999999999999999 589999999999999987654322 223679999999999984 58
Q ss_pred ChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhccc-----------------------chHHHhhcCCcHH
Q 013092 163 SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS-----------------------TSIEALCRGYPTE 219 (449)
Q Consensus 163 s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~-----------------------~~~~~l~~~~p~e 219 (449)
+...|+||.|||+.||+.|.+-|+|.++ .+.+.+|.....+ ++...++...+.+
T Consensus 180 g~~VDmWavGCI~AELllr~P~fpG~sD---idQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d 256 (318)
T KOG0659|consen 180 GTGVDMWAVGCIFAELLLRVPFFPGDSD---IDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSD 256 (318)
T ss_pred CCcchhhhHHHHHHHHHccCCCCCCCch---HHHHHHHHHHcCCCCcccCccccccccHHHHhcCCCCccccccccccHH
Confidence 9999999999999999999999988544 3333444332211 1122234456778
Q ss_pred HHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 220 FASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 220 l~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
..+|+..+|..||.+|.++.+..+
T Consensus 257 ~ldLl~~m~~ynP~~Rita~qaL~ 280 (318)
T KOG0659|consen 257 ALDLLSKMLTYNPKKRITASQALK 280 (318)
T ss_pred HHHHHHhhhccCchhcccHHHHhc
Confidence 899999999999999999877654
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=291.60 Aligned_cols=219 Identities=21% Similarity=0.292 Sum_probs=186.7
Q ss_pred EEEEEeeecccC-CChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHH
Q 013092 4 ILTVFSVQENVK-TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLA 81 (449)
Q Consensus 4 aikV~~k~~~~~-~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~ 81 (449)
|||.++|-+... +..-.+.+|++||..| +||||+.++.+|+..+..+|||||. +|.|+|++.. .+.+++.++..|+
T Consensus 82 AiKsIrKdkIkdeqDlvhIRREIeIMSsL-NHPhII~IyEVFENkdKIvivMEYaS~GeLYDYiSe-r~~LsErEaRhfF 159 (668)
T KOG0611|consen 82 AIKSIRKDKIKDEQDLVHIRREIEIMSSL-NHPHIIQIYEVFENKDKIVIVMEYASGGELYDYISE-RGSLSEREARHFF 159 (668)
T ss_pred ehhhhhhhhcccHHHHHHHHHHHHHHhhc-CCCceeehhhhhcCCceEEEEEEecCCccHHHHHHH-hccccHHHHHHHH
Confidence 444444444322 2233478999999999 9999999999999999999999999 9999999987 4579999999999
Q ss_pred HHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCC
Q 013092 82 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIE 161 (449)
Q Consensus 82 ~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~ 161 (449)
.||+.|+.|+|.++++|||||.+|||+ +.++++||+||||+..+.+... ..+++|++.|++||.+.|.+
T Consensus 160 RQIvSAVhYCHknrVvHRDLKLENILL---D~N~NiKIADFGLSNly~~~kf--------LqTFCGSPLYASPEIvNG~P 228 (668)
T KOG0611|consen 160 RQIVSAVHYCHKNRVVHRDLKLENILL---DQNNNIKIADFGLSNLYADKKF--------LQTFCGSPLYASPEIVNGTP 228 (668)
T ss_pred HHHHHHHHHHhhccceecccchhheee---cCCCCeeeeccchhhhhccccH--------HHHhcCCcccCCccccCCCC
Confidence 999999999999999999999999999 7899999999999988766433 35789999999999999999
Q ss_pred C-ChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHH
Q 013092 162 Q-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAY 240 (449)
Q Consensus 162 ~-s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~ 240 (449)
| ++.+|.||||++||.|+.|.+||.+. +....+..|....... +.-|....-||+.||-.+|+.|.|.++
T Consensus 229 Y~GPEVDsWsLGvLLYtLVyGtMPFDG~---Dhk~lvrQIs~GaYrE------P~~PSdA~gLIRwmLmVNP~RRATieD 299 (668)
T KOG0611|consen 229 YKGPEVDSWSLGVLLYTLVYGTMPFDGR---DHKRLVRQISRGAYRE------PETPSDASGLIRWMLMVNPERRATIED 299 (668)
T ss_pred CCCCccchhhHHHHHHHHhhcccccCCc---hHHHHHHHhhcccccC------CCCCchHHHHHHHHHhcCcccchhHHH
Confidence 8 78999999999999999999999884 4455566666654432 235778999999999999999999888
Q ss_pred HHHH
Q 013092 241 LKRI 244 (449)
Q Consensus 241 l~~~ 244 (449)
|...
T Consensus 300 iAsH 303 (668)
T KOG0611|consen 300 IASH 303 (668)
T ss_pred Hhhh
Confidence 7654
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=292.19 Aligned_cols=240 Identities=21% Similarity=0.256 Sum_probs=186.4
Q ss_pred EEEEEeeecccC-CChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHH
Q 013092 4 ILTVFSVQENVK-TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLA 81 (449)
Q Consensus 4 aikV~~k~~~~~-~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~ 81 (449)
|+|++.+....+ .....+..|+.++..+ +|++|+.+++++.+.+..||||||+ +++|.+++......+++..+..++
T Consensus 30 aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~ 108 (332)
T cd05623 30 AMKILNKWEMLKRAETACFREERDVLVNG-DNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYL 108 (332)
T ss_pred EEEEEeHHHHHHhhHHHHHHHHHHHHhhC-CCCCEeeEEEEEecCCEEEEEEeccCCCcHHHHHHHhcCCCCHHHHHHHH
Confidence 455554433222 2334578899999888 9999999999999999999999999 999999998655679999999999
Q ss_pred HHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhC--
Q 013092 82 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG-- 159 (449)
Q Consensus 82 ~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~-- 159 (449)
.||+.||+|||++||+||||||+|||+ +.++.+||+|||++......... ......||+.|+|||++..
T Consensus 109 ~qi~~al~~lH~~~iiHrDlkp~Nili---~~~~~~kL~DfG~a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~ 179 (332)
T cd05623 109 AEMVIAIDSVHQLHYVHRDIKPDNILM---DMNGHIRLADFGSCLKLMEDGTV------QSSVAVGTPDYISPEILQAME 179 (332)
T ss_pred HHHHHHHHHHHHCCeEecCCCHHHEEE---CCCCCEEEeecchheecccCCcc------eecccccCccccCHHHHhccc
Confidence 999999999999999999999999999 57889999999999765433221 1224579999999999873
Q ss_pred ---CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCC--
Q 013092 160 ---IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDD-- 234 (449)
Q Consensus 160 ---~~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~-- 234 (449)
..++.++|||||||++|||++|+.||... ...+.+.++........++.....+++++.+|+.+|+..+++.
T Consensus 180 ~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~---~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~ 256 (332)
T cd05623 180 DGKGKYGPECDWWSLGVCMYEMLYGETPFYAE---SLVETYGKIMNHKERFQFPAQVTDVSEDAKDLIRRLICSREHRLG 256 (332)
T ss_pred cCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCC---CHHHHHHHHhCCCccccCCCccccCCHHHHHHHHHHccChhhhcC
Confidence 45788999999999999999999999764 3445555555443333333334568999999999999765443
Q ss_pred CCCHHHHHHHHHHHHHHcCCCCCCcccchhhh
Q 013092 235 KPDYAYLKRIFRDLFIREGFQFDYVFDWTILK 266 (449)
Q Consensus 235 RPt~~~l~~~L~~~~~~~~~~~~~~~dw~~~~ 266 (449)
|+++.+++ .+++...++|+...
T Consensus 257 r~~~~~~~----------~h~~f~~~~~~~~~ 278 (332)
T cd05623 257 QNGIEDFK----------QHPFFTGIDWDNIR 278 (332)
T ss_pred CCCHHHHh----------CCCCcCCCCHHHHh
Confidence 56665553 34666778888764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=298.71 Aligned_cols=243 Identities=19% Similarity=0.278 Sum_probs=185.5
Q ss_pred cEEEEEeeeccc-CCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHH
Q 013092 3 EILTVFSVQENV-KTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLML 80 (449)
Q Consensus 3 ~aikV~~k~~~~-~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i 80 (449)
.|||++.+.... ......+..|+.+++.+ +|+||+++++.+.++++.||||||| |++|.+++.. ...+++..++.+
T Consensus 29 vaiK~~~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~-~~~l~~~~~~~~ 106 (364)
T cd05599 29 YAMKKLRKSEMLEKEQVAHVRAERDILAEA-DNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMK-KDTFTEEETRFY 106 (364)
T ss_pred EEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCcceEEEEEcCCeEEEEECCCCCcHHHHHHHH-cCCCCHHHHHHH
Confidence 456666544322 23345578899999999 8999999999999999999999999 9999999875 457999999999
Q ss_pred HHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCccc-----------------c-----
Q 013092 81 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHI-----------------P----- 138 (449)
Q Consensus 81 ~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~-----------------~----- 138 (449)
+.||+.||+|||++||+||||||+|||+ +.++.++|+|||+++.+......... +
T Consensus 107 ~~qi~~aL~~lH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 183 (364)
T cd05599 107 IAETILAIDSIHKLGYIHRDIKPDNLLL---DAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKR 183 (364)
T ss_pred HHHHHHHHHHHHHCCeEeccCCHHHeEE---CCCCCEEEeecccceeccccccccccccccccccccccccccccccccc
Confidence 9999999999999999999999999999 68889999999999765432110000 0
Q ss_pred ----c-----ccCCCCccCccccchhhhhCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchH
Q 013092 139 ----Y-----RENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 209 (449)
Q Consensus 139 ----~-----~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 209 (449)
+ ......+||+.|+|||++.+..++.++|||||||++|||++|..||.+.. ..+.+..+.........
T Consensus 184 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~~~~---~~~~~~~i~~~~~~~~~ 260 (364)
T cd05599 184 KAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDN---PQETYRKIINWKETLQF 260 (364)
T ss_pred cccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCCCCCC---HHHHHHHHHcCCCccCC
Confidence 0 00113469999999999999999999999999999999999999998643 33444444432211111
Q ss_pred HHhhcCCcHHHHHHHHHHhcCCCCCCCC---HHHHHHHHHHHHHHcCCCCCCcccchhh
Q 013092 210 EALCRGYPTEFASYFHYCRSLRFDDKPD---YAYLKRIFRDLFIREGFQFDYVFDWTIL 265 (449)
Q Consensus 210 ~~l~~~~p~el~~li~~cl~~~p~~RPt---~~~l~~~L~~~~~~~~~~~~~~~dw~~~ 265 (449)
+. ...+++++.++|..|+. +|.+|++ +.+++. +++...++|...
T Consensus 261 ~~-~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~----------h~~~~~~~~~~~ 307 (364)
T cd05599 261 PD-EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS----------HPFFKGVDWEHI 307 (364)
T ss_pred CC-CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc----------CCCcCCCCHHHH
Confidence 11 12468899999999996 8999998 555532 355566788754
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=300.36 Aligned_cols=218 Identities=20% Similarity=0.242 Sum_probs=178.3
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcC---------------------------
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCS--------------------------- 69 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~--------------------------- 69 (449)
.+.+.+|+++|..+..||||+++++++.+.+..||||||| +++|.+++....
T Consensus 84 ~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (400)
T cd05105 84 KQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADEST 163 (400)
T ss_pred HHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccc
Confidence 4568999999999966999999999999999999999999 999999886421
Q ss_pred --------------------------------------------------------------------CCCCHHHHHHHH
Q 013092 70 --------------------------------------------------------------------RKLSLKTVLMLA 81 (449)
Q Consensus 70 --------------------------------------------------------------------~~ls~~~~~~i~ 81 (449)
..+++..++.++
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~ 243 (400)
T cd05105 164 RSYVILSFENKGDYMDMKQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFT 243 (400)
T ss_pred cchhhhhhcccccccccccccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHH
Confidence 247888899999
Q ss_pred HHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCC
Q 013092 82 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIE 161 (449)
Q Consensus 82 ~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~ 161 (449)
.||+.||+|||+.+|+||||||+|||+ +.++.+||+|||+++.+...... .......++..|+|||++.+..
T Consensus 244 ~qi~~aL~~LH~~~ivH~dikp~Nill---~~~~~~kL~DfGla~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~ 315 (400)
T cd05105 244 YQVARGMEFLASKNCVHRDLAARNVLL---AQGKIVKICDFGLARDIMHDSNY-----VSKGSTFLPVKWMAPESIFDNL 315 (400)
T ss_pred HHHHHHHHHHHhCCeeCCCCChHhEEE---eCCCEEEEEeCCcceeccccccc-----cccCCcCCCcceEChhhhcCCC
Confidence 999999999999999999999999999 47788999999999876443221 1123345778899999999988
Q ss_pred CChhhHHHHHHHHHHHHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHH
Q 013092 162 QSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAY 240 (449)
Q Consensus 162 ~s~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~ 240 (449)
++.++|||||||++|+|++ |..||...... ...+..+..... ......+|.++.+++..||+.+|++||++.+
T Consensus 316 ~~~~~DiwSlGvil~ellt~g~~P~~~~~~~--~~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~ 389 (400)
T cd05105 316 YTTLSDVWSYGILLWEIFSLGGTPYPGMIVD--STFYNKIKSGYR----MAKPDHATQEVYDIMVKCWNSEPEKRPSFLH 389 (400)
T ss_pred CCchhhHHHHHHHHHHHHHCCCCCCcccchh--HHHHHHHhcCCC----CCCCccCCHHHHHHHHHHCccCHhHCcCHHH
Confidence 9999999999999999997 99999875332 122222222211 1133568899999999999999999999999
Q ss_pred HHHHHHHHH
Q 013092 241 LKRIFRDLF 249 (449)
Q Consensus 241 l~~~L~~~~ 249 (449)
|.+.|+.++
T Consensus 390 l~~~l~~l~ 398 (400)
T cd05105 390 LSDIVESLL 398 (400)
T ss_pred HHHHHHHHc
Confidence 999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=284.32 Aligned_cols=218 Identities=21% Similarity=0.285 Sum_probs=180.9
Q ss_pred hHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHc---------------CCCCCHHHHHHHHH
Q 013092 19 PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFC---------------SRKLSLKTVLMLAD 82 (449)
Q Consensus 19 ~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~---------------~~~ls~~~~~~i~~ 82 (449)
..+.+|+.+++.+ +|+||+++++++......++||||+ +++|.+++... ...+++..++.++.
T Consensus 52 ~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 130 (291)
T cd05094 52 KDFQREAELLTNL-QHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 130 (291)
T ss_pred HHHHHHHHHHhcC-CCCCcceEEEEEccCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHH
Confidence 4688999999999 8999999999999999999999999 99999999742 13488999999999
Q ss_pred HHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCC
Q 013092 83 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQ 162 (449)
Q Consensus 83 qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~ 162 (449)
||+.||+|||++||+||||||+|||+ +.++.++|+|||+++....... ........++..|+|||++.+..+
T Consensus 131 ~i~~al~~lH~~~i~H~dlkp~Nil~---~~~~~~~l~dfg~a~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~ 202 (291)
T cd05094 131 QIASGMVYLASQHFVHRDLATRNCLV---GANLLVKIGDFGMSRDVYSTDY-----YRVGGHTMLPIRWMPPESIMYRKF 202 (291)
T ss_pred HHHHHHHHHHhCCeeecccCcceEEE---ccCCcEEECCCCcccccCCCce-----eecCCCCCcceeecChHHhccCCC
Confidence 99999999999999999999999999 5788999999999976543221 111234456789999999999889
Q ss_pred ChhhHHHHHHHHHHHHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHH
Q 013092 163 SRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYL 241 (449)
Q Consensus 163 s~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l 241 (449)
+.++|||||||++|+|++ |..||..... ...++.+..... ......+|.++.+++.+||+.+|++||++.+|
T Consensus 203 ~~~~Di~slG~il~el~t~g~~p~~~~~~---~~~~~~~~~~~~----~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v 275 (291)
T cd05094 203 TTESDVWSFGVILWEIFTYGKQPWFQLSN---TEVIECITQGRV----LERPRVCPKEVYDIMLGCWQREPQQRLNIKEI 275 (291)
T ss_pred CchhhHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHhCCCC----CCCCccCCHHHHHHHHHHcccChhhCcCHHHH
Confidence 999999999999999998 9999976543 223333333222 22345578999999999999999999999999
Q ss_pred HHHHHHHHHHc
Q 013092 242 KRIFRDLFIRE 252 (449)
Q Consensus 242 ~~~L~~~~~~~ 252 (449)
.+.|.++....
T Consensus 276 ~~~l~~~~~~~ 286 (291)
T cd05094 276 YKILHALGKAT 286 (291)
T ss_pred HHHHHHHHhhc
Confidence 99999886543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=293.62 Aligned_cols=221 Identities=17% Similarity=0.218 Sum_probs=196.1
Q ss_pred cEEEEEeeecccCCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHH
Q 013092 3 EILTVFSVQENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLA 81 (449)
Q Consensus 3 ~aikV~~k~~~~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~ 81 (449)
+|+||+-|.+.......++..|++.|+.+ .|||||.||.+......+|||+|+- +|+|+|+|-+....+.++.+.+|+
T Consensus 46 VAVKviDKTKlD~~st~hlfqEVRCMKLV-QHpNiVRLYEViDTQTKlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF 124 (864)
T KOG4717|consen 46 VAVKVIDKTKLDTLSTGHLFQEVRCMKLV-QHPNIVRLYEVIDTQTKLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYF 124 (864)
T ss_pred eEEEEecccccchhhhhHHHHHHHHHHHh-cCcCeeeeeehhcccceEEEEEEecCCchHHHHHHhhhccccHHHHHHHH
Confidence 57788877777777778899999999999 9999999999999999999999999 999999998777789999999999
Q ss_pred HHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCC
Q 013092 82 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIE 161 (449)
Q Consensus 82 ~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~ 161 (449)
.||+.||.|+|+.++|||||||+|+++- .+-|.|||.|||+..++..... ..+.+|...|.|||.++|..
T Consensus 125 ~QI~~AI~YCHqLHVVHRDLKPENVVFF--EKlGlVKLTDFGFSNkf~PG~k--------L~TsCGSLAYSAPEILLGDs 194 (864)
T KOG4717|consen 125 AQIVHAISYCHQLHVVHRDLKPENVVFF--EKLGLVKLTDFGFSNKFQPGKK--------LTTSCGSLAYSAPEILLGDS 194 (864)
T ss_pred HHHHHHHHHHhhhhhhcccCCcceeEEe--eecCceEeeeccccccCCCcch--------hhcccchhhccCchhhhcCc
Confidence 9999999999999999999999999886 6789999999999988766543 35789999999999999999
Q ss_pred CC-hhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHH
Q 013092 162 QS-RRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAY 240 (449)
Q Consensus 162 ~s-~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~ 240 (449)
|+ +.+||||||+|||.|++|++||+..++ .+.+.+|+..+.. ++..++.++++||..||..||.+|.+.++
T Consensus 195 YDAPAVDiWSLGVILyMLVCGq~PFqeAND---SETLTmImDCKYt-----vPshvS~eCrdLI~sMLvRdPkkRAslEe 266 (864)
T KOG4717|consen 195 YDAPAVDIWSLGVILYMLVCGQPPFQEAND---SETLTMIMDCKYT-----VPSHVSKECRDLIQSMLVRDPKKRASLEE 266 (864)
T ss_pred cCCcchhhhHHHHHHHHHHhCCCccccccc---hhhhhhhhccccc-----CchhhhHHHHHHHHHHHhcCchhhccHHH
Confidence 85 678999999999999999999998554 4556677777764 33457899999999999999999999888
Q ss_pred HH
Q 013092 241 LK 242 (449)
Q Consensus 241 l~ 242 (449)
|.
T Consensus 267 I~ 268 (864)
T KOG4717|consen 267 IV 268 (864)
T ss_pred Hh
Confidence 75
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=320.37 Aligned_cols=221 Identities=18% Similarity=0.265 Sum_probs=187.2
Q ss_pred CChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHc------CCCCCHHHHHHHHHHHHHHH
Q 013092 16 TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFC------SRKLSLKTVLMLADQMINRV 88 (449)
Q Consensus 16 ~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~------~~~ls~~~~~~i~~qi~~aL 88 (449)
++..+|.+|..+|..+ +|||||++++.+.+....+|++||| ||+|..+|++. ...++..+.+.++.|||+|+
T Consensus 737 ~~~~~Fl~Ea~~m~~f-~HpNiv~liGv~l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~ 815 (1025)
T KOG1095|consen 737 QEVSDFLKEALLMSKF-DHPNIVSLIGVCLDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGM 815 (1025)
T ss_pred HHHHHHHHHHHHHhcC-CCcceeeEEEeecCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhh
Confidence 4566799999999999 9999999999999999999999999 99999999977 55699999999999999999
Q ss_pred HHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHH
Q 013092 89 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDL 168 (449)
Q Consensus 89 ~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~Di 168 (449)
.||+++++|||||-.+|+|| +....|||+|||+|+.+.+... |+......-..+|||||.+....++.++||
T Consensus 816 ~YLe~~~fvHRDLAaRNCLL---~~~r~VKIaDFGlArDiy~~~y-----yr~~~~a~lPvkWm~PEsl~d~iFtskSDv 887 (1025)
T KOG1095|consen 816 NYLESKHFVHRDLAARNCLL---DERRVVKIADFGLARDIYDKDY-----YRKHGEAMLPVKWMPPESLKDGIFTSKSDV 887 (1025)
T ss_pred HHHHhCCCcCcchhhhheee---cccCcEEEcccchhHhhhhchh-----eeccCccccceecCCHHHHhhcccccccch
Confidence 99999999999999999999 5779999999999995544433 333333345579999999999999999999
Q ss_pred HHHHHHHHHHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Q 013092 169 ESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRD 247 (449)
Q Consensus 169 wSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~L~~ 247 (449)
|||||+|||+++ |..||.+... .+.+..+.+.. .-..+..||..+.++|..||+.+|++||+|..|++.+.+
T Consensus 888 WsFGVllWEifslG~~PY~~~~n---~~v~~~~~~gg----RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~ 960 (1025)
T KOG1095|consen 888 WSFGVLLWEIFSLGATPYPSRSN---FEVLLDVLEGG----RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPA 960 (1025)
T ss_pred hhhHHHHHHHHhCCCCCCCCcch---HHHHHHHHhCC----ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhh
Confidence 999999999998 9999988654 23333233322 112356799999999999999999999999999998777
Q ss_pred HHHHc
Q 013092 248 LFIRE 252 (449)
Q Consensus 248 ~~~~~ 252 (449)
++...
T Consensus 961 i~~~~ 965 (1025)
T KOG1095|consen 961 ISNAA 965 (1025)
T ss_pred hhhhh
Confidence 76544
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=283.39 Aligned_cols=218 Identities=22% Similarity=0.302 Sum_probs=181.2
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcC------------CCCCHHHHHHHHHHH
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCS------------RKLSLKTVLMLADQM 84 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~------------~~ls~~~~~~i~~qi 84 (449)
...+.+|+.+++.+ .|+||+++++++...+..|+||||+ +++|.+++.... ..+++..++.++.|+
T Consensus 51 ~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql 129 (288)
T cd05093 51 RKDFHREAELLTNL-QHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQI 129 (288)
T ss_pred HHHHHHHHHHHHhC-CCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHH
Confidence 44689999999999 8999999999999999999999999 899999987432 248999999999999
Q ss_pred HHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCCh
Q 013092 85 INRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSR 164 (449)
Q Consensus 85 ~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~ 164 (449)
+.||+|||++|++||||||+|||+ +..+.++|+|||+++....... ........++..|+|||++.+..++.
T Consensus 130 ~~aL~~lH~~~i~H~dlkp~Nili---~~~~~~kl~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~ 201 (288)
T cd05093 130 AAGMVYLASQHFVHRDLATRNCLV---GENLLVKIGDFGMSRDVYSTDY-----YRVGGHTMLPIRWMPPESIMYRKFTT 201 (288)
T ss_pred HHHHHHHHhCCeeecccCcceEEE---ccCCcEEeccCCccccccCCce-----eecCCCCCccccccCHHHhccCCCCc
Confidence 999999999999999999999999 5788999999999986543221 11122344678899999999888999
Q ss_pred hhHHHHHHHHHHHHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 165 RDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 165 ~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
++|||||||++|+|++ |..||..... ...+..+..... ......++.++.+|+.+||+.+|.+||++.++..
T Consensus 202 ~sDiwslG~il~~l~t~g~~p~~~~~~---~~~~~~i~~~~~----~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 202 ESDVWSLGVVLWEIFTYGKQPWYQLSN---NEVIECITQGRV----LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred hhhHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCCc----CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 9999999999999998 9999976533 333444444322 1233567899999999999999999999999999
Q ss_pred HHHHHHHH
Q 013092 244 IFRDLFIR 251 (449)
Q Consensus 244 ~L~~~~~~ 251 (449)
.|+++...
T Consensus 275 ~l~~~~~~ 282 (288)
T cd05093 275 LLQNLAKA 282 (288)
T ss_pred HHHHHHHh
Confidence 99888654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=310.10 Aligned_cols=225 Identities=20% Similarity=0.217 Sum_probs=176.0
Q ss_pred CChhHHHHHHHHHHHhcCCCCCceEEEE-eE-----e-CCEEEEEEecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHH
Q 013092 16 TKHPQLLYESKLYRILQGGTGIPNVRWF-GV-----E-GDYNVLVMDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMIN 86 (449)
Q Consensus 16 ~~~~~~~~E~~il~~l~~hp~Iv~l~~~-~~-----~-~~~~~lVmE~~-g~sL~~ll~~~-~~~ls~~~~~~i~~qi~~ 86 (449)
...+.+++|+.+|++|++|+|||.+++. .. . .-.++|.|||| |+.|.|+++.. ...|++.++++|+.|+++
T Consensus 76 ~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~ 155 (738)
T KOG1989|consen 76 EALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCE 155 (738)
T ss_pred HHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHH
Confidence 3455588999999999999999999993 22 1 23578999999 89999999854 456999999999999999
Q ss_pred HHHHHHHCC--ceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCC-CCcccccc-cCCCCccCccccchhhhh---C
Q 013092 87 RVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS-THQHIPYR-ENKNLTGTARYASMNTHL---G 159 (449)
Q Consensus 87 aL~yLH~~g--ivHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~-~~~~~~~~-~~~~~~gT~~Y~aPE~~~---~ 159 (449)
|+.+||... |||||||-+|||| ..++..||||||.|...-... ....+.+. .......|+.|.|||++. +
T Consensus 156 AVa~mH~~~pPiIHRDLKiENvLl---s~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg 232 (738)
T KOG1989|consen 156 AVAAMHYLKPPIIHRDLKIENVLL---SADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSG 232 (738)
T ss_pred HHHHHhcCCCccchhhhhhhheEE---cCCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcC
Confidence 999999998 9999999999999 588899999999986432222 11111111 112345799999999875 6
Q ss_pred CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHH
Q 013092 160 IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYA 239 (449)
Q Consensus 160 ~~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~ 239 (449)
.+.+.|+|||+|||+||.||...+||.+.-. ..|...++..+. .+.++..|.+||..||+.+|++||+..
T Consensus 233 ~pI~eKsDIWALGclLYkLCy~t~PFe~sg~-------laIlng~Y~~P~---~p~ys~~l~~LI~~mL~~nP~~RPnI~ 302 (738)
T KOG1989|consen 233 LPIGEKSDIWALGCLLYKLCYFTTPFEESGK-------LAILNGNYSFPP---FPNYSDRLKDLIRTMLQPNPDERPNIY 302 (738)
T ss_pred CCCcchhHHHHHHHHHHHHHHhCCCcCcCcc-------eeEEeccccCCC---CccHHHHHHHHHHHHhccCcccCCCHH
Confidence 7889999999999999999999999987422 123333332211 146889999999999999999999988
Q ss_pred HHHHHHHHHHHHcC
Q 013092 240 YLKRIFRDLFIREG 253 (449)
Q Consensus 240 ~l~~~L~~~~~~~~ 253 (449)
++.+.+..+....-
T Consensus 303 Qv~~~~~~l~~~~~ 316 (738)
T KOG1989|consen 303 QVLEEIFELANKPC 316 (738)
T ss_pred HHHHHHHHHhcCCC
Confidence 88887777765443
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=281.50 Aligned_cols=213 Identities=21% Similarity=0.309 Sum_probs=176.8
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcC-------------CCCCHHHHHHHHHH
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCS-------------RKLSLKTVLMLADQ 83 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~-------------~~ls~~~~~~i~~q 83 (449)
.+.+.+|+++++.+ .|+||+++++++......|+||||+ +++|.+++.... ..+++..++.++.|
T Consensus 52 ~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 130 (280)
T cd05049 52 RKDFEREAELLTNF-QHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQ 130 (280)
T ss_pred HHHHHHHHHHHHhc-CCCCchheeeEEecCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHH
Confidence 46789999999999 8999999999999999999999999 999999997431 34788999999999
Q ss_pred HHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCC
Q 013092 84 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQS 163 (449)
Q Consensus 84 i~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s 163 (449)
++.||.|||++|++||||||+||++ +.++.++|+|||+++....... +.......+++.|+|||++.+..++
T Consensus 131 i~~~l~~lH~~~i~h~dlkp~nili---~~~~~~kl~d~g~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~ 202 (280)
T cd05049 131 IASGMVYLASQHFVHRDLATRNCLV---GYDLVVKIGDFGMSRDVYTTDY-----YRVGGHTMLPIRWMPPESIMYRKFT 202 (280)
T ss_pred HHHHHHHHhhCCeeccccccceEEE---cCCCeEEECCcccceecccCcc-----eecCCCCcccceecChhhhccCCcc
Confidence 9999999999999999999999999 5779999999999976543221 1112334567899999999999999
Q ss_pred hhhHHHHHHHHHHHHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 013092 164 RRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 242 (449)
Q Consensus 164 ~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~ 242 (449)
.++|||||||++|+|++ |..||.+... ......+..... ......++.++.+++..||..+|++||++.+++
T Consensus 203 ~~~Di~slG~il~e~~~~g~~p~~~~~~---~~~~~~~~~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil 275 (280)
T cd05049 203 TESDVWSFGVVLWEIFTYGKQPWYGLSN---EEVIECITQGRL----LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIH 275 (280)
T ss_pred hhhhHHHHHHHHHHHHhcCCCCCCCCCH---HHHHHHHHcCCc----CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHH
Confidence 99999999999999998 9999976543 233333333222 122356889999999999999999999999998
Q ss_pred HHHH
Q 013092 243 RIFR 246 (449)
Q Consensus 243 ~~L~ 246 (449)
+.|+
T Consensus 276 ~~l~ 279 (280)
T cd05049 276 ERLQ 279 (280)
T ss_pred HHhh
Confidence 8774
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=281.64 Aligned_cols=217 Identities=17% Similarity=0.319 Sum_probs=174.6
Q ss_pred CChhHHHHHHHHHHHhcCCCCCceEEEEeEeC------CEEEEEEecC-CCCHHHHHHHc-----CCCCCHHHHHHHHHH
Q 013092 16 TKHPQLLYESKLYRILQGGTGIPNVRWFGVEG------DYNVLVMDLL-GPSLEDLFNFC-----SRKLSLKTVLMLADQ 83 (449)
Q Consensus 16 ~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~------~~~~lVmE~~-g~sL~~ll~~~-----~~~ls~~~~~~i~~q 83 (449)
.....+..|+++++.+ +|+||+++++.+... ...++||||+ +++|.+++... ...+++..++.++.|
T Consensus 42 ~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 120 (272)
T cd05075 42 SEMEDFLSEAVCMKEF-DHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTD 120 (272)
T ss_pred HHHHHHHHHHHHHHhC-CCCCcceEEEEEccCCcccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHH
Confidence 3456688999999999 899999999876432 3578999999 89999887432 234889999999999
Q ss_pred HHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCC
Q 013092 84 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQS 163 (449)
Q Consensus 84 i~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s 163 (449)
++.||+|||++||+||||||+|||+ +.++.++|+|||+++.+..... +.......+++.|++||++.+..++
T Consensus 121 i~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~~~~~~~~pe~~~~~~~~ 192 (272)
T cd05075 121 IASGMEYLSSKSFIHRDLAARNCML---NENMNVCVADFGLSKKIYNGDY-----YRQGRIAKMPVKWIAIESLADRVYT 192 (272)
T ss_pred HHHHHHHHHHCCeeccccchhheEE---cCCCCEEECCCCcccccCcccc-----eecCCcccCCcccCCHHHccCCCcC
Confidence 9999999999999999999999999 5788999999999987654321 1112233567789999999999999
Q ss_pred hhhHHHHHHHHHHHHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 013092 164 RRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 242 (449)
Q Consensus 164 ~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~ 242 (449)
.++|||||||++|||++ |..||.+... .+.+..+..... ......++..+.++|.+||+.+|++||++.+|.
T Consensus 193 ~~~Di~slG~il~el~~~g~~p~~~~~~---~~~~~~~~~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~ 265 (272)
T cd05075 193 TKSDVWSFGVTMWEIATRGQTPYPGVEN---SEIYDYLRQGNR----LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLR 265 (272)
T ss_pred hHHHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHHcCCC----CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHH
Confidence 99999999999999999 8999977432 333444433221 123356889999999999999999999999999
Q ss_pred HHHHHH
Q 013092 243 RIFRDL 248 (449)
Q Consensus 243 ~~L~~~ 248 (449)
+.|+++
T Consensus 266 ~~l~~~ 271 (272)
T cd05075 266 CELEKA 271 (272)
T ss_pred HHHHhh
Confidence 988765
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=282.57 Aligned_cols=212 Identities=18% Similarity=0.260 Sum_probs=174.6
Q ss_pred hHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHc----------------CCCCCHHHHHHHH
Q 013092 19 PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFC----------------SRKLSLKTVLMLA 81 (449)
Q Consensus 19 ~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~----------------~~~ls~~~~~~i~ 81 (449)
..+.+|+.+++.+ +|+||+++++++..+...|+||||+ +++|.+++... ...+++..++.++
T Consensus 52 ~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 130 (283)
T cd05090 52 GEFQQEASLMAEL-HHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIA 130 (283)
T ss_pred HHHHHHHHHHhhC-CCCCeeeEEEEEecCCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHH
Confidence 4688999999999 8999999999999999999999999 89999998532 1247888999999
Q ss_pred HHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCC
Q 013092 82 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIE 161 (449)
Q Consensus 82 ~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~ 161 (449)
.|++.||+|||++||+||||||+|||+ +.++.+||+|||+++........ .......++..|+|||++.+..
T Consensus 131 ~~i~~al~~lH~~~i~H~dlkp~nili---~~~~~~kl~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~ 202 (283)
T cd05090 131 IQIAAGMEYLSSHFFVHKDLAARNILI---GEQLHVKISDLGLSREIYSADYY-----RVQPKSLLPIRWMPPEAIMYGK 202 (283)
T ss_pred HHHHHHHHHHHhcCeehhccccceEEE---cCCCcEEeccccccccccCCcce-----ecccCCCccceecChHHhccCC
Confidence 999999999999999999999999999 57788999999999876443221 1123345677899999999888
Q ss_pred CChhhHHHHHHHHHHHHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHH
Q 013092 162 QSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAY 240 (449)
Q Consensus 162 ~s~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~ 240 (449)
++.++|||||||++|||++ |..||.+... ......+..... ...+..+++++.+++..||+.+|++||++.+
T Consensus 203 ~~~~~Dv~slG~il~el~~~g~~p~~~~~~---~~~~~~~~~~~~----~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ 275 (283)
T cd05090 203 FSSDSDIWSFGVVLWEIFSFGLQPYYGFSN---QEVIEMVRKRQL----LPCSEDCPPRMYSLMTECWQEGPSRRPRFKD 275 (283)
T ss_pred CCchhhhHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHHcCCc----CCCCCCCCHHHHHHHHHHcccCcccCcCHHH
Confidence 9999999999999999998 9999977432 222333322221 1244568999999999999999999999999
Q ss_pred HHHHHH
Q 013092 241 LKRIFR 246 (449)
Q Consensus 241 l~~~L~ 246 (449)
|.+.|+
T Consensus 276 i~~~l~ 281 (283)
T cd05090 276 IHTRLR 281 (283)
T ss_pred HHHHhh
Confidence 988775
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=297.41 Aligned_cols=225 Identities=20% Similarity=0.256 Sum_probs=178.3
Q ss_pred cEEEEEeeecccC-CChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHH
Q 013092 3 EILTVFSVQENVK-TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLML 80 (449)
Q Consensus 3 ~aikV~~k~~~~~-~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i 80 (449)
.|+|++.+..... .....+..|+.+++.+ +||||+.+++++.+++..||||||+ |++|.+++.. ..+++..+..+
T Consensus 71 ~aiK~~~~~~~~~~~~~~~~~~e~~il~~~-~h~~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~--~~l~~~~~~~~ 147 (370)
T cd05596 71 YAMKLLSKFEMIKRSDSAFFWEERDIMAHA-NSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSN--YDIPEKWARFY 147 (370)
T ss_pred EEEEEEEHHHhhhhhhHHHHHHHHHHHHhC-CCCCcceEEEEEecCCEEEEEEcCCCCCcHHHHHHh--cCCCHHHHHHH
Confidence 3555554433222 2334577899999999 9999999999999999999999999 9999999874 46899999999
Q ss_pred HHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCC
Q 013092 81 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI 160 (449)
Q Consensus 81 ~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~ 160 (449)
+.||+.||+|||++||+||||||+|||+ +.++.+||+|||++........ .......||+.|+|||++.+.
T Consensus 148 ~~qi~~aL~~LH~~~ivHrDLkp~NILl---~~~~~~kL~DfG~~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~ 218 (370)
T cd05596 148 TAEVVLALDAIHSMGFIHRDVKPDNMLL---DKSGHLKLADFGTCMKMDANGM------VRCDTAVGTPDYISPEVLKSQ 218 (370)
T ss_pred HHHHHHHHHHHHHCCeeccCCCHHHEEE---cCCCCEEEEeccceeeccCCCc------ccCCCCCCCcCeECHHHhccC
Confidence 9999999999999999999999999999 6889999999999987643321 112345799999999998754
Q ss_pred ----CCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCC--
Q 013092 161 ----EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDD-- 234 (449)
Q Consensus 161 ----~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~-- 234 (449)
.++.++|||||||++|||++|..||.+.. ....+.++.........+. ...++.++.++|..|+..+|++
T Consensus 219 ~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~---~~~~~~~i~~~~~~~~~~~-~~~~s~~~~~li~~~L~~~p~r~~ 294 (370)
T cd05596 219 GGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS---LVGTYSKIMDHKNSLTFPD-DIEISKQAKDLICAFLTDREVRLG 294 (370)
T ss_pred CCCCCCCCceeeeehhHHHHHHHhCCCCcCCCC---HHHHHHHHHcCCCcCCCCC-cCCCCHHHHHHHHHHccChhhccC
Confidence 37889999999999999999999998743 3445555544322111111 1247899999999999988887
Q ss_pred CCCHHHHHH
Q 013092 235 KPDYAYLKR 243 (449)
Q Consensus 235 RPt~~~l~~ 243 (449)
|+++.+|+.
T Consensus 295 R~s~~ell~ 303 (370)
T cd05596 295 RNGVDEIKS 303 (370)
T ss_pred CCCHHHHhc
Confidence 999877643
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=295.46 Aligned_cols=227 Identities=20% Similarity=0.248 Sum_probs=193.5
Q ss_pred cEEEEEeeecccCC-ChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHH
Q 013092 3 EILTVFSVQENVKT-KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLML 80 (449)
Q Consensus 3 ~aikV~~k~~~~~~-~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i 80 (449)
.|+|++.|...... ....+.+|+.||++|++||||+.+++++++....+||||+| ||.|.+.+... .+++..+..+
T Consensus 63 ~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvmEL~~GGeLfd~i~~~--~~sE~da~~~ 140 (382)
T KOG0032|consen 63 VACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLVMELCEGGELFDRIVKK--HYSERDAAGI 140 (382)
T ss_pred eEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEEEEecCCchHHHHHHHc--cCCHHHHHHH
Confidence 46777776665433 45689999999999988999999999999999999999999 99999999754 3999999999
Q ss_pred HHHHHHHHHHHHHCCceecCCCCCcEEEeecCC-CCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhC
Q 013092 81 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR-ANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG 159 (449)
Q Consensus 81 ~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~-~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~ 159 (449)
+.|++.++.|||+.||+||||||+|||+..... .+.+|++|||++....... .....+||+.|+|||++..
T Consensus 141 ~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~~~--------~~~~~~Gtp~y~APEvl~~ 212 (382)
T KOG0032|consen 141 IRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKPGE--------RLHTIVGTPEYVAPEVLGG 212 (382)
T ss_pred HHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccCCc--------eEeeecCCccccCchhhcC
Confidence 999999999999999999999999999975433 3589999999999887622 1346799999999999999
Q ss_pred CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHH
Q 013092 160 IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYA 239 (449)
Q Consensus 160 ~~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~ 239 (449)
..|+..+||||+|+++|.|++|..||.+.. ....+.+|....... ....++.++....++|..|+..||..|+++.
T Consensus 213 ~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~---~~~~~~~i~~~~~~f-~~~~w~~is~~akd~i~~ll~~dp~~R~ta~ 288 (382)
T KOG0032|consen 213 RPYGDEVDVWSIGVILYILLSGVPPFWGET---EFEIFLAILRGDFDF-TSEPWDDISESAKDFIRKLLEFDPRKRLTAA 288 (382)
T ss_pred CCCCcccchhHHHHHHHHHhhCCCCCcCCC---hhHHHHHHHcCCCCC-CCCCccccCHHHHHHHHHhcccCcccCCCHH
Confidence 999999999999999999999999998844 345555666665532 2234567899999999999999999999988
Q ss_pred HHHH
Q 013092 240 YLKR 243 (449)
Q Consensus 240 ~l~~ 243 (449)
++++
T Consensus 289 ~~L~ 292 (382)
T KOG0032|consen 289 QALQ 292 (382)
T ss_pred HHhc
Confidence 7765
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=289.63 Aligned_cols=231 Identities=18% Similarity=0.266 Sum_probs=177.0
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC-C
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK-S 95 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~-g 95 (449)
...+.+|+++++.+ +|+||+++++++.++++.||||||+ +++|.+++.. .+.+++..+..++.|++.||.|||+. +
T Consensus 47 ~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~~ 124 (333)
T cd06650 47 RNQIIRELQVLHEC-NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLREKHK 124 (333)
T ss_pred HHHHHHHHHHHHHC-CCCcccceeEEEEECCEEEEEEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCC
Confidence 45689999999999 8999999999999999999999999 9999999985 45689999999999999999999985 7
Q ss_pred ceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHHH
Q 013092 96 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVL 175 (449)
Q Consensus 96 ivHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il 175 (449)
|+||||||+|||+ +..+.+||+|||++..+.... .....||..|+|||++.+..++.++|||||||++
T Consensus 125 ivH~dlkp~Nili---~~~~~~kL~Dfg~~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il 192 (333)
T cd06650 125 IMHRDVKPSNILV---NSRGEIKLCDFGVSGQLIDSM---------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSL 192 (333)
T ss_pred EEecCCChhhEEE---cCCCCEEEeeCCcchhhhhhc---------cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHH
Confidence 9999999999999 577889999999987654321 1345789999999999998899999999999999
Q ss_pred HHHHhCCCCCCCCCcCCHHHHHH-------------------------------------HHHhhcccchHHHhh-cCCc
Q 013092 176 MYFLRGSLPWQGLKAGTKKQKYE-------------------------------------KISEKKVSTSIEALC-RGYP 217 (449)
Q Consensus 176 ~elltG~~Pf~~~~~~~~~~~~~-------------------------------------~i~~~~~~~~~~~l~-~~~p 217 (449)
|+|++|+.||...........+. .+.........+.+. ..++
T Consensus 193 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (333)
T cd06650 193 VEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFG 272 (333)
T ss_pred HHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcC
Confidence 99999999997543211111000 000000000000111 1357
Q ss_pred HHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCCcccchh
Q 013092 218 TEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTI 264 (449)
Q Consensus 218 ~el~~li~~cl~~~p~~RPt~~~l~~~L~~~~~~~~~~~~~~~dw~~ 264 (449)
.++.+||.+||+.||++||++.+|+. ...+............|..
T Consensus 273 ~~~~~li~~~L~~~P~~Rpt~~ell~--h~~~~~~~~~~~~~~~~~~ 317 (333)
T cd06650 273 AEFQDFVNKCLIKNPAERADLKQLMV--HAFIKRSEAEEVDFAGWLC 317 (333)
T ss_pred HHHHHHHHHhccCCcccCcCHHHHhh--CHHHhcCccccccHHHHHH
Confidence 89999999999999999999877742 2333333334445567753
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=296.67 Aligned_cols=243 Identities=18% Similarity=0.200 Sum_probs=181.7
Q ss_pred EEEEEeeeccc-CCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHH
Q 013092 4 ILTVFSVQENV-KTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLA 81 (449)
Q Consensus 4 aikV~~k~~~~-~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~ 81 (449)
|||++.+.... ......+..|+++++.+ +|+||+++++.+.+.++.||||||| |++|.+++.. ...+++..+..++
T Consensus 30 aiK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~-~~~~~e~~~~~~~ 107 (381)
T cd05626 30 AMKTLRKKDVLNRNQVAHVKAERDILAEA-DNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIR-MEVFPEVLARFYI 107 (381)
T ss_pred EEEEEEHHHhhhhHHHHHHHHHHHHHHhc-CCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHh-cCCCCHHHHHHHH
Confidence 45554443322 23345688999999999 9999999999999999999999999 9999999875 4568999999999
Q ss_pred HHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcc-------------------------
Q 013092 82 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQH------------------------- 136 (449)
Q Consensus 82 ~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~------------------------- 136 (449)
.||+.||+|||+.||+||||||+|||| +..+.+||+|||+++.+........
T Consensus 108 ~qi~~aL~~LH~~givHrDlKp~Nili---~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 184 (381)
T cd05626 108 AELTLAIESVHKMGFIHRDIKPDNILI---DLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCR 184 (381)
T ss_pred HHHHHHHHHHHhCCeeecCCcHHHEEE---CCCCCEEEeeCcCCcccccccccccccccccccccccCcccccccccccc
Confidence 999999999999999999999999999 5788999999999864421100000
Q ss_pred ---------------cccccCCCCccCccccchhhhhCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHH
Q 013092 137 ---------------IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKIS 201 (449)
Q Consensus 137 ---------------~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~ 201 (449)
.........+||+.|+|||++.+..++.++|||||||++|||++|..||..... .+...++.
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~---~~~~~~i~ 261 (381)
T cd05626 185 CGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTP---TETQLKVI 261 (381)
T ss_pred cccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHHHHHhCCCCCcCCCH---HHHHHHHH
Confidence 000011245799999999999999999999999999999999999999987433 22233333
Q ss_pred hhcccchHHHhhcCCcHHHHHHHHHHh--cCCCCCCCCHHHHHHHHHHHHHHcCCCCCCcccchhh
Q 013092 202 EKKVSTSIEALCRGYPTEFASYFHYCR--SLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTIL 265 (449)
Q Consensus 202 ~~~~~~~~~~l~~~~p~el~~li~~cl--~~~p~~RPt~~~l~~~L~~~~~~~~~~~~~~~dw~~~ 265 (449)
.......++ ....+++++.++|.+|+ ..++..|+++.+|+. +++...++|...
T Consensus 262 ~~~~~~~~~-~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~----------hp~f~~~~~~~~ 316 (381)
T cd05626 262 NWENTLHIP-PQVKLSPEAVDLITKLCCSAEERLGRNGADDIKA----------HPFFSEVDFSSD 316 (381)
T ss_pred ccccccCCC-CCCCCCHHHHHHHHHHccCcccccCCCCHHHHhc----------CcccCCCChhHH
Confidence 211111111 11247899999999854 455556999887753 456666788754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=302.98 Aligned_cols=249 Identities=20% Similarity=0.281 Sum_probs=208.6
Q ss_pred EEEEEeeecccCCChh-HHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHH
Q 013092 4 ILTVFSVQENVKTKHP-QLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLA 81 (449)
Q Consensus 4 aikV~~k~~~~~~~~~-~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~ 81 (449)
|+|+++|.+.++++++ .+..|..||..+ ..|.||+||-.+.+..+.||+||-| ||.|+.++.. .+.|+..++.+++
T Consensus 449 AlKilkK~hIVdtkQqeHv~sEr~Im~~~-~s~fIvrLYrTfrd~kyvYmLmEaClGGElWTiLrd-Rg~Fdd~tarF~~ 526 (732)
T KOG0614|consen 449 ALKILKKKHIVDTKQQEHVFSERNIMMEC-RSDFIVRLYRTFRDSKYVYMLMEACLGGELWTILRD-RGSFDDYTARFYV 526 (732)
T ss_pred HHHHHhHhhccchhHHHHHHhHHHHHHhc-CchHHHHHHHHhccchhhhhhHHhhcCchhhhhhhh-cCCcccchhhhhH
Confidence 5788889888876554 477899999999 7999999999999999999999999 9999999986 5689999999999
Q ss_pred HHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCC
Q 013092 82 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIE 161 (449)
Q Consensus 82 ~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~ 161 (449)
..++.|++|||++|||+|||||+|+|+ +..|-+||.|||+|+++..... ..+++|||.|.|||.++...
T Consensus 527 acv~EAfeYLH~k~iIYRDLKPENllL---d~~Gy~KLVDFGFAKki~~g~K--------TwTFcGTpEYVAPEIILnKG 595 (732)
T KOG0614|consen 527 ACVLEAFEYLHRKGIIYRDLKPENLLL---DNRGYLKLVDFGFAKKIGSGRK--------TWTFCGTPEYVAPEIILNKG 595 (732)
T ss_pred HHHHHHHHHHHhcCceeccCChhheee---ccCCceEEeehhhHHHhccCCc--------eeeecCCcccccchhhhccC
Confidence 999999999999999999999999999 6899999999999999887643 35789999999999999999
Q ss_pred CChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHH
Q 013092 162 QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYL 241 (449)
Q Consensus 162 ~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l 241 (449)
.+..+|+||||+++|||++|.+||.+.++ .+.|..|....- .-.+++.++....++|+++...+|.+|..+ .
T Consensus 596 HD~avDyWaLGIli~ELL~G~pPFs~~dp---mktYn~ILkGid---~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~--~ 667 (732)
T KOG0614|consen 596 HDRAVDYWALGILIYELLTGSPPFSGVDP---MKTYNLILKGID---KIEFPRRITKTATDLIKKLCRDNPTERLGY--Q 667 (732)
T ss_pred cchhhHHHHHHHHHHHHHcCCCCCCCCch---HHHHHHHHhhhh---hhhcccccchhHHHHHHHHHhcCcHhhhcc--c
Confidence 99999999999999999999999998554 455555544311 123456788899999999999999999763 1
Q ss_pred HHHHHHHHHHcCCCCCCcccchhhhhhhccCCCCC
Q 013092 242 KRIFRDLFIREGFQFDYVFDWTILKYQQSQLATPP 276 (449)
Q Consensus 242 ~~~L~~~~~~~~~~~~~~~dw~~~~~~~~~~~~~p 276 (449)
..-+.++ ..+.++..|||+.++.....+|..|
T Consensus 668 ~~gI~DI---kkH~Wf~gfdweglr~~~L~pPi~~ 699 (732)
T KOG0614|consen 668 KGGINDI---KKHRWFEGFDWEGLRSRTLPPPIIP 699 (732)
T ss_pred cCChHHH---HhhhhhhcCChhhhhhccCCCCccc
Confidence 1112222 2346788899999988766555444
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=297.32 Aligned_cols=234 Identities=21% Similarity=0.273 Sum_probs=199.8
Q ss_pred cEEEEEeeecccC---CChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHH
Q 013092 3 EILTVFSVQENVK---TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVL 78 (449)
Q Consensus 3 ~aikV~~k~~~~~---~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~ 78 (449)
+.|.|++|..+.. ...+.|+.|..+|+.+ +||||++|++.+.+. ..|||||++ -|.|..+++.....++..+..
T Consensus 417 e~iaVAvKtCK~d~t~d~tekflqEa~iMrnf-dHphIikLIGv~~e~-P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ 494 (974)
T KOG4257|consen 417 ERIAVAVKTCKTDCTPDDTEKFLQEASIMRNF-DHPHIIKLIGVCVEQ-PMWIVMELAPLGELREYLQQNKDSLPLRTLT 494 (974)
T ss_pred cceeeeeehhccCCChhhHHHHHHHHHHHHhC-CCcchhheeeeeecc-ceeEEEecccchhHHHHHHhccccchHHHHH
Confidence 4577888877552 4567799999999999 999999999998765 689999999 999999999777779999999
Q ss_pred HHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhh
Q 013092 79 MLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHL 158 (449)
Q Consensus 79 ~i~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~ 158 (449)
.+++||+.||.|||++.+|||||-..|||+ .....|||+||||++.+.+.... ......-...|||||.+.
T Consensus 495 ly~~Qi~talaYLeSkrfVHRDIAaRNiLV---sSp~CVKLaDFGLSR~~ed~~yY------kaS~~kLPIKWmaPESIN 565 (974)
T KOG4257|consen 495 LYCYQICTALAYLESKRFVHRDIAARNILV---SSPQCVKLADFGLSRYLEDDAYY------KASRGKLPIKWMAPESIN 565 (974)
T ss_pred HHHHHHHHHHHHHHhhchhhhhhhhhheee---cCcceeeecccchhhhccccchh------hccccccceeecCccccc
Confidence 999999999999999999999999999999 48889999999999988776542 223444567899999999
Q ss_pred CCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCC
Q 013092 159 GIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPD 237 (449)
Q Consensus 159 ~~~~s~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt 237 (449)
...++..+|||.||+.+||++. |..||++.+..+....+++ ......+++||+.+..|+.+||+.+|.+||+
T Consensus 566 fRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEn-------GeRlP~P~nCPp~LYslmskcWayeP~kRPr 638 (974)
T KOG4257|consen 566 FRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIEN-------GERLPCPPNCPPALYSLMSKCWAYEPSKRPR 638 (974)
T ss_pred hhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecC-------CCCCCCCCCCChHHHHHHHHHhccCcccCCc
Confidence 9999999999999999999986 9999999877654333322 2222356789999999999999999999999
Q ss_pred HHHHHHHHHHHHHHcCC
Q 013092 238 YAYLKRIFRDLFIREGF 254 (449)
Q Consensus 238 ~~~l~~~L~~~~~~~~~ 254 (449)
|.+|+..|.++++.+..
T Consensus 639 ftei~~~lsdv~qeek~ 655 (974)
T KOG4257|consen 639 FTEIKAILSDVLQEEKI 655 (974)
T ss_pred HHHHHHHHHHHHHHhhh
Confidence 99999999999885543
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=279.13 Aligned_cols=214 Identities=18% Similarity=0.316 Sum_probs=178.2
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKS 95 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~-~~~ls~~~~~~i~~qi~~aL~yLH~~g 95 (449)
...+.+|+++++.+ .|+||+++++++......++||||+ +++|.+++... ...+++..++.++.|++.||+|||++|
T Consensus 46 ~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ 124 (263)
T cd05052 46 VEEFLKEAAVMKEI-KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN 124 (263)
T ss_pred HHHHHHHHHHHHhC-CCCChhheEEEEcCCCCcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 45688999999999 8999999999999999999999999 89999999754 345899999999999999999999999
Q ss_pred ceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHHH
Q 013092 96 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVL 175 (449)
Q Consensus 96 ivHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il 175 (449)
++||||||+||++ +.++.+||+|||++......... ......++..|+|||.+.+..++.++|||||||++
T Consensus 125 i~H~dlkp~nil~---~~~~~~kl~df~~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il 195 (263)
T cd05052 125 FIHRDLAARNCLV---GENHLVKVADFGLSRLMTGDTYT------AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLL 195 (263)
T ss_pred EeecccCcceEEE---cCCCcEEeCCCccccccccceee------ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHH
Confidence 9999999999999 57889999999999876543211 11223446789999999999999999999999999
Q ss_pred HHHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 013092 176 MYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDL 248 (449)
Q Consensus 176 ~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~L~~~ 248 (449)
|||++ |..||.+... .+.+..+.... ....+..+|.++.+++.+||..+|++||++.++.+.|+.+
T Consensus 196 ~el~t~g~~p~~~~~~---~~~~~~~~~~~----~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 196 WEIATYGMSPYPGIDL---SQVYELLEKGY----RMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred HHHHcCCCCCCCCCCH---HHHHHHHHCCC----CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 99998 9999976432 33333333211 1123467899999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=292.45 Aligned_cols=242 Identities=19% Similarity=0.221 Sum_probs=182.5
Q ss_pred cEEEEEeeeccc-CCChhHHHHHHHHHHHhc--CCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHH
Q 013092 3 EILTVFSVQENV-KTKHPQLLYESKLYRILQ--GGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVL 78 (449)
Q Consensus 3 ~aikV~~k~~~~-~~~~~~~~~E~~il~~l~--~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~ 78 (449)
.|+|++.+.... ......+..|..++..+. +||+|+.+++.+.+....||||||+ +++|.+++.. ...+++..++
T Consensus 21 ~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~ 99 (330)
T cd05586 21 YAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQK-EGRFSEDRAK 99 (330)
T ss_pred EEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCCChHHHHHHh-cCCCCHHHHH
Confidence 345555433222 123344567778877765 8999999999999999999999999 9999998875 5679999999
Q ss_pred HHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhh
Q 013092 79 MLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHL 158 (449)
Q Consensus 79 ~i~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~ 158 (449)
.++.||+.||+|||++||+||||||+|||+ +.++.++|+|||+++....... ......||+.|+|||++.
T Consensus 100 ~~~~qil~al~~LH~~~ivHrDlkp~Nili---~~~~~~kl~Dfg~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~ 169 (330)
T cd05586 100 FYIAELVLALEHLHKYDIVYRDLKPENILL---DATGHIALCDFGLSKANLTDNK-------TTNTFCGTTEYLAPEVLL 169 (330)
T ss_pred HHHHHHHHHHHHHHHCCeEeccCCHHHeEE---CCCCCEEEecCCcCcCCCCCCC-------CccCccCCccccCHHHHc
Confidence 999999999999999999999999999999 5788999999999875432211 123467999999999997
Q ss_pred CC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCC
Q 013092 159 GI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPD 237 (449)
Q Consensus 159 ~~-~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt 237 (449)
+. .++.++|||||||++|+|++|..||.+. +..+.+..+.......+ ...+++++.++|..||..+|++||+
T Consensus 170 ~~~~~~~~~DvwslGvil~elltG~~Pf~~~---~~~~~~~~i~~~~~~~~----~~~~~~~~~~li~~~L~~~P~~R~~ 242 (330)
T cd05586 170 DEKGYTKHVDFWSLGVLVFEMCCGWSPFYAE---DTQQMYRNIAFGKVRFP----KNVLSDEGRQFVKGLLNRNPQHRLG 242 (330)
T ss_pred CCCCCCCccceeccccEEEEeccCCCCCCCC---CHHHHHHHHHcCCCCCC----CccCCHHHHHHHHHHcCCCHHHCCC
Confidence 64 4789999999999999999999999763 33444454443322211 1246889999999999999999995
Q ss_pred HHH-HHHHHHHHHHHcCCCCCCcccchhhhhhh
Q 013092 238 YAY-LKRIFRDLFIREGFQFDYVFDWTILKYQQ 269 (449)
Q Consensus 238 ~~~-l~~~L~~~~~~~~~~~~~~~dw~~~~~~~ 269 (449)
... +.+++ ..++....+|.......
T Consensus 243 ~~~~~~~ll-------~h~~~~~~~~~~~~~~~ 268 (330)
T cd05586 243 AHRDAVELK-------EHPFFADIDWDLLSKKQ 268 (330)
T ss_pred CCCCHHHHh-------cCccccCCCHHHHHhCC
Confidence 321 22222 13444556787765443
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=293.12 Aligned_cols=238 Identities=19% Similarity=0.239 Sum_probs=182.8
Q ss_pred EEEEEeeeccc-CCChhHHHHHHHHH-HHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHH
Q 013092 4 ILTVFSVQENV-KTKHPQLLYESKLY-RILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLML 80 (449)
Q Consensus 4 aikV~~k~~~~-~~~~~~~~~E~~il-~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i 80 (449)
|+|++.+.... ......+..|..++ +.+ +||||+++++.+...+..||||||+ |++|.+++.. ...+++..+..+
T Consensus 24 aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~ 101 (325)
T cd05604 24 AVKVLQKKIVLNRKEQKHIMAERNVLLKNV-KHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQR-ERSFPEPRARFY 101 (325)
T ss_pred EEEEEEHHHhhhhhHHHHHHHHHHHHHHhC-CCCCCccEEEEEecCCEEEEEEcCCCCCCHHHHHHH-cCCCCHHHHHHH
Confidence 45555433221 22334566676654 445 9999999999999999999999999 9999988875 567999999999
Q ss_pred HHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCC
Q 013092 81 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI 160 (449)
Q Consensus 81 ~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~ 160 (449)
+.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++....... ......||+.|+|||++.+.
T Consensus 102 ~~qi~~al~~lH~~givH~Dlkp~NIll---~~~~~~kL~DfG~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~ 171 (325)
T cd05604 102 AAEIASALGYLHSINIVYRDLKPENILL---DSQGHVVLTDFGLCKEGIAQSD-------TTTTFCGTPEYLAPEVIRKQ 171 (325)
T ss_pred HHHHHHHHHHHHHCCeeecCCCHHHeEE---CCCCCEEEeecCCcccCCCCCC-------CcccccCChhhCCHHHHcCC
Confidence 9999999999999999999999999999 5788999999999875322111 12345799999999999999
Q ss_pred CCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHH
Q 013092 161 EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAY 240 (449)
Q Consensus 161 ~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~ 240 (449)
.++.++|||||||++|+|++|..||... +..+.+..+..... .+.+.++.++.+++..|+..+|.+||++.+
T Consensus 172 ~~~~~~DvwslG~il~el~~G~~pf~~~---~~~~~~~~~~~~~~-----~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~ 243 (325)
T cd05604 172 PYDNTVDWWCLGAVLYEMLYGLPPFYCR---DVAEMYDNILHKPL-----VLRPGASLTAWSILEELLEKDRQRRLGAKE 243 (325)
T ss_pred CCCCcCccccccceehhhhcCCCCCCCC---CHHHHHHHHHcCCc-----cCCCCCCHHHHHHHHHHhccCHHhcCCCCC
Confidence 9999999999999999999999999764 33444444444322 223467889999999999999999998642
Q ss_pred HHHHHHHHHHHcCCCCCCcccchhhhh
Q 013092 241 LKRIFRDLFIREGFQFDYVFDWTILKY 267 (449)
Q Consensus 241 l~~~L~~~~~~~~~~~~~~~dw~~~~~ 267 (449)
. +.++ ...++...++|.....
T Consensus 244 ~---~~~i---~~h~~f~~~~~~~~~~ 264 (325)
T cd05604 244 D---FLEI---QEHPFFESLSWTDLEQ 264 (325)
T ss_pred C---HHHH---hcCCCcCCCCHHHHHh
Confidence 2 2222 2345556677876543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=288.34 Aligned_cols=237 Identities=20% Similarity=0.242 Sum_probs=182.9
Q ss_pred EEEEEeeeccc-CCChhHHHHHHH-HHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHH
Q 013092 4 ILTVFSVQENV-KTKHPQLLYESK-LYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLML 80 (449)
Q Consensus 4 aikV~~k~~~~-~~~~~~~~~E~~-il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i 80 (449)
|+|++.+.... ......+..|+. +++.+ +||||+++++.+.+.+..||||||+ |++|.+.+.. ...+++..+..+
T Consensus 24 aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~ 101 (321)
T cd05603 24 AVKVLQKKTILKKKEQNHIMAERNVLLKNL-KHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQR-ERCFLEPRARFY 101 (321)
T ss_pred EEEEEEHHHHHHhhHHHHHHHHHHHHHHhC-CCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHH-cCCCCHHHHHHH
Confidence 45555443322 223345666665 45666 9999999999999999999999999 9999888875 457899999999
Q ss_pred HHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCC
Q 013092 81 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI 160 (449)
Q Consensus 81 ~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~ 160 (449)
+.||+.||+|||++||+||||||+|||| +.++.+||+|||+++....... ......||+.|+|||++.+.
T Consensus 102 ~~qi~~~L~~lH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~ 171 (321)
T cd05603 102 AAEVASAIGYLHSLNIIYRDLKPENILL---DSQGHVVLTDFGLCKEGVEPEE-------TTSTFCGTPEYLAPEVLRKE 171 (321)
T ss_pred HHHHHHHHHHHHHCCeEeccCCHHHeEE---CCCCCEEEccCCCCccCCCCCC-------ccccccCCcccCCHHHhcCC
Confidence 9999999999999999999999999999 6788999999999875322211 12345799999999999998
Q ss_pred CCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHH-
Q 013092 161 EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYA- 239 (449)
Q Consensus 161 ~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~- 239 (449)
.++.++|||||||++|||++|..||... +..+.+..+..... .++...+.++.+++..||+.+|.+||+..
T Consensus 172 ~~~~~~DiwslG~il~el~~g~~pf~~~---~~~~~~~~i~~~~~-----~~~~~~~~~~~~li~~~l~~~p~~R~~~~~ 243 (321)
T cd05603 172 PYDRTVDWWCLGAVLYEMLYGLPPFYSR---DVSQMYDNILHKPL-----QLPGGKTVAACDLLVGLLHKDQRRRLGAKA 243 (321)
T ss_pred CCCCcCcccccchhhhhhhcCCCCCCCC---CHHHHHHHHhcCCC-----CCCCCCCHHHHHHHHHHccCCHhhcCCCCC
Confidence 8999999999999999999999999874 33444555544322 23456788999999999999999999752
Q ss_pred HHHHHHHHHHHHcCCCCCCcccchhhhh
Q 013092 240 YLKRIFRDLFIREGFQFDYVFDWTILKY 267 (449)
Q Consensus 240 ~l~~~L~~~~~~~~~~~~~~~dw~~~~~ 267 (449)
.+.++ ....+....+|.....
T Consensus 244 ~~~~~-------~~~~~~~~~~~~~~~~ 264 (321)
T cd05603 244 DFLEI-------KNHVFFSPINWDDLYH 264 (321)
T ss_pred CHHHH-------hCCCCcCCCCHHHHhc
Confidence 22222 2345556678876543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=280.28 Aligned_cols=215 Identities=16% Similarity=0.332 Sum_probs=175.3
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeCCE------EEEEEecC-CCCHHHHHHHc-----CCCCCHHHHHHHHHHHH
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEGDY------NVLVMDLL-GPSLEDLFNFC-----SRKLSLKTVLMLADQMI 85 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~------~~lVmE~~-g~sL~~ll~~~-----~~~ls~~~~~~i~~qi~ 85 (449)
...+..|+++++.+ +|+||+++++++..... .++||||+ +++|.+++... ...+++..++.++.|++
T Consensus 45 ~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~ 123 (273)
T cd05035 45 IEEFLSEAACMKDF-DHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIA 123 (273)
T ss_pred HHHHHHHHHHHHhC-CCCCeeeEEeeeccCCccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHH
Confidence 45688999999999 89999999988765544 79999999 99999998532 23589999999999999
Q ss_pred HHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChh
Q 013092 86 NRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRR 165 (449)
Q Consensus 86 ~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~ 165 (449)
.||+|||+.+|+||||||+||++ +.++.+||+|||+++.+...... .......++..|++||++.+..++.+
T Consensus 124 ~aL~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~dfg~~~~~~~~~~~-----~~~~~~~~~~~~~~pe~~~~~~~~~~ 195 (273)
T cd05035 124 LGMEYLSNRNFIHRDLAARNCML---REDMTVCVADFGLSKKIYSGDYY-----RQGRIAKMPVKWIAIESLADRVYTSK 195 (273)
T ss_pred HHHHHHHhCCeeccccchheEEE---CCCCeEEECCccceeeccccccc-----cccccccCCccccCHhhcccCCCCcc
Confidence 99999999999999999999999 57889999999999876543321 11122345678999999988889999
Q ss_pred hHHHHHHHHHHHHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHH
Q 013092 166 DDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRI 244 (449)
Q Consensus 166 ~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~ 244 (449)
+|||||||++|||++ |..||.+... .+.++.+..... ...+..++.++.+++.+||+.+|++||++.+|.+.
T Consensus 196 ~Dv~SlG~il~el~~~g~~p~~~~~~---~~~~~~~~~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 196 SDVWAFGVTMWEIATRGQTPYPGVEN---HEIYDYLRHGNR----LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred cchHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCCC----CCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999 9999976433 233333333221 12345688999999999999999999999999999
Q ss_pred HHHH
Q 013092 245 FRDL 248 (449)
Q Consensus 245 L~~~ 248 (449)
|+++
T Consensus 269 l~~~ 272 (273)
T cd05035 269 LENI 272 (273)
T ss_pred HHhh
Confidence 8875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=285.18 Aligned_cols=218 Identities=18% Similarity=0.249 Sum_probs=178.3
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcC---------------CCCCHHHHHHHH
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCS---------------RKLSLKTVLMLA 81 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~---------------~~ls~~~~~~i~ 81 (449)
.+.+..|+.++.++.+||||+++++++.+.+..|+||||+ +++|.+++.... ..+++..++.++
T Consensus 46 ~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~ 125 (297)
T cd05089 46 HRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFA 125 (297)
T ss_pred HHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHH
Confidence 3568899999999988999999999999999999999999 899999996421 248899999999
Q ss_pred HHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCC
Q 013092 82 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIE 161 (449)
Q Consensus 82 ~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~ 161 (449)
.|++.||+|||++||+||||||+|||+ +.++.+||+|||++........ ......+..|++||++.+..
T Consensus 126 ~qi~~al~~lH~~~ivH~dlkp~Nill---~~~~~~kl~dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~ 194 (297)
T cd05089 126 SDVATGMQYLSEKQFIHRDLAARNVLV---GENLASKIADFGLSRGEEVYVK--------KTMGRLPVRWMAIESLNYSV 194 (297)
T ss_pred HHHHHHHHHHHHCCcccCcCCcceEEE---CCCCeEEECCcCCCccccceec--------cCCCCcCccccCchhhccCC
Confidence 999999999999999999999999999 5788999999999864321110 11123355799999999888
Q ss_pred CChhhHHHHHHHHHHHHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHH
Q 013092 162 QSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAY 240 (449)
Q Consensus 162 ~s~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~ 240 (449)
++.++|||||||++|||++ |..||.+... .+.+.++..... ......++.++.+|+..||..+|.+||++++
T Consensus 195 ~~~~~DvwSlG~il~el~t~g~~pf~~~~~---~~~~~~~~~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 267 (297)
T cd05089 195 YTTKSDVWSFGVLLWEIVSLGGTPYCGMTC---AELYEKLPQGYR----MEKPRNCDDEVYELMRQCWRDRPYERPPFAQ 267 (297)
T ss_pred CCchhhHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHhcCCC----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 9999999999999999997 9999977433 333333332211 1223468899999999999999999999999
Q ss_pred HHHHHHHHHHHcC
Q 013092 241 LKRIFRDLFIREG 253 (449)
Q Consensus 241 l~~~L~~~~~~~~ 253 (449)
|.+.|.+++....
T Consensus 268 i~~~l~~~~~~~~ 280 (297)
T cd05089 268 ISVQLSRMLEARK 280 (297)
T ss_pred HHHHHHHHHHhhc
Confidence 9999998877554
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=292.82 Aligned_cols=241 Identities=20% Similarity=0.245 Sum_probs=184.4
Q ss_pred cEEEEEeeeccc-CCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHH
Q 013092 3 EILTVFSVQENV-KTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLML 80 (449)
Q Consensus 3 ~aikV~~k~~~~-~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i 80 (449)
.|+|++.+.... ......+..|+.++..+ +|++|+.+++++.+.++.||||||+ |++|.+++......+++..+..+
T Consensus 29 ~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~l~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~ 107 (331)
T cd05624 29 YAMKILNKWEMLKRAETACFREERNVLVNG-DCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFY 107 (331)
T ss_pred EEEEEEeHHHHHhhHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHhcCCCCHHHHHHH
Confidence 355555543322 22344577889998888 9999999999999999999999999 99999999865667999999999
Q ss_pred HHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhC-
Q 013092 81 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG- 159 (449)
Q Consensus 81 ~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~- 159 (449)
+.|++.||+|||++||+||||||+|||+ +.++.+||+|||+++.+...... ......||+.|+|||++.+
T Consensus 108 ~~qi~~~L~~lH~~~iiHrDlkp~Nill---~~~~~~kl~DfG~a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~ 178 (331)
T cd05624 108 IAEMVLAIHSIHQLHYVHRDIKPDNVLL---DMNGHIRLADFGSCLKMNQDGTV------QSSVAVGTPDYISPEILQAM 178 (331)
T ss_pred HHHHHHHHHHHHHCCeeeccCchHHEEE---cCCCCEEEEeccceeeccCCCce------eeccccCCcccCCHHHHhcc
Confidence 9999999999999999999999999999 57889999999999876543221 1123579999999999876
Q ss_pred ----CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCC-
Q 013092 160 ----IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDD- 234 (449)
Q Consensus 160 ----~~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~- 234 (449)
..++.++|||||||++|+|++|+.||.... ..+.+.++........++.....+++++.++|.+|+..++..
T Consensus 179 ~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~---~~~~~~~i~~~~~~~~~p~~~~~~~~~~~~li~~ll~~~~~~~ 255 (331)
T cd05624 179 EDGMGKYGPECDWWSLGVCMYEMLYGETPFYAES---LVETYGKIMNHEERFQFPSHITDVSEEAKDLIQRLICSRERRL 255 (331)
T ss_pred ccCCCCCCCcccEEeeehhhhhhhhCCCCccCCC---HHHHHHHHHcCCCcccCCCccccCCHHHHHHHHHHccCchhhc
Confidence 457889999999999999999999997643 344455554433222223333457899999999999865433
Q ss_pred -CCCHHHHHHHHHHHHHHcCCCCCCcccchhhh
Q 013092 235 -KPDYAYLKRIFRDLFIREGFQFDYVFDWTILK 266 (449)
Q Consensus 235 -RPt~~~l~~~L~~~~~~~~~~~~~~~dw~~~~ 266 (449)
|+++++++ .+.+...++|+...
T Consensus 256 ~~~~~~~~~----------~h~~f~~~~~~~~~ 278 (331)
T cd05624 256 GQNGIEDFK----------KHAFFEGIDWENIR 278 (331)
T ss_pred CCCCHHHHh----------cCCCcCCCCHHHHh
Confidence 23444332 34556678898764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=296.24 Aligned_cols=215 Identities=15% Similarity=0.161 Sum_probs=174.3
Q ss_pred hHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q 013092 19 PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLH 98 (449)
Q Consensus 19 ~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~givH 98 (449)
..+.+|+++|+.| +|+||+++++++......|+|||+++++|.+++.. ...+++..++.++.||+.||+|||++||+|
T Consensus 131 ~~~~~E~~il~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~l~~-~~~l~~~~~~~i~~ql~~aL~~LH~~givH 208 (392)
T PHA03207 131 KTPGREIDILKTI-SHRAIINLIHAYRWKSTVCMVMPKYKCDLFTYVDR-SGPLPLEQAITIQRRLLEALAYLHGRGIIH 208 (392)
T ss_pred ccHHHHHHHHHhc-CCCCccceeeeEeeCCEEEEEehhcCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 3567899999999 89999999999999999999999998899999854 567999999999999999999999999999
Q ss_pred cCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHHHHHH
Q 013092 99 RDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYF 178 (449)
Q Consensus 99 RDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il~el 178 (449)
|||||+|||+ +..+.++|+|||+++.+...... .......||+.|+|||++.+..++.++|||||||++|||
T Consensus 209 rDlkp~Nill---~~~~~~~l~DfG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el 280 (392)
T PHA03207 209 RDVKTENIFL---DEPENAVLGDFGAACKLDAHPDT-----PQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEM 280 (392)
T ss_pred cCCCHHHEEE---cCCCCEEEccCccccccCccccc-----ccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHH
Confidence 9999999999 67889999999999876543221 112356799999999999999999999999999999999
Q ss_pred HhCCCCCCCCCcCCHHHHHHHHHhhccc---------------------------chHHHh--hcCCcHHHHHHHHHHhc
Q 013092 179 LRGSLPWQGLKAGTKKQKYEKISEKKVS---------------------------TSIEAL--CRGYPTEFASYFHYCRS 229 (449)
Q Consensus 179 ltG~~Pf~~~~~~~~~~~~~~i~~~~~~---------------------------~~~~~l--~~~~p~el~~li~~cl~ 229 (449)
++|..||.+.........+..+...... ..++.+ ...++.++.++|.+||.
T Consensus 281 ~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~ 360 (392)
T PHA03207 281 SVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLT 360 (392)
T ss_pred HHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhc
Confidence 9999999876544333333333221100 000011 12457789999999999
Q ss_pred CCCCCCCCHHHHHH
Q 013092 230 LRFDDKPDYAYLKR 243 (449)
Q Consensus 230 ~~p~~RPt~~~l~~ 243 (449)
.+|++||++.+++.
T Consensus 361 ~dp~~Rpsa~e~l~ 374 (392)
T PHA03207 361 FDQEFRPSAQDILS 374 (392)
T ss_pred cChhhCCCHHHHhh
Confidence 99999999888754
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=295.61 Aligned_cols=243 Identities=20% Similarity=0.227 Sum_probs=181.5
Q ss_pred EEEEEeeeccc-CCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHH
Q 013092 4 ILTVFSVQENV-KTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLA 81 (449)
Q Consensus 4 aikV~~k~~~~-~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~ 81 (449)
|+|++.+.... ......+..|+++++.+ +|+||+++++.+.+++..||||||| +++|.+++.. .+.+++..+..++
T Consensus 30 aiK~i~~~~~~~~~~~~~~~~E~~il~~~-~h~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~-~~~~~e~~~~~~~ 107 (382)
T cd05625 30 AMKTLRKKDVLLRNQVAHVKAERDILAEA-DNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIR-MGIFPEDLARFYI 107 (382)
T ss_pred EEEEEeHHHhhhHHHHHHHHHHHHHHHhC-CCCcCCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHH
Confidence 45554443221 23345688999999999 9999999999999999999999999 9999999875 4568999999999
Q ss_pred HHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcc-------------------------
Q 013092 82 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQH------------------------- 136 (449)
Q Consensus 82 ~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~------------------------- 136 (449)
.||+.||+|||++||+||||||+|||+ +.++.+||+|||++..+........
T Consensus 108 ~qi~~al~~lH~~~ivHrDlKp~NILl---~~~g~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 184 (382)
T cd05625 108 AELTCAVESVHKMGFIHRDIKPDNILI---DRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCR 184 (382)
T ss_pred HHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEEeECCCCcccccccccccccccccccccccccccccccccccc
Confidence 999999999999999999999999999 5788999999999864321100000
Q ss_pred ---------------cccccCCCCccCccccchhhhhCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHH
Q 013092 137 ---------------IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKIS 201 (449)
Q Consensus 137 ---------------~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~ 201 (449)
.........+||+.|+|||++.+..++.++|||||||++|||++|..||.+... .+...++.
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~---~~~~~~i~ 261 (382)
T cd05625 185 CGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQTP---LETQMKVI 261 (382)
T ss_pred ccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHHHHHhCCCCCCCCCH---HHHHHHHH
Confidence 000011235799999999999999999999999999999999999999987432 33333333
Q ss_pred hhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCC---HHHHHHHHHHHHHHcCCCCCCcccchhhh
Q 013092 202 EKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPD---YAYLKRIFRDLFIREGFQFDYVFDWTILK 266 (449)
Q Consensus 202 ~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt---~~~l~~~L~~~~~~~~~~~~~~~dw~~~~ 266 (449)
........+ ....+++++.++|..|+ .+|++|++ +.+++ .+++...++|....
T Consensus 262 ~~~~~~~~p-~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~----------~hp~f~~~~~~~~~ 317 (382)
T cd05625 262 NWQTSLHIP-PQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIK----------AHPFFKTIDFSSDL 317 (382)
T ss_pred ccCCCcCCC-CcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHh----------cCCCcCCcChHHHH
Confidence 322111111 12356889999998876 59999997 55443 23555667887543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=288.30 Aligned_cols=212 Identities=18% Similarity=0.296 Sum_probs=169.4
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC-C
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK-S 95 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~-g 95 (449)
...+.+|+++++.+ +||||+++++++..++..+|||||+ +++|.+++.. ...+++..+..++.|++.||.|||++ +
T Consensus 47 ~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~ 124 (331)
T cd06649 47 RNQIIRELQVLHEC-NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKE-AKRIPEEILGKVSIAVLRGLAYLREKHQ 124 (331)
T ss_pred HHHHHHHHHHHHHC-CCCCCCeEEEEEEECCEEEEEeecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhcCC
Confidence 45689999999999 8999999999999999999999999 9999999985 45689999999999999999999986 6
Q ss_pred ceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHHH
Q 013092 96 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVL 175 (449)
Q Consensus 96 ivHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il 175 (449)
|+||||||+|||+ +.++.+||+|||++....... .....||+.|+|||++.+..++.++|||||||++
T Consensus 125 ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~---------~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il 192 (331)
T cd06649 125 IMHRDVKPSNILV---NSRGEIKLCDFGVSGQLIDSM---------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSL 192 (331)
T ss_pred EEcCCCChhhEEE---cCCCcEEEccCcccccccccc---------cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHH
Confidence 9999999999999 577899999999997654322 1345789999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCcCCHHHHHHH---------------------------------------HHhhcccchHHHh-hcC
Q 013092 176 MYFLRGSLPWQGLKAGTKKQKYEK---------------------------------------ISEKKVSTSIEAL-CRG 215 (449)
Q Consensus 176 ~elltG~~Pf~~~~~~~~~~~~~~---------------------------------------i~~~~~~~~~~~l-~~~ 215 (449)
|||++|+.||...........+.. ..........+.. ...
T Consensus 193 ~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (331)
T cd06649 193 VELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGV 272 (331)
T ss_pred HHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCcc
Confidence 999999999975432111100000 0000000000000 124
Q ss_pred CcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 216 YPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 216 ~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
+++++.+||.+||..||++||++.+|.+
T Consensus 273 ~~~~l~~li~~~L~~~P~~Rpt~~ell~ 300 (331)
T cd06649 273 FTPDFQEFVNKCLIKNPAERADLKMLMN 300 (331)
T ss_pred ccHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 6889999999999999999999887753
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=278.13 Aligned_cols=214 Identities=17% Similarity=0.317 Sum_probs=178.0
Q ss_pred ChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHC
Q 013092 17 KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSK 94 (449)
Q Consensus 17 ~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~-~~~ls~~~~~~i~~qi~~aL~yLH~~ 94 (449)
..+.+.+|+.+++.+ +|+||+++++.+.+.+..|+||||+ +++|.+++... ...+++..++.++.|++.||+|||+.
T Consensus 44 ~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~ 122 (261)
T cd05072 44 SVQAFLEEANLMKTL-QHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK 122 (261)
T ss_pred hHHHHHHHHHHHHhC-CCCCeeeEEEEEcCCCCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 456789999999999 8999999999999999999999999 99999998753 45689999999999999999999999
Q ss_pred CceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHH
Q 013092 95 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYV 174 (449)
Q Consensus 95 givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~i 174 (449)
+++||||||+||++ +.++.++|+|||++......... ......++..|+|||++.+..++.++|||||||+
T Consensus 123 ~i~H~dl~p~nili---~~~~~~~l~dfg~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~ 193 (261)
T cd05072 123 NYIHRDLRAANVLV---SESLMCKIADFGLARVIEDNEYT------AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGIL 193 (261)
T ss_pred CeeccccchhhEEe---cCCCcEEECCCccceecCCCcee------ccCCCccceecCCHHHhccCCCChhhhhhhhHHH
Confidence 99999999999999 57889999999999876543221 1123346778999999998889999999999999
Q ss_pred HHHHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Q 013092 175 LMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRD 247 (449)
Q Consensus 175 l~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~L~~ 247 (449)
+|+|++ |..||..... ......+..... ......+|.++.+++.+||..+|++||++++|.+.|++
T Consensus 194 l~~l~t~g~~p~~~~~~---~~~~~~~~~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 194 LYEIVTYGKIPYPGMSN---SDVMSALQRGYR----MPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred HHHHHccCCCCCCCCCH---HHHHHHHHcCCC----CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 999998 9999976433 233333332211 11234688999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=274.78 Aligned_cols=213 Identities=18% Similarity=0.289 Sum_probs=172.8
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 96 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gi 96 (449)
...+.+|+++++.+ +|+||+++++++......||||||+ +++|.+++......+++..++.++.|++.||+|||++||
T Consensus 37 ~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i 115 (252)
T cd05084 37 KAKFLQEARILKQY-SHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHC 115 (252)
T ss_pred HHHHHHHHHHHHhC-CCCCcceEEEEEcCCCCeEEEEeeccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence 45689999999999 8999999999999999999999999 999999997545568999999999999999999999999
Q ss_pred eecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHHHH
Q 013092 97 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLM 176 (449)
Q Consensus 97 vHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il~ 176 (449)
+|+||||+||++ +.++.+||+|||++......... ........+..|+|||.+.+..++.++|||||||++|
T Consensus 116 ~H~dl~p~nil~---~~~~~~kl~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ 187 (252)
T cd05084 116 IHRDLAARNCLV---TEKNVLKISDFGMSREEEDGVYA-----STGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLW 187 (252)
T ss_pred cccccchheEEE---cCCCcEEECccccCccccccccc-----ccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHH
Confidence 999999999999 57788999999998765432110 0011122346799999999888999999999999999
Q ss_pred HHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 013092 177 YFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFR 246 (449)
Q Consensus 177 ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~L~ 246 (449)
+|++ |..||..... ......+.. .... .....+|.++.+++.+||..+|++||++.+|.+.|+
T Consensus 188 e~~~~~~~p~~~~~~---~~~~~~~~~-~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 188 EAFSLGAVPYANLSN---QQTREAIEQ-GVRL---PCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred HHHhCCCCCccccCH---HHHHHHHHc-CCCC---CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 9997 9999976433 222222221 1111 233467899999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=280.44 Aligned_cols=224 Identities=18% Similarity=0.196 Sum_probs=180.6
Q ss_pred EEeeecccCCC---hhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHc--------------
Q 013092 7 VFSVQENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFC-------------- 68 (449)
Q Consensus 7 V~~k~~~~~~~---~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~-------------- 68 (449)
|++|....... ...+..|+.++..+ .||||+++++++.+....++++||+ +++|.+++...
T Consensus 38 vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~ 116 (283)
T cd05091 38 VAIKTLKDKAEGPLREEFKHEAMMRSRL-QHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKT 116 (283)
T ss_pred EEEEEccCCCCHHHHHHHHHHHHHHhcC-CCCCcCeEEEEEcCCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccc
Confidence 44444433322 34588999999999 8999999999999999999999999 89999998521
Q ss_pred -CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCcc
Q 013092 69 -SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTG 147 (449)
Q Consensus 69 -~~~ls~~~~~~i~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~g 147 (449)
...+++..++.++.|++.||+|||++||+||||||.|||+ +.++.+||+|||+++....... ........+
T Consensus 117 ~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~~ 188 (283)
T cd05091 117 VKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLV---FDKLNVKISDLGLFREVYAADY-----YKLMGNSLL 188 (283)
T ss_pred cccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEe---cCCCceEecccccccccccchh-----eeeccCccC
Confidence 2347888999999999999999999999999999999999 5778899999999886543221 111233456
Q ss_pred CccccchhhhhCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHH
Q 013092 148 TARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHY 226 (449)
Q Consensus 148 T~~Y~aPE~~~~~~~s~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~ 226 (449)
++.|+|||++.+..++.++|||||||++|||++ |..||.+.. ..+.+..+...... .....+|.++.+++..
T Consensus 189 ~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~---~~~~~~~i~~~~~~----~~~~~~~~~~~~li~~ 261 (283)
T cd05091 189 PIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS---NQDVIEMIRNRQVL----PCPDDCPAWVYTLMLE 261 (283)
T ss_pred CccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCC---HHHHHHHHHcCCcC----CCCCCCCHHHHHHHHH
Confidence 789999999998889999999999999999998 889997743 33444444443322 2346789999999999
Q ss_pred HhcCCCCCCCCHHHHHHHHH
Q 013092 227 CRSLRFDDKPDYAYLKRIFR 246 (449)
Q Consensus 227 cl~~~p~~RPt~~~l~~~L~ 246 (449)
||+.+|++||++.+|...|+
T Consensus 262 cl~~~p~~RP~~~~i~~~l~ 281 (283)
T cd05091 262 CWNEFPSRRPRFKDIHSRLR 281 (283)
T ss_pred HhCCCcccCCCHHHHHHHhh
Confidence 99999999999999988875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=295.23 Aligned_cols=243 Identities=19% Similarity=0.235 Sum_probs=182.6
Q ss_pred EEEEEeeeccc-CCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHH
Q 013092 4 ILTVFSVQENV-KTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLA 81 (449)
Q Consensus 4 aikV~~k~~~~-~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~ 81 (449)
|+|++.+.... ......+.+|+++++.+ +|+||+++++.+.+++..||||||| +++|.+++.. .+.+++..+..++
T Consensus 30 avK~~~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~-~~~~~~~~~~~~~ 107 (376)
T cd05598 30 AMKTLRKADVLMRNQAAHVKAERDILAEA-DNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIR-LGIFEEDLARFYI 107 (376)
T ss_pred EEEEEcHHHHHhhhhHHHHHHHHHHHHhC-CCCCcceEEEEEEcCCEEEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHH
Confidence 45555443322 23455688999999999 9999999999999999999999999 9999999975 4568999999999
Q ss_pred HHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCc--------------------------
Q 013092 82 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ-------------------------- 135 (449)
Q Consensus 82 ~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~-------------------------- 135 (449)
.||+.||+|||++||+||||||+|||+ +.++.+||+|||++..+.......
T Consensus 108 ~qi~~al~~lH~~~ivHrDlkp~Nill---~~~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 184 (376)
T cd05598 108 AELTCAIESVHKMGFIHRDIKPDNILI---DRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCR 184 (376)
T ss_pred HHHHHHHHHHHHCCeEeCCCCHHHEEE---CCCCCEEEEeCCCCcccccccccccccccccccccccccccccccccccc
Confidence 999999999999999999999999999 578899999999986432100000
Q ss_pred ----------ccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcc
Q 013092 136 ----------HIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 205 (449)
Q Consensus 136 ----------~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~ 205 (449)
...........||+.|+|||++.+..++.++|||||||++|||++|+.||.+... .+.+..+.....
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~---~~~~~~i~~~~~ 261 (376)
T cd05598 185 LKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLADTP---AETQLKVINWET 261 (376)
T ss_pred ccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhhCCCCCCCCCH---HHHHHHHhccCc
Confidence 0000011245799999999999999999999999999999999999999987433 222333332211
Q ss_pred cchHHHhhcCCcHHHHHHHHHHhcCCCCCCC---CHHHHHHHHHHHHHHcCCCCCCcccchhhh
Q 013092 206 STSIEALCRGYPTEFASYFHYCRSLRFDDKP---DYAYLKRIFRDLFIREGFQFDYVFDWTILK 266 (449)
Q Consensus 206 ~~~~~~l~~~~p~el~~li~~cl~~~p~~RP---t~~~l~~~L~~~~~~~~~~~~~~~dw~~~~ 266 (449)
.... .....+++++.++|..|+ .+|.+|+ ++.+++. .++...++|....
T Consensus 262 ~~~~-~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~----------h~~~~~~~~~~~~ 313 (376)
T cd05598 262 TLHI-PSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKA----------HPFFKGIDFASLI 313 (376)
T ss_pred cccC-CCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhC----------CCCcCCCCHHHHh
Confidence 1111 112357889999999987 4999999 6666642 3555566776654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=295.69 Aligned_cols=225 Identities=20% Similarity=0.252 Sum_probs=176.1
Q ss_pred cEEEEEeeecccC-CChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHH
Q 013092 3 EILTVFSVQENVK-TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLML 80 (449)
Q Consensus 3 ~aikV~~k~~~~~-~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i 80 (449)
.|+|++.+..... .....+..|+.+++.+ +||||+++++.+.++...||||||| |++|.+++.. ..+++..+..+
T Consensus 71 ~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~-~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~--~~~~~~~~~~~ 147 (370)
T cd05621 71 YAMKLLSKFEMIKRSDSAFFWEERDIMAFA-NSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSN--YDVPEKWAKFY 147 (370)
T ss_pred EEEEEEEHHHhhhhhhHHHHHHHHHHHHhC-CCCCEeeEEEEEEcCCEEEEEEcCCCCCcHHHHHHh--cCCCHHHHHHH
Confidence 4566665544333 2344577899999998 9999999999999999999999999 9999999974 46899999999
Q ss_pred HHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCC
Q 013092 81 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI 160 (449)
Q Consensus 81 ~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~ 160 (449)
+.||+.||+|||++||+||||||+|||+ +..+.+||+|||+++....... .......||+.|+|||++.+.
T Consensus 148 ~~qil~aL~~LH~~~IvHrDLKp~NILl---~~~~~~kL~DFG~a~~~~~~~~------~~~~~~~gt~~Y~aPE~~~~~ 218 (370)
T cd05621 148 TAEVVLALDAIHSMGLIHRDVKPDNMLL---DKHGHLKLADFGTCMKMDETGM------VRCDTAVGTPDYISPEVLKSQ 218 (370)
T ss_pred HHHHHHHHHHHHHCCeEecCCCHHHEEE---CCCCCEEEEecccceecccCCc------eecccCCCCcccCCHHHHhcc
Confidence 9999999999999999999999999999 6789999999999987643221 112356799999999999864
Q ss_pred C----CChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCC--C
Q 013092 161 E----QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFD--D 234 (449)
Q Consensus 161 ~----~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~--~ 234 (449)
. ++.++|||||||++|+|++|..||.+. .....+.++........++. ...++..+.+++..|+..++. .
T Consensus 219 ~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~---~~~~~~~~i~~~~~~~~~p~-~~~~s~~~~~li~~~L~~~~~r~~ 294 (370)
T cd05621 219 GGDGYYGRECDWWSVGVFLFEMLVGDTPFYAD---SLVGTYSKIMDHKNSLNFPE-DVEISKHAKNLICAFLTDREVRLG 294 (370)
T ss_pred CCCCCCCcccCEEeehHHHHHHHhCCCCCCCC---CHHHHHHHHHhCCcccCCCC-cccCCHHHHHHHHHHccCchhccC
Confidence 3 788999999999999999999999764 33445555554332211111 124688999999999985443 3
Q ss_pred CCCHHHHHH
Q 013092 235 KPDYAYLKR 243 (449)
Q Consensus 235 RPt~~~l~~ 243 (449)
|+++.++++
T Consensus 295 R~~~~e~l~ 303 (370)
T cd05621 295 RNGVEEIKQ 303 (370)
T ss_pred CCCHHHHhc
Confidence 778766643
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=320.28 Aligned_cols=237 Identities=22% Similarity=0.291 Sum_probs=199.3
Q ss_pred EEEEEeeecccC-CChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHH
Q 013092 4 ILTVFSVQENVK-TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLA 81 (449)
Q Consensus 4 aikV~~k~~~~~-~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~ 81 (449)
|+|++.|-+..+ .....|..|.+||-.- +.+.|+++++.|++.+++||||||+ ||+|..++.+.. +++++-+.+|+
T Consensus 104 AMK~lnK~eMlKr~~tA~F~EERDimv~~-ns~Wiv~LhyAFQD~~~LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~ 181 (1317)
T KOG0612|consen 104 AMKILNKWEMLKRAETACFREERDIMVFG-NSEWIVQLHYAFQDERYLYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYT 181 (1317)
T ss_pred hHHHhhHHHHhhchhHHHHHHHhHHHHcC-CcHHHHHHHHHhcCccceEEEEecccCchHHHHHhhcC-CChHHHHHHHH
Confidence 456666655553 4455677888888776 8999999999999999999999999 999999998766 89999999999
Q ss_pred HHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhC--
Q 013092 82 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG-- 159 (449)
Q Consensus 82 ~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~-- 159 (449)
..|+.||..||+.|+|||||||+|||| +..|+|||+|||.+-++..+++- .....+|||.|.+||++..
T Consensus 182 aEiVlAldslH~mgyVHRDiKPDNvLl---d~~GHikLADFGsClkm~~dG~V------~s~~aVGTPDYISPEvLqs~~ 252 (1317)
T KOG0612|consen 182 AEIVLALDSLHSMGYVHRDIKPDNVLL---DKSGHIKLADFGSCLKMDADGTV------RSSVAVGTPDYISPEVLQSQG 252 (1317)
T ss_pred HHHHHHHHHHHhccceeccCCcceeEe---cccCcEeeccchhHHhcCCCCcE------EeccccCCCCccCHHHHHhhc
Confidence 999999999999999999999999999 79999999999999988865542 2356789999999999973
Q ss_pred ---CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCC
Q 013092 160 ---IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKP 236 (449)
Q Consensus 160 ---~~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RP 236 (449)
+.|++.+|+||+||++|||+.|..||.. ......|.+|...+-...++.. -.++++..+||...+. +|+.|.
T Consensus 253 ~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa---dslveTY~KIm~hk~~l~FP~~-~~VSeeakdLI~~ll~-~~e~RL 327 (1317)
T KOG0612|consen 253 DGKGEYGRECDWWSLGVFMYEMLYGETPFYA---DSLVETYGKIMNHKESLSFPDE-TDVSEEAKDLIEALLC-DREVRL 327 (1317)
T ss_pred CCccccCCccchhhhHHHHHHHHcCCCcchH---HHHHHHHHHHhchhhhcCCCcc-cccCHHHHHHHHHHhc-Chhhhc
Confidence 5689999999999999999999999976 5678889999887554444422 2389999999999886 578887
Q ss_pred C---HHHHHHHHHHHHHHcCCCCCCcccchhhh
Q 013092 237 D---YAYLKRIFRDLFIREGFQFDYVFDWTILK 266 (449)
Q Consensus 237 t---~~~l~~~L~~~~~~~~~~~~~~~dw~~~~ 266 (449)
. +++++ .++|+...||...+
T Consensus 328 grngiedik----------~HpFF~g~~W~~iR 350 (1317)
T KOG0612|consen 328 GRNGIEDIK----------NHPFFEGIDWDNIR 350 (1317)
T ss_pred ccccHHHHH----------hCccccCCChhhhh
Confidence 6 55553 46889999996554
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=274.41 Aligned_cols=212 Identities=17% Similarity=0.233 Sum_probs=175.3
Q ss_pred ChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 013092 17 KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 95 (449)
Q Consensus 17 ~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~g 95 (449)
...++..|+.+++.+ +||||+++++++.+.+..|+||||+ +++|.+++......+++..++.++.|++.||+|||++|
T Consensus 42 ~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 120 (256)
T cd05114 42 SEEDFIEEAKVMMKL-SHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS 120 (256)
T ss_pred cHHHHHHHHHHHHHC-CCCCceeEEEEEccCCCEEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 346789999999999 8999999999999999999999999 99999999754456899999999999999999999999
Q ss_pred ceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHHH
Q 013092 96 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVL 175 (449)
Q Consensus 96 ivHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il 175 (449)
|+||||||+||++ +.++.+||+|||+++....... .......++..|+|||++.+..++.++||||||+++
T Consensus 121 i~H~dl~p~ni~i---~~~~~~kl~d~g~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l 191 (256)
T cd05114 121 FIHRDLAARNCLV---SSTGVVKVSDFGMTRYVLDDEY------TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLM 191 (256)
T ss_pred ccccccCcceEEE---cCCCeEEECCCCCccccCCCce------eccCCCCCchhhCChhhcccCccchhhhhHHHHHHH
Confidence 9999999999999 5778999999999876543221 111233456789999999988899999999999999
Q ss_pred HHHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Q 013092 176 MYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIF 245 (449)
Q Consensus 176 ~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~L 245 (449)
|+|++ |+.||...+ ..+.+..+...... ..+...+.++.+++..||..+|++||++.+|...|
T Consensus 192 ~el~~~g~~p~~~~~---~~~~~~~i~~~~~~----~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 192 WEVFTEGKMPFEKKS---NYEVVEMISRGFRL----YRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred HHHHcCCCCCCCCCC---HHHHHHHHHCCCCC----CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 99999 999997643 23344444432211 11234678999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=282.82 Aligned_cols=218 Identities=19% Similarity=0.209 Sum_probs=176.0
Q ss_pred CCChhHHHHHHHHHHHhcCCCCCceEEEEeEe-----CCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHH
Q 013092 15 KTKHPQLLYESKLYRILQGGTGIPNVRWFGVE-----GDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVE 89 (449)
Q Consensus 15 ~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~-----~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~ 89 (449)
...-+.-.+|+++|+.+ +|+||+.+++.+.. -+..|+|+|+|+.+|.++++. +..++.+.+..+++|+++||.
T Consensus 62 ~~~akRtlRElklLr~~-~HeNIi~l~di~~p~~~~~f~DvYiV~elMetDL~~iik~-~~~L~d~H~q~f~YQiLrgLK 139 (359)
T KOG0660|consen 62 QIDAKRTLRELKLLRHL-RHENIIGLLDIFRPPSRDKFNDVYLVFELMETDLHQIIKS-QQDLTDDHAQYFLYQILRGLK 139 (359)
T ss_pred hHHHHHHHHHHHHHHHh-cCCCcceEEeecccccccccceeEEehhHHhhHHHHHHHc-CccccHHHHHHHHHHHHHhcc
Confidence 34455678999999999 69999999998764 456899999999999999994 445999999999999999999
Q ss_pred HHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhC-CCCChhhHH
Q 013092 90 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDL 168 (449)
Q Consensus 90 yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~-~~~s~~~Di 168 (449)
|+|+.+++||||||.|+|+ +.++.+||||||||+..... .+ -...+.++-|.+|.|||.+.. .+|+...||
T Consensus 140 yiHSAnViHRDLKPsNll~---n~~c~lKI~DFGLAR~~~~~-~~----~~~mTeYVaTRWYRAPElll~~~~Yt~aiDi 211 (359)
T KOG0660|consen 140 YIHSANVIHRDLKPSNLLL---NADCDLKICDFGLARYLDKF-FE----DGFMTEYVATRWYRAPELLLNSSEYTKAIDI 211 (359)
T ss_pred hhhcccccccccchhheee---ccCCCEEeccccceeecccc-Cc----ccchhcceeeeeecCHHHHhccccccchhhh
Confidence 9999999999999999999 68888999999999987543 11 112356788999999999875 679999999
Q ss_pred HHHHHHHHHHHhCCCCCCCCCcCCHHH------------HHHHHHh-----------hcccchHHHhhcCCcHHHHHHHH
Q 013092 169 ESLGYVLMYFLRGSLPWQGLKAGTKKQ------------KYEKISE-----------KKVSTSIEALCRGYPTEFASYFH 225 (449)
Q Consensus 169 wSlG~il~elltG~~Pf~~~~~~~~~~------------~~~~i~~-----------~~~~~~~~~l~~~~p~el~~li~ 225 (449)
||+||||.||++|++-|.|.+.-+..+ .+..|.. .....++..+.++..++..+|++
T Consensus 212 WSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLle 291 (359)
T KOG0660|consen 212 WSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLE 291 (359)
T ss_pred hhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHH
Confidence 999999999999999999854322211 1111211 11223445566778899999999
Q ss_pred HHhcCCCCCCCCHHHHH
Q 013092 226 YCRSLRFDDKPDYAYLK 242 (449)
Q Consensus 226 ~cl~~~p~~RPt~~~l~ 242 (449)
+||..||.+|+|+++.+
T Consensus 292 kmL~fdP~kRita~eAL 308 (359)
T KOG0660|consen 292 KMLVFDPKKRITAEEAL 308 (359)
T ss_pred HHhccCccccCCHHHHh
Confidence 99999999999977653
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=281.28 Aligned_cols=213 Identities=17% Similarity=0.268 Sum_probs=173.6
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcC---------CCCCHHHHHHHHHHHHHH
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCS---------RKLSLKTVLMLADQMINR 87 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~---------~~ls~~~~~~i~~qi~~a 87 (449)
..++.+|+.+++.+ +|+||+++++++.++...++||||+ +++|.+++.... ..+++..++.++.|++.|
T Consensus 53 ~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 131 (277)
T cd05062 53 RIEFLNEASVMKEF-NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADG 131 (277)
T ss_pred HHHHHHHHHHHHhC-CCCCeeeEEEEEcCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHH
Confidence 34588999999999 8999999999999999999999999 999999987432 135788899999999999
Q ss_pred HHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhH
Q 013092 88 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDD 167 (449)
Q Consensus 88 L~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~D 167 (449)
|+|||+.|++|+||||+||++ +.++.++|+|||+++........ .......++..|+|||++.+..++.++|
T Consensus 132 l~~lH~~~~vH~dlkp~Nil~---~~~~~~~l~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~D 203 (277)
T cd05062 132 MAYLNANKFVHRDLAARNCMV---AEDFTVKIGDFGMTRDIYETDYY-----RKGGKGLLPVRWMSPESLKDGVFTTYSD 203 (277)
T ss_pred HHHHHHCCcccCCcchheEEE---cCCCCEEECCCCCccccCCccee-----ecCCCCccCHhhcChhHhhcCCcCchhH
Confidence 999999999999999999999 57889999999998765433221 1112335678899999999988999999
Q ss_pred HHHHHHHHHHHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 013092 168 LESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFR 246 (449)
Q Consensus 168 iwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~L~ 246 (449)
||||||++|||++ |..||.+... .+.+..+.+... ..+...++.++.+++.+||+.+|++||++.++.+.|+
T Consensus 204 i~slG~~l~el~~~~~~p~~~~~~---~~~~~~~~~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 204 VWSFGVVLWEIATLAEQPYQGMSN---EQVLRFVMEGGL----LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred HHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHHcCCc----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 9999999999998 7899977533 233333333222 2234568899999999999999999999999987764
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=297.34 Aligned_cols=210 Identities=21% Similarity=0.293 Sum_probs=171.3
Q ss_pred HHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q 013092 20 QLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHR 99 (449)
Q Consensus 20 ~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~givHR 99 (449)
-|..|+.+|.+|++|.+|+.|+++...++++||||||=..+|..++++....++...+..+..||+.|+.++|+.||||.
T Consensus 405 gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~Gd~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHS 484 (677)
T KOG0596|consen 405 GYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMECGDIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHS 484 (677)
T ss_pred HHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeecccccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeec
Confidence 48999999999999999999999999999999999988999999999765556655889999999999999999999999
Q ss_pred CCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCC-----------CChhhHH
Q 013092 100 DIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIE-----------QSRRDDL 168 (449)
Q Consensus 100 DLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~-----------~s~~~Di 168 (449)
||||.|||| -.|.+||+|||+|..+....+.. .....+||+.||+||.+.... .++++||
T Consensus 485 DLKPANFLl----VkG~LKLIDFGIA~aI~~DTTsI-----~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDv 555 (677)
T KOG0596|consen 485 DLKPANFLL----VKGRLKLIDFGIANAIQPDTTSI-----VKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDV 555 (677)
T ss_pred CCCcccEEE----EeeeEEeeeechhcccCccccce-----eeccccCcccccCHHHHhhccccccCCCcceeecCccch
Confidence 999999999 57899999999999887665432 134678999999999987432 4678999
Q ss_pred HHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 013092 169 ESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 242 (449)
Q Consensus 169 wSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~ 242 (449)
||||||||+|+.|+.||.... +...++..|.+-.....++.+... .++.++|+.||..||++||+..+|+
T Consensus 556 WSLGCILYqMvYgktPf~~~~--n~~aKl~aI~~P~~~Iefp~~~~~--~~li~~mK~CL~rdPkkR~si~eLL 625 (677)
T KOG0596|consen 556 WSLGCILYQMVYGKTPFGQII--NQIAKLHAITDPNHEIEFPDIPEN--DELIDVMKCCLARDPKKRWSIPELL 625 (677)
T ss_pred hhhhhHHHHHHhcCCchHHHH--HHHHHHHhhcCCCccccccCCCCc--hHHHHHHHHHHhcCcccCCCcHHHh
Confidence 999999999999999997642 223344444332222222233222 3499999999999999999977764
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=295.76 Aligned_cols=248 Identities=17% Similarity=0.243 Sum_probs=187.1
Q ss_pred cEEEEEeeeccc-CCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHH
Q 013092 3 EILTVFSVQENV-KTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLML 80 (449)
Q Consensus 3 ~aikV~~k~~~~-~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i 80 (449)
.|||++.+.... ......+..|+.++..+ +|++|+++++.+.+.+..||||||| |++|.+++.. ...+++..+..+
T Consensus 29 ~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~-~~~l~~~~~~~~ 106 (360)
T cd05627 29 YAMKILRKADMLEKEQVAHIRAERDILVEA-DGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMK-KDTLSEEATQFY 106 (360)
T ss_pred EEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-CCCCEeeEEEEEEcCCEEEEEEeCCCCccHHHHHHh-cCCCCHHHHHHH
Confidence 355655543322 33456688899999999 8999999999999999999999999 9999999875 457999999999
Q ss_pred HHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcc------------------------
Q 013092 81 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQH------------------------ 136 (449)
Q Consensus 81 ~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~------------------------ 136 (449)
+.|++.||+|||++||+||||||+|||| +..+.++|+|||+++.+........
T Consensus 107 ~~qi~~~L~~lH~~givHrDLkp~NIli---~~~~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 183 (360)
T cd05627 107 IAETVLAIDAIHQLGFIHRDIKPDNLLL---DAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAE 183 (360)
T ss_pred HHHHHHHHHHHHHCCeEccCCCHHHEEE---CCCCCEEEeeccCCcccccccccccccccccCCcccccccccccccccc
Confidence 9999999999999999999999999999 5789999999999875532110000
Q ss_pred ----cccccCCCCccCccccchhhhhCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHh
Q 013092 137 ----IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 212 (449)
Q Consensus 137 ----~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 212 (449)
.........+||+.|+|||++.+..++.++|||||||++|||++|..||.+.. ....+.++........++.
T Consensus 184 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~~---~~~~~~~i~~~~~~~~~p~- 259 (360)
T cd05627 184 TWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSET---PQETYRKVMNWKETLVFPP- 259 (360)
T ss_pred cccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCCCC---HHHHHHHHHcCCCceecCC-
Confidence 00001124579999999999999999999999999999999999999998743 3344444443221111111
Q ss_pred hcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCCcccchhhhh
Q 013092 213 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKY 267 (449)
Q Consensus 213 ~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~L~~~~~~~~~~~~~~~dw~~~~~ 267 (449)
...+++++.++|..|+ .+|.+|++...+.++ ..+++...++|.....
T Consensus 260 ~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei-------~~hp~f~~~~~~~~~~ 306 (360)
T cd05627 260 EVPISEKAKDLILRFC-TDSENRIGSNGVEEI-------KSHPFFEGVDWGHIRE 306 (360)
T ss_pred CCCCCHHHHHHHHHhc-cChhhcCCCCCHHHH-------hcCCCCCCCCHHHHhc
Confidence 1136789999999877 499999864323222 2356777889987643
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=281.67 Aligned_cols=218 Identities=15% Similarity=0.280 Sum_probs=178.2
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcC-----------------------CCCC
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCS-----------------------RKLS 73 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~-----------------------~~ls 73 (449)
..++..|+.++..+ .||||+++++.+...+..|+||||+ +++|.+++.... ..++
T Consensus 47 ~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 125 (290)
T cd05045 47 LRDLLSEFNLLKQV-NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALT 125 (290)
T ss_pred HHHHHHHHHHHhhC-CCCCEeeEEEEEecCCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccC
Confidence 35688999999999 8999999999999999999999999 899999986421 2478
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccc
Q 013092 74 LKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYAS 153 (449)
Q Consensus 74 ~~~~~~i~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~a 153 (449)
+..++.++.|++.||+|||+.||+||||||+|||+ +.++.++|+|||+++........ .......++..|++
T Consensus 126 ~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nill---~~~~~~kl~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~a 197 (290)
T cd05045 126 MGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLV---AEGRKMKISDFGLSRDVYEEDSY-----VKRSKGRIPVKWMA 197 (290)
T ss_pred HHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEEE---cCCCcEEeccccccccccCccch-----hcccCCCCCccccC
Confidence 89999999999999999999999999999999999 57789999999999865433221 11123345678999
Q ss_pred hhhhhCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCC
Q 013092 154 MNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRF 232 (449)
Q Consensus 154 PE~~~~~~~s~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p 232 (449)
||++.+..++.++|||||||++|+|++ |..||.+... .+.+..+... ... .....++.++.+++..||+.+|
T Consensus 198 pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~~~~~~-~~~---~~~~~~~~~~~~~i~~cl~~~P 270 (290)
T cd05045 198 IESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP---ERLFNLLKTG-YRM---ERPENCSEEMYNLMLTCWKQEP 270 (290)
T ss_pred HHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH---HHHHHHHhCC-CCC---CCCCCCCHHHHHHHHHHccCCc
Confidence 999998889999999999999999998 9999976433 2222222221 111 1235678999999999999999
Q ss_pred CCCCCHHHHHHHHHHHHHH
Q 013092 233 DDKPDYAYLKRIFRDLFIR 251 (449)
Q Consensus 233 ~~RPt~~~l~~~L~~~~~~ 251 (449)
++||++.+|.+.|++++.+
T Consensus 271 ~~Rp~~~~i~~~l~~~~~~ 289 (290)
T cd05045 271 DKRPTFADISKELEKMMVK 289 (290)
T ss_pred ccCCCHHHHHHHHHHHHhc
Confidence 9999999999999998753
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=282.57 Aligned_cols=220 Identities=15% Similarity=0.257 Sum_probs=181.4
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcC---------------CCCCHHHHHHHH
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCS---------------RKLSLKTVLMLA 81 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~---------------~~ls~~~~~~i~ 81 (449)
...+.+|+.+++.+.+|+||+++++++......|+||||+ +++|.+++.... ..+++..++.++
T Consensus 64 ~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 143 (304)
T cd05101 64 LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCT 143 (304)
T ss_pred HHHHHHHHHHHHhhccCCCchheeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHH
Confidence 4568899999999988999999999999999999999999 899999997531 247888999999
Q ss_pred HHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCC
Q 013092 82 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIE 161 (449)
Q Consensus 82 ~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~ 161 (449)
.||+.||.|||++||+||||||+||++ +.++.+||+|||+++.+...... .......++..|+|||++.+..
T Consensus 144 ~qi~~al~~LH~~givH~dlkp~Nili---~~~~~~kl~D~g~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~ 215 (304)
T cd05101 144 YQVARGMEYLASQKCIHRDLAARNVLV---TENNVMKIADFGLARDVNNIDYY-----KKTTNGRLPVKWMAPEALFDRV 215 (304)
T ss_pred HHHHHHHHHHHHCCeeecccccceEEE---cCCCcEEECCCccceeccccccc-----ccccCCCCCceeeCchhhccCC
Confidence 999999999999999999999999999 57789999999999876543221 1112334667899999999888
Q ss_pred CChhhHHHHHHHHHHHHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHH
Q 013092 162 QSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAY 240 (449)
Q Consensus 162 ~s~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~ 240 (449)
++.++||||||+++|+|++ |..||.+.. ..+.+..+...... .....++.++.+++.+||..+|++||++.+
T Consensus 216 ~~~~~Di~slG~~l~el~~~g~~p~~~~~---~~~~~~~~~~~~~~----~~~~~~~~~~~~li~~cl~~~p~~Rps~~e 288 (304)
T cd05101 216 YTHQSDVWSFGVLMWEIFTLGGSPYPGIP---VEELFKLLKEGHRM----DKPANCTNELYMMMRDCWHAIPSHRPTFKQ 288 (304)
T ss_pred CCchhhHHHHHHHHHHHHcCCCCCcccCC---HHHHHHHHHcCCcC----CCCCCCCHHHHHHHHHHcccChhhCCCHHH
Confidence 9999999999999999998 889997643 33444444332211 123568899999999999999999999999
Q ss_pred HHHHHHHHHHHc
Q 013092 241 LKRIFRDLFIRE 252 (449)
Q Consensus 241 l~~~L~~~~~~~ 252 (449)
|.+.|++++.-.
T Consensus 289 ~l~~l~~~~~~~ 300 (304)
T cd05101 289 LVEDLDRILTLT 300 (304)
T ss_pred HHHHHHHHHHhh
Confidence 999999887643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=286.21 Aligned_cols=216 Identities=18% Similarity=0.246 Sum_probs=175.7
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 96 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gi 96 (449)
...+..|+.+++.+ +||||+++++++... ..++|+||+ +++|.+++......+++..++.++.||+.||+|||++||
T Consensus 53 ~~~~~~e~~~l~~l-~h~niv~~~g~~~~~-~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i 130 (316)
T cd05108 53 NKEILDEAYVMASV-DNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRL 130 (316)
T ss_pred HHHHHHHHHHHHhC-CCCCCCeEEEEEcCC-CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCe
Confidence 45688999999999 999999999998765 467999999 999999998655568999999999999999999999999
Q ss_pred eecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHHHH
Q 013092 97 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLM 176 (449)
Q Consensus 97 vHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il~ 176 (449)
+||||||+|||+ +.++.+||+|||+++.+....... ......++..|++||++.+..++.++|||||||++|
T Consensus 131 iH~dlkp~Nill---~~~~~~kl~DfG~a~~~~~~~~~~-----~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~ 202 (316)
T cd05108 131 VHRDLAARNVLV---KTPQHVKITDFGLAKLLGADEKEY-----HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVW 202 (316)
T ss_pred eccccchhheEe---cCCCcEEEccccccccccCCCcce-----eccCCccceeecChHHhccCCCCchhhhHHHHHHHH
Confidence 999999999999 577899999999998765432211 112234567899999999999999999999999999
Q ss_pred HHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 013092 177 YFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFI 250 (449)
Q Consensus 177 ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~L~~~~~ 250 (449)
||++ |..||.+.... + +..+....... .....++.++.+++..||..+|++||++.+|...|.++..
T Consensus 203 el~t~g~~p~~~~~~~---~-~~~~~~~~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~ 270 (316)
T cd05108 203 ELMTFGSKPYDGIPAS---E-ISSILEKGERL---PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 270 (316)
T ss_pred HHHcCCCCCCCCCCHH---H-HHHHHhCCCCC---CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence 9997 99999764332 2 22222222111 1234578899999999999999999999999998887753
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=291.46 Aligned_cols=206 Identities=20% Similarity=0.268 Sum_probs=164.9
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 96 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gi 96 (449)
...+.+|+++++.+ +|+||+++++++.+.+..|+||||+ +++|.+. ..+.+..+..++.||+.||+|||++||
T Consensus 116 ~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~i 189 (353)
T PLN00034 116 RRQICREIEILRDV-NHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGT-----HIADEQFLADVARQILSGIAYLHRRHI 189 (353)
T ss_pred HHHHHHHHHHHHhC-CCCCcceeeeEeccCCeEEEEEecCCCCccccc-----ccCCHHHHHHHHHHHHHHHHHHHHCCE
Confidence 35688999999999 8999999999999999999999999 8888643 235677888999999999999999999
Q ss_pred eecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhC-----CCCChhhHHHHH
Q 013092 97 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG-----IEQSRRDDLESL 171 (449)
Q Consensus 97 vHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~-----~~~s~~~DiwSl 171 (449)
+||||||+|||+ +.++.+||+|||+++.+..... ......||..|+|||++.. ...+.++|||||
T Consensus 190 vHrDlkp~NIll---~~~~~~kL~DfG~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~Dvwsl 259 (353)
T PLN00034 190 VHRDIKPSNLLI---NSAKNVKIADFGVSRILAQTMD-------PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSL 259 (353)
T ss_pred eecCCCHHHEEE---cCCCCEEEcccccceecccccc-------cccccccCccccCccccccccccCcCCCcchhHHHH
Confidence 999999999999 5788999999999987643221 1234579999999998743 234568999999
Q ss_pred HHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 172 GYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 172 G~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
||++|||++|+.||......+.......+.... .......++.++.+||..||+.+|++||++.+|++
T Consensus 260 Gvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~ 327 (353)
T PLN00034 260 GVSILEFYLGRFPFGVGRQGDWASLMCAICMSQ----PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQ 327 (353)
T ss_pred HHHHHHHHhCCCCCCCCCCccHHHHHHHHhccC----CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 999999999999998543333322222222111 11234567899999999999999999999888754
|
|
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=283.41 Aligned_cols=220 Identities=17% Similarity=0.268 Sum_probs=179.7
Q ss_pred hHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcC---------------CCCCHHHHHHHHH
Q 013092 19 PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCS---------------RKLSLKTVLMLAD 82 (449)
Q Consensus 19 ~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~---------------~~ls~~~~~~i~~ 82 (449)
..+..|+.+++.+.+|+||+++++++...+..|+||||+ +++|.+++.... ..+++.+++.++.
T Consensus 68 ~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 147 (307)
T cd05098 68 SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAY 147 (307)
T ss_pred HHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHH
Confidence 458889999999988999999999999999999999999 899999997531 2488999999999
Q ss_pred HHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCC
Q 013092 83 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQ 162 (449)
Q Consensus 83 qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~ 162 (449)
|++.||+|||++|++||||||+||++ +.++.++|+|||+++........ .......++..|+|||++.+..+
T Consensus 148 qi~~aL~~lH~~gi~H~dlkp~Nill---~~~~~~kL~dfg~a~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~ 219 (307)
T cd05098 148 QVARGMEYLASKKCIHRDLAARNVLV---TEDNVMKIADFGLARDIHHIDYY-----KKTTNGRLPVKWMAPEALFDRIY 219 (307)
T ss_pred HHHHHHHHHHHCCcccccccHHheEE---cCCCcEEECCCcccccccccchh-----hccccCCCccceeChHHhccCCC
Confidence 99999999999999999999999999 57789999999998765432111 01112234578999999999889
Q ss_pred ChhhHHHHHHHHHHHHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHH
Q 013092 163 SRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYL 241 (449)
Q Consensus 163 s~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l 241 (449)
+.++|||||||++|+|++ |..||.+.. ..+....+..... ...+..++.++.+++..||..+|++||++.++
T Consensus 220 ~~~~DvwslG~~l~el~~~g~~p~~~~~---~~~~~~~~~~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ev 292 (307)
T cd05098 220 THQSDVWSFGVLLWEIFTLGGSPYPGVP---VEELFKLLKEGHR----MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQL 292 (307)
T ss_pred CcHHHHHHHHHHHHHHHcCCCCCCCcCC---HHHHHHHHHcCCC----CCCCCcCCHHHHHHHHHHcccChhhCcCHHHH
Confidence 999999999999999998 899997633 2333333332221 12345678999999999999999999999999
Q ss_pred HHHHHHHHHHcC
Q 013092 242 KRIFRDLFIREG 253 (449)
Q Consensus 242 ~~~L~~~~~~~~ 253 (449)
.+.|.+++....
T Consensus 293 l~~l~~~~~~~~ 304 (307)
T cd05098 293 VEDLDRILALTS 304 (307)
T ss_pred HHHHHHHHHHhh
Confidence 999999877543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=293.17 Aligned_cols=222 Identities=20% Similarity=0.268 Sum_probs=174.3
Q ss_pred EEEEEeeecccCC-ChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHH
Q 013092 4 ILTVFSVQENVKT-KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLA 81 (449)
Q Consensus 4 aikV~~k~~~~~~-~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~ 81 (449)
|+|++.+.+.... ....+.+|+.+++.+ +||||+++++.+.++.+.||||||| |++|.+++.. ..++...+..++
T Consensus 72 aiK~i~~~~~~~~~~~~~~~~e~~i~~~~-~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~~~~--~~~~~~~~~~~~ 148 (371)
T cd05622 72 AMKLLSKFEMIKRSDSAFFWEERDIMAFA-NSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN--YDVPEKWARFYT 148 (371)
T ss_pred EEEEEEHHHhhhhHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHh--cCCCHHHHHHHH
Confidence 5555554333322 334577899999988 9999999999999999999999999 9999999974 468999999999
Q ss_pred HHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCC
Q 013092 82 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIE 161 (449)
Q Consensus 82 ~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~ 161 (449)
.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++....... .......||+.|+|||++.+..
T Consensus 149 ~qi~~aL~~LH~~~ivHrDLkp~NIll---~~~~~ikL~DfG~a~~~~~~~~------~~~~~~~gt~~y~aPE~l~~~~ 219 (371)
T cd05622 149 AEVVLALDAIHSMGFIHRDVKPDNMLL---DKSGHLKLADFGTCMKMNKEGM------VRCDTAVGTPDYISPEVLKSQG 219 (371)
T ss_pred HHHHHHHHHHHHCCEEeCCCCHHHEEE---CCCCCEEEEeCCceeEcCcCCc------ccccCcccCccccCHHHHhccC
Confidence 999999999999999999999999999 5788999999999987654321 1123567999999999997643
Q ss_pred ----CChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCC---
Q 013092 162 ----QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDD--- 234 (449)
Q Consensus 162 ----~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~--- 234 (449)
++.++|||||||++|||++|..||.+. +....+.++........++ ....++.++.++|..|+. ++..
T Consensus 220 ~~~~~~~~~DiwSlGvilyell~G~~Pf~~~---~~~~~~~~i~~~~~~~~~~-~~~~~s~~~~~li~~~L~-~~~~r~~ 294 (371)
T cd05622 220 GDGYYGRECDWWSVGVFLYEMLVGDTPFYAD---SLVGTYSKIMNHKNSLTFP-DDNDISKEAKNLICAFLT-DREVRLG 294 (371)
T ss_pred CCccCCCccceeehhHHHHHHHhCCCCCCCC---CHHHHHHHHHcCCCcccCC-CcCCCCHHHHHHHHHHcC-ChhhhcC
Confidence 788999999999999999999999763 3345556655433221111 123578999999999998 4554
Q ss_pred CCCHHHHH
Q 013092 235 KPDYAYLK 242 (449)
Q Consensus 235 RPt~~~l~ 242 (449)
|+++.+|+
T Consensus 295 r~~~~ei~ 302 (371)
T cd05622 295 RNGVEEIK 302 (371)
T ss_pred CCCHHHHh
Confidence 56665554
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=282.18 Aligned_cols=216 Identities=18% Similarity=0.238 Sum_probs=171.6
Q ss_pred ChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 013092 17 KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 96 (449)
Q Consensus 17 ~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gi 96 (449)
....+.+|+.+++.+ +|+||+++++++..++..|+||||+.++|.+++......+++..+..++.||+.||+|||++||
T Consensus 47 ~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i 125 (309)
T cd07872 47 APCTAIREVSLLKDL-KHANIVTLHDIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKV 125 (309)
T ss_pred cchhHHHHHHHHHhC-CCCCcceEEEEEeeCCeEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 344678999999999 8999999999999999999999999779999987666668999999999999999999999999
Q ss_pred eecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhC-CCCChhhHHHHHHHHH
Q 013092 97 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVL 175 (449)
Q Consensus 97 vHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~-~~~s~~~DiwSlG~il 175 (449)
+||||||+|||+ +..+.+||+|||+++....... ......+|+.|+|||++.+ ..++.++|||||||++
T Consensus 126 vH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il 195 (309)
T cd07872 126 LHRDLKPQNLLI---NERGELKLADFGLARAKSVPTK-------TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIF 195 (309)
T ss_pred ecCCCCHHHEEE---CCCCCEEECccccceecCCCcc-------ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHH
Confidence 999999999999 5788999999999976543221 1123467899999999875 4579999999999999
Q ss_pred HHHHhCCCCCCCCCcCCHHHHHHHHHhhcc----------------------cchHHHhhcCCcHHHHHHHHHHhcCCCC
Q 013092 176 MYFLRGSLPWQGLKAGTKKQKYEKISEKKV----------------------STSIEALCRGYPTEFASYFHYCRSLRFD 233 (449)
Q Consensus 176 ~elltG~~Pf~~~~~~~~~~~~~~i~~~~~----------------------~~~~~~l~~~~p~el~~li~~cl~~~p~ 233 (449)
|+|++|..||.+.+..+....+........ ..........++.++.++|..|+..||.
T Consensus 196 ~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~ 275 (309)
T cd07872 196 FEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESK 275 (309)
T ss_pred HHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChh
Confidence 999999999987544322222211110000 0001112245788999999999999999
Q ss_pred CCCCHHHHHH
Q 013092 234 DKPDYAYLKR 243 (449)
Q Consensus 234 ~RPt~~~l~~ 243 (449)
+||++.+++.
T Consensus 276 ~R~t~~e~l~ 285 (309)
T cd07872 276 KRISAEEAMK 285 (309)
T ss_pred hCCCHHHHhc
Confidence 9999877754
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=293.35 Aligned_cols=247 Identities=18% Similarity=0.205 Sum_probs=199.8
Q ss_pred cCCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHH
Q 013092 14 VKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFV 91 (449)
Q Consensus 14 ~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~-~~~ls~~~~~~i~~qi~~aL~yL 91 (449)
.+.....-++|..||.++ +.+.||.+-+.+++.+.+|+||.+| ||+|.-.|-+. +..|++..+++++.+|++||++|
T Consensus 225 kr~ge~maLnEk~iL~kV-~s~FiVslaYAfeTkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehl 303 (591)
T KOG0986|consen 225 KRKGETMALNEKQILEKV-SSPFIVSLAYAFETKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHL 303 (591)
T ss_pred HhhhhHHhhHHHHHHHHh-ccCcEEEEeeeecCCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHH
Confidence 334444578899999999 8899999999999999999999999 99997666443 44699999999999999999999
Q ss_pred HHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHH
Q 013092 92 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESL 171 (449)
Q Consensus 92 H~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSl 171 (449)
|+.+||+|||||+|||+ |+.|+|.|+|+|||..+...... ...+||.+|||||++.+..|+...|+|||
T Consensus 304 H~~~iVYRDLKPeNILL---Dd~GhvRISDLGLAvei~~g~~~--------~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~l 372 (591)
T KOG0986|consen 304 HRRRIVYRDLKPENILL---DDHGHVRISDLGLAVEIPEGKPI--------RGRVGTVGYMAPEVLQNEVYDFSPDWFSL 372 (591)
T ss_pred HhcceeeccCChhheee---ccCCCeEeeccceEEecCCCCcc--------ccccCcccccCHHHHcCCcccCCccHHHH
Confidence 99999999999999999 79999999999999988776543 34589999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 013092 172 GYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIR 251 (449)
Q Consensus 172 G~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~L~~~~~~ 251 (449)
||+||||+.|+.||...+.....+. +... .....+++.++++++..+|.+..|+.||.+|.....- ..-.-
T Consensus 373 GCllYemi~G~sPFr~~KeKvk~eE---vdrr-~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~-----ga~ev 443 (591)
T KOG0986|consen 373 GCLLYEMIAGHSPFRQRKEKVKREE---VDRR-TLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGE-----GAQEV 443 (591)
T ss_pred HhHHHHHHcccCchhhhhhhhhHHH---HHHH-HhcchhhcccccCHHHHHHHHHHHccCHHHhccCCCc-----Ccchh
Confidence 9999999999999987544333322 2222 2234456678899999999999999999999754210 11112
Q ss_pred cCCCCCCcccchhhhhhhccCCCCCCccCC
Q 013092 252 EGFQFDYVFDWTILKYQQSQLATPPARALV 281 (449)
Q Consensus 252 ~~~~~~~~~dw~~~~~~~~~~~~~p~~~~~ 281 (449)
..++++..++|..+......+|..|.+..+
T Consensus 444 k~HpfFk~lnw~rleagml~PPfiPdp~aV 473 (591)
T KOG0986|consen 444 KEHPFFKDLNWRRLEAGMLEPPFIPDPGAV 473 (591)
T ss_pred hhCcccccCCHhHHhccCCCCCCCCCcccc
Confidence 335778889999998877776666655444
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=293.90 Aligned_cols=215 Identities=14% Similarity=0.171 Sum_probs=168.7
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFL 97 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~giv 97 (449)
...+.+|+.+|+.| +||||+++++++......|+|||+++++|.+++.. ...+++..++.++.||+.||+|||++||+
T Consensus 127 ~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~lv~e~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~ylH~~~Iv 204 (391)
T PHA03212 127 RGGTATEAHILRAI-NHPSIIQLKGTFTYNKFTCLILPRYKTDLYCYLAA-KRNIAICDILAIERSVLRAIQYLHENRII 204 (391)
T ss_pred hhhhHHHHHHHHhC-CCCCCCCEeEEEEECCeeEEEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence 34678999999999 89999999999999999999999998899988875 45689999999999999999999999999
Q ss_pred ecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHHHHH
Q 013092 98 HRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMY 177 (449)
Q Consensus 98 HRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il~e 177 (449)
||||||+|||+ +..+.+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++||
T Consensus 205 HrDiKP~NIll---~~~~~vkL~DFG~a~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~e 275 (391)
T PHA03212 205 HRDIKAENIFI---NHPGDVCLGDFGAACFPVDINA------NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFE 275 (391)
T ss_pred cCCCChHhEEE---cCCCCEEEEeCCcccccccccc------cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHH
Confidence 99999999999 5778999999999975432211 11234679999999999999999999999999999999
Q ss_pred HHhCCCCCCCCCcCC----HHHHHHHHHhhccc------------------------------chHHHhhcCCcHHHHHH
Q 013092 178 FLRGSLPWQGLKAGT----KKQKYEKISEKKVS------------------------------TSIEALCRGYPTEFASY 223 (449)
Q Consensus 178 lltG~~Pf~~~~~~~----~~~~~~~i~~~~~~------------------------------~~~~~l~~~~p~el~~l 223 (449)
|++|..||......+ ....+..+...... .+.......+|.++.+|
T Consensus 276 lltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~L 355 (391)
T PHA03212 276 MATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYL 355 (391)
T ss_pred HHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHH
Confidence 999998876432110 01111111110000 00000112357789999
Q ss_pred HHHHhcCCCCCCCCHHHHHH
Q 013092 224 FHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 224 i~~cl~~~p~~RPt~~~l~~ 243 (449)
|.+||+.||++||++.++++
T Consensus 356 i~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 356 ICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred HHHHhcCChhhCCCHHHHhc
Confidence 99999999999999887753
|
|
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=282.81 Aligned_cols=217 Identities=21% Similarity=0.275 Sum_probs=177.0
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCC
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKS 95 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~-~~ls~~~~~~i~~qi~~aL~yLH~~g 95 (449)
.+.+..|+++++.+.+|+||+++++++...+..|+||||+ +++|.+++.... ..+++..++.++.|++.||+|||+++
T Consensus 82 ~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ 161 (302)
T cd05055 82 REALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN 161 (302)
T ss_pred HHHHHHHHHHHHhccCCCCcceEEEEEecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 3458899999999988999999999999999999999999 899999997532 23899999999999999999999999
Q ss_pred ceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHHH
Q 013092 96 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVL 175 (449)
Q Consensus 96 ivHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il 175 (449)
|+|+||||+|||+ +.++.++|+|||+++.+...... .......++..|+|||++.+..++.++|||||||++
T Consensus 162 ivH~dlkp~Nil~---~~~~~~~l~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil 233 (302)
T cd05055 162 CIHRDLAARNVLL---THGKIVKICDFGLARDIMNDSNY-----VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILL 233 (302)
T ss_pred eehhhhccceEEE---cCCCeEEECCCcccccccCCCce-----eecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHH
Confidence 9999999999999 57789999999999866443211 111234567889999999998899999999999999
Q ss_pred HHHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 013092 176 MYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDL 248 (449)
Q Consensus 176 ~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~L~~~ 248 (449)
|+|++ |..||....... ..+..+... ... ......++++.+++.+||..+|++||++.+|...|.++
T Consensus 234 ~el~t~g~~p~~~~~~~~--~~~~~~~~~-~~~---~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 234 WEIFSLGSNPYPGMPVDS--KFYKLIKEG-YRM---AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred HHHHhCCCCCcCCCCchH--HHHHHHHcC-CcC---CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 99998 999998754321 112222211 111 12345688999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=278.45 Aligned_cols=226 Identities=19% Similarity=0.219 Sum_probs=174.9
Q ss_pred EEEEEeeecccCCChhHHHHHHHHHHHhc--CCCCCceEEEEeEe-----CCEEEEEEecCCCCHHHHHHHcC-CCCCHH
Q 013092 4 ILTVFSVQENVKTKHPQLLYESKLYRILQ--GGTGIPNVRWFGVE-----GDYNVLVMDLLGPSLEDLFNFCS-RKLSLK 75 (449)
Q Consensus 4 aikV~~k~~~~~~~~~~~~~E~~il~~l~--~hp~Iv~l~~~~~~-----~~~~~lVmE~~g~sL~~ll~~~~-~~ls~~ 75 (449)
|+|++.+..........+.+|+.+++.++ +||||+++++++.. ....++||||+.++|.+++.... ..+++.
T Consensus 29 aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~ 108 (288)
T cd07863 29 ALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAE 108 (288)
T ss_pred EEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceEEEEEcccccCHHHHHHhcCCCCCCHH
Confidence 44544433222333446778999998875 69999999988764 35689999999779999987543 358999
Q ss_pred HHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchh
Q 013092 76 TVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMN 155 (449)
Q Consensus 76 ~~~~i~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE 155 (449)
.+..++.|++.||+|||++||+||||||+|||+ +.++.+||+|||+++....... .....||..|+|||
T Consensus 109 ~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili---~~~~~~kl~dfg~~~~~~~~~~--------~~~~~~~~~y~aPE 177 (288)
T cd07863 109 TIKDLMRQFLRGLDFLHANCIVHRDLKPENILV---TSGGQVKLADFGLARIYSCQMA--------LTPVVVTLWYRAPE 177 (288)
T ss_pred HHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEECccCccccccCccc--------CCCccccccccCch
Confidence 999999999999999999999999999999999 5788999999999986643221 12356899999999
Q ss_pred hhhCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhc----------------------ccchHHHhh
Q 013092 156 THLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK----------------------VSTSIEALC 213 (449)
Q Consensus 156 ~~~~~~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~----------------------~~~~~~~l~ 213 (449)
++.+..++.++|||||||++|+|++|..||.+.... +.+.++.... .......+.
T Consensus 178 ~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (288)
T cd07863 178 VLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA---DQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVV 254 (288)
T ss_pred HhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHH---HHHHHHHHHhCCCChhhCcccccccccccCCCCCCchHHhC
Confidence 999989999999999999999999999999764332 2222222110 011122344
Q ss_pred cCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 214 RGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 214 ~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
+.++.++.+++..|++.||++||++.+++.
T Consensus 255 ~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 255 PEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred cCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 567889999999999999999999887753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=276.65 Aligned_cols=215 Identities=13% Similarity=0.247 Sum_probs=178.2
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 96 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gi 96 (449)
...|.+|+.+++.+ +|+||+++++++.+.+..|+||||+ +++|.+++......+++..++.++.|++.||+|||+++|
T Consensus 49 ~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i 127 (266)
T cd05033 49 RLDFLTEASIMGQF-DHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNY 127 (266)
T ss_pred HHHHHHHHHHHHhC-CCCCcceEeEEEecCCceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence 35688999999999 8999999999999999999999999 899999998655679999999999999999999999999
Q ss_pred eecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHHHH
Q 013092 97 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLM 176 (449)
Q Consensus 97 vHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il~ 176 (449)
+|+||||.||++ +.++.++|+|||+++.+....... ......++..|++||.+.+..++.++||||||+++|
T Consensus 128 ~H~di~p~nili---~~~~~~~l~dfg~~~~~~~~~~~~-----~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~ 199 (266)
T cd05033 128 VHRDLAARNILV---NSNLVCKVSDFGLSRRLEDSEATY-----TTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMW 199 (266)
T ss_pred ccCCCCcceEEE---cCCCCEEECccchhhcccccccce-----eccCCCCCccccChhhhccCCCccccchHHHHHHHH
Confidence 999999999999 578899999999998775221110 011234567899999999888999999999999999
Q ss_pred HHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 013092 177 YFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDL 248 (449)
Q Consensus 177 ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~L~~~ 248 (449)
+|++ |..||..... .+....+...... .....+|.++.+++..||+.+|++||++.+|.+.|.++
T Consensus 200 ~l~~~g~~p~~~~~~---~~~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 200 EVMSYGERPYWDMSN---QDVIKAVEDGYRL----PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred HHHccCCCCCCCCCH---HHHHHHHHcCCCC----CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 9998 9999976432 2333333322111 12346789999999999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=279.33 Aligned_cols=203 Identities=19% Similarity=0.251 Sum_probs=167.7
Q ss_pred hHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 013092 19 PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSF 96 (449)
Q Consensus 19 ~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~-~~~ls~~~~~~i~~qi~~aL~yLH~~gi 96 (449)
..+..|+.+++.+ +|++|+.+.+.+.+.+..|+||||+ |++|.+++... ...+++..++.++.|++.||.|||+.||
T Consensus 45 ~~~~~E~~il~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i 123 (285)
T cd05630 45 SMALNEKQILEKV-NSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERI 123 (285)
T ss_pred HHHHHHHHHHHhC-CCCCeeeeeEEEecCCEEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCE
Confidence 4577899999999 8999999999999999999999999 99999988643 3458999999999999999999999999
Q ss_pred eecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHHHH
Q 013092 97 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLM 176 (449)
Q Consensus 97 vHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il~ 176 (449)
+||||||+||++ +..+.++|+|||++........ .....|+..|+|||++.+..++.++|||||||++|
T Consensus 124 iH~dikp~Nil~---~~~~~~~l~Dfg~~~~~~~~~~--------~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~ 192 (285)
T cd05630 124 VYRDLKPENILL---DDHGHIRISDLGLAVHVPEGQT--------IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLY 192 (285)
T ss_pred EeCCCCHHHEEE---CCCCCEEEeeccceeecCCCcc--------ccCCCCCccccChHHHcCCCCCCccccHHHHHHHH
Confidence 999999999999 5778899999999876543221 12347899999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCC
Q 013092 177 YFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPD 237 (449)
Q Consensus 177 elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt 237 (449)
+|++|..||..............+.. .....+...+++++.+|+..||+.+|++||+
T Consensus 193 ~l~~g~~Pf~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s 249 (285)
T cd05630 193 EMIAGQSPFQQRKKKIKREEVERLVK----EVQEEYSEKFSPDARSLCKMLLCKDPKERLG 249 (285)
T ss_pred HHHhCCCCCCCCCccchHHHHHhhhh----hhhhhcCccCCHHHHHHHHHHhhcCHHHccC
Confidence 99999999987543222222222111 1112344568899999999999999999998
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=272.75 Aligned_cols=210 Identities=23% Similarity=0.286 Sum_probs=176.5
Q ss_pred CChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHH
Q 013092 16 TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHS 93 (449)
Q Consensus 16 ~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~-~~~ls~~~~~~i~~qi~~aL~yLH~ 93 (449)
.....+..|+++++.+ +||||+++++.+.+.+..|+||||+ +++|.+++... ...+++..++.++.|++.||.|||+
T Consensus 41 ~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~ 119 (256)
T cd08529 41 REREEAIDEARVLAKL-DSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS 119 (256)
T ss_pred HHHHHHHHHHHHHHhc-CCCCeehheeeeccCCEEEEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 3456688999999999 8999999999999999999999999 99999999764 4568999999999999999999999
Q ss_pred CCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHH
Q 013092 94 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGY 173 (449)
Q Consensus 94 ~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~ 173 (449)
+||+|+||||+||++ +.++.++|+|||+++.+..... ......|++.|+|||++.+..++.++|+|||||
T Consensus 120 ~~i~h~dl~~~nili---~~~~~~~l~df~~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 189 (256)
T cd08529 120 KKILHRDIKSLNLFL---DAYDNVKIGDLGVAKLLSDNTN-------FANTIVGTPYYLSPELCEDKPYNEKSDVWALGV 189 (256)
T ss_pred CCcccCCCCcceEEE---eCCCCEEEcccccceeccCccc-------hhhccccCccccCHHHhcCCCCCCccchHHHHH
Confidence 999999999999999 5778999999999987654322 123456889999999999988999999999999
Q ss_pred HHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 174 VLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 174 il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
++|+|++|..||.... ......++..... +.+...++.++.++|.+||+.+|++||++.+|.+
T Consensus 190 il~~l~~g~~p~~~~~---~~~~~~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 252 (256)
T cd08529 190 VLYECCTGKHPFDANN---QGALILKIIRGVF----PPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLR 252 (256)
T ss_pred HHHHHHhCCCCCCCCC---HHHHHHHHHcCCC----CCCccccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence 9999999999997643 2333333333222 2233367899999999999999999999988764
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=275.10 Aligned_cols=212 Identities=16% Similarity=0.245 Sum_probs=175.3
Q ss_pred ChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 013092 17 KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 95 (449)
Q Consensus 17 ~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~g 95 (449)
....+.+|+.+++.+ +||||+++++++.+....|+||||+ +++|.+++......+++..++.++.||+.||.|||+.|
T Consensus 42 ~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 120 (256)
T cd05113 42 SEDEFIEEAKVMMKL-SHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ 120 (256)
T ss_pred cHHHHHHHHHHHhcC-CCCCeeeEEEEEccCCCcEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 356789999999999 8999999999999999999999999 89999999865557899999999999999999999999
Q ss_pred ceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHHH
Q 013092 96 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVL 175 (449)
Q Consensus 96 ivHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il 175 (449)
++|+||||.||++ +.++.+||+|||+++....... .......++..|++||++.+..++.++|||||||++
T Consensus 121 i~H~dl~p~nili---~~~~~~kl~d~g~~~~~~~~~~------~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l 191 (256)
T cd05113 121 FIHRDLAARNCLV---DDQGCVKVSDFGLSRYVLDDEY------TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLM 191 (256)
T ss_pred eeccccCcceEEE---cCCCCEEECCCccceecCCCce------eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHH
Confidence 9999999999999 5778999999999886544321 111233466789999999988899999999999999
Q ss_pred HHHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Q 013092 176 MYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIF 245 (449)
Q Consensus 176 ~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~L 245 (449)
|+|++ |..||..... ......+...... ......+.++.+++..||..+|++||++.+|...|
T Consensus 192 ~~l~~~g~~p~~~~~~---~~~~~~~~~~~~~----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~ 255 (256)
T cd05113 192 WEVYSLGKMPYERFNN---SETVEKVSQGLRL----YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSI 255 (256)
T ss_pred HHHhcCCCCCcCcCCH---HHHHHHHhcCCCC----CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhh
Confidence 99998 9999976443 2333334332221 12234688999999999999999999999987765
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=273.74 Aligned_cols=211 Identities=19% Similarity=0.264 Sum_probs=174.4
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 96 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gi 96 (449)
...+.+|+++++.+ +|+||+++++++...+..|+||||+ +++|.+++......+++..++.++.|++.||.|||+.||
T Consensus 43 ~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i 121 (256)
T cd05059 43 EDDFIEEAKVMMKL-SHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGF 121 (256)
T ss_pred HHHHHHHHHHHHhC-CCCCEEEEEEEEcCCCceEEEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 45688999999999 8999999999999999999999999 999999997645578999999999999999999999999
Q ss_pred eecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHHHH
Q 013092 97 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLM 176 (449)
Q Consensus 97 vHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il~ 176 (449)
+||||||+||++ +.++.+||+|||+++...+.... ......++..|+|||.+.+..++.++|||||||++|
T Consensus 122 ~H~dl~p~ni~i---~~~~~~kl~dfg~~~~~~~~~~~------~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~ 192 (256)
T cd05059 122 IHRDLAARNCLV---GEDNVVKVSDFGLARYVLDDQYT------SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMW 192 (256)
T ss_pred ccccccHhhEEE---CCCCcEEECCcccceeccccccc------ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHH
Confidence 999999999999 57889999999999866433211 111223456899999999989999999999999999
Q ss_pred HHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Q 013092 177 YFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIF 245 (449)
Q Consensus 177 ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~L 245 (449)
+|++ |..||..... .+.+..+..... ......+|.++.+++.+||..+|++||++.++.+.|
T Consensus 193 ~l~~~g~~p~~~~~~---~~~~~~~~~~~~----~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 193 EVFSEGKMPYERFSN---SEVVESVSAGYR----LYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred HHhccCCCCCCCCCH---HHHHHHHHcCCc----CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 9998 8999976433 333333332211 122345799999999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=281.64 Aligned_cols=217 Identities=18% Similarity=0.281 Sum_probs=174.3
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcC----------CCCCHHHHHHHHHHHHH
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCS----------RKLSLKTVLMLADQMIN 86 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~----------~~ls~~~~~~i~~qi~~ 86 (449)
...+.+|+++++.+ .|+||+++++++..++..++||||+ +++|.+++.... ..+++..++.++.|++.
T Consensus 63 ~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 141 (296)
T cd05051 63 REDFLKEVKILSRL-SDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIAS 141 (296)
T ss_pred HHHHHHHHHHHHhc-CCCCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHH
Confidence 45688999999999 8999999999999999999999999 899999997543 26899999999999999
Q ss_pred HHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhh
Q 013092 87 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRD 166 (449)
Q Consensus 87 aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~ 166 (449)
||+|||++||+||||||+||++ +..+.++|+|||+++........ .......++..|+|||++.+..++.++
T Consensus 142 al~~LH~~~i~H~dlkp~Nili---~~~~~~~l~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~ 213 (296)
T cd05051 142 GMRYLESLNFVHRDLATRNCLV---GKNYTIKIADFGMSRNLYSSDYY-----RVQGRAPLPIRWMAWESVLLGKFTTKS 213 (296)
T ss_pred HHHHHHHcCccccccchhceee---cCCCceEEccccceeecccCcce-----eecCcCCCCceecCHHHhhcCCCCccc
Confidence 9999999999999999999999 57789999999999865433211 112234567899999999988899999
Q ss_pred HHHHHHHHHHHHHh--CCCCCCCCCcCCHHHHHHHHHhh---cccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHH
Q 013092 167 DLESLGYVLMYFLR--GSLPWQGLKAGTKKQKYEKISEK---KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYL 241 (449)
Q Consensus 167 DiwSlG~il~ellt--G~~Pf~~~~~~~~~~~~~~i~~~---~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l 241 (449)
|||||||++|||++ +..||..... .+.+..+... ............+|.++.+++..||+.+|++||++.+|
T Consensus 214 Dv~slG~~l~el~~~~~~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el 290 (296)
T cd05051 214 DVWAFGVTLWEILTLCREQPYEHLTD---QQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREI 290 (296)
T ss_pred hhhhhHHHHHHHHhcCCCCCCCCcCh---HHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHH
Confidence 99999999999998 7788876433 2222222221 00011111234578999999999999999999999999
Q ss_pred HHHHH
Q 013092 242 KRIFR 246 (449)
Q Consensus 242 ~~~L~ 246 (449)
.+.|+
T Consensus 291 ~~~L~ 295 (296)
T cd05051 291 HLFLQ 295 (296)
T ss_pred HHHhc
Confidence 88764
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=280.60 Aligned_cols=220 Identities=16% Similarity=0.235 Sum_probs=172.5
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcC----------CCCCHHHHHHHHHHHHH
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCS----------RKLSLKTVLMLADQMIN 86 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~----------~~ls~~~~~~i~~qi~~ 86 (449)
...+.+|+.+++.+ +|+||+++++++...+..|+||||+ +++|.+++.... ..+++.+++.++.|++.
T Consensus 63 ~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 141 (296)
T cd05095 63 RNDFLKEIKIMSRL-KDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIAS 141 (296)
T ss_pred HHHHHHHHHHHHhC-CCCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHH
Confidence 35688999999999 8999999999999999999999999 899999987531 23678899999999999
Q ss_pred HHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhh
Q 013092 87 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRD 166 (449)
Q Consensus 87 aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~ 166 (449)
||+|||++||+|+||||+|||+ +.++.++|+|||+++.+...... .......++..|++||+..+..++.++
T Consensus 142 al~~lH~~~i~H~dlkp~Nili---~~~~~~~l~dfg~~~~~~~~~~~-----~~~~~~~~~~~~~~pe~~~~~~~~~~~ 213 (296)
T cd05095 142 GMKYLSSLNFVHRDLATRNCLV---GKNYTIKIADFGMSRNLYSGDYY-----RIQGRAVLPIRWMSWESILLGKFTTAS 213 (296)
T ss_pred HHHHHHHCCeecccCChheEEE---cCCCCEEeccCcccccccCCcce-----eccCcCcCccccCCHHHHhcCCccchh
Confidence 9999999999999999999999 57789999999999865432211 111223456789999999888899999
Q ss_pred HHHHHHHHHHHHHh--CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHH
Q 013092 167 DLESLGYVLMYFLR--GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRI 244 (449)
Q Consensus 167 DiwSlG~il~ellt--G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~ 244 (449)
|||||||++|||++ |..||..............................+|+.+.+||..||+.+|++||++.+|.+.
T Consensus 214 DiwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 293 (296)
T cd05095 214 DVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHAT 293 (296)
T ss_pred hhhHHHHHHHHHHHhCCCCCccccChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 99999999999998 7899976543221111111111100001111234578999999999999999999999999888
Q ss_pred HH
Q 013092 245 FR 246 (449)
Q Consensus 245 L~ 246 (449)
|+
T Consensus 294 l~ 295 (296)
T cd05095 294 LL 295 (296)
T ss_pred Hh
Confidence 75
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=279.47 Aligned_cols=204 Identities=19% Similarity=0.259 Sum_probs=168.0
Q ss_pred hHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 013092 19 PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSF 96 (449)
Q Consensus 19 ~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~-~~~ls~~~~~~i~~qi~~aL~yLH~~gi 96 (449)
..+.+|+++++.+ +|++|+.+.+.+.+++..|+||||+ +++|.+++... ...+++..++.++.|++.||.|||+.||
T Consensus 45 ~~~~~E~~il~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i 123 (285)
T cd05632 45 SMALNEKQILEKV-NSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENT 123 (285)
T ss_pred HHHHHHHHHHHHc-CCcCceeEEEEEecCCEEEEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 4578899999999 9999999999999999999999999 89999888643 3469999999999999999999999999
Q ss_pred eecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHHHH
Q 013092 97 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLM 176 (449)
Q Consensus 97 vHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il~ 176 (449)
+||||||+||++ +..+.++|+|||++........ .....|+..|+|||++.+..++.++|+|||||++|
T Consensus 124 iH~dikp~Nili---~~~~~~kl~Dfg~~~~~~~~~~--------~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~ 192 (285)
T cd05632 124 VYRDLKPENILL---DDYGHIRISDLGLAVKIPEGES--------IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIY 192 (285)
T ss_pred eecCCCHHHEEE---CCCCCEEEecCCcceecCCCCc--------ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHH
Confidence 999999999999 5778899999999976543221 12347899999999999989999999999999999
Q ss_pred HHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCH
Q 013092 177 YFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDY 238 (449)
Q Consensus 177 elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~ 238 (449)
+|++|..||.+..... ....+.... ......+...++.++.+|+..||+.+|++||+.
T Consensus 193 ~l~~g~~P~~~~~~~~---~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~ 250 (285)
T cd05632 193 EMIEGQSPFRGRKEKV---KREEVDRRV-LETEEVYSAKFSEEAKSICKMLLTKDPKQRLGC 250 (285)
T ss_pred HHHhCCCCCCCCCHHH---HHHHHHHhh-hccccccCccCCHHHHHHHHHHccCCHhHcCCC
Confidence 9999999998643321 112222111 111123345688999999999999999999994
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=276.54 Aligned_cols=216 Identities=14% Similarity=0.246 Sum_probs=178.3
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 96 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gi 96 (449)
...+.+|+.+++.+ +||||+++++++..++..|+||||+ +++|.+++......+++.+++.++.|++.||+|||++|+
T Consensus 49 ~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i 127 (267)
T cd05066 49 RRDFLSEASIMGQF-DHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGY 127 (267)
T ss_pred HHHHHHHHHHHHhC-CCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCE
Confidence 45689999999999 8999999999999999999999999 899999998655678999999999999999999999999
Q ss_pred eecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHHHH
Q 013092 97 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLM 176 (449)
Q Consensus 97 vHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il~ 176 (449)
+||||||+|||+ +.++.++|+|||++..+....... .......++..|++||++.+..++.++|+|||||++|
T Consensus 128 ~h~dlkp~nili---~~~~~~~l~dfg~~~~~~~~~~~~----~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ 200 (267)
T cd05066 128 VHRDLAARNILV---NSNLVCKVSDFGLSRVLEDDPEAA----YTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMW 200 (267)
T ss_pred eehhhchhcEEE---CCCCeEEeCCCCccccccccccee----eecCCCccceeecCHhHhccCccCchhhhHHHHHHHH
Confidence 999999999999 578899999999998765432211 0112233456899999999888999999999999999
Q ss_pred HHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 013092 177 YFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDL 248 (449)
Q Consensus 177 ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~L~~~ 248 (449)
++++ |..||..... .+.+..+.+... . .....+|+++.+++.+||+.+|++||++.++.+.|.++
T Consensus 201 ell~~g~~p~~~~~~---~~~~~~~~~~~~-~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 201 EVMSYGERPYWEMSN---QDVIKAIEEGYR-L---PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred HHhcCCCCCcccCCH---HHHHHHHhCCCc-C---CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 9886 9999987543 223333333211 1 12345789999999999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-34 Score=276.18 Aligned_cols=215 Identities=19% Similarity=0.304 Sum_probs=173.2
Q ss_pred hHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcC------CCCCHHHHHHHHHHHHHHHHHH
Q 013092 19 PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCS------RKLSLKTVLMLADQMINRVEFV 91 (449)
Q Consensus 19 ~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~------~~ls~~~~~~i~~qi~~aL~yL 91 (449)
..+..|+.+++.+ +|+||+++++++.+.+..|+||||+ |++|.+++.... ..+++..++.++.||+.||+||
T Consensus 54 ~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~L 132 (277)
T cd05036 54 SDFLMEALIMSKF-NHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYL 132 (277)
T ss_pred HHHHHHHHHHHhC-CCCCEeeEEEEEccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHH
Confidence 4588999999999 8999999999999999999999999 999999997532 2489999999999999999999
Q ss_pred HHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHH
Q 013092 92 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESL 171 (449)
Q Consensus 92 H~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSl 171 (449)
|+++++||||||+||++........+||+|||+++.+...... ........+..|+|||++.+..++.++|||||
T Consensus 133 H~~~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl 207 (277)
T cd05036 133 EENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYY-----RKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSF 207 (277)
T ss_pred HHCCEeecccchheEEEeccCCCcceEeccCccccccCCccce-----ecCCCCCccHhhCCHHHHhcCCcCchhHHHHH
Confidence 9999999999999999963333457999999999876332210 11122234568999999999899999999999
Q ss_pred HHHHHHHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 013092 172 GYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFR 246 (449)
Q Consensus 172 G~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~L~ 246 (449)
||++|+|++ |..||.+.+. ...+..+..... ...+..+|.++.+++..||+.+|++||++.+|.+.|.
T Consensus 208 G~il~el~~~g~~pf~~~~~---~~~~~~~~~~~~----~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 208 GVLLWEIFSLGYMPYPGRTN---QEVMEFVTGGGR----LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred HHHHHHHHcCCCCCCCCCCH---HHHHHHHHcCCc----CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 999999997 9999986433 222332222111 1234568899999999999999999999999987764
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=272.46 Aligned_cols=214 Identities=19% Similarity=0.317 Sum_probs=176.9
Q ss_pred ChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHC
Q 013092 17 KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSK 94 (449)
Q Consensus 17 ~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~-~~ls~~~~~~i~~qi~~aL~yLH~~ 94 (449)
...++.+|+.+++.+ .|+||+++++++...+..|+||||+ +++|.+++.... ..+++..+..++.|++.||.|||++
T Consensus 44 ~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 122 (261)
T cd05068 44 DPKDFLAEAQIMKKL-RHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ 122 (261)
T ss_pred cHHHHHHHHHHHHHC-CCCCccceeEEEecCCCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 456799999999999 7999999999999999999999999 999999997532 4689999999999999999999999
Q ss_pred CceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHH
Q 013092 95 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYV 174 (449)
Q Consensus 95 givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~i 174 (449)
||+|+||||+||++ +.++.++|+|||+++.+...... .......+..|+|||++.+..++.++||||||++
T Consensus 123 ~i~H~dl~p~Nil~---~~~~~~~l~dfg~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~ 193 (261)
T cd05068 123 NYIHRDLAARNVLV---GENNICKVADFGLARVIKEDIYE------AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGIL 193 (261)
T ss_pred CeeeccCCcceEEE---cCCCCEEECCcceEEEccCCccc------ccCCCcCceeccCccccccCCCCchhhHHHHHHH
Confidence 99999999999999 57889999999999877633211 1112223468999999998889999999999999
Q ss_pred HHHHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Q 013092 175 LMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRD 247 (449)
Q Consensus 175 l~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~L~~ 247 (449)
+|+|++ |+.||.+... .+.+..+...... .....++.++.+++..||+.+|++||++.+|...|++
T Consensus 194 l~el~t~g~~p~~~~~~---~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 194 LTEIVTYGRMPYPGMTN---AEVLQQVDQGYRM----PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred HHHHHhcCCCCCCCCCH---HHHHHHHHcCCCC----CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 999999 9999977533 2333333322111 1234578999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=273.73 Aligned_cols=216 Identities=13% Similarity=0.216 Sum_probs=177.1
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 96 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gi 96 (449)
...+..|+++++.+ .|+||+++.+++.+.+..|+||||+ +++|.+++......+++..++.++.|++.||+|||+.|+
T Consensus 50 ~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i 128 (268)
T cd05063 50 RQDFLSEASIMGQF-SHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNY 128 (268)
T ss_pred HHHHHHHHHHHhcC-CCCCeeEEEEEEccCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 45688999999999 8999999999999999999999999 899999997655679999999999999999999999999
Q ss_pred eecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHHHH
Q 013092 97 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLM 176 (449)
Q Consensus 97 vHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il~ 176 (449)
+|+||||+||++ +.++.++|+|||++.......... ........+..|++||++.+..++.++|||||||++|
T Consensus 129 ~H~dlkp~Nili---~~~~~~kl~dfg~~~~~~~~~~~~----~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ 201 (268)
T cd05063 129 VHRDLAARNILV---NSNLECKVSDFGLSRVLEDDPEGT----YTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMW 201 (268)
T ss_pred eccccchhhEEE---cCCCcEEECCCccceecccccccc----eeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHH
Confidence 999999999999 578899999999998665432211 0011122346799999999888999999999999999
Q ss_pred HHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 013092 177 YFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDL 248 (449)
Q Consensus 177 ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~L~~~ 248 (449)
||++ |..||..... .+....+...... .....++.++.+++..||..+|++||++.+|...|+++
T Consensus 202 ell~~g~~p~~~~~~---~~~~~~i~~~~~~----~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 202 EVMSFGERPYWDMSN---HEVMKAINDGFRL----PAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred HHHhCCCCCCCcCCH---HHHHHHHhcCCCC----CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 9997 9999976433 2333333322111 12235789999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=278.10 Aligned_cols=219 Identities=21% Similarity=0.276 Sum_probs=172.9
Q ss_pred ChhHHHHHHHHHHHhcCCCCCceEEEEeEe--CCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH
Q 013092 17 KHPQLLYESKLYRILQGGTGIPNVRWFGVE--GDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 93 (449)
Q Consensus 17 ~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~--~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~ 93 (449)
....+.+|+++++.+ +||||+++++++.. ....|+||||+ +++|.+++.. ..+++..++.++.|++.||+|||+
T Consensus 49 ~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~l~~~~~~~i~~~l~~~l~~lH~ 125 (283)
T cd05080 49 NTSGWKKEINILKTL-YHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPK--HKLNLAQLLLFAQQICEGMAYLHS 125 (283)
T ss_pred HHHHHHHHHHHHHhC-CCCCEeeEEEEEecCCCceEEEEecCCCCCCHHHHHHH--cCCCHHHHHHHHHHHHHHHHHHHH
Confidence 345688999999999 89999999998765 44689999999 9999999974 469999999999999999999999
Q ss_pred CCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHH
Q 013092 94 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGY 173 (449)
Q Consensus 94 ~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~ 173 (449)
+||+||||||+|||+ +.++.++|+|||+++.+...... +.......++..|++||.+.+..++.++|||||||
T Consensus 126 ~~i~H~dlkp~Nili---~~~~~~~l~dfg~~~~~~~~~~~----~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~ 198 (283)
T cd05080 126 QHYIHRDLAARNVLL---DNDRLVKIGDFGLAKAVPEGHEY----YRVREDGDSPVFWYAVECLKENKFSYASDVWSFGV 198 (283)
T ss_pred CCeeccccChheEEE---cCCCcEEEeecccccccCCcchh----hccCCCCCCCceeeCHhHhcccCCCcccccHHHHH
Confidence 999999999999999 57789999999999876543221 11112334567799999999888999999999999
Q ss_pred HHHHHHhCCCCCCCCCcCCHHH-----------HHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 013092 174 VLMYFLRGSLPWQGLKAGTKKQ-----------KYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 242 (449)
Q Consensus 174 il~elltG~~Pf~~~~~~~~~~-----------~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~ 242 (449)
++|+|++|..||.......... .......... .......+|.++.+++..||+.+|++||++.+|.
T Consensus 199 ~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~ 275 (283)
T cd05080 199 TLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGM---RLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLI 275 (283)
T ss_pred HHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcCC---CCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHH
Confidence 9999999999996543210000 0000000000 0012345789999999999999999999999999
Q ss_pred HHHHHH
Q 013092 243 RIFRDL 248 (449)
Q Consensus 243 ~~L~~~ 248 (449)
+.|+++
T Consensus 276 ~~l~~~ 281 (283)
T cd05080 276 PILKEM 281 (283)
T ss_pred HHHHHh
Confidence 998876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=287.09 Aligned_cols=219 Identities=19% Similarity=0.269 Sum_probs=175.9
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEe-CCEEEEEEecC-CCCHHHHHHHcC--------------------------
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVE-GDYNVLVMDLL-GPSLEDLFNFCS-------------------------- 69 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~-~~~~~lVmE~~-g~sL~~ll~~~~-------------------------- 69 (449)
.+.+..|+.++..+.+|+||+++++++.. +...+++|||+ +++|.+++....
T Consensus 54 ~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 133 (337)
T cd05054 54 YKALMTELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRL 133 (337)
T ss_pred HHHHHHHHHHHHhhccCcchhheeeeEecCCCCEEEEEecCCCCCHHHHHHhcccccccccccccccccccccccccccc
Confidence 34678899999999889999999988764 56789999999 999999986421
Q ss_pred ----------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCC
Q 013092 70 ----------------------------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN 115 (449)
Q Consensus 70 ----------------------------------~~ls~~~~~~i~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~ 115 (449)
..+++..+..++.||+.||+|||++||+||||||+|||+ +.++
T Consensus 134 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill---~~~~ 210 (337)
T cd05054 134 DSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILL---SENN 210 (337)
T ss_pred ccCCccccccccccccCcchhhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEE---eCCC
Confidence 257899999999999999999999999999999999999 4678
Q ss_pred eEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCCHH
Q 013092 116 QVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKK 194 (449)
Q Consensus 116 ~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~ 194 (449)
.++|+|||+++.+...... .......++..|+|||++.+..++.++|||||||++|||++ |..||.+.....
T Consensus 211 ~vkL~DfG~a~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~-- 283 (337)
T cd05054 211 VVKICDFGLARDIYKDPDY-----VRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE-- 283 (337)
T ss_pred cEEEeccccchhcccCcch-----hhccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH--
Confidence 8999999999876432211 11223456778999999999999999999999999999997 999998743321
Q ss_pred HHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 013092 195 QKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFI 250 (449)
Q Consensus 195 ~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~L~~~~~ 250 (449)
.....+..... ......+++++.+++..||+.+|++||++.+|.+.|++++.
T Consensus 284 ~~~~~~~~~~~----~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 284 EFCRRLKEGTR----MRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHHHhccCC----CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 11122222111 11234578899999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=282.39 Aligned_cols=219 Identities=17% Similarity=0.287 Sum_probs=179.0
Q ss_pred hHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcC---------------CCCCHHHHHHHHH
Q 013092 19 PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCS---------------RKLSLKTVLMLAD 82 (449)
Q Consensus 19 ~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~---------------~~ls~~~~~~i~~ 82 (449)
..+..|+.+++.+.+||||+++++++.+.+..|+||||+ +++|.+++.... ..+++..++.++.
T Consensus 62 ~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 141 (314)
T cd05099 62 ADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAY 141 (314)
T ss_pred HHHHHHHHHHHhccCCCCeeeEEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHH
Confidence 457899999999978999999999999999999999999 999999997521 3488999999999
Q ss_pred HHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCC
Q 013092 83 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQ 162 (449)
Q Consensus 83 qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~ 162 (449)
|++.||.|||++||+||||||+|||+ +.++.+||+|||+++........ .......++..|+|||++.+..+
T Consensus 142 qi~~aL~~lH~~gi~H~dlkp~Nill---~~~~~~kL~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~ 213 (314)
T cd05099 142 QVARGMEYLESRRCIHRDLAARNVLV---TEDNVMKIADFGLARGVHDIDYY-----KKTSNGRLPVKWMAPEALFDRVY 213 (314)
T ss_pred HHHHHHHHHHHCCeeeccccceeEEE---cCCCcEEEccccccccccccccc-----cccccCCCCccccCHHHHccCCc
Confidence 99999999999999999999999999 57789999999999866432211 00112234568999999998889
Q ss_pred ChhhHHHHHHHHHHHHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHH
Q 013092 163 SRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYL 241 (449)
Q Consensus 163 s~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l 241 (449)
+.++|||||||++|+|++ |..||.+... .+.+..+..... ......++.++.+++..||..+|++||++.++
T Consensus 214 ~~~~DiwslG~~l~el~~~g~~p~~~~~~---~~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l 286 (314)
T cd05099 214 THQSDVWSFGILMWEIFTLGGSPYPGIPV---EELFKLLREGHR----MDKPSNCTHELYMLMRECWHAVPTQRPTFKQL 286 (314)
T ss_pred CccchhhHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCCC----CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHH
Confidence 999999999999999999 8999976432 333333333221 12345678899999999999999999999999
Q ss_pred HHHHHHHHHHc
Q 013092 242 KRIFRDLFIRE 252 (449)
Q Consensus 242 ~~~L~~~~~~~ 252 (449)
.+.|.++....
T Consensus 287 l~~l~~~~~~~ 297 (314)
T cd05099 287 VEALDKVLAAV 297 (314)
T ss_pred HHHHHHHHHHh
Confidence 99999886543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=273.13 Aligned_cols=215 Identities=22% Similarity=0.311 Sum_probs=177.0
Q ss_pred ChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHC
Q 013092 17 KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSK 94 (449)
Q Consensus 17 ~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~-~~ls~~~~~~i~~qi~~aL~yLH~~ 94 (449)
....+..|+.+++.+ +|+||+++++.+.+ ...++||||+ +++|.+++.... ..+++..++.++.|++.||+|||++
T Consensus 39 ~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~ 116 (257)
T cd05040 39 IMDDFLKEAAIMHSL-DHENLIRLYGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK 116 (257)
T ss_pred HHHHHHHHHHHHhhc-CCCCccceeEEEcC-CeEEEEEEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhC
Confidence 345688999999999 89999999999888 8999999999 999999997543 4689999999999999999999999
Q ss_pred CceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHH
Q 013092 95 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYV 174 (449)
Q Consensus 95 givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~i 174 (449)
|++|+||||+||++ +.++.+||+|||+++.+...... +.......++..|++||++.+..++.++|||||||+
T Consensus 117 ~i~H~di~p~nil~---~~~~~~kl~dfg~~~~~~~~~~~----~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~ 189 (257)
T cd05040 117 RFIHRDLAARNILL---ASDDKVKIGDFGLMRALPQNEDH----YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVT 189 (257)
T ss_pred CccccccCcccEEE---ecCCEEEeccccccccccccccc----eecccCCCCCceecCHHHhcccCcCchhhhHHHHHH
Confidence 99999999999999 57789999999999877543221 222234567889999999999899999999999999
Q ss_pred HHHHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 013092 175 LMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFR 246 (449)
Q Consensus 175 l~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~L~ 246 (449)
+|+|++ |..||..... .+.+..+.... ........+|..+.+++..||..+|++||++.+|.+.|.
T Consensus 190 l~el~t~g~~p~~~~~~---~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 190 LWEMFTYGEEPWAGLSG---SQILKKIDKEG---ERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred HHHHHhCCCCCCCCCCH---HHHHHHHHhcC---CcCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 999998 9999976433 23333333211 111123457899999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=273.21 Aligned_cols=220 Identities=19% Similarity=0.255 Sum_probs=177.0
Q ss_pred EEeeecccCCChhHHHHHHHHHHHhcCCCCCceEEEEeE-eCCEEEEEEecC-CCCHHHHHHHcCC-CCCHHHHHHHHHH
Q 013092 7 VFSVQENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGV-EGDYNVLVMDLL-GPSLEDLFNFCSR-KLSLKTVLMLADQ 83 (449)
Q Consensus 7 V~~k~~~~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~-~~~~~~lVmE~~-g~sL~~ll~~~~~-~ls~~~~~~i~~q 83 (449)
|++|..........+.+|+.+++.+ +|+||+++++++. +++..|+||||+ +++|.+++..... .+++..++.++.|
T Consensus 32 ~~~k~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~ 110 (256)
T cd05082 32 VAVKCIKNDATAQAFLAEASVMTQL-RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLD 110 (256)
T ss_pred EEEEEeCCCchHHHHHHHHHHHHhC-CCCCeeeEEEEEEcCCCceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHH
Confidence 3444443444456789999999999 8999999998764 556789999999 8999999975433 4889999999999
Q ss_pred HHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCC
Q 013092 84 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQS 163 (449)
Q Consensus 84 i~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s 163 (449)
++.||+|||++||+||||||+||++ +.++.+||+|||+++...... ....++..|+|||++.+..++
T Consensus 111 i~~~l~~lH~~~i~H~dlkp~nil~---~~~~~~kl~dfg~~~~~~~~~----------~~~~~~~~y~aPE~~~~~~~~ 177 (256)
T cd05082 111 VCEAMEYLEANNFVHRDLAARNVLV---SEDNVAKVSDFGLTKEASSTQ----------DTGKLPVKWTAPEALREKKFS 177 (256)
T ss_pred HHHHHHHHHhCCEeccccchheEEE---cCCCcEEecCCccceeccccC----------CCCccceeecCHHHHccCCCC
Confidence 9999999999999999999999999 578899999999987654322 122345689999999988899
Q ss_pred hhhHHHHHHHHHHHHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 013092 164 RRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 242 (449)
Q Consensus 164 ~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~ 242 (449)
.++|||||||++|+|++ |..||.... ..+....+..... ......+|+++.+++.+||..+|++||++.++.
T Consensus 178 ~~~Dv~slG~i~~~l~~~g~~p~~~~~---~~~~~~~~~~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~ 250 (256)
T cd05082 178 TKSDVWSFGILLWEIYSFGRVPYPRIP---LKDVVPRVEKGYK----MDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLR 250 (256)
T ss_pred chhhhHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHHhcCCC----CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHH
Confidence 99999999999999997 999997632 2333333322211 123456899999999999999999999999999
Q ss_pred HHHHH
Q 013092 243 RIFRD 247 (449)
Q Consensus 243 ~~L~~ 247 (449)
+.|++
T Consensus 251 ~~l~~ 255 (256)
T cd05082 251 EQLEH 255 (256)
T ss_pred HHHhc
Confidence 88764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=278.87 Aligned_cols=224 Identities=17% Similarity=0.271 Sum_probs=178.6
Q ss_pred hHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcC---------CCCCHHHHHHHHHHHHHHH
Q 013092 19 PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCS---------RKLSLKTVLMLADQMINRV 88 (449)
Q Consensus 19 ~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~---------~~ls~~~~~~i~~qi~~aL 88 (449)
..+.+|+.+++.+ +|+||+++++.+.+....|+||||+ +++|.+++.... ..++...++.++.|++.||
T Consensus 54 ~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l 132 (288)
T cd05061 54 IEFLNEASVMKGF-TCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 132 (288)
T ss_pred HHHHHHHHHHHhC-CCCCeeeEEEEEcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHH
Confidence 3577899999999 8999999999999999999999999 999999997431 2346778899999999999
Q ss_pred HHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHH
Q 013092 89 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDL 168 (449)
Q Consensus 89 ~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~Di 168 (449)
.|||+++|+||||||+|||+ +.++.++|+|||+++....... ........++..|++||.+.+..++.++||
T Consensus 133 ~~lH~~~i~H~dikp~nili---~~~~~~~L~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv 204 (288)
T cd05061 133 AYLNAKKFVHRDLAARNCMV---AHDFTVKIGDFGMTRDIYETDY-----YRKGGKGLLPVRWMAPESLKDGVFTTSSDM 204 (288)
T ss_pred HHHHhCCCcCCCCChheEEE---cCCCcEEECcCCcccccccccc-----ccccCCCcccccccCHHHhccCCCChHhHH
Confidence 99999999999999999999 5788999999999986543221 111223345778999999998889999999
Q ss_pred HHHHHHHHHHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Q 013092 169 ESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRD 247 (449)
Q Consensus 169 wSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~L~~ 247 (449)
|||||++|||++ |..||.+... .+.+..+.... ....+..+++++.+++..||+.+|++||++.++.+.|++
T Consensus 205 wslG~~l~el~~~~~~p~~~~~~---~~~~~~~~~~~----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~ 277 (288)
T cd05061 205 WSFGVVLWEITSLAEQPYQGLSN---EQVLKFVMDGG----YLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKD 277 (288)
T ss_pred HHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCC----CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 999999999998 8999976433 22233232221 112345678999999999999999999999999888877
Q ss_pred HHHHcCCCCCCcccc
Q 013092 248 LFIREGFQFDYVFDW 262 (449)
Q Consensus 248 ~~~~~~~~~~~~~dw 262 (449)
.+ .+....+||
T Consensus 278 ~~----~~~~~~~~~ 288 (288)
T cd05061 278 DL----HPSFPEVSF 288 (288)
T ss_pred hc----CCCCCCCCC
Confidence 64 344455565
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=282.64 Aligned_cols=217 Identities=18% Similarity=0.244 Sum_probs=177.2
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcC---------------CCCCHHHHHHHH
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCS---------------RKLSLKTVLMLA 81 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~---------------~~ls~~~~~~i~ 81 (449)
...+.+|++++.++.+|+||+++++++.+++..|+||||+ +++|.+++.... ..+++..++.++
T Consensus 51 ~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 130 (303)
T cd05088 51 HRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 130 (303)
T ss_pred HHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHH
Confidence 4568899999999988999999999999999999999999 999999997432 257899999999
Q ss_pred HHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCC
Q 013092 82 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIE 161 (449)
Q Consensus 82 ~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~ 161 (449)
.|++.||+|||++||+||||||+|||+ +.++.+||+|||+++..... .......++..|+|||++.+..
T Consensus 131 ~qi~~al~~LH~~gi~H~dlkp~Nili---~~~~~~kl~dfg~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~ 199 (303)
T cd05088 131 ADVARGMDYLSQKQFIHRDLAARNILV---GENYVAKIADFGLSRGQEVY--------VKKTMGRLPVRWMAIESLNYSV 199 (303)
T ss_pred HHHHHHHHHHHhCCccccccchheEEe---cCCCcEEeCccccCcccchh--------hhcccCCCcccccCHHHHhccC
Confidence 999999999999999999999999999 57889999999998632211 0111223467899999998888
Q ss_pred CChhhHHHHHHHHHHHHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHH
Q 013092 162 QSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAY 240 (449)
Q Consensus 162 ~s~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~ 240 (449)
++.++|||||||++|+|++ |..||.+.+. .+.+..+.... .......+++++.+|+.+||+.+|++||++.+
T Consensus 200 ~~~~~Di~slG~il~ellt~g~~p~~~~~~---~~~~~~~~~~~----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 272 (303)
T cd05088 200 YTTNSDVWSYGVLLWEIVSLGGTPYCGMTC---AELYEKLPQGY----RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQ 272 (303)
T ss_pred CcccccchhhhhHHHHHHhcCCCCcccCCh---HHHHHHHhcCC----cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 9999999999999999998 9999976443 23333332211 11123357889999999999999999999999
Q ss_pred HHHHHHHHHHHc
Q 013092 241 LKRIFRDLFIRE 252 (449)
Q Consensus 241 l~~~L~~~~~~~ 252 (449)
++..|.+++...
T Consensus 273 il~~l~~~~~~~ 284 (303)
T cd05088 273 ILVSLNRMLEER 284 (303)
T ss_pred HHHHHHHHHHhh
Confidence 999998887655
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=274.93 Aligned_cols=211 Identities=20% Similarity=0.197 Sum_probs=171.4
Q ss_pred HHHHHHHHHHhcCCCCCceEEEEeE--eCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q 013092 21 LLYESKLYRILQGGTGIPNVRWFGV--EGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLH 98 (449)
Q Consensus 21 ~~~E~~il~~l~~hp~Iv~l~~~~~--~~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~givH 98 (449)
-++|+.+|..+ +|||||.+....+ +-+..|||||||..+|..+++....+|...++..++.|++.||+|||.+.|+|
T Consensus 122 sLREIniLl~~-~H~NIV~vkEVVvG~~~d~iy~VMe~~EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilH 200 (419)
T KOG0663|consen 122 SLREINILLKA-RHPNIVEVKEVVVGSNMDKIYIVMEYVEHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILH 200 (419)
T ss_pred hHHHHHHHHhc-CCCCeeeeEEEEeccccceeeeeHHHHHhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEe
Confidence 68999999999 7999999966544 55679999999999999999988889999999999999999999999999999
Q ss_pred cCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCC-CChhhHHHHHHHHHHH
Q 013092 99 RDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMY 177 (449)
Q Consensus 99 RDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~-~s~~~DiwSlG~il~e 177 (449)
||||+.|+|+ ...|.+||+|||||+.+..... .....+-|.+|.|||.++|.+ |+...|+||+|||+.|
T Consensus 201 RDLK~SNLLm---~~~G~lKiaDFGLAR~ygsp~k-------~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE 270 (419)
T KOG0663|consen 201 RDLKTSNLLL---SHKGILKIADFGLAREYGSPLK-------PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAE 270 (419)
T ss_pred cccchhheee---ccCCcEEecccchhhhhcCCcc-------cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHH
Confidence 9999999999 5889999999999999887632 234567899999999999854 8999999999999999
Q ss_pred HHhCCCCCCCCCcCCHHHHHHHHHhhcc-------------------cchHHHhhc---C--CcHHHHHHHHHHhcCCCC
Q 013092 178 FLRGSLPWQGLKAGTKKQKYEKISEKKV-------------------STSIEALCR---G--YPTEFASYFHYCRSLRFD 233 (449)
Q Consensus 178 lltG~~Pf~~~~~~~~~~~~~~i~~~~~-------------------~~~~~~l~~---~--~p~el~~li~~cl~~~p~ 233 (449)
|+++++.|.+....+...++.++..... ..+...+.+ . +++.-.+|++.++.+||.
T Consensus 271 ~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~ 350 (419)
T KOG0663|consen 271 LLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPG 350 (419)
T ss_pred HHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCcc
Confidence 9999999998654333333322221100 000111111 1 346788999999999999
Q ss_pred CCCCHHHHH
Q 013092 234 DKPDYAYLK 242 (449)
Q Consensus 234 ~RPt~~~l~ 242 (449)
+|.++.+.+
T Consensus 351 kR~tA~~~L 359 (419)
T KOG0663|consen 351 KRITAEDGL 359 (419)
T ss_pred ccccHHHhh
Confidence 999987654
|
|
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=280.66 Aligned_cols=220 Identities=17% Similarity=0.260 Sum_probs=172.9
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcC-----------CCCCHHHHHHHHHHHH
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCS-----------RKLSLKTVLMLADQMI 85 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~-----------~~ls~~~~~~i~~qi~ 85 (449)
...|.+|+++++.+ +|+||+++++++...+..|+||||+ +++|.+++.... ..+++..++.++.|++
T Consensus 61 ~~~~~~ei~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~ 139 (295)
T cd05097 61 RNDFLKEIKIMSRL-KNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIA 139 (295)
T ss_pred HHHHHHHHHHHHhC-CCCCcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHH
Confidence 35688999999999 8999999999999999999999999 999999986421 1368889999999999
Q ss_pred HHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChh
Q 013092 86 NRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRR 165 (449)
Q Consensus 86 ~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~ 165 (449)
.||+|||+.|++|+||||.||++ +.++.+||+|||++........ +.......++..|+|||++.+..++.+
T Consensus 140 ~al~~lH~~~i~H~dlkp~Nill---~~~~~~kl~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~ 211 (295)
T cd05097 140 SGMKYLASLNFVHRDLATRNCLV---GNHYTIKIADFGMSRNLYSGDY-----YRIQGRAVLPIRWMAWESILLGKFTTA 211 (295)
T ss_pred HHHHHHHhcCeeccccChhhEEE---cCCCcEEecccccccccccCcc-----eeccCcCcCceeecChhhhccCCcCch
Confidence 99999999999999999999999 5678899999999976543221 111233455778999999998889999
Q ss_pred hHHHHHHHHHHHHHh--CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 166 DDLESLGYVLMYFLR--GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 166 ~DiwSlG~il~ellt--G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
+|||||||++|+|++ |..||.........+...+..............+.+|+.+.+|+..||+.+|++||++.+|.+
T Consensus 212 ~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 212 SDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred hhHHHHHHHHHHHHHcCCCCCCcccChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 999999999999988 678887654322111111111111111111223457899999999999999999999999988
Q ss_pred HHH
Q 013092 244 IFR 246 (449)
Q Consensus 244 ~L~ 246 (449)
.|+
T Consensus 292 ~l~ 294 (295)
T cd05097 292 FLR 294 (295)
T ss_pred HHh
Confidence 775
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=275.22 Aligned_cols=215 Identities=17% Similarity=0.248 Sum_probs=169.4
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHH
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCS----RKLSLKTVLMLADQMINRVEFVH 92 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~----~~ls~~~~~~i~~qi~~aL~yLH 92 (449)
...+.+|+.+++.+ +|+||+++++.+.+....||||||+ +++|.+++.... ..+++..++.++.||+.||+|||
T Consensus 39 ~~~~~~e~~~~~~l-~h~nii~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH 117 (269)
T cd05042 39 QLLFLQEVQPYREL-NHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH 117 (269)
T ss_pred HHHHHHHHHHHHhC-CCCCcceEEEEECCCCceEEEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHH
Confidence 34578999999999 8999999999999999999999999 899999997532 22467888999999999999999
Q ss_pred HCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhC-------CCCChh
Q 013092 93 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG-------IEQSRR 165 (449)
Q Consensus 93 ~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~-------~~~s~~ 165 (449)
++||+||||||+|||+ +.++.+||+|||++........ +.......++..|+|||++.. ..++.+
T Consensus 118 ~~~ivH~dlkp~Nill---~~~~~~kl~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~ 189 (269)
T cd05042 118 QADFIHSDLALRNCQL---TADLSVKIGDYGLALEQYPEDY-----YITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKK 189 (269)
T ss_pred hcCEecccccHhheEe---cCCCcEEEeccccccccccchh-----eeccCCCCCcccccCHHHHhhccccccccccchh
Confidence 9999999999999999 5788999999999865432211 011123346778999999753 356889
Q ss_pred hHHHHHHHHHHHHHh-CCCCCCCCCcCCHHHHHHH-HHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 166 DDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEK-ISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 166 ~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~-i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
+|||||||++|||++ |..||..... .+.+.. +.........+.+...++.++.+++..|| .+|++||++.+|.+
T Consensus 190 ~DiwslG~~l~el~~~~~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 190 SNIWSLGVTMWELFTAADQPYPDLSD---EQVLKQVVREQDIKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred hHHHHHHHHHHHHHhCCCCCCCcCCH---HHHHHHHhhccCccCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 999999999999998 8899976433 222222 22222222233445678899999999999 59999999999988
Q ss_pred HH
Q 013092 244 IF 245 (449)
Q Consensus 244 ~L 245 (449)
+|
T Consensus 266 ~l 267 (269)
T cd05042 266 LL 267 (269)
T ss_pred Hh
Confidence 76
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=295.61 Aligned_cols=209 Identities=18% Similarity=0.224 Sum_probs=163.2
Q ss_pred HHHHHHHHHHHhcCCCCCceEEEEeEe--------CCEEEEEEecCCCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHH
Q 013092 20 QLLYESKLYRILQGGTGIPNVRWFGVE--------GDYNVLVMDLLGPSLEDLFNFC---SRKLSLKTVLMLADQMINRV 88 (449)
Q Consensus 20 ~~~~E~~il~~l~~hp~Iv~l~~~~~~--------~~~~~lVmE~~g~sL~~ll~~~---~~~ls~~~~~~i~~qi~~aL 88 (449)
...+|+.+|+.+ +|+||+++++++.. ..+.++||||++++|.+++... ...+++..++.++.||+.||
T Consensus 105 ~~~~Ei~il~~l-~h~niv~l~~~~~~~~~~~~~~~~~l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL 183 (440)
T PTZ00036 105 YKNRELLIMKNL-NHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRAL 183 (440)
T ss_pred hHHHHHHHHHhc-CCCCCcceeeeEeecccccCCCceEEEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHH
Confidence 456899999999 89999999877643 2357899999988898887532 45699999999999999999
Q ss_pred HHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCC-CCChhhH
Q 013092 89 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDD 167 (449)
Q Consensus 89 ~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~-~~s~~~D 167 (449)
+|||++||+||||||+||||. ...+.+||+|||+++.+..... .....||+.|+|||++.+. .++.++|
T Consensus 184 ~yLH~~~IiHrDLKp~NILl~--~~~~~vkL~DFGla~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~D 253 (440)
T PTZ00036 184 AYIHSKFICHRDLKPQNLLID--PNTHTLKLCDFGSAKNLLAGQR--------SVSYICSRFYRAPELMLGATNYTTHID 253 (440)
T ss_pred HHHHHCCEecCCcCHHHEEEc--CCCCceeeeccccchhccCCCC--------cccCCCCcCccCHHHhcCCCCCCcHHH
Confidence 999999999999999999994 2345799999999987643221 1245789999999998764 6899999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhccc------------------------chHHHhhcCCcHHHHHH
Q 013092 168 LESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS------------------------TSIEALCRGYPTEFASY 223 (449)
Q Consensus 168 iwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~------------------------~~~~~l~~~~p~el~~l 223 (449)
||||||++|||++|.+||.+.... +.+.++...... .....++...|.++.+|
T Consensus 254 iwSlGvil~elltG~~pf~~~~~~---~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~l 330 (440)
T PTZ00036 254 LWSLGCIIAEMILGYPIFSGQSSV---DQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINF 330 (440)
T ss_pred HHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHH
Confidence 999999999999999999875432 222222211100 01112234578899999
Q ss_pred HHHHhcCCCCCCCCHHHHH
Q 013092 224 FHYCRSLRFDDKPDYAYLK 242 (449)
Q Consensus 224 i~~cl~~~p~~RPt~~~l~ 242 (449)
|..||..+|.+||++.+++
T Consensus 331 i~~~L~~dP~~R~ta~e~l 349 (440)
T PTZ00036 331 ISQFLKYEPLKRLNPIEAL 349 (440)
T ss_pred HHHHCCCChhHCcCHHHHh
Confidence 9999999999999988775
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=290.27 Aligned_cols=213 Identities=19% Similarity=0.217 Sum_probs=169.6
Q ss_pred ChhHHHHHHHHHHHhcCCCCCceEEEEeEeCC-----EEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHH
Q 013092 17 KHPQLLYESKLYRILQGGTGIPNVRWFGVEGD-----YNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 91 (449)
Q Consensus 17 ~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~-----~~~lVmE~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yL 91 (449)
....+.+|+++++.+ .|+||+.+++++...+ ..|+||||++++|.+++.. ...+++..+..++.||+.||+||
T Consensus 42 ~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~-~~~l~~~~~~~~~~qi~~aL~~L 119 (372)
T cd07853 42 SCKRVFRELKMLCFF-KHDNVLSALDILQPPHIDPFEEIYVVTELMQSDLHKIIVS-PQPLSSDHVKVFLYQILRGLKYL 119 (372)
T ss_pred HHHHHHHHHHHHHhC-CCCCcCCHhheecCCCccccceEEEEeeccccCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHH
Confidence 345688999999999 8999999999988776 8899999998889888864 56799999999999999999999
Q ss_pred HHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCC-CCChhhHHHH
Q 013092 92 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLES 170 (449)
Q Consensus 92 H~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~-~~s~~~DiwS 170 (449)
|++||+||||||+|||+ +.++.+||+|||+++........ ......+|..|+|||++.+. .++.++||||
T Consensus 120 H~~~ivH~dlkp~Nili---~~~~~~kL~Dfg~a~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~Diws 190 (372)
T cd07853 120 HSAGILHRDIKPGNLLV---NSNCVLKICDFGLARVEEPDESK------HMTQEVVTQYYRAPEILMGSRHYTSAVDIWS 190 (372)
T ss_pred HhCCeeCCCCChHHEEE---CCCCCEEeccccceeecccCccc------cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHh
Confidence 99999999999999999 57889999999999865433211 12234678999999999874 4789999999
Q ss_pred HHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccc------------------------hHH---HhhcCCcHHHHHH
Q 013092 171 LGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST------------------------SIE---ALCRGYPTEFASY 223 (449)
Q Consensus 171 lG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~------------------------~~~---~l~~~~p~el~~l 223 (449)
|||++|||++|+.||.+.+.. +.+..+.+..... ... .+...+++++.+|
T Consensus 191 lG~il~el~~g~~pf~~~~~~---~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 267 (372)
T cd07853 191 VGCIFAELLGRRILFQAQSPI---QQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHL 267 (372)
T ss_pred HHHHHHHHHcCCCCCCCCCHH---HHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHH
Confidence 999999999999999875432 2222222211100 011 1223467899999
Q ss_pred HHHHhcCCCCCCCCHHHHHH
Q 013092 224 FHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 224 i~~cl~~~p~~RPt~~~l~~ 243 (449)
|..||+.||++||++.+++.
T Consensus 268 i~~mL~~dP~~R~t~~e~l~ 287 (372)
T cd07853 268 LCRMLVFDPDKRISAADALA 287 (372)
T ss_pred HHHhCCCChhhCcCHHHHhc
Confidence 99999999999999877643
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=272.22 Aligned_cols=212 Identities=25% Similarity=0.356 Sum_probs=179.3
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHc--------CCCCCHHHHHHHHHHHHHHH
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFC--------SRKLSLKTVLMLADQMINRV 88 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~--------~~~ls~~~~~~i~~qi~~aL 88 (449)
...+.+|++++..+ +|+||+++++++.++...+|||||+ +++|.+++... ...+++..++.++.|++.||
T Consensus 40 ~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al 118 (262)
T cd00192 40 RKDFLKEARVMKKL-GHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGM 118 (262)
T ss_pred HHHHHHHHHHHhhc-CCCChheeeeeecCCCceEEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHH
Confidence 56789999999999 5999999999999999999999999 99999999865 36799999999999999999
Q ss_pred HHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHH
Q 013092 89 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDL 168 (449)
Q Consensus 89 ~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~Di 168 (449)
+|||++||+|+||||+||++ +.++.++|+|||.+........ +.......++..|+|||.+....++.++||
T Consensus 119 ~~lH~~~i~H~di~p~nili---~~~~~~~l~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di 190 (262)
T cd00192 119 EYLASKKFVHRDLAARNCLV---GEDLVVKISDFGLSRDVYDDDY-----YRKKTGGKLPIRWMAPESLKDGIFTSKSDV 190 (262)
T ss_pred HHHHcCCcccCccCcceEEE---CCCCcEEEcccccccccccccc-----cccccCCCcCccccCHHHhccCCcchhhcc
Confidence 99999999999999999999 5779999999999987765432 122344567889999999998889999999
Q ss_pred HHHHHHHHHHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Q 013092 169 ESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIF 245 (449)
Q Consensus 169 wSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~L 245 (449)
|||||++|+|++ |..||..... .+....+.... .......+|.++.+++..||..+|++||++.+|...|
T Consensus 191 ~slG~il~~l~~~g~~p~~~~~~---~~~~~~~~~~~----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l 261 (262)
T cd00192 191 WSFGVLLWEIFTLGATPYPGLSN---EEVLEYLRKGY----RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERL 261 (262)
T ss_pred HHHHHHHHHHHhcCCCCCCCCCH---HHHHHHHHcCC----CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 999999999999 6999987533 33333333321 1123456789999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=276.36 Aligned_cols=214 Identities=19% Similarity=0.252 Sum_probs=174.8
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcC---------------CCCCHHHHHHHH
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCS---------------RKLSLKTVLMLA 81 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~---------------~~ls~~~~~~i~ 81 (449)
.+.+..|+.++..+.+||||+++++++...+..|+||||+ +++|.+++.... ..+++..++.++
T Consensus 39 ~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 118 (270)
T cd05047 39 HRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 118 (270)
T ss_pred HHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHH
Confidence 3568899999999989999999999999999999999999 899999987421 247899999999
Q ss_pred HHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCC
Q 013092 82 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIE 161 (449)
Q Consensus 82 ~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~ 161 (449)
.|++.||+|||++|++||||||+|||+ +.++.+||+|||++....... .......+..|+|||++....
T Consensus 119 ~~i~~al~~lH~~~i~H~dikp~nili---~~~~~~kl~dfgl~~~~~~~~--------~~~~~~~~~~y~apE~~~~~~ 187 (270)
T cd05047 119 ADVARGMDYLSQKQFIHRDLAARNILV---GENYVAKIADFGLSRGQEVYV--------KKTMGRLPVRWMAIESLNYSV 187 (270)
T ss_pred HHHHHHHHHHHHCCEeecccccceEEE---cCCCeEEECCCCCccccchhh--------hccCCCCccccCChHHHccCC
Confidence 999999999999999999999999999 578899999999986322110 111223456799999998888
Q ss_pred CChhhHHHHHHHHHHHHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHH
Q 013092 162 QSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAY 240 (449)
Q Consensus 162 ~s~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~ 240 (449)
++.++|||||||++|||++ |..||.+.+. ...+..+..... ......++.++.+++.+||..+|.+||++.+
T Consensus 188 ~~~~~Di~slG~il~el~~~g~~pf~~~~~---~~~~~~~~~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 260 (270)
T cd05047 188 YTTNSDVWSYGVLLWEIVSLGGTPYCGMTC---AELYEKLPQGYR----LEKPLNCDDEVYDLMRQCWREKPYERPSFAQ 260 (270)
T ss_pred CCchhhHHHHHHHHHHHHcCCCCCccccCH---HHHHHHHhCCCC----CCCCCcCCHHHHHHHHHHcccChhhCCCHHH
Confidence 9999999999999999997 9999976433 233333322211 1123457889999999999999999999999
Q ss_pred HHHHHHHHH
Q 013092 241 LKRIFRDLF 249 (449)
Q Consensus 241 l~~~L~~~~ 249 (449)
+...|.+++
T Consensus 261 il~~l~~~~ 269 (270)
T cd05047 261 ILVSLNRML 269 (270)
T ss_pred HHHHHHHhh
Confidence 999988775
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=280.71 Aligned_cols=216 Identities=19% Similarity=0.288 Sum_probs=177.5
Q ss_pred hHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHc---------------CCCCCHHHHHHHHH
Q 013092 19 PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFC---------------SRKLSLKTVLMLAD 82 (449)
Q Consensus 19 ~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~---------------~~~ls~~~~~~i~~ 82 (449)
..+.+|+.+++.+.+|+||+++++++..++..|+||||+ +++|.+++... ...+++..++.++.
T Consensus 60 ~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~ 139 (293)
T cd05053 60 SDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAY 139 (293)
T ss_pred HHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHH
Confidence 458899999999988999999999999999999999999 99999998632 34689999999999
Q ss_pred HHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCC
Q 013092 83 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQ 162 (449)
Q Consensus 83 qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~ 162 (449)
|++.||+|||+.||+||||||+||++ +.++.+||+|||+++.+...... .......++..|+|||++.+..+
T Consensus 140 qi~~al~~LH~~~ivH~dlkp~Nil~---~~~~~~kL~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~ 211 (293)
T cd05053 140 QVARGMEFLASKKCIHRDLAARNVLV---TEDHVMKIADFGLARDIHHIDYY-----RKTTNGRLPVKWMAPEALFDRVY 211 (293)
T ss_pred HHHHHHHHHHHCCccccccceeeEEE---cCCCeEEeCccccccccccccce-----eccCCCCCCccccCHHHhccCCc
Confidence 99999999999999999999999999 57889999999999876543221 11122345678999999998889
Q ss_pred ChhhHHHHHHHHHHHHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHH
Q 013092 163 SRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYL 241 (449)
Q Consensus 163 s~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l 241 (449)
+.++|||||||++|||++ |..||.+... .+.+..+...... .....++.++.+|+..||..+|++||++.+|
T Consensus 212 ~~~~Di~slG~il~el~~~g~~p~~~~~~---~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~ei 284 (293)
T cd05053 212 THQSDVWSFGVLLWEIFTLGGSPYPGIPV---EELFKLLKEGYRM----EKPQNCTQELYHLMRDCWHEVPSQRPTFKQL 284 (293)
T ss_pred CcccceeehhhHHHHHhcCCCCCCCCCCH---HHHHHHHHcCCcC----CCCCCCCHHHHHHHHHHcccCcccCcCHHHH
Confidence 999999999999999997 9999976432 2333333322211 1234578899999999999999999999999
Q ss_pred HHHHHHHH
Q 013092 242 KRIFRDLF 249 (449)
Q Consensus 242 ~~~L~~~~ 249 (449)
.+.|.+++
T Consensus 285 l~~l~~~~ 292 (293)
T cd05053 285 VEDLDRML 292 (293)
T ss_pred HHHHHHhh
Confidence 99988764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=278.40 Aligned_cols=203 Identities=27% Similarity=0.490 Sum_probs=160.7
Q ss_pred CCCCCceEEEEeEeCC----EEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEE
Q 013092 33 GGTGIPNVRWFGVEGD----YNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM 108 (449)
Q Consensus 33 ~hp~Iv~l~~~~~~~~----~~~lVmE~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~givHRDLKP~NiLl 108 (449)
.|++|+.+++.+.... +.|++|+++..++.+++.. ...+++..++.++.|++.||+|||+++|+||||||+|||+
T Consensus 81 ~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill 159 (294)
T PHA02882 81 DHLGIPKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKR-IKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMV 159 (294)
T ss_pred CCCCCCcEEEeeeEecCCceEEEEEEehhccCHHHHHHh-hccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE
Confidence 7899999998876543 5689999998888888875 3346888999999999999999999999999999999999
Q ss_pred eecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHHHHHHHhCCCCCCCC
Q 013092 109 GLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGL 188 (449)
Q Consensus 109 ~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il~elltG~~Pf~~~ 188 (449)
+..+.++|+|||+++.+..................||+.|+|||++.+..++.++|||||||++|||++|..||.+.
T Consensus 160 ---~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~ 236 (294)
T PHA02882 160 ---DGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGF 236 (294)
T ss_pred ---cCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCcc
Confidence 57789999999999877543222111111223457999999999999999999999999999999999999999876
Q ss_pred CcCCHHHH------HHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Q 013092 189 KAGTKKQK------YEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIF 245 (449)
Q Consensus 189 ~~~~~~~~------~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~L 245 (449)
........ +..+...+ .....+|+++.+++..||..+|++||+|.+|++.|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 237 GHNGNLIHAAKCDFIKRLHEGK------IKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred ccchHHHHHhHHHHHHHhhhhh------hccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 33221111 11111111 12356789999999999999999999999998875
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=298.32 Aligned_cols=221 Identities=24% Similarity=0.321 Sum_probs=185.2
Q ss_pred CCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH
Q 013092 15 KTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 93 (449)
Q Consensus 15 ~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~ 93 (449)
+.+..+|.+|+++|+.+ +|||||.++++......+|||||+| ||+|.+++++....++..+.+.++.+.++||+|||+
T Consensus 202 ~~~~~e~m~EArvMr~l-~H~NVVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~ 280 (474)
T KOG0194|consen 202 KEQIKEFMKEARVMRQL-NHPNVVRFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHS 280 (474)
T ss_pred HHHHHHHHHHHHHHHhC-CCCCEEEEEEEEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHH
Confidence 45667799999999999 9999999999999999999999999 999999999755569999999999999999999999
Q ss_pred CCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCC-CCccCccccchhhhhCCCCChhhHHHHHH
Q 013092 94 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENK-NLTGTARYASMNTHLGIEQSRRDDLESLG 172 (449)
Q Consensus 94 ~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~-~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG 172 (449)
+++|||||-.+|+|+ ...+.+||+||||++.... |.... ...-..+|+|||++...-|+.++||||||
T Consensus 281 k~~IHRDIAARNcL~---~~~~~vKISDFGLs~~~~~--------~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfG 349 (474)
T KOG0194|consen 281 KNCIHRDIAARNCLY---SKKGVVKISDFGLSRAGSQ--------YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFG 349 (474)
T ss_pred CCCcchhHhHHHhee---cCCCeEEeCccccccCCcc--------eeeccccccCcceecChhhhccCccccccchhhee
Confidence 999999999999999 4667789999999875431 11111 11245799999999999999999999999
Q ss_pred HHHHHHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 013092 173 YVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIR 251 (449)
Q Consensus 173 ~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~L~~~~~~ 251 (449)
|++||+++ |..||.+.... +...+|........ .+...|.++..++..||..+|++||++.++.+.|+.+...
T Consensus 350 V~~~Eif~~g~~Py~g~~~~---~v~~kI~~~~~r~~---~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~ 423 (474)
T KOG0194|consen 350 VLLWEIFENGAEPYPGMKNY---EVKAKIVKNGYRMP---IPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKK 423 (474)
T ss_pred eeEEeeeccCCCCCCCCCHH---HHHHHHHhcCccCC---CCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhc
Confidence 99999998 89999997653 34444433222221 2336789999999999999999999999999999988655
Q ss_pred cC
Q 013092 252 EG 253 (449)
Q Consensus 252 ~~ 253 (449)
..
T Consensus 424 ~~ 425 (474)
T KOG0194|consen 424 KE 425 (474)
T ss_pred cc
Confidence 43
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=290.68 Aligned_cols=217 Identities=23% Similarity=0.283 Sum_probs=176.2
Q ss_pred hHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcC----------------------------
Q 013092 19 PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCS---------------------------- 69 (449)
Q Consensus 19 ~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~---------------------------- 69 (449)
..+.+|+++|.++..||||+.+++++...+..||||||| +++|.+++....
T Consensus 85 ~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (401)
T cd05107 85 QALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQR 164 (401)
T ss_pred HHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhccccccccccccccccccccc
Confidence 468899999999966999999999999999999999999 999999986431
Q ss_pred ---------------------------------------------------------------------CCCCHHHHHHH
Q 013092 70 ---------------------------------------------------------------------RKLSLKTVLML 80 (449)
Q Consensus 70 ---------------------------------------------------------------------~~ls~~~~~~i 80 (449)
..+++..++.+
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 244 (401)
T cd05107 165 KSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGF 244 (401)
T ss_pred ccchhhhhccCccccccCCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHH
Confidence 13677788999
Q ss_pred HHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCC
Q 013092 81 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI 160 (449)
Q Consensus 81 ~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~ 160 (449)
+.||+.||+|||+.+|+||||||+|||+ +..+.++|+|||+++.+...... .......++..|++||++.+.
T Consensus 245 ~~qi~~aL~~LH~~~ivHrdlkp~NiLl---~~~~~~kL~DfGla~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~ 316 (401)
T cd05107 245 SYQVANGMEFLASKNCVHRDLAARNVLI---CEGKLVKICDFGLARDIMRDSNY-----ISKGSTFLPLKWMAPESIFNN 316 (401)
T ss_pred HHHHHHHHHHHhcCCcCcccCCcceEEE---eCCCEEEEEecCcceeccccccc-----ccCCCcCCCCceeChHHhcCC
Confidence 9999999999999999999999999999 46789999999999865432211 112234578899999999988
Q ss_pred CCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHH
Q 013092 161 EQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYA 239 (449)
Q Consensus 161 ~~s~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~ 239 (449)
.++.++|||||||++|||++ |..||...... ......+... ... ..+..++.++.+|+..||..+|++||++.
T Consensus 317 ~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~--~~~~~~~~~~-~~~---~~p~~~~~~l~~li~~cl~~~P~~RPs~~ 390 (401)
T cd05107 317 LYTTLSDVWSFGILLWEIFTLGGTPYPELPMN--EQFYNAIKRG-YRM---AKPAHASDEIYEIMQKCWEEKFEIRPDFS 390 (401)
T ss_pred CCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch--HHHHHHHHcC-CCC---CCCCCCCHHHHHHHHHHcCCChhHCcCHH
Confidence 89999999999999999998 89999765332 1222222221 111 12345789999999999999999999999
Q ss_pred HHHHHHHHHH
Q 013092 240 YLKRIFRDLF 249 (449)
Q Consensus 240 ~l~~~L~~~~ 249 (449)
+|+..|++++
T Consensus 391 ell~~L~~~~ 400 (401)
T cd05107 391 QLVHLVGDLL 400 (401)
T ss_pred HHHHHHHHHh
Confidence 9999998875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=277.18 Aligned_cols=213 Identities=21% Similarity=0.294 Sum_probs=175.5
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcC--------------CCCCHHHHHHHHH
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCS--------------RKLSLKTVLMLAD 82 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~--------------~~ls~~~~~~i~~ 82 (449)
...+.+|+++++.+ .|+||+++++++.++...|+||||+ +++|.+++.... ..+++..++.++.
T Consensus 51 ~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 129 (280)
T cd05092 51 RQDFQREAELLTVL-QHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIAS 129 (280)
T ss_pred HHHHHHHHHHHhcC-CCCCCceEEEEEecCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHH
Confidence 45689999999999 8999999999999999999999999 999999987532 2488999999999
Q ss_pred HHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCC
Q 013092 83 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQ 162 (449)
Q Consensus 83 qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~ 162 (449)
|++.||+|||++||+||||||+|||+ +.++.++|+|||++........ +.......+++.|+|||++.+..+
T Consensus 130 qi~~al~~LH~~~i~H~dlkp~nil~---~~~~~~kL~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~ 201 (280)
T cd05092 130 QIASGMVYLASLHFVHRDLATRNCLV---GQGLVVKIGDFGMSRDIYSTDY-----YRVGGRTMLPIRWMPPESILYRKF 201 (280)
T ss_pred HHHHHHHHHHHCCeecccccHhhEEE---cCCCCEEECCCCceeEcCCCce-----eecCCCccccccccCHHHhccCCc
Confidence 99999999999999999999999999 5788999999999976543221 122233456788999999999999
Q ss_pred ChhhHHHHHHHHHHHHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHH
Q 013092 163 SRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYL 241 (449)
Q Consensus 163 s~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l 241 (449)
+.++|||||||++|+|++ |..||..... ...+..+..... ......+|+.+.+++..||+.+|++||++.+|
T Consensus 202 ~~~~Di~slG~il~el~~~g~~p~~~~~~---~~~~~~~~~~~~----~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l 274 (280)
T cd05092 202 TTESDIWSFGVVLWEIFTYGKQPWYQLSN---TEAIECITQGRE----LERPRTCPPEVYAIMQGCWQREPQQRMVIKDI 274 (280)
T ss_pred CchhhHHHHHHHHHHHHcCCCCCCccCCH---HHHHHHHHcCcc----CCCCCCCCHHHHHHHHHHccCChhhCCCHHHH
Confidence 999999999999999998 9999976433 223333322211 12234688999999999999999999999999
Q ss_pred HHHHH
Q 013092 242 KRIFR 246 (449)
Q Consensus 242 ~~~L~ 246 (449)
.+.|+
T Consensus 275 ~~~l~ 279 (280)
T cd05092 275 HSRLQ 279 (280)
T ss_pred HHHHh
Confidence 88764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=275.01 Aligned_cols=228 Identities=16% Similarity=0.171 Sum_probs=178.9
Q ss_pred EEEeeecccCC---ChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHH
Q 013092 6 TVFSVQENVKT---KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLA 81 (449)
Q Consensus 6 kV~~k~~~~~~---~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~ 81 (449)
++++|...... ....+..|+.++..+ +||||+++++++. +...+++|||+ +++|.+++......+++..++.++
T Consensus 38 ~~~~k~~~~~~~~~~~~~~~~~~~~l~~l-~h~~iv~~~~~~~-~~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~ 115 (279)
T cd05111 38 PVAIKTIQDRSGRQTFQEITDHMLAMGSL-DHAYIVRLLGICP-GASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWC 115 (279)
T ss_pred EEEEeecccccchHHHHHHHHHHHHHhcC-CCCCcceEEEEEC-CCccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHH
Confidence 45555553322 224566777788888 8999999999875 45578899999 999999998656679999999999
Q ss_pred HHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCC
Q 013092 82 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIE 161 (449)
Q Consensus 82 ~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~ 161 (449)
.||+.||+|||++|++||||||+|||+ +.++.+||+|||+++......... ......++..|++||++.+..
T Consensus 116 ~qi~~~l~~lH~~~iiH~dlkp~nili---~~~~~~kl~Dfg~~~~~~~~~~~~-----~~~~~~~~~~y~~pE~~~~~~ 187 (279)
T cd05111 116 VQIAKGMYYLEEHRMVHRNLAARNILL---KSDSIVQIADFGVADLLYPDDKKY-----FYSEHKTPIKWMALESILFGR 187 (279)
T ss_pred HHHHHHHHHHHHCCEeccccCcceEEE---cCCCcEEEcCCccceeccCCCccc-----ccCCCCCcccccCHHHhccCC
Confidence 999999999999999999999999999 578899999999998764332111 112345778899999999888
Q ss_pred CChhhHHHHHHHHHHHHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHH
Q 013092 162 QSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAY 240 (449)
Q Consensus 162 ~s~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~ 240 (449)
++.++|||||||++|||++ |..||.+.... .+..+.+..... .....++.++..++..||..+|++||++.+
T Consensus 188 ~~~~~Dv~slG~il~el~t~g~~p~~~~~~~----~~~~~~~~~~~~---~~~~~~~~~~~~li~~c~~~~p~~Rps~~e 260 (279)
T cd05111 188 YTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH----EVPDLLEKGERL---AQPQICTIDVYMVMVKCWMIDENVRPTFKE 260 (279)
T ss_pred cCchhhHHHHHHHHHHHHcCCCCCCCCCCHH----HHHHHHHCCCcC---CCCCCCCHHHHHHHHHHcCCCcccCcCHHH
Confidence 9999999999999999998 99999875332 222222221111 122347889999999999999999999999
Q ss_pred HHHHHHHHHH
Q 013092 241 LKRIFRDLFI 250 (449)
Q Consensus 241 l~~~L~~~~~ 250 (449)
+.+.|..+..
T Consensus 261 l~~~l~~~~~ 270 (279)
T cd05111 261 LANEFTRMAR 270 (279)
T ss_pred HHHHHHHHHh
Confidence 9998887654
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=272.64 Aligned_cols=215 Identities=22% Similarity=0.287 Sum_probs=175.8
Q ss_pred ChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 013092 17 KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 95 (449)
Q Consensus 17 ~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~g 95 (449)
...++..|+.+++.+ +|+||+++++++. .+..++||||+ +++|.+++.. ...+++..++.++.|++.||+|||..+
T Consensus 39 ~~~~~~~e~~~l~~l-~h~~iv~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lh~~~ 115 (257)
T cd05060 39 GKKEFLREASVMAQL-DHPCIVRLIGVCK-GEPLMLVMELAPLGPLLKYLKK-RREIPVSDLKELAHQVAMGMAYLESKH 115 (257)
T ss_pred HHHHHHHHHHHHHhc-CCCCeeeEEEEEc-CCceEEEEEeCCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhhcC
Confidence 345688999999999 8999999998775 55689999999 8999999985 346999999999999999999999999
Q ss_pred ceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHHH
Q 013092 96 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVL 175 (449)
Q Consensus 96 ivHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il 175 (449)
++|+||||+|||+ +.++.+||+|||+++.+...... +.......++..|+|||.+.+..++.++|||||||++
T Consensus 116 i~H~di~p~nili---~~~~~~kl~df~~~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l 188 (257)
T cd05060 116 FVHRDLAARNVLL---VNRHQAKISDFGMSRALGAGSDY----YRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTL 188 (257)
T ss_pred eeccCcccceEEE---cCCCcEEeccccccceeecCCcc----cccccCccccccccCHHHhcCCCCCccchHHHHHHHH
Confidence 9999999999999 57889999999999876543321 1112223345789999999988899999999999999
Q ss_pred HHHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 013092 176 MYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDL 248 (449)
Q Consensus 176 ~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~L~~~ 248 (449)
|+|++ |..||...+. .+....+..... ......++.++.++|..||..+|++||++.+|.+.|+++
T Consensus 189 ~~~~~~g~~p~~~~~~---~~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 189 WEAFSYGAKPYGEMKG---AEVIAMLESGER----LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred HHHHcCCCCCcccCCH---HHHHHHHHcCCc----CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 99998 9999976533 233333333221 123456889999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=289.16 Aligned_cols=222 Identities=21% Similarity=0.253 Sum_probs=169.6
Q ss_pred EEEEEeeecccCCChhHHHHHHHHHHHhcCCCCCceEEEEeEeC------CEEEEEEecCCCCHHHHHHHcCCCCCHHHH
Q 013092 4 ILTVFSVQENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEG------DYNVLVMDLLGPSLEDLFNFCSRKLSLKTV 77 (449)
Q Consensus 4 aikV~~k~~~~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~------~~~~lVmE~~g~sL~~ll~~~~~~ls~~~~ 77 (449)
|+|++.+..........+.+|+.+++.+ +||||+++++++... ...|+||||++++|.+++. ..++...+
T Consensus 50 avK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~---~~~~~~~~ 125 (359)
T cd07876 50 AVKKLSRPFQNQTHAKRAYRELVLLKCV-NHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIH---MELDHERM 125 (359)
T ss_pred EEEEecccccchhHHHHHHHHHHHHHhC-CCCCEeeeeeeeccCCCccccceeEEEEeCCCcCHHHHHh---ccCCHHHH
Confidence 4454443333334456688999999999 899999999887643 3579999999778887775 35889999
Q ss_pred HHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhh
Q 013092 78 LMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTH 157 (449)
Q Consensus 78 ~~i~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~ 157 (449)
..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++....... .....||+.|+|||++
T Consensus 126 ~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~---~~~~~~kl~Dfg~a~~~~~~~~--------~~~~~~t~~y~aPE~~ 194 (359)
T cd07876 126 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTACTNFM--------MTPYVVTRYYRAPEVI 194 (359)
T ss_pred HHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---CCCCCEEEecCCCccccccCcc--------CCCCcccCCCCCchhc
Confidence 9999999999999999999999999999999 5788999999999975433211 1345789999999999
Q ss_pred hCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccc-------------------------hHHHh
Q 013092 158 LGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST-------------------------SIEAL 212 (449)
Q Consensus 158 ~~~~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~-------------------------~~~~l 212 (449)
.+..++.++|||||||++|+|++|..||.+.+... .+..+.+....+ ...++
T Consensus 195 ~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (359)
T cd07876 195 LGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHID---QWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEEL 271 (359)
T ss_pred cCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhh
Confidence 99999999999999999999999999998754321 111111110000 00000
Q ss_pred ------------hcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 213 ------------CRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 213 ------------~~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
....++++.+||.+||..||++||++.+++.
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 314 (359)
T cd07876 272 FPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR 314 (359)
T ss_pred ccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhc
Confidence 1123578999999999999999999887754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-34 Score=273.62 Aligned_cols=216 Identities=23% Similarity=0.315 Sum_probs=176.8
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHH
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHS 93 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~---~~~ls~~~~~~i~~qi~~aL~yLH~ 93 (449)
...+.+|+++++.+ +||||+++++++.+.+..++||||+ +++|.+++... ...++...++.++.|++.||+|||+
T Consensus 46 ~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~ 124 (267)
T cd08228 46 RQDCVKEIDLLKQL-NHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHS 124 (267)
T ss_pred HHHHHHHHHHHHhC-CCcceeeeeeeEEECCeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhh
Confidence 34588999999999 8999999999999999999999999 88999988632 3458999999999999999999999
Q ss_pred CCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHH
Q 013092 94 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGY 173 (449)
Q Consensus 94 ~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~ 173 (449)
+|++|+||||+||++ +.++.++|+|||++..+..... ......|++.|+|||.+.+..++.++|+||||+
T Consensus 125 ~~i~H~dl~~~nil~---~~~~~~~l~d~g~~~~~~~~~~-------~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~ 194 (267)
T cd08228 125 RRVMHRDIKPANVFI---TATGVVKLGDLGLGRFFSSKTT-------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGC 194 (267)
T ss_pred CCeeCCCCCHHHEEE---cCCCCEEECccccceeccchhH-------HHhcCCCCccccChhhhccCCCCchhhHHHHHH
Confidence 999999999999999 5778899999999987654321 112346889999999999888999999999999
Q ss_pred HHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 013092 174 VLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDL 248 (449)
Q Consensus 174 il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~L~~~ 248 (449)
++|+|++|..||..... ........+....... .....++.++.++|.+||..+|++||++.++++.|+.+
T Consensus 195 ~l~el~~g~~p~~~~~~-~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 195 LLYEMAALQSPFYGDKM-NLFSLCQKIEQCDYPP---LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred HHHHHhcCCCCCccccc-cHHHHHHHHhcCCCCC---CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 99999999999976432 2222333332222111 11235778999999999999999999999999988764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=281.21 Aligned_cols=221 Identities=16% Similarity=0.262 Sum_probs=180.9
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHc---------------CCCCCHHHHHHHH
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFC---------------SRKLSLKTVLMLA 81 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~---------------~~~ls~~~~~~i~ 81 (449)
...+.+|+.+++.+.+|+||+++++++...+..|+||||+ +++|.+++... ...+++..++.++
T Consensus 61 ~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 140 (334)
T cd05100 61 LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCA 140 (334)
T ss_pred HHHHHHHHHHHHhhcCCCCeeeeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHH
Confidence 3568899999999988999999999999999999999999 89999998742 1247889999999
Q ss_pred HHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCC
Q 013092 82 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIE 161 (449)
Q Consensus 82 ~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~ 161 (449)
.|++.||+|||++||+||||||+|||+ +.++.+||+|||+++........ .......++..|+|||++.+..
T Consensus 141 ~qi~~al~~LH~~givH~dlkp~Nill---~~~~~~kL~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~ 212 (334)
T cd05100 141 YQVARGMEYLASQKCIHRDLAARNVLV---TEDNVMKIADFGLARDVHNIDYY-----KKTTNGRLPVKWMAPEALFDRV 212 (334)
T ss_pred HHHHHHHHHHHHCCeeccccccceEEE---cCCCcEEECCcccceeccccccc-----ccccCCCcCceEcCHHHhccCC
Confidence 999999999999999999999999999 57789999999999876543211 1112234457899999999999
Q ss_pred CChhhHHHHHHHHHHHHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHH
Q 013092 162 QSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAY 240 (449)
Q Consensus 162 ~s~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~ 240 (449)
++.++|||||||++|||++ |..||.+.+. .+.+..+..... ......++.++.+++..||+.+|++||++.+
T Consensus 213 ~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e 285 (334)
T cd05100 213 YTHQSDVWSFGVLLWEIFTLGGSPYPGIPV---EELFKLLKEGHR----MDKPANCTHELYMIMRECWHAVPSQRPTFKQ 285 (334)
T ss_pred cCchhhhHHHHHHHHHHHhcCCCCCCCCCH---HHHHHHHHcCCC----CCCCCCCCHHHHHHHHHHcccChhhCcCHHH
Confidence 9999999999999999998 8999977432 333333333221 1233467889999999999999999999999
Q ss_pred HHHHHHHHHHHcC
Q 013092 241 LKRIFRDLFIREG 253 (449)
Q Consensus 241 l~~~L~~~~~~~~ 253 (449)
|++.|+.++....
T Consensus 286 ll~~l~~~~~~~~ 298 (334)
T cd05100 286 LVEDLDRVLTVTS 298 (334)
T ss_pred HHHHHHHHhhhcC
Confidence 9999998876554
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=273.74 Aligned_cols=215 Identities=19% Similarity=0.262 Sum_probs=168.7
Q ss_pred hHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHH
Q 013092 19 PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCS----RKLSLKTVLMLADQMINRVEFVHS 93 (449)
Q Consensus 19 ~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~----~~ls~~~~~~i~~qi~~aL~yLH~ 93 (449)
..+.+|+.+++.+ +||||+++++.+.+....|+||||+ +++|.+++.... ..+++..++.++.|++.||+|||+
T Consensus 40 ~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~ 118 (269)
T cd05087 40 MKFLEEAQPYRSL-QHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK 118 (269)
T ss_pred HHHHHHHHHHHhC-CCCCEeeEEEEEcCCCCcEEEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH
Confidence 4688899999999 8999999999999999999999999 899999986421 245777888999999999999999
Q ss_pred CCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCC-------CCChhh
Q 013092 94 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI-------EQSRRD 166 (449)
Q Consensus 94 ~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~-------~~s~~~ 166 (449)
.|++||||||+||++ +..+.++|+|||+++....... +.......++..|+|||++.+. .++.++
T Consensus 119 ~~i~H~dlkp~nil~---~~~~~~kL~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~ 190 (269)
T cd05087 119 NNFIHSDLALRNCLL---TADLTVKIGDYGLSHNKYKEDY-----YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKES 190 (269)
T ss_pred CCEeccccCcceEEE---cCCCcEEECCccccccccCcce-----eecCCCcCCcccccCHhHhccccccccccCCCccc
Confidence 999999999999999 5778999999999875433221 1122345678899999998642 357899
Q ss_pred HHHHHHHHHHHHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Q 013092 167 DLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIF 245 (449)
Q Consensus 167 DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~L 245 (449)
|||||||++|||++ |..||....... .....+.........+.+...+++++.++|..|| .+|++||++.+|...|
T Consensus 191 DiwslG~~l~el~~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l 267 (269)
T cd05087 191 NVWSLGVTIWELFELGSQPYRHLSDEQ--VLTYTVREQQLKLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLL 267 (269)
T ss_pred hhHHHHHHHHHHHhCCCCCCCCCChHH--HHHHHhhcccCCCCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHh
Confidence 99999999999996 999997654322 1111222222222222333457889999999999 6899999999998765
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=284.64 Aligned_cols=219 Identities=15% Similarity=0.194 Sum_probs=166.9
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKS 95 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~-~~~ls~~~~~~i~~qi~~aL~yLH~~g 95 (449)
...+.+|+.+++.+ +||||+++++++..++..|+||||+ +++|.+++... ...+++..++.++.|++.||+|||++|
T Consensus 43 ~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ 121 (327)
T cd08227 43 VTFLQGELHVSKLF-NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG 121 (327)
T ss_pred HHHHHHHHHHHHhc-CCCCeeeEEEEEEECCEEEEEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 45677899999999 9999999999999999999999999 89999999653 345899999999999999999999999
Q ss_pred ceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhC--CCCChhhHHHHHHH
Q 013092 96 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG--IEQSRRDDLESLGY 173 (449)
Q Consensus 96 ivHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~--~~~s~~~DiwSlG~ 173 (449)
|+||||||+|||+ +.++.++++||+.......................++..|+|||++.+ ..++.++|||||||
T Consensus 122 iiH~dlkp~Nil~---~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~ 198 (327)
T cd08227 122 YVHRSVKASHILI---SVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGI 198 (327)
T ss_pred EecCCCChhhEEE---ecCCcEEEcccchhhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHH
Confidence 9999999999999 577899999998765443221111000011223457788999999986 45899999999999
Q ss_pred HHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccc-----------------------------------------hHHHh
Q 013092 174 VLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST-----------------------------------------SIEAL 212 (449)
Q Consensus 174 il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~-----------------------------------------~~~~l 212 (449)
++|||++|..||....... .+.......... .....
T Consensus 199 il~el~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (327)
T cd08227 199 TACELANGHVPFKDMPATQ---MLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPY 275 (327)
T ss_pred HHHHHHHCCCCCCCcchhH---HHHHHhcCCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCccccc
Confidence 9999999999997643311 111111100000 00011
Q ss_pred hcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 213 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 213 ~~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
...+++++.+|+..||+.||++||++.+|.+
T Consensus 276 ~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 276 NRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred ccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 2235678999999999999999999988754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=272.27 Aligned_cols=215 Identities=18% Similarity=0.312 Sum_probs=175.4
Q ss_pred ChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHC
Q 013092 17 KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSK 94 (449)
Q Consensus 17 ~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~-~~~ls~~~~~~i~~qi~~aL~yLH~~ 94 (449)
....+.+|+.+++.+ +|+||+++++.+. ....|+||||+ +++|.+++... ...+++..++.++.|++.||+|||+.
T Consensus 44 ~~~~~~~E~~~l~~l-~~~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~ 121 (262)
T cd05071 44 SPEAFLQEAQVMKKL-RHEKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM 121 (262)
T ss_pred CHHHHHHHHHHHHhC-CCCCcceEEEEEC-CCCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 345789999999999 8999999988764 45689999999 88999999753 34589999999999999999999999
Q ss_pred CceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHH
Q 013092 95 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYV 174 (449)
Q Consensus 95 givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~i 174 (449)
+|+|+||||.||++ +.++.++|+|||+++.+..... .......++..|++||+..+..++.++|||||||+
T Consensus 122 ~i~H~dl~p~Nill---~~~~~~~L~dfg~~~~~~~~~~------~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~ 192 (262)
T cd05071 122 NYVHRDLRAANILV---GENLVCKVADFGLARLIEDNEY------TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGIL 192 (262)
T ss_pred CccccccCcccEEE---cCCCcEEeccCCceeecccccc------ccccCCcccceecCHhHhccCCCCchhhHHHHHHH
Confidence 99999999999999 5778899999999987654321 11123346778999999998889999999999999
Q ss_pred HHHHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 013092 175 LMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLF 249 (449)
Q Consensus 175 l~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~L~~~~ 249 (449)
+|+|++ |..||.+... .+.+..+..... ......+|..+.+++..||+.+|++||++.++.+.|++.+
T Consensus 193 l~ellt~g~~p~~~~~~---~~~~~~~~~~~~----~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 193 LTELTTKGRVPYPGMVN---REVLDQVERGYR----MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred HHHHHcCCCCCCCCCCh---HHHHHHHhcCCC----CCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 999999 8999976432 333333322211 1123457899999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=280.14 Aligned_cols=258 Identities=43% Similarity=0.674 Sum_probs=213.8
Q ss_pred EEeeecccC--CChhHHHHHHHHHHHhc---CCCCCceEEEEe-EeCCEEEEEEecCCCCHHHHHHHcC-CCCCHHHHHH
Q 013092 7 VFSVQENVK--TKHPQLLYESKLYRILQ---GGTGIPNVRWFG-VEGDYNVLVMDLLGPSLEDLFNFCS-RKLSLKTVLM 79 (449)
Q Consensus 7 V~~k~~~~~--~~~~~~~~E~~il~~l~---~hp~Iv~l~~~~-~~~~~~~lVmE~~g~sL~~ll~~~~-~~ls~~~~~~ 79 (449)
+++|.+... .....+..|+.+|..+. +..+++.+++.| ....+.||||+++|.+|.++..... +.|+..+++.
T Consensus 47 ~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~iVM~l~G~sL~dl~~~~~~~~fs~~T~l~ 126 (322)
T KOG1164|consen 47 YAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFIVMSLLGPSLEDLRKRNPPGRFSRKTVLR 126 (322)
T ss_pred EEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEEEEeccCccHHHHHHhCCCCCcCHhHHHH
Confidence 455555443 22337999999999997 457999999999 5888999999999999999997654 7899999999
Q ss_pred HHHHHHHHHHHHHHCCceecCCCCCcEEEeecCC--CCeEEEeecCcce--eecCCCCCccccccc-CCCCccCccccch
Q 013092 80 LADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR--ANQVYIIDFGLAK--KYRDTSTHQHIPYRE-NKNLTGTARYASM 154 (449)
Q Consensus 80 i~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~--~~~vkL~DFGla~--~~~~~~~~~~~~~~~-~~~~~gT~~Y~aP 154 (449)
++.|++.+|++||+.|++||||||+|++++.... ...++|+|||+++ .+.........+.+. ...+.||.+|+++
T Consensus 127 ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~ 206 (322)
T KOG1164|consen 127 IAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASI 206 (322)
T ss_pred HHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccH
Confidence 9999999999999999999999999999985432 2679999999999 443333222334444 3467799999999
Q ss_pred hhhhCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCC
Q 013092 155 NTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDD 234 (449)
Q Consensus 155 E~~~~~~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~ 234 (449)
+++.+.++++++|+|||++++.+|+.|.+||.+.......+.+........... ++...|.++.+++..+-..++.+
T Consensus 207 ~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 283 (322)
T KOG1164|consen 207 NVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRKLLTDR---FGDLKPEEFAKILEYIDSLDYED 283 (322)
T ss_pred HHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhhhhcccc---ccCCChHHHHHHHHHhhccCCcC
Confidence 999999999999999999999999999999998876655555555554443322 44557889999999999999999
Q ss_pred CCCHHHHHHHHHHHHHHcCCCCCCcccchhhhh
Q 013092 235 KPDYAYLKRIFRDLFIREGFQFDYVFDWTILKY 267 (449)
Q Consensus 235 RPt~~~l~~~L~~~~~~~~~~~~~~~dw~~~~~ 267 (449)
+|+|..+...|++.+...+...+.++||+....
T Consensus 284 ~Pdy~~~~~~l~~~~~~~~~~~~~~~dw~~~~~ 316 (322)
T KOG1164|consen 284 KPDYEKLAELLKDVFDSEGSKEDSPFDWEVKLR 316 (322)
T ss_pred CCCHHHHHHHHHHHHHhcCCCCCCCCccccccc
Confidence 999999999999999999999999999997644
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=267.60 Aligned_cols=220 Identities=21% Similarity=0.240 Sum_probs=191.9
Q ss_pred cEEEEEeeecccCCC-hhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHc-CCCCCHHHHHH
Q 013092 3 EILTVFSVQENVKTK-HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFC-SRKLSLKTVLM 79 (449)
Q Consensus 3 ~aikV~~k~~~~~~~-~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~-~~~ls~~~~~~ 79 (449)
+|+||+-|-+..+.+ ..++.+|++|-..| .||||.++++++.+....||++||. .|.|...+... ..+|++..+..
T Consensus 50 valKVlfKsqi~~~~v~~qlrREiEIqs~L-~hpnilrlY~~fhd~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~ 128 (281)
T KOG0580|consen 50 VALKVLFKSQILKTQVEHQLRREIEIQSHL-RHPNILRLYGYFHDSKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAAT 128 (281)
T ss_pred EEEeeeeHHHHHHhcchhhhhheeEeeccc-CCccHHhhhhheeccceeEEEEEecCCchHHHHHHhcccccccccchhH
Confidence 588999888866544 45688999999999 9999999999999999999999999 89998888733 45699999999
Q ss_pred HHHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhC
Q 013092 80 LADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG 159 (449)
Q Consensus 80 i~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~ 159 (449)
++.|++.||.|+|.+++|||||||+|+|+ +..+.+||+|||-+.....+ ...+++||..|.+||+..+
T Consensus 129 Yi~q~A~Al~y~h~k~VIhRdiKpenlLl---g~~~~lkiAdfGwsV~~p~~---------kR~tlcgt~dyl~pEmv~~ 196 (281)
T KOG0580|consen 129 YIKQLANALLYCHLKRVIHRDIKPENLLL---GSAGELKIADFGWSVHAPSN---------KRKTLCGTLDYLPPEMVEG 196 (281)
T ss_pred HHHHHHHHHHHhccCCcccCCCCHHHhcc---CCCCCeeccCCCceeecCCC---------CceeeecccccCCHhhcCC
Confidence 99999999999999999999999999999 58899999999988765432 2357899999999999999
Q ss_pred CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHH
Q 013092 160 IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYA 239 (449)
Q Consensus 160 ~~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~ 239 (449)
..++...|+|++|++.|||+.|..||.... ..+.|.+|....... +..++.+..++|.+|+..+|.+|....
T Consensus 197 ~~hd~~Vd~w~lgvl~yeflvg~ppFes~~---~~etYkrI~k~~~~~-----p~~is~~a~dlI~~ll~~~p~~r~~l~ 268 (281)
T KOG0580|consen 197 RGHDKFVDLWSLGVLCYEFLVGLPPFESQS---HSETYKRIRKVDLKF-----PSTISGGAADLISRLLVKNPIERLALT 268 (281)
T ss_pred CCccchhhHHHHHHHHHHHHhcCCchhhhh---hHHHHHHHHHccccC-----CcccChhHHHHHHHHhccCccccccHH
Confidence 999999999999999999999999998743 567788887765532 356899999999999999999999866
Q ss_pred HHHH
Q 013092 240 YLKR 243 (449)
Q Consensus 240 ~l~~ 243 (449)
++..
T Consensus 269 ~v~~ 272 (281)
T KOG0580|consen 269 EVMD 272 (281)
T ss_pred HHhh
Confidence 6543
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=277.80 Aligned_cols=225 Identities=22% Similarity=0.358 Sum_probs=176.3
Q ss_pred EEEEeeecccCC---ChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHc-CCCCCHHHHHH
Q 013092 5 LTVFSVQENVKT---KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFC-SRKLSLKTVLM 79 (449)
Q Consensus 5 ikV~~k~~~~~~---~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~-~~~ls~~~~~~ 79 (449)
..|++|...... ....+.+|+++++.+ +||||+++++++...+..++||||+ +++|.+++... ...+++...+.
T Consensus 29 ~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~g~~~~~~~~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~ 107 (259)
T PF07714_consen 29 QPVAVKILKPSSSEEEEEEFLNEIQILRKL-RHPNIVKLYGFCIENEPLFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLS 107 (259)
T ss_dssp EEEEEEEESTTSSHHHHHHHHHHHHHHHTH-SBTTBE-EEEEEESSSSEEEEEE--TTEBHHHHHHHTCTTTSBHHHHHH
T ss_pred EEEEEEEeccccccccceeeeecccccccc-ccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 345555553322 256799999999999 9999999999999888899999999 89999999875 46799999999
Q ss_pred HHHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhC
Q 013092 80 LADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG 159 (449)
Q Consensus 80 i~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~ 159 (449)
|+.||+.||.|||+++|+|+||++.||++ +.++.+||+|||++......... .......+...|+|||.+..
T Consensus 108 i~~~i~~~l~~Lh~~~iiH~~l~~~nill---~~~~~~Kl~~f~~~~~~~~~~~~-----~~~~~~~~~~~~~aPE~~~~ 179 (259)
T PF07714_consen 108 IAIQIAEALSYLHSNNIIHGNLSPSNILL---DSNGQVKLSDFGLSRPISEKSKY-----KNDSSQQLPLRYLAPEVLKD 179 (259)
T ss_dssp HHHHHHHHHHHHHHTTEEEST-SGGGEEE---ETTTEEEEESTTTGEETTTSSSE-----EESTTSESGGGGS-HHHHHH
T ss_pred ccccccccccccccccccccccccccccc---ccccccccccccccccccccccc-----cccccccccccccccccccc
Confidence 99999999999999999999999999999 57889999999999876322111 11233456789999999998
Q ss_pred CCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCH
Q 013092 160 IEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDY 238 (449)
Q Consensus 160 ~~~s~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~ 238 (449)
..++.++||||||+++|||++ |..||.... ..+...++.+... ......+|..+.++|..||+.+|++||++
T Consensus 180 ~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~---~~~~~~~~~~~~~----~~~~~~~~~~~~~li~~C~~~~p~~RPs~ 252 (259)
T PF07714_consen 180 GEYTKKSDVYSFGMLLYEILTLGKFPFSDYD---NEEIIEKLKQGQR----LPIPDNCPKDIYSLIQQCWSHDPEKRPSF 252 (259)
T ss_dssp SEESHHHHHHHHHHHHHHHHTTSSGTTTTSC---HHHHHHHHHTTEE----TTSBTTSBHHHHHHHHHHT-SSGGGS--H
T ss_pred ccccccccccccccccccccccccccccccc---ccccccccccccc----ceeccchhHHHHHHHHHHcCCChhhCcCH
Confidence 889999999999999999999 789997753 3444445533322 12345689999999999999999999999
Q ss_pred HHHHHHH
Q 013092 239 AYLKRIF 245 (449)
Q Consensus 239 ~~l~~~L 245 (449)
.+|.+.|
T Consensus 253 ~~i~~~L 259 (259)
T PF07714_consen 253 QEILQEL 259 (259)
T ss_dssp HHHHHHH
T ss_pred HHHHhcC
Confidence 9998765
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=275.40 Aligned_cols=215 Identities=17% Similarity=0.238 Sum_probs=173.9
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 96 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gi 96 (449)
...+..|+.++..+ +|+||+.+++++... ..+++|||+ +++|.+++......+++..++.++.|++.||+|||++||
T Consensus 53 ~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~-~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i 130 (279)
T cd05109 53 NKEILDEAYVMAGV-GSPYVCRLLGICLTS-TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRL 130 (279)
T ss_pred HHHHHHHHHHHHhc-CCCCCceEEEEEcCC-CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 45688999999999 899999999988754 578999999 999999997655679999999999999999999999999
Q ss_pred eecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHHHH
Q 013092 97 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLM 176 (449)
Q Consensus 97 vHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il~ 176 (449)
+||||||+|||+ +.++.+||+|||+++.+....... ......++..|++||.+.+..++.++|||||||++|
T Consensus 131 iH~dlkp~Nil~---~~~~~~kL~dfG~~~~~~~~~~~~-----~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~ 202 (279)
T cd05109 131 VHRDLAARNVLV---KSPNHVKITDFGLARLLDIDETEY-----HADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVW 202 (279)
T ss_pred eccccccceEEE---cCCCcEEECCCCceeeccccccee-----ecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHH
Confidence 999999999999 567889999999998775432211 011234567899999999989999999999999999
Q ss_pred HHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 013092 177 YFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLF 249 (449)
Q Consensus 177 ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~L~~~~ 249 (449)
||++ |..||..... ......+...... .....++.++.+++..||..+|++||++.+|.+.|+++.
T Consensus 203 el~t~g~~p~~~~~~---~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05109 203 ELMTFGAKPYDGIPA---REIPDLLEKGERL----PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMA 269 (279)
T ss_pred HHHcCCCCCCCCCCH---HHHHHHHHCCCcC----CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 9998 9999976433 2222222221111 123457899999999999999999999999998887764
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=301.15 Aligned_cols=224 Identities=21% Similarity=0.214 Sum_probs=177.2
Q ss_pred EEEEEeeecccCCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCC--------EEEEEEecC-CCCHHHHHHHc---CCC
Q 013092 4 ILTVFSVQENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGD--------YNVLVMDLL-GPSLEDLFNFC---SRK 71 (449)
Q Consensus 4 aikV~~k~~~~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~--------~~~lVmE~~-g~sL~~ll~~~---~~~ 71 (449)
|||++.+..........+.+|+.++..+ +|+||++++..+.... ..+|||||+ +++|.+++... ...
T Consensus 61 AvK~i~~~~~~~~~~~~~~~Ei~~l~~~-~h~~iv~~~~~~~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~ 139 (496)
T PTZ00283 61 AVKVVDMEGMSEADKNRAQAEVCCLLNC-DFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRT 139 (496)
T ss_pred EEEEEecccCCHHHHHHHHHHHHHHhcC-CCCcEEEeecceecccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCC
Confidence 4444443332233345678899999998 8999999876654322 468999999 99999998642 346
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccc
Q 013092 72 LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY 151 (449)
Q Consensus 72 ls~~~~~~i~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y 151 (449)
+++..+..++.|++.||.|||++||+||||||+|||+ +.++.+||+|||+++.+...... .......||+.|
T Consensus 140 l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl---~~~~~vkL~DFGls~~~~~~~~~-----~~~~~~~Gt~~Y 211 (496)
T PTZ00283 140 FREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILL---CSNGLVKLGDFGFSKMYAATVSD-----DVGRTFCGTPYY 211 (496)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE---eCCCCEEEEecccCeeccccccc-----cccccccCCcce
Confidence 8999999999999999999999999999999999999 57889999999999876543221 112356799999
Q ss_pred cchhhhhCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCC
Q 013092 152 ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLR 231 (449)
Q Consensus 152 ~aPE~~~~~~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~ 231 (449)
+|||++.+..++.++|||||||++|||++|..||.+. .....+.++..... ..++..+++++.+++..||+.+
T Consensus 212 ~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~---~~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~~L~~d 284 (496)
T PTZ00283 212 VAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGE---NMEEVMHKTLAGRY----DPLPPSISPEMQEIVTALLSSD 284 (496)
T ss_pred eCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC---CHHHHHHHHhcCCC----CCCCCCCCHHHHHHHHHHcccC
Confidence 9999999999999999999999999999999999763 23333444333222 2345678999999999999999
Q ss_pred CCCCCCHHHHHH
Q 013092 232 FDDKPDYAYLKR 243 (449)
Q Consensus 232 p~~RPt~~~l~~ 243 (449)
|++||++.+++.
T Consensus 285 P~~RPs~~ell~ 296 (496)
T PTZ00283 285 PKRRPSSSKLLN 296 (496)
T ss_pred hhhCcCHHHHHh
Confidence 999999988864
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=273.96 Aligned_cols=216 Identities=17% Similarity=0.176 Sum_probs=169.7
Q ss_pred ChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecCCCCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHC
Q 013092 17 KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCS--RKLSLKTVLMLADQMINRVEFVHSK 94 (449)
Q Consensus 17 ~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~g~sL~~ll~~~~--~~ls~~~~~~i~~qi~~aL~yLH~~ 94 (449)
....+.+|+.+++.+ +||||+++++++.+++..|+||||+.++|.+++.... ..+++..++.++.||+.||+|||++
T Consensus 42 ~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~ 120 (285)
T cd07861 42 VPSTAIREISLLKEL-QHPNIVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR 120 (285)
T ss_pred chHHHHHHHHHHHhc-CCCCEeeeEEEEeeCCeEEEEEecCCCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC
Confidence 446788999999999 8999999999999999999999999778998886432 5689999999999999999999999
Q ss_pred CceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCC-CCChhhHHHHHHH
Q 013092 95 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGY 173 (449)
Q Consensus 95 givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~-~~s~~~DiwSlG~ 173 (449)
||+|+||||+||++ +.++.++|+|||++........ ......+++.|+|||++.+. .++.++|||||||
T Consensus 121 ~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~ 190 (285)
T cd07861 121 RVLHRDLKPQNLLI---DNKGVIKLADFGLARAFGIPVR-------VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGT 190 (285)
T ss_pred CeeecCCCHHHEEE---cCCCcEEECcccceeecCCCcc-------cccCCcccccccChHHhcCCCCcCcHHHHHHHHH
Confidence 99999999999999 5788999999999976543211 11234578899999998764 4688999999999
Q ss_pred HHHHHHhCCCCCCCCCcCCHHHHH---------------------HHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCC
Q 013092 174 VLMYFLRGSLPWQGLKAGTKKQKY---------------------EKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRF 232 (449)
Q Consensus 174 il~elltG~~Pf~~~~~~~~~~~~---------------------~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p 232 (449)
++|+|++|..||.+.......... ..................+++++.++|..||..||
T Consensus 191 il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP 270 (285)
T cd07861 191 IFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDP 270 (285)
T ss_pred HHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCCh
Confidence 999999999999864321110000 00000001111222234578999999999999999
Q ss_pred CCCCCHHHHHH
Q 013092 233 DDKPDYAYLKR 243 (449)
Q Consensus 233 ~~RPt~~~l~~ 243 (449)
++||++.+|++
T Consensus 271 ~~Rpt~~~ll~ 281 (285)
T cd07861 271 AKRISAKKALN 281 (285)
T ss_pred hhCCCHHHHhc
Confidence 99999888754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=270.84 Aligned_cols=213 Identities=18% Similarity=0.229 Sum_probs=174.7
Q ss_pred ChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 013092 17 KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 95 (449)
Q Consensus 17 ~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~g 95 (449)
....+.+|+.+++.+ +||||+++++.+.+++..|++|||+ +++|.+++......+++..+..++.|++.||.|||+.|
T Consensus 43 ~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~ 121 (262)
T cd06613 43 DFEIIQQEISMLKEC-RHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETG 121 (262)
T ss_pred hHHHHHHHHHHHHhC-CCCChhceEEEEEeCCEEEEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 456789999999999 9999999999999999999999999 88999998764467999999999999999999999999
Q ss_pred ceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCC---CCChhhHHHHHH
Q 013092 96 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI---EQSRRDDLESLG 172 (449)
Q Consensus 96 ivHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~---~~s~~~DiwSlG 172 (449)
|+|+||||+||++ +.++.++|+|||++........ ......++..|++||.+.+. .++.++|+||||
T Consensus 122 i~h~dl~p~ni~i---~~~~~~~l~d~g~~~~~~~~~~-------~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG 191 (262)
T cd06613 122 KIHRDIKGANILL---TEDGDVKLADFGVSAQLTATIA-------KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALG 191 (262)
T ss_pred ceecCCChhhEEE---CCCCCEEECccccchhhhhhhh-------ccccccCCccccCchhhcccccCCcCchhhhHHHH
Confidence 9999999999999 5788999999999876543221 12345788899999999877 789999999999
Q ss_pred HHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 173 YVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 173 ~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
|++|+|++|..||..... .+....+...............++.++.+++..||..+|++||++.+|+.
T Consensus 192 ~~l~~~~tg~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 192 ITAIELAELQPPMFDLHP---MRALFLISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred HHHHHHHhCCCCCCCCCH---HHHHHHHHhccCCCccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 999999999999977543 22222222221111111123456789999999999999999999988754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=270.71 Aligned_cols=213 Identities=18% Similarity=0.339 Sum_probs=173.5
Q ss_pred ChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHC
Q 013092 17 KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSK 94 (449)
Q Consensus 17 ~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~-~~~ls~~~~~~i~~qi~~aL~yLH~~ 94 (449)
....+.+|+++++.+ +|+||+++++++. .+..|+||||+ +++|.+++... ...+++..++.++.|++.||+|||+.
T Consensus 44 ~~~~~~~E~~~l~~l-~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~ 121 (260)
T cd05069 44 MPEAFLQEAQIMKKL-RHDKLVPLYAVVS-EEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERM 121 (260)
T ss_pred cHHHHHHHHHHHHhC-CCCCeeeEEEEEc-CCCcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 345689999999999 8999999988764 55689999999 88999999753 33589999999999999999999999
Q ss_pred CceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHH
Q 013092 95 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYV 174 (449)
Q Consensus 95 givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~i 174 (449)
|++|+||||+||++ +.++.++|+|||++........ .......++..|++||++.+..++.++|||||||+
T Consensus 122 ~i~H~dl~~~Nill---~~~~~~~l~dfg~~~~~~~~~~------~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~ 192 (260)
T cd05069 122 NYIHRDLRAANILV---GDNLVCKIADFGLARLIEDNEY------TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGIL 192 (260)
T ss_pred CEeecccCcceEEE---cCCCeEEECCCccceEccCCcc------cccCCCccchhhCCHHHhccCCcChHHHHHHHHHH
Confidence 99999999999999 5788999999999987643321 11123346778999999998889999999999999
Q ss_pred HHHHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Q 013092 175 LMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRD 247 (449)
Q Consensus 175 l~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~L~~ 247 (449)
+|+|++ |..||.+... ...+..+..... ......+|.++.+++.+||..+|++||++.+|.+.|++
T Consensus 193 l~el~t~g~~p~~~~~~---~~~~~~~~~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 193 LTELVTKGRVPYPGMVN---REVLEQVERGYR----MPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred HHHHHhCCCCCCCCCCH---HHHHHHHHcCCC----CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 999999 9999987543 233333332211 12234678999999999999999999999999988864
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=272.13 Aligned_cols=218 Identities=12% Similarity=0.244 Sum_probs=176.7
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 96 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gi 96 (449)
...|..|+.+++.+ .||||+++.+++.++...++||||+ +++|.+++......+++..++.++.|++.||+|||++|+
T Consensus 49 ~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~ 127 (269)
T cd05065 49 RRDFLSEASIMGQF-DHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNY 127 (269)
T ss_pred HHHHHHHHHHHHhC-CCcCcceEEEEECCCCceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCE
Confidence 45789999999999 9999999999999999999999999 889999998656678999999999999999999999999
Q ss_pred eecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHHHH
Q 013092 97 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLM 176 (449)
Q Consensus 97 vHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il~ 176 (449)
+|+||||+||++ +.++.++|+|||++.......... .+........+..|++||++.+..++.++|||||||++|
T Consensus 128 ~H~dl~p~nili---~~~~~~kl~dfg~~~~~~~~~~~~--~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ 202 (269)
T cd05065 128 VHRDLAARNILV---NSNLVCKVSDFGLSRFLEDDTSDP--TYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMW 202 (269)
T ss_pred eecccChheEEE---cCCCcEEECCCccccccccCcccc--ccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHH
Confidence 999999999999 577899999999987664432211 011111112245799999999989999999999999999
Q ss_pred HHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 013092 177 YFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDL 248 (449)
Q Consensus 177 ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~L~~~ 248 (449)
||++ |..||..... ......+..... . .....+|.++.+++..||..+|++||++.+|...|+.+
T Consensus 203 e~l~~g~~p~~~~~~---~~~~~~i~~~~~-~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 203 EVMSYGERPYWDMSN---QDVINAIEQDYR-L---PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred HHhcCCCCCCCCCCH---HHHHHHHHcCCc-C---CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 9886 9999976433 233333322211 1 12246789999999999999999999999999887764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-33 Score=304.27 Aligned_cols=224 Identities=19% Similarity=0.254 Sum_probs=172.6
Q ss_pred EEEEEeeecccCCChhHHHHHHHHHHHhcCCCCCceEEEEeEe--CCEEEEEEecC-CCCHHHHHHHc---CCCCCHHHH
Q 013092 4 ILTVFSVQENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVE--GDYNVLVMDLL-GPSLEDLFNFC---SRKLSLKTV 77 (449)
Q Consensus 4 aikV~~k~~~~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~--~~~~~lVmE~~-g~sL~~ll~~~---~~~ls~~~~ 77 (449)
|+|++.+..........|..|+.+|+.| .||||+.+++++.+ ...+||||||| +++|.++|... ...+++..+
T Consensus 42 AlKvIk~~~l~e~~~~~~~~EI~IL~~L-~HPNIVrl~d~f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~I 120 (1021)
T PTZ00266 42 CWKAISYRGLKEREKSQLVIEVNVMREL-KHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAI 120 (1021)
T ss_pred EEEEEeccccCHHHHHHHHHHHHHHHHc-CCCCcCeEEEEEEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHH
Confidence 4444443333334456789999999999 89999999988754 46799999999 89999998753 356999999
Q ss_pred HHHHHHHHHHHHHHHHC-------CceecCCCCCcEEEeec--------------CCCCeEEEeecCcceeecCCCCCcc
Q 013092 78 LMLADQMINRVEFVHSK-------SFLHRDIKPDNFLMGLG--------------RRANQVYIIDFGLAKKYRDTSTHQH 136 (449)
Q Consensus 78 ~~i~~qi~~aL~yLH~~-------givHRDLKP~NiLl~~~--------------~~~~~vkL~DFGla~~~~~~~~~~~ 136 (449)
+.|+.||+.||.|||+. +||||||||+||||..+ +....+||+|||+++.+.....
T Consensus 121 l~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~--- 197 (1021)
T PTZ00266 121 VDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESM--- 197 (1021)
T ss_pred HHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccccccCCCCceEEccCCcccccccccc---
Confidence 99999999999999985 49999999999999532 1234589999999986643221
Q ss_pred cccccCCCCccCccccchhhhhC--CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhc
Q 013092 137 IPYRENKNLTGTARYASMNTHLG--IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 214 (449)
Q Consensus 137 ~~~~~~~~~~gT~~Y~aPE~~~~--~~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~ 214 (449)
.....||+.|+|||++.+ ..++.++||||||||||+|++|..||..... ..+.+..+.... .. ...
T Consensus 198 -----~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~--~~qli~~lk~~p-~l----pi~ 265 (1021)
T PTZ00266 198 -----AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANN--FSQLISELKRGP-DL----PIK 265 (1021)
T ss_pred -----ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCc--HHHHHHHHhcCC-CC----CcC
Confidence 134579999999999965 4578999999999999999999999976432 222232222211 11 123
Q ss_pred CCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 215 GYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 215 ~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
.++.++.+||..||..+|++||++.+++.
T Consensus 266 ~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 266 GKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred CCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 57899999999999999999999887753
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=273.59 Aligned_cols=220 Identities=15% Similarity=0.160 Sum_probs=169.9
Q ss_pred EEEEeeecccC--CChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHH
Q 013092 5 LTVFSVQENVK--TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLA 81 (449)
Q Consensus 5 ikV~~k~~~~~--~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~ 81 (449)
++|++|..... .....+..|+.++..+ +||||+++++++......+|||||+ +++|..++......+++..++.++
T Consensus 33 ~~v~~k~~~~~~~~~~~~~~~~~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~ 111 (262)
T cd05077 33 IKVILKVLDPSHRDISLAFFETASMMRQV-SHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVA 111 (262)
T ss_pred eeEEEeecChhhhhHHHHHHHHHHHHHhC-CCCCEeeEEEEEecCCCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHH
Confidence 34555554332 2234578889999999 9999999999999999999999999 889988887555679999999999
Q ss_pred HHHHHHHHHHHHCCceecCCCCCcEEEeecC----CCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhh
Q 013092 82 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGR----RANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTH 157 (449)
Q Consensus 82 ~qi~~aL~yLH~~givHRDLKP~NiLl~~~~----~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~ 157 (449)
.||+.||+|||++||+||||||+|||+.... ....++++|||++...... ....++..|+|||++
T Consensus 112 ~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~~~~~~-----------~~~~~~~~y~aPE~~ 180 (262)
T cd05077 112 KQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSR-----------QECVERIPWIAPECV 180 (262)
T ss_pred HHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCCCccccCc-----------ccccccccccChhhh
Confidence 9999999999999999999999999995221 1124899999998654321 234578899999998
Q ss_pred h-CCCCChhhHHHHHHHHHHHHH-hCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCC
Q 013092 158 L-GIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDK 235 (449)
Q Consensus 158 ~-~~~~s~~~DiwSlG~il~ell-tG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~R 235 (449)
. +..++.++|||||||++|||+ .|..||........ ........ ......+.++.+||..||+.+|++|
T Consensus 181 ~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~----~~~~~~~~-----~~~~~~~~~~~~li~~cl~~dp~~R 251 (262)
T cd05077 181 EDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK----ERFYEGQC-----MLVTPSCKELADLMTHCMNYDPNQR 251 (262)
T ss_pred cCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH----HHHHhcCc-----cCCCCChHHHHHHHHHHcCCChhhC
Confidence 7 466899999999999999998 58999876432211 11111111 1122346789999999999999999
Q ss_pred CCHHHHHHHH
Q 013092 236 PDYAYLKRIF 245 (449)
Q Consensus 236 Pt~~~l~~~L 245 (449)
|++.+|.+.+
T Consensus 252 p~~~~il~~~ 261 (262)
T cd05077 252 PFFRAIMRDI 261 (262)
T ss_pred cCHHHHHHhc
Confidence 9999887654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=291.57 Aligned_cols=209 Identities=19% Similarity=0.277 Sum_probs=178.2
Q ss_pred CCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH
Q 013092 15 KTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 93 (449)
Q Consensus 15 ~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~ 93 (449)
+...+.+..|+.+|..+ +++||...++.+..+..++|+|||| ||++.++++. ...+.+..+..++.+++.||.|||.
T Consensus 52 ~deIediqqei~~Ls~~-~~~~it~yygsyl~g~~LwiiMey~~gGsv~~lL~~-~~~~~E~~i~~ilre~l~~l~ylH~ 129 (467)
T KOG0201|consen 52 EDEIEDIQQEISVLSQC-DSPNITEYYGSYLKGTKLWIIMEYCGGGSVLDLLKS-GNILDEFEIAVILREVLKGLDYLHS 129 (467)
T ss_pred chhhHHHHHHHHHHHhc-CcchHHhhhhheeecccHHHHHHHhcCcchhhhhcc-CCCCccceeeeehHHHHHHhhhhhh
Confidence 34556788999999999 8899999999999999999999999 9999999984 3445888889999999999999999
Q ss_pred CCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHH
Q 013092 94 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGY 173 (449)
Q Consensus 94 ~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~ 173 (449)
++.+|||||+.|||+. ..+.|||+|||.+..+..... + ..+++||+.|||||++.+..|+.++||||||+
T Consensus 130 ~~kiHrDIKaanil~s---~~g~vkl~DfgVa~ql~~~~~------r-r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGI 199 (467)
T KOG0201|consen 130 EKKIHRDIKAANILLS---ESGDVKLADFGVAGQLTNTVK------R-RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGI 199 (467)
T ss_pred cceecccccccceeEe---ccCcEEEEecceeeeeechhh------c-cccccccccccchhhhccccccchhhhhhhhH
Confidence 9999999999999995 669999999999988766543 2 26889999999999999889999999999999
Q ss_pred HHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 013092 174 VLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 242 (449)
Q Consensus 174 il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~ 242 (449)
+.+||++|.+||..+.+.. +.........+.+...+++.|++||..||+.+|+.||++.+|+
T Consensus 200 TaiEla~GePP~s~~hPmr-------vlflIpk~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LL 261 (467)
T KOG0201|consen 200 TAIELAKGEPPHSKLHPMR-------VLFLIPKSAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELL 261 (467)
T ss_pred HHHHHhcCCCCCcccCcce-------EEEeccCCCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHh
Confidence 9999999999999876621 1111111223344457899999999999999999999987764
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=276.94 Aligned_cols=223 Identities=16% Similarity=0.155 Sum_probs=167.0
Q ss_pred CChhHHHHHHHHHHHhcCCCCCceEEEEeE--eCCEEEEEEecCCCCHHHHHHHc--------CCCCCHHHHHHHHHHHH
Q 013092 16 TKHPQLLYESKLYRILQGGTGIPNVRWFGV--EGDYNVLVMDLLGPSLEDLFNFC--------SRKLSLKTVLMLADQMI 85 (449)
Q Consensus 16 ~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~--~~~~~~lVmE~~g~sL~~ll~~~--------~~~ls~~~~~~i~~qi~ 85 (449)
.....+.+|+.+++.+ +||||+++++.+. .+...|+||||++++|.+++... ...+++..+..++.||+
T Consensus 40 ~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~ 118 (317)
T cd07868 40 GISMSACREIALLREL-KHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQIL 118 (317)
T ss_pred CCcHHHHHHHHHHHhc-CCCCCcceeeeEecCCCcEEEEEEeccCCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHH
Confidence 3445688999999999 9999999998875 35678999999988999988642 12489999999999999
Q ss_pred HHHHHHHHCCceecCCCCCcEEEeec-CCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCC-CCC
Q 013092 86 NRVEFVHSKSFLHRDIKPDNFLMGLG-RRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI-EQS 163 (449)
Q Consensus 86 ~aL~yLH~~givHRDLKP~NiLl~~~-~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~-~~s 163 (449)
.||+|||++||+||||||+|||+... +..+.+||+|||+++.+...... ........||+.|+|||++.+. .++
T Consensus 119 ~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~----~~~~~~~~~t~~y~aPE~~~~~~~~~ 194 (317)
T cd07868 119 DGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKP----LADLDPVVVTFWYRAPELLLGARHYT 194 (317)
T ss_pred HHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCCCCcc----ccccCCccccccccCCHHHcCCCCcC
Confidence 99999999999999999999999532 35578999999999876543221 1122356789999999999874 589
Q ss_pred hhhHHHHHHHHHHHHHhCCCCCCCCCcCC------HHHHHHHHHhhccc-------------------------------
Q 013092 164 RRDDLESLGYVLMYFLRGSLPWQGLKAGT------KKQKYEKISEKKVS------------------------------- 206 (449)
Q Consensus 164 ~~~DiwSlG~il~elltG~~Pf~~~~~~~------~~~~~~~i~~~~~~------------------------------- 206 (449)
.++|||||||++|+|++|..||....... ....+..+......
T Consensus 195 ~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (317)
T cd07868 195 KAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCS 274 (317)
T ss_pred chhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCccc
Confidence 99999999999999999999997533210 01111111110000
Q ss_pred --chHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 207 --TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 207 --~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
..++......+.++.++|..||+.||++||+++++.+
T Consensus 275 ~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~ 313 (317)
T cd07868 275 LIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 313 (317)
T ss_pred ccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0000011123467889999999999999999888753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=269.13 Aligned_cols=219 Identities=15% Similarity=0.252 Sum_probs=173.5
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeE-eCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGV-EGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 95 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~-~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~g 95 (449)
...+.+|+.+++.+ +||||+++++++. .++..|+||||+ +++|.+++......+++..++.++.|++.||+|||+.+
T Consensus 40 ~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 118 (262)
T cd05058 40 VEQFLKEGIIMKDF-SHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKK 118 (262)
T ss_pred HHHHHHHHHHHccC-CCCCcceEEEEeecCCCCcEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 35688899999998 9999999999765 456789999999 99999999865556788888999999999999999999
Q ss_pred ceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHHH
Q 013092 96 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVL 175 (449)
Q Consensus 96 ivHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il 175 (449)
|+||||||+|||+ +.++.+||+|||+++......... ........++..|+|||.+.+..++.++|||||||++
T Consensus 119 i~H~dlk~~nili---~~~~~~kl~dfg~~~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l 192 (262)
T cd05058 119 FVHRDLAARNCML---DESFTVKVADFGLARDIYDKEYYS---VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLL 192 (262)
T ss_pred ccccccCcceEEE---cCCCcEEECCccccccccCCccee---ecccccCcCCccccChhHhccCccchHHHHHHHHHHH
Confidence 9999999999999 577889999999998654322110 0111234567789999999988999999999999999
Q ss_pred HHHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 013092 176 MYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFI 250 (449)
Q Consensus 176 ~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~L~~~~~ 250 (449)
|||++ |.+||...+. ......+..... ......+|..+.+++..||..+|++||++.+|...|++++.
T Consensus 193 ~el~~~~~~~~~~~~~---~~~~~~~~~~~~----~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 193 WELMTRGAPPYPDVDS---FDITVYLLQGRR----LLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred HHHHcCCCCCCCCCCH---HHHHHHHhcCCC----CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 99999 5677765432 222222222111 11224568899999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=292.73 Aligned_cols=232 Identities=20% Similarity=0.325 Sum_probs=193.3
Q ss_pred EEEEeeecccC-CChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCC-CCHHHHHHHH
Q 013092 5 LTVFSVQENVK-TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRK-LSLKTVLMLA 81 (449)
Q Consensus 5 ikV~~k~~~~~-~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~-ls~~~~~~i~ 81 (449)
+.|++|..+.. -..++|+.|+.+|+.+ +|||+|+|+++|.....+|||.||| .|+|.++++.|++. ++.-..+.++
T Consensus 293 lTvAVKtLKEDtMeveEFLkEAAvMKei-kHpNLVqLLGVCT~EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMA 371 (1157)
T KOG4278|consen 293 LTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQLLGVCTHEPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMA 371 (1157)
T ss_pred eeeehhhhhhcchhHHHHHHHHHHHHhh-cCccHHHHhhhhccCCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHH
Confidence 34555544332 3567899999999999 9999999999999999999999999 99999999998654 6777888999
Q ss_pred HHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCC
Q 013092 82 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIE 161 (449)
Q Consensus 82 ~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~ 161 (449)
.||..|++||..++||||||-..|+|++ .+..|||+||||++.+.......| ....-...|.|||.+....
T Consensus 372 tQIsSaMeYLEkknFIHRDLAARNCLVg---EnhiVKvADFGLsRlMtgDTYTAH------AGAKFPIKWTAPEsLAyNt 442 (1157)
T KOG4278|consen 372 TQISSAMEYLEKKNFIHRDLAARNCLVG---ENHIVKVADFGLSRLMTGDTYTAH------AGAKFPIKWTAPESLAYNT 442 (1157)
T ss_pred HHHHHHHHHHHHhhhhhhhhhhhhcccc---ccceEEeeccchhhhhcCCceecc------cCccCcccccCcccccccc
Confidence 9999999999999999999999999994 888999999999999877654333 2233457899999999889
Q ss_pred CChhhHHHHHHHHHHHHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHH
Q 013092 162 QSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAY 240 (449)
Q Consensus 162 ~s~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~ 240 (449)
++.++|||+||++|||+.| |..||.+.+- .+.|..+ ++... -.-+.+||+.+.+||..||++.|.+||+|.+
T Consensus 443 FSiKSDVWAFGVLLWEIATYGMsPYPGidl---SqVY~LL-EkgyR---M~~PeGCPpkVYeLMraCW~WsPsDRPsFae 515 (1157)
T KOG4278|consen 443 FSIKSDVWAFGVLLWEIATYGMSPYPGIDL---SQVYGLL-EKGYR---MDGPEGCPPKVYELMRACWNWSPSDRPSFAE 515 (1157)
T ss_pred cccchhhHHHHHHHHHHHhcCCCCCCCccH---HHHHHHH-hcccc---ccCCCCCCHHHHHHHHHHhcCCcccCccHHH
Confidence 9999999999999999998 9999999654 3444322 22111 1234689999999999999999999999999
Q ss_pred HHHHHHHHHHHcC
Q 013092 241 LKRIFRDLFIREG 253 (449)
Q Consensus 241 l~~~L~~~~~~~~ 253 (449)
|...|+.+|....
T Consensus 516 iHqafEtmf~~sS 528 (1157)
T KOG4278|consen 516 IHQAFETMFSSSS 528 (1157)
T ss_pred HHHHHHHHhcccc
Confidence 9999998876443
|
|
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=269.38 Aligned_cols=230 Identities=22% Similarity=0.299 Sum_probs=183.0
Q ss_pred EEEEEeeecccC-CChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHc---CCCCCHHHHH
Q 013092 4 ILTVFSVQENVK-TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFC---SRKLSLKTVL 78 (449)
Q Consensus 4 aikV~~k~~~~~-~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~---~~~ls~~~~~ 78 (449)
++|+.++..... .....+.+|+++++.+ +|++|+.+++.+.+.+..++||||+ +++|.+++... ...+++..++
T Consensus 31 ~ik~~~~~~~~~~~~~~~~~~ei~~l~~~-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 109 (267)
T cd08224 31 ALKKVQIFEMMDAKARQDCLKEIDLLKQL-DHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIW 109 (267)
T ss_pred EEEEeecccccchhhHHHHHHHHHHHHhC-CCCCeeeeeeeeecCCeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHH
Confidence 344444333332 2356789999999999 9999999999999999999999999 89999998643 3458999999
Q ss_pred HHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhh
Q 013092 79 MLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHL 158 (449)
Q Consensus 79 ~i~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~ 158 (449)
.++.|++.||.|||+.||+|+||||+||++ +.++.++|+|||++..+..... ......++..|+|||.+.
T Consensus 110 ~~~~~l~~~l~~lh~~~i~h~dl~p~nil~---~~~~~~~l~d~~~~~~~~~~~~-------~~~~~~~~~~y~apE~~~ 179 (267)
T cd08224 110 KYFVQLCSALEHMHSKRIMHRDIKPANVFI---TATGVVKLGDLGLGRFFSSKTT-------AAHSLVGTPYYMSPERIH 179 (267)
T ss_pred HHHHHHHHHHHHHHhCCEecCCcChhhEEE---CCCCcEEEeccceeeeccCCCc-------ccceecCCccccCHHHhc
Confidence 999999999999999999999999999999 5788999999999876543321 112346888999999999
Q ss_pred CCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCH
Q 013092 159 GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDY 238 (449)
Q Consensus 159 ~~~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~ 238 (449)
+..++.++|+|||||++|+|++|..||..... ...+....+......... ...++.++.++|..||..+|++||++
T Consensus 180 ~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~i~~cl~~~p~~Rp~~ 255 (267)
T cd08224 180 ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-NLYSLCKKIEKCDYPPLP---ADHYSEELRDLVSRCINPDPEKRPDI 255 (267)
T ss_pred cCCCCchhcHHHHHHHHHHHHHCCCCcccCCc-cHHHHHhhhhcCCCCCCC---hhhcCHHHHHHHHHHcCCCcccCCCH
Confidence 88899999999999999999999999965432 222223333222221111 12578899999999999999999999
Q ss_pred HHHHHHHHHH
Q 013092 239 AYLKRIFRDL 248 (449)
Q Consensus 239 ~~l~~~L~~~ 248 (449)
.+|.+.|+++
T Consensus 256 ~~il~~~~~~ 265 (267)
T cd08224 256 SYVLQVAKEM 265 (267)
T ss_pred HHHHHHHHHh
Confidence 9999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=270.10 Aligned_cols=211 Identities=23% Similarity=0.282 Sum_probs=173.2
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 96 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gi 96 (449)
...+.+|+++++.+ +||||+++++++.+.+..|+||||+ +++|.+++.. ...++...+..++.|++.||.|||+.||
T Consensus 48 ~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~i 125 (263)
T cd06625 48 VNALECEIQLLKNL-QHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKA-YGALTETVTRKYTRQILEGVEYLHSNMI 125 (263)
T ss_pred HHHHHHHHHHHHhC-CCCCeeeeEEEEccCCeEEEEEEECCCCcHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 35688999999999 9999999999999999999999999 9999999875 4568999999999999999999999999
Q ss_pred eecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHHHH
Q 013092 97 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLM 176 (449)
Q Consensus 97 vHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il~ 176 (449)
+|+||||+||++ +.++.++|+|||+++......... .......|+..|+|||++.+..++.++||||||+++|
T Consensus 126 ~H~dl~p~nilv---~~~~~~~l~dfg~~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 198 (263)
T cd06625 126 VHRDIKGANILR---DSAGNVKLGDFGASKRLQTICSSG----TGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVV 198 (263)
T ss_pred ecCCCCHHHEEE---cCCCCEEEeecccceecccccccc----ccccCCCcCccccCcceeccCCCCchhhhHHHHHHHH
Confidence 999999999999 577899999999997654321110 0012346788999999999988999999999999999
Q ss_pred HHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 177 YFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 177 elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
+|++|+.||..... ...+..+.... ....+...++.++.++|..||..+|++||++.+|+.
T Consensus 199 el~~g~~p~~~~~~---~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 259 (263)
T cd06625 199 EMLTEKPPWAEFEA---MAAIFKIATQP---TNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLR 259 (263)
T ss_pred HHHhCCCCccccch---HHHHHHHhccC---CCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhh
Confidence 99999999976422 22222222221 122344568899999999999999999999888764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-34 Score=286.84 Aligned_cols=222 Identities=18% Similarity=0.248 Sum_probs=169.5
Q ss_pred EEEEEeeecccCCChhHHHHHHHHHHHhcCCCCCceEEEEeEeC------CEEEEEEecCCCCHHHHHHHcCCCCCHHHH
Q 013092 4 ILTVFSVQENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEG------DYNVLVMDLLGPSLEDLFNFCSRKLSLKTV 77 (449)
Q Consensus 4 aikV~~k~~~~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~------~~~~lVmE~~g~sL~~ll~~~~~~ls~~~~ 77 (449)
|||++.+..........+.+|+.+++.+ +|+||+.+++.+... ...|+||||++++|.+++.. .+++..+
T Consensus 53 aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~ii~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~---~~~~~~~ 128 (364)
T cd07875 53 AIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQM---ELDHERM 128 (364)
T ss_pred EEEEeCccccCchhHHHHHHHHHHHHhc-CCCCccccceeecccccccccCeEEEEEeCCCCCHHHHHHh---cCCHHHH
Confidence 3444433322333445688999999999 899999998876533 46799999998888888763 5889999
Q ss_pred HHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhh
Q 013092 78 LMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTH 157 (449)
Q Consensus 78 ~~i~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~ 157 (449)
..++.|++.||+|||++||+||||||+|||+ +.++.+||+|||+++....... .....||..|+|||++
T Consensus 129 ~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~DfG~a~~~~~~~~--------~~~~~~t~~y~aPE~~ 197 (364)
T cd07875 129 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFM--------MTPYVVTRYYRAPEVI 197 (364)
T ss_pred HHHHHHHHHHHHHHhhCCeecCCCCHHHEEE---CCCCcEEEEeCCCccccCCCCc--------ccCCcccCCcCCHHHH
Confidence 9999999999999999999999999999999 5788999999999986543221 1345789999999999
Q ss_pred hCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccch-------------------------HHHh
Q 013092 158 LGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS-------------------------IEAL 212 (449)
Q Consensus 158 ~~~~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~-------------------------~~~l 212 (449)
.+..++.++|||||||++|+|++|+.||.+.+. ...+.++......+. .+.+
T Consensus 198 ~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (364)
T cd07875 198 LGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH---IDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKL 274 (364)
T ss_pred hCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhh
Confidence 999999999999999999999999999987433 222332222110000 0000
Q ss_pred ------------hcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 213 ------------CRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 213 ------------~~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
....+.++.+||..|+..||.+||++.++++
T Consensus 275 ~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~ 317 (364)
T cd07875 275 FPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 317 (364)
T ss_pred CccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0112457899999999999999999887643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=270.16 Aligned_cols=209 Identities=21% Similarity=0.213 Sum_probs=174.8
Q ss_pred ChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHC
Q 013092 17 KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSK 94 (449)
Q Consensus 17 ~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~-~~~ls~~~~~~i~~qi~~aL~yLH~~ 94 (449)
..+.+..|+.+++.+ +|+||+++++.+.+++..|+||||+ +++|.+++... ...++...++.++.|++.||.|||++
T Consensus 41 ~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~ 119 (255)
T cd08219 41 AVEDSRKEAVLLAKM-KHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK 119 (255)
T ss_pred HHHHHHHHHHHHHhC-CCCCcceEEEEEEECCEEEEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhC
Confidence 456788999999999 8999999999999999999999999 89999988643 34589999999999999999999999
Q ss_pred CceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHH
Q 013092 95 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYV 174 (449)
Q Consensus 95 givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~i 174 (449)
||+|+||||+||++ +..+.++|+|||++........ ......|++.|+|||++.+..++.++|+||||++
T Consensus 120 ~i~H~dl~p~nili---~~~~~~~l~dfg~~~~~~~~~~-------~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i 189 (255)
T cd08219 120 RVLHRDIKSKNIFL---TQNGKVKLGDFGSARLLTSPGA-------YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCI 189 (255)
T ss_pred CcccCCCCcceEEE---CCCCcEEEcccCcceeeccccc-------ccccccCCccccCHHHHccCCcCchhhhhhhchh
Confidence 99999999999999 5788999999999987654321 1234568899999999999889999999999999
Q ss_pred HHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 175 LMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 175 l~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
+|+|++|..||...+ ....+..+..... ..+...++.++.++|.+||+.+|++||++.+|..
T Consensus 190 ~~~l~~g~~p~~~~~---~~~~~~~~~~~~~----~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 251 (255)
T cd08219 190 LYELCTLKHPFQANS---WKNLILKVCQGSY----KPLPSHYSYELRSLIKQMFKRNPRSRPSATTILS 251 (255)
T ss_pred heehhhccCCCCCCC---HHHHHHHHhcCCC----CCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhh
Confidence 999999999997632 2333333333222 1233567889999999999999999999988754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-34 Score=284.54 Aligned_cols=208 Identities=21% Similarity=0.310 Sum_probs=166.2
Q ss_pred ChhHHHHHHHHHHHhcCCCCCceEEEEeEeC------CEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHH
Q 013092 17 KHPQLLYESKLYRILQGGTGIPNVRWFGVEG------DYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEF 90 (449)
Q Consensus 17 ~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~------~~~~lVmE~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~y 90 (449)
....+.+|+++++.+ +|+||+++++++... ...|++|++++++|.++++ ...+++..+..++.||+.||+|
T Consensus 57 ~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~--~~~l~~~~~~~i~~qi~~aL~~ 133 (343)
T cd07878 57 HARRTYRELRLLKHM-KHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVK--CQKLSDEHVQFLIYQLLRGLKY 133 (343)
T ss_pred HHHHHHHHHHHHHhc-CCCchhhhhhhhcccccccccCcEEEEeecCCCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHH
Confidence 345678999999999 899999998876532 4579999999999999887 4579999999999999999999
Q ss_pred HHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhC-CCCChhhHHH
Q 013092 91 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLE 169 (449)
Q Consensus 91 LH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~-~~~s~~~Diw 169 (449)
||++||+||||||+|||+ +.++.+||+|||+++...... ....||+.|+|||++.+ ..++.++|||
T Consensus 134 LH~~~ivHrdikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~----------~~~~~t~~y~aPE~~~~~~~~~~~~Diw 200 (343)
T cd07878 134 IHSAGIIHRDLKPSNVAV---NEDCELRILDFGLARQADDEM----------TGYVATRWYRAPEIMLNWMHYNQTVDIW 200 (343)
T ss_pred HHHCCeecccCChhhEEE---CCCCCEEEcCCccceecCCCc----------CCccccccccCchHhcCCccCCchhhhH
Confidence 999999999999999999 578899999999998654321 24578999999999987 5689999999
Q ss_pred HHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcc--------------------------cchHHHhhcCCcHHHHHH
Q 013092 170 SLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV--------------------------STSIEALCRGYPTEFASY 223 (449)
Q Consensus 170 SlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~--------------------------~~~~~~l~~~~p~el~~l 223 (449)
||||++|+|++|..||.+... .+.+..+..... ......+...+++.+.+|
T Consensus 201 slG~il~el~~g~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 277 (343)
T cd07878 201 SVGCIMAELLKGKALFPGNDY---IDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDL 277 (343)
T ss_pred hHHHHHHHHHHCCCCCCCCCH---HHHHHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHH
Confidence 999999999999999976432 222222211100 001112234566778999
Q ss_pred HHHHhcCCCCCCCCHHHHHH
Q 013092 224 FHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 224 i~~cl~~~p~~RPt~~~l~~ 243 (449)
+..|+..||++||++.+++.
T Consensus 278 i~~mL~~dp~~R~s~~ell~ 297 (343)
T cd07878 278 LEKMLVLDSDKRISASEALA 297 (343)
T ss_pred HHHHcCCChhhCCCHHHHhc
Confidence 99999999999999887753
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=266.27 Aligned_cols=211 Identities=18% Similarity=0.272 Sum_probs=173.2
Q ss_pred hHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q 013092 19 PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFL 97 (449)
Q Consensus 19 ~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~giv 97 (449)
..+.+|+.+++.+ +|+||+++++++...+..|+||||+ +++|.+++......+++..++.++.|++.+|.|||++|++
T Consensus 37 ~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ 115 (250)
T cd05085 37 IKFLSEARILKQY-DHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCI 115 (250)
T ss_pred HHHHHHHHHHHhC-CCCCcCeEEEEEecCCccEEEEECCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 3588999999999 9999999999999999999999999 9999999875555689999999999999999999999999
Q ss_pred ecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHHHHH
Q 013092 98 HRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMY 177 (449)
Q Consensus 98 HRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il~e 177 (449)
|+||||+||++ +.++.++|+|||++........ .......++..|+|||++.+..++.++||||||+++|+
T Consensus 116 H~dl~p~nili---~~~~~~~l~d~g~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~ 186 (250)
T cd05085 116 HRDLAARNCLV---GENNVLKISDFGMSRQEDDGIY------SSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWE 186 (250)
T ss_pred ecccChheEEE---cCCCeEEECCCccceecccccc------ccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHH
Confidence 99999999999 5788999999999876443221 11122344678999999998889999999999999999
Q ss_pred HHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 013092 178 FLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFR 246 (449)
Q Consensus 178 llt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~L~ 246 (449)
+++ |..||.+... ......+..... ......++.++.+++.+||..+|++||++.++.+.|.
T Consensus 187 ~~~~g~~p~~~~~~---~~~~~~~~~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 187 TFSLGVCPYPGMTN---QQAREQVEKGYR----MSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HhcCCCCCCCCCCH---HHHHHHHHcCCC----CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 998 9999987533 222222222111 1223467899999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=273.99 Aligned_cols=214 Identities=18% Similarity=0.196 Sum_probs=170.6
Q ss_pred ChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 013092 17 KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 96 (449)
Q Consensus 17 ~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gi 96 (449)
....+.+|+++++.+ +|+||+++++++.+....|+||||++++|.+++......+++..++.++.||+.||.|||++||
T Consensus 42 ~~~~~~~ei~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i 120 (284)
T cd07839 42 VPSSALREICLLKEL-KHKNIVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNV 120 (284)
T ss_pred CccchhHHHHHHHhc-CCCCeeeHHHHhccCCceEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCE
Confidence 345688999999999 8999999999999999999999999889998887656679999999999999999999999999
Q ss_pred eecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCC-CChhhHHHHHHHHH
Q 013092 97 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVL 175 (449)
Q Consensus 97 vHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~-~s~~~DiwSlG~il 175 (449)
+||||||+||++ +.++.++|+|||+++.+..... ......++..|+|||++.+.. ++.++|||||||++
T Consensus 121 ~H~dl~~~nil~---~~~~~~~l~dfg~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il 190 (284)
T cd07839 121 LHRDLKPQNLLI---NKNGELKLADFGLARAFGIPVR-------CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIF 190 (284)
T ss_pred ecCCCCHHHEEE---cCCCcEEECccchhhccCCCCC-------CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHH
Confidence 999999999999 5788999999999986543221 112346788999999988754 68999999999999
Q ss_pred HHHHhCCCCCCCCCcCCHHHHHHHHHhhcc------------------------cchHHHhhcCCcHHHHHHHHHHhcCC
Q 013092 176 MYFLRGSLPWQGLKAGTKKQKYEKISEKKV------------------------STSIEALCRGYPTEFASYFHYCRSLR 231 (449)
Q Consensus 176 ~elltG~~Pf~~~~~~~~~~~~~~i~~~~~------------------------~~~~~~l~~~~p~el~~li~~cl~~~ 231 (449)
|+|++|..||.... +..+.+..+..... ..........+++++.++|..||..+
T Consensus 191 ~~l~tg~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 268 (284)
T cd07839 191 AELANAGRPLFPGN--DVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCN 268 (284)
T ss_pred HHHHhcCCCCcCCC--CHHHHHHHHHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCC
Confidence 99999988864422 22222222221100 00112233457889999999999999
Q ss_pred CCCCCCHHHHHH
Q 013092 232 FDDKPDYAYLKR 243 (449)
Q Consensus 232 p~~RPt~~~l~~ 243 (449)
|++||++.++..
T Consensus 269 P~~R~t~~~il~ 280 (284)
T cd07839 269 PVQRISAEEALQ 280 (284)
T ss_pred hhhcCCHHHHhc
Confidence 999999888754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=271.17 Aligned_cols=216 Identities=22% Similarity=0.305 Sum_probs=177.1
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHH
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHS 93 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~---~~~ls~~~~~~i~~qi~~aL~yLH~ 93 (449)
...+..|+.+++.+ +|+||+++++++.+++..++||||+ +++|.+++... ...+++..++.++.||+.||.|||+
T Consensus 46 ~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~ 124 (267)
T cd08229 46 RADCIKEIDLLKQL-NHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS 124 (267)
T ss_pred HHHHHHHHHHHHHc-cCCchhhhhheeEeCCeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 35688999999999 9999999999999999999999999 89999998642 3458999999999999999999999
Q ss_pred CCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHH
Q 013092 94 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGY 173 (449)
Q Consensus 94 ~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~ 173 (449)
+|++|+||||+||++ +.++.++|+|||++..+...... .....|+..|+|||++.+..++.++|+||||+
T Consensus 125 ~~i~H~dl~p~nili---~~~~~~~l~dfg~~~~~~~~~~~-------~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~ 194 (267)
T cd08229 125 RRVMHRDIKPANVFI---TATGVVKLGDLGLGRFFSSKTTA-------AHSLVGTPYYMSPERIHENGYNFKSDIWSLGC 194 (267)
T ss_pred CCeecCCCCHHHEEE---cCCCCEEECcchhhhccccCCcc-------cccccCCcCccCHHHhcCCCccchhhHHHHHH
Confidence 999999999999999 57789999999998766443211 12346889999999999888999999999999
Q ss_pred HHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 013092 174 VLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDL 248 (449)
Q Consensus 174 il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~L~~~ 248 (449)
++|+|++|..||.+.... .......+....... .....+++++.+++.+||..+|++||++.+|.+.++++
T Consensus 195 il~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 195 LLYEMAALQSPFYGDKMN-LYSLCKKIEQCDYPP---LPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred HHHHHHhCCCCcccccch-HHHHhhhhhcCCCCC---CCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 999999999999764321 122222222211111 11234788999999999999999999999999988775
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-34 Score=285.88 Aligned_cols=209 Identities=18% Similarity=0.234 Sum_probs=164.0
Q ss_pred ChhHHHHHHHHHHHhcCCCCCceEEEEeEeC------CEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHH
Q 013092 17 KHPQLLYESKLYRILQGGTGIPNVRWFGVEG------DYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEF 90 (449)
Q Consensus 17 ~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~------~~~~lVmE~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~y 90 (449)
....+.+|+.+++.+ +|+||+++++++... ...|+||||+.++|.+++.. .++...+..++.|++.||+|
T Consensus 59 ~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~---~l~~~~~~~~~~qi~~aL~~ 134 (355)
T cd07874 59 HAKRAYRELVLMKCV-NHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKH 134 (355)
T ss_pred HHHHHHHHHHHHHHh-CCCchhceeeeeeccccccccceeEEEhhhhcccHHHHHhh---cCCHHHHHHHHHHHHHHHHH
Confidence 345678899999999 899999999887643 35799999997788887763 58999999999999999999
Q ss_pred HHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHH
Q 013092 91 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLES 170 (449)
Q Consensus 91 LH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwS 170 (449)
||++||+||||||+|||+ +.++.+||+|||+++....... .....||..|+|||++.+..++.++||||
T Consensus 135 LH~~givHrDikp~Nill---~~~~~~kl~Dfg~~~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~Diws 203 (355)
T cd07874 135 LHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFM--------MTPYVVTRYYRAPEVILGMGYKENVDIWS 203 (355)
T ss_pred HHhCCcccCCCChHHEEE---CCCCCEEEeeCcccccCCCccc--------cCCccccCCccCHHHHcCCCCCchhhHHH
Confidence 999999999999999999 5788999999999986543221 23457899999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccc-------------------------hHH------------Hhh
Q 013092 171 LGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST-------------------------SIE------------ALC 213 (449)
Q Consensus 171 lG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~-------------------------~~~------------~l~ 213 (449)
|||++|+|++|+.||.+... ...+..+.+..... ... ...
T Consensus 204 lG~il~el~~g~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (355)
T cd07874 204 VGCIMGEMVRHKILFPGRDY---IDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHN 280 (355)
T ss_pred HHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccc
Confidence 99999999999999987432 11121111110000 000 001
Q ss_pred cCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 214 RGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 214 ~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
...+.++.+||..|+..||++||++.++++
T Consensus 281 ~~~~~~~~~li~~mL~~dP~~Rps~~ell~ 310 (355)
T cd07874 281 KLKASQARDLLSKMLVIDPAKRISVDEALQ 310 (355)
T ss_pred cccchHHHHHHHHHhcCCchhcCCHHHHhc
Confidence 123567899999999999999999888754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=266.83 Aligned_cols=211 Identities=20% Similarity=0.262 Sum_probs=177.5
Q ss_pred CCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHH
Q 013092 15 KTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVH 92 (449)
Q Consensus 15 ~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~-~~~ls~~~~~~i~~qi~~aL~yLH 92 (449)
......+.+|+++++.+ +|+||+++++++.+.+..++||||+ +++|.+++... ...+++..+..++.|++.+|.|||
T Consensus 40 ~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh 118 (256)
T cd08221 40 EKERRDALNEIVILSLL-QHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH 118 (256)
T ss_pred hhHHHHHHHHHHHHHhC-CCCCeeEEEeEEecCCeEEEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH
Confidence 34456788999999999 8999999999999999999999999 99999999753 346899999999999999999999
Q ss_pred HCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHH
Q 013092 93 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLG 172 (449)
Q Consensus 93 ~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG 172 (449)
+.|++|+||||+||++ +..+.+||+|||++........ ......|++.|+|||++.+..++.++|+||||
T Consensus 119 ~~~i~h~dl~p~ni~~---~~~~~~kl~d~~~~~~~~~~~~-------~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG 188 (256)
T cd08221 119 KAGILHRDIKTLNIFL---TKAGLIKLGDFGISKILGSEYS-------MAETVVGTPYYMSPELCQGVKYNFKSDIWALG 188 (256)
T ss_pred hCCccccCCChHhEEE---eCCCCEEECcCcceEEcccccc-------cccccCCCccccCHhhcCCCCCCCcchhHHHH
Confidence 9999999999999999 5778899999999987654332 12345789999999999988889999999999
Q ss_pred HHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 173 YVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 173 ~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
+++|+|++|..||... +..+.+..+....... ....++.++.++|..||..+|++||++.++.+
T Consensus 189 ~i~~~l~~g~~~~~~~---~~~~~~~~~~~~~~~~----~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~ 252 (256)
T cd08221 189 CVLYELLTLKRTFDAT---NPLNLVVKIVQGNYTP----VVSVYSSELISLVHSLLQQDPEKRPTADEVLD 252 (256)
T ss_pred HHHHHHHHCCCCCCCC---CHHHHHHHHHcCCCCC----CccccCHHHHHHHHHHcccCcccCCCHHHHhh
Confidence 9999999999999763 3334444444333221 23567899999999999999999999888765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=269.88 Aligned_cols=212 Identities=21% Similarity=0.309 Sum_probs=174.6
Q ss_pred hHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q 013092 19 PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFL 97 (449)
Q Consensus 19 ~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~giv 97 (449)
+.+.+|+.+++.+ +||||+++++++.+.++.++||||+ +++|.+++.. ...+++..+..++.|++.||+|||+.|++
T Consensus 51 ~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~~l~~~l~~lH~~~iv 128 (267)
T cd06628 51 DALAREIALLKEL-QHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNN-YGAFEETLVRNFVRQILKGLNYLHNRGII 128 (267)
T ss_pred HHHHHHHHHHHhc-CCCCeeeEEEEEEeCCccEEEEEecCCCCHHHHHHh-ccCccHHHHHHHHHHHHHHHHHHHhcCcc
Confidence 4578899999999 9999999999999999999999999 8999999975 45789999999999999999999999999
Q ss_pred ecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHHHHH
Q 013092 98 HRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMY 177 (449)
Q Consensus 98 HRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il~e 177 (449)
||||||+||++ +.++.++|+|||+++........... ........|+..|++||.+.+..++.++|+|||||++|+
T Consensus 129 H~di~p~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~-~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~ 204 (267)
T cd06628 129 HRDIKGANILV---DNKGGIKISDFGISKKLEANSLSTKT-NGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVE 204 (267)
T ss_pred cccCCHHHEEE---cCCCCEEecccCCCcccccccccCCc-cccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHH
Confidence 99999999999 57889999999999877532211110 111234568899999999998889999999999999999
Q ss_pred HHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 178 FLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 178 lltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
|++|..||..... .+.+..+... ..+.+...++.++.++|.+||+.+|++||++.+|++
T Consensus 205 l~~g~~p~~~~~~---~~~~~~~~~~----~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 205 MLTGKHPFPDCTQ---LQAIFKIGEN----ASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred HhhCCCCCCCccH---HHHHHHHhcc----CCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 9999999986432 2223222221 122344568899999999999999999999888764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=268.40 Aligned_cols=213 Identities=19% Similarity=0.279 Sum_probs=173.9
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 96 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gi 96 (449)
...+..|+++++.+ .|+||+.+++++.+....|+||||+ +++|.+++......+++..++.++.|++.+|+|||++++
T Consensus 36 ~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i 114 (251)
T cd05041 36 KRKFLQEAEILKQY-DHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNC 114 (251)
T ss_pred HHHHHHHHHHHHhC-CCCCeEEEEEEEecCCCeEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCE
Confidence 45789999999999 8999999999999999999999999 999999997655568999999999999999999999999
Q ss_pred eecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHHHH
Q 013092 97 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLM 176 (449)
Q Consensus 97 vHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il~ 176 (449)
+||||||+||++ +.++.++|+|||+++........ .......++..|+|||.+.+..++.++|+|||||++|
T Consensus 115 ~h~di~p~nili---~~~~~~~l~d~g~~~~~~~~~~~-----~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~ 186 (251)
T cd05041 115 IHRDLAARNCLV---GENNVLKISDFGMSREEEGGIYT-----VSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLW 186 (251)
T ss_pred ehhhcCcceEEE---cCCCcEEEeeccccccccCCcce-----eccccCcceeccCChHhhccCCCCcchhHHHHHHHHH
Confidence 999999999999 57889999999999765432110 0011223456799999999888999999999999999
Q ss_pred HHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 013092 177 YFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFR 246 (449)
Q Consensus 177 ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~L~ 246 (449)
+|++ |..||...... .....+... .. ......+|.++.++|.+||..+|++||++.+|.+.|+
T Consensus 187 ~l~t~~~~p~~~~~~~---~~~~~~~~~-~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 187 ETFSLGDTPYPGMSNQ---QTRERIESG-YR---MPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred HHHhccCCCCccCCHH---HHHHHHhcC-CC---CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 9998 89999775432 222222211 11 1123467899999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=293.50 Aligned_cols=215 Identities=20% Similarity=0.230 Sum_probs=169.4
Q ss_pred hHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q 013092 19 PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLH 98 (449)
Q Consensus 19 ~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~givH 98 (449)
..+.+|+++|+.| +|+||+++++++..++..|||||++.++|.+++......+++..++.|+.||+.||+|||++||+|
T Consensus 205 ~~~~~E~~iL~~L-~HpnIv~l~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvH 283 (461)
T PHA03211 205 ASSVHEARLLRRL-SHPAVLALLDVRVVGGLTCLVLPKYRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIH 283 (461)
T ss_pred cCHHHHHHHHHHC-CCCCCCcEEEEEEECCEEEEEEEccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEE
Confidence 4578999999999 999999999999999999999999988999988765567999999999999999999999999999
Q ss_pred cCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHHHHHH
Q 013092 99 RDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYF 178 (449)
Q Consensus 99 RDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il~el 178 (449)
|||||+|||| +..+.+||+|||+++.+...... .......||..|+|||++.+..++.++|||||||+||||
T Consensus 284 rDLKP~NILl---~~~~~vkL~DFGla~~~~~~~~~-----~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El 355 (461)
T PHA03211 284 RDIKTENVLV---NGPEDICLGDFGAACFARGSWST-----PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEA 355 (461)
T ss_pred CcCCHHHEEE---CCCCCEEEcccCCceeccccccc-----ccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHH
Confidence 9999999999 57788999999999876432211 111245799999999999999999999999999999999
Q ss_pred HhCCCCCCCCCcC-----CHHHHHHHHHhhcccc------------------------------hHHHhhcCCcHHHHHH
Q 013092 179 LRGSLPWQGLKAG-----TKKQKYEKISEKKVST------------------------------SIEALCRGYPTEFASY 223 (449)
Q Consensus 179 ltG~~Pf~~~~~~-----~~~~~~~~i~~~~~~~------------------------------~~~~l~~~~p~el~~l 223 (449)
++|..|+...... ...+....+....... .+..+ ..++.++.+|
T Consensus 356 ~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~dl 434 (461)
T PHA03211 356 AVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRY-YKLDLDVEYL 434 (461)
T ss_pred HHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhh-ccccchHHHH
Confidence 9987665433211 1122222222211100 00000 1345689999
Q ss_pred HHHHhcCCCCCCCCHHHHHH
Q 013092 224 FHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 224 i~~cl~~~p~~RPt~~~l~~ 243 (449)
|..||+.||.+||++.+|++
T Consensus 435 i~~mL~~DP~~RPsa~elL~ 454 (461)
T PHA03211 435 VCRALTFDGARRPSAAELLR 454 (461)
T ss_pred HHHHcccChhhCcCHHHHhh
Confidence 99999999999999888765
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=285.27 Aligned_cols=219 Identities=21% Similarity=0.299 Sum_probs=171.8
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeCC-EEEEEEecC-CCCHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHHC
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEGD-YNVLVMDLL-GPSLEDLFNFCSR-KLSLKTVLMLADQMINRVEFVHSK 94 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~-~~~lVmE~~-g~sL~~ll~~~~~-~ls~~~~~~i~~qi~~aL~yLH~~ 94 (449)
..+|..|+.++..+ +|+|+|+|++||.+.+ ..+||+||+ +|+|.+.+..... .++|...++|+.++|.||+|||..
T Consensus 115 ~~eF~~Ei~~ls~l-~H~Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~ 193 (361)
T KOG1187|consen 115 EREFLNEVEILSRL-RHPNLVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEG 193 (361)
T ss_pred hhHHHHHHHHHhcC-CCcCcccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccC
Confidence 56799999999999 6999999999999998 599999999 8999999985444 899999999999999999999985
Q ss_pred C---ceecCCCCCcEEEeecCCCCeEEEeecCcceeecC-CCCCcccccccCCCC-ccCccccchhhhhCCCCChhhHHH
Q 013092 95 S---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD-TSTHQHIPYRENKNL-TGTARYASMNTHLGIEQSRRDDLE 169 (449)
Q Consensus 95 g---ivHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~-~~~~~~~~~~~~~~~-~gT~~Y~aPE~~~~~~~s~~~Diw 169 (449)
. |||||||+.|||| +.+...||+|||+|+.... .... ... .||.+|++||++.....+.++|||
T Consensus 194 ~~~~iiHrDiKssNILL---D~~~~aKlsDFGLa~~~~~~~~~~--------~~~~~gt~gY~~PEy~~~g~lt~KsDVy 262 (361)
T KOG1187|consen 194 CPPPIIHRDIKSSNILL---DEDFNAKLSDFGLAKLGPEGDTSV--------STTVMGTFGYLAPEYASTGKLTEKSDVY 262 (361)
T ss_pred CCCCEecCCCCHHHeeE---CCCCCEEccCccCcccCCccccce--------eeecCCCCccCChhhhccCCcCcccccc
Confidence 4 9999999999999 7899999999999965543 2110 112 799999999999988899999999
Q ss_pred HHHHHHHHHHhCCCCCCCCCcCC---HHHHHHH-HHhhcccchHH-Hhh-cCCc-----HHHHHHHHHHhcCCCCCCCCH
Q 013092 170 SLGYVLMYFLRGSLPWQGLKAGT---KKQKYEK-ISEKKVSTSIE-ALC-RGYP-----TEFASYFHYCRSLRFDDKPDY 238 (449)
Q Consensus 170 SlG~il~elltG~~Pf~~~~~~~---~~~~~~~-i~~~~~~~~~~-~l~-~~~p-----~el~~li~~cl~~~p~~RPt~ 238 (449)
|||++|+|+++|+.|........ ..+.... +.+......+. .+. ..++ ..+..+...|++.+|.+||++
T Consensus 263 SFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m 342 (361)
T KOG1187|consen 263 SFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTM 342 (361)
T ss_pred cchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCH
Confidence 99999999999998887533111 1111111 11111111111 111 2333 236678889999999999999
Q ss_pred HHHHHHHHHH
Q 013092 239 AYLKRIFRDL 248 (449)
Q Consensus 239 ~~l~~~L~~~ 248 (449)
.++.+.|+.+
T Consensus 343 ~~Vv~~L~~~ 352 (361)
T KOG1187|consen 343 SQVVKELEGI 352 (361)
T ss_pred HHHHHHHHhh
Confidence 9998887544
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=271.40 Aligned_cols=213 Identities=17% Similarity=0.201 Sum_probs=170.5
Q ss_pred ChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 013092 17 KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 95 (449)
Q Consensus 17 ~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~g 95 (449)
....+.+|+.+++.+ +|+||+++++.+...+..|+||||+ +++|.+++.. ...+++..+..++.|++.||.|||+.|
T Consensus 49 ~~~~~~~e~~~l~~~-~h~~ii~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ 126 (267)
T cd06646 49 DFSLIQQEIFMVKEC-KHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHV-TGPLSELQIAYVCRETLQGLAYLHSKG 126 (267)
T ss_pred hHHHHHHHHHHHHhc-CCCCeeeeeEEEEeCCEEEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 344578899999999 9999999999999999999999999 8899999875 457899999999999999999999999
Q ss_pred ceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhh---CCCCChhhHHHHHH
Q 013092 96 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHL---GIEQSRRDDLESLG 172 (449)
Q Consensus 96 ivHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~---~~~~s~~~DiwSlG 172 (449)
|+||||||+||++ +..+.++|+|||++..+..... ......|+..|+|||.+. ...++.++|+||||
T Consensus 127 i~H~dl~p~nill---~~~~~~~l~dfg~~~~~~~~~~-------~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G 196 (267)
T cd06646 127 KMHRDIKGANILL---TDNGDVKLADFGVAAKITATIA-------KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVG 196 (267)
T ss_pred ccccCCCHHHEEE---CCCCCEEECcCccceeeccccc-------ccCccccCccccCHhHcccccCCCCcchhhHHHHH
Confidence 9999999999999 5778899999999987643221 123456889999999985 34478899999999
Q ss_pred HHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHH
Q 013092 173 YVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRI 244 (449)
Q Consensus 173 ~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~ 244 (449)
|++|+|++|..||...... .....+...............++.++.++|..||..+|++||++++|++.
T Consensus 197 ~il~el~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 265 (267)
T cd06646 197 ITAIELAELQPPMFDLHPM---RALFLMSKSNFQPPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTH 265 (267)
T ss_pred HHHHHHHhCCCCccccchh---hhheeeecCCCCCCCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcC
Confidence 9999999999999764321 11111111111111111234578899999999999999999999888653
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=272.23 Aligned_cols=212 Identities=17% Similarity=0.292 Sum_probs=174.6
Q ss_pred hHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcC---------CCCCHHHHHHHHHHHHHHH
Q 013092 19 PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCS---------RKLSLKTVLMLADQMINRV 88 (449)
Q Consensus 19 ~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~---------~~ls~~~~~~i~~qi~~aL 88 (449)
..+.+|+.++..+ +|+||+++++++......|+||||+ +++|.+++.... ..+++..++.++.|++.||
T Consensus 54 ~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 132 (277)
T cd05032 54 IEFLNEASVMKEF-NCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGM 132 (277)
T ss_pred HHHHHHHHHHHhC-CCCceeEEEEEEcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHH
Confidence 4588999999999 8999999999999999999999999 899999986421 2368889999999999999
Q ss_pred HHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHH
Q 013092 89 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDL 168 (449)
Q Consensus 89 ~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~Di 168 (449)
.|||+.||+||||||+||++ +.++.+||+|||+++....... +.......++..|+|||.+.+..++.++||
T Consensus 133 ~~lH~~~i~H~di~p~nill---~~~~~~kl~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di 204 (277)
T cd05032 133 AYLAAKKFVHRDLAARNCMV---AEDLTVKIGDFGMTRDIYETDY-----YRKGGKGLLPVRWMAPESLKDGVFTTKSDV 204 (277)
T ss_pred HHHHhCCccccccChheEEE---cCCCCEEECCcccchhhccCcc-----cccCCCCCccccccCHHHHhcCCCCcccch
Confidence 99999999999999999999 5788999999999986644321 112234457889999999998889999999
Q ss_pred HHHHHHHHHHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 013092 169 ESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFR 246 (449)
Q Consensus 169 wSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~L~ 246 (449)
|||||++||+++ |..||.+... .+....+.... ....+..++.++.+++..||..+|++||++.+|...|+
T Consensus 205 ~slG~il~el~t~g~~p~~~~~~---~~~~~~~~~~~----~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 205 WSFGVVLWEMATLAEQPYQGLSN---EEVLKFVIDGG----HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred HHHHHHHHHhhccCCCCCccCCH---HHHHHHHhcCC----CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 999999999998 9999976433 23333333221 12234567899999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=272.89 Aligned_cols=220 Identities=16% Similarity=0.195 Sum_probs=170.6
Q ss_pred EEEEeeecccC--CChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHH
Q 013092 5 LTVFSVQENVK--TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLA 81 (449)
Q Consensus 5 ikV~~k~~~~~--~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~ 81 (449)
++|++|..... .....+..|+.+++.+ .||||+++++++.+....||||||+ +++|.+++......+++..++.++
T Consensus 45 ~~v~~k~~~~~~~~~~~~~~~~~~~~~~l-~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~ 123 (274)
T cd05076 45 LRVVLKVLDPSHRDIALAFFETASLMSQV-SHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVA 123 (274)
T ss_pred eeEEEEecChHHHHHHHHHHHHHHHHhcC-CCCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHH
Confidence 34555544322 2234578889999988 8999999999999999999999999 999999987656678999999999
Q ss_pred HHHHHHHHHHHHCCceecCCCCCcEEEeec----CCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhh
Q 013092 82 DQMINRVEFVHSKSFLHRDIKPDNFLMGLG----RRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTH 157 (449)
Q Consensus 82 ~qi~~aL~yLH~~givHRDLKP~NiLl~~~----~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~ 157 (449)
.||+.||+|||++||+||||||+|||+... .....++|+|||++...... ....++..|+|||.+
T Consensus 124 ~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~-----------~~~~~~~~~~aPe~~ 192 (274)
T cd05076 124 QQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR-----------EERVERIPWIAPECV 192 (274)
T ss_pred HHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCccceeeecCCccccccccc-----------cccccCCcccCchhh
Confidence 999999999999999999999999999531 11235899999987643221 123577889999988
Q ss_pred hC-CCCChhhHHHHHHHHHHHHH-hCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCC
Q 013092 158 LG-IEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDK 235 (449)
Q Consensus 158 ~~-~~~s~~~DiwSlG~il~ell-tG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~R 235 (449)
.+ ..++.++|||||||++|||+ +|..||.......... +..... .++...++++.++|..||+.+|++|
T Consensus 193 ~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~----~~~~~~-----~~~~~~~~~~~~li~~cl~~~p~~R 263 (274)
T cd05076 193 PGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER----FYEKKH-----RLPEPSCKELATLISQCLTYEPTQR 263 (274)
T ss_pred cCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH----HHHhcc-----CCCCCCChHHHHHHHHHcccChhhC
Confidence 75 56899999999999999995 6999998754322211 111111 1122345789999999999999999
Q ss_pred CCHHHHHHHH
Q 013092 236 PDYAYLKRIF 245 (449)
Q Consensus 236 Pt~~~l~~~L 245 (449)
|++.+|++.|
T Consensus 264 ps~~~il~~L 273 (274)
T cd05076 264 PSFRTILRDL 273 (274)
T ss_pred cCHHHHHHhh
Confidence 9999887755
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=269.68 Aligned_cols=213 Identities=17% Similarity=0.283 Sum_probs=178.2
Q ss_pred ChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHC
Q 013092 17 KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSK 94 (449)
Q Consensus 17 ~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~-~~~ls~~~~~~i~~qi~~aL~yLH~~ 94 (449)
....+..|+.+++.+ +|+||+++++++.+.+..|+||||+ +++|.+++... ...+++..++.++.||+.||.|||++
T Consensus 45 ~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~ 123 (261)
T cd05148 45 KQQDFQKEVQALKRL-RHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ 123 (261)
T ss_pred hHHHHHHHHHHHhcC-CCcchhheeeeEecCCCeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 356789999999999 8999999999999999999999999 89999999753 34689999999999999999999999
Q ss_pred CceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHH
Q 013092 95 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYV 174 (449)
Q Consensus 95 givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~i 174 (449)
||+|+||||+||++ +.++.+||+|||++........ ......++..|++||++.+..++.++||||||++
T Consensus 124 ~i~h~dl~~~nilv---~~~~~~kl~d~g~~~~~~~~~~-------~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~ 193 (261)
T cd05148 124 NSIHRDLAARNILV---GEDLVCKVADFGLARLIKEDVY-------LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGIL 193 (261)
T ss_pred CeeccccCcceEEE---cCCceEEEccccchhhcCCccc-------cccCCCCceEecCHHHHccCCCCchhhHHHHHHH
Confidence 99999999999999 5788999999999976644321 1123346778999999998889999999999999
Q ss_pred HHHHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Q 013092 175 LMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRD 247 (449)
Q Consensus 175 l~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~L~~ 247 (449)
+|+|++ |..||.... ..+.+..+..... ......+++++.++|..||..+|++||++.+|.+.|+.
T Consensus 194 l~~l~~~g~~p~~~~~---~~~~~~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 194 LYEMFTYGQVPYPGMN---NHEVYDQITAGYR----MPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred HHHHHcCCCCCCCcCC---HHHHHHHHHhCCc----CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 999998 899997744 2334444432211 12235688999999999999999999999999988864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=270.70 Aligned_cols=219 Identities=22% Similarity=0.298 Sum_probs=171.4
Q ss_pred HHHHHHHHHHHhc--CCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 013092 20 QLLYESKLYRILQ--GGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 96 (449)
Q Consensus 20 ~~~~E~~il~~l~--~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gi 96 (449)
.+.+|..+++.+. +|++|+.+++.+...+..|+||||+ +++|.+++.. ...+++..+..++.|++.||+|||++||
T Consensus 40 ~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~lH~~~i 118 (279)
T cd05633 40 LALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQ-HGVFSEKEMRFYATEIILGLEHMHNRFV 118 (279)
T ss_pred HHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 3456665555543 7899999999999999999999999 9999998875 4569999999999999999999999999
Q ss_pred eecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhh-CCCCChhhHHHHHHHHH
Q 013092 97 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHL-GIEQSRRDDLESLGYVL 175 (449)
Q Consensus 97 vHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~-~~~~s~~~DiwSlG~il 175 (449)
+||||||+|||+ +.++.++|+|||++........ ....||..|+|||.+. +..++.++|||||||++
T Consensus 119 vH~dikp~Nil~---~~~~~~~l~dfg~~~~~~~~~~---------~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l 186 (279)
T cd05633 119 VYRDLKPANILL---DEHGHVRISDLGLACDFSKKKP---------HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCML 186 (279)
T ss_pred CCCCCCHHHEEE---CCCCCEEEccCCcceeccccCc---------cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHH
Confidence 999999999999 5788999999999876543221 2346899999999987 45689999999999999
Q ss_pred HHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCC-----CHHHHHHHHHHHHH
Q 013092 176 MYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKP-----DYAYLKRIFRDLFI 250 (449)
Q Consensus 176 ~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RP-----t~~~l~~~L~~~~~ 250 (449)
|+|++|..||.......... .... ... ....++..++.++.++|..||..+|.+|| ++.++++
T Consensus 187 ~~l~~g~~pf~~~~~~~~~~-~~~~---~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~------- 254 (279)
T cd05633 187 FKLLRGHSPFRQHKTKDKHE-IDRM---TLT-VNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKE------- 254 (279)
T ss_pred HHHHhCCCCcCCCCCcCHHH-HHHH---hhc-CCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHh-------
Confidence 99999999998654433222 1111 111 11124456889999999999999999999 4655533
Q ss_pred HcCCCCCCcccchhhh
Q 013092 251 REGFQFDYVFDWTILK 266 (449)
Q Consensus 251 ~~~~~~~~~~dw~~~~ 266 (449)
+++...++|....
T Consensus 255 ---h~~~~~~~~~~~~ 267 (279)
T cd05633 255 ---HVFFKGIDWQQVY 267 (279)
T ss_pred ---CccccCCCHhHHh
Confidence 3455556676653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=272.36 Aligned_cols=207 Identities=17% Similarity=0.178 Sum_probs=165.3
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 96 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gi 96 (449)
...+..|+.+++.+ +||||+++++++..+...++||||+ +++|.+++......+++..++.++.||+.||+|||++||
T Consensus 43 ~~~~~~e~~~l~~~-~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i 121 (258)
T cd05078 43 SESFFEAASMMSQL-SHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGL 121 (258)
T ss_pred HHHHHHHHHHHHhC-CCCChhheeeEEEeCCCcEEEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 34678899999998 8999999999999999999999999 999999998655568999999999999999999999999
Q ss_pred eecCCCCCcEEEeecCC-----CCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhC-CCCChhhHHHH
Q 013092 97 LHRDIKPDNFLMGLGRR-----ANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLES 170 (449)
Q Consensus 97 vHRDLKP~NiLl~~~~~-----~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~-~~~s~~~DiwS 170 (449)
+||||||+||+++.+.. ...++++|||++...... ....++..|+|||++.+ ..++.++||||
T Consensus 122 iH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~~Diws 190 (258)
T cd05078 122 THGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPK-----------EILLERIPWVPPECIENPQNLSLAADKWS 190 (258)
T ss_pred ecCCCccceEEEecccccccCCCceEEecccccccccCCc-----------hhccccCCccCchhccCCCCCCchhhHHH
Confidence 99999999999953211 123799999998654321 23467889999999987 45789999999
Q ss_pred HHHHHHHHHhC-CCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Q 013092 171 LGYVLMYFLRG-SLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIF 245 (449)
Q Consensus 171 lG~il~elltG-~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~L 245 (449)
|||++|+|++| ..||....... . ..+.... ..++...+.++.+++..||+.+|++||++.+|.+.|
T Consensus 191 lG~~l~~l~~g~~~~~~~~~~~~---~-~~~~~~~-----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 191 FGTTLWEIFSGGDKPLSALDSQK---K-LQFYEDR-----HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred HHHHHHHHHcCCCCChhhccHHH---H-HHHHHcc-----ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 99999999998 46665533211 1 1111111 123334567899999999999999999999987764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=268.36 Aligned_cols=215 Identities=19% Similarity=0.327 Sum_probs=177.3
Q ss_pred CChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHH
Q 013092 16 TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHS 93 (449)
Q Consensus 16 ~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~-~~~ls~~~~~~i~~qi~~aL~yLH~ 93 (449)
.....+.+|+.+++.+ +|+||+++++++......++||||+ +++|.+++... ...+++..++.++.|++.||.|||+
T Consensus 43 ~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~ 121 (261)
T cd05034 43 MSPEAFLQEAQIMKKL-RHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLES 121 (261)
T ss_pred cCHHHHHHHHHHHhhC-CCCCEeeeeeeeecCCceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 4456799999999999 8999999999999989999999999 89999999753 3468999999999999999999999
Q ss_pred CCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHH
Q 013092 94 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGY 173 (449)
Q Consensus 94 ~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~ 173 (449)
+||+|+||||+||++ +.++.++|+|||+++.+..... .......++..|++||.+.+..++.++|+|||||
T Consensus 122 ~~i~h~di~p~nili---~~~~~~~l~d~g~~~~~~~~~~------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~ 192 (261)
T cd05034 122 RNYIHRDLAARNILV---GENLVCKIADFGLARLIEDDEY------TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGI 192 (261)
T ss_pred CCcccCCcchheEEE---cCCCCEEECccccceeccchhh------hhhhccCCCccccCHHHhccCCcCchhHHHHHHH
Confidence 999999999999999 5789999999999987654211 1112334567899999999888999999999999
Q ss_pred HHHHHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Q 013092 174 VLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRD 247 (449)
Q Consensus 174 il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~L~~ 247 (449)
++|+|++ |+.||.+... ...+..+..... ......+|.++.+++.+||..+|++||++.+|.+.|++
T Consensus 193 il~~l~t~g~~p~~~~~~---~~~~~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 193 LLTEIVTYGRVPYPGMTN---REVLEQVERGYR----MPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred HHHHHHhCCCCCCCCCCH---HHHHHHHHcCCC----CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 9999998 9999976432 333333332211 11234568999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=270.93 Aligned_cols=217 Identities=18% Similarity=0.292 Sum_probs=174.1
Q ss_pred ChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHc------CCCCCHHHHHHHHHHHHHHHH
Q 013092 17 KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFC------SRKLSLKTVLMLADQMINRVE 89 (449)
Q Consensus 17 ~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~------~~~ls~~~~~~i~~qi~~aL~ 89 (449)
....+.+|+.+++.+ +||||+++++++...+..|+||||+ +++|.+++... ...+++..++.++.|++.||+
T Consensus 42 ~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~ 120 (269)
T cd05044 42 EKKEFLKEAHLMSNF-NHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120 (269)
T ss_pred hHHHHHHHHHHHHhc-CCCCeeeEeeeecCCCCeEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHH
Confidence 455788999999999 9999999999999999999999999 99999998642 133788999999999999999
Q ss_pred HHHHCCceecCCCCCcEEEeecC--CCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhH
Q 013092 90 FVHSKSFLHRDIKPDNFLMGLGR--RANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDD 167 (449)
Q Consensus 90 yLH~~givHRDLKP~NiLl~~~~--~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~D 167 (449)
|||+++++|+||||+||++..+. ....++|+|||+++........ .......++..|+|||++.+..++.++|
T Consensus 121 ~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~D 195 (269)
T cd05044 121 YLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYY-----RKEGEGLLPVRWMAPESLLDGKFTTQSD 195 (269)
T ss_pred HHHhCCcccCCCChheEEEecCCCCCCcceEECCccccccccccccc-----ccCcccCCCccccCHHHHccCCcccchh
Confidence 99999999999999999995221 1238999999999765433211 1122345678899999999989999999
Q ss_pred HHHHHHHHHHHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 013092 168 LESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFR 246 (449)
Q Consensus 168 iwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~L~ 246 (449)
||||||++|+|++ |..||..... .+....+.... .......+|.++.++|.+||..+|++||++.+|.+.|.
T Consensus 196 v~slG~il~ellt~g~~p~~~~~~---~~~~~~~~~~~----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 196 VWSFGVLMWEILTLGQQPYPALNN---QEVLQHVTAGG----RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred HHHHHHHHHHHHHcCCCCCcccCH---HHHHHHHhcCC----ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 9999999999998 9999976433 22233332211 11233567899999999999999999999999988775
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=278.69 Aligned_cols=212 Identities=19% Similarity=0.245 Sum_probs=169.9
Q ss_pred HHHHHHHHHHHhcCCCCCceEEEEeEeC-----CEEEEEEecCCCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHH
Q 013092 20 QLLYESKLYRILQGGTGIPNVRWFGVEG-----DYNVLVMDLLGPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFV 91 (449)
Q Consensus 20 ~~~~E~~il~~l~~hp~Iv~l~~~~~~~-----~~~~lVmE~~g~sL~~ll~~~---~~~ls~~~~~~i~~qi~~aL~yL 91 (449)
--.+|+.||+.+ +|||||.|..++... -+..+||||+..+|.++++.. +.+++...+.-+.+||.+||.||
T Consensus 63 ~knrEl~im~~l-~HpNIV~L~~~f~~~~~~d~~~lnlVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yL 141 (364)
T KOG0658|consen 63 YKNRELQIMRKL-DHPNIVRLLYFFSSSTESDEVYLNLVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYL 141 (364)
T ss_pred cCcHHHHHHHhc-CCcCeeeEEEEEEecCCCchhHHHHHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHH
Confidence 346899999988 999999998888632 246789999999999999843 56799999999999999999999
Q ss_pred HHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhC-CCCChhhHHHH
Q 013092 92 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLES 170 (449)
Q Consensus 92 H~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~-~~~s~~~DiwS 170 (449)
|+.||+||||||+|+|+. ...+.+||||||.|+.+..+.. +..+..|..|.|||.+.| .+|+.+.||||
T Consensus 142 h~~~IcHRDIKPqNlLvD--~~tg~LKicDFGSAK~L~~~ep--------niSYicSRyYRaPELifga~~Yt~~IDiWS 211 (364)
T KOG0658|consen 142 HSHGICHRDIKPQNLLVD--PDTGVLKICDFGSAKVLVKGEP--------NISYICSRYYRAPELIFGATEYTTSIDIWS 211 (364)
T ss_pred HhcCcccCCCChheEEEc--CCCCeEEeccCCcceeeccCCC--------ceeEEEeccccCHHHHcCccccCceeEEhh
Confidence 999999999999999995 5569999999999998876543 245677899999999998 56999999999
Q ss_pred HHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHh---------hccc-----------chH-HHhhcCCcHHHHHHHHHHhc
Q 013092 171 LGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE---------KKVS-----------TSI-EALCRGYPTEFASYFHYCRS 229 (449)
Q Consensus 171 lG~il~elltG~~Pf~~~~~~~~~~~~~~i~~---------~~~~-----------~~~-~~l~~~~p~el~~li~~cl~ 229 (449)
.|||+.||+.|++-|.|....+....+-++.. .... ..+ +.+....+++..+|+.+++.
T Consensus 212 aGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~ 291 (364)
T KOG0658|consen 212 AGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQ 291 (364)
T ss_pred hhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhc
Confidence 99999999999999999554332222222211 1100 000 11335578999999999999
Q ss_pred CCCCCCCCHHHHH
Q 013092 230 LRFDDKPDYAYLK 242 (449)
Q Consensus 230 ~~p~~RPt~~~l~ 242 (449)
.+|.+|.+..++.
T Consensus 292 Y~P~~R~~~~~~l 304 (364)
T KOG0658|consen 292 YSPSKRLSALEAL 304 (364)
T ss_pred cChhhcCCHHHHh
Confidence 9999999976654
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=268.62 Aligned_cols=214 Identities=18% Similarity=0.333 Sum_probs=174.7
Q ss_pred CChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHH
Q 013092 16 TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHS 93 (449)
Q Consensus 16 ~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~-~~~ls~~~~~~i~~qi~~aL~yLH~ 93 (449)
.....+.+|+.+++.+ +|+||+++++++ ..+..|+||||+ +++|.+++... ...+++..++.++.|++.||+|||+
T Consensus 43 ~~~~~~~~E~~~l~~l-~h~~i~~~~~~~-~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~ 120 (260)
T cd05067 43 MSPEAFLAEANLMKQL-QHPRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIER 120 (260)
T ss_pred CcHHHHHHHHHHHHhc-CCcCeeeEEEEE-ccCCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhc
Confidence 3456799999999999 899999999876 456789999999 99999998643 3468999999999999999999999
Q ss_pred CCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHH
Q 013092 94 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGY 173 (449)
Q Consensus 94 ~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~ 173 (449)
.|++|+||||+||++ +.++.++|+|||++........ .......++..|++||++.+..++.++||||||+
T Consensus 121 ~~i~H~dl~p~ni~i---~~~~~~~l~dfg~~~~~~~~~~------~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~ 191 (260)
T cd05067 121 KNYIHRDLRAANILV---SETLCCKIADFGLARLIEDNEY------TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGI 191 (260)
T ss_pred CCeecccccHHhEEE---cCCCCEEEccCcceeecCCCCc------ccccCCcccccccCHHHhccCCcCcccchHHHHH
Confidence 999999999999999 5788999999999987653221 1112334677899999999888999999999999
Q ss_pred HHHHHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Q 013092 174 VLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRD 247 (449)
Q Consensus 174 il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~L~~ 247 (449)
++|+|++ |.+||.+.... +.+..+...... .....+|.++.+++.+||..+|++||++++|...|++
T Consensus 192 ~l~el~~~g~~p~~~~~~~---~~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 192 LLTEIVTYGRIPYPGMTNP---EVIQNLERGYRM----PRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred HHHHHHhCCCCCCCCCChH---HHHHHHHcCCCC----CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 9999998 99999875432 223333222111 2335678999999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=267.68 Aligned_cols=213 Identities=18% Similarity=0.329 Sum_probs=173.0
Q ss_pred ChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHC
Q 013092 17 KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSK 94 (449)
Q Consensus 17 ~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~-~~~ls~~~~~~i~~qi~~aL~yLH~~ 94 (449)
....+.+|+.+++.+ +|++|+++++++. ....|+||||+ +++|.+++... ...+++..++.++.|++.||+|||+.
T Consensus 44 ~~~~~~~E~~~l~~l-~~~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~ 121 (260)
T cd05070 44 SPESFLEEAQIMKKL-RHDKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM 121 (260)
T ss_pred CHHHHHHHHHHHHhc-CCCceEEEEeEEC-CCCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 345789999999999 8999999998774 45689999999 89999998753 34589999999999999999999999
Q ss_pred CceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHH
Q 013092 95 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYV 174 (449)
Q Consensus 95 givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~i 174 (449)
||+||||||+||++ +.++.++|+|||++..+...... ......++..|+|||++.+..++.++||||||++
T Consensus 122 ~i~H~di~p~Nili---~~~~~~~l~dfg~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~ 192 (260)
T cd05070 122 NYIHRDLRSANILV---GDGLVCKIADFGLARLIEDNEYT------ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGIL 192 (260)
T ss_pred CcccCCCccceEEE---eCCceEEeCCceeeeeccCcccc------cccCCCCCccccChHHHhcCCCcchhhhHHHHHH
Confidence 99999999999999 46789999999999876543211 1122345678999999998889999999999999
Q ss_pred HHHHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Q 013092 175 LMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRD 247 (449)
Q Consensus 175 l~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~L~~ 247 (449)
+|+|++ |..||.+.+. ......+.... . ......++.++.+++.+||..+|++||++.+|.+.|++
T Consensus 193 l~~l~~~g~~p~~~~~~---~~~~~~~~~~~-~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 193 LTELVTKGRVPYPGMNN---REVLEQVERGY-R---MPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred HHHHHhcCCCCCCCCCH---HHHHHHHHcCC-C---CCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 999999 9999976433 22333332211 1 12335678999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=270.56 Aligned_cols=216 Identities=16% Similarity=0.230 Sum_probs=177.3
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 96 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gi 96 (449)
...+.+|+.++..+ +|+||+++++++.. ...++||||+ +++|.+++......+++..++.++.||+.||+|||++||
T Consensus 53 ~~~~~~e~~~l~~l-~h~~i~~~~~~~~~-~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i 130 (279)
T cd05057 53 NKEILDEAYVMASV-DHPHVVRLLGICLS-SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRL 130 (279)
T ss_pred HHHHHHHHHHHHhC-CCCCcceEEEEEec-CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCE
Confidence 35688999999999 99999999999887 7899999999 999999998655679999999999999999999999999
Q ss_pred eecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHHHH
Q 013092 97 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLM 176 (449)
Q Consensus 97 vHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il~ 176 (449)
+||||||+||++ +.++.+||+|||+++......... ......++..|++||.+....++.++|+|||||++|
T Consensus 131 ~H~di~p~nil~---~~~~~~kL~dfg~~~~~~~~~~~~-----~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~ 202 (279)
T cd05057 131 VHRDLAARNVLV---KTPQHVKITDFGLAKLLDVDEKEY-----HAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVW 202 (279)
T ss_pred EecccCcceEEE---cCCCeEEECCCcccccccCcccce-----ecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHH
Confidence 999999999999 578899999999998765332211 011223457899999998888999999999999999
Q ss_pred HHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 013092 177 YFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFI 250 (449)
Q Consensus 177 ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~L~~~~~ 250 (449)
|+++ |..||.+... .+....+..... ......++.++.+++..||..+|++||++.+|.+.|.+++.
T Consensus 203 el~~~g~~p~~~~~~---~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 203 ELMTFGAKPYEGIPA---VEIPDLLEKGER----LPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred HHhcCCCCCCCCCCH---HHHHHHHhCCCC----CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 9998 9999987533 223333332211 11234467899999999999999999999999999998854
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=272.13 Aligned_cols=233 Identities=23% Similarity=0.303 Sum_probs=187.2
Q ss_pred EEEEEeeecccC-CChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHH
Q 013092 4 ILTVFSVQENVK-TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLA 81 (449)
Q Consensus 4 aikV~~k~~~~~-~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~ 81 (449)
|+|+..+..... .....+.+|+++++.+ +||||+++++++.+++..|+||||+ +++|.+++.. ...+++..+..++
T Consensus 30 aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~-~~~l~~~~~~~~~ 107 (290)
T cd05580 30 ALKILSKAKIVKLKQVEHVLNEKRILQSI-RHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRK-SGRFPEPVARFYA 107 (290)
T ss_pred EEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCccceeeEEEcCCeEEEEEecCCCCCHHHHHHH-cCCCCHHHHHHHH
Confidence 445444333222 2345688999999999 7999999999999999999999999 9999999976 4679999999999
Q ss_pred HHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCC
Q 013092 82 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIE 161 (449)
Q Consensus 82 ~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~ 161 (449)
.||+.||+|||++||+|+||+|.||++ +.++.+||+|||+++..... .....+++.|++||.+.+..
T Consensus 108 ~qil~~l~~lH~~~i~H~dl~p~nili---~~~~~~kl~dfg~~~~~~~~----------~~~~~~~~~y~aPE~~~~~~ 174 (290)
T cd05580 108 AQVVLALEYLHSLDIVYRDLKPENLLL---DSDGYIKITDFGFAKRVKGR----------TYTLCGTPEYLAPEIILSKG 174 (290)
T ss_pred HHHHHHHHHHHHCCEecCCCCHHHEEE---CCCCCEEEeeCCCccccCCC----------CCCCCCCccccChhhhcCCC
Confidence 999999999999999999999999999 57789999999999876443 12446899999999999888
Q ss_pred CChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCC-----
Q 013092 162 QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKP----- 236 (449)
Q Consensus 162 ~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RP----- 236 (449)
++.++||||||+++|+|++|..||.... ..+.+..+..... .+...++..+.+++..||..+|++|+
T Consensus 175 ~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~~~~~~~-----~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~ 246 (290)
T cd05580 175 YGKAVDWWALGILIYEMLAGYPPFFDDN---PIQIYEKILEGKV-----RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKN 246 (290)
T ss_pred CCccccHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHhcCCc-----cCCccCCHHHHHHHHHHccCCHHHccCcccC
Confidence 8999999999999999999999997643 2333444432221 23455789999999999999999998
Q ss_pred CHHHHHHHHHHHHHHcCCCCCCcccchhhhhhh
Q 013092 237 DYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQ 269 (449)
Q Consensus 237 t~~~l~~~L~~~~~~~~~~~~~~~dw~~~~~~~ 269 (449)
+..++. .+++...++|.......
T Consensus 247 ~~~~l~----------~~~~~~~~~~~~~~~~~ 269 (290)
T cd05580 247 GVNDIK----------NHPWFAGIDWIALLQRK 269 (290)
T ss_pred CHHHHH----------cCcccccCCHHHHhhcc
Confidence 433332 24666778898775443
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=273.50 Aligned_cols=213 Identities=21% Similarity=0.322 Sum_probs=173.9
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcC---------------------CCCCHH
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCS---------------------RKLSLK 75 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~---------------------~~ls~~ 75 (449)
...+.+|+.++..+ +||||+++++++.++...|+||||+ +++|.+++.... ..+++.
T Consensus 52 ~~~~~~ei~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 130 (288)
T cd05050 52 QADFQREAALMAEF-DHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCT 130 (288)
T ss_pred HHHHHHHHHHHHhc-CCCchheEEEEEcCCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHH
Confidence 45688999999999 9999999999999999999999999 899999986421 247788
Q ss_pred HHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchh
Q 013092 76 TVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMN 155 (449)
Q Consensus 76 ~~~~i~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE 155 (449)
.++.++.|++.||+|||++|++||||||.||++ +.++.++|+|||++..+..... +........+..|+|||
T Consensus 131 ~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE 202 (288)
T cd05050 131 EQLCIAKQVAAGMAYLSERKFVHRDLATRNCLV---GENMVVKIADFGLSRNIYSADY-----YKASENDAIPIRWMPPE 202 (288)
T ss_pred HHHHHHHHHHHHHHHHHhCCeecccccHhheEe---cCCCceEECccccceecccCcc-----ccccCCCccChhhcCHH
Confidence 899999999999999999999999999999999 5788999999999876543221 11122234567899999
Q ss_pred hhhCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCC
Q 013092 156 THLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDD 234 (449)
Q Consensus 156 ~~~~~~~s~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~ 234 (449)
++.+..++.++|||||||++|+|++ |..||.+... .+....+...... .....+|.++.+|+.+||+.+|++
T Consensus 203 ~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~---~~~~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~~p~~ 275 (288)
T cd05050 203 SIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH---EEVIYYVRDGNVL----SCPDNCPLELYNLMRLCWSKLPSD 275 (288)
T ss_pred HHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHhcCCCC----CCCCCCCHHHHHHHHHHcccCccc
Confidence 9998899999999999999999997 8899976533 3333333332221 123467899999999999999999
Q ss_pred CCCHHHHHHHHH
Q 013092 235 KPDYAYLKRIFR 246 (449)
Q Consensus 235 RPt~~~l~~~L~ 246 (449)
||++.+|...|+
T Consensus 276 Rpt~~el~~~l~ 287 (288)
T cd05050 276 RPSFASINRILQ 287 (288)
T ss_pred CCCHHHHHHHhh
Confidence 999999988875
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=270.83 Aligned_cols=210 Identities=17% Similarity=0.253 Sum_probs=171.1
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 96 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gi 96 (449)
...+.+|+++++.+ +|+||+.+++.+..++..|+||||+ +++|.+++......+++..+..++.|++.||.|||+.||
T Consensus 46 ~~~~~~e~~~l~~l-~h~~ii~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i 124 (282)
T cd06643 46 LEDYMVEIDILASC-DHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKI 124 (282)
T ss_pred HHHHHHHHHHHHHC-CCCCeeeEEEEEeeCCEEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 45688899999999 8999999999999999999999999 889988886545679999999999999999999999999
Q ss_pred eecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhh-----CCCCChhhHHHHH
Q 013092 97 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHL-----GIEQSRRDDLESL 171 (449)
Q Consensus 97 vHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~-----~~~~s~~~DiwSl 171 (449)
+||||||+|||+ +.++.++|+|||++........ ......++..|+|||++. +..++.++|||||
T Consensus 125 ~H~dlkp~nili---~~~~~~kl~dfg~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~sl 194 (282)
T cd06643 125 IHRDLKAGNILF---TLDGDIKLADFGVSAKNTRTIQ-------RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSL 194 (282)
T ss_pred eecCCCcccEEE---ccCCCEEEcccccccccccccc-------ccccccccccccCHhhccccCCCCCCCCccchhhhH
Confidence 999999999999 5788999999999876543221 123456899999999984 4557889999999
Q ss_pred HHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 172 GYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 172 G~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
||++|+|++|..||...+. .+.+..+...... .......++.++.++|..||+.+|++||++.+++.
T Consensus 195 Gvil~el~~g~~p~~~~~~---~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 195 GITLIEMAQIEPPHHELNP---MRVLLKIAKSEPP--TLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred HHHHHHHccCCCCccccCH---HHHHHHHhhcCCC--CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 9999999999999976432 2333333222111 11123457899999999999999999999887743
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=267.79 Aligned_cols=206 Identities=16% Similarity=0.191 Sum_probs=165.6
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 96 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gi 96 (449)
...+.+|+.+++.+ +|+||+++++++.. ...|+||||+ +++|.+++......+++..++.++.||+.||+|||++||
T Consensus 45 ~~~~~~e~~~l~~l-~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i 122 (259)
T cd05037 45 SLAFFETASLMSQL-SHKHLVKLYGVCVR-DENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKL 122 (259)
T ss_pred HHHHHHHHHHHHcC-CCcchhheeeEEec-CCcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCe
Confidence 56789999999999 89999999999888 7789999999 999999998644478999999999999999999999999
Q ss_pred eecCCCCCcEEEeecC----CCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCC--CCChhhHHHH
Q 013092 97 LHRDIKPDNFLMGLGR----RANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI--EQSRRDDLES 170 (449)
Q Consensus 97 vHRDLKP~NiLl~~~~----~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~--~~s~~~DiwS 170 (449)
+||||||+|||++... ....++|+|||++...... ....++..|+|||++.+. .++.++||||
T Consensus 123 ~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~s 191 (259)
T cd05037 123 VHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSR-----------EERVERIPWIAPECIRNGQASLTIAADKWS 191 (259)
T ss_pred ecccCccceEEEecCccccCCceeEEeCCCCcccccccc-----------cccccCCCccChhhhcCCCCCcchhhHHHH
Confidence 9999999999995221 1127999999999765431 233567789999999876 7899999999
Q ss_pred HHHHHHHHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Q 013092 171 LGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIF 245 (449)
Q Consensus 171 lG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~L 245 (449)
|||++|+|++ |..||...........+. .... +......++.+++..||..+|++||++.+|.+.|
T Consensus 192 lG~~~~~l~~~~~~p~~~~~~~~~~~~~~---~~~~------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 192 FGTTLLEICSNGEEPLSTLSSSEKERFYQ---DQHR------LPMPDCAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred HHHHHHHHHhCCCCCcccCCchhHHHHHh---cCCC------CCCCCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 9999999999 688887754322222211 1110 1111237899999999999999999999887765
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=267.59 Aligned_cols=211 Identities=17% Similarity=0.207 Sum_probs=169.8
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 96 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gi 96 (449)
...+.+|+.+++.+ +||||+++++.+...+..|+||||+ +++|.+++.. .+.+++.+++.++.|++.||.|||+.||
T Consensus 50 ~~~~~~e~~~~~~l-~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i 127 (267)
T cd06645 50 FAVVQQEIIMMKDC-KHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHV-TGPLSESQIAYVSRETLQGLYYLHSKGK 127 (267)
T ss_pred HHHHHHHHHHHHhC-CCCCeeeEEEEEEeCCEEEEEEeccCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 34578899999999 9999999999999999999999999 8999999875 4579999999999999999999999999
Q ss_pred eecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhh---CCCCChhhHHHHHHH
Q 013092 97 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHL---GIEQSRRDDLESLGY 173 (449)
Q Consensus 97 vHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~---~~~~s~~~DiwSlG~ 173 (449)
+|+||||+||++ +..+.++|+|||++........ ......|+..|+|||++. ...++.++|+|||||
T Consensus 128 ~H~dlkp~nili---~~~~~~~l~dfg~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~ 197 (267)
T cd06645 128 MHRDIKGANILL---TDNGHVKLADFGVSAQITATIA-------KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGI 197 (267)
T ss_pred ecCCCCHHHEEE---CCCCCEEECcceeeeEccCccc-------ccccccCcccccChhhhccccCCCCCchhhhHHHHH
Confidence 999999999999 5778999999999876643221 123457899999999985 455788999999999
Q ss_pred HHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 174 VLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 174 il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
++|+|++|..||...... .....................++..+.++|..||..+|++||++.+|+.
T Consensus 198 il~~l~~~~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 198 TAIELAELQPPMFDLHPM---RALFLMTKSNFQPPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred HHHHHhcCCCCcccccch---hhHHhhhccCCCCCcccccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 999999999999764331 1111111111111111111247889999999999999999999887754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=272.96 Aligned_cols=209 Identities=19% Similarity=0.278 Sum_probs=166.6
Q ss_pred ChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 013092 17 KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 95 (449)
Q Consensus 17 ~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~g 95 (449)
..+.+.+|++++..+ +||||+++++.+...+..++||||+ +++|..+ ..+++..+..++.|++.||+|||+.|
T Consensus 42 ~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~ 115 (279)
T cd06619 42 LQKQIMSELEILYKC-DSPYIIGFYGAFFVENRISICTEFMDGGSLDVY-----RKIPEHVLGRIAVAVVKGLTYLWSLK 115 (279)
T ss_pred HHHHHHHHHHHHHhC-CCCCeeeEEEEEEECCEEEEEEecCCCCChHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 345688999999999 9999999999999999999999999 8888654 24788999999999999999999999
Q ss_pred ceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHHH
Q 013092 96 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVL 175 (449)
Q Consensus 96 ivHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il 175 (449)
|+|+||||+|||+ +.++.++|+|||++..+.... .....||..|+|||++.+..++.++|+|||||++
T Consensus 116 i~H~dlkp~Nill---~~~~~~~l~dfg~~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l 183 (279)
T cd06619 116 ILHRDVKPSNMLV---NTRGQVKLCDFGVSTQLVNSI---------AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISF 183 (279)
T ss_pred EeeCCCCHHHEEE---CCCCCEEEeeCCcceeccccc---------ccCCCCChhhcCceeecCCCCCCcchHHHHHHHH
Confidence 9999999999999 578899999999998664322 2345789999999999998999999999999999
Q ss_pred HHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHH-hhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 176 MYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA-LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 176 ~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~-l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
|+|++|..||.......................... ....+++++.++|.+||+.+|++||++.++.+
T Consensus 184 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~ 252 (279)
T cd06619 184 MELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMD 252 (279)
T ss_pred HHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 999999999976432211111111111100000011 12346789999999999999999999887754
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=272.78 Aligned_cols=220 Identities=20% Similarity=0.244 Sum_probs=172.6
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeC--CEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEG--DYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 94 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~--~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~ 94 (449)
...+.+|+.+++.+ .|+||+++.+++.+. ...|+||||+ |++|.+++......+++..++.++.|++.||+|||++
T Consensus 50 ~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~ 128 (284)
T cd05079 50 IADLKKEIEILRNL-YHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSR 128 (284)
T ss_pred HHHHHHHHHHHHhC-CCCCeeeeeeEEecCCCCceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 45688999999999 999999999988764 6789999999 9999999975445689999999999999999999999
Q ss_pred CceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHH
Q 013092 95 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYV 174 (449)
Q Consensus 95 givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~i 174 (449)
|++||||||+||++ +.++.++|+|||+++.+...... +.......++..|+|||++.+..++.++|||||||+
T Consensus 129 gi~H~dlkp~Nil~---~~~~~~~l~dfg~~~~~~~~~~~----~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~i 201 (284)
T cd05079 129 QYVHRDLAARNVLV---ESEHQVKIGDFGLTKAIETDKEY----YTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVT 201 (284)
T ss_pred CeeecccchheEEE---cCCCCEEECCCccccccccCccc----eeecCCCCCCccccCHHHhccCCCCccccchhhhhh
Confidence 99999999999999 57788999999999876543221 111234567788999999998889999999999999
Q ss_pred HHHHHhCCCCCCCCCc-----------CCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 175 LMYFLRGSLPWQGLKA-----------GTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 175 l~elltG~~Pf~~~~~-----------~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
+|+|+++..|+..... ............. .........++.++.+|+..||+.+|++||++.++.+
T Consensus 202 l~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 278 (284)
T cd05079 202 LYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEE---GKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIE 278 (284)
T ss_pred hhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHc---CccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 9999998766532110 0000000000110 0111123568899999999999999999999999999
Q ss_pred HHHHH
Q 013092 244 IFRDL 248 (449)
Q Consensus 244 ~L~~~ 248 (449)
.|+++
T Consensus 279 ~l~~~ 283 (284)
T cd05079 279 GFEAI 283 (284)
T ss_pred HHHhh
Confidence 88775
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=266.06 Aligned_cols=209 Identities=21% Similarity=0.247 Sum_probs=171.7
Q ss_pred ChhHHHHHHHHHHHhcCCCCCceEEEEeE-eCCEEEEEEecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHH
Q 013092 17 KHPQLLYESKLYRILQGGTGIPNVRWFGV-EGDYNVLVMDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHS 93 (449)
Q Consensus 17 ~~~~~~~E~~il~~l~~hp~Iv~l~~~~~-~~~~~~lVmE~~-g~sL~~ll~~~-~~~ls~~~~~~i~~qi~~aL~yLH~ 93 (449)
....+..|+++++.+ +|+||+++.+.+. .....|+||||+ +++|.+++... ...+++.+++.++.|++.||++||+
T Consensus 42 ~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~ 120 (257)
T cd08223 42 ERKAAEQEAQLLSQL-KHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHE 120 (257)
T ss_pred HHHHHHHHHHHHHhC-CCCCeeeeeeeecCCCCEEEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 345688999999999 8999999988776 355789999999 89999998753 3458999999999999999999999
Q ss_pred CCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHH
Q 013092 94 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGY 173 (449)
Q Consensus 94 ~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~ 173 (449)
.||+|+||||+||++ +..+.++|+|||++..+..... ......+++.|+|||++.+..++.++|||||||
T Consensus 121 ~~i~H~di~p~nil~---~~~~~~~l~df~~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~ 190 (257)
T cd08223 121 KHILHRDLKTQNVFL---TRTNIIKVGDLGIARVLENQCD-------MASTLIGTPYYMSPELFSNKPYNYKSDVWALGC 190 (257)
T ss_pred CCeeccCCCchhEEE---ecCCcEEEecccceEEecccCC-------ccccccCCcCccChhHhcCCCCCchhhhHHHHH
Confidence 999999999999999 5788999999999987654322 123457899999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 174 VLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 174 il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
++|+|++|..||...+ .......+..... ..+...+++++.+++.+||+.+|++||++.++++
T Consensus 191 il~~l~~g~~~~~~~~---~~~~~~~~~~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 191 CVYEMATLKHAFNAKD---MNSLVYRIIEGKL----PPMPKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred HHHHHHcCCCCCCCCC---HHHHHHHHHhcCC----CCCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 9999999999997532 2223333333222 1234568899999999999999999999887754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=280.35 Aligned_cols=220 Identities=19% Similarity=0.273 Sum_probs=174.4
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEe-CCEEEEEEecC-CCCHHHHHHHcC--------------------------
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVE-GDYNVLVMDLL-GPSLEDLFNFCS-------------------------- 69 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~-~~~~~lVmE~~-g~sL~~ll~~~~-------------------------- 69 (449)
...+.+|+.++..+.+|+||+++++++.. +...++||||| +++|.+++....
T Consensus 54 ~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 133 (343)
T cd05103 54 HRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISED 133 (343)
T ss_pred HHHHHHHHHHHHhccCCccHhhhcceeecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhh
Confidence 45688999999999889999999987754 55789999999 999999986421
Q ss_pred ----------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEe
Q 013092 70 ----------------------------------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMG 109 (449)
Q Consensus 70 ----------------------------------------~~ls~~~~~~i~~qi~~aL~yLH~~givHRDLKP~NiLl~ 109 (449)
..+++..++.++.||+.||+|||++||+||||||.|||+
T Consensus 134 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~- 212 (343)
T cd05103 134 LKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILL- 212 (343)
T ss_pred hhhhccccccccccccccccCCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEE-
Confidence 236788889999999999999999999999999999999
Q ss_pred ecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHHHHHHHh-CCCCCCCC
Q 013092 110 LGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGL 188 (449)
Q Consensus 110 ~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il~ellt-G~~Pf~~~ 188 (449)
+.++.+||+|||++........ +.......++..|+|||++.+..++.++|||||||++|+|++ |..||...
T Consensus 213 --~~~~~~kl~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 285 (343)
T cd05103 213 --SENNVVKICDFGLARDIYKDPD-----YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 285 (343)
T ss_pred --cCCCcEEEEecccccccccCcc-----hhhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCc
Confidence 5778999999999986543221 111223345678999999999889999999999999999997 99999764
Q ss_pred CcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 013092 189 KAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIR 251 (449)
Q Consensus 189 ~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~L~~~~~~ 251 (449)
... ......+..... ...+..+++++.+++..||+.+|++||++.+|++.|+.++..
T Consensus 286 ~~~--~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 286 KID--EEFCRRLKEGTR----MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred ccc--HHHHHHHhccCC----CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 332 122222222111 112234678999999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=267.75 Aligned_cols=228 Identities=18% Similarity=0.255 Sum_probs=174.5
Q ss_pred EEEEEeeecccCCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHH
Q 013092 4 ILTVFSVQENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLAD 82 (449)
Q Consensus 4 aikV~~k~~~~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~ 82 (449)
|+|+..+........+.+.+|+.+++.+ .|+||+.+++++..+...++||||+ ++.|..++.. ...+++..++.++.
T Consensus 30 ~iK~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~ 107 (286)
T cd07847 30 AIKKFVESEDDPVIKKIALREIRMLKQL-KHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKN-PRGVPEHLIKKIIW 107 (286)
T ss_pred EEEEEeecccCccccHHHHHHHHHHHhC-CCCCEeeeeeEEeeCCEEEEEEeccCccHHHHHHhC-CCCCCHHHHHHHHH
Confidence 4444443332233345688999999999 8999999999999999999999999 6666666553 45699999999999
Q ss_pred HHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhC-CC
Q 013092 83 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG-IE 161 (449)
Q Consensus 83 qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~-~~ 161 (449)
|++.||+|||+.|++|+||||+||++ +.++.++|+|||++......... .....++..|+|||++.+ ..
T Consensus 108 ql~~~l~~LH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~~~~-------~~~~~~~~~~~aPE~~~~~~~ 177 (286)
T cd07847 108 QTLQAVNFCHKHNCIHRDVKPENILI---TKQGQIKLCDFGFARILTGPGDD-------YTDYVATRWYRAPELLVGDTQ 177 (286)
T ss_pred HHHHHHHHHHHCCceecCCChhhEEE---cCCCcEEECccccceecCCCccc-------ccCcccccccCCHHHHhCCCC
Confidence 99999999999999999999999999 57789999999999876543211 123467889999999876 45
Q ss_pred CChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhh-----------------------cccchHHHhhcCCcH
Q 013092 162 QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK-----------------------KVSTSIEALCRGYPT 218 (449)
Q Consensus 162 ~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~-----------------------~~~~~~~~l~~~~p~ 218 (449)
++.++||||||+++|+|++|..||.+....+........... ......+.....++.
T Consensus 178 ~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (286)
T cd07847 178 YGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISS 257 (286)
T ss_pred cCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccCCCcccccCHHHHhccCCH
Confidence 788999999999999999999999875432221111111000 000112223456788
Q ss_pred HHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 219 EFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 219 el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
.+.+|+..||+.+|++||++.++..
T Consensus 258 ~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 258 PALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred HHHHHHHHHhcCCccccCCHHHHhc
Confidence 9999999999999999999887753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-33 Score=267.55 Aligned_cols=216 Identities=20% Similarity=0.290 Sum_probs=177.0
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 96 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gi 96 (449)
...+.+|+.+++.+ +|+||+++++++.+ ...|+||||+ +++|.+++......+++..++.++.|++.||+|||+.|+
T Consensus 51 ~~~~~~e~~~l~~~-~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ 128 (270)
T cd05056 51 REKFLQEAYIMRQF-DHPHIVKLIGVITE-NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRF 128 (270)
T ss_pred HHHHHHHHHHHHhC-CCCchhceeEEEcC-CCcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 44688999999999 89999999998865 4578999999 999999998655568999999999999999999999999
Q ss_pred eecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHHHH
Q 013092 97 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLM 176 (449)
Q Consensus 97 vHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il~ 176 (449)
+|+||||+||++ +..+.++|+|||+++........ ......++..|+|||.+.+..++.++|||||||++|
T Consensus 129 ~H~dl~p~nili---~~~~~~~l~d~g~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 199 (270)
T cd05056 129 VHRDIAARNVLV---SSPDCVKLGDFGLSRYLEDESYY------KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMW 199 (270)
T ss_pred eccccChheEEE---ecCCCeEEccCceeeecccccce------ecCCCCccccccChhhhccCCCCchhhhHHHHHHHH
Confidence 999999999999 47789999999999876543211 112233456899999998888999999999999999
Q ss_pred HHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 013092 177 YFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIR 251 (449)
Q Consensus 177 ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~L~~~~~~ 251 (449)
+|++ |..||.+.... +....+...... ..+..+|.++.++|.+||..+|++||++.++++.|.++...
T Consensus 200 el~~~g~~pf~~~~~~---~~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 200 EILMLGVKPFQGVKNN---DVIGRIENGERL----PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred HHHHcCCCCCCCCCHH---HHHHHHHcCCcC----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 9996 99999875432 233333332211 23457899999999999999999999999999999887543
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-33 Score=265.54 Aligned_cols=210 Identities=18% Similarity=0.250 Sum_probs=171.7
Q ss_pred CCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHH
Q 013092 15 KTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVH 92 (449)
Q Consensus 15 ~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~-~~ls~~~~~~i~~qi~~aL~yLH 92 (449)
......+.+|+.+++.+ +|+||+++++++... ..|+||||+ +++|.+++.... ..+++..++.++.|++.||.|||
T Consensus 40 ~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH 117 (254)
T cd05083 40 DVTAQAFLEETAVMTKL-HHKNLVRLLGVILHN-GLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE 117 (254)
T ss_pred cchHHHHHHHHHHHHhC-CCCCcCeEEEEEcCC-CcEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 33456789999999999 899999999988765 479999999 899999997543 35899999999999999999999
Q ss_pred HCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHH
Q 013092 93 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLG 172 (449)
Q Consensus 93 ~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG 172 (449)
+.|++||||||+||++ +.++.++|+|||++........ ....+..|++||.+.+..++.++|+||||
T Consensus 118 ~~~~~H~dl~p~nili---~~~~~~kl~Dfg~~~~~~~~~~----------~~~~~~~y~~pe~~~~~~~~~~~Dv~slG 184 (254)
T cd05083 118 SKKLVHRDLAARNILV---SEDGVAKVSDFGLARVGSMGVD----------NSKLPVKWTAPEALKHKKFSSKSDVWSYG 184 (254)
T ss_pred hCCeeccccCcceEEE---cCCCcEEECCCccceeccccCC----------CCCCCceecCHHHhccCCcCchhhHHHHH
Confidence 9999999999999999 5778999999999976543211 22345689999999988899999999999
Q ss_pred HHHHHHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 013092 173 YVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFR 246 (449)
Q Consensus 173 ~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~L~ 246 (449)
|++|+|++ |..||..... ......+..... ......+|.++.+++..||+.+|++||++.+|.+.|+
T Consensus 185 ~~l~el~~~g~~p~~~~~~---~~~~~~~~~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 252 (254)
T cd05083 185 VLLWEVFSYGRAPYPKMSL---KEVKECVEKGYR----MEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLE 252 (254)
T ss_pred HHHHHHHhCCCCCCccCCH---HHHHHHHhCCCC----CCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHc
Confidence 99999997 9999976433 222232222211 1123568899999999999999999999999988775
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-33 Score=272.43 Aligned_cols=212 Identities=17% Similarity=0.237 Sum_probs=170.3
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFL 97 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~giv 97 (449)
...+.+|+.+++.+ +|+||+++++++.+.+..|+||||+.++|.+++......+++..+..++.||+.||+|||+.||+
T Consensus 48 ~~~~~~E~~~l~~l-~h~nI~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~ 126 (301)
T cd07873 48 PCTAIREVSLLKDL-KHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVL 126 (301)
T ss_pred hhHHHHHHHHHHhc-CCCCcceEEEEEecCCeEEEEEeccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 34678999999999 89999999999999999999999998799999886666789999999999999999999999999
Q ss_pred ecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCC-CCChhhHHHHHHHHHH
Q 013092 98 HRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLM 176 (449)
Q Consensus 98 HRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~-~~s~~~DiwSlG~il~ 176 (449)
|+||||+||++ +.++.++|+|||++........ ......+++.|+|||++.+. .++.++|||||||++|
T Consensus 127 H~dlkp~Nil~---~~~~~~kl~dfg~~~~~~~~~~-------~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~ 196 (301)
T cd07873 127 HRDLKPQNLLI---NERGELKLADFGLARAKSIPTK-------TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFY 196 (301)
T ss_pred CCCCCHHHEEE---CCCCcEEECcCcchhccCCCCC-------cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHH
Confidence 99999999999 5788999999999875433211 11234578999999998764 5788999999999999
Q ss_pred HHHhCCCCCCCCCcCCHHHHHHHHHhhcc-------------------------cchHHHhhcCCcHHHHHHHHHHhcCC
Q 013092 177 YFLRGSLPWQGLKAGTKKQKYEKISEKKV-------------------------STSIEALCRGYPTEFASYFHYCRSLR 231 (449)
Q Consensus 177 elltG~~Pf~~~~~~~~~~~~~~i~~~~~-------------------------~~~~~~l~~~~p~el~~li~~cl~~~ 231 (449)
+|++|++||...+.. +.+..+..... ..........+++++.+||.+|+..+
T Consensus 197 el~tg~~~f~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~d 273 (301)
T cd07873 197 EMSTGRPLFPGSTVE---EQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFE 273 (301)
T ss_pred HHHhCCCCCCCCCHH---HHHHHHHHHcCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCC
Confidence 999999999875432 22222111100 00111223457889999999999999
Q ss_pred CCCCCCHHHHHH
Q 013092 232 FDDKPDYAYLKR 243 (449)
Q Consensus 232 p~~RPt~~~l~~ 243 (449)
|.+||+..+++.
T Consensus 274 p~~R~t~~eil~ 285 (301)
T cd07873 274 GRKRISAEEAMK 285 (301)
T ss_pred cccCcCHHHHhc
Confidence 999999887754
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=275.43 Aligned_cols=232 Identities=16% Similarity=0.158 Sum_probs=168.9
Q ss_pred EEeeecccCCChhHHHHHHHHHHHhcCCCCCceEEEEeE--eCCEEEEEEecCCCCHHHHHHHc--------CCCCCHHH
Q 013092 7 VFSVQENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGV--EGDYNVLVMDLLGPSLEDLFNFC--------SRKLSLKT 76 (449)
Q Consensus 7 V~~k~~~~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~--~~~~~~lVmE~~g~sL~~ll~~~--------~~~ls~~~ 76 (449)
+++|..........+.+|+++++.+ .||||+++++++. .+...|+||||++++|.+++... ...+++..
T Consensus 31 ~a~k~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~ 109 (317)
T cd07867 31 YALKQIEGTGISMSACREIALLREL-KHPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSM 109 (317)
T ss_pred EEEEEecCCCCcHHHHHHHHHHHhC-CCCCeeeEEEEEeccCCCeEEEEEeeeCCcHHHHHHhhhccccCCCCccCCHHH
Confidence 3334333333445688999999999 8999999998875 45678999999988999887532 12488999
Q ss_pred HHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeec-CCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchh
Q 013092 77 VLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG-RRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMN 155 (449)
Q Consensus 77 ~~~i~~qi~~aL~yLH~~givHRDLKP~NiLl~~~-~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE 155 (449)
++.++.||+.||.|||+.||+||||||+|||+... +..+.+||+|||+++.+...... ........||+.|+|||
T Consensus 110 ~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~----~~~~~~~~~t~~y~aPE 185 (317)
T cd07867 110 VKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKP----LADLDPVVVTFWYRAPE 185 (317)
T ss_pred HHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCCCccc----ccccCcceecccccCcH
Confidence 99999999999999999999999999999999432 35678999999999876543221 11223457899999999
Q ss_pred hhhCC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCH------HHHHHHHHhhcc-----------------------
Q 013092 156 THLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK------KQKYEKISEKKV----------------------- 205 (449)
Q Consensus 156 ~~~~~-~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~------~~~~~~i~~~~~----------------------- 205 (449)
++.+. .++.++|||||||++|||++|..||........ ...+..+.....
T Consensus 186 ~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (317)
T cd07867 186 LLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDF 265 (317)
T ss_pred HhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhcCCCChhhhhhhhhcccchhhhhhh
Confidence 99874 579999999999999999999999975332110 001111110000
Q ss_pred ------cch----HHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 206 ------STS----IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 206 ------~~~----~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
... .+.........+.+++..|+..||.+||++.++++
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~ 313 (317)
T cd07867 266 RRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQ 313 (317)
T ss_pred cccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhc
Confidence 000 00011123456889999999999999999887753
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=266.74 Aligned_cols=212 Identities=18% Similarity=0.286 Sum_probs=169.6
Q ss_pred CChhHHHHHHHHHHHhcCCCCCceEEEEeEeC------CEEEEEEecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHH
Q 013092 16 TKHPQLLYESKLYRILQGGTGIPNVRWFGVEG------DYNVLVMDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINR 87 (449)
Q Consensus 16 ~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~------~~~~lVmE~~-g~sL~~ll~~~-~~~ls~~~~~~i~~qi~~a 87 (449)
.....+..|+.++..+.+|+||+++.+.+... ...|+||||+ +++|.+++... ...+++..++.++.|++.|
T Consensus 44 ~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~ 123 (272)
T cd06637 44 DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRG 123 (272)
T ss_pred ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHH
Confidence 44567899999999998899999999988753 4689999999 88999998863 3468999999999999999
Q ss_pred HHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhh-----CCCC
Q 013092 88 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHL-----GIEQ 162 (449)
Q Consensus 88 L~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~-----~~~~ 162 (449)
|+|||+++|+|+||||+||++ +.++.++|+|||++........ ......|+..|+|||++. +..+
T Consensus 124 l~~LH~~~ivh~dl~~~nili---~~~~~~~l~Dfg~~~~~~~~~~-------~~~~~~g~~~y~aPE~~~~~~~~~~~~ 193 (272)
T cd06637 124 LSHLHQHKVIHRDIKGQNVLL---TENAEVKLVDFGVSAQLDRTVG-------RRNTFIGTPYWMAPEVIACDENPDATY 193 (272)
T ss_pred HHHHHHCCCccCCCCHHHEEE---CCCCCEEEccCCCceecccccc-------cCCcccccccccCHhHhccccCcCCCC
Confidence 999999999999999999999 5778899999999986543221 123457899999999986 3457
Q ss_pred ChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 013092 163 SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 242 (449)
Q Consensus 163 s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~ 242 (449)
+.++|||||||++|||++|..||..... ......+..... .......++.++.+|+..||..+|.+||++.++.
T Consensus 194 ~~~~Dv~slGv~l~el~~g~~p~~~~~~---~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il 267 (272)
T cd06637 194 DFKSDLWSLGITAIEMAEGAPPLCDMHP---MRALFLIPRNPA---PRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLM 267 (272)
T ss_pred CchhhHHHHHHHHHHHHhCCCCccccCH---HHHHHHHhcCCC---CCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHh
Confidence 8899999999999999999999976432 122222211111 1112245788999999999999999999988775
Q ss_pred H
Q 013092 243 R 243 (449)
Q Consensus 243 ~ 243 (449)
+
T Consensus 268 ~ 268 (272)
T cd06637 268 K 268 (272)
T ss_pred h
Confidence 4
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=268.21 Aligned_cols=210 Identities=18% Similarity=0.213 Sum_probs=171.0
Q ss_pred hHHHHHHHHHHHhcCCCC-CceEEEEeEeCC------EEEEEEecCCCCHHHHHHHcC---CCCCHHHHHHHHHHHHHHH
Q 013092 19 PQLLYESKLYRILQGGTG-IPNVRWFGVEGD------YNVLVMDLLGPSLEDLFNFCS---RKLSLKTVLMLADQMINRV 88 (449)
Q Consensus 19 ~~~~~E~~il~~l~~hp~-Iv~l~~~~~~~~------~~~lVmE~~g~sL~~ll~~~~---~~ls~~~~~~i~~qi~~aL 88 (449)
....+|+-+|+.| +|+| |+.|.+++.+.+ ..+|||||+..+|.++++... ..++...+..++.||+.||
T Consensus 55 ~taiREisllk~L-~~~~~iv~L~dv~~~~~~~~~~~~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl 133 (323)
T KOG0594|consen 55 STAIREISLLKRL-SHANHIVRLHDVIHTSNNHRGIGKLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGL 133 (323)
T ss_pred chhhHHHHHHHHh-CCCcceEEEEeeeeecccccccceEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHH
Confidence 4478999999999 6666 999999998877 889999999999999999765 3588889999999999999
Q ss_pred HHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCC-CCChhhH
Q 013092 89 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDD 167 (449)
Q Consensus 89 ~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~-~~s~~~D 167 (449)
+|||+++|+||||||+|||| ++.+.+||+|||+|+.+.-+ .+.....++|..|.|||++.+. .|+...|
T Consensus 134 ~~~H~~~IlHRDLKPQNlLi---~~~G~lKlaDFGlAra~~ip-------~~~yt~evvTlWYRaPEvLlGs~~Ys~~vD 203 (323)
T KOG0594|consen 134 AFLHSHGILHRDLKPQNLLI---SSSGVLKLADFGLARAFSIP-------MRTYTPEVVTLWYRAPEVLLGSTSYSTSVD 203 (323)
T ss_pred HHHHhCCeecccCCcceEEE---CCCCcEeeeccchHHHhcCC-------cccccccEEEeeccCHHHhcCCCcCCCCcc
Confidence 99999999999999999999 57999999999999955432 2334567899999999999987 6899999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHH-------------------------HhhcCCcHHHHH
Q 013092 168 LESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE-------------------------ALCRGYPTEFAS 222 (449)
Q Consensus 168 iwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~-------------------------~l~~~~p~el~~ 222 (449)
|||+|||++||++++..|.+... .+...+|.+...++... ...+...+...+
T Consensus 204 iWs~GcIfaEm~~~~~LFpG~se---~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~d 280 (323)
T KOG0594|consen 204 IWSLGCIFAEMFTRRPLFPGDSE---IDQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIE 280 (323)
T ss_pred hHhHHHHHHHHHhCCCCCCCCcH---HHHHHHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHH
Confidence 99999999999999999998655 33333443322111111 111222347889
Q ss_pred HHHHHhcCCCCCCCCHHHHH
Q 013092 223 YFHYCRSLRFDDKPDYAYLK 242 (449)
Q Consensus 223 li~~cl~~~p~~RPt~~~l~ 242 (449)
++..|++.+|.+|.++....
T Consensus 281 ll~~~L~y~p~~R~Sa~~al 300 (323)
T KOG0594|consen 281 LLSKLLQYDPAKRISAKGAL 300 (323)
T ss_pred HHHHHhccCcccCcCHHHHh
Confidence 99999999999999976654
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-33 Score=268.90 Aligned_cols=217 Identities=20% Similarity=0.300 Sum_probs=176.9
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEe-CCEEEEEEecC-CCCHHHHHHHcC-------CCCCHHHHHHHHHHHHHHH
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVE-GDYNVLVMDLL-GPSLEDLFNFCS-------RKLSLKTVLMLADQMINRV 88 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~-~~~~~lVmE~~-g~sL~~ll~~~~-------~~ls~~~~~~i~~qi~~aL 88 (449)
...+.+|+.+++.+ +|+||+++++++.. +...+++++|+ +++|.+++.... ..+++..++.++.|++.||
T Consensus 52 ~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l 130 (280)
T cd05043 52 VTLLLQESCLLYGL-SHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGM 130 (280)
T ss_pred HHHHHHHHHHHHhC-CCCCCCeEEEEEecCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHH
Confidence 45588999999999 99999999998776 57789999999 899999987542 3589999999999999999
Q ss_pred HHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHH
Q 013092 89 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDL 168 (449)
Q Consensus 89 ~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~Di 168 (449)
+|||+.+++||||||+||++ +.++.+||+|||+++.+....... ......++..|+|||++.+..++.++||
T Consensus 131 ~~LH~~~i~H~di~p~nil~---~~~~~~kl~d~g~~~~~~~~~~~~-----~~~~~~~~~~y~apE~~~~~~~~~~~Di 202 (280)
T cd05043 131 SYLHKRGVIHKDIAARNCVI---DEELQVKITDNALSRDLFPMDYHC-----LGDNENRPVKWMALESLVNKEYSSASDV 202 (280)
T ss_pred HHHHHCCEeecccCHhhEEE---cCCCcEEECCCCCcccccCCceEE-----eCCCCCcchhccCHHHHhcCCCCchhhH
Confidence 99999999999999999999 577899999999998764432211 1123346778999999998889999999
Q ss_pred HHHHHHHHHHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Q 013092 169 ESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRD 247 (449)
Q Consensus 169 wSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~L~~ 247 (449)
|||||++|++++ |..||..... .+....+..... . .....+|+++.+++.+||..+|++||++.++...|.+
T Consensus 203 ~slG~~l~el~~~g~~p~~~~~~---~~~~~~~~~~~~-~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~ 275 (280)
T cd05043 203 WSFGVLLWELMTLGQTPYVEIDP---FEMAAYLKDGYR-L---AQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTD 275 (280)
T ss_pred HHhHHHHHHHhcCCCCCcCcCCH---HHHHHHHHcCCC-C---CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence 999999999998 9999976433 223332222111 1 1223578999999999999999999999999999998
Q ss_pred HHH
Q 013092 248 LFI 250 (449)
Q Consensus 248 ~~~ 250 (449)
+.+
T Consensus 276 ~~~ 278 (280)
T cd05043 276 FHA 278 (280)
T ss_pred HHh
Confidence 865
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-33 Score=264.91 Aligned_cols=210 Identities=19% Similarity=0.273 Sum_probs=174.8
Q ss_pred ChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHC
Q 013092 17 KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSK 94 (449)
Q Consensus 17 ~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~-~~ls~~~~~~i~~qi~~aL~yLH~~ 94 (449)
...++..|+.+++.+ .|+||+++++++.+....|+||||+ +++|.+++.... ..+++..++.++.|++.||.|||++
T Consensus 43 ~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~ 121 (256)
T cd05039 43 AAQAFLAEASVMTTL-RHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK 121 (256)
T ss_pred HHHHHHHHHHHHHhc-CCcceeeeEEEEcCCCCeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 356799999999999 8999999999999999999999999 899999997543 2689999999999999999999999
Q ss_pred CceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHH
Q 013092 95 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYV 174 (449)
Q Consensus 95 givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~i 174 (449)
||+|+||||+||++ +.++.++|+|||+++....... ...++..|+|||++....++.++||||||++
T Consensus 122 ~i~H~di~p~Nili---~~~~~~~l~d~g~~~~~~~~~~----------~~~~~~~~~ape~~~~~~~~~~~Di~slG~i 188 (256)
T cd05039 122 NFVHRDLAARNVLV---SEDLVAKVSDFGLAKEASQGQD----------SGKLPVKWTAPEALREKKFSTKSDVWSFGIL 188 (256)
T ss_pred CccchhcccceEEE---eCCCCEEEcccccccccccccc----------cCCCcccccCchhhcCCcCCcHHHHHHHHHH
Confidence 99999999999999 5788999999999987633221 2234568999999998889999999999999
Q ss_pred HHHHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Q 013092 175 LMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRD 247 (449)
Q Consensus 175 l~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~L~~ 247 (449)
+|+|++ |..||..... ......+..... ......+|+++.+++..||..+|++||++.+|.+.|+.
T Consensus 189 l~~l~~~g~~p~~~~~~---~~~~~~~~~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 189 LWEIYSFGRVPYPRIPL---KDVVPHVEKGYR----MEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred HHHHHhcCCCCCCCCCH---HHHHHHHhcCCC----CCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 999997 9999976432 222332322211 12335678999999999999999999999999888764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=275.14 Aligned_cols=248 Identities=18% Similarity=0.252 Sum_probs=202.0
Q ss_pred cEEEEEeeeccc-CCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHH
Q 013092 3 EILTVFSVQENV-KTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLML 80 (449)
Q Consensus 3 ~aikV~~k~~~~-~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i 80 (449)
-|||+++|--.. +.+...-+.|-++|+.. .||.+..|.+.++..+++|+||||. ||.|.-.+.+ .+.|+++.+..+
T Consensus 196 YAiKIlkKeviiakdEVAHTlTE~RVL~~~-~HPFLt~LKYsFQt~drlCFVMeyanGGeLf~HLsr-er~FsE~RtRFY 273 (516)
T KOG0690|consen 196 YAIKILKKEVIIAKDEVAHTLTENRVLQNC-RHPFLTSLKYSFQTQDRLCFVMEYANGGELFFHLSR-ERVFSEDRTRFY 273 (516)
T ss_pred eehhhhhhhheeehHHhhhhhhHHHHHHhc-cCcHHHHhhhhhccCceEEEEEEEccCceEeeehhh-hhcccchhhhhh
Confidence 466666664433 45566678899999998 9999999999999999999999999 9999877775 567999999999
Q ss_pred HHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCC
Q 013092 81 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI 160 (449)
Q Consensus 81 ~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~ 160 (449)
..+|+.||.|||+++||+||||.+|+|+ +++|++||+||||++.--... ...++++|||.|+|||++...
T Consensus 274 GaEIvsAL~YLHs~~ivYRDlKLENLlL---DkDGHIKitDFGLCKE~I~~g-------~t~kTFCGTPEYLAPEVleDn 343 (516)
T KOG0690|consen 274 GAEIVSALGYLHSRNIVYRDLKLENLLL---DKDGHIKITDFGLCKEEIKYG-------DTTKTFCGTPEYLAPEVLEDN 343 (516)
T ss_pred hHHHHHHhhhhhhCCeeeeechhhhhee---ccCCceEeeecccchhccccc-------ceeccccCChhhcCchhhccc
Confidence 9999999999999999999999999999 799999999999997532211 234689999999999999999
Q ss_pred CCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCC--H
Q 013092 161 EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPD--Y 238 (449)
Q Consensus 161 ~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt--~ 238 (449)
+|++.+|+|.+|+++|||++|++||...+. ...++.|.-..+ .++..+++|...|+..+|..||.+|.. -
T Consensus 344 DYgraVDWWG~GVVMYEMmCGRLPFyn~dh---~kLFeLIl~ed~-----kFPr~ls~eAktLLsGLL~kdP~kRLGgGp 415 (516)
T KOG0690|consen 344 DYGRAVDWWGVGVVMYEMMCGRLPFYNKDH---EKLFELILMEDL-----KFPRTLSPEAKTLLSGLLKKDPKKRLGGGP 415 (516)
T ss_pred cccceeehhhhhHHHHHHHhccCcccccch---hHHHHHHHhhhc-----cCCccCCHHHHHHHHHHhhcChHhhcCCCc
Confidence 999999999999999999999999987433 334444433222 245678999999999999999999964 2
Q ss_pred HHHHHHHHHHHHHcCCCCCCcccchhhhhhhccCCCCCC
Q 013092 239 AYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQLATPPA 277 (449)
Q Consensus 239 ~~l~~~L~~~~~~~~~~~~~~~dw~~~~~~~~~~~~~p~ 277 (449)
++.+++.+ +.|+..++|+..-..+..+|..|.
T Consensus 416 dDakEi~~-------h~FF~~v~W~~~~~Kki~PPfKPq 447 (516)
T KOG0690|consen 416 DDAKEIMR-------HRFFASVDWEATYRKKIEPPFKPQ 447 (516)
T ss_pred hhHHHHHh-------hhhhccCCHHHHHHhccCCCCCCC
Confidence 44555543 356677899988777766666554
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-33 Score=264.59 Aligned_cols=222 Identities=21% Similarity=0.273 Sum_probs=178.7
Q ss_pred EEEEEeeecccCCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHc-CCCCCHHHHHHHH
Q 013092 4 ILTVFSVQENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFC-SRKLSLKTVLMLA 81 (449)
Q Consensus 4 aikV~~k~~~~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~-~~~ls~~~~~~i~ 81 (449)
|+|+..+..........+..|+.+++.+ +|+||+++++.+..++..++||||+ +++|.+++... ...+++..++.++
T Consensus 29 ~ik~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ 107 (256)
T cd08220 29 IIKQIPVEQMTKDERLAAQNECQVLKLL-SHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFF 107 (256)
T ss_pred EEEEEeccccccHHHHHHHHHHHHHhhC-CCCchhheeeeEecCCEEEEEEecCCCCCHHHHHHHhcccCCCHHHHHHHH
Confidence 3444433332334456789999999999 8999999999999999999999999 89999999754 3458999999999
Q ss_pred HHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCC
Q 013092 82 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIE 161 (449)
Q Consensus 82 ~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~ 161 (449)
.|++.+|+|||++||+|+||||+||++. ..++.++|+|||++........ .....++..|+|||.+.+..
T Consensus 108 ~~i~~~l~~lh~~~i~h~dl~~~nil~~--~~~~~~~l~d~~~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~ 177 (256)
T cd08220 108 VQILLALHHVHTKLILHRDLKTQNILLD--KHKMVVKIGDFGISKILSSKSK--------AYTVVGTPCYISPELCEGKP 177 (256)
T ss_pred HHHHHHHHHHHhCCeecCCCCHHHEEEc--CCCCEEEEccCCCceecCCCcc--------ccccccCCcccCchhccCCC
Confidence 9999999999999999999999999994 3456789999999987654321 12356889999999999888
Q ss_pred CChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHH
Q 013092 162 QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYL 241 (449)
Q Consensus 162 ~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l 241 (449)
++.++||||||+++|+|++|..||...+. ......+..... ..+...++.++.+++..||..+|++||++.+|
T Consensus 178 ~~~~~Dv~slG~~l~~l~~~~~~~~~~~~---~~~~~~~~~~~~----~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l 250 (256)
T cd08220 178 YNQKSDIWALGCVLYELASLKRAFEAANL---PALVLKIMSGTF----APISDRYSPDLRQLILSMLNLDPSKRPQLSQI 250 (256)
T ss_pred CCcccchHHHHHHHHHHHhCCCCcccCch---HHHHHHHHhcCC----CCCCCCcCHHHHHHHHHHccCChhhCCCHHHH
Confidence 89999999999999999999999976432 223333332211 22345688999999999999999999999887
Q ss_pred HH
Q 013092 242 KR 243 (449)
Q Consensus 242 ~~ 243 (449)
..
T Consensus 251 l~ 252 (256)
T cd08220 251 MA 252 (256)
T ss_pred hh
Confidence 54
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=291.02 Aligned_cols=215 Identities=17% Similarity=0.194 Sum_probs=159.6
Q ss_pred hhHHHHHHHHHHHhc-----CCCCCceEEEEeEe-CCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHH
Q 013092 18 HPQLLYESKLYRILQ-----GGTGIPNVRWFGVE-GDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 91 (449)
Q Consensus 18 ~~~~~~E~~il~~l~-----~hp~Iv~l~~~~~~-~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yL 91 (449)
...+..|+.+++.+. ++.+|+.++.++.. ..+.|||||++|++|.+++.. .+.+++..+..|+.||+.||+||
T Consensus 169 ~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~iv~~~~g~~l~~~l~~-~~~l~~~~~~~i~~qi~~aL~yL 247 (467)
T PTZ00284 169 TRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIVMPKYGPCLLDWIMK-HGPFSHRHLAQIIFQTGVALDYF 247 (467)
T ss_pred HHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEEEEEeccCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHH
Confidence 445677888888874 34468888877765 468999999999999998875 45799999999999999999999
Q ss_pred HH-CCceecCCCCCcEEEeecC-------------CCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhh
Q 013092 92 HS-KSFLHRDIKPDNFLMGLGR-------------RANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTH 157 (449)
Q Consensus 92 H~-~givHRDLKP~NiLl~~~~-------------~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~ 157 (449)
|+ .|||||||||+|||+..+. ....+||+|||++...... ....+||+.|+|||++
T Consensus 248 H~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~~----------~~~~~gt~~Y~APE~~ 317 (467)
T PTZ00284 248 HTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERHS----------RTAIVSTRHYRSPEVV 317 (467)
T ss_pred HhcCCeecCCCCHHHEEEecCCcccccccccccCCCCceEEECCCCccccCccc----------cccccCCccccCcHHh
Confidence 98 5999999999999995321 1125999999987543221 2356899999999999
Q ss_pred hCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhccc---------------------------chHH
Q 013092 158 LGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS---------------------------TSIE 210 (449)
Q Consensus 158 ~~~~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~---------------------------~~~~ 210 (449)
.+..++.++|||||||++|||++|+.||.+.+.......+.++...... ..+.
T Consensus 318 ~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 397 (467)
T PTZ00284 318 LGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLA 397 (467)
T ss_pred hcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHH
Confidence 9999999999999999999999999999875432222111111100000 0000
Q ss_pred Hhhc-------CCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 211 ALCR-------GYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 211 ~l~~-------~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
.+.. ...+.+.+||..||..||++||++.++++
T Consensus 398 ~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~ 437 (467)
T PTZ00284 398 RIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTT 437 (467)
T ss_pred hhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhc
Confidence 0000 01356789999999999999999888754
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=271.37 Aligned_cols=215 Identities=16% Similarity=0.233 Sum_probs=173.6
Q ss_pred HHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q 013092 20 QLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLH 98 (449)
Q Consensus 20 ~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~givH 98 (449)
.+.+|+.+++.+ +|+||+++++++... ..+++|||+ +++|.+++......+++..++.++.|++.||+|||++||+|
T Consensus 55 ~~~~e~~~~~~l-~h~niv~~~~~~~~~-~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH 132 (303)
T cd05110 55 EFMDEALIMASM-DHPHLVRLLGVCLSP-TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVH 132 (303)
T ss_pred HHHHHHHHHHhC-CCCCcccEEEEEcCC-CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeec
Confidence 578999999999 999999999988654 467999999 89999999865556899999999999999999999999999
Q ss_pred cCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHHHHHH
Q 013092 99 RDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYF 178 (449)
Q Consensus 99 RDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il~el 178 (449)
|||||+||++ +.++.+||+|||+++.+...... .......++..|++||++.+..++.++|||||||++|||
T Consensus 133 ~dikp~Nill---~~~~~~kL~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el 204 (303)
T cd05110 133 RDLAARNVLV---KSPNHVKITDFGLARLLEGDEKE-----YNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWEL 204 (303)
T ss_pred cccccceeee---cCCCceEEccccccccccCcccc-----cccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHH
Confidence 9999999999 56788999999999876432211 011233457789999999999999999999999999999
Q ss_pred Hh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 013092 179 LR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIR 251 (449)
Q Consensus 179 lt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~L~~~~~~ 251 (449)
++ |..||.+.... . +..+....... .....++..+.+++..||..+|++||++.+|.+.|+++...
T Consensus 205 ~t~g~~p~~~~~~~---~-~~~~~~~~~~~---~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 205 MTFGGKPYDGIPTR---E-IPDLLEKGERL---PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred HhCCCCCCCCCCHH---H-HHHHHHCCCCC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 97 99999764321 1 22222221111 12245788999999999999999999999999998887543
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=270.64 Aligned_cols=220 Identities=21% Similarity=0.274 Sum_probs=175.3
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEe--CCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVE--GDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 94 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~--~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~ 94 (449)
...+..|+++++.+ .|+||+++++++.. ....++||||+ +++|.+++......+++..++.++.|++.||+|||++
T Consensus 50 ~~~~~~ei~~l~~l-~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~ 128 (284)
T cd05038 50 RSDFEREIEILRTL-DHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQ 128 (284)
T ss_pred HHHHHHHHHHHHhC-CCCChheEEeeeecCCCCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhC
Confidence 56799999999999 89999999998876 66899999999 8999999986555699999999999999999999999
Q ss_pred CceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHH
Q 013092 95 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYV 174 (449)
Q Consensus 95 givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~i 174 (449)
||+|+||||.||++ +.++.++|+|||++......... +.......++..|++||.+.+..++.++|||||||+
T Consensus 129 ~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~~~~----~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~ 201 (284)
T cd05038 129 RYIHRDLAARNILV---ESEDLVKISDFGLAKVLPEDKDY----YYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVT 201 (284)
T ss_pred CeecCCCCHHhEEE---cCCCCEEEcccccccccccCCcc----eeccCCCCCcccccCcHHHccCCCCcccchHHHhhh
Confidence 99999999999999 57789999999999877533221 111122345667999999998889999999999999
Q ss_pred HHHHHhCCCCCCCCCcCCH-----------HHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 175 LMYFLRGSLPWQGLKAGTK-----------KQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 175 l~elltG~~Pf~~~~~~~~-----------~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
+|||++|..||........ ............ .......+|.++.+++..||..+|++||++.+|.+
T Consensus 202 l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 202 LYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGE---RLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred hheeeccCCCcccccchhccccccccccccHHHHHHHHHcCC---cCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 9999999999876432110 111111111111 11112457889999999999999999999999999
Q ss_pred HHHHH
Q 013092 244 IFRDL 248 (449)
Q Consensus 244 ~L~~~ 248 (449)
.|+.+
T Consensus 279 ~l~~i 283 (284)
T cd05038 279 IVDRL 283 (284)
T ss_pred HHhhc
Confidence 88764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=265.97 Aligned_cols=214 Identities=19% Similarity=0.269 Sum_probs=173.7
Q ss_pred hHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q 013092 19 PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFL 97 (449)
Q Consensus 19 ~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~giv 97 (449)
..+.+|+.+++.+ +|+||+++.+++.+.+..|+||||+ +++|.+++.. ...+++..+..++.|++.||+|||+.+|+
T Consensus 47 ~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~ 124 (265)
T cd06631 47 EKLQEEVDLLKSL-KHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNR-FGPLPEPVFCKYTKQILDGVAYLHNNCVV 124 (265)
T ss_pred HHHHHHHHHHHhc-CCCCEeeEeeEeecCCeEEEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence 4588999999999 8999999999999999999999999 9999999975 45789999999999999999999999999
Q ss_pred ecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHHHHH
Q 013092 98 HRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMY 177 (449)
Q Consensus 98 HRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il~e 177 (449)
|+||||.||++ +..+.++|+|||++............ ........|+..|+|||++.+..++.++|+|||||++|+
T Consensus 125 H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~ 200 (265)
T cd06631 125 HRDIKGNNVML---MPNGIIKLIDFGCARRLAWVGLHGTH-SNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFE 200 (265)
T ss_pred cCCcCHHhEEE---CCCCeEEeccchhhHhhhhccccccc-cccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHH
Confidence 99999999999 57889999999998765322111000 011234568999999999999889999999999999999
Q ss_pred HHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 178 FLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 178 lltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
|++|..||...... .....+... ....+.+...++.++.++|..||+.+|++||++.+++.
T Consensus 201 l~~g~~p~~~~~~~---~~~~~~~~~--~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 201 MATGKPPLASMDRL---AAMFYIGAH--RGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred HHhCCCccccCChH---HHHHHhhhc--cCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 99999999764321 111112111 12233455678999999999999999999999887753
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-33 Score=268.51 Aligned_cols=207 Identities=18% Similarity=0.281 Sum_probs=172.6
Q ss_pred ChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 013092 17 KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 95 (449)
Q Consensus 17 ~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~g 95 (449)
....+.+|+++++.+ +|+||+++++.+.++...||||||+ |++|.+++. ..+++...+..++.|++.||+|||+.+
T Consensus 45 ~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~--~~~l~~~~~~~~~~~l~~~l~~lh~~~ 121 (277)
T cd06640 45 EIEDIQQEITVLSQC-DSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLR--AGPFDEFQIATMLKEILKGLDYLHSEK 121 (277)
T ss_pred HHHHHHHHHHHHHhC-CCCCEeeEEEEEEECCEEEEEEecCCCCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 345688999999999 9999999999999999999999999 999999987 457899999999999999999999999
Q ss_pred ceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHHH
Q 013092 96 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVL 175 (449)
Q Consensus 96 ivHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il 175 (449)
++|+||+|.||++ +.++.++|+|||++........ ......++..|+|||++.+..++.++|+|||||++
T Consensus 122 ivH~dl~p~Nil~---~~~~~~~l~dfg~~~~~~~~~~-------~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il 191 (277)
T cd06640 122 KIHRDIKAANVLL---SEQGDVKLADFGVAGQLTDTQI-------KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITA 191 (277)
T ss_pred ccCcCCChhhEEE---cCCCCEEEcccccceeccCCcc-------ccccccCcccccCHhHhccCCCccHHHHHHHHHHH
Confidence 9999999999999 5778899999999987644321 11234678899999999988899999999999999
Q ss_pred HHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 176 MYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 176 ~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
|||++|..||...... .....+... ..+.+...++.++.+++..||..+|++||++.++..
T Consensus 192 ~el~tg~~p~~~~~~~---~~~~~~~~~----~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06640 192 IELAKGEPPNSDMHPM---RVLFLIPKN----NPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLK 252 (277)
T ss_pred HHHHHCCCCCCCcChH---hHhhhhhcC----CCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHh
Confidence 9999999999765432 222222111 112334457889999999999999999999988854
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-33 Score=280.18 Aligned_cols=212 Identities=19% Similarity=0.234 Sum_probs=164.3
Q ss_pred HHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q 013092 20 QLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHR 99 (449)
Q Consensus 20 ~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~givHR 99 (449)
....|+.+++.+ +|+||+++++++.++...|+|||++.++|.+++......+++..++.|+.||+.||.|||++||+||
T Consensus 103 ~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHr 181 (357)
T PHA03209 103 TTLIEAMLLQNV-NHPSVIRMKDTLVSGAITCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHR 181 (357)
T ss_pred ccHHHHHHHHhC-CCCCCcChhheEEeCCeeEEEEEccCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecC
Confidence 456799999999 8999999999999999999999999889999987656779999999999999999999999999999
Q ss_pred CCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHHHHHHH
Q 013092 100 DIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFL 179 (449)
Q Consensus 100 DLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il~ell 179 (449)
||||+|||+ +..+.+||+|||+++....... .....||..|+|||++.+..++.++|||||||++|||+
T Consensus 182 Dlkp~Nill---~~~~~~kl~DfG~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell 250 (357)
T PHA03209 182 DVKTENIFI---NDVDQVCIGDLGAAQFPVVAPA--------FLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250 (357)
T ss_pred CCCHHHEEE---CCCCCEEEecCccccccccCcc--------cccccccccccCCeecCCCCCCchhhHHHHHHHHHHHH
Confidence 999999999 6788999999999975332211 13457899999999999999999999999999999999
Q ss_pred hCCCCCCCCCcCCHH-------HHHHHHHhh-cc-----c-----chHHH-----------------h-hcCCcHHHHHH
Q 013092 180 RGSLPWQGLKAGTKK-------QKYEKISEK-KV-----S-----TSIEA-----------------L-CRGYPTEFASY 223 (449)
Q Consensus 180 tG~~Pf~~~~~~~~~-------~~~~~i~~~-~~-----~-----~~~~~-----------------l-~~~~p~el~~l 223 (449)
++..|+......... ..+.++... .. . ..... + ...++.++.+|
T Consensus 251 ~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 330 (357)
T PHA03209 251 AYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFL 330 (357)
T ss_pred HcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHH
Confidence 854444332221110 011111110 00 0 00000 0 12457778889
Q ss_pred HHHHhcCCCCCCCCHHHHHH
Q 013092 224 FHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 224 i~~cl~~~p~~RPt~~~l~~ 243 (449)
|..||+.||.+||++.+++.
T Consensus 331 i~~mL~~dP~~Rpta~e~l~ 350 (357)
T PHA03209 331 VHKMLTFDAAMRPSAEEILN 350 (357)
T ss_pred HHHHHcCCcccCcCHHHHhc
Confidence 99999999999999887753
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=266.51 Aligned_cols=216 Identities=18% Similarity=0.252 Sum_probs=168.6
Q ss_pred ChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHH
Q 013092 17 KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVH 92 (449)
Q Consensus 17 ~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~---~~~ls~~~~~~i~~qi~~aL~yLH 92 (449)
....+.+|+.+++.+ +||||+++++.+.+....||||||+ +++|.+++... ...++...++.++.||+.||+|||
T Consensus 38 ~~~~~~~e~~~~~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH 116 (268)
T cd05086 38 EQNEFLQQGDPYRIL-QHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH 116 (268)
T ss_pred HHHHHHHHHHHHhcc-CCcchhheEEEecCCCccEEEEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH
Confidence 346789999999999 9999999999999999999999999 89999998753 234667788899999999999999
Q ss_pred HCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhC-------CCCChh
Q 013092 93 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG-------IEQSRR 165 (449)
Q Consensus 93 ~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~-------~~~s~~ 165 (449)
+.+++||||||+|||+ +.++.++|+|||++........ ........++..|+|||++.. ..++.+
T Consensus 117 ~~~i~H~dikp~nil~---~~~~~~~l~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~ 188 (268)
T cd05086 117 KHNFLHSDLALRNCFL---TSDLTVKVGDYGIGPSRYKEDY-----IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKP 188 (268)
T ss_pred HCCeeccCCccceEEE---cCCccEEecccccccccCcchh-----hhcccCCcCcccccCchhcccccCccccCCCCCc
Confidence 9999999999999999 5778999999999864322110 011234568899999999753 345789
Q ss_pred hHHHHHHHHHHHHHh-CCCCCCCCCcCCHHHHHHHHHhh-cccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 166 DDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEK-KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 166 ~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~-~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
+|||||||++|||++ |..||..... ...+.++... ......+.+...+++.+.+++..|| .+|++||++.+|.+
T Consensus 189 ~DiwslG~~l~el~~~~~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 189 SNVWALGVTLWELFENAAQPYSHLSD---REVLNHVIKDQQVKLFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred chhHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHhhcccccCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 999999999999997 6778876433 2333333222 2222223344567889999999999 67999999999987
Q ss_pred HH
Q 013092 244 IF 245 (449)
Q Consensus 244 ~L 245 (449)
.|
T Consensus 265 ~l 266 (268)
T cd05086 265 LL 266 (268)
T ss_pred Hh
Confidence 76
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-34 Score=269.00 Aligned_cols=233 Identities=19% Similarity=0.231 Sum_probs=185.2
Q ss_pred EEEEeeecccCCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHH
Q 013092 5 LTVFSVQENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQ 83 (449)
Q Consensus 5 ikV~~k~~~~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~q 83 (449)
+||+-|. .......+.+|++++.++++|+||++|+.||+++..+|||||-| ||.|...|.+ ...|++.++..+..+
T Consensus 108 VKiidKq--~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGplLshI~~-~~~F~E~EAs~vvkd 184 (463)
T KOG0607|consen 108 VKIIDKQ--PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPLLSHIQK-RKHFNEREASRVVKD 184 (463)
T ss_pred hhhhhcC--CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchHHHHHHH-hhhccHHHHHHHHHH
Confidence 4444444 23455679999999999999999999999999999999999999 9999988875 457999999999999
Q ss_pred HHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhC----
Q 013092 84 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG---- 159 (449)
Q Consensus 84 i~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~---- 159 (449)
|+.||.+||.+||.||||||+|||-..-+.-.-||||||.|..-+...............+.+|+..|||||+..-
T Consensus 185 ia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~q 264 (463)
T KOG0607|consen 185 IASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQ 264 (463)
T ss_pred HHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccc
Confidence 9999999999999999999999998533344468999998876543322221111222345689999999998752
Q ss_pred -CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcC------------CHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHH
Q 013092 160 -IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG------------TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHY 226 (449)
Q Consensus 160 -~~~s~~~DiwSlG~il~elltG~~Pf~~~~~~------------~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~ 226 (449)
.-|+.++|+||||+|||-||.|.+||.+.-.. .....++.|++.+...+-. -+..++.+..++|..
T Consensus 265 A~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGkYeFPdk-dWahIS~eakdlisn 343 (463)
T KOG0607|consen 265 ATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDK-DWAHISSEAKDLISN 343 (463)
T ss_pred cccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhccCCcCChh-hhHHhhHHHHHHHHH
Confidence 34899999999999999999999999886432 1255677888888765443 346788999999999
Q ss_pred HhcCCCCCCCCHHHH
Q 013092 227 CRSLRFDDKPDYAYL 241 (449)
Q Consensus 227 cl~~~p~~RPt~~~l 241 (449)
++..++.+|..+.++
T Consensus 344 Llvrda~~rlsa~~v 358 (463)
T KOG0607|consen 344 LLVRDAKQRLSAAQV 358 (463)
T ss_pred HHhccHHhhhhhhhc
Confidence 999999999765544
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=265.48 Aligned_cols=213 Identities=17% Similarity=0.324 Sum_probs=174.2
Q ss_pred ChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHC
Q 013092 17 KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSK 94 (449)
Q Consensus 17 ~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~-~~~ls~~~~~~i~~qi~~aL~yLH~~ 94 (449)
....+.+|+++++.+ +|+||+++.+.+.+ ...|++|||+ +++|.+++... ...+++..++.++.|++.||.|||+.
T Consensus 44 ~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~ 121 (260)
T cd05073 44 SVEAFLAEANVMKTL-QHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR 121 (260)
T ss_pred HHHHHHHHHHHHHhc-CCCCcceEEEEEcC-CCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhC
Confidence 345789999999999 89999999988877 7789999999 89999999753 34578999999999999999999999
Q ss_pred CceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHH
Q 013092 95 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYV 174 (449)
Q Consensus 95 givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~i 174 (449)
|++|+||||+||++ +..+.++|+|||++......... ......++..|++||++....++.++|+|||||+
T Consensus 122 ~i~H~dl~p~ni~i---~~~~~~~l~d~~~~~~~~~~~~~------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~ 192 (260)
T cd05073 122 NYIHRDLRAANILV---SASLVCKIADFGLARVIEDNEYT------AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGIL 192 (260)
T ss_pred CccccccCcceEEE---cCCCcEEECCCcceeeccCCCcc------cccCCcccccccCHhHhccCCcCccccchHHHHH
Confidence 99999999999999 57889999999999866443211 1123345678999999998889999999999999
Q ss_pred HHHHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Q 013092 175 LMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRD 247 (449)
Q Consensus 175 l~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~L~~ 247 (449)
+|++++ |..||.+.+.. .....+...... .....++.++.+++.+||..+|++||++.+|.+.|.+
T Consensus 193 l~~l~t~g~~p~~~~~~~---~~~~~~~~~~~~----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 193 LMEIVTYGRIPYPGMSNP---EVIRALERGYRM----PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred HHHHHhcCCCCCCCCCHH---HHHHHHhCCCCC----CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 999998 99999875432 222333222111 1235678999999999999999999999999988864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-33 Score=263.97 Aligned_cols=210 Identities=19% Similarity=0.296 Sum_probs=174.2
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 96 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gi 96 (449)
..++.+|+++++.+ +|+||+++.+.+.+....|++|||+ +++|.+++......+++..++.++.|++.||.|||+.++
T Consensus 42 ~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i 120 (256)
T cd06612 42 LQEIIKEISILKQC-DSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKK 120 (256)
T ss_pred HHHHHHHHHHHHhC-CCCcEeeeeeeeecCCcEEEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 67899999999999 9999999999999999999999999 899999997656779999999999999999999999999
Q ss_pred eecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHHHH
Q 013092 97 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLM 176 (449)
Q Consensus 97 vHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il~ 176 (449)
+|+||+|+||++ +.++.++|+|||++........ ......++..|++||++.+..++.++||||||+++|
T Consensus 121 ~H~dl~~~ni~~---~~~~~~~l~dfg~~~~~~~~~~-------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~ 190 (256)
T cd06612 121 IHRDIKAGNILL---NEEGQAKLADFGVSGQLTDTMA-------KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAI 190 (256)
T ss_pred ccCCCCcceEEE---CCCCcEEEcccccchhcccCcc-------ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHH
Confidence 999999999999 5788999999999987654321 122345788999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 177 YFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 177 elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
+|++|..||...... +....+.... .........++.++.++|..||+.+|++||++.+++.
T Consensus 191 ~l~~g~~p~~~~~~~---~~~~~~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 191 EMAEGKPPYSDIHPM---RAIFMIPNKP--PPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred HHHhCCCCCCCcchh---hhhhhhccCC--CCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 999999999764332 1111111111 1111122357789999999999999999999888754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=265.75 Aligned_cols=227 Identities=19% Similarity=0.218 Sum_probs=178.0
Q ss_pred EEEEEeeecccCCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHH
Q 013092 4 ILTVFSVQENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQ 83 (449)
Q Consensus 4 aikV~~k~~~~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~~~~i~~q 83 (449)
++|+..+..........+.+|+.+++.+ +|+||+++++++.++...|+||||++++|.+++......+++..++.++.|
T Consensus 29 ~vK~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~~~~ 107 (286)
T cd07832 29 ALKKVALRRLEGGIPNQALREIKALQAC-QHPYVVKLLDVFPHGSGFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRM 107 (286)
T ss_pred EEEEEEcccccchhhHHHHHHHHHHHhC-CCCCCcceeeEEecCCeeEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHH
Confidence 3444433332233456789999999999 799999999999999999999999999999999765677999999999999
Q ss_pred HHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCC-CC
Q 013092 84 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI-EQ 162 (449)
Q Consensus 84 i~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~-~~ 162 (449)
|+.||+|||+.|++|+||||+||++ +..+.++|+|||++........ .......|+..|+|||.+.+. .+
T Consensus 108 i~~~l~~lH~~~i~H~dl~p~ni~~---~~~~~~~l~dfg~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~ 178 (286)
T cd07832 108 LLKGVAYMHANGIMHRDLKPANLLI---SADGVLKIADFGLARLFSEEEP------RLYSHQVATRWYRAPELLYGARKY 178 (286)
T ss_pred HHHHHHHHHHCCeecCCcCHHHEEE---cCCCcEEEeeeeecccccCCCC------CccccccCcccccCceeeeccccC
Confidence 9999999999999999999999999 5688999999999987654321 112334689999999998764 46
Q ss_pred ChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhc-------------------------ccchHHHhhcCCc
Q 013092 163 SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK-------------------------VSTSIEALCRGYP 217 (449)
Q Consensus 163 s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~-------------------------~~~~~~~l~~~~p 217 (449)
+.++|||||||++|+|++|..||.+... ...+..+.... ....+..+.+.++
T Consensus 179 ~~~~Di~slG~~l~~l~tg~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (286)
T cd07832 179 DPGVDLWAVGCIFAELLNGSPLFPGEND---IEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDAS 255 (286)
T ss_pred CchhHHHHHHHHHHHHHcCCcCcCCCCH---HHHHHHHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCcc
Confidence 8999999999999999999888876432 12222221110 0011223445678
Q ss_pred HHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 218 TEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 218 ~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
.++.+++..|+..+|++||++.++..
T Consensus 256 ~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 256 PEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred HHHHHHHHHHhccChhhCCCHHHHhh
Confidence 99999999999999999999887754
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=265.32 Aligned_cols=225 Identities=25% Similarity=0.390 Sum_probs=176.3
Q ss_pred EEEEEeeecccCCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHH
Q 013092 4 ILTVFSVQENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLAD 82 (449)
Q Consensus 4 aikV~~k~~~~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~ 82 (449)
|+|+..+.............|+.+++.+ .|+||+++++++.+....++||||+ +++|.+++.. ...+++..++.++.
T Consensus 28 ~~K~~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~~v~~~~~~~~L~~~l~~-~~~~~~~~~~~~~~ 105 (260)
T PF00069_consen 28 AVKIIDKSEIEEEEREENIREIKILRRL-RHPNIVQILDVFQDDNYLYIVMEYCPGGSLQDYLQK-NKPLSEEEILKIAY 105 (260)
T ss_dssp EEEEEESTTHHHHHHHHHHHHHHHHHHH-TBTTBCHEEEEEEESSEEEEEEEEETTEBHHHHHHH-HSSBBHHHHHHHHH
T ss_pred EEEEeccccccccccchhhhhhhccccc-cccccccccccccccccccccccccccccccccccc-cccccccccccccc
Confidence 4444444433333333445699999999 9999999999999999999999999 6699999983 46789999999999
Q ss_pred HHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhh-CCC
Q 013092 83 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHL-GIE 161 (449)
Q Consensus 83 qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~-~~~ 161 (449)
||+.||++||++||+|+||||+||++ +.++.++|+|||++..+.... .......++..|+|||++. +..
T Consensus 106 qi~~~L~~Lh~~~i~H~dikp~NIl~---~~~~~~~l~Dfg~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~ 175 (260)
T PF00069_consen 106 QILEALAYLHSKGIVHRDIKPENILL---DENGEVKLIDFGSSVKLSENN-------ENFNPFVGTPEYMAPEVLQQGKK 175 (260)
T ss_dssp HHHHHHHHHHHTTEEESSBSGGGEEE---STTSEEEESSGTTTEESTSTT-------SEBSSSSSSGGGSCHHHHTTTSS
T ss_pred cccccccccccccccccccccccccc---ccccccccccccccccccccc-------ccccccccccccccccccccccc
Confidence 99999999999999999999999999 688999999999998752211 1224567899999999998 788
Q ss_pred CChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhh--cCCcHHHHHHHHHHhcCCCCCCCCHH
Q 013092 162 QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC--RGYPTEFASYFHYCRSLRFDDKPDYA 239 (449)
Q Consensus 162 ~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~--~~~p~el~~li~~cl~~~p~~RPt~~ 239 (449)
++.++||||||+++|+|++|..||...........+.+..... ...... ...+.++.++|..||+.+|++||++.
T Consensus 176 ~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~ 252 (260)
T PF00069_consen 176 YTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRP---LPSSSQQSREKSEELRDLIKKMLSKDPEQRPSAE 252 (260)
T ss_dssp BSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTH---HHHHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHH
T ss_pred ccccccccccccccccccccccccccccchhhhhhhhhccccc---ccccccccchhHHHHHHHHHHHccCChhHCcCHH
Confidence 9999999999999999999999998752222222222222211 111111 12248999999999999999999988
Q ss_pred HHHH
Q 013092 240 YLKR 243 (449)
Q Consensus 240 ~l~~ 243 (449)
++++
T Consensus 253 ~l~~ 256 (260)
T PF00069_consen 253 ELLK 256 (260)
T ss_dssp HHHT
T ss_pred HHhc
Confidence 8754
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=271.39 Aligned_cols=209 Identities=21% Similarity=0.300 Sum_probs=171.2
Q ss_pred ChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 013092 17 KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 95 (449)
Q Consensus 17 ~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~g 95 (449)
....+.+|+.+++.+ +|+||+++.+.+.++...|+||||+ +++|.+++. ...+++..++.++.|++.||+|||+.|
T Consensus 60 ~~~~~~~e~~~l~~~-~h~~v~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~--~~~~~~~~~~~i~~ql~~aL~~LH~~g 136 (296)
T cd06654 60 KKELIINEILVMREN-KNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT--ETCMDEGQIAAVCRECLQALEFLHSNQ 136 (296)
T ss_pred hHHHHHHHHHHHHhC-CCCCEeeEEEEEEeCCEEEEeecccCCCCHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 346688999999998 9999999999999999999999999 999999987 346899999999999999999999999
Q ss_pred ceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHHH
Q 013092 96 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVL 175 (449)
Q Consensus 96 ivHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il 175 (449)
|+|+||||+|||+ +.++.++|+|||++........ ......|++.|+|||.+.+..++.++|||||||++
T Consensus 137 i~H~dLkp~Nill---~~~~~~kl~dfg~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil 206 (296)
T cd06654 137 VIHRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQS-------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMA 206 (296)
T ss_pred cccCCCCHHHEEE---cCCCCEEECccccchhcccccc-------ccCcccCCccccCHHHHcCCCCCccchHHHHHHHH
Confidence 9999999999999 5778999999999876543221 11234688999999999988889999999999999
Q ss_pred HHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 176 MYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 176 ~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
|+|++|..||...... ...+. +..... ........++..+.++|.+||..+|++||++.+|+.
T Consensus 207 ~~l~~g~~pf~~~~~~--~~~~~-~~~~~~--~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 207 IEMIEGEPPYLNENPL--RALYL-IATNGT--PELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred HHHHhCCCCCCCCCHH--HhHHH-HhcCCC--CCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 9999999999764331 11111 111111 111123457889999999999999999999888764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-33 Score=270.30 Aligned_cols=209 Identities=18% Similarity=0.265 Sum_probs=170.5
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHH-
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVHS- 93 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~--~~~ls~~~~~~i~~qi~~aL~yLH~- 93 (449)
..++.+|+.+++.+ +|+||+++++.+...+..|+||||+ +++|.+++... ...+++..+..++.|++.||.|||+
T Consensus 43 ~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~ 121 (286)
T cd06622 43 FNQIIMELDILHKA-VSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE 121 (286)
T ss_pred HHHHHHHHHHHHhc-CCCcHHhhhhheecCCeEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhc
Confidence 45788999999999 9999999999999999999999999 99999998753 2368999999999999999999997
Q ss_pred CCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCC------CCChhhH
Q 013092 94 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI------EQSRRDD 167 (449)
Q Consensus 94 ~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~------~~s~~~D 167 (449)
.||+|+||||+||++ +..+.++|+|||++..+..... ....++..|++||++.+. .++.++|
T Consensus 122 ~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~~~---------~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~D 189 (286)
T cd06622 122 HNIIHRDVKPTNVLV---NGNGQVKLCDFGVSGNLVASLA---------KTNIGCQSYMAPERIKSGGPNQNPTYTVQSD 189 (286)
T ss_pred CCEeeCCCCHHHEEE---CCCCCEEEeecCCcccccCCcc---------ccCCCccCccCcchhcCCCCCccCCCCcccc
Confidence 599999999999999 5688999999999976643221 234678899999998654 3478999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 168 LESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 168 iwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
+|||||++|+|++|..||...........+..+.... ...+...++.++.+||..||..+|++||++.+|..
T Consensus 190 iwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 190 VWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGD----PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred hHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcC----CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 9999999999999999997643322222222222221 12234558899999999999999999999887764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=286.93 Aligned_cols=222 Identities=21% Similarity=0.246 Sum_probs=181.3
Q ss_pred EEEEeeeccc--CCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCC--CHHHHHH
Q 013092 5 LTVFSVQENV--KTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKL--SLKTVLM 79 (449)
Q Consensus 5 ikV~~k~~~~--~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~l--s~~~~~~ 79 (449)
+.+++|-... ....+-+..|+.+.++| .|.|||+..+.+.+++++-|.||-+ ||+|.++++...+++ .+.++-+
T Consensus 601 vrIaIKEIpekdsr~~QPLhEEIaLH~~L-rHkNIVrYLGs~senGf~kIFMEqVPGGSLSsLLrskWGPlKDNEstm~f 679 (1226)
T KOG4279|consen 601 VRIAIKEIPEKDSREVQPLHEEIALHSTL-RHKNIVRYLGSVSENGFFKIFMEQVPGGSLSSLLRSKWGPLKDNESTMNF 679 (1226)
T ss_pred eEEEeeecccccchhhccHHHHHHHHHHH-hhHhHHHHhhccCCCCeEEEEeecCCCCcHHHHHHhccCCCccchhHHHH
Confidence 3444444433 34455589999999999 9999999999999999999999999 999999998767777 7889999
Q ss_pred HHHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhC
Q 013092 80 LADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG 159 (449)
Q Consensus 80 i~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~ 159 (449)
+..||+.||.|||++.|||||||.+|+||. .-.|.+||+|||.++.+..-. ....++.||..|||||++..
T Consensus 680 YtkQILeGLkYLHen~IVHRDIKGDNVLvN--TySGvlKISDFGTsKRLAgin-------P~TETFTGTLQYMAPEvIDq 750 (1226)
T KOG4279|consen 680 YTKQILEGLKYLHENKIVHRDIKGDNVLVN--TYSGVLKISDFGTSKRLAGIN-------PCTETFTGTLQYMAPEVIDQ 750 (1226)
T ss_pred HHHHHHHHhhhhhhcceeeccccCCcEEEe--eccceEEecccccchhhccCC-------ccccccccchhhhChHhhcc
Confidence 999999999999999999999999999996 778999999999998764321 12367899999999999986
Q ss_pred C--CCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCC
Q 013092 160 I--EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPD 237 (449)
Q Consensus 160 ~--~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt 237 (449)
+ .|+..+|||||||++.||.||++||..+.. ....+.++.--+.- +.++..++.+...||.+|+..+|.+||+
T Consensus 751 G~RGYG~aADIWS~GCT~vEMATGrPPF~Elgs--pqAAMFkVGmyKvH---P~iPeelsaeak~FilrcFepd~~~R~s 825 (1226)
T KOG4279|consen 751 GPRGYGKAADIWSFGCTMVEMATGRPPFVELGS--PQAAMFKVGMYKVH---PPIPEELSAEAKNFILRCFEPDPCDRPS 825 (1226)
T ss_pred CCcCCCchhhhhhccceeEeeccCCCCeeecCC--hhHhhhhhcceecC---CCCcHHHHHHHHHHHHHHcCCCcccCcc
Confidence 5 489999999999999999999999987643 23333333222222 2233456788999999999999999999
Q ss_pred HHHH
Q 013092 238 YAYL 241 (449)
Q Consensus 238 ~~~l 241 (449)
+.+|
T Consensus 826 A~~L 829 (1226)
T KOG4279|consen 826 AKDL 829 (1226)
T ss_pred HHHh
Confidence 7765
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=267.29 Aligned_cols=216 Identities=20% Similarity=0.286 Sum_probs=173.9
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 96 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gi 96 (449)
...+..|+++++.+ .|+||+++++.+.+.+..++||||+ +++|.+++.. ...+++..++.++.|++.||.|||++|+
T Consensus 47 ~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~ql~~al~~LH~~~i 124 (268)
T cd06630 47 VEALRKEIRLMARL-NHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSK-YGAFKEAVIINYTEQLLRGLSYLHENQI 124 (268)
T ss_pred HHHHHHHHHHHHHc-CCCceehhhceeccCCeEEEEEeccCCCcHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 35689999999999 8999999999999999999999999 9999999975 4578999999999999999999999999
Q ss_pred eecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHHHH
Q 013092 97 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLM 176 (449)
Q Consensus 97 vHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il~ 176 (449)
+|+||||.||++. ..+..++|+|||++..+........ .......++..|+|||.+.+..++.++|+|||||++|
T Consensus 125 ~H~~i~~~nil~~--~~~~~~~l~dfg~~~~~~~~~~~~~---~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~ 199 (268)
T cd06630 125 IHRDVKGANLLID--STGQRLRIADFGAAARLAAKGTGAG---EFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVII 199 (268)
T ss_pred ecCCCCHHHEEEc--CCCCEEEEcccccccccccccccCC---ccccccccccceeCHhHhccCCCCcccchHHHHHHHH
Confidence 9999999999993 2334699999999987755422111 1123456889999999999888999999999999999
Q ss_pred HHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 177 YFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 177 elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
+|++|..||..............+... .....+...+++++.+++..||..+|++||++.+|+.
T Consensus 200 ~l~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 200 EMATAKPPWNAEKHSNHLALIFKIASA---TTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred HHHhCCCCCCCCCCcchHHHHHHHhcc---CCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 999999999764432222222222111 1122334457889999999999999999999888753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=266.43 Aligned_cols=210 Identities=20% Similarity=0.202 Sum_probs=167.9
Q ss_pred hHHHHHHHHHHHhcCCCCCceEEEEeEeC--CEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 013092 19 PQLLYESKLYRILQGGTGIPNVRWFGVEG--DYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 96 (449)
Q Consensus 19 ~~~~~E~~il~~l~~hp~Iv~l~~~~~~~--~~~~lVmE~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gi 96 (449)
....+|+.++..+.+|+||+++++++.+. +..++||||+.++|.+++......+++..++.++.|++.||+|||+.|+
T Consensus 42 ~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i 121 (282)
T cd07831 42 VNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGI 121 (282)
T ss_pred hhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 34567999999997899999999999987 8999999999778988887545578999999999999999999999999
Q ss_pred eecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhC-CCCChhhHHHHHHHHH
Q 013092 97 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVL 175 (449)
Q Consensus 97 vHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~-~~~s~~~DiwSlG~il 175 (449)
+||||||+||++. . +.+||+|||+++....... .....++..|+|||++.. ..++.++|||||||++
T Consensus 122 ~H~dl~p~ni~l~---~-~~~kl~dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l 189 (282)
T cd07831 122 FHRDIKPENILIK---D-DILKLADFGSCRGIYSKPP--------YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVF 189 (282)
T ss_pred eecccCHHHEEEc---C-CCeEEEecccccccccCCC--------cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHH
Confidence 9999999999994 5 9999999999986644322 123467899999998754 4568899999999999
Q ss_pred HHHHhCCCCCCCCCcCCHHHHHHHHHhhc------------------------ccchHHHhhcCCcHHHHHHHHHHhcCC
Q 013092 176 MYFLRGSLPWQGLKAGTKKQKYEKISEKK------------------------VSTSIEALCRGYPTEFASYFHYCRSLR 231 (449)
Q Consensus 176 ~elltG~~Pf~~~~~~~~~~~~~~i~~~~------------------------~~~~~~~l~~~~p~el~~li~~cl~~~ 231 (449)
|||++|..||.+.+.. ..+..+.... ....+..+...++.++.++|..||..+
T Consensus 190 ~el~~~~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 266 (282)
T cd07831 190 FEILSLFPLFPGTNEL---DQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYD 266 (282)
T ss_pred HHHHcCCcCCCCCCHH---HHHHHHHHHcCCCCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccC
Confidence 9999999999774332 2222221100 001122334567899999999999999
Q ss_pred CCCCCCHHHHHH
Q 013092 232 FDDKPDYAYLKR 243 (449)
Q Consensus 232 p~~RPt~~~l~~ 243 (449)
|++||++.++.+
T Consensus 267 P~~R~~~~~~l~ 278 (282)
T cd07831 267 PDERITAKQALR 278 (282)
T ss_pred cccccCHHHHhh
Confidence 999999888754
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-33 Score=272.64 Aligned_cols=232 Identities=18% Similarity=0.236 Sum_probs=180.3
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 96 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gi 96 (449)
...+..|+++++.+ +||||+++++.+..+++.|+||||+ |++|.+++.. ...+++..+..++.|++.||.|||+.||
T Consensus 45 ~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i 122 (305)
T cd05609 45 IQQVFVERDILTFA-ENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKN-IGALPVDMARMYFAETVLALEYLHNYGI 122 (305)
T ss_pred HHHHHHHHHHHHhC-CCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 34678999999999 8999999999999999999999999 8999999975 4578999999999999999999999999
Q ss_pred eecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCc--------ccccccCCCCccCccccchhhhhCCCCChhhHH
Q 013092 97 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ--------HIPYRENKNLTGTARYASMNTHLGIEQSRRDDL 168 (449)
Q Consensus 97 vHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~--------~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~Di 168 (449)
+||||||.||++ +..+.++|+|||+++......... ...........++..|+|||.+.+..++.++|+
T Consensus 123 ~H~dl~p~NIll---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di 199 (305)
T cd05609 123 VHRDLKPDNLLI---TSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDW 199 (305)
T ss_pred cccCCchHHEEE---CCCCCEEEeeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhH
Confidence 999999999999 578899999999987422111100 000011123467889999999998889999999
Q ss_pred HHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 013092 169 ESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDL 248 (449)
Q Consensus 169 wSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~L~~~ 248 (449)
|||||++|+|++|..||.+.. ..+.+..+....... +.....+|.++.++|.+||+.+|++||+...+.++|..
T Consensus 200 ~slG~vl~el~~g~~pf~~~~---~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~- 273 (305)
T cd05609 200 WAMGIILYEFLVGCVPFFGDT---PEELFGQVISDDIEW--PEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH- 273 (305)
T ss_pred HHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhcccCC--CCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC-
Confidence 999999999999999997643 233333333322111 11123578999999999999999999997666665543
Q ss_pred HHHcCCCCCCcccchhhh
Q 013092 249 FIREGFQFDYVFDWTILK 266 (449)
Q Consensus 249 ~~~~~~~~~~~~dw~~~~ 266 (449)
++....||....
T Consensus 274 ------~~~~~~~~~~~~ 285 (305)
T cd05609 274 ------RFFLGLDWNGLL 285 (305)
T ss_pred ------ccccCCCHHHHh
Confidence 344456777643
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=267.76 Aligned_cols=223 Identities=20% Similarity=0.205 Sum_probs=170.5
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEe--CCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVE--GDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 94 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~--~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~ 94 (449)
...+.+|+++++.+ .||||+++.+++.. ....||||||+ +++|.+++......+++..++.++.|++.||+|||++
T Consensus 49 ~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~ 127 (284)
T cd05081 49 LRDFEREIEILKSL-QHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSK 127 (284)
T ss_pred HHHHHHHHHHHHhC-CCCCeeEEEEEEccCCCCceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 45688999999999 89999999887653 45689999999 9999999976555689999999999999999999999
Q ss_pred CceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHH
Q 013092 95 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYV 174 (449)
Q Consensus 95 givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~i 174 (449)
||+||||||+||++ +.++.++|+|||+++......... .......++..|+|||++.+..++.++|||||||+
T Consensus 128 ~i~H~dlkp~nili---~~~~~~~l~dfg~~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~ 200 (284)
T cd05081 128 RYVHRDLATRNILV---ESENRVKIGDFGLTKVLPQDKEYY----KVREPGESPIFWYAPESLTESKFSVASDVWSFGVV 200 (284)
T ss_pred CceeccCCHhhEEE---CCCCeEEECCCcccccccCCCcce----eecCCCCCceEeeCHHHhccCCcChHHHHHHHHHH
Confidence 99999999999999 578899999999998765432210 11112234556999999998889999999999999
Q ss_pred HHHHHhCCCCCCCCCcCCHH---------HHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Q 013092 175 LMYFLRGSLPWQGLKAGTKK---------QKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIF 245 (449)
Q Consensus 175 l~elltG~~Pf~~~~~~~~~---------~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~L 245 (449)
+|||++|..|+......... .....+.+.............++.++.+++..||..+|++||++.+|...|
T Consensus 201 l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l 280 (284)
T cd05081 201 LYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQV 280 (284)
T ss_pred HHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHH
Confidence 99999988776543211000 000000000000000112346789999999999999999999999999988
Q ss_pred HHH
Q 013092 246 RDL 248 (449)
Q Consensus 246 ~~~ 248 (449)
+++
T Consensus 281 ~~~ 283 (284)
T cd05081 281 EAI 283 (284)
T ss_pred Hhc
Confidence 754
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=267.24 Aligned_cols=229 Identities=20% Similarity=0.232 Sum_probs=178.2
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCC
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKS 95 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~-~~ls~~~~~~i~~qi~~aL~yLH~~g 95 (449)
...+..|+++++.+ +||||+++++.+...+..|+||||+ +++|.+++.... ..+++..++.++.|++.||.|||++|
T Consensus 37 ~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~ 115 (277)
T cd05577 37 EQMALNEKKILEKV-SSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR 115 (277)
T ss_pred hHHHHHHHHHHHhC-CCCCEeeeeeEEecCCeEEEEEecCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 44567899999999 7999999999999999999999999 899999987533 36899999999999999999999999
Q ss_pred ceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHHH
Q 013092 96 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVL 175 (449)
Q Consensus 96 ivHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il 175 (449)
++|+||+|+||++ +.++.++|+|||++....... ......++..|++||++.+..++.++|||||||++
T Consensus 116 i~H~di~p~Nil~---~~~~~~~l~dfg~~~~~~~~~--------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il 184 (277)
T cd05577 116 IVYRDLKPENVLL---DDHGNVRISDLGLAVELKGGK--------KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTL 184 (277)
T ss_pred cccCCCCHHHEEE---CCCCCEEEccCcchhhhccCC--------ccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHH
Confidence 9999999999999 578899999999987654311 12344678899999999988899999999999999
Q ss_pred HHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHH-HHHHHHHHHHHcCC
Q 013092 176 MYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAY-LKRIFRDLFIREGF 254 (449)
Q Consensus 176 ~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~-l~~~L~~~~~~~~~ 254 (449)
|+|++|+.||........... +..... .....+...+++++.++|..||+.+|++||++.+ ....+. ..
T Consensus 185 ~~l~~g~~p~~~~~~~~~~~~---~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll------~h 254 (277)
T cd05577 185 YEMIAGRSPFRQRKEKVEKEE---LKRRTL-EMAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVR------EH 254 (277)
T ss_pred HHHhhCCCCCCCCcccccHHH---HHhccc-cccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHH------hC
Confidence 999999999977543222211 111111 1112234567899999999999999999995433 211111 13
Q ss_pred CCCCcccchhhhhh
Q 013092 255 QFDYVFDWTILKYQ 268 (449)
Q Consensus 255 ~~~~~~dw~~~~~~ 268 (449)
++...++|......
T Consensus 255 ~~~~~~~~~~~~~~ 268 (277)
T cd05577 255 PLFKDLNWRRLEAG 268 (277)
T ss_pred hhhhcCChhhhhcC
Confidence 44456788776543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=272.90 Aligned_cols=235 Identities=17% Similarity=0.219 Sum_probs=177.7
Q ss_pred cEEEEEeeecccCCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHc-CCCCCHHHHHHH
Q 013092 3 EILTVFSVQENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFC-SRKLSLKTVLML 80 (449)
Q Consensus 3 ~aikV~~k~~~~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~-~~~ls~~~~~~i 80 (449)
.|+|+..+..........+..|+++++.+ +|+||+++++.+.+.+..|++|||+ +++|.+++... ...+++..+..+
T Consensus 28 ~avK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~ 106 (314)
T cd08216 28 VAVKKINLDSCSKEDLKLLQQEIITSRQL-QHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFI 106 (314)
T ss_pred EEEEEEeccccchhHHHHHHHHHHHHHhc-CCcchhhhhheeecCCeEEEEEeccCCCCHHHHHHHhcccCCCHHHHHHH
Confidence 45565554433444556799999999999 7999999999999999999999999 89999999753 356899999999
Q ss_pred HHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhC-
Q 013092 81 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG- 159 (449)
Q Consensus 81 ~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~- 159 (449)
+.|++.||+|||+++|+||||||+||++ +.++.++|+|||.+..+..................++..|+|||++..
T Consensus 107 ~~~l~~~L~~LH~~~ivH~dlk~~Nili---~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 183 (314)
T cd08216 107 LKDVLNALDYIHSKGFIHRSVKASHILL---SGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQN 183 (314)
T ss_pred HHHHHHHHHHHHHCCeecCCCCcceEEE---ecCCceEEecCccceeeccccccccccccccccccccccccCHHHhcCC
Confidence 9999999999999999999999999999 577899999999988665432211111122234567889999999876
Q ss_pred -CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhc---------------cc-------------chHH
Q 013092 160 -IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK---------------VS-------------TSIE 210 (449)
Q Consensus 160 -~~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~---------------~~-------------~~~~ 210 (449)
..++.++|+|||||++|+|++|..||...... ....+++.... .. ....
T Consensus 184 ~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (314)
T cd08216 184 LQGYNEKSDIYSVGITACELANGHVPFKDMPAT--QMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDH 261 (314)
T ss_pred CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhccCccccccCchhhhcCCcCcccccccccchhhhhhc
Confidence 35788999999999999999999999864321 11222221100 00 0000
Q ss_pred HhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 211 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 211 ~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
.....++.++.+|+..||..+|++||++.++++
T Consensus 262 ~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 262 PYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred chhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 111234568999999999999999999887754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=266.03 Aligned_cols=220 Identities=21% Similarity=0.275 Sum_probs=173.5
Q ss_pred HHHHHHHHHHhc--CCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q 013092 21 LLYESKLYRILQ--GGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFL 97 (449)
Q Consensus 21 ~~~E~~il~~l~--~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~giv 97 (449)
+..|..+++.++ +||+|+.+.+.+.+.+..|+||||+ |++|.+++.. ...+++..++.++.|++.||+|||+.+|+
T Consensus 41 ~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~g~~L~~~l~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~i~ 119 (278)
T cd05606 41 ALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ-HGVFSEAEMRFYAAEIILGLEHMHNRFVV 119 (278)
T ss_pred HHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEE
Confidence 455655555542 7899999999999999999999999 9999998875 45799999999999999999999999999
Q ss_pred ecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhC-CCCChhhHHHHHHHHHH
Q 013092 98 HRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLM 176 (449)
Q Consensus 98 HRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~-~~~s~~~DiwSlG~il~ 176 (449)
||||||+||++ +.++.++|+|||++..+.... .....|+..|+|||++.+ ..++.++|||||||++|
T Consensus 120 H~di~p~nili---~~~~~~kl~dfg~~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~ 187 (278)
T cd05606 120 YRDLKPANILL---DEHGHVRISDLGLACDFSKKK---------PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLF 187 (278)
T ss_pred cCCCCHHHEEE---CCCCCEEEccCcCccccCccC---------CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHH
Confidence 99999999999 577899999999987554321 124478999999999975 46899999999999999
Q ss_pred HHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCC-----CHHHHHHHHHHHHHH
Q 013092 177 YFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKP-----DYAYLKRIFRDLFIR 251 (449)
Q Consensus 177 elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RP-----t~~~l~~~L~~~~~~ 251 (449)
+|++|..||..............+... ...++..++.++.+++..|+..+|.+|| ++.++++
T Consensus 188 ~l~~g~~p~~~~~~~~~~~~~~~~~~~-----~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~-------- 254 (278)
T cd05606 188 KLLRGHSPFRQHKTKDKHEIDRMTLTM-----AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE-------- 254 (278)
T ss_pred HHHhCCCCCCCCCccchHHHHHHhhcc-----CCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh--------
Confidence 999999999875433322222111111 1123445789999999999999999999 7777643
Q ss_pred cCCCCCCcccchhhhhh
Q 013092 252 EGFQFDYVFDWTILKYQ 268 (449)
Q Consensus 252 ~~~~~~~~~dw~~~~~~ 268 (449)
.++...++|......
T Consensus 255 --~~~~~~~~~~~~~~~ 269 (278)
T cd05606 255 --HPFFRSLDWQMVFLQ 269 (278)
T ss_pred --CccccCCCchHhhhc
Confidence 355556778766443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=261.61 Aligned_cols=212 Identities=17% Similarity=0.240 Sum_probs=173.5
Q ss_pred ChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 013092 17 KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 95 (449)
Q Consensus 17 ~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~g 95 (449)
...++..|+++++.+ +||+|+++++++......|+||||+ +++|.+++......++++.++.++.|++.+|+|||+.+
T Consensus 42 ~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~ 120 (256)
T cd05112 42 SEEDFIEEAQVMMKL-SHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN 120 (256)
T ss_pred CHHHHHHHHHHHHhC-CCCCeeeEEEEEccCCceEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 346799999999999 8999999999999999999999999 89999999765566899999999999999999999999
Q ss_pred ceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHHH
Q 013092 96 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVL 175 (449)
Q Consensus 96 ivHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il 175 (449)
++|+||||.||++ +.++.++|+|||+++....... .......++..|+|||++.+..++.++||||||+++
T Consensus 121 i~h~dl~p~ni~i---~~~~~~~l~d~g~~~~~~~~~~------~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l 191 (256)
T cd05112 121 VIHRDLAARNCLV---GENQVVKVSDFGMTRFVLDDQY------TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLM 191 (256)
T ss_pred ccccccccceEEE---cCCCeEEECCCcceeecccCcc------cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHH
Confidence 9999999999999 5778999999999986643321 111223456789999999988899999999999999
Q ss_pred HHHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Q 013092 176 MYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIF 245 (449)
Q Consensus 176 ~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~L 245 (449)
|||++ |..||..... ......+...... ......+.++.+|+..||+.+|++||++.++.+.|
T Consensus 192 ~el~~~g~~p~~~~~~---~~~~~~~~~~~~~----~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 192 WEVFSEGKTPYENRSN---SEVVETINAGFRL----YKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred HHHHcCCCCCCCcCCH---HHHHHHHhCCCCC----CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 99998 9999976332 2333333221110 11234688999999999999999999999987765
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=267.49 Aligned_cols=213 Identities=17% Similarity=0.292 Sum_probs=171.2
Q ss_pred ChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-C
Q 013092 17 KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS-K 94 (449)
Q Consensus 17 ~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~-~ 94 (449)
....+.+|+++++.+ +|+||+++++.+...+..||||||+ +++|.+++.. .+.+++..+..++.|++.+|.|||+ .
T Consensus 46 ~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~ 123 (284)
T cd06620 46 VRKQILRELQIMHEC-RSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKK-GGPIPVEILGKIAVAVVEGLTYLYNVH 123 (284)
T ss_pred HHHHHHHHHHHHHHc-CCCCcceEeeeEecCCEEEEEEecCCCCCHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHhc
Confidence 346788999999999 8999999999999999999999999 8999999875 4578999999999999999999997 6
Q ss_pred CceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHH
Q 013092 95 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYV 174 (449)
Q Consensus 95 givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~i 174 (449)
+++||||||+||++ +.++.++|+|||++........ ....|+..|+|||++.+..++.++|||||||+
T Consensus 124 ~i~H~dl~p~nil~---~~~~~~~l~d~gl~~~~~~~~~---------~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~ 191 (284)
T cd06620 124 RIMHRDIKPSNILV---NSRGQIKLCDFGVSGELINSIA---------DTFVGTSTYMSPERIQGGKYTVKSDVWSLGIS 191 (284)
T ss_pred CeeccCCCHHHEEE---CCCCcEEEccCCcccchhhhcc---------CccccCcccCCHHHHccCCCCccchHHHHHHH
Confidence 99999999999999 5778999999999875533221 23578999999999988889999999999999
Q ss_pred HHHHHhCCCCCCCCCcC-----CHHHHHHHHHhhcccchHHHhh-cCCcHHHHHHHHHHhcCCCCCCCCHHHHHHH
Q 013092 175 LMYFLRGSLPWQGLKAG-----TKKQKYEKISEKKVSTSIEALC-RGYPTEFASYFHYCRSLRFDDKPDYAYLKRI 244 (449)
Q Consensus 175 l~elltG~~Pf~~~~~~-----~~~~~~~~i~~~~~~~~~~~l~-~~~p~el~~li~~cl~~~p~~RPt~~~l~~~ 244 (449)
+|+|++|..||...... ....... +...........+. ..++.++.+++..||..+|++||++.++...
T Consensus 192 l~~l~tg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~ 266 (284)
T cd06620 192 IIELALGKFPFAFSNIDDDGQDDPMGILD-LLQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAM 266 (284)
T ss_pred HHHHHhCCCCCcccchhhhhhhhhhHHHH-HHHHHhhccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 99999999999864431 1111111 11111111111111 2378899999999999999999999887653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-33 Score=270.15 Aligned_cols=214 Identities=17% Similarity=0.285 Sum_probs=168.9
Q ss_pred ChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecCCCCHHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHH
Q 013092 17 KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNF----CSRKLSLKTVLMLADQMINRVEFVH 92 (449)
Q Consensus 17 ~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~g~sL~~ll~~----~~~~ls~~~~~~i~~qi~~aL~yLH 92 (449)
....+.+|+.++.++.+|+||+++++++..++..+++|||++.+|.++... ....+++..+..++.|++.||+|||
T Consensus 45 ~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh 124 (288)
T cd06616 45 EQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLK 124 (288)
T ss_pred HHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh
Confidence 345688999999999679999999999999999999999998787776532 1356999999999999999999999
Q ss_pred HC-CceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCC---CCChhhHH
Q 013092 93 SK-SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI---EQSRRDDL 168 (449)
Q Consensus 93 ~~-givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~---~~s~~~Di 168 (449)
+. +|+||||||+||++ +..+.++|+|||+++.+..... .....|+..|+|||++.+. .++.++||
T Consensus 125 ~~~~i~H~dlkp~Nil~---~~~~~~kl~dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di 193 (288)
T cd06616 125 EELKIIHRDVKPSNILL---DRNGNIKLCDFGISGQLVDSIA--------KTRDAGCRPYMAPERIDPSARDGYDVRSDV 193 (288)
T ss_pred hcCCeeccCCCHHHEEE---ccCCcEEEeecchhHHhccCCc--------cccccCccCccCHHHhccccccCCcchhhh
Confidence 74 99999999999999 5778999999999976543321 1234688899999999876 68899999
Q ss_pred HHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 169 ESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 169 wSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
|||||++|+|++|+.||.... ...+.+..+...............++.++.+||..||+.+|++||++.+|..
T Consensus 194 ~slG~il~el~~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~ 266 (288)
T cd06616 194 WSLGITLYEVATGKFPYPKWN--SVFDQLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE 266 (288)
T ss_pred hHHHHHHHHHHhCCCCchhcc--hHHHHHhhhcCCCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 999999999999999997643 1122222222211111111122457899999999999999999999988754
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=263.04 Aligned_cols=214 Identities=19% Similarity=0.340 Sum_probs=181.6
Q ss_pred CCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC
Q 013092 15 KTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 94 (449)
Q Consensus 15 ~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~ 94 (449)
+++...++..++++....++|.||+.+++|..+...+|+||+|+..++.+++...+++++..+-++...++.||.||-++
T Consensus 131 kee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeK 210 (391)
T KOG0983|consen 131 KEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMSTCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEK 210 (391)
T ss_pred HHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHHHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHh
Confidence 34566788888888887679999999999999999999999999899999998888999999999999999999999975
Q ss_pred -CceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhC---CCCChhhHHHH
Q 013092 95 -SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG---IEQSRRDDLES 170 (449)
Q Consensus 95 -givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~---~~~s~~~DiwS 170 (449)
||+|||+||.|||+ +..|.|||||||++-.+.+...+ ....|.+.|||||.+.- ..|+.++||||
T Consensus 211 H~viHRDvKPSNILl---De~GniKlCDFGIsGrlvdSkAh--------trsAGC~~YMaPERidp~~~~kYDiRaDVWS 279 (391)
T KOG0983|consen 211 HGVIHRDVKPSNILL---DERGNIKLCDFGISGRLVDSKAH--------TRSAGCAAYMAPERIDPPDKPKYDIRADVWS 279 (391)
T ss_pred cceeecccCccceEE---ccCCCEEeecccccceeeccccc--------ccccCCccccCccccCCCCCCccchhhhhhh
Confidence 79999999999999 79999999999999888776543 34579999999999874 35899999999
Q ss_pred HHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 171 LGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 171 lG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
||++|+||.||..||.+.+. ..+.+.++..... +.++ -..++++.|++|+..||..|+.+||.|.+|.+
T Consensus 280 lGITlveLaTg~yPy~~c~t--dFe~ltkvln~eP-P~L~-~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 280 LGITLVELATGQYPYKGCKT--DFEVLTKVLNEEP-PLLP-GHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred hccchhhhhcccCCCCCCCc--cHHHHHHHHhcCC-CCCC-cccCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 99999999999999988543 3455566665332 2221 12358999999999999999999999988754
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=290.29 Aligned_cols=216 Identities=20% Similarity=0.220 Sum_probs=166.3
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecCCCCHHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHH
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFC----SRKLSLKTVLMLADQMINRVEFVHS 93 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~g~sL~~ll~~~----~~~ls~~~~~~i~~qi~~aL~yLH~ 93 (449)
..++.+|+.+|+.| +|+||+++++++.+.+..|+||++++++|.+++... ........++.|+.||+.||+|||+
T Consensus 207 ~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~ 285 (501)
T PHA03210 207 AIQLENEILALGRL-NHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD 285 (501)
T ss_pred HHHHHHHHHHHHhC-CCCCcCcEeEEEEECCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh
Confidence 44588999999999 999999999999999999999999988888887532 1224467788999999999999999
Q ss_pred CCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHH
Q 013092 94 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGY 173 (449)
Q Consensus 94 ~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~ 173 (449)
+|||||||||+|||| +.++.+||+|||+++.+...... ......||..|+|||++.+..++.++|||||||
T Consensus 286 ~gIiHrDLKP~NILl---~~~~~vkL~DFGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv 356 (501)
T PHA03210 286 KKLIHRDIKLENIFL---NCDGKIVLGDFGTAMPFEKEREA------FDYGWVGTVATNSPEILAGDGYCEITDIWSCGL 356 (501)
T ss_pred CCeecCCCCHHHEEE---CCCCCEEEEeCCCceecCccccc------ccccccCCcCCCCchhhcCCCCCcHHHHHHHHH
Confidence 999999999999999 57889999999999877543221 123467999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCCcCCHHHHHHHHHhhc------c-------------------cchHHHhh--cCCcHHHHHHHHH
Q 013092 174 VLMYFLRGSLPWQGLKAGTKKQKYEKISEKK------V-------------------STSIEALC--RGYPTEFASYFHY 226 (449)
Q Consensus 174 il~elltG~~Pf~~~~~~~~~~~~~~i~~~~------~-------------------~~~~~~l~--~~~p~el~~li~~ 226 (449)
+||||++|..++...........+.++.... . ...++.+. ..++.++.++|.+
T Consensus 357 il~ell~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~k 436 (501)
T PHA03210 357 ILLDMLSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVK 436 (501)
T ss_pred HHHHHHHCCCCCccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHH
Confidence 9999999875443322222222222221100 0 00111111 2467788999999
Q ss_pred HhcCCCCCCCCHHHHHH
Q 013092 227 CRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 227 cl~~~p~~RPt~~~l~~ 243 (449)
|+..||.+||++.+++.
T Consensus 437 mL~~DP~~Rpsa~elL~ 453 (501)
T PHA03210 437 MLTFDWHLRPGAAELLA 453 (501)
T ss_pred HhccCcccCcCHHHHhh
Confidence 99999999999888753
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=270.20 Aligned_cols=212 Identities=18% Similarity=0.294 Sum_probs=168.3
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-CC
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS-KS 95 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~-~g 95 (449)
..++.+|+++++.+ +||||+++++.+.+++..||||||+ +++|.+++.. ...+++..+..++.|++.||.|||+ .+
T Consensus 43 ~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ey~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~ 120 (308)
T cd06615 43 RNQIIRELKVLHEC-NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK-AGRIPENILGKISIAVLRGLTYLREKHK 120 (308)
T ss_pred HHHHHHHHHHHHhC-CCCCCCeEEEEEeeCCEEEEEeeccCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhhCC
Confidence 35688999999999 9999999999999999999999999 8999999986 4678999999999999999999997 59
Q ss_pred ceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHHH
Q 013092 96 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVL 175 (449)
Q Consensus 96 ivHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il 175 (449)
|+|+||||+|||+ +.++.++|+|||++....... .....|+..|++||++.+..++.++|+|||||++
T Consensus 121 i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~~---------~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l 188 (308)
T cd06615 121 IMHRDVKPSNILV---NSRGEIKLCDFGVSGQLIDSM---------ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSL 188 (308)
T ss_pred EEECCCChHHEEE---ecCCcEEEccCCCcccccccc---------cccCCCCcCccChhHhcCCCCCccchHHHHHHHH
Confidence 9999999999999 577889999999987553322 1345789999999999988899999999999999
Q ss_pred HHHHhCCCCCCCCCcCCHHHHHHHH-----------------------------HhhcccchHHHhh-cCCcHHHHHHHH
Q 013092 176 MYFLRGSLPWQGLKAGTKKQKYEKI-----------------------------SEKKVSTSIEALC-RGYPTEFASYFH 225 (449)
Q Consensus 176 ~elltG~~Pf~~~~~~~~~~~~~~i-----------------------------~~~~~~~~~~~l~-~~~p~el~~li~ 225 (449)
|+|++|..||...+.......+... .+.......+.++ ..++.++.+||.
T Consensus 189 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 268 (308)
T cd06615 189 VEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVD 268 (308)
T ss_pred HHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHH
Confidence 9999999999754321111111000 0000000000111 136788999999
Q ss_pred HHhcCCCCCCCCHHHHHH
Q 013092 226 YCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 226 ~cl~~~p~~RPt~~~l~~ 243 (449)
+||..+|++||++.+|..
T Consensus 269 ~~l~~~P~~Rpt~~~ll~ 286 (308)
T cd06615 269 KCLKKNPKERADLKELTK 286 (308)
T ss_pred HHccCChhhCcCHHHHhc
Confidence 999999999999877654
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=268.36 Aligned_cols=212 Identities=17% Similarity=0.288 Sum_probs=169.1
Q ss_pred CChhHHHHHHHHHHHhcCCCCCceEEEEeEe------CCEEEEEEecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHH
Q 013092 16 TKHPQLLYESKLYRILQGGTGIPNVRWFGVE------GDYNVLVMDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINR 87 (449)
Q Consensus 16 ~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~------~~~~~lVmE~~-g~sL~~ll~~~-~~~ls~~~~~~i~~qi~~a 87 (449)
....++..|+.++.++.+|+||+++++++.. ....||||||+ +++|.+++... ...+++..++.++.||+.|
T Consensus 54 ~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~a 133 (282)
T cd06636 54 DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRG 133 (282)
T ss_pred HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHH
Confidence 3456788999999999899999999998853 56889999999 88999998753 3458888999999999999
Q ss_pred HHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhh-----CCCC
Q 013092 88 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHL-----GIEQ 162 (449)
Q Consensus 88 L~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~-----~~~~ 162 (449)
|.|||+.||+|+||||+||++ +.++.++|+|||++........ ......|+..|+|||++. ...+
T Consensus 134 l~~LH~~~ivH~dl~~~nili---~~~~~~~l~dfg~~~~~~~~~~-------~~~~~~~~~~y~aPE~l~~~~~~~~~~ 203 (282)
T cd06636 134 LAHLHAHKVIHRDIKGQNVLL---TENAEVKLVDFGVSAQLDRTVG-------RRNTFIGTPYWMAPEVIACDENPDATY 203 (282)
T ss_pred HHHHHHCCcccCCCCHHHEEE---CCCCCEEEeeCcchhhhhcccc-------CCCcccccccccCHhhcCcccCcCcCC
Confidence 999999999999999999999 5778899999999876543211 123457899999999986 3457
Q ss_pred ChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 013092 163 SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 242 (449)
Q Consensus 163 s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~ 242 (449)
+.++|||||||++|+|++|..||..... ...+..+... .........++.++.+||.+||..+|.+||++.+|.
T Consensus 204 ~~~~DvwslG~~l~el~~g~~p~~~~~~---~~~~~~~~~~---~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell 277 (282)
T cd06636 204 DYRSDIWSLGITAIEMAEGAPPLCDMHP---MRALFLIPRN---PPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLL 277 (282)
T ss_pred CcccchhHHHHHHHHHHhCCCCccccCH---HhhhhhHhhC---CCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHh
Confidence 8899999999999999999999976432 1112222221 111112346889999999999999999999998875
Q ss_pred H
Q 013092 243 R 243 (449)
Q Consensus 243 ~ 243 (449)
+
T Consensus 278 ~ 278 (282)
T cd06636 278 K 278 (282)
T ss_pred c
Confidence 3
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=267.74 Aligned_cols=210 Identities=17% Similarity=0.251 Sum_probs=170.3
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 96 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gi 96 (449)
...+.+|+.+++.+ +|+||+++++.+..++..|+||||+ +++|..++......+++..++.++.|++.+|+|||+.||
T Consensus 53 ~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i 131 (292)
T cd06644 53 LEDYMVEIEILATC-NHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKI 131 (292)
T ss_pred HHHHHHHHHHHHhC-CCCcEeeeEEEEEeCCeEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCe
Confidence 45688899999999 8999999999999999999999999 899988886555679999999999999999999999999
Q ss_pred eecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhh-----CCCCChhhHHHHH
Q 013092 97 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHL-----GIEQSRRDDLESL 171 (449)
Q Consensus 97 vHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~-----~~~~s~~~DiwSl 171 (449)
+||||||+||++ +.++.++|+|||++........ ......++..|+|||++. ...++.++|+|||
T Consensus 132 ~H~dlkp~Nili---~~~~~~kl~dfg~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~sl 201 (292)
T cd06644 132 IHRDLKAGNVLL---TLDGDIKLADFGVSAKNVKTLQ-------RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSL 201 (292)
T ss_pred eecCCCcceEEE---cCCCCEEEccCccceecccccc-------ccceecCCccccCceeeccccccCCCCCchhhhHhH
Confidence 999999999999 5788999999999876433211 123456889999999985 3456889999999
Q ss_pred HHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 172 GYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 172 G~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
||++|+|++|..||..... .+.+.++..... ........++.++.++|..||..+|++||++.++++
T Consensus 202 G~il~el~~g~~p~~~~~~---~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 202 GITLIEMAQIEPPHHELNP---MRVLLKIAKSEP--PTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred HHHHHHHhcCCCCCccccH---HHHHHHHhcCCC--ccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 9999999999999976432 233333322211 111223467889999999999999999999887753
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=265.22 Aligned_cols=207 Identities=19% Similarity=0.288 Sum_probs=173.2
Q ss_pred ChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 013092 17 KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 95 (449)
Q Consensus 17 ~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~g 95 (449)
....+.+|+++++.+ +|+||+++.+.+.++...|+||||+ +++|.+++.. ..+++..++.++.|++.||.|||+.+
T Consensus 42 ~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lh~~~ 118 (274)
T cd06609 42 EIEDIQQEIQFLSQC-RSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKP--GKLDETYIAFILREVLLGLEYLHEEG 118 (274)
T ss_pred HHHHHHHHHHHHHHc-CCCCeeeeeEEEEECCeEEEEEEeeCCCcHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 345688999999999 7999999999999999999999999 8999999984 37899999999999999999999999
Q ss_pred ceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHHH
Q 013092 96 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVL 175 (449)
Q Consensus 96 ivHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il 175 (449)
++|+||+|+||++ +.++.++|+|||+++.+..... ......+++.|++||++.+..++.++|||||||++
T Consensus 119 i~h~dl~p~ni~i---~~~~~~~l~d~g~~~~~~~~~~-------~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il 188 (274)
T cd06609 119 KIHRDIKAANILL---SEEGDVKLADFGVSGQLTSTMS-------KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITA 188 (274)
T ss_pred cccCCCCHHHEEE---CCCCCEEEcccccceeeccccc-------ccccccCCccccChhhhccCCCCchhhHHHHHHHH
Confidence 9999999999999 5788999999999988765321 12345688899999999998899999999999999
Q ss_pred HHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcC-CcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 176 MYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRG-YPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 176 ~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~-~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
|+|++|..||..... .+....+..... +.+... ++.++.+++..||..+|++||+++++..
T Consensus 189 ~~l~tg~~p~~~~~~---~~~~~~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 189 IELAKGEPPLSDLHP---MRVLFLIPKNNP----PSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred HHHHhCCCCcccCch---HHHHHHhhhcCC----CCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 999999999976432 222222222211 112223 8899999999999999999999887754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=260.43 Aligned_cols=211 Identities=24% Similarity=0.352 Sum_probs=175.2
Q ss_pred ChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCC-CCHHHHHHHHHHHHHHHHHHHHC
Q 013092 17 KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRK-LSLKTVLMLADQMINRVEFVHSK 94 (449)
Q Consensus 17 ~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~-ls~~~~~~i~~qi~~aL~yLH~~ 94 (449)
....+..|+.+++.+ +|+||+++++.+.+.+..|++|||+ +++|.+++...... +++..+..++.|++.||+|||+.
T Consensus 44 ~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~ 122 (258)
T smart00219 44 QIEEFLREARIMRKL-DHPNIVKLLGVCTEEEPLMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK 122 (258)
T ss_pred HHHHHHHHHHHHHhc-CCCchheEEEEEcCCCeeEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcC
Confidence 456789999999999 9999999999999999999999999 99999999753333 99999999999999999999999
Q ss_pred CceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHH
Q 013092 95 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYV 174 (449)
Q Consensus 95 givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~i 174 (449)
|++|+||||+||++ +.++.++|+|||+++......... . ....++..|++||.+.+..++.++|||||||+
T Consensus 123 ~~~h~dl~~~nil~---~~~~~~~l~dfg~~~~~~~~~~~~-----~-~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i 193 (258)
T smart00219 123 NFIHRDLAARNCLV---GENLVVKISDFGLSRDLYDDDYYK-----K-KGGKLPIRWMAPESLKDGKFTSKSDVWSFGVL 193 (258)
T ss_pred CeeecccccceEEE---ccCCeEEEcccCCceecccccccc-----c-ccCCCcccccChHHhccCCCCcchhHHHHHHH
Confidence 99999999999999 577899999999998776542211 1 12237789999999988889999999999999
Q ss_pred HHHHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHH
Q 013092 175 LMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRI 244 (449)
Q Consensus 175 l~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~ 244 (449)
+|+|++ |..||...+ ....+..+...... .....++.++.+++.+||..+|++||++.++++.
T Consensus 194 ~~~l~~~g~~p~~~~~---~~~~~~~~~~~~~~----~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 257 (258)
T smart00219 194 LWEIFTLGESPYPGMS---NEEVLEYLKKGYRL----PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEI 257 (258)
T ss_pred HHHHHhCCCCCCCCCC---HHHHHHHHhcCCCC----CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhh
Confidence 999998 889997633 23334444333222 2234589999999999999999999999988765
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=264.08 Aligned_cols=217 Identities=18% Similarity=0.223 Sum_probs=174.6
Q ss_pred EEEEEeeeccc-CCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHH
Q 013092 4 ILTVFSVQENV-KTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLA 81 (449)
Q Consensus 4 aikV~~k~~~~-~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~ 81 (449)
++|+..+.... ......+..|+++++.+ +|+||+++++.+.++...|+||||+ +++|.+++.. ...++...+..++
T Consensus 22 ~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~ 99 (262)
T cd05572 22 ALKCVKKRHIVETGQQEHIFSEKEILEEC-NHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRD-RGLFDEYTARFYI 99 (262)
T ss_pred EEEEEehhcchhhhHHHHHHHHHHHHHhC-CCCCEeeeeeeEEcCCccEEEEecCCCCcHHHHHhh-cCCCCHHHHHHHH
Confidence 44444433322 23345689999999999 8999999999999999999999999 9999999975 3568999999999
Q ss_pred HHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCC
Q 013092 82 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIE 161 (449)
Q Consensus 82 ~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~ 161 (449)
.|++.||+|||++|++|+||||+||++ +.++.++|+|||+++....... .....++..|++||.+.+..
T Consensus 100 ~~i~~~l~~lH~~~~~h~dl~~~nilv---~~~~~~~l~df~~~~~~~~~~~--------~~~~~~~~~~~~PE~~~~~~ 168 (262)
T cd05572 100 ACVVLAFEYLHNRGIIYRDLKPENLLL---DSNGYVKLVDFGFAKKLKSGQK--------TWTFCGTPEYVAPEIILNKG 168 (262)
T ss_pred HHHHHHHHHHhhCCcccCCCCHHHEEE---cCCCCEEEeeCCcccccCcccc--------cccccCCcCccChhHhcCCC
Confidence 999999999999999999999999999 5788999999999987654321 12346889999999998888
Q ss_pred CChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCC
Q 013092 162 QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPD 237 (449)
Q Consensus 162 ~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt 237 (449)
++.++|+||||+++|+|++|..||..... +..+.+..+....... ..+..++.++.++|..||..+|++||+
T Consensus 169 ~~~~~Di~slG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~~p~~R~~ 240 (262)
T cd05572 169 YDFSVDYWSLGILLYELLTGRPPFGEDDE-DPMEIYNDILKGNGKL---EFPNYIDKAAKDLIKQLLRRNPEERLG 240 (262)
T ss_pred CCChhhhhhhHHHHHHHHhCCCCcCCCCC-CHHHHHHHHhccCCCC---CCCcccCHHHHHHHHHHccCChhhCcC
Confidence 99999999999999999999999987543 2233333333211111 123345889999999999999999999
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-33 Score=268.68 Aligned_cols=206 Identities=20% Similarity=0.274 Sum_probs=171.6
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 96 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gi 96 (449)
...+.+|+++++.+ +|+||+++++.+..+...|+||||+ +++|.+++. ...+++..+..++.|++.||.|||++|+
T Consensus 46 ~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~i 122 (277)
T cd06642 46 IEDIQQEITVLSQC-DSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLK--PGPLEETYIATILREILKGLDYLHSERK 122 (277)
T ss_pred HHHHHHHHHHHHcC-CCCccHhhhcccccCCceEEEEEccCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhcCCe
Confidence 34688999999999 8999999999999999999999999 899999887 4578999999999999999999999999
Q ss_pred eecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHHHH
Q 013092 97 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLM 176 (449)
Q Consensus 97 vHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il~ 176 (449)
+|+||+|+||++ +.++.++|+|||++..+..... ......|+..|++||++.+..++.++|+|||||++|
T Consensus 123 vH~dl~p~ni~i---~~~~~~~l~dfg~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ 192 (277)
T cd06642 123 IHRDIKAANVLL---SEQGDVKLADFGVAGQLTDTQI-------KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAI 192 (277)
T ss_pred eccCCChheEEE---eCCCCEEEccccccccccCcch-------hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHH
Confidence 999999999999 4778899999999976543221 112346888999999999988999999999999999
Q ss_pred HHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 177 YFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 177 elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
+|++|..||....... ....+.... ...+...++.++.++|..||..+|++||++.++..
T Consensus 193 el~tg~~p~~~~~~~~---~~~~~~~~~----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06642 193 ELAKGEPPNSDLHPMR---VLFLIPKNS----PPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLK 252 (277)
T ss_pred HHHhCCCCCcccchhh---HHhhhhcCC----CCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 9999999997644322 111111111 11233457889999999999999999999988865
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=270.07 Aligned_cols=212 Identities=21% Similarity=0.274 Sum_probs=169.6
Q ss_pred ChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHC
Q 013092 17 KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSK 94 (449)
Q Consensus 17 ~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~-~~~ls~~~~~~i~~qi~~aL~yLH~~ 94 (449)
....+..|++++..+ +|+||+++++.+.++...|+||||+ |++|.+++... ...+++..++.++.|++.||+|||+.
T Consensus 44 ~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~ 122 (316)
T cd05574 44 KVKRVLTEQEILATL-DHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLL 122 (316)
T ss_pred HHHHHHHHHHHHHhC-CCCCchhheeeeecCCEEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHC
Confidence 345688999999999 7999999999999999999999999 99999998753 35689999999999999999999999
Q ss_pred CceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCccc----------------------ccccCCCCccCcccc
Q 013092 95 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHI----------------------PYRENKNLTGTARYA 152 (449)
Q Consensus 95 givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~----------------------~~~~~~~~~gT~~Y~ 152 (449)
|++|+||||+||++ +.++.++|+|||++............ .........||..|+
T Consensus 123 ~i~H~dlkp~Nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~ 199 (316)
T cd05574 123 GIVYRDLKPENILL---HESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYI 199 (316)
T ss_pred CeeccCCChHHeEE---cCCCCEEEeecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCc
Confidence 99999999999999 57789999999998765332111000 000112457899999
Q ss_pred chhhhhCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCC
Q 013092 153 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRF 232 (449)
Q Consensus 153 aPE~~~~~~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p 232 (449)
|||++.+..++.++||||||+++|+|++|..||.+... ...+..+....... . ....++.++.++|..||..+|
T Consensus 200 aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~---~~~~~~~~~~~~~~--~-~~~~~~~~~~~li~~~l~~~p 273 (316)
T cd05574 200 APEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR---DETFSNILKKEVTF--P-GSPPVSSSARDLIRKLLVKDP 273 (316)
T ss_pred CHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch---HHHHHHHhcCCccC--C-CccccCHHHHHHHHHHccCCH
Confidence 99999998899999999999999999999999976433 23333333322211 1 112268999999999999999
Q ss_pred CCCCCH
Q 013092 233 DDKPDY 238 (449)
Q Consensus 233 ~~RPt~ 238 (449)
++||+.
T Consensus 274 ~~R~s~ 279 (316)
T cd05574 274 SKRLGS 279 (316)
T ss_pred hHCCCc
Confidence 999993
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-32 Score=265.34 Aligned_cols=215 Identities=19% Similarity=0.205 Sum_probs=168.0
Q ss_pred ChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCE-----EEEEEecCCCCHHHHHHHc----CCCCCHHHHHHHHHHHHHH
Q 013092 17 KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDY-----NVLVMDLLGPSLEDLFNFC----SRKLSLKTVLMLADQMINR 87 (449)
Q Consensus 17 ~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~-----~~lVmE~~g~sL~~ll~~~----~~~ls~~~~~~i~~qi~~a 87 (449)
....+.+|+.+++.+.+|+||+++++++...+. .|+||||+.++|.+++... ...+++..++.++.||+.|
T Consensus 43 ~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~ 122 (295)
T cd07837 43 IPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKG 122 (295)
T ss_pred CchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHH
Confidence 346788999999999888999999998887665 8999999966899988643 2358999999999999999
Q ss_pred HHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhC-CCCChhh
Q 013092 88 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRD 166 (449)
Q Consensus 88 L~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~-~~~s~~~ 166 (449)
|.|||++||+||||||+||+++ ..++.++|+|||+++.+..... ......+++.|+|||.+.+ ..++.++
T Consensus 123 L~~LH~~~i~H~dl~~~nil~~--~~~~~~kl~dfg~~~~~~~~~~-------~~~~~~~~~~~~aPE~~~~~~~~~~~~ 193 (295)
T cd07837 123 VAHCHKHGVMHRDLKPQNLLVD--KQKGLLKIADLGLGRAFSIPVK-------SYTHEIVTLWYRAPEVLLGSTHYSTPV 193 (295)
T ss_pred HHHHHHCCeeecCCChHHEEEe--cCCCeEEEeecccceecCCCcc-------ccCCcccccCCCChHHhhCCCCCCchH
Confidence 9999999999999999999994 2278999999999986543211 1122356889999999875 4578999
Q ss_pred HHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhc-----------------------ccchHHHhhcCCcHHHHHH
Q 013092 167 DLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK-----------------------VSTSIEALCRGYPTEFASY 223 (449)
Q Consensus 167 DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~-----------------------~~~~~~~l~~~~p~el~~l 223 (449)
||||||+++|+|++|..||.+.... ..+.++.... ....+....+.++.++.++
T Consensus 194 Di~slG~~l~~l~~g~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (295)
T cd07837 194 DIWSVGCIFAEMSRKQPLFPGDSEL---QQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDL 270 (295)
T ss_pred HHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHH
Confidence 9999999999999999999874332 2222221110 0111222335688999999
Q ss_pred HHHHhcCCCCCCCCHHHHHH
Q 013092 224 FHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 224 i~~cl~~~p~~RPt~~~l~~ 243 (449)
|..||..+|.+||++.+++.
T Consensus 271 i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 271 LQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred HHHHccCChhhcCCHHHHhc
Confidence 99999999999999877753
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-32 Score=267.42 Aligned_cols=209 Identities=20% Similarity=0.294 Sum_probs=172.3
Q ss_pred ChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 013092 17 KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 95 (449)
Q Consensus 17 ~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~g 95 (449)
....+.+|+++++.+ +|+||+.+++.+..++..|+||||+ +++|.+++.. ..+++..++.++.|++.||+|||+.|
T Consensus 59 ~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~~ 135 (296)
T cd06655 59 KKELIINEILVMKEL-KNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTE--TCMDEAQIAAVCRECLQALEFLHANQ 135 (296)
T ss_pred hHHHHHHHHHHHHhc-CCCceeeeeeeEecCceEEEEEEecCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 455688999999999 8999999999999999999999999 9999999873 46899999999999999999999999
Q ss_pred ceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHHH
Q 013092 96 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVL 175 (449)
Q Consensus 96 ivHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il 175 (449)
++|+||||+||++ +.++.++|+|||++........ ......++..|+|||.+.+..++.++|||||||++
T Consensus 136 i~H~dL~p~Nili---~~~~~~kl~dfg~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil 205 (296)
T cd06655 136 VIHRDIKSDNVLL---GMDGSVKLTDFGFCAQITPEQS-------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMA 205 (296)
T ss_pred cccCCCCHHHEEE---CCCCCEEEccCccchhcccccc-------cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHH
Confidence 9999999999999 5788999999999876543321 11234688999999999988899999999999999
Q ss_pred HHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 176 MYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 176 ~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
|+|++|..||..... ......+.... .........++.++.++|.+||..+|++||++.+|..
T Consensus 206 ~~lltg~~pf~~~~~---~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 206 IEMVEGEPPYLNENP---LRALYLIATNG--TPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred HHHHhCCCCCCCCCH---HHHHHHHHhcC--CcccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 999999999977433 22222222111 1111223567899999999999999999999888754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=286.88 Aligned_cols=219 Identities=21% Similarity=0.262 Sum_probs=185.1
Q ss_pred cEEEEEeeecccCCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHH
Q 013092 3 EILTVFSVQENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLA 81 (449)
Q Consensus 3 ~aikV~~k~~~~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~ 81 (449)
+|||++.|........+.+.+|+++|+.| +|||||+++.+......+|+||||+ ++.+++++.+ .+++.+.++..++
T Consensus 84 VaiK~idkt~ln~~~~~k~~rev~imk~l-~HPnIvkl~~v~~t~~~lylV~eya~~ge~~~yl~~-~gr~~e~~ar~~F 161 (596)
T KOG0586|consen 84 VAIKIIDKTQLNPSKRQKLGREVDIMKSL-NHPNIVKLFSVIETEATLYLVMEYASGGELFDYLVK-HGRMKEKEARAKF 161 (596)
T ss_pred EEEEEehhcccChHHHHHHHHHHHHHHhc-CCcceeeeeeeeeecceeEEEEEeccCchhHHHHHh-cccchhhhhhhhh
Confidence 56777777666666666789999999999 9999999999999999999999999 9999999987 4556679999999
Q ss_pred HHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCC
Q 013092 82 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIE 161 (449)
Q Consensus 82 ~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~ 161 (449)
.|++.|++|||+++|||||||.+|+|| +.+..+||+|||++..+..... ..+++|++.|+|||++.+.+
T Consensus 162 ~q~vsaveYcH~k~ivHrdLk~eNilL---~~~mnikIaDfgfS~~~~~~~~--------lqt~cgsppyAaPEl~~g~~ 230 (596)
T KOG0586|consen 162 RQIVSAVEYCHSKNIVHRDLKAENILL---DENMNIKIADFGFSTFFDYGLM--------LQTFCGSPPYAAPELFNGKK 230 (596)
T ss_pred HHHHHHHHHHhhcceeccccchhhccc---ccccceeeeccccceeeccccc--------ccccCCCCCccChHhhcCcc
Confidence 999999999999999999999999999 6778899999999988875433 35779999999999999988
Q ss_pred C-ChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHH
Q 013092 162 Q-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAY 240 (449)
Q Consensus 162 ~-s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~ 240 (449)
| ++.+|+||+|++||-|+.|.+||.+.+- ...-.++...++. ++-.++.++.++|++++-++|.+|++.++
T Consensus 231 y~gpe~D~Wslgvvly~LV~GsLPFDG~~l---k~Lr~rvl~gk~r-----Ip~~ms~dce~lLrk~lvl~Pskr~~~dq 302 (596)
T KOG0586|consen 231 YDGPEVDIWSLGVVLYALVEGSLPFDGQNL---KELRPRVLRGKYR-----IPFYMSCDCEDLLRKFLVLNPSKRGPCDQ 302 (596)
T ss_pred cCCcceehhhhhhhheeeeecccccCCccc---ccccchheeeeec-----ccceeechhHHHHHHhhccCccccCCHHH
Confidence 7 7899999999999999999999987432 2222333333332 22235789999999999999999999887
Q ss_pred HH
Q 013092 241 LK 242 (449)
Q Consensus 241 l~ 242 (449)
|.
T Consensus 303 im 304 (596)
T KOG0586|consen 303 IM 304 (596)
T ss_pred hh
Confidence 74
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=261.00 Aligned_cols=210 Identities=19% Similarity=0.192 Sum_probs=175.2
Q ss_pred CChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHH
Q 013092 16 TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHS 93 (449)
Q Consensus 16 ~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~-~~~ls~~~~~~i~~qi~~aL~yLH~ 93 (449)
....++.+|+.+++.+ +|+||+++.+++.+.++.|+||||+ +++|.+++... ...+++..++.++.|++.||.|||+
T Consensus 41 ~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~ 119 (256)
T cd08218 41 KEREESRKEVAVLSNM-KHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHD 119 (256)
T ss_pred HHHHHHHHHHHHHHhC-CCCCeeeeEeeecCCCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 3445789999999999 8999999999999999999999999 99999998753 3358999999999999999999999
Q ss_pred CCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHH
Q 013092 94 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGY 173 (449)
Q Consensus 94 ~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~ 173 (449)
+|++|+||+|+||++ +.++.++|+|||++..+...... .....|++.|+|||++.+..++.++|+|||||
T Consensus 120 ~~i~h~~l~~~nil~---~~~~~~~l~d~~~~~~~~~~~~~-------~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~ 189 (256)
T cd08218 120 RKILHRDIKSQNIFL---TKDGTIKLGDFGIARVLNSTVEL-------ARTCIGTPYYLSPEICENRPYNNKSDIWALGC 189 (256)
T ss_pred CCEecCCCCHHHEEE---cCCCCEEEeeccceeecCcchhh-------hhhccCCccccCHHHhCCCCCCCccchhHHHH
Confidence 999999999999999 57788999999999876543211 12346888999999999888999999999999
Q ss_pred HHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 174 VLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 174 il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
++|+|++|..||... .....+..+..... ......++.++.++|..||+.+|++||++.++++
T Consensus 190 i~~~l~~g~~~~~~~---~~~~~~~~~~~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 190 VLYEMCTLKHAFEAG---NMKNLVLKIIRGSY----PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred HHHHHHcCCCCccCC---CHHHHHHHHhcCCC----CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 999999999999753 33334444433322 2234567899999999999999999999888764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=265.30 Aligned_cols=211 Identities=19% Similarity=0.284 Sum_probs=172.1
Q ss_pred ChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 013092 17 KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 95 (449)
Q Consensus 17 ~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~g 95 (449)
....+..|+++++.+ +|+||+++++.+......||||||+ +++|.+++......+++..++.++.|++.||.|||++|
T Consensus 45 ~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~ 123 (280)
T cd06611 45 ELEDFMVEIDILSEC-KHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHK 123 (280)
T ss_pred HHHHHHHHHHHHHhC-CCCceeEEEEEEecCCeEEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 345688999999999 6999999999999999999999999 89999999866667999999999999999999999999
Q ss_pred ceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhh-----CCCCChhhHHHH
Q 013092 96 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHL-----GIEQSRRDDLES 170 (449)
Q Consensus 96 ivHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~-----~~~~s~~~DiwS 170 (449)
|+|+||||+||++ +.++.++|+|||++........ ......+++.|++||++. ...++.++|+||
T Consensus 124 i~h~dl~p~nili---~~~~~~~l~d~g~~~~~~~~~~-------~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~s 193 (280)
T cd06611 124 VIHRDLKAGNILL---TLDGDVKLADFGVSAKNKSTLQ-------KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWS 193 (280)
T ss_pred cccCCCChhhEEE---CCCCCEEEccCccchhhccccc-------ccceeecchhhcCHHHHhhcccCCCCCCccccHHH
Confidence 9999999999999 5788999999999876543221 123456899999999985 344678999999
Q ss_pred HHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 171 LGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 171 lG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
|||++|+|++|..||..... .+.+.++...... .......++.++.++|..||+.+|++||++.++++
T Consensus 194 lG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (280)
T cd06611 194 LGITLIELAQMEPPHHELNP---MRVLLKILKSEPP--TLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLK 261 (280)
T ss_pred HHHHHHHHHhCCCCcccCCH---HHHHHHHhcCCCC--CcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhc
Confidence 99999999999999976532 2333333322111 11123457899999999999999999999887743
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=261.82 Aligned_cols=210 Identities=24% Similarity=0.315 Sum_probs=173.6
Q ss_pred CChhHHHHHHHHHHHhcCCCCCceEEEEeE--eCCEEEEEEecC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHH
Q 013092 16 TKHPQLLYESKLYRILQGGTGIPNVRWFGV--EGDYNVLVMDLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVE 89 (449)
Q Consensus 16 ~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~--~~~~~~lVmE~~-g~sL~~ll~~~---~~~ls~~~~~~i~~qi~~aL~ 89 (449)
.....+..|+++++.+ +|+||+++++.+. .+...|++|||+ +++|.+++... ..++++..++.++.||+.||+
T Consensus 41 ~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~ 119 (265)
T cd08217 41 KEKQQLVSEVNILREL-KHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALY 119 (265)
T ss_pred HHHHHHHHHHHHHHhc-CCCccceeeeeeecCCCCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHH
Confidence 3455688999999999 9999999988775 456789999999 89999999754 457899999999999999999
Q ss_pred HHH-----HCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCCh
Q 013092 90 FVH-----SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSR 164 (449)
Q Consensus 90 yLH-----~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~ 164 (449)
||| +.+|+|+||||+||++ +..+.++|+|||++......... .....+++.|++||++.+..++.
T Consensus 120 ~lH~~~~~~~~i~h~dl~p~nili---~~~~~~kl~d~g~~~~~~~~~~~-------~~~~~~~~~~~~pE~~~~~~~~~ 189 (265)
T cd08217 120 ECHNRSDPGNTVLHRDLKPANIFL---DANNNVKLGDFGLAKILGHDSSF-------AKTYVGTPYYMSPEQLNHMSYDE 189 (265)
T ss_pred HHhcCccccCcceecCCCHHHEEE---ecCCCEEEecccccccccCCccc-------ccccccCCCccChhhhcCCCCCc
Confidence 999 8999999999999999 57789999999999876543211 12346899999999999888999
Q ss_pred hhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 165 RDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 165 ~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
++|+||||+++|+|++|..||.... .......+.... ...+...++.++.+++..|+..+|++||++.+|++
T Consensus 190 ~~Dv~slG~il~~l~~g~~p~~~~~---~~~~~~~~~~~~----~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~ 261 (265)
T cd08217 190 KSDIWSLGCLIYELCALSPPFTARN---QLQLASKIKEGK----FRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ 261 (265)
T ss_pred hhHHHHHHHHHHHHHHCCCcccCcC---HHHHHHHHhcCC----CCCCccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 9999999999999999999998743 223333333322 22344578899999999999999999999988865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=263.80 Aligned_cols=211 Identities=20% Similarity=0.345 Sum_probs=173.3
Q ss_pred CChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-
Q 013092 16 TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS- 93 (449)
Q Consensus 16 ~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~- 93 (449)
....++.+|+++++.+ .|+||+++++.+...+..||||||+ +++|.+++......+++..+..++.|++.||+|||+
T Consensus 41 ~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~ 119 (265)
T cd06605 41 AIQKQILRELDILHKC-NSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEK 119 (265)
T ss_pred HHHHHHHHHHHHHHHC-CCCchhhhheeeecCCEEEEEEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCC
Confidence 3445689999999999 6999999999999999999999999 799999998655679999999999999999999999
Q ss_pred CCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHH
Q 013092 94 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGY 173 (449)
Q Consensus 94 ~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~ 173 (449)
.|++|+||||+||++ +..+.++|+|||++........ ....++..|++||.+.+..++.++||||||+
T Consensus 120 ~~i~H~dl~~~ni~~---~~~~~~~l~d~g~~~~~~~~~~---------~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ 187 (265)
T cd06605 120 HKIIHRDVKPSNILV---NSRGQIKLCDFGVSGQLVNSLA---------KTFVGTSSYMAPERIQGNDYSVKSDIWSLGL 187 (265)
T ss_pred CCeecCCCCHHHEEE---CCCCCEEEeecccchhhHHHHh---------hcccCChhccCHHHHcCCCCCchhhHHHHHH
Confidence 999999999999999 5788999999999876543221 1257889999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCCc--CCHHHHHHHHHhhcccchHHHhhcC-CcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 174 VLMYFLRGSLPWQGLKA--GTKKQKYEKISEKKVSTSIEALCRG-YPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 174 il~elltG~~Pf~~~~~--~~~~~~~~~i~~~~~~~~~~~l~~~-~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
++|+|++|..||..... ....+....+..... ..+... ++.++.++|..||..+|++||++.+|..
T Consensus 188 ~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 188 SLIELATGRFPYPPENDPPDGIFELLQYIVNEPP----PRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred HHHHHHhCCCCCCccccccccHHHHHHHHhcCCC----CCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 99999999999976431 112222222222211 112222 7889999999999999999999888753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-32 Score=263.22 Aligned_cols=212 Identities=17% Similarity=0.302 Sum_probs=173.8
Q ss_pred hHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcC--------CCCCHHHHHHHHHHHHHHHH
Q 013092 19 PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCS--------RKLSLKTVLMLADQMINRVE 89 (449)
Q Consensus 19 ~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~--------~~ls~~~~~~i~~qi~~aL~ 89 (449)
..+..|+++++.+ +|+||+++++++.+....|+||||+ +++|.+++.... ..+++..++.++.|++.||.
T Consensus 53 ~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~ 131 (275)
T cd05046 53 SEFRRELDMFRKL-SHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMD 131 (275)
T ss_pred HHHHHHHHHHHhc-CCcceeeeEEEECCCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHH
Confidence 5689999999999 8999999999999999999999999 899999997532 15899999999999999999
Q ss_pred HHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHH
Q 013092 90 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLE 169 (449)
Q Consensus 90 yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~Diw 169 (449)
|||+.||+||||||+||++ +..+.++|+|||+++....... .......++..|++||.+.+..++.++|||
T Consensus 132 ~LH~~~i~H~dlkp~Nili---~~~~~~~l~~~~~~~~~~~~~~------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~ 202 (275)
T cd05046 132 HLSNARFVHRDLAARNCLV---SSQREVKVSLLSLSKDVYNSEY------YKLRNALIPLRWLAPEAVQEDDFSTKSDVW 202 (275)
T ss_pred HhhhcCcccCcCccceEEE---eCCCcEEEcccccccccCcccc------cccCCceeEEeecChhhhccCCCCchhhHH
Confidence 9999999999999999999 5778999999999875432211 112334567889999999988899999999
Q ss_pred HHHHHHHHHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 013092 170 SLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFR 246 (449)
Q Consensus 170 SlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~L~ 246 (449)
|||+++|+|++ |..||..... .+.+..+....... .....+|.++.+++.+||..+|++||++.++...|.
T Consensus 203 slG~~l~~l~~~~~~p~~~~~~---~~~~~~~~~~~~~~---~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 203 SFGVLMWEVFTQGELPFYGLSD---EEVLNRLQAGKLEL---PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred HHHHHHHHHHhCCCCCccccch---HHHHHHHHcCCcCC---CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 99999999998 8899976433 23333333222211 123468899999999999999999999999987764
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=272.35 Aligned_cols=219 Identities=13% Similarity=0.166 Sum_probs=165.7
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKS 95 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~-~~~ls~~~~~~i~~qi~~aL~yLH~~g 95 (449)
.+.+.+|+.+++.+ +||||+++++++..++..|+||||+ +++|.+++... ...+++..+..++.|++.||+|||++|
T Consensus 43 ~~~~~~e~~~~~~l-~h~niv~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ 121 (328)
T cd08226 43 LKALQNEVVLSHFF-RHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG 121 (328)
T ss_pred HHHHHHHHHHHHhC-CCCCcceEeeeEecCCceEEEEecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 45688999999888 8999999999999999999999999 89999998753 345899999999999999999999999
Q ss_pred ceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCC--CCChhhHHHHHHH
Q 013092 96 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI--EQSRRDDLESLGY 173 (449)
Q Consensus 96 ivHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~--~~s~~~DiwSlG~ 173 (449)
|+||||||+|||+ +..+.++++||+.+.............+.......++..|++||++.+. .++.++|||||||
T Consensus 122 ivHrDlkp~Nill---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~ 198 (328)
T cd08226 122 YIHRNIKASHILI---SGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGI 198 (328)
T ss_pred eecCCCCHHHEEE---eCCCcEEEechHHHhhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHH
Confidence 9999999999999 5778999999986644332221111111122233456789999999763 4789999999999
Q ss_pred HHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcc-------------------------------c----------chHHHh
Q 013092 174 VLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV-------------------------------S----------TSIEAL 212 (449)
Q Consensus 174 il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~-------------------------------~----------~~~~~l 212 (449)
++|+|++|..||....... .....+..... . ......
T Consensus 199 ~l~el~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (328)
T cd08226 199 TACELATGRVPFQDMLRTQ--MLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPS 276 (328)
T ss_pred HHHHHHhCCCCCCCcChHH--HHHHHhcCCCCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchh
Confidence 9999999999997753211 11111100000 0 000011
Q ss_pred hcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 013092 213 CRGYPTEFASYFHYCRSLRFDDKPDYAYLK 242 (449)
Q Consensus 213 ~~~~p~el~~li~~cl~~~p~~RPt~~~l~ 242 (449)
...++.++.+|+..||..||++||++.+++
T Consensus 277 ~~~~~~~~~~li~~~l~~dP~~Rpta~e~l 306 (328)
T cd08226 277 SKTFSPAFQNLVELCLQQDPEKRPSASSLL 306 (328)
T ss_pred hhhhhHHHHHHHHHHccCCcccCCCHHHHh
Confidence 234677899999999999999999988875
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=263.70 Aligned_cols=216 Identities=15% Similarity=0.288 Sum_probs=171.1
Q ss_pred ChhHHHHHHHHHHHhcCCCCCceEEEEeEeCC------EEEEEEecC-CCCHHHHHHHc-----CCCCCHHHHHHHHHHH
Q 013092 17 KHPQLLYESKLYRILQGGTGIPNVRWFGVEGD------YNVLVMDLL-GPSLEDLFNFC-----SRKLSLKTVLMLADQM 84 (449)
Q Consensus 17 ~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~------~~~lVmE~~-g~sL~~ll~~~-----~~~ls~~~~~~i~~qi 84 (449)
...++.+|+++++.+ +||||+++++++.... ..++++||+ +++|.+++... ...+++..++.++.|+
T Consensus 44 ~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i 122 (273)
T cd05074 44 DIEEFLREAACMKEF-DHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDI 122 (273)
T ss_pred HHHHHHHHHHHHhcC-CCCCcceEEEEEccCCCCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Confidence 344688999999999 8999999999886532 347899999 89998887422 1247899999999999
Q ss_pred HHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCCh
Q 013092 85 INRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSR 164 (449)
Q Consensus 85 ~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~ 164 (449)
+.||+|||++||+||||||+||++ +.++.+||+|||+++....... +.......+++.|++||.+....++.
T Consensus 123 ~~~l~~lH~~~i~H~dikp~nili---~~~~~~kl~dfg~~~~~~~~~~-----~~~~~~~~~~~~~~~pe~~~~~~~~~ 194 (273)
T cd05074 123 ASGMEYLSSKNFIHRDLAARNCML---NENMTVCVADFGLSKKIYSGDY-----YRQGCASKLPVKWLALESLADNVYTT 194 (273)
T ss_pred HHHHHHHHhCCEeecccchhhEEE---cCCCCEEECcccccccccCCcc-----eecCCCccCchhhcCHhHHhcCccch
Confidence 999999999999999999999999 5788999999999986643221 11122344567899999999888999
Q ss_pred hhHHHHHHHHHHHHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 165 RDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 165 ~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
++|||||||++|+|++ |..||.+.+. ...+..+...... .....++.++.+++..||+.+|++||++.++..
T Consensus 195 ~sDi~slG~il~el~~~g~~p~~~~~~---~~~~~~~~~~~~~----~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~ 267 (273)
T cd05074 195 HSDVWAFGVTMWEIMTRGQTPYAGVEN---SEIYNYLIKGNRL----KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRD 267 (273)
T ss_pred hhhhHHHHHHHHHHhhCCCCCCCCCCH---HHHHHHHHcCCcC----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 9999999999999998 8999976433 2233333322111 122457889999999999999999999999999
Q ss_pred HHHHH
Q 013092 244 IFRDL 248 (449)
Q Consensus 244 ~L~~~ 248 (449)
.|+.+
T Consensus 268 ~l~~~ 272 (273)
T cd05074 268 QLELI 272 (273)
T ss_pred HHHhh
Confidence 88765
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=265.39 Aligned_cols=212 Identities=19% Similarity=0.287 Sum_probs=167.8
Q ss_pred ChhHHHHHHHHHHHhcCCCCCceEEEEeE-----eCCEEEEEEecC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHH
Q 013092 17 KHPQLLYESKLYRILQGGTGIPNVRWFGV-----EGDYNVLVMDLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINR 87 (449)
Q Consensus 17 ~~~~~~~E~~il~~l~~hp~Iv~l~~~~~-----~~~~~~lVmE~~-g~sL~~ll~~~---~~~ls~~~~~~i~~qi~~a 87 (449)
...++..|+.+++.+.+|+||+++++++. .++..|+||||+ |++|.+++... ...+++..+..++.|++.|
T Consensus 57 ~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~ 136 (286)
T cd06638 57 IDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMG 136 (286)
T ss_pred hHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHH
Confidence 34678899999999988999999998874 456799999999 99999987532 3568899999999999999
Q ss_pred HHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhC-----CCC
Q 013092 88 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG-----IEQ 162 (449)
Q Consensus 88 L~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~-----~~~ 162 (449)
|.|||+.+|+||||||+||++ +..+.++|+|||+++.+..... ......|++.|+|||++.. ..+
T Consensus 137 l~~lH~~~i~H~dlkp~nili---~~~~~~kl~dfg~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~ 206 (286)
T cd06638 137 LQHLHVNKTIHRDVKGNNILL---TTEGGVKLVDFGVSAQLTSTRL-------RRNTSVGTPFWMAPEVIACEQQLDSTY 206 (286)
T ss_pred HHHHHhCCccccCCCHHhEEE---CCCCCEEEccCCceeecccCCC-------ccccccCCCcccChhhhchhhhccccc
Confidence 999999999999999999999 5678899999999987644321 1123468999999999853 447
Q ss_pred ChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 013092 163 SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 242 (449)
Q Consensus 163 s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~ 242 (449)
+.++|||||||++|+|++|..||...... ..+.++.... .........++.++.++|.+||+.+|++||++.+|+
T Consensus 207 ~~~~Dv~slGvi~~el~~g~~p~~~~~~~---~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell 281 (286)
T cd06638 207 DARCDVWSLGITAIELGDGDPPLADLHPM---RALFKIPRNP--PPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLL 281 (286)
T ss_pred cchhhhhhHHHHHHHHhcCCCCCCCCchh---HHHhhccccC--CCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 88999999999999999999999765331 1121211111 111112344678999999999999999999988876
Q ss_pred H
Q 013092 243 R 243 (449)
Q Consensus 243 ~ 243 (449)
+
T Consensus 282 ~ 282 (286)
T cd06638 282 Q 282 (286)
T ss_pred h
Confidence 5
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=271.09 Aligned_cols=209 Identities=17% Similarity=0.300 Sum_probs=171.3
Q ss_pred ChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 013092 17 KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 95 (449)
Q Consensus 17 ~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~g 95 (449)
....+.+|+.+++.+ +|+||+++++.+..+++.|+||||+ +++|.+++. ...+++..++.++.||+.||+|||++|
T Consensus 62 ~~~~~~~e~~~l~~l-~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~--~~~l~~~~~~~~~~qi~~~l~~LH~~~ 138 (292)
T cd06658 62 RRELLFNEVVIMRDY-HHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVT--HTRMNEEQIATVCLSVLRALSYLHNQG 138 (292)
T ss_pred HHHHHHHHHHHHHhC-CCCcHHHHHHheecCCeEEEEEeCCCCCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 345688999999999 8999999999999999999999999 889999886 456899999999999999999999999
Q ss_pred ceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHHH
Q 013092 96 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVL 175 (449)
Q Consensus 96 ivHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il 175 (449)
|+||||||+||++ +.++.++|+|||++........ ......|+..|+|||++.+..++.++||||||+++
T Consensus 139 ivH~dlkp~Nill---~~~~~~kL~dfg~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil 208 (292)
T cd06658 139 VIHRDIKSDSILL---TSDGRIKLSDFGFCAQVSKEVP-------KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMV 208 (292)
T ss_pred EeecCCCHHHEEE---cCCCCEEEccCcchhhcccccc-------cCceeecCccccCHHHHccCCCCchhhHHHHHHHH
Confidence 9999999999999 5778999999999876543221 12345689999999999988899999999999999
Q ss_pred HHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 176 MYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 176 ~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
|||++|..||..... .+.+..+... ..... .....++.++.+++..||..+|.+||++.++++
T Consensus 209 ~el~~g~~p~~~~~~---~~~~~~~~~~-~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 271 (292)
T cd06658 209 IEMIDGEPPYFNEPP---LQAMRRIRDN-LPPRV-KDSHKVSSVLRGFLDLMLVREPSQRATAQELLQ 271 (292)
T ss_pred HHHHhCCCCCCCCCH---HHHHHHHHhc-CCCcc-ccccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 999999999976432 2222222221 11111 112346889999999999999999999887764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=262.41 Aligned_cols=211 Identities=22% Similarity=0.314 Sum_probs=172.1
Q ss_pred hHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q 013092 19 PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFL 97 (449)
Q Consensus 19 ~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~giv 97 (449)
..+..|..++....+|+||+++++.+..++..|+||||+ +++|.+++.. ...+++..+..++.|++.||.|||+.+++
T Consensus 41 ~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~i~ 119 (260)
T cd05611 41 TNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKT-LGGLPEDWAKQYIAEVVLGVEDLHQRGII 119 (260)
T ss_pred HHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 345667666666559999999999999999999999999 9999999985 35689999999999999999999999999
Q ss_pred ecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHHHHH
Q 013092 98 HRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMY 177 (449)
Q Consensus 98 HRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il~e 177 (449)
|+||+|.||++ +..+.++|+|||+++.... .....++..|++||.+.+..++.++||||||+++|+
T Consensus 120 H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~-----------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~ 185 (260)
T cd05611 120 HRDIKPENLLI---DQTGHLKLTDFGLSRNGLE-----------NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFE 185 (260)
T ss_pred cCCCCHHHeEE---CCCCcEEEeecccceeccc-----------cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHH
Confidence 99999999999 5778999999999875433 123468889999999998888999999999999999
Q ss_pred HHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 013092 178 FLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDL 248 (449)
Q Consensus 178 lltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~L~~~ 248 (449)
|++|..||...+. .+.+..+....... .......++.++.+++.+||+.+|++||++..+.++|.+-
T Consensus 186 l~~g~~p~~~~~~---~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~ 252 (260)
T cd05611 186 FLFGYPPFHAETP---DAVFDNILSRRINW-PEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHP 252 (260)
T ss_pred HHHCCCCCCCCCH---HHHHHHHHhcccCC-CCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcCh
Confidence 9999999976432 33344433322211 1122346789999999999999999999877676665544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-33 Score=283.93 Aligned_cols=167 Identities=24% Similarity=0.306 Sum_probs=145.5
Q ss_pred ccCCChhHHHHHHHHHHHhcC-----CCCCceEEEEeEeCCEEEEEEecCCCCHHHHHHHcC-CCCCHHHHHHHHHHHHH
Q 013092 13 NVKTKHPQLLYESKLYRILQG-----GTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCS-RKLSLKTVLMLADQMIN 86 (449)
Q Consensus 13 ~~~~~~~~~~~E~~il~~l~~-----hp~Iv~l~~~~~~~~~~~lVmE~~g~sL~~ll~~~~-~~ls~~~~~~i~~qi~~ 86 (449)
+.+....+-..|++||..|.. .-|||.++++|...++.|||+|++..+|.++++..+ ..|+...+..|+.||+.
T Consensus 221 N~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciVfELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~ 300 (586)
T KOG0667|consen 221 NKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIVFELLSTNLYELLKNNKFRGLSLPLVRKFAQQILT 300 (586)
T ss_pred cChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeeeehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHH
Confidence 344567778899999999972 358999999999999999999999999999998642 45899999999999999
Q ss_pred HHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhh
Q 013092 87 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRD 166 (449)
Q Consensus 87 aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~ 166 (449)
||.+||+.||||+||||+||||..- ....|||+|||.+....... .+++-+..|.|||+++|.+|+.+.
T Consensus 301 ~L~~L~~l~IIHcDLKPENILL~~~-~r~~vKVIDFGSSc~~~q~v----------ytYiQSRfYRAPEVILGlpY~~~I 369 (586)
T KOG0667|consen 301 ALLFLHELGIIHCDLKPENILLKDP-KRSRIKVIDFGSSCFESQRV----------YTYIQSRFYRAPEVILGLPYDTAI 369 (586)
T ss_pred HHHHHHhCCeeeccCChhheeeccC-CcCceeEEecccccccCCcc----------eeeeeccccccchhhccCCCCCcc
Confidence 9999999999999999999999643 33489999999998655432 145678899999999999999999
Q ss_pred HHHHHHHHHHHHHhCCCCCCCCCc
Q 013092 167 DLESLGYVLMYFLRGSLPWQGLKA 190 (449)
Q Consensus 167 DiwSlG~il~elltG~~Pf~~~~~ 190 (449)
||||||||++||++|.+.|.|.+.
T Consensus 370 DmWSLGCIlAEL~tG~PLfpG~ne 393 (586)
T KOG0667|consen 370 DMWSLGCILAELFTGEPLFPGDNE 393 (586)
T ss_pred ceeehhhhHHhHhcCccccCCCCH
Confidence 999999999999999999998543
|
|
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-32 Score=262.32 Aligned_cols=212 Identities=21% Similarity=0.257 Sum_probs=168.9
Q ss_pred ChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCC--CHHHHHHHHHHHHHHHHHHHH
Q 013092 17 KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKL--SLKTVLMLADQMINRVEFVHS 93 (449)
Q Consensus 17 ~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~l--s~~~~~~i~~qi~~aL~yLH~ 93 (449)
..+.+.+|+.+++.+ .|+||+++++++..++..++||||+ +++|.+++......+ +...++.++.||+.||+|||+
T Consensus 48 ~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~ 126 (268)
T cd06624 48 YVQPLHEEIALHSYL-KHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHD 126 (268)
T ss_pred HHHHHHHHHHHHHhc-CCCCeeeeeeeeccCCEEEEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHH
Confidence 345688999999999 8999999999999999999999999 899999997543445 888899999999999999999
Q ss_pred CCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCC--CChhhHHHHH
Q 013092 94 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIE--QSRRDDLESL 171 (449)
Q Consensus 94 ~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~--~s~~~DiwSl 171 (449)
+||+||||||.||+++ ...+.++|+|||++........ ......|+..|+|||++.+.. ++.++|+|||
T Consensus 127 ~~i~h~dl~p~nil~~--~~~~~~~l~dfg~~~~~~~~~~-------~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~sl 197 (268)
T cd06624 127 NQIVHRDIKGDNVLVN--TYSGVVKISDFGTSKRLAGINP-------CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSL 197 (268)
T ss_pred CCEeecCCCHHHEEEc--CCCCeEEEecchhheecccCCC-------ccccCCCCccccChhhhccccccCCchhhhHHH
Confidence 9999999999999994 3367899999999876543221 112346889999999987643 7889999999
Q ss_pred HHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 172 GYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 172 G~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
|+++|+|++|..||....... ....+.. .......++..+++++.+++..||+.+|++||++.+|..
T Consensus 198 Gvvl~~l~~g~~p~~~~~~~~--~~~~~~~---~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 198 GCTIVEMATGKPPFIELGEPQ--AAMFKVG---MFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred HHHHHHHHhCCCCCccccChh--hhHhhhh---hhccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 999999999999997643211 1111111 111112234567889999999999999999999988754
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-32 Score=276.36 Aligned_cols=224 Identities=17% Similarity=0.214 Sum_probs=185.1
Q ss_pred EEEEEeeecccCC---ChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHH-cCCCCCHHHHH
Q 013092 4 ILTVFSVQENVKT---KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNF-CSRKLSLKTVL 78 (449)
Q Consensus 4 aikV~~k~~~~~~---~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~-~~~~ls~~~~~ 78 (449)
.|-|++|.-.... .-..|++|+.+|..| .|+|++.||+...+ ....||||++ +|+|.+-+.+ ....|......
T Consensus 138 ~V~VAVKclr~d~l~~~mddflrEas~M~~L-~H~hliRLyGvVl~-qp~mMV~ELaplGSLldrLrka~~~~llv~~Lc 215 (1039)
T KOG0199|consen 138 HVNVAVKCLRDDSLNAIMDDFLREASHMLKL-QHPHLIRLYGVVLD-QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLC 215 (1039)
T ss_pred EEeEEEEeccCCccchhHHHHHHHHHHHHhc-cCcceeEEeeeecc-chhhHHhhhcccchHHHHHhhccccceeHHHHH
Confidence 4455555443322 446799999999999 99999999999887 7789999999 9999999986 35568899999
Q ss_pred HHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhh
Q 013092 79 MLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHL 158 (449)
Q Consensus 79 ~i~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~ 158 (449)
.|+.||+.||.||..+++|||||-..|+|+ -....||||||||.+.+..+... |.......-...|+|||.+.
T Consensus 216 dya~QiA~aM~YLeskrlvHRDLAARNlll---asprtVKI~DFGLmRaLg~ned~----Yvm~p~rkvPfAWCaPEsLr 288 (1039)
T KOG0199|consen 216 DYAMQIAKAMQYLESKRLVHRDLAARNLLL---ASPRTVKICDFGLMRALGENEDM----YVMAPQRKVPFAWCAPESLR 288 (1039)
T ss_pred HHHHHHHHHHHHHhhhhhhhhhhhhhhhee---cccceeeeecccceeccCCCCcc----eEecCCCcCcccccCHhHhc
Confidence 999999999999999999999999999999 46889999999999988776543 22233444556899999999
Q ss_pred CCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCC
Q 013092 159 GIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPD 237 (449)
Q Consensus 159 ~~~~s~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt 237 (449)
...++.++|||+|||+||||++ |..||.+... .+++++|.++... .-++.||+++++++..||..+|+|||+
T Consensus 289 h~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g---~qIL~~iD~~erL----pRPk~csedIY~imk~cWah~paDRpt 361 (1039)
T KOG0199|consen 289 HRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG---IQILKNIDAGERL----PRPKYCSEDIYQIMKNCWAHNPADRPT 361 (1039)
T ss_pred cccccccchhhhhhhhHHhhhccCCCCCCCCCH---HHHHHhccccccC----CCCCCChHHHHHHHHHhccCCcccccc
Confidence 9999999999999999999998 9999999755 3445544432221 124679999999999999999999999
Q ss_pred HHHHHH
Q 013092 238 YAYLKR 243 (449)
Q Consensus 238 ~~~l~~ 243 (449)
|..|.+
T Consensus 362 Fsair~ 367 (1039)
T KOG0199|consen 362 FSAIRE 367 (1039)
T ss_pred HHHHHH
Confidence 999973
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-32 Score=295.62 Aligned_cols=224 Identities=25% Similarity=0.333 Sum_probs=174.9
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHc----------CCCCCHHHHHHHHHHHHH
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFC----------SRKLSLKTVLMLADQMIN 86 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~----------~~~ls~~~~~~i~~qi~~ 86 (449)
...+.+|++++..+ .||||+++++++.+++..|+||||+ |++|.+++... ...+++..++.++.||+.
T Consensus 46 ~~rflrEi~ILs~L-~HPNIVkl~~v~~d~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~ 124 (932)
T PRK13184 46 KKRFLREAKIAADL-IHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICA 124 (932)
T ss_pred HHHHHHHHHHHHhC-CCcCcCeEEEEEeeCCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHH
Confidence 45688999999999 8999999999999999999999999 99999998642 123567788999999999
Q ss_pred HHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCc-----------ccccccCCCCccCccccchh
Q 013092 87 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ-----------HIPYRENKNLTGTARYASMN 155 (449)
Q Consensus 87 aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~-----------~~~~~~~~~~~gT~~Y~aPE 155 (449)
||+|||++||+||||||+|||+ +.++.++|+|||+++......... ...........||+.|+|||
T Consensus 125 AL~yLHs~GIIHRDLKPeNILL---d~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE 201 (932)
T PRK13184 125 TIEYVHSKGVLHRDLKPDNILL---GLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPE 201 (932)
T ss_pred HHHHHHHCCccccCCchheEEE---cCCCCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHH
Confidence 9999999999999999999999 578899999999998762211000 00011223467999999999
Q ss_pred hhhCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHH-HhhcCCcHHHHHHHHHHhcCCCCC
Q 013092 156 THLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE-ALCRGYPTEFASYFHYCRSLRFDD 234 (449)
Q Consensus 156 ~~~~~~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~-~l~~~~p~el~~li~~cl~~~p~~ 234 (449)
++.+..++.++|||||||++|||++|..||........ .+. .....+.. .....+|+.+.+++.+|+..+|++
T Consensus 202 ~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki--~~~----~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~k 275 (932)
T PRK13184 202 RLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKI--SYR----DVILSPIEVAPYREIPPFLSQIAMKALAVDPAE 275 (932)
T ss_pred HhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhh--hhh----hhccChhhccccccCCHHHHHHHHHHccCChhh
Confidence 99999999999999999999999999999976332111 111 11111111 112468899999999999999999
Q ss_pred CC-CHHHHHHHHHHHHHH
Q 013092 235 KP-DYAYLKRIFRDLFIR 251 (449)
Q Consensus 235 RP-t~~~l~~~L~~~~~~ 251 (449)
|| +++++.+.|+..+..
T Consensus 276 R~ss~eeLl~~Le~~lq~ 293 (932)
T PRK13184 276 RYSSVQELKQDLEPHLQG 293 (932)
T ss_pred CcCHHHHHHHHHHHHHhc
Confidence 97 457777777777653
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=284.33 Aligned_cols=237 Identities=20% Similarity=0.238 Sum_probs=183.7
Q ss_pred CCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH
Q 013092 15 KTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 93 (449)
Q Consensus 15 ~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~ 93 (449)
+.+...++.|.+||... +.+.||+|++.|++++.+|+||||+ ||++-.|+-+ -+-|.++.+.+++.++.+|++++|.
T Consensus 670 rnQvaHVKAERDILAEA-Dn~WVVrLyySFQDkdnLYFVMdYIPGGDmMSLLIr-mgIFeE~LARFYIAEltcAiesVHk 747 (1034)
T KOG0608|consen 670 RNQVAHVKAERDILAEA-DNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIR-MGIFEEDLARFYIAELTCAIESVHK 747 (1034)
T ss_pred hhhhhhhhhhhhhHhhc-CCcceEEEEEEeccCCceEEEEeccCCccHHHHHHH-hccCHHHHHHHHHHHHHHHHHHHHh
Confidence 34556688999999998 9999999999999999999999999 9999999875 4579999999999999999999999
Q ss_pred CCceecCCCCCcEEEeecCCCCeEEEeecCcceeec--------CCCCCccc-------------------c--------
Q 013092 94 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR--------DTSTHQHI-------------------P-------- 138 (449)
Q Consensus 94 ~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~--------~~~~~~~~-------------------~-------- 138 (449)
.|||||||||+|||| +.+|+|||.||||+.-+. ....+... .
T Consensus 748 mGFIHRDiKPDNILI---DrdGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~ 824 (1034)
T KOG0608|consen 748 MGFIHRDIKPDNILI---DRDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQ 824 (1034)
T ss_pred ccceecccCccceEE---ccCCceeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhh
Confidence 999999999999999 799999999999986442 11111000 0
Q ss_pred cccCCCCccCccccchhhhhCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcH
Q 013092 139 YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPT 218 (449)
Q Consensus 139 ~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~ 218 (449)
....-.++||+.|+|||++....|+..+|+||.|||||||+.|+.||...++.....++..+.. ...-..+.++++
T Consensus 825 r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~nw~~----~l~~~~~~~ls~ 900 (1034)
T KOG0608|consen 825 RILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQPPFLADTPGETQYKVINWRN----FLHIPYQGNLSK 900 (1034)
T ss_pred hhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCCCCccCCCCCcceeeeeehhh----ccccccccccCH
Confidence 0012357899999999999999999999999999999999999999988666544333222211 111234567899
Q ss_pred HHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCCcccchhhhhh
Q 013092 219 EFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQ 268 (449)
Q Consensus 219 el~~li~~cl~~~p~~RPt~~~l~~~L~~~~~~~~~~~~~~~dw~~~~~~ 268 (449)
|+.++|.+++. .+++|.. +--.+ .-..+.|+..+||..++.+
T Consensus 901 e~~~li~kLc~-sad~RLG-----kng~d--~vKaHpfFkgIDfsslRkq 942 (1034)
T KOG0608|consen 901 EALDLIQKLCC-SADSRLG-----KNGAD--QVKAHPFFKGIDFSSLRKQ 942 (1034)
T ss_pred HHHHHHHHHhc-Chhhhhc-----ccchh--hhhcCccccccchHhhhhc
Confidence 99999887664 5677743 21122 1234688889999986554
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-32 Score=265.23 Aligned_cols=212 Identities=19% Similarity=0.188 Sum_probs=170.0
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFL 97 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~giv 97 (449)
...+..|+++++.+ +|+||+++++++.+.+..|+||||++++|.+++......+++..++.++.||+.||.|||++||+
T Consensus 46 ~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~lv~e~~~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~ 124 (298)
T cd07841 46 NFTALREIKLLQEL-KHPNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWIL 124 (298)
T ss_pred hHHHHHHHHHHhhc-CCCCChhhhheeecCCEEEEEEcccCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 34577899999999 79999999999999999999999998899999975333699999999999999999999999999
Q ss_pred ecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhC-CCCChhhHHHHHHHHHH
Q 013092 98 HRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLM 176 (449)
Q Consensus 98 HRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~-~~~s~~~DiwSlG~il~ 176 (449)
|+||||+||++ +.++.++|+|||+++........ .....++..|+|||.+.+ ..++.++|||||||++|
T Consensus 125 H~dl~p~nill---~~~~~~~l~dfg~~~~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~ 194 (298)
T cd07841 125 HRDLKPNNLLI---ASDGVLKLADFGLARSFGSPNRK-------MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFA 194 (298)
T ss_pred ecCCChhhEEE---cCCCCEEEccceeeeeccCCCcc-------ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHH
Confidence 99999999999 57889999999999876543211 123356788999999865 45789999999999999
Q ss_pred HHHhCCCCCCCCCcCCHHHHHHHHHhhc-----------------------ccchHHHhhcCCcHHHHHHHHHHhcCCCC
Q 013092 177 YFLRGSLPWQGLKAGTKKQKYEKISEKK-----------------------VSTSIEALCRGYPTEFASYFHYCRSLRFD 233 (449)
Q Consensus 177 elltG~~Pf~~~~~~~~~~~~~~i~~~~-----------------------~~~~~~~l~~~~p~el~~li~~cl~~~p~ 233 (449)
+|++|..||.+.... ..+.++.... .......+....+.++.++|..||..+|+
T Consensus 195 e~~~g~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~ 271 (298)
T cd07841 195 ELLLRVPFLPGDSDI---DQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPN 271 (298)
T ss_pred HHHcCCccccCCccH---HHHHHHHHHcCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcc
Confidence 999998888764432 2222222111 01112223345678899999999999999
Q ss_pred CCCCHHHHHH
Q 013092 234 DKPDYAYLKR 243 (449)
Q Consensus 234 ~RPt~~~l~~ 243 (449)
+||++.++++
T Consensus 272 ~R~s~~e~l~ 281 (298)
T cd07841 272 KRITARQALE 281 (298)
T ss_pred cCcCHHHHhh
Confidence 9999888765
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-32 Score=265.17 Aligned_cols=228 Identities=16% Similarity=0.208 Sum_probs=181.0
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 96 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gi 96 (449)
...+..|++++..+.+|++|+++.+.+..+...||||||+ +++|.+++.. ...+++..++.++.|++.+|+|||+.|+
T Consensus 48 ~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~~ 126 (288)
T cd05583 48 AEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQ-REHFTESEVRVYIAEIVLALDHLHQLGI 126 (288)
T ss_pred HHHHHHHHHHHHhccCCcchhhhheeeecCCEEEEEEecCCCCcHHHHHhh-cCCcCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 3457899999999989999999999999999999999999 8899999874 4568999999999999999999999999
Q ss_pred eecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCC--CChhhHHHHHHHH
Q 013092 97 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIE--QSRRDDLESLGYV 174 (449)
Q Consensus 97 vHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~--~s~~~DiwSlG~i 174 (449)
+|+||||.||++ +.++.++|+|||+++.+...... ......|+..|++||.+.+.. .+.++||||||++
T Consensus 127 ~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~i 197 (288)
T cd05583 127 IYRDIKLENILL---DSEGHVVLTDFGLSKEFLAEEEE------RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVL 197 (288)
T ss_pred eccCCCHHHeEE---CCCCCEEEEECcccccccccccc------ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHH
Confidence 999999999999 57789999999998765433211 122356889999999987755 6889999999999
Q ss_pred HHHHHhCCCCCCCCCcCCHH-HHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Q 013092 175 LMYFLRGSLPWQGLKAGTKK-QKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREG 253 (449)
Q Consensus 175 l~elltG~~Pf~~~~~~~~~-~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~L~~~~~~~~ 253 (449)
+|+|++|..||......... .....+... .......++.++.+++.+||+.+|++||++..+.++|..
T Consensus 198 l~el~tg~~p~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~------ 266 (288)
T cd05583 198 TFELLTGASPFTVDGEQNSQSEISRRILKS-----KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH------ 266 (288)
T ss_pred HHHHHhCCCCcccCcccchHHHHHHHHHcc-----CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC------
Confidence 99999999999643222111 111111111 112334578899999999999999999998888777654
Q ss_pred CCCCCcccchhhhh
Q 013092 254 FQFDYVFDWTILKY 267 (449)
Q Consensus 254 ~~~~~~~dw~~~~~ 267 (449)
.+...++|.....
T Consensus 267 -~~~~~~~~~~~~~ 279 (288)
T cd05583 267 -PFFQGIDWDDLAA 279 (288)
T ss_pred -cccccCCHHHHhh
Confidence 3455668876543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-32 Score=267.38 Aligned_cols=209 Identities=17% Similarity=0.277 Sum_probs=173.2
Q ss_pred ChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 013092 17 KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 95 (449)
Q Consensus 17 ~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~g 95 (449)
....+.+|+.+++.+ +||||+++++++..++..|+||||+ +++|.+++. ...+++..++.++.|++.||+|||+.|
T Consensus 61 ~~~~~~~e~~~l~~l-~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~ 137 (297)
T cd06659 61 RRELLFNEVVIMRDY-QHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVS--QTRLNEEQIATVCESVLQALCYLHSQG 137 (297)
T ss_pred hHHHHHHHHHHHHhC-CCCchhhhhhheeeCCeEEEEEecCCCCCHHHHHh--hcCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 456688999999999 8999999999999999999999999 899999886 356899999999999999999999999
Q ss_pred ceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHHH
Q 013092 96 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVL 175 (449)
Q Consensus 96 ivHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il 175 (449)
|+||||||+||++ +.++.++|+|||++..+..... ......|+..|+|||++.+..++.++|||||||++
T Consensus 138 ivH~dl~p~Nill---~~~~~~kL~dfg~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il 207 (297)
T cd06659 138 VIHRDIKSDSILL---TLDGRVKLSDFGFCAQISKDVP-------KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMV 207 (297)
T ss_pred eecCCCCHHHeEE---ccCCcEEEeechhHhhcccccc-------cccceecCccccCHHHHccCCCCchhhHHHHHHHH
Confidence 9999999999999 5788999999999875543221 12345689999999999998899999999999999
Q ss_pred HHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 176 MYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 176 ~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
|+|++|..||..... .+.+..+..... ........++.++.++|..||+.+|++||++.+|+.
T Consensus 208 ~el~~g~~p~~~~~~---~~~~~~~~~~~~--~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~ 270 (297)
T cd06659 208 IEMVDGEPPYFSDSP---VQAMKRLRDSPP--PKLKNAHKISPVLRDFLERMLTREPQERATAQELLD 270 (297)
T ss_pred HHHHhCCCCCCCCCH---HHHHHHHhccCC--CCccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 999999999976432 233333322211 111223467889999999999999999999888765
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=262.75 Aligned_cols=216 Identities=16% Similarity=0.155 Sum_probs=179.1
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEe----CCEEEEEEecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHH
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVE----GDYNVLVMDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFV 91 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~----~~~~~lVmE~~-g~sL~~ll~~~-~~~ls~~~~~~i~~qi~~aL~yL 91 (449)
.+...+|+++.....+|||||.+++.+.. ...+.||||.| ||.|+.-|... ...|++.++-.|+.||..|+.||
T Consensus 98 s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~l 177 (400)
T KOG0604|consen 98 SPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYL 177 (400)
T ss_pred CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHH
Confidence 45578999999999999999999998863 34678999999 99999999764 45699999999999999999999
Q ss_pred HHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHH
Q 013092 92 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESL 171 (449)
Q Consensus 92 H~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSl 171 (449)
|+.+|.||||||+|+|......+..+||+|||+|+....... ..+.+-|+.|.|||++-...|+..+|+||+
T Consensus 178 H~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~~~--------L~TPc~TPyYvaPevlg~eKydkscdmwSl 249 (400)
T KOG0604|consen 178 HSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEPGD--------LMTPCFTPYYVAPEVLGPEKYDKSCDMWSL 249 (400)
T ss_pred HhcchhhccCChhheeeecCCCCcceEecccccccccCCCcc--------ccCCcccccccCHHHhCchhcCCCCCccch
Confidence 999999999999999998777788999999999987654332 234577999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCCcCCH-HHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 013092 172 GYVLMYFLRGSLPWQGLKAGTK-KQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 242 (449)
Q Consensus 172 G~il~elltG~~Pf~~~~~~~~-~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~ 242 (449)
|||+|-||+|.+||........ ...-.+|.......+-++ +..++++..++|+.+|..+|.+|.+..++.
T Consensus 250 gVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pE-Ws~VSe~aKdlIR~LLkt~PteRlTI~~~m 320 (400)
T KOG0604|consen 250 GVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPE-WSCVSEAAKDLIRKLLKTEPTERLTIEEVM 320 (400)
T ss_pred hHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChh-HhHHHHHHHHHHHHHhcCCchhheeHHHhh
Confidence 9999999999999987554221 223345555555444333 345788999999999999999999966653
|
|
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-32 Score=260.73 Aligned_cols=216 Identities=21% Similarity=0.281 Sum_probs=175.0
Q ss_pred ChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHH
Q 013092 17 KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVHS 93 (449)
Q Consensus 17 ~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~--~~~ls~~~~~~i~~qi~~aL~yLH~ 93 (449)
....+.+|+++++.+ .|+||+++++.+..++..|+|||++ +++|.+++... ...+++..+..++.|++.||+|||+
T Consensus 42 ~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~ 120 (267)
T cd06610 42 SVDELRKEVQAMSQC-NHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS 120 (267)
T ss_pred HHHHHHHHHHHHHhc-CCCCEEEEEEEEeeCCEEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 456789999999999 8999999999999999999999999 99999999753 2468999999999999999999999
Q ss_pred CCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCC-CCChhhHHHHHH
Q 013092 94 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLG 172 (449)
Q Consensus 94 ~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~-~~s~~~DiwSlG 172 (449)
.||+|+||||+||++ +.++.++|+|||++..+....... ........|+..|++||++... .++.++|+||||
T Consensus 121 ~~i~h~~l~p~ni~~---~~~~~~~l~df~~~~~~~~~~~~~---~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG 194 (267)
T cd06610 121 NGQIHRDIKAGNILL---GEDGSVKIADFGVSASLADGGDRT---RKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFG 194 (267)
T ss_pred CCeecCCCCHHhEEE---cCCCCEEEcccchHHHhccCcccc---ccccccccCChhhcChHHHccccCcCcccchHhHh
Confidence 999999999999999 567889999999998766543221 0122445789999999998876 689999999999
Q ss_pred HHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHh--hcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 173 YVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL--CRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 173 ~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l--~~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
|++|+|++|+.||..... .+.+.++..... ..+... ...+++++.+++..||..+|++||++.+|++
T Consensus 195 ~i~~~l~~g~~p~~~~~~---~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 195 ITAIELATGAAPYSKYPP---MKVLMLTLQNDP-PSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred HHHHHHHhCCCCccccCh---hhhHHHHhcCCC-CCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 999999999999976533 222333222211 111111 1367899999999999999999999888754
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-32 Score=266.52 Aligned_cols=212 Identities=19% Similarity=0.186 Sum_probs=168.2
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeC--CEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEG--DYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 95 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~--~~~~lVmE~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~g 95 (449)
...+.+|+.+++.+ +|+||+++++++.+. +..|+||||++++|.+++......+++..++.++.||+.||.|||+.|
T Consensus 50 ~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ 128 (309)
T cd07845 50 PISSLREITLLLNL-RHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF 128 (309)
T ss_pred cchhhHHHHHHHhC-CCCCCcceEEEEecCCCCeEEEEEecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 34567899999999 899999999988754 578999999987999999866677999999999999999999999999
Q ss_pred ceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhC-CCCChhhHHHHHHHH
Q 013092 96 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYV 174 (449)
Q Consensus 96 ivHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~-~~~s~~~DiwSlG~i 174 (449)
++||||||+||++ +..+.+||+|||++..+...... .....++..|+|||++.+ ..++.++|||||||+
T Consensus 129 i~H~dl~p~nil~---~~~~~~kL~dfg~~~~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~i 198 (309)
T cd07845 129 IIHRDLKVSNLLL---TDKGCLKIADFGLARTYGLPAKP-------MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCI 198 (309)
T ss_pred eecCCCCHHHEEE---CCCCCEEECccceeeecCCccCC-------CCcccccccccChhhhcCCCCcCchHHHHHHHHH
Confidence 9999999999999 57889999999999876543211 122345788999999876 457899999999999
Q ss_pred HHHHHhCCCCCCCCCcCCHHHHHHHHHhhccc-------------------------chHHHhhcCCcHHHHHHHHHHhc
Q 013092 175 LMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS-------------------------TSIEALCRGYPTEFASYFHYCRS 229 (449)
Q Consensus 175 l~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~-------------------------~~~~~l~~~~p~el~~li~~cl~ 229 (449)
+|+|++|..||...+. .+.+..+...... ..+......+++++.++|..|+.
T Consensus 199 l~el~~g~~~f~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~ 275 (309)
T cd07845 199 LAELLAHKPLLPGKSE---IEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLM 275 (309)
T ss_pred HHHHHhCCCCCCCCCH---HHHHHHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhc
Confidence 9999999999986443 2333333221100 00111122357889999999999
Q ss_pred CCCCCCCCHHHHHH
Q 013092 230 LRFDDKPDYAYLKR 243 (449)
Q Consensus 230 ~~p~~RPt~~~l~~ 243 (449)
.||++||++.+++.
T Consensus 276 ~dp~~R~t~~~il~ 289 (309)
T cd07845 276 YDPKKRATAEEALE 289 (309)
T ss_pred CChhhCcCHHHHhc
Confidence 99999999887753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-32 Score=264.40 Aligned_cols=212 Identities=17% Similarity=0.200 Sum_probs=168.9
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecCCCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSF 96 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~g~sL~~ll~~~-~~~ls~~~~~~i~~qi~~aL~yLH~~gi 96 (449)
...+..|+++++.+ +||||+++++++.+++..|+||||+.++|.+++... ...+++..++.++.|++.||+|||+.|+
T Consensus 43 ~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i 121 (284)
T cd07860 43 PSTAIREISLLKEL-NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRV 121 (284)
T ss_pred chHHHHHHHHHHhc-CCCCCcchhhhcccCCcEEEEeeccccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 35688999999999 899999999999999999999999977899988754 3568999999999999999999999999
Q ss_pred eecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCC-CChhhHHHHHHHHH
Q 013092 97 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVL 175 (449)
Q Consensus 97 vHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~-~s~~~DiwSlG~il 175 (449)
+|+||+|+||++ +.++.++|+|||++........ ......++..|+|||++.+.. ++.++|||||||++
T Consensus 122 ~H~~l~p~nill---~~~~~~~l~dfg~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il 191 (284)
T cd07860 122 LHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVR-------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIF 191 (284)
T ss_pred ecCCCCHHHEEE---CCCCCEEEeeccchhhcccCcc-------ccccccccccccCCeEEecCCCCCcHHHHHHHHHHH
Confidence 999999999999 6788999999999876543211 112335688999999887644 58899999999999
Q ss_pred HHHHhCCCCCCCCCcCCHHHHHHHHHhhc------------------------ccchHHHhhcCCcHHHHHHHHHHhcCC
Q 013092 176 MYFLRGSLPWQGLKAGTKKQKYEKISEKK------------------------VSTSIEALCRGYPTEFASYFHYCRSLR 231 (449)
Q Consensus 176 ~elltG~~Pf~~~~~~~~~~~~~~i~~~~------------------------~~~~~~~l~~~~p~el~~li~~cl~~~ 231 (449)
|+|++|..||...+.. ....++.+.. .......+.+.+++++.++|.+||+.|
T Consensus 192 ~~l~tg~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 268 (284)
T cd07860 192 AEMVTRRALFPGDSEI---DQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYD 268 (284)
T ss_pred HHHHHCCCCCCCCCHH---HHHHHHHHHhCCCChhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCC
Confidence 9999999999764321 1111111110 011122233457889999999999999
Q ss_pred CCCCCCHHHHHH
Q 013092 232 FDDKPDYAYLKR 243 (449)
Q Consensus 232 p~~RPt~~~l~~ 243 (449)
|++||++.+++.
T Consensus 269 P~~Rpt~~~~l~ 280 (284)
T cd07860 269 PNKRISAKAALA 280 (284)
T ss_pred cccCCCHHHHhc
Confidence 999999887753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-31 Score=263.12 Aligned_cols=213 Identities=18% Similarity=0.187 Sum_probs=167.5
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecCCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSF 96 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~g~sL~~ll~~~~-~~ls~~~~~~i~~qi~~aL~yLH~~gi 96 (449)
...+..|+++++.+ +|+||+++++++.++...|+||||++++|.+++.... ..+++..+..++.||+.||+|||++|+
T Consensus 45 ~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i 123 (294)
T PLN00009 45 PSTAIREISLLKEM-QHGNIVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRV 123 (294)
T ss_pred hHHHHHHHHHHHhc-cCCCEeeEEEEEecCCeEEEEEecccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 45688999999999 8999999999999999999999999778988886432 336888899999999999999999999
Q ss_pred eecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCC-CCChhhHHHHHHHHH
Q 013092 97 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVL 175 (449)
Q Consensus 97 vHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~-~~s~~~DiwSlG~il 175 (449)
+|+||||+||++. ..++.+||+|||++........ ......+++.|++||++.+. .++.++|||||||++
T Consensus 124 ~H~dl~p~nill~--~~~~~~kl~dfg~~~~~~~~~~-------~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~ 194 (294)
T PLN00009 124 LHRDLKPQNLLID--RRTNALKLADFGLARAFGIPVR-------TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIF 194 (294)
T ss_pred eCCCCCcceEEEE--CCCCEEEEcccccccccCCCcc-------ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHH
Confidence 9999999999994 3456899999999976543211 11234678899999998764 578999999999999
Q ss_pred HHHHhCCCCCCCCCcCCHHHHHHHHHhhc------------------------ccchHHHhhcCCcHHHHHHHHHHhcCC
Q 013092 176 MYFLRGSLPWQGLKAGTKKQKYEKISEKK------------------------VSTSIEALCRGYPTEFASYFHYCRSLR 231 (449)
Q Consensus 176 ~elltG~~Pf~~~~~~~~~~~~~~i~~~~------------------------~~~~~~~l~~~~p~el~~li~~cl~~~ 231 (449)
|+|++|..||...... ..+.++.... .........+.+++++.+++..|++.+
T Consensus 195 ~~l~tg~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~ 271 (294)
T PLN00009 195 AEMVNQKPLFPGDSEI---DELFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLD 271 (294)
T ss_pred HHHHhCCCCCCCCCHH---HHHHHHHHHhCCCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCC
Confidence 9999999999764331 2222221100 001111223567889999999999999
Q ss_pred CCCCCCHHHHHH
Q 013092 232 FDDKPDYAYLKR 243 (449)
Q Consensus 232 p~~RPt~~~l~~ 243 (449)
|++||++.++++
T Consensus 272 P~~Rps~~~~l~ 283 (294)
T PLN00009 272 PSKRITARAALE 283 (294)
T ss_pred hhhCcCHHHHhc
Confidence 999999888764
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-31 Score=262.45 Aligned_cols=212 Identities=20% Similarity=0.210 Sum_probs=168.5
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeC--CEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEG--DYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 95 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~--~~~~lVmE~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~g 95 (449)
...+.+|+.+++.+ .||||+++++++... ...||||||++++|.+++......+++..++.++.||+.||+|||++|
T Consensus 48 ~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ 126 (293)
T cd07843 48 PITSLREINILLKL-QHPNIVTVKEVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNW 126 (293)
T ss_pred hhhHHHHHHHHHhc-CCCCEEEEEEEEEecCCCcEEEEehhcCcCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 34567899999999 799999999988877 899999999977999999865556999999999999999999999999
Q ss_pred ceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCC-CChhhHHHHHHHH
Q 013092 96 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYV 174 (449)
Q Consensus 96 ivHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~-~s~~~DiwSlG~i 174 (449)
|+|+||||+||++ +..+.++|+|||++..+..... ......++..|+|||.+.+.. ++.++|+||||++
T Consensus 127 i~H~dl~p~nili---~~~~~~~l~d~g~~~~~~~~~~-------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~ 196 (293)
T cd07843 127 ILHRDLKTSNLLL---NNRGILKICDFGLAREYGSPLK-------PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCI 196 (293)
T ss_pred eeeccCCHHHEEE---CCCCcEEEeecCceeeccCCcc-------ccccccccccccCchhhcCCccccchhhHHHHHHH
Confidence 9999999999999 5778999999999987655321 112345788999999987644 6889999999999
Q ss_pred HHHHHhCCCCCCCCCcCCHHHHHHHHHhhccc-------------------------chHHHhhcC--CcHHHHHHHHHH
Q 013092 175 LMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS-------------------------TSIEALCRG--YPTEFASYFHYC 227 (449)
Q Consensus 175 l~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~-------------------------~~~~~l~~~--~p~el~~li~~c 227 (449)
+|+|++|..||...... +.+.++...... ..+....+. +++.+.++|..|
T Consensus 197 l~~l~~g~~~f~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 273 (293)
T cd07843 197 FAELLTKKPLFPGKSEI---DQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRL 273 (293)
T ss_pred HHHHHhCCCCCCCCChH---HHHHHHHHHhCCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHH
Confidence 99999999999865432 222222211000 000111112 478899999999
Q ss_pred hcCCCCCCCCHHHHHH
Q 013092 228 RSLRFDDKPDYAYLKR 243 (449)
Q Consensus 228 l~~~p~~RPt~~~l~~ 243 (449)
|+.+|++||++.+++.
T Consensus 274 l~~~p~~R~t~~ell~ 289 (293)
T cd07843 274 LTYDPAKRISAEDALK 289 (293)
T ss_pred hccCccccCCHHHHhc
Confidence 9999999999888754
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-32 Score=261.83 Aligned_cols=209 Identities=22% Similarity=0.290 Sum_probs=166.5
Q ss_pred hHHHHHHHHHHHhcCCCCCceEEEEeEe--CCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 013092 19 PQLLYESKLYRILQGGTGIPNVRWFGVE--GDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 95 (449)
Q Consensus 19 ~~~~~E~~il~~l~~hp~Iv~l~~~~~~--~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~g 95 (449)
..+.+|+.+++.+ +|+||+++++++.+ ....+++|||+ +++|.+++.. ...+++..++.++.|++.||+|||+++
T Consensus 49 ~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~ 126 (266)
T cd06651 49 SALECEIQLLKNL-QHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKA-YGALTESVTRKYTRQILEGMSYLHSNM 126 (266)
T ss_pred HHHHHHHHHHHHc-CCCCeeeEEEEEEcCCCCEEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 4588899999999 89999999988765 46789999999 8999999875 456899999999999999999999999
Q ss_pred ceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHHH
Q 013092 96 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVL 175 (449)
Q Consensus 96 ivHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il 175 (449)
|+|+||||+||++ +.++.++|+|||+++......... .......++..|+|||++.+..++.++|||||||++
T Consensus 127 i~H~~l~p~nil~---~~~~~~~l~dfg~~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~ 199 (266)
T cd06651 127 IVHRDIKGANILR---DSAGNVKLGDFGASKRLQTICMSG----TGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTV 199 (266)
T ss_pred eeeCCCCHHHEEE---CCCCCEEEccCCCccccccccccC----CccccCCccccccCHHHhCCCCCCchhhhHHHHHHH
Confidence 9999999999999 577889999999997654321110 111234688999999999998899999999999999
Q ss_pred HHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 176 MYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 176 ~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
|+|++|..||..... .+.+..+... ...+.+...+++.+.+++ .||..+|++||++.+|++
T Consensus 200 ~el~~g~~pf~~~~~---~~~~~~~~~~---~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 200 VEMLTEKPPWAEYEA---MAAIFKIATQ---PTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred HHHHHCCCCccccch---HHHHHHHhcC---CCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 999999999976422 2222222211 111223345678889998 688899999999888754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=267.77 Aligned_cols=228 Identities=18% Similarity=0.249 Sum_probs=189.7
Q ss_pred EEEeeecccCCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHH
Q 013092 6 TVFSVQENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQM 84 (449)
Q Consensus 6 kV~~k~~~~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi 84 (449)
.|++|.-.+....++++.|+.||+++ +.++||+.|+.+.....+||||||| .|++.|+++..+++++++++..++...
T Consensus 60 v~AIK~VPV~sDLQEIIKEISIMQQC-~S~yVVKYYGSYFK~sDLWIVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~T 138 (502)
T KOG0574|consen 60 VLAIKKVPVDTDLQEIIKEISIMQQC-KSKYVVKYYGSYFKHSDLWIVMEYCGAGSISDIMRARRKPLSEQEISAVLRDT 138 (502)
T ss_pred EEEEEecCccchHHHHHHHHHHHHHc-CCchhhhhhhhhccCCceEeehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHH
Confidence 35666677888889999999999999 9999999999999999999999999 899999999878899999999999999
Q ss_pred HHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCCh
Q 013092 85 INRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSR 164 (449)
Q Consensus 85 ~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~ 164 (449)
+.||+|||...-||||||..|||+ ...|..||+|||.|-.+.+.... ..+..||+.|||||++....|+.
T Consensus 139 LKGL~YLH~~~KIHRDIKAGNILL---NT~G~AKLADFGVAGQLTDTMAK-------RNTVIGTPFWMAPEVI~EIGY~~ 208 (502)
T KOG0574|consen 139 LKGLQYLHDLKKIHRDIKAGNILL---NTDGIAKLADFGVAGQLTDTMAK-------RNTVIGTPFWMAPEVIEEIGYDT 208 (502)
T ss_pred HhHHHHHHHHHHHHhhcccccEEE---cccchhhhhhccccchhhhhHHh-------hCccccCcccccHHHHHHhccch
Confidence 999999999999999999999999 68899999999999877665432 35678999999999999999999
Q ss_pred hhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHH
Q 013092 165 RDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRI 244 (449)
Q Consensus 165 ~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~ 244 (449)
++||||||++..||..|++||.+..+.. .+..|... +++...-++.++.+|.+|++.||-..|++|-++.+|
T Consensus 209 ~ADIWSLGITaIEMAEG~PPYsDIHPMR---AIFMIPT~--PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L--- 280 (502)
T KOG0574|consen 209 KADIWSLGITAIEMAEGRPPYSDIHPMR---AIFMIPTK--PPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRL--- 280 (502)
T ss_pred hhhHhhhcchhhhhhcCCCCcccccccc---eeEeccCC--CCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHH---
Confidence 9999999999999999999998765421 01111111 111112234578899999999999999999886554
Q ss_pred HHHHHHHc
Q 013092 245 FRDLFIRE 252 (449)
Q Consensus 245 L~~~~~~~ 252 (449)
++.-|.+.
T Consensus 281 ~~H~Fikn 288 (502)
T KOG0574|consen 281 CEHTFIKN 288 (502)
T ss_pred hhhhhhcC
Confidence 44444443
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-32 Score=264.43 Aligned_cols=212 Identities=21% Similarity=0.286 Sum_probs=169.2
Q ss_pred ChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 013092 17 KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 95 (449)
Q Consensus 17 ~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~g 95 (449)
....+..|+++++.+ +|+||+++++++..++..|+||||+ ++.|.++... ...+++..++.++.||+.||+|||+.|
T Consensus 43 ~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~ 120 (286)
T cd07846 43 VKKIAMREIRMLKQL-RHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKY-PNGLDESRVRKYLFQILRGIEFCHSHN 120 (286)
T ss_pred hhHHHHHHHHHHHhc-CCcchhhHHHhcccCCeEEEEEecCCccHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 345688999999999 9999999999999999999999999 7777776653 446899999999999999999999999
Q ss_pred ceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCC-CCChhhHHHHHHHH
Q 013092 96 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYV 174 (449)
Q Consensus 96 ivHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~-~~s~~~DiwSlG~i 174 (449)
|+|+||+|+||++ +.++.++|+|||++........ ......++..|+|||++.+. .++.++||||||++
T Consensus 121 i~h~~l~p~ni~~---~~~~~~~l~dfg~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~ 190 (286)
T cd07846 121 IIHRDIKPENILV---SQSGVVKLCDFGFARTLAAPGE-------VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCL 190 (286)
T ss_pred ccccCCCHHHEEE---CCCCcEEEEeeeeeeeccCCcc-------ccCcccceeeccCcHHhccccccCchHhHHHHHHH
Confidence 9999999999999 5788999999999987644321 11234688999999998763 46889999999999
Q ss_pred HHHHHhCCCCCCCCCcCCHHHHHHHHHhh--------------------------cccchHHHhhcCCcHHHHHHHHHHh
Q 013092 175 LMYFLRGSLPWQGLKAGTKKQKYEKISEK--------------------------KVSTSIEALCRGYPTEFASYFHYCR 228 (449)
Q Consensus 175 l~elltG~~Pf~~~~~~~~~~~~~~i~~~--------------------------~~~~~~~~l~~~~p~el~~li~~cl 228 (449)
+|+|++|..||..... ...+..+... ..........++++..+.+++..||
T Consensus 191 l~el~~g~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 267 (286)
T cd07846 191 VTEMLTGEPLFPGDSD---IDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCL 267 (286)
T ss_pred HHHHHcCCCCCCCCch---HHHHHHHHHHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHh
Confidence 9999999999976432 1111111110 0011122234577899999999999
Q ss_pred cCCCCCCCCHHHHHH
Q 013092 229 SLRFDDKPDYAYLKR 243 (449)
Q Consensus 229 ~~~p~~RPt~~~l~~ 243 (449)
..+|++||++.+|++
T Consensus 268 ~~~P~~Rp~~~~il~ 282 (286)
T cd07846 268 RIDPDDRPSSSQLLH 282 (286)
T ss_pred cCCcccchhHHHHhc
Confidence 999999999987754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-32 Score=258.06 Aligned_cols=208 Identities=23% Similarity=0.285 Sum_probs=172.9
Q ss_pred ChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 013092 17 KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 95 (449)
Q Consensus 17 ~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~g 95 (449)
....+..|+.+++.+ +|+||+++++++.++...|+||||+ +++|.+++.. ...+++..++.++.|++.||+|||+.|
T Consensus 45 ~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~ 122 (258)
T cd06632 45 AVKQLEQEIALLSKL-QHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKK-YGSFPEPVIRLYTRQILLGLEYLHDRN 122 (258)
T ss_pred HHHHHHHHHHHHHhc-CCCCchheeeeEecCCeEEEEEEecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 445688999999999 9999999999999999999999999 8999999975 346899999999999999999999999
Q ss_pred ceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCC-CChhhHHHHHHHH
Q 013092 96 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYV 174 (449)
Q Consensus 96 ivHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~-~s~~~DiwSlG~i 174 (449)
|+|+||+|+||++ +.++.+||+|||++....... ......|+..|++||.+.... ++.++|+|||||+
T Consensus 123 i~H~dl~~~ni~~---~~~~~~kl~d~~~~~~~~~~~--------~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~ 191 (258)
T cd06632 123 TVHRDIKGANILV---DTNGVVKLADFGMAKQVVEFS--------FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCT 191 (258)
T ss_pred cccCCCCHHHEEE---CCCCCEEEccCccceeccccc--------cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHH
Confidence 9999999999999 578899999999988764432 123456889999999998766 8999999999999
Q ss_pred HHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 175 LMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 175 l~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
+|+|++|..||..... .+...++... .....+...+++++.+++.+||+.+|++||++.++..
T Consensus 192 l~~l~~g~~pf~~~~~---~~~~~~~~~~---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 192 VLEMATGKPPWSQLEG---VAAVFKIGRS---KELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred HHHHHhCCCCcccCcH---HHHHHHHHhc---ccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 9999999999976432 2222222221 1122344567899999999999999999999888754
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-32 Score=263.41 Aligned_cols=219 Identities=19% Similarity=0.255 Sum_probs=169.4
Q ss_pred CCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC
Q 013092 15 KTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 94 (449)
Q Consensus 15 ~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~ 94 (449)
......+.+|+++++.+ .|+||+++.+++..++..|+||||+++++.+.+......+++..++.++.||+.||.|||+.
T Consensus 41 ~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~ 119 (288)
T cd07833 41 EDVKKTALREVKVLRQL-RHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSH 119 (288)
T ss_pred ccchhHHHHHHHHHHhc-CCCCeeehhheEEECCEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 34456789999999999 79999999999999999999999994455444443355699999999999999999999999
Q ss_pred CceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCC-CCChhhHHHHHHH
Q 013092 95 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGY 173 (449)
Q Consensus 95 givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~-~~s~~~DiwSlG~ 173 (449)
|++|+||+|+||++ +.++.++|+|||++......... ......++..|+|||++.+. .++.++||||||+
T Consensus 120 ~i~H~dl~~~ni~~---~~~~~~kl~d~g~~~~~~~~~~~------~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~ 190 (288)
T cd07833 120 NIIHRDIKPENILV---SESGVLKLCDFGFARALRARPAS------PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGC 190 (288)
T ss_pred CeecCCCCHHHeEE---CCCCCEEEEeeecccccCCCccc------cccCcccccCCcCCchhcCCCCcCchhhHHHHHH
Confidence 99999999999999 57889999999999876543321 12345678899999999888 7899999999999
Q ss_pred HHHHHHhCCCCCCCCCcCCHHHHHHHHHhh-----------------------cccchHH-HhhcCCcHHHHHHHHHHhc
Q 013092 174 VLMYFLRGSLPWQGLKAGTKKQKYEKISEK-----------------------KVSTSIE-ALCRGYPTEFASYFHYCRS 229 (449)
Q Consensus 174 il~elltG~~Pf~~~~~~~~~~~~~~i~~~-----------------------~~~~~~~-~l~~~~p~el~~li~~cl~ 229 (449)
++|+|++|..||.+....+.......+... ......+ .....++.++.+||..||.
T Consensus 191 ~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 270 (288)
T cd07833 191 IMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLR 270 (288)
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhc
Confidence 999999999999764322111111110000 0000011 1223358999999999999
Q ss_pred CCCCCCCCHHHHHH
Q 013092 230 LRFDDKPDYAYLKR 243 (449)
Q Consensus 230 ~~p~~RPt~~~l~~ 243 (449)
.+|++||++.+|.+
T Consensus 271 ~~p~~Rps~~~il~ 284 (288)
T cd07833 271 MDPKERLTCDELLQ 284 (288)
T ss_pred cCchhcccHHHHhc
Confidence 99999999887754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-32 Score=261.38 Aligned_cols=212 Identities=20% Similarity=0.318 Sum_probs=168.8
Q ss_pred ChhHHHHHHHHHHHhcCCCCCceEEEEeEeC------CEEEEEEecC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHH
Q 013092 17 KHPQLLYESKLYRILQGGTGIPNVRWFGVEG------DYNVLVMDLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMIN 86 (449)
Q Consensus 17 ~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~------~~~~lVmE~~-g~sL~~ll~~~---~~~ls~~~~~~i~~qi~~ 86 (449)
...++..|+.+++.+.+|+||+++++++.+. ...||||||+ +++|.+++... +..+++..+..++.|++.
T Consensus 45 ~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~ 124 (275)
T cd06608 45 EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLR 124 (275)
T ss_pred hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHH
Confidence 4567899999999998899999999998754 4589999999 88999998643 357899999999999999
Q ss_pred HHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhC-----CC
Q 013092 87 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG-----IE 161 (449)
Q Consensus 87 aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~-----~~ 161 (449)
||.|||+.|++|+||+|+||++ +.++.++|+|||++........ ......|+..|+|||++.. ..
T Consensus 125 al~~lH~~~i~H~~l~p~ni~~---~~~~~~~l~d~~~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~ 194 (275)
T cd06608 125 GLAYLHENKVIHRDIKGQNILL---TKNAEVKLVDFGVSAQLDSTLG-------RRNTFIGTPYWMAPEVIACDEQPDAS 194 (275)
T ss_pred HHHHHhcCCcccCCCCHHHEEE---ccCCeEEECCCccceecccchh-------hhcCccccccccCHhHhcccccccCC
Confidence 9999999999999999999999 5778999999999876544321 1234568999999999864 34
Q ss_pred CChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHH
Q 013092 162 QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYL 241 (449)
Q Consensus 162 ~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l 241 (449)
++.++|||||||++|+|++|..||..... ......+....... . .....++.++.++|..||..||++||++.+|
T Consensus 195 ~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~-~-~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~l 269 (275)
T cd06608 195 YDARSDVWSLGITAIELADGKPPLCDMHP---MRALFKIPRNPPPT-L-KSPENWSKKFNDFISECLIKNYEQRPFMEEL 269 (275)
T ss_pred ccccccHHHhHHHHHHHHhCCCCccccch---HHHHHHhhccCCCC-C-CchhhcCHHHHHHHHHHhhcChhhCcCHHHH
Confidence 67889999999999999999999975432 22222222221111 0 1123477899999999999999999999887
Q ss_pred HH
Q 013092 242 KR 243 (449)
Q Consensus 242 ~~ 243 (449)
++
T Consensus 270 l~ 271 (275)
T cd06608 270 LE 271 (275)
T ss_pred hc
Confidence 64
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=279.88 Aligned_cols=236 Identities=15% Similarity=0.203 Sum_probs=192.8
Q ss_pred EEEEEeeecccC---CChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCC-CCHHHHH
Q 013092 4 ILTVFSVQENVK---TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRK-LSLKTVL 78 (449)
Q Consensus 4 aikV~~k~~~~~---~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~-ls~~~~~ 78 (449)
++||++|.-... .....|.+|+++|.+| .||||+.|.++|..++.++|||||+ .|+|.+++....-+ +.....+
T Consensus 562 ~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqL-khPNIveLvGVC~~DePicmI~EYmEnGDLnqFl~aheapt~~t~~~v 640 (807)
T KOG1094|consen 562 PLKVAVKILRPDATKNARNDFLKEIKILSRL-KHPNIVELLGVCVQDDPLCMITEYMENGDLNQFLSAHELPTAETAPGV 640 (807)
T ss_pred ceEEEEeecCcccchhHHHHHHHHHHHHhcc-CCCCeeEEEeeeecCCchHHHHHHHhcCcHHHHHHhccCcccccchhH
Confidence 467777765332 3346799999999999 9999999999999999999999999 99999999865333 3455667
Q ss_pred HHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhh
Q 013092 79 MLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHL 158 (449)
Q Consensus 79 ~i~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~ 158 (449)
.|+.||+.||+||.+.+||||||.+.|+|+ +..+++||+|||+++.+..... |+.....+-..+|||+|.+.
T Consensus 641 si~tqiasgmaYLes~nfVHrd~a~rNcLv---~~e~~iKiadfgmsR~lysg~y-----y~vqgr~vlpiRwmawEsil 712 (807)
T KOG1094|consen 641 SICTQIASGMAYLESLNFVHRDLATRNCLV---DGEFTIKIADFGMSRNLYSGDY-----YRVQGRAVLPIRWMAWESIL 712 (807)
T ss_pred HHHHHHHHHHHHHHhhchhhccccccceee---cCcccEEecCcccccccccCCc-----eeeecceeeeeeehhHHHHH
Confidence 899999999999999999999999999999 6899999999999997766554 34445667788999999999
Q ss_pred CCCCChhhHHHHHHHHHHHHHh--CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCC
Q 013092 159 GIEQSRRDDLESLGYVLMYFLR--GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKP 236 (449)
Q Consensus 159 ~~~~s~~~DiwSlG~il~ellt--G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RP 236 (449)
-.+++.++|+|+||+++||++. ...||..+.++...+..-.+............+.-||.++.++|..||..+-.+||
T Consensus 713 lgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RP 792 (807)
T KOG1094|consen 713 LGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRP 792 (807)
T ss_pred hccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCC
Confidence 9999999999999999999864 78999887654333222222233333333334567999999999999999999999
Q ss_pred CHHHHHHHHHHH
Q 013092 237 DYAYLKRIFRDL 248 (449)
Q Consensus 237 t~~~l~~~L~~~ 248 (449)
+|++|...|.+.
T Consensus 793 sFe~lh~~lq~~ 804 (807)
T KOG1094|consen 793 SFEQLHLFLQED 804 (807)
T ss_pred CHHHHHHHHHHh
Confidence 999999887754
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-32 Score=260.85 Aligned_cols=209 Identities=19% Similarity=0.285 Sum_probs=170.6
Q ss_pred CChhHHHHHHHHHHHhc--CCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH
Q 013092 16 TKHPQLLYESKLYRILQ--GGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 92 (449)
Q Consensus 16 ~~~~~~~~E~~il~~l~--~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH 92 (449)
....++.+|+.+++.+. .|+||+++++++.++...|+||||+ +++|.+++.. ..+++..++.++.|++.||.|||
T Consensus 41 ~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh 118 (277)
T cd06917 41 DDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKA--GPIAEKYISVIIREVLVALKYIH 118 (277)
T ss_pred hhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEecCCCCcHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHH
Confidence 34567889999999995 4999999999999999999999999 9999999874 47899999999999999999999
Q ss_pred HCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhC-CCCChhhHHHHH
Q 013092 93 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESL 171 (449)
Q Consensus 93 ~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~-~~~s~~~DiwSl 171 (449)
+.||+|+||+|+||++ +..+.++|+|||++..+...... .....|+..|+|||.+.+ ..++.++|+|||
T Consensus 119 ~~~i~H~dl~p~ni~i---~~~~~~~l~dfg~~~~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~sl 188 (277)
T cd06917 119 KVGVIHRDIKAANILV---TNTGNVKLCDFGVAALLNQNSSK-------RSTFVGTPYWMAPEVITEGKYYDTKADIWSL 188 (277)
T ss_pred hCCcccCCcCHHHEEE---cCCCCEEEccCCceeecCCCccc-------cccccCCcceeCHHHhccCCccccchhHHHH
Confidence 9999999999999999 56889999999999877554321 123468899999999875 456889999999
Q ss_pred HHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhc-CCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 172 GYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR-GYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 172 G~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~-~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
||++|+|++|..||.+... ......+... ..+.+.. .++.++.+++..||..+|++||++.++..
T Consensus 189 G~~l~~ll~g~~p~~~~~~---~~~~~~~~~~----~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 189 GITIYEMATGNPPYSDVDA---FRAMMLIPKS----KPPRLEDNGYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred HHHHHHHHhCCCCCCCCCh---hhhhhccccC----CCCCCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 9999999999999976432 1111111111 1112222 37889999999999999999999888754
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-31 Score=262.62 Aligned_cols=213 Identities=20% Similarity=0.233 Sum_probs=167.0
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFL 97 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~giv 97 (449)
...+.+|+.+++.+ +|+||+++++++.+++..|+||||++++|.+++......+++..+..++.|++.||.|||++||+
T Consensus 47 ~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~ 125 (291)
T cd07844 47 PFTAIREASLLKDL-KHANIVTLHDIIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVL 125 (291)
T ss_pred chhHHHHHHHHhhC-CCcceeeEEEEEecCCeEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 34577899999999 89999999999999999999999997799999886556789999999999999999999999999
Q ss_pred ecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhC-CCCChhhHHHHHHHHHH
Q 013092 98 HRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLM 176 (449)
Q Consensus 98 HRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~-~~~s~~~DiwSlG~il~ 176 (449)
||||||+||++ +..+.+||+|||+++....... ......++..|+|||++.+ ..++.++|||||||++|
T Consensus 126 H~dl~p~nil~---~~~~~~kl~dfg~~~~~~~~~~-------~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~ 195 (291)
T cd07844 126 HRDLKPQNLLI---SERGELKLADFGLARAKSVPSK-------TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFY 195 (291)
T ss_pred cccCCHHHEEE---cCCCCEEECccccccccCCCCc-------cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHH
Confidence 99999999999 5788999999999875432111 1122346889999999876 45789999999999999
Q ss_pred HHHhCCCCCCCCCcCCHHHHHHHHHhhc-------------------------ccchHHHhhcCCc--HHHHHHHHHHhc
Q 013092 177 YFLRGSLPWQGLKAGTKKQKYEKISEKK-------------------------VSTSIEALCRGYP--TEFASYFHYCRS 229 (449)
Q Consensus 177 elltG~~Pf~~~~~~~~~~~~~~i~~~~-------------------------~~~~~~~l~~~~p--~el~~li~~cl~ 229 (449)
+|++|..||.+... ..+.+..+.... ....+......+. .++.+++.+|++
T Consensus 196 ~l~~g~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 273 (291)
T cd07844 196 EMATGRPLFPGSTD--VEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQ 273 (291)
T ss_pred HHHhCCCCCCCCcc--HHHHHHHHHHhcCCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhc
Confidence 99999999976432 111111111100 0011112222334 788999999999
Q ss_pred CCCCCCCCHHHHHH
Q 013092 230 LRFDDKPDYAYLKR 243 (449)
Q Consensus 230 ~~p~~RPt~~~l~~ 243 (449)
.+|++||++.+++.
T Consensus 274 ~~p~~Rps~~e~l~ 287 (291)
T cd07844 274 YEPKKRISAAEAMK 287 (291)
T ss_pred cCcccccCHHHHhc
Confidence 99999999887653
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-32 Score=265.83 Aligned_cols=209 Identities=21% Similarity=0.293 Sum_probs=171.1
Q ss_pred ChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 013092 17 KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 95 (449)
Q Consensus 17 ~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~g 95 (449)
....+..|+.+++.+ +|+||+++++.+..++..|+||||+ +++|.+++.. ..+++..++.++.|++.||.|||+.|
T Consensus 59 ~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~l~~~L~~LH~~~ 135 (297)
T cd06656 59 KKELIINEILVMREN-KNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALDFLHSNQ 135 (297)
T ss_pred hHHHHHHHHHHHHhC-CCCCEeeEEEEEecCCEEEEeecccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 345688999999999 9999999999999999999999999 9999999873 56899999999999999999999999
Q ss_pred ceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHHH
Q 013092 96 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVL 175 (449)
Q Consensus 96 ivHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il 175 (449)
|+||||||+|||+ +.++.++|+|||++......... .....+++.|++||.+.+..++.++|+|||||++
T Consensus 136 i~H~dL~p~Nili---~~~~~~~l~Dfg~~~~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil 205 (297)
T cd06656 136 VIHRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQSK-------RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMA 205 (297)
T ss_pred cccCCCCHHHEEE---CCCCCEEECcCccceEccCCccC-------cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHH
Confidence 9999999999999 57889999999999876443221 1234688999999999998899999999999999
Q ss_pred HHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 176 MYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 176 ~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
|+|++|..||....... ..+ .+.... .+.......++..+.+++.+||..+|++||++.+|+.
T Consensus 206 ~~l~tg~~pf~~~~~~~--~~~-~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 206 IEMVEGEPPYLNENPLR--ALY-LIATNG--TPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred HHHHhCCCCCCCCCcch--hee-eeccCC--CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 99999999997643311 111 111110 1111123457889999999999999999999887754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-31 Score=268.09 Aligned_cols=232 Identities=17% Similarity=0.201 Sum_probs=173.9
Q ss_pred EEEEEeeecccCCChhHHHHHHHHHHHhcCCCCCceEEEEeEe----CCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHH
Q 013092 4 ILTVFSVQENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVE----GDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLM 79 (449)
Q Consensus 4 aikV~~k~~~~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~----~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~~~~ 79 (449)
|+|++.+..........+.+|+.+++.+.+|+||+++++.+.. ....|++|||++++|.+++.. ...+++..++.
T Consensus 31 aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~-~~~~~~~~~~~ 109 (332)
T cd07857 31 AIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRS-GQPLTDAHFQS 109 (332)
T ss_pred EEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEEEEEecccCCHHHHHhc-CCCCCHHHHHH
Confidence 4444433222233456788999999999889999999887543 256899999998899999874 56799999999
Q ss_pred HHHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhC
Q 013092 80 LADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG 159 (449)
Q Consensus 80 i~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~ 159 (449)
++.||+.||+|||+.||+||||||+|||+ +.++.++|+|||+++.+....... ........||..|+|||++.+
T Consensus 110 ~~~qi~~aL~~LH~~givH~dlkp~Nili---~~~~~~kl~Dfg~a~~~~~~~~~~---~~~~~~~~g~~~y~aPE~~~~ 183 (332)
T cd07857 110 FIYQILCGLKYIHSANVLHRDLKPGNLLV---NADCELKICDFGLARGFSENPGEN---AGFMTEYVATRWYRAPEIMLS 183 (332)
T ss_pred HHHHHHHHHHHHHhCCcccCCCCHHHeEE---cCCCCEEeCcCCCceecccccccc---cccccCcccCccccCcHHHhC
Confidence 99999999999999999999999999999 578899999999998765432211 011234578999999998876
Q ss_pred -CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHH------------HHHHHHhh-----------cccchHHHhhcC
Q 013092 160 -IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQ------------KYEKISEK-----------KVSTSIEALCRG 215 (449)
Q Consensus 160 -~~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~------------~~~~i~~~-----------~~~~~~~~l~~~ 215 (449)
..++.++|||||||++|+|++|..||.......... .+..+... .....+..+.+.
T Consensus 184 ~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (332)
T cd07857 184 FQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPN 263 (332)
T ss_pred CCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCC
Confidence 468999999999999999999999997643211110 11111000 001122333455
Q ss_pred CcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 013092 216 YPTEFASYFHYCRSLRFDDKPDYAYLK 242 (449)
Q Consensus 216 ~p~el~~li~~cl~~~p~~RPt~~~l~ 242 (449)
++.++.+++..|++.+|.+||++.+++
T Consensus 264 ~~~~~~~li~~~l~~~P~~R~t~~~ll 290 (332)
T cd07857 264 ANPLALDLLEKLLAFDPTKRISVEEAL 290 (332)
T ss_pred CCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 688999999999999999999988774
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-31 Score=262.51 Aligned_cols=214 Identities=20% Similarity=0.281 Sum_probs=167.9
Q ss_pred ChhHHHHHHHHHHHhcCCCCCceEEEEeEe--CCEEEEEEecC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHH
Q 013092 17 KHPQLLYESKLYRILQGGTGIPNVRWFGVE--GDYNVLVMDLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEF 90 (449)
Q Consensus 17 ~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~--~~~~~lVmE~~-g~sL~~ll~~~---~~~ls~~~~~~i~~qi~~aL~y 90 (449)
....+.+|+++++.+ +|+||+++++++.+ ....||||||+ +++|.+++... ...++...+..++.||+.||.|
T Consensus 42 ~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~ 120 (287)
T cd06621 42 LQKQILRELEINKSC-KSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSY 120 (287)
T ss_pred HHHHHHHHHHHHHhC-CCCCeeeeeeEEEccCCCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence 345689999999999 89999999988764 44789999999 99999987532 3558999999999999999999
Q ss_pred HHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHH
Q 013092 91 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLES 170 (449)
Q Consensus 91 LH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwS 170 (449)
||+.|++|+||+|+||++ +..+.++|+|||++........ ....++..|++||.+.+..++.++||||
T Consensus 121 lH~~~i~H~dl~~~nil~---~~~~~~~l~dfg~~~~~~~~~~---------~~~~~~~~y~~pE~~~~~~~~~~~Dv~s 188 (287)
T cd06621 121 LHSRKIIHRDIKPSNILL---TRKGQVKLCDFGVSGELVNSLA---------GTFTGTSFYMAPERIQGKPYSITSDVWS 188 (287)
T ss_pred HHHCCcccCCCCHHHEEE---ecCCeEEEeecccccccccccc---------ccccCCccccCHHHhcCCCCCchhhHHH
Confidence 999999999999999999 5778899999999875543211 2345788999999999989999999999
Q ss_pred HHHHHHHHHhCCCCCCCCCc--CCHHHHHHHHHhhcccchHHHhh--cCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 171 LGYVLMYFLRGSLPWQGLKA--GTKKQKYEKISEKKVSTSIEALC--RGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 171 lG~il~elltG~~Pf~~~~~--~~~~~~~~~i~~~~~~~~~~~l~--~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
|||++|+|++|..||..... ....+....+............. ..+++++.++|..||..+|++||++.+|.+
T Consensus 189 lG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 189 LGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred HHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 99999999999999986532 12222222222211111100111 235678999999999999999999887754
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=283.89 Aligned_cols=212 Identities=17% Similarity=0.273 Sum_probs=179.2
Q ss_pred CCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH
Q 013092 15 KTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 93 (449)
Q Consensus 15 ~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~ 93 (449)
.+..+.++-|++||..+ +||+||+|++.+...+.+||+.||| ||-...++-..++.+++..+..+++|++.||.|||+
T Consensus 70 eEELEDylVEIeILa~C-dHP~ivkLl~ayy~enkLwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs 148 (1187)
T KOG0579|consen 70 EEELEDYLVEIEILAEC-DHPVIVKLLSAYYFENKLWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHS 148 (1187)
T ss_pred hhHHhhhhhhhhhhhcC-CChHHHHHHHHHhccCceEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhh
Confidence 35567799999999999 8999999999999999999999999 888888887778899999999999999999999999
Q ss_pred CCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhh-----CCCCChhhHH
Q 013092 94 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHL-----GIEQSRRDDL 168 (449)
Q Consensus 94 ~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~-----~~~~s~~~Di 168 (449)
++|||||||..|||+ .-+|.|+|+|||.+-+..... .....+.|||.|||||+.. ..+|+.++||
T Consensus 149 ~~iIHRDLKAGNiL~---TldGdirLADFGVSAKn~~t~-------qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDi 218 (1187)
T KOG0579|consen 149 QNIIHRDLKAGNILL---TLDGDIRLADFGVSAKNKSTR-------QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADI 218 (1187)
T ss_pred cchhhhhccccceEE---EecCcEeeecccccccchhHH-------hhhccccCCcccccchheeeccccCCCchhhhhH
Confidence 999999999999999 477899999999876543321 1235789999999999865 5689999999
Q ss_pred HHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 013092 169 ESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 242 (449)
Q Consensus 169 wSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~ 242 (449)
||||++|+||..+.+|.+.+++. ..+.+|.....++. ..+..++..|.+|+..||..||+.||+..+|+
T Consensus 219 WSlGITLIEMAqiEPPHhelnpM---RVllKiaKSePPTL--lqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll 287 (1187)
T KOG0579|consen 219 WSLGITLIEMAQIEPPHHELNPM---RVLLKIAKSEPPTL--LQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLL 287 (1187)
T ss_pred HhhhhHHHHHhccCCCccccchH---HHHHHHhhcCCCcc--cCcchhhhHHHHHHHHHHhcCCccCCCHHHHh
Confidence 99999999999999999887653 23334443333222 23456788999999999999999999998875
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-31 Score=260.33 Aligned_cols=213 Identities=20% Similarity=0.237 Sum_probs=169.6
Q ss_pred ChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecCCCCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHC
Q 013092 17 KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCS--RKLSLKTVLMLADQMINRVEFVHSK 94 (449)
Q Consensus 17 ~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~g~sL~~ll~~~~--~~ls~~~~~~i~~qi~~aL~yLH~~ 94 (449)
....+.+|+.+++.+ +|+||+++++.+.+.+..||||||+.++|.+++.... ..+++..++.++.|++.||+|||+.
T Consensus 41 ~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~ 119 (284)
T cd07836 41 TPSTAIREISLMKEL-KHENIVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN 119 (284)
T ss_pred chHHHHHHHHHHHhh-cCCCEeeeeeeEeeCCcEEEEEecCCccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC
Confidence 345678899999999 8999999999999999999999999779999887533 4589999999999999999999999
Q ss_pred CceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCC-CCChhhHHHHHHH
Q 013092 95 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGY 173 (449)
Q Consensus 95 givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~-~~s~~~DiwSlG~ 173 (449)
||+|+||||+||++ +.++.++|+|||++........ ......++..|++||++.+. .++.++|||||||
T Consensus 120 ~i~h~dl~p~ni~~---~~~~~~~l~d~g~~~~~~~~~~-------~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~ 189 (284)
T cd07836 120 RVLHRDLKPQNLLI---NKRGELKLADFGLARAFGIPVN-------TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGC 189 (284)
T ss_pred CeeeCCCCHHHEEE---CCCCcEEEeecchhhhhcCCcc-------ccccccccccccChHHhcCCCCCCcHHHHHHHHH
Confidence 99999999999999 5788999999999975543211 11234578899999998764 4688999999999
Q ss_pred HHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcc------------------------cchHHHhhcCCcHHHHHHHHHHhc
Q 013092 174 VLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV------------------------STSIEALCRGYPTEFASYFHYCRS 229 (449)
Q Consensus 174 il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~------------------------~~~~~~l~~~~p~el~~li~~cl~ 229 (449)
++|+|++|..||.+.+.. +.+.++.+... ......+.+.++.++.++|..|++
T Consensus 190 ~l~~l~~g~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 266 (284)
T cd07836 190 IMAEMITGRPLFPGTNNE---DQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQ 266 (284)
T ss_pred HHHHHHhCCCCCCCCCcH---HHHHHHHHHhCCCChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhc
Confidence 999999999999875432 22222211100 011122234568889999999999
Q ss_pred CCCCCCCCHHHHHH
Q 013092 230 LRFDDKPDYAYLKR 243 (449)
Q Consensus 230 ~~p~~RPt~~~l~~ 243 (449)
.+|++||++.+|.+
T Consensus 267 ~~p~~R~~~~~~l~ 280 (284)
T cd07836 267 LNPELRISAHDALQ 280 (284)
T ss_pred CCcccCCCHHHHhc
Confidence 99999999887753
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-31 Score=259.17 Aligned_cols=209 Identities=22% Similarity=0.252 Sum_probs=166.6
Q ss_pred hHHHHHHHHHHHhcCCCCCceEEEEeEe--CCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 013092 19 PQLLYESKLYRILQGGTGIPNVRWFGVE--GDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 95 (449)
Q Consensus 19 ~~~~~E~~il~~l~~hp~Iv~l~~~~~~--~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~g 95 (449)
..+.+|+.+++.+ +|+||+++++++.+ ....++||||+ +++|.+++.. ...+++..++.++.|++.||+|||+++
T Consensus 49 ~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~ 126 (265)
T cd06652 49 NALECEIQLLKNL-LHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKS-YGALTENVTRKYTRQILEGVSYLHSNM 126 (265)
T ss_pred HHHHHHHHHHHhc-CCCCeeeEEeEeccCCCceEEEEEEecCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 4678899999999 99999999998876 35788999999 8999999875 356899999999999999999999999
Q ss_pred ceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHHH
Q 013092 96 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVL 175 (449)
Q Consensus 96 ivHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il 175 (449)
|+|+||||+||++ +.++.++|+|||+++........ ........|+..|+|||++.+..++.++|||||||++
T Consensus 127 i~H~dl~p~nil~---~~~~~~~l~Dfg~~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il 199 (265)
T cd06652 127 IVHRDIKGANILR---DSVGNVKLGDFGASKRLQTICLS----GTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTV 199 (265)
T ss_pred EecCCCCHHHEEe---cCCCCEEECcCcccccccccccc----ccccccCCCCccccChhhhcCCCCCcchhHHHHHHHH
Confidence 9999999999999 57889999999998865432111 0112335688999999999988899999999999999
Q ss_pred HHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 176 MYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 176 ~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
|+|++|+.||..... ...+..+.... ....++..++..+.+++..||. +|++||++++|++
T Consensus 200 ~el~~g~~p~~~~~~---~~~~~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 200 VEMLTEKPPWAEFEA---MAAIFKIATQP---TNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred HHHhhCCCCCCccch---HHHHHHHhcCC---CCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 999999999976422 22222222211 1122334567789999999994 8999999888754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-32 Score=261.98 Aligned_cols=212 Identities=17% Similarity=0.196 Sum_probs=169.3
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecCCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSF 96 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~g~sL~~ll~~~~-~~ls~~~~~~i~~qi~~aL~yLH~~gi 96 (449)
...+.+|+++++.+ +|+||+++++++.+++..|+||||++++|.+++.... ..+++..++.++.|++.||+|||++++
T Consensus 42 ~~~~~~E~~~l~~l-~~~~iv~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~ 120 (283)
T cd07835 42 PSTAIREISLLKEL-NHPNIVRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRV 120 (283)
T ss_pred hhHHHHHHHHHHhc-CCCCccCHhheeccCCeEEEEEeccCcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 35688999999999 8999999999999999999999999889999987532 368999999999999999999999999
Q ss_pred eecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCC-CCChhhHHHHHHHHH
Q 013092 97 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVL 175 (449)
Q Consensus 97 vHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~-~~s~~~DiwSlG~il 175 (449)
+|+||+|.||++ +.++.++|+|||+++.+..... ......++..|+|||++.+. .++.++||||||+++
T Consensus 121 ~H~dl~p~nil~---~~~~~~~l~df~~~~~~~~~~~-------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l 190 (283)
T cd07835 121 LHRDLKPQNLLI---DREGALKLADFGLARAFGVPVR-------TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIF 190 (283)
T ss_pred eCCCCCHHHEEE---cCCCcEEEeecccccccCCCcc-------ccCccccccCCCCCceeecCcccCcHHHHHHHHHHH
Confidence 999999999999 5688999999999976543211 11223568899999988764 568899999999999
Q ss_pred HHHHhCCCCCCCCCcCCHHHHHHHHHhh------------------------cccchHHHhhcCCcHHHHHHHHHHhcCC
Q 013092 176 MYFLRGSLPWQGLKAGTKKQKYEKISEK------------------------KVSTSIEALCRGYPTEFASYFHYCRSLR 231 (449)
Q Consensus 176 ~elltG~~Pf~~~~~~~~~~~~~~i~~~------------------------~~~~~~~~l~~~~p~el~~li~~cl~~~ 231 (449)
|+|++|..||...... ..+.++.+. ............++.++.++|.+||+.+
T Consensus 191 ~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 267 (283)
T cd07835 191 AEMVNRRPLFPGDSEI---DQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYD 267 (283)
T ss_pred HHHHhCCCCCCCCCHH---HHHHHHHHHhCCCChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCC
Confidence 9999999999764321 111111111 0011222334567889999999999999
Q ss_pred CCCCCCHHHHHH
Q 013092 232 FDDKPDYAYLKR 243 (449)
Q Consensus 232 p~~RPt~~~l~~ 243 (449)
|++||++.++.+
T Consensus 268 P~~Rpt~~~il~ 279 (283)
T cd07835 268 PAKRISAKAALQ 279 (283)
T ss_pred hhhCcCHHHHhc
Confidence 999999887753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-31 Score=261.67 Aligned_cols=211 Identities=19% Similarity=0.317 Sum_probs=173.3
Q ss_pred ChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 013092 17 KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 95 (449)
Q Consensus 17 ~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~g 95 (449)
....+.+|+++++.+ +|+||+++++.+......|+||||+ +++|.+++......+++..++.++.|++.||.|||+.|
T Consensus 58 ~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~g 136 (286)
T cd06614 58 NKELIINEILIMKDC-KHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQN 136 (286)
T ss_pred hHHHHHHHHHHHHHC-CCCCeeEEEEEEEECCEEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 456789999999999 8999999999999999999999999 89999999864447999999999999999999999999
Q ss_pred ceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHHH
Q 013092 96 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVL 175 (449)
Q Consensus 96 ivHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il 175 (449)
|+|+||||+||++ +.++.++|+|||++........ ......++..|++||++.+..++.++|+||||+++
T Consensus 137 i~H~dl~p~ni~i---~~~~~~~l~d~~~~~~~~~~~~-------~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil 206 (286)
T cd06614 137 VIHRDIKSDNILL---SKDGSVKLADFGFAAQLTKEKS-------KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMC 206 (286)
T ss_pred eeeCCCChhhEEE---cCCCCEEECccchhhhhccchh-------hhccccCCcccCCHhHhcCCCCCCccccHHHHHHH
Confidence 9999999999999 5788999999999865543221 11234578899999999988899999999999999
Q ss_pred HHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 176 MYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 176 ~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
|+|++|..||..... ......+....... . .....++.++.++|..||+.+|.+||++.+|++
T Consensus 207 ~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~-~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 207 IEMAEGEPPYLREPP---LRALFLITTKGIPP-L-KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred HHHHhCCCCCCCCCH---HHHHHHHHhcCCCC-C-cchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 999999999976432 22222232222111 1 112347899999999999999999999888754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-31 Score=259.59 Aligned_cols=212 Identities=22% Similarity=0.354 Sum_probs=171.0
Q ss_pred hHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q 013092 19 PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFL 97 (449)
Q Consensus 19 ~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~giv 97 (449)
+.+..|+.+++.+ +|+||+++++++...+..++||||+ +++|.+++... ..++...+..++.|++.||.|||+++++
T Consensus 53 ~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~ 130 (272)
T cd06629 53 KALRSEIETLKDL-DHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLHSKGIL 130 (272)
T ss_pred HHHHHHHHHHHhc-CCCCcceEEEEeccCCceEEEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCCee
Confidence 3578899999999 8999999999999999999999999 99999999863 5799999999999999999999999999
Q ss_pred ecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCC--CChhhHHHHHHHHH
Q 013092 98 HRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIE--QSRRDDLESLGYVL 175 (449)
Q Consensus 98 HRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~--~s~~~DiwSlG~il 175 (449)
|+||||+||++ +.++.++|+|||+++........ .......|+..|++||++.... ++.++|+||||+++
T Consensus 131 H~dl~~~nil~---~~~~~~~l~d~~~~~~~~~~~~~-----~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l 202 (272)
T cd06629 131 HRDLKADNLLV---DADGICKISDFGISKKSDDIYDN-----DQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVV 202 (272)
T ss_pred ecCCChhhEEE---cCCCeEEEeeccccccccccccc-----cccccccCCccccCHHHhccccCCCCccchhHHHHHHH
Confidence 99999999999 57889999999999765432111 1123456889999999988754 78899999999999
Q ss_pred HHHHhCCCCCCCCCcCCHHHHHHHHHhhc-ccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 176 MYFLRGSLPWQGLKAGTKKQKYEKISEKK-VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 176 ~elltG~~Pf~~~~~~~~~~~~~~i~~~~-~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
|++++|..||..... ...+..+.... ...........++.++.++|..||..+|++||++.++++
T Consensus 203 ~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 203 LEMFAGRRPWSDEEA---IAAMFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred HHHHhCCCCCcCcch---HHHHHHhhccccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 999999999965322 22222222111 111122334567899999999999999999999888754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-31 Score=262.32 Aligned_cols=209 Identities=19% Similarity=0.293 Sum_probs=172.2
Q ss_pred ChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 013092 17 KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 95 (449)
Q Consensus 17 ~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~g 95 (449)
....+.+|+.+++.+ +|+||+++++++..++..|+||||+ |++|.+++.. .++++..+..++.|++.||+|||++|
T Consensus 59 ~~~~~~~e~~~l~~~-~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~ 135 (285)
T cd06648 59 RRELLFNEVVIMRDY-QHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTH--TRMNEEQIATVCLAVLKALSFLHAQG 135 (285)
T ss_pred HHHHHHHHHHHHHHc-CCCChheEEEEEEcCCeEEEEEeccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 345688999999999 8999999999999999999999999 9999999884 57899999999999999999999999
Q ss_pred ceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHHH
Q 013092 96 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVL 175 (449)
Q Consensus 96 ivHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il 175 (449)
|+||||||.||++ +.++.++|+|||++........ ......|+..|++||++.+..++.++|||||||++
T Consensus 136 i~H~dl~p~Nil~---~~~~~~~l~d~g~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l 205 (285)
T cd06648 136 VIHRDIKSDSILL---TSDGRVKLSDFGFCAQVSKEVP-------RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMV 205 (285)
T ss_pred eecCCCChhhEEE---cCCCcEEEcccccchhhccCCc-------ccccccCCccccCHHHhcCCCCCCcccHHHHHHHH
Confidence 9999999999999 5788999999998875443211 11235689999999999988899999999999999
Q ss_pred HHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 176 MYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 176 ~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
|+|++|..||.... ....+..+...... .. .....++.++.++|..||..+|++||++.+|++
T Consensus 206 ~ell~g~~p~~~~~---~~~~~~~~~~~~~~-~~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 206 IEMVDGEPPYFNEP---PLQAMKRIRDNLPP-KL-KNLHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred HHHHhCCCCCcCCC---HHHHHHHHHhcCCC-CC-cccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 99999999997633 23333333332111 11 112347889999999999999999999887754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-33 Score=279.27 Aligned_cols=205 Identities=20% Similarity=0.281 Sum_probs=175.0
Q ss_pred ChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 013092 17 KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 96 (449)
Q Consensus 17 ~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gi 96 (449)
+-+.++.|++.|++| .|||++...+++......|||||||-|+-.|++.-..+++-+.++..|+.+.+.||+|||+.+.
T Consensus 69 KWqDIlKEVrFL~~l-~HPntieYkgCyLre~TaWLVMEYClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~ 147 (948)
T KOG0577|consen 69 KWQDILKEVRFLRQL-RHPNTIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNR 147 (948)
T ss_pred HHHHHHHHHHHHHhc-cCCCcccccceeeccchHHHHHHHHhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhH
Confidence 344589999999999 9999999999999999999999999888889988777889999999999999999999999999
Q ss_pred eecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhC---CCCChhhHHHHHHH
Q 013092 97 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG---IEQSRRDDLESLGY 173 (449)
Q Consensus 97 vHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~---~~~s~~~DiwSlG~ 173 (449)
||||||..|||+ ...+.|||+|||.|..... ...++|||.|||||+++. +.|+-++||||||+
T Consensus 148 IHRDiKAGNILL---se~g~VKLaDFGSAsi~~P-----------AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGI 213 (948)
T KOG0577|consen 148 IHRDIKAGNILL---SEPGLVKLADFGSASIMAP-----------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGI 213 (948)
T ss_pred HhhhccccceEe---cCCCeeeeccccchhhcCc-----------hhcccCCccccchhHheeccccccCCccceeeccc
Confidence 999999999999 5899999999999865432 357899999999999874 56999999999999
Q ss_pred HHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 013092 174 VLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 242 (449)
Q Consensus 174 il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~ 242 (449)
+++||...++|+..+++.. ..|. |.+...++.- ...++..|+.|+..||+.-|.+||+.++++
T Consensus 214 TCIELAERkPPlFnMNAMS--ALYH-IAQNesPtLq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll 276 (948)
T KOG0577|consen 214 TCIELAERKPPLFNMNAMS--ALYH-IAQNESPTLQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELL 276 (948)
T ss_pred hhhhhhhcCCCccCchHHH--HHHH-HHhcCCCCCC---CchhHHHHHHHHHHHHhhCcccCCcHHHHh
Confidence 9999999999998876532 3332 3332222111 245788999999999999999999988764
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-31 Score=270.72 Aligned_cols=209 Identities=20% Similarity=0.280 Sum_probs=165.1
Q ss_pred ChhHHHHHHHHHHHhcCCCCCceEEEEeEeC------CEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHH
Q 013092 17 KHPQLLYESKLYRILQGGTGIPNVRWFGVEG------DYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEF 90 (449)
Q Consensus 17 ~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~------~~~~lVmE~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~y 90 (449)
....+.+|+.+++.+ +|+||+++++++... ...||||||++++|.+++.. .++...+..++.|++.||+|
T Consensus 58 ~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~---~l~~~~~~~~~~ql~~aL~~ 133 (353)
T cd07850 58 HAKRAYRELVLMKLV-NHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQM---DLDHERMSYLLYQMLCGIKH 133 (353)
T ss_pred HHHHHHHHHHHHHhc-CCCCCcceeeeeccCCCccccCcEEEEEeccCCCHHHHHhh---cCCHHHHHHHHHHHHHHHHH
Confidence 345677899999999 999999999887633 35799999998899998873 28999999999999999999
Q ss_pred HHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHH
Q 013092 91 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLES 170 (449)
Q Consensus 91 LH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwS 170 (449)
||++||+||||||+||++ +.++.+||+|||+++....... .....++..|+|||++.+..++.++||||
T Consensus 134 LH~~gi~H~dlkp~Nil~---~~~~~~kL~Dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~Dvws 202 (353)
T cd07850 134 LHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFM--------MTPYVVTRYYRAPEVILGMGYKENVDIWS 202 (353)
T ss_pred HHhCCeeeCCCCHHHEEE---CCCCCEEEccCccceeCCCCCC--------CCCCcccccccCHHHHhCCCCCCchhhHh
Confidence 999999999999999999 6788999999999987644221 23346889999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccc-------------------------hHHHh-------------
Q 013092 171 LGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST-------------------------SIEAL------------- 212 (449)
Q Consensus 171 lG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~-------------------------~~~~l------------- 212 (449)
|||++|+|++|+.||...+. ...+.++......+ .+..+
T Consensus 203 lG~~l~~l~~g~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (353)
T cd07850 203 VGCIMGEMIRGTVLFPGTDH---IDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESH 279 (353)
T ss_pred HHHHHHHHHHCCCCCCCCCH---HHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccc
Confidence 99999999999999976432 22222221110000 00000
Q ss_pred hcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 213 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 213 ~~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
....+.++.++|..||..||.+||++.+++.
T Consensus 280 ~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~ 310 (353)
T cd07850 280 NKLKASQARDLLSKMLVIDPEKRISVDDALQ 310 (353)
T ss_pred cccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 1134667899999999999999999887754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-31 Score=262.72 Aligned_cols=223 Identities=20% Similarity=0.195 Sum_probs=170.1
Q ss_pred CChhHHHHHHHHHHHhcCCCCCceEEEEeEeC--CEEEEEEecCCCCHHHHHHHcC----CCCCHHHHHHHHHHHHHHHH
Q 013092 16 TKHPQLLYESKLYRILQGGTGIPNVRWFGVEG--DYNVLVMDLLGPSLEDLFNFCS----RKLSLKTVLMLADQMINRVE 89 (449)
Q Consensus 16 ~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~--~~~~lVmE~~g~sL~~ll~~~~----~~ls~~~~~~i~~qi~~aL~ 89 (449)
...+.+.+|+.++..+ +||||+++++++.+. ...||||||++++|.+++.... ..+++..++.++.||+.||.
T Consensus 44 ~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~ 122 (316)
T cd07842 44 GISQSACREIALLREL-KHENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVH 122 (316)
T ss_pred CccHHHHHHHHHHHhc-CCCCccceEEEEeCCCCceEEEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHH
Confidence 3446788999999999 899999999999988 8899999999888988876431 26899999999999999999
Q ss_pred HHHHCCceecCCCCCcEEEee-cCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCC-CCChhhH
Q 013092 90 FVHSKSFLHRDIKPDNFLMGL-GRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDD 167 (449)
Q Consensus 90 yLH~~givHRDLKP~NiLl~~-~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~-~~s~~~D 167 (449)
|||+++|+||||||+|||+.. ++..+.+||+|||++......... ........++..|+|||++.+. .++.++|
T Consensus 123 ~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~D 198 (316)
T cd07842 123 YLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKP----LADLDPVVVTIWYRAPELLLGARHYTKAID 198 (316)
T ss_pred HHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccccccCCCccc----ccccCCccccccccCHHHHhCCCCCCcHHH
Confidence 999999999999999999942 112789999999999876543221 1123445788999999998774 5789999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCCcCC------HHHHHHHHHhhc----------------------------cc-chHHH-
Q 013092 168 LESLGYVLMYFLRGSLPWQGLKAGT------KKQKYEKISEKK----------------------------VS-TSIEA- 211 (449)
Q Consensus 168 iwSlG~il~elltG~~Pf~~~~~~~------~~~~~~~i~~~~----------------------------~~-~~~~~- 211 (449)
||||||++|+|++|..||.+..... ....+..+.+.. .. ..+..
T Consensus 199 v~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (316)
T cd07842 199 IWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKW 278 (316)
T ss_pred HHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHH
Confidence 9999999999999999998654332 001111111100 00 00001
Q ss_pred hh--cCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 212 LC--RGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 212 l~--~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
.. ...+.++.+++..||+.+|++||++.++..
T Consensus 279 ~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 279 MEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 11 156778999999999999999999888754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-31 Score=261.25 Aligned_cols=205 Identities=15% Similarity=0.217 Sum_probs=165.2
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 96 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gi 96 (449)
...+..|+++++.+.+|++|+.+++++..+...||||||+ +++|.+++.. ...+++..+..++.|++.||.|||+.|+
T Consensus 48 ~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~al~~lH~~~i 126 (290)
T cd05613 48 TEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQ-RERFKEQEVQIYSGEIVLALEHLHKLGI 126 (290)
T ss_pred HHHHHHHHHHHHhcccCCChhceeeEeecCCeEEEEEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 4567889999999988999999999999999999999999 8999999875 4568999999999999999999999999
Q ss_pred eecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCC--CCChhhHHHHHHHH
Q 013092 97 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI--EQSRRDDLESLGYV 174 (449)
Q Consensus 97 vHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~--~~s~~~DiwSlG~i 174 (449)
+||||||+|||+ +.++.++|+|||++......... ......|+..|++||.+.+. .++.++||||||++
T Consensus 127 ~H~dl~p~nil~---~~~~~~kl~dfg~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~ 197 (290)
T cd05613 127 IYRDIKLENILL---DSNGHVVLTDFGLSKEFHEDEVE------RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVL 197 (290)
T ss_pred eccCCCHHHeEE---CCCCCEEEeeCccceeccccccc------ccccccCCcccCChhhccCCCCCCCccccHHHHHHH
Confidence 999999999999 57789999999999876443211 11245688999999998753 36789999999999
Q ss_pred HHHHHhCCCCCCCCCcCCH-HHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCC
Q 013092 175 LMYFLRGSLPWQGLKAGTK-KQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPD 237 (449)
Q Consensus 175 l~elltG~~Pf~~~~~~~~-~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt 237 (449)
+|+|++|..||........ ......+... ...+...++..+.+++.+||..+|++||+
T Consensus 198 l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~ll~~~l~~~p~~R~~ 256 (290)
T cd05613 198 MYELLTGASPFTVDGEKNSQAEISRRILKS-----EPPYPQEMSALAKDIIQRLLMKDPKKRLG 256 (290)
T ss_pred HHHHhcCCCCCCcCCccccHHHHHHHhhcc-----CCCCCccCCHHHHHHHHHHhcCCHHHhcC
Confidence 9999999999965322211 1111111111 11234557889999999999999999973
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-31 Score=263.30 Aligned_cols=219 Identities=18% Similarity=0.189 Sum_probs=165.3
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeCC--------EEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHH
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEGD--------YNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVE 89 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~--------~~~lVmE~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~ 89 (449)
...+.+|+++++.+ .||||+++++++...+ ..|+||||++++|.+++......+++.+++.++.|++.||+
T Consensus 55 ~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~ 133 (310)
T cd07865 55 PITALREIKILQLL-KHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLY 133 (310)
T ss_pred hhHHHHHHHHHHhC-CCCCccceEEEEecccccccCCCceEEEEEcCCCcCHHHHHHhcccCCCHHHHHHHHHHHHHHHH
Confidence 44567899999999 9999999999876543 45999999988999988765557999999999999999999
Q ss_pred HHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCC-CCChhhHH
Q 013092 90 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDL 168 (449)
Q Consensus 90 yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~-~~s~~~Di 168 (449)
|||++|++|+||||+||++ +.++.+||+|||++..+........ .......++..|+|||.+.+. .++.++||
T Consensus 134 ~lH~~~i~H~dl~p~nil~---~~~~~~kl~dfg~~~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di 207 (310)
T cd07865 134 YIHRNKILHRDMKAANILI---TKDGILKLADFGLARAFSLSKNSKP---NRYTNRVVTLWYRPPELLLGERDYGPPIDM 207 (310)
T ss_pred HHHHCCeeccCCCHHHEEE---CCCCcEEECcCCCcccccCCcccCC---CCccCcccCccccCcHHhcCCcccCchhhh
Confidence 9999999999999999999 5788999999999987654322110 112344678899999998764 36889999
Q ss_pred HHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccc------------------h----H-HHhh-cCCcHHHHHHH
Q 013092 169 ESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST------------------S----I-EALC-RGYPTEFASYF 224 (449)
Q Consensus 169 wSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~------------------~----~-~~l~-~~~p~el~~li 224 (449)
||||+++|+|++|..||.+.........+..+....... . . ..+. ......+.++|
T Consensus 208 ~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli 287 (310)
T cd07865 208 WGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLI 287 (310)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHH
Confidence 999999999999999997644322222222211100000 0 0 0000 11246778999
Q ss_pred HHHhcCCCCCCCCHHHHHH
Q 013092 225 HYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 225 ~~cl~~~p~~RPt~~~l~~ 243 (449)
..||..+|++||++.++.+
T Consensus 288 ~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 288 DKLLVLDPAKRIDADTALN 306 (310)
T ss_pred HHHhcCChhhccCHHHHhc
Confidence 9999999999999887753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-32 Score=264.31 Aligned_cols=210 Identities=20% Similarity=0.344 Sum_probs=166.3
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecCCCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHC
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSK 94 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~g~sL~~ll~~~---~~~ls~~~~~~i~~qi~~aL~yLH~~ 94 (449)
..++..|+.++.+..+|+||+++++++..++..|+||||+.++|.+++... ...+++..++.++.||+.||+|||++
T Consensus 43 ~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~ 122 (283)
T cd06617 43 QKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSK 122 (283)
T ss_pred HHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhc
Confidence 345777888766666999999999999999999999999988998888642 34689999999999999999999997
Q ss_pred -CceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhC----CCCChhhHHH
Q 013092 95 -SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG----IEQSRRDDLE 169 (449)
Q Consensus 95 -givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~----~~~s~~~Diw 169 (449)
+++||||||+||++ +.++.+||+|||++..+..... .....++..|+|||++.+ ..++.++|+|
T Consensus 123 ~~i~h~dlkp~nil~---~~~~~~kl~dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~ 191 (283)
T cd06617 123 LSVIHRDVKPSNVLI---NRNGQVKLCDFGISGYLVDSVA--------KTIDAGCKPYMAPERINPELNQKGYDVKSDVW 191 (283)
T ss_pred CCeecCCCCHHHEEE---CCCCCEEEeecccccccccccc--------cccccCCccccChhhcCCcccccccCccccch
Confidence 99999999999999 6788999999999986643221 123468889999999865 4468899999
Q ss_pred HHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 170 SLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 170 SlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
||||++|+|++|+.||..... ..+.+..+..... ... ....+|.++.++|..||..+|++||++.+|++
T Consensus 192 slG~~l~~l~~g~~p~~~~~~--~~~~~~~~~~~~~-~~~--~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 192 SLGITMIELATGRFPYDSWKT--PFQQLKQVVEEPS-PQL--PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred hhHHHHHHHHhCCCCCCcccc--CHHHHHHHHhcCC-CCC--CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 999999999999999965322 1222222222111 111 12347899999999999999999999988754
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-32 Score=265.80 Aligned_cols=204 Identities=19% Similarity=0.266 Sum_probs=167.5
Q ss_pred hHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q 013092 19 PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLH 98 (449)
Q Consensus 19 ~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~givH 98 (449)
..+.+|+++++.+ +||||+++.+++.+++..||||||+.++|.+++......+++..+..++.|++.||.|||+.||+|
T Consensus 60 ~~~~~Ei~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H 138 (307)
T cd06607 60 QDIIKEVRFLQQL-RHPNTIEYKGCYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIH 138 (307)
T ss_pred HHHHHHHHHHHhC-CCCCEEEEEEEEEeCCeEEEEHHhhCCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCcee
Confidence 4688999999999 899999999999999999999999988898888765667999999999999999999999999999
Q ss_pred cCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhh---CCCCChhhHHHHHHHHH
Q 013092 99 RDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHL---GIEQSRRDDLESLGYVL 175 (449)
Q Consensus 99 RDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~---~~~~s~~~DiwSlG~il 175 (449)
+||+|.||++ +.++.++|+|||++...... ....++..|+|||++. ...++.++||||||+++
T Consensus 139 ~dl~p~nIl~---~~~~~~kL~dfg~~~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il 204 (307)
T cd06607 139 RDIKAGNILL---TEPGTVKLADFGSASLVSPA-----------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITC 204 (307)
T ss_pred cCCCcccEEE---CCCCCEEEeecCcceecCCC-----------CCccCCccccCceeeeccCCCCCCcccchHHHHHHH
Confidence 9999999999 57789999999998754322 2346788999999875 35578899999999999
Q ss_pred HHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 176 MYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 176 ~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
|+|++|..||..... ......+....... .....++.++.++|..||..+|++||++.+|+.
T Consensus 205 ~el~tg~~p~~~~~~---~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 266 (307)
T cd06607 205 IELAERKPPLFNMNA---MSALYHIAQNDSPT---LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLK 266 (307)
T ss_pred HHHHcCCCCCCCccH---HHHHHHHhcCCCCC---CCchhhCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 999999999976432 11111222111111 112346889999999999999999999888854
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-32 Score=257.80 Aligned_cols=211 Identities=20% Similarity=0.229 Sum_probs=172.2
Q ss_pred CChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHH
Q 013092 16 TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHS 93 (449)
Q Consensus 16 ~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~-~~~ls~~~~~~i~~qi~~aL~yLH~ 93 (449)
.....+.+|+.+++.+ +|+||+++++.+......|+||||+ +++|.+++... ...+++..++.++.|++.||.|||+
T Consensus 41 ~~~~~~~~E~~~l~~~-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~ 119 (257)
T cd08225 41 KEKEASKKEVILLAKM-KHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHD 119 (257)
T ss_pred hhhHHHHHHHHHHHhC-CCCChhhhhheeccCCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 3456788999999999 8999999999999999999999999 99999998753 2358999999999999999999999
Q ss_pred CCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHH
Q 013092 94 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGY 173 (449)
Q Consensus 94 ~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~ 173 (449)
.+|+|+||||.||+++ +....++|+|||++......... .....|+..|+|||++.+..++.++|+||||+
T Consensus 120 ~~i~H~dl~~~nil~~--~~~~~~~l~d~~~~~~~~~~~~~-------~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~ 190 (257)
T cd08225 120 RKILHRDIKSQNIFLS--KNGMVAKLGDFGIARQLNDSMEL-------AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGC 190 (257)
T ss_pred CCcccccCCHHHEEEc--CCCCeEEecccccchhccCCccc-------ccccCCCccccCHHHHcCCCCCchhhHHHHHH
Confidence 9999999999999994 23346799999999876543211 12346889999999998888999999999999
Q ss_pred HHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 174 VLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 174 il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
++|+|++|..||..... .+.+..+.... .......++.++.++|.+||..+|++||++.+|..
T Consensus 191 il~~l~~g~~p~~~~~~---~~~~~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 191 VLYELCTLKHPFEGNNL---HQLVLKICQGY----FAPISPNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred HHHHHHhCCCCCCCccH---HHHHHHHhccc----CCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 99999999999976432 22333222222 22234567889999999999999999999888754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-32 Score=266.33 Aligned_cols=213 Identities=18% Similarity=0.350 Sum_probs=170.2
Q ss_pred ChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-CC
Q 013092 17 KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS-KS 95 (449)
Q Consensus 17 ~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~-~g 95 (449)
....+..|+.++..+.+|+||+.+++++.++...|+||||++++|.+++......+++..+..++.|++.||+|||+ .|
T Consensus 56 ~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~ 135 (296)
T cd06618 56 ENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHG 135 (296)
T ss_pred HHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeeccCcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC
Confidence 34557778888888878999999999999999999999999889999887656689999999999999999999997 69
Q ss_pred ceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCC----CChhhHHHHH
Q 013092 96 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIE----QSRRDDLESL 171 (449)
Q Consensus 96 ivHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~----~s~~~DiwSl 171 (449)
|+||||+|+||++ +.++.++|+|||++..+..... .....++..|+|||++.+.. ++.++|||||
T Consensus 136 i~H~dl~p~nill---~~~~~~kL~dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~sl 204 (296)
T cd06618 136 VIHRDVKPSNILL---DASGNVKLCDFGISGRLVDSKA--------KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSL 204 (296)
T ss_pred EecCCCcHHHEEE---cCCCCEEECccccchhccCCCc--------ccCCCCCccccCHhhcCCCCCccccccchhHHHH
Confidence 9999999999999 5788999999999876644322 12235788999999987654 7889999999
Q ss_pred HHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHH
Q 013092 172 GYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRI 244 (449)
Q Consensus 172 G~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~ 244 (449)
|+++|+|++|+.||..... ..+.+..+....... . .....++.++.+|+..||..+|++||++.++...
T Consensus 205 G~il~el~~g~~p~~~~~~--~~~~~~~~~~~~~~~-~-~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 205 GISLVELATGQFPYKNCKT--EFEVLTKILQEEPPS-L-PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred HHHHHHHHhCCCCCCcchh--HHHHHHHHhcCCCCC-C-CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 9999999999999965322 122233332221111 1 1112478999999999999999999999888643
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-31 Score=263.52 Aligned_cols=227 Identities=21% Similarity=0.213 Sum_probs=173.6
Q ss_pred EEEEEeeecccCCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCC----------EEEEEEecCCCCHHHHHHHcCCCCC
Q 013092 4 ILTVFSVQENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGD----------YNVLVMDLLGPSLEDLFNFCSRKLS 73 (449)
Q Consensus 4 aikV~~k~~~~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~----------~~~lVmE~~g~sL~~ll~~~~~~ls 73 (449)
|+|++.+..........+.+|+++++.+ +||||+++++++.+.. ..||||||++++|.+++......++
T Consensus 36 ~iK~~~~~~~~~~~~~~~~~e~~~~~~l-~h~~i~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~ 114 (302)
T cd07864 36 ALKKVRLDNEKEGFPITAIREIKILRQL-NHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFS 114 (302)
T ss_pred EEEEEeecccccCchHHHHHHHHHHHhC-CCCCeeeeeheecCcchhhhccccCCcEEEEEcccCccHHHHHhcCCCCCC
Confidence 4454443332233445678899999999 8999999998887654 8999999997788888875445799
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccc
Q 013092 74 LKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYAS 153 (449)
Q Consensus 74 ~~~~~~i~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~a 153 (449)
+..++.++.|++.||+|||+.||+|+||||.||++ +..+.+||+|||++..+...... ......++..|++
T Consensus 115 ~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili---~~~~~~kl~dfg~~~~~~~~~~~------~~~~~~~~~~y~~ 185 (302)
T cd07864 115 EDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILL---NNKGQIKLADFGLARLYNSEESR------PYTNKVITLWYRP 185 (302)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCcEEeCcccccccccCCccc------ccccceeccCccC
Confidence 99999999999999999999999999999999999 67889999999999876543210 1122346788999
Q ss_pred hhhhhCC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcc---cc----------------------
Q 013092 154 MNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV---ST---------------------- 207 (449)
Q Consensus 154 PE~~~~~-~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~---~~---------------------- 207 (449)
||++.+. .++.++|||||||++|+|++|+.||..... .+.+..+..... ..
T Consensus 186 PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (302)
T cd07864 186 PELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQE---LAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRR 262 (302)
T ss_pred hHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHhCCCChhhccccccccccccccccccccc
Confidence 9988754 468899999999999999999999976432 223333322111 00
Q ss_pred hHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 208 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 208 ~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
........+|.++.+++..||..+|++||++.+++.
T Consensus 263 ~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 263 RLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred chhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 111223457899999999999999999999888754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-31 Score=260.68 Aligned_cols=207 Identities=19% Similarity=0.280 Sum_probs=173.2
Q ss_pred ChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 013092 17 KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 95 (449)
Q Consensus 17 ~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~g 95 (449)
....+.+|++++..+ +|+||+++++++..+...|+||||+ +++|.+++. ...+++..++.++.|++.+|.|||+.|
T Consensus 45 ~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~i~--~~~~~~~~~~~~~~~l~~~l~~lh~~~ 121 (277)
T cd06641 45 EIEDIQQEITVLSQC-DSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE--PGPLDETQIATILREILKGLDYLHSEK 121 (277)
T ss_pred HHHHHHHHHHHHHhc-CCCCEeEEEEEEEeCCeEEEEEEeCCCCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHccCC
Confidence 345688999999999 9999999999999999999999999 889999987 456899999999999999999999999
Q ss_pred ceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHHH
Q 013092 96 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVL 175 (449)
Q Consensus 96 ivHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il 175 (449)
++|+||||.||++ +.++.++|+|||++..+..... ......++..|++||.+.+..++.++|+|||||++
T Consensus 122 i~h~dl~p~Ni~i---~~~~~~~l~dfg~~~~~~~~~~-------~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l 191 (277)
T cd06641 122 KIHRDIKAANVLL---SEHGEVKLADFGVAGQLTDTQI-------KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITA 191 (277)
T ss_pred eecCCCCHHhEEE---CCCCCEEEeecccceecccchh-------hhccccCCccccChhhhccCCCCchhhHHHHHHHH
Confidence 9999999999999 5778899999999876643221 11234688899999999988889999999999999
Q ss_pred HHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 176 MYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 176 ~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
|+|++|..||..... ......+.... .+.+...++.++.+++..||..+|++||++.++..
T Consensus 192 ~~l~~g~~p~~~~~~---~~~~~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 252 (277)
T cd06641 192 IELAKGEPPHSELHP---MKVLFLIPKNN----PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLK 252 (277)
T ss_pred HHHHcCCCCCCccch---HHHHHHHhcCC----CCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 999999999976432 22222222221 22234567899999999999999999999988876
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=309.16 Aligned_cols=225 Identities=20% Similarity=0.283 Sum_probs=183.0
Q ss_pred EEEEEeeecccCCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHH
Q 013092 4 ILTVFSVQENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLAD 82 (449)
Q Consensus 4 aikV~~k~~~~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~ 82 (449)
|+|.++.......-.+.+.+|.+++..| +|||+|..++.-++.+..+|.|||| ||+|.+++.. ++..++.....+..
T Consensus 1264 AvKEI~iq~~~~k~~~~i~eEm~vlE~l-nHpNlV~YyGVEvHRekv~IFMEyC~~GsLa~ll~~-gri~dE~vt~vyt~ 1341 (1509)
T KOG4645|consen 1264 AVKEIKIQDSDHKTFKLIAEEMKVLEGL-NHPNLVRYYGVEVHREKVYIFMEYCEGGSLASLLEH-GRIEDEMVTRVYTK 1341 (1509)
T ss_pred hhhhhhcCccccccCcchHHHHHHHHhc-cCccccccCceeecHHHHHHHHHHhccCcHHHHHHh-cchhhhhHHHHHHH
Confidence 3444444444445567789999999999 9999999999999999999999999 9999999985 45567777888999
Q ss_pred HHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCC-
Q 013092 83 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIE- 161 (449)
Q Consensus 83 qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~- 161 (449)
|++.||.|||+.|||||||||+||++ +.+|.+|+.|||.|+++..+.. .++ .+-....||+.|||||++.+..
T Consensus 1342 qll~gla~LH~~gIVHRDIK~aNI~L---d~~g~iK~~DFGsa~ki~~~~~--~~~-~el~~~~GT~~YMAPEvit~t~~ 1415 (1509)
T KOG4645|consen 1342 QLLEGLAYLHEHGIVHRDIKPANILL---DFNGLIKYGDFGSAVKIKNNAQ--TMP-GELQSMMGTPMYMAPEVITGTKG 1415 (1509)
T ss_pred HHHHHHHHHHhcCceecCCCccceee---ecCCcEEeecccceeEecCchh--cCC-HHHHhhcCCchhcCchhhccccc
Confidence 99999999999999999999999999 6788999999999999876531 112 2334678999999999998744
Q ss_pred --CChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHH
Q 013092 162 --QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYA 239 (449)
Q Consensus 162 --~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~ 239 (449)
-...+||||||||+.||+||+.||..++.. .+++.++.-. -.+.++..++.+-.+||..|+..||..|=++.
T Consensus 1416 kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne--~aIMy~V~~g----h~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~ 1489 (1509)
T KOG4645|consen 1416 KGHGGAADIWSLGCVVLEMATGKRPWAELDNE--WAIMYHVAAG----HKPQIPERLSSEGRDFLEHCLEQDPKMRWTAS 1489 (1509)
T ss_pred CCCCcchhhhcccceEEEeecCCCchhhccch--hHHHhHHhcc----CCCCCchhhhHhHHHHHHHHHhcCchhhhHHH
Confidence 467899999999999999999999887553 4444444333 33345556899999999999999999996555
Q ss_pred HHH
Q 013092 240 YLK 242 (449)
Q Consensus 240 ~l~ 242 (449)
||+
T Consensus 1490 qll 1492 (1509)
T KOG4645|consen 1490 QLL 1492 (1509)
T ss_pred HHH
Confidence 443
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=261.47 Aligned_cols=218 Identities=24% Similarity=0.269 Sum_probs=177.6
Q ss_pred EEEEEeeecccC-CChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHH
Q 013092 4 ILTVFSVQENVK-TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLA 81 (449)
Q Consensus 4 aikV~~k~~~~~-~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~ 81 (449)
|+|+..+..... .....+.+|+++++.+ +||||+.+++++.++...|+||||+ |++|.+++.. ...+++..++.++
T Consensus 29 ~ik~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~ 106 (258)
T cd05578 29 AMKYMNKQKCVEKGSVRNVLNERRILQEL-NHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQ-KVKFSEEQVKFWI 106 (258)
T ss_pred EEEEEehhhhcchhHHHHHHHHHHHHHhC-CCCChHHHHHhhcCCCeEEEEEeCCCCCCHHHHHHh-cCCcCHHHHHHHH
Confidence 455555433222 3456789999999999 9999999999999999999999999 9999999985 3579999999999
Q ss_pred HHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCC
Q 013092 82 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIE 161 (449)
Q Consensus 82 ~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~ 161 (449)
.|++.||.|||+.|++|+||||.||++ +.++.++|+|||++........ .....|+..|++||.+.+..
T Consensus 107 ~~i~~~l~~lh~~~i~h~dl~~~nil~---~~~~~~~l~d~~~~~~~~~~~~--------~~~~~~~~~y~~PE~~~~~~ 175 (258)
T cd05578 107 CEIVLALEYLHSKGIIHRDIKPDNILL---DEQGHVHITDFNIATKVTPDTL--------TTSTSGTPGYMAPEVLCRQG 175 (258)
T ss_pred HHHHHHHHHHHhCCeeccCCCHHHeEE---cCCCCEEEeecccccccCCCcc--------ccccCCChhhcCHHHHcccC
Confidence 999999999999999999999999999 5788999999999887654321 12356888999999999888
Q ss_pred CChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHH
Q 013092 162 QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYA 239 (449)
Q Consensus 162 ~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~ 239 (449)
++.++|+||||+++|+|++|..||.........+....... .....+..+|.++.++|.+||..+|++||+..
T Consensus 176 ~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~ 248 (258)
T cd05578 176 YSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET-----ADVLYPATWSTEAIDAINKLLERDPQKRLGDN 248 (258)
T ss_pred CCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc-----ccccCcccCcHHHHHHHHHHccCChhHcCCcc
Confidence 99999999999999999999999987654322222221111 22234456889999999999999999999983
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-31 Score=260.94 Aligned_cols=212 Identities=18% Similarity=0.267 Sum_probs=168.5
Q ss_pred ChhHHHHHHHHHHHhcCCCCCceEEEEeEeC-----CEEEEEEecC-CCCHHHHHHH---cCCCCCHHHHHHHHHHHHHH
Q 013092 17 KHPQLLYESKLYRILQGGTGIPNVRWFGVEG-----DYNVLVMDLL-GPSLEDLFNF---CSRKLSLKTVLMLADQMINR 87 (449)
Q Consensus 17 ~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~-----~~~~lVmE~~-g~sL~~ll~~---~~~~ls~~~~~~i~~qi~~a 87 (449)
....+..|+.+++.+.+|+||+++++++... +..|+||||+ +++|.++++. ....+++..++.++.|++.|
T Consensus 61 ~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~a 140 (291)
T cd06639 61 VDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLG 140 (291)
T ss_pred HHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHH
Confidence 3467889999999998999999999988743 4689999999 9999998863 24568999999999999999
Q ss_pred HHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCC-----CC
Q 013092 88 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI-----EQ 162 (449)
Q Consensus 88 L~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~-----~~ 162 (449)
|+|||+.||+|+||||+||++ +.++.++|+|||++......... .....|+..|+|||++... .+
T Consensus 141 l~~lH~~~ivH~dlkp~nili---~~~~~~kl~dfg~~~~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~ 210 (291)
T cd06639 141 LQHLHNNRIIHRDVKGNNILL---TTEGGVKLVDFGVSAQLTSTRLR-------RNTSVGTPFWMAPEVIACEQQYDYSY 210 (291)
T ss_pred HHHHHhCCeeccCCCHHHEEE---cCCCCEEEeecccchhccccccc-------ccCccCCccccChhhhcCCCCccccc
Confidence 999999999999999999999 57788999999998865432211 1234688999999998643 36
Q ss_pred ChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 013092 163 SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 242 (449)
Q Consensus 163 s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~ 242 (449)
+.++|||||||++|+|++|+.||..... .+.+.++....... ......++.++.++|..||+.+|++||++.+|.
T Consensus 211 ~~~~Di~slGvi~~el~~g~~p~~~~~~---~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il 285 (291)
T cd06639 211 DARCDVWSLGITAIELGDGDPPLFDMHP---VKTLFKIPRNPPPT--LLHPEKWCRSFNHFISQCLIKDFEARPSVTHLL 285 (291)
T ss_pred CCccchHHHHHHHHHHhhCCCCCCCCcH---HHHHHHHhcCCCCC--CCcccccCHHHHHHHHHHhhcChhhCcCHHHHh
Confidence 7899999999999999999999976432 23333333221111 011234677899999999999999999988875
Q ss_pred H
Q 013092 243 R 243 (449)
Q Consensus 243 ~ 243 (449)
.
T Consensus 286 ~ 286 (291)
T cd06639 286 E 286 (291)
T ss_pred c
Confidence 4
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-32 Score=260.86 Aligned_cols=213 Identities=20% Similarity=0.203 Sum_probs=173.7
Q ss_pred ChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 013092 17 KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 96 (449)
Q Consensus 17 ~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gi 96 (449)
....+..|+.+++.+ +|+||+++++++.++...|+||||+.++|.+++......+++..++.++.|++.||.|||+.+|
T Consensus 41 ~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i 119 (283)
T cd05118 41 IPKTALREIKLLKEL-NHPNIIKLLDVFRHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGI 119 (283)
T ss_pred hHHHHHHHHHHHHHh-cCCCcchHHHhhccCCCEEEEEeccCCCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 345788999999999 7999999999999999999999999779999988655689999999999999999999999999
Q ss_pred eecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCC-CCChhhHHHHHHHHH
Q 013092 97 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVL 175 (449)
Q Consensus 97 vHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~-~~s~~~DiwSlG~il 175 (449)
+|+||||+||++ +.++.++|+|||.+........ ......++..|++||.+.+. .++.++|+||||+++
T Consensus 120 ~H~dl~p~nili---~~~~~~~l~df~~~~~~~~~~~-------~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l 189 (283)
T cd05118 120 LHRDLKPENLLI---NTEGVLKLADFGLARSFGSPVR-------PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIF 189 (283)
T ss_pred eecCcCHHHEEE---CCCCcEEEeeeeeeEecCCCcc-------cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHH
Confidence 999999999999 5778999999999987755431 11234678899999999876 789999999999999
Q ss_pred HHHHhCCCCCCCCCcCCHHHHHHHHHhhc-------------------------ccchHHHhhcCCcHHHHHHHHHHhcC
Q 013092 176 MYFLRGSLPWQGLKAGTKKQKYEKISEKK-------------------------VSTSIEALCRGYPTEFASYFHYCRSL 230 (449)
Q Consensus 176 ~elltG~~Pf~~~~~~~~~~~~~~i~~~~-------------------------~~~~~~~l~~~~p~el~~li~~cl~~ 230 (449)
|+|++|+.||...+. .+.+.++.+.. .......+.+.++.++.++|..||..
T Consensus 190 ~~l~tg~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 266 (283)
T cd05118 190 AELLSRRPLFPGKSE---IDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHY 266 (283)
T ss_pred HHHHhCCCCCCCCCH---HHHHHHHHHHcCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhcc
Confidence 999999999976433 22222221110 01112233456789999999999999
Q ss_pred CCCCCCCHHHHHH
Q 013092 231 RFDDKPDYAYLKR 243 (449)
Q Consensus 231 ~p~~RPt~~~l~~ 243 (449)
+|.+||++.+|+.
T Consensus 267 ~P~~Rp~~~~ll~ 279 (283)
T cd05118 267 DPHKRITAEQALA 279 (283)
T ss_pred CcccCcCHHHHhh
Confidence 9999999988754
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-31 Score=256.48 Aligned_cols=228 Identities=22% Similarity=0.349 Sum_probs=176.9
Q ss_pred EEEEEeeecccCCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHH
Q 013092 4 ILTVFSVQENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLAD 82 (449)
Q Consensus 4 aikV~~k~~~~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~ 82 (449)
++|+..+..........+..|+.+++.+ +|+||+++++.+...+..++||||+ +++|.+++.. ...+++..+..++.
T Consensus 29 ~ik~~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~ 106 (264)
T cd06626 29 AVKEIRIQDNDPKTIKEIADEMKVLELL-KHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEH-GRILDEHVIRVYTL 106 (264)
T ss_pred EEEEEECcccchHHHHHHHHHHHHHHhC-CCCChhheeeeEecCCEEEEEEecCCCCcHHHHHhh-cCCCChHHHHHHHH
Confidence 3444433332223556789999999999 9999999999999999999999999 9999999985 34589999999999
Q ss_pred HHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCC-
Q 013092 83 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIE- 161 (449)
Q Consensus 83 qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~- 161 (449)
|++.||.|||+.||+|+||+|+||++ +..+.+||+|||++........... .......++..|++||++.+..
T Consensus 107 ~i~~~l~~lh~~~i~H~dl~~~nil~---~~~~~~kl~d~g~~~~~~~~~~~~~---~~~~~~~~~~~~~~PE~~~~~~~ 180 (264)
T cd06626 107 QLLEGLAYLHSHGIVHRDIKPANIFL---DHNGVIKLGDFGCAVKLKNNTTTMG---EEVQSLAGTPAYMAPEVITGGKG 180 (264)
T ss_pred HHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEcccccccccCCCCCccc---ccccCCcCCcCccChhhccCCCC
Confidence 99999999999999999999999999 5788999999999987654332110 0012356889999999998766
Q ss_pred --CChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHH
Q 013092 162 --QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYA 239 (449)
Q Consensus 162 --~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~ 239 (449)
++.++||||||+++|++++|..||..... .......+.... ...++ ....++.++.++|..||+.+|++||++.
T Consensus 181 ~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~--~~~~~~~~~~~~-~~~~~-~~~~~~~~~~~li~~~l~~~p~~R~~~~ 256 (264)
T cd06626 181 KGHGRAADIWSLGCVVLEMATGKRPWSELDN--EFQIMFHVGAGH-KPPIP-DSLQLSPEGKDFLDRCLESDPKKRPTAS 256 (264)
T ss_pred CCCCcccchHHHHHHHHHHHhCCCCccCCcc--hHHHHHHHhcCC-CCCCC-cccccCHHHHHHHHHHccCCcccCCCHH
Confidence 78999999999999999999999976532 122222222211 11111 1123588999999999999999999988
Q ss_pred HHHH
Q 013092 240 YLKR 243 (449)
Q Consensus 240 ~l~~ 243 (449)
++..
T Consensus 257 ~i~~ 260 (264)
T cd06626 257 ELLQ 260 (264)
T ss_pred HHhc
Confidence 8753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-31 Score=256.32 Aligned_cols=211 Identities=21% Similarity=0.306 Sum_probs=172.4
Q ss_pred hHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHH-
Q 013092 19 PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHS- 93 (449)
Q Consensus 19 ~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~---~~~~ls~~~~~~i~~qi~~aL~yLH~- 93 (449)
.++..|+.++....+|+||+++++++.+++..|+||||+ +++|.+++.. ....+++..++.++.|++.||.|||+
T Consensus 53 ~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~ 132 (269)
T cd08528 53 GDIVSEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKE 132 (269)
T ss_pred HHHHHHHHHHhhcCCCCCeeeEEeeEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccC
Confidence 446778888877559999999999999999999999999 8999998753 24568999999999999999999996
Q ss_pred CCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHH
Q 013092 94 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGY 173 (449)
Q Consensus 94 ~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~ 173 (449)
.|++|+||||+||++ +..+.++|+|||++....... ......|+..|++||++.+..++.++|+||||+
T Consensus 133 ~~i~H~dl~~~nil~---~~~~~~~l~dfg~~~~~~~~~--------~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ 201 (269)
T cd08528 133 KRIVHRDLTPNNIML---GEDDKVTITDFGLAKQKQPES--------KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGC 201 (269)
T ss_pred CceeecCCCHHHEEE---CCCCcEEEecccceeeccccc--------ccccccCcccCcChhhhcCCCCchHHHHHHHHH
Confidence 789999999999999 578899999999998755432 123456889999999999888999999999999
Q ss_pred HHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 013092 174 VLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFR 246 (449)
Q Consensus 174 il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~L~ 246 (449)
++|+|++|..||..... ......+....... .....++.++.++|..||+.+|++||++.++...+.
T Consensus 202 ll~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 202 ILYQMCTLQPPFYSTNM---LSLATKIVEAVYEP---LPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred HHHHHHhCCCcccccCH---HHHHHHHhhccCCc---CCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 99999999999975322 22233333322211 111357889999999999999999999999988764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=278.66 Aligned_cols=224 Identities=18% Similarity=0.248 Sum_probs=189.8
Q ss_pred ccEEEEEeeecccCCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecCCCCHHHHH-HHcCCCCCHHHHHHH
Q 013092 2 YEILTVFSVQENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLF-NFCSRKLSLKTVLML 80 (449)
Q Consensus 2 ~~aikV~~k~~~~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~g~sL~~ll-~~~~~~ls~~~~~~i 80 (449)
.+||||+-|+...+.+..++.+|+.||+.+ +||+||.+...++..+..|+|||-+.|++.+.| ..-.+++++....++
T Consensus 591 dVAvKvIdKlrFp~kqesqlR~EVaILq~l-~HPGiV~le~M~ET~ervFVVMEKl~GDMLEMILSsEkgRL~er~TkFl 669 (888)
T KOG4236|consen 591 DVAVKVIDKLRFPTKQESQLRNEVAILQNL-HHPGIVNLECMFETPERVFVVMEKLHGDMLEMILSSEKGRLPERITKFL 669 (888)
T ss_pred eeeeeeeecccCCCchHHHHHHHHHHHHhc-CCCCeeEEEEeecCCceEEEEehhhcchHHHHHHHhhcccchHHHHHHH
Confidence 368999999998888889999999999999 999999999999999999999999966666555 444678999999999
Q ss_pred HHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCC
Q 013092 81 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI 160 (449)
Q Consensus 81 ~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~ 160 (449)
+.||+.||.|||.++|+|+||||+|||+...+.-.++||||||+|+.+++.... ...+||+.|+|||++...
T Consensus 670 vtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFR--------rsVVGTPAYLaPEVLrnk 741 (888)
T KOG4236|consen 670 VTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFR--------RSVVGTPAYLAPEVLRNK 741 (888)
T ss_pred HHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhhh--------hhhcCCccccCHHHHhhc
Confidence 999999999999999999999999999976666679999999999999876542 456899999999999999
Q ss_pred CCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHH
Q 013092 161 EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAY 240 (449)
Q Consensus 161 ~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~ 240 (449)
.|.+.-|+||+|+|+|--|.|..||... .++-+.|+...+..+.. -+..++++..+||..+|+..-.+|.+.+.
T Consensus 742 GyNrSLDMWSVGVIiYVsLSGTFPFNEd-----EdIndQIQNAaFMyPp~-PW~eis~~AidlIn~LLqVkm~kRysvdk 815 (888)
T KOG4236|consen 742 GYNRSLDMWSVGVIIYVSLSGTFPFNED-----EDINDQIQNAAFMYPPN-PWSEISPEAIDLINNLLQVKMRKRYSVDK 815 (888)
T ss_pred cccccccceeeeEEEEEEecccccCCCc-----cchhHHhhccccccCCC-chhhcCHHHHHHHHHHHHHHHHHhcchHh
Confidence 9999999999999999999999999642 23334455444332222 23457889999999999998888877543
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-31 Score=255.49 Aligned_cols=211 Identities=25% Similarity=0.342 Sum_probs=177.8
Q ss_pred ChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-C
Q 013092 17 KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS-K 94 (449)
Q Consensus 17 ~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~-~ 94 (449)
....+..|+.++..+ .|+||+++++++...+..++||||+ +++|.+++.. ...+++..++.++.|++.||+|||+ .
T Consensus 42 ~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~~l~~~l~~lh~~~ 119 (264)
T cd06623 42 FRKQLLRELKTLRSC-ESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKK-VGKIPEPVLAYIARQILKGLDYLHTKR 119 (264)
T ss_pred HHHHHHHHHHHHHhc-CCCCeeeEEEEEccCCeEEEEEEecCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhccC
Confidence 356799999999999 6999999999999999999999999 8999999985 3679999999999999999999999 9
Q ss_pred CceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHH
Q 013092 95 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYV 174 (449)
Q Consensus 95 givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~i 174 (449)
|++|+||+|+||++ +.++.++|+|||++......... .....++..|++||.+.+..++.++|+||||++
T Consensus 120 ~~~H~~l~~~ni~~---~~~~~~~l~df~~~~~~~~~~~~-------~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~i 189 (264)
T cd06623 120 HIIHRDIKPSNLLI---NSKGEVKIADFGISKVLENTLDQ-------CNTFVGTVTYMSPERIQGESYSYAADIWSLGLT 189 (264)
T ss_pred CCccCCCCHHHEEE---CCCCCEEEccCccceecccCCCc-------ccceeecccccCHhhhCCCCCCchhhHHHHHHH
Confidence 99999999999999 67899999999999876543221 124468899999999999889999999999999
Q ss_pred HHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcC-CcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 175 LMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRG-YPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 175 l~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~-~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
+|+|++|..||.........+....+.... ...+... ++..+.++|..||..+|++||++.+|.+
T Consensus 190 l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~ 255 (264)
T cd06623 190 LLECALGKFPFLPPGQPSFFELMQAICDGP----PPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQ 255 (264)
T ss_pred HHHHHhCCCCCccccccCHHHHHHHHhcCC----CCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 999999999998765333344444443222 2223444 8899999999999999999999888765
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=271.92 Aligned_cols=251 Identities=18% Similarity=0.227 Sum_probs=204.8
Q ss_pred EEEEEeeecccCCCh-hHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHH
Q 013092 4 ILTVFSVQENVKTKH-PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLA 81 (449)
Q Consensus 4 aikV~~k~~~~~~~~-~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~ 81 (449)
||||++|--.....+ +--..|-++|......|.+++|..+++.-+.+|+||||+ ||+|--.|++ -++|.+..+..++
T Consensus 378 AiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVMEyvnGGDLMyhiQQ-~GkFKEp~AvFYA 456 (683)
T KOG0696|consen 378 AIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQ-VGKFKEPVAVFYA 456 (683)
T ss_pred hhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEEEEecCchhhhHHHH-hcccCCchhhhhh
Confidence 567776655443332 334578888888867789999999999999999999999 9999888876 4679999999999
Q ss_pred HHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCC
Q 013092 82 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIE 161 (449)
Q Consensus 82 ~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~ 161 (449)
.+|+-||-+||++|||+||||.+|||+ +..|+|||+|||+++.---.. ....+++|||.|+|||.+...+
T Consensus 457 aEiaigLFFLh~kgIiYRDLKLDNvmL---d~eGHiKi~DFGmcKEni~~~-------~TTkTFCGTPdYiAPEIi~YqP 526 (683)
T KOG0696|consen 457 AEIAIGLFFLHSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKENIFDG-------VTTKTFCGTPDYIAPEIIAYQP 526 (683)
T ss_pred HHHHHHhhhhhcCCeeeeeccccceEe---ccCCceEeeecccccccccCC-------cceeeecCCCcccccceEEecc
Confidence 999999999999999999999999999 799999999999997532221 2236789999999999999999
Q ss_pred CChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHH
Q 013092 162 QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYL 241 (449)
Q Consensus 162 ~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l 241 (449)
|+..+|+||+|++||||+.|+.||.+. +..+.+..|.+.... +++.++.|..++....+...|.+|....--
T Consensus 527 YgksvDWWa~GVLLyEmlaGQpPFdGe---DE~elF~aI~ehnvs-----yPKslSkEAv~ickg~ltK~P~kRLGcg~~ 598 (683)
T KOG0696|consen 527 YGKSVDWWAFGVLLYEMLAGQPPFDGE---DEDELFQAIMEHNVS-----YPKSLSKEAVAICKGLLTKHPGKRLGCGPE 598 (683)
T ss_pred cccchhHHHHHHHHHHHHcCCCCCCCC---CHHHHHHHHHHccCc-----CcccccHHHHHHHHHHhhcCCccccCCCCc
Confidence 999999999999999999999999884 456677778877663 456789999999999999999999643111
Q ss_pred HHHHHHHHHHcCCCCCCcccchhhhhhhccCCCCCCc
Q 013092 242 KRIFRDLFIREGFQFDYVFDWTILKYQQSQLATPPAR 278 (449)
Q Consensus 242 ~~~L~~~~~~~~~~~~~~~dw~~~~~~~~~~~~~p~~ 278 (449)
-+ +++ ..+.|+.-+||+.++..+.+++..|-.
T Consensus 599 ge--~di---~~H~FFR~iDWek~E~~eiqPPfkPk~ 630 (683)
T KOG0696|consen 599 GE--RDI---REHPFFRRIDWEKLERREIQPPFKPKI 630 (683)
T ss_pred cc--cch---hhCcchhhccHHHHhhccCCCCCCCcc
Confidence 11 111 235677788999999999888777643
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.7e-31 Score=258.21 Aligned_cols=211 Identities=21% Similarity=0.251 Sum_probs=169.2
Q ss_pred hhHHHHHHHHHHHhc--CCCCCceEEEEeEeCCE-----EEEEEecCCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHH
Q 013092 18 HPQLLYESKLYRILQ--GGTGIPNVRWFGVEGDY-----NVLVMDLLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVE 89 (449)
Q Consensus 18 ~~~~~~E~~il~~l~--~hp~Iv~l~~~~~~~~~-----~~lVmE~~g~sL~~ll~~~~-~~ls~~~~~~i~~qi~~aL~ 89 (449)
...+.+|+.+++++. .|+||+++.+++...+. .+++|||+.++|.+++.... ..+++..++.++.|++.||.
T Consensus 42 ~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l~~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~ 121 (287)
T cd07838 42 PLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVD 121 (287)
T ss_pred hhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeEEEehhcccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHH
Confidence 345778999998885 59999999999988776 99999999778999887543 35899999999999999999
Q ss_pred HHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHH
Q 013092 90 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLE 169 (449)
Q Consensus 90 yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~Diw 169 (449)
|||+.+++|+||||+||++ +.++.++|+|||++..+..... .....++..|++||++.+..++.++|+|
T Consensus 122 ~LH~~~i~h~~l~~~nili---~~~~~~~l~dfg~~~~~~~~~~--------~~~~~~~~~~~~PE~~~~~~~~~~~Di~ 190 (287)
T cd07838 122 FLHSHRIVHRDLKPQNILV---TSDGQVKIADFGLARIYSFEMA--------LTSVVVTLWYRAPEVLLQSSYATPVDMW 190 (287)
T ss_pred HHHHCCeeeccCChhhEEE---ccCCCEEEeccCcceeccCCcc--------cccccccccccChHHhccCCCCCcchhh
Confidence 9999999999999999999 5678999999999987654321 1233578899999999998899999999
Q ss_pred HHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhc----------------------ccchHHHhhcCCcHHHHHHHHHH
Q 013092 170 SLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK----------------------VSTSIEALCRGYPTEFASYFHYC 227 (449)
Q Consensus 170 SlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~----------------------~~~~~~~l~~~~p~el~~li~~c 227 (449)
||||++|+|++|..||.+.... +.+.++.+.. ...........++.++.++|..|
T Consensus 191 s~G~~l~~l~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 267 (287)
T cd07838 191 SVGCIFAELFRRRPLFRGTSEA---DQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKM 267 (287)
T ss_pred hHHHHHHHHHhCCCcccCCChH---HHHHHHHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHH
Confidence 9999999999999999874432 2233332210 01111222334568889999999
Q ss_pred hcCCCCCCCCHHHHH
Q 013092 228 RSLRFDDKPDYAYLK 242 (449)
Q Consensus 228 l~~~p~~RPt~~~l~ 242 (449)
|+.+|++||++.++.
T Consensus 268 l~~dp~~Rp~~~~il 282 (287)
T cd07838 268 LTFNPHKRISAFEAL 282 (287)
T ss_pred hccCCccCCCHHHHh
Confidence 999999999988775
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.2e-31 Score=258.19 Aligned_cols=200 Identities=20% Similarity=0.291 Sum_probs=162.2
Q ss_pred HHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCC
Q 013092 24 ESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIK 102 (449)
Q Consensus 24 E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~givHRDLK 102 (449)
|+.+...+.+|+||+++++.+...+..|+||||+ +++|.+++.. ...+++..++.++.|++.||.|||+.|++|||||
T Consensus 58 e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~ 136 (267)
T PHA03390 58 EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKK-EGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIK 136 (267)
T ss_pred hHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCC
Confidence 4545555568999999999999999999999999 9999999985 3479999999999999999999999999999999
Q ss_pred CCcEEEeecCCCC-eEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHHHHHHHhC
Q 013092 103 PDNFLMGLGRRAN-QVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRG 181 (449)
Q Consensus 103 P~NiLl~~~~~~~-~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il~elltG 181 (449)
|+||++. .++ .++|+|||+++...... ...++..|+|||++.+..++.++||||||+++|+|++|
T Consensus 137 p~nil~~---~~~~~~~l~dfg~~~~~~~~~-----------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g 202 (267)
T PHA03390 137 LENVLYD---RAKDRIYLCDYGLCKIIGTPS-----------CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTG 202 (267)
T ss_pred HHHEEEe---CCCCeEEEecCccceecCCCc-----------cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHC
Confidence 9999994 555 89999999987654321 23688999999999998999999999999999999999
Q ss_pred CCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCC-HHHHH
Q 013092 182 SLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPD-YAYLK 242 (449)
Q Consensus 182 ~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt-~~~l~ 242 (449)
..||......... ...+.... .. .....+.+++.+.++|..||+.+|.+||+ +++|+
T Consensus 203 ~~p~~~~~~~~~~--~~~~~~~~-~~-~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l 260 (267)
T PHA03390 203 KHPFKEDEDEELD--LESLLKRQ-QK-KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEII 260 (267)
T ss_pred CCCCCCCCcchhh--HHHHHHhh-cc-cCCcccccCHHHHHHHHHHhccChhhCCchHHHHh
Confidence 9999854332210 11111111 11 11233468899999999999999999995 57665
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.7e-32 Score=257.86 Aligned_cols=219 Identities=22% Similarity=0.296 Sum_probs=175.0
Q ss_pred ChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 013092 17 KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 95 (449)
Q Consensus 17 ~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~g 95 (449)
....+.+|+++++.+ .|+||+++++.+..+...|+||||+ +++|.+++... ..+++..++.++.||+.||+|||+.|
T Consensus 36 ~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~ 113 (265)
T cd05579 36 QVDQVLTERDILSQA-QSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLENV-GSLDEDVARIYIAEIVLALEYLHSNG 113 (265)
T ss_pred HHHHHHHHHHHHHhC-CCcchhHHHHheecCcEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcC
Confidence 455688999999999 7999999999999999999999999 88999999863 47899999999999999999999999
Q ss_pred ceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCc-ccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHH
Q 013092 96 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ-HIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYV 174 (449)
Q Consensus 96 ivHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~-~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~i 174 (449)
++|+||+|+||++ +.++.++|+|||++.......... ...........++..|++||.+....++.++||||||++
T Consensus 114 i~H~di~~~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~ 190 (265)
T cd05579 114 IIHRDLKPDNILI---DSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCI 190 (265)
T ss_pred eecCCCCHHHeEE---cCCCCEEEEecccchhcccCcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHH
Confidence 9999999999999 578899999999987654321100 000011234567889999999998889999999999999
Q ss_pred HHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 013092 175 LMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFR 246 (449)
Q Consensus 175 l~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~L~ 246 (449)
+|+|++|..||.... ..+.+..+....... +. ...++.++.+++..||+.+|++||++..+.++|.
T Consensus 191 ~~~l~~g~~p~~~~~---~~~~~~~~~~~~~~~--~~-~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 191 LYEFLVGIPPFHGET---PEEIFQNILNGKIEW--PE-DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred HHHHHhCCCCCCCCC---HHHHHHHHhcCCcCC--Cc-cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 999999999997643 333444443322211 11 1124899999999999999999999976666654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.5e-32 Score=269.40 Aligned_cols=220 Identities=18% Similarity=0.210 Sum_probs=170.1
Q ss_pred CChhHHHHHHHHHHHhcCCCCCceEEEEeE----eCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHH
Q 013092 16 TKHPQLLYESKLYRILQGGTGIPNVRWFGV----EGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 91 (449)
Q Consensus 16 ~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~----~~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yL 91 (449)
.....+.+|+.+++.+ +|+||+++++++. .....|+||||++++|.+++.. ...+++..++.++.||+.||.||
T Consensus 46 ~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~-~~~~~~~~~~~i~~qi~~aL~~L 123 (334)
T cd07855 46 TLAKRTLRELKILRHF-KHDNIIAIRDILRPPGADFKDVYVVMDLMESDLHHIIHS-DQPLTEEHIRYFLYQLLRGLKYI 123 (334)
T ss_pred cchHHHHHHHHHHHhc-CCCCccCHHHhccccCCCCceEEEEEehhhhhHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHH
Confidence 3445678899999999 7999999987765 3457899999997799999874 45699999999999999999999
Q ss_pred HHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhC-CCCChhhHHHH
Q 013092 92 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLES 170 (449)
Q Consensus 92 H~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~-~~~s~~~DiwS 170 (449)
|+.||+||||||+||++ +.++.+||+|||++.......... ........|+..|++||.+.+ ..++.++||||
T Consensus 124 H~~~ivH~dlkp~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~---~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~s 197 (334)
T cd07855 124 HSANVIHRDLKPSNLLV---NEDCELRIGDFGMARGLSSSPTEH---KYFMTEYVATRWYRAPELLLSLPEYTTAIDMWS 197 (334)
T ss_pred HHCCeecCCCCHHHEEE---cCCCcEEecccccceeecccCcCC---CcccccccccccccChHHhcCCcccccccchHH
Confidence 99999999999999999 578899999999998765432211 111234578999999999876 45789999999
Q ss_pred HHHHHHHHHhCCCCCCCCCcCCHHHHHHH-----------------------HHhhcccchHHHhhcCCcHHHHHHHHHH
Q 013092 171 LGYVLMYFLRGSLPWQGLKAGTKKQKYEK-----------------------ISEKKVSTSIEALCRGYPTEFASYFHYC 227 (449)
Q Consensus 171 lG~il~elltG~~Pf~~~~~~~~~~~~~~-----------------------i~~~~~~~~~~~l~~~~p~el~~li~~c 227 (449)
|||++|+|++|+.||.+............ ............+.+.++.++.++|..|
T Consensus 198 lG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 277 (334)
T cd07855 198 VGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQM 277 (334)
T ss_pred HHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHH
Confidence 99999999999999976433211110000 0001111222334466789999999999
Q ss_pred hcCCCCCCCCHHHHHH
Q 013092 228 RSLRFDDKPDYAYLKR 243 (449)
Q Consensus 228 l~~~p~~RPt~~~l~~ 243 (449)
|+.+|++||++.++..
T Consensus 278 l~~~P~~Rpt~~~~l~ 293 (334)
T cd07855 278 LQFDPEERITVEQALQ 293 (334)
T ss_pred ccCChhhCcCHHHHHh
Confidence 9999999999877654
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-31 Score=267.30 Aligned_cols=218 Identities=18% Similarity=0.231 Sum_probs=170.4
Q ss_pred CChhHHHHHHHHHHHhcCCCCCceEEEEeEe--CCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH
Q 013092 16 TKHPQLLYESKLYRILQGGTGIPNVRWFGVE--GDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 93 (449)
Q Consensus 16 ~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~--~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~ 93 (449)
.....+.+|+.++..+.+|+||+++++++.. ....||||||++++|.+++.. ..+++..++.++.||+.||+|||+
T Consensus 48 ~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~ 125 (337)
T cd07852 48 TDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRA--NILEDVHKRYIMYQLLKALKYIHS 125 (337)
T ss_pred hhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEecccccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH
Confidence 3445678899999999899999999998764 447899999997799999874 378999999999999999999999
Q ss_pred CCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhC-CCCChhhHHHHHH
Q 013092 94 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLG 172 (449)
Q Consensus 94 ~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~-~~~s~~~DiwSlG 172 (449)
.||+||||||+||++ +.++.++|+|||+++.+........ ........||..|++||.+.+ ..++.++||||||
T Consensus 126 ~~i~H~dl~p~nill---~~~~~~kl~d~g~~~~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG 200 (337)
T cd07852 126 GNVIHRDLKPSNILL---NSDCRVKLADFGLARSLSELEENPE--NPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVG 200 (337)
T ss_pred CCeecCCCCHHHEEE---cCCCcEEEeeccchhcccccccccc--CcchhcccccccccCceeeeccccccccchHHHHH
Confidence 999999999999999 5888999999999987654322110 011234578999999998865 4578899999999
Q ss_pred HHHHHHHhCCCCCCCCCcCCHHHHHHHHHhh--------------------------cccchHHHhhcCCcHHHHHHHHH
Q 013092 173 YVLMYFLRGSLPWQGLKAGTKKQKYEKISEK--------------------------KVSTSIEALCRGYPTEFASYFHY 226 (449)
Q Consensus 173 ~il~elltG~~Pf~~~~~~~~~~~~~~i~~~--------------------------~~~~~~~~l~~~~p~el~~li~~ 226 (449)
|++|+|++|+.||.+...... +.++... .....+..+.+.++.++.++|..
T Consensus 201 ~~l~el~tg~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 277 (337)
T cd07852 201 CILGEMLLGKPLFPGTSTLNQ---LEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKK 277 (337)
T ss_pred HHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHH
Confidence 999999999999976433221 1111111 01112233445578999999999
Q ss_pred HhcCCCCCCCCHHHHHH
Q 013092 227 CRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 227 cl~~~p~~RPt~~~l~~ 243 (449)
||+.+|++||++.++.+
T Consensus 278 ~l~~~P~~Rps~~~il~ 294 (337)
T cd07852 278 LLVFNPNKRLTAEEALE 294 (337)
T ss_pred hccCCcccccCHHHHhh
Confidence 99999999999887764
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.5e-31 Score=264.10 Aligned_cols=206 Identities=19% Similarity=0.268 Sum_probs=169.0
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFL 97 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~giv 97 (449)
...+..|+++++.+ +|+||+++++++.++...||||||+.++|.+++......+++..+..++.|++.||.|||+.||+
T Consensus 69 ~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~ 147 (317)
T cd06635 69 WQDIIKEVKFLQRI-KHPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMI 147 (317)
T ss_pred HHHHHHHHHHHHhC-CCCCEEEEEEEEeeCCeEEEEEeCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 34688999999999 89999999999999999999999997788888876566799999999999999999999999999
Q ss_pred ecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhh---CCCCChhhHHHHHHHH
Q 013092 98 HRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHL---GIEQSRRDDLESLGYV 174 (449)
Q Consensus 98 HRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~---~~~~s~~~DiwSlG~i 174 (449)
|+||+|+||++ +.++.++|+|||++...... ....|+..|+|||++. ...++.++|||||||+
T Consensus 148 H~dL~p~Nil~---~~~~~~kl~dfg~~~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvi 213 (317)
T cd06635 148 HRDIKAGNILL---TEPGQVKLADFGSASIASPA-----------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 213 (317)
T ss_pred cCCCCcccEEE---CCCCCEEEecCCCccccCCc-----------ccccCCccccChhhhhcCCCCCCCccccHHHHHHH
Confidence 99999999999 57789999999998654321 2346888999999984 3557889999999999
Q ss_pred HHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHH
Q 013092 175 LMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRI 244 (449)
Q Consensus 175 l~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~ 244 (449)
+|+|++|..||..... ...+..+....... .....++..+.+++.+||+.+|.+||++.+|.+.
T Consensus 214 l~el~~g~~p~~~~~~---~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 277 (317)
T cd06635 214 CIELAERKPPLFNMNA---MSALYHIAQNESPT---LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKH 277 (317)
T ss_pred HHHHHhCCCCCCCccH---HHHHHHHHhccCCC---CCCccccHHHHHHHHHHccCCcccCcCHHHHHhC
Confidence 9999999999976432 22222222221111 1123578899999999999999999999888654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.1e-31 Score=257.37 Aligned_cols=211 Identities=18% Similarity=0.222 Sum_probs=164.9
Q ss_pred hHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q 013092 19 PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLH 98 (449)
Q Consensus 19 ~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~givH 98 (449)
..+.+|+.+++.+ +|+||+++.+++..++..|+||||++++|.+++......+++..+..++.|++.||+|||+.||+|
T Consensus 48 ~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H 126 (291)
T cd07870 48 FTAIREASLLKGL-KHANIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILH 126 (291)
T ss_pred HHHHHHHHHHHhc-CCCCEeEEEEEEecCCeEEEEEecccCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 3678999999999 899999999999999999999999988888877654456888999999999999999999999999
Q ss_pred cCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCC-CCChhhHHHHHHHHHHH
Q 013092 99 RDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMY 177 (449)
Q Consensus 99 RDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~-~~s~~~DiwSlG~il~e 177 (449)
+||||+|||+ +.++.++|+|||+++....... ......++..|+|||++.+. .++.++|||||||++|+
T Consensus 127 ~dlkp~Nil~---~~~~~~~l~Dfg~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ 196 (291)
T cd07870 127 RDLKPQNLLI---SYLGELKLADFGLARAKSIPSQ-------TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIE 196 (291)
T ss_pred CCCChHHEEE---cCCCcEEEeccccccccCCCCC-------CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHH
Confidence 9999999999 5788999999999976433221 11234578999999998764 57889999999999999
Q ss_pred HHhCCCCCCCCCcCCHHHHHHHHHhhcc-------------------------cchHHHhhc--CCcHHHHHHHHHHhcC
Q 013092 178 FLRGSLPWQGLKAGTKKQKYEKISEKKV-------------------------STSIEALCR--GYPTEFASYFHYCRSL 230 (449)
Q Consensus 178 lltG~~Pf~~~~~~~~~~~~~~i~~~~~-------------------------~~~~~~l~~--~~p~el~~li~~cl~~ 230 (449)
|++|..||.+... ..+.+.++..... ......... ..+.++.+++..|+..
T Consensus 197 l~~g~~~f~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~ 274 (291)
T cd07870 197 MLQGQPAFPGVSD--VFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMM 274 (291)
T ss_pred HHhCCCCCCCchh--HHHHHHHHHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCc
Confidence 9999999976433 1122222111000 000111111 1357899999999999
Q ss_pred CCCCCCCHHHHH
Q 013092 231 RFDDKPDYAYLK 242 (449)
Q Consensus 231 ~p~~RPt~~~l~ 242 (449)
+|.+||++.++.
T Consensus 275 dp~~R~t~~~~l 286 (291)
T cd07870 275 FPKDRISAQDAL 286 (291)
T ss_pred CcccCcCHHHHh
Confidence 999999987764
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-31 Score=262.71 Aligned_cols=223 Identities=21% Similarity=0.194 Sum_probs=167.2
Q ss_pred ChhHHHHHHHHHHHhcCCCCCceEEEEeEe--------CCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHH
Q 013092 17 KHPQLLYESKLYRILQGGTGIPNVRWFGVE--------GDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRV 88 (449)
Q Consensus 17 ~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~--------~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL 88 (449)
....+.+|+++++.+ +|+||+++++++.+ ....|+||||++.+|.+++......+++..+..++.|++.||
T Consensus 50 ~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~~~~lv~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al 128 (311)
T cd07866 50 FPITALREIKILKKL-KHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGI 128 (311)
T ss_pred cchhHHHHHHHHHhc-CCCCccchhhheecccccccccCceEEEEEecCCcCHHHHHhccccCCCHHHHHHHHHHHHHHH
Confidence 345678999999999 89999999887653 335799999998888888875456799999999999999999
Q ss_pred HHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCccc----ccccCCCCccCccccchhhhhCC-CCC
Q 013092 89 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHI----PYRENKNLTGTARYASMNTHLGI-EQS 163 (449)
Q Consensus 89 ~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~----~~~~~~~~~gT~~Y~aPE~~~~~-~~s 163 (449)
+|||++||+|+||||+||++ +.++.++|+|||+++........... .........+++.|+|||++.+. .++
T Consensus 129 ~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 205 (311)
T cd07866 129 NYLHENHILHRDIKAANILI---DNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYT 205 (311)
T ss_pred HHHHhCCeecCCCCHHHEEE---CCCCCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccC
Confidence 99999999999999999999 67889999999999866543221110 01112334678899999998764 578
Q ss_pred hhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhh----------------------cccchHHHhhcCCcHHHH
Q 013092 164 RRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK----------------------KVSTSIEALCRGYPTEFA 221 (449)
Q Consensus 164 ~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~----------------------~~~~~~~~l~~~~p~el~ 221 (449)
.++|||||||++|+|++|..||.+.......+.+...... ............+.+++.
T Consensus 206 ~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (311)
T cd07866 206 TAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGL 285 (311)
T ss_pred chhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHH
Confidence 9999999999999999999999764432221111111000 001111122234567899
Q ss_pred HHHHHHhcCCCCCCCCHHHHHH
Q 013092 222 SYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 222 ~li~~cl~~~p~~RPt~~~l~~ 243 (449)
++|..||..+|.+||+..+++.
T Consensus 286 ~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 286 DLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHHHHHcccCcccCcCHHHHhc
Confidence 9999999999999999877653
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=256.41 Aligned_cols=208 Identities=17% Similarity=0.246 Sum_probs=173.1
Q ss_pred CChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHH
Q 013092 16 TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFV 91 (449)
Q Consensus 16 ~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~---~~~ls~~~~~~i~~qi~~aL~yL 91 (449)
.....+..|+++++.+ .|+||+++.+.+.+....|+||||+ +++|.+++... ...+++..++.++.|++.||+||
T Consensus 41 ~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~l 119 (256)
T cd08530 41 KEREDAVNEIRILASV-NHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQAL 119 (256)
T ss_pred HHHHHHHHHHHHHHhC-CCCCchhhhhhhccCCEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHH
Confidence 3455678999999999 6999999999999999999999999 99999998642 35689999999999999999999
Q ss_pred HHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHH
Q 013092 92 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESL 171 (449)
Q Consensus 92 H~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSl 171 (449)
|+.|++|+||+|.||+++ ..+.+||+|||++........ ....++..|++||.+.+..++.++|+|||
T Consensus 120 h~~~i~h~~l~~~ni~~~---~~~~~kl~d~g~~~~~~~~~~---------~~~~~~~~~~~Pe~~~~~~~~~~~D~~sl 187 (256)
T cd08530 120 HEQKILHRDLKSANILLV---ANDLVKIGDLGISKVLKKNMA---------KTQIGTPHYMAPEVWKGRPYSYKSDIWSL 187 (256)
T ss_pred hhCCcccCCCCcceEEEe---cCCcEEEeeccchhhhccCCc---------ccccCCccccCHHHHCCCCCCchhhHHHH
Confidence 999999999999999994 678899999999987654311 23457889999999999889999999999
Q ss_pred HHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 172 GYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 172 G~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
|+++|+|++|+.||...+. ......+..... +.+...++.++.+++.+||..+|++||++.++..
T Consensus 188 G~~~~~l~~g~~p~~~~~~---~~~~~~~~~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 188 GCLLYEMATFAPPFEARSM---QDLRYKVQRGKY----PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred HHHHHHHHhCCCCCCCCCH---HHHHHHHhcCCC----CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 9999999999999976432 222223332222 2233467899999999999999999999988754
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=3e-31 Score=252.80 Aligned_cols=208 Identities=21% Similarity=0.291 Sum_probs=174.5
Q ss_pred ChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 013092 17 KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 95 (449)
Q Consensus 17 ~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~g 95 (449)
....+.+|++++..+ .|+||+++.+++.+++..|+||||+ +++|.+++.. ...+++..++.++.|++.||.|||+.|
T Consensus 42 ~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lH~~~ 119 (254)
T cd06627 42 ALKSIMQEIDLLKNL-KHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKK-FGPFPESLVAVYVYQVLQGLAYLHEQG 119 (254)
T ss_pred HHHHHHHHHHHHHhC-CCCCccEEEEEEEeCCEEEEEEecCCCCcHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHhhCC
Confidence 456789999999999 8999999999999999999999999 8899999985 367999999999999999999999999
Q ss_pred ceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHHH
Q 013092 96 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVL 175 (449)
Q Consensus 96 ivHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il 175 (449)
|+|+||||+||++ +.++.++|+|||++......... .....++..|++||.+.+..++.++|||+||+++
T Consensus 120 i~H~dl~p~ni~i---~~~~~~~l~d~~~~~~~~~~~~~-------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l 189 (254)
T cd06627 120 VIHRDIKAANILT---TKDGVVKLADFGVATKLNDVSKD-------DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTV 189 (254)
T ss_pred cccCCCCHHHEEE---CCCCCEEEeccccceecCCCccc-------ccccccchhhcCHhhhcCCCCCcchhHHHHHHHH
Confidence 9999999999999 46789999999999877553321 2345688999999999888889999999999999
Q ss_pred HHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 176 MYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 176 ~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
|+|++|..||..... ...+.++... ....+...++.++.+++..||..+|++||++.++..
T Consensus 190 ~~l~~g~~p~~~~~~---~~~~~~~~~~----~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 190 IELLTGNPPYYDLNP---MAALFRIVQD----DHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred HHHHhCCCCCCCccH---HHHHHHHhcc----CCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 999999999976432 2222222221 122344567899999999999999999999887753
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-31 Score=253.90 Aligned_cols=221 Identities=22% Similarity=0.262 Sum_probs=180.5
Q ss_pred EEEEeeecccCCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHc---CCCCCHHHHHHH
Q 013092 5 LTVFSVQENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFC---SRKLSLKTVLML 80 (449)
Q Consensus 5 ikV~~k~~~~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~---~~~ls~~~~~~i 80 (449)
+|+.............+..|+++++.+ +|+|++++.+.+..+...++||||+ +++|.+++... ...+++..++.+
T Consensus 30 ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i 108 (258)
T cd08215 30 LKEIDLSNMSEKEREDALNEVKILKKL-NHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDW 108 (258)
T ss_pred EEEeecccCChHHHHHHHHHHHHHHhc-CCCChhheEEEEecCCEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHH
Confidence 344333332234556789999999999 7999999999999999999999999 88999999764 367999999999
Q ss_pred HHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCC
Q 013092 81 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI 160 (449)
Q Consensus 81 ~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~ 160 (449)
+.|++.||.|||+.|++|+||+|+||++ +.++.++|+|||++........ ......|++.|++||.+.+.
T Consensus 109 ~~~i~~~l~~lh~~~~~H~dl~~~nil~---~~~~~~~l~d~~~~~~~~~~~~-------~~~~~~~~~~y~~pe~~~~~ 178 (258)
T cd08215 109 FVQLCLALKYLHSRKILHRDIKPQNIFL---TSNGLVKLGDFGISKVLSSTVD-------LAKTVVGTPYYLSPELCQNK 178 (258)
T ss_pred HHHHHHHHHHHHhCCEecccCChHHeEE---cCCCcEEECCccceeecccCcc-------eecceeeeecccChhHhccC
Confidence 9999999999999999999999999999 5778999999999987654321 12345788999999999988
Q ss_pred CCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHH
Q 013092 161 EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAY 240 (449)
Q Consensus 161 ~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~ 240 (449)
.++.++|+||||+++|+|++|..||.... ..+....+.... ...+...++.++.+++..||..+|++||++.+
T Consensus 179 ~~~~~~Dv~slG~~~~~l~~g~~p~~~~~---~~~~~~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ 251 (258)
T cd08215 179 PYNYKSDIWSLGCVLYELCTLKHPFEGEN---LLELALKILKGQ----YPPIPSQYSSELRNLVSSLLQKDPEERPSIAQ 251 (258)
T ss_pred CCCccccHHHHHHHHHHHHcCCCCCCCCc---HHHHHHHHhcCC----CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 89999999999999999999999997643 233333333222 22344578899999999999999999999988
Q ss_pred HHH
Q 013092 241 LKR 243 (449)
Q Consensus 241 l~~ 243 (449)
+.+
T Consensus 252 ll~ 254 (258)
T cd08215 252 ILQ 254 (258)
T ss_pred Hhc
Confidence 754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=4e-31 Score=251.63 Aligned_cols=213 Identities=23% Similarity=0.305 Sum_probs=176.7
Q ss_pred CChhHHHHHHHHHHHhcCCCCCceEEEEeEeC--CEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH
Q 013092 16 TKHPQLLYESKLYRILQGGTGIPNVRWFGVEG--DYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 92 (449)
Q Consensus 16 ~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~--~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH 92 (449)
.....+.+|+++++.+ +|+||+++++.+.+. ...++||||+ +++|.+++... ..+++..++.++.|++.+|+|||
T Consensus 41 ~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh 118 (260)
T cd06606 41 EELEALEREIRILSSL-QHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKF-GKLPEPVIRKYTRQILEGLAYLH 118 (260)
T ss_pred HHHHHHHHHHHHHHHc-CCCCEeeEEEEEecCCCCeEEEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH
Confidence 3466789999999999 799999999999988 8999999999 99999999863 37999999999999999999999
Q ss_pred HCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHH
Q 013092 93 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLG 172 (449)
Q Consensus 93 ~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG 172 (449)
+.|++|+||+|+||++ +..+.++|+|||.+......... .......++..|++||.+.+..++.++||||||
T Consensus 119 ~~~~~h~dl~p~ni~i---~~~~~~~l~d~~~~~~~~~~~~~-----~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG 190 (260)
T cd06606 119 SNGIVHRDIKGANILV---DSDGVVKLADFGCAKRLGDIETG-----EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLG 190 (260)
T ss_pred HCCccccCCCHHHEEE---cCCCCEEEcccccEEeccccccc-----ccccCCCCCccccCHhhhcCCCCCchhhHHHHH
Confidence 9999999999999999 56789999999999877654321 012345688999999999988899999999999
Q ss_pred HHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 173 YVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 173 ~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
+++|+|++|..||.... ........+.. ......++..++.++.++|..|++.+|++||++.++..
T Consensus 191 ~il~~l~~g~~p~~~~~--~~~~~~~~~~~---~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 191 CTVIEMATGKPPWSELG--NPMAALYKIGS---SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred HHHHHHHhCCCCCCCCC--chHHHHHhccc---cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 99999999999998754 12222222221 12222344567899999999999999999999888754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=266.73 Aligned_cols=228 Identities=18% Similarity=0.187 Sum_probs=178.4
Q ss_pred EEEEEeeecccCCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCC-----EEEEEEecCCCCHHHHHHHcCCCCCHHHHH
Q 013092 4 ILTVFSVQENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGD-----YNVLVMDLLGPSLEDLFNFCSRKLSLKTVL 78 (449)
Q Consensus 4 aikV~~k~~~~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~-----~~~lVmE~~g~sL~~ll~~~~~~ls~~~~~ 78 (449)
+||++.+........+.+.+|+.+++.+ +|+||+++.+++.... ..|+||||++++|.+++.. ...+++..++
T Consensus 29 ~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~-~~~l~~~~~~ 106 (330)
T cd07834 29 AIKKISNVFDDLIDAKRILREIKLLRHL-RHENIIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKS-PQPLTDDHIQ 106 (330)
T ss_pred EEEeeccccccchhhhhHHHHHHHHHhc-CCcchhhhhhhhcccCcccccceEEEecchhhhHHHHHhC-CCCCCHHHHH
Confidence 3444443332234556799999999999 7999999999887765 7899999998789999874 4479999999
Q ss_pred HHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhh
Q 013092 79 MLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHL 158 (449)
Q Consensus 79 ~i~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~ 158 (449)
.++.||+.||+|||+.||+|+||||.|||+ +.++.++|+|||++.......... .......++..|+|||++.
T Consensus 107 ~i~~~l~~~l~~LH~~gi~H~dlkp~nili---~~~~~~~L~dfg~~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~ 179 (330)
T cd07834 107 YFLYQILRGLKYLHSANVIHRDLKPSNILV---NSNCDLKICDFGLARGVDPDEDEK----GFLTEYVVTRWYRAPELLL 179 (330)
T ss_pred HHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEcccCceEeeccccccc----ccccccccccCcCCceeee
Confidence 999999999999999999999999999999 577999999999998776543110 1123456889999999998
Q ss_pred CC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcc--------------------------cchHHH
Q 013092 159 GI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV--------------------------STSIEA 211 (449)
Q Consensus 159 ~~-~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~--------------------------~~~~~~ 211 (449)
+. .++.++|+|||||++|+|++|..||.+... .+.+..+..... ......
T Consensus 180 ~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~---~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (330)
T cd07834 180 SSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDY---IDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSK 256 (330)
T ss_pred cccCCCcchhHHHHHHHHHHHHcCCCCcCCCCH---HHHHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHH
Confidence 87 789999999999999999999999987543 222222222111 111222
Q ss_pred hhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 212 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 212 l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
+.+.++.++.++|..||+.+|++||++.++..
T Consensus 257 ~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 288 (330)
T cd07834 257 LFPGASPEAIDLLEKMLVFDPKKRITADEALA 288 (330)
T ss_pred hcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 33557889999999999999999999887754
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.9e-31 Score=257.83 Aligned_cols=226 Identities=19% Similarity=0.246 Sum_probs=174.2
Q ss_pred EEEEeeecccCCChhHHHHHHHHHHHhcCCCCCceEEEEeEeC--CEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHH
Q 013092 5 LTVFSVQENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEG--DYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLAD 82 (449)
Q Consensus 5 ikV~~k~~~~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~--~~~~lVmE~~g~sL~~ll~~~~~~ls~~~~~~i~~ 82 (449)
+|+..+..........+.+|+.+++.+ +|+||+++++++.+. +..||||||++++|.+++......+++..++.++.
T Consensus 29 ~K~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~ 107 (287)
T cd07840 29 LKKIRMENEKEGFPITAIREIKLLQKL-RHPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMK 107 (287)
T ss_pred EEEEecccccccchHHHHHHHHHHHhc-cCCCeeeheeeEecCCCCcEEEEeccccccHHHHHhccCCCCCHHHHHHHHH
Confidence 444443322233445688999999999 799999999999887 89999999997799999875445799999999999
Q ss_pred HHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhC-CC
Q 013092 83 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG-IE 161 (449)
Q Consensus 83 qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~-~~ 161 (449)
||+.||+|||+.|++|+||||.||++ +.++.++|+|||++......... ......++..|+|||.+.+ ..
T Consensus 108 ~i~~al~~LH~~~~~h~dl~p~nil~---~~~~~~~l~d~g~~~~~~~~~~~------~~~~~~~~~~y~~PE~~~~~~~ 178 (287)
T cd07840 108 QLLEGLQYLHSNGILHRDIKGSNILI---NNDGVLKLADFGLARPYTKRNSA------DYTNRVITLWYRPPELLLGATR 178 (287)
T ss_pred HHHHHHHHHHHCCceeccCcHHHeEE---cCCCCEEEccccceeeccCCCcc------cccccccccccCCceeeEcccc
Confidence 99999999999999999999999999 57889999999999877554310 1123356788999998775 45
Q ss_pred CChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhc-------------------------ccchHHHhhcC-
Q 013092 162 QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK-------------------------VSTSIEALCRG- 215 (449)
Q Consensus 162 ~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~-------------------------~~~~~~~l~~~- 215 (449)
++.++||||||+++|+|++|..||...... ..+..+.... ....+......
T Consensus 179 ~~~~~Dv~slG~~l~el~t~~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (287)
T cd07840 179 YGPEVDMWSVGCILAELFLGKPIFQGSTEL---EQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHL 255 (287)
T ss_pred CChHHHHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCCCchhhccccccchhhhhccccccchhHHHHHhccc
Confidence 789999999999999999999999775432 2222221110 00011122223
Q ss_pred CcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 216 YPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 216 ~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
++.++.+++..||..+|++||++.++.+
T Consensus 256 ~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 256 IDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 4889999999999999999999887754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-31 Score=266.44 Aligned_cols=217 Identities=19% Similarity=0.199 Sum_probs=166.9
Q ss_pred ChhHHHHHHHHHHHhcCCCCCceEEEEeEeC-----CEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHH
Q 013092 17 KHPQLLYESKLYRILQGGTGIPNVRWFGVEG-----DYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 91 (449)
Q Consensus 17 ~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~-----~~~~lVmE~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yL 91 (449)
....+..|+.+++.+ +|+||+++++++... ...|+||||++++|.+++. ...+++..+..++.|++.||+||
T Consensus 46 ~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~--~~~l~~~~~~~i~~ql~~aL~~L 122 (336)
T cd07849 46 FCQRTLREIKILRRF-KHENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIK--TQHLSNDHIQYFLYQILRGLKYI 122 (336)
T ss_pred hHHHHHHHHHHHHhC-CCCCcCchhheeecccccccceEEEEehhcccCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHH
Confidence 345578899999999 799999998876543 3589999999889998887 46799999999999999999999
Q ss_pred HHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhC-CCCChhhHHHH
Q 013092 92 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLES 170 (449)
Q Consensus 92 H~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~-~~~s~~~DiwS 170 (449)
|+.||+||||||+||++ +..+.+||+|||++.......... .......||..|+|||.+.+ ..++.++||||
T Consensus 123 H~~~ivH~dlkp~Nill---~~~~~~kl~dfg~~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dvws 195 (336)
T cd07849 123 HSANVLHRDLKPSNLLL---NTNCDLKICDFGLARIADPEHDHT----GFLTEYVATRWYRAPEIMLNSKGYTKAIDIWS 195 (336)
T ss_pred HhCCeeccCCCHHHEEE---CCCCCEEECcccceeecccccccc----CCcCCcCcCCCccChHHhhCCCCCCcHHHHHH
Confidence 99999999999999999 578899999999998765432211 11234578999999998765 46899999999
Q ss_pred HHHHHHHHHhCCCCCCCCCcCCHHHH------------HHHHHhh-----------cccchHHHhhcCCcHHHHHHHHHH
Q 013092 171 LGYVLMYFLRGSLPWQGLKAGTKKQK------------YEKISEK-----------KVSTSIEALCRGYPTEFASYFHYC 227 (449)
Q Consensus 171 lG~il~elltG~~Pf~~~~~~~~~~~------------~~~i~~~-----------~~~~~~~~l~~~~p~el~~li~~c 227 (449)
|||++|+|++|+.||.+.+....... +..+... ........+.+.++.++.++|..|
T Consensus 196 lGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 275 (336)
T cd07849 196 VGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKM 275 (336)
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHH
Confidence 99999999999999976432111100 0000000 001111223345678899999999
Q ss_pred hcCCCCCCCCHHHHHH
Q 013092 228 RSLRFDDKPDYAYLKR 243 (449)
Q Consensus 228 l~~~p~~RPt~~~l~~ 243 (449)
|+.+|++||++.++++
T Consensus 276 l~~dP~~Rpt~~e~l~ 291 (336)
T cd07849 276 LTFNPHKRITVEEALA 291 (336)
T ss_pred cCCChhhCcCHHHHhc
Confidence 9999999999887754
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=6e-31 Score=261.07 Aligned_cols=204 Identities=21% Similarity=0.307 Sum_probs=167.8
Q ss_pred hHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q 013092 19 PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLH 98 (449)
Q Consensus 19 ~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~givH 98 (449)
..+..|+.+++.+ +|+||+.+.+++.+....|+||||+.++|.+++......+++..++.++.|++.+|.|||++||+|
T Consensus 66 ~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H 144 (313)
T cd06633 66 QDIIKEVKFLQQL-KHPNTIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIH 144 (313)
T ss_pred HHHHHHHHHHHhC-CCCCCccEEEEEEeCCEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence 4678999999999 899999999999999999999999977898888765667999999999999999999999999999
Q ss_pred cCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhh---CCCCChhhHHHHHHHHH
Q 013092 99 RDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHL---GIEQSRRDDLESLGYVL 175 (449)
Q Consensus 99 RDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~---~~~~s~~~DiwSlG~il 175 (449)
+||||+||++ +.++.++|+|||++..... .....|+..|+|||++. ...++.++|||||||++
T Consensus 145 ~dl~p~nili---~~~~~~kL~dfg~~~~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil 210 (313)
T cd06633 145 RDIKAGNILL---TEPGQVKLADFGSASKSSP-----------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITC 210 (313)
T ss_pred CCCChhhEEE---CCCCCEEEeecCCCcccCC-----------CCCccccccccChhhccccCCCCCCchhhHHHHHHHH
Confidence 9999999999 5778999999999854321 23457889999999985 35578899999999999
Q ss_pred HHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 176 MYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 176 ~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
|+|++|..||..... ......+...... ......++..+.+++.+||+.+|++||++.++..
T Consensus 211 ~el~~g~~p~~~~~~---~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~ 272 (313)
T cd06633 211 IELAERKPPLFNMNA---MSALYHIAQNDSP---TLQSNEWTDSFRGFVDYCLQKIPQERPASAELLR 272 (313)
T ss_pred HHHHhCCCCCCCCCh---HHHHHHHHhcCCC---CCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 999999999977433 2222222222111 1123457788999999999999999999887753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.4e-31 Score=258.45 Aligned_cols=209 Identities=17% Similarity=0.282 Sum_probs=171.3
Q ss_pred ChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 013092 17 KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 95 (449)
Q Consensus 17 ~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~g 95 (449)
....+.+|+.+++.+ +|+||+++++.+..++..|+||||+ +++|.+++. ...+++..+..++.|++.||+|||+.|
T Consensus 60 ~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~g 136 (292)
T cd06657 60 RRELLFNEVVIMRDY-QHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVT--HTRMNEEQIAAVCLAVLKALSVLHAQG 136 (292)
T ss_pred HHHHHHHHHHHHHhc-CCcchhheeeEEEeCCEEEEEEecCCCCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 445688999999999 8999999999999999999999999 889999876 456899999999999999999999999
Q ss_pred ceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHHH
Q 013092 96 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVL 175 (449)
Q Consensus 96 ivHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il 175 (449)
|+|+||||.||++ +.++.++|+|||++........ ......|+..|++||.+.+..++.++|+||||+++
T Consensus 137 ivH~dl~p~Nilv---~~~~~~~l~dfg~~~~~~~~~~-------~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil 206 (292)
T cd06657 137 VIHRDIKSDSILL---THDGRVKLSDFGFCAQVSKEVP-------RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMV 206 (292)
T ss_pred eecCCCCHHHEEE---CCCCCEEEcccccceecccccc-------cccccccCccccCHHHhcCCCCCchhhHHHHHHHH
Confidence 9999999999999 5778899999999876543221 11335688999999999888899999999999999
Q ss_pred HHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 176 MYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 176 ~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
|+|++|..||.+... .+....+... ....+. ....++.++.+++..||+.+|.+||++.+++.
T Consensus 207 ~el~tg~~p~~~~~~---~~~~~~~~~~-~~~~~~-~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 207 IEMVDGEPPYFNEPP---LKAMKMIRDN-LPPKLK-NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred HHHHhCCCCCCCCCH---HHHHHHHHhh-CCcccC-CcccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 999999999976432 2222222221 111111 12457889999999999999999999888754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.9e-32 Score=275.71 Aligned_cols=210 Identities=20% Similarity=0.322 Sum_probs=181.3
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeCCE--EEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEGDY--NVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 94 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~--~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~ 94 (449)
.+.|..|+.+|+-| .|+||+++++.+.+... ..+|.|++ .|+|..|+++ .++++...+..|+.||+.||.|||++
T Consensus 85 leR~~~Ev~lLKsL-~H~NIirfy~SW~d~~n~~in~iTEL~TSGtLr~Y~kk-~~~vn~kaik~W~RQILkGL~yLHs~ 162 (632)
T KOG0584|consen 85 LERLYSEVHLLKSL-KHPNIIRFYDSWVDTDNKTINFITELFTSGTLREYRKK-HRRVNIKAIKSWCRQILKGLVYLHSQ 162 (632)
T ss_pred HHHHHHHHHHHccC-CCCceeeeeeheecCCCceeeeeeecccCCcHHHHHHH-hccCCHHHHHHHHHHHHHHhhhhhcC
Confidence 36689999999999 99999999998886554 78899999 9999999987 46799999999999999999999998
Q ss_pred C--ceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHH
Q 013092 95 S--FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLG 172 (449)
Q Consensus 95 g--ivHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG 172 (449)
. |||||||.+||+|. ...|.|||.|+|||........ ....|||.|||||++. ..|+...||||||
T Consensus 163 ~PPIIHRDLKCDNIFin--G~~G~VKIGDLGLAtl~r~s~a---------ksvIGTPEFMAPEmYE-E~YnE~VDVYaFG 230 (632)
T KOG0584|consen 163 DPPIIHRDLKCDNIFVN--GNLGEVKIGDLGLATLLRKSHA---------KSVIGTPEFMAPEMYE-ENYNELVDVYAFG 230 (632)
T ss_pred CCCccccccccceEEEc--CCcCceeecchhHHHHhhcccc---------ceeccCccccChHHHh-hhcchhhhhhhhh
Confidence 5 99999999999996 6789999999999998776543 4468999999999998 7899999999999
Q ss_pred HHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 013092 173 YVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFI 250 (449)
Q Consensus 173 ~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~L~~~~~ 250 (449)
+.++||+|+..||.... +..|+|.++.....+..+..+. .+++++||.+|+.. ..+||++.+| |.+.|.
T Consensus 231 MCmLEMvT~eYPYsEC~--n~AQIYKKV~SGiKP~sl~kV~---dPevr~fIekCl~~-~~~R~sa~eL---L~d~Ff 299 (632)
T KOG0584|consen 231 MCMLEMVTSEYPYSECT--NPAQIYKKVTSGIKPAALSKVK---DPEVREFIEKCLAT-KSERLSAKEL---LKDPFF 299 (632)
T ss_pred HHHHHHHhccCChhhhC--CHHHHHHHHHcCCCHHHhhccC---CHHHHHHHHHHhcC-chhccCHHHH---hhChhh
Confidence 99999999999998764 4578899988877665554432 57999999999998 8999996554 444443
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.2e-31 Score=266.93 Aligned_cols=215 Identities=19% Similarity=0.197 Sum_probs=167.9
Q ss_pred ChhHHHHHHHHHHHhcCCCCCceEEEEeEeC-----CEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHH
Q 013092 17 KHPQLLYESKLYRILQGGTGIPNVRWFGVEG-----DYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 91 (449)
Q Consensus 17 ~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~-----~~~~lVmE~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yL 91 (449)
....+.+|+.+++.+ +|+||+++++++... ...||||||++++|.+++.. ...+++..++.++.|++.||.||
T Consensus 47 ~~~~~~~E~~~l~~l-~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~-~~~l~~~~~~~i~~qi~~aL~~L 124 (337)
T cd07858 47 DAKRTLREIKLLRHL-DHENVIAIKDIMPPPHREAFNDVYIVYELMDTDLHQIIRS-SQTLSDDHCQYFLYQLLRGLKYI 124 (337)
T ss_pred hhHHHHHHHHHHHhc-CCCCccchHHheecccccccCcEEEEEeCCCCCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHH
Confidence 345678899999999 899999998877643 35899999998899999875 46799999999999999999999
Q ss_pred HHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhC-CCCChhhHHHH
Q 013092 92 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLES 170 (449)
Q Consensus 92 H~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~-~~~s~~~DiwS 170 (449)
|+++++||||||+||++ +.++.+||+|||+++....... ......++..|+|||++.. ..++.++||||
T Consensus 125 H~~~i~H~dlkp~Nil~---~~~~~~kL~Dfg~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~Diws 194 (337)
T cd07858 125 HSANVLHRDLKPSNLLL---NANCDLKICDFGLARTTSEKGD-------FMTEYVVTRWYRAPELLLNCSEYTTAIDVWS 194 (337)
T ss_pred HhCCEecCCCCHHHEEE---cCCCCEEECcCccccccCCCcc-------cccccccccCccChHHHhcCCCCCCcccHHH
Confidence 99999999999999999 5778999999999986644321 1234567899999999875 45889999999
Q ss_pred HHHHHHHHHhCCCCCCCCCcCCHHHHHHHHH-----------------------hhcccchHHHhhcCCcHHHHHHHHHH
Q 013092 171 LGYVLMYFLRGSLPWQGLKAGTKKQKYEKIS-----------------------EKKVSTSIEALCRGYPTEFASYFHYC 227 (449)
Q Consensus 171 lG~il~elltG~~Pf~~~~~~~~~~~~~~i~-----------------------~~~~~~~~~~l~~~~p~el~~li~~c 227 (449)
|||++|+|++|..||.+.+..........+. ............+.+++++.++|..|
T Consensus 195 lG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 274 (337)
T cd07858 195 VGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKM 274 (337)
T ss_pred HHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHH
Confidence 9999999999999997643211111000000 00011122233456889999999999
Q ss_pred hcCCCCCCCCHHHHHH
Q 013092 228 RSLRFDDKPDYAYLKR 243 (449)
Q Consensus 228 l~~~p~~RPt~~~l~~ 243 (449)
|+.+|++||++.++++
T Consensus 275 l~~~P~~Rps~~ell~ 290 (337)
T cd07858 275 LVFDPSKRITVEEALA 290 (337)
T ss_pred hcCChhhccCHHHHHc
Confidence 9999999999877754
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.2e-31 Score=250.48 Aligned_cols=208 Identities=23% Similarity=0.385 Sum_probs=172.8
Q ss_pred ChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 013092 17 KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 95 (449)
Q Consensus 17 ~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~g 95 (449)
....+.+|+.+++.+ .|++|+++.+++......+++|||+ +++|.+++......+++..+..++.|++.+|.|||.+|
T Consensus 40 ~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 118 (253)
T cd05122 40 KKEKIINEIQILKKC-KHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG 118 (253)
T ss_pred HHHHHHHHHHHHHhC-CCCCEeEEEEEEecCCeEEEEEecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCC
Confidence 556799999999999 6999999999999999999999999 79999999864467999999999999999999999999
Q ss_pred ceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHHH
Q 013092 96 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVL 175 (449)
Q Consensus 96 ivHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il 175 (449)
++|+||+|+||++ +.++.++|+|||++........ .....++..|++||.+.+..++.++|+||||+++
T Consensus 119 i~h~dl~p~ni~i---~~~~~~~l~d~~~~~~~~~~~~--------~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il 187 (253)
T cd05122 119 IIHRDIKAANILL---TSDGEVKLIDFGLSAQLSDTKA--------RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITA 187 (253)
T ss_pred EecCCCCHHHEEE---ccCCeEEEeecccccccccccc--------ccceecCCcccCHHHHcCCCCCccccHHHHHHHH
Confidence 9999999999999 5788999999999877654321 1345688999999999988889999999999999
Q ss_pred HHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhh--cCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 176 MYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC--RGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 176 ~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~--~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
|+|++|..||...... .....+..... ..+. ..++.++.++|..||+.+|++||++.++.+
T Consensus 188 ~~l~~g~~p~~~~~~~---~~~~~~~~~~~----~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 188 IELAEGKPPYSELPPM---KALFKIATNGP----PGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred HHHHhCCCCCCCCchH---HHHHHHHhcCC----CCcCcccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 9999999999764321 22222221111 1112 224889999999999999999999888754
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-31 Score=257.78 Aligned_cols=227 Identities=22% Similarity=0.336 Sum_probs=180.0
Q ss_pred EEEEEeeeccc-CCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHH
Q 013092 4 ILTVFSVQENV-KTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLA 81 (449)
Q Consensus 4 aikV~~k~~~~-~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~ 81 (449)
++|+..+.... ......+..|+.+++.+.+|+||+++++++..++..|+||||+ +++|.+++.. ...+++..++.++
T Consensus 30 ~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~ 108 (280)
T cd05581 30 AIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRK-YGSLDEKCTRFYA 108 (280)
T ss_pred EEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEcCCCCCcHHHHHHH-cCCCCHHHHHHHH
Confidence 44554442221 2234568899999999955999999999999999999999999 9999999986 4479999999999
Q ss_pred HHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCccc-------------ccccCCCCccC
Q 013092 82 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHI-------------PYRENKNLTGT 148 (449)
Q Consensus 82 ~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~-------------~~~~~~~~~gT 148 (449)
.|++.||.|||+.|++|+||||+||++ +.++.++|+|||++............ .........++
T Consensus 109 ~ql~~~l~~Lh~~~~~H~dl~~~ni~i---~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 185 (280)
T cd05581 109 AEILLALEYLHSKGIIHRDLKPENILL---DKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGT 185 (280)
T ss_pred HHHHHHHHHHHHCCeeecCCCHHHeEE---CCCCCEEecCCccccccCCccccccCCCCCccccccccccccccccccCC
Confidence 999999999999999999999999999 57889999999999876543321110 01223455688
Q ss_pred ccccchhhhhCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHh
Q 013092 149 ARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCR 228 (449)
Q Consensus 149 ~~Y~aPE~~~~~~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl 228 (449)
..|++||++....++.++|+||||+++|++++|..||.... ..+.+..+..... .+...+++.+.++|..||
T Consensus 186 ~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~~~~~~~~~~~~-----~~~~~~~~~~~~li~~~l 257 (280)
T cd05581 186 AEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN---EYLTFQKILKLEY-----SFPPNFPPDAKDLIEKLL 257 (280)
T ss_pred ccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCcc---HHHHHHHHHhcCC-----CCCCccCHHHHHHHHHHh
Confidence 99999999998889999999999999999999999998643 2333333332111 233567899999999999
Q ss_pred cCCCCCCCCH----HHHH
Q 013092 229 SLRFDDKPDY----AYLK 242 (449)
Q Consensus 229 ~~~p~~RPt~----~~l~ 242 (449)
+.+|++||++ .+|+
T Consensus 258 ~~~p~~R~~~~~~~~~ll 275 (280)
T cd05581 258 VLDPQDRLGVNEGYDELK 275 (280)
T ss_pred cCCHhhCCCcccCHHHHh
Confidence 9999999998 6554
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-32 Score=285.79 Aligned_cols=232 Identities=12% Similarity=0.208 Sum_probs=191.4
Q ss_pred cEEEEEeeecccCCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHH
Q 013092 3 EILTVFSVQENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLA 81 (449)
Q Consensus 3 ~aikV~~k~~~~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~ 81 (449)
+|||-+|.-.. ..+...|+.|+.||.++ +||||+.|.++.......+||.||| +|+|..+++...+.|++.+...++
T Consensus 660 VAIKTLK~Gyt-ekqrrdFL~EAsIMGQF-dHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgML 737 (996)
T KOG0196|consen 660 VAIKTLKAGYT-EKQRRDFLSEASIMGQF-DHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGML 737 (996)
T ss_pred EEEeeeccCcc-HHHHhhhhhhhhhcccC-CCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHH
Confidence 44444443322 23456799999999999 9999999999999999999999999 999999999888889999999999
Q ss_pred HHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCC
Q 013092 82 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIE 161 (449)
Q Consensus 82 ~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~ 161 (449)
+.|+.|+.||-+.++|||||-..|||+ +.+-.+|++||||++.+.+.... +.......-..+|.|||.+....
T Consensus 738 rGIAsGMkYLsdm~YVHRDLAARNILV---NsnLvCKVsDFGLSRvledd~~~----~ytt~GGKIPiRWTAPEAIa~RK 810 (996)
T KOG0196|consen 738 RGIASGMKYLSDMNYVHRDLAARNILV---NSNLVCKVSDFGLSRVLEDDPEA----AYTTLGGKIPIRWTAPEAIAYRK 810 (996)
T ss_pred HHHHHHhHHHhhcCchhhhhhhhheee---ccceEEEeccccceeecccCCCc----cccccCCccceeecChhHhhhcc
Confidence 999999999999999999999999999 67788999999999988765421 11111222347899999999999
Q ss_pred CChhhHHHHHHHHHHHHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHH
Q 013092 162 QSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAY 240 (449)
Q Consensus 162 ~s~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~ 240 (449)
++..+||||+|+++||.+. |..||.++.+. +.+..|.+. ...+. +-+||..+..||..||++|-++||.|.+
T Consensus 811 FTsASDVWSyGIVmWEVmSyGERPYWdmSNQ---dVIkaIe~g-yRLPp---PmDCP~aL~qLMldCWqkdR~~RP~F~q 883 (996)
T KOG0196|consen 811 FTSASDVWSYGIVMWEVMSYGERPYWDMSNQ---DVIKAIEQG-YRLPP---PMDCPAALYQLMLDCWQKDRNRRPKFAQ 883 (996)
T ss_pred cCchhhccccceEEEEecccCCCcccccchH---HHHHHHHhc-cCCCC---CCCCcHHHHHHHHHHHHHHhhcCCCHHH
Confidence 9999999999999999886 99999987653 233333332 21111 2469999999999999999999999999
Q ss_pred HHHHHHHHHH
Q 013092 241 LKRIFRDLFI 250 (449)
Q Consensus 241 l~~~L~~~~~ 250 (449)
|+..|.+++.
T Consensus 884 iV~~lDklIr 893 (996)
T KOG0196|consen 884 IVSTLDKLIR 893 (996)
T ss_pred HHHHHHHHhc
Confidence 9999988864
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.3e-31 Score=263.41 Aligned_cols=211 Identities=20% Similarity=0.232 Sum_probs=167.2
Q ss_pred CChhHHHHHHHHHHHhcCCCCCceEEEEeEe-CCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC
Q 013092 16 TKHPQLLYESKLYRILQGGTGIPNVRWFGVE-GDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 94 (449)
Q Consensus 16 ~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~-~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~ 94 (449)
.....+..|+++++.+ .||||+++.+++.. ....|+||||++++|.++++ ...++...+..++.|++.||.|||+.
T Consensus 51 ~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~lv~e~~~~~L~~~~~--~~~~~~~~~~~~~~ql~~aL~~LH~~ 127 (328)
T cd07856 51 VLAKRTYRELKLLKHL-RHENIISLSDIFISPLEDIYFVTELLGTDLHRLLT--SRPLEKQFIQYFLYQILRGLKYVHSA 127 (328)
T ss_pred chhHHHHHHHHHHHhc-CCCCeeeEeeeEecCCCcEEEEeehhccCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 3456788999999999 89999999998865 56889999999889999887 45689999999999999999999999
Q ss_pred CceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhC-CCCChhhHHHHHHH
Q 013092 95 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGY 173 (449)
Q Consensus 95 givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~-~~~s~~~DiwSlG~ 173 (449)
||+||||||.||++ +..+.++|+|||++...... .....++..|++||.+.+ ..++.++|||||||
T Consensus 128 ~iiH~dl~p~Nili---~~~~~~~l~dfg~~~~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~ 194 (328)
T cd07856 128 GVVHRDLKPSNILI---NENCDLKICDFGLARIQDPQ----------MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGC 194 (328)
T ss_pred CcccCCCCHHHEeE---CCCCCEEeCccccccccCCC----------cCCCcccccccCceeeeccCCcCcHHHHHHHHH
Confidence 99999999999999 57889999999998754321 123467889999998766 56899999999999
Q ss_pred HHHHHHhCCCCCCCCCcCCHHHHHHHH------------Hh-----------hcccchHHHhhcCCcHHHHHHHHHHhcC
Q 013092 174 VLMYFLRGSLPWQGLKAGTKKQKYEKI------------SE-----------KKVSTSIEALCRGYPTEFASYFHYCRSL 230 (449)
Q Consensus 174 il~elltG~~Pf~~~~~~~~~~~~~~i------------~~-----------~~~~~~~~~l~~~~p~el~~li~~cl~~ 230 (449)
++|+|++|..||..............+ .. .....+.....+.++.++.++|..||+.
T Consensus 195 il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 274 (328)
T cd07856 195 IFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVF 274 (328)
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCC
Confidence 999999999999764321111111000 00 0011122334456789999999999999
Q ss_pred CCCCCCCHHHHH
Q 013092 231 RFDDKPDYAYLK 242 (449)
Q Consensus 231 ~p~~RPt~~~l~ 242 (449)
+|++||++.+++
T Consensus 275 ~P~~R~t~~ell 286 (328)
T cd07856 275 DPQKRISAAEAL 286 (328)
T ss_pred ChhhCCCHHHHh
Confidence 999999987764
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-31 Score=259.81 Aligned_cols=206 Identities=18% Similarity=0.254 Sum_probs=168.3
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFL 97 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~giv 97 (449)
...+..|+++++.+ +|+|++++.+++......|+||||+.++|.+++......+++..++.++.|++.||.|||+.+++
T Consensus 59 ~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~ 137 (308)
T cd06634 59 WQDIIKEVRFLQKL-RHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMI 137 (308)
T ss_pred HHHHHHHHHHHHhC-CCCCcccEEEEEEcCCeeEEEEEccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence 34678899999999 89999999999999999999999997789888865566789999999999999999999999999
Q ss_pred ecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhC---CCCChhhHHHHHHHH
Q 013092 98 HRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG---IEQSRRDDLESLGYV 174 (449)
Q Consensus 98 HRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~---~~~s~~~DiwSlG~i 174 (449)
||||||.||++ +.++.++|+|||++...... ....++..|+|||++.+ ..++.++|||||||+
T Consensus 138 H~dl~p~nil~---~~~~~~kl~dfg~~~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~i 203 (308)
T cd06634 138 HRDVKAGNILL---SEPGLVKLGDFGSASIMAPA-----------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 203 (308)
T ss_pred cCCCCHHhEEE---CCCCcEEECCcccceeecCc-----------ccccCCccccCHHHHhhcccCCCCcccchHHHHHH
Confidence 99999999999 57789999999998765432 23468889999999853 457889999999999
Q ss_pred HHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHH
Q 013092 175 LMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRI 244 (449)
Q Consensus 175 l~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~ 244 (449)
+|+|++|..||...... .....+...... ......++.++.++|.+||..+|++||++.++...
T Consensus 204 l~el~~g~~p~~~~~~~---~~~~~~~~~~~~---~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~ 267 (308)
T cd06634 204 CIELAERKPPLFNMNAM---SALYHIAQNESP---ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (308)
T ss_pred HHHHHcCCCCCccccHH---HHHHHHhhcCCC---CcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence 99999999999764332 111222221111 11123578899999999999999999999887643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=284.82 Aligned_cols=232 Identities=19% Similarity=0.279 Sum_probs=189.6
Q ss_pred EEEEeeecccC---CChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcC-----------
Q 013092 5 LTVFSVQENVK---TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCS----------- 69 (449)
Q Consensus 5 ikV~~k~~~~~---~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~----------- 69 (449)
+.|++|..+.. .+.+.+..|+++|+.+..|+||+.+.+++...+..++|+||+ .|+|.++++.+.
T Consensus 329 ~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~ 408 (609)
T KOG0200|consen 329 VTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVF 408 (609)
T ss_pred EEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCC
Confidence 44555554332 456779999999999989999999999999999999999999 999999998654
Q ss_pred ----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCC
Q 013092 70 ----RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNL 145 (449)
Q Consensus 70 ----~~ls~~~~~~i~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~ 145 (449)
..++....+.++.||+.|++||++..+|||||-.+|||+ ..+..+||+|||+|+....... |.. ...
T Consensus 409 ~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi---~~~~~~kIaDFGlar~~~~~~~-----y~~-~~~ 479 (609)
T KOG0200|consen 409 PNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLI---TKNKVIKIADFGLARDHYNKDY-----YRT-KSS 479 (609)
T ss_pred ccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEe---cCCCEEEEccccceeccCCCCc-----eEe-cCC
Confidence 238999999999999999999999999999999999999 5778999999999996554332 111 111
Q ss_pred c--cCccccchhhhhCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHH
Q 013092 146 T--GTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFAS 222 (449)
Q Consensus 146 ~--gT~~Y~aPE~~~~~~~s~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~ 222 (449)
. -...|||||.+....|+.++||||||++|||+++ |..||.+.... ...++.+.+... .+.+..|+.++.+
T Consensus 480 ~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~--~~l~~~l~~G~r----~~~P~~c~~eiY~ 553 (609)
T KOG0200|consen 480 AGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPT--EELLEFLKEGNR----MEQPEHCSDEIYD 553 (609)
T ss_pred CCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcH--HHHHHHHhcCCC----CCCCCCCCHHHHH
Confidence 2 2446999999999999999999999999999998 99999884321 222443433322 2345678999999
Q ss_pred HHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 013092 223 YFHYCRSLRFDDKPDYAYLKRIFRDLFIR 251 (449)
Q Consensus 223 li~~cl~~~p~~RPt~~~l~~~L~~~~~~ 251 (449)
+|..||+.+|++||+|.++.+.|...+..
T Consensus 554 iM~~CW~~~p~~RP~F~~~~~~~~~~l~~ 582 (609)
T KOG0200|consen 554 LMKSCWNADPEDRPTFSECVEFFEKHLQD 582 (609)
T ss_pred HHHHHhCCCcccCCCHHHHHHHHHHHHHH
Confidence 99999999999999999999999987654
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.3e-31 Score=252.48 Aligned_cols=210 Identities=22% Similarity=0.272 Sum_probs=168.8
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeC--CEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEG--DYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 94 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~--~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~ 94 (449)
...+.+|+++++.+ +|+||+++++++.+. ...++||||+ +++|.+++.. ...+++..++.++.|++.||.|||+.
T Consensus 48 ~~~~~~ei~~l~~l-~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~-~~~l~~~~~~~~~~~i~~al~~LH~~ 125 (264)
T cd06653 48 VNALECEIQLLKNL-RHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKA-YGALTENVTRRYTRQILQGVSYLHSN 125 (264)
T ss_pred HHHHHHHHHHHHHc-CCCCcceEEEEEEcCCCCEEEEEEEeCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 34688999999999 899999999988754 5689999999 8999999875 34689999999999999999999999
Q ss_pred CceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHH
Q 013092 95 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYV 174 (449)
Q Consensus 95 givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~i 174 (449)
|++|+||||+||++ +.++.++|+|||+++......... .......++..|+|||++.+..++.++|+|||||+
T Consensus 126 ~i~H~dl~p~ni~i---~~~~~~~l~dfg~~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~i 198 (264)
T cd06653 126 MIVHRDIKGANILR---DSAGNVKLGDFGASKRIQTICMSG----TGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACT 198 (264)
T ss_pred CEecCCCCHHHEEE---cCCCCEEECccccccccccccccC----ccccccCCcccccCHhhhcCCCCCccccHHHHHHH
Confidence 99999999999999 577889999999998654321100 11123568999999999998888999999999999
Q ss_pred HHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 175 LMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 175 l~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
+|+|++|..||..... .....++. .....+.++..+++++.++|.+||. ++..||+..++..
T Consensus 199 l~~l~~g~~p~~~~~~---~~~~~~~~---~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 199 VVEMLTEKPPWAEYEA---MAAIFKIA---TQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred HHHHHhCCCCCCccCH---HHHHHHHH---cCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 9999999999976422 22222222 1222234566788999999999999 5799999887653
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=260.05 Aligned_cols=216 Identities=21% Similarity=0.270 Sum_probs=170.1
Q ss_pred HHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q 013092 20 QLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHR 99 (449)
Q Consensus 20 ~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~givHR 99 (449)
.+.+|+++++.+ .|+||+++++++..+++.|+||||+.++|.+++.. ...+++..++.++.|++.||+|||+.||+|+
T Consensus 66 ~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~ 143 (335)
T PTZ00024 66 TTLRELKIMNEI-KHENIMGLVDVYVEGDFINLVMDIMASDLKKVVDR-KIRLTESQVKCILLQILNGLNVLHKWYFMHR 143 (335)
T ss_pred hHHHHHHHHHhC-CCcceeeeeEEEecCCcEEEEEeccccCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecc
Confidence 578999999999 89999999999999999999999997799999874 4569999999999999999999999999999
Q ss_pred CCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCccc-------ccccCCCCccCccccchhhhhCCC-CChhhHHHHH
Q 013092 100 DIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHI-------PYRENKNLTGTARYASMNTHLGIE-QSRRDDLESL 171 (449)
Q Consensus 100 DLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~-------~~~~~~~~~gT~~Y~aPE~~~~~~-~s~~~DiwSl 171 (449)
||||+||++ +..+.++|+|||++..+......... .........++..|+|||.+.+.. ++.++|||||
T Consensus 144 dl~~~nill---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~sl 220 (335)
T PTZ00024 144 DLSPANIFI---NSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSV 220 (335)
T ss_pred cccHHHeEE---CCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHH
Confidence 999999999 57789999999999876522111000 001112345688999999987644 6899999999
Q ss_pred HHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcc-----------------------cchHHHhhcCCcHHHHHHHHHHh
Q 013092 172 GYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV-----------------------STSIEALCRGYPTEFASYFHYCR 228 (449)
Q Consensus 172 G~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~-----------------------~~~~~~l~~~~p~el~~li~~cl 228 (449)
||++|+|++|..||.+... ...+..+.+... ..........++.++.+++..||
T Consensus 221 G~~l~el~tg~~p~~~~~~---~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 297 (335)
T PTZ00024 221 GCIFAELLTGKPLFPGENE---IDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLL 297 (335)
T ss_pred HHHHHHHHhCCCCCCCCCH---HHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHc
Confidence 9999999999999987543 222332222110 11122233456889999999999
Q ss_pred cCCCCCCCCHHHHHH
Q 013092 229 SLRFDDKPDYAYLKR 243 (449)
Q Consensus 229 ~~~p~~RPt~~~l~~ 243 (449)
+.+|++||++++++.
T Consensus 298 ~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 298 KLNPLERISAKEALK 312 (335)
T ss_pred CCCchhccCHHHHhc
Confidence 999999999887753
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=265.94 Aligned_cols=208 Identities=20% Similarity=0.289 Sum_probs=166.9
Q ss_pred ChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCE------EEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHH
Q 013092 17 KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDY------NVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEF 90 (449)
Q Consensus 17 ~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~------~~lVmE~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~y 90 (449)
....+.+|+.+++.+ .|+||+.+.+++...+. .|+||||++++|.+++. ...+++..++.++.|++.||+|
T Consensus 57 ~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~--~~~l~~~~~~~~~~ql~~aL~~ 133 (343)
T cd07851 57 HAKRTYRELRLLKHM-DHENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVK--CQKLSDDHIQFLVYQILRGLKY 133 (343)
T ss_pred HHHHHHHHHHHHHhc-cCCCHHHHHHHhhccccccccccEEEEEecCCCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHH
Confidence 345678899999999 99999999887765544 89999999999999998 4579999999999999999999
Q ss_pred HHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhC-CCCChhhHHH
Q 013092 91 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLE 169 (449)
Q Consensus 91 LH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~-~~~s~~~Diw 169 (449)
||+.||+||||||+||++ +.++.++|+|||++....... ....++..|+|||.+.+ ..++.++|||
T Consensus 134 LH~~gi~H~dlkp~Nill---~~~~~~kL~dfg~~~~~~~~~----------~~~~~~~~y~aPE~~~~~~~~~~~~Dvw 200 (343)
T cd07851 134 IHSAGIIHRDLKPSNIAV---NEDCELKILDFGLARHTDDEM----------TGYVATRWYRAPEIMLNWMHYNQTVDIW 200 (343)
T ss_pred HHHCCeecCCCCHHHeEE---CCCCCEEEccccccccccccc----------cCCcccccccCHHHHhCCCCCCchHhHH
Confidence 999999999999999999 577899999999998654321 23467889999999875 4678999999
Q ss_pred HHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcc--------------------------cchHHHhhcCCcHHHHHH
Q 013092 170 SLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV--------------------------STSIEALCRGYPTEFASY 223 (449)
Q Consensus 170 SlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~--------------------------~~~~~~l~~~~p~el~~l 223 (449)
||||++|+|++|..||.+... .+.+..+..... ......+...++.++.++
T Consensus 201 slGv~l~elltg~~pf~~~~~---~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dl 277 (343)
T cd07851 201 SVGCIMAELLTGKTLFPGSDH---IDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDL 277 (343)
T ss_pred HHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHH
Confidence 999999999999999976433 222332222110 011122234568899999
Q ss_pred HHHHhcCCCCCCCCHHHHHH
Q 013092 224 FHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 224 i~~cl~~~p~~RPt~~~l~~ 243 (449)
|..||..+|++||++.+|+.
T Consensus 278 i~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 278 LEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred HHHhCCCChhhCCCHHHHhc
Confidence 99999999999999888753
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-31 Score=259.54 Aligned_cols=209 Identities=21% Similarity=0.278 Sum_probs=170.1
Q ss_pred ChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 013092 17 KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 95 (449)
Q Consensus 17 ~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~g 95 (449)
....+.+|+.+++.+ +||||+.+++.+...+..|+||||+ +++|.+++.. ..+++..+..++.|++.||.|||++|
T Consensus 59 ~~~~~~~e~~~l~~l-~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~g 135 (293)
T cd06647 59 KKELIINEILVMREN-KHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQ 135 (293)
T ss_pred HHHHHHHHHHHHhhc-CCCCeeehhheeeeCCcEEEEEecCCCCcHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 345688999999999 7999999999999999999999999 9999999873 46899999999999999999999999
Q ss_pred ceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHHH
Q 013092 96 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVL 175 (449)
Q Consensus 96 ivHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il 175 (449)
++|+||||+||++ +.++.++|+|||++........ ......|++.|++||.+.+..++.++|+|||||++
T Consensus 136 i~H~dL~p~Nili---~~~~~~kL~dfg~~~~~~~~~~-------~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll 205 (293)
T cd06647 136 VIHRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQS-------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMA 205 (293)
T ss_pred EeeccCCHHHEEE---cCCCCEEEccCcceeccccccc-------ccccccCChhhcCchhhccCCCCchhhHHHHHHHH
Confidence 9999999999999 5778999999999876544322 11334688999999999988899999999999999
Q ss_pred HHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 176 MYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 176 ~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
|++++|..||...... ..+..+.... .+.......++.++.++|..||..+|++||++.+|..
T Consensus 206 ~~ll~g~~pf~~~~~~---~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 268 (293)
T cd06647 206 IEMVEGEPPYLNENPL---RALYLIATNG--TPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 268 (293)
T ss_pred HHHHhCCCCCCCCChh---hheeehhcCC--CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 9999999999764331 1111111111 1111123346788999999999999999999887754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=253.06 Aligned_cols=226 Identities=19% Similarity=0.189 Sum_probs=176.3
Q ss_pred EEEEEeeecccCCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHH
Q 013092 4 ILTVFSVQENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQ 83 (449)
Q Consensus 4 aikV~~k~~~~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~~~~i~~q 83 (449)
++|+..+........+.+..|+.+++.+ .|+||+++++++.+.+..|+||||++++|.+++......+++..++.++.|
T Consensus 28 ~iK~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~~v~e~~~~~l~~~i~~~~~~~~~~~~~~~~~~ 106 (282)
T cd07829 28 ALKKIRLDNEEEGIPSTALREISLLKEL-KHPNIVKLLDVIHTERKLYLVFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQ 106 (282)
T ss_pred EEEEeccccccccccHHHHHHHHHHHhc-CCCCHHHHHhhhhcCCceEEEecCcCcCHHHHHHhhccCCCHHHHHHHHHH
Confidence 3444443332233456788999999999 799999999999999999999999977999999865457999999999999
Q ss_pred HHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCC-CC
Q 013092 84 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI-EQ 162 (449)
Q Consensus 84 i~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~-~~ 162 (449)
++.||+|||+.||+|+||+|+||++ +.++.++|+|||+++....... ......++..|+|||.+.+. .+
T Consensus 107 i~~~l~~LH~~~i~H~~l~~~ni~~---~~~~~~~l~d~g~~~~~~~~~~-------~~~~~~~~~~~~aPE~~~~~~~~ 176 (282)
T cd07829 107 LLRGLAYCHSHRILHRDLKPQNILI---NRDGVLKLADFGLARAFGIPLR-------TYTHEVVTLWYRAPEILLGSKHY 176 (282)
T ss_pred HHHHHHHHHHCCcccCCCChheEEE---cCCCCEEEecCCcccccCCCcc-------ccCccccCcCcCChHHhcCCcCC
Confidence 9999999999999999999999999 5788999999999986644321 11234567889999999876 78
Q ss_pred ChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhc------------------------ccchHHHhhcCCcH
Q 013092 163 SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK------------------------VSTSIEALCRGYPT 218 (449)
Q Consensus 163 s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~------------------------~~~~~~~l~~~~p~ 218 (449)
+.++|||||||++|||++|..||..... ...+.++.... .........+.++.
T Consensus 177 ~~~~Dv~slG~~l~~l~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (282)
T cd07829 177 STAVDIWSVGCIFAEMITGKPLFPGDSE---IDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDP 253 (282)
T ss_pred CccccHHHHHHHHHHHHhCCCCCCCccH---HHHHHHHHHHhCCCcHHHHHhhcccccccccccccCccchHHhcccccH
Confidence 9999999999999999999999976432 22222222110 00111122344578
Q ss_pred HHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 219 EFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 219 el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
++.++|..||..+|++||++.++..
T Consensus 254 ~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 254 EGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred HHHHHHHHhhccCcccCCCHHHHhh
Confidence 9999999999999999999888754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=262.23 Aligned_cols=207 Identities=19% Similarity=0.255 Sum_probs=166.3
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeCC------EEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHH
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEGD------YNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 91 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~------~~~lVmE~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yL 91 (449)
...+.+|+.+++.+ +|+||+++.+++.... ..|+||||+|++|.+++. ...+++..++.++.||+.||+||
T Consensus 58 ~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~--~~~l~~~~~~~i~~qi~~al~~L 134 (343)
T cd07880 58 AKRAYRELRLLKHM-KHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMK--HEKLSEDRIQFLVYQMLKGLKYI 134 (343)
T ss_pred HHHHHHHHHHHHhc-CCCCccceeeeecCCccccccceEEEEEecCCCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHH
Confidence 34688999999999 9999999999887543 469999999999999987 45799999999999999999999
Q ss_pred HHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhC-CCCChhhHHHH
Q 013092 92 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLES 170 (449)
Q Consensus 92 H~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~-~~~s~~~DiwS 170 (449)
|+.||+||||||.||++ +..+.++|+|||++....... ....+++.|++||++.+ ..++.++|+||
T Consensus 135 H~~gi~H~dlkp~Nill---~~~~~~kl~dfg~~~~~~~~~----------~~~~~~~~y~aPE~~~~~~~~~~~~Di~s 201 (343)
T cd07880 135 HAAGIIHRDLKPGNLAV---NEDCELKILDFGLARQTDSEM----------TGYVVTRWYRAPEVILNWMHYTQTVDIWS 201 (343)
T ss_pred HhCCeecCCCCHHHEEE---cCCCCEEEeecccccccccCc----------cccccCCcccCHHHHhCCCCCCcHHHHHH
Confidence 99999999999999999 577889999999997654321 23467889999999876 45789999999
Q ss_pred HHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcc--------------------------cchHHHhhcCCcHHHHHHH
Q 013092 171 LGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV--------------------------STSIEALCRGYPTEFASYF 224 (449)
Q Consensus 171 lG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~--------------------------~~~~~~l~~~~p~el~~li 224 (449)
|||++|+|++|..||.+.+.. ..+.++..... ...+..+...++.++.++|
T Consensus 202 lG~ll~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 278 (343)
T cd07880 202 VGCIMAEMLTGKPLFKGHDHL---DQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVL 278 (343)
T ss_pred HHHHHHHHHhCCCCCCCCCHH---HHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHH
Confidence 999999999999999864331 22222211100 0112233456788999999
Q ss_pred HHHhcCCCCCCCCHHHHHH
Q 013092 225 HYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 225 ~~cl~~~p~~RPt~~~l~~ 243 (449)
..|+..+|++||+..+++.
T Consensus 279 ~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 279 EKMLVLDAESRITAAEALA 297 (343)
T ss_pred HHHcCCChhhCCCHHHHhc
Confidence 9999999999999887753
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=262.99 Aligned_cols=207 Identities=20% Similarity=0.273 Sum_probs=163.5
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeC------CEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHH
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEG------DYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 91 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~------~~~~lVmE~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yL 91 (449)
...+.+|+.+++.+ +|+||+++.+++... ...|+++++++++|.+++. ...+++..++.++.|++.||.||
T Consensus 60 ~~~~~~Ei~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~~lv~~~~~~~L~~~~~--~~~l~~~~~~~i~~qi~~aL~~L 136 (345)
T cd07877 60 AKRTYRELRLLKHM-KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYI 136 (345)
T ss_pred HHHHHHHHHHHHHc-CCCcccceeeeeeecccccccccEEEEehhcccCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHH
Confidence 45688899999999 899999999887543 3478999999999999887 35699999999999999999999
Q ss_pred HHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhC-CCCChhhHHHH
Q 013092 92 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLES 170 (449)
Q Consensus 92 H~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~-~~~s~~~DiwS 170 (449)
|+.||+||||||+||++ +.++.++|+|||+++..... .....++..|+|||.+.+ ..++.++||||
T Consensus 137 H~~~ivH~dlkp~NIll---~~~~~~kl~dfg~~~~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~Dvws 203 (345)
T cd07877 137 HSADIIHRDLKPSNLAV---NEDCELKILDFGLARHTDDE----------MTGYVATRWYRAPEIMLNWMHYNQTVDIWS 203 (345)
T ss_pred HHCCeeecCCChHHEEE---cCCCCEEEeccccccccccc----------ccccccCCCccCHHHHhCccCCCchhhHHH
Confidence 99999999999999999 57889999999998764322 123467899999999876 56789999999
Q ss_pred HHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcc--------------------------cchHHHhhcCCcHHHHHHH
Q 013092 171 LGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV--------------------------STSIEALCRGYPTEFASYF 224 (449)
Q Consensus 171 lG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~--------------------------~~~~~~l~~~~p~el~~li 224 (449)
|||++|+|++|..||...... ..+..+..... ...........++++.++|
T Consensus 204 lG~il~el~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 280 (345)
T cd07877 204 VGCIMAELLTGRTLFPGTDHI---DQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL 280 (345)
T ss_pred HHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHH
Confidence 999999999999999764322 22222111100 0011111234678899999
Q ss_pred HHHhcCCCCCCCCHHHHHH
Q 013092 225 HYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 225 ~~cl~~~p~~RPt~~~l~~ 243 (449)
..|+..+|++||+..+++.
T Consensus 281 ~~~L~~dp~~R~t~~e~l~ 299 (345)
T cd07877 281 EKMLVLDSDKRITAAQALA 299 (345)
T ss_pred HHHcCCChhhcCCHHHHhc
Confidence 9999999999999877653
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=254.02 Aligned_cols=208 Identities=22% Similarity=0.236 Sum_probs=170.7
Q ss_pred ChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHH
Q 013092 17 KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVH 92 (449)
Q Consensus 17 ~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~---~~~ls~~~~~~i~~qi~~aL~yLH 92 (449)
...++..|+.+++.+ +||||+++++++.+....++||||+ +++|.+++... ...+++..++.++.|++.||.|||
T Consensus 45 ~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH 123 (260)
T cd08222 45 ETVQANQEAQLLSKL-DHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH 123 (260)
T ss_pred hHHHHHHHHHHHHhC-CCCcHHHHHHHHhcCCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHH
Confidence 344577899999999 8999999999999999999999999 89999988642 456899999999999999999999
Q ss_pred HCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHH
Q 013092 93 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLG 172 (449)
Q Consensus 93 ~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG 172 (449)
+.|++|+||||+||++. .+.++|+|||+++....... ......|+..|++||.+.+..++.++|+||||
T Consensus 124 ~~~i~h~~l~~~nili~----~~~~~l~d~g~~~~~~~~~~-------~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG 192 (260)
T cd08222 124 QRRILHRDLKAKNIFLK----NNLLKIGDFGVSRLLMGSCD-------LATTFTGTPYYMSPEALKHQGYDSKSDIWSLG 192 (260)
T ss_pred HcCccccCCChhheEee----cCCEeecccCceeecCCCcc-------cccCCCCCcCccCHHHHccCCCCchhhHHHHH
Confidence 99999999999999993 35699999999987644322 12345688999999999888889999999999
Q ss_pred HHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 173 YVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 173 ~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
+++|+|++|..||... .....+..+... ....+...++.++.++|..||..+|++||++.++.+
T Consensus 193 ~~~~~l~~~~~~~~~~---~~~~~~~~~~~~----~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 193 CILYEMCCLAHAFEGQ---NFLSVVLRIVEG----PTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred HHHHHHHhCCCCCCCc---cHHHHHHHHHcC----CCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 9999999999999652 223333333322 222234568899999999999999999999888754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.9e-32 Score=247.68 Aligned_cols=227 Identities=18% Similarity=0.200 Sum_probs=171.2
Q ss_pred CCChhHHHHHHHHHHHhcCCCCCceEEEEeEe-----CCEEEEEEecC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHH
Q 013092 15 KTKHPQLLYESKLYRILQGGTGIPNVRWFGVE-----GDYNVLVMDLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMI 85 (449)
Q Consensus 15 ~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~-----~~~~~lVmE~~-g~sL~~ll~~~---~~~ls~~~~~~i~~qi~ 85 (449)
.+..+...+|++.++++ +||||.++.+.... ....||+++|+ .|+|.+.++.+ +..+++..++.|+.+|+
T Consensus 59 ~~~~e~~~rEid~~rkf-~s~~vl~l~dh~l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic 137 (302)
T KOG2345|consen 59 QEDIEEALREIDNHRKF-NSPNVLRLVDHQLREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGIC 137 (302)
T ss_pred hHHHHHHHHHHHHHHhh-CCcchHHHHHHHHHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHH
Confidence 35566789999999999 88999999776653 34589999999 99999999765 23589999999999999
Q ss_pred HHHHHHHHCC--ceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCC--cccccccCCCCccCccccchhhhhC--
Q 013092 86 NRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH--QHIPYRENKNLTGTARYASMNTHLG-- 159 (449)
Q Consensus 86 ~aL~yLH~~g--ivHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~--~~~~~~~~~~~~gT~~Y~aPE~~~~-- 159 (449)
.||++||+.. +.||||||.|||++ ..+.++|.|||.+....-.... .+.....-.....|..|.|||.|.-
T Consensus 138 ~gL~~lH~~~~~yAH~DiKP~NILls---~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~ 214 (302)
T KOG2345|consen 138 RGLEALHEKEPPYAHRDIKPANILLS---DSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKS 214 (302)
T ss_pred HHHHHHhccCCcccccCCCcceeEec---CCCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheeccc
Confidence 9999999999 99999999999994 6899999999998765432111 1111112223456889999999874
Q ss_pred -CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCH
Q 013092 160 -IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDY 238 (449)
Q Consensus 160 -~~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~ 238 (449)
...+.++|||||||+||.|+.|.-||......- ......+...++.. +. ...+++.+.++|+.|++.||.+||+.
T Consensus 215 ~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~G-gSlaLAv~n~q~s~--P~-~~~yse~l~~lik~mlqvdP~qRP~i 290 (302)
T KOG2345|consen 215 HCTITERTDIWSLGCTLYAMMFGESPFERIYQQG-GSLALAVQNAQISI--PN-SSRYSEALHQLIKSMLQVDPNQRPTI 290 (302)
T ss_pred CcccccccchhhhhHHHHHHHHcCCcchHHhhcC-CeEEEeeecccccc--CC-CCCccHHHHHHHHHHhcCCcccCCCH
Confidence 456889999999999999999999995421100 00000011111110 00 12389999999999999999999999
Q ss_pred HHHHHHHHHHH
Q 013092 239 AYLKRIFRDLF 249 (449)
Q Consensus 239 ~~l~~~L~~~~ 249 (449)
.+|...+.++.
T Consensus 291 ~~ll~~~d~Li 301 (302)
T KOG2345|consen 291 PELLSKLDDLI 301 (302)
T ss_pred HHHHHHHHhhc
Confidence 99998887653
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=253.91 Aligned_cols=213 Identities=21% Similarity=0.234 Sum_probs=167.8
Q ss_pred HHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecCCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q 013092 20 QLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLH 98 (449)
Q Consensus 20 ~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~g~sL~~ll~~~~-~~ls~~~~~~i~~qi~~aL~yLH~~givH 98 (449)
...+|+..++.+.+|+||+++++.+.+++..|+||||++++|.+++.... ..+++..++.++.|++.+|.|||++|++|
T Consensus 43 ~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H 122 (283)
T cd07830 43 MNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFH 122 (283)
T ss_pred HHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 45679999999966999999999999999999999999889999887543 46899999999999999999999999999
Q ss_pred cCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhC-CCCChhhHHHHHHHHHHH
Q 013092 99 RDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMY 177 (449)
Q Consensus 99 RDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~-~~~s~~~DiwSlG~il~e 177 (449)
+||+|+||++ +..+.++|+|||++........ .....++..|+|||++.. ..++.++|+||||+++|+
T Consensus 123 ~dl~~~ni~i---~~~~~~~l~d~~~~~~~~~~~~--------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~e 191 (283)
T cd07830 123 RDLKPENLLV---SGPEVVKIADFGLAREIRSRPP--------YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAE 191 (283)
T ss_pred CCCChhhEEE---cCCCCEEEeecccceeccCCCC--------cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHH
Confidence 9999999999 5789999999999986654321 134568889999998854 457899999999999999
Q ss_pred HHhCCCCCCCCCcCCHHHHHHHHHhh----------------------cccchHHHhhcCCcHHHHHHHHHHhcCCCCCC
Q 013092 178 FLRGSLPWQGLKAGTKKQKYEKISEK----------------------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDK 235 (449)
Q Consensus 178 lltG~~Pf~~~~~~~~~~~~~~i~~~----------------------~~~~~~~~l~~~~p~el~~li~~cl~~~p~~R 235 (449)
|++|..||..............+... ........+....+.++.++|..||..+|++|
T Consensus 192 l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~R 271 (283)
T cd07830 192 LYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKR 271 (283)
T ss_pred HHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccC
Confidence 99999999775432211111110000 00011122233447889999999999999999
Q ss_pred CCHHHHHH
Q 013092 236 PDYAYLKR 243 (449)
Q Consensus 236 Pt~~~l~~ 243 (449)
|++.++..
T Consensus 272 pt~~ei~~ 279 (283)
T cd07830 272 PTASQALQ 279 (283)
T ss_pred CCHHHHhh
Confidence 99887754
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=272.45 Aligned_cols=202 Identities=19% Similarity=0.210 Sum_probs=169.1
Q ss_pred hHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q 013092 19 PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFL 97 (449)
Q Consensus 19 ~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~giv 97 (449)
.+.-+|+.++....+|+||+++.+.+.++.+.|+|||++ |+-|.+-+.. ...+. .++..|+.+|+.|+.|||++|+|
T Consensus 360 ~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~ell~ri~~-~~~~~-~e~~~w~~~lv~Av~~LH~~gvv 437 (612)
T KOG0603|consen 360 DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGGELLRRIRS-KPEFC-SEASQWAAELVSAVDYLHEQGVV 437 (612)
T ss_pred cccccccchhhhhcCCCcceeecceecCCceeeeeehhccccHHHHHHHh-cchhH-HHHHHHHHHHHHHHHHHHhcCee
Confidence 345678889999999999999999999999999999999 7766666653 33344 77888999999999999999999
Q ss_pred ecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHHHHH
Q 013092 98 HRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMY 177 (449)
Q Consensus 98 HRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il~e 177 (449)
||||||+|||+. +..++++|+|||.++..+.. ..+-+-|..|.|||++...+|+..+||||||++||+
T Consensus 438 hRDLkp~NIL~~--~~~g~lrltyFG~a~~~~~~----------~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ 505 (612)
T KOG0603|consen 438 HRDLKPGNILLD--GSAGHLRLTYFGFWSELERS----------CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYE 505 (612)
T ss_pred ecCCChhheeec--CCCCcEEEEEechhhhCchh----------hcccchhhcccChhhhccCCCCcchhhHHHHHHHHH
Confidence 999999999994 37789999999999876654 123356889999999999999999999999999999
Q ss_pred HHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 178 FLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 178 lltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
||+|+.||.....+ .+.+.++...+.. ..++.+.++|+..||+.+|.+||++.++..
T Consensus 506 ML~G~tp~~~~P~~--~ei~~~i~~~~~s-------~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 506 MLTGRTLFAAHPAG--IEIHTRIQMPKFS-------ECVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred HHhCCCccccCCch--HHHHHhhcCCccc-------cccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 99999999876554 3444444443332 457899999999999999999999988753
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=260.13 Aligned_cols=206 Identities=19% Similarity=0.257 Sum_probs=162.9
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeC------CEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHH
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEG------DYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 91 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~------~~~~lVmE~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yL 91 (449)
...+.+|+.+++.+ .|+||+++++++... ...|+||||+..+|.+++. ..+++..+..++.|++.||+||
T Consensus 58 ~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~~~~qi~~aL~~L 133 (342)
T cd07879 58 AKRAYRELTLLKHM-QHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMG---HPLSEDKVQYLVYQMLCGLKYI 133 (342)
T ss_pred hhHHHHHHHHHHhc-CCCCccchhheecccccCCCCceEEEEecccccCHHHHHc---CCCCHHHHHHHHHHHHHHHHHH
Confidence 45688999999999 999999999887654 3569999999778877653 4689999999999999999999
Q ss_pred HHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhC-CCCChhhHHHH
Q 013092 92 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLES 170 (449)
Q Consensus 92 H~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~-~~~s~~~DiwS 170 (449)
|+.||+||||||+||++ +.++.++|+|||+++...... ....++..|+|||++.+ ..++.++||||
T Consensus 134 H~~~i~H~dlkp~NIll---~~~~~~kL~dfg~~~~~~~~~----------~~~~~~~~y~aPE~~~~~~~~~~~~Dv~s 200 (342)
T cd07879 134 HSAGIIHRDLKPGNLAV---NEDCELKILDFGLARHADAEM----------TGYVVTRWYRAPEVILNWMHYNQTVDIWS 200 (342)
T ss_pred HHCCcccCCCCHHHEEE---CCCCCEEEeeCCCCcCCCCCC----------CCceeeecccChhhhcCccccCchHHHHH
Confidence 99999999999999999 578899999999987543211 23467889999999876 46889999999
Q ss_pred HHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhc--------------------------ccchHHHhhcCCcHHHHHHH
Q 013092 171 LGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK--------------------------VSTSIEALCRGYPTEFASYF 224 (449)
Q Consensus 171 lG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~--------------------------~~~~~~~l~~~~p~el~~li 224 (449)
|||++|||++|+.||.+... ...+..+.... ....+..+.+.++.++.++|
T Consensus 201 lGvil~el~~g~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 277 (342)
T cd07879 201 VGCIMAEMLTGKTLFKGKDY---LDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLL 277 (342)
T ss_pred HHHHHHHHHhCCCCCCCCCH---HHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHH
Confidence 99999999999999986432 12222221100 00111222345678899999
Q ss_pred HHHhcCCCCCCCCHHHHHH
Q 013092 225 HYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 225 ~~cl~~~p~~RPt~~~l~~ 243 (449)
..||+.+|++||++.+++.
T Consensus 278 ~~~l~~dP~~R~~~~e~l~ 296 (342)
T cd07879 278 EKMLELDVDKRLTATEALE 296 (342)
T ss_pred HHHcCCChhhCcCHHHHhc
Confidence 9999999999999888754
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=246.62 Aligned_cols=204 Identities=21% Similarity=0.272 Sum_probs=171.3
Q ss_pred ChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 013092 17 KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 95 (449)
Q Consensus 17 ~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~g 95 (449)
....+..|+++++.+ .|+||+++++.+..+...|+||||+ +++|.+++.. ...+++..+..++.|++.||.|||+.+
T Consensus 36 ~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lh~~~ 113 (250)
T cd05123 36 EVEHTLTERNILSRI-NHPFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSK-EGRFSEERARFYAAEIVLALEYLHSLG 113 (250)
T ss_pred HHHHHHHHHHHHHHc-CCCcHHHHHHHeecCCeeEEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 344688999999999 7999999999999999999999999 9999999985 346899999999999999999999999
Q ss_pred ceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHHH
Q 013092 96 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVL 175 (449)
Q Consensus 96 ivHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il 175 (449)
++|+||||+||++ +..+.++|+|||++........ ......++..|++||.+.+...+.++|+||||+++
T Consensus 114 ~~H~~l~p~ni~~---~~~~~~~l~d~~~~~~~~~~~~-------~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~ 183 (250)
T cd05123 114 IIYRDLKPENILL---DADGHIKLTDFGLAKELSSEGS-------RTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLL 183 (250)
T ss_pred ceecCCCcceEEE---cCCCcEEEeecCcceecccCCC-------cccCCcCCccccChHHhCCCCCCchhhHHHHHHHH
Confidence 9999999999999 5778999999999987654321 12345688899999999988889999999999999
Q ss_pred HHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHH
Q 013092 176 MYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAY 240 (449)
Q Consensus 176 ~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~ 240 (449)
|+|++|..||..... .+.+..+.+.. ..+...++.++.+++..||..+|++||+..+
T Consensus 184 ~~l~~g~~p~~~~~~---~~~~~~~~~~~-----~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 184 YEMLTGKPPFYAEDR---KEIYEKILKDP-----LRFPEFLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred HHHHHCCCCCCCCCH---HHHHHHHhcCC-----CCCCCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 999999999976432 33334433321 1234556899999999999999999999844
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=259.64 Aligned_cols=219 Identities=20% Similarity=0.210 Sum_probs=165.8
Q ss_pred CChhHHHHHHHHHHHhcCCCCCceEEEEeEeC--------------CEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHH
Q 013092 16 TKHPQLLYESKLYRILQGGTGIPNVRWFGVEG--------------DYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLA 81 (449)
Q Consensus 16 ~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~--------------~~~~lVmE~~g~sL~~ll~~~~~~ls~~~~~~i~ 81 (449)
.....+.+|+++++.+ +||||+++++++... ...|+||||++++|.+++. ...+++..++.++
T Consensus 44 ~~~~~~~~Ei~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~--~~~l~~~~~~~~~ 120 (342)
T cd07854 44 QSVKHALREIKIIRRL-DHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLE--QGPLSEEHARLFM 120 (342)
T ss_pred chHHHHHHHHHHHHhc-CCCcchhhHhhhcccccccccccccccccceEEEEeecccccHHHHHH--cCCCCHHHHHHHH
Confidence 3445688999999999 999999998765533 3689999999779998887 4579999999999
Q ss_pred HHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhC-C
Q 013092 82 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG-I 160 (449)
Q Consensus 82 ~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~-~ 160 (449)
.||+.||+|||+.||+||||||+||+++ ..++.++|+|||+++......... .......++..|+|||++.. .
T Consensus 121 ~qi~~aL~~LH~~givH~dikp~Nili~--~~~~~~kl~dfg~~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~ 194 (342)
T cd07854 121 YQLLRGLKYIHSANVLHRDLKPANVFIN--TEDLVLKIGDFGLARIVDPHYSHK----GYLSEGLVTKWYRSPRLLLSPN 194 (342)
T ss_pred HHHHHHHHHHHhCCcccCCCCHHHEEEc--CCCceEEECCcccceecCCccccc----cccccccccccccCHHHHhCcc
Confidence 9999999999999999999999999994 355679999999998654322111 01123457889999998765 5
Q ss_pred CCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHH----------------H----H--hhcccchHHHhhcCCcH
Q 013092 161 EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEK----------------I----S--EKKVSTSIEALCRGYPT 218 (449)
Q Consensus 161 ~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~----------------i----~--~~~~~~~~~~l~~~~p~ 218 (449)
.++.++|||||||++|+|++|..||.+............ + . ..........+...++.
T Consensus 195 ~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (342)
T cd07854 195 NYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNP 274 (342)
T ss_pred ccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCH
Confidence 578899999999999999999999976432111111000 0 0 00111122233456788
Q ss_pred HHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 219 EFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 219 el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
++.+||..||..+|++||++.+++.
T Consensus 275 ~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 275 EALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred HHHHHHHHHhCCCchhccCHHHHhC
Confidence 9999999999999999999888754
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=276.51 Aligned_cols=119 Identities=20% Similarity=0.349 Sum_probs=102.9
Q ss_pred cEEEEEeeecccC-CChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHH
Q 013092 3 EILTVFSVQENVK-TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLML 80 (449)
Q Consensus 3 ~aikV~~k~~~~~-~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i 80 (449)
+|||++.+..... .....+..|+.++..+ .|+||+++++++....+.||||||+ |++|.+++.. .+.+++..++.|
T Consensus 32 vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~~~~~~~~~~~~~lVmEy~~g~~L~~li~~-~~~l~~~~~~~i 109 (669)
T cd05610 32 YAVKVVKKADMINKNMVHQVQAERDALALS-KSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHI-YGYFDEEMAVKY 109 (669)
T ss_pred EEEEEEehhhccCHHHHHHHHHHHHHHHhc-CCCCcCeEEEEEEECCEEEEEEeCCCCCCHHHHHHh-cCCCCHHHHHHH
Confidence 4566655443222 2235688999999998 9999999999999999999999999 9999999975 456899999999
Q ss_pred HHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcce
Q 013092 81 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 126 (449)
Q Consensus 81 ~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~ 126 (449)
+.||+.||+|||.+|||||||||+|||| +..+.+||+|||+++
T Consensus 110 ~~qil~aL~yLH~~gIiHrDLKP~NILl---~~~g~vkL~DFGls~ 152 (669)
T cd05610 110 ISEVALALDYLHRHGIIHRDLKPDNMLI---SNEGHIKLTDFGLSK 152 (669)
T ss_pred HHHHHHHHHHHHhCCEEeCCccHHHEEE---cCCCCEEEEeCCCCc
Confidence 9999999999999999999999999999 577899999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=246.64 Aligned_cols=191 Identities=16% Similarity=0.132 Sum_probs=155.5
Q ss_pred HHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q 013092 21 LLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHR 99 (449)
Q Consensus 21 ~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~givHR 99 (449)
+..|...+... .||||+.+++++.+.+..||||||+ |++|.+++.. ...+++..+..++.|++.||+|||++||+||
T Consensus 32 ~~~~~~~~~~~-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~ 109 (237)
T cd05576 32 YSRERLTIIPH-CVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK-FLNIPEECVKRWAAEMVVALDALHREGIVCR 109 (237)
T ss_pred hhhHHHHHHhc-CCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHhCCeecc
Confidence 34455544444 6899999999999999999999999 8999999875 3469999999999999999999999999999
Q ss_pred CCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHHHHHHH
Q 013092 100 DIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFL 179 (449)
Q Consensus 100 DLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il~ell 179 (449)
||||+||++ +.++.++|+|||++....... ....++..|+|||.+.+..++.++|+||+||++|||+
T Consensus 110 dlkp~Nil~---~~~~~~~l~df~~~~~~~~~~----------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~ 176 (237)
T cd05576 110 DLNPNNILL---DDRGHIQLTYFSRWSEVEDSC----------DGEAVENMYCAPEVGGISEETEACDWWSLGAILFELL 176 (237)
T ss_pred CCCHHHEEE---cCCCCEEEecccchhcccccc----------ccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHH
Confidence 999999999 577889999999886654321 1234577899999998888999999999999999999
Q ss_pred hCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCH
Q 013092 180 RGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDY 238 (449)
Q Consensus 180 tG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~ 238 (449)
+|..||...... +... . ...++..+++++.++|..|++.||++||+.
T Consensus 177 ~g~~~~~~~~~~--------~~~~-~---~~~~~~~~~~~~~~li~~~l~~dp~~R~~~ 223 (237)
T cd05576 177 TGKTLVECHPSG--------INTH-T---TLNIPEWVSEEARSLLQQLLQFNPTERLGA 223 (237)
T ss_pred HCcchhhcCchh--------cccc-c---ccCCcccCCHHHHHHHHHHccCCHHHhcCC
Confidence 999988642211 0000 0 011334578899999999999999999985
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=272.11 Aligned_cols=217 Identities=18% Similarity=0.313 Sum_probs=180.3
Q ss_pred eeecccCCChhHHHHHHHHHHHhcCCCCCceEEEEeE-----eCCEEEEEEecC-CCCHHHHHHHc-CCCCCHHHHHHHH
Q 013092 9 SVQENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGV-----EGDYNVLVMDLL-GPSLEDLFNFC-SRKLSLKTVLMLA 81 (449)
Q Consensus 9 ~k~~~~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~-----~~~~~~lVmE~~-g~sL~~ll~~~-~~~ls~~~~~~i~ 81 (449)
+++......+++++.|..|++.+.+|||++.++++|. .++.+||||||| ||+.-|+++.. +.++.++.+..|+
T Consensus 50 kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~ 129 (953)
T KOG0587|consen 50 KIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYIL 129 (953)
T ss_pred EeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHH
Confidence 3334555678889999999999999999999999987 357899999999 99999999854 5679999999999
Q ss_pred HHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCC-
Q 013092 82 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI- 160 (449)
Q Consensus 82 ~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~- 160 (449)
+.++.||.+||...++|||||-.|||+ +..+.|||+|||+...+..... ...+++||+.|||||++...
T Consensus 130 re~lrgl~HLH~nkviHRDikG~NiLL---T~e~~VKLvDFGvSaQldsT~g-------rRnT~iGtP~WMAPEViac~e 199 (953)
T KOG0587|consen 130 REILRGLAHLHNNKVIHRDIKGQNVLL---TENAEVKLVDFGVSAQLDSTVG-------RRNTFIGTPYWMAPEVIACDE 199 (953)
T ss_pred HHHHHHHHHHhhcceeeecccCceEEE---eccCcEEEeeeeeeeeeecccc-------cccCcCCCcccccceeeeccc
Confidence 999999999999999999999999999 5889999999999887655322 23678999999999998743
Q ss_pred ----CCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHh--hcCCcHHHHHHHHHHhcCCCCC
Q 013092 161 ----EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL--CRGYPTEFASYFHYCRSLRFDD 234 (449)
Q Consensus 161 ----~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l--~~~~p~el~~li~~cl~~~p~~ 234 (449)
.|+.++|+||||++.+||..|.+|+.++.+. ..+.+|.. .+.+.+ +.++..+|.+||..|+..|.+.
T Consensus 200 ~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPm---raLF~IpR----NPPPkLkrp~kWs~~FndFIs~cL~Kd~e~ 272 (953)
T KOG0587|consen 200 SPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPM---RALFLIPR----NPPPKLKRPKKWSKKFNDFISTCLVKDYEQ 272 (953)
T ss_pred CCCCCcccccchhhccceeehhcCCCCCccCcchh---hhhccCCC----CCCccccchhhHHHHHHHHHHHHHhhcccc
Confidence 3788999999999999999999999886552 22222322 222222 4567899999999999999999
Q ss_pred CCCHHHHH
Q 013092 235 KPDYAYLK 242 (449)
Q Consensus 235 RPt~~~l~ 242 (449)
||...+++
T Consensus 273 RP~~~~ll 280 (953)
T KOG0587|consen 273 RPSTEELL 280 (953)
T ss_pred Ccchhhhc
Confidence 99977664
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-31 Score=250.69 Aligned_cols=251 Identities=16% Similarity=0.238 Sum_probs=196.4
Q ss_pred EEEEEeeecccCCChhH-HHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHH
Q 013092 4 ILTVFSVQENVKTKHPQ-LLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLA 81 (449)
Q Consensus 4 aikV~~k~~~~~~~~~~-~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~ 81 (449)
|+||++|-.....++-. +..|-.+..+..++|.+|-+..+++....+|+|.||+ ||+|--.+.+ .++++++.+..+.
T Consensus 279 amkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvieyv~ggdlmfhmqr-qrklpeeharfys 357 (593)
T KOG0695|consen 279 AMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQR-QRKLPEEHARFYS 357 (593)
T ss_pred ehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEecCcceeeehhh-hhcCcHHHhhhhh
Confidence 56666665544333333 4568888999999999999999999999999999999 9988666654 6789999999999
Q ss_pred HHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCC
Q 013092 82 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIE 161 (449)
Q Consensus 82 ~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~ 161 (449)
.+|+.||.|||++|||+||||.+|+|| +..+++||.|||+++.--.+. ....+++|||.|.|||.+.|.+
T Consensus 358 ~ei~lal~flh~rgiiyrdlkldnvll---daeghikltdygmcke~l~~g-------d~tstfcgtpnyiapeilrgee 427 (593)
T KOG0695|consen 358 AEICLALNFLHERGIIYRDLKLDNVLL---DAEGHIKLTDYGMCKEGLGPG-------DTTSTFCGTPNYIAPEILRGEE 427 (593)
T ss_pred HHHHHHHHHHhhcCeeeeeccccceEE---ccCCceeecccchhhcCCCCC-------cccccccCCCcccchhhhcccc
Confidence 999999999999999999999999999 789999999999997533222 2346899999999999999999
Q ss_pred CChhhHHHHHHHHHHHHHhCCCCCCCCC-----cCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCC
Q 013092 162 QSRRDDLESLGYVLMYFLRGSLPWQGLK-----AGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKP 236 (449)
Q Consensus 162 ~s~~~DiwSlG~il~elltG~~Pf~~~~-----~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RP 236 (449)
|+...|+|+||++++||+.|+.||.-.. ..+..-.+..|.++.+. +++.++-....+++.-+..||.+|.
T Consensus 428 ygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqir-----iprslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 428 YGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIR-----IPRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred cCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccc-----ccceeehhhHHHHHHhhcCCcHHhc
Confidence 9999999999999999999999996322 12223334455555543 3456677788899999999999985
Q ss_pred CHHHHHHHHHHHHHHcCCCCCCcccchhhhhhhccCCC
Q 013092 237 DYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQLAT 274 (449)
Q Consensus 237 t~~~l~~~L~~~~~~~~~~~~~~~dw~~~~~~~~~~~~ 274 (449)
... ...-|.++ .+++|+..+||+.++..+..++.
T Consensus 503 gc~-~~~g~~di---k~h~ffr~idwd~leqk~v~ppf 536 (593)
T KOG0695|consen 503 GCR-PQTGFSDI---KSHAFFRSIDWDLLEQKQVLPPF 536 (593)
T ss_pred CCC-cccchhhh---hcchhhhhCCHHHHhhcccCCCC
Confidence 421 01123333 45677888999999876544333
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=255.95 Aligned_cols=234 Identities=21% Similarity=0.280 Sum_probs=181.9
Q ss_pred ccEEEEEeeeccc-----CCChhHHHHHHHHHHHhcCCCCCceEEEEeE-eCCEEEEEEecC-CCCHHHHHHHcCCCCCH
Q 013092 2 YEILTVFSVQENV-----KTKHPQLLYESKLYRILQGGTGIPNVRWFGV-EGDYNVLVMDLL-GPSLEDLFNFCSRKLSL 74 (449)
Q Consensus 2 ~~aikV~~k~~~~-----~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~-~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~ 74 (449)
|+|+|+....+.- ...++...+|.+|.+.| +||.||++|+++. +.+.+|-|+||| |.+|.=+++. .+-+++
T Consensus 490 YvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeL-DHpRIVKlYDyfslDtdsFCTVLEYceGNDLDFYLKQ-hklmSE 567 (775)
T KOG1151|consen 490 YVAVKIHQLNKNWRDEKKENYHKHACREYRIHKEL-DHPRIVKLYDYFSLDTDSFCTVLEYCEGNDLDFYLKQ-HKLMSE 567 (775)
T ss_pred eeeEeeehhccchhhHhhhhHHHHHHHHHhhhhcc-CcceeeeeeeeeeeccccceeeeeecCCCchhHHHHh-hhhhhH
Confidence 5666665544322 23455577899999999 9999999999886 667789999999 8888777775 556899
Q ss_pred HHHHHHHHHHHHHHHHHHHC--CceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCcccc
Q 013092 75 KTVLMLADQMINRVEFVHSK--SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 152 (449)
Q Consensus 75 ~~~~~i~~qi~~aL~yLH~~--givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~ 152 (449)
+++..|+.||+.||.||.+. -|||-||||.|||+-.+...|.+||.||||++.+.+..........-...+.||.+|+
T Consensus 568 KEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYL 647 (775)
T KOG1151|consen 568 KEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYL 647 (775)
T ss_pred HHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeec
Confidence 99999999999999999986 4999999999999988889999999999999999887655443333445678999999
Q ss_pred chhhhhCC----CCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHH---hhcCCcHHHHHHHH
Q 013092 153 SMNTHLGI----EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA---LCRGYPTEFASYFH 225 (449)
Q Consensus 153 aPE~~~~~----~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~---l~~~~p~el~~li~ 225 (449)
+||+|.-. ..+.++||||+|||+|+++.|+.||...-. .+.+ +.+..+....+. ..+-++.+..+||+
T Consensus 648 PPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqs---QQdI--LqeNTIlkAtEVqFP~KPvVsseAkaFIR 722 (775)
T KOG1151|consen 648 PPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQS---QQDI--LQENTILKATEVQFPPKPVVSSEAKAFIR 722 (775)
T ss_pred CcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchh---HHHH--HhhhchhcceeccCCCCCccCHHHHHHHH
Confidence 99998743 368899999999999999999999976321 1111 111111111111 12346789999999
Q ss_pred HHhcCCCCCCCCHHHHH
Q 013092 226 YCRSLRFDDKPDYAYLK 242 (449)
Q Consensus 226 ~cl~~~p~~RPt~~~l~ 242 (449)
+||+..-++|.+..+|.
T Consensus 723 RCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 723 RCLAYRKEDRIDVQQLA 739 (775)
T ss_pred HHHHhhhhhhhhHHHHc
Confidence 99999999998876663
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-32 Score=249.72 Aligned_cols=229 Identities=18% Similarity=0.300 Sum_probs=180.7
Q ss_pred cEEEEEeeecccC-CChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecCCCCHHHHHHHc----CCCCCHHHH
Q 013092 3 EILTVFSVQENVK-TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFC----SRKLSLKTV 77 (449)
Q Consensus 3 ~aikV~~k~~~~~-~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~g~sL~~ll~~~----~~~ls~~~~ 77 (449)
+.+.|..+..... ..+.+|+.|.+..++-.+.|+||++++....++..||+||+|..+|..+.+.. +..+++..+
T Consensus 90 ~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd~SlDklYk~vy~vq~~~ipE~Il 169 (361)
T KOG1006|consen 90 KLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMDISLDKLYKRVYSVQKSRIPENIL 169 (361)
T ss_pred cEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHhhhHHHHHHHHHHHHhccCcHhhh
Confidence 4455555555444 45667999999999988999999999999999999999999999998886532 456899999
Q ss_pred HHHHHHHHHHHHHHHH-CCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhh
Q 013092 78 LMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNT 156 (449)
Q Consensus 78 ~~i~~qi~~aL~yLH~-~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~ 156 (449)
-.|...++.||+||-+ ..||||||||.|||+ +..|.|||||||++-.+.+... ...-.|...|||||.
T Consensus 170 g~ItvatV~AL~yLK~~lkiIHRDvKPSNILl---dr~G~vKLCDFGIcGqLv~SiA--------kT~daGCrpYmAPER 238 (361)
T KOG1006|consen 170 GHITVATVDALDYLKEELKIIHRDVKPSNILL---DRHGDVKLCDFGICGQLVDSIA--------KTVDAGCRPYMAPER 238 (361)
T ss_pred hheeeeehhHHHHHHHHhhhhhccCChhheEE---ecCCCEeeecccchHhHHHHHH--------hhhccCCccccChhc
Confidence 9999999999999986 589999999999999 7999999999999876655432 234578899999999
Q ss_pred hhC--CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchH-HHhhcCCcHHHHHHHHHHhcCCCC
Q 013092 157 HLG--IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI-EALCRGYPTEFASYFHYCRSLRFD 233 (449)
Q Consensus 157 ~~~--~~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~-~~l~~~~p~el~~li~~cl~~~p~ 233 (449)
+.. ..|+.++|+||||++|||+.||..||.+-+. ..+.+..+.....+... ..-+-.++..+..+|.-|+.+|-.
T Consensus 239 i~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s--vfeql~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~ 316 (361)
T KOG1006|consen 239 IDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS--VFEQLCQVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRS 316 (361)
T ss_pred cCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH--HHHHHHHHHcCCCCeecCcccccccCHHHHHHHHHHhhcccc
Confidence 874 3489999999999999999999999976322 22223333332222111 111234788999999999999999
Q ss_pred CCCCHHHHHHH
Q 013092 234 DKPDYAYLKRI 244 (449)
Q Consensus 234 ~RPt~~~l~~~ 244 (449)
+||.|..|++.
T Consensus 317 ~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 317 DRPKYDDLKKF 327 (361)
T ss_pred cCcchhhhhcC
Confidence 99999998753
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-29 Score=249.17 Aligned_cols=237 Identities=20% Similarity=0.260 Sum_probs=193.1
Q ss_pred EEEEeeecccCCChhHHHHHHHHHHHh-cCCCCCceEEEEeEeCC----EEEEEEecC-CCCHHHHHHHcCCCCCHHHHH
Q 013092 5 LTVFSVQENVKTKHPQLLYESKLYRIL-QGGTGIPNVRWFGVEGD----YNVLVMDLL-GPSLEDLFNFCSRKLSLKTVL 78 (449)
Q Consensus 5 ikV~~k~~~~~~~~~~~~~E~~il~~l-~~hp~Iv~l~~~~~~~~----~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~ 78 (449)
=+|++|+....++ +.+.+|.+||+.+ -.|+||..++.....++ .+|||.+|. .|+|+|+++. ..++.+..+
T Consensus 235 e~VAVKiF~srdE-~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r--~tv~~~~ml 311 (513)
T KOG2052|consen 235 EDVAVKIFSSRDE-RSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNR--NTVTTEGML 311 (513)
T ss_pred CceEEEEecccch-hhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeecccCCcHHHHHhh--ccCCHHHHH
Confidence 3677777766544 6899999999984 39999999988876543 579999999 9999999994 679999999
Q ss_pred HHHHHHHHHHHHHHHC--------CceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCcc
Q 013092 79 MLADQMINRVEFVHSK--------SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTAR 150 (449)
Q Consensus 79 ~i~~qi~~aL~yLH~~--------givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~ 150 (449)
+++..+++||++||-. .|.|||||..|||+ .+++.+.|+|||||...........++ .+..+||.+
T Consensus 312 ~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILV---Kkn~~C~IADLGLAv~h~~~t~~idi~---~N~rVGTKR 385 (513)
T KOG2052|consen 312 KLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVRHDSDTDTIDIP---PNPRVGTKR 385 (513)
T ss_pred HHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEE---ccCCcEEEeeceeeEEecccCCcccCC---CCCccceee
Confidence 9999999999999952 49999999999999 799999999999999887654444333 467899999
Q ss_pred ccchhhhhCC------CCChhhHHHHHHHHHHHHHhC----------CCCCCCCCcCCH--HHHHHHHHhhcccchHHHh
Q 013092 151 YASMNTHLGI------EQSRRDDLESLGYVLMYFLRG----------SLPWQGLKAGTK--KQKYEKISEKKVSTSIEAL 212 (449)
Q Consensus 151 Y~aPE~~~~~------~~s~~~DiwSlG~il~elltG----------~~Pf~~~~~~~~--~~~~~~i~~~~~~~~~~~l 212 (449)
|||||++... +.-..+||||||.|+||++.. ++||.+..+.+. .+..+.++..+..+.++..
T Consensus 386 YMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnr 465 (513)
T KOG2052|consen 386 YMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNR 465 (513)
T ss_pred ccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHHHHhcceeecccCCCCCcc
Confidence 9999998753 223578999999999999753 789988765443 4445555666666666666
Q ss_pred hcCCc--HHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 013092 213 CRGYP--TEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFI 250 (449)
Q Consensus 213 ~~~~p--~el~~li~~cl~~~p~~RPt~~~l~~~L~~~~~ 250 (449)
+...| ..+.++|+.||..+|.-|.++-.|++.|.++.+
T Consensus 466 W~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 466 WKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred cccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 65554 458899999999999999999999999888753
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.1e-30 Score=264.42 Aligned_cols=240 Identities=20% Similarity=0.268 Sum_probs=174.3
Q ss_pred EEEEEeeecccCCChhHHHHHHHHHHHhcCCCCCceEEEEeEeC------CEEEEEEecC-CCCHHHHHHHc--CCCCCH
Q 013092 4 ILTVFSVQENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEG------DYNVLVMDLL-GPSLEDLFNFC--SRKLSL 74 (449)
Q Consensus 4 aikV~~k~~~~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~------~~~~lVmE~~-g~sL~~ll~~~--~~~ls~ 74 (449)
|||++.+.-. ....+.+.+|++||++| +|+|||++++.-.+. ...++||||| ||+|..+++.. ...+++
T Consensus 42 AvK~~~~~~~-~r~~e~~~~EieilkKL-nh~NIVk~f~iee~~~~~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE 119 (732)
T KOG4250|consen 42 AVKTFNKESS-LRPRERWCREIEILKKL-NHPNIVKLFDIEETKFLGLVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPE 119 (732)
T ss_pred hHHhhhhhcc-cchHHHHHHHHHHHHHc-CchhhhhhcccCCccccCcccccceEEEeecCCCcHHHHhcCcccccCCCH
Confidence 4444444332 34456788999999999 599999998876644 4679999999 99999999754 245999
Q ss_pred HHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCCC-CeEEEeecCcceeecCCCCCcccccccCCCCccCccccc
Q 013092 75 KTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRA-NQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYAS 153 (449)
Q Consensus 75 ~~~~~i~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~-~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~a 153 (449)
.+++.++.+++.||.|||++||+||||||.||++-.+.++ -..||+|||.|+.+.++.. ...++||..|.+
T Consensus 120 ~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~s~--------~~S~vGT~~YLh 191 (732)
T KOG4250|consen 120 SEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDDNSL--------FTSLVGTEEYLH 191 (732)
T ss_pred HHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccccCCCCCe--------eeeecCchhhcC
Confidence 9999999999999999999999999999999999766533 3468999999998887653 357899999999
Q ss_pred hhhhhC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcC-CHHHHHHHHHhhcc-----------cch---------HHH
Q 013092 154 MNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG-TKKQKYEKISEKKV-----------STS---------IEA 211 (449)
Q Consensus 154 PE~~~~-~~~s~~~DiwSlG~il~elltG~~Pf~~~~~~-~~~~~~~~i~~~~~-----------~~~---------~~~ 211 (449)
||++.. ..|+..+|+|||||++|+++||.+||...-.. ...+..-.+..++. +.+ ...
T Consensus 192 Pel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~ 271 (732)
T KOG4250|consen 192 PELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIGAQEEENGPVEWSSTLPQPNH 271 (732)
T ss_pred hHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEeeecccCCceeeeccCCCccc
Confidence 999995 78899999999999999999999999653221 11112222221111 000 011
Q ss_pred hhcCCcHHHHHHHHHHhcCCCCCCC--CHHHHHHHHHHHHHHcC
Q 013092 212 LCRGYPTEFASYFHYCRSLRFDDKP--DYAYLKRIFRDLFIREG 253 (449)
Q Consensus 212 l~~~~p~el~~li~~cl~~~p~~RP--t~~~l~~~L~~~~~~~~ 253 (449)
+...+-..+-.++.-++..++.+|= .+.+....+.+++...-
T Consensus 272 Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~~v 315 (732)
T KOG4250|consen 272 LSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNLKV 315 (732)
T ss_pred ccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhhhe
Confidence 1122223345566666677777776 55556666666666543
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-28 Score=230.30 Aligned_cols=209 Identities=24% Similarity=0.308 Sum_probs=171.8
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 96 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gi 96 (449)
...+..|+++++.+ +|+||+++.+.+......+++|||+ +++|.+++... ..+++..++.++.+++.+|.+||+.++
T Consensus 31 ~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i 108 (244)
T smart00220 31 RERILREISILKKL-KHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKKR-GRLSEDEARFYARQILSALEYLHSNGI 108 (244)
T ss_pred HHHHHHHHHHHHhC-CCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHcCe
Confidence 57899999999999 9999999999999999999999999 66999999753 338999999999999999999999999
Q ss_pred eecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHHHH
Q 013092 97 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLM 176 (449)
Q Consensus 97 vHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il~ 176 (449)
+|+||+|.||++ +.++.++|+|||++....... ......++..|++||.+.+..++.++|||+||+++|
T Consensus 109 ~h~~i~~~ni~~---~~~~~~~l~d~~~~~~~~~~~--------~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~ 177 (244)
T smart00220 109 IHRDLKPENILL---DEDGHVKLADFGLARQLDPGG--------LLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILY 177 (244)
T ss_pred ecCCcCHHHeEE---CCCCcEEEccccceeeecccc--------ccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHH
Confidence 999999999999 567899999999998776532 123456788999999999888899999999999999
Q ss_pred HHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 177 YFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 177 elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
+|++|..||..... ....+..+....... ......++.++.+++..||..+|++||++.++.+
T Consensus 178 ~l~~~~~p~~~~~~--~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 178 ELLTGKPPFPGDDQ--LLELFKKIGKPKPPF--PPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHhCCCCCCCCCc--HHHHHHHHhccCCCC--ccccccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence 99999999976322 222222222221111 1111127899999999999999999999888764
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-29 Score=240.54 Aligned_cols=219 Identities=18% Similarity=0.215 Sum_probs=168.9
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEe-CCEEEEEEecCCCCHHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHH
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVE-GDYNVLVMDLLGPSLEDLFNFC----SRKLSLKTVLMLADQMINRVEFVH 92 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~-~~~~~lVmE~~g~sL~~ll~~~----~~~ls~~~~~~i~~qi~~aL~yLH 92 (449)
.....+|+.+++.| .|+||+.|..++.. +...+|++||..-+|+++|+.. .+.++...+..|+.||+.|+.|||
T Consensus 71 S~SAcREiaL~REl-~h~nvi~Lv~Vfl~~d~~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH 149 (438)
T KOG0666|consen 71 SMSACREIALLREL-KHPNVISLVKVFLSHDKKVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLH 149 (438)
T ss_pred CHHHHHHHHHHHHh-cCCcchhHHHHHhccCceEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHh
Confidence 34578999999999 99999999877766 8889999999999999999754 245899999999999999999999
Q ss_pred HCCceecCCCCCcEEEe-ecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCC-CCChhhHHHH
Q 013092 93 SKSFLHRDIKPDNFLMG-LGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLES 170 (449)
Q Consensus 93 ~~givHRDLKP~NiLl~-~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~-~~s~~~DiwS 170 (449)
++.|+||||||.|||+. .+...|.|||+|||+++.+.+.-. |.......+-|..|.|||.++|. .|+...|||+
T Consensus 150 ~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGlaR~~~~plk----pl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWA 225 (438)
T KOG0666|consen 150 SNWVLHRDLKPANILVMGDGPERGRVKIADLGLARLFNNPLK----PLASLDPVVVTIWYRAPELLLGARHYTKAIDVWA 225 (438)
T ss_pred hhheeeccCCcceEEEeccCCccCeeEeecccHHHHhhcccc----ccccCCceEEEEEecChHHhcccccccchhhhHH
Confidence 99999999999999984 234559999999999999876532 23344567789999999999985 5899999999
Q ss_pred HHHHHHHHHhCCCCCCCCCcCC------HHHHHHHHHhhcccch-----------------------------HHHh---
Q 013092 171 LGYVLMYFLRGSLPWQGLKAGT------KKQKYEKISEKKVSTS-----------------------------IEAL--- 212 (449)
Q Consensus 171 lG~il~elltG~~Pf~~~~~~~------~~~~~~~i~~~~~~~~-----------------------------~~~l--- 212 (449)
+|||+.||++-.+.|.+..... ....+.+|.+....+. +..+
T Consensus 226 iGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~ 305 (438)
T KOG0666|consen 226 IGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHK 305 (438)
T ss_pred HHHHHHHHHccCccccchhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHH
Confidence 9999999999999887742211 1112233332111000 0000
Q ss_pred hcCCcHHHHHHHHHHhcCCCCCCCCHHHH
Q 013092 213 CRGYPTEFASYFHYCRSLRFDDKPDYAYL 241 (449)
Q Consensus 213 ~~~~p~el~~li~~cl~~~p~~RPt~~~l 241 (449)
.+.-++...+|+.++|+.||.+|.|.++.
T Consensus 306 ~k~k~~~a~~LL~klL~yDP~kRIta~qA 334 (438)
T KOG0666|consen 306 HKVKDPSALDLLQKLLTYDPIKRITAEQA 334 (438)
T ss_pred hcCCCchHHHHHHHHhccCchhhccHHHH
Confidence 11123447789999999999999997654
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.1e-30 Score=248.12 Aligned_cols=220 Identities=19% Similarity=0.224 Sum_probs=171.6
Q ss_pred ccCCChhHHHHHHHHHHHhcCC-----CCCceEEEEeEeCCEEEEEEecCCCCHHHHHHHc-CCCCCHHHHHHHHHHHHH
Q 013092 13 NVKTKHPQLLYESKLYRILQGG-----TGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFC-SRKLSLKTVLMLADQMIN 86 (449)
Q Consensus 13 ~~~~~~~~~~~E~~il~~l~~h-----p~Iv~l~~~~~~~~~~~lVmE~~g~sL~~ll~~~-~~~ls~~~~~~i~~qi~~ 86 (449)
.+....+.-+-|+++|+++..+ .-++++.+++.-.++.|||+|.+|.++.+++... -.+|+.+.+..+++|++.
T Consensus 124 ~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiCivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~ 203 (415)
T KOG0671|consen 124 NVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHICIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLE 203 (415)
T ss_pred HHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceEEEEeccChhHHHHhccCCccccchHHHHHHHHHHHH
Confidence 4445556677899999999432 3577888889899999999999999999999853 346999999999999999
Q ss_pred HHHHHHHCCceecCCCCCcEEEeecC-----------------CCCeEEEeecCcceeecCCCCCcccccccCCCCccCc
Q 013092 87 RVEFVHSKSFLHRDIKPDNFLMGLGR-----------------RANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTA 149 (449)
Q Consensus 87 aL~yLH~~givHRDLKP~NiLl~~~~-----------------~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~ 149 (449)
++++||+.+++|-||||+|||+..++ +.-.|+|+|||.|+.-.+.. ...+.|.
T Consensus 204 sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h----------s~iVsTR 273 (415)
T KOG0671|consen 204 SVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH----------STIVSTR 273 (415)
T ss_pred HHHHHHhcceeecCCChheEEEeccceEEEeccCCccceeccCCCcceEEEecCCcceeccCc----------ceeeecc
Confidence 99999999999999999999995311 13468999999998765433 3567899
Q ss_pred cccchhhhhCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHH------------------
Q 013092 150 RYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA------------------ 211 (449)
Q Consensus 150 ~Y~aPE~~~~~~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~------------------ 211 (449)
.|.|||++++..++..+||||+||||+|+++|...|+.-++.+....+++|........+..
T Consensus 274 HYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~ 353 (415)
T KOG0671|consen 274 HYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVS 353 (415)
T ss_pred ccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCcccc
Confidence 99999999999999999999999999999999999998765444445555433111000000
Q ss_pred -------hhcCC-------------cHHHHHHHHHHhcCCCCCCCCHHHHH
Q 013092 212 -------LCRGY-------------PTEFASYFHYCRSLRFDDKPDYAYLK 242 (449)
Q Consensus 212 -------l~~~~-------------p~el~~li~~cl~~~p~~RPt~~~l~ 242 (449)
..+.| -.+|.+|++.||..||.+|+|+.+++
T Consensus 354 ~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL 404 (415)
T KOG0671|consen 354 SKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREAL 404 (415)
T ss_pred ccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHHh
Confidence 00001 23588999999999999999976653
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=216.23 Aligned_cols=224 Identities=19% Similarity=0.216 Sum_probs=179.7
Q ss_pred EEEEEeeecccCCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHH
Q 013092 4 ILTVFSVQENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQ 83 (449)
Q Consensus 4 aikV~~k~~~~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~~~~i~~q 83 (449)
|+|-...-+...--....++|+-+++.| .|.|||.+++.-..++..-+|+|||..+|..+++.+++.++.+.+..++.|
T Consensus 31 alkrvrlddddegvpssalreicllkel-khknivrl~dvlhsdkkltlvfe~cdqdlkkyfdslng~~d~~~~rsfmlq 109 (292)
T KOG0662|consen 31 ALKRVRLDDDDEGVPSSALREICLLKEL-KHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSLNGDLDPEIVRSFMLQ 109 (292)
T ss_pred EEEEEeccCCCCCCcHHHHHHHHHHHHh-hhcceeehhhhhccCceeEEeHHHhhHHHHHHHHhcCCcCCHHHHHHHHHH
Confidence 3343333333333344589999999999 999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCC-C
Q 013092 84 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIE-Q 162 (449)
Q Consensus 84 i~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~-~ 162 (449)
++.||.++|+++++||||||+|+|| ..+|.+||+|||+++.++-+ .++....+-|..|.+|.++.|.. |
T Consensus 110 llrgl~fchshnvlhrdlkpqnlli---n~ngelkladfglarafgip-------vrcysaevvtlwyrppdvlfgakly 179 (292)
T KOG0662|consen 110 LLRGLGFCHSHNVLHRDLKPQNLLI---NRNGELKLADFGLARAFGIP-------VRCYSAEVVTLWYRPPDVLFGAKLY 179 (292)
T ss_pred HHhhhhhhhhhhhhhccCCcceEEe---ccCCcEEecccchhhhcCCc-------eEeeeceeeeeeccCcceeeeeehh
Confidence 9999999999999999999999999 68999999999999877643 34455667899999999999865 7
Q ss_pred ChhhHHHHHHHHHHHHHh-CCCCCCCCCcCCHHHHHHHHHhhcc------------------------cchHHHhhcCCc
Q 013092 163 SRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKV------------------------STSIEALCRGYP 217 (449)
Q Consensus 163 s~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~------------------------~~~~~~l~~~~p 217 (449)
+..-|+||.|||+.|+.. |++.|++.+..+ .+.+|..... ...+..+.+++.
T Consensus 180 ~tsidmwsagcifaelanagrplfpg~dvdd---qlkrif~~lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp~ln 256 (292)
T KOG0662|consen 180 STSIDMWSAGCIFAELANAGRPLFPGNDVDD---QLKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLN 256 (292)
T ss_pred ccchHhhhcchHHHHHhhcCCCCCCCCcHHH---HHHHHHHHhCCCccccCCccccCCCCcccCCccccchHHHHhhhhc
Confidence 889999999999999996 888998855433 3333332211 111222334445
Q ss_pred HHHHHHHHHHhcCCCCCCCCHHHH
Q 013092 218 TEFASYFHYCRSLRFDDKPDYAYL 241 (449)
Q Consensus 218 ~el~~li~~cl~~~p~~RPt~~~l 241 (449)
..-+++++..+.-+|..|.+++..
T Consensus 257 s~grdllqkll~cnp~qrisaeaa 280 (292)
T KOG0662|consen 257 STGRDLLQKLLKCNPAQRISAEAA 280 (292)
T ss_pred chhHHHHHHHhccCcccccCHHHH
Confidence 556789999999999999887654
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=263.90 Aligned_cols=225 Identities=19% Similarity=0.185 Sum_probs=171.9
Q ss_pred EEEeeecccCCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecCCCCHHHHHHHcCCCC---CHHHHHHHHH
Q 013092 6 TVFSVQENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKL---SLKTVLMLAD 82 (449)
Q Consensus 6 kV~~k~~~~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~g~sL~~ll~~~~~~l---s~~~~~~i~~ 82 (449)
.|++|.... +...-..+|+..|+.-..||||+..++...+..+.||+.|+|..+|.++++.....+ .....+.+..
T Consensus 535 ~VAVKrll~-e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~sL~dlie~~~~d~~~~~~i~~~~~l~ 613 (903)
T KOG1027|consen 535 EVAVKRLLE-EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCACSLQDLIESSGLDVEMQSDIDPISVLS 613 (903)
T ss_pred eehHHHHhh-HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhhhHHHHHhccccchhhcccccHHHHHH
Confidence 444444322 233456799999999989999999999999999999999999999999998531111 1134577889
Q ss_pred HHHHHHHHHHHCCceecCCCCCcEEEeec--CCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCC
Q 013092 83 QMINRVEFVHSKSFLHRDIKPDNFLMGLG--RRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI 160 (449)
Q Consensus 83 qi~~aL~yLH~~givHRDLKP~NiLl~~~--~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~ 160 (449)
|++.||++||+.+||||||||+||||... +...+++|+|||+++++...... +....+..||-+|+|||++...
T Consensus 614 q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS----~~r~s~~sGt~GW~APE~L~~~ 689 (903)
T KOG1027|consen 614 QIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSS----FSRLSGGSGTSGWQAPEQLRED 689 (903)
T ss_pred HHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCcch----hhcccCCCCcccccCHHHHhcc
Confidence 99999999999999999999999999743 23357899999999998765543 2335678899999999999998
Q ss_pred CCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHH
Q 013092 161 EQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYA 239 (449)
Q Consensus 161 ~~s~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~ 239 (449)
..+..+|||||||++|+.++ |.+||..... .-..|....... ..+...-..+..+||..|++.+|..||++.
T Consensus 690 ~~~~avDiFslGCvfyYvltgG~HpFGd~~~-----R~~NIl~~~~~L--~~L~~~~d~eA~dLI~~ml~~dP~~RPsa~ 762 (903)
T KOG1027|consen 690 RKTQAVDIFSLGCVFYYVLTGGSHPFGDSLE-----RQANILTGNYTL--VHLEPLPDCEAKDLISRMLNPDPQLRPSAT 762 (903)
T ss_pred ccCcccchhhcCceEEEEecCCccCCCchHH-----hhhhhhcCccce--eeeccCchHHHHHHHHHhcCCCcccCCCHH
Confidence 88889999999999999998 5999965322 112232222111 111111112889999999999999999988
Q ss_pred HHH
Q 013092 240 YLK 242 (449)
Q Consensus 240 ~l~ 242 (449)
++.
T Consensus 763 ~VL 765 (903)
T KOG1027|consen 763 DVL 765 (903)
T ss_pred HHh
Confidence 874
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-28 Score=276.66 Aligned_cols=209 Identities=13% Similarity=0.144 Sum_probs=159.4
Q ss_pred HHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---HCCce
Q 013092 22 LYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH---SKSFL 97 (449)
Q Consensus 22 ~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH---~~giv 97 (449)
..|+++++.+ +||||+++++++.+.+..||||||+ +++|.++++ .+++..+..++.|++.||+||| +.+|+
T Consensus 731 ~~~~~~l~~l-~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~----~l~~~~~~~i~~~ia~~L~yLH~~~~~~ii 805 (968)
T PLN00113 731 SSEIADMGKL-QHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR----NLSWERRRKIAIGIAKALRFLHCRCSPAVV 805 (968)
T ss_pred HHHHHHHhhC-CCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHh----cCCHHHHHHHHHHHHHHHHHhccCCCCCee
Confidence 4678899999 9999999999999999999999999 999999997 3899999999999999999999 67999
Q ss_pred ecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHHHHH
Q 013092 98 HRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMY 177 (449)
Q Consensus 98 HRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il~e 177 (449)
||||||+||++ +..+..++. ||....... .....||+.|+|||++.+..++.++|||||||++||
T Consensus 806 H~dlkp~Nil~---~~~~~~~~~-~~~~~~~~~-----------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~e 870 (968)
T PLN00113 806 VGNLSPEKIII---DGKDEPHLR-LSLPGLLCT-----------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIE 870 (968)
T ss_pred cCCCCHHhEEE---CCCCceEEE-ecccccccc-----------CCCccccccccCcccccCCCCCcccchhhHHHHHHH
Confidence 99999999999 455666654 665443221 122368899999999999999999999999999999
Q ss_pred HHhCCCCCCCCCcCC--HHHHHHHHHhh-----cccchHH---HhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Q 013092 178 FLRGSLPWQGLKAGT--KKQKYEKISEK-----KVSTSIE---ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRD 247 (449)
Q Consensus 178 lltG~~Pf~~~~~~~--~~~~~~~i~~~-----~~~~~~~---~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~L~~ 247 (449)
|++|+.||....... ..+........ ...+.+. ........++.+++..||+.+|++||++.++.+.|++
T Consensus 871 l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~ 950 (968)
T PLN00113 871 LLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLES 950 (968)
T ss_pred HHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHH
Confidence 999999995432211 11111100000 0000000 0001123467889999999999999999999999887
Q ss_pred HHH
Q 013092 248 LFI 250 (449)
Q Consensus 248 ~~~ 250 (449)
+..
T Consensus 951 ~~~ 953 (968)
T PLN00113 951 ASR 953 (968)
T ss_pred hhc
Confidence 744
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-28 Score=241.65 Aligned_cols=232 Identities=20% Similarity=0.242 Sum_probs=180.0
Q ss_pred EEEeeecccCCChhHHHHHHHHHHHh-cCCCCCceEEEEeEeCC----EEEEEEecC-CCCHHHHHHHcCCCCCHHHHHH
Q 013092 6 TVFSVQENVKTKHPQLLYESKLYRIL-QGGTGIPNVRWFGVEGD----YNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLM 79 (449)
Q Consensus 6 kV~~k~~~~~~~~~~~~~E~~il~~l-~~hp~Iv~l~~~~~~~~----~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~ 79 (449)
-|++|+... ..++.|..|..|+... ..|+||+.++....-+. .++||++|. .|+|.++++ ...++|....+
T Consensus 235 ~VAVKifp~-~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~kGsL~dyL~--~ntisw~~~cr 311 (534)
T KOG3653|consen 235 LVAVKIFPE-QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFHPKGSLCDYLK--ANTISWNSLCR 311 (534)
T ss_pred eeEEEecCH-HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeeccCCcHHHHHH--hccccHHHHHH
Confidence 366666644 3557899999999984 48999999988876554 899999999 999999999 46799999999
Q ss_pred HHHHHHHHHHHHHH---------CCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCcc
Q 013092 80 LADQMINRVEFVHS---------KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTAR 150 (449)
Q Consensus 80 i~~qi~~aL~yLH~---------~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~ 150 (449)
|+..|++||+|||+ ..|+|||||..|||| ..+.++.|+|||||.++...... ......+||.+
T Consensus 312 ia~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLv---K~DlTccIaDFGLAl~~~p~~~~-----~d~~~qVGT~R 383 (534)
T KOG3653|consen 312 IAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLV---KNDLTCCIADFGLALRLEPGKPQ-----GDTHGQVGTRR 383 (534)
T ss_pred HHHHHHHHHHHhcccCCcCCCCCCccccccccccceEE---ccCCcEEeeccceeEEecCCCCC-----cchhhhhhhhh
Confidence 99999999999996 359999999999999 79999999999999988743221 12234789999
Q ss_pred ccchhhhhCCC-CC-----hhhHHHHHHHHHHHHHhC------------CCCCCCCC--cCCHHHHHHHHHhhcccchHH
Q 013092 151 YASMNTHLGIE-QS-----RRDDLESLGYVLMYFLRG------------SLPWQGLK--AGTKKQKYEKISEKKVSTSIE 210 (449)
Q Consensus 151 Y~aPE~~~~~~-~s-----~~~DiwSlG~il~elltG------------~~Pf~~~~--~~~~~~~~~~i~~~~~~~~~~ 210 (449)
|||||++.+.- +. .+.||||+|.|||||++. ++||...- .....+....+..++..+.++
T Consensus 384 YMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p 463 (534)
T KOG3653|consen 384 YMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIP 463 (534)
T ss_pred hcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHHHHHHHHHhhccCCCCh
Confidence 99999998742 22 468999999999999874 23443211 122344444555556555555
Q ss_pred HhhcC--CcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 013092 211 ALCRG--YPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDL 248 (449)
Q Consensus 211 ~l~~~--~p~el~~li~~cl~~~p~~RPt~~~l~~~L~~~ 248 (449)
..+.+ ...-+++.+..||+.|++-|.|+.-+.+.+..+
T Consensus 464 ~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l 503 (534)
T KOG3653|consen 464 DAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAEL 503 (534)
T ss_pred hhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHH
Confidence 44433 346699999999999999999998888777665
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=227.22 Aligned_cols=216 Identities=19% Similarity=0.210 Sum_probs=167.9
Q ss_pred HHHHHHHHHHHhcCCCCCceEEEEeE--------eCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHH
Q 013092 20 QLLYESKLYRILQGGTGIPNVRWFGV--------EGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 91 (449)
Q Consensus 20 ~~~~E~~il~~l~~hp~Iv~l~~~~~--------~~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yL 91 (449)
.-++|++||..| .|+||+.++..|. +...+||||++|..+|.-++.....+|+..++..++.++..||.|+
T Consensus 62 talreikiL~~l-kHenv~nliEic~tk~Tp~~r~r~t~ylVf~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~i 140 (376)
T KOG0669|consen 62 TALREIKILQLL-KHENVVNLIEICRTKATPTNRDRATFYLVFDFCEHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYI 140 (376)
T ss_pred HHHHHHHHHHHh-cchhHHHHHHHHhhccCCcccccceeeeeHHHhhhhHHHHhcCccccccHHHHHHHHHHHHHHHHHH
Confidence 468999999999 9999999976654 2345899999999999999986667899999999999999999999
Q ss_pred HHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhC-CCCChhhHHHH
Q 013092 92 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLES 170 (449)
Q Consensus 92 H~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~-~~~s~~~DiwS 170 (449)
|...|+|||+||+|+|| +.++.+||+|||+++.+.......... ....+-|..|.+||.+.| .+|++..|||.
T Consensus 141 Hr~kilHRDmKaaNvLI---t~dgilklADFGlar~fs~~~n~~kpr---ytnrvvTLwYrppEllLG~r~yg~~iDiWg 214 (376)
T KOG0669|consen 141 HRNKILHRDMKAANVLI---TKDGILKLADFGLARAFSTSKNVVKPR---YTNRVVTLWYRPPELLLGDREYGPPIDIWG 214 (376)
T ss_pred HHhhHHhhcccHhhEEE---cCCceEEeeccccccceecccccCCCC---cccceeeeecCCHHHhhcccccCCcchhHh
Confidence 99999999999999999 688999999999998776543322222 345677999999999998 56899999999
Q ss_pred HHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhccc---------chHHH-----hh-----------cC--CcHHHHHH
Q 013092 171 LGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS---------TSIEA-----LC-----------RG--YPTEFASY 223 (449)
Q Consensus 171 lG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~---------~~~~~-----l~-----------~~--~p~el~~l 223 (449)
.|||+.||+++.+-|++.+.......+..++..... +.... +. +. -.++..+|
T Consensus 215 AgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dL 294 (376)
T KOG0669|consen 215 AGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDL 294 (376)
T ss_pred HHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHH
Confidence 999999999999999885443222222222211000 00000 10 00 13478899
Q ss_pred HHHHhcCCCCCCCCHHHHH
Q 013092 224 FHYCRSLRFDDKPDYAYLK 242 (449)
Q Consensus 224 i~~cl~~~p~~RPt~~~l~ 242 (449)
+..++.+||.+|++.++..
T Consensus 295 le~ll~~DP~kR~~ad~al 313 (376)
T KOG0669|consen 295 LEKLLKLDPTKRIDADQAL 313 (376)
T ss_pred HHHHhccCcccCcchHhhh
Confidence 9999999999999987764
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-28 Score=256.09 Aligned_cols=230 Identities=17% Similarity=0.209 Sum_probs=190.9
Q ss_pred cEEEEEeeecccCCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHH
Q 013092 3 EILTVFSVQENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLA 81 (449)
Q Consensus 3 ~aikV~~k~~~~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~ 81 (449)
+||||+..... .+...+++.|+-+|..| +|||+++|++++.... ..||.+|+ +|+|.|+++..+.++-.+..+.|.
T Consensus 728 VaiKvl~~~t~-~~~s~e~LdeAl~masl-dHpnl~RLLgvc~~s~-~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~ 804 (1177)
T KOG1025|consen 728 VAIKVLIEFTS-PKASIELLDEALRMASL-DHPNLLRLLGVCMLST-LQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWC 804 (1177)
T ss_pred eEEEEeeccCC-chhhHHHHHHHHHHhcC-CCchHHHHhhhcccch-HHHHHHhcccchHHHHHHHhhccccHHHHHHHH
Confidence 34454443332 23467899999999999 9999999999998776 88999999 999999999878889999999999
Q ss_pred HHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCC
Q 013092 82 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIE 161 (449)
Q Consensus 82 ~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~ 161 (449)
.||+.||.|||++++|||||-.+|+|+ ...++|||.|||+++.+.......+. ....-.+.|||-|.+....
T Consensus 805 ~QIAkgM~YLe~qrlVHrdLaaRNVLV---ksP~hvkitdfgla~ll~~d~~ey~~-----~~gK~pikwmale~i~~~~ 876 (1177)
T KOG1025|consen 805 YQIAKGMKYLEEQRLVHRDLAARNVLV---KSPNHVKITDFGLAKLLAPDEKEYSA-----PGGKVPIKWMALESIRIRK 876 (1177)
T ss_pred HHHHHHHHHHHhcchhhhhhhhhheee---cCCCeEEEEecchhhccCcccccccc-----cccccCcHHHHHHHhhccC
Confidence 999999999999999999999999999 78999999999999988765443222 2233457899999999999
Q ss_pred CChhhHHHHHHHHHHHHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHH
Q 013092 162 QSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAY 240 (449)
Q Consensus 162 ~s~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~ 240 (449)
|+.++|||||||++||++| |..||.++...+....+++-.+ -..++-|+-++.-++.+||..|++.||+|.+
T Consensus 877 ~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geR-------LsqPpiCtiDVy~~mvkCwmid~~~rp~fke 949 (1177)
T KOG1025|consen 877 YTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGER-------LSQPPICTIDVYMVMVKCWMIDADSRPTFKE 949 (1177)
T ss_pred CCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhcccc-------CCCCCCccHHHHHHHHHHhccCcccCccHHH
Confidence 9999999999999999998 9999999876544433332211 1234568899999999999999999999999
Q ss_pred HHHHHHHHHH
Q 013092 241 LKRIFRDLFI 250 (449)
Q Consensus 241 l~~~L~~~~~ 250 (449)
+...|..+..
T Consensus 950 l~~~fs~~ar 959 (1177)
T KOG1025|consen 950 LAEEFSRMAR 959 (1177)
T ss_pred HHHHHHHHhc
Confidence 9988887754
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-27 Score=214.18 Aligned_cols=175 Identities=22% Similarity=0.293 Sum_probs=148.9
Q ss_pred CChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecCCCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHH
Q 013092 16 TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVH 92 (449)
Q Consensus 16 ~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~g~sL~~ll~~~---~~~ls~~~~~~i~~qi~~aL~yLH 92 (449)
+.+.++++|+.+.++...+|.+|.+++........||+||.|..+|..+.++. ++.+++..+-+|+..++.||+|||
T Consensus 86 q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~ 165 (282)
T KOG0984|consen 86 QEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLH 165 (282)
T ss_pred HHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHH
Confidence 34566899999999988999999999999999999999999999998886532 667999999999999999999999
Q ss_pred HC-CceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhC----CCCChhhH
Q 013092 93 SK-SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG----IEQSRRDD 167 (449)
Q Consensus 93 ~~-givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~----~~~s~~~D 167 (449)
++ .+||||+||.|||| +..|+|||||||++-.+.+... ...-.|...|||||.+.. ..|+.++|
T Consensus 166 ~kL~vIHRDvKPsNiLI---n~~GqVKiCDFGIsG~L~dSiA--------kt~daGCkpYmaPEri~~e~n~~gY~vksD 234 (282)
T KOG0984|consen 166 SKLSVIHRDVKPSNILI---NYDGQVKICDFGISGYLVDSIA--------KTMDAGCKPYMAPERINPELNQKGYSVKSD 234 (282)
T ss_pred HHhhhhhccCCcceEEE---ccCCcEEEcccccceeehhhhH--------HHHhcCCCccCChhhcCcccCcccceeehh
Confidence 86 89999999999999 7999999999999987766432 122468899999999874 35899999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhh
Q 013092 168 LESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK 203 (449)
Q Consensus 168 iwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~ 203 (449)
|||||++++||.+++.||.. ..+..+.+..+.+.
T Consensus 235 vWSLGItmiElA~lr~PY~~--w~tpF~qLkqvVee 268 (282)
T KOG0984|consen 235 VWSLGITMIEMAILRFPYES--WGTPFQQLKQVVEE 268 (282)
T ss_pred hhhhhhhhhhhhhccccccc--cCCHHHHHHHHhcC
Confidence 99999999999999999965 34556666665554
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.8e-28 Score=229.67 Aligned_cols=210 Identities=20% Similarity=0.245 Sum_probs=165.7
Q ss_pred CCChhHHHHHHHHHHHhcCCCCCceEEEEeEeC------CEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHH
Q 013092 15 KTKHPQLLYESKLYRILQGGTGIPNVRWFGVEG------DYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRV 88 (449)
Q Consensus 15 ~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~------~~~~lVmE~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL 88 (449)
...-+.-.+|..++..+ .|+||+.++.++.-. ...|+|||||..+|.+++. ..++-+++..|+.|+++|+
T Consensus 56 ~~~akra~rel~l~~~v-~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m~~nl~~vi~---~elDH~tis~i~yq~~~~i 131 (369)
T KOG0665|consen 56 QTHAKRAYRELKLMKCV-NHKNIISLLNVFTPQKTLEEFQEVYLVMELMDANLCQVIL---MELDHETISYILYQMLCGI 131 (369)
T ss_pred Cccchhhhhhhhhhhhh-cccceeeeeeccCccccHHHHHhHHHHHHhhhhHHHHHHH---HhcchHHHHHHHHHHHHHH
Confidence 34445577899999999 999999999988633 3579999999999999987 3578889999999999999
Q ss_pred HHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHH
Q 013092 89 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDL 168 (449)
Q Consensus 89 ~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~Di 168 (449)
.|||+.||+||||||+||++ ...+.+||+|||+|+...... ....++.|..|.|||++.+..+...+||
T Consensus 132 k~lhs~~IihRdLkPsnivv---~~~~~lKi~dfg~ar~e~~~~--------~mtpyVvtRyyrapevil~~~~ke~vdi 200 (369)
T KOG0665|consen 132 KHLHSAGIIHRDLKPSNIVV---NSDCTLKILDFGLARTEDTDF--------MMTPYVVTRYYRAPEVILGMGYKENVDI 200 (369)
T ss_pred HHHHhcceeecccCccccee---cchhheeeccchhhcccCccc--------ccCchhheeeccCchheeccCCcccchh
Confidence 99999999999999999999 688999999999998654431 2355688999999999999999999999
Q ss_pred HHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhccc-------------------------chHHHhhcC--------
Q 013092 169 ESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS-------------------------TSIEALCRG-------- 215 (449)
Q Consensus 169 wSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~-------------------------~~~~~l~~~-------- 215 (449)
||+|||+.||++|..-|.+.+ ....+.++.+.... ....++.++
T Consensus 201 wSvGci~gEli~~~Vlf~g~d---~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e 277 (369)
T KOG0665|consen 201 WSVGCIMGELILGTVLFPGKD---HIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLE 277 (369)
T ss_pred hhhhhHHHHHhhceEEecCch---HHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCccccccccc
Confidence 999999999999999998743 23333333222111 111111111
Q ss_pred ----CcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 013092 216 ----YPTEFASYFHYCRSLRFDDKPDYAYLK 242 (449)
Q Consensus 216 ----~p~el~~li~~cl~~~p~~RPt~~~l~ 242 (449)
-..-.++++..||..+|++|-+.++++
T Consensus 278 ~~~~~~~~ardll~~MLvi~pe~Risv~daL 308 (369)
T KOG0665|consen 278 GSKLDCSLARDLLSKMLVIDPEKRISVDDAL 308 (369)
T ss_pred CCccchHHHHHHHHHhhccChhhcccHHHHh
Confidence 023478899999999999999966553
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.2e-28 Score=241.70 Aligned_cols=177 Identities=22% Similarity=0.234 Sum_probs=149.6
Q ss_pred EEEeeec-ccCCChhHHHHHHHHHHHhcC-----CCCCceEEEEeEeCCEEEEEEecCCCCHHHHHHHcCC--CCCHHHH
Q 013092 6 TVFSVQE-NVKTKHPQLLYESKLYRILQG-----GTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSR--KLSLKTV 77 (449)
Q Consensus 6 kV~~k~~-~~~~~~~~~~~E~~il~~l~~-----hp~Iv~l~~~~~~~~~~~lVmE~~g~sL~~ll~~~~~--~ls~~~~ 77 (449)
.|++|+. +....+..=+.|++||+.|.. .-|++.++-.|...+++|||+|-+..+|.+++++.+. .|....+
T Consensus 459 ~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLClVFE~LslNLRevLKKyG~nvGL~ikaV 538 (752)
T KOG0670|consen 459 EVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLCLVFEPLSLNLREVLKKYGRNVGLHIKAV 538 (752)
T ss_pred eeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeEEEehhhhchHHHHHHHhCcccceeehHH
Confidence 3444443 333456667899999999963 3589999999999999999999999999999987644 3788899
Q ss_pred HHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhh
Q 013092 78 LMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTH 157 (449)
Q Consensus 78 ~~i~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~ 157 (449)
..|+.|+..||..|-.+||+|.||||+|||+. .....+||||||.|....++.. ..+.-+..|.|||.+
T Consensus 539 RsYaqQLflALklLK~c~vlHaDIKPDNiLVN--E~k~iLKLCDfGSA~~~~enei---------tPYLVSRFYRaPEIi 607 (752)
T KOG0670|consen 539 RSYAQQLFLALKLLKKCGVLHADIKPDNILVN--ESKNILKLCDFGSASFASENEI---------TPYLVSRFYRAPEII 607 (752)
T ss_pred HHHHHHHHHHHHHHHhcCeeecccCccceEec--cCcceeeeccCccccccccccc---------cHHHHHHhccCccee
Confidence 99999999999999999999999999999996 5667899999999987766543 233456789999999
Q ss_pred hCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCH
Q 013092 158 LGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK 193 (449)
Q Consensus 158 ~~~~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~ 193 (449)
+|.+|+..-|+||+||+||||.||+..|+|.+....
T Consensus 608 LG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~M 643 (752)
T KOG0670|consen 608 LGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQM 643 (752)
T ss_pred ecCcccCCccceeeceeeEEeeccceecCCCCcHHH
Confidence 999999999999999999999999999999766443
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.5e-26 Score=228.53 Aligned_cols=105 Identities=25% Similarity=0.415 Sum_probs=89.4
Q ss_pred ccEEEEEeeecccCCChhHHHHHHHHHHHhcCC-------CCCceEEEEeE----eCCEEEEEEecCCCCHHHHHHHcC-
Q 013092 2 YEILTVFSVQENVKTKHPQLLYESKLYRILQGG-------TGIPNVRWFGV----EGDYNVLVMDLLGPSLEDLFNFCS- 69 (449)
Q Consensus 2 ~~aikV~~k~~~~~~~~~~~~~E~~il~~l~~h-------p~Iv~l~~~~~----~~~~~~lVmE~~g~sL~~ll~~~~- 69 (449)
|+|+||.+-.+ ...+.-+.||++|++++.+ .+||+|++.|. .+.++|||+|++|.+|..+|.+++
T Consensus 105 ~VAlKVvKSAq---hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvLGdnLLklI~~s~Y 181 (590)
T KOG1290|consen 105 YVALKVVKSAQ---HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVLGDNLLKLIKYSNY 181 (590)
T ss_pred EEEEEEEehhh---HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCCCcEEEEEehhhhhHHHHHHHHhCC
Confidence 66777766433 4456678999999999743 47999988876 577999999999999999999875
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCcEEEe
Q 013092 70 RKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMG 109 (449)
Q Consensus 70 ~~ls~~~~~~i~~qi~~aL~yLH~-~givHRDLKP~NiLl~ 109 (449)
+.++...+..|+.||+.||.|||. +||||-||||+||||+
T Consensus 182 rGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 182 RGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLC 222 (590)
T ss_pred CCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeee
Confidence 459999999999999999999996 6999999999999994
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.9e-27 Score=261.72 Aligned_cols=200 Identities=13% Similarity=0.150 Sum_probs=142.5
Q ss_pred CCCceEEEEe-------EeCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEE
Q 013092 35 TGIPNVRWFG-------VEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFL 107 (449)
Q Consensus 35 p~Iv~l~~~~-------~~~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~givHRDLKP~NiL 107 (449)
+||..+++.+ .....++++||+++++|.++++.....+++.+++.|+.||+.||+|||++||+||||||+|||
T Consensus 33 ~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~NiL 112 (793)
T PLN00181 33 DYVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCFV 112 (793)
T ss_pred HHHHHhhcccCCccccccccchhhhhhccCCccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhEE
Confidence 5777777665 233567888999999999999855566999999999999999999999999999999999999
Q ss_pred Eee----------------cCCCCeEEEeecCcceeecCCCC--------Cccccc-ccCCCCccCccccchhhhhCCCC
Q 013092 108 MGL----------------GRRANQVYIIDFGLAKKYRDTST--------HQHIPY-RENKNLTGTARYASMNTHLGIEQ 162 (449)
Q Consensus 108 l~~----------------~~~~~~vkL~DFGla~~~~~~~~--------~~~~~~-~~~~~~~gT~~Y~aPE~~~~~~~ 162 (449)
|+. .+..+.+||+|||+++....... ....++ .......||+.|||||++.+..+
T Consensus 113 l~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~ 192 (793)
T PLN00181 113 MSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSSS 192 (793)
T ss_pred EcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccCCC
Confidence 942 12344567777777654321100 000000 00112468999999999999999
Q ss_pred ChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 013092 163 SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 242 (449)
Q Consensus 163 s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~ 242 (449)
+.++|||||||+||||++|..||... ...+..+....... ..... .++...++..||..+|.+||++.+|+
T Consensus 193 ~~~sDVwSlGviL~ELl~~~~~~~~~-----~~~~~~~~~~~~~~---~~~~~-~~~~~~~~~~~L~~~P~~Rps~~eil 263 (793)
T PLN00181 193 NCASDVYRLGVLLFELFCPVSSREEK-----SRTMSSLRHRVLPP---QILLN-WPKEASFCLWLLHPEPSCRPSMSELL 263 (793)
T ss_pred CchhhhhhHHHHHHHHhhCCCchhhH-----HHHHHHHHHhhcCh---hhhhc-CHHHHHHHHHhCCCChhhCcChHHHh
Confidence 99999999999999999998887531 11222222221111 11112 34567889999999999999998885
Q ss_pred H
Q 013092 243 R 243 (449)
Q Consensus 243 ~ 243 (449)
+
T Consensus 264 ~ 264 (793)
T PLN00181 264 Q 264 (793)
T ss_pred h
Confidence 3
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.7e-26 Score=207.10 Aligned_cols=166 Identities=17% Similarity=0.184 Sum_probs=128.3
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccc
Q 013092 59 PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIP 138 (449)
Q Consensus 59 ~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~ 138 (449)
|+|.+++...+..+++..++.|+.||+.||.|||+.+ ||+|||+ +.++.+++ ||+++......
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~---~~~~~~~~--fG~~~~~~~~~------ 63 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILL---TWDGLLKL--DGSVAFKTPEQ------ 63 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeE---cCccceee--ccceEeecccc------
Confidence 6899999865667999999999999999999999998 9999999 57788888 99998764421
Q ss_pred cccCCCCccCccccchhhhhCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHH--HhhcCC
Q 013092 139 YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE--ALCRGY 216 (449)
Q Consensus 139 ~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~--~l~~~~ 216 (449)
..||+.|||||++.+..++.++|||||||++|||++|..||...... ...+..+.......... .....+
T Consensus 64 ------~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 135 (176)
T smart00750 64 ------SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEEREL--SAILEILLNGMPADDPRDRSNLESV 135 (176)
T ss_pred ------CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchh--cHHHHHHHHHhccCCccccccHHHH
Confidence 25889999999999999999999999999999999999999764321 12222222211111000 011123
Q ss_pred cH--HHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 013092 217 PT--EFASYFHYCRSLRFDDKPDYAYLKRIFRDLF 249 (449)
Q Consensus 217 p~--el~~li~~cl~~~p~~RPt~~~l~~~L~~~~ 249 (449)
+. ++.++|..||..+|++||++.+|.+.+....
T Consensus 136 ~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 136 SAARSFADFMRVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred HhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence 33 6999999999999999999999988766553
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-26 Score=211.98 Aligned_cols=219 Identities=16% Similarity=0.242 Sum_probs=164.0
Q ss_pred EEeeecccCCChhHHHHHHHHHHHhcCCCCCceEEEEeEe--CCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHH
Q 013092 7 VFSVQENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVE--GDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQ 83 (449)
Q Consensus 7 V~~k~~~~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~--~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~q 83 (449)
|++.++.+ +.+.+.+|++||+-|.+||||++|.+...+ ....-||+||+ ..++..+.. .++...+..++.|
T Consensus 67 ViKiLKPV--kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly~----tl~d~dIryY~~e 140 (338)
T KOG0668|consen 67 VIKILKPV--KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNNTDFKQLYP----TLTDYDIRYYIYE 140 (338)
T ss_pred EEeeechH--HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhhccccHHHHhh----hhchhhHHHHHHH
Confidence 33334433 456899999999999999999999998775 45678999999 777777765 5888899999999
Q ss_pred HHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCC-CC
Q 013092 84 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI-EQ 162 (449)
Q Consensus 84 i~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~-~~ 162 (449)
++.||.|||+.||.|||+||.|++|. .....++|+|+|||..+...... ...+.+..|--||.+... .|
T Consensus 141 lLkALdyCHS~GImHRDVKPhNvmId--h~~rkLrlIDWGLAEFYHp~~eY--------nVRVASRyfKGPELLVdy~~Y 210 (338)
T KOG0668|consen 141 LLKALDYCHSMGIMHRDVKPHNVMID--HELRKLRLIDWGLAEFYHPGKEY--------NVRVASRYFKGPELLVDYQMY 210 (338)
T ss_pred HHHHHhHHHhcCcccccCCcceeeec--hhhceeeeeecchHhhcCCCcee--------eeeeehhhcCCchheeechhc
Confidence 99999999999999999999999995 45568999999999887654432 334556677889998864 47
Q ss_pred ChhhHHHHHHHHHHHHHhCCCCCCCCCc-CCHHHHHHHHHh------------hcccchHHHhh----------------
Q 013092 163 SRRDDLESLGYVLMYFLRGSLPWQGLKA-GTKKQKYEKISE------------KKVSTSIEALC---------------- 213 (449)
Q Consensus 163 s~~~DiwSlG~il~elltG~~Pf~~~~~-~~~~~~~~~i~~------------~~~~~~~~~l~---------------- 213 (449)
+..-|+|||||+|..|+..+.||..... .+..-++.++.. ..+.+....+.
T Consensus 211 DYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n 290 (338)
T KOG0668|consen 211 DYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSEN 290 (338)
T ss_pred cccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccc
Confidence 8999999999999999998888865332 221111222110 01111111111
Q ss_pred -cCCcHHHHHHHHHHhcCCCCCCCCHHHH
Q 013092 214 -RGYPTEFASYFHYCRSLRFDDKPDYAYL 241 (449)
Q Consensus 214 -~~~p~el~~li~~cl~~~p~~RPt~~~l 241 (449)
.-+.+|..+|+..++..|-.+|+|+.+.
T Consensus 291 ~hl~~peaiDlldklLrYDHqeRlTakEa 319 (338)
T KOG0668|consen 291 QHLVSPEAIDLLDKLLRYDHQERLTAKEA 319 (338)
T ss_pred cccCChHHHHHHHHHHhhccccccchHHH
Confidence 1135889999999999999999997665
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4e-26 Score=221.73 Aligned_cols=217 Identities=18% Similarity=0.262 Sum_probs=174.7
Q ss_pred HHHHHHHHHHHhcCCCCCceEEEEeE-eCCEEEEEEecC-CCCHHHHHHHcC-------CCCCHHHHHHHHHHHHHHHHH
Q 013092 20 QLLYESKLYRILQGGTGIPNVRWFGV-EGDYNVLVMDLL-GPSLEDLFNFCS-------RKLSLKTVLMLADQMINRVEF 90 (449)
Q Consensus 20 ~~~~E~~il~~l~~hp~Iv~l~~~~~-~~~~~~lVmE~~-g~sL~~ll~~~~-------~~ls~~~~~~i~~qi~~aL~y 90 (449)
.++.|.-.+.-+ .|||+..+.+.+. +....++++.++ -++|..++..|+ +.++..+...++.|++.|++|
T Consensus 333 ~~L~es~lly~~-sH~nll~V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~h 411 (563)
T KOG1024|consen 333 LLLQESMLLYGA-SHPNLLSVLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEH 411 (563)
T ss_pred HHHHHHHHHhcC-cCCCccceeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHH
Confidence 356666666666 7999999988876 456789999999 789999998552 246777888999999999999
Q ss_pred HHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHH
Q 013092 91 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLES 170 (449)
Q Consensus 91 LH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwS 170 (449)
||+.|+||.||-.+|++| ++.-+|||+|=.|++.+-....+.. ....-....||+||.+....|+..+|+||
T Consensus 412 lh~~~ViHkDiAaRNCvI---dd~LqVkltDsaLSRDLFP~DYhcL-----GDnEnRPvkWMslEal~n~~yssasDvWs 483 (563)
T KOG1024|consen 412 LHNHGVIHKDIAARNCVI---DDQLQVKLTDSALSRDLFPGDYHCL-----GDNENRPVKWMSLEALQNSHYSSASDVWS 483 (563)
T ss_pred HHhcCcccchhhhhccee---hhheeEEeccchhccccCccccccc-----CCCCCCcccccCHHHHhhhhhcchhhhHH
Confidence 999999999999999999 6778999999999987655443321 11223457899999999999999999999
Q ss_pred HHHHHHHHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 013092 171 LGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLF 249 (449)
Q Consensus 171 lG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~L~~~~ 249 (449)
||++||||++ |+.||...++. +.+..+.+...- ..+-+||.|+..+|..||...|++||+++++..-|.++.
T Consensus 484 fGVllWELmtlg~~PyaeIDPf---Em~~ylkdGyRl----aQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~ 556 (563)
T KOG1024|consen 484 FGVLLWELMTLGKLPYAEIDPF---EMEHYLKDGYRL----AQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFH 556 (563)
T ss_pred HHHHHHHHHhcCCCCccccCHH---HHHHHHhcccee----cCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHH
Confidence 9999999998 99999886553 333333333221 234579999999999999999999999999999988876
Q ss_pred HHc
Q 013092 250 IRE 252 (449)
Q Consensus 250 ~~~ 252 (449)
.+.
T Consensus 557 ~ql 559 (563)
T KOG1024|consen 557 TQL 559 (563)
T ss_pred HHH
Confidence 543
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.4e-26 Score=244.08 Aligned_cols=187 Identities=17% Similarity=0.148 Sum_probs=129.8
Q ss_pred EeCCEEEEEEecC-CCCHHHHHHHcCCCC-------------------CHHHHHHHHHHHHHHHHHHHHCCceecCCCCC
Q 013092 45 VEGDYNVLVMDLL-GPSLEDLFNFCSRKL-------------------SLKTVLMLADQMINRVEFVHSKSFLHRDIKPD 104 (449)
Q Consensus 45 ~~~~~~~lVmE~~-g~sL~~ll~~~~~~l-------------------s~~~~~~i~~qi~~aL~yLH~~givHRDLKP~ 104 (449)
..+...+|||||+ +++|.+++......+ ....+..++.||+.||+|||++||+||||||+
T Consensus 205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~ 284 (566)
T PLN03225 205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQ 284 (566)
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHH
Confidence 4567899999999 899999987432111 12345679999999999999999999999999
Q ss_pred cEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCC----------------------C
Q 013092 105 NFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIE----------------------Q 162 (449)
Q Consensus 105 NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~----------------------~ 162 (449)
|||+. ...+.+||+|||+++.+...... ....+.+|+.|||||.+.... +
T Consensus 285 NILl~--~~~~~~KL~DFGlA~~l~~~~~~------~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~ 356 (566)
T PLN03225 285 NIIFS--EGSGSFKIIDLGAAADLRVGINY------IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNL 356 (566)
T ss_pred HEEEe--CCCCcEEEEeCCCcccccccccc------CCcccccCCCccChHHhhccCCCCCCccccccccccchhccccC
Confidence 99994 34578999999999866443221 124568899999999765322 3
Q ss_pred ChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhccc-------------chHH---HhhcCCcHHHHHHHHH
Q 013092 163 SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS-------------TSIE---ALCRGYPTEFASYFHY 226 (449)
Q Consensus 163 s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~-------------~~~~---~l~~~~p~el~~li~~ 226 (449)
+.++||||||||||||+++..|+.. ...+....+...... .... .+......+..+||..
T Consensus 357 ~~k~DVwSlGviL~el~~~~~~~~~----~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~ 432 (566)
T PLN03225 357 PDRFDIYSAGLIFLQMAFPNLRSDS----NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKS 432 (566)
T ss_pred CCCcccHHHHHHHHHHHhCcCCCch----HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHH
Confidence 3456999999999999998776542 111111111111100 0000 0111123345689999
Q ss_pred HhcCCCCCCCCHHHHHH
Q 013092 227 CRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 227 cl~~~p~~RPt~~~l~~ 243 (449)
|++.||.+||++.++++
T Consensus 433 mL~~dP~kR~ta~e~L~ 449 (566)
T PLN03225 433 MMRFKGRQRISAKAALA 449 (566)
T ss_pred HccCCcccCCCHHHHhC
Confidence 99999999999887754
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.3e-25 Score=200.38 Aligned_cols=177 Identities=27% Similarity=0.383 Sum_probs=155.6
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 96 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gi 96 (449)
...+.+|+++++.+ .|++|++++.++......+++||++ |++|.+++......++...++.++.+++.+|.+||+.|+
T Consensus 35 ~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~ 113 (215)
T cd00180 35 LEELLREIEILKKL-NHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGI 113 (215)
T ss_pred HHHHHHHHHHHHhc-CCCCeeeEeeeeecCCeEEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 36799999999999 7799999999999999999999999 799999998643468999999999999999999999999
Q ss_pred eecCCCCCcEEEeecCC-CCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCC-CCChhhHHHHHHHH
Q 013092 97 LHRDIKPDNFLMGLGRR-ANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYV 174 (449)
Q Consensus 97 vHRDLKP~NiLl~~~~~-~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~-~~s~~~DiwSlG~i 174 (449)
+|+||+|.||++. . .+.++|+|||.+........ ......+...|++||.+... .++.+.|+|+||++
T Consensus 114 ~H~dl~~~ni~~~---~~~~~~~l~d~~~~~~~~~~~~-------~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~ 183 (215)
T cd00180 114 IHRDLKPENILLD---SDNGKVKLADFGLSKLLTSDKS-------LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVI 183 (215)
T ss_pred eccCCCHhhEEEe---CCCCcEEEecCCceEEccCCcc-------hhhcccCCCCccChhHhcccCCCCchhhhHHHHHH
Confidence 9999999999994 5 68999999999987655321 11234578899999999887 78899999999999
Q ss_pred HHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHH
Q 013092 175 LMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRI 244 (449)
Q Consensus 175 l~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~ 244 (449)
+++| .++.+++..|++.+|++||++.++.+.
T Consensus 184 ~~~l---------------------------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 184 LYEL---------------------------------------PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred HHHH---------------------------------------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 9998 478999999999999999998887653
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.4e-26 Score=246.03 Aligned_cols=184 Identities=21% Similarity=0.284 Sum_probs=134.6
Q ss_pred EEEEEEecC-CCCHHHHHHHcCCCC-CHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcce
Q 013092 49 YNVLVMDLL-GPSLEDLFNFCSRKL-SLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 126 (449)
Q Consensus 49 ~~~lVmE~~-g~sL~~ll~~~~~~l-s~~~~~~i~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~ 126 (449)
.+||-|||| ...|.+++++ +... ..+.++.++.||++||.|+|++|||||||||.||++ +..+.|||.|||+|+
T Consensus 670 ~LYIQMEyCE~~ll~~iI~~-N~~~~~~d~~wrLFreIlEGLaYIH~~giIHRDLKP~NIFL---d~~~~VKIGDFGLAt 745 (1351)
T KOG1035|consen 670 ILYIQMEYCEKTLLRDIIRR-NHFNSQRDEAWRLFREILEGLAYIHDQGIIHRDLKPRNIFL---DSRNSVKIGDFGLAT 745 (1351)
T ss_pred EEEEEHhhhhhhHHHHHHHh-cccchhhHHHHHHHHHHHHHHHHHHhCceeeccCCcceeEE---cCCCCeeecccccch
Confidence 579999999 5555666663 3222 478899999999999999999999999999999999 689999999999998
Q ss_pred eec---C-------CCCCcccc-cccCCCCccCccccchhhhhCCC---CChhhHHHHHHHHHHHHHhCCCCCCCCCcCC
Q 013092 127 KYR---D-------TSTHQHIP-YRENKNLTGTARYASMNTHLGIE---QSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 192 (449)
Q Consensus 127 ~~~---~-------~~~~~~~~-~~~~~~~~gT~~Y~aPE~~~~~~---~s~~~DiwSlG~il~elltG~~Pf~~~~~~~ 192 (449)
... . ..+..... .-.....+||..|+|||++.+.. |+.+.|+||||+||+||+. ||.. ..+
T Consensus 746 ~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~T--sME 820 (1351)
T KOG1035|consen 746 DLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGT--SME 820 (1351)
T ss_pred hhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhc---cCCc--hHH
Confidence 722 0 00111111 11335678999999999998765 9999999999999999994 5743 222
Q ss_pred HHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 013092 193 KKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 242 (449)
Q Consensus 193 ~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~ 242 (449)
....+..+....++.+ ..+..+--++-..+|+.+++.||++||++.+|+
T Consensus 821 Ra~iL~~LR~g~iP~~-~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL 869 (1351)
T KOG1035|consen 821 RASILTNLRKGSIPEP-ADFFDPEHPEEASLIRWLLSHDPSKRPTATELL 869 (1351)
T ss_pred HHHHHHhcccCCCCCC-cccccccchHHHHHHHHHhcCCCccCCCHHHHh
Confidence 3333334443333332 222322234568899999999999999998875
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.9e-26 Score=231.73 Aligned_cols=155 Identities=23% Similarity=0.353 Sum_probs=139.9
Q ss_pred HHHHHHHHHHHhc--CCCCCceEEEEeEeCCEEEEEEecC--CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 013092 20 QLLYESKLYRILQ--GGTGIPNVRWFGVEGDYNVLVMDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 95 (449)
Q Consensus 20 ~~~~E~~il~~l~--~hp~Iv~l~~~~~~~~~~~lVmE~~--g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~g 95 (449)
.+-.|+.||..|. .|+||++++++|++++++||+||-. |.+|+++|.. +..+++.++..|+.||+.|+++||+.|
T Consensus 612 tVp~EIqIla~l~~~sH~NIlKlLdfFEddd~yyl~te~hg~gIDLFd~IE~-kp~m~E~eAk~IFkQV~agi~hlh~~~ 690 (772)
T KOG1152|consen 612 TVPSEIQILATLNKHSHENILKLLDFFEDDDYYYLETEVHGEGIDLFDFIEF-KPRMDEPEAKLIFKQVVAGIKHLHDQG 690 (772)
T ss_pred ccchhHHHHHHhhhcCccchhhhhheeecCCeeEEEecCCCCCcchhhhhhc-cCccchHHHHHHHHHHHhccccccccC
Confidence 3567999999995 3899999999999999999999999 7799999986 567999999999999999999999999
Q ss_pred ceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCC-ChhhHHHHHHHH
Q 013092 96 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQ-SRRDDLESLGYV 174 (449)
Q Consensus 96 ivHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~-s~~~DiwSlG~i 174 (449)
|||||||-+|+.+ +.+|.+||+|||.+....... ...++||..|+|||++.|.+| +...|||+||++
T Consensus 691 ivhrdikdenviv---d~~g~~klidfgsaa~~ksgp---------fd~f~gtv~~aapevl~g~~y~gk~qdiwalgil 758 (772)
T KOG1152|consen 691 IVHRDIKDENVIV---DSNGFVKLIDFGSAAYTKSGP---------FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGIL 758 (772)
T ss_pred ceecccccccEEE---ecCCeEEEeeccchhhhcCCC---------cceeeeeccccchhhhCCCccCCCcchhhhhhhe
Confidence 9999999999999 799999999999987655443 257899999999999999887 677899999999
Q ss_pred HHHHHhCCCCCCC
Q 013092 175 LMYFLRGSLPWQG 187 (449)
Q Consensus 175 l~elltG~~Pf~~ 187 (449)
||.++....||..
T Consensus 759 lytivykenpyyn 771 (772)
T KOG1152|consen 759 LYTIVYKENPYYN 771 (772)
T ss_pred eeEEEeccCCCcC
Confidence 9999999999864
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-25 Score=208.86 Aligned_cols=233 Identities=20% Similarity=0.254 Sum_probs=176.6
Q ss_pred EEeeecccCCChhHHHHHHHHHHHhcCCCCCceEEE-EeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHH
Q 013092 7 VFSVQENVKTKHPQLLYESKLYRILQGGTGIPNVRW-FGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQM 84 (449)
Q Consensus 7 V~~k~~~~~~~~~~~~~E~~il~~l~~hp~Iv~l~~-~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi 84 (449)
|++..........+|.+|.----.|..|.||+.-+. .|+..+.++++|||+ -|+|..-+.. ..+-+.-...++.|+
T Consensus 53 vlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~aP~gdL~snv~~--~GigE~~~K~v~~ql 130 (378)
T KOG1345|consen 53 VLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEFAPRGDLRSNVEA--AGIGEANTKKVFAQL 130 (378)
T ss_pred EeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeeccCccchhhhhcCc--ccccHHHHHHHHHHH
Confidence 344444444566778888887777889999988764 567788999999999 8999887763 457788889999999
Q ss_pred HHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCC----
Q 013092 85 INRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI---- 160 (449)
Q Consensus 85 ~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~---- 160 (449)
+.||+|||++++||||||.+||||-. .+...|||||||+.++.+.... ..--+..|.+||.....
T Consensus 131 ~SAi~fMHsknlVHRdlK~eNiLif~-~df~rvKlcDFG~t~k~g~tV~----------~~~~~~~y~~pe~~~~~~ne~ 199 (378)
T KOG1345|consen 131 LSAIEFMHSKNLVHRDLKAENILIFD-ADFYRVKLCDFGLTRKVGTTVK----------YLEYVNNYHAPELCDTVVNEK 199 (378)
T ss_pred HHHHHHhhccchhhcccccceEEEec-CCccEEEeeecccccccCceeh----------hhhhhcccCCcHHHhhccccc
Confidence 99999999999999999999999953 3445999999999887654321 22345679999987643
Q ss_pred -CCChhhHHHHHHHHHHHHHhCCCCCCCCCcCC-HHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCH
Q 013092 161 -EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT-KKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDY 238 (449)
Q Consensus 161 -~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~-~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~ 238 (449)
...+..|+|.||+|+|++++|.+||+.....+ ..-.+.++...+. +.++..+..+++....++++-+..++++|...
T Consensus 200 ~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~-~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki 278 (378)
T KOG1345|consen 200 LVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKN-PALPKKFNPFSEKALRLFKKSLTPRFKDRCKI 278 (378)
T ss_pred eEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccC-ccCchhhcccCHHHHHHHHHhcCCcccccchh
Confidence 24678999999999999999999998532221 1122334444443 35556667788999999999999999999877
Q ss_pred HHHHHHHHHHHHHcC
Q 013092 239 AYLKRIFRDLFIREG 253 (449)
Q Consensus 239 ~~l~~~L~~~~~~~~ 253 (449)
.+.++...+.+...-
T Consensus 279 ~~~kk~rk~~w~E~~ 293 (378)
T KOG1345|consen 279 WTAKKMRKCLWKEKL 293 (378)
T ss_pred HHHHHHHHHHHHHhh
Confidence 777777766665443
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-26 Score=216.54 Aligned_cols=209 Identities=18% Similarity=0.239 Sum_probs=161.6
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeC-----CEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEG-----DYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 92 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~-----~~~~lVmE~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH 92 (449)
-+.+.+|+++|..+ .|.||....+.-+-. ...|++.|+|..+|..+|-. ...++.+.+..+++||+.||.|||
T Consensus 96 ~krvFre~kmLcfF-kHdNVLSaLDILQPph~dfFqEiYV~TELmQSDLHKIIVS-PQ~Ls~DHvKVFlYQILRGLKYLH 173 (449)
T KOG0664|consen 96 CKRVFREIKMLSSF-RHDNVLSLLDILQPANPSFFQELYVLTELMQSDLHKIIVS-PQALTPDHVKVFVYQILRGLKYLH 173 (449)
T ss_pred HHHHHHHHHHHHhh-ccccHHHHHHhcCCCCchHHHHHHHHHHHHHhhhhheecc-CCCCCcchhhhhHHHHHhhhHHHh
Confidence 34588999999999 899998887665432 24688999998899988864 567999999999999999999999
Q ss_pred HCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCC-CCChhhHHHHH
Q 013092 93 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESL 171 (449)
Q Consensus 93 ~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~-~~s~~~DiwSl 171 (449)
+.+|+||||||.|+|+ +.+..+||||||+|+....... +.....+-|..|.|||.++|. .|+...||||+
T Consensus 174 sA~ILHRDIKPGNLLV---NSNCvLKICDFGLARvee~d~~------~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSV 244 (449)
T KOG0664|consen 174 TANILHRDIKPGNLLV---NSNCILKICDFGLARTWDQRDR------LNMTHEVVTQYYRAPELLMGARRYTGAVDIWSV 244 (449)
T ss_pred hcchhhccCCCccEEe---ccCceEEecccccccccchhhh------hhhHHHHHHHHhccHHHhhcchhhcCccceehh
Confidence 9999999999999999 6888999999999997665432 122344668899999999985 58999999999
Q ss_pred HHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCC-----------------------------cHHHHH
Q 013092 172 GYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGY-----------------------------PTEFAS 222 (449)
Q Consensus 172 G~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~-----------------------------p~el~~ 222 (449)
|||+.|++..+..|+...+ .+.++.|.+...++..+.....| -.+...
T Consensus 245 GCIFaELLgRrILFQAq~P---iqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~ 321 (449)
T KOG0664|consen 245 GCIFAELLQRKILFQAAGP---IEQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVD 321 (449)
T ss_pred hHHHHHHHhhhhhhhccCh---HHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHH
Confidence 9999999999999987443 45555555444444333321111 234566
Q ss_pred HHHHHhcCCCCCCCCHHH
Q 013092 223 YFHYCRSLRFDDKPDYAY 240 (449)
Q Consensus 223 li~~cl~~~p~~RPt~~~ 240 (449)
++..++..+|++|.+..+
T Consensus 322 ~~~~~l~~d~dkris~~~ 339 (449)
T KOG0664|consen 322 LLQKLLHFDPDKRISVEE 339 (449)
T ss_pred HHHHHhCCCCcccccHhh
Confidence 777778888888876443
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.4e-24 Score=222.22 Aligned_cols=211 Identities=17% Similarity=0.124 Sum_probs=145.9
Q ss_pred HHHHHHHHHHhcCCCC----CceEEEEeE--------eCCEEEEEEecC-CCCHHHHHHHcC------------------
Q 013092 21 LLYESKLYRILQGGTG----IPNVRWFGV--------EGDYNVLVMDLL-GPSLEDLFNFCS------------------ 69 (449)
Q Consensus 21 ~~~E~~il~~l~~hp~----Iv~l~~~~~--------~~~~~~lVmE~~-g~sL~~ll~~~~------------------ 69 (449)
...|+.++.++++++. ++.+++++. +.+..||||||+ +++|.++++...
T Consensus 219 ~~vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~ 298 (507)
T PLN03224 219 GMVEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIP 298 (507)
T ss_pred hHHHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchh
Confidence 3457777777744432 345555543 245689999999 999999986321
Q ss_pred -----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCC
Q 013092 70 -----RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKN 144 (449)
Q Consensus 70 -----~~ls~~~~~~i~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~ 144 (449)
..+++..++.++.|++.+|.|||+.+|+||||||+|||+ +.++.+||+|||+++.+...... ....
T Consensus 299 ~~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl---~~~~~~kL~DFGla~~~~~~~~~------~~~~ 369 (507)
T PLN03224 299 DNMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLV---TVDGQVKIIDFGAAVDMCTGINF------NPLY 369 (507)
T ss_pred hhcccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEE---CCCCcEEEEeCcCccccccCCcc------Cccc
Confidence 124567888999999999999999999999999999999 57789999999999765432110 1112
Q ss_pred CccCccccchhhhhCCCC----------------------ChhhHHHHHHHHHHHHHhCCC-CCCCCCcCCHH-------
Q 013092 145 LTGTARYASMNTHLGIEQ----------------------SRRDDLESLGYVLMYFLRGSL-PWQGLKAGTKK------- 194 (449)
Q Consensus 145 ~~gT~~Y~aPE~~~~~~~----------------------s~~~DiwSlG~il~elltG~~-Pf~~~~~~~~~------- 194 (449)
..+|+.|++||.+..... ..+.||||+|||+|+|++|.+ ||.........
T Consensus 370 g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~ 449 (507)
T PLN03224 370 GMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDND 449 (507)
T ss_pred cCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccch
Confidence 345889999999864321 124699999999999999886 77653221110
Q ss_pred -HHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCC---CCCCCHHHHHH
Q 013092 195 -QKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRF---DDKPDYAYLKR 243 (449)
Q Consensus 195 -~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p---~~RPt~~~l~~ 243 (449)
..+..+..... .+ .....++++..+|+.+|+..++ .+|+++.++++
T Consensus 450 ~~~~r~~~~~~~--~~-~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 450 LNRWRMYKGQKY--DF-SLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred HHHHHhhcccCC--Cc-ccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 11111111111 11 1235578899999999999866 68999877753
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.7e-24 Score=208.20 Aligned_cols=232 Identities=22% Similarity=0.303 Sum_probs=174.8
Q ss_pred EEEEeeecccCCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHH
Q 013092 5 LTVFSVQENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQ 83 (449)
Q Consensus 5 ikV~~k~~~~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~q 83 (449)
.+|+.|..........+..|+++|..+.++.||+++.+++...+..++||||+ .....++.. .++...+..++..
T Consensus 65 ~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~~H~~f~~l~~----~l~~~~i~~Yl~~ 140 (418)
T KOG1167|consen 65 RYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYFEHDRFRDLYR----SLSLAEIRWYLRN 140 (418)
T ss_pred ceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEecccCccCHHHHHh----cCCHHHHHHHHHH
Confidence 45677777677777789999999999999999999999999999999999999 778888776 4789999999999
Q ss_pred HHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCC------C----Cc------------------
Q 013092 84 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS------T----HQ------------------ 135 (449)
Q Consensus 84 i~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~------~----~~------------------ 135 (449)
++.||.++|.+|||||||||.|||.+ ...+.-.|+|||||....... . +.
T Consensus 141 ll~Al~~~h~~GIvHRDiKpsNFL~n--~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~ 218 (418)
T KOG1167|consen 141 LLKALAHLHKNGIVHRDIKPSNFLYN--RRTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASK 218 (418)
T ss_pred HHHHhhhhhccCccccCCCccccccc--cccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccC
Confidence 99999999999999999999999996 566778999999997321100 0 00
Q ss_pred ---------ccccccCCCCccCccccchhhhhCCC-CChhhHHHHHHHHHHHHHhCCCCCCCCCcCCH--HHH-------
Q 013092 136 ---------HIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK--KQK------- 196 (449)
Q Consensus 136 ---------~~~~~~~~~~~gT~~Y~aPE~~~~~~-~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~--~~~------- 196 (449)
...........||++|.|||++...+ ++.+.||||.|+|+.-++++..||....+... .+.
T Consensus 219 p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~ 298 (418)
T KOG1167|consen 219 PAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSA 298 (418)
T ss_pred CCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChH
Confidence 00011123467999999999998754 78999999999999999999999976543211 000
Q ss_pred -HHHH---------Hhh-----------ccc--------------chHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHH
Q 013092 197 -YEKI---------SEK-----------KVS--------------TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYL 241 (449)
Q Consensus 197 -~~~i---------~~~-----------~~~--------------~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l 241 (449)
+.+. .++ ... ...+...+.+|..+.+|+.+|++.||.+|-++++.
T Consensus 299 ~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeA 378 (418)
T KOG1167|consen 299 EMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDA 378 (418)
T ss_pred HHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHH
Confidence 0010 000 000 00111112346689999999999999999998765
Q ss_pred H
Q 013092 242 K 242 (449)
Q Consensus 242 ~ 242 (449)
+
T Consensus 379 L 379 (418)
T KOG1167|consen 379 L 379 (418)
T ss_pred h
Confidence 4
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.90 E-value=1e-22 Score=189.97 Aligned_cols=161 Identities=27% Similarity=0.364 Sum_probs=139.7
Q ss_pred ChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 013092 17 KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 95 (449)
Q Consensus 17 ~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~g 95 (449)
....+.+|++.++.+ .|+||+++++++......+++|||+ +++|.+++......+++..+..++.+++.+|.+||+.+
T Consensus 40 ~~~~~~~e~~~~~~~-~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ 118 (225)
T smart00221 40 QREEFLREIRILKKL-KHPNIVKLYGVFEDPEPLYLVMEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLG 118 (225)
T ss_pred HHHHHHHHHHHHHhC-CCCChhhheeeeecCCceEEEEeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 456788999999999 8999999999999999999999999 77999999853322899999999999999999999999
Q ss_pred ceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhh-hCCCCChhhHHHHHHHH
Q 013092 96 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTH-LGIEQSRRDDLESLGYV 174 (449)
Q Consensus 96 ivHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~-~~~~~s~~~DiwSlG~i 174 (449)
++|+||+|.||++ +..+.++|+|||++..+...... ......++..|++||.+ ....++.++|+|+||++
T Consensus 119 i~h~di~~~ni~v---~~~~~~~l~d~g~~~~~~~~~~~------~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~ 189 (225)
T smart00221 119 IVHRDLKPENILL---GMDGLVKLADFGLARFIHRDLAA------LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVI 189 (225)
T ss_pred eecCCCCHHHEEE---cCCCCEEEeeCceeeEecCcccc------cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHH
Confidence 9999999999999 46689999999999877654200 12345678899999999 66677889999999999
Q ss_pred HHHHHhCCCCCCC
Q 013092 175 LMYFLRGSLPWQG 187 (449)
Q Consensus 175 l~elltG~~Pf~~ 187 (449)
+|+|++|+.||..
T Consensus 190 ~~~l~~g~~pf~~ 202 (225)
T smart00221 190 LYELLWGPEPFSG 202 (225)
T ss_pred HHHHHHCCCCccc
Confidence 9999999999955
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.3e-24 Score=217.14 Aligned_cols=209 Identities=18% Similarity=0.197 Sum_probs=169.2
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 96 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gi 96 (449)
..-+..|+-+++-+ .|+|||.+++.+...+..||+|||| |++|.++..- .+++++.++..++.+.+.||+|||+.|-
T Consensus 56 ~~~iqqei~~~~dc-~h~nivay~gsylr~dklwicMEycgggslQdiy~~-TgplselqiayvcRetl~gl~ylhs~gk 133 (829)
T KOG0576|consen 56 FSGIQQEIGMLRDC-RHPNIVAYFGSYLRRDKLWICMEYCGGGSLQDIYHV-TGPLSELQIAYVCRETLQGLKYLHSQGK 133 (829)
T ss_pred ccccccceeeeecC-CCcChHHHHhhhhhhcCcEEEEEecCCCcccceeee-cccchhHHHHHHHhhhhccchhhhcCCc
Confidence 34566788888888 9999999999999999999999999 8999998763 6789999999999999999999999999
Q ss_pred eecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhh---CCCCChhhHHHHHHH
Q 013092 97 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHL---GIEQSRRDDLESLGY 173 (449)
Q Consensus 97 vHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~---~~~~s~~~DiwSlG~ 173 (449)
+|||||-.|||+ ...+.+|++|||.+-.+..... ..+.+.||+.|||||+.. ...|...+|||++|+
T Consensus 134 ~hRdiKGanill---td~gDvklaDfgvsaqitati~-------KrksfiGtpywmapEvaaverkggynqlcdiwa~gi 203 (829)
T KOG0576|consen 134 IHRDIKGANILL---TDEGDVKLADFGVSAQITATIA-------KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGI 203 (829)
T ss_pred ccccccccceee---cccCceeecccCchhhhhhhhh-------hhhcccCCccccchhHHHHHhccccccccccccccc
Confidence 999999999999 5889999999999877665432 235789999999999864 456899999999999
Q ss_pred HHHHHHhCCCCCCCCCcCCHHHHHHHHHhhc-ccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 013092 174 VLMYFLRGSLPWQGLKAGTKKQKYEKISEKK-VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 242 (449)
Q Consensus 174 il~elltG~~Pf~~~~~~~~~~~~~~i~~~~-~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~ 242 (449)
...|+-.-+.|-..+.+. +. ..++.+. ..++.-+-...+.+.|.+|++.|+..+|.+||+.+.++
T Consensus 204 tAiel~eLqpplfdlhpm---r~-l~LmTkS~~qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL 269 (829)
T KOG0576|consen 204 TAIELGELQPPLFDLHPM---RA-LFLMTKSGFQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLL 269 (829)
T ss_pred chhhhhhcCCcccccchH---HH-HHHhhccCCCCCcccCCccchHHHHHHHHHHhcCCCccCCChhhhe
Confidence 999999888887664332 11 1222221 11222222345788999999999999999999987653
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.1e-21 Score=183.47 Aligned_cols=236 Identities=28% Similarity=0.357 Sum_probs=175.9
Q ss_pred EEEEEeeecccCC-ChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcC--CCCCHHHHHH
Q 013092 4 ILTVFSVQENVKT-KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCS--RKLSLKTVLM 79 (449)
Q Consensus 4 aikV~~k~~~~~~-~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~--~~ls~~~~~~ 79 (449)
++|++.+...... ....+.+|+.++..+.++++|+.+...+......+++++++ +++|.+++.... ..++...+..
T Consensus 26 ~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 105 (384)
T COG0515 26 ALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALF 105 (384)
T ss_pred EEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCCCCcHHHHHHhcccccCCCHHHHHH
Confidence 4555555554443 46779999999999955558999999998888899999999 899998877532 2689999999
Q ss_pred HHHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCC-eEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhh
Q 013092 80 LADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHL 158 (449)
Q Consensus 80 i~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~-~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~ 158 (449)
++.|++.+|.|+|+.+++||||||+||++ +..+ .++++|||+++.+.......... .......||..|++||.+.
T Consensus 106 ~~~~~~~~l~~~H~~~~~hrd~kp~nil~---~~~~~~~~l~dfg~~~~~~~~~~~~~~~-~~~~~~~~t~~~~~pe~~~ 181 (384)
T COG0515 106 ILAQILSALEYLHSKGIIHRDIKPENILL---DRDGRVVKLIDFGLAKLLPDPGSTSSIP-ALPSTSVGTPGYMAPEVLL 181 (384)
T ss_pred HHHHHHHHHHHHHhCCeeccCCCHHHeee---cCCCCeEEEeccCcceecCCCCcccccc-ccccccccccccCCHHHhc
Confidence 99999999999999999999999999999 4555 79999999998665443211100 1235678999999999999
Q ss_pred C---CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcC-CHHHHHHHHHhhcccchHHHhhcCC----cHHHHHHHHHHhcC
Q 013092 159 G---IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG-TKKQKYEKISEKKVSTSIEALCRGY----PTEFASYFHYCRSL 230 (449)
Q Consensus 159 ~---~~~s~~~DiwSlG~il~elltG~~Pf~~~~~~-~~~~~~~~i~~~~~~~~~~~l~~~~----p~el~~li~~cl~~ 230 (449)
+ ..+....|+|++|++++++++|..||...... ...+....+................ ...+.+++..|+..
T Consensus 182 ~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (384)
T COG0515 182 GLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAK 261 (384)
T ss_pred CCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccccCccccchhhHHHHHHHHHHHhc
Confidence 8 57889999999999999999999998765431 1222333333222110111111111 25789999999999
Q ss_pred CCCCCCCHHHHHH
Q 013092 231 RFDDKPDYAYLKR 243 (449)
Q Consensus 231 ~p~~RPt~~~l~~ 243 (449)
+|..|.+......
T Consensus 262 ~~~~r~~~~~~~~ 274 (384)
T COG0515 262 DPKNRLSSSSDLS 274 (384)
T ss_pred CchhcCCHHHHhh
Confidence 9999988765543
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.84 E-value=5.7e-22 Score=211.68 Aligned_cols=212 Identities=20% Similarity=0.213 Sum_probs=162.6
Q ss_pred HHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCC
Q 013092 23 YESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIK 102 (449)
Q Consensus 23 ~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~givHRDLK 102 (449)
.|.-+-..| .|+|++.......+....+-+||||..+|+.++.. ...++..++..++.|++.||.|||+.||.|||||
T Consensus 370 sE~~i~~~l-~h~~~~e~l~~~~~~~~~~~~mE~~~~Dlf~~~~~-~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK 447 (601)
T KOG0590|consen 370 SEFCIGSSL-SHPNIIETLDIVQEIDGILQSMEYCPYDLFSLVMS-NGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLK 447 (601)
T ss_pred hheeecccc-cCCchhhhHHHHhhcccchhhhhcccHHHHHHHhc-ccccchhhhhHHHHHHHHHHHHHHhcCceeccCc
Confidence 344444445 88998776665555554555599993399999884 3479999999999999999999999999999999
Q ss_pred CCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCCh-hhHHHHHHHHHHHHHhC
Q 013092 103 PDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSR-RDDLESLGYVLMYFLRG 181 (449)
Q Consensus 103 P~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~-~~DiwSlG~il~elltG 181 (449)
++|+++ ...+.+||+|||.+..+....... .......+|+..|+|||++.+.+|++ ..||||.|++++.|++|
T Consensus 448 ~enll~---~~~g~lki~Dfg~~~vf~~~~e~~---~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~ 521 (601)
T KOG0590|consen 448 LENLLV---TENGILKIIDFGAASVFRYPWEKN---IHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILG 521 (601)
T ss_pred cccEEE---ecCCceEEeecCcceeeccCcchh---hhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecC
Confidence 999999 578899999999998765443211 12345788999999999999999965 57999999999999999
Q ss_pred CCCCCCCCcCCHHH-HHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 013092 182 SLPWQGLKAGTKKQ-KYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 242 (449)
Q Consensus 182 ~~Pf~~~~~~~~~~-~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~ 242 (449)
+.||.-....+... ......+.........+...+|.+.+.+|.+|++.+|.+|.++++|.
T Consensus 522 ~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~ 583 (601)
T KOG0590|consen 522 RFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQIL 583 (601)
T ss_pred CCccccccccccchhhhccccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHh
Confidence 99997654433221 11111222333444556677899999999999999999999976653
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.1e-21 Score=201.76 Aligned_cols=239 Identities=17% Similarity=0.206 Sum_probs=186.4
Q ss_pred EEEEEeeecccCCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHH
Q 013092 4 ILTVFSVQENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLAD 82 (449)
Q Consensus 4 aikV~~k~~~~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~ 82 (449)
|+||++|.............|..++..++.||.++.+.+.++.+...+++++|. |+.|..-+.. ...+....+..+..
T Consensus 26 amkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rgg~lft~l~~-~~~f~~~~~~~~~a 104 (612)
T KOG0603|consen 26 AMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRGGDLFTRLSK-EVMFDELDVAFYLA 104 (612)
T ss_pred hhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcccchhhhcccc-CCchHHHHHHHHHH
Confidence 467777766544333466789999999988999999999999999999999999 8888877664 45688888999999
Q ss_pred HHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCC
Q 013092 83 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQ 162 (449)
Q Consensus 83 qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~ 162 (449)
.++.+++++|+.+|+|||+|++||++ +..|++++.|||+.+..-.... .+||..|||||++. ..
T Consensus 105 elaLald~lh~l~iiyrd~k~enill---d~~Ghi~~tdfglske~v~~~~-----------~cgt~eymApEI~~--gh 168 (612)
T KOG0603|consen 105 ELALALDHLHKLGIAYRDYKLENVLL---LLEGHIKLTDFGLSKEAVKEKI-----------ACGTYEYRAPEIIN--GH 168 (612)
T ss_pred HHHHHHhhcchhHHHHhcccccceee---cccCccccCCchhhhHhHhhhh-----------cccchhhhhhHhhh--cc
Confidence 99999999999999999999999999 7899999999999987654322 28999999999998 45
Q ss_pred ChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 013092 163 SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 242 (449)
Q Consensus 163 s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~ 242 (449)
....|.||||++.+||++|..||.+ +....|...+.. .+..+..+..+++..++..+|..|.-..
T Consensus 169 ~~a~D~ws~gvl~felltg~~pf~~-------~~~~~Il~~~~~-----~p~~l~~~a~~~~~~l~~r~p~nrLg~~--- 233 (612)
T KOG0603|consen 169 LSAADWWSFGVLAFELLTGTLPFGG-------DTMKRILKAELE-----MPRELSAEARSLFRQLFKRNPENRLGAG--- 233 (612)
T ss_pred CCcccchhhhhhHHHHhhCCCCCch-------HHHHHHhhhccC-----CchhhhHHHHHHHHHHHhhCHHHHhccC---
Confidence 6788999999999999999999976 334444443332 1233566788899999999999885431
Q ss_pred HHHHHHHHHcCCCCCCcccchhhhhhhccCCCCC
Q 013092 243 RIFRDLFIREGFQFDYVFDWTILKYQQSQLATPP 276 (449)
Q Consensus 243 ~~L~~~~~~~~~~~~~~~dw~~~~~~~~~~~~~p 276 (449)
-....+.....+....||..+...+..++..|
T Consensus 234 --~~~~~eik~h~f~~~i~~~~l~~r~~~~~fkp 265 (612)
T KOG0603|consen 234 --PDGVDEIKQHEFFQSIDWNELEARSRPPPFKP 265 (612)
T ss_pred --cchhHHHhccchheeeeHhhHhhcCCCCCCCC
Confidence 11112223345667789998877766555444
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.3e-20 Score=199.64 Aligned_cols=228 Identities=17% Similarity=0.096 Sum_probs=163.1
Q ss_pred ccEEEEEeeecccC--CChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecCCCCHHHHHHHcCCC-CCHHHHH
Q 013092 2 YEILTVFSVQENVK--TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRK-LSLKTVL 78 (449)
Q Consensus 2 ~~aikV~~k~~~~~--~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~g~sL~~ll~~~~~~-ls~~~~~ 78 (449)
+.++||.+|....- ...++.+.|++ ..+..+||++.+.-.-+.....|||-+|+..+|+|-+. .++ +..-+..
T Consensus 48 ~vVvKVFvk~~p~~sL~~~~qrL~~ik--~~l~~~pn~lPfqk~~~t~kAAylvRqyvkhnLyDRlS--TRPFL~~iEKk 123 (1431)
T KOG1240|consen 48 LVVVKVFVKQDPTISLRPFKQRLEEIK--FALMKAPNCLPFQKVLVTDKAAYLVRQYVKHNLYDRLS--TRPFLVLIEKK 123 (1431)
T ss_pred eEEEEEEeccCCCCCchHHHHHHHHHH--HHhhcCCcccchHHHHHhhHHHHHHHHHHhhhhhhhhc--cchHHHHHHHH
Confidence 35788888877443 23445555666 44558999999988878888899999999999999987 445 5777889
Q ss_pred HHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhh
Q 013092 79 MLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHL 158 (449)
Q Consensus 79 ~i~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~ 158 (449)
.|+.|++.||..+|..||+|+|||.+|||| ..-+.++|+||...+...-+..+..-......+..--.+|.|||.|.
T Consensus 124 WiaFQLL~al~qcH~~gVcHGDIKsENILi---TSWNW~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv 200 (1431)
T KOG1240|consen 124 WIAFQLLKALSQCHKLGVCHGDIKSENILI---TSWNWLYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFV 200 (1431)
T ss_pred HHHHHHHHHHHHHHHcCccccccccceEEE---eeechhhhhcccccCCccCCCCCcccceEEEecCCceeeecChHhhh
Confidence 999999999999999999999999999999 58889999999877643222111110000111122235899999987
Q ss_pred CC----------C-CChhhHHHHHHHHHHHHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCc-HHHHHHHH
Q 013092 159 GI----------E-QSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYP-TEFASYFH 225 (449)
Q Consensus 159 ~~----------~-~s~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p-~el~~li~ 225 (449)
.. . .+++-||||+||+++||++ |++||.- .|.+. ..... ....+.+.+.++ ..++.+|.
T Consensus 201 ~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L------SQL~a-Yr~~~-~~~~e~~Le~Ied~~~Rnlil 272 (1431)
T KOG1240|consen 201 SALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL------SQLLA-YRSGN-ADDPEQLLEKIEDVSLRNLIL 272 (1431)
T ss_pred ccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH------HHHHh-HhccC-ccCHHHHHHhCcCccHHHHHH
Confidence 52 1 5678999999999999987 8999942 12111 11110 122233333332 36899999
Q ss_pred HHhcCCCCCCCCHHHHHHH
Q 013092 226 YCRSLRFDDKPDYAYLKRI 244 (449)
Q Consensus 226 ~cl~~~p~~RPt~~~l~~~ 244 (449)
.|++.||..|.++++.++.
T Consensus 273 ~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 273 SMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred HHHccCchhccCHHHHHHh
Confidence 9999999999998877654
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=5.4e-19 Score=172.81 Aligned_cols=205 Identities=18% Similarity=0.218 Sum_probs=154.5
Q ss_pred hcCCCCCceEEEEeEe---------------------------CCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHH
Q 013092 31 LQGGTGIPNVRWFGVE---------------------------GDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQ 83 (449)
Q Consensus 31 l~~hp~Iv~l~~~~~~---------------------------~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~~~~i~~q 83 (449)
|..|||||.+..+|.+ ....|+||.-+..+|.+++. .+..+......++.|
T Consensus 272 La~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~tLr~yl~--~~~~s~r~~~~~laQ 349 (598)
T KOG4158|consen 272 LAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQTLREYLW--TRHRSYRTGRVILAQ 349 (598)
T ss_pred cCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchhhHHHHHh--cCCCchHHHHHHHHH
Confidence 3479999999877653 23579999999999999997 456788899999999
Q ss_pred HHHHHHHHHHCCceecCCCCCcEEEeecCC-CCeEEEeecCcceeecCCCCCcccccccC-CCCccCccccchhhhhCCC
Q 013092 84 MINRVEFVHSKSFLHRDIKPDNFLMGLGRR-ANQVYIIDFGLAKKYRDTSTHQHIPYREN-KNLTGTARYASMNTHLGIE 161 (449)
Q Consensus 84 i~~aL~yLH~~givHRDLKP~NiLl~~~~~-~~~vkL~DFGla~~~~~~~~~~~~~~~~~-~~~~gT~~Y~aPE~~~~~~ 161 (449)
+++|+.|||++||.|||+|.+||||-++++ ...+.|+|||.+--... .....||... ...-|....||||+....+
T Consensus 350 lLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~--hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P 427 (598)
T KOG4158|consen 350 LLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDN--HGLQLPYESDEVDLGGNAKLMAPEIATAVP 427 (598)
T ss_pred HHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccc--cccccccccccccCCCcceecchhhhhcCC
Confidence 999999999999999999999999987633 34788999998754332 2223344322 2355788999999987543
Q ss_pred C------ChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCC
Q 013092 162 Q------SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDK 235 (449)
Q Consensus 162 ~------s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~R 235 (449)
- -.++|.|+.|.+.||++....||.+.-.... ......+ ..++.++..+|+.+++++..+++.||.+|
T Consensus 428 Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L--~~r~Yqe----~qLPalp~~vpp~~rqlV~~lL~r~pskR 501 (598)
T KOG4158|consen 428 GPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLL--DTRTYQE----SQLPALPSRVPPVARQLVFDLLKRDPSKR 501 (598)
T ss_pred CCceeeccchhhhhhhhhhHHHHhccCCcccccchhee--chhhhhh----hhCCCCcccCChHHHHHHHHHhcCCcccc
Confidence 1 2488999999999999999999987221110 0111222 23445677899999999999999999999
Q ss_pred CCHHHHHHHH
Q 013092 236 PDYAYLKRIF 245 (449)
Q Consensus 236 Pt~~~l~~~L 245 (449)
++..-....|
T Consensus 502 vsp~iAANvl 511 (598)
T KOG4158|consen 502 VSPNIAANVL 511 (598)
T ss_pred CCccHHHhHH
Confidence 9865444443
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.3e-19 Score=169.29 Aligned_cols=220 Identities=13% Similarity=0.118 Sum_probs=168.9
Q ss_pred EEEEeeecccCCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcC-CCCCHHHHHHHHH
Q 013092 5 LTVFSVQENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCS-RKLSLKTVLMLAD 82 (449)
Q Consensus 5 ikV~~k~~~~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~-~~ls~~~~~~i~~ 82 (449)
.||+.+.+........|..|.-.|+.+ .||||..+++.|....+..++..|| -++|+.++.... -..+..++.+++.
T Consensus 218 akil~vr~~t~risrdfneefp~lrif-shpnilpvlgacnsppnlv~isq~mp~gslynvlhe~t~vvvd~sqav~fal 296 (448)
T KOG0195|consen 218 AKILNVREVTARISRDFNEEFPALRIF-SHPNILPVLGACNSPPNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFAL 296 (448)
T ss_pred hhhhhhhhcchhhcchhhhhCcceeee-cCCchhhhhhhccCCCCceEeeeeccchHHHHHHhcCccEEEecchHHHHHH
Confidence 345555555555667799999999988 9999999999999999999999999 999999998532 2357778999999
Q ss_pred HHHHHHHHHHHCC--ceecCCCCCcEEEeecCCCCeEEE--eecCcceeecCCCCCcccccccCCCCccCccccchhhhh
Q 013092 83 QMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYI--IDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHL 158 (449)
Q Consensus 83 qi~~aL~yLH~~g--ivHRDLKP~NiLl~~~~~~~~vkL--~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~ 158 (449)
+|+.|++|||+.. |.---|....++| +++-+.+| +|--++.. .....-.|.||+||.+.
T Consensus 297 diargmaflhslep~ipr~~lns~hvmi---dedltarismad~kfsfq--------------e~gr~y~pawmspealq 359 (448)
T KOG0195|consen 297 DIARGMAFLHSLEPMIPRFYLNSKHVMI---DEDLTARISMADTKFSFQ--------------EVGRAYSPAWMSPEALQ 359 (448)
T ss_pred HHHhhHHHHhhcchhhhhhhcccceEEe---cchhhhheecccceeeee--------------ccccccCcccCCHHHHh
Confidence 9999999999874 4444677788888 45554444 34322211 11223468999999998
Q ss_pred CCCC---ChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCC
Q 013092 159 GIEQ---SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDK 235 (449)
Q Consensus 159 ~~~~---s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~R 235 (449)
..+- -..+|+|||+++||||.|...||....+.+-..+ ..+......++++++..+..+|..|+..||.+|
T Consensus 360 rkped~n~raadmwsfaillwel~trevpfadlspmecgmk------ialeglrv~ippgis~hm~klm~icmnedpgkr 433 (448)
T KOG0195|consen 360 RKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMK------IALEGLRVHIPPGISRHMNKLMNICMNEDPGKR 433 (448)
T ss_pred cCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhh------hhhccccccCCCCccHHHHHHHHHHhcCCCCcC
Confidence 7654 3578999999999999999999998766432211 122334445678889999999999999999999
Q ss_pred CCHHHHHHHHHHH
Q 013092 236 PDYAYLKRIFRDL 248 (449)
Q Consensus 236 Pt~~~l~~~L~~~ 248 (449)
|.|..|.-+|+++
T Consensus 434 pkfdmivpilekm 446 (448)
T KOG0195|consen 434 PKFDMIVPILEKM 446 (448)
T ss_pred CCcceehhhHHHh
Confidence 9999999888765
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=7.8e-19 Score=162.54 Aligned_cols=155 Identities=16% Similarity=0.095 Sum_probs=115.6
Q ss_pred HHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q 013092 20 QLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLH 98 (449)
Q Consensus 20 ~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~givH 98 (449)
.+.+|+++|++|.++++|++++++ +..|++|||+ |.+|.+.+.. . ...++.|++.+|+++|++||+|
T Consensus 47 l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~G~~L~~~~~~-------~-~~~~~~qi~~~L~~lH~~GIvH 114 (218)
T PRK12274 47 LARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLAGAAMYQRPPR-------G-DLAYFRAARRLLQQLHRCGVAH 114 (218)
T ss_pred HHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeecCccHHhhhhh-------h-hHHHHHHHHHHHHHHHHCcCcc
Confidence 478999999999888999999886 3479999999 8888654321 1 2357789999999999999999
Q ss_pred cCC-CCCcEEEeecCCCCeEEEeecCcceeecCCCCC------cccccccCCCCccCccccchhhhhCC-CCC-hhhHHH
Q 013092 99 RDI-KPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH------QHIPYRENKNLTGTARYASMNTHLGI-EQS-RRDDLE 169 (449)
Q Consensus 99 RDL-KP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~------~~~~~~~~~~~~gT~~Y~aPE~~~~~-~~s-~~~Diw 169 (449)
||| ||+|||+ +.++.++|+|||++......... ..+.....-....++.|+.|+...-. ..+ ...+++
T Consensus 115 rDL~kp~NILv---~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~ 191 (218)
T PRK12274 115 NDLAKEANWLV---QEDGSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWF 191 (218)
T ss_pred CCCCCcceEEE---cCCCCEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHH
Confidence 999 7999999 46788999999999865443210 00000000112357788888865543 233 577999
Q ss_pred HHHHHHHHHHhCCCCCCCCC
Q 013092 170 SLGYVLMYFLRGSLPWQGLK 189 (449)
Q Consensus 170 SlG~il~elltG~~Pf~~~~ 189 (449)
+.|+.+|.|+|+.+++.+..
T Consensus 192 ~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 192 ATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred HhcchHHHHHhccCCccccC
Confidence 99999999999999886643
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.5e-18 Score=176.80 Aligned_cols=213 Identities=16% Similarity=0.220 Sum_probs=165.1
Q ss_pred HHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCc-eecCCCCCcE
Q 013092 29 RILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF-LHRDIKPDNF 106 (449)
Q Consensus 29 ~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gi-vHRDLKP~Ni 106 (449)
+.+ .|.|+.++++.+.++...++|.+|| .|+|.|++......+++-....+..+|+.||+|+|.--| .|+.++..|+
T Consensus 2 ~~l-~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 2 RQL-DHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred ccc-chhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 345 7999999999999999999999999 999999998766678888889999999999999998655 9999999999
Q ss_pred EEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCC-------CChhhHHHHHHHHHHHHH
Q 013092 107 LMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIE-------QSRRDDLESLGYVLMYFL 179 (449)
Q Consensus 107 Ll~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~-------~s~~~DiwSlG~il~ell 179 (449)
++ +..+.+||+|||+......... +.......-..-|.|||.+.+.. .+.+.|+||||++++|++
T Consensus 81 lv---d~~w~lklt~~Gl~~~~~~~~~-----~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~ 152 (484)
T KOG1023|consen 81 LV---DSRWVLKLTDFGLNSLLEETAE-----PEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEIL 152 (484)
T ss_pred ee---eeeEEEEechhhhccccccccc-----ccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHH
Confidence 99 7899999999999876643100 00111222445789999988642 366799999999999999
Q ss_pred hCCCCCCCCCcCC-HHHHHHHHHhhcc---cchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 013092 180 RGSLPWQGLKAGT-KKQKYEKISEKKV---STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIR 251 (449)
Q Consensus 180 tG~~Pf~~~~~~~-~~~~~~~i~~~~~---~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~L~~~~~~ 251 (449)
+.+.||....... ..+.+.++..... .+.+.... .+++++..++..||..+|++||++.++...++.+...
T Consensus 153 ~r~~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~-e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~ 227 (484)
T KOG1023|consen 153 FRSGPFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLN-ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG 227 (484)
T ss_pred hccCccccccccCChHHHHHHHHhcCCCCcCcchhhhh-hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence 9999998743322 1334444433122 22222222 5677899999999999999999999999888877653
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.3e-18 Score=173.44 Aligned_cols=127 Identities=20% Similarity=0.225 Sum_probs=96.3
Q ss_pred hhHHHHHHHHHHHhcCCCCCc-eEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 013092 18 HPQLLYESKLYRILQGGTGIP-NVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 95 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv-~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~g 95 (449)
...|.+|+++|+.| .|+||+ .+++. +..||||||| |++|... . ... ...++.|++.+|.|||++|
T Consensus 65 ~~~~~~E~~iL~~L-~h~~iv~~l~~~----~~~~LVmE~~~G~~L~~~-~----~~~---~~~~~~~i~~aL~~lH~~g 131 (365)
T PRK09188 65 RHLAAREIRALKTV-RGIGVVPQLLAT----GKDGLVRGWTEGVPLHLA-R----PHG---DPAWFRSAHRALRDLHRAG 131 (365)
T ss_pred HHHHHHHHHHHHhc-cCCCCCcEEEEc----CCcEEEEEccCCCCHHHh-C----ccc---hHHHHHHHHHHHHHHHHCC
Confidence 34589999999999 677766 45543 4579999999 8888632 1 111 1467889999999999999
Q ss_pred ceecCC-CCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccc-cccCCCCccCccccchhhhhCC
Q 013092 96 FLHRDI-KPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIP-YRENKNLTGTARYASMNTHLGI 160 (449)
Q Consensus 96 ivHRDL-KP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~-~~~~~~~~gT~~Y~aPE~~~~~ 160 (449)
|+|||| ||+|||+ +.++.+||+|||+++.+........+. +..-....+++.|++||.+...
T Consensus 132 IiHrDL~KP~NILv---~~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 132 ITHNDLAKPQNWLM---GPDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred CeeCCCCCcceEEE---cCCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 999999 9999999 466789999999999887654332221 1222466788999999998754
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.72 E-value=6e-18 Score=182.28 Aligned_cols=172 Identities=24% Similarity=0.355 Sum_probs=125.2
Q ss_pred HHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCc----cc----ccccCCCCccCccccch
Q 013092 83 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ----HI----PYRENKNLTGTARYASM 154 (449)
Q Consensus 83 qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~----~~----~~~~~~~~~gT~~Y~aP 154 (449)
+++.+++|||+.||+|||+||+|++| +.-|++|+.|||+.+...-..+.. ++ .-...+..+||+.|.||
T Consensus 151 dmvla~Eylh~ygivhrdlkpdnllI---T~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaP 227 (1205)
T KOG0606|consen 151 DMVLAVEYLHSYGIVHRDLKPDNLLI---TSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAP 227 (1205)
T ss_pred hhhHHhHhhccCCeecCCCCCCccee---eecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccCh
Confidence 34789999999999999999999999 689999999999987542211110 00 01123467899999999
Q ss_pred hhhhCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCC
Q 013092 155 NTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDD 234 (449)
Q Consensus 155 E~~~~~~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~ 234 (449)
|++....|+..+|+|++|+|+||++.|..||.+.++ .+.+..+....+.. .+. -..+++|.++++.++|..+|.+
T Consensus 228 eVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtp---eelfg~visd~i~w-pE~-dea~p~Ea~dli~~LL~qnp~~ 302 (1205)
T KOG0606|consen 228 EVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP---EELFGQVISDDIEW-PEE-DEALPPEAQDLIEQLLRQNPLC 302 (1205)
T ss_pred hhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCH---HHHHhhhhhhhccc-ccc-CcCCCHHHHHHHHHHHHhChHh
Confidence 999999999999999999999999999999998544 44444443333221 111 3568899999999999999999
Q ss_pred CCCHHHHHHHHHHHHHHcCCCCCCcccchhhhhhh
Q 013092 235 KPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQ 269 (449)
Q Consensus 235 RPt~~~l~~~L~~~~~~~~~~~~~~~dw~~~~~~~ 269 (449)
|---.. .+.-....++..+||..+-.++
T Consensus 303 Rlgt~g-------a~evk~h~ff~~LDw~~llRqk 330 (1205)
T KOG0606|consen 303 RLGTGG-------ALEVKQHGFFQLLDWKSLLRQK 330 (1205)
T ss_pred hcccch-------hhhhhhccceeecccchhhhhh
Confidence 953221 1222334566677888554443
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.72 E-value=5.9e-18 Score=171.48 Aligned_cols=173 Identities=25% Similarity=0.341 Sum_probs=132.6
Q ss_pred CEEEEEEecC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCc
Q 013092 48 DYNVLVMDLL-GPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGL 124 (449)
Q Consensus 48 ~~~~lVmE~~-g~sL~~ll~~~--~~~ls~~~~~~i~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGl 124 (449)
.+.||.|++| ..+|.+++... ....++...+.++.|++.|++| +|.+|||+||-||.. ..+..+||.|||+
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~---~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFF---SDDDQLKIGDFGL 402 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhcccccccc---ccchhhhhhhhhh
Confidence 4689999999 99999999632 3447888999999999999999 999999999999999 4666899999999
Q ss_pred ceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCCHHHHHHHHHhh
Q 013092 125 AKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEK 203 (449)
Q Consensus 125 a~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~ 203 (449)
........+ ...++......+||..||+||.+.+..|+.++|||+||+||+|++. -...|.. ...+..+...
T Consensus 403 ~ts~~~~~~-~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er------~~t~~d~r~g 475 (516)
T KOG1033|consen 403 VTSQDKDET-VAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER------IATLTDIRDG 475 (516)
T ss_pred eeecccCCc-ccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH------HHhhhhhhcC
Confidence 987765441 1112233456789999999999999999999999999999999997 4444432 1222333333
Q ss_pred cccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCC
Q 013092 204 KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPD 237 (449)
Q Consensus 204 ~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt 237 (449)
.++ +....++|. -..|+..++...|.+||+
T Consensus 476 ~ip---~~~~~d~p~-e~~ll~~lls~~p~~RP~ 505 (516)
T KOG1033|consen 476 IIP---PEFLQDYPE-EYTLLQQLLSPSPEERPS 505 (516)
T ss_pred CCC---hHHhhcCcH-HHHHHHHhcCCCcccCch
Confidence 222 123344554 467999999999999993
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.7e-17 Score=160.93 Aligned_cols=161 Identities=22% Similarity=0.255 Sum_probs=110.1
Q ss_pred EEEEEecCCCCHHHHHHHc---CCC---CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecC
Q 013092 50 NVLVMDLLGPSLEDLFNFC---SRK---LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFG 123 (449)
Q Consensus 50 ~~lVmE~~g~sL~~ll~~~---~~~---ls~~~~~~i~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFG 123 (449)
.+++|+-+-++|.+++... ... +.....+.+..|++..+++||..|+||+||||+||++ +.+|.++|.||+
T Consensus 114 ~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~~~nfll---~~~G~v~Lg~F~ 190 (288)
T PF14531_consen 114 RFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIKPENFLL---DQDGGVFLGDFS 190 (288)
T ss_dssp EEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEE----TTS-EEE--GG
T ss_pred hhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccceeeEEE---cCCCCEEEcChH
Confidence 3789999989999987532 211 2233345667999999999999999999999999999 689999999999
Q ss_pred cceeecCCCCCcccccccCCCCccCccccchhhhhC--------CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHH
Q 013092 124 LAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG--------IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQ 195 (449)
Q Consensus 124 la~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~--------~~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~ 195 (449)
.....+.... . ...+..|.+||.... ..++.+.|.|+||+++|.|++|.+||..........
T Consensus 191 ~~~r~g~~~~-------~---~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~ 260 (288)
T PF14531_consen 191 SLVRAGTRYR-------C---SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADPE 260 (288)
T ss_dssp GEEETTEEEE-------G---GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSG
T ss_pred HHeecCceee-------c---cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCcccccc
Confidence 8876554221 0 234577999997753 247899999999999999999999998654322110
Q ss_pred HHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCC
Q 013092 196 KYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDK 235 (449)
Q Consensus 196 ~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~R 235 (449)
..-..|.++|+.++.||..+|+.+|++|
T Consensus 261 ------------~~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 261 ------------WDFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp ------------GGGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred ------------ccchhcCCcCHHHHHHHHHHccCCcccC
Confidence 0122455889999999999999999987
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.71 E-value=5e-17 Score=150.11 Aligned_cols=99 Identities=22% Similarity=0.223 Sum_probs=77.6
Q ss_pred HHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHH-HHCCceec
Q 013092 22 LYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV-HSKSFLHR 99 (449)
Q Consensus 22 ~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yL-H~~givHR 99 (449)
..|++++..| .+++|+........ ..+|||||+ |++|...+.. ...++...++.++.|++.+|.+| |+.||+||
T Consensus 67 ~~E~~~l~~l-~~~~v~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHr 142 (190)
T cd05147 67 EKEMRNLKRL-VTAGIPCPEPILLK--SHVLVMEFIGDDGWAAPRLK-DAPLSESKARELYLQVIQIMRILYQDCRLVHA 142 (190)
T ss_pred HHHHHHHHHH-HHCCCCCCcEEEec--CCEEEEEEeCCCCCcchhhh-cCCCCHHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence 3599999999 56666443333222 238999999 6665544322 46799999999999999999999 79999999
Q ss_pred CCCCCcEEEeecCCCCeEEEeecCcceee
Q 013092 100 DIKPDNFLMGLGRRANQVYIIDFGLAKKY 128 (449)
Q Consensus 100 DLKP~NiLl~~~~~~~~vkL~DFGla~~~ 128 (449)
||||+|||+. .+.++|+|||++...
T Consensus 143 DlkP~NIli~----~~~v~LiDFG~a~~~ 167 (190)
T cd05147 143 DLSEYNLLYH----DGKLYIIDVSQSVEH 167 (190)
T ss_pred CCCHHHEEEE----CCcEEEEEccccccC
Confidence 9999999994 468999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.69 E-value=4.6e-17 Score=153.51 Aligned_cols=126 Identities=15% Similarity=0.270 Sum_probs=98.2
Q ss_pred HHHHHHHHHHhcCCCCCceEEEEeEeC--------CEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHH
Q 013092 21 LLYESKLYRILQGGTGIPNVRWFGVEG--------DYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 91 (449)
Q Consensus 21 ~~~E~~il~~l~~hp~Iv~l~~~~~~~--------~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yL 91 (449)
+.+|+..+.+| .|+||+.+.+++... +..+|||||+ |.+|.++.. ++. ....+++.+|..|
T Consensus 82 ~e~Ea~~l~rL-~~~GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~----~~~~~i~~~l~~l 151 (232)
T PRK10359 82 YENLIVQTDRV-RSEGLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE-----ISE----DVKAKIKASIESL 151 (232)
T ss_pred HHHHHHHHHHH-HHCCCCcceEeeeecccccccccCCeEEEEEEECCccHHHhhh-----ccH----HHHHHHHHHHHHH
Confidence 67899999999 999999998887643 3589999999 889988743 333 2456999999999
Q ss_pred HHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHH
Q 013092 92 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESL 171 (449)
Q Consensus 92 H~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSl 171 (449)
|..|++|||+||.||++. .++ ++|+|||..+....... .-..++...+..++|+|+|
T Consensus 152 H~~gi~H~Dikp~Nili~---~~g-i~liDfg~~~~~~e~~a-------------------~d~~vler~y~~~~di~~l 208 (232)
T PRK10359 152 HQHGMVSGDPHKGNFIVS---KNG-LRIIDLSGKRCTAQRKA-------------------KDRIDLERHYGIKNEIKDL 208 (232)
T ss_pred HHcCCccCCCChHHEEEe---CCC-EEEEECCCcccccchhh-------------------HHHHHHHhHhcccccccce
Confidence 999999999999999994 556 99999998865532211 1113444556778999999
Q ss_pred HHHHHHHH
Q 013092 172 GYVLMYFL 179 (449)
Q Consensus 172 G~il~ell 179 (449)
||++..+.
T Consensus 209 g~~~~~~~ 216 (232)
T PRK10359 209 GYYLLIYK 216 (232)
T ss_pred eEeehHHH
Confidence 99987654
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.68 E-value=4.6e-16 Score=145.66 Aligned_cols=105 Identities=15% Similarity=0.154 Sum_probs=84.3
Q ss_pred ChhHHHHHHHHHHHhc----CCCCCceEEEEeEeCC---E-EEEEEecC---CCCHHHHHHHcCCCCCHHHHHHHHHHHH
Q 013092 17 KHPQLLYESKLYRILQ----GGTGIPNVRWFGVEGD---Y-NVLVMDLL---GPSLEDLFNFCSRKLSLKTVLMLADQMI 85 (449)
Q Consensus 17 ~~~~~~~E~~il~~l~----~hp~Iv~l~~~~~~~~---~-~~lVmE~~---g~sL~~ll~~~~~~ls~~~~~~i~~qi~ 85 (449)
...++.+|+++|+.|. .||||+.+++++.++. . ..+||||+ +++|.++++. ..+++. ..++.|++
T Consensus 39 ~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e~~G~~~~tL~~~l~~--~~~~e~--~~~~~~~L 114 (210)
T PRK10345 39 GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIADFDGKPSITLTEFAEQ--CRYEED--VAQLRQLL 114 (210)
T ss_pred hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEecCCCCcchhHHHHHHc--ccccHh--HHHHHHHH
Confidence 4567999999999995 4899999999998763 4 34799995 5899999974 346655 35678888
Q ss_pred HHH-HHHHHCCceecCCCCCcEEEeecC-CCCeEEEeecCcc
Q 013092 86 NRV-EFVHSKSFLHRDIKPDNFLMGLGR-RANQVYIIDFGLA 125 (449)
Q Consensus 86 ~aL-~yLH~~givHRDLKP~NiLl~~~~-~~~~vkL~DFGla 125 (449)
.++ +|||+++|+||||||+|||+...+ ....++|+||+.+
T Consensus 115 ~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 115 KKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred HHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 777 999999999999999999996433 3348999995544
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.66 E-value=7.7e-16 Score=168.73 Aligned_cols=199 Identities=22% Similarity=0.294 Sum_probs=150.3
Q ss_pred CCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeec--
Q 013092 35 TGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG-- 111 (449)
Q Consensus 35 p~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~givHRDLKP~NiLl~~~-- 111 (449)
+.|..+..+..-.+..+||+||. .|+|.++++ ..+.+++..++.++.|++..|+.||..+|||+||||+|+||...
T Consensus 754 ~~~~~~~~a~~~~~~S~lv~ey~~~Gtlld~~N-~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~ 832 (974)
T KOG1166|consen 754 PSIMHISSAHVFQNASVLVSEYSPYGTLLDLIN-TNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREIC 832 (974)
T ss_pred cchHHHHHHHccCCcceeeeeccccccHHHhhc-cCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccC
Confidence 56666666666777889999999 999999999 46679999999999999999999999999999999999999642
Q ss_pred --CCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHHHHHHHhCCCCCCCCC
Q 013092 112 --RRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLK 189 (449)
Q Consensus 112 --~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il~elltG~~Pf~~~~ 189 (449)
.....++|+|||-+..+.--... ......++|-.+-++|+..|.+++...|.|.|+.+++-||.|+.-= ..
T Consensus 833 ~~~~~~~l~lIDfG~siDm~lfp~~-----~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q--~~ 905 (974)
T KOG1166|consen 833 ADSDSKGLYLIDFGRSIDMKLFPDG-----TKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME--VK 905 (974)
T ss_pred CCCcccceEEEecccceeeeEcCCC-----cEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH--hc
Confidence 23457999999998765432221 1234567899999999999999999999999999999999985311 00
Q ss_pred cCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 013092 190 AGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIRE 252 (449)
Q Consensus 190 ~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~L~~~~~~~ 252 (449)
.+.. ......++.++. -.-+.+|+..+|..+-+.-|...+|...|+..+.+.
T Consensus 906 ~g~~---------~~~~~~~~Ry~~--~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~~~ 957 (974)
T KOG1166|consen 906 NGSS---------WMVKTNFPRYWK--RDMWNKFFDLLLNPDCDTLPNLQELRTELEEVLAEH 957 (974)
T ss_pred CCcc---------eeccccchhhhh--HHHHHHHHHHHhCcCcccchhHHHHHHHHHHHHHHH
Confidence 0000 001111111111 134678888889877777788888888888887655
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.65 E-value=1.1e-15 Score=141.18 Aligned_cols=101 Identities=21% Similarity=0.250 Sum_probs=80.3
Q ss_pred HHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHH-HHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-CCce
Q 013092 21 LLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLE-DLFNFCSRKLSLKTVLMLADQMINRVEFVHS-KSFL 97 (449)
Q Consensus 21 ~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~-~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~-~giv 97 (449)
+..|.+.+.++ .+++|.....+.... .||||||+ |+++. ..+. ...++...+..++.|++.+|.+||. .||+
T Consensus 66 ~~~E~~~l~~l-~~~~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~--~~~~~~~~~~~i~~~l~~~l~~lH~~~giv 140 (190)
T cd05145 66 AEKEFRNLKRL-YEAGVPVPEPILLKK--NVLVMEFIGDDGSPAPRLK--DVPLEEEEAEELYEQVVEQMRRLYQEAGLV 140 (190)
T ss_pred HHHHHHHHHHH-HhCCCCCceEEEecC--CEEEEEEecCCCchhhhhh--hccCCHHHHHHHHHHHHHHHHHHHHhCCEe
Confidence 46789999999 677775544443332 48999999 55443 3344 3568889999999999999999999 9999
Q ss_pred ecCCCCCcEEEeecCCCCeEEEeecCcceeecC
Q 013092 98 HRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 130 (449)
Q Consensus 98 HRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~ 130 (449)
||||||+|||+. ++.++|+|||+++....
T Consensus 141 HrDlkP~NIll~----~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 141 HGDLSEYNILYH----DGKPYIIDVSQAVELDH 169 (190)
T ss_pred cCCCChhhEEEE----CCCEEEEEcccceecCC
Confidence 999999999993 67899999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.59 E-value=1.1e-14 Score=135.86 Aligned_cols=98 Identities=26% Similarity=0.447 Sum_probs=85.1
Q ss_pred HHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q 013092 20 QLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLH 98 (449)
Q Consensus 20 ~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~givH 98 (449)
.+.+|++++..+ .+++|+....++.+....+|||||+ |++|.+++... .. ....++.+++.+|.+||+.|++|
T Consensus 45 ~~~~E~~~l~~l-~~~~i~~p~~~~~~~~~~~lv~e~~~G~~L~~~~~~~----~~-~~~~i~~~i~~~l~~lH~~~i~H 118 (211)
T PRK14879 45 RTRREARIMSRA-RKAGVNVPAVYFVDPENFIIVMEYIEGEPLKDLINSN----GM-EELELSREIGRLVGKLHSAGIIH 118 (211)
T ss_pred HHHHHHHHHHHH-HHCCCCCCeEEEEeCCCCEEEEEEeCCcCHHHHHHhc----cH-HHHHHHHHHHHHHHHHHhCCccc
Confidence 477899999999 7788877777777778899999999 99999998742 12 78899999999999999999999
Q ss_pred cCCCCCcEEEeecCCCCeEEEeecCccee
Q 013092 99 RDIKPDNFLMGLGRRANQVYIIDFGLAKK 127 (449)
Q Consensus 99 RDLKP~NiLl~~~~~~~~vkL~DFGla~~ 127 (449)
+|++|.|||+. .+.++|+|||++..
T Consensus 119 ~Dl~p~Nil~~----~~~~~liDf~~a~~ 143 (211)
T PRK14879 119 GDLTTSNMILS----GGKIYLIDFGLAEF 143 (211)
T ss_pred CCCCcccEEEE----CCCEEEEECCcccC
Confidence 99999999993 67899999999864
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.57 E-value=2.1e-14 Score=132.83 Aligned_cols=96 Identities=24% Similarity=0.415 Sum_probs=79.7
Q ss_pred hHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q 013092 19 PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFL 97 (449)
Q Consensus 19 ~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~giv 97 (449)
..+.+|++++..+ .+++++....++......+|||||+ |++|.+++.... . .++.|++.+|.+||+.|++
T Consensus 42 ~~~~~E~~~l~~l-~~~~i~~p~~~~~~~~~~~lv~e~~~g~~l~~~~~~~~--~------~~~~~i~~~l~~lH~~gi~ 112 (199)
T TIGR03724 42 ERTRNEARLLSRA-RKAGVNTPVVYDVDPDNKTIVMEYIEGKPLKDVIEEGN--D------ELLREIGRLVGKLHKAGIV 112 (199)
T ss_pred HHHHHHHHHHHHH-HHCCCCCCEEEEEECCCCEEEEEEECCccHHHHHhhcH--H------HHHHHHHHHHHHHHHCCee
Confidence 4567899999999 5666555555556677789999999 999999876311 1 7899999999999999999
Q ss_pred ecCCCCCcEEEeecCCCCeEEEeecCccee
Q 013092 98 HRDIKPDNFLMGLGRRANQVYIIDFGLAKK 127 (449)
Q Consensus 98 HRDLKP~NiLl~~~~~~~~vkL~DFGla~~ 127 (449)
|+|++|.||++. .+.++|+|||++..
T Consensus 113 H~Dl~~~Nil~~----~~~~~liDfg~a~~ 138 (199)
T TIGR03724 113 HGDLTTSNIIVR----DDKLYLIDFGLGKY 138 (199)
T ss_pred cCCCCcceEEEE----CCcEEEEECCCCcC
Confidence 999999999993 68899999999865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.48 E-value=1e-15 Score=163.79 Aligned_cols=211 Identities=22% Similarity=0.270 Sum_probs=165.6
Q ss_pred HHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHH-HCCce
Q 013092 21 LLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSR-KLSLKTVLMLADQMINRVEFVH-SKSFL 97 (449)
Q Consensus 21 ~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~-~ls~~~~~~i~~qi~~aL~yLH-~~giv 97 (449)
...|..+-..+..|.|++.++....+.+..+++++|. |+++.+.+..... ..+...+-.++.|+..+|.|+| ..++.
T Consensus 67 i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~ 146 (601)
T KOG0590|consen 67 IDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVT 146 (601)
T ss_pred cCccccccccccccccccccCCccCCCcccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccc
Confidence 4458888888867999999999999999999999999 9999988832233 5677888899999999999999 99999
Q ss_pred ecCCCCCcEEEeecCCCC-eEEEeecCcceeecC-CCCCcccccccCCCCcc-CccccchhhhhCCC-CChhhHHHHHHH
Q 013092 98 HRDIKPDNFLMGLGRRAN-QVYIIDFGLAKKYRD-TSTHQHIPYRENKNLTG-TARYASMNTHLGIE-QSRRDDLESLGY 173 (449)
Q Consensus 98 HRDLKP~NiLl~~~~~~~-~vkL~DFGla~~~~~-~~~~~~~~~~~~~~~~g-T~~Y~aPE~~~~~~-~s~~~DiwSlG~ 173 (449)
||||||+|.++ +..+ .+++.|||+|..+.. .... +.....+| ++.|+|||.+.+.. .....|+||.|+
T Consensus 147 h~~ikP~n~~l---~~s~~~l~~~df~~At~~~~~~g~~-----~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~ 218 (601)
T KOG0590|consen 147 HRDIKPSNSLL---DESGSALKIADFGLATAYRNKNGAE-----RSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGI 218 (601)
T ss_pred cCCCCCccchh---ccCCCcccCCCchhhccccccCCcc-----eeeecccCCCCCCCCcccccchhhcCCCcccccccc
Confidence 99999999999 5666 899999999998876 3332 22334567 99999999999854 467899999999
Q ss_pred HHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 013092 174 VLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 242 (449)
Q Consensus 174 il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~ 242 (449)
++.-+++|..||....... +.+..+...+.. .....+.++.....+++.+++..++..|.+.+++.
T Consensus 219 ~l~~~~~g~~p~~~~~~~~--~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 219 VLSAMLTGELPWDFPSRKD--GRYSSWKSNKGR-FTQLPWNSISDQAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred cccccccCCCCcccccccc--ccceeecccccc-cccCccccCChhhhhcccccccCCchhcccccccc
Confidence 9999999999997654332 222222222211 01123456778889999999999999999877664
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.48 E-value=2.1e-13 Score=145.47 Aligned_cols=95 Identities=26% Similarity=0.499 Sum_probs=84.2
Q ss_pred hHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q 013092 19 PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFL 97 (449)
Q Consensus 19 ~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~giv 97 (449)
..+.+|+++++.+ .|++|+....++.+....+|||||+ |++|.+++. ....++.|++.+|.+||+.||+
T Consensus 381 ~~~~~E~~~l~~l-~~~~i~~p~~~~~~~~~~~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~~gii 450 (535)
T PRK09605 381 ERTRAEARLLSEA-RRAGVPTPVIYDVDPEEKTIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLHKAGIV 450 (535)
T ss_pred HHHHHHHHHHHhh-cccCCCeeEEEEEeCCCCEEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHhCCCc
Confidence 4578999999999 7888988888888878889999999 999999876 3467899999999999999999
Q ss_pred ecCCCCCcEEEeecCCCCeEEEeecCccee
Q 013092 98 HRDIKPDNFLMGLGRRANQVYIIDFGLAKK 127 (449)
Q Consensus 98 HRDLKP~NiLl~~~~~~~~vkL~DFGla~~ 127 (449)
||||||+|||+ .++.++|+|||+++.
T Consensus 451 HrDlkp~NILl----~~~~~~liDFGla~~ 476 (535)
T PRK09605 451 HGDLTTSNFIV----RDDRLYLIDFGLGKY 476 (535)
T ss_pred cCCCChHHEEE----ECCcEEEEeCccccc
Confidence 99999999999 356899999999865
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.47 E-value=1.8e-13 Score=130.72 Aligned_cols=100 Identities=21% Similarity=0.250 Sum_probs=78.3
Q ss_pred HHHHHHHHHHhcC-CCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC-ce
Q 013092 21 LLYESKLYRILQG-GTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS-FL 97 (449)
Q Consensus 21 ~~~E~~il~~l~~-hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~g-iv 97 (449)
+.+|+.++.++.. +..++.++... ..||||||+ |.+|..++.. ...+....+..++.|++.+|.+||+.| |+
T Consensus 97 ~~~E~~~L~~L~~~~i~~p~~~~~~----~~~lV~E~~~g~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~g~ii 171 (237)
T smart00090 97 AEKEFRNLQRLYEAGVPVPKPIAWR----RNVLVMEFIGGDGLPAPRLK-DVEPEEEEEFELYDDILEEMRKLYKEGELV 171 (237)
T ss_pred HHHHHHHHHHHHhcCCCCCeeeEec----CceEEEEEecCCcccccccc-cCCcchHHHHHHHHHHHHHHHHHHhcCCEE
Confidence 5689999999954 23455555432 358999999 6677665422 345667778899999999999999999 99
Q ss_pred ecCCCCCcEEEeecCCCCeEEEeecCcceeec
Q 013092 98 HRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 129 (449)
Q Consensus 98 HRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~ 129 (449)
||||||+||++. .+.++|+|||++....
T Consensus 172 H~Dikp~NIli~----~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 172 HGDLSEYNILVH----DGKVVIIDVSQSVELD 199 (237)
T ss_pred eCCCChhhEEEE----CCCEEEEEChhhhccC
Confidence 999999999993 6789999999987543
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.45 E-value=5.6e-13 Score=127.55 Aligned_cols=100 Identities=19% Similarity=0.264 Sum_probs=78.1
Q ss_pred hhHHHHHHHHHHHhcCCCCC--ceEEEEeEeC-C---EEEEEEecC-C-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHH
Q 013092 18 HPQLLYESKLYRILQGGTGI--PNVRWFGVEG-D---YNVLVMDLL-G-PSLEDLFNFCSRKLSLKTVLMLADQMINRVE 89 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~I--v~l~~~~~~~-~---~~~lVmE~~-g-~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~ 89 (449)
...+.+|+.++..| .+++| +..+.++... . ..+||||++ | .+|.+++.. ..++... +.|++.+|.
T Consensus 84 ~~r~~rE~~ll~~L-~~~gi~vP~pl~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~--~~l~~~~----~~~i~~~l~ 156 (239)
T PRK01723 84 RTRAFAEFRLLAQL-YEAGLPVPRPIAARVVRHGLFYRADILIERIEGARDLVALLQE--APLSEEQ----WQAIGQLIA 156 (239)
T ss_pred hhHHHHHHHHHHHH-HhCCCCCceeEeeeeeecCcceeeeEEEEecCCCCCHHHHHhc--CCCCHHH----HHHHHHHHH
Confidence 35688899999999 66664 6666654432 2 235999999 6 699999873 4566543 568999999
Q ss_pred HHHHCCceecCCCCCcEEEeecCCCCeEEEeecCccee
Q 013092 90 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 127 (449)
Q Consensus 90 yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~ 127 (449)
+||++||+||||||.|||+ +.++.++|+|||.+..
T Consensus 157 ~lH~~GI~HrDlkp~NILv---~~~~~v~LIDfg~~~~ 191 (239)
T PRK01723 157 RFHDAGVYHADLNAHNILL---DPDGKFWLIDFDRGEL 191 (239)
T ss_pred HHHHCCCCCCCCCchhEEE---cCCCCEEEEECCCccc
Confidence 9999999999999999999 4567899999998854
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.37 E-value=3.6e-12 Score=110.73 Aligned_cols=98 Identities=22% Similarity=0.353 Sum_probs=84.0
Q ss_pred hhHHHHHHHHHHHhcCC-CCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC-
Q 013092 18 HPQLLYESKLYRILQGG-TGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK- 94 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~h-p~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~- 94 (449)
...+..|+.+++.+.++ .+++.++.++...+..|++|||+ |..+..+ +......++.+++.+|++||..
T Consensus 35 ~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~ 106 (155)
T cd05120 35 GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLDEV--------SEEEKEDIAEQLAELLAKLHQLP 106 (155)
T ss_pred hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeecccC--------CHHHHHHHHHHHHHHHHHHhCCC
Confidence 45799999999999665 78999999888888999999999 6666543 5566777899999999999985
Q ss_pred --CceecCCCCCcEEEeecCCCCeEEEeecCcce
Q 013092 95 --SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 126 (449)
Q Consensus 95 --givHRDLKP~NiLl~~~~~~~~vkL~DFGla~ 126 (449)
+++|+||+|.||++. ..+.++++|||++.
T Consensus 107 ~~~i~H~Dl~~~Nil~~---~~~~~~l~Df~~~~ 137 (155)
T cd05120 107 LLVLCHGDLHPGNILVD---DGKILGIIDWEYAG 137 (155)
T ss_pred ceEEEecCCCcceEEEE---CCcEEEEEeccccc
Confidence 799999999999994 57889999999875
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.36 E-value=2.7e-12 Score=119.05 Aligned_cols=95 Identities=17% Similarity=0.243 Sum_probs=75.5
Q ss_pred HHHHHHHHHHhcCCC--CCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q 013092 21 LLYESKLYRILQGGT--GIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFL 97 (449)
Q Consensus 21 ~~~E~~il~~l~~hp--~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~giv 97 (449)
+..|..++..+ .++ .++.+++. ...++||||+ |++|.++... .....++.+++.++.++|+.||+
T Consensus 80 ~~~E~~~l~~l-~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh~~gi~ 147 (198)
T cd05144 80 AQKEFAALKAL-YEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAYKHGII 147 (198)
T ss_pred HHHHHHHHHHH-HHcCCCCCceeec----CCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHHHCCCC
Confidence 67889999998 555 45544442 3458999999 8888765431 34567889999999999999999
Q ss_pred ecCCCCCcEEEeecCCCCeEEEeecCcceeecC
Q 013092 98 HRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 130 (449)
Q Consensus 98 HRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~ 130 (449)
|+||||.||++ +.++.++|+|||++.....
T Consensus 148 H~Dl~p~Nill---~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 148 HGDLSEFNILV---DDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred cCCCCcccEEE---cCCCcEEEEECCccccCCC
Confidence 99999999999 5688999999999976544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.27 E-value=1.1e-12 Score=142.03 Aligned_cols=221 Identities=20% Similarity=0.159 Sum_probs=165.4
Q ss_pred CCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeec
Q 013092 33 GGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 111 (449)
Q Consensus 33 ~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~givHRDLKP~NiLl~~~ 111 (449)
.+|-++.....+......+|||+|+ +++|...+... ...+.+-+..+...+..+++|||...++|||++|.|+|+
T Consensus 862 ~~P~v~~~~~s~~~rsP~~L~~~~~~~~~~~Skl~~~-~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~--- 937 (1205)
T KOG0606|consen 862 RSPAVVRSFPSFPCRSPLPLVGHYLNGGDLPSKLHNS-GCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLI--- 937 (1205)
T ss_pred CCCceecccCCCCCCCCcchhhHHhccCCchhhhhcC-CCcccccccchhHHHHhhhhccccchhhcccccccchhh---
Confidence 3444554444556778899999999 88999988853 346777778888899999999999999999999999999
Q ss_pred CCCCeEEEeecCcceeecCC--------CC----------------CcccccccCCCCccCccccchhhhhCCCCChhhH
Q 013092 112 RRANQVYIIDFGLAKKYRDT--------ST----------------HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDD 167 (449)
Q Consensus 112 ~~~~~vkL~DFGla~~~~~~--------~~----------------~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~D 167 (449)
...+..++.|||+......- .. ......+......||+.|.+||...+......+|
T Consensus 938 ~~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad 1017 (1205)
T KOG0606|consen 938 AYDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAAD 1017 (1205)
T ss_pred cccCCcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcch
Confidence 58899999999854432211 00 0000112345578999999999999999999999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Q 013092 168 LESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRD 247 (449)
Q Consensus 168 iwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~L~~ 247 (449)
+|++|++++|.++|..||.. ....+.++.|....+..+ .-....+.+..+++...+..++.+|-.+.--
T Consensus 1018 ~~~~g~~l~e~l~g~pp~na---~tpq~~f~ni~~~~~~~p--~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~------ 1086 (1205)
T KOG0606|consen 1018 WWSSGVCLFEVLTGIPPFNA---ETPQQIFENILNRDIPWP--EGPEEGSYEAQDLINRLLTEEPTQRLGAKGA------ 1086 (1205)
T ss_pred hhhhhhhhhhhhcCCCCCCC---cchhhhhhccccCCCCCC--CCccccChhhhhhhhhhhccCchhccCcccc------
Confidence 99999999999999999976 445566666665554322 1223457789999999999999999764311
Q ss_pred HHHHcCCCCCCcccchhhhhhh
Q 013092 248 LFIREGFQFDYVFDWTILKYQQ 269 (449)
Q Consensus 248 ~~~~~~~~~~~~~dw~~~~~~~ 269 (449)
-...+..++...+|+.+..+.
T Consensus 1087 -~e~k~~~~~~~~~~~~l~~q~ 1107 (1205)
T KOG0606|consen 1087 -AEVKGHPFFQDVDWENLALQK 1107 (1205)
T ss_pred -cccccCCccCCCCcccccccc
Confidence 134677888999999886654
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.26 E-value=7.2e-12 Score=129.53 Aligned_cols=209 Identities=18% Similarity=0.144 Sum_probs=162.0
Q ss_pred HHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHH----HHHHHHHCCc
Q 013092 21 LLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMIN----RVEFVHSKSF 96 (449)
Q Consensus 21 ~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~----aL~yLH~~gi 96 (449)
-.+|+...+.+.-|++++..+..+..++..||-.|+|+.+|.+++.....-++...++.+..++.. ||.++|..++
T Consensus 164 k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfiqtE~~~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~ 243 (524)
T KOG0601|consen 164 KLREFLSHHKIDSHENPVRDSPAWEGSGILFIQTELCGESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNI 243 (524)
T ss_pred ccchhhcccccCccccccccCcccccCCcceeeeccccchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcc
Confidence 467888888888899999988899999999999999999999998765555788888999999998 9999999999
Q ss_pred eecCCCCCcEEEeecCCC-CeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHHH
Q 013092 97 LHRDIKPDNFLMGLGRRA-NQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVL 175 (449)
Q Consensus 97 vHRDLKP~NiLl~~~~~~-~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il 175 (449)
+|-|+||+||++. .+ ..+++.|||+...+.+...... +.......|...|++||+..+. ++..+|||+||.++
T Consensus 244 ~~~~~kp~~i~~~---~~~~s~~~~df~~v~~i~~~~~~~~--~~~~~r~~~~~~Y~~ke~~~~l-~~~~~di~sl~ev~ 317 (524)
T KOG0601|consen 244 VHDDLKPANIFTT---SDWTSCKLTDFGLVSKISDGNFSSV--FKVSKRPEGDCIYAAKELLNGL-ATFASDIFSLGEVI 317 (524)
T ss_pred cccccchhheecc---cccceeecCCcceeEEccCCccccc--eeeeecCCCCceEeChhhhccc-cchHhhhcchhhhh
Confidence 9999999999994 55 7899999999999887653321 1112233678899999998765 67899999999999
Q ss_pred HHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 013092 176 MYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 242 (449)
Q Consensus 176 ~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~ 242 (449)
.+-.++..++....... +..++. .....+++.+...++...+..+++.++-.|++.+.+.
T Consensus 318 l~~~l~~~~~~~g~~~~-W~~~r~------~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~ 377 (524)
T KOG0601|consen 318 LEAILGSHLPSVGKNSS-WSQLRQ------GYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILT 377 (524)
T ss_pred HhhHhhcccccCCCCCC-cccccc------ccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHh
Confidence 99988876665432111 111111 1123356667777888899999998888888766543
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.24 E-value=4.2e-11 Score=109.50 Aligned_cols=98 Identities=22% Similarity=0.279 Sum_probs=70.7
Q ss_pred HHHHHHHHHhcCC-CCCceEEEEeEeCCEEEEEEecC-CCCHH-HHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-CCce
Q 013092 22 LYESKLYRILQGG-TGIPNVRWFGVEGDYNVLVMDLL-GPSLE-DLFNFCSRKLSLKTVLMLADQMINRVEFVHS-KSFL 97 (449)
Q Consensus 22 ~~E~~il~~l~~h-p~Iv~l~~~~~~~~~~~lVmE~~-g~sL~-~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~-~giv 97 (449)
..|...+..+.++ -.++..+.+. ..+|||||+ |+.+. ..+.... .. ..+..++.+++.++.++|. .||+
T Consensus 65 ~~e~~~l~~l~~~~~~~~~~~~~~----~~~lv~e~~~g~~~~~~~l~~~~--~~-~~~~~~~~~~~~~l~~lh~~~~iv 137 (187)
T cd05119 65 EKEFRNLKRLYEAGVPVPKPIDLN----RHVLVMEFIGGDGIPAPRLKDVR--LL-EDPEELYDQILELMRKLYREAGLV 137 (187)
T ss_pred HHHHHHHHHHHHcCCCCCceEecC----CCEEEEEEeCCCCccChhhhhhh--hc-ccHHHHHHHHHHHHHHHhhccCcC
Confidence 4677777777333 2355555442 369999999 53322 2222111 11 6678899999999999999 9999
Q ss_pred ecCCCCCcEEEeecCCCCeEEEeecCcceeecC
Q 013092 98 HRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 130 (449)
Q Consensus 98 HRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~ 130 (449)
|+||||+||+++ ++.++|+|||.+.....
T Consensus 138 H~Dl~p~Nili~----~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 138 HGDLSEYNILVD----DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred cCCCChhhEEEE----CCcEEEEECcccccccC
Confidence 999999999993 78899999999975544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.17 E-value=1.2e-10 Score=107.50 Aligned_cols=97 Identities=20% Similarity=0.263 Sum_probs=75.6
Q ss_pred HHHHHHHHhcCC-CCCceEEEEeEeCCEEEEEEecCCCC-H-HHHHHHcCCCCCHHHHHHHHHHHHHHHHHH-HHCCcee
Q 013092 23 YESKLYRILQGG-TGIPNVRWFGVEGDYNVLVMDLLGPS-L-EDLFNFCSRKLSLKTVLMLADQMINRVEFV-HSKSFLH 98 (449)
Q Consensus 23 ~E~~il~~l~~h-p~Iv~l~~~~~~~~~~~lVmE~~g~s-L-~~ll~~~~~~ls~~~~~~i~~qi~~aL~yL-H~~givH 98 (449)
+|.+.|+++... -.+|.++++ ...+|||||+|++ + ...++ +..++.+.+..+..+++.+|..| |+.||||
T Consensus 75 kE~r~L~rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk--d~~~~~~~~~~i~~~i~~~l~~l~H~~glVH 148 (197)
T cd05146 75 KEMHNLKRMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK--DAKLNDEEMKNAYYQVLSMMKQLYKECNLVH 148 (197)
T ss_pred HHHHHHHHHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh--ccccCHHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 899999998643 577887765 5688999999543 3 12233 23456667778889999999999 8999999
Q ss_pred cCCCCCcEEEeecCCCCeEEEeecCcceeec
Q 013092 99 RDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 129 (449)
Q Consensus 99 RDLKP~NiLl~~~~~~~~vkL~DFGla~~~~ 129 (449)
+||++.|||+. ++.++|+|||.+....
T Consensus 149 GDLs~~NIL~~----~~~v~iIDF~qav~~~ 175 (197)
T cd05146 149 ADLSEYNMLWH----DGKVWFIDVSQSVEPT 175 (197)
T ss_pred CCCCHHHEEEE----CCcEEEEECCCceeCC
Confidence 99999999993 4679999999887543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.11 E-value=6.2e-10 Score=100.32 Aligned_cols=93 Identities=24% Similarity=0.437 Sum_probs=75.1
Q ss_pred HHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q 013092 21 LLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHR 99 (449)
Q Consensus 21 ~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~givHR 99 (449)
-.+|++++..+ ..-+|+.-..+..+.....|+|||+ |..|.+++... . ..++..+-.-+.-||..||+|+
T Consensus 46 t~~Earil~~a-~~~GV~~P~v~dvD~~~~~I~me~I~G~~lkd~l~~~----~----~~~~r~vG~~vg~lH~~givHG 116 (204)
T COG3642 46 TRREARILAKA-REAGVPVPIVYDVDPDNGLIVMEYIEGELLKDALEEA----R----PDLLREVGRLVGKLHKAGIVHG 116 (204)
T ss_pred HHHHHHHHHHH-HHcCCCCCeEEEEcCCCCEEEEEEeCChhHHHHHHhc----c----hHHHHHHHHHHHHHHhcCeecC
Confidence 46799999998 4447777777777888889999999 77888888742 2 3455566666778999999999
Q ss_pred CCCCCcEEEeecCCCCeEEEeecCcce
Q 013092 100 DIKPDNFLMGLGRRANQVYIIDFGLAK 126 (449)
Q Consensus 100 DLKP~NiLl~~~~~~~~vkL~DFGla~ 126 (449)
||.+.||+++ ++.++++||||+.
T Consensus 117 DLTtsNiIl~----~~~i~~IDfGLg~ 139 (204)
T COG3642 117 DLTTSNIILS----GGRIYFIDFGLGE 139 (204)
T ss_pred CCccceEEEe----CCcEEEEECCccc
Confidence 9999999993 4559999999986
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.09 E-value=4.1e-10 Score=101.00 Aligned_cols=105 Identities=18% Similarity=0.279 Sum_probs=76.2
Q ss_pred EEeeecccCC-ChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHH
Q 013092 7 VFSVQENVKT-KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQM 84 (449)
Q Consensus 7 V~~k~~~~~~-~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi 84 (449)
+++|...... ....+..|+++++.+.+...++.+++++. ...++||||+ |.++.+. . . ....++.++
T Consensus 24 ~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l~~~-~-----~---~~~~~~~~l 92 (170)
T cd05151 24 YVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSELLTE-D-----F---SDPENLEKI 92 (170)
T ss_pred EEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCccccc-c-----c---cCHHHHHHH
Confidence 4445443322 23457899999999966555677776653 3358999999 7776543 1 1 113456789
Q ss_pred HHHHHHHHHCCc-----eecCCCCCcEEEeecCCCCeEEEeecCcce
Q 013092 85 INRVEFVHSKSF-----LHRDIKPDNFLMGLGRRANQVYIIDFGLAK 126 (449)
Q Consensus 85 ~~aL~yLH~~gi-----vHRDLKP~NiLl~~~~~~~~vkL~DFGla~ 126 (449)
+.+|+.||..++ +|+|++|.||++. ++.++|+||+.+.
T Consensus 93 ~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~----~~~~~liDf~~a~ 135 (170)
T cd05151 93 AKLLKKLHSSPLPDLVPCHNDLLPGNFLLD----DGRLWLIDWEYAG 135 (170)
T ss_pred HHHHHHHhCCCCCCceeecCCCCcCcEEEE----CCeEEEEeccccc
Confidence 999999999885 9999999999993 5679999999874
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=98.99 E-value=1.2e-09 Score=113.59 Aligned_cols=104 Identities=21% Similarity=0.336 Sum_probs=73.7
Q ss_pred HHHHHHHHHHhc----CCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHH-HHHHHHHC
Q 013092 21 LLYESKLYRILQ----GGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMIN-RVEFVHSK 94 (449)
Q Consensus 21 ~~~E~~il~~l~----~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~-aL~yLH~~ 94 (449)
|.+|.+.+.++. ++++|.....+.......+|||||+ |.+|.++.......+. ...++.+++. .+..+|..
T Consensus 200 f~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~ 276 (437)
T TIGR01982 200 LRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRD 276 (437)
T ss_pred HHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhC
Confidence 566777777764 4455433333333344579999999 9999888753222232 2345555555 47889999
Q ss_pred CceecCCCCCcEEEeecCCCCeEEEeecCcceeecC
Q 013092 95 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 130 (449)
Q Consensus 95 givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~ 130 (449)
|++|+|+||.||++ ..++.++|+|||++..+..
T Consensus 277 g~~H~D~hPgNilv---~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 277 GFFHADLHPGNIFV---LKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred CceeCCCCcccEEE---CCCCcEEEEeCCCeeECCH
Confidence 99999999999999 5778999999999987653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.98 E-value=8.9e-09 Score=108.07 Aligned_cols=146 Identities=16% Similarity=0.132 Sum_probs=112.6
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH-HCCc
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH-SKSF 96 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH-~~gi 96 (449)
....++-++-|+.| .||+|..++...+..+..|||+|-+-+ |..+++. +....+..-+.||+.||.+|| ++++
T Consensus 53 ~~~~~~A~k~lKtl-RHP~Il~yL~t~e~~~~~ylvTErV~P-l~~~lk~----l~~~~v~~Gl~qIl~AL~FL~~d~~l 126 (690)
T KOG1243|consen 53 TELAKRAVKRLKTL-RHPNILSYLDTTEEEGTLYLVTERVRP-LETVLKE----LGKEEVCLGLFQILAALSFLNDDCNL 126 (690)
T ss_pred hHHHHHHHHHhhhc-cCchhhhhhhhhcccCceEEEeecccc-HHHHHHH----hHHHHHHHHHHHHHHHHHHHhccCCe
Confidence 45577888889999 999999999999999999999999942 5666664 346677788999999999998 6789
Q ss_pred eecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHHHH
Q 013092 97 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLM 176 (449)
Q Consensus 97 vHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il~ 176 (449)
+|++|.-..|++ +..|..||.+|-++......... .....--..|..|+.+...+ ...|.|-|||+++
T Consensus 127 vHgNv~~~SVfV---n~~GeWkLggle~v~~~~~~~~~-------~~~~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~ 194 (690)
T KOG1243|consen 127 VHGNVCKDSVFV---NESGEWKLGGLELVSKASGFNAP-------AKSLYLIESFDDPEEIDPSE--WSIDSWGLGCLIE 194 (690)
T ss_pred eeccEeeeeEEE---cCCCcEEEeeeEEEeccccCCcc-------cccchhhhcccChhhcCccc--cchhhhhHHHHHH
Confidence 999999999999 69999999999888655432210 01111223455565544332 3469999999999
Q ss_pred HHHhC
Q 013092 177 YFLRG 181 (449)
Q Consensus 177 elltG 181 (449)
+++.|
T Consensus 195 el~ng 199 (690)
T KOG1243|consen 195 ELFNG 199 (690)
T ss_pred HHhCc
Confidence 99999
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.96 E-value=1.1e-09 Score=105.97 Aligned_cols=193 Identities=11% Similarity=0.136 Sum_probs=127.5
Q ss_pred CCCCCceEEEEeEeC-----CEEEEEEecC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCC
Q 013092 33 GGTGIPNVRWFGVEG-----DYNVLVMDLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSKS--FLHRDI 101 (449)
Q Consensus 33 ~hp~Iv~l~~~~~~~-----~~~~lVmE~~-g~sL~~ll~~~---~~~ls~~~~~~i~~qi~~aL~yLH~~g--ivHRDL 101 (449)
.|.|||+++-++.+. ....++.||+ -++|.+++++. ...+....-.+|+.||+.||.|||+.. |+|+++
T Consensus 125 vHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppiihgnl 204 (458)
T KOG1266|consen 125 VHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNL 204 (458)
T ss_pred HHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCc
Confidence 677899986665543 3578899999 99999998743 455778888899999999999999875 999999
Q ss_pred CCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHHHHHHHhC
Q 013092 102 KPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRG 181 (449)
Q Consensus 102 KP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il~elltG 181 (449)
..+-|++ ..++.||+.--.-. .... .. ....-.+.....+-+.|.+||.=.....+..+|||+||....+|..+
T Consensus 205 Tc~tifi---q~ngLIkig~~ap~-s~h~-s~-~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemail 278 (458)
T KOG1266|consen 205 TCDTIFI---QHNGLIKIGSVAPD-STHP-SV-NSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAIL 278 (458)
T ss_pred chhheee---cCCceEEecccCcc-ccch-hh-hhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHh
Confidence 9999999 57776666421100 0000 00 00000112234567889999987766777889999999999999887
Q ss_pred CCCCCCC-CcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 013092 182 SLPWQGL-KAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 242 (449)
Q Consensus 182 ~~Pf~~~-~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~ 242 (449)
..--... ...... +.+..... -+. ..--+.++..|++-.|+.||++..+.
T Consensus 279 Eiq~tnseS~~~~e---e~ia~~i~-----~le---n~lqr~~i~kcl~~eP~~rp~ar~ll 329 (458)
T KOG1266|consen 279 EIQSTNSESKVEVE---ENIANVII-----GLE---NGLQRGSITKCLEGEPNGRPDARLLL 329 (458)
T ss_pred eeccCCCcceeehh---hhhhhhee-----ecc---CccccCcCcccccCCCCCCcchhhhh
Confidence 6532221 111111 11111100 000 11235688899999999999987653
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.96 E-value=6.9e-09 Score=93.33 Aligned_cols=106 Identities=19% Similarity=0.271 Sum_probs=83.4
Q ss_pred HHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecCCC--CHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q 013092 21 LLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGP--SLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFL 97 (449)
Q Consensus 21 ~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~g~--sL~~ll~~~-~~~ls~~~~~~i~~qi~~aL~yLH~~giv 97 (449)
.+.|+++|.++ .--+|..-..++.+....+|+|||+.| ++.+++... ...........++.+|-..|.-||..+|+
T Consensus 57 t~~Ear~l~k~-~~~GI~~P~l~~~D~~~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndii 135 (229)
T KOG3087|consen 57 TKQEARLLAKC-RALGIPAPRLIFIDTYGGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDII 135 (229)
T ss_pred HHHHHHHHHHH-HHhCCCCceEEEEecCCCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCee
Confidence 47799999998 444777777777888888999999944 888887643 22233333367888899999999999999
Q ss_pred ecCCCCCcEEEeecCCCCeEEEeecCccee
Q 013092 98 HRDIKPDNFLMGLGRRANQVYIIDFGLAKK 127 (449)
Q Consensus 98 HRDLKP~NiLl~~~~~~~~vkL~DFGla~~ 127 (449)
|+||...||++..+.....+.++|||+...
T Consensus 136 HGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 136 HGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred cccccccceEEecCCCcCceEEEeecchhc
Confidence 999999999997555555679999999753
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.93 E-value=1.4e-08 Score=98.63 Aligned_cols=107 Identities=21% Similarity=0.191 Sum_probs=81.5
Q ss_pred HHHHHHHHHHHhcC-CCCCceEEEEeEe-----CCEEEEEEecC-CC-CHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHH
Q 013092 20 QLLYESKLYRILQG-GTGIPNVRWFGVE-----GDYNVLVMDLL-GP-SLEDLFNFC-SRKLSLKTVLMLADQMINRVEF 90 (449)
Q Consensus 20 ~~~~E~~il~~l~~-hp~Iv~l~~~~~~-----~~~~~lVmE~~-g~-sL~~ll~~~-~~~ls~~~~~~i~~qi~~aL~y 90 (449)
.+.+|...+.+|.. .-.++.+..+++. ....|||||++ +. +|.+++... ....+......++.+++..+.-
T Consensus 74 ~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~ 153 (268)
T PRK15123 74 GADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRD 153 (268)
T ss_pred HHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHH
Confidence 37899999988842 2233344555543 23578999999 54 799998643 3446667788999999999999
Q ss_pred HHHCCceecCCCCCcEEEee----cCCCCeEEEeecCcce
Q 013092 91 VHSKSFLHRDIKPDNFLMGL----GRRANQVYIIDFGLAK 126 (449)
Q Consensus 91 LH~~givHRDLKP~NiLl~~----~~~~~~vkL~DFGla~ 126 (449)
||..||+|+|+++.|||+.. +.....++|+||+.+.
T Consensus 154 LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 154 MHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred HHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 99999999999999999953 1235789999999875
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.81 E-value=6.8e-08 Score=90.35 Aligned_cols=110 Identities=20% Similarity=0.304 Sum_probs=85.1
Q ss_pred ChhHHHHHHHHHHHhcC-CCCCceEEEEeEeC----CEEEEEEecC-C-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHH
Q 013092 17 KHPQLLYESKLYRILQG-GTGIPNVRWFGVEG----DYNVLVMDLL-G-PSLEDLFNFCSRKLSLKTVLMLADQMINRVE 89 (449)
Q Consensus 17 ~~~~~~~E~~il~~l~~-hp~Iv~l~~~~~~~----~~~~lVmE~~-g-~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~ 89 (449)
......+|...+..|.. .=.++....+++.. ...+||||++ + .+|.+++.... .++......++.+++..+.
T Consensus 54 ~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~-~~~~~~~~~ll~~l~~~i~ 132 (206)
T PF06293_consen 54 RRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE-QLDPSQRRELLRALARLIA 132 (206)
T ss_pred cchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc-ccchhhHHHHHHHHHHHHH
Confidence 44568899999888842 23355666666652 2458999999 5 48999988532 2667778899999999999
Q ss_pred HHHHCCceecCCCCCcEEEeecCCCCeEEEeecCccee
Q 013092 90 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 127 (449)
Q Consensus 90 yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~ 127 (449)
-||..||+|+|+++.|||+..++....+.|+||+.++.
T Consensus 133 ~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 133 KLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 99999999999999999995433344899999998764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.79 E-value=9.4e-08 Score=95.61 Aligned_cols=192 Identities=13% Similarity=0.196 Sum_probs=129.9
Q ss_pred eCCEEEEEEecC-CC-CHHHHHHHc--C---CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEE
Q 013092 46 EGDYNVLVMDLL-GP-SLEDLFNFC--S---RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVY 118 (449)
Q Consensus 46 ~~~~~~lVmE~~-g~-sL~~ll~~~--~---~~ls~~~~~~i~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vk 118 (449)
.+...-+.|+.+ |. -+..+++-. . ..+.|+.++..+..++.+.+.||..|.+-+|+.++|||++ ++..|.
T Consensus 81 ~~~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVs---d~~~V~ 157 (637)
T COG4248 81 RGKVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVS---DDSKVV 157 (637)
T ss_pred ccceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeee---cCceEE
Confidence 344477899998 54 344444311 1 1278999999999999999999999999999999999995 778899
Q ss_pred EeecCcceeecCCCCCcccccccCCCCccCccccchhhhh-----CCCCChhhHHHHHHHHHHHHHhC-CCCCCCCCcC-
Q 013092 119 IIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHL-----GIEQSRRDDLESLGYVLMYFLRG-SLPWQGLKAG- 191 (449)
Q Consensus 119 L~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~-----~~~~s~~~DiwSlG~il~elltG-~~Pf~~~~~~- 191 (449)
|+|-.......+ .+. .-..+|.+.|.+||.-. +.+-+...|.|.||++++++|.| ++||.+....
T Consensus 158 LVdsDsfqi~~n-g~~-------~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~ 229 (637)
T COG4248 158 LVDSDSFQINAN-GTL-------HLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLIS 229 (637)
T ss_pred EEcccceeeccC-Cce-------EecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccC
Confidence 987554433322 211 12347899999999754 45567889999999999999985 9999986421
Q ss_pred ---CHHH-HHH-------HHHh-hcccchHHHhhcCCcHHHHHHHHHHhcC--CCCCCCCHHHHHHHHHHH
Q 013092 192 ---TKKQ-KYE-------KISE-KKVSTSIEALCRGYPTEFASYFHYCRSL--RFDDKPDYAYLKRIFRDL 248 (449)
Q Consensus 192 ---~~~~-~~~-------~i~~-~~~~~~~~~l~~~~p~el~~li~~cl~~--~p~~RPt~~~l~~~L~~~ 248 (449)
...+ .+. +-.. ...+++...-+.-+|+.+..++..|+.. .+.-||+.+.....|..+
T Consensus 230 ~ap~p~E~~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al 300 (637)
T COG4248 230 DAPNPLETDIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDAL 300 (637)
T ss_pred CCCCcchhhhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHH
Confidence 1111 000 0000 1111122112234689999999999975 356899987766555443
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.75 E-value=1.2e-08 Score=93.88 Aligned_cols=99 Identities=24% Similarity=0.322 Sum_probs=64.8
Q ss_pred HHHHHHHHHHhcCC-CCCceEEEEeEeCCEEEEEEecCC--CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHH-HHHCCc
Q 013092 21 LLYESKLYRILQGG-TGIPNVRWFGVEGDYNVLVMDLLG--PSLEDLFNFCSRKLSLKTVLMLADQMINRVEF-VHSKSF 96 (449)
Q Consensus 21 ~~~E~~il~~l~~h-p~Iv~l~~~~~~~~~~~lVmE~~g--~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~y-LH~~gi 96 (449)
..+|.++|.++... -++|.++++. ..+|||||++ |.....+.. ..++.+....++.+++..+.. +|..||
T Consensus 55 ~~~E~~~L~~l~~~Gv~vP~p~~~~----~~~ivME~I~~~G~~~~~l~~--~~~~~~~~~~~~~~il~~~~~~~~~~gi 128 (188)
T PF01163_consen 55 AKKEFRNLKRLYEAGVPVPKPYDYN----RNVIVMEYIGEDGVPLPRLKD--VDLSPEEPKELLEEILEEIIKMLHKAGI 128 (188)
T ss_dssp HHHHHHHHHHCCCTT-SS--EEEEE----TTEEEEE--EETTEEGGCHHH--CGGGGSTHHHHHHHHHHHHHHHHHCTTE
T ss_pred HHHHHHHHHHHHHCCccCCcEEEEe----CCEEEEEecCCCccchhhHHh--ccccchhHHHHHHHHHHHHHHHHHhcCc
Confidence 57899999999544 3678877553 4579999996 543333332 122244556677788885555 579999
Q ss_pred eecCCCCCcEEEeecCCCCeEEEeecCcceeec
Q 013092 97 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 129 (449)
Q Consensus 97 vHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~ 129 (449)
+|+||.+.|||+. .+.++|+|||.+....
T Consensus 129 vHGDLs~~NIlv~----~~~~~iIDf~qav~~~ 157 (188)
T PF01163_consen 129 VHGDLSEYNILVD----DGKVYIIDFGQAVDSS 157 (188)
T ss_dssp EESS-STTSEEEE----TTCEEE--GTTEEETT
T ss_pred eecCCChhhEEee----cceEEEEecCcceecC
Confidence 9999999999994 3489999999887543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.63 E-value=1.6e-07 Score=87.62 Aligned_cols=104 Identities=24% Similarity=0.328 Sum_probs=77.5
Q ss_pred hhHHHHHHHHHHHhcCC-CCCceEEEEeEeC---CEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH
Q 013092 18 HPQLLYESKLYRILQGG-TGIPNVRWFGVEG---DYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 92 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~h-p~Iv~l~~~~~~~---~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH 92 (449)
...+..|++++..+..+ ..+++++.+.... +..|+||||+ |.+|.+.+. ...++......++.+++.+|..||
T Consensus 39 ~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~G~~l~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH 116 (223)
T cd05154 39 AHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVDGRVLRDRLL--RPELSPEERRALARALADTLAALH 116 (223)
T ss_pred cccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeCCEecCCCCC--CCCCCHHHHHHHHHHHHHHHHHHh
Confidence 45789999999999653 3467787777654 3678999999 777766543 134666666777777777777777
Q ss_pred H--------------------------------------------------------CCceecCCCCCcEEEeecCC--C
Q 013092 93 S--------------------------------------------------------KSFLHRDIKPDNFLMGLGRR--A 114 (449)
Q Consensus 93 ~--------------------------------------------------------~givHRDLKP~NiLl~~~~~--~ 114 (449)
+ ..++|+|+.|.||+++ . .
T Consensus 117 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~---~~~~ 193 (223)
T cd05154 117 SVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFH---PDEP 193 (223)
T ss_pred CCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEc---CCCC
Confidence 3 2469999999999994 4 4
Q ss_pred CeEEEeecCcce
Q 013092 115 NQVYIIDFGLAK 126 (449)
Q Consensus 115 ~~vkL~DFGla~ 126 (449)
+.+.|+||+.+.
T Consensus 194 ~~~~iID~e~~~ 205 (223)
T cd05154 194 RVVAVLDWELAT 205 (223)
T ss_pred cEEEEEeccccc
Confidence 668999998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=98.61 E-value=1.7e-07 Score=99.17 Aligned_cols=98 Identities=23% Similarity=0.405 Sum_probs=63.0
Q ss_pred HHHHHHHHHHhc----CCCC--CceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCC-----CCHHHHHHHHHHHHHHH
Q 013092 21 LLYESKLYRILQ----GGTG--IPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRK-----LSLKTVLMLADQMINRV 88 (449)
Q Consensus 21 ~~~E~~il~~l~----~hp~--Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~-----ls~~~~~~i~~qi~~aL 88 (449)
|.+|+..+.++. +.+. |+.+++- -....+|||||+ |+.|.++-...... +....+..++.|
T Consensus 203 ~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d--~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q----- 275 (537)
T PRK04750 203 LMREAANASQLRRNFEDSDMLYVPEVYWD--YCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ----- 275 (537)
T ss_pred HHHHHHHHHHHHHHccCCCCeecceeecc--cCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH-----
Confidence 455666665553 2232 3333332 245689999999 99998753211122 333333334444
Q ss_pred HHHHHCCceecCCCCCcEEEeecCCCC----eEEEeecCcceeecC
Q 013092 89 EFVHSKSFLHRDIKPDNFLMGLGRRAN----QVYIIDFGLAKKYRD 130 (449)
Q Consensus 89 ~yLH~~givHRDLKP~NiLl~~~~~~~----~vkL~DFGla~~~~~ 130 (449)
++..||+|+|+||.||++. .++ .++++|||++..+..
T Consensus 276 --if~~GffHaDpHPGNIlv~---~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 276 --VFRDGFFHADMHPGNIFVS---YDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred --HHhCCeeeCCCChHHeEEe---cCCCCCCeEEEEecceEEECCH
Confidence 4468999999999999994 444 899999999987654
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.61 E-value=1.3e-08 Score=105.58 Aligned_cols=196 Identities=19% Similarity=0.136 Sum_probs=139.6
Q ss_pred HHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecC
Q 013092 22 LYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRD 100 (449)
Q Consensus 22 ~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~givHRD 100 (449)
..|+.+...+.-|.+++.....+......||--||| ++++..-+. ....+.+...+.+..|++.++.++|++.++|+|
T Consensus 313 l~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~~~s~~l~~~-~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d 391 (524)
T KOG0601|consen 313 LGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCEGGSSSLRSV-TSQMLDEDPRLRLTAQILTALNVIHSKLFVHLD 391 (524)
T ss_pred hhhhhHhhHhhcccccCCCCCCccccccccCchhhhcCcchhhhhH-HHHhcCcchhhhhHHHHHhccccccchhhhccc
Confidence 467777777878888888777777777788999999 777665542 345688889999999999999999999999999
Q ss_pred CCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCcccc--chhhhhCCCCChhhHHHHHHHHHHHH
Q 013092 101 IKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA--SMNTHLGIEQSRRDDLESLGYVLMYF 178 (449)
Q Consensus 101 LKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~--aPE~~~~~~~s~~~DiwSlG~il~el 178 (449)
+||.||++.. .++..++.|||++..+.-.. ....+.-+++ ++......++..+.|+++||..+.+.
T Consensus 392 ~~psni~i~~--~~~~~~~~~~~~~t~~~~~~----------~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~ 459 (524)
T KOG0601|consen 392 VKPSNILISN--DGFFSKLGDFGCWTRLAFSS----------GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEA 459 (524)
T ss_pred ccccceeecc--chhhhhccccccccccceec----------ccccccccccccchhhcccccccccccccccccccccc
Confidence 9999999952 12788999999986532211 1223333444 55555567788899999999999999
Q ss_pred HhCCC-CCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 013092 179 LRGSL-PWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 242 (449)
Q Consensus 179 ltG~~-Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~ 242 (449)
+++.. ++.+.. ...|...... ...+...++..+.+.+...++..||.+.++.
T Consensus 460 ~~~~~ls~~~~~-------~~~i~~~~~p-----~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~ 512 (524)
T KOG0601|consen 460 ITGSPLSESGVQ-------SLTIRSGDTP-----NLPGLKLQLQVLLKVMINPDRKRRPSAVELS 512 (524)
T ss_pred ccCcccCccccc-------ceeeeccccc-----CCCchHHhhhhhhhhhcCCccccchhhhhhc
Confidence 98753 333211 1112222111 1123346788888888889999888765543
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.57 E-value=4e-06 Score=86.10 Aligned_cols=177 Identities=19% Similarity=0.249 Sum_probs=126.3
Q ss_pred HHHHHHHHHhcCCCCCceEEEEeE----eCCEEEEEEecC--CCCHHHHHHHc--------------CCCCCHHHHHHHH
Q 013092 22 LYESKLYRILQGGTGIPNVRWFGV----EGDYNVLVMDLL--GPSLEDLFNFC--------------SRKLSLKTVLMLA 81 (449)
Q Consensus 22 ~~E~~il~~l~~hp~Iv~l~~~~~----~~~~~~lVmE~~--g~sL~~ll~~~--------------~~~ls~~~~~~i~ 81 (449)
..=+++++++ -|+|||++...+. .+..+++|++|+ .++|.++.-.. +.+.++..+|.++
T Consensus 321 t~lve~wkkl-~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~ 399 (655)
T KOG3741|consen 321 TSLVEAWKKL-CHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYI 399 (655)
T ss_pred hHHHHHHHHh-ccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHH
Confidence 4456778888 9999999988776 345689999999 67898875211 2246789999999
Q ss_pred HHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCC
Q 013092 82 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIE 161 (449)
Q Consensus 82 ~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~ 161 (449)
.|+..||.++|+.|+.-+-|.|.+||+ ....+++|+-.|..-....+.+ +.+.
T Consensus 400 ~QLtaaL~sIHssGLAck~L~~~kIlv---~G~~RIriS~C~i~Dvl~~d~~---------------------~~le--- 452 (655)
T KOG3741|consen 400 SQLTAALYSIHSSGLACKTLDLKKILV---TGKMRIRISGCGIMDVLQEDPT---------------------EPLE--- 452 (655)
T ss_pred HHHHHHHHHHHhcCceeecccHhHeEe---eCcceEEEecccceeeecCCCC---------------------cchh---
Confidence 999999999999999999999999999 4555899988887654433221 1111
Q ss_pred CChhhHHHHHHHHHHHHHhCCCC-CCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHH
Q 013092 162 QSRRDDLESLGYVLMYFLRGSLP-WQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAY 240 (449)
Q Consensus 162 ~s~~~DiwSlG~il~elltG~~P-f~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~ 240 (449)
.-.+.|.-.||.+++.|.+|..- |.. +..+.+ .++.+...++.++++++.+.....+++ -+..+
T Consensus 453 ~~Qq~D~~~lG~ll~aLAt~~~ns~~~----d~~~~s----------~~~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~ 517 (655)
T KOG3741|consen 453 SQQQNDLRDLGLLLLALATGTENSNRT----DSTQSS----------HLTRITTTYSTDLRNVVEYLESLNFRE-KSIQD 517 (655)
T ss_pred HHhhhhHHHHHHHHHHHhhcccccccc----cchHHH----------HHHHhhhhhhHHHHHHHHHHHhcCccc-ccHHH
Confidence 12367999999999999998543 221 111111 112233457788888888888888886 33444
Q ss_pred H
Q 013092 241 L 241 (449)
Q Consensus 241 l 241 (449)
|
T Consensus 518 l 518 (655)
T KOG3741|consen 518 L 518 (655)
T ss_pred H
Confidence 3
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.53 E-value=4.1e-08 Score=103.55 Aligned_cols=163 Identities=12% Similarity=0.163 Sum_probs=111.5
Q ss_pred CHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCC--CCccCc
Q 013092 73 SLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENK--NLTGTA 149 (449)
Q Consensus 73 s~~~~~~i~~qi~~aL~yLH~-~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~--~~~gT~ 149 (449)
.-+....=+.+++.||.|+|. .++||+.|.|++|.+ +..+.+||+.|+.+..........-..|...- -..-..
T Consensus 97 aTe~~f~nl~~v~dgl~flh~sAk~VH~ni~p~~i~~---na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~ 173 (700)
T KOG2137|consen 97 ATEDGFANLGNVADGLAFLHRSAKVVHGNIQPEAIVV---NANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHL 173 (700)
T ss_pred cccHhhhhhhcccchhhhhccCcceeecccchhheee---ccCcceeeccchhhhccCCCCccccccCCCCCChhhccCc
Confidence 344444556777899999996 589999999999999 68899999999988765442211111111111 123446
Q ss_pred cccchhhhhCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHh
Q 013092 150 RYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCR 228 (449)
Q Consensus 150 ~Y~aPE~~~~~~~s~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl 228 (449)
.|.|||++.+.-.+..+|+|||||++|.+.. |+.-+..... .. +.................++|+|+.+=+.+++
T Consensus 174 ~f~apE~~~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~-~~---~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l 249 (700)
T KOG2137|consen 174 NFLAPEYLLGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGG-LL---SYSFSRNLLNAGAFGYSNNLPSELRESLKKLL 249 (700)
T ss_pred ccccchhhccccccccccceeeeeEEEEEecCCcchhhccCC-cc---hhhhhhcccccccccccccCcHHHHHHHHHHh
Confidence 8999999999888999999999999999884 5555543221 11 11122222222222233678999999999999
Q ss_pred cCCCCCCCCHHHHH
Q 013092 229 SLRFDDKPDYAYLK 242 (449)
Q Consensus 229 ~~~p~~RPt~~~l~ 242 (449)
..+...||++..+.
T Consensus 250 ~~~~~~rp~~~~l~ 263 (700)
T KOG2137|consen 250 NGDSAVRPTLDLLL 263 (700)
T ss_pred cCCcccCcchhhhh
Confidence 99999999765553
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.47 E-value=1.7e-06 Score=80.51 Aligned_cols=108 Identities=13% Similarity=0.122 Sum_probs=82.3
Q ss_pred ChhHHHHHHHHHHHhc--CCCCCceEEEEeEeC----CEEEEEEecCC--CCHHHHHHHc-CCCCCHHHHHHHHHHHHHH
Q 013092 17 KHPQLLYESKLYRILQ--GGTGIPNVRWFGVEG----DYNVLVMDLLG--PSLEDLFNFC-SRKLSLKTVLMLADQMINR 87 (449)
Q Consensus 17 ~~~~~~~E~~il~~l~--~hp~Iv~l~~~~~~~----~~~~lVmE~~g--~sL~~ll~~~-~~~ls~~~~~~i~~qi~~a 87 (449)
..+.|.+|...+.+|. +-| ++.+..+.... -..+||+|-++ .+|.+++... -.+.+......++.+|+..
T Consensus 62 g~ptf~rE~~~L~~L~~~GvP-VP~pvf~~~~k~~~~~rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ 140 (216)
T PRK09902 62 GRPTIVREVAVIKELERAGVI-VPKIVFGEAVKIEGEWRALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALA 140 (216)
T ss_pred CchHHHHHHHHHHHHHHcCCC-CCccceeeeeccCCceEEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHH
Confidence 4677999999999985 334 66666444332 24689999885 7999988642 1245777778999999999
Q ss_pred HHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcce
Q 013092 88 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 126 (449)
Q Consensus 88 L~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~ 126 (449)
|.-||+.|+.|+|+-+.|||+..+ ....|+++||--++
T Consensus 141 ia~LH~~Gv~Hgdly~khIll~~~-g~~~v~lIDlEk~r 178 (216)
T PRK09902 141 FKKMHSVNRQHGCCYVRHIYVKTE-GKAEAGFLDLEKSR 178 (216)
T ss_pred HHHHHHCCCcCCCCCHhheeecCC-CCeeEEEEEhhccc
Confidence 999999999999999999999421 12349999997654
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.20 E-value=7.9e-06 Score=76.48 Aligned_cols=66 Identities=30% Similarity=0.541 Sum_probs=52.2
Q ss_pred CEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcce
Q 013092 48 DYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 126 (449)
Q Consensus 48 ~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~ 126 (449)
...+|||||+ |..|.++.. ++. .+...+..+|.-||+.|++|+|+.|.||++. ++.++++||+..+
T Consensus 116 ~~~~ll~EYIeG~~l~d~~~-----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~----~~~i~iID~~~k~ 182 (229)
T PF06176_consen 116 SSYVLLMEYIEGVELNDIED-----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVS----NNGIRIIDTQGKR 182 (229)
T ss_pred eEEEEEEEEecCeecccchh-----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEE----CCcEEEEECcccc
Confidence 4567999999 888877643 232 2445677889999999999999999999993 5569999998654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.03 E-value=4.8e-05 Score=72.61 Aligned_cols=57 Identities=19% Similarity=0.232 Sum_probs=42.2
Q ss_pred EEeeecccCCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHH
Q 013092 7 VFSVQENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDL 64 (449)
Q Consensus 7 V~~k~~~~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~l 64 (449)
+.+|+..... ..++.+|+++++.+..+--++++++++...+..+||||++ |.+|.+.
T Consensus 25 ~~vk~~~~~~-~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~ 82 (244)
T cd05150 25 LYLKIAPSGP-TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAAL 82 (244)
T ss_pred EEEEecCCCc-ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHh
Confidence 3444443322 4568899999999987766888898888777889999999 7666543
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.01 E-value=8.5e-05 Score=70.50 Aligned_cols=44 Identities=16% Similarity=0.049 Sum_probs=35.6
Q ss_pred CChhHHHHHHHHHHHhcCCCC-CceEEEEeEeCCEEEEEEecC-CC
Q 013092 16 TKHPQLLYESKLYRILQGGTG-IPNVRWFGVEGDYNVLVMDLL-GP 59 (449)
Q Consensus 16 ~~~~~~~~E~~il~~l~~hp~-Iv~l~~~~~~~~~~~lVmE~~-g~ 59 (449)
.....+.+|.+++..+....- ++.+++++.+.+...+|||++ |.
T Consensus 34 ~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~ 79 (226)
T TIGR02172 34 FDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGK 79 (226)
T ss_pred CCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCc
Confidence 344568999999999965443 788899998888899999999 64
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.97 E-value=0.00019 Score=66.68 Aligned_cols=99 Identities=21% Similarity=0.297 Sum_probs=77.4
Q ss_pred ChhHHHHHHHHHHHhc-----CCCCCceEEEEeEeCCEEEEEEecC-C------CCHHHHHHHcCCCCCHHHHHHHHHHH
Q 013092 17 KHPQLLYESKLYRILQ-----GGTGIPNVRWFGVEGDYNVLVMDLL-G------PSLEDLFNFCSRKLSLKTVLMLADQM 84 (449)
Q Consensus 17 ~~~~~~~E~~il~~l~-----~hp~Iv~l~~~~~~~~~~~lVmE~~-g------~sL~~ll~~~~~~ls~~~~~~i~~qi 84 (449)
...+..+|++-+..+. .+.+|++++++.+++...-+|+|.+ + .+|.+++. ...++. ... ..+
T Consensus 54 ~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~--~~~~~~-~~~---~~L 127 (199)
T PF10707_consen 54 RYRQNRRELRYYKQLSLRRGVDWSHIPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLK--EGGLTE-ELR---QAL 127 (199)
T ss_pred hhHHHHHHHHHHHHHhhccCCcccccccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHH--cCCccH-HHH---HHH
Confidence 4677889999888885 2678999999999998899999987 2 47888886 445665 333 334
Q ss_pred HHHHHHHHHCCceecCCCCCcEEEeecCCCC-eEEEee
Q 013092 85 INRVEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYIID 121 (449)
Q Consensus 85 ~~aL~yLH~~givHRDLKP~NiLl~~~~~~~-~vkL~D 121 (449)
-.-.+||-+.+|+.+||+|.||++...+... .++|+|
T Consensus 128 ~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~~~lvlID 165 (199)
T PF10707_consen 128 DEFKRYLLDHHIVIRDLNPHNIVVQRRDSGEFRLVLID 165 (199)
T ss_pred HHHHHHHHHcCCeecCCCcccEEEEecCCCceEEEEEe
Confidence 4455788889999999999999998766666 789998
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.87 E-value=4.4e-05 Score=70.35 Aligned_cols=98 Identities=22% Similarity=0.231 Sum_probs=77.9
Q ss_pred HHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecCC-CCHHH----HHHHcCCCCCHHHHHHHHHHHHHHHHHHHH---
Q 013092 22 LYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLG-PSLED----LFNFCSRKLSLKTVLMLADQMINRVEFVHS--- 93 (449)
Q Consensus 22 ~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~g-~sL~~----ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~--- 93 (449)
..|.-+++.+++.+++++++++| ..++|.||.+ +++.. +.+ -...+|.....|+.+++..+++|+.
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~~--~~~~~w~~R~~iA~~lL~~l~~l~~~~~ 80 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPLSQ--FLQSPWEQRAKIALQLLELLEELDHGPL 80 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCcccccccccccc--ccccCHHHHHHHHHHHHHHHHHHhcCCC
Confidence 45888999998878999999998 3467899994 55532 111 1236899999999999999999997
Q ss_pred CCceecCCCCCcEEEeecCCCCeEEEeecCcceee
Q 013092 94 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 128 (449)
Q Consensus 94 ~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~ 128 (449)
..+.-.|++++||.+ ..++.+|++|...+...
T Consensus 81 ~~~~lcDv~~~nfgv---~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 81 GFFYLCDVSPDNFGV---NDDGRLKLIDLDDVFVE 112 (188)
T ss_pred CcEEEeecchHHeEE---eCCCcEEEEechhcchh
Confidence 348889999999999 47788999999876543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.87 E-value=4.7e-05 Score=73.03 Aligned_cols=93 Identities=19% Similarity=0.276 Sum_probs=68.8
Q ss_pred HHHHHHHHHHhcCC-CCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q 013092 21 LLYESKLYRILQGG-TGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLH 98 (449)
Q Consensus 21 ~~~E~~il~~l~~h-p~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~givH 98 (449)
..+|.++|.+|... -.||..++. +...+||||+ |..|..+- +..+..-.++..|+.-+..+-..||||
T Consensus 156 A~rEf~~L~~L~~~G~~VP~P~~~----nRHaVvMe~ieG~eL~~~r------~~~en~~~il~~il~~~~~~~~~GiVH 225 (304)
T COG0478 156 AEREFEALQRLYPEGVKVPKPIAW----NRHAVVMEYIEGVELYRLR------LDVENPDEILDKILEEVRKAYRRGIVH 225 (304)
T ss_pred HHHHHHHHHHhhhcCCCCCCcccc----ccceeeeehcccceeeccc------CcccCHHHHHHHHHHHHHHHHHcCccc
Confidence 57899999999554 456666544 5678999999 75555432 234444555666666666667899999
Q ss_pred cCCCCCcEEEeecCCCCeEEEeecCcce
Q 013092 99 RDIKPDNFLMGLGRRANQVYIIDFGLAK 126 (449)
Q Consensus 99 RDLKP~NiLl~~~~~~~~vkL~DFGla~ 126 (449)
+|+.+-||++ +.+|.++++||--+.
T Consensus 226 GDlSefNIlV---~~dg~~~vIDwPQ~v 250 (304)
T COG0478 226 GDLSEFNILV---TEDGDIVVIDWPQAV 250 (304)
T ss_pred cCCchheEEE---ecCCCEEEEeCcccc
Confidence 9999999999 588899999996554
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.70 E-value=0.00014 Score=69.12 Aligned_cols=98 Identities=22% Similarity=0.302 Sum_probs=71.7
Q ss_pred HHHHHHHHHhc-CCCCCceEEEEeEeCCEEEEEEecCCCCH--HHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-CCce
Q 013092 22 LYESKLYRILQ-GGTGIPNVRWFGVEGDYNVLVMDLLGPSL--EDLFNFCSRKLSLKTVLMLADQMINRVEFVHS-KSFL 97 (449)
Q Consensus 22 ~~E~~il~~l~-~hp~Iv~l~~~~~~~~~~~lVmE~~g~sL--~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~-~giv 97 (449)
.+|.+-|+++. .+-.+|+-+.+. ..+|||||+|... .-.++ .-.+..+++..+..+++..+.-|-. .|+|
T Consensus 116 ~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~Lk--Dv~~e~~e~~~~~~~~v~~~~~l~~~a~LV 189 (268)
T COG1718 116 RKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLK--DVPLELEEAEGLYEDVVEYMRRLYKEAGLV 189 (268)
T ss_pred HHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCcc--cCCcCchhHHHHHHHHHHHHHHHHHhcCcc
Confidence 56888888874 335566555553 5689999996441 11122 2234455788888999999999887 8999
Q ss_pred ecCCCCCcEEEeecCCCCeEEEeecCcceeec
Q 013092 98 HRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 129 (449)
Q Consensus 98 HRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~ 129 (449)
|+||..-|||+ ..+.++|+|||-|....
T Consensus 190 HgDLSEyNiL~----~~~~p~iID~~QaV~~~ 217 (268)
T COG1718 190 HGDLSEYNILV----HDGEPYIIDVSQAVTID 217 (268)
T ss_pred cccchhhheEE----ECCeEEEEECccccccC
Confidence 99999999999 37889999999886543
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.59 E-value=0.00025 Score=75.00 Aligned_cols=105 Identities=18% Similarity=0.289 Sum_probs=71.7
Q ss_pred HHHHHHHHHHhc----CCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 013092 21 LLYESKLYRILQ----GGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 95 (449)
Q Consensus 21 ~~~E~~il~~l~----~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~g 95 (449)
+.+|...+.++. +.+.|..-..+..-....+|+|||+ |..+.++.......++.+.+.....++. +..+-..|
T Consensus 208 y~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f--~~q~~~dg 285 (517)
T COG0661 208 YRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAF--LRQLLRDG 285 (517)
T ss_pred HHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHH--HHHHHhcC
Confidence 566777777664 4555444444444456689999999 8888888532234466444443333322 34444589
Q ss_pred ceecCCCCCcEEEeecCCCCeEEEeecCcceeecC
Q 013092 96 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 130 (449)
Q Consensus 96 ivHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~ 130 (449)
++|.|..|.||++ ..++.+.+.|||+...+..
T Consensus 286 ffHaDpHpGNi~v---~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 286 FFHADPHPGNILV---RSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred ccccCCCccceEE---ecCCcEEEEcCcceecCCH
Confidence 9999999999999 5779999999999876644
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.58 E-value=0.00023 Score=75.11 Aligned_cols=106 Identities=23% Similarity=0.334 Sum_probs=71.6
Q ss_pred HHHHHHHHHHhc---CCCC------CceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHH
Q 013092 21 LLYESKLYRILQ---GGTG------IPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEF 90 (449)
Q Consensus 21 ~~~E~~il~~l~---~hp~------Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~y 90 (449)
|..|++-..+++ .|-+ ||++++.+. ...+|+|||| |..+.|+-.-....++...+...+.++. ++-
T Consensus 241 F~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~s--t~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~--~~q 316 (538)
T KOG1235|consen 241 FTKEAKNAERFRENFKDFSLLTYVLVPKVYWDLS--TKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAY--LEQ 316 (538)
T ss_pred hHHHHHhHHHHHHHHHhcccccceeCCeehhhcC--cceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHH--HHH
Confidence 566666665553 2333 677766653 4578999999 8766665322245577776665555543 234
Q ss_pred HHHCCceecCCCCCcEEEeec-CCCCeEEEeecCcceeecC
Q 013092 91 VHSKSFLHRDIKPDNFLMGLG-RRANQVYIIDFGLAKKYRD 130 (449)
Q Consensus 91 LH~~givHRDLKP~NiLl~~~-~~~~~vkL~DFGla~~~~~ 130 (449)
|-..|++|.|=.|.||++..+ ..+..+.+.|||+...+..
T Consensus 317 If~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 317 IFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred HHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 445799999999999999632 2467899999999876544
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.55 E-value=1.7e-05 Score=83.44 Aligned_cols=153 Identities=16% Similarity=0.077 Sum_probs=111.2
Q ss_pred hhHHHHHHHHHHHhcCCCC-CceEEEEeEeCCEEEEEEecC-CC-CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC
Q 013092 18 HPQLLYESKLYRILQGGTG-IPNVRWFGVEGDYNVLVMDLL-GP-SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 94 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~-Iv~l~~~~~~~~~~~lVmE~~-g~-sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~ 94 (449)
.....-++++|.++ +||| ++.-++-+..+.+.+++|+++ ++ +-...+......|..-....+...-+.+|+++|+-
T Consensus 277 ~l~~rl~~eLLdK~-n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~ 355 (829)
T KOG0576|consen 277 TLSRRLAIELLDKV-NNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSS 355 (829)
T ss_pred chhhHHHHHHHHHc-cCCCCcccccccCCcccccchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccc
Confidence 34566788999999 8888 444445555677899999999 44 33332221122244444555666777889999988
Q ss_pred CceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHH
Q 013092 95 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYV 174 (449)
Q Consensus 95 givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~i 174 (449)
--+||| ||+. ..+.++..||+....+.... ......+|+.+++||+.....+....|.|+++.-
T Consensus 356 ~~~~~d----~~l~----s~~~~~~~~~~v~~~L~~~~--------~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~ 419 (829)
T KOG0576|consen 356 YKVHRD----NILG----SEEEVKLLDFAVPPQLTRTM--------KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVS 419 (829)
T ss_pred cccCcc----cccc----cccccccccccCCcccCccc--------ccccCCCCCCCCCchhhcccccccCCCccCCCcc
Confidence 778998 8886 45788999999887665543 1356789999999999999999999999999987
Q ss_pred HHHHHhCCCCCCC
Q 013092 175 LMYFLRGSLPWQG 187 (449)
Q Consensus 175 l~elltG~~Pf~~ 187 (449)
-.++.-|-+|-..
T Consensus 420 ~~~~ap~~pPr~~ 432 (829)
T KOG0576|consen 420 AIQMAPGLPPRSS 432 (829)
T ss_pred hhhcCCCCCCCCC
Confidence 7777777666543
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.46 E-value=0.00069 Score=76.28 Aligned_cols=42 Identities=21% Similarity=0.315 Sum_probs=32.4
Q ss_pred hHHHHHHHHHHHhcCCCCC--ceEEEEeEeC---CEEEEEEecC-CCC
Q 013092 19 PQLLYESKLYRILQGGTGI--PNVRWFGVEG---DYNVLVMDLL-GPS 60 (449)
Q Consensus 19 ~~~~~E~~il~~l~~hp~I--v~l~~~~~~~---~~~~lVmE~~-g~s 60 (449)
..+.+|.++|+.|..|.+| +.+++++.+. +..|+||||+ |..
T Consensus 83 ~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVME~v~G~~ 130 (822)
T PLN02876 83 HAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIMEYLEGRI 130 (822)
T ss_pred HHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEEEecCCcc
Confidence 4689999999999656655 7777777654 4679999999 543
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.44 E-value=0.00097 Score=62.20 Aligned_cols=108 Identities=21% Similarity=0.332 Sum_probs=59.8
Q ss_pred ChhHHHHHHHHHHHhcCCC-CCceEEEEeE---eCCEEEEEEecC-CCCHHH----------------HHHH---cC---
Q 013092 17 KHPQLLYESKLYRILQGGT-GIPNVRWFGV---EGDYNVLVMDLL-GPSLED----------------LFNF---CS--- 69 (449)
Q Consensus 17 ~~~~~~~E~~il~~l~~hp-~Iv~l~~~~~---~~~~~~lVmE~~-g~sL~~----------------ll~~---~~--- 69 (449)
....+..|..+++.|..+. .++.++.++. .....+++|+++ |..+.. ++.. ..
T Consensus 33 ~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~ 112 (239)
T PF01636_consen 33 AAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPF 112 (239)
T ss_dssp HHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTC
T ss_pred CHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEeccccccccccccccccccccchhhhhhcccccccc
Confidence 4467889999999996553 3777877543 344679999999 777776 2211 10
Q ss_pred CCCCHHH------HHHH---------------HHHHHH-HHHHHHH-------CCceecCCCCCcEEEeecCCCCeEEEe
Q 013092 70 RKLSLKT------VLML---------------ADQMIN-RVEFVHS-------KSFLHRDIKPDNFLMGLGRRANQVYII 120 (449)
Q Consensus 70 ~~ls~~~------~~~i---------------~~qi~~-aL~yLH~-------~givHRDLKP~NiLl~~~~~~~~vkL~ 120 (449)
..+.... ...+ ...+.. .++.+++ ..++|+|+.|.|||+. ..++.+.|+
T Consensus 113 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~HgD~~~~Nil~~--~~~~~i~iI 190 (239)
T PF01636_consen 113 SPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEALLPKPLPPVLIHGDLHPGNILVD--PSDGRIGII 190 (239)
T ss_dssp CCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHCCSCEEEE-SS-SGGGEEEE--SSTTEEEE-
T ss_pred cccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhhhccCCCcEEEEeccccccceee--eccceeEEE
Confidence 1111111 0000 011222 2333332 4599999999999994 356777899
Q ss_pred ecCcce
Q 013092 121 DFGLAK 126 (449)
Q Consensus 121 DFGla~ 126 (449)
||+.+.
T Consensus 191 D~e~a~ 196 (239)
T PF01636_consen 191 DFEDAG 196 (239)
T ss_dssp -GTT-E
T ss_pred ecccce
Confidence 998764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.37 E-value=0.00086 Score=63.74 Aligned_cols=45 Identities=20% Similarity=0.132 Sum_probs=31.5
Q ss_pred ChhHHHHHHHHHHHhcCC--CCCceEEEEeEeC---CEEEEEEecC-CCCH
Q 013092 17 KHPQLLYESKLYRILQGG--TGIPNVRWFGVEG---DYNVLVMDLL-GPSL 61 (449)
Q Consensus 17 ~~~~~~~E~~il~~l~~h--p~Iv~l~~~~~~~---~~~~lVmE~~-g~sL 61 (449)
....+.+|.+++..|..+ --++.++..+... ...|++|+++ |.++
T Consensus 31 ~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i~G~~l 81 (235)
T cd05155 31 YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWLEGETA 81 (235)
T ss_pred hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEeecCCCC
Confidence 345799999999999654 2466666665543 2458999999 7554
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.21 E-value=0.0024 Score=57.81 Aligned_cols=105 Identities=25% Similarity=0.336 Sum_probs=77.7
Q ss_pred EEEeeecccCCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHH
Q 013092 6 TVFSVQENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQM 84 (449)
Q Consensus 6 kV~~k~~~~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi 84 (449)
+++.|..........|..|+++|..+++-..-+.++.++.+. +.|||+ |..|.++... .+.++++ .+
T Consensus 47 ~~a~Kvrr~ds~r~~l~kEakiLeil~g~~~~p~vy~yg~~~----i~me~i~G~~L~~~~~~----~~rk~l~----~v 114 (201)
T COG2112 47 EVALKVRRRDSPRRNLEKEAKILEILAGEGVTPEVYFYGEDF----IRMEYIDGRPLGKLEIG----GDRKHLL----RV 114 (201)
T ss_pred eEEEEEecCCcchhhHHHHHHHHHHhhhcCCCceEEEechhh----hhhhhhcCcchhhhhhc----ccHHHHH----HH
Confidence 566777777788889999999999998888888888887654 559999 8798887652 1333433 33
Q ss_pred HHHHHHHHHCCceecCCCC--CcEEEeecCCCCeEEEeecCcce
Q 013092 85 INRVEFVHSKSFLHRDIKP--DNFLMGLGRRANQVYIIDFGLAK 126 (449)
Q Consensus 85 ~~aL~yLH~~givHRDLKP--~NiLl~~~~~~~~vkL~DFGla~ 126 (449)
+..---|-..||-|..|.- .||++ .++.++|+||..|+
T Consensus 115 lE~a~~LD~~GI~H~El~~~~k~vlv----~~~~~~iIDFd~At 154 (201)
T COG2112 115 LEKAYKLDRLGIEHGELSRPWKNVLV----NDRDVYIIDFDSAT 154 (201)
T ss_pred HHHHHHHHHhccchhhhcCCceeEEe----cCCcEEEEEccchh
Confidence 4444445667999998864 45665 55589999998886
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.15 E-value=0.0028 Score=71.30 Aligned_cols=196 Identities=15% Similarity=0.121 Sum_probs=126.9
Q ss_pred HHHHHHHHHHhcCCCCCceEEEEeEeCCEEE----EEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 013092 21 LLYESKLYRILQGGTGIPNVRWFGVEGDYNV----LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 95 (449)
Q Consensus 21 ~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~----lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~g 95 (449)
...|...+..+ .|+|++..+.++.+....- +..++| .-++..++.. -..++..+++.+..++..||+|+|+..
T Consensus 229 ~E~e~~~l~k~-~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~-v~~i~~~~~r~~~~~~~~GL~~~h~~~ 306 (1351)
T KOG1035|consen 229 TEIELESLSKI-AHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQS-VGSIPLETLRILHQKLLEGLAYLHSLS 306 (1351)
T ss_pred HHHHHHHHHhh-ccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhh-ccccCHHHHHHHHHHHhhhHHHHHHhc
Confidence 44566666666 8899999888876543332 344677 7788877764 456899999999999999999999985
Q ss_pred ceecCCCCCcEEEeecCCCCeEEEe--ecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCC--hhhHHHHH
Q 013092 96 FLHRDIKPDNFLMGLGRRANQVYII--DFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQS--RRDDLESL 171 (449)
Q Consensus 96 ivHRDLKP~NiLl~~~~~~~~vkL~--DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s--~~~DiwSl 171 (449)
..|.-+...-..-...+..+.+.+. ||+..+.+.+..... ...-+..+.++|......+. ...|+|.+
T Consensus 307 l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~--------~~~~~~~~~~~e~~~~~~~~~~r~~dL~~l 378 (1351)
T KOG1035|consen 307 LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF--------SDLLAEIRNADEDLKENTAKKSRLTDLWCL 378 (1351)
T ss_pred cceeEEecccccccccCccceeecchhhhcccccCCCcccch--------hhcCccccccccccccccchhhhhhHHHHH
Confidence 5554443331111112344555555 888877666543221 22334556677776655544 44799999
Q ss_pred HHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 172 GYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 172 G~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
|..+..+..|..+-... . ....-++..+..+..+....|+..+.++|+...++..
T Consensus 379 gll~~~~~~~~~i~~~~------~-----------~~~~~l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~ 433 (1351)
T KOG1035|consen 379 GLLLLQLSQGEDISEKS------A-----------VPVSLLDVLSTSELLDALPKCLDEDSEERLSALELLT 433 (1351)
T ss_pred HHHHhhhhhcCcccccc------c-----------chhhhhccccchhhhhhhhhhcchhhhhccchhhhhh
Confidence 99999998875443110 0 0001111223337888899999999999998766644
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.84 E-value=0.00031 Score=80.42 Aligned_cols=153 Identities=11% Similarity=-0.073 Sum_probs=107.6
Q ss_pred HHHHHHHHhcCCCCCceEEEEeE--eCCEEEEEEecC-CCCHHHHHHHcCCCCC--HHHHHHHHHHH-HHHHHHHHHC--
Q 013092 23 YESKLYRILQGGTGIPNVRWFGV--EGDYNVLVMDLL-GPSLEDLFNFCSRKLS--LKTVLMLADQM-INRVEFVHSK-- 94 (449)
Q Consensus 23 ~E~~il~~l~~hp~Iv~l~~~~~--~~~~~~lVmE~~-g~sL~~ll~~~~~~ls--~~~~~~i~~qi-~~aL~yLH~~-- 94 (449)
.|+..++.. .|+++.....--. +....|++|+|+ +|.+.+.+-+...+++ ....+....++ +.+..-+|..
T Consensus 1278 ~e~de~~~~-~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tn 1356 (2724)
T KOG1826|consen 1278 SERDELREA-KHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTN 1356 (2724)
T ss_pred hhhhhhhhh-hceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhccc
Confidence 344434344 5565554433222 345578999999 9999999865422222 22334444444 6777777754
Q ss_pred ---CceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHH
Q 013092 95 ---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESL 171 (449)
Q Consensus 95 ---givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSl 171 (449)
--+|+++|+.|.+| ..+..+|+.++|+.+...... ...+...+++-|+.++......++.++|+|..
T Consensus 1357 lg~T~v~~~Lkf~lpmI---Vtny~v~~gk~gLdKIknp~~-------sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~ 1426 (2724)
T KOG1826|consen 1357 LGNTNVSKSLKFTLPMI---VTNYNVKLGKGGLDKIKNPVL-------SFFGLELCSPIYVLQLIKNEIKFTKRSDILRR 1426 (2724)
T ss_pred CCccchhhhhhhhccce---ecCCcccccccccccccCchH-------hhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHH
Confidence 27899999999999 577789999999998322211 22345678889999999999999999999999
Q ss_pred HHHHHHHHhCCCCCC
Q 013092 172 GYVLMYFLRGSLPWQ 186 (449)
Q Consensus 172 G~il~elltG~~Pf~ 186 (449)
++-+|....|..+|.
T Consensus 1427 s~~ly~rs~~n~~fi 1441 (2724)
T KOG1826|consen 1427 SLSLYLRSDGNAYFI 1441 (2724)
T ss_pred HHHHHHHhcccHHHH
Confidence 999999999888773
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.74 E-value=0.0067 Score=60.77 Aligned_cols=86 Identities=22% Similarity=0.297 Sum_probs=65.0
Q ss_pred CCCCCceEEEEe-EeCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCcEEEee
Q 013092 33 GGTGIPNVRWFG-VEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK-SFLHRDIKPDNFLMGL 110 (449)
Q Consensus 33 ~hp~Iv~l~~~~-~~~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~-givHRDLKP~NiLl~~ 110 (449)
+.++..+.+.+- .+..+.|++|++.|++|.-. + -..+++++.|+.+++..|.-+..+ .+-|||+.-.||||
T Consensus 283 g~~~~e~~~vv~~de~~y~yl~~kdhgt~is~i-k----~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLI-- 355 (488)
T COG5072 283 GSVFLETLKVVSLDETLYLYLHFKDHGTPISII-K----ADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILI-- 355 (488)
T ss_pred cchhhhcceEEecCCceEEEEEEecCCceeeee-e----cccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceee--
Confidence 333433333333 34567899999998887643 2 235788999999998887777754 68999999999999
Q ss_pred cCCCCeEEEeecCccee
Q 013092 111 GRRANQVYIIDFGLAKK 127 (449)
Q Consensus 111 ~~~~~~vkL~DFGla~~ 127 (449)
+ .|+|.|+||-+++.
T Consensus 356 -d-~GnvtLIDfklsRl 370 (488)
T COG5072 356 -D-EGNVTLIDFKLSRL 370 (488)
T ss_pred -e-cCceEEEEeeeeec
Confidence 4 88999999999984
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=96.49 E-value=0.037 Score=53.15 Aligned_cols=99 Identities=21% Similarity=0.226 Sum_probs=57.2
Q ss_pred HHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHH--------------HHHHHc-C-----CCCCHH-HH
Q 013092 20 QLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLE--------------DLFNFC-S-----RKLSLK-TV 77 (449)
Q Consensus 20 ~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~--------------~ll~~~-~-----~~ls~~-~~ 77 (449)
....|.++++.+..+.-.+.+++.+. .++||||+ |..+. +++.+. . .+++.. .+
T Consensus 37 ~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~ 112 (256)
T TIGR02721 37 DRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARI 112 (256)
T ss_pred cHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 46889999999966544566666543 36999999 65432 112211 1 112221 11
Q ss_pred HHHHHHH---------HHHHHHHHH--------CCceecCCCCCcEEEeecCCCCeEEEeecCcce
Q 013092 78 LMLADQM---------INRVEFVHS--------KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 126 (449)
Q Consensus 78 ~~i~~qi---------~~aL~yLH~--------~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~ 126 (449)
..+..++ ...++.+-. ..++|+|+.|.||+++ .++ ++|+||..+.
T Consensus 113 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Nil~~---~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 113 AHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNLVVT---PQG-LKLIDWEYAS 174 (256)
T ss_pred HHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcEEEe---CCC-CEEEeccccC
Confidence 2221111 111222221 2589999999999994 333 7899998764
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.46 E-value=0.016 Score=54.67 Aligned_cols=29 Identities=31% Similarity=0.519 Sum_probs=24.5
Q ss_pred CceecCCCCCcEEEeecCC-CCeEEEeecCcce
Q 013092 95 SFLHRDIKPDNFLMGLGRR-ANQVYIIDFGLAK 126 (449)
Q Consensus 95 givHRDLKP~NiLl~~~~~-~~~vkL~DFGla~ 126 (449)
+++|+|+.+.|||+. . ++.+.|+||..|.
T Consensus 171 ~l~H~Dl~~~Nil~~---~~~~~~~lIDwe~a~ 200 (235)
T cd05157 171 VFCHNDLLSGNIIYN---EEKNSVKFIDYEYAG 200 (235)
T ss_pred EEEcCCCCcCcEEEe---CCCCCEEEEEcccCC
Confidence 699999999999994 3 4679999997663
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.41 E-value=0.011 Score=61.59 Aligned_cols=160 Identities=21% Similarity=0.205 Sum_probs=94.2
Q ss_pred hHHHHHHHHHHHhcCCCCCceEEEEeEe-CCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q 013092 19 PQLLYESKLYRILQGGTGIPNVRWFGVE-GDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFL 97 (449)
Q Consensus 19 ~~~~~E~~il~~l~~hp~Iv~l~~~~~~-~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~giv 97 (449)
.+++--..+++.+ -|+|.....++-.. .....+|||+++.+|+|++.... +-..... ..|+.
T Consensus 27 ~~ilgr~~~lktl-~~~~l~~yl~~~r~~~~r~IVV~e~~~~Sled~~~~~~--l~~~s~~--------------~~~~~ 89 (725)
T KOG1093|consen 27 IQILGRFQYLKSL-QHDNLCQYLDFSRGKHERVIVVMEHYTMSLEDILKTGN--LKDESLL--------------AHGVL 89 (725)
T ss_pred HHHhhhhHHHHhh-cCccceeeEeeecCccceEEEEehhhccchHHHHHhcc--cchhhhc--------------ccccc
Confidence 3455556666677 78888888777653 34578999999999999988532 2111111 12222
Q ss_pred ecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHHHHH
Q 013092 98 HRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMY 177 (449)
Q Consensus 98 HRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il~e 177 (449)
| . +.++++| -++... .. +..+++|||++|.++.+
T Consensus 90 ~-----~----------~~~~~td-~~~t~~--------------~~----------------~~~pKsdVwsl~~i~~e 123 (725)
T KOG1093|consen 90 H-----L----------NIIYITD-HFLTKY--------------PS----------------PIGPKSDVWSLGFIILE 123 (725)
T ss_pred e-----e----------hhhhccc-cccccC--------------CC----------------CCCcchhhhhHHHHHHH
Confidence 2 1 2233444 111100 00 11248999999999999
Q ss_pred HHhCCCCCCCCCcCCHHHHHHHHHhhc---ccchHH-HhhcCCcHHHHHHHHHHhcCCCCCCCCHHHH
Q 013092 178 FLRGSLPWQGLKAGTKKQKYEKISEKK---VSTSIE-ALCRGYPTEFASYFHYCRSLRFDDKPDYAYL 241 (449)
Q Consensus 178 lltG~~Pf~~~~~~~~~~~~~~i~~~~---~~~~~~-~l~~~~p~el~~li~~cl~~~p~~RPt~~~l 241 (449)
++.|..-|...+.......+.+..... .....+ .+-..++..+.++...|+-..|..||...++
T Consensus 124 l~L~~~l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~ 191 (725)
T KOG1093|consen 124 LYLGISLEAELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMEL 191 (725)
T ss_pred HHHhhHHHHHHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHH
Confidence 999988887654433333322221110 001111 1123467889999999999999999876554
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.34 E-value=0.19 Score=51.00 Aligned_cols=28 Identities=21% Similarity=0.484 Sum_probs=22.8
Q ss_pred CCceecCCCCCcEEEeecCCCCeEEEeecCcc
Q 013092 94 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 125 (449)
Q Consensus 94 ~givHRDLKP~NiLl~~~~~~~~vkL~DFGla 125 (449)
..++|+|+.+.||++. ...++++||..+
T Consensus 192 ~~llHGDl~~gNi~~~----~~~~~~iD~e~~ 219 (370)
T TIGR01767 192 ETLLHGDLHSGSIFVS----EHETKVIDPEFA 219 (370)
T ss_pred ceeeeccCCcccEEEc----CCCCEEEcCccc
Confidence 3589999999999993 345889999755
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.29 E-value=0.011 Score=59.50 Aligned_cols=96 Identities=24% Similarity=0.276 Sum_probs=69.7
Q ss_pred HHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecCCCCHH--HHHHHcCCCCCHHHHHHHHHHHHHHHHHHH-HCCcee
Q 013092 22 LYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLE--DLFNFCSRKLSLKTVLMLADQMINRVEFVH-SKSFLH 98 (449)
Q Consensus 22 ~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~g~sL~--~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH-~~givH 98 (449)
..|++-|.+| +.-+|+.-.-... ...+|||+|+|.+=+ -.++ .-.++...+..+-.|++.-+.-|- .+++||
T Consensus 214 EKE~RNLkRl-~~aGIP~PePIlL--k~hVLVM~FlGrdgw~aPkLK--d~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVH 288 (520)
T KOG2270|consen 214 EKEMRNLKRL-NNAGIPCPEPILL--KNHVLVMEFLGRDGWAAPKLK--DASLSTSKARELYQQCVRIMRRLYQKCRLVH 288 (520)
T ss_pred HHHHHHHHHH-HhcCCCCCCceee--ecceEeeeeccCCCCcCcccc--cccCChHHHHHHHHHHHHHHHHHHHHhceec
Confidence 5688889998 5555654322221 236899999964332 2233 445777788888888888877775 579999
Q ss_pred cCCCCCcEEEeecCCCCeEEEeecCcce
Q 013092 99 RDIKPDNFLMGLGRRANQVYIIDFGLAK 126 (449)
Q Consensus 99 RDLKP~NiLl~~~~~~~~vkL~DFGla~ 126 (449)
.||.--|+|+ ..|.++|+|.+-+.
T Consensus 289 ADLSEfN~Ly----hdG~lyiIDVSQSV 312 (520)
T KOG2270|consen 289 ADLSEFNLLY----HDGKLYIIDVSQSV 312 (520)
T ss_pred cchhhhhheE----ECCEEEEEEccccc
Confidence 9999999999 78999999987654
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.29 E-value=0.0041 Score=61.39 Aligned_cols=92 Identities=17% Similarity=0.275 Sum_probs=66.3
Q ss_pred HHHHHHHHHHhcCCC-CCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q 013092 21 LLYESKLYRILQGGT-GIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLH 98 (449)
Q Consensus 21 ~~~E~~il~~l~~hp-~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~givH 98 (449)
..+|...|+.|..|- -|++.+++ +..++|||++ |-.|.++-+- .... .+...+..-|--|...|+||
T Consensus 157 a~kEfafmkaL~e~gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v----~d~~---~ly~~lm~~Iv~la~~GlIH 225 (465)
T KOG2268|consen 157 ATKEFAFMKALYERGFPVPKPIDH----NRHCVVMELVDGYPLRQVRHV----EDPP---TLYDDLMGLIVRLANHGLIH 225 (465)
T ss_pred HHHHHHHHHHHHHcCCCCCCcccc----cceeeHHHhhcccceeeeeec----CChH---HHHHHHHHHHHHHHHcCcee
Confidence 356888888886543 25555544 4678999999 8777765431 2233 34445556667788899999
Q ss_pred cCCCCCcEEEeecCCCCeEEEeecCcce
Q 013092 99 RDIKPDNFLMGLGRRANQVYIIDFGLAK 126 (449)
Q Consensus 99 RDLKP~NiLl~~~~~~~~vkL~DFGla~ 126 (449)
+|..-=||+| +.++.++++||--+.
T Consensus 226 gDFNEFNimv---~dd~~i~vIDFPQmv 250 (465)
T KOG2268|consen 226 GDFNEFNIMV---KDDDKIVVIDFPQMV 250 (465)
T ss_pred cccchheeEE---ecCCCEEEeechHhh
Confidence 9999999999 578889999996543
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.17 E-value=0.51 Score=48.63 Aligned_cols=38 Identities=21% Similarity=0.225 Sum_probs=29.0
Q ss_pred hhHHHHHHHHHHHhcCC--CCCceEEEEeEeCCEEEEEEecC
Q 013092 18 HPQLLYESKLYRILQGG--TGIPNVRWFGVEGDYNVLVMDLL 57 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~h--p~Iv~l~~~~~~~~~~~lVmE~~ 57 (449)
...+..|.+.|+.+... .+||+++.+.. +..++|||++
T Consensus 74 ~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~--~~~~lVME~L 113 (401)
T PRK09550 74 LDRARIEAEALKIQAKYVPDLVPKVYHYDE--ELAVTVMEDL 113 (401)
T ss_pred HHHHHHHHHHHHHHHhhCCCCCCeEEEECC--CCCEEEEecC
Confidence 44578899999987543 46888888844 5688999998
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=96.04 E-value=0.043 Score=53.74 Aligned_cols=107 Identities=16% Similarity=0.160 Sum_probs=60.5
Q ss_pred ChhHHHHHHHHHHHhcCCC-CCceEEEE------eEeCCEEEEEEecC-CCCHH-----------HHHHHc---CCCC--
Q 013092 17 KHPQLLYESKLYRILQGGT-GIPNVRWF------GVEGDYNVLVMDLL-GPSLE-----------DLFNFC---SRKL-- 72 (449)
Q Consensus 17 ~~~~~~~E~~il~~l~~hp-~Iv~l~~~------~~~~~~~~lVmE~~-g~sL~-----------~ll~~~---~~~l-- 72 (449)
....+..|++++..|..+- .++.++.. ....+..++||+++ |..+. ..+.+. ...+
T Consensus 49 ~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~ 128 (296)
T cd05153 49 SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPG 128 (296)
T ss_pred ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCc
Confidence 3456888999999995432 25555432 23345678999999 65432 111111 0011
Q ss_pred --------CHHHHH----------HHHHHHHHHHHHHHH-------CCceecCCCCCcEEEeecCCCCeEEEeecCcce
Q 013092 73 --------SLKTVL----------MLADQMINRVEFVHS-------KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 126 (449)
Q Consensus 73 --------s~~~~~----------~i~~qi~~aL~yLH~-------~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~ 126 (449)
.+.... .....+..++.++.. .+++|+|+.|.|||+ +.++.+.|+||+.+.
T Consensus 129 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~---~~~~~~~iIDfe~a~ 204 (296)
T cd05153 129 ERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPRGVIHADLFRDNVLF---DGDELSGVIDFYFAC 204 (296)
T ss_pred cCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCCcCCccCcCcccEEE---eCCceEEEeehhhhc
Confidence 111100 011112333444443 479999999999999 455556899998763
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.98 E-value=0.13 Score=51.04 Aligned_cols=30 Identities=30% Similarity=0.388 Sum_probs=24.2
Q ss_pred CCceecCCCCCcEEEeecCCCCeEEEeecCcce
Q 013092 94 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 126 (449)
Q Consensus 94 ~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~ 126 (449)
.+++|+|+.|.|||+. .+..+-|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~---~~~~~~iIDf~~~~ 216 (319)
T PRK05231 187 RGVIHADLFRDNVLFE---GDRLSGFIDFYFAC 216 (319)
T ss_pred cccCCCCCCCCcEEEE---CCceEEEEeccccc
Confidence 4899999999999993 44445799998763
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=95.88 E-value=0.035 Score=54.65 Aligned_cols=39 Identities=10% Similarity=-0.026 Sum_probs=28.3
Q ss_pred hHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCH
Q 013092 19 PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSL 61 (449)
Q Consensus 19 ~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL 61 (449)
....+|.+++..+...--.+++++++.. .+||||+ |..+
T Consensus 45 ~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~i~G~~l 84 (302)
T cd05156 45 IDRERELVVFARLSERNLGPKLYGIFPN----GRIEEFIPSRTL 84 (302)
T ss_pred echHHHHHHHHHHHhCCCCCceEEEeCC----CchhheeCCCcC
Confidence 4578999999999765556777776643 3689998 6554
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=95.55 E-value=0.056 Score=52.87 Aligned_cols=29 Identities=31% Similarity=0.539 Sum_probs=23.4
Q ss_pred CceecCCCCCcEEEeecCC-CCeEEEeecCcce
Q 013092 95 SFLHRDIKPDNFLMGLGRR-ANQVYIIDFGLAK 126 (449)
Q Consensus 95 givHRDLKP~NiLl~~~~~-~~~vkL~DFGla~ 126 (449)
.++|+|+.|.|||+. . ....-|+||+.+.
T Consensus 186 ~lvHGD~~~~Nilv~---~~~~~~gviDWe~a~ 215 (276)
T cd05152 186 VLVHGDLHPGHILID---EDARVTGLIDWTEAK 215 (276)
T ss_pred eeEeCCCCCCcEEEe---CCCCEEEEECcHhcc
Confidence 489999999999994 3 3345799999874
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.20 E-value=0.072 Score=53.08 Aligned_cols=30 Identities=23% Similarity=0.522 Sum_probs=25.2
Q ss_pred CceecCCCCCcEEEeecCCCCeEEEeecCccee
Q 013092 95 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 127 (449)
Q Consensus 95 givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~ 127 (449)
.++|+|+.+.|++|. ..+-+-|+||+++..
T Consensus 199 ~lvHGD~~~gNlii~---~~~~~gVlDwe~~~l 228 (321)
T COG3173 199 VLVHGDYRPGNLIID---PGRPTGVLDWELATL 228 (321)
T ss_pred eeeeCCcccCCEEEe---CCCeeEEEecccccc
Confidence 489999999999994 555588999998853
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=95.12 E-value=0.1 Score=48.47 Aligned_cols=84 Identities=20% Similarity=0.394 Sum_probs=59.2
Q ss_pred HHHHHHHHHHHhc--CCCCC--ceEEEEeEeC------------------CEEEEEEecC-CCCHHHHHHHcCCCCCHHH
Q 013092 20 QLLYESKLYRILQ--GGTGI--PNVRWFGVEG------------------DYNVLVMDLL-GPSLEDLFNFCSRKLSLKT 76 (449)
Q Consensus 20 ~~~~E~~il~~l~--~hp~I--v~l~~~~~~~------------------~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~ 76 (449)
-|..|.+.+.+|+ ++.++ |+.+++..-. ...-||.||. ... .+....
T Consensus 100 PF~~ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------~~~~~~ 169 (207)
T PF13095_consen 100 PFNCECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------PLQIRD 169 (207)
T ss_pred hHHHHHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------ccchhH
Confidence 4789999999987 44566 6666665311 1246788877 322 233333
Q ss_pred HHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcc
Q 013092 77 VLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 125 (449)
Q Consensus 77 ~~~i~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla 125 (449)
+.+|..-|..+|..||+-+|+|+.|..= -+|+|||.+
T Consensus 170 ----~~~~~~dl~~~~k~gI~~~Dv~~~ny~~--------G~lvDfs~~ 206 (207)
T PF13095_consen 170 ----IPQMLRDLKILHKLGIVPRDVKPRNYRG--------GKLVDFSSS 206 (207)
T ss_pred ----HHHHHHHHHHHHHCCeeeccCccccccC--------CEEEecccC
Confidence 4567778889999999999999999873 289999864
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=94.98 E-value=0.2 Score=50.68 Aligned_cols=100 Identities=14% Similarity=0.197 Sum_probs=59.0
Q ss_pred HHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHH-----------H---HHHc-CCC------C-CHHHH
Q 013092 21 LLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLED-----------L---FNFC-SRK------L-SLKTV 77 (449)
Q Consensus 21 ~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~-----------l---l~~~-~~~------l-s~~~~ 77 (449)
-..|..+++.+..+.--+++++.+..+ .|++|+ |.+|.. + +.+. ... + .++.+
T Consensus 83 R~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i 158 (344)
T PLN02236 83 RDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRL 158 (344)
T ss_pred hHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHH
Confidence 467999999997766677777776443 578888 655431 1 1111 111 1 12333
Q ss_pred HHHHHHH-----------------HHHHHHH----H----HCCceecCCCCCcEEEeecCCCCeEEEeecCcce
Q 013092 78 LMLADQM-----------------INRVEFV----H----SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 126 (449)
Q Consensus 78 ~~i~~qi-----------------~~aL~yL----H----~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~ 126 (449)
..+..++ ...+..| . ...++|+|+++.|||+. +.++.++|+||..+.
T Consensus 159 ~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~~~~~~cH~Dl~~~Nil~~--~~~~~~~lID~Eya~ 230 (344)
T PLN02236 159 RNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDDQEIGFCHNDLQYGNIMID--EETRAITIIDYEYAS 230 (344)
T ss_pred HHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccCCCceEEeCCCCcCcEEEe--CCCCcEEEEeehhcc
Confidence 3332221 1111112 1 23589999999999995 334689999998764
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=94.63 E-value=0.15 Score=50.48 Aligned_cols=72 Identities=19% Similarity=0.139 Sum_probs=54.2
Q ss_pred ChhHHHHHHHHHHHhcCC--CCCceEEEEeEe---CCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHH
Q 013092 17 KHPQLLYESKLYRILQGG--TGIPNVRWFGVE---GDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEF 90 (449)
Q Consensus 17 ~~~~~~~E~~il~~l~~h--p~Iv~l~~~~~~---~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~y 90 (449)
....+..|.+.|+.|... -.|+++++.+.+ .+..|||||++ |.++.+. ..+......+..+++.+|..
T Consensus 50 ~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~G~~~~~~------~~~~~~~~~l~~~l~~~La~ 123 (297)
T PRK10593 50 TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLRGVSVEAP------ARTPERWEQLKDQIVEGLLA 123 (297)
T ss_pred cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccCCEecCCC------CCCHHHHHHHHHHHHHHHHH
Confidence 345899999999999765 468889987754 36789999999 7777651 12344455677888899999
Q ss_pred HHHC
Q 013092 91 VHSK 94 (449)
Q Consensus 91 LH~~ 94 (449)
||+.
T Consensus 124 LH~~ 127 (297)
T PRK10593 124 WHRI 127 (297)
T ss_pred HhCC
Confidence 9974
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=94.51 E-value=0.14 Score=51.34 Aligned_cols=29 Identities=28% Similarity=0.666 Sum_probs=24.5
Q ss_pred ceecCCCCCcEEEeecCCCCeEEEeecCcce
Q 013092 96 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 126 (449)
Q Consensus 96 ivHRDLKP~NiLl~~~~~~~~vkL~DFGla~ 126 (449)
+.|.|+.+.|||+. +.++.++++||..|-
T Consensus 184 ~CHnDl~~~NiL~~--~~~~~l~lID~EYag 212 (330)
T PLN02421 184 FAHNDLLSGNLMLN--EDEGKLYFIDFEYGS 212 (330)
T ss_pred EEECCCCcccEEEe--CCCCcEEEEcccccC
Confidence 79999999999994 345689999998763
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=94.20 E-value=0.16 Score=47.97 Aligned_cols=85 Identities=14% Similarity=0.173 Sum_probs=59.0
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecCC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH--C
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLG-PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS--K 94 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~g-~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~--~ 94 (449)
..-|..+.+|+.++ .+|+++.-- ++..+-++.|+|. .... ... ++..=+..|..+|+ .
T Consensus 102 ~~~y~nky~v~Arm---hGilrL~ND--n~~~yGvIlE~Cy~~~i~----------~~N----~i~agi~~L~~fH~~~~ 162 (308)
T PF07387_consen 102 DALYFNKYRVFARM---HGILRLKND--NNYKYGVILERCYKIKIN----------FSN----FITAGIKDLMDFHSENQ 162 (308)
T ss_pred hhhhhhhhhHHHHh---hheeEeecC--CCceeEEEEeeccCcccc----------hhH----HHHHhHHHHHHhhccCC
Confidence 44567788888777 678888732 4445668999993 2211 111 11111467888894 4
Q ss_pred CceecCCCCCcEEEeecCCCCeEEEeecCc
Q 013092 95 SFLHRDIKPDNFLMGLGRRANQVYIIDFGL 124 (449)
Q Consensus 95 givHRDLKP~NiLl~~~~~~~~vkL~DFGl 124 (449)
+.+|+|..|+|||- +..|-+||.|=+.
T Consensus 163 ~~lHGD~np~NiM~---D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 163 HCLHGDCNPDNIMC---DKFGYLKLVDPVC 189 (308)
T ss_pred CeecCCCChhheee---cCCCCEEecChhh
Confidence 79999999999998 7999999999764
|
The function of this family is unknown. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=93.35 E-value=0.22 Score=46.35 Aligned_cols=30 Identities=37% Similarity=0.707 Sum_probs=20.3
Q ss_pred CceecCCCCCcEEEeecCCCCeEEEeecCcce
Q 013092 95 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 126 (449)
Q Consensus 95 givHRDLKP~NiLl~~~~~~~~vkL~DFGla~ 126 (449)
.+.|.|+.|.|||+. ..++.++|+||..|.
T Consensus 144 v~cHnDl~~~Nil~~--~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 144 VFCHNDLNPGNILIN--NKDGEVKLIDFEYAG 173 (211)
T ss_dssp EEE-S--SGGGEEET--SSSSCEEE--GTT-E
T ss_pred eEeeccCccccEEec--cCCCeEEEecHHHHh
Confidence 589999999999993 477899999998764
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=92.69 E-value=0.56 Score=48.13 Aligned_cols=36 Identities=8% Similarity=0.074 Sum_probs=29.2
Q ss_pred HHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCH
Q 013092 22 LYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSL 61 (449)
Q Consensus 22 ~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL 61 (449)
.+|.++++.|..+..-+++++.+.. ++|.||+ |..|
T Consensus 100 ~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~efIeGr~l 136 (383)
T PTZ00384 100 DLQYNIAKLLGDNNFGPKIIGRFGD----FTIQEWVEGNTM 136 (383)
T ss_pred HHHHHHHHHHHhCCCCCeEEEecCC----EEEEEEeccccC
Confidence 5699999999888888888888753 5899999 6554
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=92.30 E-value=0.27 Score=48.33 Aligned_cols=28 Identities=39% Similarity=0.753 Sum_probs=23.9
Q ss_pred CCceecCCCCCcEEEeecCCCCeEEEeecCcc
Q 013092 94 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 125 (449)
Q Consensus 94 ~givHRDLKP~NiLl~~~~~~~~vkL~DFGla 125 (449)
.+++|+|+.+.||++. . +.+.|+||+.+
T Consensus 187 ~~liHgD~~~~Nil~~---~-~~i~lIDfd~~ 214 (313)
T TIGR02906 187 RGFCHQDYAYHNILLK---D-NEVYVIDFDYC 214 (313)
T ss_pred CceEcCCCCcccEEEe---C-CcEEEEECccc
Confidence 5799999999999994 3 56899999865
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=92.16 E-value=0.23 Score=49.05 Aligned_cols=29 Identities=34% Similarity=0.565 Sum_probs=24.6
Q ss_pred CCceecCCCCCcEEEeecCCCCeEEEeecCcc
Q 013092 94 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 125 (449)
Q Consensus 94 ~givHRDLKP~NiLl~~~~~~~~vkL~DFGla 125 (449)
.+++|+|+.+.||++. .++.+.|+||+.+
T Consensus 187 ~~l~HgD~~~~Nvl~~---~~~~~~vIDfd~~ 215 (307)
T TIGR00938 187 RGVIHADLFPDNVLFD---GDSVKGVIDFYFA 215 (307)
T ss_pred CccCCCCCCcCcEEEE---CCceEEEeecccc
Confidence 6899999999999994 4555689999876
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PHA03111 Ser/Thr kinase; Provisional | Back alignment and domain information |
|---|
Probab=90.29 E-value=0.47 Score=47.34 Aligned_cols=63 Identities=22% Similarity=0.246 Sum_probs=38.8
Q ss_pred CEEEEEEecCCCCHHHH-----HHHcCCCCCHHHHHHHHHHHHHHHHHHHH----CCceecCCCCCcEEEeec
Q 013092 48 DYNVLVMDLLGPSLEDL-----FNFCSRKLSLKTVLMLADQMINRVEFVHS----KSFLHRDIKPDNFLMGLG 111 (449)
Q Consensus 48 ~~~~lVmE~~g~sL~~l-----l~~~~~~ls~~~~~~i~~qi~~aL~yLH~----~givHRDLKP~NiLl~~~ 111 (449)
....||+++.-++-.++ .+. +-.--.+-+..+..||+.-.-.+-+ ..++|-||||+||||-..
T Consensus 248 rGnIIIfPLArcSadkv~~~~~~e~-GF~s~~~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds 319 (444)
T PHA03111 248 RGNIIIFPLARCSADKVTEENAAEL-GFKSLVEYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDS 319 (444)
T ss_pred CCcEEEEehhhcccccCCHHHHHHc-CCccHHHHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecC
Confidence 35679999873332222 221 2112234566778888766544433 369999999999999643
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=89.55 E-value=4 Score=42.19 Aligned_cols=37 Identities=19% Similarity=0.246 Sum_probs=26.4
Q ss_pred hHHHHHHHHHHHhcCC--CCCceEEEEeEeCCEEEEEEecC
Q 013092 19 PQLLYESKLYRILQGG--TGIPNVRWFGVEGDYNVLVMDLL 57 (449)
Q Consensus 19 ~~~~~E~~il~~l~~h--p~Iv~l~~~~~~~~~~~lVmE~~ 57 (449)
..-..|...|+.+... ..||+++.++. +..+++||++
T Consensus 79 ~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlvME~L 117 (418)
T PLN02756 79 ERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIGMRYL 117 (418)
T ss_pred cHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEEEeec
Confidence 3445667777776432 47888888887 4578899999
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=89.10 E-value=4.1 Score=41.95 Aligned_cols=28 Identities=18% Similarity=0.427 Sum_probs=23.3
Q ss_pred CCceecCCCCCcEEEeecCCCCeEEEeecCcc
Q 013092 94 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 125 (449)
Q Consensus 94 ~givHRDLKP~NiLl~~~~~~~~vkL~DFGla 125 (449)
..++|+||.|.|||++ ...+|++|.-+|
T Consensus 227 ~aLlHGDlHtGSI~v~----~~~~kvIDpEFA 254 (409)
T PRK12396 227 QALIHGDLHTGSVFVK----NDSTKVIDPEFA 254 (409)
T ss_pred hhhccCcCCCCCEEec----CCceEEEccccc
Confidence 4699999999999993 456999997665
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=88.69 E-value=1.2 Score=43.90 Aligned_cols=50 Identities=18% Similarity=0.250 Sum_probs=34.1
Q ss_pred EEeeecccCCChhHHHHHHHHHHHhc--CCCCCceEEEEeEeCCEEEEEEecC
Q 013092 7 VFSVQENVKTKHPQLLYESKLYRILQ--GGTGIPNVRWFGVEGDYNVLVMDLL 57 (449)
Q Consensus 7 V~~k~~~~~~~~~~~~~E~~il~~l~--~hp~Iv~l~~~~~~~~~~~lVmE~~ 57 (449)
+.+|... ......|..|.+-|+.|. ..-.||+++.++...+..||||||+
T Consensus 43 ~FvK~~~-~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l 94 (288)
T PF03881_consen 43 YFVKVNS-ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFL 94 (288)
T ss_dssp EEEEEEE-GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE--
T ss_pred EEEEecC-hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEee
Confidence 3444444 344567999999999993 3456899999999888889999998
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly | Back alignment and domain information |
|---|
Probab=88.42 E-value=0.8 Score=45.94 Aligned_cols=62 Identities=24% Similarity=0.225 Sum_probs=35.7
Q ss_pred EEEEEEecCCCCHHHHHH----HcCCCCCHHHHHHHHHHHHHHHHHHH----HCCceecCCCCCcEEEee
Q 013092 49 YNVLVMDLLGPSLEDLFN----FCSRKLSLKTVLMLADQMINRVEFVH----SKSFLHRDIKPDNFLMGL 110 (449)
Q Consensus 49 ~~~lVmE~~g~sL~~ll~----~~~~~ls~~~~~~i~~qi~~aL~yLH----~~givHRDLKP~NiLl~~ 110 (449)
...||+++.-.+-.++-. ..+-.--.+-+..+..||+.-.--+- ...++|-||||+||||-.
T Consensus 245 GnIIIfPLA~~Sadkv~~~~~~e~GF~s~~~YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFd 314 (434)
T PF05445_consen 245 GNIIIFPLARCSADKVTESNAAELGFKSNVEYVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFD 314 (434)
T ss_pred CcEEEEehhhcchhhcCHHHHHhcCchhHHHHHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEec
Confidence 356999988433333211 11111123345667777765431122 246999999999999963
|
; GO: 0004672 protein kinase activity, 0005524 ATP binding |
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=86.62 E-value=1.8 Score=41.16 Aligned_cols=42 Identities=21% Similarity=0.295 Sum_probs=35.2
Q ss_pred CChhHHHHHHHHHHHhcCC--CCCceEEEEeEeCCEEEEEEecC
Q 013092 16 TKHPQLLYESKLYRILQGG--TGIPNVRWFGVEGDYNVLVMDLL 57 (449)
Q Consensus 16 ~~~~~~~~E~~il~~l~~h--p~Iv~l~~~~~~~~~~~lVmE~~ 57 (449)
+....|..|+.-|+.|... -.|++++..+.+..+.||||||+
T Consensus 50 ~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L 93 (286)
T COG3001 50 EQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYL 93 (286)
T ss_pred hhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeec
Confidence 3445688999999988543 47899999999999999999999
|
|
| >smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain | Back alignment and domain information |
|---|
Probab=86.48 E-value=1.3 Score=40.84 Aligned_cols=33 Identities=24% Similarity=0.457 Sum_probs=24.8
Q ss_pred CCceecCCCCCcEEEeecCC--CCeEEEeecCcce
Q 013092 94 KSFLHRDIKPDNFLMGLGRR--ANQVYIIDFGLAK 126 (449)
Q Consensus 94 ~givHRDLKP~NiLl~~~~~--~~~vkL~DFGla~ 126 (449)
..++|+|+.+.||++..+.. ...+.|+||..+.
T Consensus 120 ~vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~ 154 (196)
T smart00587 120 NVLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSH 154 (196)
T ss_pred eEEeeCCCCccceeeccCCCCCccceEEEecccCC
Confidence 46999999999999953211 1268999998764
|
subfamily of choline kinases |
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=86.15 E-value=0.61 Score=42.87 Aligned_cols=28 Identities=25% Similarity=0.449 Sum_probs=23.1
Q ss_pred CceecCCCCCcEEEeecCCCCeEEEeecCcce
Q 013092 95 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 126 (449)
Q Consensus 95 givHRDLKP~NiLl~~~~~~~~vkL~DFGla~ 126 (449)
-.+|+|+.|.||+++ .++ ++|+||+.+.
T Consensus 78 ~p~H~D~~~~N~~~~---~~~-~~lIDwe~a~ 105 (188)
T PRK10271 78 APLHMDVHAGNLVHS---ASG-LRLIDWEYAG 105 (188)
T ss_pred eeecCCCCCccEEEE---CCC-EEEEeCCccc
Confidence 479999999999983 444 8999999774
|
|
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=86.09 E-value=1.1 Score=43.55 Aligned_cols=44 Identities=23% Similarity=0.403 Sum_probs=32.2
Q ss_pred HHHHHHHHHHHHHHC--CceecCCCCCcEEEeecCCCCeEEEeecCcce
Q 013092 80 LADQMINRVEFVHSK--SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 126 (449)
Q Consensus 80 i~~qi~~aL~yLH~~--givHRDLKP~NiLl~~~~~~~~vkL~DFGla~ 126 (449)
.+..+-.++.-++.. -++|.|+.|.|+|+ +..+.++|+||--|.
T Consensus 137 ~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~---t~~~~l~LIDWEyAg 182 (269)
T COG0510 137 KLKELRRALEEVPKDDLVPCHNDLNPGNLLL---TDKGGLFLIDWEYAG 182 (269)
T ss_pred HHHHHHHHhhhcCCCceeeecCCCCccceEE---cCCCcEEEEecccCC
Confidence 444444455555544 59999999999999 456999999997653
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 449 | ||||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 1e-176 | ||
| 1ckj_A | 317 | Casein Kinase I Delta Truncation Mutant Containing | 1e-119 | ||
| 3uys_A | 296 | Crystal Structure Of Apo Human Ck1d Length = 296 | 1e-118 | ||
| 4hni_A | 296 | Crystal Structure Of Ck1e In Complex With Pf4800567 | 1e-117 | ||
| 2c47_A | 313 | Structure Of Casein Kinase 1 Gamma 2 Length = 313 | 2e-82 | ||
| 4hgl_A | 330 | Crystal Structure Of Ck1g3 With Compound 1 Length = | 8e-82 | ||
| 2chl_A | 351 | Structure Of Casein Kinase 1 Gamma 3 Length = 351 | 3e-81 | ||
| 2izr_A | 330 | Structure Of Casein Kinase Gamma 3 In Complex With | 3e-81 | ||
| 2cmw_A | 310 | Structure Of Human Casein Kinase 1 Gamma-1 In Compl | 4e-81 | ||
| 2csn_A | 297 | Binary Complex Of Casein Kinase-1 With Cki7 Length | 7e-81 | ||
| 1eh4_A | 298 | Binary Complex Of Casein Kinase-1 From S. Pombe Wit | 8e-81 | ||
| 2lav_A | 361 | Nmr Solution Structure Of Human Vaccinia-Related Ki | 3e-24 | ||
| 2kty_A | 368 | Solution Structure Of Human Vaccinia Related Kinase | 3e-24 | ||
| 3op5_A | 364 | Human Vaccinia-Related Kinase 1 Length = 364 | 5e-24 | ||
| 2v62_A | 345 | Structure Of Vaccinia-Related Kinase 2 Length = 345 | 7e-23 | ||
| 2jii_A | 352 | Structure Of Vaccinia Related Kinase 3 Length = 352 | 2e-17 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-09 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-09 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-09 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 6e-09 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 6e-09 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 6e-09 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 7e-09 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 9e-09 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 7e-08 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 7e-08 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 8e-08 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 8e-08 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-07 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-07 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-07 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-07 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-07 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-07 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-07 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-07 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-07 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-07 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-07 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-07 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-07 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-07 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-07 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-07 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-07 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-07 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-07 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-07 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-07 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-07 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-07 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-07 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-07 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-07 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-07 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 6e-07 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 7e-07 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-06 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-06 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-06 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-06 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-06 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-06 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-06 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-06 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-06 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-06 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-06 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-06 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-06 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-06 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-06 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-06 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-06 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-06 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-06 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-06 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-06 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-06 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-06 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-06 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-06 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-06 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 3e-06 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 3e-06 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 3e-06 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 3e-06 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-06 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-06 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 4e-06 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 4e-06 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 4e-06 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-06 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 4e-06 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 4e-06 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 5e-06 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 5e-06 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 5e-06 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 5e-06 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-06 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 5e-06 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 5e-06 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 5e-06 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-06 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 5e-06 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 6e-06 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 6e-06 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 6e-06 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-06 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 6e-06 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 6e-06 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-06 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 7e-06 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 7e-06 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 7e-06 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 7e-06 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 7e-06 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 7e-06 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 7e-06 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 8e-06 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 9e-06 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 9e-06 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-05 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-05 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 1e-05 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-05 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-05 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 1e-05 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-05 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-05 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-05 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-05 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-05 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-05 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 1e-05 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-05 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-05 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-05 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-05 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-05 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-05 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-05 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-05 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-05 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-05 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-05 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-05 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-05 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-05 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-05 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-05 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 3e-05 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 4e-05 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 4e-05 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-05 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 4e-05 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 4e-05 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 4e-05 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 4e-05 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 4e-05 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 4e-05 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 4e-05 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 4e-05 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 4e-05 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 5e-05 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-05 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 5e-05 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 5e-05 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-05 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 5e-05 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 5e-05 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-05 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-05 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 5e-05 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-05 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-05 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 5e-05 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 5e-05 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 5e-05 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 5e-05 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-05 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 5e-05 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 5e-05 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 5e-05 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 5e-05 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 5e-05 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 6e-05 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 6e-05 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 6e-05 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 6e-05 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 6e-05 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-05 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 6e-05 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 6e-05 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 6e-05 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 6e-05 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 6e-05 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 6e-05 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 6e-05 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 6e-05 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 7e-05 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 7e-05 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 7e-05 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 7e-05 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 7e-05 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 7e-05 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 7e-05 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-05 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 8e-05 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 8e-05 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 8e-05 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 8e-05 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-05 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-05 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 8e-05 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 8e-05 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 8e-05 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 9e-05 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-04 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-04 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-04 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-04 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-04 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-04 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-04 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-04 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-04 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-04 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-04 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-04 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-04 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-04 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-04 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-04 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-04 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-04 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-04 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-04 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-04 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-04 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-04 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-04 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-04 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-04 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-04 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-04 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-04 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-04 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-04 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-04 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-04 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-04 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-04 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-04 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-04 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-04 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-04 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-04 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-04 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-04 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-04 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-04 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-04 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-04 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-04 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-04 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-04 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-04 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-04 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-04 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-04 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-04 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-04 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-04 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-04 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-04 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-04 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-04 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-04 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 2e-04 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-04 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-04 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 2e-04 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 2e-04 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-04 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-04 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-04 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-04 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-04 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-04 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-04 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 2e-04 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 3e-04 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-04 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-04 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 3e-04 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 3e-04 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-04 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 3e-04 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 3e-04 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-04 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-04 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-04 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-04 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-04 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-04 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-04 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-04 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 3e-04 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 3e-04 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 3e-04 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-04 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-04 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 4e-04 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 4e-04 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 4e-04 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 4e-04 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 4e-04 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 4e-04 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 4e-04 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 4e-04 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 5e-04 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 5e-04 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 5e-04 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 5e-04 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 5e-04 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 5e-04 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 5e-04 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 5e-04 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 5e-04 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 5e-04 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 5e-04 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 5e-04 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 5e-04 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-04 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 7e-04 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 7e-04 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-04 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 7e-04 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 7e-04 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 8e-04 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 8e-04 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 8e-04 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 8e-04 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 8e-04 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-04 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 8e-04 |
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317 | Back alignment and structure |
|
| >pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296 | Back alignment and structure |
|
| >pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296 | Back alignment and structure |
|
| >pdb|2C47|A Chain A, Structure Of Casein Kinase 1 Gamma 2 Length = 313 | Back alignment and structure |
|
| >pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330 | Back alignment and structure |
|
| >pdb|2CHL|A Chain A, Structure Of Casein Kinase 1 Gamma 3 Length = 351 | Back alignment and structure |
|
| >pdb|2IZR|A Chain A, Structure Of Casein Kinase Gamma 3 In Complex With Inhibitor Length = 330 | Back alignment and structure |
|
| >pdb|2CMW|A Chain A, Structure Of Human Casein Kinase 1 Gamma-1 In Complex With 2-(2-Hydroxyethylamino)-6-(3-Chloroanilino)-9- Isopropylpurine (Casp Target) Length = 310 | Back alignment and structure |
|
| >pdb|2CSN|A Chain A, Binary Complex Of Casein Kinase-1 With Cki7 Length = 297 | Back alignment and structure |
|
| >pdb|1EH4|A Chain A, Binary Complex Of Casein Kinase-1 From S. Pombe With An Atp Competitive Inhibitor, Ic261 Length = 298 | Back alignment and structure |
|
| >pdb|2LAV|A Chain A, Nmr Solution Structure Of Human Vaccinia-Related Kinase 1 Length = 361 | Back alignment and structure |
|
| >pdb|2KTY|A Chain A, Solution Structure Of Human Vaccinia Related Kinase-1 Length = 368 | Back alignment and structure |
|
| >pdb|3OP5|A Chain A, Human Vaccinia-Related Kinase 1 Length = 364 | Back alignment and structure |
|
| >pdb|2V62|A Chain A, Structure Of Vaccinia-Related Kinase 2 Length = 345 | Back alignment and structure |
|
| >pdb|2JII|A Chain A, Structure Of Vaccinia Related Kinase 3 Length = 352 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 449 | |||
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 0.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 0.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 1e-180 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 1e-179 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 1e-166 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 1e-154 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 1e-153 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 1e-16 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 5e-16 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 8e-16 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 8e-16 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 3e-15 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 3e-15 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 4e-15 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 4e-15 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 7e-15 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 4e-14 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 4e-14 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 6e-14 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 1e-13 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 4e-13 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 4e-13 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 1e-12 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 3e-12 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 2e-11 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 2e-11 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 3e-11 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 4e-11 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 4e-11 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 4e-11 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 5e-11 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 6e-11 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 7e-11 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 7e-11 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 2e-10 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 2e-10 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 2e-10 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 2e-10 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 3e-10 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 3e-10 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 3e-10 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 4e-10 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 4e-10 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 4e-10 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 4e-10 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 4e-10 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 5e-10 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 5e-10 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 5e-10 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 6e-10 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 7e-10 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 8e-10 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 8e-10 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 9e-10 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 9e-10 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 1e-09 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 1e-09 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 1e-09 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 1e-09 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 2e-09 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 2e-09 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 2e-09 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 2e-09 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 2e-09 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 2e-09 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 2e-09 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 2e-09 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 2e-09 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 2e-09 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 2e-09 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 3e-09 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 5e-09 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 7e-09 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 7e-09 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 1e-08 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 1e-08 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 1e-08 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 1e-08 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 1e-08 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 1e-08 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 1e-08 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 2e-08 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 2e-08 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 2e-08 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 2e-08 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 2e-08 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 2e-08 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 3e-08 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 3e-08 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 3e-08 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 3e-08 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 3e-08 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 4e-08 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 1e-06 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 5e-08 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 6e-08 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 7e-08 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 7e-08 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 8e-08 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 8e-08 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 9e-08 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 9e-08 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 1e-07 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 1e-07 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 1e-07 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 1e-07 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 1e-07 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 2e-07 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 2e-07 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 2e-07 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 2e-07 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 2e-07 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 2e-07 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 2e-07 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 2e-07 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 3e-07 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 3e-07 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 3e-07 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 3e-07 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 3e-07 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 3e-07 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 4e-07 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 5e-07 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 5e-07 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 5e-07 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 6e-07 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 6e-07 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 7e-07 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 7e-07 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 8e-07 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 8e-07 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 9e-07 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 9e-07 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 1e-06 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 2e-06 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 3e-06 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 4e-06 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 4e-06 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 6e-06 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 8e-06 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 8e-06 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 1e-05 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 1e-05 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 1e-05 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 1e-05 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 1e-05 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 2e-05 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 2e-05 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 3e-05 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 3e-05 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 4e-05 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 5e-05 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 1e-04 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 1e-04 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 1e-04 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 2e-04 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 2e-04 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 2e-04 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 3e-04 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 3e-04 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 3e-04 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 3e-04 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 4e-04 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 4e-04 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 5e-04 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 5e-04 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 8e-04 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 8e-04 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 8e-04 |
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 610 bits (1574), Expect = 0.0
Identities = 344/439 (78%), Positives = 381/439 (86%), Gaps = 5/439 (1%)
Query: 11 QENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSR 70
ENVKTKHPQLLYESK+YRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSR
Sbjct: 39 LENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSR 98
Query: 71 KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 130
KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD
Sbjct: 99 KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158
Query: 131 TSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 190
TSTHQHIPYRENKNLTGTARYAS+NTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA
Sbjct: 159 TSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 218
Query: 191 GTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFI 250
GTKKQKYEKISEKKV+TSIEALCRGYPTEFASYFHYCRSLRFDDKPDY+YLKR+FRDLFI
Sbjct: 219 GTKKQKYEKISEKKVATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFI 278
Query: 251 REGFQFDYVFDWTILKYQQSQLATPPARALVPGAGTSGAPPAIASGDRQTGGGEEGRPAG 310
REGFQFDYVFDWTILKYQQSQ+A+ P RA+ GAG SG P DRQ+ G +EGR +G
Sbjct: 279 REGFQFDYVFDWTILKYQQSQIASAPPRAVGHGAGPSGLAPPALQNDRQS-GVDEGRTSG 337
Query: 311 LSSMDSSRRRMSGPVINSGSFSKQKSPVVNEPTMTKDTMLSSSNFLGRSGGGSSRRAAAV 370
SSMD RRR P+ + G+ +KQK+PV N+ + +K+ ++S+SNFLGRS G S R AV
Sbjct: 338 WSSMD--RRRAPPPIASVGTLAKQKAPVGNDASFSKEPVISASNFLGRSSGSSRR--PAV 393
Query: 371 SSSRDAFVGSETEPQRSRTTEASPGAMHRISSGPRGSPIGSSDPKRSSSGRNTTHIKTYE 430
SSSRD +EP R+R T+ASPGA R S + SP+ S++PK SSS R+++++K YE
Sbjct: 394 SSSRDVMPIDTSEPSRTRATDASPGAFRRTSGPQKSSPVNSAEPKHSSSARHSSNVKNYE 453
Query: 431 TTLKGIESLHFDTDERVHY 449
+ LKGIE L+FD DERV Y
Sbjct: 454 SALKGIEGLNFDGDERVQY 472
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 512 bits (1320), Expect = 0.0
Identities = 151/290 (52%), Positives = 199/290 (68%), Gaps = 3/290 (1%)
Query: 12 ENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRK 71
E +K++ PQL E + Y+ L G GIP V +FG G YN +V++LLGPSLEDLF+ C R
Sbjct: 42 EPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELLGPSLEDLFDLCDRT 101
Query: 72 LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG--RRANQVYIIDFGLAKKYR 129
SLKTVLM+A Q+I+R+E+VHSK+ ++RD+KP+NFL+G + ++IIDF LAK+Y
Sbjct: 102 FSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYI 161
Query: 130 DTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLK 189
D T +HIPYRE+K+LTGTARY S+NTHLG EQSRRDDLE+LG++ MYFLRGSLPWQGLK
Sbjct: 162 DPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLK 221
Query: 190 AGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLF 249
A T K++Y+KI + K +T IE LC +P E A+Y Y R L F +KPDY YL+++F DLF
Sbjct: 222 ADTLKERYQKIGDTKRATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLF 280
Query: 250 IREGFQFDYVFDWTILKYQQSQLATPPARALVPGAGTSGAPPAIASGDRQ 299
R+G+ FDY +DW + A AL + Q
Sbjct: 281 DRKGYMFDYEYDWIGKQLPTPVGAVQQDPALSSNREAHQHRDKMQQSKNQ 330
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 503 bits (1296), Expect = e-180
Identities = 200/256 (78%), Positives = 234/256 (91%)
Query: 11 QENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSR 70
E VKTKHPQL ESK+Y+++QGG GIP +RW G EGDYNV+VM+LLGPSLEDLFNFCSR
Sbjct: 41 LECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSR 100
Query: 71 KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 130
K SLKTVL+LADQMI+R+E++HSK+F+HRD+KPDNFLMGLG++ N VYIIDFGLAKKYRD
Sbjct: 101 KFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160
Query: 131 TSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 190
THQHIPYRENKNLTGTARYAS+NTHLGIEQSRRDDLESLGYVLMYF GSLPWQGLKA
Sbjct: 161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKA 220
Query: 191 GTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFI 250
TK+QKYE+ISEKK+ST IE LC+GYP+EFA+Y ++CRSLRFDDKPDY+YL+++FR+LF
Sbjct: 221 ATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 280
Query: 251 REGFQFDYVFDWTILK 266
R+GF +DYVFDW +LK
Sbjct: 281 RQGFSYDYVFDWNMLK 296
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 502 bits (1295), Expect = e-179
Identities = 154/257 (59%), Positives = 187/257 (72%), Gaps = 2/257 (0%)
Query: 11 QENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSR 70
E ++ PQL E + Y++L G TGIPNV +FG EG +NVLV+DLLGPSLEDL + C R
Sbjct: 42 FEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGR 101
Query: 71 KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL--GRRANQVYIIDFGLAKKY 128
K S+KTV M A QM+ RV+ +H KS ++RDIKPDNFL+G + AN +Y++DFG+ K Y
Sbjct: 102 KFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161
Query: 129 RDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGL 188
RD T QHIPYRE KNL+GTARY S+NTHLG EQSRRDDLE+LG+V MYFLRGSLPWQGL
Sbjct: 162 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGL 221
Query: 189 KAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDL 248
KA T KQKYE+I EKK ST + LC G+P EF Y HY R+L FD PDY YL+ +F +
Sbjct: 222 KAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 281
Query: 249 FIREGFQFDYVFDWTIL 265
R D FDW +L
Sbjct: 282 LERLNTTEDENFDWNLL 298
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 472 bits (1216), Expect = e-166
Identities = 73/285 (25%), Positives = 127/285 (44%), Gaps = 22/285 (7%)
Query: 15 KTKHPQLLYESKLYRILQ--------------GGTGIPNVRWFGVEG----DYNVLVMDL 56
+ + L E K Y+ G+P G+ Y ++MD
Sbjct: 74 PSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDR 133
Query: 57 LGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQ 116
G L+ ++ +++ S KTVL L+ ++++ +E++H ++H DIK N L+ +Q
Sbjct: 134 FGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKN-PDQ 192
Query: 117 VYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLM 176
VY++D+GLA +Y H+ + GT + S++ H G+ SRR DLE LGY ++
Sbjct: 193 VYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMI 252
Query: 177 YFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC---RGYPTEFASYFHYCRSLRFD 233
+L G LPW+ K + KI ++ S+ C P E A Y + L +
Sbjct: 253 QWLTGHLPWEDNLKDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYT 312
Query: 234 DKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQLATPPAR 278
+KP Y L+ I G + D D ++++ + T +
Sbjct: 313 EKPLYENLRDILLQGLKAIGSKDDGKLDLSVVENGGLKAKTITKK 357
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 441 bits (1135), Expect = e-154
Identities = 73/271 (26%), Positives = 116/271 (42%), Gaps = 28/271 (10%)
Query: 15 KTKHPQLLYESKLYRILQGGT--------------GIPNVRWFGV----EGDYNVLVMDL 56
++ L E K Y+ + GIP G+ Y +VM+
Sbjct: 74 YQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMER 133
Query: 57 LGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQ 116
LG L+ + + TVL L +M++ +E++H ++H DIK N L+G +Q
Sbjct: 134 LGIDLQKISG-QNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKN-PDQ 191
Query: 117 VYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLM 176
VY+ D+GL+ +Y H+ K GT + S++ H G+ SRR D+E LGY ++
Sbjct: 192 VYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCML 251
Query: 177 YFLRGSLPWQGL---KAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFD 233
+L G LPW+ + K + E S A E A + SL +D
Sbjct: 252 RWLCGKLPWEQNLKDPVAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYD 311
Query: 234 DKPDYAYLKRIFRDLFIREGFQFDYVFDWTI 264
+KP+Y LK+I I G D++
Sbjct: 312 EKPNYQALKKILNPHGIPLGP-----LDFST 337
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 436 bits (1124), Expect = e-153
Identities = 65/255 (25%), Positives = 109/255 (42%), Gaps = 12/255 (4%)
Query: 17 KHPQLLYESKLYRILQGGTGIPNVRWFGV-EGDYNVLVMDLLGPSLEDLFNFCSRK-LSL 74
K Q+ KLY IP FGV + Y LV+ LG SL+ + + LS
Sbjct: 101 KPLQVNKWKKLYST--PLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSE 158
Query: 75 KTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 134
++VL +A ++++ +EF+H ++H ++ +N + + +QV + +G A +Y +
Sbjct: 159 RSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQ-SQVTLAGYGFAFRYCPS--G 215
Query: 135 QHIPYRENKN--LTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 192
+H+ Y E G + SM+ H G SRR DL+SLGY ++ +L G LPW T
Sbjct: 216 KHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNT 275
Query: 193 KKQKYEKISEKKVSTSIEALCRGY---PTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLF 249
+ +K C + Y +L +++KP YA L+ L
Sbjct: 276 EDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALL 335
Query: 250 IREGFQFDYVFDWTI 264
+
Sbjct: 336 QDLRVSPYDPIGLPM 350
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 80.1 bits (197), Expect = 1e-16
Identities = 26/152 (17%), Positives = 46/152 (30%), Gaps = 23/152 (15%)
Query: 51 VLVMDLLGPSLEDLFNFCSR------KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPD 104
+L+M LE LF+ + + +L Q+I + SK +H PD
Sbjct: 164 LLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPD 223
Query: 105 NFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYAS--MNTHLGIEQ 162
N + ++ + D K + YA
Sbjct: 224 NLFIM---PDGRLMLGDVSALWKVGTRGP----------ASSVPVTYAPREFLNASTATF 270
Query: 163 SRRDDLESLGYVLMY-FLRGSLPWQGLKAGTK 193
+ + LG + +Y LP+ + G K
Sbjct: 271 THALNAWQLG-LSIYRVWCLFLPFGLVTPGIK 301
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 5e-16
Identities = 40/188 (21%), Positives = 68/188 (36%), Gaps = 35/188 (18%)
Query: 40 VRWFGVEGDYN--VLVMDLLGPSLEDLFNFCSRK--LSLKTVLMLADQMINRVEFVHSKS 95
+R + E +VM+ DL ++ +K + M+ V +H
Sbjct: 72 IRLYDYEITDQYIYMVMECGN---IDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG 128
Query: 96 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYAS-- 153
+H D+KP NFL+ G + +IDFG+A + + +T + GT Y
Sbjct: 129 IVHSDLKPANFLIVDGM----LKLIDFGIANQMQPDTTSVVK-----DSQVGTVNYMPPE 179
Query: 154 ---------MNTHLGIEQSRRDDLESLG---YVLMYFLRGSLPWQGLKAGTKKQKYEKIS 201
N + S + D+ SLG Y + Y G P+Q + + K I
Sbjct: 180 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY---GKTPFQQII--NQISKLHAII 234
Query: 202 EKKVSTSI 209
+
Sbjct: 235 DPNHEIEF 242
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 77.7 bits (191), Expect = 8e-16
Identities = 30/194 (15%), Positives = 57/194 (29%), Gaps = 21/194 (10%)
Query: 36 GIPNV-RWFGVEGDYN----VLVMDLLGPSLEDLFNF------CSRKLSLKTVLMLADQM 84
+ R E D + + +L+ + L L L Q+
Sbjct: 156 QKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQV 215
Query: 85 INRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKN 144
I + +H +H ++P + ++ + V++ F + E
Sbjct: 216 IRLLASLHHYGLVHTYLRPVDIVLD---QRGGVFLTGFEHLVRDGARVVSSVSRGFEPPE 272
Query: 145 LTGTARYASMNTHLGIEQSRRDDLESLGYVLMY-FLRGSLPWQGLKAGTKKQKYEKI--S 201
L S + + D +LG +++Y LP E I S
Sbjct: 273 LEARRATISYHRDRRTLMTFSFDAWALG-LVIYWIWCADLPITK---DAALGGSEWIFRS 328
Query: 202 EKKVSTSIEALCRG 215
K + + AL G
Sbjct: 329 CKNIPQPVRALLEG 342
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 8e-16
Identities = 39/186 (20%), Positives = 68/186 (36%), Gaps = 31/186 (16%)
Query: 40 VRWFGVEGDYN--VLVMDLLGPSLEDLFNFCSRK--LSLKTVLMLADQMINRVEFVHSKS 95
+R + E +VM+ DL ++ +K + M+ V +H
Sbjct: 91 IRLYDYEITDQYIYMVMECGNI---DLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG 147
Query: 96 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYAS-- 153
+H D+KP NFL+ G + +IDFG+A + + +T + GT Y
Sbjct: 148 IVHSDLKPANFLIVDGM----LKLIDFGIANQMQPDTTSVVK-----DSQVGTVNYMPPE 198
Query: 154 ---------MNTHLGIEQSRRDDLESLGYVLMY-FLRGSLPWQGLKAGTKKQKYEKISEK 203
N + S + D+ SLG ++Y G P+Q + + K I +
Sbjct: 199 AIKDMSSSRENGKSKSKISPKSDVWSLG-CILYYMTYGKTPFQQII--NQISKLHAIIDP 255
Query: 204 KVSTSI 209
Sbjct: 256 NHEIEF 261
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 76.4 bits (188), Expect = 3e-15
Identities = 39/185 (21%), Positives = 67/185 (36%), Gaps = 29/185 (15%)
Query: 40 VRWFGVEGDYN--VLVMDLLGPSLEDLFNFCSRK--LSLKTVLMLADQMINRVEFVHSKS 95
+R + E +VM+ DL ++ +K + M+ V +H
Sbjct: 119 IRLYDYEITDQYIYMVMECGN---IDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG 175
Query: 96 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYAS-- 153
+H D+KP NFL+ G + +IDFG+A + + +T + G Y
Sbjct: 176 IVHSDLKPANFLIVDGM----LKLIDFGIANQMQPDTTSVVK-----DSQVGAVNYMPPE 226
Query: 154 ---------MNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 204
N + S + D+ SLG +L Y G P+Q + + K I +
Sbjct: 227 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII--NQISKLHAIIDPN 284
Query: 205 VSTSI 209
Sbjct: 285 HEIEF 289
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 75.6 bits (186), Expect = 3e-15
Identities = 53/269 (19%), Positives = 88/269 (32%), Gaps = 57/269 (21%)
Query: 17 KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL--GPSLEDLFNFCSRK--- 71
H ++ KL+ I + T + VL+M+ G L+
Sbjct: 65 NHKNIV---KLFAIEEETTT-----------RHKVLIMEFCPCG----SLYTVLEEPSNA 106
Query: 72 --LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVY-IIDFGLAKKY 128
L L++ ++ + + +HR+IKP N + +G VY + DFG A++
Sbjct: 107 YGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL 166
Query: 129 RDTSTHQHIPYRENKNLTGTARYAS--------MNTHLGIEQSRRDDLESLGYVLMY-FL 179
D +L GT Y + + DL S+G V Y
Sbjct: 167 EDDEQF--------VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIG-VTFYHAA 217
Query: 180 RGSLPWQGLKAG-TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDY 238
GSLP++ + K+ KI K S +I + + D P
Sbjct: 218 TGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSG---------DMPVS 268
Query: 239 AYLKRIFRDL---FIREGFQFDYVFDWTI 264
L R + L + + D W
Sbjct: 269 CSLSRGLQVLLTPVLANILEADQEKCWGF 297
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 4e-15
Identities = 45/160 (28%), Positives = 75/160 (46%), Gaps = 25/160 (15%)
Query: 36 GIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 94
I ++ E D LVM+ + GP+L + LS+ T + +Q+++ ++ H
Sbjct: 72 NIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIE-SHGPLSVDTAINFTNQILDGIKHAHDM 130
Query: 95 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASM 154
+HRDIKP N L+ + I DFG+AK +TS Q ++ GT +Y S
Sbjct: 131 RIVHRDIKPQNILID---SNKTLKIFDFGIAKALSETSLTQ------TNHVLGTVQYFSP 181
Query: 155 NTHLGIEQSR------RDDLESLGYVLMY-FLRGSLPWQG 187
EQ++ D+ S+G +++Y L G P+ G
Sbjct: 182 ------EQAKGEATDECTDIYSIG-IVLYEMLVGEPPFNG 214
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 75.9 bits (186), Expect = 4e-15
Identities = 25/180 (13%), Positives = 52/180 (28%), Gaps = 29/180 (16%)
Query: 51 VLVMDLLGPSLEDLFNFCSRK------LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPD 104
+ + +L+ L L L Q+I + +H +H ++P
Sbjct: 181 FFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPV 240
Query: 105 NFLMGLGRRANQVYIIDFGLAKKY-RDTSTHQHIPYRENKNLTGTARYAS-----MNTHL 158
+ ++ + V++ F + + + + H
Sbjct: 241 DIVLD---QRGGVFLTGFEHLVRDGASAVSPIGRGF-------APPETTAERMLPFGQHH 290
Query: 159 GIEQSRRDDLESLGYVLMYF-LRGSLPWQGLKAGTKKQKYEKI--SEKKVSTSIEALCRG 215
+ D +LG + +Y+ LP E I S K + + AL G
Sbjct: 291 PTLMTFAFDTWTLG-LAIYWIWCADLPNTD---DAALGGSEWIFRSCKNIPQPVRALLEG 346
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 74.9 bits (184), Expect = 7e-15
Identities = 53/269 (19%), Positives = 88/269 (32%), Gaps = 57/269 (21%)
Query: 17 KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL--GPSLEDLFNFCSRK--- 71
H ++ KL+ I + T + VL+M+ G L+
Sbjct: 65 NHKNIV---KLFAIEEETTT-----------RHKVLIMEFCPCG----SLYTVLEEPSNA 106
Query: 72 --LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVY-IIDFGLAKKY 128
L L++ ++ + + +HR+IKP N + +G VY + DFG A++
Sbjct: 107 YGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL 166
Query: 129 RDTSTHQHIPYRENKNLTGTARYAS--------MNTHLGIEQSRRDDLESLGYVLMY-FL 179
D +L GT Y + + DL S+G V Y
Sbjct: 167 EDDEQF--------VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIG-VTFYHAA 217
Query: 180 RGSLPWQGLKAG-TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDY 238
GSLP++ + K+ KI K S +I + + D P
Sbjct: 218 TGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSG---------DMPVS 268
Query: 239 AYLKRIFRDL---FIREGFQFDYVFDWTI 264
L R + L + + D W
Sbjct: 269 CSLSRGLQVLLTPVLANILEADQEKCWGF 297
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 73.7 bits (181), Expect = 4e-14
Identities = 29/163 (17%), Positives = 58/163 (35%), Gaps = 35/163 (21%)
Query: 36 GIPNVRWFGVEGDYNV-----LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVE 89
I + F D + +VM+ + G SL+ +KL + + +++ +
Sbjct: 140 SIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG---QKLPVAEAIAYLLEILPALS 196
Query: 90 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTA 149
++HS ++ D+KP+N ++ Q+ +ID G + L GT
Sbjct: 197 YLHSIGLVYNDLKPENIML----TEEQLKLIDLGAVSRINSFGY-----------LYGTP 241
Query: 150 RYASMNTHLGIEQSR-----RDDLESLGYVLMYFLRGSLPWQG 187
+ + E R D+ ++G L G
Sbjct: 242 GFQAP------EIVRTGPTVATDIYTVGRTLAALTLDLPTRNG 278
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 72.9 bits (179), Expect = 4e-14
Identities = 36/160 (22%), Positives = 64/160 (40%), Gaps = 15/160 (9%)
Query: 38 PN-VRWFGVEGDYNV--LVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 94
PN +R+F E D + ++L +L++ + L Q + + +HS
Sbjct: 78 PNVIRYFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSL 137
Query: 95 SFLHRDIKPDNFL--MGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 152
+ +HRD+KP N L M + I DFGL KK + + GT +
Sbjct: 138 NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHS----FSRRSGVPGTEGWI 193
Query: 153 S---MNTHLGIEQSRRDDLESLGYVLMYFL--RGSLPWQG 187
+ ++ + D+ S G + Y++ GS P+
Sbjct: 194 APEMLSEDCKENPTYTVDIFSAG-CVFYYVISEGSHPFGK 232
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 72.5 bits (178), Expect = 6e-14
Identities = 46/206 (22%), Positives = 78/206 (37%), Gaps = 37/206 (17%)
Query: 29 RILQGGTGIPN-VRWFGVEGDYNV--LVMDLLGPSLEDL------FNFCSRKLSLKTVLM 79
++L PN +R++ E + ++L +L+DL + + +
Sbjct: 60 KLLTESDDHPNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPIS 119
Query: 80 LADQMINRVEFVHSKSFLHRDIKPDNFL----------MGLGRRANQVYIIDFGLAKKYR 129
L Q+ + V +HS +HRD+KP N L G ++ I DFGL KK
Sbjct: 120 LLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLD 179
Query: 130 DTSTHQHIPYRENKNLTGTARYA-------SMNTHLGIEQSRRDDLESLGYVLMYFL--R 180
Q N +GT+ + S N +R D+ S+G + Y++ +
Sbjct: 180 SG---QSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMG-CVFYYILSK 235
Query: 181 GSLPWQGLKAGTKKQKYEKISEKKVS 206
G P+ G K + I S
Sbjct: 236 GKHPF-----GDKYSRESNIIRGIFS 256
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 1e-13
Identities = 38/153 (24%), Positives = 63/153 (41%), Gaps = 11/153 (7%)
Query: 36 GIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 94
+ + FG + M L+ G L + L+ + + Q+ + ++ H+
Sbjct: 95 HVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGP-LAPPRAVAIVRQIGSALDAAHAA 153
Query: 95 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASM 154
HRD+KP+N L+ + Y++DFG+A D Q N GT Y +
Sbjct: 154 GATHRDVKPENILVS---ADDFAYLVDFGIASATTDEKLTQ------LGNTVGTLYYMAP 204
Query: 155 NTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 187
+ R D+ +L VL L GS P+QG
Sbjct: 205 ERFSESHATYRADIYALTCVLYECLTGSPPYQG 237
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 4e-13
Identities = 40/152 (26%), Positives = 68/152 (44%), Gaps = 23/152 (15%)
Query: 44 GVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIK 102
G +VM+ + G +L D+ + ++ K + + + F H +HRD+K
Sbjct: 85 TPAGPLPYIVMEYVDGVTLRDIVH-TEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVK 143
Query: 103 PDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQ 162
P N ++ N V ++DFG+A+ D+ + + GTA+Y S EQ
Sbjct: 144 PANIMIS---ATNAVKVMDFGIARAIADSGN----SVTQTAAVIGTAQYLSP------EQ 190
Query: 163 SR------RDDLESLGYVLMY-FLRGSLPWQG 187
+R R D+ SLG ++Y L G P+ G
Sbjct: 191 ARGDSVDARSDVYSLG-CVLYEVLTGEPPFTG 221
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 4e-13
Identities = 36/178 (20%), Positives = 65/178 (36%), Gaps = 28/178 (15%)
Query: 17 KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLK 75
H Y + Y + + M+ +L DL + +
Sbjct: 60 NHQ---YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRD 116
Query: 76 TVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT---- 131
L Q++ + ++HS+ +HRD+KP N + + V I DFGLAK +
Sbjct: 117 EYWRLFRQILEALSYIHSQGIIHRDLKPMNIFID---ESRNVKIGDFGLAKNVHRSLDIL 173
Query: 132 STHQHIPYRENKNLT---GTARYAS--MNTHLGIEQSRRDDLE----SLG---YVLMY 177
+ NLT GTA Y + + ++ + + + SLG + ++Y
Sbjct: 174 KLDSQNLPGSSDNLTSAIGTAMYVATEV-----LDGTGHYNEKIDMYSLGIIFFEMIY 226
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 43/270 (15%), Positives = 86/270 (31%), Gaps = 55/270 (20%)
Query: 17 KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRK----- 71
HP ++ + G + D +L M+ DL + ++
Sbjct: 70 NHPNVV---SAREVPDGLQKLA-------PNDLPLLAMEYC--EGGDLRKYLNQFENCCG 117
Query: 72 LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 131
L + L + + + ++H +HRD+KP+N ++ G + IID G AK+
Sbjct: 118 LKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG 177
Query: 132 STHQHIPYRENKNLTGTARYAS--MNTHLGIEQSRRD---DLESLGYVLMYFL-RGSLPW 185
GT +Y + + +EQ + D S G L + G P+
Sbjct: 178 EL--------CTEFVGTLQYLAPEL-----LEQKKYTVTVDYWSFG-TLAFECITGFRPF 223
Query: 186 QGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRF-DDKPDYAYLKRI 244
+ ++ +K + I Y +++F P +L I
Sbjct: 224 LP---NWQPVQWHGKVREKSNEHIVV-----------YDDLTGAVKFSSVLPTPNHLSGI 269
Query: 245 FRDL---FIREGFQFDYVFDWTILKYQQSQ 271
+++ + T +
Sbjct: 270 LAGKLERWLQCMLMWHQRQRGTDPQNPNVG 299
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 3e-12
Identities = 30/139 (21%), Positives = 55/139 (39%), Gaps = 15/139 (10%)
Query: 52 LVMDL-LGPSLEDLFNFCSRK---LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFL 107
L++ +L + K L+ +L L + +E +H+K + HRD+KP N L
Sbjct: 107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNIL 166
Query: 108 MGLGRRANQVYIIDFGLAKKYRDT--STHQHIPYRENKNLTGTARYAS---MNTHLGIEQ 162
+G Q ++D G + + Q + ++ T Y + +
Sbjct: 167 LG---DEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVI 223
Query: 163 SRRDDLESLG---YVLMYF 178
R D+ SLG Y +M+
Sbjct: 224 DERTDVWSLGCVLYAMMFG 242
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 2e-11
Identities = 27/132 (20%), Positives = 55/132 (41%), Gaps = 21/132 (15%)
Query: 29 RILQGGTGIPN-VRWFGV--EGDYNVLVMDLL--GPSLEDLFNFCSRK----LSLKTVLM 79
+L+ P + V +L+++ G ++F+ C + +S V+
Sbjct: 80 AVLELAKSCPRVINLHEVYENTSEIILILEYAAGG----EIFSLCLPELAEMVSENDVIR 135
Query: 80 LADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPY 139
L Q++ V ++H + +H D+KP N L+ + I+DFG+++K
Sbjct: 136 LIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACEL----- 190
Query: 140 RENKNLTGTARY 151
+ + GT Y
Sbjct: 191 ---REIMGTPEY 199
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 2e-11
Identities = 44/182 (24%), Positives = 78/182 (42%), Gaps = 35/182 (19%)
Query: 38 PN-VRWFGV-EGDYNV-LVMDLL--GPSLEDLFN-FCSRK-LSLKTVLMLADQMINRVEF 90
PN ++ + E LV ++ G +LF+ SRK S + Q+++ + +
Sbjct: 86 PNIMKLYEFFEDKGYFYLVGEVYTGG----ELFDEIISRKRFSEVDAARIIRQVLSGITY 141
Query: 91 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTAR 150
+H +HRD+KP+N L+ + + IIDFGL+ + + K+ GTA
Sbjct: 142 MHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM--------KDKIGTAY 193
Query: 151 YASMNTHLGIEQSRRD-----DLESLGYVLMYF-LRGSLPWQGLKAGTKKQKYEKISEKK 204
Y + E D+ S G V++Y L G P+ G + +K+ + K
Sbjct: 194 YIAP------EVLHGTYDEKCDVWSTG-VILYILLSGCPPFNG---ANEYDILKKVEKGK 243
Query: 205 VS 206
+
Sbjct: 244 YT 245
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 3e-11
Identities = 22/108 (20%), Positives = 49/108 (45%), Gaps = 18/108 (16%)
Query: 51 VLVMDLL--GPSLEDLFNFCSRK---LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDN 105
V++ + + D+F + L+ + ++ Q+ ++F+HS + H DI+P+N
Sbjct: 77 VMIFEFISGL----DIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPEN 132
Query: 106 FLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYAS 153
+ RR++ + II+FG A++ + + L Y +
Sbjct: 133 IIY-QTRRSSTIKIIEFGQARQLKPGDNF--------RLLFTAPEYYA 171
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 4e-11
Identities = 25/101 (24%), Positives = 38/101 (37%), Gaps = 6/101 (5%)
Query: 38 PN-VRWFG--VEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 94
P VR EG L +L GPSL+ L V + + +HS+
Sbjct: 117 PCCVRLEQAWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQ 176
Query: 95 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ 135
+H D+KP N +G + + DFGL + +
Sbjct: 177 GLVHLDVKPANIFLG---PRGRCKLGDFGLLVELGTAGAGE 214
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 4e-11
Identities = 44/182 (24%), Positives = 82/182 (45%), Gaps = 35/182 (19%)
Query: 38 PN-VRWFGV-EGDYNV-LVMDLL--GPSLEDLFN-FCSRK-LSLKTVLMLADQMINRVEF 90
PN ++ + E N LVM+ G +LF+ R + ++ Q+++ V +
Sbjct: 96 PNIMKLYDFFEDKRNYYLVMECYKGG----ELFDEIIHRMKFNEVDAAVIIKQVLSGVTY 151
Query: 91 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTAR 150
+H + +HRD+KP+N L+ + + I+DFGL+ + + K GTA
Sbjct: 152 LHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKM--------KERLGTAY 203
Query: 151 YASMNTHLGIEQSRRD-----DLESLGYVLMYF-LRGSLPWQGLKAGTKKQKYEKISEKK 204
Y + E R+ D+ S+G V+++ L G P+ G T ++ K+ + K
Sbjct: 204 YIAP------EVLRKKYDEKCDVWSIG-VILFILLAGYPPFGG---QTDQEILRKVEKGK 253
Query: 205 VS 206
+
Sbjct: 254 YT 255
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 4e-11
Identities = 42/180 (23%), Positives = 72/180 (40%), Gaps = 38/180 (21%)
Query: 24 ESKLYRILQGGTGIPNV----RWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVL- 78
E L + G G P V WF + + +LV++ P+ +DLF++ + K L
Sbjct: 84 EVALLWKVGAGGGHPGVIRLLDWFETQEGF-MLVLERPLPA-QDLFDYITEKGPLGEGPS 141
Query: 79 -MLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHI 137
Q++ ++ HS+ +HRDIK +N L + R +IDFG D
Sbjct: 142 RCFFGQVVAAIQHCHSRGVVHRDIKDENIL--IDLRRGCAKLIDFGSGALLHDEPYT--- 196
Query: 138 PYRENKNLT--GTARYA-----SMNTHLGIEQSRRDDLESLG---YVLMYFLRGSLPWQG 187
GT Y+ S + + + + SLG Y ++ G +P++
Sbjct: 197 --------DFDGTRVYSPPEWISRHQYHALPA----TVWSLGILLYDMVC---GDIPFER 241
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 63.7 bits (155), Expect = 5e-11
Identities = 26/108 (24%), Positives = 52/108 (48%), Gaps = 18/108 (16%)
Query: 51 VLVMDLL--GPSLEDLFNFCSRK---LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDN 105
V++ + + G +LF + + +S + Q+ + +H +++H D+KP+N
Sbjct: 230 VMIYEFMSGG----ELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPEN 285
Query: 106 FLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYAS 153
+ +R+N++ +IDFGL P + K TGTA +A+
Sbjct: 286 IMF-TTKRSNELKLIDFGLTAHLD--------PKQSVKVTTGTAEFAA 324
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 62.6 bits (152), Expect = 6e-11
Identities = 31/110 (28%), Positives = 41/110 (37%), Gaps = 13/110 (11%)
Query: 53 VMDLL-GPSLEDLFNFCSRKLSL--KTVLMLADQMINRVEFVHSKSFLHRDIKPDN-FLM 108
M L +L+D N L + Q+ VEF+HSK +HRD+KP N F
Sbjct: 139 QMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFT 198
Query: 109 GLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLT-----GTARYAS 153
+ V + DFGL Q + T GT Y S
Sbjct: 199 ----MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS 244
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 7e-11
Identities = 51/184 (27%), Positives = 85/184 (46%), Gaps = 35/184 (19%)
Query: 38 PN-VRWFGV-EGDYNV-LVMDLL--GPSLEDLF------NFCSRKLSLKTVLMLADQMIN 86
PN ++ F V E +N+ +VM+ G +L + LS V L QM+N
Sbjct: 80 PNIIKIFEVFEDYHNMYIVMETCEGG----ELLERIVSAQARGKALSEGYVAELMKQMMN 135
Query: 87 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLT 146
+ + HS+ +H+D+KP+N L + + IIDFGLA+ ++ N
Sbjct: 136 ALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS--------TNAA 187
Query: 147 GTARYAS---MNTHLGIEQSRRDDLESLGYVLMYF-LRGSLPWQGLKAGTKKQKYEKISE 202
GTA Y + + + D+ S G V+MYF L G LP+ G + ++ +K +
Sbjct: 188 GTALYMAPEVFKRDVTFKC----DIWSAG-VVMYFLLTGCLPFTG---TSLEEVQQKATY 239
Query: 203 KKVS 206
K+ +
Sbjct: 240 KEPN 243
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 7e-11
Identities = 39/138 (28%), Positives = 63/138 (45%), Gaps = 27/138 (19%)
Query: 51 VLVMDLL--GPSLEDLFNFCSRK---LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDN 105
VL+++ L G +LF+ + + +S V+ Q ++ +H S +H DIKP+N
Sbjct: 124 VLILEFLSGG----ELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPEN 179
Query: 106 FLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYAS----MNTHLGIE 161
+ ++A+ V IIDFGLA K K T TA +A+ +G
Sbjct: 180 IMC-ETKKASSVKIIDFGLATKLNPDEIV--------KVTTATAEFAAPEIVDREPVGFY 230
Query: 162 QSRRDDLESLGYVLMYFL 179
D+ ++G VL Y L
Sbjct: 231 T----DMWAIG-VLGYVL 243
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 44/182 (24%), Positives = 81/182 (44%), Gaps = 35/182 (19%)
Query: 38 PN-VRWFGV-EGDYNV-LVMDLL--GPSLEDLFN-FCSRK-LSLKTVLMLADQMINRVEF 90
PN ++ F + E + +V +L G +LF+ RK S + Q+ + + +
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGG----ELFDEIIKRKRFSEHDAARIIKQVFSGITY 136
Query: 91 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTAR 150
+H + +HRD+KP+N L+ + + IIDFGL+ ++ + K+ GTA
Sbjct: 137 MHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM--------KDRIGTAY 188
Query: 151 YASMNTHLGIEQSRRD-----DLESLGYVLMYF-LRGSLPWQGLKAGTKKQKYEKISEKK 204
Y + E R D+ S G V++Y L G+ P+ G + +++ K
Sbjct: 189 YIAP------EVLRGTYDEKCDVWSAG-VILYILLSGTPPFYG---KNEYDILKRVETGK 238
Query: 205 VS 206
+
Sbjct: 239 YA 240
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 61.5 bits (149), Expect = 2e-10
Identities = 25/95 (26%), Positives = 43/95 (45%), Gaps = 13/95 (13%)
Query: 48 DYNVLVMDLL-GPSLEDLFN----FCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIK 102
+ +VLV +L +L + N + + V+ A +M+ +E VH +H DIK
Sbjct: 140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIK 199
Query: 103 PDNFLMGLGRRANQ--------VYIIDFGLAKKYR 129
PDNF++G G + +ID G + +
Sbjct: 200 PDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMK 234
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 2e-10
Identities = 45/130 (34%), Positives = 64/130 (49%), Gaps = 27/130 (20%)
Query: 83 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYREN 142
++ N + + HSK +HRDIKP+N L+G A ++ I DFG + H P
Sbjct: 117 ELANALSYCHSKRVIHRDIKPENLLLG---SAGELKIADFGWSV---------HAPSSRR 164
Query: 143 KNLTGTARYAS--MNTHLGIEQSRRD---DLESLGYVLMY-FLRGSLPWQGLKAGTKKQK 196
+L GT Y M IE D DL SLG VL Y FL G P++ A T ++
Sbjct: 165 TDLCGTLDYLPPEM-----IEGRMHDEKVDLWSLG-VLCYEFLVGKPPFE---ANTYQET 215
Query: 197 YEKISEKKVS 206
Y++IS + +
Sbjct: 216 YKRISRVEFT 225
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 2e-10
Identities = 31/107 (28%), Positives = 56/107 (52%), Gaps = 19/107 (17%)
Query: 51 VLVMDLL--GPSLEDLFNFCSRKLSL--KTVLMLADQMINRVEFVHSKSFLHRDIKPDNF 106
VL+++L+ G +LF+F ++K SL + Q+++ V ++H+K H D+KP+N
Sbjct: 91 VLILELVSGG----ELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENI 146
Query: 107 LMGLGRRAN--QVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY 151
++ L + + +IDFGLA + D KN+ GT +
Sbjct: 147 ML-LDKNIPIPHIKLIDFGLAHEIEDGVEF--------KNIFGTPEF 184
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 59.9 bits (146), Expect = 3e-10
Identities = 30/106 (28%), Positives = 53/106 (50%), Gaps = 17/106 (16%)
Query: 51 VLVMDLL--GPSLEDLFNFCSRKLSL--KTVLMLADQMINRVEFVHSKSFLHRDIKPDNF 106
VL+++L+ G +LF+F + K SL Q+++ V ++HSK H D+KP+N
Sbjct: 84 VLILELVSGG----ELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENI 139
Query: 107 LM-GLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY 151
++ ++ +IDFG+A K + KN+ GT +
Sbjct: 140 MLLDKNVPNPRIKLIDFGIAHKIEAGNEF--------KNIFGTPEF 177
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 3e-10
Identities = 39/162 (24%), Positives = 67/162 (41%), Gaps = 24/162 (14%)
Query: 52 LVMDLL--GPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFL 107
+V+DLL G DL + +TV + +++ ++++ ++ +HRD+KPDN L
Sbjct: 92 MVVDLLLGG----DLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNIL 147
Query: 108 MGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYAS---MNTHLGIEQSR 164
+ V+I DF +A + + GT Y + ++ G S
Sbjct: 148 LD---EHGHVHITDFNIAAMLPRETQI--------TTMAGTKPYMAPEMFSSRKGAGYSF 196
Query: 165 RDDLESLGYVLMY-FLRGSLPWQGLKAGTKKQKYEKISEKKV 205
D SLG V Y LRG P+ + + K+ V
Sbjct: 197 AVDWWSLG-VTAYELLRGRRPYHIRSSTSSKEIVHTFETTVV 237
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 60.2 bits (146), Expect = 4e-10
Identities = 29/127 (22%), Positives = 61/127 (48%), Gaps = 11/127 (8%)
Query: 83 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYREN 142
Q+ + + ++H++ HRDIKP+NFL ++ ++ ++DFGL+K++ + ++
Sbjct: 176 QIFSALHYLHNQGICHRDIKPENFLF-STNKSFEIKLVDFGLSKEFYKLNNGEYYGMTT- 233
Query: 143 KNLTGTARYAS--MNTHLGIEQSRRDDLESLGYVLMYF-LRGSLPWQGLKAGTKKQKYEK 199
GT + + + + D S G VL++ L G++P+ G +
Sbjct: 234 --KAGTPYFVAPEVLNTTNESYGPKCDAWSAG-VLLHLLLMGAVPFPG---VNDADTISQ 287
Query: 200 ISEKKVS 206
+ KK+
Sbjct: 288 VLNKKLC 294
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 4e-10
Identities = 31/107 (28%), Positives = 56/107 (52%), Gaps = 19/107 (17%)
Query: 51 VLVMDLL--GPSLEDLFNFCSRKLSL--KTVLMLADQMINRVEFVHSKSFLHRDIKPDNF 106
VL+++L+ G +LF+F ++K SL + Q+++ V ++H+K H D+KP+N
Sbjct: 91 VLILELVSGG----ELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENI 146
Query: 107 LMGLGRRAN--QVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY 151
++ L + + +IDFGLA + D KN+ GT +
Sbjct: 147 ML-LDKNIPIPHIKLIDFGLAHEIEDGVEF--------KNIFGTPEF 184
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 4e-10
Identities = 38/151 (25%), Positives = 59/151 (39%), Gaps = 35/151 (23%)
Query: 52 LVMDLLGPSLEDLFNFCSRK--LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMG 109
LVM+ G L+ LF F R L + Q+++ V ++ K +HRDIK +N +
Sbjct: 106 LVMEKHGSGLD-LFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIV-- 162
Query: 110 LGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLT---GTARYA-----SMNTHLGIE 161
+ + +IDFG A K GT Y N + G E
Sbjct: 163 IAEDFT-IKLIDFGSAAYLER-----------GKLFYTFCGTIEYCAPEVLMGNPYRGPE 210
Query: 162 QSRRDDLESLG---YVLMYFLRGSLPWQGLK 189
++ SLG Y L++ P+ L+
Sbjct: 211 L----EMWSLGVTLYTLVF---EENPFCELE 234
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 4e-10
Identities = 29/109 (26%), Positives = 39/109 (35%), Gaps = 11/109 (10%)
Query: 53 VMDLL-GPSLEDLFNFCSRKLSL--KTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMG 109
M L +L+D N L + Q+ VEF+HSK +HRD+KP N
Sbjct: 93 QMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFT 152
Query: 110 LGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLT-----GTARYAS 153
+ V + DFGL Q + GT Y S
Sbjct: 153 ---MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMS 198
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 4e-10
Identities = 31/109 (28%), Positives = 46/109 (42%), Gaps = 17/109 (15%)
Query: 52 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF--------LHRDIK 102
L+ D SL D S L K++L LA ++ + +H++ F HRD+K
Sbjct: 112 LITDYHENGSLYDYLK--STTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLK 169
Query: 103 PDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY 151
N L+ ++ I D GLA K+ + IP GT RY
Sbjct: 170 SKNILV---KKNGTCCIADLGLAVKFISDTNEVDIP---PNTRVGTKRY 212
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 5e-10
Identities = 39/168 (23%), Positives = 66/168 (39%), Gaps = 38/168 (22%)
Query: 36 GIPNV----RWFGVEGDYNVLVMDLLGPSLEDLFNFCSRK--LSLKTVLMLADQMINRVE 89
G V WF + VL+++ P +DLF+F + + L + Q++ V
Sbjct: 106 GFSGVIRLLDWFERPDSF-VLILERPEPV-QDLFDFITERGALQEELARSFFWQVLEAVR 163
Query: 90 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLT--G 147
H+ LHRDIK +N L + ++ +IDFG +DT G
Sbjct: 164 HCHNCGVLHRDIKDENIL--IDLNRGELKLIDFGSGALLKDTVYT-----------DFDG 210
Query: 148 TARYA-----SMNTHLGIEQSRRDDLESLG---YVLMYFLRGSLPWQG 187
T Y+ + + G + SLG Y ++ G +P++
Sbjct: 211 TRVYSPPEWIRYHRYHGRSA----AVWSLGILLYDMVC---GDIPFEH 251
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 5e-10
Identities = 31/106 (29%), Positives = 53/106 (50%), Gaps = 17/106 (16%)
Query: 51 VLVMDLL--GPSLEDLFNFCSRKLSL--KTVLMLADQMINRVEFVHSKSFLHRDIKPDNF 106
+L+++L+ G +LF+F + K SL + Q++N V ++HS H D+KP+N
Sbjct: 90 ILILELVAGG----ELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENI 145
Query: 107 LMG-LGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY 151
++ ++ IIDFGLA K + KN+ GT +
Sbjct: 146 MLLDRNVPKPRIKIIDFGLAHKIDFGNEF--------KNIFGTPEF 183
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 5e-10
Identities = 43/201 (21%), Positives = 83/201 (41%), Gaps = 14/201 (6%)
Query: 52 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL 110
+V G SL + K +K ++ +A Q ++++H+KS +HRD+K +N +
Sbjct: 96 IVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLH- 154
Query: 111 GRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYAS---MNTHLGIEQSRRDD 167
N V I DFGLA + S + + L+G+ + + + S + D
Sbjct: 155 --EDNTVKIGDFGLATEKSRWSG-----SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSD 207
Query: 168 LESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYC 227
+ + G VL + G LP+ + + Q E + +S + + P C
Sbjct: 208 VYAFGIVLYELMTGQLPYSNINN--RDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAEC 265
Query: 228 RSLRFDDKPDYAYLKRIFRDL 248
+ D++P + + +L
Sbjct: 266 LKKKRDERPSFPRILAEIEEL 286
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 6e-10
Identities = 31/106 (29%), Positives = 50/106 (47%), Gaps = 18/106 (16%)
Query: 51 VLVMDLL--GPSLEDLFNFCSRK---LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDN 105
VLVM+ + G +LF+ + L+ ++ Q+ + +H LH D+KP+N
Sbjct: 162 VLVMEYVDGG----ELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPEN 217
Query: 106 FLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY 151
L + R A Q+ IIDFGLA++Y+ K GT +
Sbjct: 218 ILC-VNRDAKQIKIIDFGLARRYKPREKL--------KVNFGTPEF 254
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 7e-10
Identities = 26/101 (25%), Positives = 48/101 (47%), Gaps = 10/101 (9%)
Query: 38 PN-VRWFGVEGDYNV-LVMDLL--GPSLEDLFNF-CSR-KLSLKTVLMLADQMINRVEFV 91
P ++ + +V++L+ G +LF+ +L T + QM+ V+++
Sbjct: 200 PCIIKIKNFFDAEDYYIVLELMEGG----ELFDKVVGNKRLKEATCKLYFYQMLLAVQYL 255
Query: 92 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 132
H +HRD+KP+N L+ + I DFG +K +TS
Sbjct: 256 HENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS 296
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 8e-10
Identities = 26/148 (17%), Positives = 53/148 (35%), Gaps = 18/148 (12%)
Query: 52 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL 110
++ L G +L + L + +A +++ + ++H+K LH+D+K N
Sbjct: 106 IITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYDN 165
Query: 111 GRRANQVYIIDFGLAK-KYRDTSTHQHIPYRENKNLTGTARY---------ASMNTHLGI 160
G+ V I DFGL + + R G + + +
Sbjct: 166 GK----VVITDFGLFSISGVLQAGRREDKLRIQ---NGWLCHLAPEIIRQLSPDTEEDKL 218
Query: 161 EQSRRDDLESLGYVLMYFLRGSLPWQGL 188
S+ D+ +LG + P++
Sbjct: 219 PFSKHSDVFALGTIWYELHAREWPFKTQ 246
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 8e-10
Identities = 26/85 (30%), Positives = 37/85 (43%), Gaps = 11/85 (12%)
Query: 69 SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 128
KL L L +Q+ V+++HSK ++RD+KP N + QV I DFGL
Sbjct: 116 GEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLV---DTKQVKIGDFGLVTSL 172
Query: 129 RDTSTHQHIPYRENKNLTGTARYAS 153
++ GT RY S
Sbjct: 173 KNDGKRTRS--------KGTLRYMS 189
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 9e-10
Identities = 43/182 (23%), Positives = 75/182 (41%), Gaps = 35/182 (19%)
Query: 38 PN-VRWFGV-EGDYNV-LVMDLL--GPSLEDLFN-FCSRK-LSLKTVLMLADQMINRVEF 90
PN ++ F V E LV + G +LF +R + Q+++ + +
Sbjct: 106 PNIIKLFDVFEDKKYFYLVTEFYEGG----ELFEQIINRHKFDECDAANIMKQILSGICY 161
Query: 91 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTAR 150
+H + +HRDIKP+N L+ + I+DFGL+ + ++ GTA
Sbjct: 162 LHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKL--------RDRLGTAY 213
Query: 151 YASMNTHLGIEQSRRD-----DLESLGYVLMYF-LRGSLPWQGLKAGTKKQKYEKISEKK 204
Y + E ++ D+ S G V+MY L G P+ G + +K+ + K
Sbjct: 214 YIAP------EVLKKKYNEKCDVWSCG-VIMYILLCGYPPFGG---QNDQDIIKKVEKGK 263
Query: 205 VS 206
Sbjct: 264 YY 265
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 9e-10
Identities = 35/130 (26%), Positives = 55/130 (42%), Gaps = 27/130 (20%)
Query: 83 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYREN 142
++ + + + H + +HRDIKP+N LMG ++ I DFG + H P
Sbjct: 122 ELADALHYCHERKVIHRDIKPENLLMG---YKGELKIADFGWSV---------HAPSLRR 169
Query: 143 KNLTGTARYAS--MNTHLGIEQSRRD---DLESLGYVLMY-FLRGSLPWQGLKAGTKKQK 196
+ + GT Y M IE D DL G VL Y FL G P+ + + +
Sbjct: 170 RTMCGTLDYLPPEM-----IEGKTHDEKVDLWCAG-VLCYEFLVGMPPFD---SPSHTET 220
Query: 197 YEKISEKKVS 206
+ +I +
Sbjct: 221 HRRIVNVDLK 230
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 1e-09
Identities = 47/180 (26%), Positives = 74/180 (41%), Gaps = 31/180 (17%)
Query: 38 PN-VRWFGV-EGDYNV-LVMDLL--GPSLEDLFNFCSRK--LSLKTVLMLADQMINRVEF 90
PN +R + E + ++ LVM+L G +LF K + +++ V +
Sbjct: 66 PNIIRLYETFEDNTDIYLVMELCTGG----ELFERVVHKRVFRESDAARIMKDVLSAVAY 121
Query: 91 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTAR 150
H + HRD+KP+NFL + + +IDFGLA +++ + GT
Sbjct: 122 CHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM--------RTKVGTPY 173
Query: 151 YAS---MNTHLGIEQSRRDDLESLGYVLMYF-LRGSLPWQGLKAGTKKQKYEKISEKKVS 206
Y S + G E D S G V+MY L G P+ T + KI E +
Sbjct: 174 YVSPQVLEGLYGPEC----DEWSAG-VMMYVLLCGYPPFSA---PTDSEVMLKIREGTFT 225
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 58.3 bits (142), Expect = 1e-09
Identities = 35/122 (28%), Positives = 52/122 (42%), Gaps = 19/122 (15%)
Query: 83 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYREN 142
Q+I + ++HS LHRD+ N L+ R + I DFGL +T +P+ ++
Sbjct: 120 QIITGMLYLHSHGILHRDLTLSNLLLT---RNMNIKIADFGL-------ATQLKMPHEKH 169
Query: 143 KNLTGTARYAS--MNTHLGIEQSRRDDLESLGYVLMY-FLRGSLPWQGLKAGTKKQKYEK 199
L GT Y S + T D+ SLG + Y L G P+ T K K
Sbjct: 170 YTLCGTPNYISPEIAT--RSAHGLESDVWSLG-CMFYTLLIGRPPFD---TDTVKNTLNK 223
Query: 200 IS 201
+
Sbjct: 224 VV 225
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 1e-09
Identities = 28/102 (27%), Positives = 44/102 (43%), Gaps = 6/102 (5%)
Query: 83 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYREN 142
+ + ++F+H+K HRD+KP+N L + + V I DF L + I E
Sbjct: 119 DVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPEL 178
Query: 143 KNLTGTARYASMNTHLGIEQSRRD-----DLESLGYVLMYFL 179
G+A Y + + DL SLG V++Y L
Sbjct: 179 LTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLG-VILYIL 219
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 58.3 bits (142), Expect = 1e-09
Identities = 20/87 (22%), Positives = 38/87 (43%), Gaps = 6/87 (6%)
Query: 52 LVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 111
LV + ++ + R + V + Q + V F H + +HRD+KP+N L+
Sbjct: 79 LVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILIT-- 136
Query: 112 RRANQVYIIDFGLAKKYR---DTSTHQ 135
+ + + + DFG A+ D +
Sbjct: 137 -KHSVIKLCDFGFARLLTGPSDYYDDE 162
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 57.9 bits (141), Expect = 2e-09
Identities = 28/87 (32%), Positives = 43/87 (49%), Gaps = 6/87 (6%)
Query: 52 LVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 111
LV + L L+ L + C L T Q++N + + H + LHRD+KP N L+
Sbjct: 77 LVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLIN-- 134
Query: 112 RRANQVYIIDFGLAKKYRD---TSTHQ 135
R ++ I DFGLA+ + TH+
Sbjct: 135 -REGELKIADFGLARAFGIPVRKYTHE 160
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 2e-09
Identities = 22/87 (25%), Positives = 39/87 (44%), Gaps = 6/87 (6%)
Query: 52 LVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 111
LV + + L+ + + L + + Q++ V H LHRD+KP N L+
Sbjct: 96 LVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLIN-- 153
Query: 112 RRANQVYIIDFGLAKKYRD---TSTHQ 135
+ + DFGLA+ + + TH+
Sbjct: 154 -SDGALKLADFGLARAFGIPVRSYTHE 179
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 2e-09
Identities = 30/143 (20%), Positives = 55/143 (38%), Gaps = 18/143 (12%)
Query: 51 VLVMDLLGPSLEDLFNFCSRK--LSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNF 106
+L+ +L L + + LS TVL + Q V+ +H + +HRD+K +N
Sbjct: 110 LLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENL 169
Query: 107 LMGLGRRANQVYIIDFGLAKKYRD-----TSTHQHIPYRENKNLTGTARYAS---MNTHL 158
L+ + + DFG A S + E T Y + ++ +
Sbjct: 170 LLS---NQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYS 226
Query: 159 GIEQSRRDDLESLG---YVLMYF 178
+ D+ +LG Y+L +
Sbjct: 227 NFPIGEKQDIWALGCILYLLCFR 249
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 2e-09
Identities = 36/151 (23%), Positives = 66/151 (43%), Gaps = 22/151 (14%)
Query: 38 PN-VRWFGVEGDYNV-LVMDLL--GPSLEDLFNF-CSR-KLSLKTVLMLADQMINRVEFV 91
P ++ + +V++L+ G +LF+ +L T + QM+ V+++
Sbjct: 75 PCIIKIKNFFDAEDYYIVLELMEGG----ELFDKVVGNKRLKEATCKLYFYQMLLAVQYL 130
Query: 92 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY 151
H +HRD+KP+N L+ + I DFG +K +TS + L GT Y
Sbjct: 131 HENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM--------RTLCGTPTY 182
Query: 152 AS---MNTHLGIEQSRRDDLESLGYVLMYFL 179
+ + + +R D SLG V+++
Sbjct: 183 LAPEVLVSVGTAGYNRAVDCWSLG-VILFIC 212
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 57.5 bits (140), Expect = 2e-09
Identities = 24/87 (27%), Positives = 44/87 (50%), Gaps = 6/87 (6%)
Query: 52 LVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 111
LV + L+ F+ C+ L + V Q++ + F HS++ LHRD+KP N L+
Sbjct: 78 LVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLIN-- 135
Query: 112 RRANQVYIIDFGLAKKYRD---TSTHQ 135
R ++ + +FGLA+ + + +
Sbjct: 136 -RNGELKLANFGLARAFGIPVRCYSAE 161
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 57.9 bits (140), Expect = 2e-09
Identities = 26/109 (23%), Positives = 45/109 (41%), Gaps = 17/109 (15%)
Query: 52 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK--------SFLHRDIK 102
LV D SL D N ++++ ++ LA + + +H + + HRD+K
Sbjct: 117 LVSDYHEHGSLFDYLN--RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLK 174
Query: 103 PDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY 151
N L+ ++ I D GLA ++ + I + GT RY
Sbjct: 175 SKNILV---KKNGTCCIADLGLAVRHDSATDTIDIA---PNHRVGTKRY 217
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 2e-09
Identities = 33/149 (22%), Positives = 60/149 (40%), Gaps = 28/149 (18%)
Query: 10 VQENVKTKHPQLLYESKLYRIL-------QGGTGIPNV----RWF---GVEGDYNVLVMD 55
+ K E KL + + + G ++ F G G + V+V +
Sbjct: 51 IVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFE 110
Query: 56 LLGPSLEDL---FNFCSRKLSLKTVLMLADQMINRVEFVHSK-SFLHRDIKPDNFLMGLG 111
+LG +L L + R + L V ++ Q++ ++++H + +H DIKP+N LM +
Sbjct: 111 VLGENLLALIKKYEH--RGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIV 168
Query: 112 RR---ANQVYIIDFGLAKKYRDTSTHQHI 137
Q+ I D G A +H
Sbjct: 169 DSPENLIQIKIADLGNA-----CWYDEHY 192
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 57.6 bits (140), Expect = 2e-09
Identities = 24/87 (27%), Positives = 41/87 (47%), Gaps = 6/87 (6%)
Query: 52 LVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 111
LV + + ++ D L + V Q+IN + F HS + +HRDIKP+N L+
Sbjct: 101 LVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVS-- 158
Query: 112 RRANQVYIIDFGLAKKYR---DTSTHQ 135
++ V + DFG A+ + +
Sbjct: 159 -QSGVVKLCDFGFARTLAAPGEVYDDE 184
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 2e-09
Identities = 21/77 (27%), Positives = 39/77 (50%), Gaps = 6/77 (7%)
Query: 52 LVMDLLGPSLEDLF---NFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM 108
+ +LL +L +L F + SL V A ++ ++ +H +H D+KP+N L+
Sbjct: 176 MTFELLSMNLYELIKKNKF--QGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILL 233
Query: 109 GLGRRANQVYIIDFGLA 125
R + + +IDFG +
Sbjct: 234 KQQGR-SGIKVIDFGSS 249
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 2e-09
Identities = 21/120 (17%), Positives = 49/120 (40%), Gaps = 16/120 (13%)
Query: 38 PN-VRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 95
PN V+ +G+ + +VM+ + L + + L L + +E++ +++
Sbjct: 83 PNIVKLYGLMHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQN 142
Query: 96 --FLHRDIKPDNFLMGLGRRANQVY--IIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY 151
+HRD++ N + V + DFGL+++ + + L G ++
Sbjct: 143 PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVS----------GLLGNFQW 192
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 2e-09
Identities = 25/109 (22%), Positives = 41/109 (37%), Gaps = 17/109 (15%)
Query: 52 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF--------LHRDIK 102
L+ SL D L + L + + + + +H + F HRD+K
Sbjct: 83 LITHYHEMGSLYDYLQ--LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLK 140
Query: 103 PDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY 151
N L+ ++ Q I D GLA + ++ + N GT RY
Sbjct: 141 SKNILV---KKNGQCCIADLGLAVMHSQSTNQLDVG---NNPRVGTKRY 183
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 57.6 bits (140), Expect = 3e-09
Identities = 24/88 (27%), Positives = 39/88 (44%), Gaps = 3/88 (3%)
Query: 52 LVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 111
LV D L L + K +L + + ++N + ++H LHRD+K N L+
Sbjct: 101 LVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLIT-- 158
Query: 112 RRANQVYIIDFGLAKKYRDTSTHQHIPY 139
R + + DFGLA+ + Q Y
Sbjct: 159 -RDGVLKLADFGLARAFSLAKNSQPNRY 185
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 56.8 bits (138), Expect = 5e-09
Identities = 28/89 (31%), Positives = 42/89 (47%), Gaps = 10/89 (11%)
Query: 52 LVMDLLGPSLEDLFNFCSRKLSLKTV--LMLADQMINRVEFVHSKSFLHRDIKPDNFLMG 109
LV D + LE + S L+ + ML + +E++H LHRD+KP+N L+
Sbjct: 89 LVFDFMETDLEVIIKDNSLVLTPSHIKAYML--MTLQGLEYLHQHWILHRDLKPNNLLLD 146
Query: 110 LGRRANQVYIIDFGLAKKYRD---TSTHQ 135
+ + DFGLAK + THQ
Sbjct: 147 ---ENGVLKLADFGLAKSFGSPNRAYTHQ 172
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 7e-09
Identities = 31/121 (25%), Positives = 58/121 (47%), Gaps = 19/121 (15%)
Query: 38 PN-VRWFGV-EGDYNV-LVMDLL--GPSLEDLFN-FCSR-KLSLKTVLMLADQMINRVEF 90
PN ++ F + E + +V +L G +LF+ R + S + Q+ + + +
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGG----ELFDEIIKRKRFSEHDAARIIKQVFSGITY 136
Query: 91 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTAR 150
+H + +HRD+KP+N L+ + + IIDFGL+ ++ + K+ GTA
Sbjct: 137 MHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM--------KDRIGTAY 188
Query: 151 Y 151
Y
Sbjct: 189 Y 189
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 7e-09
Identities = 36/186 (19%), Positives = 67/186 (36%), Gaps = 38/186 (20%)
Query: 38 PN-VRWFGV-EGDYNV-LVMDLL--GPSLEDLFNFCSRKLSLKTVLMLAD------QMIN 86
P+ V D + +V + + DL ++ V A Q++
Sbjct: 86 PHIVELLETYSSDGMLYMVFEFMDGA----DLCFEIVKRADAGFVYSEAVASHYMRQILE 141
Query: 87 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLT 146
+ + H + +HRD+KP L+ + V + FG+A + +
Sbjct: 142 ALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGE-------SGLVAGGRV 194
Query: 147 GTARYAS----MNTHLGIEQSRRDDLESLGYVLMYF-LRGSLP-WQGLKAGTKKQKYEKI 200
GT + + G D+ G V+++ L G LP + GTK++ +E I
Sbjct: 195 GTPHFMAPEVVKREPYGKPV----DVWGCG-VILFILLSGCLPFY-----GTKERLFEGI 244
Query: 201 SEKKVS 206
+ K
Sbjct: 245 IKGKYK 250
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 1e-08
Identities = 22/87 (25%), Positives = 42/87 (48%), Gaps = 6/87 (6%)
Query: 52 LVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 111
LV + L L+ + C +++ V + Q++ + + H + LHRD+KP N L+
Sbjct: 77 LVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLI--- 133
Query: 112 RRANQVYIIDFGLAKKYRD---TSTHQ 135
++ + DFGLA+ T ++
Sbjct: 134 NERGELKLADFGLARAKSIPTKTYDNE 160
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 1e-08
Identities = 26/128 (20%), Positives = 51/128 (39%), Gaps = 19/128 (14%)
Query: 83 QMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRE 141
++N ++H+ K+ HRD+KP N LM + +V + DFG ++ D
Sbjct: 159 SVLNSFSYIHNEKNICHRDVKPSNILMD---KNGRVKLSDFGESEYMVDKKIK------- 208
Query: 142 NKNLTGTARYAS--MNTHLGIEQSRRDDLESLGYVLMY-FLRGSLPWQGLKAGTKKQKYE 198
GT + ++ + D+ SLG + +Y +P+ + + +
Sbjct: 209 --GSRGTYEFMPPEFFSNESSYNGAKVDIWSLG-ICLYVMFYNVVPFSL--KISLVELFN 263
Query: 199 KISEKKVS 206
I K +
Sbjct: 264 NIRTKNIE 271
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 1e-08
Identities = 43/166 (25%), Positives = 68/166 (40%), Gaps = 35/166 (21%)
Query: 29 RILQGGTGIPN-VRWFGV-EGDYNV-LVMDLL--GPSLEDLF-------NFCSRKLSLKT 76
L+ G PN V+ V + LVM+LL G +LF +F + S
Sbjct: 57 TALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGG----ELFERIKKKKHFSETEAS--- 109
Query: 77 VLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQH 136
+ ++++ V +H +HRD+KP+N L ++ IIDFG A+
Sbjct: 110 --YIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPP------ 161
Query: 137 IPYRENKNLT---GTARYASMNTHLGIEQSRRDDLESLGYVLMYFL 179
+N+ L T YA+ DL SLG V++Y +
Sbjct: 162 ----DNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLG-VILYTM 202
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 54.9 bits (133), Expect = 1e-08
Identities = 33/123 (26%), Positives = 51/123 (41%), Gaps = 19/123 (15%)
Query: 38 PN-VRWFGV-EGDYNV-LVMDLL--GPSLEDLFNF-CSR-KLSLKTVLMLADQMINRVEF 90
PN VR + + LV DL+ G +LF +R S Q++ + +
Sbjct: 65 PNIVRLHDSIQEESFHYLVFDLVTGG----ELFEDIVAREFYSEADASHCIQQILESIAY 120
Query: 91 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTAR 150
HS +HR++KP+N L+ + V + DFGLA + D+ GT
Sbjct: 121 CHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW--------HGFAGTPG 172
Query: 151 YAS 153
Y S
Sbjct: 173 YLS 175
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 54.9 bits (133), Expect = 1e-08
Identities = 33/126 (26%), Positives = 51/126 (40%), Gaps = 25/126 (19%)
Query: 83 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYREN 142
Q++ +++H +HRD+K N + +V I DFGL +T
Sbjct: 123 QIVLGCQYLHRNRVIHRDLKLGNLFLN---EDLEVKIGDFGL-------ATKVEYDGERK 172
Query: 143 KNLTGTARYA-----SMNTHLGIEQSRRDDLESLGYVLMY-FLRGSLPWQGLKAGTKKQK 196
K L GT Y S H S D+ S+G +MY L G P++ K+
Sbjct: 173 KVLCGTPNYIAPEVLSKKGH-----SFEVDVWSIG-CIMYTLLVGKPPFE---TSCLKET 223
Query: 197 YEKISE 202
Y +I +
Sbjct: 224 YLRIKK 229
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 55.2 bits (133), Expect = 1e-08
Identities = 26/142 (18%), Positives = 49/142 (34%), Gaps = 23/142 (16%)
Query: 52 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS---------KSFLHRDI 101
LVM+ SL + + LA + + ++H+ + HRD+
Sbjct: 89 LVMEYYPNGSLXKYLS--LHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDL 146
Query: 102 KPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPY-RENKNLTGTARY-------AS 153
N L+ + I DFGL+ + + + GT RY +
Sbjct: 147 NSRNVLV---KNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGA 203
Query: 154 MNTHLGIEQSRRDDLESLGYVL 175
+N ++ D+ +LG +
Sbjct: 204 VNLRDXESALKQVDMYALGLIY 225
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 1e-08
Identities = 39/164 (23%), Positives = 69/164 (42%), Gaps = 29/164 (17%)
Query: 29 RILQGGTGIPN-VRWFGV-EGDYNV-LVMDLL--GPSLEDLFNF-CSR-KLSLKTVLMLA 81
IL+ +G PN ++ E + LV DL+ G +LF++ + LS K +
Sbjct: 75 DILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKG----ELFDYLTEKVTLSEKETRKIM 130
Query: 82 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRE 141
++ + +H + +HRD+KP+N L L N + + DFG + +
Sbjct: 131 RALLEVICALHKLNIVHRDLKPENIL--LDDDMN-IKLTDFGFSCQLDPGEKL------- 180
Query: 142 NKNLTGTARYAS---MNTHLGIEQSRRD---DLESLGYVLMYFL 179
+ + GT Y + + + D+ S G V+MY L
Sbjct: 181 -REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTG-VIMYTL 222
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 54.9 bits (133), Expect = 2e-08
Identities = 26/89 (29%), Positives = 44/89 (49%), Gaps = 6/89 (6%)
Query: 52 LVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 111
L+ + L+ + +S++ + Q+IN V F HS+ LHRD+KP N L+ +
Sbjct: 110 LIFEYAENDLKKYMDKN-PDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVS 168
Query: 112 RRAN--QVYIIDFGLAKKYRD---TSTHQ 135
+ + I DFGLA+ + TH+
Sbjct: 169 DASETPVLKIGDFGLARAFGIPIRQFTHE 197
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 2e-08
Identities = 28/128 (21%), Positives = 53/128 (41%), Gaps = 18/128 (14%)
Query: 83 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYREN 142
+I +E++H + +HRDIKP N L+G + I DFG++ +++ +
Sbjct: 145 DLIKGIEYLHYQKIIHRDIKPSNLLVG---EDGHIKIADFGVSNEFKGSDALLS------ 195
Query: 143 KNLTGTARYAS----MNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYE 198
N GT + + T + D+ ++G L F+ G P+ +
Sbjct: 196 -NTVGTPAFMAPESLSETRKIFS-GKALDVWAMGVTLYCFVFGQCPFMD---ERIMCLHS 250
Query: 199 KISEKKVS 206
KI + +
Sbjct: 251 KIKSQALE 258
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 2e-08
Identities = 32/121 (26%), Positives = 50/121 (41%), Gaps = 19/121 (15%)
Query: 38 PN-VRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFVHS 93
PN V+ +G + LVM+ G SL ++ + + + Q V ++HS
Sbjct: 61 PNIVKLYGACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHS 120
Query: 94 ---KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTAR 150
K+ +HRD+KP N L L + I DFG A + T N G+A
Sbjct: 121 MQPKALIHRDLKPPNLL--LVAGGTVLKICDFGTACDIQTHMT----------NNKGSAA 168
Query: 151 Y 151
+
Sbjct: 169 W 169
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 2e-08
Identities = 33/124 (26%), Positives = 54/124 (43%), Gaps = 21/124 (16%)
Query: 83 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYREN 142
Q+++ V++ H K +HRD+K +N L L N + I DFG + ++
Sbjct: 122 QIVSAVQYCHQKRIVHRDLKAENLL--LDADMN-IKIADFGFSNEFTV-----------G 167
Query: 143 KNLT---GTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYE 198
L G YA+ G + D+ SLG +L + GSLP+ G K+ E
Sbjct: 168 GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG---QNLKELRE 224
Query: 199 KISE 202
++
Sbjct: 225 RVLR 228
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 54.5 bits (132), Expect = 2e-08
Identities = 24/87 (27%), Positives = 40/87 (45%), Gaps = 6/87 (6%)
Query: 52 LVMDLLGPSLEDLFNFCSRK-LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL 110
LV + + L + L +T+ L Q + ++F+H+ +HRD+KP+N L+
Sbjct: 96 LVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVT- 154
Query: 111 GRRANQVYIIDFGLAKKYRD--TSTHQ 135
V + DFGLA+ Y T
Sbjct: 155 --SGGTVKLADFGLARIYSYQMALTPV 179
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 54.9 bits (132), Expect = 2e-08
Identities = 28/174 (16%), Positives = 61/174 (35%), Gaps = 13/174 (7%)
Query: 10 VQENVKTKHPQLLYESKLYRILQGG----TGIPNVR----WF---GVEGDYNVLVMDLLG 58
V ++ + L E +L + ++ V F GV G + +V ++LG
Sbjct: 69 VVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLG 128
Query: 59 PSLEDL-FNFCSRKLSLKTVLMLADQMINRVEFVHSK-SFLHRDIKPDNFLMGLGRRANQ 116
L + L L V + Q++ ++++H+K +H DIKP+N L+ + + +
Sbjct: 129 HHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIR 188
Query: 117 VYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLES 170
+ ++ + + + DL +
Sbjct: 189 RLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGN 242
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 3e-08
Identities = 31/160 (19%), Positives = 64/160 (40%), Gaps = 28/160 (17%)
Query: 52 LVMDLLGPSLEDLFNF-CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL 110
+VM+ ++++ + ++ + Q+I+ +E++HS+ +H+DIKP N L L
Sbjct: 85 MVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLL--L 142
Query: 111 GRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLT---GTARYAS------MNTHLGIE 161
+ I G+A+ P+ + G+ + ++T G +
Sbjct: 143 TTGGT-LKISALGVAEALH--------PFAADDTCRTSQGSPAFQPPEIANGLDTFSGFK 193
Query: 162 QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKIS 201
D+ S G L G P++G + +E I
Sbjct: 194 V----DIWSAGVTLYNITTGLYPFEG---DNIYKLFENIG 226
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 54.1 bits (131), Expect = 3e-08
Identities = 25/88 (28%), Positives = 41/88 (46%), Gaps = 7/88 (7%)
Query: 52 LVMDLLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL 110
LV + L L+ + + + L + Q++ + F HS LHRD+KP N L+
Sbjct: 79 LVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLIN- 137
Query: 111 GRRANQVYIIDFGLAKKYRD---TSTHQ 135
+ + DFGLA+ + T TH+
Sbjct: 138 --TEGAIKLADFGLARAFGVPVRTYTHE 163
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 3e-08
Identities = 34/126 (26%), Positives = 50/126 (39%), Gaps = 25/126 (19%)
Query: 83 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYREN 142
Q++ +++H +HRD+K N L V I DFGL +T
Sbjct: 149 QIVLGCQYLHRNRVIHRDLKLGNLF--LNEDLE-VKIGDFGL-------ATKVEYDGERK 198
Query: 143 KNLTGTARYA-----SMNTHLGIEQSRRDDLESLGYVLMY-FLRGSLPWQGLKAGTKKQK 196
K L GT Y S H S D+ S+G +MY L G P++ K+
Sbjct: 199 KVLCGTPNYIAPEVLSKKGH-----SFEVDVWSIG-CIMYTLLVGKPPFE---TSCLKET 249
Query: 197 YEKISE 202
Y +I +
Sbjct: 250 YLRIKK 255
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 53.7 bits (130), Expect = 3e-08
Identities = 39/130 (30%), Positives = 52/130 (40%), Gaps = 19/130 (14%)
Query: 83 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYREN 142
Q++ V ++H HRDIKP+N L L R N + I DFGLA +R + + +
Sbjct: 113 QLMAGVVYLHGIGITHRDIKPENLL--LDERDN-LKISDFGLATVFRYNNRERLL----- 164
Query: 143 KNLTGTARYA-----SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKY 197
+ GT Y D+ S G VL L G LPW Q+Y
Sbjct: 165 NKMCGTLPYVAPELLKRREFHAEPV----DVWSCGIVLTAMLAGELPWDQ--PSDSCQEY 218
Query: 198 EKISEKKVST 207
EKK
Sbjct: 219 SDWKEKKTYL 228
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 3e-08
Identities = 30/115 (26%), Positives = 48/115 (41%), Gaps = 9/115 (7%)
Query: 38 PN-VRWFGVE--GDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 93
P V +G G + + M+LL G SL L L L Q + +E++H+
Sbjct: 110 PRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQM-GCLPEDRALYYLGQALEGLEYLHT 168
Query: 94 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGT 148
+ LH D+K DN L L ++ + DFG A + + + + GT
Sbjct: 169 RRILHGDVKADNVL--LSSDGSRAALCDFGHALCLQPDGLGKSLLTG--DYIPGT 219
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 54.9 bits (131), Expect = 4e-08
Identities = 50/297 (16%), Positives = 91/297 (30%), Gaps = 108/297 (36%)
Query: 1 MYEILTVFSVQENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPS 60
M++ L+VF + P + L ++ WF V ++V++ L
Sbjct: 374 MFDRLSVF--PPSAHI--P-----TILLSLI----------WFDVIKSDVMVVVNKL--- 411
Query: 61 LEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDI--KPDNFLMGLGRRANQVY 118
K SL + Q + S ++ ++ K +N L R Y
Sbjct: 412 ---------HKYSL-----VEKQPKESTISIPS---IYLELKVKLEN-EYALHRSIVDHY 453
Query: 119 II-----DFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHL-GIEQSRRDDLESLG 172
I L Y D + HI + HL IE R L +
Sbjct: 454 NIPKTFDSDDLIPPYLDQYFYSHIGH-----------------HLKNIEHPERMTLFRMV 496
Query: 173 YVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRF 232
++ FL +K +++ + + + L + Y Y
Sbjct: 497 FLDFRFLE------------QKIRHDSTAWNASGSILNTL-----QQLKFYKPYI----C 535
Query: 233 DDKPDYA--------YLKRI--------FRDLFIREGFQFD--YVFDWTILKYQQSQ 271
D+ P Y +L +I + DL +R + +F+ ++Q Q
Sbjct: 536 DNDPKYERLVNAILDFLPKIEENLICSKYTDL-LRIALMAEDEAIFEEA---HKQVQ 588
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 49.9 bits (118), Expect = 1e-06
Identities = 39/378 (10%), Positives = 100/378 (26%), Gaps = 119/378 (31%)
Query: 1 MYEILTVFSVQENVKTKHPQLLYESKLYRI----LQGGTGIPNVRWFGVEG----DYNVL 52
IL+ + + +K S R+ L + V+ F VE +Y L
Sbjct: 42 PKSILSKEEIDHIIMSKDA----VSGTLRLFWTLLSKQEEM--VQKF-VEEVLRINYKFL 94
Query: 53 VMDL----LGPSLE-DLFNFCSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNF 106
+ + PS+ ++ +L + A ++R++ + L ++P
Sbjct: 95 MSPIKTEQRQPSMMTRMYIEQRDRLY-NDNQVFAKYNVSRLQPYLKLRQALLE-LRPAKN 152
Query: 107 L----M-GLG----------------RRANQVYIIDFGLAKKYRDTSTH-QHIPYRENKN 144
+ + G G + +++ ++ Q + Y+ + N
Sbjct: 153 VLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPN 212
Query: 145 LTGTARYAS---MNTHLGIEQSRR--------------DDLESLGYVLMYF--------- 178
T + ++S + H + RR ++++ F
Sbjct: 213 WTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAK-AWNAFNLSCKILLT 271
Query: 179 -------------LRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL----CRGYP---- 217
+ + + + K + + L P
Sbjct: 272 TRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLS 331
Query: 218 ------TEFASYFHYCRSLRFD----------DKPDYAYLKRIFRDLFIREGFQFD---- 257
+ + + + + D + + A +++F L + F
Sbjct: 332 IIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSV---FPPSAHIP 388
Query: 258 ---YVFDWTILKYQQSQL 272
W + +
Sbjct: 389 TILLSLIWFDVIKSDVMV 406
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 5e-08
Identities = 29/111 (26%), Positives = 50/111 (45%), Gaps = 14/111 (12%)
Query: 29 RILQGGTGIPN-VRWFGV-EGDYNV-LVMDLL--GPSLEDLFNF-CSR-KLSLKTVLMLA 81
IL+ G P+ + E + LV DL+ G +LF++ + LS K +
Sbjct: 151 HILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKG----ELFDYLTEKVALSEKETRSIM 206
Query: 82 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 132
++ V F+H+ + +HRD+KP+N L L + + DFG +
Sbjct: 207 RSLLEAVSFLHANNIVHRDLKPENIL--LDDNMQ-IRLSDFGFSCHLEPGE 254
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 6e-08
Identities = 22/78 (28%), Positives = 41/78 (52%), Gaps = 4/78 (5%)
Query: 52 LVMDLLGPSLEDLFNFCSRK-LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL 110
LV + + L + + +T+ + Q++ ++F+HS +HRD+KP N L+
Sbjct: 96 LVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVT- 154
Query: 111 GRRANQVYIIDFGLAKKY 128
+ Q+ + DFGLA+ Y
Sbjct: 155 --SSGQIKLADFGLARIY 170
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 7e-08
Identities = 32/152 (21%), Positives = 51/152 (33%), Gaps = 26/152 (17%)
Query: 52 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF----------LHRD 100
L+ SL D + +S + +A+ M + ++H HRD
Sbjct: 99 LITAFHEKGSLSDFLK--ANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRD 156
Query: 101 IKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY-----ASMN 155
IK N L+ + I DFGLA K+ + + GT RY
Sbjct: 157 IKSKNVLL---KNNLTACIADFGLALKFEAGKSAG-----DTHGQVGTRRYMAPEVLEGA 208
Query: 156 THLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 187
+ + R D+ ++G VL G
Sbjct: 209 INFQRDAFLRIDMYAMGLVLWELASRCTAADG 240
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 8e-08
Identities = 29/103 (28%), Positives = 47/103 (45%), Gaps = 11/103 (10%)
Query: 38 PN-VRWFGV-EGDYNV-LVMDLL--GPSLEDLFNF-CSR-KLSLKTVLMLADQMINRVEF 90
PN VR + + LV DL+ G +LF +R S Q++ + +
Sbjct: 88 PNIVRLHDSIQEESFHYLVFDLVTGG----ELFEDIVAREFYSEADASHCIQQILESIAY 143
Query: 91 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 133
HS +HR++KP+N L+ + V + DFGLA + D+
Sbjct: 144 CHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA 186
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 8e-08
Identities = 31/116 (26%), Positives = 52/116 (44%), Gaps = 24/116 (20%)
Query: 17 KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRK--LSL 74
+HP ++ KLY ++ T I V+V++ G +LF++ K ++
Sbjct: 67 RHPHII---KLYDVITTPTDI-------------VMVIEYAG---GELFDYIVEKKRMTE 107
Query: 75 KTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 130
Q+I +E+ H +HRD+KP+N L+ V I DFGL+ D
Sbjct: 108 DEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLD---DNLNVKIADFGLSNIMTD 160
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 9e-08
Identities = 42/163 (25%), Positives = 65/163 (39%), Gaps = 25/163 (15%)
Query: 52 LVMDLL--GPSLEDLFNFCSR-KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM 108
+VM+ + G DL N S + K +++ ++ +HS F+HRD+KPDN L+
Sbjct: 146 MVMEYMPGG----DLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL 201
Query: 109 GLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYAS----MNTHLGIEQSR 164
++ + + DFG K + GT Y S + R
Sbjct: 202 D---KSGHLKLADFGTCMKMNKEGMVR------CDTAVGTPDYISPEVLKSQGGDGYYGR 252
Query: 165 RDDLESLGYVLMY-FLRGSLPWQGLKAGTKKQKYEKISEKKVS 206
D S+G V +Y L G P+ A + Y KI K S
Sbjct: 253 ECDWWSVG-VFLYEMLVGDTPF---YADSLVGTYSKIMNHKNS 291
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 9e-08
Identities = 39/130 (30%), Positives = 52/130 (40%), Gaps = 19/130 (14%)
Query: 83 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYREN 142
Q++ V ++H HRDIKP+N L L R N + I DFGLA +R + + +
Sbjct: 113 QLMAGVVYLHGIGITHRDIKPENLL--LDERDN-LKISDFGLATVFRYNNRERLL----- 164
Query: 143 KNLTGTARYA-----SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKY 197
+ GT Y D+ S G VL L G LPW Q+Y
Sbjct: 165 NKMCGTLPYVAPELLKRREFHAEPV----DVWSCGIVLTAMLAGELPWDQ--PSDSCQEY 218
Query: 198 EKISEKKVST 207
EKK
Sbjct: 219 SDWKEKKTYL 228
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 1e-07
Identities = 28/117 (23%), Positives = 52/117 (44%), Gaps = 15/117 (12%)
Query: 38 PN-VRWFGVEGDYNVL--VMDLL-GPSLEDL--FNFCSRKLSLKTVLMLADQMINRVEFV 91
N V++ G + + M+ + G SL L + K + +T+ Q++ ++++
Sbjct: 79 KNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYL 138
Query: 92 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGT 148
H +HRDIK DN L + + + I DFG +K+ + + TGT
Sbjct: 139 HDNQIVHRDIKGDNVL--INTYSGVLKISDFGTSKRLAGINPC-------TETFTGT 186
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 1e-07
Identities = 43/198 (21%), Positives = 75/198 (37%), Gaps = 32/198 (16%)
Query: 38 PNV-----RWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRK---LSLKTVLMLADQMINRV 88
PN+ R +VM+ G L + +++ L + VL + Q+ +
Sbjct: 65 PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 89 EFVHSKSF-----LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENK 143
+ H +S LHRD+KP N + V + DFGLA+ ++ K
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLD---GKQNVKLGDFGLARILNHDTSF-------AK 174
Query: 144 NLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFL-RGSLPWQG-----LKAGTKKQKY 197
GT Y S + + + D+ SLG L+Y L P+ L ++ K+
Sbjct: 175 TFVGTPYYMSPEQMNRMSYNEKSDIWSLG-CLLYELCALMPPFTAFSQKELAGKIREGKF 233
Query: 198 EKISEKKVSTSIEALCRG 215
+I + S + +
Sbjct: 234 RRIPY-RYSDELNEIITR 250
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 1e-07
Identities = 26/126 (20%), Positives = 51/126 (40%), Gaps = 23/126 (18%)
Query: 38 PN-VRWFGV--EGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 93
PN + GV + LVM+ G L + + +++ ++ A Q+ + ++H
Sbjct: 66 PNIIALRGVCLKEPNLCLVMEFARGGPLNRVLS--GKRIPPDILVNWAVQIARGMNYLHD 123
Query: 94 K---SFLHRDIKPDNFLMGLGRRANQVY-----IIDFGLAKKYRDTSTHQHIPYRENKNL 145
+ +HRD+K N L+ + I DFGLA+++ T+ +
Sbjct: 124 EAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK---------MSA 174
Query: 146 TGTARY 151
G +
Sbjct: 175 AGAYAW 180
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 1e-07
Identities = 36/133 (27%), Positives = 53/133 (39%), Gaps = 24/133 (18%)
Query: 83 QMINRVEFVHSKSFLHRDIKPDNFLM-GLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRE 141
+ VE++H++ +HRD+KP N L + I DFG AK+ R E
Sbjct: 124 TITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA----------E 173
Query: 142 NKNLT---GTARYAS----MNTHLGIEQSRRDDLESLGYVLMYF-LRGSLPWQGLKAGTK 193
N L TA + + D+ SLG VL+Y L G P+ T
Sbjct: 174 NGLLMTPCYTANFVAPEVLERQGYDAAC----DIWSLG-VLLYTMLTGYTPFANGPDDTP 228
Query: 194 KQKYEKISEKKVS 206
++ +I K S
Sbjct: 229 EEILARIGSGKFS 241
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 1e-07
Identities = 20/74 (27%), Positives = 32/74 (43%), Gaps = 7/74 (9%)
Query: 63 DLFNFCSRK----LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVY 118
DLF + + +L Q+ ++ VH + LHRDIK N + + V
Sbjct: 109 DLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLT---KDGTVQ 165
Query: 119 IIDFGLAKKYRDTS 132
+ DFG+A+ T
Sbjct: 166 LGDFGIARVLNSTV 179
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 2e-07
Identities = 27/79 (34%), Positives = 43/79 (54%), Gaps = 8/79 (10%)
Query: 52 LVMDLLGPSLEDL---FNFCSRKLSLKTVLMLADQMINRVEFVHSK--SFLHRDIKPDNF 106
LV ++L +L DL NF R +SL A QM + F+ + S +H D+KP+N
Sbjct: 133 LVFEMLSYNLYDLLRNTNF--RGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENI 190
Query: 107 LMGLGRRANQVYIIDFGLA 125
L+ +R + + I+DFG +
Sbjct: 191 LLCNPKR-SAIKIVDFGSS 208
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 52.6 bits (126), Expect = 2e-07
Identities = 43/176 (24%), Positives = 68/176 (38%), Gaps = 29/176 (16%)
Query: 52 LVMDLL--GPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFL 107
++DL+ G DL S+ S + A ++I +E +H++ ++RD+KP N L
Sbjct: 269 FILDLMNGG----DLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANIL 324
Query: 108 MGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY-ASMNTHLGIEQSRRD 166
+ V I D GLA + H GT Y A G+
Sbjct: 325 LD---EHGHVRISDLGLACDFSKKKPH---------ASVGTHGYMAPEVLQKGVAYDSSA 372
Query: 167 DLESLGYVLMY-FLRGSLPWQGLKAGTKKQKYEKISEKKV------STSIEALCRG 215
D SLG +++ LRG P++ K K + V S + +L G
Sbjct: 373 DWFSLG-CMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEG 427
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 51.4 bits (124), Expect = 2e-07
Identities = 16/48 (33%), Positives = 31/48 (64%)
Query: 83 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 130
Q+++ V+++H +HRD+KP+N L +++ I DFGL+K ++
Sbjct: 114 QVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN 161
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 2e-07
Identities = 27/139 (19%), Positives = 46/139 (33%), Gaps = 34/139 (24%)
Query: 38 PN-VRWFG--VEGDYNVLVMDLL-GPSLEDLFNFCSRKLSL---KTVLMLADQMINRVEF 90
+ VR+F E D+ ++ + G SL D + R +S + L Q+ + +
Sbjct: 71 SHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRY 130
Query: 91 VHSKSFLHRDIKPDN-FLMGLGRRANQVYII---------------DFGLAKKYRDTSTH 134
+HS S +H DIKP N F+ D G +
Sbjct: 131 IHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQV- 189
Query: 135 QHIPYRENKNLTGTARYAS 153
G +R+ +
Sbjct: 190 ----------EEGDSRFLA 198
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 2e-07
Identities = 33/124 (26%), Positives = 59/124 (47%), Gaps = 13/124 (10%)
Query: 83 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYREN 142
++++ +E++H K +HRD+KP+N L+ + I DFG AK S
Sbjct: 138 EIVSALEYLHGKGIIHRDLKPENILLN---EDMHIQITDFGTAKVLSPESKQA-----RA 189
Query: 143 KNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMY-FLRGSLPWQGLKAGTKKQKYEKIS 201
+ GTA+Y S + DL +LG ++Y + G P+ +AG + ++KI
Sbjct: 190 NSFVGTAQYVSPELLTEKSACKSSDLWALG-CIIYQLVAGLPPF---RAGNEYLIFQKII 245
Query: 202 EKKV 205
+ +
Sbjct: 246 KLEY 249
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 51.4 bits (124), Expect = 2e-07
Identities = 25/92 (27%), Positives = 40/92 (43%), Gaps = 11/92 (11%)
Query: 52 LVMDLLGPSLEDL-----FNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNF 106
LV + + L+ R L L V Q++ + F H LHRD+KP N
Sbjct: 80 LVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNL 139
Query: 107 LMGLGRRANQVYIIDFGLAKKYRD---TSTHQ 135
L+ + Q+ + DFGLA+ + T + +
Sbjct: 140 LIN---KRGQLKLGDFGLARAFGIPVNTFSSE 168
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 2e-07
Identities = 20/69 (28%), Positives = 30/69 (43%), Gaps = 8/69 (11%)
Query: 83 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYREN 142
Q++ V ++H +HRD+KP+N L + I DFGL+K
Sbjct: 156 QILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLM-------- 207
Query: 143 KNLTGTARY 151
K + GT Y
Sbjct: 208 KTVCGTPGY 216
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 3e-07
Identities = 17/48 (35%), Positives = 27/48 (56%), Gaps = 1/48 (2%)
Query: 83 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 130
Q+++ V + HS HRD+K +N L+ G A ++ I DFG +K
Sbjct: 124 QLLSGVSYCHSMQICHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVL 170
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 3e-07
Identities = 17/81 (20%), Positives = 37/81 (45%), Gaps = 2/81 (2%)
Query: 52 LVMDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMG 109
++M+ + G + + + + + + ++F+HS + HRD+KP+N L
Sbjct: 103 IIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYT 162
Query: 110 LGRRANQVYIIDFGLAKKYRD 130
+ + + DFG AK+
Sbjct: 163 SKEKDAVLKLTDFGFAKETTQ 183
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 3e-07
Identities = 24/86 (27%), Positives = 39/86 (45%), Gaps = 9/86 (10%)
Query: 52 LVMD--------LLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKP 103
L+ D ++ N +L V L Q+++ + ++H+ LHRD+KP
Sbjct: 97 LLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKP 156
Query: 104 DNFL-MGLGRRANQVYIIDFGLAKKY 128
N L MG G +V I D G A+ +
Sbjct: 157 ANILVMGEGPERGRVKIADMGFARLF 182
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 3e-07
Identities = 27/100 (27%), Positives = 43/100 (43%), Gaps = 11/100 (11%)
Query: 38 PN-VRWFGV-EGDYNV-LVMDLL--GPSLEDLFNF-CSR-KLSLKTVLMLADQMINRVEF 90
PN VR + + L+ DL+ G +LF +R S Q++ V
Sbjct: 70 PNIVRLHDSISEEGHHYLIFDLVTGG----ELFEDIVAREYYSEADASHCIQQILEAVLH 125
Query: 91 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 130
H +HR++KP+N L+ + V + DFGLA +
Sbjct: 126 CHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG 165
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 3e-07
Identities = 15/44 (34%), Positives = 25/44 (56%)
Query: 83 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 126
+ ++++HS + HRD+KP+N L R + + DFG AK
Sbjct: 125 SIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 3e-07
Identities = 18/48 (37%), Positives = 27/48 (56%), Gaps = 3/48 (6%)
Query: 83 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 130
Q+++ V++ H +HRD+KP+N L L N I DFGL+ D
Sbjct: 119 QILSAVDYCHRHMVVHRDLKPENVL--LDAHMN-AKIADFGLSNMMSD 163
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 4e-07
Identities = 21/91 (23%), Positives = 41/91 (45%), Gaps = 13/91 (14%)
Query: 52 LVMDLLGPSLEDL------FNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDN 105
LV++ + E + + + + + + + Q++ + ++HS HRDIKP N
Sbjct: 115 LVLEYVP---ETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQN 171
Query: 106 FLMGLGRRANQVYIIDFGLAKKYR--DTSTH 134
L L + + +IDFG AK + +
Sbjct: 172 LL--LDPPSGVLKLIDFGSAKILIAGEPNVS 200
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 5e-07
Identities = 15/48 (31%), Positives = 26/48 (54%)
Query: 83 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 130
+ ++++HS + HRD+KP+N L R + + DFG AK+
Sbjct: 169 SIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS 216
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 5e-07
Identities = 20/91 (21%), Positives = 35/91 (38%), Gaps = 21/91 (23%)
Query: 52 LVMDLLGPSLEDL---FNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM 108
+ +LLG + + NF + L V +A Q+ + + F+H H D+KP+N L
Sbjct: 99 IAFELLGKNTFEFLKENNF--QPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILF 156
Query: 109 ----------------GLGRRANQVYIIDFG 123
+ + + DFG
Sbjct: 157 VNSEFETLYNEHKSCEEKSVKNTSIRVADFG 187
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 5e-07
Identities = 26/105 (24%), Positives = 50/105 (47%), Gaps = 12/105 (11%)
Query: 38 PN-VRWFG--VEGDYNVLVMDLL-GPSLEDLFNFCSRKLSL---KTVLMLADQMINRVEF 90
PN ++++ +E + +V++L L + ++ L +TV Q+ + +E
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 91 VHSKSFLHRDIKPDN-FLMGLGRRANQVYIIDFGLAKKYRDTSTH 134
+HS+ +HRDIKP N F+ V + D GL + + +T
Sbjct: 152 MHSRRVMHRDIKPANVFIT----ATGVVKLGDLGLGRFFSSKTTA 192
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 6e-07
Identities = 23/91 (25%), Positives = 34/91 (37%), Gaps = 21/91 (23%)
Query: 52 LVMDLLGPSLEDL---FNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM 108
+V +LLG S D F L + +A Q+ V F+HS H D+KP+N L
Sbjct: 94 IVFELLGLSTYDFIKENGF--LPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILF 151
Query: 109 ----------------GLGRRANQVYIIDFG 123
+ ++DFG
Sbjct: 152 VQSDYTEAYNPKIKRDERTLINPDIKVVDFG 182
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 6e-07
Identities = 41/168 (24%), Positives = 62/168 (36%), Gaps = 30/168 (17%)
Query: 52 LVMDLL--GPSLEDLFNFCSR---KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNF 106
LVM+ G DL S+ ++ + +++ ++ VH ++HRDIKPDN
Sbjct: 138 LVMEYYVGG----DLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNI 193
Query: 107 LMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY-------ASMNTHLG 159
L+ R + + DFG K R T + + GT Y A
Sbjct: 194 LLD---RCGHIRLADFGSCLKLRADGTVR------SLVAVGTPDYLSPEILQAVGGGPGT 244
Query: 160 IEQSRRDDLESLGYVLMY-FLRGSLPWQGLKAGTKKQKYEKISEKKVS 206
D +LG V Y G P+ A + + Y KI K
Sbjct: 245 GSYGPECDWWALG-VFAYEMFYGQTPFY---ADSTAETYGKIVHYKEH 288
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 7e-07
Identities = 48/166 (28%), Positives = 66/166 (39%), Gaps = 28/166 (16%)
Query: 52 LVMDLL--GPSLEDLFNFCSR---KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNF 106
LVMD G DL S+ +L + +M+ ++ VH ++HRDIKPDN
Sbjct: 151 LVMDYYVGG----DLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNI 206
Query: 107 LMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRD 166
LM + + DFG K + T Q + GT Y S +E +
Sbjct: 207 LMD---MNGHIRLADFGSCLKLMEDGTVQ------SSVAVGTPDYISPEILQAMEGGKGR 257
Query: 167 -----DLESLGYVLMY-FLRGSLPWQGLKAGTKKQKYEKISEKKVS 206
D SLG V MY L G P+ A + + Y KI K
Sbjct: 258 YGPECDWWSLG-VCMYEMLYGETPFY---AESLVETYGKIMNHKER 299
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 7e-07
Identities = 35/167 (20%), Positives = 67/167 (40%), Gaps = 30/167 (17%)
Query: 38 PN-VRWFGV--EGDYNVLVMDLL-GPSLEDLF--NFCSRKLSLKTVLMLADQMINRVEFV 91
PN V + G + +V + L SL L + +L + L +A + + ++
Sbjct: 94 PNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYL 153
Query: 92 HSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTA 149
H+++ +HR++K N L+ + V + DFGL++ T + +K+ GT
Sbjct: 154 HNRNPPIVHRNLKSPNLLVD---KKYTVKVCDFGLSRLKAST-------FLSSKSAAGTP 203
Query: 150 RYASM------NTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 190
+ M + + + D+ S G +L PW L
Sbjct: 204 EW--MAPEVLRDEPS----NEKSDVYSFGVILWELATLQQPWGNLNP 244
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 8e-07
Identities = 23/84 (27%), Positives = 35/84 (41%), Gaps = 11/84 (13%)
Query: 52 LVMDLLGPSLEDLFNFCSRKLSLKTVLMLAD------QMINRVEFVHSKSFLHRDIKPDN 105
LV+D + E ++ K L + Q+ + ++HS HRDIKP N
Sbjct: 130 LVLDYVP---ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQN 186
Query: 106 FLMGLGRRANQVYIIDFGLAKKYR 129
L L + + DFG AK+
Sbjct: 187 LL--LDPDTAVLKLCDFGSAKQLV 208
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 8e-07
Identities = 25/126 (19%), Positives = 49/126 (38%), Gaps = 16/126 (12%)
Query: 38 PN-VRWFGV---EGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 92
PN +++ GV + N + + + G +L + + + A + + + ++H
Sbjct: 67 PNVLKFIGVLYKDKRLN-FITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH 125
Query: 93 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKN-------L 145
S + +HRD+ N L+ V + DFGLA+ D T K +
Sbjct: 126 SMNIIHRDLNSHNCLVR---ENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTV 182
Query: 146 TGTARY 151
G +
Sbjct: 183 VGNPYW 188
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 9e-07
Identities = 15/54 (27%), Positives = 31/54 (57%), Gaps = 2/54 (3%)
Query: 83 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQH 136
+++ +++ HS +HRD+KP N ++ R ++ +ID+GLA+ Y +
Sbjct: 138 EILKALDYCHSMGIMHRDVKPHNVMIDHEHR--KLRLIDWGLAEFYHPGQEYNV 189
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 9e-07
Identities = 29/134 (21%), Positives = 51/134 (38%), Gaps = 13/134 (9%)
Query: 3 EILTVFSVQENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNV--LVMDLLGPS 60
+++ F + + K PQ + G + ++M+ +
Sbjct: 64 KLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-- 121
Query: 61 LEDL------FNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRA 114
+ L F R + + + + Q+ V F+HS HRDIKP N L + +
Sbjct: 122 -DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLL--VNSKD 178
Query: 115 NQVYIIDFGLAKKY 128
N + + DFG AKK
Sbjct: 179 NTLKLCDFGSAKKL 192
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 49.4 bits (118), Expect = 1e-06
Identities = 18/48 (37%), Positives = 27/48 (56%), Gaps = 3/48 (6%)
Query: 83 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 130
Q+++ V++ H +HRD+KP+N L L N I DFGL+ D
Sbjct: 124 QILSGVDYCHRHMVVHRDLKPENVL--LDAHMN-AKIADFGLSNMMSD 168
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 18/97 (18%), Positives = 40/97 (41%), Gaps = 27/97 (27%)
Query: 52 LVMDLLGPSLEDL---FNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM 108
L+ + LGPSL ++ N+ ++ + + +++ + ++ S H D+KP+N L+
Sbjct: 113 LIFEPLGPSLYEIITRNNY--NGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILL 170
Query: 109 ----------------------GLGRRANQVYIIDFG 123
++ + +IDFG
Sbjct: 171 DDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFG 207
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 3e-06
Identities = 17/66 (25%), Positives = 33/66 (50%), Gaps = 5/66 (7%)
Query: 83 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAKKYRDTSTHQHIPYRE 141
Q + V+ +H + +HRD+KP N L+ +N + + DFGLA+ +++ P +
Sbjct: 120 QTLRAVKVLHGSNVIHRDLKPSNLLI----NSNCDLKVCDFGLARIIDESAADNSEPTGQ 175
Query: 142 NKNLTG 147
+
Sbjct: 176 QSGMVE 181
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 4e-06
Identities = 25/83 (30%), Positives = 41/83 (49%), Gaps = 8/83 (9%)
Query: 52 LVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 111
LVM + DL K S + + L QM+ ++++HS +HRD+KP N +
Sbjct: 106 LVMPFMQ---TDLQKIMGLKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAV--- 159
Query: 112 RRAN-QVYIIDFGLAKKYRDTST 133
+ ++ I+DFGLA+ T
Sbjct: 160 -NEDCELKILDFGLARHADAEMT 181
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 4e-06
Identities = 20/81 (24%), Positives = 38/81 (46%), Gaps = 4/81 (4%)
Query: 52 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL 110
+VM+ S+ D+ ++ L+ + + + +E++H +HRDIK N L+
Sbjct: 101 IVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLN- 159
Query: 111 GRRANQVYIIDFGLAKKYRDT 131
+ DFG+A + DT
Sbjct: 160 --TEGHAKLADFGVAGQLTDT 178
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 46.7 bits (111), Expect = 6e-06
Identities = 16/153 (10%), Positives = 32/153 (20%), Gaps = 41/153 (26%)
Query: 36 GIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 94
G+ V ++V + + G SL+++ S + + + H
Sbjct: 92 GVARVLDVVHTRAGGLVVAEWIRGGSLQEVA---DTSPSPVGAIRAMQSLAAAADAAHRA 148
Query: 95 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASM 154
P + V +
Sbjct: 149 GVALSIDHPSRVRVS---IDGDVVLAYPA---------------------------TMPD 178
Query: 155 NTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 187
+DD+ +G L L P
Sbjct: 179 ANP-------QDDIRGIGASLYALLVNRWPLPE 204
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 8e-06
Identities = 26/83 (31%), Positives = 45/83 (54%), Gaps = 7/83 (8%)
Query: 52 LVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 111
LV L+G L ++ +KL+ V L Q++ ++++HS +HRD+KP N +
Sbjct: 111 LVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV--- 165
Query: 112 RRAN-QVYIIDFGLAKKYRDTST 133
+ ++ I+DFGLA+ D T
Sbjct: 166 -NEDCELKILDFGLARHTADEMT 187
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 8e-06
Identities = 20/74 (27%), Positives = 33/74 (44%), Gaps = 3/74 (4%)
Query: 52 LVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 111
LVM+ S DL + L + + + + ++HS + +HRD+K N L+
Sbjct: 131 LVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSE- 189
Query: 112 RRANQVYIIDFGLA 125
V + DFG A
Sbjct: 190 --PGLVKLGDFGSA 201
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 1e-05
Identities = 22/75 (29%), Positives = 42/75 (56%), Gaps = 8/75 (10%)
Query: 52 LVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 111
+VM+L+ +L +L + + L QM+ ++ +HS +HRD+KP N ++
Sbjct: 107 IVMELMD---ANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV--- 160
Query: 112 RRAN-QVYIIDFGLA 125
+++ + I+DFGLA
Sbjct: 161 -KSDCTLKILDFGLA 174
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 46.4 bits (109), Expect = 1e-05
Identities = 23/120 (19%), Positives = 45/120 (37%), Gaps = 7/120 (5%)
Query: 14 VKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLS 73
V+ +P LL ++ + G+ +F + + VL + G LE ++ S
Sbjct: 103 VQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLE---QMRTKLSS 159
Query: 74 LKTVLMLADQMINRVEFVHSK-SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 132
L T + Q+ + + F HRD+ N L+ ++ + + K S
Sbjct: 160 LATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLL---KKTSLKKLHYTLNGKSSTIPS 216
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 1e-05
Identities = 21/81 (25%), Positives = 42/81 (51%), Gaps = 4/81 (4%)
Query: 52 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL 110
++++ G +++ + R L+ + ++ QM+ + F+HSK +HRD+K N LM
Sbjct: 93 IMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMT- 151
Query: 111 GRRANQVYIIDFGLAKKYRDT 131
+ + DFG++ K T
Sbjct: 152 --LEGDIRLADFGVSAKNLKT 170
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 1e-05
Identities = 23/88 (26%), Positives = 34/88 (38%), Gaps = 13/88 (14%)
Query: 49 YNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLAD------QMINRVEFVHSKSF--LHRD 100
Y +VM+ + + L C + Q+I + +H S HRD
Sbjct: 100 YLNVVMEYVP---DTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRD 156
Query: 101 IKPDNFLMGLGRRANQVYIIDFGLAKKY 128
IKP N L + + + DFG AKK
Sbjct: 157 IKPHNVL--VNEADGTLKLCDFGSAKKL 182
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 1e-05
Identities = 25/83 (30%), Positives = 41/83 (49%), Gaps = 7/83 (8%)
Query: 52 LVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 111
LVM +G L L KL + L QM+ + ++H+ +HRD+KP N +
Sbjct: 107 LVMPFMGTDLGKLMK--HEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAV--- 161
Query: 112 RRAN-QVYIIDFGLAKKYRDTST 133
+ ++ I+DFGLA++ T
Sbjct: 162 -NEDCELKILDFGLARQADSEMT 183
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 2e-05
Identities = 41/181 (22%), Positives = 68/181 (37%), Gaps = 36/181 (19%)
Query: 52 LVMDLL--GPSLEDLF----NFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDN 105
LV+ L+ G DL + + A ++ +E +H + ++RD+KP+N
Sbjct: 261 LVLTLMNGG----DLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPEN 316
Query: 106 FLM---GLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQ 162
L+ G + I D GLA + T K GT Y +
Sbjct: 317 ILLDDHG------HIRISDLGLAVHVPEGQT--------IKGRVGTVGYMAPEVVKNERY 362
Query: 163 SRRDDLESLGYVLMY-FLRGSLPWQGLKAGTKKQK-YEKISEKKV----STSIEA--LCR 214
+ D +LG L+Y + G P+Q K K+++ + E S +A LC
Sbjct: 363 TFSPDWWALG-CLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCS 421
Query: 215 G 215
Sbjct: 422 Q 422
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 2e-05
Identities = 38/127 (29%), Positives = 58/127 (45%), Gaps = 20/127 (15%)
Query: 81 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD-TSTHQHIPY 139
A Q++ E++HS ++RD+KP+N L+ + + + DFG AK+ + T T
Sbjct: 147 AAQIVLTFEYLHSLDLIYRDLKPENLLID---QQGYIQVTDFGFAKRVKGRTWT------ 197
Query: 140 RENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMY-FLRGSLPWQGLKAGTKKQKYE 198
L GT + L ++ D +LG VL+Y G P+ A Q YE
Sbjct: 198 -----LCGTPEALAPEIILSKGYNKAVDWWALG-VLIYEMAAGYPPF---FADQPIQIYE 248
Query: 199 KISEKKV 205
KI KV
Sbjct: 249 KIVSGKV 255
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 44.5 bits (106), Expect = 3e-05
Identities = 12/123 (9%), Positives = 31/123 (25%), Gaps = 24/123 (19%)
Query: 38 PN-VRWFGV----EGDYNVLVMDLL-GPSLED-LFNFCSRKLSLKTVLMLADQMINRVEF 90
PN + G + L+ + SL + L + + + A M + F
Sbjct: 67 PNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAF 126
Query: 91 VHSKSF--LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGT 148
+H+ + + ++ I + ++
Sbjct: 127 LHTLEPLIPRHALNSRSVMIDEDMT---ARISMADVKFSFQSPGR------------MYA 171
Query: 149 ARY 151
+
Sbjct: 172 PAW 174
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 45.2 bits (107), Expect = 3e-05
Identities = 36/182 (19%), Positives = 71/182 (39%), Gaps = 35/182 (19%)
Query: 52 LVMDLL--GPSLEDLF------NFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKP 103
LVM ++ G D+ + + + Q+++ +E +H ++ ++RD+KP
Sbjct: 262 LVMTIMNGG----DIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKP 317
Query: 104 DNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLT--GTARYASMNTHLGIE 161
+N L+ V I D GLA + + K GT + + LG E
Sbjct: 318 ENVLLD---DDGNVRISDLGLAV---------ELKAGQTKTKGYAGTPGFMAPELLLGEE 365
Query: 162 QSRRDDLESLGYVLMY-FLRGSLPWQGLKAGTKKQK-YEKISEKKV----STSIEA--LC 213
D +LG V +Y + P++ + ++ +++ E+ V S + C
Sbjct: 366 YDFSVDYFALG-VTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKDFC 424
Query: 214 RG 215
Sbjct: 425 EA 426
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 44.8 bits (106), Expect = 4e-05
Identities = 23/78 (29%), Positives = 43/78 (55%), Gaps = 8/78 (10%)
Query: 52 LVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 111
LVM+L+ +L +L + + L QM+ ++ +HS +HRD+KP N ++
Sbjct: 144 LVMELMD---ANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV--- 197
Query: 112 RRAN-QVYIIDFGLAKKY 128
+++ + I+DFGLA+
Sbjct: 198 -KSDCTLKILDFGLARTA 214
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 44.1 bits (105), Expect = 5e-05
Identities = 35/129 (27%), Positives = 53/129 (41%), Gaps = 40/129 (31%)
Query: 89 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD-TSTHQHIPYRENKNLTG 147
E++HSK ++RD+KP+N L L + + + I DFG AK D T T L G
Sbjct: 120 EYLHSKDIIYRDLKPENIL--LDKNGH-IKITDFGFAKYVPDVTYT-----------LCG 165
Query: 148 TARYASMNTHLGIEQSRRDDLESLGY----------VLMY-FLRGSLPWQGLKAGTKKQK 196
T Y + E + + Y +L+Y L G P+ +
Sbjct: 166 TPDY------IAPEV-----VSTKPYNKSIDWWSFGILIYEMLAGYTPFY---DSNTMKT 211
Query: 197 YEKISEKKV 205
YEKI ++
Sbjct: 212 YEKILNAEL 220
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 1e-04
Identities = 18/81 (22%), Positives = 38/81 (46%), Gaps = 4/81 (4%)
Query: 52 LVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK-SFLHRDIKPDNFLMGL 110
+ M+L+G E L + + + + ++ + ++ K +HRD+KP N L+
Sbjct: 101 IAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLD- 159
Query: 111 GRRANQVYIIDFGLAKKYRDT 131
Q+ + DFG++ + D
Sbjct: 160 --ERGQIKLCDFGISGRLVDD 178
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 1e-04
Identities = 31/114 (27%), Positives = 48/114 (42%), Gaps = 14/114 (12%)
Query: 38 PNV-RWFG--VEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQM--INR---- 87
PN+ ++ V D LVM LL G S+ D+ K K+ ++ + I R
Sbjct: 73 PNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLE 132
Query: 88 -VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYR 140
+E++H +HRD+K N L+G V I DFG++ R
Sbjct: 133 GLEYLHKNGQIHRDVKAGNILLG---EDGSVQIADFGVSAFLATGGDITRNKVR 183
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 1e-04
Identities = 18/44 (40%), Positives = 27/44 (61%), Gaps = 5/44 (11%)
Query: 83 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLA 125
Q+I ++++HS LHRD+KP N L+ A V + DFGL+
Sbjct: 117 QLIKVIKYLHSGGLLHRDMKPSNILL----NAECHVKVADFGLS 156
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 18/75 (24%), Positives = 33/75 (44%), Gaps = 5/75 (6%)
Query: 52 LVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 111
LV +L+ L + + +S + + ++ + +H +HRD+ P N L+
Sbjct: 111 LVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILL--- 167
Query: 112 RRAN-QVYIIDFGLA 125
N + I DF LA
Sbjct: 168 -ADNNDITICDFNLA 181
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 42.6 bits (100), Expect = 2e-04
Identities = 20/86 (23%), Positives = 35/86 (40%), Gaps = 8/86 (9%)
Query: 59 PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVY 118
E + L+L+ ++ + Q+ +EF+ S+ +HRD+ N L+ V
Sbjct: 177 EEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN---VVK 233
Query: 119 IIDFGLAKKYRDTSTHQHIPYRENKN 144
I DFGLA+ Y +
Sbjct: 234 ICDFGLARDIYKDPD-----YVRKGD 254
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 2e-04
Identities = 17/53 (32%), Positives = 30/53 (56%), Gaps = 2/53 (3%)
Query: 83 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ 135
Q++ ++++HS + LHRD+KP N + + I DFGLA+ +H+
Sbjct: 128 QLLRGLKYIHSANVLHRDLKPANLF--INTEDLVLKIGDFGLARIMDPHYSHK 178
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 42.1 bits (99), Expect = 3e-04
Identities = 20/46 (43%), Positives = 26/46 (56%), Gaps = 9/46 (19%)
Query: 83 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQ---VYIIDFGLA 125
++ V++VHS LHRD+KP N L NQ V + DFGLA
Sbjct: 164 NLLVGVKYVHSAGILHRDLKPANCL------VNQDCSVKVCDFGLA 203
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 3e-04
Identities = 17/43 (39%), Positives = 22/43 (51%), Gaps = 3/43 (6%)
Query: 89 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 131
EF+HS +HRDIK DN L+G V + DFG +
Sbjct: 130 EFLHSNQVIHRDIKSDNILLG---MDGSVKLTDFGFCAQITPE 169
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 3e-04
Identities = 17/46 (36%), Positives = 23/46 (50%), Gaps = 9/46 (19%)
Query: 83 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQ---VYIIDFGLA 125
++ F+H +HRD+KP N L NQ V + DFGLA
Sbjct: 137 NLLLGENFIHESGIIHRDLKPANCL------LNQDCSVKVCDFGLA 176
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 3e-04
Identities = 24/75 (32%), Positives = 39/75 (52%), Gaps = 7/75 (9%)
Query: 52 LVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 111
+V DL+ L L ++ LS + Q++ ++++HS + LHRD+KP N L+
Sbjct: 107 IVQDLMETDLYKLLK--TQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL--- 161
Query: 112 RRAN-QVYIIDFGLA 125
+ I DFGLA
Sbjct: 162 -NTTCDLKICDFGLA 175
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 4e-04
Identities = 20/82 (24%), Positives = 38/82 (46%), Gaps = 5/82 (6%)
Query: 52 LVMDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMG 109
LVM+ S+ DL L + + + +++ + +H +HRDIK N L+
Sbjct: 104 LVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLT 163
Query: 110 LGRRANQVYIIDFGLAKKYRDT 131
+V ++DFG++ + T
Sbjct: 164 ---ENAEVKLVDFGVSAQLDRT 182
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 4e-04
Identities = 12/43 (27%), Positives = 22/43 (51%), Gaps = 3/43 (6%)
Query: 89 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 131
++H++ +HRDIK D+ L+ +V + DFG +
Sbjct: 155 AYLHAQGVIHRDIKSDSILLT---LDGRVKLSDFGFCAQISKD 194
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 41.5 bits (97), Expect = 5e-04
Identities = 41/182 (22%), Positives = 69/182 (37%), Gaps = 43/182 (23%)
Query: 52 LVMDLL--GPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFL 107
VM+ + G DL + + + A ++ + F+ SK ++RD+K DN +
Sbjct: 419 FVMEYVNGG----DLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVM 474
Query: 108 M---GLGRRANQVYIIDFGLAK---KYRD-TSTHQHIPYRENKNLTGTARYASMNTHLGI 160
+ G + I DFG+ K T T GT Y +
Sbjct: 475 LDSEG------HIKIADFGMCKENIWDGVTTKT-----------FCGTPDYIAPEIIAYQ 517
Query: 161 EQSRRDDLESLGYVLMY-FLRGSLPWQGLKAGTKKQKYEKISEKKV------STSIEALC 213
+ D + G VL+Y L G P++G + + ++ I E V S A+C
Sbjct: 518 PYGKSVDWWAFG-VLLYEMLAGQAPFEG---EDEDELFQSIMEHNVAYPKSMSKEAVAIC 573
Query: 214 RG 215
+G
Sbjct: 574 KG 575
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 5e-04
Identities = 25/100 (25%), Positives = 49/100 (49%), Gaps = 9/100 (9%)
Query: 38 PN-VRWFG--VEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 93
P +++G ++ ++M+ L G S DL L + + +++ ++++HS
Sbjct: 80 PYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE--PGPLDETQIATILREILKGLDYLHS 137
Query: 94 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 133
+ +HRDIK N L+ +V + DFG+A + DT
Sbjct: 138 EKKIHRDIKAANVLLS---EHGEVKLADFGVAGQLTDTQI 174
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 8e-04
Identities = 29/112 (25%), Positives = 50/112 (44%), Gaps = 12/112 (10%)
Query: 38 PN-VRWFGV--EGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 93
PN VR GV + +VM+L+ G +L +KT+L + +E++ S
Sbjct: 172 PNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLES 231
Query: 94 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQH-----IPYR 140
K +HRD+ N L+ N + I DFG++++ D +P +
Sbjct: 232 KCCIHRDLAARNCLVT---EKNVLKISDFGMSREEADGVYAASGGLRQVPVK 280
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 40.3 bits (95), Expect = 8e-04
Identities = 37/142 (26%), Positives = 58/142 (40%), Gaps = 35/142 (24%)
Query: 88 VEFVHSKSFLHRDIKPDNFLM---GLGRRANQVYIIDFGLAK---KYRD-TSTHQHIPYR 140
+ F+ SK ++RD+K DN ++ G + I DFG+ K T T
Sbjct: 134 LFFLQSKGIIYRDLKLDNVMLDSEG------HIKIADFGMCKENIWDGVTTKT------- 180
Query: 141 ENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMY-FLRGSLPWQGLKAGTKKQKYEK 199
GT Y + + D + G VL+Y L G P++G + + ++
Sbjct: 181 ----FCGTPDYIAPEIIAYQPYGKSVDWWAFG-VLLYEMLAGQAPFEG---EDEDELFQS 232
Query: 200 ISEKKV----STSIEA--LCRG 215
I E V S S EA +C+G
Sbjct: 233 IMEHNVAYPKSMSKEAVAICKG 254
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 40.3 bits (95), Expect = 8e-04
Identities = 35/141 (24%), Positives = 54/141 (38%), Gaps = 35/141 (24%)
Query: 89 EFVHSKSFLHRDIKPDNFLM---GLGRRANQVYIIDFGLAK---KYRD-TSTHQHIPYRE 141
+F+HSK ++RD+K DN L+ G + I DFG+ K T+T
Sbjct: 132 QFLHSKGIVYRDLKLDNILLDKDG------HIKIADFGMCKENMLGDAKTNT-------- 177
Query: 142 NKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMY-FLRGSLPWQGLKAGTKKQKYEKI 200
GT Y + LG + + D S G VL+Y L G P+ G +++ + I
Sbjct: 178 ---FCGTPDYIAPEILLGQKYNHSVDWWSFG-VLLYEMLIGQSPFHG---QDEEELFHSI 230
Query: 201 SEKKV------STSIEALCRG 215
+ L
Sbjct: 231 RMDNPFYPRWLEKEAKDLLVK 251
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 449 | |||
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.98 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.97 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.97 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.88 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.72 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.58 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.21 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.06 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.85 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.76 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.72 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.28 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.26 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.23 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.8 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.71 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.27 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.24 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.06 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.0 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 96.75 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 96.7 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 96.43 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 96.41 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.11 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 95.86 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 95.44 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 95.29 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.2 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 94.96 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 93.66 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 92.73 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 89.63 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 83.54 |
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-72 Score=588.71 Aligned_cols=439 Identities=79% Similarity=1.244 Sum_probs=243.7
Q ss_pred EEEeeecccCCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHH
Q 013092 6 TVFSVQENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMI 85 (449)
Q Consensus 6 kV~~k~~~~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~ 85 (449)
.|++|+........++.+|+++++.|+++++|+.+.+++.+.+..||||||++++|.+++..+...+++..++.|+.||+
T Consensus 34 ~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~g~sL~~ll~~~~~~l~~~~~~~i~~qi~ 113 (483)
T 3sv0_A 34 EVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMI 113 (483)
T ss_dssp EEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHH
T ss_pred EEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECCCCCHHHHHHhhcCCCCHHHHHHHHHHHH
Confidence 35666665666677899999999999888999999999999999999999999999999998778899999999999999
Q ss_pred HHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChh
Q 013092 86 NRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRR 165 (449)
Q Consensus 86 ~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~ 165 (449)
.||+|||++|||||||||+||||+.++..+.+||+|||+++.+.........++.......||+.|+|||++.+..++.+
T Consensus 114 ~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~ 193 (483)
T 3sv0_A 114 NRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRR 193 (483)
T ss_dssp HHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHH
T ss_pred HHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChH
Confidence 99999999999999999999999666678899999999999988877766667777778899999999999999999999
Q ss_pred hHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Q 013092 166 DDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIF 245 (449)
Q Consensus 166 ~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~L 245 (449)
+||||||||||||++|..||.+.......+.+.++........++.++..+|.++.+||..||+.+|++||++.+|+++|
T Consensus 194 sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L 273 (483)
T 3sv0_A 194 DDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLF 273 (483)
T ss_dssp HHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHH
Confidence 99999999999999999999998888888899999998888888899999999999999999999999999999999999
Q ss_pred HHHHHHcCCCCCCcccchhhhhhhccCCCCCCccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCCCCCC
Q 013092 246 RDLFIREGFQFDYVFDWTILKYQQSQLATPPARALVPGAGTSGAPPAIASGDRQTGGGEEGRPAGLSSMDSSRRRMSGPV 325 (449)
Q Consensus 246 ~~~~~~~~~~~~~~~dw~~~~~~~~~~~~~p~~~~~p~~~~s~~~~~~~~~~~~~~~~~~~~~~g~~s~~~~~r~~~~~~ 325 (449)
++++...+++++..+||+..+..+.+.+.+|+++..++++++..+++....++.++ .++.+..|++++. +|+.+++.
T Consensus 274 ~~l~~~~~~~~~~~~dW~~~~~~~~~~~~~p~~~~~~~~~~s~~~~~~~~~~~~~~-~~~~~~~~~~~~~--~~~~~~~~ 350 (483)
T 3sv0_A 274 RDLFIREGFQFDYVFDWTILKYQQSQIASAPPRAVGHGAGPSGLAPPALQNDRQSG-VDEGRTSGWSSMD--RRRAPPPI 350 (483)
T ss_dssp HHHHHHTTCCCSSCCHHHHHTC----------------------------------------------------------
T ss_pred HHHHHHcCCCccCCcCchhhccccccccCCCCCCCCCCCCCCCCCCccccccccCc-cccccccCCcccc--cccCCccc
Confidence 99999999999999999999988887777777666666555555444445555554 6777888877763 77888888
Q ss_pred cCCCCCcccCCCCCCCCCCCccccccCCCCCCCCCCCCCCccccccCCCCCCCCCCCCCCCcccccCCCCCCccCCCCCC
Q 013092 326 INSGSFSKQKSPVVNEPTMTKDTMLSSSNFLGRSGGGSSRRAAAVSSSRDAFVGSETEPQRSRTTEASPGAMHRISSGPR 405 (449)
Q Consensus 326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 405 (449)
...|+++++++++.++++.+++.+.++++..+|+.| +||+ .++|+||++..++..++.++|++++++|+.+|+++.||
T Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 428 (483)
T 3sv0_A 351 ASVGTLAKQKAPVGNDASFSKEPVISASNFLGRSSG-SSRR-PAVSSSRDVMPIDTSEPSRTRATDASPGAFRRTSGPQK 428 (483)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred ccccccccccCCCCCCccccccccccccccccccCC-cccc-ccccccccccCCCCCCcccccccccCchhhhcCCCCcc
Confidence 889999999999999999999999999999999844 8899 78899999866666677788889999999899999999
Q ss_pred CCCCCCCCCCcCCCCCccccccccccccccccceeccCCCcccC
Q 013092 406 GSPIGSSDPKRSSSGRNTTHIKTYETTLKGIESLHFDTDERVHY 449 (449)
Q Consensus 406 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 449 (449)
.++..+.++|+++++|++++++|||+||||||+|+|++|+|+||
T Consensus 429 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 472 (483)
T 3sv0_A 429 SSPVNSAEPKHSSSARHSSNVKNYESALKGIEGLNFDGDERVQY 472 (483)
T ss_dssp --------------------------------------------
T ss_pred cCCCCccccccccccccccccccHHHHhhhhhhcccCCchHHHH
Confidence 99999999999999999999999999999999999999999998
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-49 Score=388.26 Aligned_cols=234 Identities=19% Similarity=0.270 Sum_probs=188.2
Q ss_pred cEEEEEeeecccCCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHH
Q 013092 3 EILTVFSVQENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLA 81 (449)
Q Consensus 3 ~aikV~~k~~~~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~ 81 (449)
+|||++++........+.|.+|+++|+.| +|||||++++++.+ +..||||||| ||+|.+++.....++++..++.|+
T Consensus 61 vAvK~~~~~~~~~~~~~~f~~E~~il~~l-~HpNIV~l~g~~~~-~~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~ 138 (307)
T 3omv_A 61 VAVKILKVVDPTPEQFQAFRNEVAVLRKT-RHVNILLFMGYMTK-DNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIA 138 (307)
T ss_dssp EEEEECCCSSCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECS-SSCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHH
T ss_pred EEEEEEEecCCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEC-CeEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHH
Confidence 35666554444444556799999999999 99999999998765 5689999999 999999998666789999999999
Q ss_pred HHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCC-
Q 013092 82 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI- 160 (449)
Q Consensus 82 ~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~- 160 (449)
.||+.||+|||+++||||||||+|||| +.++.+||+|||+|+........ ......+||+.|||||++.+.
T Consensus 139 ~qia~gL~yLH~~~IiHRDlKp~NILl---~~~~~~Ki~DFGla~~~~~~~~~-----~~~~~~~GT~~ymAPE~l~~~~ 210 (307)
T 3omv_A 139 RQTAQGMDYLHAKNIIHRDMKSNNIFL---HEGLTVKIGDFGLATVKSRWSGS-----QQVEQPTGSVLWMAPEVIRMQD 210 (307)
T ss_dssp HHHHHHHHHHHHTTCBCSCCCSSSEEE---ETTEEEEECCCSSCBC-----------------CCCCTTSCCHHHHHCCS
T ss_pred HHHHHHHHHHHHCCccCCccCHHHEEE---CCCCcEEEeeccCceecccCCcc-----eeecccccCCCccCHHHhhccC
Confidence 999999999999999999999999999 57889999999999876543221 122456899999999999753
Q ss_pred --CCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCH
Q 013092 161 --EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDY 238 (449)
Q Consensus 161 --~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~ 238 (449)
.|+.++|||||||+||||++|+.||.+.+. .......+......+.+..+...+|+++.+||..||+.+|++||++
T Consensus 211 ~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~--~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 288 (307)
T 3omv_A 211 NNPFSFQSDVYSYGIVLYELMTGELPYSHINN--RDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLF 288 (307)
T ss_dssp SCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC--HHHHHHHHHTTCCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCH
T ss_pred CCCCCcHHHhHhHHHHHHHHHHCCCCCCCCCh--HHHHHHHHhcCCCCCCcccccccchHHHHHHHHHHcCCCHhHCcCH
Confidence 589999999999999999999999987543 2233333444434444556667899999999999999999999999
Q ss_pred HHHHHHHHHH
Q 013092 239 AYLKRIFRDL 248 (449)
Q Consensus 239 ~~l~~~L~~~ 248 (449)
.+|.+.|+.+
T Consensus 289 ~ei~~~Le~l 298 (307)
T 3omv_A 289 PQILSSIELL 298 (307)
T ss_dssp HHHHHHHHHH
T ss_pred HHHHHHHHHH
Confidence 9999888755
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-49 Score=389.97 Aligned_cols=244 Identities=17% Similarity=0.265 Sum_probs=205.0
Q ss_pred cEEEEEeeeccc-CCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHH
Q 013092 3 EILTVFSVQENV-KTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLML 80 (449)
Q Consensus 3 ~aikV~~k~~~~-~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i 80 (449)
.|||++.|.... ....+.+.+|+++|+.| +|||||++++++++.+..||||||| ||+|.+++.. .+.+++..+..|
T Consensus 60 ~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~yivmEy~~gG~L~~~i~~-~~~l~e~~~~~~ 137 (311)
T 4aw0_A 60 YAIKILEKRHIIKENKVPYVTRERDVMSRL-DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK-IGSFDETCTRFY 137 (311)
T ss_dssp EEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHH-HSSCCHHHHHHH
T ss_pred EEEEEEEHHHCCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHH-cCCCCHHHHHHH
Confidence 577777665432 34567799999999999 8999999999999999999999999 9999999986 467999999999
Q ss_pred HHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCC
Q 013092 81 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI 160 (449)
Q Consensus 81 ~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~ 160 (449)
+.||+.||+|||++||+||||||+|||| +.++.+||+|||+|+.+...... ......+||+.|||||++.+.
T Consensus 138 ~~qi~~al~ylH~~~IiHRDlKPeNILl---~~~g~vKl~DFGla~~~~~~~~~-----~~~~~~~GTp~YmAPEvl~~~ 209 (311)
T 4aw0_A 138 TAEIVSALEYLHGKGIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQ-----ARANSFVGTAQYVSPELLTEK 209 (311)
T ss_dssp HHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCTTCEECCTTTTC-----CCBCCCCSCGGGCCHHHHHHS
T ss_pred HHHHHHHHHHHHHCCCccCCCCHHHeEE---cCCCCEEEEEcCCceecCCCCCc-----ccccCcccCcccCCHHHHcCC
Confidence 9999999999999999999999999999 68899999999999987543321 123467899999999999999
Q ss_pred CCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHH
Q 013092 161 EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAY 240 (449)
Q Consensus 161 ~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~ 240 (449)
.|+.++|||||||+||+|++|..||.+ .+..+.+.+|...... ++..+++++.+||..||+.||++||++.+
T Consensus 210 ~y~~~~DiWSlGvilyeml~G~~PF~~---~~~~~~~~~i~~~~~~-----~p~~~s~~~~dli~~lL~~dp~~R~t~~e 281 (311)
T 4aw0_A 210 SACKSSDLWALGCIIYQLVAGLPPFRA---GNEGLIFAKIIKLEYD-----FPEKFFPKARDLVEKLLVLDATKRLGCEE 281 (311)
T ss_dssp CBCHHHHHHHHHHHHHHHHHSSCSSCC---SSHHHHHHHHHHTCCC-----CCTTCCHHHHHHHHHHSCSSGGGSTTSGG
T ss_pred CCCcHHHHHHHHHHHHHHHhCCCCCCC---CCHHHHHHHHHcCCCC-----CCcccCHHHHHHHHHHccCCHhHCcChHH
Confidence 999999999999999999999999976 3456667777765543 34578999999999999999999999877
Q ss_pred HHHHHHHHHHHcCCCCCCcccchhhhhh
Q 013092 241 LKRIFRDLFIREGFQFDYVFDWTILKYQ 268 (449)
Q Consensus 241 l~~~L~~~~~~~~~~~~~~~dw~~~~~~ 268 (449)
+... ..+ ..++|+..+||+.+..+
T Consensus 282 ~~~~-~~i---~~Hp~F~~idw~~l~~~ 305 (311)
T 4aw0_A 282 MEGY-GPL---KAHPFFESVTWENLHQQ 305 (311)
T ss_dssp GTCH-HHH---HTSGGGTTCCCTTGGGS
T ss_pred HcCC-HHH---HCCCCcCCCCHHHhcCC
Confidence 5321 111 23577788999987643
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-49 Score=390.54 Aligned_cols=244 Identities=18% Similarity=0.248 Sum_probs=195.2
Q ss_pred cEEEEEeeecccCCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHH
Q 013092 3 EILTVFSVQENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLA 81 (449)
Q Consensus 3 ~aikV~~k~~~~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~ 81 (449)
.|||++.+..........+.+|+++|+.| +|||||++++++.+.+..||||||| ||+|.+++.. .+.+++..+..++
T Consensus 55 vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~-~~~l~e~~~~~~~ 132 (304)
T 3ubd_A 55 YAMKVLKKATLKVRDRVRTKMERDILVEV-NHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSK-EVMFTEEDVKFYL 132 (304)
T ss_dssp EEEEEEESEEEEEEECC------CCCCCC-CCTTEECEEEEEEETTEEEEEECCCTTCEEHHHHHH-HCCCCHHHHHHHH
T ss_pred EEEEEEehHHcChHHHHHHHHHHHHHHHC-CCCCCCeEEEEEEECCEEEEEEEcCCCCCHHHHHHh-cCCCCHHHHHHHH
Confidence 47777766554444455789999999999 8999999999999999999999999 9999999986 4579999999999
Q ss_pred HHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCC
Q 013092 82 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIE 161 (449)
Q Consensus 82 ~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~ 161 (449)
.||+.||+|||++||+||||||+|||+ +.++.+||+|||+|+....... .....+||+.|||||++.+..
T Consensus 133 ~qi~~aL~ylH~~~IiHRDlKp~NILl---~~~g~vKl~DFGla~~~~~~~~-------~~~~~~GT~~YmAPE~~~~~~ 202 (304)
T 3ubd_A 133 AELALALDHLHSLGIIYRDLKPENILL---DEEGHIKLTDFGLSKESIDHEK-------KAYSFCGTVEYMAPEVVNRRG 202 (304)
T ss_dssp HHHHHHHHHHHHTTCCCSSCCGGGEEE---CTTSCEEEESSEEEEC-----C-------CCCSCCCCGGGCCHHHHHTSC
T ss_pred HHHHHHHHHHHHCCCcCCCCCHHHeEE---cCCCCEEecccccceeccCCCc-------cccccccCcccCCHHHhccCC
Confidence 999999999999999999999999999 6889999999999987644322 124578999999999999999
Q ss_pred CChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHH-
Q 013092 162 QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAY- 240 (449)
Q Consensus 162 ~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~- 240 (449)
|+.++|||||||+||||++|..||.+. +..+.+.+|...... ++..+++++.+||..||+.||++||++..
T Consensus 203 y~~~~DiwSlGvilyemltG~~PF~~~---~~~~~~~~i~~~~~~-----~p~~~s~~~~~li~~~L~~dP~~R~ta~~~ 274 (304)
T 3ubd_A 203 HTQSADWWSFGVLMFEMLTGTLPFQGK---DRKETMTMILKAKLG-----MPQFLSPEAQSLLRMLFKRNPANRLGAGPD 274 (304)
T ss_dssp CCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHCCCC-----CCTTSCHHHHHHHHHHTCSSGGGSTTCSTT
T ss_pred CCCCCcccchHHHHHHHHhCCCCCCCc---CHHHHHHHHHcCCCC-----CCCcCCHHHHHHHHHHcccCHHHCCCCCcC
Confidence 999999999999999999999999873 445666666665432 34568999999999999999999998521
Q ss_pred -HHHHHHHHHHHcCCCCCCcccchhhhhhhccCC
Q 013092 241 -LKRIFRDLFIREGFQFDYVFDWTILKYQQSQLA 273 (449)
Q Consensus 241 -l~~~L~~~~~~~~~~~~~~~dw~~~~~~~~~~~ 273 (449)
+.+++ .++|...+||+.+..++.++|
T Consensus 275 ~~~eil-------~Hp~f~~idw~~l~~~~~~pP 301 (304)
T 3ubd_A 275 GVEEIK-------RHSFFSTIDWNKLYRREIHPP 301 (304)
T ss_dssp THHHHH-------TSGGGTTCCHHHHHTTCSCCS
T ss_pred CHHHHH-------cCccccCCCHHHHHhCCCCcC
Confidence 22222 346667789998876655443
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=391.08 Aligned_cols=223 Identities=19% Similarity=0.191 Sum_probs=190.0
Q ss_pred cEEEEEeeecccCCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHc-CCCCCHHHHHHH
Q 013092 3 EILTVFSVQENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFC-SRKLSLKTVLML 80 (449)
Q Consensus 3 ~aikV~~k~~~~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~-~~~ls~~~~~~i 80 (449)
+|||++.+........+.+.+|+++|+.| +|||||++++++.+.+..||||||| ||+|.+++... ...+++..++.|
T Consensus 52 vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIV~~~~~~~~~~~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~ 130 (350)
T 4b9d_A 52 YVIKEINISRMSSKEREESRREVAVLANM-KHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDW 130 (350)
T ss_dssp EEEEEEECTTSCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHH
T ss_pred EEEEEEehHHCCHHHHHHHHHHHHHHHHC-CCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHH
Confidence 56777665554444556799999999999 8999999999999999999999999 99999999754 345799999999
Q ss_pred HHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCC
Q 013092 81 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI 160 (449)
Q Consensus 81 ~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~ 160 (449)
+.||+.||+|||++|||||||||+|||| +.++.+||+|||+|+.+..... .....+||+.|||||++.+.
T Consensus 131 ~~qi~~aL~ylH~~~IiHRDlKp~NILl---~~~g~vKl~DFGla~~~~~~~~-------~~~~~~GT~~YmAPE~l~~~ 200 (350)
T 4b9d_A 131 FVQICLALKHVHDRKILHRDIKSQNIFL---TKDGTVQLGDFGIARVLNSTVE-------LARACIGTPYYLSPEICENK 200 (350)
T ss_dssp HHHHHHHHHHHHHTTCEETTCCGGGEEE---CTTCCEEECSTTEESCCCHHHH-------HHHHHHSCCTTCCHHHHTTC
T ss_pred HHHHHHHHHHHHHCCeeeccCCHHHEEE---CCCCCEEEcccccceeecCCcc-------cccccCCCccccCHHHHCCC
Confidence 9999999999999999999999999999 6889999999999987643211 12346799999999999999
Q ss_pred CCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHH
Q 013092 161 EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAY 240 (449)
Q Consensus 161 ~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~ 240 (449)
.|+.++||||||||||||++|+.||.+. +..+.+.++...... .+...+++++.+||..||+.||++||++.+
T Consensus 201 ~y~~~~DiwSlGvilyemltG~~PF~~~---~~~~~~~~i~~~~~~----~~~~~~s~~~~~li~~~L~~dP~~R~s~~e 273 (350)
T 4b9d_A 201 PYNNKSDIWALGCVLYELCTLKHAFEAG---SMKNLVLKIISGSFP----PVSLHYSYDLRSLVSQLFKRNPRDRPSVNS 273 (350)
T ss_dssp CCCHHHHHHHHHHHHHHHHHSSCSCCCS---SHHHHHHHHHHTCCC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CCCcHHHHHHHHHHHHHHHHCCCCCCCc---CHHHHHHHHHcCCCC----CCCccCCHHHHHHHHHHccCChhHCcCHHH
Confidence 9999999999999999999999999873 445666666665443 234578999999999999999999999887
Q ss_pred HHH
Q 013092 241 LKR 243 (449)
Q Consensus 241 l~~ 243 (449)
|++
T Consensus 274 ~l~ 276 (350)
T 4b9d_A 274 ILE 276 (350)
T ss_dssp HHT
T ss_pred Hhc
Confidence 753
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-48 Score=384.12 Aligned_cols=220 Identities=20% Similarity=0.235 Sum_probs=184.7
Q ss_pred HHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecC
Q 013092 22 LYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRD 100 (449)
Q Consensus 22 ~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~givHRD 100 (449)
.+|+.+|+.| +|||||++++++.+++..||||||| |++|.++++. .+.|++..++.|+.||+.||+|||++||||||
T Consensus 98 ~~E~~il~~l-~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRD 175 (336)
T 4g3f_A 98 VEELVACAGL-SSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQ-MGCLPEDRALYYLGQALEGLEYLHTRRILHGD 175 (336)
T ss_dssp THHHHTTTTC-CCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTTTEECSC
T ss_pred HHHHHHHHhC-CCCCCCcEEEEEEECCEEEEEEeccCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecc
Confidence 5799999999 9999999999999999999999999 9999999986 45799999999999999999999999999999
Q ss_pred CCCCcEEEeecCCCC-eEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHHHHHHH
Q 013092 101 IKPDNFLMGLGRRAN-QVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFL 179 (449)
Q Consensus 101 LKP~NiLl~~~~~~~-~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il~ell 179 (449)
|||+|||| +.++ .+||+|||+|+.+........ .......+||+.|||||++.+..|+.++|||||||+||||+
T Consensus 176 lKp~NILl---~~~g~~vKl~DFGla~~~~~~~~~~~--~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyeml 250 (336)
T 4g3f_A 176 VKADNVLL---SSDGSRAALCDFGHALCLQPDGLGKS--LLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHML 250 (336)
T ss_dssp CCGGGEEE---CTTSCCEEECCCTTCEEC--------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHH
T ss_pred cCHHHEEE---eCCCCEEEEeeCCCCeEccCCCcccc--eecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHH
Confidence 99999999 4555 699999999998765332111 11234568999999999999999999999999999999999
Q ss_pred hCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Q 013092 180 RGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREG 253 (449)
Q Consensus 180 tG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~L~~~~~~~~ 253 (449)
+|..||.+..... .+.+|.... .++..+++.+++++.+||..||+.||++||++.+|++.|...+...+
T Consensus 251 tG~~Pf~~~~~~~---~~~~i~~~~--~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~ 319 (336)
T 4g3f_A 251 NGCHPWTQYFRGP---LCLKIASEP--PPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVG 319 (336)
T ss_dssp HSSCSSTTTCCSC---CHHHHHHSC--CGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred HCcCCCCCCCHHH---HHHHHHcCC--CCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhh
Confidence 9999998865543 234444432 23445677899999999999999999999999999999988877654
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=383.98 Aligned_cols=221 Identities=16% Similarity=0.255 Sum_probs=187.0
Q ss_pred cEEEEEeeecccCCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHH
Q 013092 3 EILTVFSVQENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLA 81 (449)
Q Consensus 3 ~aikV~~k~~~~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~ 81 (449)
+|||++.+.. ....+.+.+|+++|+.| +|||||++++++.+.+..||||||| ||+|.+++.. .++++..+..|+
T Consensus 102 vAiK~i~~~~--~~~~~~~~~Ei~il~~l-~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~--~~l~e~~~~~~~ 176 (346)
T 4fih_A 102 VAVKKMDLRK--QQRRELLFNEVVIMRDY-QHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH--TRMNEEQIAAVC 176 (346)
T ss_dssp EEEEEEEGGG--CSSGGGGHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEEECCCTTEEHHHHHHH--SCCCHHHHHHHH
T ss_pred EEEEEEecCc--hhHHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHc--CCCCHHHHHHHH
Confidence 4666665432 34456789999999999 8999999999999999999999999 9999999984 579999999999
Q ss_pred HHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCC
Q 013092 82 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIE 161 (449)
Q Consensus 82 ~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~ 161 (449)
.||+.||+|||++|||||||||+|||| +.++.+||+|||+|+.+..... .....+||+.|||||++.+..
T Consensus 177 ~qi~~aL~ylH~~~IiHRDlKp~NILl---~~~g~vKl~DFGla~~~~~~~~-------~~~~~~GTp~YmAPEvl~~~~ 246 (346)
T 4fih_A 177 LAVLQALSVLHAQGVIHRDIKSDSILL---THDGRVKLSDFGFCAQVSKEVP-------RRKSLVGTPYWMAPELISRLP 246 (346)
T ss_dssp HHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECCSSSC-------CBCCCCSCGGGCCHHHHTTCC
T ss_pred HHHHHHHHHHHHCCcccccCCHHHEEE---CCCCCEEEecCcCceecCCCCC-------cccccccCcCcCCHHHHCCCC
Confidence 999999999999999999999999999 6889999999999998765432 124678999999999999999
Q ss_pred CChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHH
Q 013092 162 QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYL 241 (449)
Q Consensus 162 ~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l 241 (449)
|+.++||||||||||||++|..||.+. +..+.+..|...... . ...+..+++++.+||..||+.||++||++.+|
T Consensus 247 y~~~~DiWSlGvilyeml~G~~PF~~~---~~~~~~~~i~~~~~~-~-~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~ 321 (346)
T 4fih_A 247 YGPEVDIWSLGIMVIEMVDGEPPYFNE---PPLKAMKMIRDNLPP-R-LKNLHKVSPSLKGFLDRLLVRDPAQRATAAEL 321 (346)
T ss_dssp BCTHHHHHHHHHHHHHHHHSSCTTTTS---CHHHHHHHHHHSSCC-C-CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred CCcHHHHHHHHHHHHHHHHCCCCCCCc---CHHHHHHHHHcCCCC-C-CCccccCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence 999999999999999999999999874 344555555543221 1 12235689999999999999999999998877
Q ss_pred HH
Q 013092 242 KR 243 (449)
Q Consensus 242 ~~ 243 (449)
++
T Consensus 322 l~ 323 (346)
T 4fih_A 322 LK 323 (346)
T ss_dssp TT
T ss_pred hc
Confidence 43
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-48 Score=379.83 Aligned_cols=220 Identities=22% Similarity=0.303 Sum_probs=189.1
Q ss_pred ChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHc------------CCCCCHHHHHHHHHH
Q 013092 17 KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFC------------SRKLSLKTVLMLADQ 83 (449)
Q Consensus 17 ~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~------------~~~ls~~~~~~i~~q 83 (449)
..++|.+|+++|+.| +|||||++++++.+++..||||||| +|+|.+++... ...+++..++.|+.|
T Consensus 58 ~~~~f~~E~~il~~l-~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~q 136 (299)
T 4asz_A 58 ARKDFHREAELLTNL-QHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQ 136 (299)
T ss_dssp HHHHHHHHHHHHTTC-CCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhC-CCCCCccEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHH
Confidence 346699999999999 8999999999999999999999999 99999999753 246999999999999
Q ss_pred HHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCC
Q 013092 84 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQS 163 (449)
Q Consensus 84 i~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s 163 (449)
|+.||+|||+++||||||||+|||| +.++.+||+|||+++....... +.......||+.|||||++.+..|+
T Consensus 137 ia~gl~yLH~~~iiHRDlKp~NILl---~~~~~~Ki~DFGla~~~~~~~~-----~~~~~~~~gt~~ymAPE~~~~~~~~ 208 (299)
T 4asz_A 137 IAAGMVYLASQHFVHRDLATRNCLV---GENLLVKIGDFGMSRDVYSTDY-----YRVGGHTMLPIRWMPPESIMYRKFT 208 (299)
T ss_dssp HHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCSCHHHHTGGGC-----EEETTTEEECGGGCCHHHHHHCCCC
T ss_pred HHHHHHHHHhCCcccCccCHhhEEE---CCCCcEEECCcccceecCCCCc-----eeecCceecChhhcCHHHHcCCCCC
Confidence 9999999999999999999999999 6888999999999987644322 1222345799999999999999999
Q ss_pred hhhHHHHHHHHHHHHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 013092 164 RRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 242 (449)
Q Consensus 164 ~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~ 242 (449)
.++|||||||+||||+| |+.||.+.+ ..+.+..+...... ..+..+|+++.+||..||+.||++||++.+|.
T Consensus 209 ~k~DVwS~Gvvl~Ellt~G~~Pf~~~~---~~~~~~~i~~~~~~----~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~ 281 (299)
T 4asz_A 209 TESDVWSLGVVLWEIFTYGKQPWYQLS---NNEVIECITQGRVL----QRPRTCPQEVYELMLGCWQREPHMRKNIKGIH 281 (299)
T ss_dssp HHHHHHHHHHHHHHHHTTTCCTTTTSC---HHHHHHHHHHTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred chhhHHHHHHHHHHHHcCCCCCCCCCC---HHHHHHHHHcCCCC----CCCccchHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 99999999999999998 999998754 34555556554332 23467999999999999999999999999999
Q ss_pred HHHHHHHHHc
Q 013092 243 RIFRDLFIRE 252 (449)
Q Consensus 243 ~~L~~~~~~~ 252 (449)
+.|+++....
T Consensus 282 ~~L~~~~~~~ 291 (299)
T 4asz_A 282 TLLQNLAKAS 291 (299)
T ss_dssp HHHHHHHHHS
T ss_pred HHHHHHHhcC
Confidence 9998876543
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=380.81 Aligned_cols=218 Identities=20% Similarity=0.276 Sum_probs=179.7
Q ss_pred ChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHc--------------CCCCCHHHHHHHH
Q 013092 17 KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFC--------------SRKLSLKTVLMLA 81 (449)
Q Consensus 17 ~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~--------------~~~ls~~~~~~i~ 81 (449)
..++|.+|+++|..| +|||||++++++.+.+..||||||| +|+|.+++... ..++++.+++.|+
T Consensus 86 ~~~~f~~E~~il~~l-~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~ 164 (329)
T 4aoj_A 86 ARQDFQREAELLTML-QHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164 (329)
T ss_dssp HHHHHHHHHHHHTTC-CCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHH
T ss_pred HHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHH
Confidence 346799999999999 9999999999999999999999999 99999999743 2358999999999
Q ss_pred HHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCC
Q 013092 82 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIE 161 (449)
Q Consensus 82 ~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~ 161 (449)
.||+.||+|||+++||||||||+|||| +.++.+||+|||+++....... +.......||+.|||||++.+..
T Consensus 165 ~qia~gl~yLH~~~iiHRDLKp~NILl---~~~~~~Ki~DFGla~~~~~~~~-----~~~~~~~~gt~~ymAPE~~~~~~ 236 (329)
T 4aoj_A 165 SQVAAGMVYLAGLHFVHRDLATRNCLV---GQGLVVKIGDFGMSRDIYSTDY-----YRVGGRTMLPIRWMPPESILYRK 236 (329)
T ss_dssp HHHHHHHHHHHHTTCCCSCCCGGGEEE---ETTTEEEECCCC---------------------CCCCGGGCCHHHHTTCC
T ss_pred HHHHHHHHHHhcCCeecccccHhhEEE---CCCCcEEEcccccceeccCCCc-----ceecCcccccccccChhhhcCCC
Confidence 999999999999999999999999999 5889999999999987654322 12234567999999999999999
Q ss_pred CChhhHHHHHHHHHHHHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHH
Q 013092 162 QSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAY 240 (449)
Q Consensus 162 ~s~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~ 240 (449)
++.++|||||||+||||++ |+.||.+... .+.+..+...... ..+..+|+++.+||..||+.||++||++.+
T Consensus 237 ~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~---~~~~~~i~~g~~~----~~p~~~~~~~~~li~~cl~~dP~~RPs~~e 309 (329)
T 4aoj_A 237 FTTESDVWSFGVVLWEIFTYGKQPWYQLSN---TEAIDCITQGREL----ERPRACPPEVYAIMRGCWQREPQQRHSIKD 309 (329)
T ss_dssp CCHHHHHHHHHHHHHHHHTTSCCTTCSSCH---HHHHHHHHHTCCC----CCCTTCCHHHHHHHHHHCCSSTTTSCCHHH
T ss_pred CCccccccchHHHHHHHHcCCCCCCCCCCH---HHHHHHHHcCCCC----CCcccccHHHHHHHHHHcCcChhHCcCHHH
Confidence 9999999999999999998 9999987543 4455555543321 234679999999999999999999999999
Q ss_pred HHHHHHHHHH
Q 013092 241 LKRIFRDLFI 250 (449)
Q Consensus 241 l~~~L~~~~~ 250 (449)
|.+.|+.+.+
T Consensus 310 i~~~L~~l~~ 319 (329)
T 4aoj_A 310 VHARLQALAQ 319 (329)
T ss_dssp HHHHHHHHHH
T ss_pred HHHHHHHHhh
Confidence 9999988754
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-47 Score=367.86 Aligned_cols=220 Identities=22% Similarity=0.248 Sum_probs=177.2
Q ss_pred cEEEEEeeecccC-CChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHH
Q 013092 3 EILTVFSVQENVK-TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLA 81 (449)
Q Consensus 3 ~aikV~~k~~~~~-~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~~~~i~ 81 (449)
.|||++.|..... .....+.+|+++|+.| +||||+++++++.+.+..|||||||+|+|.+++.. .+++++..+..++
T Consensus 41 vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~~~~~ivmEy~~g~L~~~l~~-~~~l~e~~~~~~~ 118 (275)
T 3hyh_A 41 VALKIINKKVLAKSDMQGRIEREISYLRLL-RHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQ-RDKMSEQEARRFF 118 (275)
T ss_dssp EEEEEEECC------CHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEEECCCEEHHHHHHH-SCSCCHHHHHHHH
T ss_pred EEEEEEeHHHcCCHHHHHHHHHHHHHHHHC-CCCCCCeEEEEEEECCEEEEEEeCCCCCHHHHHHH-cCCCCHHHHHHHH
Confidence 5677776554333 3456799999999999 89999999999999999999999998899999986 5679999999999
Q ss_pred HHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCC
Q 013092 82 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIE 161 (449)
Q Consensus 82 ~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~ 161 (449)
.||+.||+|||++||+||||||+|||| +.++.+||+|||+|+....... ....+||+.|||||++.+..
T Consensus 119 ~qi~~al~ylH~~~IiHRDiKP~NILl---~~~~~vkl~DFGla~~~~~~~~--------~~~~~GT~~Y~APE~~~~~~ 187 (275)
T 3hyh_A 119 QQIISAVEYCHRHKIVHRDLKPENLLL---DEHLNVKIADFGLSNIMTDGNF--------LKTSCGSPNYAAPEVISGKL 187 (275)
T ss_dssp HHHHHHHHHHHHTTCCCCCCCTTTEEE---CTTCCEEECCSSCC-----------------------CTTSCHHHHSSSS
T ss_pred HHHHHHHHHHHHCCcccccCChHHeEE---CCCCCEEEeecCCCeecCCCCc--------cCCeeECcccCChhhhcCCC
Confidence 999999999999999999999999999 6889999999999987654322 24568999999999999988
Q ss_pred C-ChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHH
Q 013092 162 Q-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAY 240 (449)
Q Consensus 162 ~-s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~ 240 (449)
+ +.++|||||||++|+|++|+.||.+ .+..+.+..+...... ++..+++++.+||..||+.||++||++.+
T Consensus 188 y~~~~~DiwSlGvily~lltg~~PF~~---~~~~~~~~~i~~~~~~-----~p~~~s~~~~~li~~~L~~dP~~R~s~~e 259 (275)
T 3hyh_A 188 YAGPEVDVWSCGVILYVMLCRRLPFDD---ESIPVLFKNISNGVYT-----LPKFLSPGAAGLIKRMLIVNPLNRISIHE 259 (275)
T ss_dssp CCCTHHHHHHHHHHHHHHHHSSCSSCC---SSHHHHHHHHHHTCCC-----CCTTSCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred CCCChhhhHHHHHHHHHHHHCCCCCCC---CCHHHHHHHHHcCCCC-----CCCCCCHHHHHHHHHHccCChhHCcCHHH
Confidence 6 5899999999999999999999976 3445566666655432 34568999999999999999999999877
Q ss_pred HHH
Q 013092 241 LKR 243 (449)
Q Consensus 241 l~~ 243 (449)
+++
T Consensus 260 il~ 262 (275)
T 3hyh_A 260 IMQ 262 (275)
T ss_dssp HHH
T ss_pred HHc
Confidence 643
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-47 Score=373.64 Aligned_cols=215 Identities=17% Similarity=0.195 Sum_probs=185.1
Q ss_pred ChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHc---------------CCCCCHHHHHHH
Q 013092 17 KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFC---------------SRKLSLKTVLML 80 (449)
Q Consensus 17 ~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~---------------~~~ls~~~~~~i 80 (449)
..++|.+|+.+|..| +|||||++++++.+.+..||||||| +|+|.+++... ...+++..++.|
T Consensus 72 ~~~~f~~E~~il~~l-~HpNIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i 150 (308)
T 4gt4_A 72 LREEFRHEAMLRARL-QHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 150 (308)
T ss_dssp CHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHH
T ss_pred HHHHHHHHHHHHHhC-CCCCCCCcceEEEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHH
Confidence 456799999999999 9999999999999999999999999 99999999642 135899999999
Q ss_pred HHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCC
Q 013092 81 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI 160 (449)
Q Consensus 81 ~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~ 160 (449)
+.||+.||+|||+++||||||||+|||| +.++.+||+|||+++....... +.......||+.|||||++.+.
T Consensus 151 ~~qia~gl~yLH~~~iiHRDLK~~NILl---~~~~~~Ki~DFGlar~~~~~~~-----~~~~~~~~gt~~ymAPE~l~~~ 222 (308)
T 4gt4_A 151 VAQIAAGMEYLSSHHVVHKDLATRNVLV---YDKLNVKISDLGLFREVYAADY-----YKLLGNSLLPIRWMAPEAIMYG 222 (308)
T ss_dssp HHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCSCCBCGGGGGGC-----BCSSSSSCBCGGGCCHHHHHHC
T ss_pred HHHHHHHHHHHHhCCCCCCCccccceEE---CCCCCEEECCcccceeccCCCc-----eeEecccccCCcccCHHHHhCC
Confidence 9999999999999999999999999999 6889999999999987654322 1223456899999999999999
Q ss_pred CCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHH
Q 013092 161 EQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYA 239 (449)
Q Consensus 161 ~~s~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~ 239 (449)
.|+.++|||||||+||||++ |..||.+.+. .+.+..+...... ..+..+|+++.+||..||+.||++||++.
T Consensus 223 ~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~---~~~~~~i~~~~~~----~~p~~~~~~~~~li~~C~~~dP~~RPs~~ 295 (308)
T 4gt4_A 223 KFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN---QDVVEMIRNRQVL----PCPDDCPAWVYALMIECWNEFPSRRPRFK 295 (308)
T ss_dssp CCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH---HHHHHHHHTTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred CCCccchhhhHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCCCC----CCcccchHHHHHHHHHHcCCChhHCcCHH
Confidence 99999999999999999998 8999988543 4455555554332 24567999999999999999999999999
Q ss_pred HHHHHHHH
Q 013092 240 YLKRIFRD 247 (449)
Q Consensus 240 ~l~~~L~~ 247 (449)
+|.+.|+.
T Consensus 296 ei~~~L~a 303 (308)
T 4gt4_A 296 DIHSRLRA 303 (308)
T ss_dssp HHHHHHHT
T ss_pred HHHHHHHh
Confidence 99988764
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-46 Score=367.43 Aligned_cols=253 Identities=59% Similarity=1.058 Sum_probs=228.4
Q ss_pred EEeeecccCCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHH
Q 013092 7 VFSVQENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMIN 86 (449)
Q Consensus 7 V~~k~~~~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~ 86 (449)
|++|........+.+.+|+++++.|.+||||+.+++++.+++..||||||++++|.+++......+++..++.++.||+.
T Consensus 37 vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~ 116 (330)
T 2izr_A 37 VAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLIS 116 (330)
T ss_dssp EEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHH
T ss_pred EEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeCCCCHHHHHHHcCCCCCHHHHHHHHHHHHH
Confidence 44554444455667999999999999999999999999999999999999999999999976678999999999999999
Q ss_pred HHHHHHHCCceecCCCCCcEEEeecCCCCe-----EEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCC
Q 013092 87 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQ-----VYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIE 161 (449)
Q Consensus 87 aL~yLH~~givHRDLKP~NiLl~~~~~~~~-----vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~ 161 (449)
||+|||++||+||||||+|||++ .++. +||+|||+++.+.........+++......||+.|+|||++.+..
T Consensus 117 ~l~~LH~~~iiHrDlkp~Nill~---~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 193 (330)
T 2izr_A 117 RMEYVHSKNLIYRDVKPENFLIG---RPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKE 193 (330)
T ss_dssp HHHHHHHTTEECCCCCGGGEEEC---CGGGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC
T ss_pred HHHHHHhCCeeccCCCHHHeeec---cCCCCCCceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCC
Confidence 99999999999999999999994 4444 999999999988776665556666667889999999999999999
Q ss_pred CChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHH
Q 013092 162 QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYL 241 (449)
Q Consensus 162 ~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l 241 (449)
++.++|||||||++|||++|..||.+.......+.+..+.........+.++..+| ++.+++..||+.+|.+||++.+|
T Consensus 194 ~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l 272 (330)
T 2izr_A 194 QSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYL 272 (330)
T ss_dssp CCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHH
T ss_pred CCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHH
Confidence 99999999999999999999999999877777788888877777777777888888 99999999999999999999999
Q ss_pred HHHHHHHHHHcCCCCCCcccch
Q 013092 242 KRIFRDLFIREGFQFDYVFDWT 263 (449)
Q Consensus 242 ~~~L~~~~~~~~~~~~~~~dw~ 263 (449)
.+.|++++.+.++..+..+||+
T Consensus 273 ~~~l~~~~~~~~~~~~~~~dw~ 294 (330)
T 2izr_A 273 RKLFTDLFDRKGYMFDYEYDWI 294 (330)
T ss_dssp HHHHHHHHHHTTCCCSCCCTTT
T ss_pred HHHHHHHHHHcCCCCCCCccCC
Confidence 9999999999999999999998
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-47 Score=370.38 Aligned_cols=222 Identities=17% Similarity=0.240 Sum_probs=181.0
Q ss_pred cEEEEEeeecccCCChhHHHHHHHHHHHhcCCCCCceEEEEeEe----CCEEEEEEecC-CCCHHHHHHHcCCCCCHHHH
Q 013092 3 EILTVFSVQENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVE----GDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTV 77 (449)
Q Consensus 3 ~aikV~~k~~~~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~----~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~ 77 (449)
+|+|++.+..........|.+|+++|+.| +|||||++++++.+ .+..||||||| ||+|.+++.. ...+++..+
T Consensus 54 vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIV~~~~~~~~~~~~~~~~~lvmEy~~gg~L~~~l~~-~~~l~~~~~ 131 (290)
T 3fpq_A 54 VAWCELQDRKLTKSERQRFKEEAEMLKGL-QHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR-FKVMKIKVL 131 (290)
T ss_dssp EEEEEEEGGGSCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEEEETTEEEEEEEEECCCSCBHHHHHHH-HSSCCHHHH
T ss_pred EEEEEEchhhCCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEeeccCCCcEEEEEEeCCCCCCHHHHHHh-cCCCCHHHH
Confidence 34555544443444456799999999999 89999999999875 35689999999 9999999986 457999999
Q ss_pred HHHHHHHHHHHHHHHHCC--ceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchh
Q 013092 78 LMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMN 155 (449)
Q Consensus 78 ~~i~~qi~~aL~yLH~~g--ivHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE 155 (449)
+.|+.||+.||+|||++| ||||||||+||||. ..++.+||+|||+|+...... ....+||+.|||||
T Consensus 132 ~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~--~~~g~vKl~DFGla~~~~~~~---------~~~~~GTp~YmAPE 200 (290)
T 3fpq_A 132 RSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT--GPTGSVKIGDLGLATLKRASF---------AKAVIGTPEFMAPE 200 (290)
T ss_dssp HHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEES--STTSCEEECCTTGGGGCCTTS---------BEESCSSCCCCCGG
T ss_pred HHHHHHHHHHHHHHHHCCCCEEecccChhheeEE--CCCCCEEEEeCcCCEeCCCCc---------cCCcccCccccCHH
Confidence 999999999999999999 99999999999993 246899999999997543321 24568999999999
Q ss_pred hhhCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCC
Q 013092 156 THLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDK 235 (449)
Q Consensus 156 ~~~~~~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~R 235 (449)
++.+ .|+.++|||||||+||||++|+.||.+.. ...+.+..+.....+ ..+...+++++.+||..||+.||++|
T Consensus 201 ~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~--~~~~~~~~i~~~~~~---~~~~~~~~~~~~~li~~~L~~dP~~R 274 (290)
T 3fpq_A 201 MYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ--NAAQIYRRVTSGVKP---ASFDKVAIPEVKEIIEGCIRQNKDER 274 (290)
T ss_dssp GGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS--SHHHHHHHHTTTCCC---GGGGGCCCHHHHHHHHHHSCSSGGGS
T ss_pred HcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCC--cHHHHHHHHHcCCCC---CCCCccCCHHHHHHHHHHccCChhHC
Confidence 9875 69999999999999999999999997643 334445555443322 23445688999999999999999999
Q ss_pred CCHHHHHH
Q 013092 236 PDYAYLKR 243 (449)
Q Consensus 236 Pt~~~l~~ 243 (449)
|++.+|++
T Consensus 275 ~s~~e~l~ 282 (290)
T 3fpq_A 275 YSIKDLLN 282 (290)
T ss_dssp CCHHHHHT
T ss_pred cCHHHHhc
Confidence 99887753
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=382.30 Aligned_cols=221 Identities=16% Similarity=0.255 Sum_probs=186.6
Q ss_pred cEEEEEeeecccCCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHH
Q 013092 3 EILTVFSVQENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLA 81 (449)
Q Consensus 3 ~aikV~~k~~~~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~ 81 (449)
+|||++.+.. ....+.+.+|+.+|+.| +|||||++++++.+++.+||||||| ||+|.++++. ..+++..+..|+
T Consensus 179 vAiK~i~~~~--~~~~~~~~~Ei~il~~l-~HpnIV~l~~~~~~~~~~~iVmEy~~gG~L~~~i~~--~~l~e~~~~~~~ 253 (423)
T 4fie_A 179 VAVKKMDLRK--QQRRELLFNEVVIMRDY-QHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH--TRMNEEQIAAVC 253 (423)
T ss_dssp EEEEEEESTT--CSSGGGHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHH--SCCCHHHHHHHH
T ss_pred EEEEEEeccc--hhHHHHHHHHHHHHHhC-CCCCCCceEEEEEECCEEEEEEeCCCCCcHHHHHhc--cCCCHHHHHHHH
Confidence 4566554332 34456799999999999 8999999999999999999999999 9999999984 569999999999
Q ss_pred HHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCC
Q 013092 82 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIE 161 (449)
Q Consensus 82 ~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~ 161 (449)
.||+.||+|||++|||||||||+|||| +.++.+||+|||+|+.+..... .....+||+.|||||++.+..
T Consensus 254 ~qil~aL~ylH~~~IiHRDiKp~NILl---~~~g~vKl~DFGla~~~~~~~~-------~~~~~~GTp~YmAPEvl~~~~ 323 (423)
T 4fie_A 254 LAVLQALSVLHAQGVIHRDIKSDSILL---THDGRVKLSDFGFCAQVSKEVP-------RRKSLVGTPYWMAPELISRLP 323 (423)
T ss_dssp HHHHHHHHHHHHTTEECCCCSTTTEEE---CTTCCEEECCCTTCEECCSSCC-------CBCCCEECTTTCCHHHHTTCC
T ss_pred HHHHHHHHHHHHCCeecccCCHHHEEE---cCCCCEEEecCccceECCCCCc-------cccccccCcCcCCHHHHCCCC
Confidence 999999999999999999999999999 6889999999999998765432 124678999999999999999
Q ss_pred CChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHH
Q 013092 162 QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYL 241 (449)
Q Consensus 162 ~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l 241 (449)
|+.++||||||||+|||++|..||.+. +..+.+..|...... . ......+++++.+||..||..||++||++.+|
T Consensus 324 y~~~~DiWSlGvilyeml~G~~PF~~~---~~~~~~~~i~~~~~~-~-~~~~~~~s~~~~dli~~~L~~dP~~R~ta~el 398 (423)
T 4fie_A 324 YGPEVDIWSLGIMVIEMVDGEPPYFNE---PPLKAMKMIRDNLPP-R-LKNLHKVSPSLKGFLDRLLVRDPAQRATAAEL 398 (423)
T ss_dssp BCTHHHHHHHHHHHHHHHHSSCTTTTS---CHHHHHHHHHHSCCC-C-CSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred CCcHHHHHHHHHHHHHHHHCCCCCCCc---CHHHHHHHHHcCCCC-C-CcccccCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence 999999999999999999999999874 344555555543221 1 12235689999999999999999999998877
Q ss_pred HH
Q 013092 242 KR 243 (449)
Q Consensus 242 ~~ 243 (449)
++
T Consensus 399 l~ 400 (423)
T 4fie_A 399 LK 400 (423)
T ss_dssp TT
T ss_pred hc
Confidence 43
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-45 Score=355.36 Aligned_cols=260 Identities=77% Similarity=1.334 Sum_probs=230.1
Q ss_pred EEEeeecccCCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHH
Q 013092 6 TVFSVQENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMI 85 (449)
Q Consensus 6 kV~~k~~~~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~ 85 (449)
.|++|..........+..|+++++.+.++++|+.+..++.+....||||||++++|.+++......+++..++.++.||+
T Consensus 36 ~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~ 115 (296)
T 4hgt_A 36 EVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMI 115 (296)
T ss_dssp EEEEEEEEC---CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECCCCBHHHHHHHTTSCCCHHHHHHHHHHHH
T ss_pred eEEEEeecccccchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEccCCCHHHHHHHhcCCCCHHHHHHHHHHHH
Confidence 35555555555667899999999999888888888888899999999999999999999987677899999999999999
Q ss_pred HHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChh
Q 013092 86 NRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRR 165 (449)
Q Consensus 86 ~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~ 165 (449)
.||.|||++||+||||||+|||+..++..+.+||+|||+++...........++.......||+.|+|||++.+..++.+
T Consensus 116 ~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 195 (296)
T 4hgt_A 116 SRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRR 195 (296)
T ss_dssp HHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHH
T ss_pred HHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCch
Confidence 99999999999999999999999655577899999999999887766655555666677899999999999999999999
Q ss_pred hHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Q 013092 166 DDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIF 245 (449)
Q Consensus 166 ~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~L 245 (449)
+|||||||++|+|++|..||.+.......+.+..+.......+.+.++..+|+++.++|..||+.+|++||++.+|.+.|
T Consensus 196 ~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l 275 (296)
T 4hgt_A 196 DDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLF 275 (296)
T ss_dssp HHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHH
T ss_pred hHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHH
Confidence 99999999999999999999987766666667777777777777788889999999999999999999999999999999
Q ss_pred HHHHHHcCCCCCCcccchhh
Q 013092 246 RDLFIREGFQFDYVFDWTIL 265 (449)
Q Consensus 246 ~~~~~~~~~~~~~~~dw~~~ 265 (449)
++++.+.+..++..+||+.+
T Consensus 276 ~~~~~~~~~~~~~~~dw~~~ 295 (296)
T 4hgt_A 276 RNLFHRQGFSYDYVFDWNML 295 (296)
T ss_dssp HHHHHHHTCCTTCCCGGGGC
T ss_pred HHHHHHhCCCccCccchhhc
Confidence 99999999999999999975
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-45 Score=354.03 Aligned_cols=258 Identities=60% Similarity=0.992 Sum_probs=228.0
Q ss_pred EEeeecccCCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHH
Q 013092 7 VFSVQENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMIN 86 (449)
Q Consensus 7 V~~k~~~~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~ 86 (449)
|++|..........+.+|+.+++.+.+|+||+++++++.++...||||||++++|.+++......+++..++.++.||+.
T Consensus 38 vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~ 117 (298)
T 1csn_A 38 VAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLA 117 (298)
T ss_dssp EEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHH
T ss_pred EEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEecCCCHHHHHHHhccCCCHHHHHHHHHHHHH
Confidence 44444444455667999999999999999999999999999999999999999999999876667999999999999999
Q ss_pred HHHHHHHCCceecCCCCCcEEEeec--CCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCCh
Q 013092 87 RVEFVHSKSFLHRDIKPDNFLMGLG--RRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSR 164 (449)
Q Consensus 87 aL~yLH~~givHRDLKP~NiLl~~~--~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~ 164 (449)
||+|||++||+||||||+|||+..+ .....+||+|||+++...........++.......||+.|+|||++.+..++.
T Consensus 118 ~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 197 (298)
T 1csn_A 118 RVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSR 197 (298)
T ss_dssp HHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCH
T ss_pred HHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCCh
Confidence 9999999999999999999999522 12234999999999988776555555555567788999999999999999999
Q ss_pred hhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHH
Q 013092 165 RDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRI 244 (449)
Q Consensus 165 ~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~ 244 (449)
++|||||||++|+|++|..||.+.......+.+..+...........+...+|+++.+++..||+.+|++||++.+|.+.
T Consensus 198 ~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~ 277 (298)
T 1csn_A 198 RDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGL 277 (298)
T ss_dssp HHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred HHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 99999999999999999999999877777777777777777777778888999999999999999999999999999999
Q ss_pred HHHHHHHcCCCCCCcccchh
Q 013092 245 FRDLFIREGFQFDYVFDWTI 264 (449)
Q Consensus 245 L~~~~~~~~~~~~~~~dw~~ 264 (449)
|++++.+.+...+..+||+.
T Consensus 278 l~~~~~~~~~~~~~~~dw~~ 297 (298)
T 1csn_A 278 FSKVLERLNTTEDENFDWNL 297 (298)
T ss_dssp HHHHHHHTTCCSCSCCGGGC
T ss_pred HHHHHHhcCCCCCCccccCC
Confidence 99999999999999999985
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-46 Score=375.22 Aligned_cols=221 Identities=19% Similarity=0.248 Sum_probs=185.7
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEe-CCEEEEEEecC-CCCHHHHHHHc---------------CCCCCHHHHHHH
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVE-GDYNVLVMDLL-GPSLEDLFNFC---------------SRKLSLKTVLML 80 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~-~~~~~lVmE~~-g~sL~~ll~~~---------------~~~ls~~~~~~i 80 (449)
...|.+|+++|..+.+|||||++++++.+ ++..||||||| +|+|.++++.. ...+++..++.|
T Consensus 111 ~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 190 (353)
T 4ase_A 111 HRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 190 (353)
T ss_dssp HHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHH
T ss_pred HHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHH
Confidence 45689999999999888999999999876 46789999999 99999999753 234899999999
Q ss_pred HHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCC
Q 013092 81 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI 160 (449)
Q Consensus 81 ~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~ 160 (449)
+.||+.||+|||+++||||||||+|||+ +.++.+||+|||+|+.+...... .......||+.|||||++.+.
T Consensus 191 ~~qia~gl~yLH~~~iiHRDLK~~NILl---~~~~~vKi~DFGlar~~~~~~~~-----~~~~~~~gt~~ymAPE~l~~~ 262 (353)
T 4ase_A 191 SFQVAKGMEFLASRKCIHRDLAARNILL---SEKNVVKICDFGLARDIYKDPDY-----VRKGDARLPLKWMAPETIFDR 262 (353)
T ss_dssp HHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCGGGSCTTTCTTS-----EEETTEEECGGGCCHHHHHHC
T ss_pred HHHHHHHHHhHhhCCeecCccCccceee---CCCCCEEECcchhhhhcccCCCc-----eeeccccccccccCHHHHhcC
Confidence 9999999999999999999999999999 67889999999999876543321 223456799999999999999
Q ss_pred CCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHH
Q 013092 161 EQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYA 239 (449)
Q Consensus 161 ~~s~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~ 239 (449)
.|+.++|||||||+||||++ |..||.+.... ......+..... ...+..+|+++.++|..||+.||++||++.
T Consensus 263 ~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~--~~~~~~i~~g~~----~~~p~~~~~~~~~li~~c~~~dP~~RPt~~ 336 (353)
T 4ase_A 263 VYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--EEFCRRLKEGTR----MRAPDYTTPEMYQTMLDCWHGEPSQRPTFS 336 (353)
T ss_dssp CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS--HHHHHHHHHTCC----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred CCCCcccEeehHHHHHHHHhCCCCCCCCCCHH--HHHHHHHHcCCC----CCCCccCCHHHHHHHHHHcCcChhHCcCHH
Confidence 99999999999999999998 99999886542 223333333221 123457899999999999999999999999
Q ss_pred HHHHHHHHHHHHc
Q 013092 240 YLKRIFRDLFIRE 252 (449)
Q Consensus 240 ~l~~~L~~~~~~~ 252 (449)
+|.+.|.++++..
T Consensus 337 eil~~L~~llq~~ 349 (353)
T 4ase_A 337 ELVEHLGNLLQAN 349 (353)
T ss_dssp HHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHh
Confidence 9999999987643
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=351.93 Aligned_cols=260 Identities=77% Similarity=1.334 Sum_probs=229.5
Q ss_pred EEEeeecccCCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHH
Q 013092 6 TVFSVQENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMI 85 (449)
Q Consensus 6 kV~~k~~~~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~ 85 (449)
.|++|........+.+.+|+++++.+.++++|+.+..++.++...||||||++++|.+++......+++..++.++.||+
T Consensus 36 ~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~ 115 (296)
T 3uzp_A 36 EVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMI 115 (296)
T ss_dssp EEEEEEEESCSSCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHH
T ss_pred EEEEEEecCCcchhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEecCCCHHHHHHhhccCCCHHHHHHHHHHHH
Confidence 34555544555667899999999999777888888888889999999999999999999987677899999999999999
Q ss_pred HHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChh
Q 013092 86 NRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRR 165 (449)
Q Consensus 86 ~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~ 165 (449)
.||+|||++||+||||||+|||++.++.++.+||+|||+++...........++.......||+.|+|||++.+..++.+
T Consensus 116 ~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 195 (296)
T 3uzp_A 116 SRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRR 195 (296)
T ss_dssp HHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHH
T ss_pred HHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccccccccccccccccccccccCChhhhcCCCCCcc
Confidence 99999999999999999999999655577899999999999887766555555555677889999999999999999999
Q ss_pred hHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Q 013092 166 DDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIF 245 (449)
Q Consensus 166 ~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~L 245 (449)
+|||||||++|+|++|..||.+.......+.+..+.......+.+.++..+|+++.++|..||+.+|++||++.+|.+.|
T Consensus 196 ~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l 275 (296)
T 3uzp_A 196 DDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLF 275 (296)
T ss_dssp HHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHH
T ss_pred hhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHH
Confidence 99999999999999999999987666656666777777676777778889999999999999999999999999999999
Q ss_pred HHHHHHcCCCCCCcccchhh
Q 013092 246 RDLFIREGFQFDYVFDWTIL 265 (449)
Q Consensus 246 ~~~~~~~~~~~~~~~dw~~~ 265 (449)
++++...+...+..+||+.+
T Consensus 276 ~~~~~~~~~~~~~~~dw~~~ 295 (296)
T 3uzp_A 276 RNLFHRQGFSYDYVFDWNML 295 (296)
T ss_dssp HHHHHHTTCCSSCCCGGGGC
T ss_pred HHHHHhcCCccccccccccc
Confidence 99999999999999999865
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-44 Score=380.26 Aligned_cols=247 Identities=20% Similarity=0.251 Sum_probs=203.5
Q ss_pred cEEEEEeeecccC-CChhHHHHHHHHHHHhc--CCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHH
Q 013092 3 EILTVFSVQENVK-TKHPQLLYESKLYRILQ--GGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVL 78 (449)
Q Consensus 3 ~aikV~~k~~~~~-~~~~~~~~E~~il~~l~--~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~ 78 (449)
.|||++.|..... .....+..|..++..++ +|||||++++++.+.+.+||||||| ||+|.+++.. .+.|++..+.
T Consensus 217 ~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylVmEy~~GGdL~~~l~~-~~~l~E~~a~ 295 (689)
T 3v5w_A 217 YAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ-HGVFSEADMR 295 (689)
T ss_dssp EEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH-HCCCCHHHHH
T ss_pred EEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEEEecCCCCcHHHHHHh-cCCCCHHHHH
Confidence 5788887665433 34445666766666553 7999999999999999999999999 9999999986 4679999999
Q ss_pred HHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhh
Q 013092 79 MLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHL 158 (449)
Q Consensus 79 ~i~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~ 158 (449)
.|+.||+.||+|||++|||||||||+|||| +.++.+||+|||+|+.+..... .+.+||+.|||||++.
T Consensus 296 ~y~~qIl~aL~yLH~~gIiHRDLKPeNILl---d~~G~vKL~DFGlA~~~~~~~~---------~t~~GTp~YmAPEvl~ 363 (689)
T 3v5w_A 296 FYAAEIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSKKKP---------HASVGTHGYMAPEVLQ 363 (689)
T ss_dssp HHHHHHHHHHHHHHTTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECSSCCC---------CSCCSCGGGCCHHHHS
T ss_pred HHHHHHHHHHHHHHHCCccccCCchHHeEE---eCCCCEEecccceeeecCCCCC---------CCccCCcCccCHHHHh
Confidence 999999999999999999999999999999 6889999999999998765432 4568999999999997
Q ss_pred -CCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCC
Q 013092 159 -GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPD 237 (449)
Q Consensus 159 -~~~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt 237 (449)
+..|+.++||||||||||||++|..||.+....+..+.+..+..... .++..+++++.+||..||..||.+|++
T Consensus 364 ~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~-----~~p~~~S~~a~dLI~~lL~~dP~~Rl~ 438 (689)
T 3v5w_A 364 KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV-----ELPDSFSPELRSLLEGLLQRDVNRRLG 438 (689)
T ss_dssp TTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCC-----CCCTTSCHHHHHHHHHHTCSCGGGCTT
T ss_pred CCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCC-----CCCccCCHHHHHHHHHHccCCHhHCCC
Confidence 46799999999999999999999999987655555555555544333 234678999999999999999999997
Q ss_pred -----HHHHHHHHHHHHHHcCCCCCCcccchhhhhhhccCCCCCC
Q 013092 238 -----YAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQLATPPA 277 (449)
Q Consensus 238 -----~~~l~~~L~~~~~~~~~~~~~~~dw~~~~~~~~~~~~~p~ 277 (449)
+.+| ..++|+..+||+.+...+..++..|.
T Consensus 439 ~~~~ga~ei----------~~HpfF~~idW~~l~~~~~~pP~~P~ 473 (689)
T 3v5w_A 439 CLGRGAQEV----------KESPFFRSLDWQMVFLQKYPPPLIPP 473 (689)
T ss_dssp CSSSTHHHH----------TTSGGGTTCCHHHHHTTCSCCSCCCC
T ss_pred CCCCCHHHH----------hcCccccCCCHHHHHcCCCCcCccCC
Confidence 4555 34688889999998877766655553
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-44 Score=363.56 Aligned_cols=229 Identities=19% Similarity=0.210 Sum_probs=181.3
Q ss_pred cEEEEEeeecccCCChhHHHHHHHHHHHhcCCCCCceEEEEeEe------CCEEEEEEecCCCCHHHHHHHcCCCCCHHH
Q 013092 3 EILTVFSVQENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVE------GDYNVLVMDLLGPSLEDLFNFCSRKLSLKT 76 (449)
Q Consensus 3 ~aikV~~k~~~~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~------~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~ 76 (449)
+|||++.+..........+.+|+++|+.| +|||||++++++.. .+..|||||||+++|.+++.. .+.+++..
T Consensus 82 vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~~~~~~~ivmE~~~g~L~~~i~~-~~~l~~~~ 159 (398)
T 4b99_A 82 VAIKKIPNAFDVVTNAKRTLRELKILKHF-KHDNIIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHS-SQPLTLEH 159 (398)
T ss_dssp EEEEEETTTTSSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCSSCTTTCCCEEEEEECCSEEHHHHHTS-SSCCCHHH
T ss_pred EEEEEECccccchHHHHHHHHHHHHHHhc-CCCCcceEeeeeecccccccCCEEEEEEeCCCCCHHHHHHh-cCCCCHHH
Confidence 45665544433333445688999999999 89999999998763 467899999998889999975 56799999
Q ss_pred HHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhh
Q 013092 77 VLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNT 156 (449)
Q Consensus 77 ~~~i~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~ 156 (449)
+..|+.||+.||+|||++|||||||||+|||+ +.++.+||+|||+|+.+....... .......+||+.|||||+
T Consensus 160 ~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~---~~~~~~Ki~DFGla~~~~~~~~~~---~~~~~~~~GT~~Y~APEv 233 (398)
T 4b99_A 160 VRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLV---NENCELKIGDFGMARGLCTSPAEH---QYFMTEYVATRWYRAPEL 233 (398)
T ss_dssp HHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTCCEEECCCTTCBCC----------CCCCCSSCCCCTTCCHHH
T ss_pred HHHHHHHHHHHHHHHHHCcCcCCCcCcccccc---CCCCCEEEeecceeeecccCcccc---ccccccceeChHhcCHHH
Confidence 99999999999999999999999999999999 688999999999998764432111 112356799999999999
Q ss_pred hhCCC-CChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcc--------------------------cchH
Q 013092 157 HLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV--------------------------STSI 209 (449)
Q Consensus 157 ~~~~~-~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~--------------------------~~~~ 209 (449)
+.+.. ++.++||||||||+|||++|+.||.+.+. .+.+..|..... ...+
T Consensus 234 ~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~---~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (398)
T 4b99_A 234 MLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNY---VHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPW 310 (398)
T ss_dssp HTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSH---HHHHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCH
T ss_pred hcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCH---HHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCH
Confidence 98864 69999999999999999999999987433 344444433221 1123
Q ss_pred HHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 013092 210 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 242 (449)
Q Consensus 210 ~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~ 242 (449)
..+.+.+++++.+||..||..||++||++.+++
T Consensus 311 ~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L 343 (398)
T 4b99_A 311 ETVYPGADRQALSLLGRMLRFEPSARISAAAAL 343 (398)
T ss_dssp HHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHT
T ss_pred HHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHh
Confidence 344567889999999999999999999987764
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=353.80 Aligned_cols=227 Identities=20% Similarity=0.231 Sum_probs=171.3
Q ss_pred hHHHHHHHHH--HHhcCCCCCceEEEEeEeCC----EEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHH
Q 013092 19 PQLLYESKLY--RILQGGTGIPNVRWFGVEGD----YNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 91 (449)
Q Consensus 19 ~~~~~E~~il--~~l~~hp~Iv~l~~~~~~~~----~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yL 91 (449)
..+..|.+++ ..| +|||||++++++.+.+ ..||||||| +|+|.++++. ..++++.++.++.|++.||+||
T Consensus 40 ~~~~~e~Ei~~~~~l-~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gl~yl 116 (303)
T 3hmm_A 40 RSWFREAEIYQTVML-RHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHL 116 (303)
T ss_dssp HHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHH
T ss_pred hhHHHHHHHHHHhcC-CCCCCCcEEEEEEecCCCceEEEEEecCCCCCcHHHHHHh--CCCCHHHHHHHHHHHHHHHHHH
Confidence 4455555544 456 8999999999998654 689999999 9999999984 5699999999999999999999
Q ss_pred HHC--------CceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCC---
Q 013092 92 HSK--------SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI--- 160 (449)
Q Consensus 92 H~~--------givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~--- 160 (449)
|++ +||||||||+|||| +.++.+||+|||+++.......... ......+||+.|||||++.+.
T Consensus 117 H~~~~~~~~~~~IiHRDlKp~NILl---~~~~~~Ki~DFGla~~~~~~~~~~~---~~~~~~~GT~~ymAPE~l~~~~~~ 190 (303)
T 3hmm_A 117 HMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVRHDSATDTID---IAPNHRVGTKRYMAPEVLDDSINM 190 (303)
T ss_dssp HCCBCSTTCBCCEECSCCCGGGEEE---CTTSCEEECCCTTCEEEETTTTEES---CC-----CCGGGCCHHHHTTCSCT
T ss_pred HHhhhhccCCCCEeeccCCcccEEE---CCCCCEEEEeCCCCccccCCCCcee---eecccccccccccCHHHhcccccc
Confidence 987 99999999999999 6889999999999998765432211 112346899999999999864
Q ss_pred ---CCChhhHHHHHHHHHHHHHhCCCCCCC----------CCcC--CHHHHHHHHHhhcccchHHHhhcC--CcHHHHHH
Q 013092 161 ---EQSRRDDLESLGYVLMYFLRGSLPWQG----------LKAG--TKKQKYEKISEKKVSTSIEALCRG--YPTEFASY 223 (449)
Q Consensus 161 ---~~s~~~DiwSlG~il~elltG~~Pf~~----------~~~~--~~~~~~~~i~~~~~~~~~~~l~~~--~p~el~~l 223 (449)
.++.++|||||||+||||++|..||.. .... ...+....+......+.++..... ++.++.+|
T Consensus 191 ~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~l 270 (303)
T 3hmm_A 191 KHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKI 270 (303)
T ss_dssp TCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHH
T ss_pred cCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHH
Confidence 367899999999999999999766543 2211 122333334444333333322222 34679999
Q ss_pred HHHHhcCCCCCCCCHHHHHHHHHHHHHHcCC
Q 013092 224 FHYCRSLRFDDKPDYAYLKRIFRDLFIREGF 254 (449)
Q Consensus 224 i~~cl~~~p~~RPt~~~l~~~L~~~~~~~~~ 254 (449)
|..||+.||++|||+.+|.+.|+++...++.
T Consensus 271 i~~cl~~dP~~RPt~~ei~~~L~~l~~~~~i 301 (303)
T 3hmm_A 271 MRECWYANGAARLTALRIKKTLSQLSQQEGI 301 (303)
T ss_dssp HHTTCCSSGGGSCCHHHHHHHHHHHHHC---
T ss_pred HHHHcccCHhHCcCHHHHHHHHHHHHHHcCC
Confidence 9999999999999999999999998776654
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-43 Score=352.60 Aligned_cols=246 Identities=29% Similarity=0.535 Sum_probs=195.5
Q ss_pred hHHHHHHHHHHHhcC--------------CCCCceEEEEeEeC----CEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHH
Q 013092 19 PQLLYESKLYRILQG--------------GTGIPNVRWFGVEG----DYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLML 80 (449)
Q Consensus 19 ~~~~~E~~il~~l~~--------------hp~Iv~l~~~~~~~----~~~~lVmE~~g~sL~~ll~~~~~~ls~~~~~~i 80 (449)
..+..|+++++.+.+ |+||+++++++.+. .+.||||||||++|.+++......+++..++.|
T Consensus 78 ~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~g~~L~~~~~~~~~~l~~~~~~~i 157 (364)
T 3op5_A 78 GPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQL 157 (364)
T ss_dssp HHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEEEEEEEETTEEEEEEEEECEEEEHHHHHHHTTSCCCHHHHHHH
T ss_pred hhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEeeeeeccCCcceEEEEEeCCCCCHHHHHHhccCCCCHHHHHHH
Confidence 456677777766654 99999999998764 568999999999999999876678999999999
Q ss_pred HHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCC
Q 013092 81 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI 160 (449)
Q Consensus 81 ~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~ 160 (449)
+.||+.||+|||++||+||||||+||||+. ...+.+||+|||+++.+..................||+.|+|||++.+.
T Consensus 158 ~~qi~~~l~~lH~~~iiHrDlkp~Nill~~-~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 236 (364)
T 3op5_A 158 SLRILDILEYIHEHEYVHGDIKASNLLLNY-KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGV 236 (364)
T ss_dssp HHHHHHHHHHHHHTTEECCCCCGGGEEEES-SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTC
T ss_pred HHHHHHHHHHHHHCCeEEecCCHHHEEEec-CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCC
Confidence 999999999999999999999999999942 1578999999999988765433322222223456799999999999999
Q ss_pred CCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhh------cCCcHHHHHHHHHHhcCCCCC
Q 013092 161 EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC------RGYPTEFASYFHYCRSLRFDD 234 (449)
Q Consensus 161 ~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~------~~~p~el~~li~~cl~~~p~~ 234 (449)
.++.++|||||||++|||++|..||.+....... ...........+..+. ..+|+++.+++..||..+|++
T Consensus 237 ~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~ 313 (364)
T 3op5_A 237 APSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKY---VRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTE 313 (364)
T ss_dssp CCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHH---HHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTC
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCccccccCHHH---HHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCC
Confidence 9999999999999999999999999864332211 1111111111222221 678999999999999999999
Q ss_pred CCCHHHHHHHHHHHHHHcCCCCCCcccchhhhhh
Q 013092 235 KPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQ 268 (449)
Q Consensus 235 RPt~~~l~~~L~~~~~~~~~~~~~~~dw~~~~~~ 268 (449)
||++.+|.+.|++++...+...+..+||+.....
T Consensus 314 RP~~~~l~~~l~~~~~~~~~~~~~~~dw~~~~~~ 347 (364)
T 3op5_A 314 KPLYENLRDILLQGLKAIGSKDDGKLDLSVVENG 347 (364)
T ss_dssp CCCHHHHHHHHHHHHHHTTCCCCCCCCC------
T ss_pred CCCHHHHHHHHHHHHHHcCCCcCCccceEeccCC
Confidence 9999999999999999999999999999976544
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=349.16 Aligned_cols=230 Identities=20% Similarity=0.224 Sum_probs=177.5
Q ss_pred EEEeeecccCCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHH
Q 013092 6 TVFSVQENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQM 84 (449)
Q Consensus 6 kV~~k~~~~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi 84 (449)
+|++|.........++.+|+++|+.+.+||||+++++++.+.++.||||||| |++|.++++ .+++.++..++.||
T Consensus 51 ~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE~~~g~~L~~~~~----~l~~~~~~~~~~ql 126 (361)
T 4f9c_A 51 KIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDILN----SLSFQEVREYMLNL 126 (361)
T ss_dssp EEEEEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEECCCCCCHHHHHT----TCCHHHHHHHHHHH
T ss_pred EEEEEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEeCCCcccHHHHHc----CCCHHHHHHHHHHH
Confidence 4555554445566778999999999989999999999999999999999999 999999985 49999999999999
Q ss_pred HHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCccc---------------------ccccCC
Q 013092 85 INRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHI---------------------PYRENK 143 (449)
Q Consensus 85 ~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~---------------------~~~~~~ 143 (449)
+.||+|||++||+||||||+||||+ ...+.+||+|||+|+...+....... ......
T Consensus 127 l~al~ylH~~gIiHRDiKPeNiLl~--~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 204 (361)
T 4f9c_A 127 FKALKRIHQFGIVHRDVKPSNFLYN--RRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVA 204 (361)
T ss_dssp HHHHHHHHHTTEECSCCSGGGEEEE--TTTTEEEECCCTTCEECTTCSCGGGGGC-------------------------
T ss_pred HHHHHHHHHCCeEeCcCCHHHeEEe--CCCCeEEECcCCCCcccCCcccccccccccccccccccccccccccccccccc
Confidence 9999999999999999999999995 34479999999999876543221100 001123
Q ss_pred CCccCccccchhhhhCCC-CChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhccc----------------
Q 013092 144 NLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS---------------- 206 (449)
Q Consensus 144 ~~~gT~~Y~aPE~~~~~~-~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~---------------- 206 (449)
..+||+.|||||++.+.. |+.++||||+|||+|||++|+.||..... ..+.+..|......
T Consensus 205 ~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~--~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~ 282 (361)
T 4f9c_A 205 PRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASD--DLTALAQIMTIRGSRETIQAAKTFGKSILC 282 (361)
T ss_dssp -CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSS--HHHHHHHHHHHHCHHHHHHHHHHTTEEEEE
T ss_pred ccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCC--HHHHHHHHHHhcCCccchhhhhhccccccc
Confidence 468999999999998864 89999999999999999999999975432 22222222211000
Q ss_pred ---------------------------------chHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 207 ---------------------------------TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 207 ---------------------------------~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
.........+++++.+||.+||..||++|+|++++++
T Consensus 283 ~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~ 352 (361)
T 4f9c_A 283 SKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALL 352 (361)
T ss_dssp SSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred cccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0000112457889999999999999999999887653
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=347.47 Aligned_cols=227 Identities=22% Similarity=0.260 Sum_probs=164.0
Q ss_pred cEEEEEeeecccCCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCC------------EEEEEEecC-CCCHHHHHHHcC
Q 013092 3 EILTVFSVQENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGD------------YNVLVMDLL-GPSLEDLFNFCS 69 (449)
Q Consensus 3 ~aikV~~k~~~~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~------------~~~lVmE~~-g~sL~~ll~~~~ 69 (449)
.|||++.+.. .....+.+.+|+++|+.| +|||||++++++.+.+ +.||||||| |++|.+++....
T Consensus 33 vAiK~i~~~~-~~~~~~~~~~E~~il~~l-~HpnIV~~~~~~~~~~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~ 110 (299)
T 4g31_A 33 YAIKRIRLPN-RELAREKVMREVKALAKL-EHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRC 110 (299)
T ss_dssp EEEEEEEECS-SHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEEEC----------CEEEEEEEECCCSCCHHHHHHTCC
T ss_pred EEEEEEeccC-CHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEecCccccccccCCCcEEEEEEecCCCCcHHHHHHhcC
Confidence 3556554332 222345689999999999 8999999999987543 479999999 999999998532
Q ss_pred --CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCccc-----ccccC
Q 013092 70 --RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHI-----PYREN 142 (449)
Q Consensus 70 --~~ls~~~~~~i~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~-----~~~~~ 142 (449)
...++..++.|+.||+.||+|||++|||||||||+|||| +.++.+||+|||+|+.+......... .....
T Consensus 111 ~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl---~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~ 187 (299)
T 4g31_A 111 TIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFF---TMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARH 187 (299)
T ss_dssp SGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECCCCCC----------------------
T ss_pred CCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEE---CCCCcEEEccCccceecCCCcccccccccccccccc
Confidence 124567789999999999999999999999999999999 67889999999999987654321110 01122
Q ss_pred CCCccCccccchhhhhCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHH
Q 013092 143 KNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFAS 222 (449)
Q Consensus 143 ~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~ 222 (449)
...+||+.|||||++.+..|+.++|||||||+||||++ ||.+. .+....+..+.....+. .....++++.+
T Consensus 188 ~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~--~~~~~~~~~~~~~~~p~----~~~~~~~~~~~ 258 (299)
T 4g31_A 188 TGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ--MERVRTLTDVRNLKFPP----LFTQKYPCEYV 258 (299)
T ss_dssp ----CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSH--HHHHHHHHHHHTTCCCH----HHHHHCHHHHH
T ss_pred CCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCc--cHHHHHHHHHhcCCCCC----CCcccCHHHHH
Confidence 45689999999999999999999999999999999996 88542 11222333333333322 22234567889
Q ss_pred HHHHHhcCCCCCCCCHHHHHH
Q 013092 223 YFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 223 li~~cl~~~p~~RPt~~~l~~ 243 (449)
||..||+.||++||++.+|++
T Consensus 259 li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 259 MVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHcCCChhHCcCHHHHhc
Confidence 999999999999999888753
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-42 Score=364.76 Aligned_cols=225 Identities=16% Similarity=0.222 Sum_probs=187.5
Q ss_pred cEEEEEeeecccCCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHH
Q 013092 3 EILTVFSVQENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLA 81 (449)
Q Consensus 3 ~aikV~~k~~~~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~ 81 (449)
.|||++.+.. ......+.+|+.+|+.| +||||+++++++.+.+..||||||| ||+|.+++......|++..+..|+
T Consensus 185 ~AiK~i~~~~--~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~ 261 (573)
T 3uto_A 185 FAAKFVMTPH--ESDKETVRKEIQTMSVL-RHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYM 261 (573)
T ss_dssp EEEEEEECCS--HHHHHHHHHHHHHHHHT-CCTTBCCEEEEEECSSEEEEEEECCCCCBHHHHHTCTTSCEEHHHHHHHH
T ss_pred EEEEEEeccc--hhhHHHHHHHHHHHHhC-CCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHHHhCCCCCHHHHHHHH
Confidence 3455544322 22345688999999999 8999999999999999999999999 999999997545679999999999
Q ss_pred HHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCC
Q 013092 82 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIE 161 (449)
Q Consensus 82 ~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~ 161 (449)
.||+.||+|||++||+||||||+|||+.. +..+.+||+|||+++.+..... ....+||+.|||||++.+..
T Consensus 262 ~qi~~al~ylH~~~iiHRDlKp~Nill~~-~~~~~vKl~DFG~a~~~~~~~~--------~~~~~GT~~y~APEv~~~~~ 332 (573)
T 3uto_A 262 RQVCKGLCHMHENNYVHLDLKPENIMFTT-KRSNELKLIDFGLTAHLDPKQS--------VKVTTGTAEFAAPEVAEGKP 332 (573)
T ss_dssp HHHHHHHHHHHHTTEECCCCCGGGEEESS-SSCCCEEECCCSSCEECCTTSE--------EEEECSSGGGCCHHHHTTCC
T ss_pred HHHHHHHHHHHHCCeeeccCChhhccccC-CCCCCEEEeeccceeEccCCCc--------eeeeEECccccCHHHhCCCC
Confidence 99999999999999999999999999942 2347899999999998764322 23468999999999999999
Q ss_pred CChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHH
Q 013092 162 QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYL 241 (449)
Q Consensus 162 ~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l 241 (449)
|+.++|||||||+||+|++|..||.+. +..+.+..|....... .......+++++.+||..||..||++||++.++
T Consensus 333 y~~~~DiWSlGvilyeml~G~~Pf~~~---~~~~~~~~i~~~~~~~-~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~ 408 (573)
T 3uto_A 333 VGYYTDMWSVGVLSYILLSGLSPFGGE---NDDETLRNVKSCDWNM-DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQA 408 (573)
T ss_dssp BCHHHHHHHHHHHHHHHHHSCCSSCCS---SHHHHHHHHHTTCCCC-CSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHH
T ss_pred CCcHHHHHHHHHHHHHHHHCCCCCCCc---CHHHHHHHHHhCCCCC-CcccccCCCHHHHHHHHHHccCChhHCcCHHHH
Confidence 999999999999999999999999874 4455666666554432 223456789999999999999999999998877
Q ss_pred HH
Q 013092 242 KR 243 (449)
Q Consensus 242 ~~ 243 (449)
++
T Consensus 409 l~ 410 (573)
T 3uto_A 409 LE 410 (573)
T ss_dssp HH
T ss_pred hc
Confidence 43
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-40 Score=333.51 Aligned_cols=251 Identities=16% Similarity=0.228 Sum_probs=199.7
Q ss_pred cEEEEEeeeccc-CCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHH
Q 013092 3 EILTVFSVQENV-KTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLML 80 (449)
Q Consensus 3 ~aikV~~k~~~~-~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i 80 (449)
.|+|++++.... ......+..|..++..+.+||||+++++++.+.+..||||||| |++|.+++.. .+.+++..++.+
T Consensus 80 ~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~~ 158 (396)
T 4dc2_A 80 YAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQR-QRKLPEEHARFY 158 (396)
T ss_dssp EEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHH
T ss_pred EEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEEEcCCCCcHHHHHHH-cCCCCHHHHHHH
Confidence 467777665433 2344568899999999889999999999999999999999999 9999999986 457999999999
Q ss_pred HHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCC
Q 013092 81 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI 160 (449)
Q Consensus 81 ~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~ 160 (449)
+.||+.||+|||++||+||||||+|||| +.++.+||+|||+++....... .....+||+.|+|||++.+.
T Consensus 159 ~~qi~~aL~~LH~~givHrDLKp~NILl---~~~g~ikL~DFGla~~~~~~~~-------~~~~~~gt~~Y~aPE~l~~~ 228 (396)
T 4dc2_A 159 SAEISLALNYLHERGIIYRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRPGD-------TTSTFCGTPNYIAPEILRGE 228 (396)
T ss_dssp HHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCCCCTTC-------CBCCCCBCGGGCCHHHHTTC
T ss_pred HHHHHHHHHHHHHCCEEeccCCHHHEEE---CCCCCEEEeecceeeecccCCC-------ccccccCCcccCCchhhcCC
Confidence 9999999999999999999999999999 6889999999999985332221 23467899999999999999
Q ss_pred CCChhhHHHHHHHHHHHHHhCCCCCCCCCc------CCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCC
Q 013092 161 EQSRRDDLESLGYVLMYFLRGSLPWQGLKA------GTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDD 234 (449)
Q Consensus 161 ~~s~~~DiwSlG~il~elltG~~Pf~~~~~------~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~ 234 (449)
.++.++|||||||++|||++|..||..... ......+..+..... .++..+++++.+||..||+.||.+
T Consensus 229 ~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~-----~~p~~~s~~~~~li~~lL~~dP~~ 303 (396)
T 4dc2_A 229 DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-----RIPRSLSVKAASVLKSFLNKDPKE 303 (396)
T ss_dssp CBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC-----CCCTTSCHHHHHHHHHHTCSCTTT
T ss_pred CCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc-----CCCCcCCHHHHHHHHHHhcCCHhH
Confidence 999999999999999999999999975422 122233444444333 234568999999999999999999
Q ss_pred CCCHH---HHHHHHHHHHHHcCCCCCCcccchhhhhhhccCCCCC
Q 013092 235 KPDYA---YLKRIFRDLFIREGFQFDYVFDWTILKYQQSQLATPP 276 (449)
Q Consensus 235 RPt~~---~l~~~L~~~~~~~~~~~~~~~dw~~~~~~~~~~~~~p 276 (449)
||++. .+.+++ .++|...+||+.+...+..++..|
T Consensus 304 R~~~~~~~~~~ei~-------~Hpff~~i~w~~l~~~~~~pp~~p 341 (396)
T 4dc2_A 304 RLGCHPQTGFADIQ-------GHPFFRNVDWDMMEQKQVVPPFKP 341 (396)
T ss_dssp STTCSTTTHHHHHH-------HSTTTTTCCHHHHHTTCSCCSCCC
T ss_pred cCCCCCCCCHHHHh-------cCccccCCCHHHHHcCCCCCCCcC
Confidence 99852 222222 256778899999877665544443
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=326.30 Aligned_cols=242 Identities=18% Similarity=0.241 Sum_probs=199.0
Q ss_pred cEEEEEeeecc-cCCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHH
Q 013092 3 EILTVFSVQEN-VKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLML 80 (449)
Q Consensus 3 ~aikV~~k~~~-~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i 80 (449)
.|||++.+... .......+.+|+.+++.+ +||||+++++++.+.+..||||||+ |++|.+++.. .+.+++..++.+
T Consensus 33 vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~ 110 (337)
T 1o6l_A 33 YAMKILRKEVIIAKDEVAHTVTESRVLQNT-RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSR-ERVFTEERARFY 110 (337)
T ss_dssp EEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH-HSCCCHHHHHHH
T ss_pred EEEEEEeHHHhhhhhHHHHHHHHHHHHHhC-CCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHH
Confidence 46666655432 234566789999999999 8999999999999999999999999 9999999975 457999999999
Q ss_pred HHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCC
Q 013092 81 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI 160 (449)
Q Consensus 81 ~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~ 160 (449)
+.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++....... .....+||+.|+|||++.+.
T Consensus 111 ~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~vkL~DFG~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~ 180 (337)
T 1o6l_A 111 GAEIVSALEYLHSRDVVYRDIKLENLML---DKDGHIKITDFGLCKEGISDGA-------TMKTFCGTPEYLAPEVLEDN 180 (337)
T ss_dssp HHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCSCCTTC-------CBCCCEECGGGCCGGGGSSS
T ss_pred HHHHHHHHHHHHHCCeecCcCCHHHEEE---CCCCCEEEeeccchhhcccCCC-------cccccccChhhCChhhhcCC
Confidence 9999999999999999999999999999 6889999999999986433221 12456899999999999999
Q ss_pred CCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCC----
Q 013092 161 EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKP---- 236 (449)
Q Consensus 161 ~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RP---- 236 (449)
.++.++|||||||++|||++|..||.+. +..+.+..+...... ++..+++++.+||..||+.+|++||
T Consensus 181 ~~~~~~DiwslG~il~ell~g~~Pf~~~---~~~~~~~~i~~~~~~-----~p~~~s~~~~~li~~lL~~dP~~R~g~~~ 252 (337)
T 1o6l_A 181 DYGRAVDWWGLGVVMYEMMCGRLPFYNQ---DHERLFELILMEEIR-----FPRTLSPEAKSLLAGLLKKDPKQRLGGGP 252 (337)
T ss_dssp CBCTTHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHCCCC-----CCTTSCHHHHHHHHHHTCSSTTTSTTCST
T ss_pred CCCchhhcccchhHHHHHhcCCCCCCCC---CHHHHHHHHHcCCCC-----CCCCCCHHHHHHHHHHhhcCHHHhcCCCC
Confidence 9999999999999999999999999763 334555555544332 3456899999999999999999999
Q ss_pred -CHHHHHHHHHHHHHHcCCCCCCcccchhhhhhhccCCC
Q 013092 237 -DYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQLAT 274 (449)
Q Consensus 237 -t~~~l~~~L~~~~~~~~~~~~~~~dw~~~~~~~~~~~~ 274 (449)
++.+|++ +++...+||..+...+..++.
T Consensus 253 ~~~~ei~~----------h~~f~~~~~~~~~~~~~~pp~ 281 (337)
T 1o6l_A 253 SDAKEVME----------HRFFLSINWQDVVQKKLLPPF 281 (337)
T ss_dssp TTHHHHHT----------SGGGTTCCHHHHHTTCSCCSC
T ss_pred CCHHHHHc----------CCCcCCCCHHHHHhCCCCCCC
Confidence 7776643 466777899987665544333
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=333.26 Aligned_cols=245 Identities=17% Similarity=0.208 Sum_probs=198.0
Q ss_pred cEEEEEeeecc-cCCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHH
Q 013092 3 EILTVFSVQEN-VKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLML 80 (449)
Q Consensus 3 ~aikV~~k~~~-~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i 80 (449)
.|||++.+... .......+..|+.++..+.+||||+++++++.+.+..||||||| |++|.+++.. .+.+++..++.+
T Consensus 51 ~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~ 129 (353)
T 3txo_A 51 YAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQK-SRRFDEARARFY 129 (353)
T ss_dssp EEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHH
T ss_pred EEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHH
Confidence 46666665432 23455678899999999989999999999999999999999999 9999999976 457999999999
Q ss_pred HHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCC
Q 013092 81 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI 160 (449)
Q Consensus 81 ~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~ 160 (449)
+.||+.||+|||++||+||||||+|||| +.++.+||+|||+++....... .....+||+.|+|||++.+.
T Consensus 130 ~~qi~~aL~~LH~~givHrDlkp~NILl---~~~g~ikL~DFG~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~ 199 (353)
T 3txo_A 130 AAEIISALMFLHDKGIIYRDLKLDNVLL---DHEGHCKLADFGMCKEGICNGV-------TTATFCGTPDYIAPEILQEM 199 (353)
T ss_dssp HHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCSCC----------------CCGGGCCHHHHHHH
T ss_pred HHHHHHHHHHHHHCCCcccCCCHHHEEE---CCCCCEEEccccceeecccCCc-------cccccCCCcCeEChhhcCCC
Confidence 9999999999999999999999999999 6889999999999985433221 12456899999999999998
Q ss_pred CCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCH--
Q 013092 161 EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDY-- 238 (449)
Q Consensus 161 ~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~-- 238 (449)
.++.++|||||||++|||++|..||.+. +..+.+.++...... ++..+++++.+||..||..+|++||+.
T Consensus 200 ~~~~~~DiwslG~il~ell~G~~Pf~~~---~~~~~~~~i~~~~~~-----~p~~~~~~~~~li~~lL~~dP~~R~~~~~ 271 (353)
T 3txo_A 200 LYGPAVDWWAMGVLLYEMLCGHAPFEAE---NEDDLFEAILNDEVV-----YPTWLHEDATGILKSFMTKNPTMRLGSLT 271 (353)
T ss_dssp HCTTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHCCCC-----CCTTSCHHHHHHHHHHTCSSGGGSTTSGG
T ss_pred CcCCccCCCcchHHHHHHHhCCCCCCCC---CHHHHHHHHHcCCCC-----CCCCCCHHHHHHHHHHhhhCHHHccCCcc
Confidence 9999999999999999999999999874 445566666655432 234578999999999999999999997
Q ss_pred ----HHHHHHHHHHHHHcCCCCCCcccchhhhhhhccCCCCC
Q 013092 239 ----AYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQLATPP 276 (449)
Q Consensus 239 ----~~l~~~L~~~~~~~~~~~~~~~dw~~~~~~~~~~~~~p 276 (449)
.+|+ .++|...+||..+...+..++..|
T Consensus 272 ~~~~~~il----------~hp~f~~~~w~~l~~~~~~~p~~p 303 (353)
T 3txo_A 272 QGGEHAIL----------RHPFFKEIDWAQLNHRQIEPPFRP 303 (353)
T ss_dssp GTCTHHHH----------TSGGGTTCCHHHHHTTCSCCSCCC
T ss_pred cCCHHHHh----------hCCcccCCCHHHHhcCcCCCCccC
Confidence 4442 346777889998877665544443
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-40 Score=328.62 Aligned_cols=248 Identities=17% Similarity=0.212 Sum_probs=201.1
Q ss_pred cEEEEEeeecc-cCCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHH
Q 013092 3 EILTVFSVQEN-VKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLML 80 (449)
Q Consensus 3 ~aikV~~k~~~-~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i 80 (449)
.|||++.+... .......+..|..++..+.+||+|+++++++.+.+..||||||+ |++|.+++.. .+.+++..++.+
T Consensus 48 ~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~ 126 (353)
T 2i0e_A 48 YAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQ-VGRFKEPHAVFY 126 (353)
T ss_dssp EEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHH
T ss_pred EEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHH
Confidence 46666655432 23455678899999998889999999999999999999999999 9999999985 357999999999
Q ss_pred HHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCC
Q 013092 81 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI 160 (449)
Q Consensus 81 ~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~ 160 (449)
+.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++....... .....+||+.|+|||++.+.
T Consensus 127 ~~qi~~aL~~LH~~givHrDlkp~NIll---~~~g~vkL~DFG~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~ 196 (353)
T 2i0e_A 127 AAEIAIGLFFLQSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKENIWDGV-------TTKTFCGTPDYIAPEIIAYQ 196 (353)
T ss_dssp HHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCCCCTTC-------CBCCCCSCGGGCCHHHHTTC
T ss_pred HHHHHHHHHHHHHCCEEeccCCHHHEEE---cCCCcEEEEeCCcccccccCCc-------ccccccCCccccChhhhcCC
Confidence 9999999999999999999999999999 6889999999999986432221 12456899999999999999
Q ss_pred CCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHH-
Q 013092 161 EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYA- 239 (449)
Q Consensus 161 ~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~- 239 (449)
.++.++|||||||++|||++|..||.+. +..+.+..+...... ++..+++++.+||..||..+|++||+..
T Consensus 197 ~~~~~~DiwslG~il~ell~G~~Pf~~~---~~~~~~~~i~~~~~~-----~p~~~s~~~~~li~~lL~~dP~~R~~~~~ 268 (353)
T 2i0e_A 197 PYGKSVDWWAFGVLLYEMLAGQAPFEGE---DEDELFQSIMEHNVA-----YPKSMSKEAVAICKGLMTKHPGKRLGCGP 268 (353)
T ss_dssp CBSTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHCCCC-----CCTTSCHHHHHHHHHHTCSCTTSCTTCST
T ss_pred CcCCcccccchHHHHHHHHcCCCCCCCC---CHHHHHHHHHhCCCC-----CCCCCCHHHHHHHHHHhhcCHHHcCCCCC
Confidence 9999999999999999999999999873 445566666654432 3456899999999999999999999641
Q ss_pred -HHHHHHHHHHHHcCCCCCCcccchhhhhhhccCCCCC
Q 013092 240 -YLKRIFRDLFIREGFQFDYVFDWTILKYQQSQLATPP 276 (449)
Q Consensus 240 -~l~~~L~~~~~~~~~~~~~~~dw~~~~~~~~~~~~~p 276 (449)
.+.++ ..+++...+||+.+...+.+++..|
T Consensus 269 ~~~~~i-------~~h~~f~~~~w~~l~~~~~~~p~~p 299 (353)
T 2i0e_A 269 EGERDI-------KEHAFFRYIDWEKLERKEIQPPYKP 299 (353)
T ss_dssp THHHHH-------HTSGGGTTCCHHHHHTTCSCCSCCC
T ss_pred CCHHHH-------hcCccccCCCHHHHHhCCCCCCcCC
Confidence 12222 2346667789998877665554443
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-40 Score=328.11 Aligned_cols=241 Identities=24% Similarity=0.420 Sum_probs=193.6
Q ss_pred hHHHHHHHHHHHhcCCCCCce---------------EEEEeEe-CCEEEEEEecCCCCHHHHHHHc-CCCCCHHHHHHHH
Q 013092 19 PQLLYESKLYRILQGGTGIPN---------------VRWFGVE-GDYNVLVMDLLGPSLEDLFNFC-SRKLSLKTVLMLA 81 (449)
Q Consensus 19 ~~~~~E~~il~~l~~hp~Iv~---------------l~~~~~~-~~~~~lVmE~~g~sL~~ll~~~-~~~ls~~~~~~i~ 81 (449)
..+.+|+++++.+ .||||++ +++++.. +...||||||++++|.+++... ...+++..++.++
T Consensus 87 ~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~ 165 (352)
T 2jii_A 87 GRLFNEQNFFQRA-AKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVA 165 (352)
T ss_dssp STHHHHHHHHHHH-CCHHHHHHHHHHTTCTTCSCCCCCEEEEETTTEEEEEEECCCEEHHHHHHHSGGGCCCHHHHHHHH
T ss_pred chHHHHHHHHHHh-cccchhhhhhhhccCCccCccchhhccccCCcEEEEEecCCCcCHHHHHHhCCcCCCCHHHHHHHH
Confidence 5789999999999 7877665 6777776 7899999999999999999864 3679999999999
Q ss_pred HHHHHHHHHHHHCCceecCCCCCcEEEeecCCCC--eEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhC
Q 013092 82 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN--QVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG 159 (449)
Q Consensus 82 ~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~--~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~ 159 (449)
.||+.||+|||++||+||||||+|||++ .++ .+||+|||+++.+..................||+.|+|||++.+
T Consensus 166 ~qi~~~L~~LH~~~ivH~Dikp~NIl~~---~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 242 (352)
T 2jii_A 166 CRLLDALEFLHENEYVHGNVTAENIFVD---PEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKG 242 (352)
T ss_dssp HHHHHHHHHHHHTTCBCSCCCGGGEEEE---TTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTT
T ss_pred HHHHHHHHHHHhCCccCCCCCHHHEEEc---CCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHcc
Confidence 9999999999999999999999999994 555 89999999998775433222111122345689999999999999
Q ss_pred CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHh--hcccchHH--HhhcCCcHHHHHHHHHHhcCCCCCC
Q 013092 160 IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE--KKVSTSIE--ALCRGYPTEFASYFHYCRSLRFDDK 235 (449)
Q Consensus 160 ~~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~--~~~~~~~~--~l~~~~p~el~~li~~cl~~~p~~R 235 (449)
..++.++|||||||++|+|++|..||....... ......... ........ .....+++++.+||..||+.+|++|
T Consensus 243 ~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R 321 (352)
T 2jii_A 243 CGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNT-EDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEK 321 (352)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH-HHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCC
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCcccCCcCH-HHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhC
Confidence 999999999999999999999999998754221 111111111 11100000 0013579999999999999999999
Q ss_pred CCHHHHHHHHHHHHHHcCCCCCCcccchh
Q 013092 236 PDYAYLKRIFRDLFIREGFQFDYVFDWTI 264 (449)
Q Consensus 236 Pt~~~l~~~L~~~~~~~~~~~~~~~dw~~ 264 (449)
|++.+|.+.|++++...+...+..+||+.
T Consensus 322 ps~~~l~~~L~~~~~~~~~~~~~~~dw~~ 350 (352)
T 2jii_A 322 PPYAMLRNNLEALLQDLRVSPYDPIGLPM 350 (352)
T ss_dssp CCHHHHHHHHHHHHHHTTCCTTSCCCCCC
T ss_pred CCHHHHHHHHHHHHHhcCCCcCccccCcC
Confidence 99999999999999999999999999985
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=321.50 Aligned_cols=240 Identities=19% Similarity=0.242 Sum_probs=199.8
Q ss_pred cEEEEEeeeccc-CCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHH
Q 013092 3 EILTVFSVQENV-KTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLML 80 (449)
Q Consensus 3 ~aikV~~k~~~~-~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i 80 (449)
.|+|++.+.... ......+.+|+.+++.+ +||||+++++++.+....||||||+ |++|.+++.. ...+++..++.+
T Consensus 34 ~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~-~~~~~~~~~~~~ 111 (318)
T 1fot_A 34 YAMKVLKKEIVVRLKQVEHTNDERLMLSIV-THPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRK-SQRFPNPVAKFY 111 (318)
T ss_dssp EEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH-TSSCCHHHHHHH
T ss_pred EEEEEEEHHHhhhhhHHHHHHHHHHHHhhC-CCCCCceEeEEEEeCCEEEEEEeCCCCCCHHHHHHH-cCCCCHHHHHHH
Confidence 467776654432 24556788999999999 9999999999999999999999999 8999999986 567999999999
Q ss_pred HHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCC
Q 013092 81 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI 160 (449)
Q Consensus 81 ~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~ 160 (449)
+.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++..... ....+||+.|+|||++.+.
T Consensus 112 ~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~~kL~Dfg~a~~~~~~----------~~~~~gt~~y~aPE~~~~~ 178 (318)
T 1fot_A 112 AAEVCLALEYLHSKDIIYRDLKPENILL---DKNGHIKITDFGFAKYVPDV----------TYTLCGTPDYIAPEVVSTK 178 (318)
T ss_dssp HHHHHHHHHHHHTTTEECCCCCGGGEEE---CTTSCEEECCCSSCEECSSC----------BCCCCSCTTTCCHHHHTTC
T ss_pred HHHHHHHHHHHHHCCccccCCChheEEE---cCCCCEEEeecCcceecCCc----------cccccCCccccCHhHhcCC
Confidence 9999999999999999999999999999 68899999999999876432 1346899999999999999
Q ss_pred CCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCC----
Q 013092 161 EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKP---- 236 (449)
Q Consensus 161 ~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RP---- 236 (449)
.++.++|||||||++|||++|..||.+. +..+.+.++...... ++..+++++.++|..||..+|.+||
T Consensus 179 ~~~~~~DiwslG~il~ell~g~~pf~~~---~~~~~~~~i~~~~~~-----~p~~~~~~~~~li~~lL~~dp~~R~~~~~ 250 (318)
T 1fot_A 179 PYNKSIDWWSFGILIYEMLAGYTPFYDS---NTMKTYEKILNAELR-----FPPFFNEDVKDLLSRLITRDLSQRLGNLQ 250 (318)
T ss_dssp CBCTTHHHHHHHHHHHHHHHSSCTTCCS---SHHHHHHHHHHCCCC-----CCTTSCHHHHHHHHHHTCSCTTTCTTSST
T ss_pred CCCcccchhhhHHHHHHHHhCCCCCCCC---CHHHHHHHHHhCCCC-----CCCCCCHHHHHHHHHHhccCHHHcCCCcC
Confidence 9999999999999999999999999763 345556666554432 3356889999999999999999999
Q ss_pred -CHHHHHHHHHHHHHHcCCCCCCcccchhhhhhhccCCCC
Q 013092 237 -DYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQLATP 275 (449)
Q Consensus 237 -t~~~l~~~L~~~~~~~~~~~~~~~dw~~~~~~~~~~~~~ 275 (449)
++++|+ .+++...++|..+...+..++..
T Consensus 251 ~~~~~i~----------~hp~f~~~~~~~~~~~~~~~p~~ 280 (318)
T 1fot_A 251 NGTEDVK----------NHPWFKEVVWEKLLSRNIETPYE 280 (318)
T ss_dssp TTTHHHH----------TSGGGSSCCHHHHHTTCSCCSCC
T ss_pred CCHHHHh----------cCccccCCCHHHHHhCCCCCCCC
Confidence 666553 34677788999887665544433
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=327.93 Aligned_cols=231 Identities=15% Similarity=0.239 Sum_probs=190.7
Q ss_pred EEeeecccCC---ChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcC-------------
Q 013092 7 VFSVQENVKT---KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCS------------- 69 (449)
Q Consensus 7 V~~k~~~~~~---~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~------------- 69 (449)
|++|...... ....+.+|+.+|+.+.+||||+++++++.+.+..||||||+ +++|.+++....
T Consensus 116 vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~ 195 (370)
T 2psq_A 116 VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRV 195 (370)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------
T ss_pred EEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCcccccccccccc
Confidence 5555443322 23468999999999988999999999999999999999999 899999998642
Q ss_pred --CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCcc
Q 013092 70 --RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTG 147 (449)
Q Consensus 70 --~~ls~~~~~~i~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~g 147 (449)
..+++..++.++.||+.||+|||++||+||||||+|||| +.++.+||+|||+++........ .......+
T Consensus 196 ~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~~~~kl~DFG~a~~~~~~~~~-----~~~~~~~~ 267 (370)
T 2psq_A 196 PEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV---TENNVMKIADFGLARDINNIDYY-----KKTTNGRL 267 (370)
T ss_dssp CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCCSSCEETTCCCTT-----CTTTTTTS
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEE---CCCCCEEEccccCCcccCcccce-----ecccCCCc
Confidence 348999999999999999999999999999999999999 68889999999999876543321 12234567
Q ss_pred CccccchhhhhCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHH
Q 013092 148 TARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHY 226 (449)
Q Consensus 148 T~~Y~aPE~~~~~~~s~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~ 226 (449)
|+.|+|||++.+..++.++|||||||++|||++ |..||.+.... +.+..+..... ...+..++.++.++|..
T Consensus 268 t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~---~~~~~~~~~~~----~~~~~~~~~~l~~li~~ 340 (370)
T 2psq_A 268 PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE---ELFKLLKEGHR----MDKPANCTNELYMMMRD 340 (370)
T ss_dssp CGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---GHHHHHHTTCC----CCCCTTSCHHHHHHHHH
T ss_pred ccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHHhcCCC----CCCCCCCCHHHHHHHHH
Confidence 899999999999999999999999999999999 99999875443 23333333221 12345689999999999
Q ss_pred HhcCCCCCCCCHHHHHHHHHHHHHHc
Q 013092 227 CRSLRFDDKPDYAYLKRIFRDLFIRE 252 (449)
Q Consensus 227 cl~~~p~~RPt~~~l~~~L~~~~~~~ 252 (449)
||+.+|++||++.+|++.|+.++...
T Consensus 341 ~l~~dP~~Rpt~~ell~~L~~il~~~ 366 (370)
T 2psq_A 341 CWHAVPSQRPTFKQLVEDLDRILTLT 366 (370)
T ss_dssp HTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 99999999999999999999987643
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=324.73 Aligned_cols=240 Identities=18% Similarity=0.264 Sum_probs=200.2
Q ss_pred cEEEEEeeeccc-CCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHH
Q 013092 3 EILTVFSVQENV-KTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLML 80 (449)
Q Consensus 3 ~aikV~~k~~~~-~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i 80 (449)
.|||++.+.... ......+.+|+.+++.+ +||||+++++++.+.+..||||||+ |++|.+++.. .+.+++..++.+
T Consensus 69 ~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~-~~~~~~~~~~~~ 146 (350)
T 1rdq_E 69 YAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR-IGRFSEPHARFY 146 (350)
T ss_dssp EEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH-HCCCCHHHHHHH
T ss_pred EEEEEEEhHHhccHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHH-cCCCCHHHHHHH
Confidence 456666554422 34556789999999999 9999999999999999999999999 9999999986 356999999999
Q ss_pred HHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCC
Q 013092 81 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI 160 (449)
Q Consensus 81 ~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~ 160 (449)
+.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++...... ...+||+.|+|||++.+.
T Consensus 147 ~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~~kL~DFg~a~~~~~~~----------~~~~gt~~y~aPE~~~~~ 213 (350)
T 1rdq_E 147 AAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKGRT----------WTLCGTPEALAPEIILSK 213 (350)
T ss_dssp HHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECSSCB----------CCCEECGGGCCHHHHTTC
T ss_pred HHHHHHHHHHHHHCCcccccCccceEEE---CCCCCEEEcccccceeccCCc----------ccccCCccccCHHHhcCC
Confidence 9999999999999999999999999999 688999999999998765421 345899999999999999
Q ss_pred CCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCC---
Q 013092 161 EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPD--- 237 (449)
Q Consensus 161 ~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt--- 237 (449)
.++.++|||||||++|||++|..||.+. ...+.+.++...... ++..+++++.++|..||+.||.+||+
T Consensus 214 ~~~~~~DiwslG~il~ell~g~~Pf~~~---~~~~~~~~i~~~~~~-----~p~~~~~~~~~li~~lL~~dp~~R~~~~~ 285 (350)
T 1rdq_E 214 GYNKAVDWWALGVLIYEMAAGYPPFFAD---QPIQIYEKIVSGKVR-----FPSHFSSDLKDLLRNLLQVDLTKRFGNLK 285 (350)
T ss_dssp CBCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHCCCC-----CCTTCCHHHHHHHHHHSCSCTTTCTTSST
T ss_pred CCCCcCCEecccHhHhHHhhCCCCCCCC---CHHHHHHHHHcCCCC-----CCCCCCHHHHHHHHHHhhcCHHhccCCcc
Confidence 9999999999999999999999999863 445566666665432 34568999999999999999999998
Q ss_pred --HHHHHHHHHHHHHHcCCCCCCcccchhhhhhhccCCCC
Q 013092 238 --YAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQLATP 275 (449)
Q Consensus 238 --~~~l~~~L~~~~~~~~~~~~~~~dw~~~~~~~~~~~~~ 275 (449)
+.+|+ .+++...+||..+...+..++..
T Consensus 286 ~~~~ei~----------~h~~f~~~~w~~~~~~~~~~p~~ 315 (350)
T 1rdq_E 286 NGVNDIK----------NHKWFATTDWIAIYQRKVEAPFI 315 (350)
T ss_dssp TTTHHHH----------TSGGGTTCCHHHHHTTCSCCSCC
T ss_pred CCHHHHH----------hCcCcCCCCHHHHhhccCCCCCC
Confidence 55553 24667788999887665544433
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-39 Score=326.26 Aligned_cols=245 Identities=18% Similarity=0.248 Sum_probs=200.5
Q ss_pred cEEEEEeeecc-cCCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHH
Q 013092 3 EILTVFSVQEN-VKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLML 80 (449)
Q Consensus 3 ~aikV~~k~~~-~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i 80 (449)
.|+|++.+... .......+.+|+.+|+.+ +||||+++++++.+.+..||||||+ |++|.+++.. ...+++..++.+
T Consensus 43 ~AiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~~ 120 (384)
T 4fr4_A 43 YAMKYMNKQKCVERNEVRNVFKELQIMQGL-EHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQ-NVHFKEETVKLF 120 (384)
T ss_dssp EEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHT-TCCCCHHHHHHH
T ss_pred EEEEEEehhhcccHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEeCCEEEEEEecCCCCcHHHHHHh-cCCCCHHHHHHH
Confidence 45666655442 234556789999999999 9999999999999999999999999 9999999985 557999999999
Q ss_pred HHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhC-
Q 013092 81 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG- 159 (449)
Q Consensus 81 ~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~- 159 (449)
+.||+.||+|||++||+||||||+|||| +.++.+||+|||+++.+..... .....||+.|+|||++.+
T Consensus 121 ~~qi~~aL~~LH~~givHrDlkp~NIll---~~~g~vkL~DFG~a~~~~~~~~--------~~~~~gt~~Y~aPE~~~~~ 189 (384)
T 4fr4_A 121 ICELVMALDYLQNQRIIHRDMKPDNILL---DEHGHVHITDFNIAAMLPRETQ--------ITTMAGTKPYMAPEMFSSR 189 (384)
T ss_dssp HHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECCTTCC--------BCCCCSCGGGCCGGGTCCC
T ss_pred HHHHHHHHHHHHHCCceeccCcHHHeEE---CCCCCEEEeccceeeeccCCCc--------eeccCCCccccCCeeeccC
Confidence 9999999999999999999999999999 6889999999999987654322 245689999999999974
Q ss_pred --CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCC
Q 013092 160 --IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPD 237 (449)
Q Consensus 160 --~~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt 237 (449)
..++.++|||||||++|+|++|..||.........+.+..+..... .++..++.++.+||..||+.+|++||+
T Consensus 190 ~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~-----~~p~~~s~~~~~li~~lL~~dP~~R~s 264 (384)
T 4fr4_A 190 KGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVV-----TYPSAWSQEMVSLLKKLLEPNPDQRFS 264 (384)
T ss_dssp SSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCC-----CCCTTSCHHHHHHHHHHSCSSGGGSCC
T ss_pred CCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhccc-----CCCCcCCHHHHHHHHHHhcCCHhHhcc
Confidence 4589999999999999999999999987665555555554444332 234568899999999999999999998
Q ss_pred -HHHHHHHHHHHHHHcCCCCCCcccchhhhhhhccCCCC
Q 013092 238 -YAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQLATP 275 (449)
Q Consensus 238 -~~~l~~~L~~~~~~~~~~~~~~~dw~~~~~~~~~~~~~ 275 (449)
+.+|+ .+++...++|+.+...+..++..
T Consensus 265 ~~~~l~----------~hp~f~~~~w~~~~~~~~~p~~~ 293 (384)
T 4fr4_A 265 QLSDVQ----------NFPYMNDINWDAVFQKRLIPGFI 293 (384)
T ss_dssp SHHHHH----------TSGGGTTCCHHHHHTTCSCCCCC
T ss_pred cHHHHH----------cChhhhcCCHHHHHhCCCCCCCC
Confidence 55443 35677788999887665444333
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-39 Score=320.79 Aligned_cols=247 Identities=16% Similarity=0.232 Sum_probs=195.4
Q ss_pred cEEEEEeeecccC-CChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHH
Q 013092 3 EILTVFSVQENVK-TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLML 80 (449)
Q Consensus 3 ~aikV~~k~~~~~-~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i 80 (449)
.|||++.+..... .....+.+|+.++..+.+||||+++++++.+.+..||||||+ |++|.+++.. ...+++..++.+
T Consensus 37 ~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~~ 115 (345)
T 3a8x_A 37 YAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQR-QRKLPEEHARFY 115 (345)
T ss_dssp EEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH-HSSCCHHHHHHH
T ss_pred EEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHH
Confidence 4566665544322 234458899999999889999999999999999999999999 9999999975 457999999999
Q ss_pred HHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCC
Q 013092 81 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI 160 (449)
Q Consensus 81 ~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~ 160 (449)
+.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++....... .....+||+.|+|||++.+.
T Consensus 116 ~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~~kL~DFG~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~ 185 (345)
T 3a8x_A 116 SAEISLALNYLHERGIIYRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRPGD-------TTSTFCGTPNYIAPEILRGE 185 (345)
T ss_dssp HHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCGGGCBCSCCTTC-------CBCCCCSCGGGCCHHHHTTC
T ss_pred HHHHHHHHHHHHHCCceecCCCHHHEEE---CCCCCEEEEeccccccccCCCC-------cccccCCCccccCccccCCC
Confidence 9999999999999999999999999999 6889999999999986432221 12456899999999999999
Q ss_pred CCChhhHHHHHHHHHHHHHhCCCCCCCCCc------CCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCC
Q 013092 161 EQSRRDDLESLGYVLMYFLRGSLPWQGLKA------GTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDD 234 (449)
Q Consensus 161 ~~s~~~DiwSlG~il~elltG~~Pf~~~~~------~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~ 234 (449)
.++.++|||||||++|||++|..||..... ......+..+...... ++..++.++.++|..||+.||.+
T Consensus 186 ~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~-----~p~~~s~~~~~li~~lL~~dP~~ 260 (345)
T 3a8x_A 186 DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR-----IPRSLSVKAASVLKSFLNKDPKE 260 (345)
T ss_dssp CBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCC-----CCTTSCHHHHHHHHHHTCSSTTT
T ss_pred CCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCC-----CCCCCCHHHHHHHHHHhcCCHhH
Confidence 999999999999999999999999975322 1222333444443322 34568999999999999999999
Q ss_pred CCCHH---HHHHHHHHHHHHcCCCCCCcccchhhhhhhccC
Q 013092 235 KPDYA---YLKRIFRDLFIREGFQFDYVFDWTILKYQQSQL 272 (449)
Q Consensus 235 RPt~~---~l~~~L~~~~~~~~~~~~~~~dw~~~~~~~~~~ 272 (449)
||++. .+.++ ..+++...+||+.+...+..+
T Consensus 261 R~~~~~~~~~~~i-------~~hp~f~~~~w~~~~~~~~~~ 294 (345)
T 3a8x_A 261 RLGCHPQTGFADI-------QGHPFFRNVDWDMMEQKQVVP 294 (345)
T ss_dssp STTCCTTTHHHHH-------HTSGGGTTCCHHHHHTTCSCC
T ss_pred CCCCCCcCCHHHH-------hcCCccCCCCHHHHHhCCCCC
Confidence 99852 12222 235677788999876655443
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=336.01 Aligned_cols=241 Identities=20% Similarity=0.248 Sum_probs=197.8
Q ss_pred cEEEEEeeeccc-CCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHH
Q 013092 3 EILTVFSVQENV-KTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLML 80 (449)
Q Consensus 3 ~aikV~~k~~~~-~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i 80 (449)
.|+|++.+.... ......+..|+.++..+ +||||+++++++.+.+..||||||| |++|.+++......+++..++.+
T Consensus 102 vAvK~~~~~~~~~~~~~~~~~~E~~il~~~-~hp~Iv~l~~~~~~~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~ 180 (437)
T 4aw2_A 102 FAMKILNKWEMLKRAETACFREERDVLVNG-DSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFY 180 (437)
T ss_dssp EEEEEEEHHHHHHTTTTCCHHHHHHHHHHS-CTTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHH
T ss_pred EEEEEEEHHHhhhHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEeeCCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHH
Confidence 466666654432 23445589999999999 9999999999999999999999999 99999999865678999999999
Q ss_pred HHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhh--
Q 013092 81 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHL-- 158 (449)
Q Consensus 81 ~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~-- 158 (449)
+.||+.||+|||++||+||||||+|||| +.++.+||+|||+++........ .....+||+.|+|||++.
T Consensus 181 ~~qi~~aL~~LH~~giiHrDLKp~NILl---~~~g~vkL~DFGla~~~~~~~~~------~~~~~~GT~~Y~APE~l~~~ 251 (437)
T 4aw2_A 181 LAEMVIAIDSVHQLHYVHRDIKPDNILM---DMNGHIRLADFGSCLKLMEDGTV------QSSVAVGTPDYISPEILQAM 251 (437)
T ss_dssp HHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECCTTSCE------ECCSCCSCGGGCCHHHHHHH
T ss_pred HHHHHHHHHHHHhCCeEecccCHHHeeE---cCCCCEEEcchhhhhhcccCCCc------ccccccCCcCeeChHHHhhc
Confidence 9999999999999999999999999999 68899999999999876554321 123468999999999997
Q ss_pred ---CCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCC-
Q 013092 159 ---GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDD- 234 (449)
Q Consensus 159 ---~~~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~- 234 (449)
...++.++|||||||++|||++|..||.+. +..+.+.++........++.....+++++.+||..||..+|+.
T Consensus 252 ~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~---~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~ 328 (437)
T 4aw2_A 252 EGGKGRYGPECDWWSLGVCMYEMLYGETPFYAE---SLVETYGKIMNHKERFQFPTQVTDVSENAKDLIRRLICSREHRL 328 (437)
T ss_dssp HTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCS---SHHHHHHHHHTHHHHCCCCSSCCCSCHHHHHHHHTTSSCGGGCT
T ss_pred ccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCC---ChhHHHHhhhhccccccCCcccccCCHHHHHHHHHHhccccccc
Confidence 456899999999999999999999999873 4455666665543222233334568999999999999888877
Q ss_pred -CCCHHHHHHHHHHHHHHcCCCCCCcccchhhh
Q 013092 235 -KPDYAYLKRIFRDLFIREGFQFDYVFDWTILK 266 (449)
Q Consensus 235 -RPt~~~l~~~L~~~~~~~~~~~~~~~dw~~~~ 266 (449)
||++++|++ ++|...+||+.+.
T Consensus 329 ~r~~~~eil~----------Hpff~~i~w~~l~ 351 (437)
T 4aw2_A 329 GQNGIEDFKK----------HPFFSGIDWDNIR 351 (437)
T ss_dssp TTTTTHHHHT----------SGGGTTCCTTTGG
T ss_pred CCCCHHHHhC----------CCccCCCCHHHHh
Confidence 898877643 5777788999874
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=325.09 Aligned_cols=244 Identities=18% Similarity=0.227 Sum_probs=198.3
Q ss_pred cEEEEEeeecc-cCCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHH
Q 013092 3 EILTVFSVQEN-VKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLML 80 (449)
Q Consensus 3 ~aikV~~k~~~-~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i 80 (449)
.|||++.+... .......+..|..++..+.+||||+++++++.+.+..||||||+ |++|.+++.. ...+++..+..+
T Consensus 45 vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~ 123 (345)
T 1xjd_A 45 FAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQS-CHKFDLSRATFY 123 (345)
T ss_dssp EEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHH
T ss_pred EEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHH
Confidence 45666655432 23455678899999998879999999999999999999999999 9999999986 357999999999
Q ss_pred HHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCC
Q 013092 81 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI 160 (449)
Q Consensus 81 ~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~ 160 (449)
+.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++....... .....+||+.|+|||++.+.
T Consensus 124 ~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~vkL~DFG~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~ 193 (345)
T 1xjd_A 124 AAEIILGLQFLHSKGIVYRDLKLDNILL---DKDGHIKIADFGMCKENMLGDA-------KTNTFCGTPDYIAPEILLGQ 193 (345)
T ss_dssp HHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCCCCTTC-------CBCCCCSCGGGCCHHHHTTC
T ss_pred HHHHHHHHHHHHHCCeEeCCCChhhEEE---CCCCCEEEeEChhhhhcccCCC-------cccCCCCCcccCChhhhcCC
Confidence 9999999999999999999999999999 6888999999999986433221 12456899999999999999
Q ss_pred CCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHH-
Q 013092 161 EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYA- 239 (449)
Q Consensus 161 ~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~- 239 (449)
.++.++|||||||++|||++|..||.+. +..+.+..+...... ++..+++++.+||..||..+|++||++.
T Consensus 194 ~~~~~~DiwslG~il~ell~g~~Pf~~~---~~~~~~~~i~~~~~~-----~p~~~s~~~~~li~~lL~~dp~~R~~~~~ 265 (345)
T 1xjd_A 194 KYNHSVDWWSFGVLLYEMLIGQSPFHGQ---DEEELFHSIRMDNPF-----YPRWLEKEAKDLLVKLFVREPEKRLGVRG 265 (345)
T ss_dssp CBCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHCCCC-----CCTTSCHHHHHHHHHHSCSSGGGSBTTBS
T ss_pred CCCChhhhHHHHHHHHHHhcCCCCCCCC---CHHHHHHHHHhCCCC-----CCcccCHHHHHHHHHHhcCCHhHcCCChH
Confidence 9999999999999999999999999874 344555555544322 3356889999999999999999999975
Q ss_pred HHHHHHHHHHHHcCCCCCCcccchhhhhhhccCCCC
Q 013092 240 YLKRIFRDLFIREGFQFDYVFDWTILKYQQSQLATP 275 (449)
Q Consensus 240 ~l~~~L~~~~~~~~~~~~~~~dw~~~~~~~~~~~~~ 275 (449)
+|+ .+++...+||+.+...+..++..
T Consensus 266 ~i~----------~hp~f~~~~w~~l~~~~~~~p~~ 291 (345)
T 1xjd_A 266 DIR----------QHPLFREINWEELERKEIDPPFR 291 (345)
T ss_dssp CGG----------GSGGGTTCCHHHHHTTCSCC---
T ss_pred HHH----------cCccccCCCHHHHhhCCCCCCcC
Confidence 442 34667788999887665444433
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=334.00 Aligned_cols=240 Identities=20% Similarity=0.286 Sum_probs=193.9
Q ss_pred cEEEEEeeeccc-CCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHH
Q 013092 3 EILTVFSVQENV-KTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLML 80 (449)
Q Consensus 3 ~aikV~~k~~~~-~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i 80 (449)
.|||++.|.... ......+..|+.++..+ +||||+++++++.+.+..||||||| |++|.+++......+++..++.+
T Consensus 89 vAiK~l~k~~~~~~~~~~~~~~E~~il~~~-~hp~Iv~l~~~~~~~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~ 167 (412)
T 2vd5_A 89 YAMKIMNKWDMLKRGEVSCFREERDVLVNG-DRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFY 167 (412)
T ss_dssp EEEEEEEHHHHHHHGGGCCHHHHHHHHHHS-CTTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHH
T ss_pred EEEEEEeHHHhhhHHHHHHHHHHHHHHHhc-CCCCeeeEEEEEeeCCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHH
Confidence 466766654322 23445689999999999 9999999999999999999999999 99999999865567999999999
Q ss_pred HHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhh--
Q 013092 81 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHL-- 158 (449)
Q Consensus 81 ~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~-- 158 (449)
+.||+.||+|||++||+||||||+|||| +.++.+||+|||+++........ .....+||+.|+|||++.
T Consensus 168 ~~qi~~aL~~LH~~giiHrDLKp~NILl---d~~g~vkL~DFGla~~~~~~~~~------~~~~~~Gt~~Y~APE~l~~~ 238 (412)
T 2vd5_A 168 LAEIVMAIDSVHRLGYVHRDIKPDNILL---DRCGHIRLADFGSCLKLRADGTV------RSLVAVGTPDYLSPEILQAV 238 (412)
T ss_dssp HHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECCTTSCE------ECSSCCSCGGGCCHHHHHHH
T ss_pred HHHHHHHHHHHHHCCeeecccCHHHeee---cCCCCEEEeechhheeccCCCcc------ccceeccccCcCCHHHHhhc
Confidence 9999999999999999999999999999 68899999999999877553321 123468999999999998
Q ss_pred -----CCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCC
Q 013092 159 -----GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFD 233 (449)
Q Consensus 159 -----~~~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~ 233 (449)
...++.++|||||||++|||++|..||.+. +..+.+.+|........++.+...+++++.+||..||. +|+
T Consensus 239 ~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~---~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~dli~~lL~-~p~ 314 (412)
T 2vd5_A 239 GGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYAD---STAETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLC-PPE 314 (412)
T ss_dssp HTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCS---SHHHHHHHHHTHHHHCCCC----CCCHHHHHHHHTTSS-CGG
T ss_pred ccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCC---CHHHHHHHHHhcccCcCCCccccCCCHHHHHHHHHHcC-Chh
Confidence 356899999999999999999999999873 44555666655332222233446789999999999999 999
Q ss_pred CC---CCHHHHHHHHHHHHHHcCCCCCCcccchhhh
Q 013092 234 DK---PDYAYLKRIFRDLFIREGFQFDYVFDWTILK 266 (449)
Q Consensus 234 ~R---Pt~~~l~~~L~~~~~~~~~~~~~~~dw~~~~ 266 (449)
+| |++++|+ .++|...+||+.+.
T Consensus 315 ~Rlgr~~~~ei~----------~Hpff~~i~w~~l~ 340 (412)
T 2vd5_A 315 TRLGRGGAGDFR----------THPFFFGLDWDGLR 340 (412)
T ss_dssp GCTTTTTHHHHH----------TSGGGTTCCSTTST
T ss_pred hcCCCCCHHHHh----------cCCCcCCCCHHHHh
Confidence 98 4766663 35677788999874
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=319.57 Aligned_cols=231 Identities=19% Similarity=0.265 Sum_probs=179.7
Q ss_pred EEEEEeeecccCCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcC--CCCCHHHHHHH
Q 013092 4 ILTVFSVQENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCS--RKLSLKTVLML 80 (449)
Q Consensus 4 aikV~~k~~~~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~--~~ls~~~~~~i 80 (449)
|+|++.+..........+.+|+++++.+ +||||+++++++.+.+..||||||+ +++|.+++.... ..+++..++.+
T Consensus 64 avK~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i 142 (309)
T 3p86_A 64 AVKILMEQDFHAERVNEFLREVAIMKRL-RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSM 142 (309)
T ss_dssp EEEEECCCCCSHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECSTTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHH
T ss_pred EEEEecCCCCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHH
Confidence 4444443333333445689999999999 8999999999999999999999999 899999998532 13999999999
Q ss_pred HHHHHHHHHHHHHCC--ceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhh
Q 013092 81 ADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHL 158 (449)
Q Consensus 81 ~~qi~~aL~yLH~~g--ivHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~ 158 (449)
+.||+.||+|||++| |+||||||+|||+ +.++.+||+|||+++....... ......||+.|+|||++.
T Consensus 143 ~~qi~~aL~~LH~~~~~ivH~Dikp~NIll---~~~~~~kL~Dfg~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~ 212 (309)
T 3p86_A 143 AYDVAKGMNYLHNRNPPIVHRNLKSPNLLV---DKKYTVKVCDFGLSRLKASTFL-------SSKSAAGTPEWMAPEVLR 212 (309)
T ss_dssp HHHHHHHHHHHHTSSSCCCCTTCCGGGEEE---CTTCCEEECCCC------------------------CCTTSCHHHHT
T ss_pred HHHHHHHHHHHHcCCCCEECCCCChhhEEE---eCCCcEEECCCCCCcccccccc-------ccccCCCCccccChhhhc
Confidence 999999999999999 9999999999999 6788999999999976543321 123567999999999999
Q ss_pred CCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCH
Q 013092 159 GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDY 238 (449)
Q Consensus 159 ~~~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~ 238 (449)
+..++.++|||||||++|+|++|..||.+... .+....+..... ...++..+++++.+||..||+.+|++||++
T Consensus 213 ~~~~~~~~DiwslG~il~elltg~~Pf~~~~~---~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~dP~~Rps~ 286 (309)
T 3p86_A 213 DEPSNEKSDVYSFGVILWELATLQQPWGNLNP---AQVVAAVGFKCK---RLEIPRNLNPQVAAIIEGCWTNEPWKRPSF 286 (309)
T ss_dssp TCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCH---HHHHHHHHHSCC---CCCCCTTSCHHHHHHHHHHTCSSGGGSCCH
T ss_pred CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhcCC---CCCCCccCCHHHHHHHHHHccCChhhCcCH
Confidence 99999999999999999999999999987533 333333322211 123446789999999999999999999999
Q ss_pred HHHHHHHHHHHHH
Q 013092 239 AYLKRIFRDLFIR 251 (449)
Q Consensus 239 ~~l~~~L~~~~~~ 251 (449)
.+|.+.|+.++..
T Consensus 287 ~~ll~~L~~~~~~ 299 (309)
T 3p86_A 287 ATIMDLLRPLIKS 299 (309)
T ss_dssp HHHHHHHHHHHC-
T ss_pred HHHHHHHHHHHHh
Confidence 9999999988643
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=320.60 Aligned_cols=220 Identities=20% Similarity=0.283 Sum_probs=183.5
Q ss_pred cEEEEEeeecccCCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHH
Q 013092 3 EILTVFSVQENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLA 81 (449)
Q Consensus 3 ~aikV~~k~~~~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~ 81 (449)
+|||++.+..........+.+|+++|+.+ +||||+++++++.+.+..||||||+ |++|.+++.. .+.+++..++.++
T Consensus 43 vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~ 120 (328)
T 3fe3_A 43 VAIKIIDKTQLNPTSLQKLFREVRIMKIL-NHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVA-HGRMKEKEARSKF 120 (328)
T ss_dssp EEEEEEEGGGSCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHH-HCCCCHHHHHHHH
T ss_pred EEEEEEEhhcCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEECCEEEEEEECCCCCcHHHHHHH-cCCCCHHHHHHHH
Confidence 35555544433333455688999999999 8999999999999999999999999 9999999975 4579999999999
Q ss_pred HHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCC
Q 013092 82 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIE 161 (449)
Q Consensus 82 ~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~ 161 (449)
.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.+..... ....+||+.|+|||++.+..
T Consensus 121 ~qi~~al~~lH~~~ivHrDlkp~NIll---~~~~~~kl~DFG~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~ 189 (328)
T 3fe3_A 121 RQIVSAVQYCHQKRIVHRDLKAENLLL---DADMNIKIADFGFSNEFTVGGK--------LDAFCGAPPYAAPELFQGKK 189 (328)
T ss_dssp HHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECSTTCCGGGSSSCG--------GGTTSSSGGGCCHHHHHTCC
T ss_pred HHHHHHHHHHHHCCEeccCCCHHHEEE---cCCCCEEEeeccCceecCCCCc--------cccccCCcceeCcccccCCC
Confidence 999999999999999999999999999 6888999999999976654321 24568999999999999888
Q ss_pred CC-hhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHH
Q 013092 162 QS-RRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAY 240 (449)
Q Consensus 162 ~s-~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~ 240 (449)
+. .++|||||||++|+|++|..||.+. +..+...++...... ++..+++++.+|+..||..||.+||++.+
T Consensus 190 ~~~~~~DiwslG~il~ell~g~~pf~~~---~~~~~~~~i~~~~~~-----~p~~~s~~~~~li~~~L~~dP~~R~t~~e 261 (328)
T 3fe3_A 190 YDGPEVDVWSLGVILYTLVSGSLPFDGQ---NLKELRERVLRGKYR-----IPFYMSTDCENLLKRFLVLNPIKRGTLEQ 261 (328)
T ss_dssp CCSHHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHCCCC-----CCTTSCHHHHHHHHHHCCSSTTTSCCHHH
T ss_pred cCCchhhhhhhHHHHHHHHhCCCCCCCC---CHHHHHHHHHhCCCC-----CCCCCCHHHHHHHHHHCCCChhHCcCHHH
Confidence 75 8999999999999999999999874 334445555544332 23457899999999999999999999887
Q ss_pred HHH
Q 013092 241 LKR 243 (449)
Q Consensus 241 l~~ 243 (449)
+++
T Consensus 262 il~ 264 (328)
T 3fe3_A 262 IMK 264 (328)
T ss_dssp HTT
T ss_pred Hhc
Confidence 753
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=315.98 Aligned_cols=219 Identities=23% Similarity=0.339 Sum_probs=180.8
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 96 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gi 96 (449)
...+.+|+.++..+ +||||+++++++.+.+..||||||+ |++|.+++.. ...+++..++.++.|++.||+|||++||
T Consensus 55 ~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i 132 (294)
T 4eqm_A 55 LKRFEREVHNSSQL-SHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIES-HGPLSVDTAINFTNQILDGIKHAHDMRI 132 (294)
T ss_dssp HHHHHHHHHHHTTC-CBTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred HHHHHHHHHHHhcC-CCCCCceEEEeeeeCCeEEEEEeCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 35688999999999 8999999999999999999999999 8999999986 3579999999999999999999999999
Q ss_pred eecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHHHH
Q 013092 97 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLM 176 (449)
Q Consensus 97 vHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il~ 176 (449)
+||||||+|||+ +.++.+||+|||+++.+..... .......||+.|+|||++.+..++.++|||||||++|
T Consensus 133 ~H~Dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~ 203 (294)
T 4eqm_A 133 VHRDIKPQNILI---DSNKTLKIFDFGIAKALSETSL------TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLY 203 (294)
T ss_dssp CCCCCCGGGEEE---CTTSCEEECCCSSSTTC-------------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHH
T ss_pred ccCCCCHHHEEE---CCCCCEEEEeCCCccccccccc------cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHH
Confidence 999999999999 6788999999999986644321 1123457999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCC-CHHHHHHHHHHHHH
Q 013092 177 YFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKP-DYAYLKRIFRDLFI 250 (449)
Q Consensus 177 elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RP-t~~~l~~~L~~~~~ 250 (449)
+|++|..||.+... .....+............+...+|+++.++|.+||+.+|++|| +++++.+.|..++.
T Consensus 204 ~ll~g~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~ 275 (294)
T 4eqm_A 204 EMLVGEPPFNGETA---VSIAIKHIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH 275 (294)
T ss_dssp HHHHSSCSSCSSCH---HHHHHHHHSSCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred HHHhCCCCCCCCCh---HHHHHHHhhccCCCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence 99999999987432 3333334444444445566778999999999999999999999 88888887776543
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=332.92 Aligned_cols=248 Identities=20% Similarity=0.255 Sum_probs=200.6
Q ss_pred cEEEEEeeeccc-CCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHH
Q 013092 3 EILTVFSVQENV-KTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLML 80 (449)
Q Consensus 3 ~aikV~~k~~~~-~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i 80 (449)
.|+|++.+.... ......+.+|+.++..+ +||||+++++++.+.+..||||||| |++|.+++.. ..+++..++.+
T Consensus 97 ~AiK~~~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~--~~~~e~~~~~~ 173 (410)
T 3v8s_A 97 YAMKLLSKFEMIKRSDSAFFWEERDIMAFA-NSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN--YDVPEKWARFY 173 (410)
T ss_dssp EEEEEEEHHHHHHTCCCSTHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHH--CCCCHHHHHHH
T ss_pred EEEEEEehhhhhhhHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHc--CCCCHHHHHHH
Confidence 467777664432 34455688999999999 9999999999999999999999999 9999999984 46999999999
Q ss_pred HHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCC
Q 013092 81 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI 160 (449)
Q Consensus 81 ~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~ 160 (449)
+.||+.||+|||++||+||||||+|||| +.++.+||+|||+++....... ......+||+.|+|||++.+.
T Consensus 174 ~~qi~~aL~~LH~~givHrDLKp~NILl---~~~g~ikL~DFG~a~~~~~~~~------~~~~~~~gt~~Y~APE~l~~~ 244 (410)
T 3v8s_A 174 TAEVVLALDAIHSMGFIHRDVKPDNMLL---DKSGHLKLADFGTCMKMNKEGM------VRCDTAVGTPDYISPEVLKSQ 244 (410)
T ss_dssp HHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECCTTSE------EECCSCCSCGGGCCHHHHHTT
T ss_pred HHHHHHHHHHHHHCCeEeccCCHHHeeE---CCCCCEEEeccceeEeeccCCc------ccccCCcCCccccCHHHhhcc
Confidence 9999999999999999999999999999 6889999999999987654321 112456899999999999876
Q ss_pred C----CChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCC--
Q 013092 161 E----QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDD-- 234 (449)
Q Consensus 161 ~----~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~-- 234 (449)
. ++.++|||||||++|||++|..||.+. +....+.+|.........+ ....+++++.+||..||..+|.+
T Consensus 245 ~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~---~~~~~~~~i~~~~~~~~~p-~~~~~s~~~~~li~~lL~~~~~rlg 320 (410)
T 3v8s_A 245 GGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD---SLVGTYSKIMNHKNSLTFP-DDNDISKEAKNLICAFLTDREVRLG 320 (410)
T ss_dssp TTTCEEETHHHHHHHHHHHHHHHHSSCTTCCS---SHHHHHHHHHTHHHHCCCC-TTCCCCHHHHHHHHHHSSCGGGCTT
T ss_pred CCCcCCCCcceEecchHHHHHHHhCCCCCCCC---ChhhHHHHHHhccccccCC-CcccccHHHHHHHHHHccChhhhCC
Confidence 5 789999999999999999999999863 4455666665543211111 12468999999999999988888
Q ss_pred CCCHHHHHHHHHHHHHHcCCCCCCcccchhhhhhhccCCCCC
Q 013092 235 KPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQLATPP 276 (449)
Q Consensus 235 RPt~~~l~~~L~~~~~~~~~~~~~~~dw~~~~~~~~~~~~~p 276 (449)
||++.+|++ ++|...+||......+..++..|
T Consensus 321 R~~~~ei~~----------Hp~f~~~~w~~~~~~~~~~p~~p 352 (410)
T 3v8s_A 321 RNGVEEIKR----------HLFFKNDQWAWETLRDTVAPVVP 352 (410)
T ss_dssp SSCHHHHHT----------SGGGCCSSCCSTTGGGSCCSCCC
T ss_pred CCCHHHHhc----------CccccCCCHHHHhhcccCCCCCC
Confidence 999888754 46777788887766665544443
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=320.93 Aligned_cols=236 Identities=19% Similarity=0.229 Sum_probs=194.1
Q ss_pred cEEEEEeeecccCC----ChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHH
Q 013092 3 EILTVFSVQENVKT----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTV 77 (449)
Q Consensus 3 ~aikV~~k~~~~~~----~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~ 77 (449)
.|+|++.+...... ....+.+|+.+|+.+ .||||+++++++.+....||||||+ |++|.+++.. ...+++..+
T Consensus 40 ~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~-~~~l~~~~~ 117 (361)
T 2yab_A 40 YAAKFIKKRQSRASRRGVCREEIEREVSILRQV-LHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQ-KESLSEEEA 117 (361)
T ss_dssp EEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHTT-CSCCBHHHH
T ss_pred EEEEEEEccccccccchhHHHHHHHHHHHHHhC-CCcCCCcEEEEEEeCCEEEEEEEcCCCCcHHHHHHh-cCCCCHHHH
Confidence 46666665543322 346799999999999 8999999999999999999999999 9999999975 567999999
Q ss_pred HHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCC----eEEEeecCcceeecCCCCCcccccccCCCCccCccccc
Q 013092 78 LMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN----QVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYAS 153 (449)
Q Consensus 78 ~~i~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~----~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~a 153 (449)
+.++.||+.||+|||++||+||||||+|||+. ..+ .+||+|||+++.+..... .....||+.|+|
T Consensus 118 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~---~~~~~~~~vkl~DFG~a~~~~~~~~--------~~~~~gt~~y~a 186 (361)
T 2yab_A 118 TSFIKQILDGVNYLHTKKIAHFDLKPENIMLL---DKNIPIPHIKLIDFGLAHEIEDGVE--------FKNIFGTPEFVA 186 (361)
T ss_dssp HHHHHHHHHHHHHHHHTTEECCCCSGGGEEES---CTTSSSCCEEECCCSSCEECCTTCC--------CCCCCSCGGGCC
T ss_pred HHHHHHHHHHHHHHHHCCcccCCCCHHHEEEe---CCCCCccCEEEEecCCceEcCCCCc--------cccCCCCccEEC
Confidence 99999999999999999999999999999994 333 799999999987765322 235679999999
Q ss_pred hhhhhCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCC
Q 013092 154 MNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFD 233 (449)
Q Consensus 154 PE~~~~~~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~ 233 (449)
||++.+..++.++|||||||++|+|++|..||.+. +..+.+..+....... ....+..+++++.+||..||..||+
T Consensus 187 PE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~---~~~~~~~~i~~~~~~~-~~~~~~~~s~~~~~li~~~L~~dP~ 262 (361)
T 2yab_A 187 PEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD---TKQETLANITAVSYDF-DEEFFSQTSELAKDFIRKLLVKETR 262 (361)
T ss_dssp HHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS---SHHHHHHHHHTTCCCC-CHHHHTTSCHHHHHHHHHHSCSSTT
T ss_pred chHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHHhcCCCC-CchhccCCCHHHHHHHHHHCCCChh
Confidence 99999999999999999999999999999999874 3455566665554432 2345577899999999999999999
Q ss_pred CCCCHHHHHHHHHHHHHHcCCCCCCcccchhh
Q 013092 234 DKPDYAYLKRIFRDLFIREGFQFDYVFDWTIL 265 (449)
Q Consensus 234 ~RPt~~~l~~~L~~~~~~~~~~~~~~~dw~~~ 265 (449)
+||++.++++ +++....+|...
T Consensus 263 ~R~t~~e~l~----------hp~~~~~~~~~~ 284 (361)
T 2yab_A 263 KRLTIQEALR----------HPWITPVDTQQA 284 (361)
T ss_dssp TSCCHHHHHT----------STTTSCSSHHHH
T ss_pred HCcCHHHHhc----------CcCcCCCchhhh
Confidence 9999887743 355555666543
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=319.18 Aligned_cols=219 Identities=15% Similarity=0.241 Sum_probs=183.0
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 96 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gi 96 (449)
...+.+|+++++.+ +||||+++++++.+++..||||||+ +++|.+++......+++..++.++.||+.||+|||++||
T Consensus 94 ~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i 172 (325)
T 3kul_A 94 RRDFLSEASIMGQF-DHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGY 172 (325)
T ss_dssp HHHHHHHHHHHTTC-CCTTBCCEEEEECGGGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred HHHHHHHHHHHHhC-CCCCCCcEEEEEEeCCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 45689999999999 8999999999999999999999999 999999998656689999999999999999999999999
Q ss_pred eecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHHHH
Q 013092 97 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLM 176 (449)
Q Consensus 97 vHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il~ 176 (449)
+||||||+|||+ +.++.+||+|||+++.+....... .......+|+.|+|||++.+..++.++|||||||++|
T Consensus 173 vH~Dlkp~NIll---~~~~~~kl~Dfg~a~~~~~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ 245 (325)
T 3kul_A 173 VHRDLAARNVLV---DSNLVCKVSDFGLSRVLEDDPDAA----YTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMW 245 (325)
T ss_dssp ECSCCSGGGEEE---CTTCCEEECCCSSCEECC----CC----EECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHH
T ss_pred eCCCCCcceEEE---CCCCCEEECCCCcccccccCccce----eeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHH
Confidence 999999999999 678899999999998876543211 1123345688999999999999999999999999999
Q ss_pred HHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 013092 177 YFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIR 251 (449)
Q Consensus 177 ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~L~~~~~~ 251 (449)
+|++ |..||.+... .+.+..+...... .....+++++.+||..||..+|++||++.+|.+.|+.++..
T Consensus 246 ell~~g~~p~~~~~~---~~~~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~ 314 (325)
T 3kul_A 246 EVLAYGERPYWNMTN---RDVISSVEEGYRL----PAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS 314 (325)
T ss_dssp HHHTTSCCTTTTSCH---HHHHHHHHTTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HHHcCCCCCcccCCH---HHHHHHHHcCCCC----CCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhC
Confidence 9999 9999987533 3334444333211 13356899999999999999999999999999999988653
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-39 Score=323.39 Aligned_cols=226 Identities=19% Similarity=0.242 Sum_probs=185.0
Q ss_pred EEEEEeeecccCCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHH
Q 013092 4 ILTVFSVQENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLAD 82 (449)
Q Consensus 4 aikV~~k~~~~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~ 82 (449)
|+|++.+..........+.+|+.+++.| +||||+++++++.+.+..||||||| |++|.+++.. ...+++..++.++.
T Consensus 58 avK~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~-~~~~~~~~~~~~~~ 135 (362)
T 2bdw_A 58 AAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVA-REFYSEADASHCIQ 135 (362)
T ss_dssp EEEEEETTTCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTT-CSCCCHHHHHHHHH
T ss_pred EEEEEEcccCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHH-cCCCCHHHHHHHHH
Confidence 4444443332223345688999999999 8999999999999999999999999 8999999874 45799999999999
Q ss_pred HHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCC
Q 013092 83 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQ 162 (449)
Q Consensus 83 qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~ 162 (449)
||+.||+|||++||+||||||+|||+.....++.+||+|||+++....... .....||+.|+|||++.+..+
T Consensus 136 qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~ 207 (362)
T 2bdw_A 136 QILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA--------WHGFAGTPGYLSPEVLKKDPY 207 (362)
T ss_dssp HHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCS--------CCCSCSCTTTCCHHHHTTCCC
T ss_pred HHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCcc--------cccCCCCccccCHHHHccCCC
Confidence 999999999999999999999999996444456799999999987654322 234679999999999999999
Q ss_pred ChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 013092 163 SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 242 (449)
Q Consensus 163 s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~ 242 (449)
+.++|||||||++|+|++|..||.+. +....+..+.......+. .....+++++.+||..||+.||++||++.+++
T Consensus 208 ~~~~DiwslG~il~~ll~g~~Pf~~~---~~~~~~~~i~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l 283 (362)
T 2bdw_A 208 SKPVDIWACGVILYILLVGYPPFWDE---DQHRLYAQIKAGAYDYPS-PEWDTVTPEAKSLIDSMLTVNPKKRITADQAL 283 (362)
T ss_dssp CTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHTCCCCCT-TGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHT
T ss_pred CchhhHHHHHHHHHHHHHCCCCCCCC---CHHHHHHHHHhCCCCCCc-ccccCCCHHHHHHHHHHcCCChhhCcCHHHHh
Confidence 99999999999999999999999874 334455555554433222 22356899999999999999999999988775
Q ss_pred H
Q 013092 243 R 243 (449)
Q Consensus 243 ~ 243 (449)
+
T Consensus 284 ~ 284 (362)
T 2bdw_A 284 K 284 (362)
T ss_dssp T
T ss_pred c
Confidence 3
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=329.69 Aligned_cols=227 Identities=19% Similarity=0.212 Sum_probs=188.0
Q ss_pred EEEEEeeecccCCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHH
Q 013092 4 ILTVFSVQENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLAD 82 (449)
Q Consensus 4 aikV~~k~~~~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~ 82 (449)
|+|++.+..........+.+|+++++.| +||||+++++++.+.+..||||||| |++|.+++.. ...+++..+..++.
T Consensus 40 a~K~i~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~-~~~~~e~~~~~i~~ 117 (444)
T 3soa_A 40 AAMIINTKKLSARDHQKLEREARICRLL-KHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVA-REYYSEADASHCIQ 117 (444)
T ss_dssp EEEEEESCSCHHHHHHHHHHHHHHHHHC-CBTTBCCEEEEEECSSEEEEEECCCBCCBHHHHHHH-CSCCCHHHHHHHHH
T ss_pred EEEEEEcccCCHHHHHHHHHHHHHHHhC-CCcCCCeEEEEEEECCEEEEEEEeCCCCCHHHHHHH-cCCCCHHHHHHHHH
Confidence 4444443333333456689999999999 9999999999999999999999999 9999999886 56799999999999
Q ss_pred HHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCC
Q 013092 83 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQ 162 (449)
Q Consensus 83 qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~ 162 (449)
||+.||+|||++||+||||||+|||+.....++.+||+|||+++....... ......||+.|+|||++.+..+
T Consensus 118 qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~-------~~~~~~gt~~Y~APE~l~~~~~ 190 (444)
T 3soa_A 118 QILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ-------AWFGFAGTPGYLSPEVLRKDPY 190 (444)
T ss_dssp HHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCC-------BCCCSCSCGGGCCHHHHTTCCB
T ss_pred HHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCc-------eeecccCCcccCCHHHhcCCCC
Confidence 999999999999999999999999996444678899999999987654332 1234689999999999999999
Q ss_pred ChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 013092 163 SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 242 (449)
Q Consensus 163 s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~ 242 (449)
+.++|||||||++|+|++|..||.+. .....+..+.......+. .....+++++.+||..||+.||++||++.+++
T Consensus 191 ~~~~DIwSlGvilyell~G~~Pf~~~---~~~~~~~~i~~~~~~~~~-~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L 266 (444)
T 3soa_A 191 GKPVDLWACGVILYILLVGYPPFWDE---DQHRLYQQIKAGAYDFPS-PEWDTVTPEAKDLINKMLTINPSKRITAAEAL 266 (444)
T ss_dssp CTHHHHHHHHHHHHHHHHSSCSCCCS---SHHHHHHHHHHTCCCCCT-TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred CCccccHHHHHHHHHHHhCCCCCCCc---cHHHHHHHHHhCCCCCCc-cccccCCHHHHHHHHHHcCCChhHCCCHHHHh
Confidence 99999999999999999999999773 344555666555443222 23356899999999999999999999988876
Q ss_pred H
Q 013092 243 R 243 (449)
Q Consensus 243 ~ 243 (449)
+
T Consensus 267 ~ 267 (444)
T 3soa_A 267 K 267 (444)
T ss_dssp H
T ss_pred c
Confidence 4
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=312.85 Aligned_cols=229 Identities=17% Similarity=0.207 Sum_probs=182.1
Q ss_pred EEEEEeeecccCCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHH
Q 013092 4 ILTVFSVQENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQ 83 (449)
Q Consensus 4 aikV~~k~~~~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~~~~i~~q 83 (449)
|+|++.+..........+.+|+++++.+ +||||+++++++.+.+..||||||+.++|.+++......+++..++.++.|
T Consensus 49 avK~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~q 127 (311)
T 3niz_A 49 ALKRIRLDAEDEGIPSTAIREISLLKEL-HHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQ 127 (311)
T ss_dssp EEEEEC------CHHHHHHHHHHHHHHC-CCTTBCCEEEEECCSSCEEEEEECCSEEHHHHHHTCTTCCCHHHHHHHHHH
T ss_pred EEEEEecccccchhhHHHHHHHHHHHHc-CCCCEeeeeeEEccCCEEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHH
Confidence 4454443332233346788999999999 899999999999999999999999977999998865667999999999999
Q ss_pred HHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhC-CCC
Q 013092 84 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG-IEQ 162 (449)
Q Consensus 84 i~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~-~~~ 162 (449)
|+.||+|||++||+||||||+|||+ +.++.+||+|||+++.+..... ......||+.|+|||++.+ ..+
T Consensus 128 i~~~l~~LH~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~a~~~~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~ 197 (311)
T 3niz_A 128 LLRGVAHCHQHRILHRDLKPQNLLI---NSDGALKLADFGLARAFGIPVR-------SYTHEVVTLWYRAPDVLMGSKKY 197 (311)
T ss_dssp HHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEETTSCCC----------CCCCCCTTCCHHHHTTCCSC
T ss_pred HHHHHHHHHHCCcccCCCchHhEEE---CCCCCEEEccCcCceecCCCcc-------cccCCcccCCcCCHHHhcCCCCC
Confidence 9999999999999999999999999 6788999999999987654322 1234578999999999987 568
Q ss_pred ChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcc----------------------cchHHHhhcCCcHHH
Q 013092 163 SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV----------------------STSIEALCRGYPTEF 220 (449)
Q Consensus 163 s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~----------------------~~~~~~l~~~~p~el 220 (449)
+.++|||||||++|+|++|..||.+.........+..+..... ......+.+.+++++
T Consensus 198 ~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (311)
T 3niz_A 198 STSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEG 277 (311)
T ss_dssp CTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHH
T ss_pred CchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHH
Confidence 9999999999999999999999988766554443333221111 112334456688999
Q ss_pred HHHHHHHhcCCCCCCCCHHHHHH
Q 013092 221 ASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 221 ~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
.+||..||+.||++||++.++++
T Consensus 278 ~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 278 IDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp HHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHHHHHcCCChhHCCCHHHHhc
Confidence 99999999999999999887753
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=320.07 Aligned_cols=235 Identities=17% Similarity=0.238 Sum_probs=193.8
Q ss_pred EEEeeecccCC---ChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcC------------
Q 013092 6 TVFSVQENVKT---KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCS------------ 69 (449)
Q Consensus 6 kV~~k~~~~~~---~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~------------ 69 (449)
+|++|...... ....+.+|+++++.+.+||||+++++++.+.+..||||||+ +++|.+++....
T Consensus 103 ~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~ 182 (382)
T 3tt0_A 103 KVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSH 182 (382)
T ss_dssp EEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCS
T ss_pred EEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCCceEEEEEecCCCcHHHHHHHhccccccccccccc
Confidence 35555543322 23568899999999989999999999999999999999999 899999998643
Q ss_pred ---CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCc
Q 013092 70 ---RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLT 146 (449)
Q Consensus 70 ---~~ls~~~~~~i~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~ 146 (449)
..+++..++.++.||+.||+|||++||+||||||+|||| +.++.+||+|||+++........ .......
T Consensus 183 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~DFG~a~~~~~~~~~-----~~~~~~~ 254 (382)
T 3tt0_A 183 NPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV---TEDNVMKIADFGLARDIHHIDYY-----KKTTNGR 254 (382)
T ss_dssp SCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECSCSCCCCSSCCCTT-----CCCTTCC
T ss_pred ccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEE---cCCCcEEEcccCccccccccccc-----ccccCCC
Confidence 359999999999999999999999999999999999999 57889999999999876543221 2233456
Q ss_pred cCccccchhhhhCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHH
Q 013092 147 GTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFH 225 (449)
Q Consensus 147 gT~~Y~aPE~~~~~~~s~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~ 225 (449)
+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+... .+....+...... .....+++++.+||.
T Consensus 255 ~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~---~~~~~~~~~~~~~----~~~~~~~~~l~~li~ 327 (382)
T 3tt0_A 255 LPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV---EELFKLLKEGHRM----DKPSNCTNELYMMMR 327 (382)
T ss_dssp CGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---HHHHHHHHTTCCC----CCCSSCCHHHHHHHH
T ss_pred CCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCCCC----CCCccCCHHHHHHHH
Confidence 7899999999999999999999999999999999 9999987533 3334444333221 233568999999999
Q ss_pred HHhcCCCCCCCCHHHHHHHHHHHHHHcCCC
Q 013092 226 YCRSLRFDDKPDYAYLKRIFRDLFIREGFQ 255 (449)
Q Consensus 226 ~cl~~~p~~RPt~~~l~~~L~~~~~~~~~~ 255 (449)
.||+.+|++||++.+|++.|+.++.....+
T Consensus 328 ~~l~~dP~~Rps~~ell~~L~~~~~~~~~~ 357 (382)
T 3tt0_A 328 DCWHAVPSQRPTFKQLVEDLDRIVALTSNQ 357 (382)
T ss_dssp HHTCSSGGGSCCHHHHHHHHHHHHHHSCSC
T ss_pred HHcCCChhhCcCHHHHHHHHHHHHHHHhcC
Confidence 999999999999999999999998766543
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-39 Score=313.96 Aligned_cols=226 Identities=17% Similarity=0.236 Sum_probs=183.9
Q ss_pred CChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC
Q 013092 16 TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 94 (449)
Q Consensus 16 ~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~ 94 (449)
.....+.+|+++++.+ .||||+++++++.+++..||||||+ +++|.+++......+++..++.++.||+.||+|||++
T Consensus 49 ~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~ 127 (310)
T 3s95_A 49 ETQRTFLKEVKVMRCL-EHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSM 127 (310)
T ss_dssp HHHHHHHHHHHHHTTC-CCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHHhC-CCcCcccEEEEEecCCeeEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 3456689999999999 8999999999999999999999999 9999999987677899999999999999999999999
Q ss_pred CceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCccc-------ccccCCCCccCccccchhhhhCCCCChhhH
Q 013092 95 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHI-------PYRENKNLTGTARYASMNTHLGIEQSRRDD 167 (449)
Q Consensus 95 givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~-------~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~D 167 (449)
||+||||||+|||+ +.++.+||+|||+++.+......... .........||+.|+|||++.+..++.++|
T Consensus 128 ~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 204 (310)
T 3s95_A 128 NIIHRDLNSHNCLV---RENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVD 204 (310)
T ss_dssp TEECSCCSTTSEEE---CTTSCEEECCCTTCEECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHH
T ss_pred CccCCCCCcCeEEE---CCCCCEEEeecccceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHH
Confidence 99999999999999 68889999999999877554321100 001112567999999999999999999999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCCcCCHHH--HHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Q 013092 168 LESLGYVLMYFLRGSLPWQGLKAGTKKQ--KYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIF 245 (449)
Q Consensus 168 iwSlG~il~elltG~~Pf~~~~~~~~~~--~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~L 245 (449)
||||||++|+|++|..||.......... ...... .......+|+++.++|..||+.+|++||++.+|.+.|
T Consensus 205 i~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L 277 (310)
T 3s95_A 205 VFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFL-------DRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWL 277 (310)
T ss_dssp HHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHH-------HHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccc-------cccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 9999999999999999997644322110 001111 1122467899999999999999999999999999999
Q ss_pred HHHHHHc
Q 013092 246 RDLFIRE 252 (449)
Q Consensus 246 ~~~~~~~ 252 (449)
+++....
T Consensus 278 ~~l~~~~ 284 (310)
T 3s95_A 278 ETLRMHL 284 (310)
T ss_dssp HHHHHHH
T ss_pred HHHHHhc
Confidence 8886543
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=309.62 Aligned_cols=211 Identities=20% Similarity=0.285 Sum_probs=177.6
Q ss_pred CCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH
Q 013092 15 KTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 93 (449)
Q Consensus 15 ~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~ 93 (449)
....+.+.+|+.+++.+ +||||+++++++.+++..||||||| |++|.+++.. ..+++..++.++.|++.||+|||+
T Consensus 58 ~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~ 134 (297)
T 3fxz_A 58 QPKKELIINEILVMREN-KNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHS 134 (297)
T ss_dssp CSCHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred ccHHHHHHHHHHHHhcC-CCCCCCeEeEEEEECCEEEEEEECCCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHh
Confidence 34566789999999999 9999999999999999999999999 9999999985 469999999999999999999999
Q ss_pred CCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHH
Q 013092 94 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGY 173 (449)
Q Consensus 94 ~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~ 173 (449)
+||+||||||+|||+ +.++.+||+|||++......... .....||+.|+|||++.+..++.++|||||||
T Consensus 135 ~~i~H~Dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ 204 (297)
T 3fxz_A 135 NQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQSK-------RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGI 204 (297)
T ss_dssp TTEECCCCSGGGEEE---CTTCCEEECCCTTCEECCSTTCC-------BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHH
T ss_pred CCceeCCCCHHHEEE---CCCCCEEEeeCCCceecCCcccc-------cCCccCCcCccChhhhcCCCCCcHHHHHHHHH
Confidence 999999999999999 57889999999999877554321 24567999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 174 VLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 174 il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
++|+|++|..||.+... ......+....... ......++.++.+||..||+.||++||++.++++
T Consensus 205 il~ell~g~~pf~~~~~---~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 205 MAIEMIEGEPPYLNENP---LRALYLIATNGTPE--LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp HHHHHHHSSCTTTTSCH---HHHHHHHHHHCSCC--CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHHHhCCCCCCCCCH---HHHHHHHHhCCCCC--CCCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 99999999999977433 22222222221111 1123468899999999999999999999887753
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=315.87 Aligned_cols=239 Identities=19% Similarity=0.244 Sum_probs=183.0
Q ss_pred cEEEEEeeeccc--CCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHH
Q 013092 3 EILTVFSVQENV--KTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLM 79 (449)
Q Consensus 3 ~aikV~~k~~~~--~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~ 79 (449)
.|+|++.+.... ......+.+|+.+|+.+ +||||+++++++.+.+..||||||+ |++|.+++.. ...+++..++.
T Consensus 48 ~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~ 125 (327)
T 3a62_A 48 FAMKVLKKAMIVRNAKDTAHTKAERNILEEV-KHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLER-EGIFMEDTACF 125 (327)
T ss_dssp EEEEEECCC--------------HHHHHHHC-CCTTBCCEEEEEECSSCEEEEEECCTTEEHHHHHHH-HSSCCHHHHHH
T ss_pred EEEEEEEHHHhhhhhhHHHHHHHHHHHHHhC-CCCCccceeEEEEcCCEEEEEEeCCCCCcHHHHHHh-CCCCCHHHHHH
Confidence 355665544322 22345688999999999 8999999999999999999999999 8999999975 45699999999
Q ss_pred HHHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhC
Q 013092 80 LADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG 159 (449)
Q Consensus 80 i~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~ 159 (449)
++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++....... ......||+.|+|||++.+
T Consensus 126 ~~~qi~~al~~lH~~~ivH~Dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~ 195 (327)
T 3a62_A 126 YLAEISMALGHLHQKGIIYRDLKPENIML---NHQGHVKLTDFGLCKESIHDGT-------VTHTFCGTIEYMAPEILMR 195 (327)
T ss_dssp HHHHHHHHHHHHHHTTCCCCCCCTTTEEE---CTTSCEEECCCSCC-----------------CTTSSCCTTSCHHHHTT
T ss_pred HHHHHHHHHHHHHhCCEEcccCCHHHeEE---CCCCcEEEEeCCcccccccCCc-------cccccCCCcCccCHhhCcC
Confidence 99999999999999999999999999999 5788999999999976443221 1234679999999999999
Q ss_pred CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCC---
Q 013092 160 IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKP--- 236 (449)
Q Consensus 160 ~~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RP--- 236 (449)
..++.++|||||||++|+|++|..||.+. ...+.+.++...... ++..++.++.++|..||..+|++||
T Consensus 196 ~~~~~~~DiwslG~il~el~~g~~pf~~~---~~~~~~~~i~~~~~~-----~p~~~~~~~~~li~~~L~~dp~~R~~~~ 267 (327)
T 3a62_A 196 SGHNRAVDWWSLGALMYDMLTGAPPFTGE---NRKKTIDKILKCKLN-----LPPYLTQEARDLLKKLLKRNAASRLGAG 267 (327)
T ss_dssp SCCCTHHHHHHHHHHHHHHHHSSCSCCCS---SHHHHHHHHHHTCCC-----CCTTSCHHHHHHHHHHSCSCGGGSTTSS
T ss_pred CCCCCcccchhHHHHHHHHHHCCCCCCCC---CHHHHHHHHHhCCCC-----CCCCCCHHHHHHHHHHHhcCHhhccCCC
Confidence 99999999999999999999999999874 334455555544332 3356889999999999999999999
Q ss_pred --CHHHHHHHHHHHHHHcCCCCCCcccchhhhhhhcc
Q 013092 237 --DYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQ 271 (449)
Q Consensus 237 --t~~~l~~~L~~~~~~~~~~~~~~~dw~~~~~~~~~ 271 (449)
++.++++ +++...++|+.....+..
T Consensus 268 ~~~~~e~l~----------hp~f~~~~~~~~~~~~~~ 294 (327)
T 3a62_A 268 PGDAGEVQA----------HPFFRHINWEELLARKVE 294 (327)
T ss_dssp TTTHHHHHH----------SGGGSSCCHHHHHTTCSC
T ss_pred CCCHHHHHc----------CCcccCCCHHHHhhccCC
Confidence 5555433 355567789876555433
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=316.39 Aligned_cols=214 Identities=16% Similarity=0.186 Sum_probs=179.8
Q ss_pred ChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHH
Q 013092 17 KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVH 92 (449)
Q Consensus 17 ~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~---~~~ls~~~~~~i~~qi~~aL~yLH 92 (449)
....+.+|+.+++.+ +||||+++++++.+.+..||||||| |++|.+++... ...+++..++.++.||+.||+|||
T Consensus 69 ~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH 147 (351)
T 3c0i_A 69 STEDLKREASICHML-KHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH 147 (351)
T ss_dssp CHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHhC-CCCCCCcEEEEEEeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 456799999999999 8999999999999999999999999 89998887532 345899999999999999999999
Q ss_pred HCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHH
Q 013092 93 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLG 172 (449)
Q Consensus 93 ~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG 172 (449)
++||+||||||+|||+..+.....+||+|||+++....... ......||+.|+|||++.+..++.++||||||
T Consensus 148 ~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG 220 (351)
T 3c0i_A 148 DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGL-------VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCG 220 (351)
T ss_dssp HTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEECCTTSC-------BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHH
T ss_pred HCCceeccCChHHeEEecCCCCCcEEEecCcceeEecCCCe-------eecCCcCCcCccCHHHHcCCCCCchHhhHHHH
Confidence 99999999999999996444455699999999988765332 12345799999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 173 YVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 173 ~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
|++|+|++|..||.+. ..+.+..+........ ...+..+++++.+||..||..||++||++.++++
T Consensus 221 ~il~~ll~g~~pf~~~----~~~~~~~i~~~~~~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 221 VILFILLSGCLPFYGT----KERLFEGIIKGKYKMN-PRQWSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp HHHHHHHHSSCSSCSS----HHHHHHHHHHTCCCCC-HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHHHCCCCCCCc----HHHHHHHHHcCCCCCC-ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 9999999999999863 2344555554443322 2344678999999999999999999999887754
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=325.92 Aligned_cols=248 Identities=17% Similarity=0.221 Sum_probs=191.1
Q ss_pred cEEEEEeeecccC-CChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHH
Q 013092 3 EILTVFSVQENVK-TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLML 80 (449)
Q Consensus 3 ~aikV~~k~~~~~-~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i 80 (449)
.|||++.+..... .....+..|..++....+||||+++++++.+.+..||||||+ |++|.+++.. .+.+++..++.+
T Consensus 66 ~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~ 144 (373)
T 2r5t_A 66 YAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQR-ERCFLEPRARFY 144 (373)
T ss_dssp EEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHH
T ss_pred EEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHH
Confidence 4777776655432 344557778877533339999999999999999999999999 9999999986 457999999999
Q ss_pred HHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCC
Q 013092 81 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI 160 (449)
Q Consensus 81 ~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~ 160 (449)
+.||+.||+|||++||+||||||+|||| +.++.+||+|||+++....... .....+||+.|+|||++.+.
T Consensus 145 ~~qi~~aL~~LH~~givHrDlkp~NIll---~~~g~ikL~DFG~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~ 214 (373)
T 2r5t_A 145 AAEIASALGYLHSLNIVYRDLKPENILL---DSQGHIVLTDFGLCKENIEHNS-------TTSTFCGTPEYLAPEVLHKQ 214 (373)
T ss_dssp HHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCCBCGGGBCCCC-------CCCSBSCCCCCCCHHHHTTC
T ss_pred HHHHHHHHHHHHHCCceecCCCHHHEEE---CCCCCEEEeeCccccccccCCC-------ccccccCCccccCHHHhCCC
Confidence 9999999999999999999999999999 6889999999999986433221 13456899999999999999
Q ss_pred CCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHH
Q 013092 161 EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAY 240 (449)
Q Consensus 161 ~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~ 240 (449)
.++.++|||||||++|||++|..||.+. +..+.+..+...... +...++.++.+||..||+.||.+||+..+
T Consensus 215 ~~~~~~DiwslG~il~ell~G~~Pf~~~---~~~~~~~~i~~~~~~-----~~~~~~~~~~~li~~lL~~dp~~R~~~~~ 286 (373)
T 2r5t_A 215 PYDRTVDWWCLGAVLYEMLYGLPPFYSR---NTAEMYDNILNKPLQ-----LKPNITNSARHLLEGLLQKDRTKRLGAKD 286 (373)
T ss_dssp CCCTHHHHHHHHHHHHHHHHSSCTTCCS---BHHHHHHHHHHSCCC-----CCSSSCHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred CCCchhhhHHHHHHHHHHHcCCCCCCCC---CHHHHHHHHHhcccC-----CCCCCCHHHHHHHHHHcccCHHhCCCCCC
Confidence 9999999999999999999999999763 445566666654332 34568999999999999999999998742
Q ss_pred HHHHHHHHHHHcCCCCCCcccchhhhhhhccCCCC
Q 013092 241 LKRIFRDLFIREGFQFDYVFDWTILKYQQSQLATP 275 (449)
Q Consensus 241 l~~~L~~~~~~~~~~~~~~~dw~~~~~~~~~~~~~ 275 (449)
. +.++ ..+.+...+||+.+...+..++..
T Consensus 287 ~---~~~i---~~h~~f~~~~w~~l~~~~~~pp~~ 315 (373)
T 2r5t_A 287 D---FMEI---KSHVFFSLINWDDLINKKITPPFN 315 (373)
T ss_dssp T---HHHH---HTSGGGTTCCHHHHHTTCSCCSCC
T ss_pred C---HHHH---hCCccccCCCHHHHHhCCCCCCCC
Confidence 1 1222 335677788999887665544433
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-38 Score=311.75 Aligned_cols=227 Identities=17% Similarity=0.208 Sum_probs=185.4
Q ss_pred cEEEEEeeecccCC----ChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHH
Q 013092 3 EILTVFSVQENVKT----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTV 77 (449)
Q Consensus 3 ~aikV~~k~~~~~~----~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~ 77 (449)
.|+|++.+...... ....+.+|+.+|+.+ +||||+++++++.+....||||||+ +++|.+++.. ...+++..+
T Consensus 39 ~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~ 116 (326)
T 2y0a_A 39 YAAKFIKKRRTKSSRRGVSREDIEREVSILKEI-QHPNVITLHEVYENKTDVILILELVAGGELFDFLAE-KESLTEEEA 116 (326)
T ss_dssp EEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHTT-SSCCBHHHH
T ss_pred EEEEEEEccccccccchhhHHHHHHHHHHHHhC-CCCCCCcEEEEEEeCCEEEEEEEcCCCCCHHHHHHh-cCCcCHHHH
Confidence 45666555443221 346799999999999 8999999999999999999999999 9999999974 467999999
Q ss_pred HHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecC-CCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhh
Q 013092 78 LMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR-RANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNT 156 (449)
Q Consensus 78 ~~i~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~-~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~ 156 (449)
+.++.||+.||+|||++||+||||||+|||+..+. ....+||+|||+++....... .....||+.|+|||+
T Consensus 117 ~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~ 188 (326)
T 2y0a_A 117 TEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE--------FKNIFGTPEFVAPEI 188 (326)
T ss_dssp HHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECCTTSC--------CCCCCSCTTTCCHHH
T ss_pred HHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECCCCCc--------cccccCCcCcCCcee
Confidence 99999999999999999999999999999994211 122899999999987754321 234579999999999
Q ss_pred hhCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCC
Q 013092 157 HLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKP 236 (449)
Q Consensus 157 ~~~~~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RP 236 (449)
+.+..++.++|||||||++|+|++|..||.+. ...+.+..+....... .......++.++.+||..||..||++||
T Consensus 189 ~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~---~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rp 264 (326)
T 2y0a_A 189 VNYEPLGLEADMWSIGVITYILLSGASPFLGD---TKQETLANVSAVNYEF-EDEYFSNTSALAKDFIRRLLVKDPKKRM 264 (326)
T ss_dssp HTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS---SHHHHHHHHHHTCCCC-CHHHHTTSCHHHHHHHHHHSCSSGGGSC
T ss_pred ecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCC---CHHHHHHHHHhcCCCc-CccccccCCHHHHHHHHHHccCChhhCC
Confidence 99999999999999999999999999999774 3344444444433322 2345567899999999999999999999
Q ss_pred CHHHHHH
Q 013092 237 DYAYLKR 243 (449)
Q Consensus 237 t~~~l~~ 243 (449)
++.++++
T Consensus 265 t~~e~l~ 271 (326)
T 2y0a_A 265 TIQDSLQ 271 (326)
T ss_dssp CHHHHHH
T ss_pred CHHHHhc
Confidence 9888754
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=346.37 Aligned_cols=245 Identities=17% Similarity=0.214 Sum_probs=204.9
Q ss_pred cEEEEEeeecc-cCCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHH
Q 013092 3 EILTVFSVQEN-VKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLML 80 (449)
Q Consensus 3 ~aikV~~k~~~-~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i 80 (449)
.|||++++... .......+..|..++..+.+||+|+.+++++.+.+..||||||+ |++|.+++.. .+.+++..++.|
T Consensus 369 vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~-~~~~~~~~~~~~ 447 (674)
T 3pfq_A 369 YAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQ-VGRFKEPHAVFY 447 (674)
T ss_dssp EEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHH
T ss_pred EEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEEeCcCCCcHHHHHHh-cCCCCHHHHHHH
Confidence 46777665432 23456678899999999989999999999999999999999999 9999999986 357999999999
Q ss_pred HHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCC
Q 013092 81 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI 160 (449)
Q Consensus 81 ~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~ 160 (449)
+.||+.||+|||++|||||||||+|||| +.++.+||+|||+++....... .....+||+.|+|||++.+.
T Consensus 448 ~~qi~~aL~~LH~~gIiHrDLKp~NILl---~~~g~ikL~DFGla~~~~~~~~-------~~~~~~GT~~Y~APE~l~~~ 517 (674)
T 3pfq_A 448 AAEIAIGLFFLQSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKENIWDGV-------TTKTFCGTPDYIAPEIIAYQ 517 (674)
T ss_dssp HHHHHHHHHHHHHTSEECCCCCSTTEEE---CSSSCEEECCCTTCEECCCTTC-------CBCCCCSCSSSCCHHHHTCC
T ss_pred HHHHHHHHHHHHhCCeEeccCChhhEEE---cCCCcEEEeecceeeccccCCc-------ccccccCCCcccCHhhhcCC
Confidence 9999999999999999999999999999 6889999999999986443222 12457899999999999999
Q ss_pred CCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCH--
Q 013092 161 EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDY-- 238 (449)
Q Consensus 161 ~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~-- 238 (449)
.++.++|||||||+||||++|..||.+. +..+.+..|...... ++..+++++.+||..||+.||++||++
T Consensus 518 ~~~~~~DvwSlGvilyelltG~~Pf~~~---~~~~~~~~i~~~~~~-----~p~~~s~~~~~li~~lL~~dP~~R~~~~~ 589 (674)
T 3pfq_A 518 PYGKSVDWWAFGVLLYEMLAGQAPFEGE---DEDELFQSIMEHNVA-----YPKSMSKEAVAICKGLMTKHPGKRLGCGP 589 (674)
T ss_dssp CBSTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHSSCCC-----CCTTSCHHHHHHHHHHSCSSSTTCTTCST
T ss_pred CCCccceEechHHHHHHHHcCCCCCCCC---CHHHHHHHHHhCCCC-----CCccCCHHHHHHHHHHccCCHHHCCCCCC
Confidence 9999999999999999999999999873 445666777665442 345789999999999999999999986
Q ss_pred ---HHHHHHHHHHHHHcCCCCCCcccchhhhhhhccCCCCC
Q 013092 239 ---AYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQLATPP 276 (449)
Q Consensus 239 ---~~l~~~L~~~~~~~~~~~~~~~dw~~~~~~~~~~~~~p 276 (449)
.+| ..++|+..+||+.+...+.+++..|
T Consensus 590 ~~~~ei----------~~h~ff~~i~w~~l~~~~~~pp~~p 620 (674)
T 3pfq_A 590 EGERDI----------KEHAFFRYIDWEKLERKEIQPPYKP 620 (674)
T ss_dssp THHHHH----------HSSGGGSSCCHHHHTTTCSCCSCCC
T ss_pred CcHHHH----------hcCccccCCCHHHHHhCCCCCCCCC
Confidence 333 2356778899999887766555544
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-39 Score=311.99 Aligned_cols=234 Identities=20% Similarity=0.329 Sum_probs=179.2
Q ss_pred EEEEEeeecccCCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHH
Q 013092 4 ILTVFSVQENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLAD 82 (449)
Q Consensus 4 aikV~~k~~~~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~ 82 (449)
|+|+++...........+.+|+++++.+ .|+||+.+++++ .....++||||+ +++|.+++......+++..++.++.
T Consensus 50 avK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ 127 (289)
T 3og7_A 50 AVKMLNVTAPTPQQLQAFKNEVGVLRKT-RHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIAR 127 (289)
T ss_dssp EEEEESCSSCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEE-CSSSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHH
T ss_pred EEEEEeccCCCHHHHHHHHHHHHHHHhC-CCCcEEEEEeec-cCCccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHH
Confidence 4444443333333446689999999999 899999999865 455689999999 8999999976566799999999999
Q ss_pred HHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhh---C
Q 013092 83 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHL---G 159 (449)
Q Consensus 83 qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~---~ 159 (449)
||+.||+|||++||+||||||+|||+ +.++.+||+|||+++........ .......||+.|+|||++. +
T Consensus 128 qi~~~L~~lH~~~i~H~Dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~ 199 (289)
T 3og7_A 128 QTARGMDYLHAKSIIHRDLKSNNIFL---HEDNTVKIGDFGLATEKSRWSGS-----HQFEQLSGSILWMAPEVIRMQDS 199 (289)
T ss_dssp HHHHHHHHHHHTTCCCSCCCGGGEEE---ETTTEEEECCCC-----------------------CCCTTCCHHHHC----
T ss_pred HHHHHHHHHHhCCcccccCccceEEE---CCCCCEEEccceecccccccccc-----ccccccCCCccccCchhhcccCC
Confidence 99999999999999999999999999 47789999999999865432211 1123457999999999997 5
Q ss_pred CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHH
Q 013092 160 IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYA 239 (449)
Q Consensus 160 ~~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~ 239 (449)
..++.++|||||||++|+|++|..||.+... .......+...........+...+|+++.+||..||+.+|++||++.
T Consensus 200 ~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ 277 (289)
T 3og7_A 200 NPYSFQSDVYAFGIVLYELMTGQLPYSNINN--RDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFP 277 (289)
T ss_dssp CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCC--HHHHHHHHHHTSCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred CCCCcccchHHHHHHHHHHHHCCCCccccch--HHHHHHHhcccccCcchhhccccCCHHHHHHHHHHccCChhhCCCHH
Confidence 6789999999999999999999999987543 33444445555555555556678999999999999999999999999
Q ss_pred HHHHHHHHHH
Q 013092 240 YLKRIFRDLF 249 (449)
Q Consensus 240 ~l~~~L~~~~ 249 (449)
+|++.|+++.
T Consensus 278 ell~~L~~l~ 287 (289)
T 3og7_A 278 RILAEIEELA 287 (289)
T ss_dssp HHHHHHHHTT
T ss_pred HHHHHHHHHh
Confidence 9999988763
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=321.14 Aligned_cols=220 Identities=16% Similarity=0.259 Sum_probs=183.3
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcC------CCCCHHHHHHHHHHHHHHHHH
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCS------RKLSLKTVLMLADQMINRVEF 90 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~------~~ls~~~~~~i~~qi~~aL~y 90 (449)
...+.+|+.+++.+ +||||+++++++.+....||||||| |++|.+++.... ..+++..++.++.||+.||+|
T Consensus 118 ~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~ 196 (367)
T 3l9p_A 118 ELDFLMEALIISKF-NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 196 (367)
T ss_dssp HHHHHHHHHHHHHC-CCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhC-CCCCCCeEEEEEecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHH
Confidence 34688999999999 8999999999999999999999999 999999998643 358999999999999999999
Q ss_pred HHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHH
Q 013092 91 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLES 170 (449)
Q Consensus 91 LH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwS 170 (449)
||++||+||||||+||||.....+..+||+|||+++.+..... +.......||+.|+|||++.+..++.++||||
T Consensus 197 LH~~~ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws 271 (367)
T 3l9p_A 197 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGY-----YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWS 271 (367)
T ss_dssp HHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHHHSS-----CTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHH
T ss_pred HHhCCeeCCCCChhhEEEecCCCCceEEECCCccccccccccc-----cccCCCcCCcccEECHHHhcCCCCCcHHHHHH
Confidence 9999999999999999995433555799999999986543221 12223456899999999999999999999999
Q ss_pred HHHHHHHHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 013092 171 LGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLF 249 (449)
Q Consensus 171 lG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~L~~~~ 249 (449)
|||++|||++ |..||.+.. ..+.+..+...... ..+..++.++.+||..||+.+|++||++.+|++.|+.+.
T Consensus 272 lG~il~ellt~g~~pf~~~~---~~~~~~~i~~~~~~----~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~ 344 (367)
T 3l9p_A 272 FGVLLWEIFSLGYMPYPSKS---NQEVLEFVTSGGRM----DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 344 (367)
T ss_dssp HHHHHHHHHTTSCCSSTTCC---HHHHHHHHHTTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHhCCCCCCCCCC---HHHHHHHHHcCCCC----CCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 9999999998 999998743 33444444433221 224568999999999999999999999999999988775
Q ss_pred H
Q 013092 250 I 250 (449)
Q Consensus 250 ~ 250 (449)
.
T Consensus 345 ~ 345 (367)
T 3l9p_A 345 Q 345 (367)
T ss_dssp H
T ss_pred h
Confidence 4
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=319.22 Aligned_cols=220 Identities=18% Similarity=0.234 Sum_probs=181.5
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeCC-EEEEEEecC-CCCHHHHHHHcCC-------------------------
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEGD-YNVLVMDLL-GPSLEDLFNFCSR------------------------- 70 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~-~~~lVmE~~-g~sL~~ll~~~~~------------------------- 70 (449)
...+.+|++++..+.+||||+++++++.+.+ ..||||||| +++|.+++.....
T Consensus 69 ~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 148 (359)
T 3vhe_A 69 HRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVD 148 (359)
T ss_dssp HHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------
T ss_pred HHHHHHHHHHHHhhcCCcceeeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchh
Confidence 3468999999999999999999999988754 589999999 8999999975322
Q ss_pred ----------------------------------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEee
Q 013092 71 ----------------------------------------KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL 110 (449)
Q Consensus 71 ----------------------------------------~ls~~~~~~i~~qi~~aL~yLH~~givHRDLKP~NiLl~~ 110 (449)
.+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll-- 226 (359)
T 3vhe_A 149 LKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL-- 226 (359)
T ss_dssp -----------------------------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE--
T ss_pred hhccccccCccccccccccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEE--
Confidence 18999999999999999999999999999999999999
Q ss_pred cCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCC
Q 013092 111 GRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLK 189 (449)
Q Consensus 111 ~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il~ellt-G~~Pf~~~~ 189 (449)
+.++.+||+|||+++.+...... .......||+.|+|||++.+..++.++|||||||++|||++ |..||.+..
T Consensus 227 -~~~~~~kl~Dfg~a~~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 300 (359)
T 3vhe_A 227 -SEKNVVKICDFGLARDIYKDPDY-----VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 300 (359)
T ss_dssp -CGGGCEEECCCGGGSCTTSCTTC-----EEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred -cCCCcEEEEeccceeeecccccc-----hhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccc
Confidence 57889999999999866443221 22345678999999999999999999999999999999998 999998754
Q ss_pred cCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 013092 190 AGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIR 251 (449)
Q Consensus 190 ~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~L~~~~~~ 251 (449)
... .....+..... ...+..+++++.++|..||+.+|++||++.+|.+.|+.++..
T Consensus 301 ~~~--~~~~~~~~~~~----~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 356 (359)
T 3vhe_A 301 IDE--EFCRRLKEGTR----MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 356 (359)
T ss_dssp CSH--HHHHHHHHTCC----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hhH--HHHHHHHcCCC----CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence 332 22222222211 123356889999999999999999999999999999998764
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=313.75 Aligned_cols=213 Identities=19% Similarity=0.241 Sum_probs=181.4
Q ss_pred ChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 013092 17 KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 95 (449)
Q Consensus 17 ~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~g 95 (449)
....+.+|+.+++.+ +||||+++++++.+.+..||||||| |++|.+++......+++..++.++.||+.||+|||++|
T Consensus 44 ~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g 122 (321)
T 1tki_A 44 DQVLVKKEISILNIA-RHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN 122 (321)
T ss_dssp HHHHHHHHHHHHHHS-CCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred cHHHHHHHHHHHHhC-CCCCCCeEeEEEecCCEEEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 345688999999999 8999999999999999999999999 89999999754557999999999999999999999999
Q ss_pred ceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHHH
Q 013092 96 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVL 175 (449)
Q Consensus 96 ivHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il 175 (449)
|+||||||+|||+.. +.++.+||+|||+++.+..... .....||+.|+|||++.+..++.++|||||||++
T Consensus 123 ivH~Dlkp~NIl~~~-~~~~~~kl~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il 193 (321)
T 1tki_A 123 IGHFDIRPENIIYQT-RRSSTIKIIEFGQARQLKPGDN--------FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLV 193 (321)
T ss_dssp EECCCCCGGGEEESS-SSCCCEEECCCTTCEECCTTCE--------EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHH
T ss_pred CCcCCCCHHHEEEcc-CCCCCEEEEECCCCeECCCCCc--------cccccCChhhcCcHHhcCCCCCchhhHHHHHHHH
Confidence 999999999999941 1268999999999987754322 1345789999999999998899999999999999
Q ss_pred HHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 176 MYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 176 ~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
|+|++|..||.+. ...+.+..+........ ...+..++.++.+||..||..||++||++.++++
T Consensus 194 ~~ll~g~~pf~~~---~~~~~~~~i~~~~~~~~-~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 194 YVLLSGINPFLAE---TNQQIIENIMNAEYTFD-EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HHHHHSSCTTCCS---SHHHHHHHHHHTCCCCC-HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHhCCCCCcCC---CHHHHHHHHHcCCCCCC-hhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 9999999999874 34455566665544332 3345678999999999999999999999887754
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=317.84 Aligned_cols=225 Identities=29% Similarity=0.494 Sum_probs=177.1
Q ss_pred hHHHHHHHHHHHhcCCCCCceEEEEeEe----CCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC
Q 013092 19 PQLLYESKLYRILQGGTGIPNVRWFGVE----GDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 94 (449)
Q Consensus 19 ~~~~~E~~il~~l~~hp~Iv~l~~~~~~----~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~ 94 (449)
..+.+|+.++..+ +||||+++++++.+ ....||||||++++|.+++... ..+++..++.++.||+.||+|||++
T Consensus 93 ~~~~~e~~~~~~l-~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~ 170 (345)
T 2v62_A 93 KDCIKKWIERKQL-DYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQN-GTFKKSTVLQLGIRMLDVLEYIHEN 170 (345)
T ss_dssp HHHHHHHHHHHTC-SCCCCCCEEEEEEEESSSCEEEEEEEECEEEEHHHHCBGG-GBCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred hHHHHHHHhhccc-cccCcceeecccccccCCCcEEEEEEeccCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 3466777777777 99999999999988 7899999999999999999753 3799999999999999999999999
Q ss_pred CceecCCCCCcEEEeecCCCC--eEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHH
Q 013092 95 SFLHRDIKPDNFLMGLGRRAN--QVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLG 172 (449)
Q Consensus 95 givHRDLKP~NiLl~~~~~~~--~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG 172 (449)
||+||||||+|||++ .++ .+||+|||+++.+..................||+.|+|||++.+..++.++||||||
T Consensus 171 ~ivH~Dlkp~NIll~---~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG 247 (345)
T 2v62_A 171 EYVHGDIKAANLLLG---YKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILG 247 (345)
T ss_dssp TEECSCCSGGGEEEE---SSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHH
T ss_pred CeeCCCcCHHHEEEc---cCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHH
Confidence 999999999999995 444 999999999988754332211111222456899999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCCcCCH-HHHHHHHHhhcccchHHHhhc--CCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 013092 173 YVLMYFLRGSLPWQGLKAGTK-KQKYEKISEKKVSTSIEALCR--GYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDL 248 (449)
Q Consensus 173 ~il~elltG~~Pf~~~~~~~~-~~~~~~i~~~~~~~~~~~l~~--~~p~el~~li~~cl~~~p~~RPt~~~l~~~L~~~ 248 (449)
|++|||++|..||.+...... ...............+..... .+|+++.++|..||+.+|++||++.+|.+.|+++
T Consensus 248 ~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 326 (345)
T 2v62_A 248 YCMLRWLCGKLPWEQNLKDPVAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPH 326 (345)
T ss_dssp HHHHHHHHSSCTTGGGTTCHHHHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTT
T ss_pred HHHHHHHhCCCCccccccccHHHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhcc
Confidence 999999999999965322211 111111111122222222223 7899999999999999999999999999887654
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=305.42 Aligned_cols=217 Identities=19% Similarity=0.275 Sum_probs=172.1
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 96 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gi 96 (449)
...+.+|+.+++.+ +||||+++++++. .+..||||||+ +++|.+++......+++..++.++.|++.||+|||++||
T Consensus 60 ~~~~~~e~~~l~~l-~h~~iv~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i 137 (281)
T 1mp8_A 60 REKFLQEALTMRQF-DHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRF 137 (281)
T ss_dssp HHHHHHHHHHHHTC-CCTTBCCEEEEEC-SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred HHHHHHHHHHHHhC-CCCccceEEEEEc-cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 45688999999999 8999999999874 56789999999 889999998755679999999999999999999999999
Q ss_pred eecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHHHH
Q 013092 97 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLM 176 (449)
Q Consensus 97 vHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il~ 176 (449)
+||||||+|||++ .++.+||+|||+++........ ......+|+.|+|||++.+..++.++|||||||++|
T Consensus 138 ~H~dlkp~Nil~~---~~~~~kl~Dfg~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ 208 (281)
T 1mp8_A 138 VHRDIAARNVLVS---SNDCVKLGDFGLSRYMEDSTYY------KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMW 208 (281)
T ss_dssp CCSCCSGGGEEEE---ETTEEEECC-------------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHH
T ss_pred ecccccHHHEEEC---CCCCEEECccccccccCccccc------ccccCCCcccccChhhcccCCCCCccCchHHHHHHH
Confidence 9999999999994 6789999999999876543221 123446788999999999999999999999999999
Q ss_pred HHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 013092 177 YFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIRE 252 (449)
Q Consensus 177 ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~L~~~~~~~ 252 (449)
||++ |..||.+..... .+..+...... .+...+|+++.++|..||+.+|++||++.+|.+.|++++...
T Consensus 209 ell~~g~~pf~~~~~~~---~~~~i~~~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 278 (281)
T 1mp8_A 209 EILMHGVKPFQGVKNND---VIGRIENGERL----PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 278 (281)
T ss_dssp HHHTTSCCTTTTCCGGG---HHHHHHTTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHhcCCCCCCcCCHHH---HHHHHHcCCCC----CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 9996 999998765433 33333332221 234678999999999999999999999999999999987654
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-38 Score=308.71 Aligned_cols=236 Identities=20% Similarity=0.237 Sum_probs=177.7
Q ss_pred EEEEEeeecccCCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHH
Q 013092 4 ILTVFSVQENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLAD 82 (449)
Q Consensus 4 aikV~~k~~~~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~ 82 (449)
|||++.+. .......+.+|++++..+.+||||+++++++.+.+..||||||+ +++|.+++.. ...+++..++.++.
T Consensus 42 avK~~~~~--~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~ 118 (316)
T 2ac3_A 42 AVKIIEKQ--PGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHK-RRHFNELEASVVVQ 118 (316)
T ss_dssp EEEEEECC--SSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHH
T ss_pred EEEEEeeC--cchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCcHHHHHhc-cCCCCHHHHHHHHH
Confidence 44544332 23445679999999999779999999999999999999999999 8999999986 35799999999999
Q ss_pred HHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhC---
Q 013092 83 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG--- 159 (449)
Q Consensus 83 qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~--- 159 (449)
||+.||+|||++||+||||||+|||+..+.....+||+|||++.....................||+.|+|||++.+
T Consensus 119 qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 198 (316)
T 2ac3_A 119 DVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSE 198 (316)
T ss_dssp HHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-------------------CCSGGGCCHHHHHHTSH
T ss_pred HHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccc
Confidence 99999999999999999999999999533333459999999998664322111111112234569999999999975
Q ss_pred --CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCC------------HHHHHHHHHhhcccchHHHhhcCCcHHHHHHHH
Q 013092 160 --IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT------------KKQKYEKISEKKVSTSIEALCRGYPTEFASYFH 225 (449)
Q Consensus 160 --~~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~------------~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~ 225 (449)
..++.++|||||||++|+|++|..||.+..... ....+..+.......+ ......+++++.+||.
T Consensus 199 ~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~-~~~~~~~~~~~~~li~ 277 (316)
T 2ac3_A 199 EASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFP-DKDWAHISCAAKDLIS 277 (316)
T ss_dssp HHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHHHHHCCCCCC-HHHHTTSCHHHHHHHH
T ss_pred cccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHHHHHhccCcccC-chhcccCCHHHHHHHH
Confidence 457889999999999999999999998754322 1233444444433222 2234568999999999
Q ss_pred HHhcCCCCCCCCHHHHHH
Q 013092 226 YCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 226 ~cl~~~p~~RPt~~~l~~ 243 (449)
.||+.||++||++.++++
T Consensus 278 ~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 278 KLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp HHSCSSTTTSCCHHHHHH
T ss_pred HHhhCChhhCCCHHHHhc
Confidence 999999999999888754
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=302.89 Aligned_cols=219 Identities=17% Similarity=0.233 Sum_probs=185.0
Q ss_pred CCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH
Q 013092 15 KTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 93 (449)
Q Consensus 15 ~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~ 93 (449)
....+.+.+|+++++.+ .||||+++++++.+.+..|+||||+ +++|.+++......+++..++.++.|++.||+|||+
T Consensus 46 ~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~ 124 (269)
T 4hcu_A 46 AMSEEDFIEEAEVMMKL-SHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE 124 (269)
T ss_dssp SBCHHHHHHHHHHHHTC-CCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred ccCHHHHHHHHHHHHhC-CCCCEeeEEEEEecCCceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHh
Confidence 34557799999999999 7999999999999999999999999 899999998656679999999999999999999999
Q ss_pred CCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHH
Q 013092 94 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGY 173 (449)
Q Consensus 94 ~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~ 173 (449)
+||+||||||+||++ +.++.+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||
T Consensus 125 ~~i~H~dikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 195 (269)
T 4hcu_A 125 ACVIHRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQY------TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGV 195 (269)
T ss_dssp TTCCCSCCCGGGEEE---CGGGCEEECCTTGGGGBCCHHH------HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHH
T ss_pred CCeecCCcchheEEE---cCCCCEEecccccccccccccc------ccccCcccccccCCHHHhcCCCCCchhhhHHHHH
Confidence 999999999999999 5778999999999986543211 1223456788999999999999999999999999
Q ss_pred HHHHHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 013092 174 VLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFI 250 (449)
Q Consensus 174 il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~L~~~~~ 250 (449)
++|+|++ |..||.... ..+....+...... .....+++++.+++..||+.+|++||++.++.+.|+++..
T Consensus 196 ~l~~ll~~g~~p~~~~~---~~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 196 LMWEVFSEGKIPYENRS---NSEVVEDISTGFRL----YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp HHHHHHTTSCCTTTTCC---HHHHHHHHHTTCCC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHhcCCCCCCCCCC---HHHHHHHHhcCccC----CCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence 9999999 999998743 33444444332111 1234578999999999999999999999999999998864
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=319.47 Aligned_cols=233 Identities=13% Similarity=0.182 Sum_probs=180.2
Q ss_pred cEEEEEeeecccCCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHc-CCCCCHHHHHHH
Q 013092 3 EILTVFSVQENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFC-SRKLSLKTVLML 80 (449)
Q Consensus 3 ~aikV~~k~~~~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~-~~~ls~~~~~~i 80 (449)
+|||++.+..........+.+|+++++.+ +||||+++++++.+.+..||||||| +++|.+++... ...+++..++.+
T Consensus 55 vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 133 (389)
T 3gni_B 55 VTVRRINLEACSNEMVTFLQGELHVSKLF-NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYI 133 (389)
T ss_dssp EEEEEEEGGGSCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHH
T ss_pred EEEEEecccccChHHHHHHHHHHHHHHhC-CCCCCCcEeEEEEECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHH
Confidence 45665554443334456688899999999 8999999999999999999999999 99999999764 356999999999
Q ss_pred HHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhC-
Q 013092 81 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG- 159 (449)
Q Consensus 81 ~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~- 159 (449)
+.||+.||+|||++||+||||||+|||| +.++.+||+|||++.....................||+.|+|||++.+
T Consensus 134 ~~qi~~~l~~LH~~~ivHrDlkp~NIll---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 210 (389)
T 3gni_B 134 LQGVLKALDYIHHMGYVHRSVKASHILI---SVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQN 210 (389)
T ss_dssp HHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTT
T ss_pred HHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEcccccceeeccccccccccccccccccccccccCHHHHhcc
Confidence 9999999999999999999999999999 678899999999987664432222111222344589999999999988
Q ss_pred -CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcc---------------------------------
Q 013092 160 -IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV--------------------------------- 205 (449)
Q Consensus 160 -~~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~--------------------------------- 205 (449)
..++.++|||||||++|+|++|..||.+......... +.....
T Consensus 211 ~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (389)
T 3gni_B 211 LQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLE---KLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTT 287 (389)
T ss_dssp SSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHH---C--------------------------------------
T ss_pred CCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH---HhcCCCCcccccccccccccccccccccccccccccccc
Confidence 6789999999999999999999999987554332111 110000
Q ss_pred --------cchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 013092 206 --------STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 242 (449)
Q Consensus 206 --------~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~ 242 (449)
......+...+++++.+||..||+.||++||++.+++
T Consensus 288 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell 332 (389)
T 3gni_B 288 STPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLL 332 (389)
T ss_dssp ------------------CCHHHHHHHHHHTCSCTTTSCCHHHHT
T ss_pred CccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHh
Confidence 0001123456789999999999999999999988775
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=308.04 Aligned_cols=226 Identities=19% Similarity=0.266 Sum_probs=178.5
Q ss_pred EEEEEeeecccCCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHH
Q 013092 4 ILTVFSVQENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQ 83 (449)
Q Consensus 4 aikV~~k~~~~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~~~~i~~q 83 (449)
|+|++.+..........+.+|+.+++.+ +||||+++++++.+.+..||||||+.++|.+++......+++..++.++.|
T Consensus 30 aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~q 108 (288)
T 1ob3_A 30 ALKKIRLEKEDEGIPSTTIREISILKEL-KHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQ 108 (288)
T ss_dssp EEEEECCSSGGGCCCHHHHHHHHGGGGC-CCTTBCCEEEEEECSSCEEEEEECCSEEHHHHHHTSTTCCCHHHHHHHHHH
T ss_pred EEEEEeccccccccchhHHHHHHHHHhc-CCCCEeeeeeEEccCCeEEEEEEecCCCHHHHHHhcccCCCHHHHHHHHHH
Confidence 4444443333334456789999999999 899999999999999999999999977999999876678999999999999
Q ss_pred HHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCC-CC
Q 013092 84 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI-EQ 162 (449)
Q Consensus 84 i~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~-~~ 162 (449)
|+.||+|||++||+||||||+|||+ +.++.+||+|||+++....... ......||+.|+|||++.+. .+
T Consensus 109 i~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~ 178 (288)
T 1ob3_A 109 LLNGIAYCHDRRVLHRDLKPQNLLI---NREGELKIADFGLARAFGIPVR-------KYTHEIVTLWYRAPDVLMGSKKY 178 (288)
T ss_dssp HHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECCTTHHHHHCC----------------CCCTTCCHHHHTTCCSC
T ss_pred HHHHHHHHHHCCeecCCCCHHHEEE---cCCCCEEEeECccccccCcccc-------ccccccccccccCchheeCCCCC
Confidence 9999999999999999999999999 6788999999999986643221 12345789999999999864 58
Q ss_pred ChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcc------------------------cchHHHhhcCCcH
Q 013092 163 SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV------------------------STSIEALCRGYPT 218 (449)
Q Consensus 163 s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~------------------------~~~~~~l~~~~p~ 218 (449)
+.++|||||||++|+|++|..||.+... .+.+..+..... ......+...+++
T Consensus 179 ~~~~DiwslG~il~~l~~g~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (288)
T 1ob3_A 179 STTIDIWSVGCIFAEMVNGTPLFPGVSE---ADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDE 255 (288)
T ss_dssp CTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCH
T ss_pred CcHHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHHCCCChhhchhhhcccccccccccccCccHHHHhhhcCH
Confidence 9999999999999999999999987543 222233322100 0112233456899
Q ss_pred HHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 219 EFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 219 el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
++.+||..||+.||++||++.++++
T Consensus 256 ~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 256 SGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHHHHcCCCcccCCCHHHHhc
Confidence 9999999999999999999887753
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=327.59 Aligned_cols=241 Identities=18% Similarity=0.234 Sum_probs=186.5
Q ss_pred cEEEEEeeecc-cCCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHH
Q 013092 3 EILTVFSVQEN-VKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLML 80 (449)
Q Consensus 3 ~aikV~~k~~~-~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i 80 (449)
+|||++.+... .......+.+|+++++.+ +||||+.+++++.+.+..||||||+ |++|.+++.. ...+++..++.+
T Consensus 176 vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~ 253 (446)
T 4ejn_A 176 YAMKILKKEVIVAKDEVAHTLTENRVLQNS-RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSR-ERVFSEDRARFY 253 (446)
T ss_dssp EEEEEEEHHHHC-------------CCCCC-SCTTSCCEEEEEEETTEEEEEECCCSSCBHHHHHHH-HSCCCHHHHHHH
T ss_pred EEEEEEEhhhhhhhHHHHHHHHHHHHHHhC-CCCeEeeEEEEEeeCCEEEEEEeeCCCCcHHHHHHh-cCCCCHHHHHHH
Confidence 45666554332 233445688999999999 8999999999999999999999999 9999999975 457999999999
Q ss_pred HHHHHHHHHHHHH-CCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhC
Q 013092 81 ADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG 159 (449)
Q Consensus 81 ~~qi~~aL~yLH~-~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~ 159 (449)
+.||+.||+|||+ +||+||||||+|||| +.++.+||+|||+++....... ......||+.|+|||++.+
T Consensus 254 ~~qi~~aL~~LH~~~giiHrDlkp~NIll---~~~~~~kl~DFG~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~ 323 (446)
T 4ejn_A 254 GAEIVSALDYLHSEKNVVYRDLKLENLML---DKDGHIKITDFGLCKEGIKDGA-------TMKTFCGTPEYLAPEVLED 323 (446)
T ss_dssp HHHHHHHHHHHHHHTCCCCCCCCGGGEEE---CSSSCEEECCCCCCCTTCC------------CCSSSCGGGCCHHHHHT
T ss_pred HHHHHHHHHHHhhcCCEEECCCCHHHEEE---CCCCCEEEccCCCceeccCCCc-------ccccccCCccccCHhhcCC
Confidence 9999999999998 999999999999999 5788999999999975433221 1245689999999999999
Q ss_pred CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCC---
Q 013092 160 IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKP--- 236 (449)
Q Consensus 160 ~~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RP--- 236 (449)
..++.++|||||||++|||++|..||.+. +..+.+..+...... ++..+++++.+||..||+.||++||
T Consensus 324 ~~~~~~~DiwslG~il~ell~g~~Pf~~~---~~~~~~~~i~~~~~~-----~p~~~~~~~~~li~~~L~~dP~~R~~~~ 395 (446)
T 4ejn_A 324 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQ---DHEKLFELILMEEIR-----FPRTLGPEAKSLLSGLLKKDPKQRLGGG 395 (446)
T ss_dssp SCCCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHCCCC-----CCTTSCHHHHHHHHHHTCSSTTTSTTCS
T ss_pred CCCCCccchhhhHHHHHHHhhCCCCCCCC---CHHHHHHHHHhCCCC-----CCccCCHHHHHHHHHHcccCHHHhCCCC
Confidence 99999999999999999999999999774 334445555443332 3456899999999999999999999
Q ss_pred --CHHHHHHHHHHHHHHcCCCCCCcccchhhhhhhccCC
Q 013092 237 --DYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQLA 273 (449)
Q Consensus 237 --t~~~l~~~L~~~~~~~~~~~~~~~dw~~~~~~~~~~~ 273 (449)
++.+|++ +++...++|......+..++
T Consensus 396 ~~t~~ell~----------hp~f~~~~~~~~~~~~~~pp 424 (446)
T 4ejn_A 396 SEDAKEIMQ----------HRFFAGIVWQHVYEKKLSPP 424 (446)
T ss_dssp TTTHHHHHT----------SGGGTTCCHHHHHTTCSCCS
T ss_pred CCCHHHHHh----------CccccCCCHHHHhhCcCCCC
Confidence 8777643 46667789988765544433
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-38 Score=305.64 Aligned_cols=228 Identities=18% Similarity=0.195 Sum_probs=182.5
Q ss_pred cEEEEEeeecccCCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHH
Q 013092 3 EILTVFSVQENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLAD 82 (449)
Q Consensus 3 ~aikV~~k~~~~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~~~~i~~ 82 (449)
.|+|++.+..........+.+|+++++.+ .||||+++++++.+++..||||||++++|.+++......+++..++.++.
T Consensus 30 vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~ 108 (292)
T 3o0g_A 30 VALKRVRLDDDDEGVPSSALREICLLKEL-KHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLF 108 (292)
T ss_dssp EEEEEEESSCSSTTHHHHHHHHHHHHTTC-CCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHTTTCCCHHHHHHHHH
T ss_pred EEEEeeeccCCcCCcchHHHHHHHHHhcC-CCCCEeeEEeEEEeCCEEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHH
Confidence 45565554444344456788999999999 89999999999999999999999998788888877677899999999999
Q ss_pred HHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCC-
Q 013092 83 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIE- 161 (449)
Q Consensus 83 qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~- 161 (449)
||+.||+|||++||+||||||+|||+ +.++.+||+|||+++....... ......||+.|+|||++.+..
T Consensus 109 ql~~~l~~lH~~~ivH~dikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~-------~~~~~~~t~~y~aPE~~~~~~~ 178 (292)
T 3o0g_A 109 QLLKGLGFCHSRNVLHRDLKPQNLLI---NRNGELKLANFGLARAFGIPVR-------CYSAEVVTLWYRPPDVLFGAKL 178 (292)
T ss_dssp HHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECCSCCS-------CCCSCCSCGGGCCHHHHTTCSC
T ss_pred HHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEeecccceecCCccc-------cccCCccccCCcChHHHcCCCC
Confidence 99999999999999999999999999 6788999999999987654322 234567899999999998766
Q ss_pred CChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccc------------------------hHHHhhcCCc
Q 013092 162 QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST------------------------SIEALCRGYP 217 (449)
Q Consensus 162 ~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~------------------------~~~~l~~~~p 217 (449)
++.++|||||||++|+|++|..||... ......+..+....... ......+.++
T Consensus 179 ~~~~~DiwslG~il~~l~~~~~p~~~~--~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (292)
T 3o0g_A 179 YSTSIDMWSAGCIFAELANAGRPLFPG--NDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLN 256 (292)
T ss_dssp CCTHHHHHHHHHHHHHHTTTSCCSCCC--SSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCC
T ss_pred cCchHHHHHHHHHHHHHHHcCCCCcCC--CCHHHHHHHHHHHhCCCChhhhhhhcccccccccccccCCcchhhcccccC
Confidence 799999999999999999988886442 22333334333321111 1112234578
Q ss_pred HHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 218 TEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 218 ~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
+++.+||..||+.||++||++.++++
T Consensus 257 ~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 257 ATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hHHHHHHHHHhccChhhCCCHHHHhc
Confidence 99999999999999999999887754
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=319.54 Aligned_cols=232 Identities=19% Similarity=0.190 Sum_probs=176.8
Q ss_pred cEEEEEeeecccCCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCC--EEEEEEecCCCCHHHHHHHcCCCCCHHHHHHH
Q 013092 3 EILTVFSVQENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGD--YNVLVMDLLGPSLEDLFNFCSRKLSLKTVLML 80 (449)
Q Consensus 3 ~aikV~~k~~~~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~--~~~lVmE~~g~sL~~ll~~~~~~ls~~~~~~i 80 (449)
+|||++.+..........+.+|+.+++.+.+||||+++++++...+ ..|||||||+++|.+++.. ..+++..+..+
T Consensus 37 vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~L~~~~~~--~~~~~~~~~~i 114 (388)
T 3oz6_A 37 VAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRA--NILEPVHKQYV 114 (388)
T ss_dssp EEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEEEECCSEEHHHHHHH--TCCCHHHHHHH
T ss_pred EEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEEecccCcCHHHHHHc--CCCCHHHHHHH
Confidence 3455544333333445668899999999977999999999997544 7899999998899999984 57999999999
Q ss_pred HHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcc--------------cccccCCCCc
Q 013092 81 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQH--------------IPYRENKNLT 146 (449)
Q Consensus 81 ~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~--------------~~~~~~~~~~ 146 (449)
+.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.+........ .........+
T Consensus 115 ~~qi~~~L~~LH~~~ivHrDlkp~NIll---~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (388)
T 3oz6_A 115 VYQLIKVIKYLHSGGLLHRDMKPSNILL---NAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYV 191 (388)
T ss_dssp HHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEESSSCCCCCCCGGGCCC---------------CC
T ss_pred HHHHHHHHHHHHhCCEEeCCCCHHHeEE---cCCCCEEecCCcccccccccccccccccccccccccccccccccccCCc
Confidence 9999999999999999999999999999 6888999999999987643211000 0011224468
Q ss_pred cCccccchhhhhC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHH--------------
Q 013092 147 GTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA-------------- 211 (449)
Q Consensus 147 gT~~Y~aPE~~~~-~~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~-------------- 211 (449)
||+.|+|||++.+ ..++.++||||||||+|||++|..||.+.+. ...+..+......+..+.
T Consensus 192 gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~---~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~ 268 (388)
T 3oz6_A 192 ATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSST---MNQLERIIGVIDFPSNEDVESIQSPFAKTMIE 268 (388)
T ss_dssp CGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHH
T ss_pred ccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHhcCCCCHHHHHhccCHHHHHHHH
Confidence 9999999999987 6789999999999999999999999987543 333333332111111100
Q ss_pred ----------------------------hhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 013092 212 ----------------------------LCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 242 (449)
Q Consensus 212 ----------------------------l~~~~p~el~~li~~cl~~~p~~RPt~~~l~ 242 (449)
....+++++.+||..||..||++||++.+++
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e~l 327 (388)
T 3oz6_A 269 SLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDAL 327 (388)
T ss_dssp HHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHHHT
T ss_pred hCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHHHHh
Confidence 0126789999999999999999999987764
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=313.73 Aligned_cols=217 Identities=20% Similarity=0.313 Sum_probs=183.0
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcC-----------------------CCCC
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCS-----------------------RKLS 73 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~-----------------------~~ls 73 (449)
...+.+|+.+++.+ +||||+++++++.+.+..||||||+ +++|.+++.... ..++
T Consensus 94 ~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 172 (343)
T 1luf_A 94 QADFQREAALMAEF-DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172 (343)
T ss_dssp HHHHHHHHHHHHTC-CCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCC
T ss_pred HHHHHHHHHHHHhC-CCCCEEEEEEEEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCC
Confidence 45689999999999 8999999999999999999999999 899999998632 5699
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccc
Q 013092 74 LKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYAS 153 (449)
Q Consensus 74 ~~~~~~i~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~a 153 (449)
+..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++....... +.......+|+.|+|
T Consensus 173 ~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~~t~~y~a 244 (343)
T 1luf_A 173 CAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLV---GENMVVKIADFGLSRNIYSADY-----YKADGNDAIPIRWMP 244 (343)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCSCHHHHTGGGC-----BC----CCBCGGGCC
T ss_pred HHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEE---CCCCeEEEeecCCCcccccCcc-----ccccCCCcccceecC
Confidence 99999999999999999999999999999999999 5788999999999986643221 112234578999999
Q ss_pred hhhhhCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCC
Q 013092 154 MNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRF 232 (449)
Q Consensus 154 PE~~~~~~~s~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p 232 (449)
||++.+..++.++|||||||++|+|++ |..||.+.. ..+....+...... .++..+|.++.++|..||+.+|
T Consensus 245 PE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~---~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~~p 317 (343)
T 1luf_A 245 PESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA---HEEVIYYVRDGNIL----ACPENCPLELYNLMRLCWSKLP 317 (343)
T ss_dssp HHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC---HHHHHHHHHTTCCC----CCCTTCCHHHHHHHHHHTCSSG
T ss_pred hhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCC---hHHHHHHHhCCCcC----CCCCCCCHHHHHHHHHHcccCc
Confidence 999999999999999999999999999 999998743 33444444443321 2346789999999999999999
Q ss_pred CCCCCHHHHHHHHHHHHH
Q 013092 233 DDKPDYAYLKRIFRDLFI 250 (449)
Q Consensus 233 ~~RPt~~~l~~~L~~~~~ 250 (449)
++||++.+|.+.|+++..
T Consensus 318 ~~Rps~~~~~~~L~~~~~ 335 (343)
T 1luf_A 318 ADRPSFCSIHRILQRMCE 335 (343)
T ss_dssp GGSCCHHHHHHHHHHTTC
T ss_pred ccCCCHHHHHHHHHHHHh
Confidence 999999999999988754
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=304.40 Aligned_cols=220 Identities=16% Similarity=0.253 Sum_probs=186.4
Q ss_pred CChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC
Q 013092 16 TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 94 (449)
Q Consensus 16 ~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~ 94 (449)
....++.+|+++++.+ .|+||+++++++.+.+..||||||+ +++|.+++......+++..++.++.|++.||.|||++
T Consensus 61 ~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~ 139 (283)
T 3gen_A 61 MSEDEFIEEAKVMMNL-SHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK 139 (283)
T ss_dssp BCHHHHHHHHHHHHTC-CCTTBCCEEEEECSSSSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CCHHHHHHHHHHHhcC-CCCCEeeEEEEEecCCCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 3456799999999999 7999999999999999999999999 9999999986556799999999999999999999999
Q ss_pred CceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHH
Q 013092 95 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYV 174 (449)
Q Consensus 95 givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~i 174 (449)
||+||||||+|||+ +.++.+||+|||+++....... .......+|+.|+|||++.+..++.++||||||++
T Consensus 140 ~i~H~dikp~Nili---~~~~~~kl~Dfg~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~ 210 (283)
T 3gen_A 140 QFLHRDLAARNCLV---NDQGVVKVSDFGLSRYVLDDEY------TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVL 210 (283)
T ss_dssp TCCCSSCSGGGEEE---CTTSCEEECSTTGGGGBCCHHH------HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHH
T ss_pred CccCCCCccceEEE---cCCCCEEEcccccccccccccc------ccccCCccCcccCCHHHhccCCCCchhhHHHHHHH
Confidence 99999999999999 5788999999999986543211 12234467889999999999999999999999999
Q ss_pred HHHHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 013092 175 LMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIRE 252 (449)
Q Consensus 175 l~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~L~~~~~~~ 252 (449)
+|+|++ |..||..... .+....+...... .....+++++.++|..||+.+|++||++.+|++.|.+++.++
T Consensus 211 l~~l~t~g~~p~~~~~~---~~~~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~e 282 (283)
T 3gen_A 211 MWEIYSLGKMPYERFTN---SETAEHIAQGLRL----YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEE 282 (283)
T ss_dssp HHHHHTTTCCTTTTSCH---HHHHHHHHTTCCC----CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred HHHHHhCCCCCccccCh---hHHHHHHhcccCC----CCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhcc
Confidence 999998 9999987543 3344444433211 123457899999999999999999999999999999988654
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=313.33 Aligned_cols=242 Identities=16% Similarity=0.229 Sum_probs=192.1
Q ss_pred cEEEEEeeecccCCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHc-CCCCCHHHHHHH
Q 013092 3 EILTVFSVQENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFC-SRKLSLKTVLML 80 (449)
Q Consensus 3 ~aikV~~k~~~~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~-~~~ls~~~~~~i 80 (449)
.|+|++.+..........+.+|+.+++.+.+||||+++++++.+.+..||||||+ +++|.+++... ...+++..++.+
T Consensus 57 vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i 136 (327)
T 3lm5_A 57 YAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRL 136 (327)
T ss_dssp EEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHH
T ss_pred EEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHH
Confidence 4667666655555556789999999999989999999999999999999999999 88999988532 356999999999
Q ss_pred HHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCC
Q 013092 81 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI 160 (449)
Q Consensus 81 ~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~ 160 (449)
+.||+.||+|||++||+||||||+|||+......+.+||+|||+++....... .....||+.|+|||++.+.
T Consensus 137 ~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~ 208 (327)
T 3lm5_A 137 IKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE--------LREIMGTPEYLAPEILNYD 208 (327)
T ss_dssp HHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC-----------------CCCGGGCCHHHHTTC
T ss_pred HHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCCccc--------cccccCCcCccCCeeecCC
Confidence 99999999999999999999999999995333378999999999987754322 2345799999999999999
Q ss_pred CCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHH
Q 013092 161 EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAY 240 (449)
Q Consensus 161 ~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~ 240 (449)
.++.++|||||||++|+|++|..||.+.. ..+.+..+....... .......+++++.+||..||+.+|++||++.+
T Consensus 209 ~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~~i~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ 284 (327)
T 3lm5_A 209 PITTATDMWNIGIIAYMLLTHTSPFVGED---NQETYLNISQVNVDY-SEETFSSVSQLATDFIQSLLVKNPEKRPTAEI 284 (327)
T ss_dssp CCCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHTCCCC-CTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCCCCCC---chHHHHHHHhccccc-CchhhcccCHHHHHHHHHHcCCChhhCcCHHH
Confidence 99999999999999999999999997743 344444444433322 22334578999999999999999999999887
Q ss_pred HHHHHHHHHHHcCCCCCCcccchhhh
Q 013092 241 LKRIFRDLFIREGFQFDYVFDWTILK 266 (449)
Q Consensus 241 l~~~L~~~~~~~~~~~~~~~dw~~~~ 266 (449)
|++ .++...++|....
T Consensus 285 ll~----------h~~~~~~~~~~~~ 300 (327)
T 3lm5_A 285 CLS----------HSWLQQWDFENLF 300 (327)
T ss_dssp HTT----------CGGGCCCCTTCC-
T ss_pred HhC----------CHhhccccccccc
Confidence 743 3444556666543
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=317.16 Aligned_cols=244 Identities=16% Similarity=0.211 Sum_probs=191.5
Q ss_pred cEEEEEeeecc--cCCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHH
Q 013092 3 EILTVFSVQEN--VKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLM 79 (449)
Q Consensus 3 ~aikV~~k~~~--~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~ 79 (449)
.|||++.+... .......+.+|+++|+.+.+||||+.+++++.+.+..||||||+ +++|.+++.. ...+++..++.
T Consensus 85 vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~ 163 (355)
T 1vzo_A 85 YAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQ-RERFTEHEVQI 163 (355)
T ss_dssp EEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHH-HSCCCHHHHHH
T ss_pred EEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceEEEEeecCCCCCHHHHHHH-cCCCCHHHHHH
Confidence 45666654432 22345668899999999989999999999999999999999999 8999999975 35799999999
Q ss_pred HHHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhC
Q 013092 80 LADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG 159 (449)
Q Consensus 80 i~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~ 159 (449)
++.||+.||+|||++||+||||||+|||| +.++.+||+|||+++.+...... ......||+.|+|||++.+
T Consensus 164 ~~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~DfG~a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~ 234 (355)
T 1vzo_A 164 YVGEIVLALEHLHKLGIIYRDIKLENILL---DSNGHVVLTDFGLSKEFVADETE------RAYDFCGTIEYMAPDIVRG 234 (355)
T ss_dssp HHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEESCSSEEEECCGGGGG------GGCGGGSCCTTCCHHHHTT
T ss_pred HHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCcEEEeeCCCCeecccCCCC------cccCcccCcCccChhhhcC
Confidence 99999999999999999999999999999 67889999999999876443221 1234579999999999986
Q ss_pred C--CCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCH-HHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCC
Q 013092 160 I--EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK-KQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKP 236 (449)
Q Consensus 160 ~--~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~-~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RP 236 (449)
. .++.++|||||||++|+|++|..||........ ......+.... ..++..++.++.+||..||..||++||
T Consensus 235 ~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~li~~~L~~dP~~R~ 309 (355)
T 1vzo_A 235 GDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE-----PPYPQEMSALAKDLIQRLLMKDPKKRL 309 (355)
T ss_dssp CC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCC-----CCCCTTSCHHHHHHHHHHTCSSGGGST
T ss_pred CCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccC-----CCCCcccCHHHHHHHHHHhhhCHHHhc
Confidence 3 478999999999999999999999986543322 22222222221 123456889999999999999999999
Q ss_pred -----CHHHHHHHHHHHHHHcCCCCCCcccchhhhhhhcc
Q 013092 237 -----DYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQ 271 (449)
Q Consensus 237 -----t~~~l~~~L~~~~~~~~~~~~~~~dw~~~~~~~~~ 271 (449)
++.+|++ ..+...++|..+...+.+
T Consensus 310 ~~~~~s~~ell~----------h~~f~~~~~~~l~~~~~~ 339 (355)
T 1vzo_A 310 GCGPRDADEIKE----------HLFFQKINWDDLAAKKVP 339 (355)
T ss_dssp TSSTTTHHHHHT----------SGGGTTCCHHHHHTTCSC
T ss_pred CCCCCCHHHHHc----------CcchhcCChhHhhhccCC
Confidence 7666643 345556789877665433
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=311.61 Aligned_cols=223 Identities=14% Similarity=0.276 Sum_probs=174.4
Q ss_pred CCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEE------EEEEecC-CCCHHHHHHHcC-----CCCCHHHHHHHHH
Q 013092 15 KTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYN------VLVMDLL-GPSLEDLFNFCS-----RKLSLKTVLMLAD 82 (449)
Q Consensus 15 ~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~------~lVmE~~-g~sL~~ll~~~~-----~~ls~~~~~~i~~ 82 (449)
......+.+|+++++.+ +||||+++++++...... |+||||+ +++|.+++.... ..+++..++.++.
T Consensus 66 ~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~ 144 (323)
T 3qup_A 66 SSDIEEFLREAACMKEF-DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMV 144 (323)
T ss_dssp CHHHHHHHHHHHHHTTC-CCTTBCCCCEEEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHC-CCCceehhhceeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHH
Confidence 33456799999999999 999999999999877655 9999999 899999986431 2589999999999
Q ss_pred HHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCC
Q 013092 83 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQ 162 (449)
Q Consensus 83 qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~ 162 (449)
||+.||+|||++||+||||||+|||+ +.++.+||+|||+++....... +.......+|+.|+|||++.+..+
T Consensus 145 qi~~al~~LH~~~ivH~Dikp~NIli---~~~~~~kl~Dfg~a~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~ 216 (323)
T 3qup_A 145 DIACGMEYLSSRNFIHRDLAARNCML---AEDMTVCVADFGLSRKIYSGDY-----YRQGCASKLPVKWLALESLADNLY 216 (323)
T ss_dssp HHHHHHHHHHHTTCCCSCCSGGGEEE---CTTSCEEECCCCC----------------------CCGGGCCHHHHHHCCC
T ss_pred HHHHHHHHHHcCCcccCCCCcceEEE---cCCCCEEEeecccccccccccc-----ccccccccCcccccCchhhcCCCC
Confidence 99999999999999999999999999 5788999999999987654332 122234567889999999999999
Q ss_pred ChhhHHHHHHHHHHHHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHH
Q 013092 163 SRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYL 241 (449)
Q Consensus 163 s~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l 241 (449)
+.++|||||||++|+|++ |..||.+.... +.+..+...... .....+++++.+|+..||+.+|++||++.+|
T Consensus 217 ~~~~Di~slG~il~ell~~g~~p~~~~~~~---~~~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l 289 (323)
T 3qup_A 217 TVHSDVWAFGVTMWEIMTRGQTPYAGIENA---EIYNYLIGGNRL----KQPPECMEEVYDLMYQCWSADPKQRPSFTCL 289 (323)
T ss_dssp CHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHHHHHHTTCCC----CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHH
T ss_pred CCccchhhHHHHHHHHHhCCCCCccccChH---HHHHHHhcCCCC----CCCCccCHHHHHHHHHHccCChhhCcCHHHH
Confidence 999999999999999999 99999875543 233333332221 2345689999999999999999999999999
Q ss_pred HHHHHHHHHHcC
Q 013092 242 KRIFRDLFIREG 253 (449)
Q Consensus 242 ~~~L~~~~~~~~ 253 (449)
.+.|++++....
T Consensus 290 ~~~l~~~l~~~~ 301 (323)
T 3qup_A 290 RMELENILGHLS 301 (323)
T ss_dssp HHHHHHHHHC--
T ss_pred HHHHHHHHHHhh
Confidence 999999977553
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=339.57 Aligned_cols=229 Identities=18% Similarity=0.264 Sum_probs=186.0
Q ss_pred CChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC
Q 013092 16 TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 94 (449)
Q Consensus 16 ~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~ 94 (449)
.....|.+|+++|+.| +||||+++++++.. +..||||||| +++|.+++......+++..++.++.||+.||+|||++
T Consensus 378 ~~~~~~~~E~~il~~l-~hpniv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~ 455 (613)
T 2ozo_A 378 ADTEEMMREAQIMHQL-DNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK 455 (613)
T ss_dssp TTHHHHHHHHHHHTTC-CCTTBCCEEEEEES-SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHHhC-CCCCEeeEEEEecc-CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 3567799999999999 99999999999876 5689999999 9999999976556799999999999999999999999
Q ss_pred CceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHH
Q 013092 95 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYV 174 (449)
Q Consensus 95 givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~i 174 (449)
||+||||||+|||| +.++.+||+|||+++.+...... +.......+|+.|+|||++.+..++.++|||||||+
T Consensus 456 ~iiHrDlkp~NILl---~~~~~vkL~DFGla~~~~~~~~~----~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~ 528 (613)
T 2ozo_A 456 NFVHRNLAARNVLL---VNRHYAKISDFGLSKALGADDSY----YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVT 528 (613)
T ss_dssp TCCCSCCSGGGEEE---EETTEEEECCCSTTTTCC------------------CCTTSCHHHHHHCCCCHHHHHHHHHHH
T ss_pred CEEcCcCCHHHEEE---cCCCcEEEeeccCcccccCCCce----eeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHH
Confidence 99999999999999 47789999999999876443221 111223456789999999999999999999999999
Q ss_pred HHHHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Q 013092 175 LMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREG 253 (449)
Q Consensus 175 l~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~L~~~~~~~~ 253 (449)
||||++ |..||.+.+. .+.+..+..... ...+..+|+++.+||..||+.+|++||++.+|.+.|++++...+
T Consensus 529 l~ellt~G~~Pf~~~~~---~~~~~~i~~~~~----~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~ 601 (613)
T 2ozo_A 529 MWEALSYGQKPYKKMKG---PEVMAFIEQGKR----MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 601 (613)
T ss_dssp HHHHHTTSCCTTTTCCS---HHHHHHHHTTCC----CCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHS
T ss_pred HHHHHHCCCCCCCCCCH---HHHHHHHHcCCC----CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhc
Confidence 999998 9999988654 233444443321 12345789999999999999999999999999999999988776
Q ss_pred CCCCCcc
Q 013092 254 FQFDYVF 260 (449)
Q Consensus 254 ~~~~~~~ 260 (449)
...+...
T Consensus 602 ~~~~~~s 608 (613)
T 2ozo_A 602 SKVEGGS 608 (613)
T ss_dssp CSCCCSS
T ss_pred cccCCcc
Confidence 6554433
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=309.17 Aligned_cols=218 Identities=15% Similarity=0.261 Sum_probs=184.2
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcC-----------------------CCCC
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCS-----------------------RKLS 73 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~-----------------------~~ls 73 (449)
...+.+|+++++.+ +||||+++++++.+.+..||||||+ +++|.+++.... ..++
T Consensus 70 ~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 148 (314)
T 2ivs_A 70 LRDLLSEFNVLKQV-NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148 (314)
T ss_dssp HHHHHHHHHHHTTC-CCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEEC
T ss_pred HHHHHHHHHHHhhC-CCCceeeEEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcC
Confidence 35688999999999 8999999999999999999999999 899999998632 2389
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccc
Q 013092 74 LKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYAS 153 (449)
Q Consensus 74 ~~~~~~i~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~a 153 (449)
+..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++........ .......+|+.|+|
T Consensus 149 ~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~NIli---~~~~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~a 220 (314)
T 2ivs_A 149 MGDLISFAWQISQGMQYLAEMKLVHRDLAARNILV---AEGRKMKISDFGLSRDVYEEDSY-----VKRSQGRIPVKWMA 220 (314)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---ETTTEEEECCCTTCEECTTTSCE-----ECSSCCCSCGGGCC
T ss_pred HHHHHHHHHHHHHHHHHHHHCCCcccccchheEEE---cCCCCEEEccccccccccccccc-----eeccCCCCcccccC
Confidence 99999999999999999999999999999999999 47789999999999877543321 12234567899999
Q ss_pred hhhhhCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCC
Q 013092 154 MNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRF 232 (449)
Q Consensus 154 PE~~~~~~~s~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p 232 (449)
||++.+..++.++|||||||++|+|++ |..||.+..... .+..+..... ......+++++.++|..||+.+|
T Consensus 221 PE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~~~~~~~~~~----~~~~~~~~~~~~~li~~~l~~dp 293 (314)
T 2ivs_A 221 IESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPER---LFNLLKTGHR----MERPDNCSEEMYRLMLQCWKQEP 293 (314)
T ss_dssp HHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HHHHHHTTCC----CCCCTTCCHHHHHHHHHHTCSSG
T ss_pred hhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHhhcCCc----CCCCccCCHHHHHHHHHHccCCh
Confidence 999999899999999999999999999 999998765432 2333333221 12345789999999999999999
Q ss_pred CCCCCHHHHHHHHHHHHHH
Q 013092 233 DDKPDYAYLKRIFRDLFIR 251 (449)
Q Consensus 233 ~~RPt~~~l~~~L~~~~~~ 251 (449)
++||++.+|.+.|++++.+
T Consensus 294 ~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 294 DKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp GGSCCHHHHHHHHHHHHHT
T ss_pred hhCcCHHHHHHHHHHHHhh
Confidence 9999999999999998764
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=325.06 Aligned_cols=217 Identities=18% Similarity=0.264 Sum_probs=181.9
Q ss_pred hHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q 013092 19 PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFL 97 (449)
Q Consensus 19 ~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~giv 97 (449)
..|.+|+++|+.+ +||||+++++++.+.+..||||||+ +++|.+++......+++..++.++.||+.||+|||++||+
T Consensus 157 ~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~iv 235 (377)
T 3cbl_A 157 AKFLQEARILKQY-SHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCI 235 (377)
T ss_dssp TTTTHHHHHHTTC-CCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHHHHhC-CCCCEEEEEEEEecCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcC
Confidence 4688999999999 8999999999999999999999999 8999999986556799999999999999999999999999
Q ss_pred ecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHHHHH
Q 013092 98 HRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMY 177 (449)
Q Consensus 98 HRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il~e 177 (449)
||||||+|||+ +.++.+||+|||+++........ .......+++.|+|||++.+..++.++|||||||++||
T Consensus 236 HrDlkp~Nil~---~~~~~~kl~DfG~s~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~e 307 (377)
T 3cbl_A 236 HRDLAARNCLV---TEKNVLKISDFGMSREEADGVYA-----ASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWE 307 (377)
T ss_dssp CSCCSGGGEEE---CTTCCEEECCGGGCEECTTSEEE-----CCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHH
T ss_pred CcccCHHHEEE---cCCCcEEECcCCCceecCCCcee-----ecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHH
Confidence 99999999999 57889999999999865432110 11122346788999999998899999999999999999
Q ss_pred HHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 013092 178 FLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIR 251 (449)
Q Consensus 178 llt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~L~~~~~~ 251 (449)
|++ |..||.+... .+....+..... ...+..+|+++.+||..||+.+|++||++.+|.+.|+++..+
T Consensus 308 l~t~g~~p~~~~~~---~~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 308 TFSLGASPYPNLSN---QQTREFVEKGGR----LPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp HHTTSCCSSTTSCH---HHHHHHHHTTCC----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHhCCCCCCCCCCH---HHHHHHHHcCCC----CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 998 9999987543 223333322211 113456899999999999999999999999999999988654
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-38 Score=311.60 Aligned_cols=230 Identities=16% Similarity=0.213 Sum_probs=184.3
Q ss_pred EEEEEeeeccc---CCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHH
Q 013092 4 ILTVFSVQENV---KTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLM 79 (449)
Q Consensus 4 aikV~~k~~~~---~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~ 79 (449)
+++|++|.... ......+.+|+.+++.+ +||||+++++++.++. .++||||+ +++|.+++......+++..++.
T Consensus 44 ~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~ 121 (327)
T 3poz_A 44 KIPVAIKELREATSPKANKEILDEAYVMASV-DNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLN 121 (327)
T ss_dssp CEEEEEEEC-------CHHHHHHHHHHHHHC-CBTTBCCEEEEEESSS-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHH
T ss_pred EEEEEEeecccccCHHHHHHHHHHHHHHHhC-CCCCEeEEEEEEecCC-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHH
Confidence 34556555422 24456799999999999 8999999999998765 67888888 9999999987677899999999
Q ss_pred HHHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhC
Q 013092 80 LADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG 159 (449)
Q Consensus 80 i~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~ 159 (449)
++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.+....... ......+|+.|+|||++.+
T Consensus 122 ~~~qi~~~l~~LH~~~ivH~Dikp~NIll---~~~~~~kl~Dfg~a~~~~~~~~~~-----~~~~~~~t~~y~aPE~~~~ 193 (327)
T 3poz_A 122 WCVQIAKGMNYLEDRRLVHRDLAARNVLV---KTPQHVKITDFGLAKLLGAEEKEY-----HAEGGKVPIKWMALESILH 193 (327)
T ss_dssp HHHHHHHHHHHHHHTTCCCSCCCGGGEEE---EETTEEEECCTTHHHHHTTTCC------------CCCGGGSCHHHHHH
T ss_pred HHHHHHHHHHHHhhCCeeCCCCChheEEE---CCCCCEEEccCcceeEccCCcccc-----cccCCCccccccChHHhcc
Confidence 99999999999999999999999999999 477899999999998775543221 1234567889999999999
Q ss_pred CCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCH
Q 013092 160 IEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDY 238 (449)
Q Consensus 160 ~~~s~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~ 238 (449)
..++.++|||||||++|||++ |..||.+....... ..+...... .....++.++.+++..||+.+|++||++
T Consensus 194 ~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~---~~~~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~ 266 (327)
T 3poz_A 194 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS---SILEKGERL----PQPPICTIDVYMIMVKCWMIDADSRPKF 266 (327)
T ss_dssp CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH---HHHHTTCCC----CCCTTBCHHHHHHHHHHTCSCGGGSCCH
T ss_pred CCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHH---HHHHcCCCC----CCCccCCHHHHHHHHHHcCCChhhCCCH
Confidence 999999999999999999999 99999876543322 222222111 1234578999999999999999999999
Q ss_pred HHHHHHHHHHHH
Q 013092 239 AYLKRIFRDLFI 250 (449)
Q Consensus 239 ~~l~~~L~~~~~ 250 (449)
.+|++.|+.+..
T Consensus 267 ~ell~~l~~~~~ 278 (327)
T 3poz_A 267 RELIIEFSKMAR 278 (327)
T ss_dssp HHHHHHHHHHHT
T ss_pred HHHHHHHHHHHh
Confidence 999999887753
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=314.47 Aligned_cols=223 Identities=19% Similarity=0.234 Sum_probs=183.1
Q ss_pred CChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCC----------------------CC
Q 013092 16 TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSR----------------------KL 72 (449)
Q Consensus 16 ~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~----------------------~l 72 (449)
.....+.+|+.++..+.+||||+++++++.+.+..||||||+ +++|.+++..... .+
T Consensus 90 ~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 169 (344)
T 1rjb_A 90 SEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169 (344)
T ss_dssp --CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------C
T ss_pred HHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccC
Confidence 345679999999999989999999999999999999999999 9999999985432 37
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCcccc
Q 013092 73 SLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 152 (449)
Q Consensus 73 s~~~~~~i~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~ 152 (449)
++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++........ .......||+.|+
T Consensus 170 ~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll---~~~~~~kL~Dfg~~~~~~~~~~~-----~~~~~~~~t~~y~ 241 (344)
T 1rjb_A 170 TFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLV---THGKVVKICDFGLARDIMSDSNY-----VVRGNARLPVKWM 241 (344)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEE---ETTTEEEECCCGGGSCGGGCTTS-----EEETTEEECGGGC
T ss_pred CHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEE---cCCCcEEeCCCccCcccccCccc-----eeccCccCccCcc
Confidence 999999999999999999999999999999999999 47889999999999876544321 1223456788999
Q ss_pred chhhhhCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCC
Q 013092 153 SMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLR 231 (449)
Q Consensus 153 aPE~~~~~~~s~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~ 231 (449)
|||++.+..++.++|||||||++|+|++ |..||.+..... .+..+....... .....+++++.+||..||+.+
T Consensus 242 aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~d 315 (344)
T 1rjb_A 242 APESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA---NFYKLIQNGFKM---DQPFYATEEIYIIMQSCWAFD 315 (344)
T ss_dssp CHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH---HHHHHHHTTCCC---CCCTTCCHHHHHHHHHHTCSS
T ss_pred CHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcHH---HHHHHHhcCCCC---CCCCCCCHHHHHHHHHHcCCC
Confidence 9999999999999999999999999998 999998764432 222222222111 223467999999999999999
Q ss_pred CCCCCCHHHHHHHHHHHHHHc
Q 013092 232 FDDKPDYAYLKRIFRDLFIRE 252 (449)
Q Consensus 232 p~~RPt~~~l~~~L~~~~~~~ 252 (449)
|++||++.+|.+.|+.++...
T Consensus 316 p~~Rps~~~l~~~l~~~~~~~ 336 (344)
T 1rjb_A 316 SRKRPSFPNLTSFLGCQLADA 336 (344)
T ss_dssp GGGSCCHHHHHHHHHHHC---
T ss_pred chhCcCHHHHHHHHHHHHHHH
Confidence 999999999999999886543
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=315.53 Aligned_cols=214 Identities=20% Similarity=0.208 Sum_probs=180.2
Q ss_pred HHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q 013092 20 QLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLH 98 (449)
Q Consensus 20 ~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~givH 98 (449)
.+.+|++++.++.+||||+++++++.+++..||||||| |++|.+++.. .+.+++..++.++.||+.||+|||++||+|
T Consensus 61 ~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~i~~-~~~~~~~~~~~~~~qi~~al~~lH~~givH 139 (342)
T 2qr7_A 61 DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILR-QKFFSEREASAVLFTITKTVEYLHAQGVVH 139 (342)
T ss_dssp CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHT-CTTCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEe
Confidence 45689999999989999999999999999999999999 9999999875 457999999999999999999999999999
Q ss_pred cCCCCCcEEEeec-CCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHHHHH
Q 013092 99 RDIKPDNFLMGLG-RRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMY 177 (449)
Q Consensus 99 RDLKP~NiLl~~~-~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il~e 177 (449)
|||||+|||+... ...+.+||+|||+++........ ....+||+.|+|||++.+..++.++|||||||++|+
T Consensus 140 rDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e 212 (342)
T 2qr7_A 140 RDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGL-------LMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYT 212 (342)
T ss_dssp SCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTCC-------BCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred ccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCCc-------eeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHH
Confidence 9999999998422 12246999999999877553321 234578999999999998889999999999999999
Q ss_pred HHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 013092 178 FLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 242 (449)
Q Consensus 178 lltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~ 242 (449)
|++|..||.+.......+.+..+........ ...+..+++++.+||..||..||++||++.+++
T Consensus 213 ll~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il 276 (342)
T 2qr7_A 213 MLTGYTPFANGPDDTPEEILARIGSGKFSLS-GGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVL 276 (342)
T ss_dssp HHHSSCSSCSSTTSCHHHHHHHHHHCCCCCC-STTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHT
T ss_pred HhcCCCCCCCCCcCCHHHHHHHHccCCcccC-ccccccCCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 9999999987655566666666666544321 223456899999999999999999999987764
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=305.37 Aligned_cols=222 Identities=19% Similarity=0.277 Sum_probs=185.9
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCC-----------------CCCHHHHHH
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSR-----------------KLSLKTVLM 79 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~-----------------~ls~~~~~~ 79 (449)
...+.+|+++++.+.+||||+++++++.+.+..||||||+ +++|.+++..... .+++..++.
T Consensus 70 ~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 149 (313)
T 1t46_A 70 REALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149 (313)
T ss_dssp HHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHH
T ss_pred HHHHHHHHHHHhhcccCCCeeeEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHH
Confidence 4568999999999999999999999999999999999999 8899999986432 489999999
Q ss_pred HHHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhC
Q 013092 80 LADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG 159 (449)
Q Consensus 80 i~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~ 159 (449)
++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++........ .......||+.|+|||++.+
T Consensus 150 ~~~qi~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~ 221 (313)
T 1t46_A 150 FSYQVAKGMAFLASKNCIHRDLAARNILL---THGRITKICDFGLARDIKNDSNY-----VVKGNARLPVKWMAPESIFN 221 (313)
T ss_dssp HHHHHHHHHHHHHHTTCCCSCCSGGGEEE---ETTTEEEECCCGGGSCTTSCTTS-----EECSSSEECGGGCCHHHHHH
T ss_pred HHHHHHHHHHHHHHCCeecCCCccceEEE---cCCCCEEEccccccccccccccc-----eeccCCCCcceeeChHHhcC
Confidence 99999999999999999999999999999 47889999999999876554321 12234567889999999999
Q ss_pred CCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCH
Q 013092 160 IEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDY 238 (449)
Q Consensus 160 ~~~s~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~ 238 (449)
..++.++|||||||++|+|++ |..||.+..... .....+... ... .....+|.++.++|..||+.+|++||++
T Consensus 222 ~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~~~~~~~-~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~ 295 (313)
T 1t46_A 222 CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS--KFYKMIKEG-FRM---LSPEHAPAEMYDIMKTCWDADPLKRPTF 295 (313)
T ss_dssp CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH--HHHHHHHHT-CCC---CCCTTSCHHHHHHHHHHTCSSGGGSCCH
T ss_pred CCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh--HHHHHhccC-CCC---CCcccCCHHHHHHHHHHcCCCchhCcCH
Confidence 999999999999999999998 999998754432 122222221 111 1235689999999999999999999999
Q ss_pred HHHHHHHHHHHHHcC
Q 013092 239 AYLKRIFRDLFIREG 253 (449)
Q Consensus 239 ~~l~~~L~~~~~~~~ 253 (449)
.+|.+.|++++....
T Consensus 296 ~ell~~L~~~~~~~~ 310 (313)
T 1t46_A 296 KQIVQLIEKQISEST 310 (313)
T ss_dssp HHHHHHHHHHHHHTC
T ss_pred HHHHHHHHHHHHHhh
Confidence 999999999887653
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=318.69 Aligned_cols=219 Identities=14% Similarity=0.235 Sum_probs=172.7
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 96 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gi 96 (449)
...|.+|+.++..+ +||||+++++++.+.+..||||||+ +++|.+++......+++..++.++.||+.||+|||++||
T Consensus 90 ~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i 168 (373)
T 2qol_A 90 RRDFLGEASIMGQF-DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY 168 (373)
T ss_dssp HHHHHHHHHHHTTC-CCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred HHHHHHHHHHHHhC-CCCCCCeEEEEEeeCCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 45689999999999 8999999999999999999999999 999999998655679999999999999999999999999
Q ss_pred eecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHHHH
Q 013092 97 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLM 176 (449)
Q Consensus 97 vHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il~ 176 (449)
+||||||+|||+ +.++.+||+|||+++......... .......+|+.|+|||++.+..++.++|||||||++|
T Consensus 169 vH~Dlkp~NIll---~~~~~~kl~Dfg~a~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ 241 (373)
T 2qol_A 169 VHRDLAARNILI---NSNLVCKVSDFGLGRVLEDDPEAA----YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLW 241 (373)
T ss_dssp CCSCCCGGGEEE---CTTCCEEECCC--------------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred eCCCCCcceEEE---cCCCCEEECcCccccccccCCccc----eeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHH
Confidence 999999999999 678899999999998765432211 0112234678899999999999999999999999999
Q ss_pred HHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 013092 177 YFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIR 251 (449)
Q Consensus 177 ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~L~~~~~~ 251 (449)
||++ |..||..... .+.+..+...... .....+|.++.++|..||+.+|++||++.+|.+.|+.++..
T Consensus 242 ellt~g~~P~~~~~~---~~~~~~i~~~~~~----~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 310 (373)
T 2qol_A 242 EVMSYGERPYWEMSN---QDVIKAVDEGYRL----PPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310 (373)
T ss_dssp HHHTTC-CTTTTCCH---HHHHHHHHTTEEC----CCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHhCCCCCCCCCCH---HHHHHHHHcCCCC----CCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence 9998 9999987533 3333333332211 12346899999999999999999999999999999988653
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=311.87 Aligned_cols=217 Identities=21% Similarity=0.244 Sum_probs=161.7
Q ss_pred ChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 013092 17 KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 95 (449)
Q Consensus 17 ~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~g 95 (449)
....+.+|+.+++.+.+||||+++++++.+....||||||+ |++|.+++.. ...+++..++.++.||+.||+|||++|
T Consensus 48 ~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ 126 (325)
T 3kn6_A 48 MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKK-KKHFSETEASYIMRKLVSAVSHMHDVG 126 (325)
T ss_dssp GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 45678899999999978999999999999999999999999 8999999986 567999999999999999999999999
Q ss_pred ceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHHH
Q 013092 96 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVL 175 (449)
Q Consensus 96 ivHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il 175 (449)
|+||||||+|||+..++....+||+|||+++........ .....||+.|+|||++.+..++.++|||||||++
T Consensus 127 ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il 199 (325)
T 3kn6_A 127 VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP-------LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVIL 199 (325)
T ss_dssp EECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----------------------------CCCCHHHHHHHHHHHH
T ss_pred CeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCc-------ccccCCCcCccCHHHhcCCCCCCccchHHHHHHH
Confidence 999999999999964334458999999999876543221 2345789999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCc----CCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 013092 176 MYFLRGSLPWQGLKA----GTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 242 (449)
Q Consensus 176 ~elltG~~Pf~~~~~----~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~ 242 (449)
|+|++|..||.+... ....+.+..+........ ......+++++.+||..||..||++||++.+++
T Consensus 200 ~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~-~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell 269 (325)
T 3kn6_A 200 YTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFE-GEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLR 269 (325)
T ss_dssp HHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCC-SHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTST
T ss_pred HHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCC-cccccCCCHHHHHHHHHHCCCChhHCCCHHHHh
Confidence 999999999987543 223344555554443222 223456899999999999999999999987764
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=306.67 Aligned_cols=205 Identities=18% Similarity=0.182 Sum_probs=170.6
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFL 97 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~giv 97 (449)
...+..|+..+..+.+|+||+++++++.+++..||||||++++|.+++......+++..++.++.||+.||+|||++||+
T Consensus 100 ~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iv 179 (311)
T 3p1a_A 100 RARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLV 179 (311)
T ss_dssp HHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCCCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEEeccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEe
Confidence 34566777777777799999999999999999999999999999999987677899999999999999999999999999
Q ss_pred ecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHHHHH
Q 013092 98 HRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMY 177 (449)
Q Consensus 98 HRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il~e 177 (449)
||||||+|||+ +.++.+||+|||+++....... .....||+.|+|||++.+ .++.++|||||||++||
T Consensus 180 H~Dikp~NIll---~~~~~~kl~DFG~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~e 247 (311)
T 3p1a_A 180 HLDVKPANIFL---GPRGRCKLGDFGLLVELGTAGA--------GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILE 247 (311)
T ss_dssp CCCCSGGGEEE---CGGGCEEECCCTTCEECC--------------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHH
T ss_pred cCCCCHHHEEE---CCCCCEEEccceeeeecccCCC--------CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHH
Confidence 99999999999 6788999999999987654322 234569999999999886 78999999999999999
Q ss_pred HHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 178 FLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 178 lltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
|++|..||.+. ..+..+..... ...+...+++++.++|..||+.+|++||++.+|++
T Consensus 248 l~~g~~~~~~~------~~~~~~~~~~~---~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 248 VACNMELPHGG------EGWQQLRQGYL---PPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp HHHTCCCCSSH------HHHHHHTTTCC---CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHhCCCCCCCc------cHHHHHhccCC---CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 99997666541 22233333222 23455778999999999999999999999988754
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=302.24 Aligned_cols=227 Identities=18% Similarity=0.201 Sum_probs=182.0
Q ss_pred cEEEEEeeeccc---CCChhHHHHHHHHHHHhc--CCCCCceEEEEeEeCC-----EEEEEEecCCCCHHHHHHHcC-CC
Q 013092 3 EILTVFSVQENV---KTKHPQLLYESKLYRILQ--GGTGIPNVRWFGVEGD-----YNVLVMDLLGPSLEDLFNFCS-RK 71 (449)
Q Consensus 3 ~aikV~~k~~~~---~~~~~~~~~E~~il~~l~--~hp~Iv~l~~~~~~~~-----~~~lVmE~~g~sL~~ll~~~~-~~ 71 (449)
+|||++.+.... ......+.+|+.+++.++ +||||+++++++.... ..|+||||++++|.+++.... ..
T Consensus 37 vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~ 116 (308)
T 3g33_A 37 VALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG 116 (308)
T ss_dssp EEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSSSEEEEEEEEECCCCBHHHHHHTCCTTC
T ss_pred EEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCCCceeEEEEehhhhcCHHHHHhhccCCC
Confidence 456655544322 223457889999999886 5999999999998765 689999999889999998543 23
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccc
Q 013092 72 LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY 151 (449)
Q Consensus 72 ls~~~~~~i~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y 151 (449)
+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.+..... .....||+.|
T Consensus 117 ~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~---~~~~~~kl~Dfg~a~~~~~~~~--------~~~~~gt~~y 185 (308)
T 3g33_A 117 LPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILV---TSGGTVKLADFGLARIYSYQMA--------LTPVVVTLWY 185 (308)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEE---CTTSCEEECSCSCTTTSTTCCC--------SGGGGCCCSS
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---cCCCCEEEeeCccccccCCCcc--------cCCccccccc
Confidence 9999999999999999999999999999999999999 6788999999999986643322 2346789999
Q ss_pred cchhhhhCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhc----------------------ccchH
Q 013092 152 ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK----------------------VSTSI 209 (449)
Q Consensus 152 ~aPE~~~~~~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~----------------------~~~~~ 209 (449)
+|||++.+..++.++|||||||++|+|++|..||.+... ...+.++.... .....
T Consensus 186 ~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~---~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (308)
T 3g33_A 186 RAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE---ADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPV 262 (308)
T ss_dssp CCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSH---HHHHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCH
T ss_pred cCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHhCCCChhhccchhhccccccCCCCCCcH
Confidence 999999999999999999999999999999999987443 33333333221 11223
Q ss_pred HHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 210 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 210 ~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
..+.+.+++++.+||..||+.||++||++.++++
T Consensus 263 ~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 263 QSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp HHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 3455678999999999999999999999887753
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-38 Score=305.84 Aligned_cols=218 Identities=19% Similarity=0.321 Sum_probs=181.8
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 96 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gi 96 (449)
...+.+|+++++.+ +||||+++++++ ..+..|+||||+ +++|.+++.. ...+++..++.++.||+.||+|||++||
T Consensus 62 ~~~~~~e~~~l~~l-~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i 138 (291)
T 1xbb_A 62 KDELLAEANVMQQL-DNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESNF 138 (291)
T ss_dssp HHHHHHHHHHHHTC-CCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred HHHHHHHHHHHHhC-CCCCEEEEEEEE-CCCCcEEEEEeCCCCCHHHHHHh-CcCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 56789999999999 899999999998 667789999999 8999999986 5569999999999999999999999999
Q ss_pred eecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHHHH
Q 013092 97 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLM 176 (449)
Q Consensus 97 vHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il~ 176 (449)
+||||||+|||+. .++.+||+|||+++......... .......+|+.|+|||++.+..++.++||||||+++|
T Consensus 139 ~H~dikp~Nil~~---~~~~~kl~Dfg~~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 211 (291)
T 1xbb_A 139 VHRDLAARNVLLV---TQHYAKISDFGLSKALRADENYY----KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMW 211 (291)
T ss_dssp ECSCCSGGGEEEE---ETTEEEECCCTTCEECCTTCSEE----EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHH
T ss_pred EcCCCCcceEEEe---CCCcEEEccCCcceeeccCCCcc----cccccCCCCceeeChHHhccCCCChhhhHHHHHHHHH
Confidence 9999999999994 67899999999998775443211 1123345778999999999988999999999999999
Q ss_pred HHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 013092 177 YFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIRE 252 (449)
Q Consensus 177 ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~L~~~~~~~ 252 (449)
+|++ |..||.+... .+....+..... ..++..+|+++.++|..||+.+|++||++.+|.+.|++++...
T Consensus 212 ~l~~~g~~p~~~~~~---~~~~~~~~~~~~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~ 281 (291)
T 1xbb_A 212 EAFSYGQKPYRGMKG---SEVTAMLEKGER----MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 281 (291)
T ss_dssp HHHTTTCCSSTTCCH---HHHHHHHHTTCC----CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred HHHhcCCCCCCCCCH---HHHHHHHHcCCC----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence 9999 9999987543 333333333221 1234578999999999999999999999999999999997654
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=322.19 Aligned_cols=224 Identities=18% Similarity=0.245 Sum_probs=185.2
Q ss_pred EEeeecccCCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCC-EEEEEEecC-CCCHHHHHHHcCC-CCCHHHHHHHHHH
Q 013092 7 VFSVQENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGD-YNVLVMDLL-GPSLEDLFNFCSR-KLSLKTVLMLADQ 83 (449)
Q Consensus 7 V~~k~~~~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~-~~~lVmE~~-g~sL~~ll~~~~~-~ls~~~~~~i~~q 83 (449)
|++|........+.|.+|+++|+.+ .||||+++++++.+.. ..||||||| +++|.+++..... .+++..++.++.|
T Consensus 219 vavK~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~q 297 (450)
T 1k9a_A 219 VAVKCIKNDATAQAFLAEASVMTQL-RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLD 297 (450)
T ss_dssp EEEEEESSCTTSHHHHHHHHHHHTC-CCTTBCCEEEEEECTTSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHH
T ss_pred EEEEEeCCchHHHHHHHHHHHHHhc-cCCCEEEEEEEEEcCCCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHH
Confidence 4444444445667899999999999 8999999999987665 799999999 8999999986543 3799999999999
Q ss_pred HHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCC
Q 013092 84 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQS 163 (449)
Q Consensus 84 i~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s 163 (449)
|+.||+|||++||+||||||+|||+ +.++.+||+|||+++...... ....+++.|+|||++.+..++
T Consensus 298 i~~~l~~LH~~~ivHrDlkp~Nill---~~~~~~kl~DfG~a~~~~~~~----------~~~~~~~~y~aPE~~~~~~~~ 364 (450)
T 1k9a_A 298 VCEAMEYLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLTKEASSTQ----------DTGKLPVKWTAPEALREKKFS 364 (450)
T ss_dssp HHHHHHHHHHTTEECSCCCGGGEEE---CTTSCEEECCCTTCEECC----------------CCCTTTSCHHHHHSSCCC
T ss_pred HHHHHHHHHhCCeeCCCCCHhhEEE---CCCCCEEEeeCCCcccccccc----------cCCCCCcceeCHHHhcCCCCC
Confidence 9999999999999999999999999 578899999999998543321 223578899999999999999
Q ss_pred hhhHHHHHHHHHHHHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 013092 164 RRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 242 (449)
Q Consensus 164 ~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~ 242 (449)
.++|||||||++|||++ |..||.+....... ..+..... ...+..+|+++.+||..||+.+|++||++.+|.
T Consensus 365 ~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~---~~i~~~~~----~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~ 437 (450)
T 1k9a_A 365 TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV---PRVEKGYK----MDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLR 437 (450)
T ss_dssp HHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHH---HHHHTTCC----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred cHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH---HHHHcCCC----CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 99999999999999998 99999886554332 33332211 123457899999999999999999999999999
Q ss_pred HHHHHHHHH
Q 013092 243 RIFRDLFIR 251 (449)
Q Consensus 243 ~~L~~~~~~ 251 (449)
+.|+++...
T Consensus 438 ~~L~~i~~~ 446 (450)
T 1k9a_A 438 EQLEHIRTH 446 (450)
T ss_dssp HHHHHHHHT
T ss_pred HHHHHHHHh
Confidence 999988654
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=307.56 Aligned_cols=226 Identities=19% Similarity=0.230 Sum_probs=179.0
Q ss_pred cEEEEEeeecccCCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecCCCCHHHHHHHcC-----CCCCHHHH
Q 013092 3 EILTVFSVQENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCS-----RKLSLKTV 77 (449)
Q Consensus 3 ~aikV~~k~~~~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~g~sL~~ll~~~~-----~~ls~~~~ 77 (449)
+|+|++.+.. .......+.+|+++++.+ .||||+++++++.+.+..||||||+.++|.+++.... ..+++..+
T Consensus 33 vaiK~~~~~~-~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~ 110 (317)
T 2pmi_A 33 VALKEVKLDS-EEGTPSTAIREISLMKEL-KHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLV 110 (317)
T ss_dssp EEEEEEECCS-TTCSCHHHHHHHHHHTTC-CBTTBCCEEEEECCTTEEEEEEECCCCBHHHHHHHHHSSSCCCCCCHHHH
T ss_pred EEEEEeeccc-ccccHHHHHHHHHHHHhc-CCCCcceEEEEEEECCeEEEEEEecCCCHHHHHHhccccccccCCCHHHH
Confidence 3555554332 223446789999999999 8999999999999999999999999879999987532 35899999
Q ss_pred HHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhh
Q 013092 78 LMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTH 157 (449)
Q Consensus 78 ~~i~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~ 157 (449)
..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++....... ......||+.|+|||++
T Consensus 111 ~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~~~~-------~~~~~~~t~~y~aPE~~ 180 (317)
T 2pmi_A 111 KYFQWQLLQGLAFCHENKILHRDLKPQNLLI---NKRGQLKLGDFGLARAFGIPVN-------TFSSEVVTLWYRAPDVL 180 (317)
T ss_dssp HHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCSSCEETTSCCC-------CCCCCCSCCTTCCHHHH
T ss_pred HHHHHHHHHHHHHHHHCCeeeCCCChHHeEE---cCCCCEEECcCccceecCCCcc-------cCCCCcccccccCchHh
Confidence 9999999999999999999999999999999 6788999999999987654321 12345789999999999
Q ss_pred hCC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccc------------------------h----
Q 013092 158 LGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST------------------------S---- 208 (449)
Q Consensus 158 ~~~-~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~------------------------~---- 208 (449)
.+. .++.++|||||||++|+|++|..||.+... .+.+..+....... .
T Consensus 181 ~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (317)
T 2pmi_A 181 MGSRTYSTSIDIWSCGCILAEMITGKPLFPGTND---EEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQV 257 (317)
T ss_dssp TTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHH
T ss_pred hCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHhCCCChhHhhhhhhhhhcccccccccchhHHHh
Confidence 874 689999999999999999999999987543 23333332211000 0
Q ss_pred -HHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 209 -IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 209 -~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
.......++.++.+||..||+.||++||++.++++
T Consensus 258 ~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 258 LQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp HGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 01112357899999999999999999999887743
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=306.76 Aligned_cols=226 Identities=18% Similarity=0.193 Sum_probs=174.9
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEe--CCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVE--GDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 94 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~--~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~ 94 (449)
...+.+|+++++.+ .||||+++++++.. ....||||||+ +++|.+++......+++..++.++.|++.||+|||++
T Consensus 55 ~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~ 133 (295)
T 3ugc_A 55 LRDFEREIEILKSL-QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK 133 (295)
T ss_dssp HHHHHHHHHHHHTC-CCTTBCCEEEEECHHHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHhC-CCCCEeeEEEEEecCCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcC
Confidence 35689999999999 89999999998864 45689999999 9999999987655699999999999999999999999
Q ss_pred CceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHH
Q 013092 95 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYV 174 (449)
Q Consensus 95 givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~i 174 (449)
||+||||||+|||+ +.++.+||+|||+++.+...... ........+|..|+|||++.+..++.++|||||||+
T Consensus 134 ~ivH~Dikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~ 206 (295)
T 3ugc_A 134 RYIHRDLATRNILV---ENENRVKIGDFGLTKVLPQDKEF----FKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVV 206 (295)
T ss_dssp TCCCSCCSGGGEEE---EETTEEEECCCCSCC-----------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHH
T ss_pred CcccCCCCHhhEEE---cCCCeEEEccCcccccccCCcce----eeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHH
Confidence 99999999999999 47789999999999876543221 112234567888999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCCcC---------CHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Q 013092 175 LMYFLRGSLPWQGLKAG---------TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIF 245 (449)
Q Consensus 175 l~elltG~~Pf~~~~~~---------~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~L 245 (449)
+|+|++|..||...... ........+.+..........+..+|+++.++|..||+.+|++||++.+|.+.|
T Consensus 207 l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L 286 (295)
T 3ugc_A 207 LYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRV 286 (295)
T ss_dssp HHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred HHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHH
Confidence 99999999999652110 000000011110001111122456899999999999999999999999999999
Q ss_pred HHHHHH
Q 013092 246 RDLFIR 251 (449)
Q Consensus 246 ~~~~~~ 251 (449)
+++...
T Consensus 287 ~~l~~~ 292 (295)
T 3ugc_A 287 DQIRDN 292 (295)
T ss_dssp HHHHHC
T ss_pred HHHHHh
Confidence 988653
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-38 Score=301.54 Aligned_cols=212 Identities=20% Similarity=0.350 Sum_probs=170.2
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC-
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS- 95 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~g- 95 (449)
.+.+.+|+++++.+ +||||+++++++.+.+..||||||+ +++|.+++. ...+++..++.++.|++.||+|||++|
T Consensus 50 ~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~--~~~~~~~~~~~i~~~l~~~l~~lH~~~~ 126 (271)
T 3dtc_A 50 IENVRQEAKLFAML-KHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLS--GKRIPPDILVNWAVQIARGMNYLHDEAI 126 (271)
T ss_dssp HHHHHHHHHHHHHC-CCTTBCCEEEEECCC--CEEEEECCTTEEHHHHHT--SSCCCHHHHHHHHHHHHHHHHHHHHSSS
T ss_pred HHHHHHHHHHHHhc-CCCCEeeEEEEEecCCceEEEEEcCCCCCHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCC
Confidence 46789999999999 8999999999999999999999999 999999987 567999999999999999999999999
Q ss_pred --ceecCCCCCcEEEeecC-----CCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHH
Q 013092 96 --FLHRDIKPDNFLMGLGR-----RANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDL 168 (449)
Q Consensus 96 --ivHRDLKP~NiLl~~~~-----~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~Di 168 (449)
|+||||||+|||+.... ..+.+||+|||+++.+..... ....||+.|+|||++.+..++.++||
T Consensus 127 ~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~---------~~~~~~~~y~aPE~~~~~~~~~~~Di 197 (271)
T 3dtc_A 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK---------MSAAGAYAWMAPEVIRASMFSKGSDV 197 (271)
T ss_dssp SCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC----------------------CCGGGSCHHHHHHCCCSHHHHH
T ss_pred CceeecCCchHHEEEecccccccccCcceEEccCCcccccccccc---------cCCCCccceeCHHHhccCCCCchhhH
Confidence 89999999999995211 267899999999986654322 24578999999999999999999999
Q ss_pred HHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Q 013092 169 ESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRD 247 (449)
Q Consensus 169 wSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~L~~ 247 (449)
||||+++|+|++|..||.+... ......+...... ......+++++.++|..||+.+|++||++.++.+.|++
T Consensus 198 ~slG~~l~~l~~g~~p~~~~~~---~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 198 WSYGVLLWELLTGEVPFRGIDG---LAVAYGVAMNKLA---LPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp HHHHHHHHHHHHCCCTTTTSCH---HHHHHHHHTSCCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred HHHHHHHHHHHhCCCCCCCCCH---HHHHHhhhcCCCC---CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 9999999999999999987433 2222223222221 12345789999999999999999999999999988864
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=328.57 Aligned_cols=250 Identities=16% Similarity=0.197 Sum_probs=199.8
Q ss_pred cEEEEEeeeccc-CCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHc---CCCCCHHHH
Q 013092 3 EILTVFSVQENV-KTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFC---SRKLSLKTV 77 (449)
Q Consensus 3 ~aikV~~k~~~~-~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~---~~~ls~~~~ 77 (449)
.|||++.+.... ......+.+|+++++.+ +||||+.+++++.+....||||||+ |++|.+++... ...+++..+
T Consensus 213 vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~ 291 (543)
T 3c4z_A 213 YACKKLNKKRLKKRKGYQGAMVEKKILAKV-HSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRA 291 (543)
T ss_dssp EEEEEEEHHHHHHTTCHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHH
T ss_pred EEEEEEEhHHhhhhHHHHHHHHHHHHHHhc-CCCCEeeEEEEEeeCCEEEEEEEeccCCCHHHHHHHhhcccccccHHHH
Confidence 466666554432 24456789999999999 9999999999999999999999999 99999998753 236999999
Q ss_pred HHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhh
Q 013092 78 LMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTH 157 (449)
Q Consensus 78 ~~i~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~ 157 (449)
+.++.||+.||+|||++||+||||||+|||| +.++.+||+|||+++.+...... ....+||+.|+|||++
T Consensus 292 ~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl---~~~g~vkL~DFGla~~~~~~~~~-------~~~~~GT~~Y~APE~l 361 (543)
T 3c4z_A 292 IFYTAQIVSGLEHLHQRNIIYRDLKPENVLL---DDDGNVRISDLGLAVELKAGQTK-------TKGYAGTPGFMAPELL 361 (543)
T ss_dssp HHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTSCEEECCCTTCEECCTTCCC-------BCCCCSCTTTSCHHHH
T ss_pred HHHHHHHHHHHHHHHHcCCcccCCChHHEEE---eCCCCEEEeecceeeeccCCCcc-------cccccCCccccChhhh
Confidence 9999999999999999999999999999999 68899999999999877554321 2345899999999999
Q ss_pred hCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcC-CHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCC
Q 013092 158 LGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG-TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKP 236 (449)
Q Consensus 158 ~~~~~s~~~DiwSlG~il~elltG~~Pf~~~~~~-~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RP 236 (449)
.+..++.++|||||||++|||++|..||.+.... ...+.+..+..... .++..+++++.+||..||+.+|++||
T Consensus 362 ~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~-----~~p~~~s~~~~~li~~lL~~dP~~R~ 436 (543)
T 3c4z_A 362 LGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAV-----TYPDKFSPASKDFCEALLQKDPEKRL 436 (543)
T ss_dssp TTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCC-----CCCTTSCHHHHHHHHHHSCSSGGGSC
T ss_pred cCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhccc-----CCCcccCHHHHHHHHHhccCCHhHCC
Confidence 9999999999999999999999999999875432 23444444444332 23457899999999999999999999
Q ss_pred CHHH--HHHHHHHHHHHcCCCCCCcccchhhhhhhccCCCC
Q 013092 237 DYAY--LKRIFRDLFIREGFQFDYVFDWTILKYQQSQLATP 275 (449)
Q Consensus 237 t~~~--l~~~L~~~~~~~~~~~~~~~dw~~~~~~~~~~~~~ 275 (449)
++.+ +.++ ..+++...++|..+......++..
T Consensus 437 ~~~~~~a~ei-------~~Hpff~~i~w~~l~~~~~~pp~~ 470 (543)
T 3c4z_A 437 GFRDGSCDGL-------RTHPLFRDISWRQLEAGMLTPPFV 470 (543)
T ss_dssp CCBTTBSHHH-------HTSGGGTTCCHHHHHTTCSCCSCC
T ss_pred CCcccCHHHH-------HcCccccCCCHHHHHcCCCCCCCC
Confidence 7532 1111 235677788999887655444333
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=299.59 Aligned_cols=217 Identities=14% Similarity=0.183 Sum_probs=183.2
Q ss_pred CChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC
Q 013092 16 TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 94 (449)
Q Consensus 16 ~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~ 94 (449)
....++.+|+++++.+ .||||+++++++.+.+..|+||||+ +++|.+++......+++..++.++.|++.||+|||++
T Consensus 45 ~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~ 123 (268)
T 3sxs_A 45 MSEDEFFQEAQTMMKL-SHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESH 123 (268)
T ss_dssp BCHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CcHHHHHHHHHHHHhC-CCCCEeeEEEEEccCCceEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 3556799999999999 7999999999999999999999999 9999999986556699999999999999999999999
Q ss_pred CceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHH
Q 013092 95 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYV 174 (449)
Q Consensus 95 givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~i 174 (449)
||+||||||+|||+ +.++.+||+|||+++....... .......+|+.|+|||++.+..++.++||||||++
T Consensus 124 ~i~H~dikp~Nil~---~~~~~~~l~Dfg~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~i 194 (268)
T 3sxs_A 124 QFIHRDLAARNCLV---DRDLCVKVSDFGMTRYVLDDQY------VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGIL 194 (268)
T ss_dssp TEEESSCSGGGEEE---CTTCCEEECCTTCEEECCTTCE------EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHH
T ss_pred CeecCCcCcceEEE---CCCCCEEEccCccceecchhhh------hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHH
Confidence 99999999999999 6888999999999987655432 11234457788999999999889999999999999
Q ss_pred HHHHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 013092 175 LMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLF 249 (449)
Q Consensus 175 l~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~L~~~~ 249 (449)
+|+|++ |..||..... ......+...... ..+..+++++.+++..||+.+|++||++.+|.+.|+.+.
T Consensus 195 l~~l~~~g~~p~~~~~~---~~~~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (268)
T 3sxs_A 195 MWEVFSLGKMPYDLYTN---SEVVLKVSQGHRL----YRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLR 263 (268)
T ss_dssp HHHHHTTTCCTTTTSCH---HHHHHHHHTTCCC----CCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGC
T ss_pred HHHHHcCCCCCccccCh---HHHHHHHHcCCCC----CCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 999999 9999976433 3333333332211 123457899999999999999999999999999887663
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=314.44 Aligned_cols=229 Identities=15% Similarity=0.168 Sum_probs=183.6
Q ss_pred EEEEEeeeccc---CCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHH
Q 013092 4 ILTVFSVQENV---KTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLM 79 (449)
Q Consensus 4 aikV~~k~~~~---~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~ 79 (449)
++||++|.... ......+.+|+.++..+ +||||+++++++. ++..++||||+ +++|.+++......+++..++.
T Consensus 42 ~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~ 119 (325)
T 3kex_A 42 KIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL-DHAHIVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLN 119 (325)
T ss_dssp CEEEEEEEECCTTSCSCBCSCCHHHHHHHTC-CCTTBCCEEEEEC-BSSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHH
T ss_pred EEEEEEEeccccccHHHHHHHHHHHHHHhcC-CCCCcCeEEEEEc-CCccEEEEEeCCCCCHHHHHHHccccCCHHHHHH
Confidence 45566665432 23345688999999999 8999999999886 45689999999 9999999986555799999999
Q ss_pred HHHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhC
Q 013092 80 LADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG 159 (449)
Q Consensus 80 i~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~ 159 (449)
++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.+....... ......||..|+|||++.+
T Consensus 120 ~~~qi~~~l~~lH~~~ivH~Dikp~Nil~---~~~~~~kl~Dfg~a~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~ 191 (325)
T 3kex_A 120 WGVQIAKGMYYLEEHGMVHRNLAARNVLL---KSPSQVQVADFGVADLLPPDDKQL-----LYSEAKTPIKWMALESIHF 191 (325)
T ss_dssp HHHHHHHHHHHHHHTTCCCSCCSSTTEEE---SSSSCEEECSCSGGGGSCCCTTCC-----C-----CCTTTSCHHHHHH
T ss_pred HHHHHHHHHHHHHhCCCCCCccchheEEE---CCCCeEEECCCCcccccCcccccc-----cccCCCCcccccChHHhcc
Confidence 99999999999999999999999999999 678899999999998765443211 1234568889999999999
Q ss_pred CCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCH
Q 013092 160 IEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDY 238 (449)
Q Consensus 160 ~~~s~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~ 238 (449)
..++.++|||||||++|+|++ |..||.+..... ....+...... .....++.++.++|..||..+|++||++
T Consensus 192 ~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~ 264 (325)
T 3kex_A 192 GKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE---VPDLLEKGERL----AQPQICTIDVYMVMVKCWMIDENIRPTF 264 (325)
T ss_dssp CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH---HHHHHHTTCBC----CCCTTBCTTTTHHHHHHTCSCTTTSCCH
T ss_pred CCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH---HHHHHHcCCCC----CCCCcCcHHHHHHHHHHcCCChhhCcCH
Confidence 999999999999999999999 999998755432 22223222111 1234578899999999999999999999
Q ss_pred HHHHHHHHHHH
Q 013092 239 AYLKRIFRDLF 249 (449)
Q Consensus 239 ~~l~~~L~~~~ 249 (449)
.+|.+.|+.+.
T Consensus 265 ~el~~~l~~~~ 275 (325)
T 3kex_A 265 KELANEFTRMA 275 (325)
T ss_dssp HHHHHHHHHHT
T ss_pred HHHHHHHHHHH
Confidence 99999988773
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=299.68 Aligned_cols=226 Identities=19% Similarity=0.242 Sum_probs=184.2
Q ss_pred EEEEEeeecccCCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHH
Q 013092 4 ILTVFSVQENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLAD 82 (449)
Q Consensus 4 aikV~~k~~~~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~ 82 (449)
|+|++............+.+|+++++.+ +||||+++++++.+.+..|+||||+ +++|.+++.. ...+++..++.++.
T Consensus 35 avK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~ 112 (284)
T 3kk8_A 35 AAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVA-REFYSEADASHCIQ 112 (284)
T ss_dssp EEEEEEGGGCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH-HSSCCHHHHHHHHH
T ss_pred EEEEeecccCCHHHHHHHHHHHHHHHHc-CCCCcCeEEEEEEcCCEEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHH
Confidence 4444443333333446688999999999 8999999999999999999999999 8999988875 45699999999999
Q ss_pred HHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCC
Q 013092 83 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQ 162 (449)
Q Consensus 83 qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~ 162 (449)
|++.||+|||++||+||||||+||++..+...+.+||+|||++........ .....||+.|+|||++.+..+
T Consensus 113 ~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~ 184 (284)
T 3kk8_A 113 QILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA--------WHGFAGTPGYLSPEVLKKDPY 184 (284)
T ss_dssp HHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCB--------CCCSCSCGGGCCHHHHTTCCB
T ss_pred HHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCcc--------ccCCCCCcCCcCchhhcCCCC
Confidence 999999999999999999999999996444455699999999987654322 234679999999999999999
Q ss_pred ChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 013092 163 SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 242 (449)
Q Consensus 163 s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~ 242 (449)
+.++||||||+++|+|++|..||.+.. ....+..+.......+. .....+++++.++|..||+.+|++||++.+++
T Consensus 185 ~~~~Di~slG~~l~~l~~g~~pf~~~~---~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l 260 (284)
T 3kk8_A 185 SKPVDIWACGVILYILLVGYPPFWDED---QHRLYAQIKAGAYDYPS-PEWDTVTPEAKSLIDSMLTVNPKKRITADQAL 260 (284)
T ss_dssp CTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHTCCCCCT-TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHT
T ss_pred CcccchHHHHHHHHHHHHCCCCCCCCc---hhHHHHHHHhccccCCc-hhhcccCHHHHHHHHHHcccChhhCCCHHHHh
Confidence 999999999999999999999997743 34444445444332222 22356899999999999999999999988775
Q ss_pred H
Q 013092 243 R 243 (449)
Q Consensus 243 ~ 243 (449)
+
T Consensus 261 ~ 261 (284)
T 3kk8_A 261 K 261 (284)
T ss_dssp T
T ss_pred c
Confidence 4
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-38 Score=304.56 Aligned_cols=222 Identities=19% Similarity=0.273 Sum_probs=185.9
Q ss_pred ChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 013092 17 KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 95 (449)
Q Consensus 17 ~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~g 95 (449)
..+.+.+|+++++.+ +||||+++++++ ..+..|+||||+ +++|.+++......+++..++.++.||+.||.|||++|
T Consensus 53 ~~~~~~~E~~~l~~l-~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ 130 (287)
T 1u59_A 53 DTEEMMREAQIMHQL-DNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN 130 (287)
T ss_dssp HHHHHHHHHHHHHHC-CCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHhC-CCCCEeEEEEEe-cCCCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 345688999999999 899999999998 556799999999 88999999755567999999999999999999999999
Q ss_pred ceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHHH
Q 013092 96 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVL 175 (449)
Q Consensus 96 ivHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il 175 (449)
|+||||||+|||++ .++.+||+|||+++......... .......+|+.|+|||++.+..++.++|||||||++
T Consensus 131 i~H~dlkp~Nili~---~~~~~kl~Dfg~~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 203 (287)
T 1u59_A 131 FVHRDLAARNVLLV---NRHYAKISDFGLSKALGADDSYY----TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTM 203 (287)
T ss_dssp EECCCCSGGGEEEE---ETTEEEECCCTTCEECTTCSCEE----CCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHH
T ss_pred EeeCCCchheEEEc---CCCCEEECcccceeeeccCccee----eccccccccccccCHHHhccCCCCchhhHHHHHHHH
Confidence 99999999999994 77899999999998775433211 122345678999999999988899999999999999
Q ss_pred HHHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCC
Q 013092 176 MYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGF 254 (449)
Q Consensus 176 ~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~L~~~~~~~~~ 254 (449)
|+|++ |..||..... .+.+..+..... ..++..+|+++.++|..||+.+|++||++.+|.+.|+.++...+.
T Consensus 204 ~ellt~g~~p~~~~~~---~~~~~~i~~~~~----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~ 276 (287)
T 1u59_A 204 WEALSYGQKPYKKMKG---PEVMAFIEQGKR----MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 276 (287)
T ss_dssp HHHHTTSCCTTTTCCT---HHHHHHHHTTCC----CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHT
T ss_pred HHHHcCCCCCcccCCH---HHHHHHHhcCCc----CCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCC
Confidence 99998 9999987543 233333333221 123457899999999999999999999999999999999876643
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=317.57 Aligned_cols=225 Identities=18% Similarity=0.259 Sum_probs=174.7
Q ss_pred EEEEEeeecccCCChhHHHHHHHHHHHhcC-CCCCceEEEEeEeCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHH
Q 013092 4 ILTVFSVQENVKTKHPQLLYESKLYRILQG-GTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLAD 82 (449)
Q Consensus 4 aikV~~k~~~~~~~~~~~~~E~~il~~l~~-hp~Iv~l~~~~~~~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~~~~i~~ 82 (449)
|||++.+..........+.+|+.+|+.|.+ ||||+++++++...+..|||||+.+++|.+++.. ...+++..++.++.
T Consensus 84 aiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E~~~~~L~~~l~~-~~~~~~~~~~~i~~ 162 (390)
T 2zmd_A 84 AIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKK-KKSIDPWERKSYWK 162 (390)
T ss_dssp EEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCSEEHHHHHHH-CSSCCHHHHHHHHH
T ss_pred EEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEecCCCCHHHHHHh-cCCCCHHHHHHHHH
Confidence 455444433333344678999999999975 7999999999999999999999669999999986 45799999999999
Q ss_pred HHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhC---
Q 013092 83 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG--- 159 (449)
Q Consensus 83 qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~--- 159 (449)
||+.||+|||++||+||||||+|||| .++.+||+|||+++.+...... .......||+.|+|||++.+
T Consensus 163 qi~~aL~~lH~~~ivHrDlkp~NIll----~~~~~kl~DFG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~ 233 (390)
T 2zmd_A 163 NMLEAVHTIHQHGIVHSDLKPANFLI----VDGMLKLIDFGIANQMQPDTTS-----VVKDSQVGAVNYMPPEAIKDMSS 233 (390)
T ss_dssp HHHHHHHHHHTTTCCCCCCCGGGEEE----SSSCEEECCCSSSCCC--------------CCSCCCGGGCCHHHHHCC--
T ss_pred HHHHHHHHHHHCCeeecCCCHHHEEE----ECCeEEEEecCccccccCCCcc-----ccCCCCCcCCCccChHHhhhccc
Confidence 99999999999999999999999999 3478999999999876543221 11235679999999999976
Q ss_pred --------CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCC
Q 013092 160 --------IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLR 231 (449)
Q Consensus 160 --------~~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~ 231 (449)
..++.++||||||||||||++|..||..... ....+..+....... .++..++.++.+||..||+.|
T Consensus 234 ~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~--~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~L~~d 308 (390)
T 2zmd_A 234 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN--QISKLHAIIDPNHEI---EFPDIPEKDLQDVLKCCLKRD 308 (390)
T ss_dssp ----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC--HHHHHHHHHCTTSCC---CCCCCSCHHHHHHHHHHTCSS
T ss_pred cccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH--HHHHHHHHhCccccC---CCCccchHHHHHHHHHHcccC
Confidence 3689999999999999999999999976432 222333333222111 223446789999999999999
Q ss_pred CCCCCCHHHHHH
Q 013092 232 FDDKPDYAYLKR 243 (449)
Q Consensus 232 p~~RPt~~~l~~ 243 (449)
|++||++.+|++
T Consensus 309 P~~Rps~~ell~ 320 (390)
T 2zmd_A 309 PKQRISIPELLA 320 (390)
T ss_dssp TTTSCCHHHHHT
T ss_pred hhhCCCHHHHhh
Confidence 999999887753
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-38 Score=321.05 Aligned_cols=217 Identities=16% Similarity=0.142 Sum_probs=169.3
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEe----CCEEEEEEecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHH
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVE----GDYNVLVMDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFV 91 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~----~~~~~lVmE~~-g~sL~~ll~~~-~~~ls~~~~~~i~~qi~~aL~yL 91 (449)
...+.+|+.++.++.+||||+++++++.. ....||||||| |++|.+++... ...+++..++.|+.||+.||+||
T Consensus 98 ~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~L 177 (400)
T 1nxk_A 98 CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 177 (400)
T ss_dssp SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHH
T ss_pred chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHH
Confidence 35788999999887799999999998875 66789999999 89999999853 23599999999999999999999
Q ss_pred HHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHH
Q 013092 92 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESL 171 (449)
Q Consensus 92 H~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSl 171 (449)
|++||+||||||+|||++....++.+||+|||+++....... ....+||+.|+|||++.+..++.++|||||
T Consensus 178 H~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 249 (400)
T 1nxk_A 178 HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS--------LTTPCYTPYYVAPEVLGPEKYDKSCDMWSL 249 (400)
T ss_dssp HHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC-------------------CTTCCGGGSCCCCSSSHHHHHHH
T ss_pred HHCCccccCcCcceEEEecCCCCccEEEEecccccccCCCCc--------cccCCCCCCccCHhhcCCCCCCCcccHHHH
Confidence 999999999999999995333378999999999987654221 235678999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCCcCCH-HHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 172 GYVLMYFLRGSLPWQGLKAGTK-KQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 172 G~il~elltG~~Pf~~~~~~~~-~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
||++|+|++|..||.+...... ......+......... .....+++++.+||..||..||++||++.+|++
T Consensus 250 G~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~-~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 321 (400)
T 1nxk_A 250 GVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN-PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 321 (400)
T ss_dssp HHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCT-TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCC-cccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 9999999999999987543221 1122333333322111 123568999999999999999999999877754
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=309.76 Aligned_cols=230 Identities=16% Similarity=0.217 Sum_probs=181.1
Q ss_pred EEEEEeeeccc---CCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHH
Q 013092 4 ILTVFSVQENV---KTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLM 79 (449)
Q Consensus 4 aikV~~k~~~~---~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~ 79 (449)
++||++|.... ......+.+|+.+++.+ +||||+++++++.++. .++||+|+ +++|.+++......+++..++.
T Consensus 44 ~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~ 121 (327)
T 3lzb_A 44 KIPVAIKELREATSPKANKEILDEAYVMASV-DNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLN 121 (327)
T ss_dssp CEEEEEEEECCCSSCCCHHHHHHHHHHHTTC-CBTTBCCCCEEEESSS-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHH
T ss_pred EEEEEEEeeccccCHHHHHHHHHHHHHHHhC-CCCCeeEEEEEEecCC-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHH
Confidence 45666665422 34566799999999999 8999999999998765 77888888 9999999987677899999999
Q ss_pred HHHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhC
Q 013092 80 LADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG 159 (449)
Q Consensus 80 i~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~ 159 (449)
++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.+....... ......+|+.|+|||++.+
T Consensus 122 i~~qi~~aL~~LH~~~ivH~Dikp~NIl~---~~~~~~kL~DfG~a~~~~~~~~~~-----~~~~~~~t~~y~aPE~~~~ 193 (327)
T 3lzb_A 122 WCVQIAKGMNYLEDRRLVHRDLAARNVLV---KTPQHVKITDFGLAKLLGAEEKEY-----HAEGGKVPIKWMALESILH 193 (327)
T ss_dssp HHHHHHHHHHHHHHTTCCCSCCCGGGEEE---EETTEEEECCTTC---------------------CCCGGGSCHHHHHH
T ss_pred HHHHHHHHHHHHhhCCCcCCCCCHHHEEE---cCCCCEEEccCcceeEccCccccc-----cccCCCccccccCHHHHcC
Confidence 99999999999999999999999999999 477899999999998765433211 1234567889999999999
Q ss_pred CCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCH
Q 013092 160 IEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDY 238 (449)
Q Consensus 160 ~~~s~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~ 238 (449)
..++.++|||||||++|+|++ |..||.+....... ..+...... .....++.++.++|..||..+|++||++
T Consensus 194 ~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~---~~~~~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~ 266 (327)
T 3lzb_A 194 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS---SILEKGERL----PQPPICTIDVYMIMRKCWMIDADSRPKF 266 (327)
T ss_dssp CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH---HHHHTTCCC----CCCTTBCHHHHHHHHHHTCSSGGGSCCH
T ss_pred CCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH---HHHHcCCCC----CCCccCCHHHHHHHHHHcCCChhHCcCH
Confidence 999999999999999999999 99999886554322 222222111 1235588999999999999999999999
Q ss_pred HHHHHHHHHHHH
Q 013092 239 AYLKRIFRDLFI 250 (449)
Q Consensus 239 ~~l~~~L~~~~~ 250 (449)
.+|++.|..+..
T Consensus 267 ~ell~~L~~~~~ 278 (327)
T 3lzb_A 267 RELIIEFSKMAR 278 (327)
T ss_dssp HHHHHHHHHHHT
T ss_pred HHHHHHHHHHHh
Confidence 999999988753
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=331.15 Aligned_cols=246 Identities=16% Similarity=0.164 Sum_probs=198.0
Q ss_pred cEEEEEeeeccc-CCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcC-CCCCHHHHHH
Q 013092 3 EILTVFSVQENV-KTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCS-RKLSLKTVLM 79 (449)
Q Consensus 3 ~aikV~~k~~~~-~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~-~~ls~~~~~~ 79 (449)
.|+|++.+.... ......+.+|+.+|+.+ +||||+.+++++.+.+..||||||+ |++|.+++.... ..+++..++.
T Consensus 212 vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~ 290 (576)
T 2acx_A 212 YACKKLEKKRIKKRKGEAMALNEKQILEKV-NSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVF 290 (576)
T ss_dssp EEEEEEEHHHHHHTTCHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHH
T ss_pred EEEEEEEhHhhhhhHHHHHHHHHHHHHHHc-CCCCEeeEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHH
Confidence 456666554322 34456688999999999 8999999999999999999999999 999999987532 3499999999
Q ss_pred HHHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhC
Q 013092 80 LADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG 159 (449)
Q Consensus 80 i~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~ 159 (449)
++.||+.||+|||++||+||||||+|||| +.++.+||+|||+++.+..... ....+||+.|+|||++.+
T Consensus 291 i~~qIl~aL~yLH~~gIvHrDLKPeNILl---d~~g~vKL~DFGla~~~~~~~~--------~~~~~GT~~Y~APEvl~~ 359 (576)
T 2acx_A 291 YAAEICCGLEDLHRERIVYRDLKPENILL---DDHGHIRISDLGLAVHVPEGQT--------IKGRVGTVGYMAPEVVKN 359 (576)
T ss_dssp HHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTSCEEECCCTTCEECCTTCC--------EECCCSCGGGCCHHHHTT
T ss_pred HHHHHHHHHHHHHHCCEeccCCchheEEE---eCCCCeEEEecccceecccCcc--------ccccCCCccccCHHHHcC
Confidence 99999999999999999999999999999 6889999999999987754322 134589999999999999
Q ss_pred CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCC-HHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCC--
Q 013092 160 IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT-KKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKP-- 236 (449)
Q Consensus 160 ~~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~-~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RP-- 236 (449)
..++.++|||||||++|||++|..||.+..... ..+.+..+..... .+...+++++.+||..||+.||.+||
T Consensus 360 ~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~-----~~p~~~s~~~~dLI~~lL~~dP~~R~g~ 434 (576)
T 2acx_A 360 ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPE-----EYSERFSPQARSLCSQLLCKDPAERLGC 434 (576)
T ss_dssp CEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCC-----CCCTTSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred CCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccc-----cCCccCCHHHHHHHHHhccCCHHHcCCC
Confidence 899999999999999999999999998755432 2333333333221 23456899999999999999999999
Q ss_pred ---CHHHHHHHHHHHHHHcCCCCCCcccchhhhhhhccCCCC
Q 013092 237 ---DYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQLATP 275 (449)
Q Consensus 237 ---t~~~l~~~L~~~~~~~~~~~~~~~dw~~~~~~~~~~~~~ 275 (449)
++.+|++ +++...+||..+......++..
T Consensus 435 ~~~sa~eil~----------HpfF~~i~w~~l~~~~~~pp~~ 466 (576)
T 2acx_A 435 RGGSAREVKE----------HPLFKKLNFKRLGAGMLEPPFK 466 (576)
T ss_dssp SSSHHHHHHT----------SGGGTTCCHHHHHTTCSCCSCC
T ss_pred CCCCHHHHHh----------ChhhccCCHHHHhcCCCCCCCC
Confidence 5555532 4667778999887655444333
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=311.43 Aligned_cols=225 Identities=19% Similarity=0.250 Sum_probs=172.6
Q ss_pred EEEEEeeecccCCChhHHHHHHHHHHHhcCC-CCCceEEEEeEeCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHH
Q 013092 4 ILTVFSVQENVKTKHPQLLYESKLYRILQGG-TGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLAD 82 (449)
Q Consensus 4 aikV~~k~~~~~~~~~~~~~E~~il~~l~~h-p~Iv~l~~~~~~~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~~~~i~~ 82 (449)
|||++.+..........+.+|+.+|+.+.+| +||+.+++++.+.+..|||||+.+++|.+++.. ...+++..++.++.
T Consensus 37 avK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e~~~~~L~~~l~~-~~~~~~~~~~~i~~ 115 (343)
T 3dbq_A 37 AIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKK-KKSIDPWERKSYWK 115 (343)
T ss_dssp EEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCSEEHHHHHHH-SCCCCHHHHHHHHH
T ss_pred EEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEeCCCCCHHHHHHh-cCCCCHHHHHHHHH
Confidence 4554443332223345688999999999654 999999999999999999999779999999986 56799999999999
Q ss_pred HHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhC---
Q 013092 83 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG--- 159 (449)
Q Consensus 83 qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~--- 159 (449)
||+.||+|||++||+||||||+|||+. ++.+||+|||+++.+...... .......||+.|+|||++.+
T Consensus 116 qi~~al~~lH~~~iiHrDikp~NIll~----~~~~kl~DFG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~ 186 (343)
T 3dbq_A 116 NMLEAVHTIHQHGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTS-----VVKDSQVGTVNYMPPEAIKDMSS 186 (343)
T ss_dssp HHHHHHHHHHHTTCCCCCCCGGGEEEE----TTEEEECCCSSSCCC-----------------CCCCSSCCHHHHHHCC-
T ss_pred HHHHHHHHHHhCCeecCCCCcceEEEE----CCcEEEeecccccccCccccc-----ccCCCCcCCcCcCCHHHHhhccc
Confidence 999999999999999999999999993 578999999999876543221 11235679999999999975
Q ss_pred --------CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCC
Q 013092 160 --------IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLR 231 (449)
Q Consensus 160 --------~~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~ 231 (449)
..++.++|||||||++|+|++|..||..... ....+..+..... ...+...++.++.+||..||+.|
T Consensus 187 ~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~~L~~d 261 (343)
T 3dbq_A 187 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN--QISKLHAIIDPNH---EIEFPDIPEKDLQDVLKCCLKRD 261 (343)
T ss_dssp ----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS--HHHHHHHHHCTTS---CCCCCCCSCHHHHHHHHHHTCSS
T ss_pred cccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh--HHHHHHHHhcCCc---ccCCcccCCHHHHHHHHHHcCCC
Confidence 6789999999999999999999999976432 2222222222111 11233456789999999999999
Q ss_pred CCCCCCHHHHHH
Q 013092 232 FDDKPDYAYLKR 243 (449)
Q Consensus 232 p~~RPt~~~l~~ 243 (449)
|++||++.++++
T Consensus 262 p~~Rpt~~e~l~ 273 (343)
T 3dbq_A 262 PKQRISIPELLA 273 (343)
T ss_dssp TTTSCCHHHHHT
T ss_pred hhHCCCHHHHHh
Confidence 999999887754
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=323.61 Aligned_cols=235 Identities=17% Similarity=0.154 Sum_probs=170.5
Q ss_pred EEEEEeeecccCCChhHHHHHHHHHHHhcCCCCCceEEEEeEe-----CCEEEEEEecCCCCHHHHHHHcCCCCCHHHHH
Q 013092 4 ILTVFSVQENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVE-----GDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVL 78 (449)
Q Consensus 4 aikV~~k~~~~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~-----~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~~~ 78 (449)
|||++.+..........+.+|+++|+.| +||||+++++++.. ....||||||++++|.+++.. ...+++..++
T Consensus 82 aiK~i~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~-~~~l~~~~~~ 159 (458)
T 3rp9_A 82 AIKKILRVFEDLIDCKRILREIAILNRL-NHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRT-PVYLTELHIK 159 (458)
T ss_dssp EEEEECSTTSSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCSCTTTCCCEEEEECCCSEEHHHHHHS-SCCCCHHHHH
T ss_pred EEEEechhhcCHHHHHHHHHHHHHHHhC-CCCCCCceEEEEecCCcccCceEEEEEeccccchhhhccc-CCCCCHHHHH
Confidence 4444433322223345688999999999 89999999999853 357899999999999999984 4579999999
Q ss_pred HHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCccc--------------------c
Q 013092 79 MLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHI--------------------P 138 (449)
Q Consensus 79 ~i~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~--------------------~ 138 (449)
.++.||+.||+|||++||+||||||+|||| +.++.+||+|||+++........... .
T Consensus 160 ~~~~qi~~aL~~LH~~~iiHrDlKp~NILl---~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (458)
T 3rp9_A 160 TLLYNLLVGVKYVHSAGILHRDLKPANCLV---NQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNL 236 (458)
T ss_dssp HHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTCCEEECCCTTCBCTTSCTTCCCCCC-------------------
T ss_pred HHHHHHHHHHHHHHhCCcCCCCCChhhEEE---CCCCCEeecccccchhccCccccccccccCccccccccccccccccc
Confidence 999999999999999999999999999999 68889999999999876533211100 0
Q ss_pred cccCCCCccCccccchhhhh-CCCCChhhHHHHHHHHHHHHHh-----------CCCCCCCCCcCC--------------
Q 013092 139 YRENKNLTGTARYASMNTHL-GIEQSRRDDLESLGYVLMYFLR-----------GSLPWQGLKAGT-------------- 192 (449)
Q Consensus 139 ~~~~~~~~gT~~Y~aPE~~~-~~~~s~~~DiwSlG~il~ellt-----------G~~Pf~~~~~~~-------------- 192 (449)
.......+||+.|+|||++. +..++.++||||||||||||++ |.++|.+.....
T Consensus 237 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~ 316 (458)
T 3rp9_A 237 KRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFH 316 (458)
T ss_dssp --------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGGCCCSCC--------------------
T ss_pred cccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccccccccccCCCCcccccccccccccccccc
Confidence 01234568899999999874 5669999999999999999998 677776643100
Q ss_pred ---HHHHHHHHHhhcc--------------------------cchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 193 ---KKQKYEKISEKKV--------------------------STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 193 ---~~~~~~~i~~~~~--------------------------~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
....+..+..... ...+....+.+++++.+||..||..||++||++.++++
T Consensus 317 ~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~ 396 (458)
T 3rp9_A 317 TRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLA 396 (458)
T ss_dssp CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 0111122211111 11122233566899999999999999999999877654
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=323.10 Aligned_cols=226 Identities=19% Similarity=0.275 Sum_probs=187.7
Q ss_pred cEEEEEeeecccCCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHH
Q 013092 3 EILTVFSVQENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLA 81 (449)
Q Consensus 3 ~aikV~~k~~~~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~ 81 (449)
+|||++.+..........+.+|+++|+.+ +||||+++++++.+....||||||| |++|.+++.. ...+++..++.++
T Consensus 50 vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~i~ 127 (486)
T 3mwu_A 50 YAVKVINKASAKNKDTSTILREVELLKKL-DHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIK-RKRFSEHDAARII 127 (486)
T ss_dssp EEEEEEEHHHHBCSCHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH-HSSCCHHHHHHHH
T ss_pred EEEEEEecccccchHHHHHHHHHHHHHhC-CCCCcCeEEEEEEcCCEEEEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHH
Confidence 46666665555555677899999999999 9999999999999999999999999 9999998875 4579999999999
Q ss_pred HHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCC
Q 013092 82 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIE 161 (449)
Q Consensus 82 ~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~ 161 (449)
.||+.||.|||++||+||||||+|||+...+..+.+||+|||+++.+..... .....||+.|+|||++.+ .
T Consensus 128 ~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~-~ 198 (486)
T 3mwu_A 128 KQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK--------MKDRIGTAYYIAPEVLRG-T 198 (486)
T ss_dssp HHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC------------CCTTGGGGCCGGGGGS-C
T ss_pred HHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCCc--------cCCCcCCCCCCCHHHhCC-C
Confidence 9999999999999999999999999996545667899999999986654321 234579999999999986 5
Q ss_pred CChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHH
Q 013092 162 QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYL 241 (449)
Q Consensus 162 ~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l 241 (449)
++.++|||||||++|+|++|..||.+. ...+.+..+.........+ .+..+++++.+||..||..+|.+||++.++
T Consensus 199 ~~~~~DiwslG~il~~ll~g~~pf~~~---~~~~~~~~i~~~~~~~~~~-~~~~~s~~~~~li~~~L~~dp~~R~t~~~~ 274 (486)
T 3mwu_A 199 YDEKCDVWSAGVILYILLSGTPPFYGK---NEYDILKRVETGKYAFDLP-QWRTISDDAKDLIRKMLTFHPSLRITATQC 274 (486)
T ss_dssp CCHHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHTCCCSCSG-GGGGSCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred CCchhhHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHHhCCCCCCCc-ccCCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 999999999999999999999999874 3345555565554433322 235689999999999999999999998877
Q ss_pred HH
Q 013092 242 KR 243 (449)
Q Consensus 242 ~~ 243 (449)
++
T Consensus 275 l~ 276 (486)
T 3mwu_A 275 LE 276 (486)
T ss_dssp HH
T ss_pred hc
Confidence 54
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-37 Score=302.54 Aligned_cols=224 Identities=19% Similarity=0.251 Sum_probs=185.5
Q ss_pred cEEEEEeeecccCC----ChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHH
Q 013092 3 EILTVFSVQENVKT----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTV 77 (449)
Q Consensus 3 ~aikV~~k~~~~~~----~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~ 77 (449)
.|+|++.+...... ....+.+|+.+++.+ .||||+++++++.+....||||||+ +++|.+++.. ...+++..+
T Consensus 40 vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~ 117 (321)
T 2a2a_A 40 YAAKFIKKRQSRASRRGVSREEIEREVSILRQV-LHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQ-KESLSEEEA 117 (321)
T ss_dssp EEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHT-CSCEEHHHH
T ss_pred EEEEEEecccccccccchhHHHHHHHHHHHHhC-CCCCcceEEEEEecCCEEEEEEEcCCCCcHHHHHHh-cCCCCHHHH
Confidence 35555554443222 356799999999999 8999999999999999999999999 9999999985 557999999
Q ss_pred HHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCC----eEEEeecCcceeecCCCCCcccccccCCCCccCccccc
Q 013092 78 LMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN----QVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYAS 153 (449)
Q Consensus 78 ~~i~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~----~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~a 153 (449)
+.++.||+.||+|||++||+||||||+|||+. .++ .+||+|||+++....... .....||+.|+|
T Consensus 118 ~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~---~~~~~~~~~kl~Dfg~~~~~~~~~~--------~~~~~gt~~y~a 186 (321)
T 2a2a_A 118 TSFIKQILDGVNYLHTKKIAHFDLKPENIMLL---DKNIPIPHIKLIDFGLAHEIEDGVE--------FKNIFGTPEFVA 186 (321)
T ss_dssp HHHHHHHHHHHHHHHHTTEECCCCSGGGEEES---CTTSSSCCEEECCCTTCEECCTTCC--------CCCCCSCGGGCC
T ss_pred HHHHHHHHHHHHHHHhCCeecCCCChHHEEEe---cCCCCcCCEEEccCccceecCcccc--------ccccCCCCCccC
Confidence 99999999999999999999999999999994 444 799999999987765322 234579999999
Q ss_pred hhhhhCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCC
Q 013092 154 MNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFD 233 (449)
Q Consensus 154 PE~~~~~~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~ 233 (449)
||++.+..++.++|||||||++|+|++|..||.+. ...+.+..+...... ....+...+++++.+||..||..+|+
T Consensus 187 PE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~---~~~~~~~~i~~~~~~-~~~~~~~~~~~~~~~li~~~l~~dp~ 262 (321)
T 2a2a_A 187 PEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD---TKQETLANITSVSYD-FDEEFFSHTSELAKDFIRKLLVKETR 262 (321)
T ss_dssp HHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS---SHHHHHHHHHTTCCC-CCHHHHTTCCHHHHHHHHTTSCSSTT
T ss_pred cccccCCCCCCccccHHHHHHHHHHHHCCCCCCCC---CHHHHHHHHHhcccc-cChhhhcccCHHHHHHHHHHcCCChh
Confidence 99999999999999999999999999999999774 334444445443332 22345577899999999999999999
Q ss_pred CCCCHHHHHH
Q 013092 234 DKPDYAYLKR 243 (449)
Q Consensus 234 ~RPt~~~l~~ 243 (449)
+||++.++++
T Consensus 263 ~Rps~~e~l~ 272 (321)
T 2a2a_A 263 KRLTIQEALR 272 (321)
T ss_dssp TSCCHHHHHH
T ss_pred hCcCHHHHhc
Confidence 9999888754
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=304.19 Aligned_cols=226 Identities=19% Similarity=0.228 Sum_probs=180.4
Q ss_pred CChhHHHHHHHHHHHhcCCCCCceEEEEeEeC--CEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH
Q 013092 16 TKHPQLLYESKLYRILQGGTGIPNVRWFGVEG--DYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 92 (449)
Q Consensus 16 ~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~--~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH 92 (449)
.....+.+|+++++.+ .||||+++++++.+. ...|+||||+ +++|.+++......+++..++.++.|++.||+|||
T Consensus 65 ~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH 143 (302)
T 4e5w_A 65 NHIADLKKEIEILRNL-YHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG 143 (302)
T ss_dssp CCHHHHHHHHHHHHTC-CCTTBCCEEEEEEC---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHH
T ss_pred hhHHHHHHHHHHHHhC-CCCCeeeeeeEEecCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhh
Confidence 3456799999999999 899999999999876 6789999999 88999999766677999999999999999999999
Q ss_pred HCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHH
Q 013092 93 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLG 172 (449)
Q Consensus 93 ~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG 172 (449)
++||+||||||+|||+ +.++.+||+|||+++........ +.......||..|+|||++.+..++.++||||||
T Consensus 144 ~~~i~H~dikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG 216 (302)
T 4e5w_A 144 SRQYVHRDLAARNVLV---ESEHQVKIGDFGLTKAIETDKEY----YTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFG 216 (302)
T ss_dssp HTTEECSCCSGGGEEE---EETTEEEECCCTTCEECCTTCCE----EECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHH
T ss_pred cCCcccCCCchheEEE---cCCCCEEECcccccccccCCCcc----eeccCCCCCCccccCCeeecCCCCCcchhHHHHH
Confidence 9999999999999999 46789999999999887654321 1223456788999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCCc--------CCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHH
Q 013092 173 YVLMYFLRGSLPWQGLKA--------GTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRI 244 (449)
Q Consensus 173 ~il~elltG~~Pf~~~~~--------~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~ 244 (449)
|++|+|++|..||..... .........+............+..+++++.+||..||+.+|.+||++.+|.+.
T Consensus 217 ~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 296 (302)
T 4e5w_A 217 VTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEG 296 (302)
T ss_dssp HHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHH
Confidence 999999999998753210 000000011111111111112345689999999999999999999999999999
Q ss_pred HHHHH
Q 013092 245 FRDLF 249 (449)
Q Consensus 245 L~~~~ 249 (449)
|++++
T Consensus 297 L~~ll 301 (302)
T 4e5w_A 297 FEALL 301 (302)
T ss_dssp HHHHH
T ss_pred HHHHh
Confidence 98875
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=335.07 Aligned_cols=218 Identities=19% Similarity=0.328 Sum_probs=178.8
Q ss_pred ChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 013092 17 KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 95 (449)
Q Consensus 17 ~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~g 95 (449)
....+.+|+++|+.| +||||+++++++.. +..||||||| +++|.+++.. ...+++..++.|+.||+.||+|||++|
T Consensus 413 ~~~~~~~E~~il~~l-~hpnIv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~ 489 (635)
T 4fl3_A 413 LKDELLAEANVMQQL-DNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESN 489 (635)
T ss_dssp GHHHHHHHHHHHHHC-CCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHhC-CCCCEeeEEEEEec-CCEEEEEEccCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 356799999999999 89999999999864 4588999999 9999999975 567999999999999999999999999
Q ss_pred ceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHHH
Q 013092 96 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVL 175 (449)
Q Consensus 96 ivHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il 175 (449)
|+||||||+|||| +.++.+||+|||+++.+...... +.......+|+.|+|||++.+..++.++|||||||++
T Consensus 490 iiHrDLkp~NILl---~~~~~~kL~DFGla~~~~~~~~~----~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l 562 (635)
T 4fl3_A 490 FVHRDLAARNVLL---VTQHYAKISDFGLSKALRADENY----YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLM 562 (635)
T ss_dssp CCCSCCSGGGEEE---EETTEEEECCTTHHHHTTC-----------------CGGGSCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred EeCCCCChHhEEE---eCCCCEEEEEcCCccccccCccc----cccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHH
Confidence 9999999999999 47789999999999876543221 1122344678899999999999999999999999999
Q ss_pred HHHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 013092 176 MYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIR 251 (449)
Q Consensus 176 ~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~L~~~~~~ 251 (449)
|||++ |..||.+... .+....+...... ..+..+|+++.+||..||+.+|++||++.+|.+.|++++..
T Consensus 563 ~ellt~G~~Pf~~~~~---~~~~~~i~~~~~~----~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 632 (635)
T 4fl3_A 563 WEAFSYGQKPYRGMKG---SEVTAMLEKGERM----GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 632 (635)
T ss_dssp HHHHTTTCCSSTTCCH---HHHHHHHHTTCCC----CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred HHHHhCCCCCCCCCCH---HHHHHHHHcCCCC----CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 99998 9999987544 3333334333221 23457899999999999999999999999999999998754
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=308.84 Aligned_cols=232 Identities=19% Similarity=0.243 Sum_probs=187.9
Q ss_pred EEEeeecccCC---ChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHc-------------
Q 013092 6 TVFSVQENVKT---KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFC------------- 68 (449)
Q Consensus 6 kV~~k~~~~~~---~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~------------- 68 (449)
+|++|...... ....+.+|+++++.+.+||||+++++++.+.+..||||||+ +++|.+++...
T Consensus 78 ~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~ 157 (333)
T 2i1m_A 78 KVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIA 157 (333)
T ss_dssp EEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC------
T ss_pred HHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCceEEEEecCCCCcHHHHHHHhccccccccccccc
Confidence 45555443322 34568899999999988999999999999999999999999 88999998743
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccC
Q 013092 69 SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGT 148 (449)
Q Consensus 69 ~~~ls~~~~~~i~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT 148 (449)
...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++........ .......||
T Consensus 158 ~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~~~ 229 (333)
T 2i1m_A 158 NSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLL---TNGHVAKIGDFGLARDIMNDSNY-----IVKGNARLP 229 (333)
T ss_dssp -CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEE---EGGGEEEBCCCGGGCCGGGCTTS-----EECSSCEEC
T ss_pred ccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEE---CCCCeEEECccccccccccccce-----eecCCCCCC
Confidence 2458999999999999999999999999999999999999 47789999999999876543321 122345678
Q ss_pred ccccchhhhhCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHH
Q 013092 149 ARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYC 227 (449)
Q Consensus 149 ~~Y~aPE~~~~~~~s~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~c 227 (449)
+.|+|||++.+..++.++|||||||++|+|++ |..||.+..... .+..+....... ..+..+|+++.++|..|
T Consensus 230 ~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~~~~~~~~~~~~---~~~~~~~~~l~~li~~~ 303 (333)
T 2i1m_A 230 VKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS---KFYKLVKDGYQM---AQPAFAPKNIYSIMQAC 303 (333)
T ss_dssp GGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH---HHHHHHHHTCCC---CCCTTCCHHHHHHHHHH
T ss_pred ccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH---HHHHHHhcCCCC---CCCCCCCHHHHHHHHHH
Confidence 89999999999999999999999999999998 999998754432 122222222111 12345789999999999
Q ss_pred hcCCCCCCCCHHHHHHHHHHHHHH
Q 013092 228 RSLRFDDKPDYAYLKRIFRDLFIR 251 (449)
Q Consensus 228 l~~~p~~RPt~~~l~~~L~~~~~~ 251 (449)
|+.+|++||++.+|.+.|+++...
T Consensus 304 l~~~p~~Rps~~~l~~~L~~~~~~ 327 (333)
T 2i1m_A 304 WALEPTHRPTFQQICSFLQEQAQE 327 (333)
T ss_dssp TCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hccChhhCcCHHHHHHHHHHHHHh
Confidence 999999999999999999988654
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=314.79 Aligned_cols=213 Identities=21% Similarity=0.202 Sum_probs=180.1
Q ss_pred ChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 013092 17 KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 95 (449)
Q Consensus 17 ~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~g 95 (449)
....+.+|+++|+.| +||||+++++++.+.+..||||||+ +++|.+++......+++..++.++.||+.||+|||++|
T Consensus 129 ~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ 207 (373)
T 2x4f_A 129 DKEEVKNEISVMNQL-DHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMY 207 (373)
T ss_dssp HHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred cHHHHHHHHHHHHhC-CCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 345789999999999 8999999999999999999999999 89999998765557999999999999999999999999
Q ss_pred ceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHHH
Q 013092 96 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVL 175 (449)
Q Consensus 96 ivHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il 175 (449)
|+||||||+|||+.. +..+.+||+|||+++.+..... .....||+.|+|||++.+..++.++|||||||++
T Consensus 208 ivH~Dlkp~NIll~~-~~~~~~kl~DFG~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il 278 (373)
T 2x4f_A 208 ILHLDLKPENILCVN-RDAKQIKIIDFGLARRYKPREK--------LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIA 278 (373)
T ss_dssp EECCCCCGGGEEEEE-TTTTEEEECCCSSCEECCTTCB--------CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHH
T ss_pred cccccCCHHHEEEec-CCCCcEEEEeCCCceecCCccc--------cccccCCCcEeChhhccCCCCCcHHhHHHHHHHH
Confidence 999999999999942 3457899999999987754322 2345799999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 176 MYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 176 ~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
|+|++|..||.+.. ..+.+..+........ ......+++++.+||..||+.+|.+||++.++++
T Consensus 279 ~elltg~~pf~~~~---~~~~~~~i~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 279 YMLLSGLSPFLGDN---DAETLNNILACRWDLE-DEEFQDISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp HHHHHSSCTTCCSS---HHHHHHHHHHTCCCSC-SGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHhCCCCCCCCC---HHHHHHHHHhccCCCC-hhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 99999999998743 3444555554433221 2234578999999999999999999999888764
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-37 Score=294.43 Aligned_cols=214 Identities=20% Similarity=0.218 Sum_probs=181.2
Q ss_pred CCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH
Q 013092 15 KTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 93 (449)
Q Consensus 15 ~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~ 93 (449)
......+.+|+++++.+ +||||+++++++.+.+..||||||+ +++|.+++.. ...+++..++.++.|++.||+|||+
T Consensus 47 ~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~ 124 (277)
T 3f3z_A 47 VEDVDRFKQEIEIMKSL-DHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVH-KRVFRESDAARIMKDVLSAVAYCHK 124 (277)
T ss_dssp CSCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHH
T ss_pred cchHHHHHHHHHHHHhC-CCCCEeeEEEEEecCCeEEEEEeccCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 34567899999999999 9999999999999999999999999 8999999875 4569999999999999999999999
Q ss_pred CCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHH
Q 013092 94 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGY 173 (449)
Q Consensus 94 ~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~ 173 (449)
+||+||||||+|||+..++.++.+||+|||++..+..... .....||+.|+|||++.+. ++.++|||||||
T Consensus 125 ~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~--------~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~ 195 (277)
T 3f3z_A 125 LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM--------MRTKVGTPYYVSPQVLEGL-YGPECDEWSAGV 195 (277)
T ss_dssp TTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSC--------BCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHH
T ss_pred CCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccc--------hhccCCCCCccChHHhccc-CCchhhehhHHH
Confidence 9999999999999996556778999999999987654332 2345799999999998765 899999999999
Q ss_pred HHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 174 VLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 174 il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
++|+|++|..||.... ..+.+..+.......+ ......+++++.++|..||+.+|++||++.++++
T Consensus 196 ~l~~l~~g~~p~~~~~---~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 196 MMYVLLCGYPPFSAPT---DSEVMLKIREGTFTFP-EKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp HHHHHHHSSCSSCCSS---HHHHHHHHHHCCCCCC-HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred HHHHHHHCCCCCCCCC---HHHHHHHHHhCCCCCC-chhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 9999999999998743 3444555555443322 2334578999999999999999999999887753
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-37 Score=302.42 Aligned_cols=210 Identities=16% Similarity=0.263 Sum_probs=177.6
Q ss_pred CChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC
Q 013092 16 TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 94 (449)
Q Consensus 16 ~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~ 94 (449)
.....+.+|+.+++.+ .||||+++++++...+..||||||+ |++|.+++. ...+++..++.++.||+.||+|||++
T Consensus 84 ~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~--~~~l~~~~~~~i~~qi~~~L~~LH~~ 160 (321)
T 2c30_A 84 QRRELLFNEVVIMRDY-QHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVS--QVRLNEEQIATVCEAVLQALAYLHAQ 160 (321)
T ss_dssp CSHHHHHHHHHHHTTC-CCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred hHHHHHHHHHHHHHhC-CCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 4456789999999999 8999999999999999999999999 999999987 45799999999999999999999999
Q ss_pred CceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHH
Q 013092 95 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYV 174 (449)
Q Consensus 95 givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~i 174 (449)
||+||||||+|||+ +.++.+||+|||++........ ......||+.|+|||++.+..++.++|||||||+
T Consensus 161 ~ivH~Dlkp~NIll---~~~~~~kl~Dfg~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~i 230 (321)
T 2c30_A 161 GVIHRDIKSDSILL---TLDGRVKLSDFGFCAQISKDVP-------KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIM 230 (321)
T ss_dssp TEECCCCSGGGEEE---CTTCCEEECCCTTCEECCSSSC-------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHH
T ss_pred CeecCCCCHHHEEE---CCCCcEEEeeeeeeeecccCcc-------ccccccCCccccCHhhhcCCCCCchhhHHHHHHH
Confidence 99999999999999 5788999999999987654322 1235679999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 175 LMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 175 l~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
+|+|++|..||.... ..+.+..+....... ......+++++.++|..||+.+|++||++.++++
T Consensus 231 l~el~~g~~pf~~~~---~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 231 VIEMVDGEPPYFSDS---PVQAMKRLRDSPPPK--LKNSHKVSPVLRDFLERMLVRDPQERATAQELLD 294 (321)
T ss_dssp HHHHHHSSCTTTTSC---HHHHHHHHHHSSCCC--CTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHHhCCCCCCCCC---HHHHHHHHhcCCCCC--cCccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 999999999997643 333444443332211 1123457899999999999999999999888754
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-37 Score=304.38 Aligned_cols=221 Identities=15% Similarity=0.261 Sum_probs=186.0
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcC---------------CCCCHHHHHHHH
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCS---------------RKLSLKTVLMLA 81 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~---------------~~ls~~~~~~i~ 81 (449)
...+.+|+++++.+.+||||+++++++.+.+..||||||+ +++|.+++.... ..+++..++.++
T Consensus 84 ~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 163 (334)
T 2pvf_A 84 LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCT 163 (334)
T ss_dssp HHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHH
T ss_pred HHHHHHHHHHHHHhhcCCCEeeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHH
Confidence 3468899999999989999999999999999999999999 899999997532 248999999999
Q ss_pred HHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCC
Q 013092 82 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIE 161 (449)
Q Consensus 82 ~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~ 161 (449)
.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++........ .......+|+.|+|||++.+..
T Consensus 164 ~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~ 235 (334)
T 2pvf_A 164 YQLARGMEYLASQKCIHRDLAARNVLV---TENNVMKIADFGLARDINNIDYY-----KKTTNGRLPVKWMAPEALFDRV 235 (334)
T ss_dssp HHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTTCEECTTTSSE-----ECCSCCCCCGGGCCHHHHHHCE
T ss_pred HHHHHHHHHHHhCCeeCCCCccceEEE---cCCCCEEEccccccccccccccc-----cccCCCCcccceeChHHhcCCC
Confidence 999999999999999999999999999 57889999999999876543221 1223456788999999999988
Q ss_pred CChhhHHHHHHHHHHHHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHH
Q 013092 162 QSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAY 240 (449)
Q Consensus 162 ~s~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~ 240 (449)
++.++|||||||++|+|++ |..||.+... .+.+..+...... .....++.++.++|..||+.+|++||++.+
T Consensus 236 ~~~~~Di~slG~il~ellt~g~~p~~~~~~---~~~~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~e 308 (334)
T 2pvf_A 236 YTHQSDVWSFGVLMWEIFTLGGSPYPGIPV---EELFKLLKEGHRM----DKPANCTNELYMMMRDCWHAVPSQRPTFKQ 308 (334)
T ss_dssp ECHHHHHHHHHHHHHHHHTTSCCSSTTCCH---HHHHHHHHHTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred cChHHHHHHHHHHHHHHHhCCCCCcCcCCH---HHHHHHHhcCCCC----CCCccCCHHHHHHHHHHccCChhhCcCHHH
Confidence 9999999999999999999 9999987432 3333334333211 234568999999999999999999999999
Q ss_pred HHHHHHHHHHHcC
Q 013092 241 LKRIFRDLFIREG 253 (449)
Q Consensus 241 l~~~L~~~~~~~~ 253 (449)
|.+.|+.++....
T Consensus 309 ll~~L~~l~~~~~ 321 (334)
T 2pvf_A 309 LVEDLDRILTLTT 321 (334)
T ss_dssp HHHHHHHHHHHHC
T ss_pred HHHHHHHHHhccc
Confidence 9999999987553
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=302.50 Aligned_cols=207 Identities=17% Similarity=0.253 Sum_probs=171.2
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEe--CCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVE--GDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 94 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~--~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~ 94 (449)
...+.+|+++++.+ .||||+++++++.+ .+..||||||+ +++|.+++. ...+++..++.++.||+.||+|||++
T Consensus 80 ~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~ 156 (298)
T 2zv2_A 80 IEQVYQEIAILKKL-DHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT--LKPLSEDQARFYFQDLIKGIEYLHYQ 156 (298)
T ss_dssp -CHHHHHHHHHHTC-CCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC--SSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHhC-CCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 35689999999999 89999999999986 67899999999 889988765 45799999999999999999999999
Q ss_pred CceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCC---CChhhHHHHH
Q 013092 95 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIE---QSRRDDLESL 171 (449)
Q Consensus 95 givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~---~s~~~DiwSl 171 (449)
||+||||||+|||+ +.++.+||+|||+++.+...... .....||+.|+|||++.+.. ++.++|||||
T Consensus 157 ~ivH~Dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~sl 226 (298)
T 2zv2_A 157 KIIHRDIKPSNLLV---GEDGHIKIADFGVSNEFKGSDAL-------LSNTVGTPAFMAPESLSETRKIFSGKALDVWAM 226 (298)
T ss_dssp TEECCCCCGGGEEE---CTTSCEEECCCTTCEECSSSSCE-------ECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHH
T ss_pred CeeccCCCHHHEEE---CCCCCEEEecCCCcccccccccc-------ccCCcCCccccChhhhccCCCCCCCchhhhHhH
Confidence 99999999999999 57889999999999876543221 13457999999999998765 3789999999
Q ss_pred HHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 172 GYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 172 G~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
||++|+|++|..||.+.. .......+.......+ ....+++++.+||..||+.||++||++.+|++
T Consensus 227 G~~l~~l~~g~~pf~~~~---~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 227 GVTLYCFVFGQCPFMDER---IMCLHSKIKSQALEFP---DQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp HHHHHHHHHSSCSSCCSS---HHHHHHHHHHCCCCCC---SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred HHHHHHHHHCCCCCCCcc---HHHHHHHHhcccCCCC---CccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 999999999999997642 2333344433322211 12468999999999999999999999887743
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-37 Score=303.69 Aligned_cols=220 Identities=14% Similarity=0.208 Sum_probs=178.4
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 96 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gi 96 (449)
...+.+|+++++.+ .||||+++++++.+.+..||||||+ +++|.+++......+++..++.++.||+.||+|||++||
T Consensus 90 ~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i 168 (333)
T 1mqb_A 90 RVDFLGEAGIMGQF-SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNY 168 (333)
T ss_dssp HHHHHHHHHHHHTC-CCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred HHHHHHHHHHHHhC-CCCCCCcEEEEEecCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 34588999999999 8999999999999999999999999 889999998766779999999999999999999999999
Q ss_pred eecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHHHH
Q 013092 97 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLM 176 (449)
Q Consensus 97 vHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il~ 176 (449)
+||||||+|||+ +.++.+||+|||+++......... .......+|+.|+|||++.+..++.++|||||||++|
T Consensus 169 vH~Dikp~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 241 (333)
T 1mqb_A 169 VHRDLAARNILV---NSNLVCKVSDFGLSRVLEDDPEAT----YTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMW 241 (333)
T ss_dssp CCSCCCGGGEEE---CTTCCEEECCCCC---------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHH
T ss_pred eCCCCChheEEE---CCCCcEEECCCCcchhhccccccc----cccCCCCccccccCchhcccCCCCchhhhHHHHHHHH
Confidence 999999999999 578899999999998765432211 1112345688999999999999999999999999999
Q ss_pred HHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 013092 177 YFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIRE 252 (449)
Q Consensus 177 ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~L~~~~~~~ 252 (449)
+|++ |..||.+... .+.+..+...... .....++.++.++|..||+.+|++||++.+|.+.|++++...
T Consensus 242 ellt~g~~pf~~~~~---~~~~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~ 311 (333)
T 1mqb_A 242 EVMTYGERPYWELSN---HEVMKAINDGFRL----PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 311 (333)
T ss_dssp HHHTTSCCTTTTCCH---HHHHHHHHTTCCC----CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred HHHcCCCCCcccCCH---HHHHHHHHCCCcC----CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 9998 9999977433 3334444333211 123468999999999999999999999999999999987643
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=295.57 Aligned_cols=218 Identities=17% Similarity=0.246 Sum_probs=184.3
Q ss_pred CChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC
Q 013092 16 TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 94 (449)
Q Consensus 16 ~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~ 94 (449)
...+.+.+|+++++.+ .||||+++++++.+.+..|+||||+ +++|.+++......+++..++.++.|++.||+|||++
T Consensus 45 ~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 123 (267)
T 3t9t_A 45 MSEEDFIEEAEVMMKL-SHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA 123 (267)
T ss_dssp BCHHHHHHHHHHHHTC-CCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CCHHHHHHHHHHHHhC-CCCCEeeEEEEEccCCCeEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhC
Confidence 3456799999999999 8999999999999999999999999 8999999987666799999999999999999999999
Q ss_pred CceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHH
Q 013092 95 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYV 174 (449)
Q Consensus 95 givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~i 174 (449)
||+||||||+||++ +.++.+||+|||+++...... ........+|+.|+|||++.+..++.++||||||++
T Consensus 124 ~i~H~dl~p~Nili---~~~~~~kl~dfg~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~i 194 (267)
T 3t9t_A 124 CVIHRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQ------YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVL 194 (267)
T ss_dssp TCCCSSCCGGGEEE---CGGGCEEECCTTGGGGBCCHH------HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHH
T ss_pred CcccCCCchheEEE---CCCCCEEEccccccccccccc------ccccccccccccccChhhhcCCCccchhchhhhHHH
Confidence 99999999999999 577899999999997654321 112234567889999999999999999999999999
Q ss_pred HHHHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 013092 175 LMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFI 250 (449)
Q Consensus 175 l~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~L~~~~~ 250 (449)
+|+|++ |..||.... ..+....+...... .....++.++.+++..||+.+|++||++.++.+.|+++..
T Consensus 195 l~~l~~~g~~p~~~~~---~~~~~~~i~~~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 195 MWEVFSEGKIPYENRS---NSEVVEDISTGFRL----YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp HHHHHTTSCCTTTTCC---HHHHHHHHHTTCCC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHhccCCCCCCCCC---HHHHHHHHhcCCcC----CCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 999999 999998743 33344444333211 1234578999999999999999999999999999998864
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=309.57 Aligned_cols=210 Identities=23% Similarity=0.296 Sum_probs=173.8
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 96 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gi 96 (449)
...+.+|+.+++.+ +||||+++++++.+++..||||||| |++|.+++.. ...+++..++.++.||+.||+|||++||
T Consensus 49 ~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~gi 126 (323)
T 3tki_A 49 PENIKKEICINKML-NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGI 126 (323)
T ss_dssp --CHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred HHHHHHHHHHHHhC-CCCCCCeEEEEEecCCeEEEEEEcCCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 46789999999999 8999999999999999999999999 8899999874 4569999999999999999999999999
Q ss_pred eecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCC-ChhhHHHHHHHHH
Q 013092 97 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQ-SRRDDLESLGYVL 175 (449)
Q Consensus 97 vHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~-s~~~DiwSlG~il 175 (449)
+||||||+|||+ +.++.+||+|||+++.+...... .......||+.|+|||++.+..+ +.++|||||||++
T Consensus 127 vH~Dlkp~NIll---~~~~~~kl~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il 198 (323)
T 3tki_A 127 THRDIKPENLLL---DERDNLKISDFGLATVFRYNNRE-----RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVL 198 (323)
T ss_dssp ECSCCSGGGEEE---CTTCCEEECCCTTCEECEETTEE-----CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHH
T ss_pred cccccchHHEEE---eCCCCEEEEEeeccceeccCCcc-----cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHH
Confidence 999999999999 67889999999999876543221 11235689999999999998775 7899999999999
Q ss_pred HHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 013092 176 MYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 242 (449)
Q Consensus 176 ~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~ 242 (449)
|+|++|..||....... ..+..+....... .....+++++.+||..||..||++||++.+|+
T Consensus 199 ~~ll~g~~pf~~~~~~~--~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil 260 (323)
T 3tki_A 199 TAMLAGELPWDQPSDSC--QEYSDWKEKKTYL---NPWKKIDSAPLALLHKILVENPSARITIPDIK 260 (323)
T ss_dssp HHHHHSSCSCSSSCTTS--HHHHHHHTTCTTS---TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHT
T ss_pred HHHHhCCCCCCCCchHH--HHHHHHhcccccC---CccccCCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 99999999998754432 2233232222111 12346889999999999999999999988774
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-37 Score=322.33 Aligned_cols=226 Identities=19% Similarity=0.286 Sum_probs=186.6
Q ss_pred cEEEEEeeecccCCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHH
Q 013092 3 EILTVFSVQENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLA 81 (449)
Q Consensus 3 ~aikV~~k~~~~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~ 81 (449)
+|+|++.+..........+.+|+.+++.+ +||||+++++++.+....||||||| |++|.+++.. ...+++..++.++
T Consensus 65 ~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~-~~~~~~~~~~~i~ 142 (494)
T 3lij_A 65 RAIKIIRKTSVSTSSNSKLLEEVAVLKLL-DHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIH-RMKFNEVDAAVII 142 (494)
T ss_dssp EEEEEEEC-----CTTHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHH
T ss_pred EEEEEEeccccCchHHHHHHHHHHHHHhC-CCCCCCeEEEEEEeCCEEEEEEecCCCCcHHHHHHH-cCCCCHHHHHHHH
Confidence 46777776665556677899999999999 8999999999999999999999999 9999998875 4579999999999
Q ss_pred HHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCC
Q 013092 82 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIE 161 (449)
Q Consensus 82 ~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~ 161 (449)
.||+.||.|||++||+||||||+|||+......+.+||+|||+++.+..... .....||+.|+|||++. ..
T Consensus 143 ~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~~--------~~~~~gt~~y~aPE~l~-~~ 213 (494)
T 3lij_A 143 KQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK--------MKERLGTAYYIAPEVLR-KK 213 (494)
T ss_dssp HHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTBC--------BCCCCSCTTTCCHHHHT-TC
T ss_pred HHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCcc--------ccccCCCcCeeCHHHHc-cc
Confidence 9999999999999999999999999996444567799999999987764322 23457999999999986 46
Q ss_pred CChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHH
Q 013092 162 QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYL 241 (449)
Q Consensus 162 ~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l 241 (449)
++.++|||||||++|+|++|..||.+.. ..+.+..+......... ..+..+++++.+||..||+.+|.+||++.++
T Consensus 214 ~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~~i~~~~~~~~~-~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~ 289 (494)
T 3lij_A 214 YDEKCDVWSIGVILFILLAGYPPFGGQT---DQEILRKVEKGKYTFDS-PEWKNVSEGAKDLIKQMLQFDSQRRISAQQA 289 (494)
T ss_dssp BCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHTCCCCCS-GGGTTSCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred CCCchhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhCCCCCCc-hhcccCCHHHHHHHHHHCCCChhhCccHHHH
Confidence 8999999999999999999999998743 34555556555443222 2345789999999999999999999999887
Q ss_pred HH
Q 013092 242 KR 243 (449)
Q Consensus 242 ~~ 243 (449)
++
T Consensus 290 l~ 291 (494)
T 3lij_A 290 LE 291 (494)
T ss_dssp HT
T ss_pred hc
Confidence 63
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=311.73 Aligned_cols=214 Identities=19% Similarity=0.194 Sum_probs=164.7
Q ss_pred ChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 013092 17 KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 95 (449)
Q Consensus 17 ~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~g 95 (449)
....+.+|+++++.+ .||||+++++++.+.+..||||||+ +++|.+++.. ...+++..++.++.||+.||+|||++|
T Consensus 91 ~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ 168 (349)
T 2w4o_A 91 DKKIVRTEIGVLLRL-SHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVE-KGYYSERDAADAVKQILEAVAYLHENG 168 (349)
T ss_dssp --------CHHHHHC-CCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTT-CSSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred hHHHHHHHHHHHHhC-CCCCCcceeeeEecCCeEEEEEEeCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 446788999999999 8999999999999999999999999 8999999975 456999999999999999999999999
Q ss_pred ceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHHH
Q 013092 96 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVL 175 (449)
Q Consensus 96 ivHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il 175 (449)
|+||||||+|||+...+.++.+||+|||+++....... .....||+.|+|||++.+..++.++|||||||++
T Consensus 169 ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il 240 (349)
T 2w4o_A 169 IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL--------MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIIT 240 (349)
T ss_dssp CCCCCCCGGGEEESSSSTTCCEEECCCC------------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHH
T ss_pred eEecCCCcccEEEecCCCCCCEEEccCccccccCcccc--------cccccCCCCccCHHHhcCCCCCcccchHHHHHHH
Confidence 99999999999995434578999999999987644321 2345799999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 176 MYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 176 ~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
|+|++|..||..... ....+..+...... ........++.++.+||..||..||++||++.++++
T Consensus 241 ~ell~g~~pf~~~~~--~~~~~~~i~~~~~~-~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 241 YILLCGFEPFYDERG--DQFMFRRILNCEYY-FISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp HHHHHSSCTTCCTTC--HHHHHHHHHTTCCC-CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHhCCCCCCCCcc--cHHHHHHHHhCCCc-cCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 999999999976433 22344444443332 122344678999999999999999999999877654
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-37 Score=297.84 Aligned_cols=217 Identities=16% Similarity=0.190 Sum_probs=178.3
Q ss_pred ChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 013092 17 KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 95 (449)
Q Consensus 17 ~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~g 95 (449)
..+.+.+|+.+++.+ +||||+++++++.++ ..|+||||+ +++|.+++......+++..++.++.|++.||+|||++|
T Consensus 56 ~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 133 (281)
T 3cc6_A 56 NKEKFMSEAVIMKNL-DHPHIVKLIGIIEEE-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESIN 133 (281)
T ss_dssp HHHHHHHHHHHHHHH-CCTTBCCEEEEECSS-SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHhC-CCCCcceEEEEEcCC-CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 345689999999999 899999999987654 568999999 89999999876667999999999999999999999999
Q ss_pred ceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHHH
Q 013092 96 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVL 175 (449)
Q Consensus 96 ivHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il 175 (449)
|+||||||+|||++ .++.+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||++
T Consensus 134 i~H~dlkp~Nil~~---~~~~~kl~Dfg~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 204 (281)
T 3cc6_A 134 CVHRDIAVRNILVA---SPECVKLGDFGLSRYIEDEDY------YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCM 204 (281)
T ss_dssp CCCCCCSGGGEEEE---ETTEEEECCCCGGGCC---------------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred cccCCCccceEEEC---CCCcEEeCccCCCcccccccc------cccccCCCCcceeCchhhccCCCCchhccHHHHHHH
Confidence 99999999999994 678999999999987654322 112345678899999999999999999999999999
Q ss_pred HHHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 013092 176 MYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIR 251 (449)
Q Consensus 176 ~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~L~~~~~~ 251 (449)
|+|++ |..||........ ...+...... .....+++++.++|..||..+|++||++.+|.+.|++++..
T Consensus 205 ~~llt~g~~p~~~~~~~~~---~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 274 (281)
T 3cc6_A 205 WEILSFGKQPFFWLENKDV---IGVLEKGDRL----PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274 (281)
T ss_dssp HHHHTTTCCTTTTSCGGGH---HHHHHHTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHhCCCCCcccCChHHH---HHHHhcCCCC----CCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence 99998 9999987554332 2222222111 12346899999999999999999999999999999988654
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=308.03 Aligned_cols=228 Identities=19% Similarity=0.173 Sum_probs=170.0
Q ss_pred EEEEEeeecccCCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHH
Q 013092 4 ILTVFSVQENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQ 83 (449)
Q Consensus 4 aikV~~k~~~~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~~~~i~~q 83 (449)
|||++.+..........+.+|+++++.+ .||||+++++++.+.+..||||||++++|.+++.. ...+++..++.++.|
T Consensus 63 aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~L~~~~~~-~~~~~~~~~~~i~~q 140 (329)
T 3gbz_A 63 AIKRIRLEHEEEGVPGTAIREVSLLKEL-QHRNIIELKSVIHHNHRLHLIFEYAENDLKKYMDK-NPDVSMRVIKSFLYQ 140 (329)
T ss_dssp EEEECCCCC--------CHHHHHHGGGC-CCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHH-CTTCCHHHHHHHHHH
T ss_pred EEEEEcccccccccchhHHHHHHHHHHc-CCCCcceEEEEEecCCEEEEEEecCCCCHHHHHhh-cCCCCHHHHHHHHHH
Confidence 4454443333333445678999999999 89999999999999999999999997799999986 456999999999999
Q ss_pred HHHHHHHHHHCCceecCCCCCcEEEeec--CCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCC-
Q 013092 84 MINRVEFVHSKSFLHRDIKPDNFLMGLG--RRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI- 160 (449)
Q Consensus 84 i~~aL~yLH~~givHRDLKP~NiLl~~~--~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~- 160 (449)
|+.||+|||++||+||||||+|||+..+ +..+.+||+|||+++.+..... ......||+.|+|||++.+.
T Consensus 141 l~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~~-------~~~~~~~t~~y~aPE~~~~~~ 213 (329)
T 3gbz_A 141 LINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIR-------QFTHEIITLWYRPPEILLGSR 213 (329)
T ss_dssp HHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC------------------CCTTCCHHHHTTCC
T ss_pred HHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCCccc-------ccCCCcCCccccCHHHhcCCC
Confidence 9999999999999999999999999532 2445699999999987653321 12345789999999999875
Q ss_pred CCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhccc-------------------------chHHHhhcC
Q 013092 161 EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS-------------------------TSIEALCRG 215 (449)
Q Consensus 161 ~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~-------------------------~~~~~l~~~ 215 (449)
.++.++|||||||++|+|++|..||.+... .+.+..+...... .....+...
T Consensus 214 ~~~~~~DiwslG~il~ell~g~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (329)
T 3gbz_A 214 HYSTSVDIWSIACIWAEMLMKTPLFPGDSE---IDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGAL 290 (329)
T ss_dssp CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGG
T ss_pred CCCcHHHHHHHHHHHHHHHHCCCCcCCCCH---HHHHHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccc
Confidence 489999999999999999999999987433 3333333322110 011112233
Q ss_pred CcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 216 YPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 216 ~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
+++++.+||..||+.||++||++.++++
T Consensus 291 ~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 291 LDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred cCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 7899999999999999999999887753
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=308.62 Aligned_cols=224 Identities=19% Similarity=0.200 Sum_probs=176.7
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeCC----EEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEGD----YNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 92 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~----~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH 92 (449)
...+.+|+.++..+ .||||+++++++.+.. ..||||||| +++|.++++. ..+++..++.++.|++.||+|||
T Consensus 62 ~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~qi~~al~~LH 138 (322)
T 3soc_A 62 SWQNEYEVYSLPGM-KHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA--NVVSWNELCHIAETMARGLAYLH 138 (322)
T ss_dssp HHHHHHHHHTSTTC-CCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHhcC-CCCCchhhcceeccCCCCCceEEEEEecCCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHH
Confidence 34566788889999 8999999999998743 479999999 8999999984 46999999999999999999999
Q ss_pred HC----------CceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCC--
Q 013092 93 SK----------SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI-- 160 (449)
Q Consensus 93 ~~----------givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~-- 160 (449)
+. ||+||||||+|||+ +.++.+||+|||+++.+...... .......||+.|+|||++.+.
T Consensus 139 ~~~~~l~~~~~~~ivH~Dlkp~Nill---~~~~~~kL~DFg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~ 210 (322)
T 3soc_A 139 EDIPGLKDGHKPAISHRDIKSKNVLL---KNNLTACIADFGLALKFEAGKSA-----GDTHGQVGTRRYMAPEVLEGAIN 210 (322)
T ss_dssp CCEEEETTEEECEEECSCCSGGGEEE---CTTCCEEECCCTTCEEECTTSCC-----CCCTTCCCCGGGCCHHHHTTCCC
T ss_pred hhccccccccCCCEEeCCCChHhEEE---CCCCeEEEccCCcccccccccCc-----cccccCccCccccCHhhcccccc
Confidence 99 99999999999999 67889999999999887654321 122346799999999999873
Q ss_pred ---CCChhhHHHHHHHHHHHHHhCCCCCCCCCcCC-------------HHHHHHHHHhhcccchHHHhh--cCCcHHHHH
Q 013092 161 ---EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT-------------KKQKYEKISEKKVSTSIEALC--RGYPTEFAS 222 (449)
Q Consensus 161 ---~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~-------------~~~~~~~i~~~~~~~~~~~l~--~~~p~el~~ 222 (449)
.++.++|||||||++|||++|..||.+..... .......+......+.+.... ..+++++.+
T Consensus 211 ~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 290 (322)
T 3soc_A 211 FQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCE 290 (322)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHH
T ss_pred cCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHH
Confidence 45678899999999999999999998754321 111222222222222221111 123567999
Q ss_pred HHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 013092 223 YFHYCRSLRFDDKPDYAYLKRIFRDLFIRE 252 (449)
Q Consensus 223 li~~cl~~~p~~RPt~~~l~~~L~~~~~~~ 252 (449)
||..||+.||++||++.+|.+.|+++....
T Consensus 291 li~~cl~~dP~~Rps~~ell~~L~~l~~~~ 320 (322)
T 3soc_A 291 TIEECWDHDAEARLSAGCVGERITQMQRLT 320 (322)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 999999999999999999999999886544
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=306.10 Aligned_cols=220 Identities=18% Similarity=0.242 Sum_probs=181.9
Q ss_pred CChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcC---------------CCCCHHHHHH
Q 013092 16 TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCS---------------RKLSLKTVLM 79 (449)
Q Consensus 16 ~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~---------------~~ls~~~~~~ 79 (449)
.....+.+|+++++.+.+||||+++++++.+.+..||||||+ +++|.+++.... ..+++..++.
T Consensus 67 ~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 146 (327)
T 1fvr_A 67 DDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 146 (327)
T ss_dssp ---CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHH
T ss_pred HHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHH
Confidence 345679999999999989999999999999999999999999 899999997532 3699999999
Q ss_pred HHHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhC
Q 013092 80 LADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG 159 (449)
Q Consensus 80 i~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~ 159 (449)
++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++...... ......+++.|+|||++.+
T Consensus 147 i~~qi~~aL~~LH~~~ivH~dlkp~NIl~---~~~~~~kL~Dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~ 215 (327)
T 1fvr_A 147 FAADVARGMDYLSQKQFIHRDLAARNILV---GENYVAKIADFGLSRGQEVYV--------KKTMGRLPVRWMAIESLNY 215 (327)
T ss_dssp HHHHHHHHHHHHHHTTEECSCCSGGGEEE---CGGGCEEECCTTCEESSCEEC--------CC----CCTTTCCHHHHHH
T ss_pred HHHHHHHHHHHHHhCCccCCCCccceEEE---cCCCeEEEcccCcCccccccc--------cccCCCCCccccChhhhcc
Confidence 99999999999999999999999999999 577899999999997433211 1233467889999999999
Q ss_pred CCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCH
Q 013092 160 IEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDY 238 (449)
Q Consensus 160 ~~~s~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~ 238 (449)
..++.++|||||||++|+|++ |..||.+... .+.+..+..... ......+++++.++|..||..+|++||++
T Consensus 216 ~~~~~~~Di~slG~il~ellt~g~~pf~~~~~---~~~~~~~~~~~~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~ 288 (327)
T 1fvr_A 216 SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC---AELYEKLPQGYR----LEKPLNCDDEVYDLMRQCWREKPYERPSF 288 (327)
T ss_dssp CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHGGGTCC----CCCCTTBCHHHHHHHHHHTCSSGGGSCCH
T ss_pred ccCCchhcchHHHHHHHHHHcCCCCCCCCCcH---HHHHHHhhcCCC----CCCCCCCCHHHHHHHHHHccCChhhCcCH
Confidence 889999999999999999998 9999987432 333343333211 12234678999999999999999999999
Q ss_pred HHHHHHHHHHHHHcC
Q 013092 239 AYLKRIFRDLFIREG 253 (449)
Q Consensus 239 ~~l~~~L~~~~~~~~ 253 (449)
.++.+.|..++....
T Consensus 289 ~ell~~L~~~~~~~~ 303 (327)
T 1fvr_A 289 AQILVSLNRMLEERK 303 (327)
T ss_dssp HHHHHHHHHHHHSSS
T ss_pred HHHHHHHHHHHHhhc
Confidence 999999999987654
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=300.08 Aligned_cols=209 Identities=16% Similarity=0.268 Sum_probs=172.7
Q ss_pred hHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC--
Q 013092 19 PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS-- 95 (449)
Q Consensus 19 ~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~g-- 95 (449)
..+.+|+++++.+ +||||+++++++.+.. +|||||+ +++|.+++......+++..++.++.|++.||+|||++|
T Consensus 68 ~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ 144 (287)
T 4f0f_A 68 QEFQREVFIMSNL-NHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPP 144 (287)
T ss_dssp HHHHHHHHHHTTC-CCTTBCCEEEEETTTT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSC
T ss_pred HHHHHHHHHHHhC-CCCCchhhheeecCCC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCC
Confidence 6789999999999 8999999999987665 6999999 89999998755667999999999999999999999999
Q ss_pred ceecCCCCCcEEEeecCCCCe-----EEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhh--CCCCChhhHH
Q 013092 96 FLHRDIKPDNFLMGLGRRANQ-----VYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHL--GIEQSRRDDL 168 (449)
Q Consensus 96 ivHRDLKP~NiLl~~~~~~~~-----vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~--~~~~s~~~Di 168 (449)
|+||||||+|||+. ..+. +||+|||+++..... .....||+.|+|||++. ...++.++||
T Consensus 145 ivH~dikp~Nil~~---~~~~~~~~~~kl~Dfg~~~~~~~~----------~~~~~g~~~y~aPE~~~~~~~~~~~~~Di 211 (287)
T 4f0f_A 145 IVHRDLRSPNIFLQ---SLDENAPVCAKVADFGLSQQSVHS----------VSGLLGNFQWMAPETIGAEEESYTEKADT 211 (287)
T ss_dssp CBCSCCSGGGEEES---CCCTTCSCCEEECCCTTCBCCSSC----------EECCCCCCTTSCGGGSSCSSCEECHHHHH
T ss_pred eecCCCCcceEEEe---ccCCCCceeEEeCCCCcccccccc----------ccccCCCccccCchhhccCCCCcCchhhH
Confidence 99999999999994 3343 999999999754332 23457999999999984 4557899999
Q ss_pred HHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Q 013092 169 ESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRD 247 (449)
Q Consensus 169 wSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~L~~ 247 (449)
|||||++|+|++|..||....... ......+...... ..+...+|+++.++|..||+.+|++||++.+|.+.|++
T Consensus 212 ~slG~~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 212 YSFAMILYTILTGEGPFDEYSYGK-IKFINMIREEGLR---PTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp HHHHHHHHHHHHSSCTTTTCCCCH-HHHHHHHHHSCCC---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred HHHHHHHHHHHcCCCCCccccccH-HHHHHHHhccCCC---CCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 999999999999999998755432 2222333332222 22446789999999999999999999999999988764
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=298.82 Aligned_cols=221 Identities=18% Similarity=0.318 Sum_probs=186.5
Q ss_pred CChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHH
Q 013092 16 TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHS 93 (449)
Q Consensus 16 ~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~-~~~ls~~~~~~i~~qi~~aL~yLH~ 93 (449)
...+.+.+|+++++.+ .||||+++++++.+.+..|+||||+ |++|.+++... ...+++..++.++.||+.||+|||+
T Consensus 51 ~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~ 129 (288)
T 3kfa_A 51 MEVEEFLKEAAVMKEI-KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 129 (288)
T ss_dssp THHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhC-CCCCEeeEEEEEccCCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHH
Confidence 3456799999999999 8999999999999999999999999 89999999864 3459999999999999999999999
Q ss_pred CCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHH
Q 013092 94 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGY 173 (449)
Q Consensus 94 ~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~ 173 (449)
+||+||||||+||++ +.++.+||+|||++........ .......+|+.|+|||++.+..++.++||||||+
T Consensus 130 ~~i~H~dikp~Nil~---~~~~~~~l~Dfg~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 200 (288)
T 3kfa_A 130 KNFIHRDLAARNCLV---GENHLVKVADFGLSRLMTGDTY------TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGV 200 (288)
T ss_dssp HTCCCSCCSGGGEEE---CGGGCEEECCCCGGGTSCSSSS------EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHH
T ss_pred CCccCCCCCcceEEE---cCCCCEEEccCccceeccCCcc------ccccCCccccCcCChhhhccCCCCchhhHHHHHH
Confidence 999999999999999 5778999999999986654322 1223456788999999999999999999999999
Q ss_pred HHHHHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 013092 174 VLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIRE 252 (449)
Q Consensus 174 il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~L~~~~~~~ 252 (449)
++|+|++ |..||.+..... ....+..... ......+|+++.+++..||..+|.+||++.+|.+.|+.++...
T Consensus 201 il~~ll~~g~~p~~~~~~~~---~~~~~~~~~~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~ 273 (288)
T 3kfa_A 201 LLWEIATYGMSPYPGIDLSQ---VYELLEKDYR----MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 273 (288)
T ss_dssp HHHHHHTTSCCSSTTCCGGG---HHHHHHTTCC----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHhCCCCCCCCCCHHH---HHHHHhccCC----CCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhc
Confidence 9999999 999998755433 2232322211 1223568999999999999999999999999999999998765
Q ss_pred C
Q 013092 253 G 253 (449)
Q Consensus 253 ~ 253 (449)
.
T Consensus 274 ~ 274 (288)
T 3kfa_A 274 S 274 (288)
T ss_dssp H
T ss_pred c
Confidence 3
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-37 Score=302.43 Aligned_cols=236 Identities=20% Similarity=0.225 Sum_probs=182.5
Q ss_pred cEEEEEeeecccCCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCC--EEEEEEecC-CCCHHHHHHHcC--CCCCHHHH
Q 013092 3 EILTVFSVQENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGD--YNVLVMDLL-GPSLEDLFNFCS--RKLSLKTV 77 (449)
Q Consensus 3 ~aikV~~k~~~~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~--~~~lVmE~~-g~sL~~ll~~~~--~~ls~~~~ 77 (449)
+|||++.+... ......+.+|+++++.+ +||||+++++++.+.. ..||||||+ +++|.+++.... ..+++..+
T Consensus 37 vavK~~~~~~~-~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 114 (319)
T 4euu_A 37 FAIKVFNNISF-LRPVDVQMREFEVLKKL-NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEF 114 (319)
T ss_dssp EEEEEECGGGG-GSCHHHHHHHHHHHHHC-CCTTBCCEEEEEECTTTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHH
T ss_pred EEEEEeccccc-cchHHHHHHHHHHHHhc-CCCCcceEEEEeecCCCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHH
Confidence 34555443222 23456788999999999 7999999999988655 789999999 899999998532 23999999
Q ss_pred HHHHHHHHHHHHHHHHCCceecCCCCCcEEEeec-CCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhh
Q 013092 78 LMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG-RRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNT 156 (449)
Q Consensus 78 ~~i~~qi~~aL~yLH~~givHRDLKP~NiLl~~~-~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~ 156 (449)
+.++.||+.||+|||++||+||||||+|||+..+ +..+.+||+|||+++.+..... .....||+.|+|||+
T Consensus 115 ~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~ 186 (319)
T 4euu_A 115 LIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ--------FVSLYGTEEYLHPDM 186 (319)
T ss_dssp HHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCTTCC--------BCCCCSCGGGCCHHH
T ss_pred HHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCceecCCCCc--------eeecccCCCccCHHH
Confidence 9999999999999999999999999999998443 3556799999999987765432 234579999999999
Q ss_pred hh--------CCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcC-CHHHHHHHHHhhcccchH------------------
Q 013092 157 HL--------GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG-TKKQKYEKISEKKVSTSI------------------ 209 (449)
Q Consensus 157 ~~--------~~~~s~~~DiwSlG~il~elltG~~Pf~~~~~~-~~~~~~~~i~~~~~~~~~------------------ 209 (449)
+. +..++.++|||||||++|||++|..||...... ...+.+.++........+
T Consensus 187 ~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 266 (319)
T 4euu_A 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMP 266 (319)
T ss_dssp HHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCC
T ss_pred hhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCcccchhhhcccCCccccCccCC
Confidence 87 567899999999999999999999999764432 223334444433221100
Q ss_pred --HHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 013092 210 --EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDL 248 (449)
Q Consensus 210 --~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~L~~~ 248 (449)
..+...++..+.+++..||+.||++||++.++.+...+.
T Consensus 267 ~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 267 VSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp TTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred cccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 011233467899999999999999999999988776654
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=305.30 Aligned_cols=225 Identities=19% Similarity=0.215 Sum_probs=179.7
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEe--CCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVE--GDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 94 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~--~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~ 94 (449)
...+.+|+++++.+ .||||+++++++.+ ....||||||+ +++|.+++.. ..+++..++.++.||+.||+|||++
T Consensus 77 ~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~i~~~l~~~l~~LH~~ 153 (318)
T 3lxp_A 77 RSGWKQEIDILRTL-YHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPR--HSIGLAQLLLFAQQICEGMAYLHAQ 153 (318)
T ss_dssp HHHHHHHHHHHHHC-CCTTBCCEEEEEEETTTTEEEEEECCCTTCBHHHHGGG--SCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHhC-CCcchhhEEEEEecCCCceEEEEEecccCCcHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 45689999999999 79999999999987 46899999999 8999999984 4599999999999999999999999
Q ss_pred CceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHH
Q 013092 95 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYV 174 (449)
Q Consensus 95 givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~i 174 (449)
||+||||||+|||+ +.++.+||+|||+++.+...... +.......+|..|+|||++.+..++.++|||||||+
T Consensus 154 ~ivH~Dikp~Nil~---~~~~~~kl~Dfg~a~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~i 226 (318)
T 3lxp_A 154 HYIHRDLAARNVLL---DNDRLVKIGDFGLAKAVPEGHEY----YRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVT 226 (318)
T ss_dssp TEECSCCSGGGEEE---CTTCCEEECCGGGCEECCTTCSE----EEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHH
T ss_pred CccCCCCchheEEE---cCCCCEEECCccccccccccccc----cccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHH
Confidence 99999999999999 67889999999999887654321 122344568899999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCCcCC--------HHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 013092 175 LMYFLRGSLPWQGLKAGT--------KKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFR 246 (449)
Q Consensus 175 l~elltG~~Pf~~~~~~~--------~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~L~ 246 (449)
+|+|++|..||....... .......+.+..........+..++.++.+||..||+.+|++||++.+|++.|+
T Consensus 227 l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 306 (318)
T 3lxp_A 227 LYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILK 306 (318)
T ss_dssp HHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 999999999997532100 000001111110011111234568999999999999999999999999999999
Q ss_pred HHHHHc
Q 013092 247 DLFIRE 252 (449)
Q Consensus 247 ~~~~~~ 252 (449)
.+....
T Consensus 307 ~l~~~~ 312 (318)
T 3lxp_A 307 TVHEKY 312 (318)
T ss_dssp HHHHHH
T ss_pred HHHHhh
Confidence 886644
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=303.36 Aligned_cols=222 Identities=18% Similarity=0.241 Sum_probs=183.0
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeC-CEEEEEEecC-CCCHHHHHHHcCCC---------------CCHHHHHHH
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEG-DYNVLVMDLL-GPSLEDLFNFCSRK---------------LSLKTVLML 80 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~-~~~~lVmE~~-g~sL~~ll~~~~~~---------------ls~~~~~~i 80 (449)
...+.+|++++..+.+||||+++++++... ...|+||||+ +++|.+++...... +++..++.+
T Consensus 74 ~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (316)
T 2xir_A 74 HRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 153 (316)
T ss_dssp HHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHH
T ss_pred HHHHHHHHHHHHhcccCCCeeeEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHH
Confidence 346889999999998899999999998765 4589999999 89999999853321 899999999
Q ss_pred HHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCC
Q 013092 81 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI 160 (449)
Q Consensus 81 ~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~ 160 (449)
+.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.+...... .......||+.|+|||++.+.
T Consensus 154 ~~qi~~al~~lH~~~i~H~dikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~ 225 (316)
T 2xir_A 154 SFQVAKGMEFLASRKCIHRDLAARNILL---SEKNVVKICDFGLARDIYKDPDY-----VRKGDARLPLKWMAPETIFDR 225 (316)
T ss_dssp HHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCGGGSCTTTCTTS-----EEETTEEECGGGCCHHHHHHC
T ss_pred HHHHHHHHHHHHhCCcccccCccceEEE---CCCCCEEECCCccccccccCccc-----eeccCCCcceeecCchhhccc
Confidence 9999999999999999999999999999 57789999999999876543221 122345688999999999999
Q ss_pred CCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHH
Q 013092 161 EQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYA 239 (449)
Q Consensus 161 ~~s~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~ 239 (449)
.++.++|||||||++|+|++ |..||.+..... .....+..... ......+++++.++|..||+.+|++||++.
T Consensus 226 ~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~--~~~~~~~~~~~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ 299 (316)
T 2xir_A 226 VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EFCRRLKEGTR----MRAPDYTTPEMYQTMLDCWHGEPSQRPTFS 299 (316)
T ss_dssp CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH--HHHHHHHHTCC----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred cccchhHHHHHHHHHHHHHhCCCCCCcccchhH--HHHHHhccCcc----CCCCCCCCHHHHHHHHHHcCCChhhCcCHH
Confidence 99999999999999999998 999998754322 22222222211 123355789999999999999999999999
Q ss_pred HHHHHHHHHHHHcC
Q 013092 240 YLKRIFRDLFIREG 253 (449)
Q Consensus 240 ~l~~~L~~~~~~~~ 253 (449)
+|.+.|+.++....
T Consensus 300 ell~~L~~~~~~~~ 313 (316)
T 2xir_A 300 ELVEHLGNLLQANA 313 (316)
T ss_dssp HHHHHHHHHHHHHC
T ss_pred HHHHHHHHHHhhhc
Confidence 99999999987553
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-38 Score=312.18 Aligned_cols=220 Identities=21% Similarity=0.232 Sum_probs=178.7
Q ss_pred cEEEEEeeeccc-CCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHH
Q 013092 3 EILTVFSVQENV-KTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLA 81 (449)
Q Consensus 3 ~aikV~~k~~~~-~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~~~~i~ 81 (449)
+|+|++.+.... ......+.+|+.+++.+ .||||+++++++.+.+..||||||++++|.+++.. .+.+++..++.++
T Consensus 37 vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~E~~~g~l~~~l~~-~~~l~~~~~~~i~ 114 (336)
T 3h4j_B 37 VALKFISRQLLKKSDMHMRVEREISYLKLL-RHPHIIKLYDVITTPTDIVMVIEYAGGELFDYIVE-KKRMTEDEGRRFF 114 (336)
T ss_dssp EEEEEEEHHHHHHTTCSHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEEECCCCEEHHHHHHH-HCSCCHHHHHHHH
T ss_pred EEEEEEehHHccchhHHHHHHHHHHHHHhC-CCCCCCeEEEEEEeCCEEEEEEECCCCcHHHHHHH-cCCCCHHHHHHHH
Confidence 345554433222 23456799999999999 89999999999999999999999999999998875 4579999999999
Q ss_pred HHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCC
Q 013092 82 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIE 161 (449)
Q Consensus 82 ~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~ 161 (449)
.||+.||+|||++||+||||||+|||+ +.++.+||+|||++........ ....+||+.|+|||++.+..
T Consensus 115 ~qi~~aL~~LH~~givH~Dlkp~NIll---~~~~~~kl~DFG~s~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~ 183 (336)
T 3h4j_B 115 QQIICAIEYCHRHKIVHRDLKPENLLL---DDNLNVKIADFGLSNIMTDGNF--------LKTSCGSPNYAAPEVINGKL 183 (336)
T ss_dssp HHHHHHHHHHHHHTCCCCCCSTTTEEE---CTTCCEEECCSSCTBTTTTSBT--------TCCCTTSTTTSCGGGSCCSG
T ss_pred HHHHHHHHHHHHCCeEecCCchhhEEE---cCCCCEEEEEeccceeccCCcc--------cccccCCcCcCCHHHHcCCC
Confidence 999999999999999999999999999 6788999999999986554321 23567999999999999877
Q ss_pred C-ChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHH
Q 013092 162 Q-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAY 240 (449)
Q Consensus 162 ~-s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~ 240 (449)
+ +.++|||||||++|+|++|..||.+...... +.++ ......++..+++++.+||..||..||.+||++.+
T Consensus 184 ~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~---~~~i-----~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~e 255 (336)
T 3h4j_B 184 YAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL---FKKV-----NSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQE 255 (336)
T ss_dssp GGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC---BCCC-----CSSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHH
T ss_pred CCCCccchhHHHHHHHHHHhCCCCCCCccHHHH---HHHH-----HcCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHH
Confidence 6 7899999999999999999999987433211 1111 11111234568899999999999999999999877
Q ss_pred HHH
Q 013092 241 LKR 243 (449)
Q Consensus 241 l~~ 243 (449)
|++
T Consensus 256 il~ 258 (336)
T 3h4j_B 256 IRR 258 (336)
T ss_dssp HTT
T ss_pred HHh
Confidence 743
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-37 Score=300.92 Aligned_cols=214 Identities=19% Similarity=0.235 Sum_probs=168.2
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 96 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gi 96 (449)
...+.+|+++++.+ +||||+++++++.+.+..||||||+ +++|.+++.. ...+++..++.++.|++.||+|||++||
T Consensus 46 ~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~i 123 (311)
T 4agu_A 46 KKIALREIRMLKQL-KHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRY-QRGVPEHLVKSITWQTLQAVNFCHKHNC 123 (311)
T ss_dssp HHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred HHHHHHHHHHHHhC-CCCCccchhheeecCCeEEEEEEeCCCchHHHHHhh-hcCCCHHHHHHHHHHHHHHHHHHHHCCC
Confidence 45678999999999 8999999999999999999999999 7778887764 5679999999999999999999999999
Q ss_pred eecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhC-CCCChhhHHHHHHHHH
Q 013092 97 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVL 175 (449)
Q Consensus 97 vHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~-~~~s~~~DiwSlG~il 175 (449)
+||||||+|||+ +.++.+||+|||+++........ .....||+.|+|||++.+ ..++.++|||||||++
T Consensus 124 vH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il 193 (311)
T 4agu_A 124 IHRDVKPENILI---TKHSVIKLCDFGFARLLTGPSDY-------YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVF 193 (311)
T ss_dssp ECCCCSGGGEEE---CTTSCEEECCCTTCEECC-------------------GGGCCHHHHHTCSCCCTHHHHHHHHHHH
T ss_pred cCCCCChhhEEE---cCCCCEEEeeCCCchhccCcccc-------cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHH
Confidence 999999999999 57889999999999876543221 234578999999999987 5689999999999999
Q ss_pred HHHHhCCCCCCCCCcCCHHHHHHHHHhhc-----------------------ccchHHHhhcCCcHHHHHHHHHHhcCCC
Q 013092 176 MYFLRGSLPWQGLKAGTKKQKYEKISEKK-----------------------VSTSIEALCRGYPTEFASYFHYCRSLRF 232 (449)
Q Consensus 176 ~elltG~~Pf~~~~~~~~~~~~~~i~~~~-----------------------~~~~~~~l~~~~p~el~~li~~cl~~~p 232 (449)
|+|++|..||.+.........+.+..... .........+.++.++.+||..||+.||
T Consensus 194 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 273 (311)
T 4agu_A 194 AELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDP 273 (311)
T ss_dssp HHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSST
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCCh
Confidence 99999999998754432222222111100 0011222335788999999999999999
Q ss_pred CCCCCHHHHHH
Q 013092 233 DDKPDYAYLKR 243 (449)
Q Consensus 233 ~~RPt~~~l~~ 243 (449)
++||++.++++
T Consensus 274 ~~Rpt~~ell~ 284 (311)
T 4agu_A 274 TERLTCEQLLH 284 (311)
T ss_dssp TTSCCHHHHHT
T ss_pred hhcCCHHHHhc
Confidence 99999887753
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=303.25 Aligned_cols=221 Identities=14% Similarity=0.236 Sum_probs=179.7
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeE-eCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGV-EGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 95 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~-~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~g 95 (449)
...+.+|+++++.+ +||||+++++++. ..+..|+||||+ +++|.+++......+++..++.++.|++.||+|||++|
T Consensus 70 ~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ 148 (298)
T 3f66_A 70 VSQFLTEGIIMKDF-SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK 148 (298)
T ss_dssp HHHHHHHHHHHHTC-CCTTBCCCCEEECCSSSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHhC-CCCCEeeeeeEEEcCCCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 35688999999999 8999999999854 566889999999 88999999865667999999999999999999999999
Q ss_pred ceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHHH
Q 013092 96 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVL 175 (449)
Q Consensus 96 ivHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il 175 (449)
|+||||||+|||+ +.++.+||+|||+++.+....... ........||+.|+|||++.+..++.++|||||||++
T Consensus 149 i~H~dikp~Nil~---~~~~~~kl~Dfg~a~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 222 (298)
T 3f66_A 149 FVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEYYS---VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLL 222 (298)
T ss_dssp CCCSCCSGGGEEE---CTTCCEEECSCGGGCCCSCGGGCB---C-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred ccCCCCchheEEE---CCCCCEEECcccccccccccchhc---cccccCCCCCccccChHHhcCCCCChHHHHHHHHHHH
Confidence 9999999999999 678899999999998765432111 1223445688999999999999999999999999999
Q ss_pred HHHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 013092 176 MYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIRE 252 (449)
Q Consensus 176 ~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~L~~~~~~~ 252 (449)
|+|++ |.+||.+...... ...+...... ..+..+|.++.+++..||+.+|++||++.+|++.|+.++...
T Consensus 223 ~~l~~~~~~~~~~~~~~~~---~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 293 (298)
T 3f66_A 223 WELMTRGAPPYPDVNTFDI---TVYLLQGRRL----LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 293 (298)
T ss_dssp HHHHTTSCCSSTTSCTTTH---HHHHHTTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTS
T ss_pred HHHHhCCCCCCccCCHHHH---HHHHhcCCCC----CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 99999 6677766544332 2222222211 123567999999999999999999999999999999987643
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=304.73 Aligned_cols=233 Identities=18% Similarity=0.164 Sum_probs=177.3
Q ss_pred EEEEEeeecccCCChhHHHHHHHHHHHhcCCCCCceEEEEeEe--------CCEEEEEEecCCCCHHHHHHHcCCCCCHH
Q 013092 4 ILTVFSVQENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVE--------GDYNVLVMDLLGPSLEDLFNFCSRKLSLK 75 (449)
Q Consensus 4 aikV~~k~~~~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~--------~~~~~lVmE~~g~sL~~ll~~~~~~ls~~ 75 (449)
|+|++.+..........+.+|+++++.+ .||||+++++++.+ .+..||||||++++|.+++......+++.
T Consensus 46 aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~ 124 (351)
T 3mi9_A 46 ALKKVLMENEKEGFPITALREIKILQLL-KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLS 124 (351)
T ss_dssp EEEECCCSSCSSSSCHHHHHHHHHHHHC-CCTTBCCEEEEEEEC--------CEEEEEEECCSEEHHHHHHCTTSCCCHH
T ss_pred EEEEEecccccccchHHHHHHHHHHHhc-cCCCcccHhheeeccccccccCCceEEEEEeccCCCHHHHHhhccCCCCHH
Confidence 4444433333334456788999999999 89999999999886 45789999999779998887656679999
Q ss_pred HHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchh
Q 013092 76 TVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMN 155 (449)
Q Consensus 76 ~~~~i~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE 155 (449)
.++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.+........ .......||+.|+|||
T Consensus 125 ~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~a~~~~~~~~~~~---~~~~~~~gt~~y~aPE 198 (351)
T 3mi9_A 125 EIKRVMQMLLNGLYYIHRNKILHRDMKAANVLI---TRDGVLKLADFGLARAFSLAKNSQP---NRYTNRVVTLWYRPPE 198 (351)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECCCCSSSSC---CCCCSSCSCGGGCCHH
T ss_pred HHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEE---cCCCCEEEccchhcccccccccccc---cccCCcccccCccCch
Confidence 999999999999999999999999999999999 6788999999999987754322111 1224567899999999
Q ss_pred hhhC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhh---------------------
Q 013092 156 THLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC--------------------- 213 (449)
Q Consensus 156 ~~~~-~~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~--------------------- 213 (449)
++.+ ..++.++|||||||++|+|++|..||.+.........+..+.........+...
T Consensus 199 ~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (351)
T 3mi9_A 199 LLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDR 278 (351)
T ss_dssp HHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHH
T ss_pred hhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccccccchhhcccccccccccCHHHH
Confidence 9987 457999999999999999999999998754332222222221111110000000
Q ss_pred ---cCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 214 ---RGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 214 ---~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
...++++.+||..||+.||++||++.++++
T Consensus 279 ~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 279 LKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp HHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 013678999999999999999999877754
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=303.32 Aligned_cols=219 Identities=16% Similarity=0.296 Sum_probs=173.9
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeCC-----EEEEEEecC-CCCHHHHHHHc-----CCCCCHHHHHHHHHHHHH
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEGD-----YNVLVMDLL-GPSLEDLFNFC-----SRKLSLKTVLMLADQMIN 86 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~-----~~~lVmE~~-g~sL~~ll~~~-----~~~ls~~~~~~i~~qi~~ 86 (449)
...+.+|+.+++.+ +||||+++++++.+.. ..|+||||+ +++|.+++... ...+++..++.++.||+.
T Consensus 80 ~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~ 158 (313)
T 3brb_A 80 IEEFLSEAACMKDF-SHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158 (313)
T ss_dssp HHHHHHHHHHHHTC-CCTTBCCCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhcC-CCCCeeeeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHH
Confidence 35688999999999 8999999999988654 359999999 89999998532 356999999999999999
Q ss_pred HHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhh
Q 013092 87 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRD 166 (449)
Q Consensus 87 aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~ 166 (449)
||.|||++||+||||||+|||+ +.++.+||+|||+++....... +.......+++.|+|||++.+..++.++
T Consensus 159 aL~~LH~~~ivH~dikp~NIli---~~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 230 (313)
T 3brb_A 159 GMEYLSNRNFLHRDLAARNCML---RDDMTVCVADFGLSKKIYSGDY-----YRQGRIAKMPVKWIAIESLADRVYTSKS 230 (313)
T ss_dssp HHHHHHTTTCCCCCCSGGGEEE---CTTSCEEECSCSCC---------------------CCGGGSCHHHHHSSCCCHHH
T ss_pred HHHHHHhCCcccCCCCcceEEE---cCCCcEEEeecCcceecccccc-----cCcccccCCCccccCchhhcCCCccchh
Confidence 9999999999999999999999 5788999999999987654322 1222345678899999999999999999
Q ss_pred HHHHHHHHHHHHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Q 013092 167 DLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIF 245 (449)
Q Consensus 167 DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~L 245 (449)
|||||||++|+|++ |..||.+..... .+..+..... ...+..+++++.++|..||..+|++||++.+|++.|
T Consensus 231 Di~slG~il~el~~~g~~p~~~~~~~~---~~~~~~~~~~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L 303 (313)
T 3brb_A 231 DVWAFGVTMWEIATRGMTPYPGVQNHE---MYDYLLHGHR----LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQL 303 (313)
T ss_dssp HHHHHHHHHHHHHTTSCCSSTTCCGGG---HHHHHHTTCC----CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred hhHHHHHHHHHHHhcCCCCCccCCHHH---HHHHHHcCCC----CCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 99999999999999 999998754432 2333333221 123457899999999999999999999999999999
Q ss_pred HHHHHHc
Q 013092 246 RDLFIRE 252 (449)
Q Consensus 246 ~~~~~~~ 252 (449)
++++...
T Consensus 304 ~~l~~~l 310 (313)
T 3brb_A 304 EKLLESL 310 (313)
T ss_dssp HHHHHHC
T ss_pred HHHHHhc
Confidence 9987643
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=314.47 Aligned_cols=212 Identities=21% Similarity=0.198 Sum_probs=177.9
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 96 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gi 96 (449)
...+.+|+++|+.| +||||+++++++.+....||||||| |++|.+++......+++..++.++.||+.||+|||++||
T Consensus 92 ~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~gi 170 (387)
T 1kob_A 92 KYTVKNEISIMNQL-HHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSI 170 (387)
T ss_dssp HHHHHHHHHHHTTC-CSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred HHHHHHHHHHHHhC-CCcCCCeEEEEEEeCCEEEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 44688999999999 8999999999999999999999999 999999987545579999999999999999999999999
Q ss_pred eecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHHHH
Q 013092 97 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLM 176 (449)
Q Consensus 97 vHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il~ 176 (449)
+||||||+|||+.. +..+.+||+|||+++.+..... .....||+.|+|||++.+..++.++|||||||++|
T Consensus 171 vHrDlkp~NIll~~-~~~~~vkL~DFG~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ 241 (387)
T 1kob_A 171 VHLDIKPENIMCET-KKASSVKIIDFGLATKLNPDEI--------VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGY 241 (387)
T ss_dssp ECCCCCGGGEEESS-TTCCCEEECCCTTCEECCTTSC--------EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHH
T ss_pred eecccchHHeEEec-CCCCceEEEecccceecCCCcc--------eeeeccCCCccCchhccCCCCCCcccEeeHhHHHH
Confidence 99999999999941 1346899999999987754322 12347999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 177 YFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 177 elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
+|++|..||.+.. ..+.+..+....... .......+++++.+||..||..||++||++.++++
T Consensus 242 elltg~~Pf~~~~---~~~~~~~i~~~~~~~-~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 242 VLLSGLSPFAGED---DLETLQNVKRCDWEF-DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp HHHHSCCSSCCSS---HHHHHHHHHHCCCCC-CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HHHhCCCCCCCCC---HHHHHHHHHhCCCCC-CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 9999999998743 344444444433221 12234568999999999999999999999887753
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-37 Score=319.29 Aligned_cols=223 Identities=18% Similarity=0.216 Sum_probs=170.4
Q ss_pred cEEEEEeeecccCCChhHHHHHHHHHHHhcCCCCCceEEEEeEeC------CEEEEEEecCCCCHHHHHHHcCCCCCHHH
Q 013092 3 EILTVFSVQENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEG------DYNVLVMDLLGPSLEDLFNFCSRKLSLKT 76 (449)
Q Consensus 3 ~aikV~~k~~~~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~------~~~~lVmE~~g~sL~~ll~~~~~~ls~~~ 76 (449)
+|||++.+..........+.+|+++|+.+ +||||+++++++... ...||||||++++|.+++. ..+++..
T Consensus 90 vAiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~~~~~~~lv~E~~~~~l~~~~~---~~l~~~~ 165 (464)
T 3ttj_A 90 VAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ---MELDHER 165 (464)
T ss_dssp EEEEEEESGGGSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCCSTTTCCEEEEEEECCSEEHHHHHT---SCCCHHH
T ss_pred EEEEEECccccChHHHHHHHHHHHHHHhC-CCCCCCcEEEEEccCCccccCCeEEEEEeCCCCCHHHHHh---hcCCHHH
Confidence 35555554433334456788999999999 999999999998654 4679999999777888775 3599999
Q ss_pred HHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhh
Q 013092 77 VLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNT 156 (449)
Q Consensus 77 ~~~i~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~ 156 (449)
+..++.||+.||+|||++||+||||||+|||| +.++.+||+|||+++....... ....+||+.|+|||+
T Consensus 166 ~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll---~~~~~~kl~DFG~a~~~~~~~~--------~~~~~gt~~y~aPE~ 234 (464)
T 3ttj_A 166 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFM--------MTPYVVTRYYRAPEV 234 (464)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCCCC-----CCC--------C----CCCTTCCHHH
T ss_pred HHHHHHHHHHHHHHHHHCCcccCCCChHhEEE---eCCCCEEEEEEEeeeecCCCcc--------cCCCcccccccCHHH
Confidence 99999999999999999999999999999999 6788999999999987654321 245689999999999
Q ss_pred hhCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchH-------------------------HH
Q 013092 157 HLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI-------------------------EA 211 (449)
Q Consensus 157 ~~~~~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~-------------------------~~ 211 (449)
+.+..++.++|||||||++|||++|+.||.+.+. .+.+.++.+....+.. +.
T Consensus 235 ~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~---~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (464)
T 3ttj_A 235 ILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY---IDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPK 311 (464)
T ss_dssp HTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHH
T ss_pred HcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHH
Confidence 9999999999999999999999999999987433 3334444332111110 11
Q ss_pred hhcC------------CcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 212 LCRG------------YPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 212 l~~~------------~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
+.+. .++++.+||..||..||++||++.++++
T Consensus 312 ~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 355 (464)
T 3ttj_A 312 LFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 355 (464)
T ss_dssp HSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 1110 1567999999999999999999887753
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=322.69 Aligned_cols=219 Identities=17% Similarity=0.336 Sum_probs=181.7
Q ss_pred CChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHH
Q 013092 16 TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHS 93 (449)
Q Consensus 16 ~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~-~~~ls~~~~~~i~~qi~~aL~yLH~ 93 (449)
...+.|.+|+.+|+.| .||||+++++++. .+..||||||| +++|.+++... ...+++..++.++.||+.||+|||+
T Consensus 225 ~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~ 302 (454)
T 1qcf_A 225 MSVEAFLAEANVMKTL-QHDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ 302 (454)
T ss_dssp BCHHHHHHHHHHHTTC-CCTTBCCEEEEEC-SSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHH
T ss_pred ccHHHHHHHHHHHhhC-CCCCEeeEEEEEe-CCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 4567899999999999 8999999999876 66789999999 99999999743 2368999999999999999999999
Q ss_pred CCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHH
Q 013092 94 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGY 173 (449)
Q Consensus 94 ~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~ 173 (449)
+||+||||||+|||+ +.++.+||+|||+++...... +.......+|..|+|||++....++.++|||||||
T Consensus 303 ~~ivHrDlkp~Nill---~~~~~~kl~DFG~a~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~ 373 (454)
T 1qcf_A 303 RNYIHRDLRAANILV---SASLVCKIADFGLARVIEDNE------YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGI 373 (454)
T ss_dssp TTCCCSSCSGGGEEE---CTTCCEEECSTTGGGGBCCHH------HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHH
T ss_pred CCccCCCCCHHHEEE---CCCCcEEEeeCCCceEcCCCc------eeccCCCcccccccCHHHhccCCCCcHHHHHhHHH
Confidence 999999999999999 578899999999998764321 11123345788999999999999999999999999
Q ss_pred HHHHHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 013092 174 VLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIRE 252 (449)
Q Consensus 174 il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~L~~~~~~~ 252 (449)
+||||++ |..||.+... .+.+..+...... ..+..+|+++.+||..||+.+|++||++.+|.+.|++++...
T Consensus 374 ~l~el~t~g~~P~~~~~~---~~~~~~i~~~~~~----~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~ 446 (454)
T 1qcf_A 374 LLMEIVTYGRIPYPGMSN---PEVIRALERGYRM----PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTAT 446 (454)
T ss_dssp HHHHHHTTSCCSSTTCCH---HHHHHHHHHTCCC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSS
T ss_pred HHHHHHhCCCCCCCCCCH---HHHHHHHHcCCCC----CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcc
Confidence 9999999 9999987543 3334444332211 123568999999999999999999999999999998775433
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=323.72 Aligned_cols=226 Identities=17% Similarity=0.300 Sum_probs=187.1
Q ss_pred EEeeeccc-CCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHc-CCCCCHHHHHHHHHH
Q 013092 7 VFSVQENV-KTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQ 83 (449)
Q Consensus 7 V~~k~~~~-~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~-~~~ls~~~~~~i~~q 83 (449)
|++|.... ......|.+|+.+|+.| +||||+++++++.+.+..||||||| +++|.+++... ...+++..++.++.|
T Consensus 248 vavK~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~q 326 (495)
T 1opk_A 248 VAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ 326 (495)
T ss_dssp EEEEECCSSSSCHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHH
T ss_pred EEEEEecCcccchHHHHHHHHHHHhc-CCCCEeeEEEEEecCCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHH
Confidence 44444322 33567799999999999 8999999999999999999999999 89999999864 345899999999999
Q ss_pred HHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCC
Q 013092 84 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQS 163 (449)
Q Consensus 84 i~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s 163 (449)
|+.||+|||++||+||||||+|||| +.++.+||+|||+++....... .......++..|+|||++.+..++
T Consensus 327 i~~~L~~LH~~~ivHrDlkp~NIll---~~~~~~kl~DFG~a~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~ 397 (495)
T 1opk_A 327 ISSAMEYLEKKNFIHRNLAARNCLV---GENHLVKVADFGLSRLMTGDTY------TAHAGAKFPIKWTAPESLAYNKFS 397 (495)
T ss_dssp HHHHHHHHHHTTEECSCCSGGGEEE---CGGGCEEECCTTCEECCTTCCE------ECCTTCCCCGGGCCHHHHHHCEEC
T ss_pred HHHHHHHHHhCCcccCCCChhhEEE---CCCCcEEEeecccceeccCCce------eecCCCcCCcceeCHhHHhcCCCC
Confidence 9999999999999999999999999 5788999999999987654321 222344578899999999998999
Q ss_pred hhhHHHHHHHHHHHHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 013092 164 RRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 242 (449)
Q Consensus 164 ~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~ 242 (449)
.++|||||||+||||++ |..||.+.+... .+..+..... ...+..+|+++.+||..||+.+|++||++.+|.
T Consensus 398 ~~sDvwSlG~~l~el~t~g~~p~~~~~~~~---~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~ 470 (495)
T 1opk_A 398 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---VYELLEKDYR----MERPEGCPEKVYELMRACWQWNPSDRPSFAEIH 470 (495)
T ss_dssp HHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HHHHHHTTCC----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred cHHhHHhHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHcCCC----CCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHH
Confidence 99999999999999999 999998865433 2333322211 123457899999999999999999999999999
Q ss_pred HHHHHHH
Q 013092 243 RIFRDLF 249 (449)
Q Consensus 243 ~~L~~~~ 249 (449)
+.|+.++
T Consensus 471 ~~L~~~~ 477 (495)
T 1opk_A 471 QAFETMF 477 (495)
T ss_dssp HHHHTSC
T ss_pred HHHHHHH
Confidence 9988764
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=294.38 Aligned_cols=213 Identities=23% Similarity=0.325 Sum_probs=170.9
Q ss_pred CChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHH
Q 013092 16 TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFV 91 (449)
Q Consensus 16 ~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~---~~~ls~~~~~~i~~qi~~aL~yL 91 (449)
.....+.+|+++++.+ +||||+++++++.+....|+||||+ +++|.+++... ...+++..++.++.||+.||+||
T Consensus 62 ~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~L 140 (285)
T 3is5_A 62 VPMEQIEAEIEVLKSL-DHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYF 140 (285)
T ss_dssp SCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred hhHHHHHHHHHHHHhC-CCchHHhHHHheecCCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHH
Confidence 3457799999999999 8999999999999999999999999 88999988532 46799999999999999999999
Q ss_pred HHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHH
Q 013092 92 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESL 171 (449)
Q Consensus 92 H~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSl 171 (449)
|++||+||||||+|||+..++..+.+||+|||+++.+..... .....||+.|+|||++. ..++.++|||||
T Consensus 141 H~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~--------~~~~~~t~~y~aPE~~~-~~~~~~~Di~sl 211 (285)
T 3is5_A 141 HSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH--------STNAAGTALYMAPEVFK-RDVTFKCDIWSA 211 (285)
T ss_dssp HHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC------------------CTTGGGCCHHHHT-TCCCHHHHHHHH
T ss_pred HhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCccc--------CcCcccccCcCChHHhc-cCCCcccCeehH
Confidence 999999999999999996545568899999999987654322 23457999999999986 568999999999
Q ss_pred HHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 172 GYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 172 G~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
||++|+|++|..||.+... .+....+....... ......+++++.+||..||+.||++||++.+|++
T Consensus 212 G~il~~ll~g~~pf~~~~~---~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 212 GVVMYFLLTGCLPFTGTSL---EEVQQKATYKEPNY--AVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp HHHHHHHHHSSCSSCCSSH---HHHHHHHHHCCCCC--CC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred HHHHHHHHhCCCCCCCCCH---HHHHhhhccCCccc--ccccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 9999999999999987433 23333332222211 1123457899999999999999999999888753
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-37 Score=304.25 Aligned_cols=220 Identities=16% Similarity=0.249 Sum_probs=181.6
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcC------CCCCHHHHHHHHHHHHHHHHH
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCS------RKLSLKTVLMLADQMINRVEF 90 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~------~~ls~~~~~~i~~qi~~aL~y 90 (449)
...+.+|+.+++.+ .||||+++++++.+....||||||+ +++|.+++.... ..+++..++.++.||+.||.|
T Consensus 77 ~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~ 155 (327)
T 2yfx_A 77 ELDFLMEALIISKF-NHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155 (327)
T ss_dssp HHHHHHHHHHHHHC-CCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhhC-CCCCCCeEEEEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHH
Confidence 45688999999999 9999999999999999999999999 999999998643 348999999999999999999
Q ss_pred HHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHH
Q 013092 91 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLES 170 (449)
Q Consensus 91 LH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwS 170 (449)
||++||+||||||+|||+........+||+|||+++........ .......||+.|+|||++.+..++.++||||
T Consensus 156 LH~~~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s 230 (327)
T 2yfx_A 156 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYY-----RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWS 230 (327)
T ss_dssp HHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHC-----------CCGGGSCGGGCCHHHHHHCCCCHHHHHHH
T ss_pred HhhCCeecCcCCHhHEEEecCCCcceEEECcccccccccccccc-----ccCCCcCCCcceeCHhHhcCCCCCchhhHHH
Confidence 99999999999999999954445667999999999865443221 1223456899999999999999999999999
Q ss_pred HHHHHHHHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 013092 171 LGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLF 249 (449)
Q Consensus 171 lG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~L~~~~ 249 (449)
|||++|+|++ |..||.... ..+.+..+...... .....++.++.++|..||+.+|++||++.+|.+.|..+.
T Consensus 231 lG~il~ellt~g~~p~~~~~---~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 303 (327)
T 2yfx_A 231 FGVLLWEIFSLGYMPYPSKS---NQEVLEFVTSGGRM----DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 303 (327)
T ss_dssp HHHHHHHHHTTSCCSSTTCC---HHHHHHHHHTTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHcCCCCCCCCcC---HHHHHHHHhcCCCC----CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence 9999999998 999997643 23334434333221 234568999999999999999999999999999988775
Q ss_pred H
Q 013092 250 I 250 (449)
Q Consensus 250 ~ 250 (449)
.
T Consensus 304 ~ 304 (327)
T 2yfx_A 304 Q 304 (327)
T ss_dssp H
T ss_pred c
Confidence 4
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=313.72 Aligned_cols=221 Identities=15% Similarity=0.245 Sum_probs=173.0
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeE-eCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGV-EGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 95 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~-~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~g 95 (449)
...+.+|+.+++.+ .||||+++++++. ..+..||||||+ +++|.+++......+++..++.++.||+.||+|||++|
T Consensus 134 ~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ 212 (373)
T 3c1x_A 134 VSQFLTEGIIMKDF-SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK 212 (373)
T ss_dssp HHHHHHHHTTSTTC-CCTTBCCCCEEECCCSSCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHhC-CCCCcceEEEEEEcCCCCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 45689999999999 8999999999865 456889999999 89999999865567899999999999999999999999
Q ss_pred ceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHHH
Q 013092 96 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVL 175 (449)
Q Consensus 96 ivHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il 175 (449)
|+||||||+|||+ +.++.+||+|||+++.+....... ........+|+.|+|||++.+..++.++|||||||++
T Consensus 213 ivHrDlkp~NIll---~~~~~~kL~DFG~a~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il 286 (373)
T 3c1x_A 213 FVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEFDS---VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLL 286 (373)
T ss_dssp CCCSCCCGGGEEE---CTTCCEEECCC------------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred EecCccchheEEE---CCCCCEEEeecccccccccccccc---ccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHH
Confidence 9999999999999 678899999999998765432211 1112345678899999999999999999999999999
Q ss_pred HHHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 013092 176 MYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIRE 252 (449)
Q Consensus 176 ~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~L~~~~~~~ 252 (449)
|||++ |.+||.+....... ..+...... ..+..+|.++.++|..||+.+|++||++.+|.+.|++++...
T Consensus 287 ~ellt~~~~p~~~~~~~~~~---~~~~~~~~~----~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~ 357 (373)
T 3c1x_A 287 WELMTRGAPPYPDVNTFDIT---VYLLQGRRL----LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 357 (373)
T ss_dssp HHHHTTSCCSCTTSCSSCHH---HHHHTTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred HHHHhCcCCCCCCCCHHHHH---HHHHcCCCC----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 99999 78888876554332 222222211 123568999999999999999999999999999999987654
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=305.00 Aligned_cols=216 Identities=18% Similarity=0.276 Sum_probs=181.2
Q ss_pred hHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcC---------CCCCHHHHHHHHHHHHHHH
Q 013092 19 PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCS---------RKLSLKTVLMLADQMINRV 88 (449)
Q Consensus 19 ~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~---------~~ls~~~~~~i~~qi~~aL 88 (449)
..+.+|+++++.+ +||||+++++++.+.+..||||||+ +++|.+++.... ..+++..++.++.||+.||
T Consensus 73 ~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l 151 (322)
T 1p4o_A 73 IEFLNEASVMKEF-NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGM 151 (322)
T ss_dssp HHHHHHHHHGGGC-CCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhc-CCCCEeeeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHH
Confidence 3588999999999 8999999999999999999999999 899999987431 4579999999999999999
Q ss_pred HHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHH
Q 013092 89 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDL 168 (449)
Q Consensus 89 ~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~Di 168 (449)
.|||++||+||||||+|||+ +.++.+||+|||+++....... +.......+|+.|+|||++.+..++.++||
T Consensus 152 ~~lH~~~i~H~dikp~NIli---~~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di 223 (322)
T 1p4o_A 152 AYLNANKFVHRDLAARNCMV---AEDFTVKIGDFGMTRDIYETDY-----YRKGGKGLLPVRWMSPESLKDGVFTTYSDV 223 (322)
T ss_dssp HHHHHTTCBCSCCSGGGEEE---CTTCCEEECCTTCCCGGGGGGC-----EEGGGSSEECGGGCCHHHHHHCCCCHHHHH
T ss_pred HHHHHCCCccCCCccceEEE---cCCCeEEECcCccccccccccc-----cccccCCCCCCCccChhhhccCCCCchhhH
Confidence 99999999999999999999 5788999999999986544322 122234567899999999999999999999
Q ss_pred HHHHHHHHHHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Q 013092 169 ESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRD 247 (449)
Q Consensus 169 wSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~L~~ 247 (449)
|||||++|+|++ |..||.+.. ..+....+...... .....+|.++.++|..||+.+|++||++.++.+.|++
T Consensus 224 ~slG~il~el~~~g~~p~~~~~---~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~ 296 (322)
T 1p4o_A 224 WSFGVVLWEIATLAEQPYQGLS---NEQVLRFVMEGGLL----DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 296 (322)
T ss_dssp HHHHHHHHHHHHTSCCTTTTSC---HHHHHHHHHTTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGG
T ss_pred HHHHHHHHHHHhcCCCccccCC---HHHHHHHHHcCCcC----CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence 999999999999 899998743 33344444433221 2345789999999999999999999999999998876
Q ss_pred HHH
Q 013092 248 LFI 250 (449)
Q Consensus 248 ~~~ 250 (449)
++.
T Consensus 297 ~~~ 299 (322)
T 1p4o_A 297 EME 299 (322)
T ss_dssp GSC
T ss_pred hhc
Confidence 643
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=292.01 Aligned_cols=227 Identities=19% Similarity=0.222 Sum_probs=182.0
Q ss_pred cEEEEEeeecccCC----ChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHH
Q 013092 3 EILTVFSVQENVKT----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTV 77 (449)
Q Consensus 3 ~aikV~~k~~~~~~----~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~ 77 (449)
.|+|++.+...... ....+.+|+.+++.+ .||||+++++++.+....|+||||+ +++|.+++.. ...+++..+
T Consensus 33 ~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~ 110 (283)
T 3bhy_A 33 YAAKFIKKRRLSSSRRGVSREEIEREVNILREI-RHPNIITLHDIFENKTDVVLILELVSGGELFDFLAE-KESLTEDEA 110 (283)
T ss_dssp EEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH-HSSCCHHHH
T ss_pred eehHHhhhccccccccchHHHHHHHHHHHHHhC-CCCCeeehhheecCCCeEEEEEeecCCCcHHHHHHh-cCCCCHHHH
Confidence 35555554433222 356799999999999 8999999999999999999999999 8999999975 457999999
Q ss_pred HHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecC-CCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhh
Q 013092 78 LMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR-RANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNT 156 (449)
Q Consensus 78 ~~i~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~-~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~ 156 (449)
+.++.||+.||+|||++||+||||||+||++..+. ....+||+|||++........ .....||+.|+|||+
T Consensus 111 ~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~ 182 (283)
T 3bhy_A 111 TQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE--------FKNIFGTPEFVAPEI 182 (283)
T ss_dssp HHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC----------------CCCGGGCCHHH
T ss_pred HHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceeccCCCc--------ccccCCCcCccCcce
Confidence 99999999999999999999999999999994211 123899999999987654322 134568999999999
Q ss_pred hhCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCC
Q 013092 157 HLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKP 236 (449)
Q Consensus 157 ~~~~~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RP 236 (449)
+.+..++.++||||||+++|+|++|..||.+.. ..+.+..+...... ........+++++.+++..||..+|++||
T Consensus 183 ~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~dp~~Rp 258 (283)
T 3bhy_A 183 VNYEPLGLEADMWSIGVITYILLSGASPFLGET---KQETLTNISAVNYD-FDEEYFSNTSELAKDFIRRLLVKDPKRRM 258 (283)
T ss_dssp HTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHHHHHTTCCC-CCHHHHTTCCHHHHHHHHTTSCSSGGGSC
T ss_pred ecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcc---hHHHHHHhHhcccC-CcchhcccCCHHHHHHHHHHccCCHhHCc
Confidence 999999999999999999999999999998743 33444444443332 22345567899999999999999999999
Q ss_pred CHHHHHH
Q 013092 237 DYAYLKR 243 (449)
Q Consensus 237 t~~~l~~ 243 (449)
++.++++
T Consensus 259 s~~~~l~ 265 (283)
T 3bhy_A 259 TIAQSLE 265 (283)
T ss_dssp CHHHHHH
T ss_pred CHHHHHh
Confidence 9888765
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=296.57 Aligned_cols=222 Identities=14% Similarity=0.209 Sum_probs=180.9
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEE-EEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYN-VLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 95 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~-~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~g 95 (449)
...+.+|+.+++.+ +||||+++++++.+.+.. ++||||+ +++|.+++......+++..++.++.|++.||+|||++|
T Consensus 66 ~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ 144 (298)
T 3pls_A 66 VEAFLREGLLMRGL-NHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQK 144 (298)
T ss_dssp HHHHHHHHHHHHTC-CCTTBCCCCEEECCSSSCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHhC-CCCCeeeEEEEEecCCCCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 35688999999999 899999999999866554 9999999 99999999865677999999999999999999999999
Q ss_pred ceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHHH
Q 013092 96 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVL 175 (449)
Q Consensus 96 ivHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il 175 (449)
|+||||||+|||+ +.++.+||+|||+++.+...... .........+|+.|+|||.+.+..++.++|||||||++
T Consensus 145 i~H~dikp~Nili---~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 218 (298)
T 3pls_A 145 FVHRDLAARNCML---DESFTVKVADFGLARDILDREYY---SVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLL 218 (298)
T ss_dssp CCCSCCSGGGEEE---CTTCCEEECCTTSSCTTTTGGGG---CSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHH
T ss_pred cccCCCCcceEEE---cCCCcEEeCcCCCcccccCCccc---ccccCcCCCCCccccChhhhccCCCChhhchhhHHHHH
Confidence 9999999999999 67889999999999865432211 11223456789999999999999999999999999999
Q ss_pred HHHHhCC-CCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Q 013092 176 MYFLRGS-LPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREG 253 (449)
Q Consensus 176 ~elltG~-~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~L~~~~~~~~ 253 (449)
|+|++|. +||...... .....+...... .....+++++.+++..||+.+|.+||++.+|.+.|++++....
T Consensus 219 ~~l~~g~~~~~~~~~~~---~~~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~ 290 (298)
T 3pls_A 219 WELLTRGAPPYRHIDPF---DLTHFLAQGRRL----PQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALL 290 (298)
T ss_dssp HHHHHTSCCTTTTSCGG---GHHHHHHTTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCC
T ss_pred HHHhhCCCCCCccCCHH---HHHHHhhcCCCC----CCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHh
Confidence 9999955 455443322 222223322211 1235688999999999999999999999999999999987653
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=317.74 Aligned_cols=225 Identities=19% Similarity=0.257 Sum_probs=184.4
Q ss_pred cEEEEEeeecccC-----------CChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCC
Q 013092 3 EILTVFSVQENVK-----------TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSR 70 (449)
Q Consensus 3 ~aikV~~k~~~~~-----------~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~ 70 (449)
+|+|++.+..... .....+.+|+.+|+.| +||||+++++++.+....||||||| |++|.+++.. ..
T Consensus 64 ~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~-~~ 141 (504)
T 3q5i_A 64 KAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL-DHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIIN-RH 141 (504)
T ss_dssp EEEEEEEC----------------CTHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH-HS
T ss_pred EEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEcCCEEEEEEecCCCCcHHHHHHH-cC
Confidence 4666666544321 3456799999999999 8999999999999999999999999 9999999875 45
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCcc
Q 013092 71 KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTAR 150 (449)
Q Consensus 71 ~ls~~~~~~i~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~ 150 (449)
.+++..++.++.||+.||+|||++||+||||||+|||+..+.....+||+|||+++.+..... .....||+.
T Consensus 142 ~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~--------~~~~~gt~~ 213 (504)
T 3q5i_A 142 KFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYK--------LRDRLGTAY 213 (504)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCCTTCEECCTTSC--------BCCCCSCTT
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEECCCCEEcCCCCc--------cccccCCcC
Confidence 799999999999999999999999999999999999995333334799999999987755322 234579999
Q ss_pred ccchhhhhCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcC
Q 013092 151 YASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSL 230 (449)
Q Consensus 151 Y~aPE~~~~~~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~ 230 (449)
|+|||++.+ .++.++|||||||++|+|++|..||.+. ...+.+..+.........+ .+..+++++.+||..||..
T Consensus 214 y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~---~~~~~~~~i~~~~~~~~~~-~~~~~s~~~~~li~~~L~~ 288 (504)
T 3q5i_A 214 YIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQ---NDQDIIKKVEKGKYYFDFN-DWKNISDEAKELIKLMLTY 288 (504)
T ss_dssp TCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHCCCCCCHH-HHTTSCHHHHHHHHHHTCS
T ss_pred CCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHHcCCCCCCcc-ccCCCCHHHHHHHHHHcCC
Confidence 999999874 6899999999999999999999999874 3445566666555433332 3467899999999999999
Q ss_pred CCCCCCCHHHHH
Q 013092 231 RFDDKPDYAYLK 242 (449)
Q Consensus 231 ~p~~RPt~~~l~ 242 (449)
+|.+||++.+++
T Consensus 289 dp~~R~t~~e~l 300 (504)
T 3q5i_A 289 DYNKRCTAEEAL 300 (504)
T ss_dssp STTTSCCHHHHH
T ss_pred ChhHCCCHHHHh
Confidence 999999988764
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-37 Score=319.28 Aligned_cols=228 Identities=18% Similarity=0.290 Sum_probs=180.3
Q ss_pred EEeeeccc-CCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHc-CCCCCHHHHHHHHHH
Q 013092 7 VFSVQENV-KTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQ 83 (449)
Q Consensus 7 V~~k~~~~-~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~-~~~ls~~~~~~i~~q 83 (449)
|++|.... ....+.|.+|+++|+.| .||||+++++++.+ +..||||||+ +++|.+++... ...+++..++.++.|
T Consensus 211 vavK~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~-~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~q 288 (452)
T 1fmk_A 211 VAIKTLKPGTMSPEAFLQEAQVMKKL-RHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQ 288 (452)
T ss_dssp EEEEECCTTSSCHHHHHHHHHHHHHC-CCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHH
T ss_pred EEEEEeccCCCCHHHHHHHHHHHHhC-CCCCEeeEEEEEcC-CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHH
Confidence 44444332 23456799999999999 89999999998866 6789999999 89999999743 356999999999999
Q ss_pred HHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCC
Q 013092 84 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQS 163 (449)
Q Consensus 84 i~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s 163 (449)
|+.||+|||++||+||||||+|||+ +.++.+||+|||+++....... .......+|..|+|||++.+..++
T Consensus 289 i~~~l~~LH~~~ivHrDlkp~Nill---~~~~~~kl~DfG~a~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~ 359 (452)
T 1fmk_A 289 IASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLARLIEDNEY------TARQGAKFPIKWTAPEAALYGRFT 359 (452)
T ss_dssp HHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCCTTC--------------------CCGGGSCHHHHHHCCCC
T ss_pred HHHHHHHHHhCCeeCCCCChhhEEE---CCCCCEEECCCccceecCCCce------ecccCCcccccccCHhHHhcCCCC
Confidence 9999999999999999999999999 5778999999999987654321 112344578899999999999999
Q ss_pred hhhHHHHHHHHHHHHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 013092 164 RRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 242 (449)
Q Consensus 164 ~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~ 242 (449)
.++|||||||++|||++ |..||.+... .+.+..+...... ..+..+|+++.+||..||+.+|++||++.+|.
T Consensus 360 ~~sDvwslG~~l~el~t~g~~P~~~~~~---~~~~~~i~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~ 432 (452)
T 1fmk_A 360 IKSDVWSFGILLTELTTKGRVPYPGMVN---REVLDQVERGYRM----PCPPECPESLHDLMCQCWRKEPEERPTFEYLQ 432 (452)
T ss_dssp HHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHHHHHHHTTCCC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred ccccHHhHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCCCC----CCCCCCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 99999999999999999 9999987543 3334444332111 12357899999999999999999999999999
Q ss_pred HHHHHHHHHc
Q 013092 243 RIFRDLFIRE 252 (449)
Q Consensus 243 ~~L~~~~~~~ 252 (449)
+.|++++...
T Consensus 433 ~~L~~~~~~~ 442 (452)
T 1fmk_A 433 AFLEDYFTST 442 (452)
T ss_dssp HHHHTTTSCS
T ss_pred HHHHHHhccC
Confidence 9988775433
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=298.38 Aligned_cols=223 Identities=12% Similarity=0.165 Sum_probs=180.2
Q ss_pred EEEEEeeecccCCChhHHHHHHHHHHHhcCCCCCceEEEEeEeC--CEEEEEEecC-CCCHHHHHHHcCC-CCCHHHHHH
Q 013092 4 ILTVFSVQENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEG--DYNVLVMDLL-GPSLEDLFNFCSR-KLSLKTVLM 79 (449)
Q Consensus 4 aikV~~k~~~~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~--~~~~lVmE~~-g~sL~~ll~~~~~-~ls~~~~~~ 79 (449)
|+|++.+..........+.+|+.+++.+ +||||+++++++.+. +..||||||+ +++|.+++..... .+++..++.
T Consensus 37 avK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 115 (271)
T 3kmu_A 37 VVKVLKVRDWSTRKSRDFNEECPRLRIF-SHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVK 115 (271)
T ss_dssp EEEEECCTTCCHHHHHHHHHHGGGGCCC-SCTTEECEEEEECTTTSSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHH
T ss_pred EEEEecccccCHHHHHHHHHHHHHHHhc-CCCchhheEEEEccCCCCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHH
Confidence 4444443332333445689999999999 899999999999876 7889999999 8999999985432 489999999
Q ss_pred HHHHHHHHHHHHHHCC--ceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhh
Q 013092 80 LADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTH 157 (449)
Q Consensus 80 i~~qi~~aL~yLH~~g--ivHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~ 157 (449)
++.||+.||+|||++| |+||||||+|||+ +.++.++|+|||++..... ....||+.|+|||++
T Consensus 116 i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~---~~~~~~~l~~~~~~~~~~~------------~~~~~t~~y~aPE~~ 180 (271)
T 3kmu_A 116 FALDMARGMAFLHTLEPLIPRHALNSRSVMI---DEDMTARISMADVKFSFQS------------PGRMYAPAWVAPEAL 180 (271)
T ss_dssp HHHHHHHHHHHHTTSSSCCTTCCCSGGGEEE---CTTSCEEEEGGGSCCTTSC------------TTCBSCGGGSCHHHH
T ss_pred HHHHHHHHHHHHhcCCCceecCCCccceEEE---cCCcceeEEeccceeeecc------------cCccCCccccChhhh
Confidence 9999999999999999 9999999999999 5788899999888654222 234789999999999
Q ss_pred hCCCCC---hhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCC
Q 013092 158 LGIEQS---RRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDD 234 (449)
Q Consensus 158 ~~~~~s---~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~ 234 (449)
.+..++ .++|||||||++|+|++|..||.+... .+....+...... ..++..+++++.+++..||+.+|++
T Consensus 181 ~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~---~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~ 254 (271)
T 3kmu_A 181 QKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN---MEIGMKVALEGLR---PTIPPGISPHVSKLMKICMNEDPAK 254 (271)
T ss_dssp HSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCH---HHHHHHHHHSCCC---CCCCTTCCHHHHHHHHHHTCSSGGG
T ss_pred ccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccCh---HHHHHHHHhcCCC---CCCCCCCCHHHHHHHHHHcCCChhh
Confidence 976544 489999999999999999999987433 2333333332222 2244678999999999999999999
Q ss_pred CCCHHHHHHHHHHH
Q 013092 235 KPDYAYLKRIFRDL 248 (449)
Q Consensus 235 RPt~~~l~~~L~~~ 248 (449)
||++.++.+.|+++
T Consensus 255 Rps~~~il~~L~~l 268 (271)
T 3kmu_A 255 RPKFDMIVPILEKM 268 (271)
T ss_dssp SCCHHHHHHHHHHH
T ss_pred CcCHHHHHHHHHHh
Confidence 99999999998876
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=303.67 Aligned_cols=210 Identities=22% Similarity=0.309 Sum_probs=164.0
Q ss_pred hHHHHHHHHHHHhcCCCCCceEEEEeEeCC----EEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH
Q 013092 19 PQLLYESKLYRILQGGTGIPNVRWFGVEGD----YNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 93 (449)
Q Consensus 19 ~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~----~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~ 93 (449)
..+.+|+++++.+ +||||+++++++.... ..||||||+ |++|.+++.. ...+++..++.++.||+.||+|||+
T Consensus 57 ~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~ 134 (311)
T 3ork_A 57 LRFRREAQNAAAL-NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT-EGPMTPKRAIEVIADACQALNFSHQ 134 (311)
T ss_dssp HHHHHHHTTCCCC-CCTTBCCEEEEEEEEETTEEEEEEEEECCCEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHcC-CCCCcceEEEeeeccCCCCcccEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 4588999999999 8999999999887543 459999999 8999999985 4579999999999999999999999
Q ss_pred CCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHH
Q 013092 94 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGY 173 (449)
Q Consensus 94 ~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~ 173 (449)
+||+||||||+|||+ +.++.+||+|||+++.+....... .......||+.|+|||++.+..++.++|||||||
T Consensus 135 ~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~a~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~ 207 (311)
T 3ork_A 135 NGIIHRDVKPANIMI---SATNAVKVMDFGIARAIADSGNSV----TQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGC 207 (311)
T ss_dssp TTCCCCCCCGGGEEE---ETTSCEEECCCSCC----------------------CCTTCCHHHHHTCCCCHHHHHHHHHH
T ss_pred CCCCcCCCCHHHEEE---cCCCCEEEeeccCccccccccccc----ccccccCcCcccCCHHHhcCCCCCchHhHHHHHH
Confidence 999999999999999 477899999999998765432211 1223467999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHH
Q 013092 174 VLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYL 241 (449)
Q Consensus 174 il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l 241 (449)
++|+|++|..||.+... ......+..... .........++.++.++|..||+.||++||+..++
T Consensus 208 ~l~~ll~g~~pf~~~~~---~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~ 271 (311)
T 3ork_A 208 VLYEVLTGEPPFTGDSP---VSVAYQHVREDP-IPPSARHEGLSADLDAVVLKALAKNPENRYQTAAE 271 (311)
T ss_dssp HHHHHHHSSCSCCCSSH---HHHHHHHHHCCC-CCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHH
T ss_pred HHHHHHhCCCCCCCCCh---HHHHHHHhcCCC-CCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHH
Confidence 99999999999987433 222222332222 23344557799999999999999999999975443
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=306.64 Aligned_cols=226 Identities=15% Similarity=0.165 Sum_probs=181.2
Q ss_pred ChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHH
Q 013092 17 KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCS---RKLSLKTVLMLADQMINRVEFVH 92 (449)
Q Consensus 17 ~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~---~~ls~~~~~~i~~qi~~aL~yLH 92 (449)
....+.+|+++++.+ +||||+++++++.+.+..|+||||+ +++|.+++.... ..+++..++.++.||+.||+|||
T Consensus 78 ~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH 156 (321)
T 2qkw_B 78 GIEEFETEIETLSFC-RHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH 156 (321)
T ss_dssp HHHHHHHHHHGGGSC-CCTTBCCEEEECCCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhC-CCCCEeeEEEEEcCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhc
Confidence 346789999999999 8999999999999999999999999 899999986432 35899999999999999999999
Q ss_pred HCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHH
Q 013092 93 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLG 172 (449)
Q Consensus 93 ~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG 172 (449)
++||+||||||+|||+ +.++.+||+|||+++........ .......||+.|+|||++.+..++.++||||||
T Consensus 157 ~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG 228 (321)
T 2qkw_B 157 TRAIIHRDVKSINILL---DENFVPKITDFGISKKGTELDQT-----HLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFG 228 (321)
T ss_dssp HTTEECSCCCSTTEEE---CTTCCEEECCCTTCEECSSSSCC-----CCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHH
T ss_pred CCCeecCCCCHHHEEE---CCCCCEEEeeccccccccccccc-----ccccccCCCccccCHHHhcCCCCCcccchHhHH
Confidence 9999999999999999 68889999999999875432221 112345689999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCCcCCHHHHHHHH----Hhhcccc-----hHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 173 YVLMYFLRGSLPWQGLKAGTKKQKYEKI----SEKKVST-----SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 173 ~il~elltG~~Pf~~~~~~~~~~~~~~i----~~~~~~~-----~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
|++|+|++|+.||.+............. ....... ....+...++.++.+++..||+.+|++||++.++++
T Consensus 229 ~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 308 (321)
T 2qkw_B 229 VVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLW 308 (321)
T ss_dssp HHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 9999999999999875443221111111 1111100 011122335678999999999999999999999999
Q ss_pred HHHHHHHH
Q 013092 244 IFRDLFIR 251 (449)
Q Consensus 244 ~L~~~~~~ 251 (449)
.|+.++..
T Consensus 309 ~L~~~l~~ 316 (321)
T 2qkw_B 309 KLEYALRL 316 (321)
T ss_dssp HHHHHHHS
T ss_pred HHHHHhhc
Confidence 99988653
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=305.15 Aligned_cols=213 Identities=20% Similarity=0.206 Sum_probs=164.4
Q ss_pred CCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH
Q 013092 15 KTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 93 (449)
Q Consensus 15 ~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~ 93 (449)
......+.+|+.+++.+ +||||+++++++.+.+..||||||| |++|.+++.. .+.+++..++.++.||+.||+|||+
T Consensus 57 ~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~ql~~~L~~LH~ 134 (361)
T 3uc3_A 57 AAIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIIMEYASGGELYERICN-AGRFSEDEARFFFQQLLSGVSYCHS 134 (361)
T ss_dssp TTSCHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH
T ss_pred ccccHHHHHHHHHHHhC-CCCCCCcEEEEEeeCCEEEEEEEeCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 34456799999999999 8999999999999999999999999 9999999975 4579999999999999999999999
Q ss_pred CCceecCCCCCcEEEeecCCCC--eEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChh-hHHHH
Q 013092 94 KSFLHRDIKPDNFLMGLGRRAN--QVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRR-DDLES 170 (449)
Q Consensus 94 ~givHRDLKP~NiLl~~~~~~~--~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~-~DiwS 170 (449)
+||+||||||+|||+. ..+ .+||+|||+++...... ......||+.|+|||++.+..++.+ +||||
T Consensus 135 ~~ivH~Dlkp~Nill~---~~~~~~~kl~Dfg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~Diws 203 (361)
T 3uc3_A 135 MQICHRDLKLENTLLD---GSPAPRLKICDFGYSKSSVLHS--------QPKSTVGTPAYIAPEVLLRQEYDGKIADVWS 203 (361)
T ss_dssp TTCCSCCCCGGGEEEC---SSSSCCEEECCCCCC-----------------------CTTSCHHHHHCSSCCHHHHHHHH
T ss_pred CCcccCCCCHHHEEEc---CCCCceEEEeecCccccccccC--------CCCCCcCCCCcCChhhhcCCCCCCCeeeeeh
Confidence 9999999999999993 433 59999999997543221 1234579999999999998888665 89999
Q ss_pred HHHHHHHHHhCCCCCCCCCcC-CHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 171 LGYVLMYFLRGSLPWQGLKAG-TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 171 lG~il~elltG~~Pf~~~~~~-~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
|||++|+|++|..||.+.... .....+..+.......+ ....+++++.+||..||..+|++||++.+|++
T Consensus 204 lG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~ 274 (361)
T 3uc3_A 204 CGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIP---DDIRISPECCHLISRIFVADPATRISIPEIKT 274 (361)
T ss_dssp HHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCC---TTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCC---CcCCCCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence 999999999999999875442 22333333333222111 11357899999999999999999999877653
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-37 Score=320.85 Aligned_cols=226 Identities=22% Similarity=0.300 Sum_probs=187.3
Q ss_pred cEEEEEeeeccc-CCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHH
Q 013092 3 EILTVFSVQENV-KTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLML 80 (449)
Q Consensus 3 ~aikV~~k~~~~-~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i 80 (449)
.|||++.+.... ......+.+|+.+++.+ +||||+++++++.+.+..||||||| |++|.+++.. ...+++..++.+
T Consensus 54 ~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~i 131 (484)
T 3nyv_A 54 CAVKVISKRQVKQKTDKESLLREVQLLKQL-DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIIS-RKRFSEVDAARI 131 (484)
T ss_dssp EEEEEEETTTCCBSSCHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHT-CSCCBHHHHHHH
T ss_pred EEEEEEEhhhcccchHHHHHHHHHHHHHhC-CCCCCCcEEEEEEeCCEEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHH
Confidence 456665544332 34566799999999999 8999999999999999999999999 9999999875 567999999999
Q ss_pred HHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCC
Q 013092 81 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI 160 (449)
Q Consensus 81 ~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~ 160 (449)
+.||+.||+|||++||+||||||+|||+...+..+.+||+|||+++.+..... .....||+.|+|||++.+
T Consensus 132 ~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~- 202 (484)
T 3nyv_A 132 IRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK--------MKDKIGTAYYIAPEVLHG- 202 (484)
T ss_dssp HHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCCS--------HHHHTTGGGTCCHHHHHT-
T ss_pred HHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccccc--------cccCCCCccccCceeecC-
Confidence 99999999999999999999999999996445678999999999987654322 123479999999999987
Q ss_pred CCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHH
Q 013092 161 EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAY 240 (449)
Q Consensus 161 ~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~ 240 (449)
.++.++|||||||++|+|++|..||.+. ...+.+..+.........+ .+..+++++.+||..||+.+|.+||++.+
T Consensus 203 ~~~~~~DiwslG~il~~ll~g~~pf~~~---~~~~~~~~i~~~~~~~~~~-~~~~~s~~~~~li~~~L~~dp~~R~s~~e 278 (484)
T 3nyv_A 203 TYDEKCDVWSTGVILYILLSGCPPFNGA---NEYDILKKVEKGKYTFELP-QWKKVSESAKDLIRKMLTYVPSMRISARD 278 (484)
T ss_dssp CCCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHCCCCCCSG-GGGGSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CCCCcceeHHHHHHHHHHHHCCCCCCCC---CHHHHHHHHHcCCCCCCCc-ccccCCHHHHHHHHHHCCCChhHCcCHHH
Confidence 6899999999999999999999999874 3445555665554433222 23568999999999999999999999887
Q ss_pred HHH
Q 013092 241 LKR 243 (449)
Q Consensus 241 l~~ 243 (449)
+++
T Consensus 279 ~l~ 281 (484)
T 3nyv_A 279 ALD 281 (484)
T ss_dssp HHT
T ss_pred Hhh
Confidence 753
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-37 Score=306.08 Aligned_cols=205 Identities=19% Similarity=0.263 Sum_probs=173.2
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFL 97 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~giv 97 (449)
...+.+|+++++.+ .||||+++++++.+.+..||||||+.++|.+++......+++..++.++.|++.||+|||++||+
T Consensus 98 ~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iv 176 (348)
T 1u5q_A 98 WQDIIKEVRFLQKL-RHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMI 176 (348)
T ss_dssp HHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCB
T ss_pred HHHHHHHHHHHHhC-CCCCEeeEEEEEEECCeEEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 35688999999999 89999999999999999999999998899999876677899999999999999999999999999
Q ss_pred ecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhh---CCCCChhhHHHHHHHH
Q 013092 98 HRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHL---GIEQSRRDDLESLGYV 174 (449)
Q Consensus 98 HRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~---~~~~s~~~DiwSlG~i 174 (449)
||||||+|||+ +.++.+||+|||+++..... ....||+.|+|||++. ...++.++|||||||+
T Consensus 177 H~Dlkp~NIll---~~~~~~kL~DfG~a~~~~~~-----------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~i 242 (348)
T 1u5q_A 177 HRDVKAGNILL---SEPGLVKLGDFGSASIMAPA-----------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 242 (348)
T ss_dssp CCCCSGGGEEE---ETTTEEEECCCTTCBSSSSB-----------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHH
T ss_pred eCCCCHHHEEE---CCCCCEEEeeccCceecCCC-----------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHH
Confidence 99999999999 47889999999999765432 3457999999999986 4668999999999999
Q ss_pred HHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 175 LMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 175 l~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
+|||++|..||.+... ...+..+....... .....+++++.+||..||+.+|++||++.+|++
T Consensus 243 l~ell~g~~p~~~~~~---~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 305 (348)
T 1u5q_A 243 CIELAERKPPLFNMNA---MSALYHIAQNESPA---LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 305 (348)
T ss_dssp HHHHHHSSCTTTTSCH---HHHHHHHHHSCCCC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHhCCCCCCCCCh---HHHHHHHHhcCCCC---CCCCCCCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 9999999999977432 23333333322211 123467999999999999999999999887753
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-36 Score=294.28 Aligned_cols=219 Identities=23% Similarity=0.308 Sum_probs=177.9
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHC
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVHSK 94 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~--~~~ls~~~~~~i~~qi~~aL~yLH~~ 94 (449)
...+.+|+.+++.+ .||||+++++++.+.+..|+||||+ +++|.+++... ...+++..++.++.||+.||+|||++
T Consensus 74 ~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~ 152 (307)
T 2nru_A 74 KQQFDQEIKVMAKC-QHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN 152 (307)
T ss_dssp HHHHHHHHHHHHHC-CCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHhc-CCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC
Confidence 45689999999999 8999999999999999999999999 99999999743 34699999999999999999999999
Q ss_pred CceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHH
Q 013092 95 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYV 174 (449)
Q Consensus 95 givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~i 174 (449)
||+||||||+|||+ +.++.+||+|||+++........ .......||+.|+|||++.+ .++.++|||||||+
T Consensus 153 ~i~H~dlkp~Nili---~~~~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~i 223 (307)
T 2nru_A 153 HHIHRDIKSANILL---DEAFTAKISDFGLARASEKFAQT-----VMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVV 223 (307)
T ss_dssp TEECSCCCGGGEEE---CTTCCEEECCCTTCEECCSCSSC-----EECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHH
T ss_pred CeecCCCCHHHEEE---cCCCcEEEeeccccccccccccc-----ccccccCCCcCcCChHHhcC-CCCccchhHHHHHH
Confidence 99999999999999 67889999999999876543221 11234579999999999875 47899999999999
Q ss_pred HHHHHhCCCCCCCCCcCCHHHHH-HHHHhhcccchHHH--------hhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Q 013092 175 LMYFLRGSLPWQGLKAGTKKQKY-EKISEKKVSTSIEA--------LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIF 245 (449)
Q Consensus 175 l~elltG~~Pf~~~~~~~~~~~~-~~i~~~~~~~~~~~--------l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~L 245 (449)
+|+|++|..||...........+ ..+.... ..+.. ....++.++.+++..||+.+|.+||++.+|.+.|
T Consensus 224 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L 301 (307)
T 2nru_A 224 LLEIITGLPAVDEHREPQLLLDIKEEIEDEE--KTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLL 301 (307)
T ss_dssp HHHHHHCCCSBCTTBSSSBTTHHHHHHHTTS--CCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHH
T ss_pred HHHHHHCCCCcccCcchHHHHHHHHHhhhhh--hhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 99999999999876543322222 1111111 11111 1123457899999999999999999999999999
Q ss_pred HHH
Q 013092 246 RDL 248 (449)
Q Consensus 246 ~~~ 248 (449)
+++
T Consensus 302 ~~l 304 (307)
T 2nru_A 302 QEM 304 (307)
T ss_dssp HHH
T ss_pred HHH
Confidence 876
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-37 Score=299.05 Aligned_cols=224 Identities=18% Similarity=0.220 Sum_probs=175.6
Q ss_pred ChhHHHHHHHHHHHh-cCCCCCceEEEEeEe----CCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHH
Q 013092 17 KHPQLLYESKLYRIL-QGGTGIPNVRWFGVE----GDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEF 90 (449)
Q Consensus 17 ~~~~~~~E~~il~~l-~~hp~Iv~l~~~~~~----~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~y 90 (449)
....+..|.+++..+ -+||||+++++++.+ ....||||||+ +++|.++++ ...+++..++.++.||+.||+|
T Consensus 43 ~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~--~~~~~~~~~~~i~~~i~~~l~~ 120 (301)
T 3q4u_A 43 DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQ--LTTLDTVSCLRIVLSIASGLAH 120 (301)
T ss_dssp GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEECCCTTCBHHHHHT--TCCBCHHHHHHHHHHHHHHHHH
T ss_pred cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehhhccCCCHHHHHh--hcccCHHHHHHHHHHHHHHHHH
Confidence 445678899988884 289999999988654 35689999999 899999997 5679999999999999999999
Q ss_pred HH--------HCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCC--
Q 013092 91 VH--------SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI-- 160 (449)
Q Consensus 91 LH--------~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~-- 160 (449)
|| ++||+||||||+|||+ +.++.+||+|||+++.......... .......||+.|+|||++.+.
T Consensus 121 lH~~~~~~~~~~~ivH~Dlkp~Nill---~~~~~~kl~Dfg~a~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~ 194 (301)
T 3q4u_A 121 LHIEIFGTQGKPAIAHRDLKSKNILV---KKNGQCCIADLGLAVMHSQSTNQLD---VGNNPRVGTKRYMAPEVLDETIQ 194 (301)
T ss_dssp HHSCBCSTTCBCEEECSCCCGGGEEE---CTTSCEEECCCTTCEEEETTTTEEE---CCCCCCCCCGGGCCHHHHTTCCC
T ss_pred HHHhhhhccCCCCeecCCCChHhEEE---cCCCCEEEeeCCCeeeccccccccc---ccccccccccceeChhhhcCcCC
Confidence 99 9999999999999999 5788999999999987765433211 112345799999999999876
Q ss_pred ----CCChhhHHHHHHHHHHHHHhC----------CCCCCCCCcCC-HHHHHHHHH-hhcccc--hHHHhhcCCcHHHHH
Q 013092 161 ----EQSRRDDLESLGYVLMYFLRG----------SLPWQGLKAGT-KKQKYEKIS-EKKVST--SIEALCRGYPTEFAS 222 (449)
Q Consensus 161 ----~~s~~~DiwSlG~il~elltG----------~~Pf~~~~~~~-~~~~~~~i~-~~~~~~--~~~~l~~~~p~el~~ 222 (449)
.++.++|||||||++|||++| ..||....... ....+..+. ...... +.......+++++.+
T Consensus 195 ~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 274 (301)
T 3q4u_A 195 VDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAK 274 (301)
T ss_dssp TTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHH
T ss_pred CCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHH
Confidence 455799999999999999999 88997654322 122222222 111111 111122345688999
Q ss_pred HHHHHhcCCCCCCCCHHHHHHHHHHH
Q 013092 223 YFHYCRSLRFDDKPDYAYLKRIFRDL 248 (449)
Q Consensus 223 li~~cl~~~p~~RPt~~~l~~~L~~~ 248 (449)
||..||+.+|++||++.+|.+.|+++
T Consensus 275 li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 275 LMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp HHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 99999999999999999999998865
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-38 Score=303.79 Aligned_cols=215 Identities=17% Similarity=0.218 Sum_probs=172.6
Q ss_pred CChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC
Q 013092 16 TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 94 (449)
Q Consensus 16 ~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~ 94 (449)
...+.+.+|+.+++.+ .||||+++++++.+++..||||||+ +++|.+++......+++..++.++.||+.||.|||++
T Consensus 54 ~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~ 132 (289)
T 4fvq_A 54 NYSESFFEAASMMSKL-SHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEEN 132 (289)
T ss_dssp GGHHHHHHHHHHHHTS-CCTTBCCEEEEECCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHHhC-CCCCEeEEEEEEEeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhC
Confidence 4456799999999999 8999999999999999999999999 8999999987555599999999999999999999999
Q ss_pred CceecCCCCCcEEEeecCC-----CCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhC-CCCChhhHH
Q 013092 95 SFLHRDIKPDNFLMGLGRR-----ANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDL 168 (449)
Q Consensus 95 givHRDLKP~NiLl~~~~~-----~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~-~~~s~~~Di 168 (449)
||+||||||+|||+..+.. .+.+||+|||++...... ....||+.|+|||++.+ ..++.++||
T Consensus 133 ~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~~Di 201 (289)
T 4fvq_A 133 TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK-----------DILQERIPWVPPECIENPKNLNLATDK 201 (289)
T ss_dssp TCCCCCCCGGGEEEEECCBGGGTBCCEEEECCCCSCTTTSCH-----------HHHHHTTTTSCHHHHHCGGGCCHHHHH
T ss_pred CeECCCcCcceEEEecCCcccccccceeeeccCcccccccCc-----------cccCCcCcccCHHHhCCCCCCCchhHH
Confidence 9999999999999953221 112999999998644321 23458899999999998 678999999
Q ss_pred HHHHHHHHHHHhC-CCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Q 013092 169 ESLGYVLMYFLRG-SLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRD 247 (449)
Q Consensus 169 wSlG~il~elltG-~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~L~~ 247 (449)
|||||++|+|++| ..||..... ..... +.... ..++..+++++.++|..||+.+|++||++.+|.+.|++
T Consensus 202 wslG~il~el~~g~~~~~~~~~~---~~~~~-~~~~~-----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~ 272 (289)
T 4fvq_A 202 WSFGTTLWEICSGGDKPLSALDS---QRKLQ-FYEDR-----HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNS 272 (289)
T ss_dssp HHHHHHHHHHHTTTCCTTTTSCH---HHHHH-HHHTT-----CCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHT
T ss_pred HHHHHHHHHHHcCCCCCccccch---HHHHH-Hhhcc-----CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 9999999999995 555544322 12111 11111 12334568899999999999999999999999999887
Q ss_pred HHHH
Q 013092 248 LFIR 251 (449)
Q Consensus 248 ~~~~ 251 (449)
++..
T Consensus 273 l~~p 276 (289)
T 4fvq_A 273 LFTP 276 (289)
T ss_dssp CC--
T ss_pred hcCC
Confidence 7543
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-37 Score=308.44 Aligned_cols=207 Identities=17% Similarity=0.269 Sum_probs=172.4
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeC------CEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHH
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEG------DYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 91 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~------~~~~lVmE~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yL 91 (449)
...+.+|+++|+.+ +||||+++++++... ...||||||++++|.+++.. ..+++..+..++.||+.||+||
T Consensus 68 ~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~L 144 (367)
T 1cm8_A 68 AKRAYRELRLLKHM-RHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYI 144 (367)
T ss_dssp HHHHHHHHHHHHHC-CBTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhC-CCcCCCCceeeEecCCccccCceEEEEEecCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHH
Confidence 45688999999999 799999999998765 34699999999999999985 5799999999999999999999
Q ss_pred HHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhC-CCCChhhHHHH
Q 013092 92 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLES 170 (449)
Q Consensus 92 H~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~-~~~s~~~DiwS 170 (449)
|++||+||||||+|||+ +.++.+||+|||+++...... ....||+.|+|||++.+ ..++.++||||
T Consensus 145 H~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~a~~~~~~~----------~~~~~t~~y~aPE~~~~~~~~~~~~Diws 211 (367)
T 1cm8_A 145 HAAGIIHRDLKPGNLAV---NEDCELKILDFGLARQADSEM----------TGYVVTRWYRAPEVILNWMRYTQTVDIWS 211 (367)
T ss_dssp HHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEECCSSC----------CSSCSCGGGCCTHHHHTTTCCCTTHHHHH
T ss_pred HHCCccccCcCHHHEEE---cCCCCEEEEeeeccccccccc----------CcCcCCCCcCCHHHHhCCCCCChhhhHHH
Confidence 99999999999999999 578899999999998764322 34578999999999988 67999999999
Q ss_pred HHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhccc--------------------------chHHHhhcCCcHHHHHHH
Q 013092 171 LGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS--------------------------TSIEALCRGYPTEFASYF 224 (449)
Q Consensus 171 lG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~--------------------------~~~~~l~~~~p~el~~li 224 (449)
|||++|||++|+.||.+.+. ...+..+...... ..+..+...+++++.+|+
T Consensus 212 lG~il~ell~g~~pf~~~~~---~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll 288 (367)
T 1cm8_A 212 VGCIMAEMITGKTLFKGSDH---LDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLL 288 (367)
T ss_dssp HHHHHHHHHHSSCSSCCSSH---HHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHH
T ss_pred HHHHHHHHHhCCCCCCCCCH---HHHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHH
Confidence 99999999999999987433 3333333322111 112233456789999999
Q ss_pred HHHhcCCCCCCCCHHHHHH
Q 013092 225 HYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 225 ~~cl~~~p~~RPt~~~l~~ 243 (449)
..||..||++||++.++++
T Consensus 289 ~~mL~~dP~~R~t~~e~l~ 307 (367)
T 1cm8_A 289 EKMLVLDAEQRVTAGEALA 307 (367)
T ss_dssp HHHSCSSTTTSCCHHHHHH
T ss_pred HHHccCChhHCCCHHHHhc
Confidence 9999999999999887754
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=294.56 Aligned_cols=219 Identities=21% Similarity=0.240 Sum_probs=178.5
Q ss_pred cEEEEEeeeccc-CCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHH
Q 013092 3 EILTVFSVQENV-KTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLML 80 (449)
Q Consensus 3 ~aikV~~k~~~~-~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i 80 (449)
.|+|++.+.... ......+.+|+.+++.+ .||||+++++++.+.+..|+||||+ +++|.+++... ..+++..++.+
T Consensus 37 vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~-~~~~~~~~~~~ 114 (279)
T 3fdn_A 37 LALKVLFKAQLEKAGVEHQLRREVEIQSHL-RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL-SKFDEQRTATY 114 (279)
T ss_dssp EEEEEEEHHHHHHHTCHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHH-SSCCHHHHHHH
T ss_pred EEEEEEeccccchhhHHHHHHHHHHHHHcC-CCCCCcchhheEecCCEEEEEEecCCCCcHHHHHHhc-CCCCHHHHHHH
Confidence 345554443322 23456789999999999 7999999999999999999999999 89999999763 56999999999
Q ss_pred HHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCC
Q 013092 81 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI 160 (449)
Q Consensus 81 ~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~ 160 (449)
+.||+.||+|||++||+||||||+|||+ +.++.++|+|||++....... .....||+.|+|||++.+.
T Consensus 115 ~~qi~~~l~~LH~~~i~H~dlkp~Nili---~~~~~~~l~Dfg~~~~~~~~~---------~~~~~~~~~y~aPE~~~~~ 182 (279)
T 3fdn_A 115 ITELANALSYCHSKRVIHRDIKPENLLL---GSAGELKIADFGWSVHAPSSR---------RTDLCGTLDYLPPEMIEGR 182 (279)
T ss_dssp HHHHHHHHHHHHTTTCEECCCCGGGEEE---CTTSCEEECSCCEESCC-----------------CCCCTTCCHHHHTTC
T ss_pred HHHHHHHHHHHHhCCEecccCChHhEEE---cCCCCEEEEeccccccCCccc---------ccccCCCCCccCHhHhccC
Confidence 9999999999999999999999999999 688899999999986544322 2345789999999999999
Q ss_pred CCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHH
Q 013092 161 EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAY 240 (449)
Q Consensus 161 ~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~ 240 (449)
.++.++||||||+++|+|++|..||... ...+.+..+...... ++..+++++.+||..||+.+|++||++.+
T Consensus 183 ~~~~~~Di~slG~il~~l~~g~~p~~~~---~~~~~~~~~~~~~~~-----~~~~~~~~~~~li~~~l~~~p~~Rps~~e 254 (279)
T 3fdn_A 183 MHDEKVDLWSLGVLCYEFLVGKPPFEAN---TYQETYKRISRVEFT-----FPDFVTEGARDLISRLLKHNPSQRPMLRE 254 (279)
T ss_dssp CCCTTHHHHHHHHHHHHHHHSSCTTCCS---SHHHHHHHHHHTCCC-----CCTTSCHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred CCCccchhHhHHHHHHHHHHCCCCCCCC---cHHHHHHHHHhCCCC-----CCCcCCHHHHHHHHHHhccChhhCCCHHH
Confidence 9999999999999999999999999863 334444444443322 23558899999999999999999999887
Q ss_pred HHH
Q 013092 241 LKR 243 (449)
Q Consensus 241 l~~ 243 (449)
|++
T Consensus 255 ~l~ 257 (279)
T 3fdn_A 255 VLE 257 (279)
T ss_dssp HHH
T ss_pred Hhh
Confidence 765
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=295.61 Aligned_cols=218 Identities=20% Similarity=0.259 Sum_probs=179.4
Q ss_pred ChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 013092 17 KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 95 (449)
Q Consensus 17 ~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~g 95 (449)
....+.+|+++++.+ +||||+++++++.+.. .++||||+ +++|.+++......+++..++.++.||+.||.|||++|
T Consensus 64 ~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 141 (291)
T 1u46_A 64 AMDDFIREVNAMHSL-DHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR 141 (291)
T ss_dssp HHHHHHHHHHHHHHC-CCTTBCCEEEEECSSS-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHhC-CCCCcccEEEEEccCC-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCC
Confidence 345688999999999 8999999999998765 89999999 89999999865567999999999999999999999999
Q ss_pred ceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHHH
Q 013092 96 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVL 175 (449)
Q Consensus 96 ivHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il 175 (449)
|+|+||||+|||+ +.++.+||+|||+++......... .......+|..|+|||++.+..++.++||||||+++
T Consensus 142 i~H~dikp~Nili---~~~~~~kl~Dfg~~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 214 (291)
T 1u46_A 142 FIHRDLAARNLLL---ATRDLVKIGDFGLMRALPQNDDHY----VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTL 214 (291)
T ss_dssp EECSCCCGGGEEE---EETTEEEECCCTTCEECCC-CCEE----EC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHH
T ss_pred cccCCCchheEEE---cCCCCEEEccccccccccccccch----hhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHH
Confidence 9999999999999 467899999999998775543211 112345678899999999998899999999999999
Q ss_pred HHHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 013092 176 MYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLF 249 (449)
Q Consensus 176 ~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~L~~~~ 249 (449)
|+|++ |..||.+... .+.+..+....... .....+|.++.++|..||+.+|++||++.+|.+.|+++.
T Consensus 215 ~~l~~~g~~p~~~~~~---~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 283 (291)
T 1u46_A 215 WEMFTYGQEPWIGLNG---SQILHKIDKEGERL---PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 283 (291)
T ss_dssp HHHHTTSCCTTTTCCH---HHHHHHHHTSCCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred HHHHhCCCCCcccCCH---HHHHHHHHccCCCC---CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence 99999 9999987533 34444443322211 233568999999999999999999999999999888763
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=293.13 Aligned_cols=220 Identities=19% Similarity=0.344 Sum_probs=182.7
Q ss_pred CChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHH
Q 013092 16 TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHS 93 (449)
Q Consensus 16 ~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~-~~~ls~~~~~~i~~qi~~aL~yLH~ 93 (449)
.....+.+|+++++.+ .||||+++++++. .+..|+||||+ +++|.+++... ...+++..++.++.|++.||+|||+
T Consensus 50 ~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~ 127 (279)
T 1qpc_A 50 MSPDAFLAEANLMKQL-QHQRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 127 (279)
T ss_dssp SCHHHHHHHHHHHHHC-CCTTBCCEEEEEC-SSSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHH
T ss_pred ccHHHHHHHHHHHHhC-CCcCcceEEEEEc-CCCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 3556799999999999 8999999999876 45689999999 99999998642 2269999999999999999999999
Q ss_pred CCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHH
Q 013092 94 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGY 173 (449)
Q Consensus 94 ~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~ 173 (449)
+||+||||||+|||+ +.++.+||+|||+++....... .......++..|+|||++.+..++.++|||||||
T Consensus 128 ~~i~H~dikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 198 (279)
T 1qpc_A 128 RNYIHRDLRAANILV---SDTLSCKIADFGLARLIEDNEY------TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGI 198 (279)
T ss_dssp TTEECSCCSGGGEEE---CTTSCEEECCCTTCEECSSSCE------ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHH
T ss_pred CCeeccCCCHhhEEE---cCCCCEEECCCcccccccCccc------ccccCCCCccCccChhhhccCCCCchhhhHHHHH
Confidence 999999999999999 5788999999999987754321 1223456788999999999888999999999999
Q ss_pred HHHHHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 013092 174 VLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIRE 252 (449)
Q Consensus 174 il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~L~~~~~~~ 252 (449)
++|+|++ |..||.+... .+.+..+..... ......+++++.+++..||+.+|++||++.+|.+.|++++...
T Consensus 199 il~el~~~g~~p~~~~~~---~~~~~~~~~~~~----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 271 (279)
T 1qpc_A 199 LLTEIVTHGRIPYPGMTN---PEVIQNLERGYR----MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 271 (279)
T ss_dssp HHHHHHTTTCCSSTTCCH---HHHHHHHHTTCC----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred HHHHHHhCCCCCCcccCH---HHHHHHHhcccC----CCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhc
Confidence 9999999 9999987433 333333333211 1223568999999999999999999999999999999998765
Q ss_pred C
Q 013092 253 G 253 (449)
Q Consensus 253 ~ 253 (449)
.
T Consensus 272 ~ 272 (279)
T 1qpc_A 272 E 272 (279)
T ss_dssp -
T ss_pred c
Confidence 3
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=306.95 Aligned_cols=210 Identities=18% Similarity=0.244 Sum_probs=169.0
Q ss_pred HHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q 013092 20 QLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHR 99 (449)
Q Consensus 20 ~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~givHR 99 (449)
.+.+|+++++.+ .||||+++++++.+.+..||||||++++|.+++......+++..++.++.||+.||+|||++||+||
T Consensus 46 ~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~ 124 (324)
T 3mtl_A 46 TAIREVSLLKDL-KHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHR 124 (324)
T ss_dssp CCCCCHHHHSCC-CCTTBCCEEEEEECSSCEEEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEES
T ss_pred hHHHHHHHHHhc-CCCCCCeeeeEEeeCCEEEEEecccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCC
Confidence 466899999999 8999999999999999999999999889999998766779999999999999999999999999999
Q ss_pred CCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhC-CCCChhhHHHHHHHHHHHH
Q 013092 100 DIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYF 178 (449)
Q Consensus 100 DLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~-~~~s~~~DiwSlG~il~el 178 (449)
||||+|||+ +.++.+||+|||+++....... ......||+.|+|||++.+ ..++.++|||||||++|+|
T Consensus 125 Dikp~NIl~---~~~~~~kl~Dfg~a~~~~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l 194 (324)
T 3mtl_A 125 DLKPQNLLI---NERGELKLADFGLARAKSIPTK-------TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEM 194 (324)
T ss_dssp SCCGGGEEE---CTTCCEEECSSSEEECC-------------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHH
T ss_pred CcCHHHEEE---CCCCCEEEccCcccccccCCcc-------ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHH
Confidence 999999999 5788999999999986543321 1234578999999999987 5689999999999999999
Q ss_pred HhCCCCCCCCCcCCHHHHHHHHHhhcc-------------------------cchHHHhhcCCcHHHHHHHHHHhcCCCC
Q 013092 179 LRGSLPWQGLKAGTKKQKYEKISEKKV-------------------------STSIEALCRGYPTEFASYFHYCRSLRFD 233 (449)
Q Consensus 179 ltG~~Pf~~~~~~~~~~~~~~i~~~~~-------------------------~~~~~~l~~~~p~el~~li~~cl~~~p~ 233 (449)
++|..||.+.... +.+..+..... ..........+++++.+||..||+.||+
T Consensus 195 ~~g~~pf~~~~~~---~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 271 (324)
T 3mtl_A 195 ATGRPLFPGSTVE---EQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGR 271 (324)
T ss_dssp HHSSCSCCCSSHH---HHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGG
T ss_pred HhCCCCCCCCCHH---HHHHHHHHHhCCCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcc
Confidence 9999999875433 22333222111 0111223356789999999999999999
Q ss_pred CCCCHHHHHH
Q 013092 234 DKPDYAYLKR 243 (449)
Q Consensus 234 ~RPt~~~l~~ 243 (449)
+||++.++++
T Consensus 272 ~R~t~~e~l~ 281 (324)
T 3mtl_A 272 NRISAEDAMK 281 (324)
T ss_dssp GSCCHHHHTT
T ss_pred cCCCHHHHhc
Confidence 9999887753
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=313.61 Aligned_cols=222 Identities=15% Similarity=0.184 Sum_probs=166.1
Q ss_pred ChhHHHHHHHHHHHhcCCCCCceEEEEeEeC-----CEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHH
Q 013092 17 KHPQLLYESKLYRILQGGTGIPNVRWFGVEG-----DYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 91 (449)
Q Consensus 17 ~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~-----~~~~lVmE~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yL 91 (449)
....+.+|+++|+.+ +|+||+++++++... ...||||||++++|.+++.. ...+++..++.++.||+.||+||
T Consensus 68 ~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~-~~~l~~~~~~~i~~qil~aL~~L 145 (432)
T 3n9x_A 68 DCKRILREITILNRL-KSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKT-PIFLTEEHIKTILYNLLLGENFI 145 (432)
T ss_dssp HHHHHHHHHHHHHHC-CCTTBCCEEEECCCSCTTTCCCEEEEEECCSEEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHc-CCCCcceEEEEEecCCCCcCCeEEEEEecCCcCHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHH
Confidence 345788999999999 899999999998766 57999999998899999984 45699999999999999999999
Q ss_pred HHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCccc---------------ccccCCCCccCccccchhh
Q 013092 92 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHI---------------PYRENKNLTGTARYASMNT 156 (449)
Q Consensus 92 H~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~---------------~~~~~~~~~gT~~Y~aPE~ 156 (449)
|++||+||||||+|||| +.++.+||+|||+++........... ........+||+.|+|||+
T Consensus 146 H~~givHrDlkp~NILl---~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~ 222 (432)
T 3n9x_A 146 HESGIIHRDLKPANCLL---NQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPEL 222 (432)
T ss_dssp HHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEEC-------------------------------CCCCCTTCCHHH
T ss_pred HHCCCCCCCCCHHHeEE---CCCCCEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHH
Confidence 99999999999999999 68889999999999987543221000 0011246789999999998
Q ss_pred hh-CCCCChhhHHHHHHHHHHHHHhCCCCC-----------CCCCcC--------------CHHHHHHHHHhhc------
Q 013092 157 HL-GIEQSRRDDLESLGYVLMYFLRGSLPW-----------QGLKAG--------------TKKQKYEKISEKK------ 204 (449)
Q Consensus 157 ~~-~~~~s~~~DiwSlG~il~elltG~~Pf-----------~~~~~~--------------~~~~~~~~i~~~~------ 204 (449)
+. ...++.++||||||||+|||++|..|| .+.... .....+..+.+..
T Consensus 223 ~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~ 302 (432)
T 3n9x_A 223 ILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTED 302 (432)
T ss_dssp HTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHH
T ss_pred HhcCCCCCcccccchHHHHHHHHHhcccccccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHH
Confidence 74 566999999999999999999854444 332110 0011111121111
Q ss_pred --------------------ccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 205 --------------------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 205 --------------------~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
.........+.+++++.+||..||..||++||++.++++
T Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 361 (432)
T 3n9x_A 303 DLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALD 361 (432)
T ss_dssp HHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 111223334678999999999999999999999877753
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=303.57 Aligned_cols=213 Identities=18% Similarity=0.230 Sum_probs=171.9
Q ss_pred ChhHHHHHHHHHHHhc----CCCCCceEEEEeEeCCEEEEEEecCCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHH
Q 013092 17 KHPQLLYESKLYRILQ----GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFV 91 (449)
Q Consensus 17 ~~~~~~~E~~il~~l~----~hp~Iv~l~~~~~~~~~~~lVmE~~g~sL~~ll~~~~-~~ls~~~~~~i~~qi~~aL~yL 91 (449)
....+..|+.+++.++ +||||+++++++...+..||||||++++|.+++.... ..+++..++.++.||+.||+||
T Consensus 74 ~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~L 153 (360)
T 3llt_A 74 YTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYL 153 (360)
T ss_dssp HHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred hhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH
Confidence 3456788999999996 5999999999999999999999999999999998643 3599999999999999999999
Q ss_pred HHCCceecCCCCCcEEEeec----------------------CCCCeEEEeecCcceeecCCCCCcccccccCCCCccCc
Q 013092 92 HSKSFLHRDIKPDNFLMGLG----------------------RRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTA 149 (449)
Q Consensus 92 H~~givHRDLKP~NiLl~~~----------------------~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~ 149 (449)
|++||+||||||+||||... ...+.+||+|||+++...... ....||+
T Consensus 154 H~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~----------~~~~gt~ 223 (360)
T 3llt_A 154 RKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH----------GSIINTR 223 (360)
T ss_dssp HHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC----------CSCCSCG
T ss_pred HHCCeeeCCCCcccEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCCCC----------cCccCcc
Confidence 99999999999999999421 137889999999998654322 3457999
Q ss_pred cccchhhhhCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHH-------------------
Q 013092 150 RYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE------------------- 210 (449)
Q Consensus 150 ~Y~aPE~~~~~~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~------------------- 210 (449)
.|+|||++.+..++.++|||||||++|+|++|..||.+.... +.+..+.......+..
T Consensus 224 ~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 300 (360)
T 3llt_A 224 QYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHM---EHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDEL 300 (360)
T ss_dssp GGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTT
T ss_pred cccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCcHH---HHHHHHHHhcCCCCHHHHhhhhhccCccccCcccc
Confidence 999999999999999999999999999999999999875432 2222222211110000
Q ss_pred ----------------------HhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 013092 211 ----------------------ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 242 (449)
Q Consensus 211 ----------------------~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~ 242 (449)
.+....++++.+||..||+.||++||++.+++
T Consensus 301 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL 354 (360)
T 3llt_A 301 KLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELL 354 (360)
T ss_dssp EECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHT
T ss_pred eecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhCCCHHHHh
Confidence 01112347888999999999999999988875
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-38 Score=307.19 Aligned_cols=247 Identities=15% Similarity=0.198 Sum_probs=181.4
Q ss_pred EEEEEeeecccCCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHH
Q 013092 4 ILTVFSVQENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLAD 82 (449)
Q Consensus 4 aikV~~k~~~~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~ 82 (449)
|+|++.+..........+.+|+.+++.+ .|+||+++++++.+.+..||||||+ |++|.+++......+++..++.++.
T Consensus 59 avk~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ 137 (319)
T 2y4i_B 59 AIRLIDIERDNEDQLKAFKREVMAYRQT-RHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQ 137 (319)
T ss_dssp EEEECCCCSCCCCCCCCCCTTGGGGTTC-CCTTBCCCCEEEECSSCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHH
T ss_pred EEEEeecCCCCHHHHHHHHHHHHHHhcC-CCCCEeEEEEEEecCCceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHH
Confidence 4555544443344556788999999999 8999999999999999999999999 8999999986555799999999999
Q ss_pred HHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhC---
Q 013092 83 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG--- 159 (449)
Q Consensus 83 qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~--- 159 (449)
||+.||+|||++||+||||||+|||+. ++.+||+|||+++......... .........||+.|+|||++.+
T Consensus 138 qi~~al~~lH~~~i~H~dlkp~NIl~~----~~~~~l~Dfg~~~~~~~~~~~~--~~~~~~~~~g~~~y~aPE~~~~~~~ 211 (319)
T 2y4i_B 138 EIVKGMGYLHAKGILHKDLKSKNVFYD----NGKVVITDFGLFSISGVLQAGR--REDKLRIQNGWLCHLAPEIIRQLSP 211 (319)
T ss_dssp HHHHHHHHHHHTTCCCCCCCSTTEEEC------CCEECCCSCCC------------CCSCBCCSGGGGTSCHHHHSCBSC
T ss_pred HHHHHHHHHHhCCccccCCChhhEEEe----CCCEEEeecCCccccccccccc--cccccccCCCcccccChHHhhhccc
Confidence 999999999999999999999999993 5789999999987654321111 0112234569999999999975
Q ss_pred ------CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCC
Q 013092 160 ------IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFD 233 (449)
Q Consensus 160 ------~~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~ 233 (449)
..++.++|||||||++|+|++|..||..... ...+..+....... .....+|.++.++|..||..+|+
T Consensus 212 ~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~---~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~~p~ 285 (319)
T 2y4i_B 212 DTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA---EAIIWQMGTGMKPN---LSQIGMGKEISDILLFCWAFEQE 285 (319)
T ss_dssp C--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCH---HHHHHHHHTTCCCC---CCCSSCCTTHHHHHHHHHCSSTT
T ss_pred cccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHhccCCCCC---CCcCCCCHHHHHHHHHHhcCChh
Confidence 4578999999999999999999999987433 33333333322211 11235789999999999999999
Q ss_pred CCCCHHHHHHHHHHHHHHcCCCCCCcccch
Q 013092 234 DKPDYAYLKRIFRDLFIREGFQFDYVFDWT 263 (449)
Q Consensus 234 ~RPt~~~l~~~L~~~~~~~~~~~~~~~dw~ 263 (449)
+||++.+|.+.|+++..+..........|.
T Consensus 286 ~Rpt~~~l~~~l~~l~~~~~~~~~~~~~~~ 315 (319)
T 2y4i_B 286 ERPTFTKLMDMLEKLPKRNRRLSHPGHFWK 315 (319)
T ss_dssp TSCCHHHHHHHHTTC---------------
T ss_pred hCcCHHHHHHHHHHHHHhhccCCCCccccc
Confidence 999999999999988776655445555554
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=300.34 Aligned_cols=230 Identities=20% Similarity=0.288 Sum_probs=177.7
Q ss_pred ChhHHHHHHHHHHHhc-CCCCCceEEEEeEeC----CEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHH
Q 013092 17 KHPQLLYESKLYRILQ-GGTGIPNVRWFGVEG----DYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEF 90 (449)
Q Consensus 17 ~~~~~~~E~~il~~l~-~hp~Iv~l~~~~~~~----~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~y 90 (449)
....+..|.+++..+. +||||+++++++.+. ...||||||+ +++|.++++. ..+++..++.++.|++.||+|
T Consensus 72 ~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~ 149 (337)
T 3mdy_A 72 EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKS--TTLDAKSMLKLAYSSVSGLCH 149 (337)
T ss_dssp GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHH
T ss_pred ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEEEeccCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHH
Confidence 3455677777776653 899999999999887 7899999999 8899999984 469999999999999999999
Q ss_pred HHHC--------CceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCC
Q 013092 91 VHSK--------SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQ 162 (449)
Q Consensus 91 LH~~--------givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~ 162 (449)
||++ ||+||||||+|||+ +.++.+||+|||+++.+......... ......||+.|+|||++.+..+
T Consensus 150 lH~~~~~~~~~~~ivH~Dikp~Nill---~~~~~~kl~Dfg~a~~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~ 223 (337)
T 3mdy_A 150 LHTEIFSTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVKFISDTNEVDI---PPNTRVGTKRYMPPEVLDESLN 223 (337)
T ss_dssp HHSCBCSTTCBCCEECSCCCGGGEEE---CTTSCEEECCCTTCEECC------------CCSSCSCGGGCCHHHHTTCCC
T ss_pred HHHhhhhhccCCCEEecccchHHEEE---CCCCCEEEEeCCCceeeccccccccC---CCCCCccCcceeChhhcccccC
Confidence 9998 99999999999999 57889999999999877554332211 1235679999999999988766
Q ss_pred Chh------hHHHHHHHHHHHHHhC----------CCCCCCCCcCCH-HHHHHH-HHhhcccchHHH--hhcCCcHHHHH
Q 013092 163 SRR------DDLESLGYVLMYFLRG----------SLPWQGLKAGTK-KQKYEK-ISEKKVSTSIEA--LCRGYPTEFAS 222 (449)
Q Consensus 163 s~~------~DiwSlG~il~elltG----------~~Pf~~~~~~~~-~~~~~~-i~~~~~~~~~~~--l~~~~p~el~~ 222 (449)
... +|||||||++|||++| ..||........ ...... +.........+. ....+++++.+
T Consensus 224 ~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 303 (337)
T 3mdy_A 224 RNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGK 303 (337)
T ss_dssp TTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHH
T ss_pred CccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHH
Confidence 554 9999999999999999 788876543321 122222 222221111111 12356788999
Q ss_pred HHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCC
Q 013092 223 YFHYCRSLRFDDKPDYAYLKRIFRDLFIREGF 254 (449)
Q Consensus 223 li~~cl~~~p~~RPt~~~l~~~L~~~~~~~~~ 254 (449)
||..||+.+|++||++.+|++.|+.+....+.
T Consensus 304 li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~ 335 (337)
T 3mdy_A 304 LMTECWAHNPASRLTALRVKKTLAKMSESQDI 335 (337)
T ss_dssp HHHHHSCSSGGGSCCHHHHHHHHHHHHHTTTC
T ss_pred HHHHhhhhChhhCCCHHHHHHHHHHHHhhccc
Confidence 99999999999999999999999999876654
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=293.94 Aligned_cols=220 Identities=15% Similarity=0.118 Sum_probs=177.7
Q ss_pred cEEEEEeeecccCCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHc---CCCCCHHHHH
Q 013092 3 EILTVFSVQENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFC---SRKLSLKTVL 78 (449)
Q Consensus 3 ~aikV~~k~~~~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~---~~~ls~~~~~ 78 (449)
+|+|++.+..........+.+|+.++..+.+||||+++++++.+.+..||||||+ +++|.+++... ...+++..++
T Consensus 39 vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 118 (289)
T 1x8b_A 39 YAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELK 118 (289)
T ss_dssp EEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHH
T ss_pred EEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHH
Confidence 3555555443334455678899999999989999999999999999999999999 88999999753 2569999999
Q ss_pred HHHHHHHHHHHHHHHCCceecCCCCCcEEEeecC----------------CCCeEEEeecCcceeecCCCCCcccccccC
Q 013092 79 MLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR----------------RANQVYIIDFGLAKKYRDTSTHQHIPYREN 142 (449)
Q Consensus 79 ~i~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~----------------~~~~vkL~DFGla~~~~~~~~~~~~~~~~~ 142 (449)
.++.||+.||+|||++||+||||||+|||+..+. ....+||+|||++.......
T Consensus 119 ~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~---------- 188 (289)
T 1x8b_A 119 DLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ---------- 188 (289)
T ss_dssp HHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------------CCCEEECCCTTCEETTCSC----------
T ss_pred HHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCCceEEEEcccccccccCCcc----------
Confidence 9999999999999999999999999999995322 44579999999998765432
Q ss_pred CCCccCccccchhhhhCC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHH
Q 013092 143 KNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFA 221 (449)
Q Consensus 143 ~~~~gT~~Y~aPE~~~~~-~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~ 221 (449)
...||+.|+|||++.+. .++.++|||||||++|+|++|..|+... ..+..+..... ..++..+++++.
T Consensus 189 -~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~------~~~~~~~~~~~----~~~~~~~~~~~~ 257 (289)
T 1x8b_A 189 -VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG------DQWHEIRQGRL----PRIPQVLSQEFT 257 (289)
T ss_dssp -CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS------HHHHHHHTTCC----CCCSSCCCHHHH
T ss_pred -ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch------hHHHHHHcCCC----CCCCcccCHHHH
Confidence 23589999999999876 5678999999999999999998877542 12333333322 234467899999
Q ss_pred HHHHHHhcCCCCCCCCHHHHHH
Q 013092 222 SYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 222 ~li~~cl~~~p~~RPt~~~l~~ 243 (449)
++|..||+.||++||++.++++
T Consensus 258 ~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 258 ELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHhCCCcccCCCHHHHhh
Confidence 9999999999999999888754
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=296.79 Aligned_cols=223 Identities=19% Similarity=0.221 Sum_probs=180.3
Q ss_pred EEEEEeeecccCCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHH
Q 013092 4 ILTVFSVQENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLAD 82 (449)
Q Consensus 4 aikV~~k~~~~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~ 82 (449)
|+|++.+.. ......+.+|+.+++.+ .||||+++++++.+.+..|+||||+ +++|.+++.. ...+++..++.++.
T Consensus 38 aiK~~~~~~--~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~ 113 (304)
T 2jam_A 38 ALKCIKKSP--AFRDSSLENEIAVLKKI-KHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILE-RGVYTEKDASLVIQ 113 (304)
T ss_dssp EEEEEECC--------HHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH-HSCCCHHHHHHHHH
T ss_pred EEEEEeccc--ccchHHHHHHHHHHHhC-CCCCeeehhhhcccCCEEEEEEEcCCCccHHHHHHH-cCCCCHHHHHHHHH
Confidence 445444322 22345789999999999 8999999999999999999999999 8999999875 45799999999999
Q ss_pred HHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCC
Q 013092 83 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQ 162 (449)
Q Consensus 83 qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~ 162 (449)
|++.||+|||++||+||||||+|||+...+.++.+||+|||+++...... .....||+.|+|||++.+..+
T Consensus 114 qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~ 184 (304)
T 2jam_A 114 QVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI---------MSTACGTPGYVAPEVLAQKPY 184 (304)
T ss_dssp HHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCBT---------THHHHSCCCBCCTTTBSSCSC
T ss_pred HHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCCc---------cccccCCCCccChHHhccCCC
Confidence 99999999999999999999999999544567899999999987543321 123468999999999999999
Q ss_pred ChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 013092 163 SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 242 (449)
Q Consensus 163 s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~ 242 (449)
+.++|||||||++|+|++|..||... ...+.+..+....... .......+++++.++|..||..+|++||++.+++
T Consensus 185 ~~~~Di~slG~il~~l~~g~~pf~~~---~~~~~~~~i~~~~~~~-~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l 260 (304)
T 2jam_A 185 SKAVDCWSIGVITYILLCGYPPFYEE---TESKLFEKIKEGYYEF-ESPFWDDISESAKDFICHLLEKDPNERYTCEKAL 260 (304)
T ss_dssp CHHHHHHHHHHHHHHHHHSSCTTTTS---CHHHHHHHHHHCCCCC-CTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHH
T ss_pred CchhhHHHHHHHHHHHHHCCCCCCCC---CHHHHHHHHHcCCCCC-CccccccCCHHHHHHHHHHcCCChhHCcCHHHHh
Confidence 99999999999999999999999764 3344455555443321 1233467899999999999999999999987765
Q ss_pred H
Q 013092 243 R 243 (449)
Q Consensus 243 ~ 243 (449)
+
T Consensus 261 ~ 261 (304)
T 2jam_A 261 S 261 (304)
T ss_dssp T
T ss_pred c
Confidence 3
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-36 Score=296.09 Aligned_cols=226 Identities=19% Similarity=0.215 Sum_probs=182.7
Q ss_pred cEEEEEeeecccCCChhHHHHHHHHHHHhc--CCCCCceEEEEeE-----eCCEEEEEEecCCCCHHHHHHHcC-CCCCH
Q 013092 3 EILTVFSVQENVKTKHPQLLYESKLYRILQ--GGTGIPNVRWFGV-----EGDYNVLVMDLLGPSLEDLFNFCS-RKLSL 74 (449)
Q Consensus 3 ~aikV~~k~~~~~~~~~~~~~E~~il~~l~--~hp~Iv~l~~~~~-----~~~~~~lVmE~~g~sL~~ll~~~~-~~ls~ 74 (449)
+|+|++.+..........+.+|+.+++.+. +||||+++++++. .....||||||++++|.+++.... ..+++
T Consensus 40 vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~ 119 (326)
T 1blx_A 40 VALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPT 119 (326)
T ss_dssp EEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCH
T ss_pred EEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCceEEEEEecCCCCHHHHHHhcccCCCCH
Confidence 456666554444444567889999999886 8999999999887 566789999999889999998643 34999
Q ss_pred HHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccch
Q 013092 75 KTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASM 154 (449)
Q Consensus 75 ~~~~~i~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aP 154 (449)
..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++...... ......||+.|+||
T Consensus 120 ~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili---~~~~~~kl~Dfg~~~~~~~~~--------~~~~~~~~~~y~aP 188 (326)
T 1blx_A 120 ETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILV---TSSGQIKLADFGLARIYSFQM--------ALTSVVVTLWYRAP 188 (326)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECSCCSCCCCCGGG--------GGCCCCCCCTTCCH
T ss_pred HHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEE---cCCCCEEEecCcccccccCCC--------CccccccccceeCH
Confidence 9999999999999999999999999999999999 578899999999997654321 12346789999999
Q ss_pred hhhhCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcc----------------------cchHHHh
Q 013092 155 NTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV----------------------STSIEAL 212 (449)
Q Consensus 155 E~~~~~~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~----------------------~~~~~~l 212 (449)
|++.+..++.++|||||||++|+|++|..||.+... ...+..+..... ...+..+
T Consensus 189 E~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (326)
T 1blx_A 189 EVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD---VDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKF 265 (326)
T ss_dssp HHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGT
T ss_pred HHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHHHHcCCCCcccCccccccchhhhcccCcchhhhc
Confidence 999999999999999999999999999999987443 333333332111 1123344
Q ss_pred hcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 013092 213 CRGYPTEFASYFHYCRSLRFDDKPDYAYLK 242 (449)
Q Consensus 213 ~~~~p~el~~li~~cl~~~p~~RPt~~~l~ 242 (449)
...++.++.+||..||+.+|++||++.+++
T Consensus 266 ~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l 295 (326)
T 1blx_A 266 VTDIDELGKDLLLKCLTFNPAKRISAYSAL 295 (326)
T ss_dssp CCSCCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred cccCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 567899999999999999999999988775
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=300.22 Aligned_cols=227 Identities=22% Similarity=0.242 Sum_probs=172.1
Q ss_pred cEEEEEeeecccCCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCC----------------------------------
Q 013092 3 EILTVFSVQENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGD---------------------------------- 48 (449)
Q Consensus 3 ~aikV~~k~~~~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~---------------------------------- 48 (449)
+|||++.+.. .......+.+|+++|+.| +||||+++++++.+..
T Consensus 34 vavK~~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 111 (332)
T 3qd2_B 34 YAIKRIRLPN-RELAREKVMREVKALAKL-EHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVK 111 (332)
T ss_dssp EEEEEEECCS-TTTHHHHHHHHHHHHTSC-CCTTBCCEEEEEEECCSCHHHHHHHC------------------------
T ss_pred EEEEEeecCC-chhHHHHHHHHHHHHHhC-CCCCEeeEEEEEEEeccchhhhhhhhhhhccccccccccCCCcccccccc
Confidence 3455544322 223446799999999999 8999999999886543
Q ss_pred -----------------------EEEEEEecC-CCCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCC
Q 013092 49 -----------------------YNVLVMDLL-GPSLEDLFNFCS--RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIK 102 (449)
Q Consensus 49 -----------------------~~~lVmE~~-g~sL~~ll~~~~--~~ls~~~~~~i~~qi~~aL~yLH~~givHRDLK 102 (449)
+.||||||| |++|.+++.... ...++..++.++.||+.||+|||++||+|||||
T Consensus 112 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlk 191 (332)
T 3qd2_B 112 IRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLK 191 (332)
T ss_dssp --------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCC
T ss_pred eeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHHHHHHHHHHHHHHHHHHhCCeeecCCC
Confidence 489999999 999999998532 235677799999999999999999999999999
Q ss_pred CCcEEEeecCCCCeEEEeecCcceeecCCCCCccc-----ccccCCCCccCccccchhhhhCCCCChhhHHHHHHHHHHH
Q 013092 103 PDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHI-----PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMY 177 (449)
Q Consensus 103 P~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~-----~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il~e 177 (449)
|+|||+ +.++.+||+|||+++........... .+.......||+.|+|||++.+..++.++|||||||++|+
T Consensus 192 p~NIll---~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~e 268 (332)
T 3qd2_B 192 PSNIFF---TMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFE 268 (332)
T ss_dssp GGGEEE---CTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHH
T ss_pred cccEEE---eCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHH
Confidence 999999 57889999999999987654321110 0122345679999999999999999999999999999999
Q ss_pred HHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 178 FLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 178 lltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
|++|..|+.. .......+..... +.....+++++.++|..||+.+|++||++.++++
T Consensus 269 l~~~~~~~~~-----~~~~~~~~~~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 269 LLYSFSTQME-----RVRIITDVRNLKF----PLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HHSCCCCHHH-----HHHHHHHHHTTCC----CHHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred HHHcCCChhH-----HHHHHHHhhccCC----CcccccCChhHHHHHHHHccCCCCcCCCHHHHhh
Confidence 9998777532 1222222322222 2223345678899999999999999999888764
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=298.86 Aligned_cols=223 Identities=20% Similarity=0.269 Sum_probs=175.1
Q ss_pred EEEeeecccCCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCC--CCCHHHHHHHHH
Q 013092 6 TVFSVQENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSR--KLSLKTVLMLAD 82 (449)
Q Consensus 6 kV~~k~~~~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~--~ls~~~~~~i~~ 82 (449)
+|++|..........+.+|+++++.+ +||||+++++++.+ ..||||||+ +++|.+++..... .++...++.++.
T Consensus 33 ~vavK~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~ 109 (307)
T 2eva_A 33 DVAIKQIESESERKAFIVELRQLSRV-NHPNIVKLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCL 109 (307)
T ss_dssp EEEEEECSSTTHHHHHHHHHHHHHHC-CCTTBCCEEEBCTT--TTEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHH
T ss_pred eEEEEEecChhHHHHHHHHHHHHhcC-CCCCcCeEEEEEcC--CcEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHH
Confidence 35555554455567799999999999 89999999988763 489999999 9999999985322 378999999999
Q ss_pred HHHHHHHHHHH---CCceecCCCCCcEEEeecCCCC-eEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhh
Q 013092 83 QMINRVEFVHS---KSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHL 158 (449)
Q Consensus 83 qi~~aL~yLH~---~givHRDLKP~NiLl~~~~~~~-~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~ 158 (449)
||+.||+|||+ +||+||||||+|||+. .++ .+||+|||++....... ....||+.|+|||++.
T Consensus 110 qi~~~l~~LH~~~~~~ivH~dlkp~NIll~---~~~~~~kl~Dfg~~~~~~~~~----------~~~~gt~~y~aPE~~~ 176 (307)
T 2eva_A 110 QCSQGVAYLHSMQPKALIHRDLKPPNLLLV---AGGTVLKICDFGTACDIQTHM----------TNNKGSAAWMAPEVFE 176 (307)
T ss_dssp HHHHHHHHHHTCSSSCCCCCCCSGGGEEEE---TTTTEEEECCCCC----------------------CCTTSSCHHHHT
T ss_pred HHHHHHHHHHhCCCCCeecCCCChhHEEEe---CCCCEEEEccccccccccccc----------ccCCCCCceEChhhhC
Confidence 99999999999 8999999999999995 444 58999999997654322 2346899999999999
Q ss_pred CCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCH
Q 013092 159 GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDY 238 (449)
Q Consensus 159 ~~~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~ 238 (449)
+..++.++|||||||++|+|++|..||....... ......+.... ...+...+|+++.++|..||+.+|++||++
T Consensus 177 ~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~~~~~~~~~----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~ 251 (307)
T 2eva_A 177 GSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPA-FRIMWAVHNGT----RPPLIKNLPKPIESLMTRCWSKDPSQRPSM 251 (307)
T ss_dssp CCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSH-HHHHHHHHTTC----CCCCBTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred CCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccH-HHHHHHHhcCC----CCCcccccCHHHHHHHHHHhcCChhhCcCH
Confidence 9999999999999999999999999998654322 22222222221 122346789999999999999999999999
Q ss_pred HHHHHHHHHHH
Q 013092 239 AYLKRIFRDLF 249 (449)
Q Consensus 239 ~~l~~~L~~~~ 249 (449)
.+|.+.|+.+.
T Consensus 252 ~ell~~L~~~~ 262 (307)
T 2eva_A 252 EEIVKIMTHLM 262 (307)
T ss_dssp HHHHHHHHHHG
T ss_pred HHHHHHHHHHH
Confidence 99999998874
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-37 Score=296.39 Aligned_cols=225 Identities=18% Similarity=0.239 Sum_probs=177.2
Q ss_pred EEeeecccCCChhHHHHHHHHHHHhcCCCCCceEEEEeEeC-CEEEEEEecC-CCCHHHHHHHcC-CCCCHHHHHHHHHH
Q 013092 7 VFSVQENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEG-DYNVLVMDLL-GPSLEDLFNFCS-RKLSLKTVLMLADQ 83 (449)
Q Consensus 7 V~~k~~~~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~-~~~~lVmE~~-g~sL~~ll~~~~-~~ls~~~~~~i~~q 83 (449)
|++|........+.+.+|+++++.+ +||||+++++++.+. +..|+||||+ +++|.+++.... ..+++..++.++.|
T Consensus 47 vavK~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~ 125 (278)
T 1byg_A 47 VAVKCIKNDATAQAFLAEASVMTQL-RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLD 125 (278)
T ss_dssp EEEEECCCCC--HHHHHTHHHHTTC-CCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHH
T ss_pred EEEEEecchhHHHHHHHHHHHHHhC-CCCCEeeEEEEEEcCCCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHH
Confidence 4444444445667899999999999 899999999987654 5789999999 889999997532 23899999999999
Q ss_pred HHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCC
Q 013092 84 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQS 163 (449)
Q Consensus 84 i~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s 163 (449)
++.||+|||++||+||||||+||++ +.++.+||+|||++....... ....+++.|+|||++.+..++
T Consensus 126 i~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~~l~Dfg~~~~~~~~~----------~~~~~~~~y~aPE~~~~~~~~ 192 (278)
T 1byg_A 126 VCEAMEYLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLTKEASSTQ----------DTGKLPVKWTAPEALREKKFS 192 (278)
T ss_dssp HHHHHHHHHHTTCCCSCCSGGGEEE---CTTSCEEECCCCC----------------------CCTTTSCHHHHHHCCCC
T ss_pred HHHHHHHHHhCCccccCCCcceEEE---eCCCcEEEeeccccccccccc----------cCCCccccccCHHHhCCCCCC
Confidence 9999999999999999999999999 578899999999997654322 233578899999999999999
Q ss_pred hhhHHHHHHHHHHHHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 013092 164 RRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 242 (449)
Q Consensus 164 ~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~ 242 (449)
.++||||||+++|+|++ |..||...... +....+..... ......+|+++.++|..||+.+|++||++.+|.
T Consensus 193 ~~~Di~slG~il~~l~t~g~~p~~~~~~~---~~~~~~~~~~~----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~ 265 (278)
T 1byg_A 193 TKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVPRVEKGYK----MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLR 265 (278)
T ss_dssp HHHHHHHHHHHHHHHHTTSCCSCTTSCGG---GHHHHHTTTCC----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred chhcHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHhcCCC----CCCcccCCHHHHHHHHHHhcCChhhCCCHHHHH
Confidence 99999999999999998 99999875432 22333332211 123457899999999999999999999999999
Q ss_pred HHHHHHHHHc
Q 013092 243 RIFRDLFIRE 252 (449)
Q Consensus 243 ~~L~~~~~~~ 252 (449)
+.|+++....
T Consensus 266 ~~L~~i~~~~ 275 (278)
T 1byg_A 266 EQLEHIKTHE 275 (278)
T ss_dssp HHHHHHHHHC
T ss_pred HHHHHHHhhh
Confidence 9999886543
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-36 Score=301.03 Aligned_cols=210 Identities=20% Similarity=0.233 Sum_probs=178.3
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 96 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gi 96 (449)
...+.+|+.+++.+.+||||+.+++++......||||||+ |++|.+++.. ...+++..++.++.||+.||.|||+.||
T Consensus 143 ~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~gi 221 (365)
T 2y7j_A 143 REATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTE-KVALSEKETRSIMRSLLEAVSFLHANNI 221 (365)
T ss_dssp HHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSEEEEEECCCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred HHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCEEEEEEEeCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 3467899999999988999999999999999999999999 8999999975 4579999999999999999999999999
Q ss_pred eecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhC------CCCChhhHHHH
Q 013092 97 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG------IEQSRRDDLES 170 (449)
Q Consensus 97 vHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~------~~~s~~~DiwS 170 (449)
+||||||+|||+ +.++.+||+|||++..+..... .....||+.|+|||++.+ ..++.++||||
T Consensus 222 ~H~Dlkp~NIl~---~~~~~ikl~DfG~~~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~s 290 (365)
T 2y7j_A 222 VHRDLKPENILL---DDNMQIRLSDFGFSCHLEPGEK--------LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWA 290 (365)
T ss_dssp ECSCCSGGGEEE---CTTCCEEECCCTTCEECCTTCC--------BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHH
T ss_pred ecCCCCHHHEEE---CCCCCEEEEecCcccccCCCcc--------cccCCCCCCccChhhccccccccCcCCCchhhHHh
Confidence 999999999999 6788999999999987654322 234679999999999874 35788999999
Q ss_pred HHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 171 LGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 171 lG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
|||++|+|++|..||... .....+..+.........+ ....++.++.++|..||+.+|++||++.++++
T Consensus 291 lG~il~ell~g~~pf~~~---~~~~~~~~i~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 291 CGVILFTLLAGSPPFWHR---RQILMLRMIMEGQYQFSSP-EWDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp HHHHHHHHHHSSCSSCCS---SHHHHHHHHHHTCCCCCHH-HHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHHHCCCCCCCC---CHHHHHHHHHhCCCCCCCc-ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 999999999999999763 3344455555544433332 34578999999999999999999999888764
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=303.40 Aligned_cols=212 Identities=18% Similarity=0.179 Sum_probs=176.2
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFL 97 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~giv 97 (449)
...+.+|+++++.+ +||||+++++++.+.+..||||||+.++|.+++......+++..++.++.|++.||+|||++||+
T Consensus 56 ~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iv 134 (346)
T 1ua2_A 56 NRTALREIKLLQEL-SHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWIL 134 (346)
T ss_dssp CTHHHHHHHHHHHC-CCTTBCCEEEEECCTTCCEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCC
T ss_pred hHHHHHHHHHHhhC-CCCCCCeEEEEEeeCCceEEEEEcCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEE
Confidence 35788999999999 89999999999999999999999997799999986556799999999999999999999999999
Q ss_pred ecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCC-CCChhhHHHHHHHHHH
Q 013092 98 HRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLM 176 (449)
Q Consensus 98 HRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~-~~s~~~DiwSlG~il~ 176 (449)
||||||+|||+ +.++.+||+|||+++.+..... ......||+.|+|||++.+. .++.++|||||||++|
T Consensus 135 H~Dlkp~Nil~---~~~~~~kl~Dfg~a~~~~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ 204 (346)
T 1ua2_A 135 HRDLKPNNLLL---DENGVLKLADFGLAKSFGSPNR-------AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILA 204 (346)
T ss_dssp CCCCCGGGEEE---CTTCCEEECCCGGGSTTTSCCC-------CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHH
T ss_pred CCCCCHHHEEE---cCCCCEEEEecccceeccCCcc-------cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHH
Confidence 99999999999 6788999999999987654322 12345789999999999764 4899999999999999
Q ss_pred HHHhCCCCCCCCCcCCHHHHHHHHHhhccc-----------------------chHHHhhcCCcHHHHHHHHHHhcCCCC
Q 013092 177 YFLRGSLPWQGLKAGTKKQKYEKISEKKVS-----------------------TSIEALCRGYPTEFASYFHYCRSLRFD 233 (449)
Q Consensus 177 elltG~~Pf~~~~~~~~~~~~~~i~~~~~~-----------------------~~~~~l~~~~p~el~~li~~cl~~~p~ 233 (449)
+|++|..||.+.. ..+.+..+.+.... .+...+...++.++.+||..||..||+
T Consensus 205 ell~g~~~~~~~~---~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 281 (346)
T 1ua2_A 205 ELLLRVPFLPGDS---DLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPC 281 (346)
T ss_dssp HHHHSSCSSCCSS---HHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTT
T ss_pred HHHHCCCCCCCCC---HHHHHHHHHHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChh
Confidence 9999999998743 33344444332111 112334466789999999999999999
Q ss_pred CCCCHHHHHH
Q 013092 234 DKPDYAYLKR 243 (449)
Q Consensus 234 ~RPt~~~l~~ 243 (449)
+||++.++++
T Consensus 282 ~Rpt~~ell~ 291 (346)
T 1ua2_A 282 ARITATQALK 291 (346)
T ss_dssp TSCCHHHHHT
T ss_pred hCCCHHHHhc
Confidence 9999887754
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=317.04 Aligned_cols=220 Identities=19% Similarity=0.227 Sum_probs=183.2
Q ss_pred cEEEEEeeeccc-CCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHH
Q 013092 3 EILTVFSVQENV-KTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLML 80 (449)
Q Consensus 3 ~aikV~~k~~~~-~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i 80 (449)
+|||++.+.... ......+.+|+.+++.+ +||||+++++++.+.+..||||||+ |++|.+++.. .+.+++..++.+
T Consensus 44 vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~-~~~l~~~~~~~i 121 (476)
T 2y94_A 44 VAVKILNRQKIRSLDVVGKIRREIQNLKLF-RHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICK-NGRLDEKESRRL 121 (476)
T ss_dssp EEEEEEEHHHHHHTTTHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEEEECCSSEEHHHHTTS-SSSCCHHHHHHH
T ss_pred EEEEEEEhhhccCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHH
Confidence 355555443322 23456789999999999 8999999999999999999999999 9999999874 567999999999
Q ss_pred HHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCC
Q 013092 81 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI 160 (449)
Q Consensus 81 ~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~ 160 (449)
+.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++....... ....+||+.|+|||++.+.
T Consensus 122 ~~qi~~aL~~LH~~givHrDLkp~NIll---~~~~~vkL~DFG~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~ 190 (476)
T 2y94_A 122 FQQILSGVDYCHRHMVVHRDLKPENVLL---DAHMNAKIADFGLSNMMSDGEF--------LRTSCGSPNYAAPEVISGR 190 (476)
T ss_dssp HHHHHHHHHHHHTTTEECSCCSGGGEEE---CTTCCEEECCCSSCEECCTTCC--------BCCCCSCSTTCCHHHHTTC
T ss_pred HHHHHHHHHHHHHCCCCcccccHHHEEE---ecCCCeEEEeccchhhcccccc--------ccccCCCcCeEChhhccCC
Confidence 9999999999999999999999999999 6788999999999987654322 2345799999999999987
Q ss_pred CC-ChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHH
Q 013092 161 EQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYA 239 (449)
Q Consensus 161 ~~-s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~ 239 (449)
.+ +.++|||||||++|+|++|..||.+.. ....+.++...... .+..+++++.+||..||..||++||++.
T Consensus 191 ~~~~~~~DiwSlGvil~elltG~~Pf~~~~---~~~~~~~i~~~~~~-----~p~~~s~~~~~Li~~~L~~dP~~Rpt~~ 262 (476)
T 2y94_A 191 LYAGPEVDIWSSGVILYALLCGTLPFDDDH---VPTLFKKICDGIFY-----TPQYLNPSVISLLKHMLQVDPMKRATIK 262 (476)
T ss_dssp CBCSHHHHHHHHHHHHHHHHHSSCSSCCSS---SHHHHHHHHTTCCC-----CCTTCCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred CCCCCcceehhhHHHHHHHhhCCCCCCCCC---HHHHHHHHhcCCcC-----CCccCCHHHHHHHHHHcCCCchhCcCHH
Confidence 75 789999999999999999999998643 34445555544332 2345789999999999999999999988
Q ss_pred HHHH
Q 013092 240 YLKR 243 (449)
Q Consensus 240 ~l~~ 243 (449)
+|++
T Consensus 263 eil~ 266 (476)
T 2y94_A 263 DIRE 266 (476)
T ss_dssp HHHT
T ss_pred HHHh
Confidence 7754
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=302.65 Aligned_cols=230 Identities=20% Similarity=0.287 Sum_probs=176.1
Q ss_pred cEEEEEeeecc---cCCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHc----------
Q 013092 3 EILTVFSVQEN---VKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFC---------- 68 (449)
Q Consensus 3 ~aikV~~k~~~---~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~---------- 68 (449)
+|+|++.+... .......+.+|+++++.+ +||||+++++++.+.+..||||||| |++|.+++...
T Consensus 54 vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~ 132 (345)
T 3hko_A 54 RAIKIMNKNKIRQINPKDVERIKTEVRLMKKL-HHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAM 132 (345)
T ss_dssp EEEEEEEHHHHHC---CHHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEE
T ss_pred EEEeehhhhhhcccCHHHHHHHHHHHHHHHhC-CCCCcceeehhhccCCeEEEEEeCCCCCcHHHHHHHhhccccccccc
Confidence 35555544332 223456789999999999 8999999999999999999999999 99999998521
Q ss_pred -----------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCC--eE
Q 013092 69 -----------------------------SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN--QV 117 (449)
Q Consensus 69 -----------------------------~~~ls~~~~~~i~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~--~v 117 (449)
...+++..++.++.||+.||+|||++||+||||||+|||+. .++ .+
T Consensus 133 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~---~~~~~~~ 209 (345)
T 3hko_A 133 DVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFS---TNKSFEI 209 (345)
T ss_dssp EEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEES---CSSSCCE
T ss_pred ccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEe---cCCCceE
Confidence 11246778899999999999999999999999999999994 334 89
Q ss_pred EEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhC--CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHH
Q 013092 118 YIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG--IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQ 195 (449)
Q Consensus 118 kL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~--~~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~ 195 (449)
||+|||+++.+....... +.......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+... .+
T Consensus 210 kl~Dfg~a~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---~~ 283 (345)
T 3hko_A 210 KLVDFGLSKEFYKLNNGE---YYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVND---AD 283 (345)
T ss_dssp EECCCTTCEEGGGTTCC-----------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HH
T ss_pred EEeeccccccccccCccc---cccccccCCCccccCchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCh---HH
Confidence 999999998765432211 112345679999999999976 6789999999999999999999999987533 34
Q ss_pred HHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 196 KYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 196 ~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
.+..+......... .....+++++.+||..||+.+|++||++.++++
T Consensus 284 ~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 330 (345)
T 3hko_A 284 TISQVLNKKLCFEN-PNYNVLSPLARDLLSNLLNRNVDERFDAMRALQ 330 (345)
T ss_dssp HHHHHHHCCCCTTS-GGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHH
T ss_pred HHHHHHhcccccCC-cccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 44444444332221 223457899999999999999999999877643
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=305.60 Aligned_cols=223 Identities=21% Similarity=0.228 Sum_probs=179.1
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeE--eCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGV--EGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 94 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~--~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~ 94 (449)
...+.+|+++++.+ +|+||+++++++. +....||||||+ +++|.+++......+++..++.++.||+.||+|||++
T Consensus 68 ~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~ 146 (327)
T 3lxl_A 68 QRDFQREIQILKAL-HSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSR 146 (327)
T ss_dssp HHHHHHHHHHHHTC-CCTTBCCEEEEEECSSSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHhc-CCCceeEEEEEEecCCCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 35589999999999 9999999998876 567799999999 9999999986556799999999999999999999999
Q ss_pred CceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHH
Q 013092 95 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYV 174 (449)
Q Consensus 95 givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~i 174 (449)
||+||||||+|||+ +.++.+||+|||+++........ ........||+.|+|||++.+..++.++|||||||+
T Consensus 147 ~ivH~Dikp~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~i 219 (327)
T 3lxl_A 147 RCVHRDLAARNILV---ESEAHVKIADFGLAKLLPLDKDY----YVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVV 219 (327)
T ss_dssp TEECSCCSGGGEEE---EETTEEEECCGGGCEECCTTCSE----EECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHH
T ss_pred CccCCCCChhhEEE---CCCCCEEEcccccceecccCCcc----ceeeccCCccccccCHHHhccCCCChHHhHHHHHHH
Confidence 99999999999999 47789999999999877543321 112344578899999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCCcCC------------HHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 013092 175 LMYFLRGSLPWQGLKAGT------------KKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 242 (449)
Q Consensus 175 l~elltG~~Pf~~~~~~~------------~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~ 242 (449)
+|+|++|..||....... .......+... ........+++++.+||..||+.+|++||++.+|+
T Consensus 220 l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell 295 (327)
T 3lxl_A 220 LYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEG----QRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALG 295 (327)
T ss_dssp HHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHTT----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred HHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhcc----cCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHH
Confidence 999999999996532110 00111111111 11122456899999999999999999999999999
Q ss_pred HHHHHHHHHc
Q 013092 243 RIFRDLFIRE 252 (449)
Q Consensus 243 ~~L~~~~~~~ 252 (449)
+.|+.++...
T Consensus 296 ~~L~~~~~~~ 305 (327)
T 3lxl_A 296 PQLDMLWSGS 305 (327)
T ss_dssp HHHHHC----
T ss_pred HHHHHHHhhh
Confidence 9998875433
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-36 Score=294.02 Aligned_cols=220 Identities=21% Similarity=0.295 Sum_probs=172.8
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHH
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHS 93 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~---~~~ls~~~~~~i~~qi~~aL~yLH~ 93 (449)
...+.+|+.+++.+ +||||+++++++.+.+..||||||+ +++|.+++... ...+++..++.++.||+.||.|||+
T Consensus 76 ~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~ 154 (310)
T 2wqm_A 76 RADCIKEIDLLKQL-NHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS 154 (310)
T ss_dssp HHHHHHHHHHHHTC-CCTTBCCEEEEEEETTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhC-CCCCEeeEEEEEEcCCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhh
Confidence 45688999999999 8999999999999999999999999 88999998742 4568999999999999999999999
Q ss_pred CCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHH
Q 013092 94 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGY 173 (449)
Q Consensus 94 ~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~ 173 (449)
+||+||||||+|||+ +.++.+||+|||++........ ......||+.|+|||++.+..++.++|||||||
T Consensus 155 ~~i~H~dl~p~NIl~---~~~~~~kl~Dfg~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~ 224 (310)
T 2wqm_A 155 RRVMHRDIKPANVFI---TATGVVKLGDLGLGRFFSSKTT-------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGC 224 (310)
T ss_dssp TTCCCCCCCGGGEEE---CTTSCEEECCC-------------------------CCSSCCHHHHTTCCCCHHHHHHHHHH
T ss_pred CCeeCCCCcHHHEEE---cCCCCEEEEeccceeeecCCCc-------cccccCCCeeEeChHHhCCCCCCchhhHHHHHH
Confidence 999999999999999 5788999999999986654322 123457899999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 013092 174 VLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIRE 252 (449)
Q Consensus 174 il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~L~~~~~~~ 252 (449)
++|+|++|..||.+... ........+....... .....+++++.++|..||+.||++||++.+|.+.|+++....
T Consensus 225 il~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~ 299 (310)
T 2wqm_A 225 LLYEMAALQSPFYGDKM-NLYSLCKKIEQCDYPP---LPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACT 299 (310)
T ss_dssp HHHHHHHSSCTTC---C-CHHHHHHHHHTTCSCC---CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHhCCCCCcccch-hHHHHHHHhhcccCCC---CcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhh
Confidence 99999999999976432 2223333333322211 112468999999999999999999999999999999886544
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-37 Score=299.92 Aligned_cols=216 Identities=20% Similarity=0.276 Sum_probs=170.8
Q ss_pred hHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q 013092 19 PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFL 97 (449)
Q Consensus 19 ~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~giv 97 (449)
..+.+|+.+++.+ .||||+++++++.+.+..||||||+ |++|.+++.. ...+++..++.++.||+.||+|||++||+
T Consensus 79 ~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~ 156 (309)
T 2h34_A 79 TRMQREARTAGRL-QEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRR-QGPLAPPRAVAIVRQIGSALDAAHAAGAT 156 (309)
T ss_dssp HHHHHHHHHHTTC-CCTTBCCEEEEEEETTEEEEEEECCCCEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred HHHHHHHHHHhhc-CCCCeeEEEEEEeeCCeEEEEEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCcCC
Confidence 5688999999999 8999999999999999999999999 8899999986 35799999999999999999999999999
Q ss_pred ecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHHHHH
Q 013092 98 HRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMY 177 (449)
Q Consensus 98 HRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il~e 177 (449)
||||||+|||+ +.++.+||+|||++........ .......||+.|+|||++.+..++.++||||||+++|+
T Consensus 157 H~dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ 227 (309)
T 2h34_A 157 HRDVKPENILV---SADDFAYLVDFGIASATTDEKL------TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYE 227 (309)
T ss_dssp CSCCCGGGEEE---CTTSCEEECSCCC----------------------CCGGGCCGGGTCC----CCCHHHHHHHHHHH
T ss_pred cCCCChHHEEE---cCCCCEEEecCccCcccccccc------ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHH
Confidence 99999999999 5788999999999987654321 11234579999999999999899999999999999999
Q ss_pred HHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCC-CHHHHHHHHHHHHH
Q 013092 178 FLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKP-DYAYLKRIFRDLFI 250 (449)
Q Consensus 178 lltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RP-t~~~l~~~L~~~~~ 250 (449)
|++|..||.+... . .+........ .....+...+|+++.++|..||+.+|++|| +++++.+.|+.++.
T Consensus 228 l~~g~~pf~~~~~---~-~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~ 296 (309)
T 2h34_A 228 CLTGSPPYQGDQL---S-VMGAHINQAI-PRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALA 296 (309)
T ss_dssp HHHSSCSSCSCHH---H-HHHHHHHSCC-CCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC
T ss_pred HHHCCCCCCCchH---H-HHHHHhccCC-CCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHH
Confidence 9999999986432 1 2222222211 223345577999999999999999999999 89999988877643
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=300.32 Aligned_cols=225 Identities=21% Similarity=0.261 Sum_probs=172.1
Q ss_pred EEEEEeeecccCCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHH
Q 013092 4 ILTVFSVQENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLAD 82 (449)
Q Consensus 4 aikV~~k~~~~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~ 82 (449)
|+|++.+..........+.+|+++++.+ .||||+++++++.+.+..||||||+ +++|.+++.. ...+++..++.++.
T Consensus 54 avK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~ 131 (331)
T 4aaa_A 54 AIKKFLESDDDKMVKKIAMREIKLLKQL-RHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELF-PNGLDYQVVQKYLF 131 (331)
T ss_dssp EEEEEESCSSCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHS-TTCCCHHHHHHHHH
T ss_pred EEEEEecCCCchHHHHHHHHHHHHHhhC-CCCCEeeEEEEeecCCEEEEEEecCCcchHHHHHhh-ccCCCHHHHHHHHH
Confidence 4444433332223345578999999999 7999999999999999999999999 6677766553 56799999999999
Q ss_pred HHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCC-C
Q 013092 83 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI-E 161 (449)
Q Consensus 83 qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~-~ 161 (449)
||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.+..... ......||+.|+|||++.+. .
T Consensus 132 qi~~~l~~LH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~-------~~~~~~~t~~y~aPE~~~~~~~ 201 (331)
T 4aaa_A 132 QIINGIGFCHSHNIIHRDIKPENILV---SQSGVVKLCDFGFARTLAAPGE-------VYDDEVATRWYRAPELLVGDVK 201 (331)
T ss_dssp HHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCTTC-------------------CCCCCTTCCHHHHTTCTT
T ss_pred HHHHHHHHHHHCCEEccCcChheEEE---cCCCcEEEEeCCCceeecCCcc-------ccCCCcCCccccCcccccCCCC
Confidence 99999999999999999999999999 5788999999999987654322 12345789999999999875 6
Q ss_pred CChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhc--------------------------ccchHHHhhcC
Q 013092 162 QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK--------------------------VSTSIEALCRG 215 (449)
Q Consensus 162 ~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~--------------------------~~~~~~~l~~~ 215 (449)
++.++|||||||++|+|++|..||.+.... +.+..+.... .........+.
T Consensus 202 ~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (331)
T 4aaa_A 202 YGKAVDVWAIGCLVTEMFMGEPLFPGDSDI---DQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPK 278 (331)
T ss_dssp CCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTT
T ss_pred cchHHHHHHHHHHHHHHHhCCCCCCCCCcH---HHHHHHHHHhCCCChhhhhHhhhccccccccCccccccchhhhcccc
Confidence 899999999999999999999999875432 2222222110 11122333457
Q ss_pred CcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 216 YPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 216 ~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
+++++.+||..||+.||++||++.+|++
T Consensus 279 ~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 279 LSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred hhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 8999999999999999999999877754
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=302.38 Aligned_cols=200 Identities=19% Similarity=0.182 Sum_probs=170.3
Q ss_pred ChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CC-CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC
Q 013092 17 KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GP-SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 94 (449)
Q Consensus 17 ~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~-sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~ 94 (449)
....+.+|+++++.+ +||||+++++++.+.+..||||||+ ++ +|.+++.. ...+++..++.++.||+.||+|||++
T Consensus 72 ~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~~lv~e~~~~g~~l~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~ 149 (335)
T 3dls_A 72 KLGKVTLEIAILSRV-EHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDR-HPRLDEPLASYIFRQLVSAVGYLRLK 149 (335)
T ss_dssp TTEEEEHHHHHHTTC-CCTTBCCEEEEEECSSEEEEEEECCTTSCBHHHHHHT-CCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHhC-CCCCEeeEEEEEeeCCEEEEEEEeCCCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 345688999999999 8999999999999999999999999 44 99999985 45799999999999999999999999
Q ss_pred CceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCC-ChhhHHHHHHH
Q 013092 95 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQ-SRRDDLESLGY 173 (449)
Q Consensus 95 givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~-s~~~DiwSlG~ 173 (449)
||+||||||+|||+ +.++.+||+|||+++....... .....||+.|+|||++.+..+ +.++|||||||
T Consensus 150 ~ivH~Dlkp~NIll---~~~~~~kL~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ 218 (335)
T 3dls_A 150 DIIHRDIKDENIVI---AEDFTIKLIDFGSAAYLERGKL--------FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGV 218 (335)
T ss_dssp TEECSCCSGGGEEE---CTTSCEEECCCTTCEECCTTCC--------BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHH
T ss_pred CeEEeccCHHHEEE---cCCCcEEEeecccceECCCCCc--------eeccCCCccccChhhhcCCCCCCCcccchhHHH
Confidence 99999999999999 5788999999999987755332 134579999999999998886 88999999999
Q ss_pred HHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 174 VLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 174 il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
++|+|++|..||..... ...... ..+..+++++.+||..||+.+|++||++.+|++
T Consensus 219 il~el~~g~~pf~~~~~---------~~~~~~-----~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~ 274 (335)
T 3dls_A 219 TLYTLVFEENPFCELEE---------TVEAAI-----HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVT 274 (335)
T ss_dssp HHHHHHHSSCSCSSGGG---------GTTTCC-----CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHhCCCchhhHHH---------HHhhcc-----CCCcccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 99999999999976322 111111 123457899999999999999999999877644
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-36 Score=299.54 Aligned_cols=207 Identities=22% Similarity=0.288 Sum_probs=176.7
Q ss_pred ChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 013092 17 KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 95 (449)
Q Consensus 17 ~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~g 95 (449)
....+.+|+.+++.+ +|+||+++++++.+.+..||||||+ +++|.+++.. ...+++..++.++.||+.||+|||++|
T Consensus 84 ~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ 161 (335)
T 2owb_A 84 QREKMSMEISIHRSL-AHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKR-RKALTEPEARYYLRQIVLGCQYLHRNR 161 (335)
T ss_dssp HHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHhC-CCCCCCeEEEEEecCCeEEEEEecCCCCCHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 345688999999999 9999999999999999999999999 8999999875 457999999999999999999999999
Q ss_pred ceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHHH
Q 013092 96 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVL 175 (449)
Q Consensus 96 ivHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il 175 (449)
|+||||||+|||+ +.++.+||+|||+++........ .....||+.|+|||++.+..++.++|||||||++
T Consensus 162 ivH~dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il 231 (335)
T 2owb_A 162 VIHRDLKLGNLFL---NEDLEVKIGDFGLATKVEYDGER-------KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIM 231 (335)
T ss_dssp EECSCCCGGGEEE---CTTCCEEECCCTTCEECCSTTCC-------BCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHH
T ss_pred CEecCCCchhEEE---cCCCCEEEeeccCceecccCccc-------ccccCCCccccCHHHhccCCCCchhhHHHHHHHH
Confidence 9999999999999 57889999999999876543221 2345799999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 176 MYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 176 ~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
|+|++|..||.... ..+.+..+..... .+...+++++.+||..||+.||++||++.+|++
T Consensus 232 ~~l~~g~~pf~~~~---~~~~~~~~~~~~~-----~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 232 YTLLVGKPPFETSC---LKETYLRIKKNEY-----SIPKHINPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp HHHHHSSCTTCCSS---HHHHHHHHHHTCC-----CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred HHHHHCcCCCCCCC---HHHHHHHHhcCCC-----CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 99999999997643 3334444443322 133568899999999999999999999877643
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-36 Score=290.53 Aligned_cols=226 Identities=19% Similarity=0.275 Sum_probs=184.3
Q ss_pred cEEEEEeeecccCCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHH
Q 013092 3 EILTVFSVQENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLA 81 (449)
Q Consensus 3 ~aikV~~k~~~~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~ 81 (449)
.|+|++.+..........+.+|+++++.+ +||||+++++++.+.+..|+||||+ +++|.+++.. ...+++..++.++
T Consensus 50 valK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~ 127 (287)
T 2wei_A 50 YAVKVINKASAKNKDTSTILREVELLKKL-DHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIK-RKRFSEHDAARII 127 (287)
T ss_dssp EEEEEEEGGGBSSSCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH-HSSCCHHHHHHHH
T ss_pred EEEEEecccccchHHHHHHHHHHHHHHhc-cCCCccEEEEEEeCCCeEEEEEEccCCCCHHHHHHh-cCCCCHHHHHHHH
Confidence 35565555444445667899999999999 9999999999999999999999999 9999998875 3579999999999
Q ss_pred HHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCC
Q 013092 82 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIE 161 (449)
Q Consensus 82 ~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~ 161 (449)
.||+.||+|||++||+||||||+||++........+||+|||++........ .....||+.|+|||++.+.
T Consensus 128 ~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~- 198 (287)
T 2wei_A 128 KQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK--------MKDRIGTAYYIAPEVLRGT- 198 (287)
T ss_dssp HHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSS--------CSCHHHHHTTCCHHHHTTC-
T ss_pred HHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCCc--------cccccCcccccChHHhcCC-
Confidence 9999999999999999999999999996444456899999999986644321 1234689999999998764
Q ss_pred CChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHH
Q 013092 162 QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYL 241 (449)
Q Consensus 162 ~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l 241 (449)
++.++||||||+++|+|++|..||.+.. ..+....+.........+ ....+++++.++|..||..+|++||++.++
T Consensus 199 ~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~dp~~Rps~~el 274 (287)
T 2wei_A 199 YDEKCDVWSAGVILYILLSGTPPFYGKN---EYDILKRVETGKYAFDLP-QWRTISDDAKDLIRKMLTFHPSLRITATQC 274 (287)
T ss_dssp CCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHCCCCCCSG-GGTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CCCchhhHhHHHHHHHHHhCCCCCCCCC---HHHHHHHHHcCCCCCCch-hhhhcCHHHHHHHHHHcccChhhCcCHHHH
Confidence 8999999999999999999999998743 334444454443322222 235689999999999999999999998887
Q ss_pred HH
Q 013092 242 KR 243 (449)
Q Consensus 242 ~~ 243 (449)
++
T Consensus 275 l~ 276 (287)
T 2wei_A 275 LE 276 (287)
T ss_dssp HH
T ss_pred hc
Confidence 65
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-36 Score=290.03 Aligned_cols=205 Identities=16% Similarity=0.210 Sum_probs=175.8
Q ss_pred ChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 013092 17 KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 95 (449)
Q Consensus 17 ~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~g 95 (449)
....+.+|+++++.+ +||||+++++++.+.+..|+||||+ +++|.+++.. ...+++..++.++.||+.||+|||++|
T Consensus 57 ~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ 134 (284)
T 2vgo_A 57 VEHQLRREIEIQSHL-RHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQK-HGRFDEQRSATFMEELADALHYCHERK 134 (284)
T ss_dssp CHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTTT
T ss_pred HHHHHHHHHHHHhcC-CCCCEeeEEEEEEcCCEEEEEEEeCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 446789999999999 8999999999999999999999999 8899999976 356999999999999999999999999
Q ss_pred ceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHHH
Q 013092 96 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVL 175 (449)
Q Consensus 96 ivHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il 175 (449)
|+||||||+||++ +.++.+||+|||++....... .....||+.|+|||++.+..++.++||||||+++
T Consensus 135 i~H~dl~p~Nil~---~~~~~~kl~Dfg~~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 202 (284)
T 2vgo_A 135 VIHRDIKPENLLM---GYKGELKIADFGWSVHAPSLR---------RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLC 202 (284)
T ss_dssp EECCCCSGGGEEE---CTTCCEEECCCTTCEECSSSC---------BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHH
T ss_pred ceecCCCHHHEEE---cCCCCEEEecccccccCcccc---------cccccCCCCcCCHHHhccCCCCcccchhhHHHHH
Confidence 9999999999999 578899999999997654322 1345789999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 176 MYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 176 ~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
|+|++|..||.... .......+..... .++..++.++.++|..||+.+|++||++.+|++
T Consensus 203 ~~l~~g~~pf~~~~---~~~~~~~~~~~~~-----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 203 YEFLVGMPPFDSPS---HTETHRRIVNVDL-----KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp HHHHHSSCTTCCSS---HHHHHHHHHTTCC-----CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHCCCCCCCCC---HhHHHHHHhcccc-----CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 99999999997643 2333444433322 133568899999999999999999999888754
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-36 Score=303.14 Aligned_cols=222 Identities=18% Similarity=0.244 Sum_probs=164.6
Q ss_pred EEEEEeeecccCCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCC------EEEEEEecCCCCHHHHHHHcCCCCCHHHH
Q 013092 4 ILTVFSVQENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGD------YNVLVMDLLGPSLEDLFNFCSRKLSLKTV 77 (449)
Q Consensus 4 aikV~~k~~~~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~------~~~lVmE~~g~sL~~ll~~~~~~ls~~~~ 77 (449)
|||++.+..........+.+|+.+++.+ +||||+++++++...+ ..||||||+.++|.+++. ..+++..+
T Consensus 54 avK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~---~~~~~~~~ 129 (371)
T 2xrw_A 54 AIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ---MELDHERM 129 (371)
T ss_dssp EEEEEECTTSSHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECSCCSTTTCCEEEEEEECCSEEHHHHHH---SCCCHHHH
T ss_pred EEEEeccccCChHHHHHHHHHHHHHHhc-CCCCccceEEeeccccccccccceEEEEEcCCCCHHHHHh---hccCHHHH
Confidence 4444443222223345688999999999 8999999999987654 789999999878998886 35899999
Q ss_pred HHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhh
Q 013092 78 LMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTH 157 (449)
Q Consensus 78 ~~i~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~ 157 (449)
..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++....... .....||+.|+|||++
T Consensus 130 ~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~~ 198 (371)
T 2xrw_A 130 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFM--------MTPYVVTRYYRAPEVI 198 (371)
T ss_dssp HHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECCCCC------------------------CTTCCHHHH
T ss_pred HHHHHHHHHHHHHHHHCCeecccCCHHHEEE---cCCCCEEEEEeecccccccccc--------cCCceecCCccCHHHh
Confidence 9999999999999999999999999999999 5788999999999987654321 2345799999999999
Q ss_pred hCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccch-------------------------HHHh
Q 013092 158 LGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS-------------------------IEAL 212 (449)
Q Consensus 158 ~~~~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~-------------------------~~~l 212 (449)
.+..++.++|||||||++|+|++|..||.+.+. .+.+.++......+. +..+
T Consensus 199 ~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (371)
T 2xrw_A 199 LGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH---IDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKL 275 (371)
T ss_dssp TTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHH
T ss_pred cCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhh
Confidence 999999999999999999999999999987432 333333332211110 0000
Q ss_pred h------------cCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 213 C------------RGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 213 ~------------~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
. ..++.++.+||..||..||++||++.++++
T Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 318 (371)
T 2xrw_A 276 FPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 318 (371)
T ss_dssp SCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred cccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence 0 012568999999999999999999877643
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=291.87 Aligned_cols=220 Identities=16% Similarity=0.232 Sum_probs=180.8
Q ss_pred EeeecccCCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHH
Q 013092 8 FSVQENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMIN 86 (449)
Q Consensus 8 ~~k~~~~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~ 86 (449)
++|..........+.+|+.+++.+ +||||+++++++.+.+..||||||+ +++|.+++......+++..++.++.||+.
T Consensus 58 aiK~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~ 136 (314)
T 3com_A 58 AIKQVPVESDLQEIIKEISIMQQC-DSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLK 136 (314)
T ss_dssp EEEEEETTSCCHHHHHHHHHHHTC-CCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHH
T ss_pred EEEecCchHHHHHHHHHHHHHHhC-CCCCCccEEEEEEeCCEEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHH
Confidence 333333344567899999999999 9999999999999999999999999 88999999765678999999999999999
Q ss_pred HHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhh
Q 013092 87 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRD 166 (449)
Q Consensus 87 aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~ 166 (449)
||.|||+.||+|+||||+||++ +.++.+||+|||++........ ......||+.|+|||++.+..++.++
T Consensus 137 ~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~dfg~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~ 206 (314)
T 3com_A 137 GLEYLHFMRKIHRDIKAGNILL---NTEGHAKLADFGVAGQLTDTMA-------KRNTVIGTPFWMAPEVIQEIGYNCVA 206 (314)
T ss_dssp HHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECBTTBS-------CBCCCCSCGGGCCHHHHSSSCBCTTH
T ss_pred HHHHHHhCCCcCCCcCHHHEEE---CCCCCEEEeecccchhhhhhcc-------ccCccCCCCCccChhhcCCCCCCccc
Confidence 9999999999999999999999 5788999999999987654322 12345789999999999999999999
Q ss_pred HHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 167 DLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 167 DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
|||||||++|+|++|..||..... ......+...... .......++.++.++|..||..+|++||++.++++
T Consensus 207 Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 207 DIWSLGITAIEMAEGKPPYADIHP---MRAIFMIPTNPPP--TFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp HHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHHHHSCCC--CCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred cHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHhcCCCc--ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 999999999999999999986432 2222222222111 11123457899999999999999999999887754
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=312.35 Aligned_cols=211 Identities=22% Similarity=0.269 Sum_probs=167.1
Q ss_pred hHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q 013092 19 PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFL 97 (449)
Q Consensus 19 ~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~giv 97 (449)
..+.+|+++|+.+ +||||+++++++. .+..||||||+ +++|.+++.. ...+++..++.++.||+.||+|||++||+
T Consensus 185 ~~~~~E~~~l~~l-~hpniv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~iv 261 (419)
T 3i6u_A 185 LNVETEIEILKKL-NHPCIIKIKNFFD-AEDYYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHENGII 261 (419)
T ss_dssp CCHHHHHHHHHHC-CCTTBCCCCEEEE-SSEEEEEEECCTTCBGGGGTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred HHHHHHHHHHHhC-CCCCEeeEEEEEe-cCceEEEEEcCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 3589999999999 9999999999874 55689999999 9999988864 56799999999999999999999999999
Q ss_pred ecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhC---CCCChhhHHHHHHHH
Q 013092 98 HRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG---IEQSRRDDLESLGYV 174 (449)
Q Consensus 98 HRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~---~~~s~~~DiwSlG~i 174 (449)
||||||+|||++..+....+||+|||+++....... .....||+.|+|||++.+ ..++.++|||||||+
T Consensus 262 HrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~i 333 (419)
T 3i6u_A 262 HRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL--------MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVI 333 (419)
T ss_dssp CSCCCGGGEEESSSSSSCCEEECCSSTTTSCC-------------------CTTCCTTTTC----CTTHHHHHHHHHHHH
T ss_pred ccCCChHhEEEecCCCcceEEEeecccceecCCCcc--------ccccCCCCCccCceeeecCCCCCCCchhhhHhHHHH
Confidence 999999999996444556799999999987654321 235679999999999864 567899999999999
Q ss_pred HHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 175 LMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 175 l~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
+|+|++|..||........ ....+..... ...+.....+++++.+||..||+.+|++||++.++++
T Consensus 334 l~~lltg~~pf~~~~~~~~--~~~~i~~~~~-~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 334 LFICLSGYPPFSEHRTQVS--LKDQITSGKY-NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp HHHHHHSSCSSCCCSSSCC--HHHHHHTTCC-CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHHCCCCCCCCcchHH--HHHHHhcCCC-CCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 9999999999987543321 2223333332 2334456778999999999999999999999887754
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=290.78 Aligned_cols=208 Identities=19% Similarity=0.283 Sum_probs=177.8
Q ss_pred CChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC
Q 013092 16 TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 94 (449)
Q Consensus 16 ~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~ 94 (449)
.....+.+|+.+++.+ +||||+++++++.+....||||||+ +++|.+++. ...+++..++.++.||+.||.|||++
T Consensus 62 ~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~ 138 (303)
T 3a7i_A 62 DEIEDIQQEITVLSQC-DSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE--PGPLDETQIATILREILKGLDYLHSE 138 (303)
T ss_dssp TTHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHHhC-CCCCEeEEEEEEecCCeEEEEEEeCCCCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 3457799999999999 9999999999999999999999999 889999997 46799999999999999999999999
Q ss_pred CceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHH
Q 013092 95 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYV 174 (449)
Q Consensus 95 givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~i 174 (449)
||+|+||||+||++ +.++.+||+|||++........ ......||+.|+|||++.+..++.++|||||||+
T Consensus 139 ~i~H~dl~p~Nil~---~~~~~~kl~Dfg~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~i 208 (303)
T 3a7i_A 139 KKIHRDIKAANVLL---SEHGEVKLADFGVAGQLTDTQI-------KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGIT 208 (303)
T ss_dssp TEECCCCSGGGEEE---CTTSCEEECCCTTCEECBTTBC-------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHH
T ss_pred CCccCCCChheEEE---CCCCCEEEeecccceecCcccc-------ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHH
Confidence 99999999999999 5788999999999987755322 1234579999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 175 LMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 175 l~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
+|+|++|..||..... .+....+..... ..+...++.++.++|..||+.+|++||++.+|++
T Consensus 209 l~~l~~g~~p~~~~~~---~~~~~~~~~~~~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 270 (303)
T 3a7i_A 209 AIELARGEPPHSELHP---MKVLFLIPKNNP----PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLK 270 (303)
T ss_dssp HHHHHHSSCTTTTSCH---HHHHHHHHHSCC----CCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHHccCCCCCCCcCH---HHHHHHhhcCCC----CCCccccCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 9999999999976432 233333332221 2244578999999999999999999999888764
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=307.16 Aligned_cols=207 Identities=20% Similarity=0.276 Sum_probs=158.7
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeC------CEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHH
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEG------DYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 91 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~------~~~~lVmE~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yL 91 (449)
...+.+|+++|+.+ +||||+++++++... ...||||||++++|.+++.. ..+++..++.++.||+.||+||
T Consensus 72 ~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~L 148 (367)
T 2fst_X 72 AKRTYRELRLLKHM-KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYI 148 (367)
T ss_dssp HHHHHHHHHHHHHC-CCTTBCCCSEEECSCSSGGGCCCCEEEEECCCEECC-------CCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhC-CCCCCCcEEEEEecCCccccCCeEEEEecccCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHH
Confidence 45688999999999 799999999988654 56899999999999999873 6799999999999999999999
Q ss_pred HHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhC-CCCChhhHHHH
Q 013092 92 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLES 170 (449)
Q Consensus 92 H~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~-~~~s~~~DiwS 170 (449)
|++||+||||||+|||+ +.++.+||+|||+++...... ....||+.|+|||++.+ ..++.++||||
T Consensus 149 H~~givH~Dlkp~NIll---~~~~~~kL~DFG~a~~~~~~~----------~~~~~t~~y~aPE~~~~~~~~~~~~Diws 215 (367)
T 2fst_X 149 HSADIIHRDLKPSNLAV---NEDCELKILDFGLARHTADEM----------TGYVATRWYRAPEIMLNWMHYNQTVDIWS 215 (367)
T ss_dssp HHTTCCCCCCCGGGEEE---CTTCCEEECC-------------------------CCCTTCCHHHHTTCCSCCTTHHHHH
T ss_pred HHCCeeeCCCCHhhEEE---CCCCCEEEeeccccccccccC----------CCcCcCcCccChHHHcCCcCCCchhhHHH
Confidence 99999999999999999 578899999999998754321 34579999999999987 67899999999
Q ss_pred HHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcc--------------------------cchHHHhhcCCcHHHHHHH
Q 013092 171 LGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV--------------------------STSIEALCRGYPTEFASYF 224 (449)
Q Consensus 171 lG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~--------------------------~~~~~~l~~~~p~el~~li 224 (449)
|||++|+|++|..||.+.+. ...+..+..... ...+..+...+++++.+||
T Consensus 216 lG~il~ell~g~~pf~~~~~---~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl 292 (367)
T 2fst_X 216 VGCIMAELLTGRTLFPGTDH---IDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL 292 (367)
T ss_dssp HHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHH
T ss_pred HHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHH
Confidence 99999999999999987543 223333322111 1123344456789999999
Q ss_pred HHHhcCCCCCCCCHHHHHH
Q 013092 225 HYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 225 ~~cl~~~p~~RPt~~~l~~ 243 (449)
..||..||++||++.++++
T Consensus 293 ~~mL~~dP~~R~t~~e~L~ 311 (367)
T 2fst_X 293 EKMLVLDSDKRITAAQALA 311 (367)
T ss_dssp HHHSCSSGGGSCCHHHHHT
T ss_pred HHhCCCCcccCcCHHHHhc
Confidence 9999999999999877753
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-37 Score=323.68 Aligned_cols=219 Identities=18% Similarity=0.326 Sum_probs=181.5
Q ss_pred CChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHH
Q 013092 16 TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHS 93 (449)
Q Consensus 16 ~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~-~~~ls~~~~~~i~~qi~~aL~yLH~ 93 (449)
...+.|.+|+++|+.| .|+||+++++++.+ +..||||||| +++|.+++... ...+++..++.|+.||+.||+|||+
T Consensus 304 ~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~ 381 (535)
T 2h8h_A 304 MSPEAFLQEAQVMKKL-RHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 381 (535)
T ss_dssp SCHHHHHHHHHHHHHC-CCTTBCCEEEEECS-SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHHHhC-CCCCEeeEEEEEee-ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 3456799999999999 89999999998866 6789999999 89999999743 3569999999999999999999999
Q ss_pred CCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHH
Q 013092 94 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGY 173 (449)
Q Consensus 94 ~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~ 173 (449)
+||+||||||+|||| +.++.+||+|||+++.+.... +.......++..|+|||++.+..++.++|||||||
T Consensus 382 ~~ivHrDlkp~NIll---~~~~~~kl~DFG~a~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv 452 (535)
T 2h8h_A 382 MNYVHRDLRAANILV---GENLVCKVADFGLARLIEDNE------YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGI 452 (535)
T ss_dssp TTCCCSCCSGGGEEE---CGGGCEEECCTTSTTTCCCHH------HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHH
T ss_pred CCeeCCCCCHhhEEE---cCCCcEEEcccccceecCCCc------eecccCCcCcccccCHHHhccCCCCchhhHHHHHH
Confidence 999999999999999 577899999999998654321 11123445788999999999999999999999999
Q ss_pred HHHHHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 013092 174 VLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIRE 252 (449)
Q Consensus 174 il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~L~~~~~~~ 252 (449)
+||||++ |..||.+... .+.+..+...... .....+|+++.+||..||+.+|++||++.+|.+.|++++...
T Consensus 453 ~l~el~t~g~~P~~~~~~---~~~~~~i~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~ 525 (535)
T 2h8h_A 453 LLTELTTKGRVPYPGMVN---REVLDQVERGYRM----PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 525 (535)
T ss_dssp HHHHHTTTTCCSSTTCCH---HHHHHHHHTTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCC
T ss_pred HHHHHHhCCCCCCCCCCH---HHHHHHHHcCCCC----CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhcc
Confidence 9999999 9999987543 3334444332111 123578999999999999999999999999999988775433
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-36 Score=291.03 Aligned_cols=206 Identities=22% Similarity=0.287 Sum_probs=176.1
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 96 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gi 96 (449)
...+.+|+.+++.+ +|+||+++++++.+.+..||||||+ +++|.+++.. ...+++..++.++.||+.||+|||++||
T Consensus 59 ~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i 136 (294)
T 2rku_A 59 REKMSMEISIHRSL-AHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKR-RKALTEPEARYYLRQIVLGCQYLHRNRV 136 (294)
T ss_dssp HHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred HHHHHHHHHHHHhC-CCCCEeeeeeeeccCCEEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 45688999999999 9999999999999999999999999 8999999875 4579999999999999999999999999
Q ss_pred eecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHHHH
Q 013092 97 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLM 176 (449)
Q Consensus 97 vHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il~ 176 (449)
+||||||+|||+ +.++.+||+|||+++........ .....||+.|+|||++.+..++.++||||||+++|
T Consensus 137 ~H~dl~p~Nil~---~~~~~~kl~dfg~~~~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ 206 (294)
T 2rku_A 137 IHRDLKLGNLFL---NEDLEVKIGDFGLATKVEYDGER-------KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMY 206 (294)
T ss_dssp ECCCCCGGGEEE---CTTCCEEECCCTTCEECCSTTCC-------BCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHH
T ss_pred cccCCChHhEEE---cCCCCEEEEeccCceecccCccc-------cccccCCCCcCCcchhccCCCCchhhHHHHHHHHH
Confidence 999999999999 57889999999999876543221 23457899999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 177 YFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 177 elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
+|++|..||.... ..+.+..+..... .++..+++++.++|..||+.+|++||++.++++
T Consensus 207 ~l~~g~~p~~~~~---~~~~~~~~~~~~~-----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 265 (294)
T 2rku_A 207 TLLVGKPPFETSC---LKETYLRIKKNEY-----SIPKHINPVAASLIQKMLQTDPTARPTINELLN 265 (294)
T ss_dssp HHHHSSCTTCCSS---HHHHHHHHHTTCC-----CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred HHHhCCCCCCCCC---HHHHHHHHhhccC-----CCccccCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 9999999997643 3334444433322 134568899999999999999999999877654
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=298.97 Aligned_cols=228 Identities=18% Similarity=0.200 Sum_probs=164.0
Q ss_pred CChhHHHHHHHHHHHhcCCCCCceEEEEeE--------eCCEEEEEEecCCCCHHHHHHHc--CCCCCHHHHHHHHHHHH
Q 013092 16 TKHPQLLYESKLYRILQGGTGIPNVRWFGV--------EGDYNVLVMDLLGPSLEDLFNFC--SRKLSLKTVLMLADQMI 85 (449)
Q Consensus 16 ~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~--------~~~~~~lVmE~~g~sL~~ll~~~--~~~ls~~~~~~i~~qi~ 85 (449)
.....+.+|+.+++.+.+||||+++++++. .....||||||++++|.+++... ...+++..++.++.||+
T Consensus 67 ~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~ 146 (337)
T 3ll6_A 67 EKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTC 146 (337)
T ss_dssp HHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEEEEEEECCSEEHHHHHHHHHTTCSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCceEEEEEEecCCCHHHHHHHhhccCCCCHHHHHHHHHHHH
Confidence 345568999999999977999999999884 34568999999988999998752 45699999999999999
Q ss_pred HHHHHHHHCC--ceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccc-----cccCCCCccCccccchhhh-
Q 013092 86 NRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIP-----YRENKNLTGTARYASMNTH- 157 (449)
Q Consensus 86 ~aL~yLH~~g--ivHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~-----~~~~~~~~gT~~Y~aPE~~- 157 (449)
.||+|||++| |+||||||+|||+ +.++.+||+|||+++............ ........||+.|+|||++
T Consensus 147 ~~l~~LH~~~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~ 223 (337)
T 3ll6_A 147 RAVQHMHRQKPPIIHRDLKVENLLL---SNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIID 223 (337)
T ss_dssp HHHHHHHTSSSCCBCCCCCGGGCEE---CTTSCEEBCCCTTCBCCSSCC-------------------------------
T ss_pred HHHHHHHhCCCCEEEccCCcccEEE---CCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhh
Confidence 9999999999 9999999999999 578899999999998765432211000 0112245699999999998
Q ss_pred --hCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCC
Q 013092 158 --LGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDK 235 (449)
Q Consensus 158 --~~~~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~R 235 (449)
.+..++.++|||||||++|+|++|..||...... .+....... .....++.++.+||..||+.+|++|
T Consensus 224 ~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-------~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~R 293 (337)
T 3ll6_A 224 LYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL-------RIVNGKYSI---PPHDTQYTVFHSLIRAMLQVNPEER 293 (337)
T ss_dssp CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-------------------CCC---CTTCCSSGGGHHHHHHHSCSSGGGS
T ss_pred ccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH-------HhhcCcccC---CcccccchHHHHHHHHHccCChhhC
Confidence 5667899999999999999999999999763221 111111111 1124567889999999999999999
Q ss_pred CCHHHHHHHHHHHHHHcCCCC
Q 013092 236 PDYAYLKRIFRDLFIREGFQF 256 (449)
Q Consensus 236 Pt~~~l~~~L~~~~~~~~~~~ 256 (449)
|++.++++.|+.+........
T Consensus 294 ps~~e~l~~l~~~~~~~~~~~ 314 (337)
T 3ll6_A 294 LSIAEVVHQLQEIAAARNVNP 314 (337)
T ss_dssp CCHHHHHHHHHHHHHHTTCCT
T ss_pred cCHHHHHHHHHHHHhccCCCC
Confidence 999999999999987665443
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-36 Score=291.98 Aligned_cols=221 Identities=17% Similarity=0.239 Sum_probs=176.9
Q ss_pred EEEEEeeecccCCChhHHHHHHHHHHHhcCCCCCceEEEEeEe----CCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHH
Q 013092 4 ILTVFSVQENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVE----GDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVL 78 (449)
Q Consensus 4 aikV~~k~~~~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~----~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~ 78 (449)
|+|++............+.+|+.+++.+ .||||+++++++.. ....||||||+ +++|.+++.. ...+++..++
T Consensus 55 a~k~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~ 132 (290)
T 1t4h_A 55 AWCELQDRKLTKSERQRFKEEAEMLKGL-QHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR-FKVMKIKVLR 132 (290)
T ss_dssp EEEEEEGGGSCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHH-HSSCCHHHHH
T ss_pred EEEEecchhhCHHHHHHHHHHHHHHHhC-CCCCeeeeeeeeccccCCCceEEEEEEecCCCCHHHHHHH-ccCCCHHHHH
Confidence 3444443333334456689999999999 89999999998765 46789999999 8999999985 3569999999
Q ss_pred HHHHHHHHHHHHHHHCC--ceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhh
Q 013092 79 MLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNT 156 (449)
Q Consensus 79 ~i~~qi~~aL~yLH~~g--ivHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~ 156 (449)
.++.||+.||.|||++| |+||||||+|||+. ..++.+||+|||++....... .....||+.|+|||+
T Consensus 133 ~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~--~~~~~~kl~Dfg~~~~~~~~~---------~~~~~~t~~y~aPE~ 201 (290)
T 1t4h_A 133 SWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT--GPTGSVKIGDLGLATLKRASF---------AKAVIGTPEFMAPEM 201 (290)
T ss_dssp HHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEES--STTSCEEECCTTGGGGCCTTS---------BEESCSSCCCCCGGG
T ss_pred HHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEE--CCCCCEEEeeCCCcccccccc---------cccccCCcCcCCHHH
Confidence 99999999999999999 99999999999993 367899999999997544321 134578999999998
Q ss_pred hhCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCC
Q 013092 157 HLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKP 236 (449)
Q Consensus 157 ~~~~~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RP 236 (449)
+.+ .++.++|||||||++|+|++|..||..... ..+.+..+..... ...+...+++++.++|..||+.+|++||
T Consensus 202 ~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~--~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~dp~~Rp 275 (290)
T 1t4h_A 202 YEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN--AAQIYRRVTSGVK---PASFDKVAIPEVKEIIEGCIRQNKDERY 275 (290)
T ss_dssp GGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS--HHHHHHHHTTTCC---CGGGGGCCCHHHHHHHHHHSCSSGGGSC
T ss_pred Hhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCc--HHHHHHHHhccCC---ccccCCCCCHHHHHHHHHHccCChhhCC
Confidence 875 589999999999999999999999976433 3334443333322 2234456789999999999999999999
Q ss_pred CHHHHHH
Q 013092 237 DYAYLKR 243 (449)
Q Consensus 237 t~~~l~~ 243 (449)
++.+|++
T Consensus 276 s~~ell~ 282 (290)
T 1t4h_A 276 SIKDLLN 282 (290)
T ss_dssp CHHHHHT
T ss_pred CHHHHhh
Confidence 9888754
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-36 Score=301.08 Aligned_cols=220 Identities=17% Similarity=0.181 Sum_probs=178.7
Q ss_pred CChhHHHHHHHHHHHhcC--CCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHc----CCCCCHHHHHHHHHHHHHHH
Q 013092 16 TKHPQLLYESKLYRILQG--GTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFC----SRKLSLKTVLMLADQMINRV 88 (449)
Q Consensus 16 ~~~~~~~~E~~il~~l~~--hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~----~~~ls~~~~~~i~~qi~~aL 88 (449)
....++..|+.+++.+.. |+||+.+++++...+..||||||| +++|.+++... ...+++..++.|+.||+.||
T Consensus 106 ~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L 185 (365)
T 3e7e_A 106 ANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMI 185 (365)
T ss_dssp CCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHH
T ss_pred CChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHH
Confidence 355678999999999843 899999999999999999999999 99999999752 45699999999999999999
Q ss_pred HHHHHCCceecCCCCCcEEEee--------cCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCC
Q 013092 89 EFVHSKSFLHRDIKPDNFLMGL--------GRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI 160 (449)
Q Consensus 89 ~yLH~~givHRDLKP~NiLl~~--------~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~ 160 (449)
+|||++||+||||||+||||+. +...+.+||+|||+++.+...... ......+||+.|+|||++.+.
T Consensus 186 ~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~ 260 (365)
T 3e7e_A 186 EQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKG-----TIFTAKCETSGFQCVEMLSNK 260 (365)
T ss_dssp HHHHTTTEECCCCSGGGEEECGGGTCC------CTTEEECCCTTCEEGGGSCTT-----EEECCSSCTTSCCCHHHHTTC
T ss_pred HHHhhCCeecCCCCHHHEEecccccCccccccccCCEEEeeCchhhhhhccCCC-----ceeeeecCCCCCCChHHhcCC
Confidence 9999999999999999999942 111789999999999876532221 122456799999999999999
Q ss_pred CCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCC-CCHH
Q 013092 161 EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDK-PDYA 239 (449)
Q Consensus 161 ~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~R-Pt~~ 239 (449)
.++.++|||||||++|||++|+.||....... ......+.. ...++.+.+++..|++.+|.+| |++.
T Consensus 261 ~~~~~~DiwslG~il~elltg~~pf~~~~~~~----------~~~~~~~~~--~~~~~~~~~~~~~~l~~~p~~r~~~~~ 328 (365)
T 3e7e_A 261 PWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE----------CKPEGLFRR--LPHLDMWNEFFHVMLNIPDCHHLPSLD 328 (365)
T ss_dssp CBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE----------EEECSCCTT--CSSHHHHHHHHHHHHCCCCTTCCCCHH
T ss_pred CCCccccHHHHHHHHHHHHhCCCccccCCCCc----------eeechhccc--cCcHHHHHHHHHHHcCCCCCCcchHHH
Confidence 99999999999999999999999996533211 001111111 1246789999999999999999 5788
Q ss_pred HHHHHHHHHHHHc
Q 013092 240 YLKRIFRDLFIRE 252 (449)
Q Consensus 240 ~l~~~L~~~~~~~ 252 (449)
+|.+.|++.+...
T Consensus 329 ~l~~~l~~~l~~~ 341 (365)
T 3e7e_A 329 LLRQKLKKVFQQH 341 (365)
T ss_dssp HHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHh
Confidence 9999999888765
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=293.51 Aligned_cols=212 Identities=16% Similarity=0.228 Sum_probs=169.8
Q ss_pred CChhHHHHHHHHHHHhcCCCCCceEEEEeEe--CCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH
Q 013092 16 TKHPQLLYESKLYRILQGGTGIPNVRWFGVE--GDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 92 (449)
Q Consensus 16 ~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~--~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH 92 (449)
.....+.+|+++++.|.+||||+++++++.+ ....+|||||+ +++|.+++. .+++..++.++.||+.||+|||
T Consensus 72 ~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH 147 (330)
T 3nsz_A 72 VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCH 147 (330)
T ss_dssp CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECCCCCCHHHHGG----GCCHHHHHHHHHHHHHHHHHHH
T ss_pred cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEeccCchhHHHHHH----hCCHHHHHHHHHHHHHHHHHHH
Confidence 4457899999999999889999999999987 67899999999 899999886 3899999999999999999999
Q ss_pred HCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhC-CCCChhhHHHHH
Q 013092 93 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESL 171 (449)
Q Consensus 93 ~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~-~~~s~~~DiwSl 171 (449)
++||+||||||+|||++ .....+||+|||+++.+..... .....||..|+|||++.+ ..++.++|||||
T Consensus 148 ~~~ivH~Dikp~Nil~~--~~~~~~kl~Dfg~a~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~Diwsl 217 (330)
T 3nsz_A 148 SMGIMHRDVKPHNVMID--HEHRKLRLIDWGLAEFYHPGQE--------YNVRVASRYFKGPELLVDYQMYDYSLDMWSL 217 (330)
T ss_dssp HTTEECCCCSGGGEEEE--TTTTEEEECCCTTCEECCTTCC--------CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHH
T ss_pred hCCeeeCCCCHHHEEEc--CCCCEEEEEeCCCceEcCCCCc--------cccccccccccChhhhcCCCcCCchhhHHHH
Confidence 99999999999999995 3344899999999987654332 234578999999999987 668999999999
Q ss_pred HHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccch---------------HHH-----------------hhcCCcHH
Q 013092 172 GYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS---------------IEA-----------------LCRGYPTE 219 (449)
Q Consensus 172 G~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~---------------~~~-----------------l~~~~p~e 219 (449)
||++|+|++|..||..... ....+..+........ ... ....++++
T Consensus 218 G~il~~ll~g~~p~~~~~~--~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (330)
T 3nsz_A 218 GCMLASMIFRKEPFFHGHD--NYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPE 295 (330)
T ss_dssp HHHHHHHHHTCSSSSCCSS--HHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHH
T ss_pred HHHHHHHHhCCCCcccCCc--hHHHHHHHHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHH
Confidence 9999999999999965322 1222222211111000 000 01227899
Q ss_pred HHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 220 FASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 220 l~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
+.+||..||+.||++||++.++++
T Consensus 296 ~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 296 ALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHhcCCcccCCCHHHHhc
Confidence 999999999999999999888754
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=300.61 Aligned_cols=234 Identities=15% Similarity=0.173 Sum_probs=177.7
Q ss_pred cEEEEEeeecccCCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHc---CCCCCHHHHH
Q 013092 3 EILTVFSVQENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFC---SRKLSLKTVL 78 (449)
Q Consensus 3 ~aikV~~k~~~~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~---~~~ls~~~~~ 78 (449)
+|+|++.+... ......+.+|+++++.+ .||||+++++++.+.+..||||||+ +++|.+++... ...+++..++
T Consensus 57 vavK~~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 134 (326)
T 3uim_A 57 VAVKRLKEERT-QGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQ 134 (326)
T ss_dssp EEEEECCC------CCCHHHHHHHGGGTC-CCTTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHH
T ss_pred EEEEEeccccC-chHHHHHHHHHHHHHhc-cCCCccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHH
Confidence 34554443321 22334789999999999 8999999999999999999999999 89999999753 2349999999
Q ss_pred HHHHHHHHHHHHHHHC---CceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchh
Q 013092 79 MLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMN 155 (449)
Q Consensus 79 ~i~~qi~~aL~yLH~~---givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE 155 (449)
.++.|++.||+|||++ ||+||||||+|||+ +.++.+||+|||+++........ ......||+.|+|||
T Consensus 135 ~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~------~~~~~~gt~~y~aPE 205 (326)
T 3uim_A 135 RIALGSARGLAYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKLMDYKDTH------VTTAVRGTIGHIAPE 205 (326)
T ss_dssp HHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEE---CTTCCEEECCCSSCEECCSSSSC------EECCCCSCGGGCCHH
T ss_pred HHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEE---CCCCCEEeccCccccccCccccc------ccccccCCcCccCHH
Confidence 9999999999999999 99999999999999 57889999999999877543321 123456999999999
Q ss_pred hhhCCCCChhhHHHHHHHHHHHHHhCCCCCCCCC-----cCCHHHHHHHHHhh-cccc-----hHHHhhcCCcHHHHHHH
Q 013092 156 THLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLK-----AGTKKQKYEKISEK-KVST-----SIEALCRGYPTEFASYF 224 (449)
Q Consensus 156 ~~~~~~~s~~~DiwSlG~il~elltG~~Pf~~~~-----~~~~~~~~~~i~~~-~~~~-----~~~~l~~~~p~el~~li 224 (449)
++.+..++.++|||||||++|+|++|..||.... .............. .... ........++.++.+++
T Consensus 206 ~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 285 (326)
T 3uim_A 206 YLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVA 285 (326)
T ss_dssp HHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHH
T ss_pred HhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHH
Confidence 9998889999999999999999999999995211 11111111000000 0000 00011122357899999
Q ss_pred HHHhcCCCCCCCCHHHHHHHHHH
Q 013092 225 HYCRSLRFDDKPDYAYLKRIFRD 247 (449)
Q Consensus 225 ~~cl~~~p~~RPt~~~l~~~L~~ 247 (449)
..||+.+|.+||++.+|++.|+.
T Consensus 286 ~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 286 LLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp HHHTCSCGGGSCCHHHHHHHHHT
T ss_pred HHHhCcCCccCCCHHHHHHHhcC
Confidence 99999999999999999988764
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-36 Score=300.66 Aligned_cols=215 Identities=19% Similarity=0.209 Sum_probs=173.7
Q ss_pred hHHHHHHHHHHHhcCCCCCceEEEEeEeC-----CEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH
Q 013092 19 PQLLYESKLYRILQGGTGIPNVRWFGVEG-----DYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 93 (449)
Q Consensus 19 ~~~~~E~~il~~l~~hp~Iv~l~~~~~~~-----~~~~lVmE~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~ 93 (449)
..+.+|+++++.+ .||||+++++++... ...||||||++++|.+++.. ..+++..++.++.||+.||+|||+
T Consensus 70 ~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~iv~e~~~~~L~~~l~~--~~~~~~~~~~i~~qi~~aL~~LH~ 146 (364)
T 3qyz_A 70 QRTLREIKILLRF-RHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT--QHLSNDHICYFLYQILRGLKYIHS 146 (364)
T ss_dssp HHHHHHHHHHHHC-CCTTBCCCCEEECCSSTTTCCCEEEEEECCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhc-CCCCCccceeEEecCCccccceEEEEEcccCcCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHH
Confidence 5688999999999 899999999988754 47899999998899999984 569999999999999999999999
Q ss_pred CCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhC-CCCChhhHHHHHH
Q 013092 94 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLG 172 (449)
Q Consensus 94 ~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~-~~~s~~~DiwSlG 172 (449)
+||+||||||+|||+ +.++.+||+|||+++......... .......||+.|+|||++.+ ..++.++||||||
T Consensus 147 ~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~a~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG 219 (364)
T 3qyz_A 147 ANVLHRDLKPSNLLL---NTTCDLKICDFGLARVADPDHDHT----GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVG 219 (364)
T ss_dssp TTEECCCCCGGGEEE---CTTCCEEECCCTTCEECCGGGCBC----CTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHH
T ss_pred CCeecCCCChHhEEE---CCCCCEEEEeCcceEecCCCCCcc----ccccccccccCCCCCHHhcCCCCCCcchhHHHHH
Confidence 999999999999999 678899999999998765432211 11245689999999998765 4589999999999
Q ss_pred HHHHHHHhCCCCCCCCCcCCHHHHHHHHHhh-----------------------cccchHHHhhcCCcHHHHHHHHHHhc
Q 013092 173 YVLMYFLRGSLPWQGLKAGTKKQKYEKISEK-----------------------KVSTSIEALCRGYPTEFASYFHYCRS 229 (449)
Q Consensus 173 ~il~elltG~~Pf~~~~~~~~~~~~~~i~~~-----------------------~~~~~~~~l~~~~p~el~~li~~cl~ 229 (449)
|++|+|++|..||.+.........+..+... ........+...+++++.+||..||+
T Consensus 220 ~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 299 (364)
T 3qyz_A 220 CILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLT 299 (364)
T ss_dssp HHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTC
T ss_pred HHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcC
Confidence 9999999999999886544333222211110 01112334456789999999999999
Q ss_pred CCCCCCCCHHHHHH
Q 013092 230 LRFDDKPDYAYLKR 243 (449)
Q Consensus 230 ~~p~~RPt~~~l~~ 243 (449)
.||++||++.++++
T Consensus 300 ~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 300 FNPHKRIEVEQALA 313 (364)
T ss_dssp SSTTTSCCHHHHHT
T ss_pred CChhhCCCHHHHhc
Confidence 99999999877753
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-36 Score=297.65 Aligned_cols=230 Identities=20% Similarity=0.249 Sum_probs=182.7
Q ss_pred ChhHHHHHHHHHHHh-cCCCCCceEEEEeEeCC----EEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHH
Q 013092 17 KHPQLLYESKLYRIL-QGGTGIPNVRWFGVEGD----YNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEF 90 (449)
Q Consensus 17 ~~~~~~~E~~il~~l-~~hp~Iv~l~~~~~~~~----~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~y 90 (449)
....+.+|++++..+ ..||||+++++++.... ..||||||+ +++|.+++.. ..+++..++.++.|++.||+|
T Consensus 77 ~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~ 154 (342)
T 1b6c_B 77 EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAH 154 (342)
T ss_dssp GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEEEeecCCCcHHHHHhc--cCccHHHHHHHHHHHHHHHHH
Confidence 456788999999984 28999999999998776 899999999 8899999984 469999999999999999999
Q ss_pred HH--------HCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCC-
Q 013092 91 VH--------SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIE- 161 (449)
Q Consensus 91 LH--------~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~- 161 (449)
|| +.||+||||||+|||+ +.++.+||+|||+++.......... .......||+.|+|||++.+..
T Consensus 155 lH~~~~~~~~~~~ivH~Dlkp~NIll---~~~~~~kL~Dfg~~~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~ 228 (342)
T 1b6c_B 155 LHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVRHDSATDTID---IAPNHRVGTKRYMAPEVLDDSIN 228 (342)
T ss_dssp HHCCBCSTTCBCEEECSCCSGGGEEE---CTTSCEEECCCTTCEEEETTTTEEE---ECCCSCCCCGGGCCHHHHTSCCC
T ss_pred HHHHHhhhcccCCeeeCCCCHHHEEE---CCCCCEEEEECCCceeccccccccc---cccccCCcCcccCCHhhhccccc
Confidence 99 8999999999999999 5788999999999988765432111 1124557999999999998752
Q ss_pred -----CChhhHHHHHHHHHHHHHhC----------CCCCCCCCcCC--HHHHHHHHHhhcccchHHHh--hcCCcHHHHH
Q 013092 162 -----QSRRDDLESLGYVLMYFLRG----------SLPWQGLKAGT--KKQKYEKISEKKVSTSIEAL--CRGYPTEFAS 222 (449)
Q Consensus 162 -----~s~~~DiwSlG~il~elltG----------~~Pf~~~~~~~--~~~~~~~i~~~~~~~~~~~l--~~~~p~el~~ 222 (449)
++.++|||||||++|||++| ..||....... .......+........++.. ...++..+.+
T Consensus 229 ~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 308 (342)
T 1b6c_B 229 MKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAK 308 (342)
T ss_dssp TTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHH
T ss_pred ccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHH
Confidence 34789999999999999999 88998754322 23333333333322222211 1234578999
Q ss_pred HHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCC
Q 013092 223 YFHYCRSLRFDDKPDYAYLKRIFRDLFIREGF 254 (449)
Q Consensus 223 li~~cl~~~p~~RPt~~~l~~~L~~~~~~~~~ 254 (449)
||..||+.+|++||++.+|.+.|+++....+.
T Consensus 309 li~~cl~~dp~~Rps~~~i~~~L~~i~~~~~~ 340 (342)
T 1b6c_B 309 IMRECWYANGAARLTALRIKKTLSQLSQQEGI 340 (342)
T ss_dssp HHHHHCCSSGGGSCCHHHHHHHHHHHHHTTC-
T ss_pred HHHHHhccChhhCCCHHHHHHHHHHHHHHhcC
Confidence 99999999999999999999999999877654
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=291.13 Aligned_cols=222 Identities=22% Similarity=0.267 Sum_probs=176.6
Q ss_pred EEEEEeeecccCCChhHHHHHHHHHHHhcCCCCCceEEEEeE--eCCEEEEEEecC-CCCHHHHHHHc---CCCCCHHHH
Q 013092 4 ILTVFSVQENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGV--EGDYNVLVMDLL-GPSLEDLFNFC---SRKLSLKTV 77 (449)
Q Consensus 4 aikV~~k~~~~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~--~~~~~~lVmE~~-g~sL~~ll~~~---~~~ls~~~~ 77 (449)
|+|++.+..........+.+|+++++.+ +||||+++++++. .....||||||+ +++|.+++... ...+++..+
T Consensus 35 aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 113 (279)
T 2w5a_A 35 VWKELDYGSMTEAEKQMLVSEVNLLREL-KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFV 113 (279)
T ss_dssp EEEEEECTTCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEEGGGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHH
T ss_pred EEEEEEcccCCHHHHHHHHHHHHHHHhc-CCCCCCeEEEEEecCCCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHH
Confidence 3444433222233455689999999999 8999999999775 467899999999 88999999753 334999999
Q ss_pred HHHHHHHHHHHHHHHHCC-----ceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCcccc
Q 013092 78 LMLADQMINRVEFVHSKS-----FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 152 (449)
Q Consensus 78 ~~i~~qi~~aL~yLH~~g-----ivHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~ 152 (449)
+.++.|++.||+|||+.| |+||||||+|||+ +.++.+||+|||+++....... ......||+.|+
T Consensus 114 ~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~---~~~~~~kl~dfg~~~~~~~~~~-------~~~~~~~~~~y~ 183 (279)
T 2w5a_A 114 LRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL---DGKQNVKLGDFGLARILNHDTS-------FAKTFVGTPYYM 183 (279)
T ss_dssp HHHHHHHHHHHHHHHHHC------CCCCCSGGGEEE---CSSSCEEECCCCHHHHC---CH-------HHHHHHSCCTTC
T ss_pred HHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEE---cCCCCEEEecCchheeeccccc-------cccccCCCcccc
Confidence 999999999999999999 9999999999999 5788999999999986644221 112346899999
Q ss_pred chhhhhCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCC
Q 013092 153 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRF 232 (449)
Q Consensus 153 aPE~~~~~~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p 232 (449)
|||++.+..++.++||||||+++|+|++|..||.... ..+....+...... .++..++.++.++|..||+.+|
T Consensus 184 aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~i~~~~~~----~~~~~~~~~l~~li~~~l~~~p 256 (279)
T 2w5a_A 184 SPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS---QKELAGKIREGKFR----RIPYRYSDELNEIITRMLNLKD 256 (279)
T ss_dssp CHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHTCCC----CCCTTSCHHHHHHHHHHTCSSG
T ss_pred ChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccC---HHHHHHHHhhcccc----cCCcccCHHHHHHHHHHcCCCc
Confidence 9999999999999999999999999999999998743 33344444443322 2345789999999999999999
Q ss_pred CCCCCHHHHHH
Q 013092 233 DDKPDYAYLKR 243 (449)
Q Consensus 233 ~~RPt~~~l~~ 243 (449)
++||++.+|++
T Consensus 257 ~~Rps~~~ll~ 267 (279)
T 2w5a_A 257 YHRPSVEEILE 267 (279)
T ss_dssp GGSCCHHHHHT
T ss_pred ccCCCHHHHHh
Confidence 99999888865
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=303.63 Aligned_cols=209 Identities=19% Similarity=0.286 Sum_probs=169.8
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC-C
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK-S 95 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~-g 95 (449)
...+.+|+.+++.+ +||||+++++++.+++..||||||+ |++|.+++.. ...+++..+..++.|++.||+|||++ |
T Consensus 75 ~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 152 (360)
T 3eqc_A 75 RNQIIRELQVLHEC-NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLREKHK 152 (360)
T ss_dssp HHHHHHHHGGGGGC-CCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHHHC
T ss_pred HHHHHHHHHHHHHC-CCCCEEEEeEEEEECCEEEEEEECCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 45689999999999 8999999999999999999999999 8899999986 35699999999999999999999996 9
Q ss_pred ceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHHH
Q 013092 96 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVL 175 (449)
Q Consensus 96 ivHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il 175 (449)
|+||||||+|||+ +.++.+||+|||++..+.... .....||+.|+|||++.+..++.++|||||||++
T Consensus 153 i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il 220 (360)
T 3eqc_A 153 IMHRDVKPSNILV---NSRGEIKLCDFGVSGQLIDSM---------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSL 220 (360)
T ss_dssp CCCSCCSGGGEEE---CTTCCEEECCCCCCHHHHHHC-------------CCCCTTCCHHHHTTCCCSHHHHHHHHHHHH
T ss_pred EEcCCccHHHEEE---CCCCCEEEEECCCCccccccc---------ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHH
Confidence 9999999999999 578899999999997654322 1345799999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCcCCHHHHH---------------------------------------HHHHhhcccchHHHhhcCC
Q 013092 176 MYFLRGSLPWQGLKAGTKKQKY---------------------------------------EKISEKKVSTSIEALCRGY 216 (449)
Q Consensus 176 ~elltG~~Pf~~~~~~~~~~~~---------------------------------------~~i~~~~~~~~~~~l~~~~ 216 (449)
|+|++|..||...........+ ..+...... ......+
T Consensus 221 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~ 297 (360)
T 3eqc_A 221 VEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPP---KLPSGVF 297 (360)
T ss_dssp HHHHHTSCCSSCCCHHHHHHHHC------------------------------CCCHHHHHHHHHHSCCC---CCCTTTS
T ss_pred HHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCCC---CCCcccc
Confidence 9999999999864332111110 000000000 0001246
Q ss_pred cHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 217 PTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 217 p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
+.++.+||..||+.||++||++.++++
T Consensus 298 ~~~~~~li~~~L~~dP~~Rpt~~ell~ 324 (360)
T 3eqc_A 298 SLEFQDFVNKCLIKNPAERADLKQLMV 324 (360)
T ss_dssp CHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred cHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 889999999999999999999887753
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-36 Score=296.63 Aligned_cols=226 Identities=18% Similarity=0.184 Sum_probs=178.2
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeCC--EEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEGD--YNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 94 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~--~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~ 94 (449)
...+.+|+++++.+ .||||+++++++...+ ..||||||+ +++|.+++......+++..++.++.||+.||+|||++
T Consensus 86 ~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~ 164 (326)
T 2w1i_A 86 LRDFEREIEILKSL-QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK 164 (326)
T ss_dssp HHHHHHHHHHHHTC-CCTTBCCEEEEECC----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHhC-CCCCeeeEEEEEEecCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 45689999999999 8999999999886543 789999999 8999999987666799999999999999999999999
Q ss_pred CceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHH
Q 013092 95 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYV 174 (449)
Q Consensus 95 givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~i 174 (449)
||+||||||+|||+ +.++.+||+|||+++......... .......++..|+|||++.+..++.++|||||||+
T Consensus 165 ~ivH~dikp~NIli---~~~~~~kL~Dfg~~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~i 237 (326)
T 2w1i_A 165 RYIHRDLATRNILV---ENENRVKIGDFGLTKVLPQDKEYY----KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVV 237 (326)
T ss_dssp TEECSCCCGGGEEE---EETTEEEECCCTTCEECCSSCSEE----ECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHH
T ss_pred CEeccCCCcceEEE---cCCCcEEEecCcchhhcccccccc----ccccCCCCceeEECchhhcCCCCCchhhHHHHHHH
Confidence 99999999999999 467899999999998876543211 11234567888999999999889999999999999
Q ss_pred HHHHHhCCCCCCCCCcC---------CHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Q 013092 175 LMYFLRGSLPWQGLKAG---------TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIF 245 (449)
Q Consensus 175 l~elltG~~Pf~~~~~~---------~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~L 245 (449)
+|+|++|..||...... ........+.+..........+..+|.++.++|..||+.+|++||++.+|.+.|
T Consensus 238 l~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L 317 (326)
T 2w1i_A 238 LYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRV 317 (326)
T ss_dssp HHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred HHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 99999999998642100 000000011110000001112456899999999999999999999999999999
Q ss_pred HHHHHH
Q 013092 246 RDLFIR 251 (449)
Q Consensus 246 ~~~~~~ 251 (449)
+++...
T Consensus 318 ~~l~~~ 323 (326)
T 2w1i_A 318 DQIRDQ 323 (326)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 887653
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=293.14 Aligned_cols=208 Identities=20% Similarity=0.255 Sum_probs=153.8
Q ss_pred ChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 013092 17 KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 95 (449)
Q Consensus 17 ~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~g 95 (449)
....+.+|+++++.+ +||||+++++++.+.+..||||||+ +++|.+++......+++..++.++.|++.||+|||++|
T Consensus 54 ~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ 132 (278)
T 3cok_A 54 MVQRVQNEVKIHCQL-KHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG 132 (278)
T ss_dssp CHHHHHHHHHHHTTB-CCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHhC-CCCCeEeEEEEEccCCeEEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 346789999999999 8999999999999999999999999 88999999865567999999999999999999999999
Q ss_pred ceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHHH
Q 013092 96 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVL 175 (449)
Q Consensus 96 ivHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il 175 (449)
|+||||||+||++ +.++.+||+|||++........ ......||+.|+|||++.+..++.++|||||||++
T Consensus 133 i~H~dl~p~Nili---~~~~~~kl~dfg~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 202 (278)
T 3cok_A 133 ILHRDLTLSNLLL---TRNMNIKIADFGLATQLKMPHE-------KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMF 202 (278)
T ss_dssp EECSSCCGGGEEE---CTTCCEEECCCTTCEECC-----------------------------------CTHHHHHHHHH
T ss_pred eecCCCCHHHEEE---cCCCCEEEEeecceeeccCCCC-------cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHH
Confidence 9999999999999 5788999999999987653321 11245789999999999998899999999999999
Q ss_pred HHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 176 MYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 176 ~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
|+|++|..||....... .+.++..... .++..++.++.++|..||+.||++||++.++++
T Consensus 203 ~~l~~g~~p~~~~~~~~---~~~~~~~~~~-----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 203 YTLLIGRPPFDTDTVKN---TLNKVVLADY-----EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp HHHHHSSCSSCCCSCC--------CCSSCC-----CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred HHHHhCCCCCCChhHHH---HHHHHhhccc-----CCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 99999999998754322 1222211111 123457899999999999999999999887753
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=305.32 Aligned_cols=209 Identities=20% Similarity=0.216 Sum_probs=165.7
Q ss_pred HHHHHHHHHHhcCCCCCceEEEEeEe------CCEEEEEEecCCCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHH
Q 013092 21 LLYESKLYRILQGGTGIPNVRWFGVE------GDYNVLVMDLLGPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFV 91 (449)
Q Consensus 21 ~~~E~~il~~l~~hp~Iv~l~~~~~~------~~~~~lVmE~~g~sL~~ll~~---~~~~ls~~~~~~i~~qi~~aL~yL 91 (449)
+.+|+++|+.| +|+||+++++++.. ..+.+|||||+.++|.+++.. ....+++..++.++.||+.||+||
T Consensus 94 ~~~E~~il~~l-~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~L 172 (420)
T 1j1b_A 94 KNRELQIMRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 172 (420)
T ss_dssp CCHHHHHHHTC-CCTTBCCEEEEEEEEETTTTEEEEEEEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHc-CCCCccceeeEEeccCCCCcceeEEeehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHH
Confidence 45799999999 89999999888753 224789999997788877653 256799999999999999999999
Q ss_pred HHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCC-CCChhhHHHH
Q 013092 92 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLES 170 (449)
Q Consensus 92 H~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~-~~s~~~DiwS 170 (449)
|++||+||||||+||||. ...+.+||+|||+++.+..... .....||+.|+|||++.+. .++.++||||
T Consensus 173 H~~~ivHrDlkp~NILl~--~~~~~~kl~DFG~a~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwS 242 (420)
T 1j1b_A 173 HSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLVRGEP--------NVSYICSRYYRAPELIFGATDYTSSIDVWS 242 (420)
T ss_dssp HTTTEECSCCSGGGEEEE--TTTTEEEECCCTTCEECCTTCC--------CCSCCSCTTSCCHHHHTTCSSCCTHHHHHH
T ss_pred HHCCccccCCChhhEEEe--CCCCeEEeccchhhhhcccCCC--------ceeeeeCCCcCCHHHHcCCCCCCchhhhHH
Confidence 999999999999999994 3456789999999987654322 2345789999999999875 7899999999
Q ss_pred HHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccc------------------------hHHHhhcCCcHHHHHHHHH
Q 013092 171 LGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST------------------------SIEALCRGYPTEFASYFHY 226 (449)
Q Consensus 171 lG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~------------------------~~~~l~~~~p~el~~li~~ 226 (449)
||||||||++|+.||.+... .+.+.++......+ ....+...+++++.+||..
T Consensus 243 lG~il~ell~G~~pf~~~~~---~~~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~ 319 (420)
T 1j1b_A 243 AGCVLAELLLGQPIFPGDSG---VDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSR 319 (420)
T ss_dssp HHHHHHHHHHSSCSSCCSSH---HHHHHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHH
T ss_pred HHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHH
Confidence 99999999999999987533 22333332211111 1111234578999999999
Q ss_pred HhcCCCCCCCCHHHHHH
Q 013092 227 CRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 227 cl~~~p~~RPt~~~l~~ 243 (449)
||..||++||++.++++
T Consensus 320 ~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 320 LLEYTPTARLTPLEACA 336 (420)
T ss_dssp HSCSSGGGSCCHHHHHT
T ss_pred hccCChhHCCCHHHHhC
Confidence 99999999999877653
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=309.60 Aligned_cols=240 Identities=20% Similarity=0.225 Sum_probs=186.0
Q ss_pred cEEEEEeeecccCCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCC--EEEEEEecC-CCCHHHHHHHcC--CCCCHHHH
Q 013092 3 EILTVFSVQENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGD--YNVLVMDLL-GPSLEDLFNFCS--RKLSLKTV 77 (449)
Q Consensus 3 ~aikV~~k~~~~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~--~~~lVmE~~-g~sL~~ll~~~~--~~ls~~~~ 77 (449)
+|||++.+... ......+.+|+++++.+ +||||+++++++.+.. ..||||||| +++|.+++.... ..+++..+
T Consensus 37 vaiK~~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~ 114 (396)
T 4eut_A 37 FAIKVFNNISF-LRPVDVQMREFEVLKKL-NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEF 114 (396)
T ss_dssp EEEEEECGGGG-GSCHHHHHHHHHHHHHC-CCTTBCCEEEEEECTTTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHH
T ss_pred EEEEEeccccc-cchHHHHHHHHHHHHhc-CCCCCCeEEEeeccCCCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHH
Confidence 34555443222 23456788999999999 8999999999988655 789999999 899999997432 23999999
Q ss_pred HHHHHHHHHHHHHHHHCCceecCCCCCcEEEeec-CCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhh
Q 013092 78 LMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG-RRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNT 156 (449)
Q Consensus 78 ~~i~~qi~~aL~yLH~~givHRDLKP~NiLl~~~-~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~ 156 (449)
+.++.||+.||+|||++||+||||||+|||+..+ +..+.+||+|||+++....... .....||+.|+|||+
T Consensus 115 ~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~~~~--------~~~~~gt~~y~aPE~ 186 (396)
T 4eut_A 115 LIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ--------FVSLYGTEEYLHPDM 186 (396)
T ss_dssp HHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCCGGG--------SSCSSSCCTTCCHHH
T ss_pred HHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceEccCCCc--------cccccCCccccCHHH
Confidence 9999999999999999999999999999998443 3456799999999987654321 234579999999999
Q ss_pred hhC--------CCCChhhHHHHHHHHHHHHHhCCCCCCCCCc-CCHHHHHHHHHhhcccchH------------------
Q 013092 157 HLG--------IEQSRRDDLESLGYVLMYFLRGSLPWQGLKA-GTKKQKYEKISEKKVSTSI------------------ 209 (449)
Q Consensus 157 ~~~--------~~~s~~~DiwSlG~il~elltG~~Pf~~~~~-~~~~~~~~~i~~~~~~~~~------------------ 209 (449)
+.+ ..++.++|||||||++|||++|..||..... ....+.+.++........+
T Consensus 187 ~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 266 (396)
T 4eut_A 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMP 266 (396)
T ss_dssp HHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCC
T ss_pred hhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCcccchhheeccCCCcccCccCC
Confidence 875 4578899999999999999999999976443 2223444444433221100
Q ss_pred --HHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 013092 210 --EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIRE 252 (449)
Q Consensus 210 --~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~L~~~~~~~ 252 (449)
..+...++..+.+++..||+.||++||++.++.+.+.+++.+.
T Consensus 267 ~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~~ 311 (396)
T 4eut_A 267 VSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRM 311 (396)
T ss_dssp TTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTCE
T ss_pred cccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhce
Confidence 0111335678999999999999999999999999999887654
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=298.24 Aligned_cols=210 Identities=17% Similarity=0.180 Sum_probs=165.1
Q ss_pred hHHHHHHHHHHHhcCCCCCceEEEEeEe-----CCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH
Q 013092 19 PQLLYESKLYRILQGGTGIPNVRWFGVE-----GDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 93 (449)
Q Consensus 19 ~~~~~E~~il~~l~~hp~Iv~l~~~~~~-----~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~ 93 (449)
..+.+|+++++.+ .||||+++++++.. ....||||||++++|.+++......+++..++.++.||+.||.|||+
T Consensus 74 ~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~ 152 (362)
T 3pg1_A 74 KRVLREIRLLNHF-HHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHE 152 (362)
T ss_dssp HHHHHHHHHHHHC-CCTTBCCCSEEEEECCTTTCCEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhC-CCcCccceeeeEEeccCCCcceEEEEEccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH
Confidence 6789999999999 89999999998853 34789999999889999988655679999999999999999999999
Q ss_pred CCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhC-CCCChhhHHHHHH
Q 013092 94 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLG 172 (449)
Q Consensus 94 ~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~-~~~s~~~DiwSlG 172 (449)
+||+||||||+|||+ +.++.+||+|||+++....... .....||+.|+|||++.+ ..++.++||||||
T Consensus 153 ~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG 221 (362)
T 3pg1_A 153 AGVVHRDLHPGNILL---ADNNDITICDFNLAREDTADAN--------KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAG 221 (362)
T ss_dssp TTCCCCCCCGGGEEE---CTTCCEEECCTTC-----------------------CGGGCCHHHHTTCTTCCTHHHHHHHH
T ss_pred CcCEecCCChHHEEE---cCCCCEEEEecCcccccccccc--------cceecccceecCcHHhcCCCCCCcHhHHHhHH
Confidence 999999999999999 5788999999999975543322 234578999999999987 6789999999999
Q ss_pred HHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhccc---------------------------chHHHhhcCCcHHHHHHHH
Q 013092 173 YVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS---------------------------TSIEALCRGYPTEFASYFH 225 (449)
Q Consensus 173 ~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~---------------------------~~~~~l~~~~p~el~~li~ 225 (449)
|++|+|++|..||.+... ...+..+.+.... .........+++++.+||.
T Consensus 222 ~il~~l~~g~~pf~~~~~---~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 298 (362)
T 3pg1_A 222 CVMAEMFNRKALFRGSTF---YNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIA 298 (362)
T ss_dssp HHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHH
T ss_pred HHHHHHHhCCCCCCCCCH---HHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHH
Confidence 999999999999987443 3333333221111 1223344567899999999
Q ss_pred HHhcCCCCCCCCHHHHHH
Q 013092 226 YCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 226 ~cl~~~p~~RPt~~~l~~ 243 (449)
.||+.||++||++.++++
T Consensus 299 ~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 299 KMLEFNPQRRISTEQALR 316 (362)
T ss_dssp HHTCSSGGGSCCHHHHHT
T ss_pred HHhcCChhhCCCHHHHHc
Confidence 999999999999887753
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=289.47 Aligned_cols=210 Identities=18% Similarity=0.215 Sum_probs=176.2
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 96 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gi 96 (449)
...+.+|+++++.+.+||||+++++++.+.+..||||||+ +++|.+++.. ...+++..++.++.||+.||+|||++||
T Consensus 67 ~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i 145 (298)
T 1phk_A 67 REATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVICALHKLNI 145 (298)
T ss_dssp HHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred HHHHHHHHHHHHHhcCCCCEeeeeeeeccCCeEEEEEeccCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 3567899999999978999999999999999999999999 8999999985 4579999999999999999999999999
Q ss_pred eecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhh------CCCCChhhHHHH
Q 013092 97 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHL------GIEQSRRDDLES 170 (449)
Q Consensus 97 vHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~------~~~~s~~~DiwS 170 (449)
+|+||||+||++ +.++.+||+|||++........ .....||+.|+|||++. ...++.++||||
T Consensus 146 ~H~dl~p~Nil~---~~~~~~kl~dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~s 214 (298)
T 1phk_A 146 VHRDLKPENILL---DDDMNIKLTDFGFSCQLDPGEK--------LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWS 214 (298)
T ss_dssp ECSCCSGGGEEE---CTTCCEEECCCTTCEECCTTCC--------BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHH
T ss_pred ccCCCCcceEEE---cCCCcEEEecccchhhcCCCcc--------cccccCCccccCHHHhccccccccccCCcccccHh
Confidence 999999999999 5788999999999987654322 23457899999999986 456889999999
Q ss_pred HHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 171 LGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 171 lG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
||+++|+|++|..||.... .......+......... .....++.++.++|..||+.+|++||++.++++
T Consensus 215 lG~~l~~l~~g~~p~~~~~---~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 215 TGVIMYTLLAGSPPFWHRK---QMLMLRMIMSGNYQFGS-PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HHHHHHHHHHSSCSSCCSS---HHHHHHHHHHTCCCCCT-TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHHHHHHHHCCCCCcCcc---HHHHHHHHhcCCcccCc-ccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 9999999999999997643 33444444443332221 223468999999999999999999999887743
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=285.41 Aligned_cols=206 Identities=21% Similarity=0.260 Sum_probs=173.8
Q ss_pred hHHHHHHHHHHHhcCCCCCceEEEEeEe----------------CCEEEEEEecC-CCCHHHHHHHc-CCCCCHHHHHHH
Q 013092 19 PQLLYESKLYRILQGGTGIPNVRWFGVE----------------GDYNVLVMDLL-GPSLEDLFNFC-SRKLSLKTVLML 80 (449)
Q Consensus 19 ~~~~~E~~il~~l~~hp~Iv~l~~~~~~----------------~~~~~lVmE~~-g~sL~~ll~~~-~~~ls~~~~~~i 80 (449)
..+.+|+++++.+ .||||+++++++.. ....||||||+ +++|.+++... ...+++..++.+
T Consensus 49 ~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i 127 (284)
T 2a19_B 49 EKAEREVKALAKL-DHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALEL 127 (284)
T ss_dssp GGGHHHHHHHHHC-CCTTBCCEEEEEEEEEEC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHH
T ss_pred HHHHHHHHHHHhC-CCCCEEEEeeeEeccccCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHH
Confidence 5788999999999 89999999988754 45589999999 88999999754 357999999999
Q ss_pred HHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCC
Q 013092 81 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI 160 (449)
Q Consensus 81 ~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~ 160 (449)
+.||+.||.|||++||+||||||+|||+ +.++.+||+|||++........ .....||+.|+|||++.+.
T Consensus 128 ~~qi~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~ 196 (284)
T 2a19_B 128 FEQITKGVDYIHSKKLINRDLKPSNIFL---VDTKQVKIGDFGLVTSLKNDGK--------RTRSKGTLRYMSPEQISSQ 196 (284)
T ss_dssp HHHHHHHHHHHHHTTEECSCCSGGGEEE---EETTEEEECCCTTCEESSCCSC--------CCCCCSCCTTSCHHHHHCS
T ss_pred HHHHHHHHHHHHhCCeeeccCCHHHEEE---cCCCCEEECcchhheecccccc--------ccccCCcccccChhhhccC
Confidence 9999999999999999999999999999 4778999999999987755322 2345689999999999999
Q ss_pred CCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHH
Q 013092 161 EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAY 240 (449)
Q Consensus 161 ~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~ 240 (449)
.++.++|||||||++|+|++|..||.. ....+..+.... +...++.++.++|..||+.+|++||++.+
T Consensus 197 ~~~~~~Di~slG~il~~l~~~~~~~~~-----~~~~~~~~~~~~-------~~~~~~~~~~~li~~~l~~dp~~Rps~~e 264 (284)
T 2a19_B 197 DYGKEVDLYALGLILAELLHVCDTAFE-----TSKFFTDLRDGI-------ISDIFDKKEKTLLQKLLSKKPEDRPNTSE 264 (284)
T ss_dssp CCCTHHHHHHHHHHHHHHHSCCSSHHH-----HHHHHHHHHTTC-------CCTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CCcchhhhHHHHHHHHHHHhcCCcchh-----HHHHHHHhhccc-------ccccCCHHHHHHHHHHccCChhhCcCHHH
Confidence 999999999999999999999988843 122222222221 23457899999999999999999999999
Q ss_pred HHHHHHHH
Q 013092 241 LKRIFRDL 248 (449)
Q Consensus 241 l~~~L~~~ 248 (449)
+.+.|..+
T Consensus 265 ~l~~l~~~ 272 (284)
T 2a19_B 265 ILRTLTVW 272 (284)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHHH
Confidence 99888766
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-36 Score=292.97 Aligned_cols=225 Identities=19% Similarity=0.257 Sum_probs=172.0
Q ss_pred EEEEEeeecccCCChhHHHHHHHHHHHhcC-CCCCceEEEEeEeCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHH
Q 013092 4 ILTVFSVQENVKTKHPQLLYESKLYRILQG-GTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLAD 82 (449)
Q Consensus 4 aikV~~k~~~~~~~~~~~~~E~~il~~l~~-hp~Iv~l~~~~~~~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~~~~i~~ 82 (449)
|+|++.+..........+.+|+++++.+.+ |+||+++++++.+.+..|||||+.+++|.+++.. ...+++..++.++.
T Consensus 56 avK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e~~~~~L~~~l~~-~~~~~~~~~~~i~~ 134 (313)
T 3cek_A 56 AIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKK-KKSIDPWERKSYWK 134 (313)
T ss_dssp EEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEECCCSEEHHHHHHH-CSSCCHHHHHHHHH
T ss_pred EEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEecCCCcHHHHHHh-cCCCCHHHHHHHHH
Confidence 444444333223344668999999999975 7999999999999999999999779999999986 46799999999999
Q ss_pred HHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhC---
Q 013092 83 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG--- 159 (449)
Q Consensus 83 qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~--- 159 (449)
||+.||.|||++||+||||||+|||+. ++.+||+|||+++.+...... .......||+.|+|||++.+
T Consensus 135 qi~~aL~~LH~~~ivH~dlkp~NIl~~----~~~~kL~Dfg~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~ 205 (313)
T 3cek_A 135 NMLEAVHTIHQHGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTS-----VVKDSQVGTVNYMPPEAIKDMSS 205 (313)
T ss_dssp HHHHHHHHHHHTTCCCCCCCGGGEEEE----TTEEEECCCSSSCC-------------------CCGGGCCHHHHTTCC-
T ss_pred HHHHHHHHHHHCCceecCCCcccEEEE----CCeEEEeeccccccccCcccc-----ccccCCCCCCCcCCHHHHhhccc
Confidence 999999999999999999999999993 488999999999876543221 11234579999999999976
Q ss_pred --------CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCC
Q 013092 160 --------IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLR 231 (449)
Q Consensus 160 --------~~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~ 231 (449)
..++.++|||||||++|+|++|..||..... ....+..+...... ..+...++.++.++|..||+.+
T Consensus 206 ~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~--~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~d 280 (313)
T 3cek_A 206 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN--QISKLHAIIDPNHE---IEFPDIPEKDLQDVLKCCLKRD 280 (313)
T ss_dssp ---------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCS--HHHHHHHHHCTTSC---CCCCCCSCHHHHHHHHHHTCSS
T ss_pred ccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHH--HHHHHHHHHhcccc---cCCcccchHHHHHHHHHHccCC
Confidence 4688999999999999999999999976432 22222222222111 1233456889999999999999
Q ss_pred CCCCCCHHHHHH
Q 013092 232 FDDKPDYAYLKR 243 (449)
Q Consensus 232 p~~RPt~~~l~~ 243 (449)
|++||++.++++
T Consensus 281 p~~Rps~~ell~ 292 (313)
T 3cek_A 281 PKQRISIPELLA 292 (313)
T ss_dssp TTTSCCHHHHHT
T ss_pred cccCcCHHHHhc
Confidence 999999877754
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-35 Score=303.60 Aligned_cols=211 Identities=19% Similarity=0.207 Sum_probs=172.0
Q ss_pred ChhHHHHHHHHHHHhc-----CCCCCceEEEEeEeCCEEEEEEecCCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHH
Q 013092 17 KHPQLLYESKLYRILQ-----GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEF 90 (449)
Q Consensus 17 ~~~~~~~E~~il~~l~-----~hp~Iv~l~~~~~~~~~~~lVmE~~g~sL~~ll~~~~-~~ls~~~~~~i~~qi~~aL~y 90 (449)
...++.+|+++++.++ +|+||+.+++++...+..||||||++++|.+++.... ..+++..++.++.||+.||+|
T Consensus 136 ~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~ 215 (429)
T 3kvw_A 136 FHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDA 215 (429)
T ss_dssp HHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEEEeccCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Confidence 3467889999999985 5679999999999999999999999889999998643 459999999999999999999
Q ss_pred HHHCCceecCCCCCcEEEeecCCCCe--EEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHH
Q 013092 91 VHSKSFLHRDIKPDNFLMGLGRRANQ--VYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDL 168 (449)
Q Consensus 91 LH~~givHRDLKP~NiLl~~~~~~~~--vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~Di 168 (449)
||++||+||||||+|||| +..+. +||+|||+++...... ....||+.|+|||++.+..++.++||
T Consensus 216 LH~~~ivHrDlKp~NILl---~~~~~~~vkL~DFG~a~~~~~~~----------~~~~gt~~y~aPE~~~~~~~~~~~Di 282 (429)
T 3kvw_A 216 LHKNRIIHCDLKPENILL---KQQGRSGIKVIDFGSSCYEHQRV----------YTYIQSRFYRAPEVILGARYGMPIDM 282 (429)
T ss_dssp HHHHTEECSCCSGGGEEE---SSTTSCCEEECCCTTCEETTCCC----------CSSCSCGGGCCHHHHHTBCCCTHHHH
T ss_pred HHHCCeecCCCCHHHeEE---ccCCCcceEEeecccceecCCcc----------cccCCCCCccChHHHhCCCCCchHHH
Confidence 999999999999999999 45555 9999999997654322 34579999999999999999999999
Q ss_pred HHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccc-----------------------------------------
Q 013092 169 ESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST----------------------------------------- 207 (449)
Q Consensus 169 wSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~----------------------------------------- 207 (449)
|||||++|||++|..||.+.+.. +.+..+.+....+
T Consensus 283 wSlG~il~elltG~~pf~~~~~~---~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 359 (429)
T 3kvw_A 283 WSLGCILAELLTGYPLLPGEDEG---DQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRS 359 (429)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHHHCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEEC
T ss_pred HhHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHcCCCCHHHHHhhhhhhhccCCCCCccccccccccccccccccccc
Confidence 99999999999999999875432 2232222211100
Q ss_pred -------------hHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 208 -------------SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 208 -------------~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
....+....++++.+||..||+.||++||++.++++
T Consensus 360 ~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~ 408 (429)
T 3kvw_A 360 RRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALR 408 (429)
T ss_dssp TTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred chhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHhC
Confidence 011122334788999999999999999999888754
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=322.15 Aligned_cols=216 Identities=19% Similarity=0.275 Sum_probs=179.7
Q ss_pred hHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q 013092 19 PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFL 97 (449)
Q Consensus 19 ~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~giv 97 (449)
..+.+|+.+++.+ +||||+++++++. .+..||||||+ +++|.+++......+++..++.++.||+.||+|||++||+
T Consensus 436 ~~~~~E~~~l~~l-~HpnIv~l~~~~~-~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~giv 513 (656)
T 2j0j_A 436 EKFLQEALTMRQF-DHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFV 513 (656)
T ss_dssp HHHHHHHHHHHHC-CCTTBCCEEEEEC-SSSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred HHHHHHHHHHHhC-CCCCCCeEEEEEe-cCceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence 5689999999999 9999999999885 45689999999 8999999986556799999999999999999999999999
Q ss_pred ecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHHHHH
Q 013092 98 HRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMY 177 (449)
Q Consensus 98 HRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il~e 177 (449)
||||||+|||+ +.++.+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||++||
T Consensus 514 HrDikp~NILl---~~~~~vkL~DFG~a~~~~~~~~------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~e 584 (656)
T 2j0j_A 514 HRDIAARNVLV---SSNDCVKLGDFGLSRYMEDSTY------YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWE 584 (656)
T ss_dssp CSCCSGGGEEE---EETTEEEECCCCCCCSCCC----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred ccccchHhEEE---eCCCCEEEEecCCCeecCCCcc------eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHH
Confidence 99999999999 4678999999999987654322 11234467889999999999999999999999999999
Q ss_pred HHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 013092 178 FLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIRE 252 (449)
Q Consensus 178 llt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~L~~~~~~~ 252 (449)
|++ |..||.+... .+.+..+...... .++..+|+++.++|..||+.+|++||++.+|.+.|++++..+
T Consensus 585 llt~g~~Pf~~~~~---~~~~~~i~~~~~~----~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~~ 653 (656)
T 2j0j_A 585 ILMHGVKPFQGVKN---NDVIGRIENGERL----PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 653 (656)
T ss_dssp HHTTSCCTTTTCCH---HHHHHHHHHTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHcCCCCCCCCCH---HHHHHHHHcCCCC----CCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence 997 9999987543 3344444433221 234578999999999999999999999999999999987654
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-36 Score=287.38 Aligned_cols=212 Identities=23% Similarity=0.293 Sum_probs=174.8
Q ss_pred ChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 013092 17 KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 95 (449)
Q Consensus 17 ~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~g 95 (449)
....+.+|+.+++.+ +||||+++++++.+++..|+||||+ +++|.+++.. ...+++..++.++.|++.||+|||++|
T Consensus 48 ~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~ 125 (276)
T 2yex_A 48 CPENIKKEICINKML-NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIG 125 (276)
T ss_dssp HHHHHHHHHHHHHTC-CCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred hhHHHHHHHHHHHhc-CCCCceeeeeEEEcCCEEEEEEEecCCCcHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 346789999999999 8999999999999999999999999 8899998874 456999999999999999999999999
Q ss_pred ceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCC-ChhhHHHHHHHH
Q 013092 96 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQ-SRRDDLESLGYV 174 (449)
Q Consensus 96 ivHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~-s~~~DiwSlG~i 174 (449)
|+|+||||+||++ +.++.+||+|||++..+...... .......||+.|+|||++.+..+ +.++|||||||+
T Consensus 126 i~H~dl~p~Nil~---~~~~~~kl~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~i 197 (276)
T 2yex_A 126 ITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRE-----RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIV 197 (276)
T ss_dssp EECSCCSGGGEEE---CTTCCEEECCCTTCEECEETTEE-----CCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHH
T ss_pred eeccCCChHHEEE---ccCCCEEEeeCCCccccCCCcch-----hcccCCccccCccChHHHhcCCCCCCcchHHHHHHH
Confidence 9999999999999 57889999999999876543211 11235679999999999988775 789999999999
Q ss_pred HHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 175 LMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 175 l~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
+|+|++|..||....... ..+..+....... .....+++++.++|..||+.+|++||++.+|++
T Consensus 198 l~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 198 LTAMLAGELPWDQPSDSC--QEYSDWKEKKTYL---NPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp HHHHHHSSCCCSCSCTTS--HHHHHHHTTCTTS---TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHHhCCCCCCCCchHH--HHHHHhhhccccc---CchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 999999999998754432 2233333222111 123468899999999999999999999887753
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-36 Score=297.22 Aligned_cols=211 Identities=22% Similarity=0.272 Sum_probs=171.7
Q ss_pred hHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q 013092 19 PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFL 97 (449)
Q Consensus 19 ~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~giv 97 (449)
..+.+|+++++.+ +||||+++++++.... .||||||+ +++|.+++.. ...+++..++.++.||+.||+|||++||+
T Consensus 60 ~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~-~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~iv 136 (322)
T 2ycf_A 60 LNVETEIEILKKL-NHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHENGII 136 (322)
T ss_dssp -CHHHHHHHHHHC-CCTTBCCEEEEEESSS-EEEEEECCTTEETHHHHST-TCCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred hhHHHHHHHHHhC-CCCCCceEeeEEcCCc-eEEEEecCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 4588999999999 9999999999987665 89999999 8899998874 56799999999999999999999999999
Q ss_pred ecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhh---CCCCChhhHHHHHHHH
Q 013092 98 HRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHL---GIEQSRRDDLESLGYV 174 (449)
Q Consensus 98 HRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~---~~~~s~~~DiwSlG~i 174 (449)
||||||+|||+..+.....+||+|||+++....... .....||+.|+|||++. ...++.++|||||||+
T Consensus 137 H~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~i 208 (322)
T 2ycf_A 137 HRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL--------MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVI 208 (322)
T ss_dssp CCCCSGGGEEESSSSSSCCEEECCCTTCEECCCCHH--------HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHH
T ss_pred ccCCCHHHEEEecCCCCCeEEEccCccceecccccc--------cccccCCcCccCchhhccCCCCCCCchhhHHHHHHH
Confidence 999999999996433445699999999987654211 12346899999999975 4668999999999999
Q ss_pred HHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 175 LMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 175 l~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
+|+|++|..||........ ....+..... ...+..+..+++++.+||..||..||++||++.++++
T Consensus 209 l~~l~~g~~pf~~~~~~~~--~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 209 LFICLSGYPPFSEHRTQVS--LKDQITSGKY-NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp HHHHHHSSCSSCSTTCSSC--HHHHHHHTCC-CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHHhCCCCCcccchHHH--HHHHHHhCcc-ccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 9999999999987544321 2222333322 2234456778999999999999999999999888753
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=298.88 Aligned_cols=209 Identities=21% Similarity=0.256 Sum_probs=168.8
Q ss_pred HHHHHHHHHHhcCCCCCceEEEEeEe--------------------------------------CCEEEEEEecCCCCHH
Q 013092 21 LLYESKLYRILQGGTGIPNVRWFGVE--------------------------------------GDYNVLVMDLLGPSLE 62 (449)
Q Consensus 21 ~~~E~~il~~l~~hp~Iv~l~~~~~~--------------------------------------~~~~~lVmE~~g~sL~ 62 (449)
..+|+++|+.+ +||||+++++++.. ..+.+|||||+.++|.
T Consensus 47 ~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~ 125 (383)
T 3eb0_A 47 KNRELDIMKVL-DHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLH 125 (383)
T ss_dssp CCHHHHHHTTC-CCTTBCCEEEEEEEC-------------------------------------CCEEEEEECCCSEEHH
T ss_pred HHHHHHHHHHc-CCCCccchhheeeecCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCCccHH
Confidence 45899999999 99999999998843 4458999999977988
Q ss_pred HHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCccccc
Q 013092 63 DLFNF---CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPY 139 (449)
Q Consensus 63 ~ll~~---~~~~ls~~~~~~i~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~ 139 (449)
+++.. ....+++..++.++.||+.||+|||++||+||||||+|||+. ..++.+||+|||+++.+.....
T Consensus 126 ~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~gi~H~Dikp~Nil~~--~~~~~~kl~Dfg~a~~~~~~~~------ 197 (383)
T 3eb0_A 126 KVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVN--SKDNTLKLCDFGSAKKLIPSEP------ 197 (383)
T ss_dssp HHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEEE--TTTTEEEECCCTTCEECCTTSC------
T ss_pred HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCcCccCccCHHHEEEc--CCCCcEEEEECCCCcccCCCCC------
Confidence 88763 256799999999999999999999999999999999999994 3578999999999987654332
Q ss_pred ccCCCCccCccccchhhhhCC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhccc------------
Q 013092 140 RENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS------------ 206 (449)
Q Consensus 140 ~~~~~~~gT~~Y~aPE~~~~~-~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~------------ 206 (449)
.....||+.|+|||++.+. .++.++|||||||++|+|++|..||.+... .+.+..+......
T Consensus 198 --~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---~~~~~~i~~~~g~p~~~~~~~~~~~ 272 (383)
T 3eb0_A 198 --SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETS---IDQLVRIIQIMGTPTKEQMIRMNPH 272 (383)
T ss_dssp --CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHHHCCCCHHHHHHHCTT
T ss_pred --CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHhCCCCHHHHHHhCcc
Confidence 2345789999999999875 489999999999999999999999987543 2333333221111
Q ss_pred ------------chHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 207 ------------TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 207 ------------~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
.....+...+|+++.+||..||..+|++||++.++++
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (383)
T 3eb0_A 273 YTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMA 321 (383)
T ss_dssp C--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred cccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1112234568999999999999999999999888753
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-36 Score=297.29 Aligned_cols=217 Identities=17% Similarity=0.192 Sum_probs=171.1
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeC-----CEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEG-----DYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 92 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~-----~~~~lVmE~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH 92 (449)
...+.+|+++++.+ +||||+++++++... ...||||||++++|.+++.. ..+++..++.++.||+.||+|||
T Consensus 53 ~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH 129 (353)
T 2b9h_A 53 ALRTLREIKILKHF-KHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVIST--QMLSDDHIQYFIYQTLRAVKVLH 129 (353)
T ss_dssp HHHHHHHHHHHHHC-CCTTBCCEEEECCCSCSTTCCCEEEEECCCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhC-cCCCcCCeeeeecccccCccceEEEEEeccCccHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHH
Confidence 34578999999999 899999999987754 67899999998899999984 57999999999999999999999
Q ss_pred HCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccc---cccCCCCccCccccchhhhhC-CCCChhhHH
Q 013092 93 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIP---YRENKNLTGTARYASMNTHLG-IEQSRRDDL 168 (449)
Q Consensus 93 ~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~---~~~~~~~~gT~~Y~aPE~~~~-~~~s~~~Di 168 (449)
++||+||||||+|||+ +.++.+||+|||+++.+.........+ ........||+.|+|||++.+ ..++.++||
T Consensus 130 ~~~ivH~Dlkp~Nil~---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di 206 (353)
T 2b9h_A 130 GSNVIHRDLKPSNLLI---NSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDV 206 (353)
T ss_dssp HTTEECSCCCGGGEEE---CTTCCEEECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHH
T ss_pred HCCeecCCCCHHHeEE---cCCCcEEEEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhH
Confidence 9999999999999999 578899999999998775432211100 011234578999999999875 678999999
Q ss_pred HHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhh---------------------------cccchHHHhhcCCcHHHH
Q 013092 169 ESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK---------------------------KVSTSIEALCRGYPTEFA 221 (449)
Q Consensus 169 wSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~---------------------------~~~~~~~~l~~~~p~el~ 221 (449)
|||||++|+|++|..||.+.... ..+..+... ........+...+++++.
T Consensus 207 ~slG~il~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (353)
T 2b9h_A 207 WSCGCILAELFLRRPIFPGRDYR---HQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGI 283 (353)
T ss_dssp HHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHH
T ss_pred HHHHHHHHHHHhCCCCCCCCCcH---HHHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHH
Confidence 99999999999999999875432 222211110 011223445567899999
Q ss_pred HHHHHHhcCCCCCCCCHHHHHH
Q 013092 222 SYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 222 ~li~~cl~~~p~~RPt~~~l~~ 243 (449)
+||..||+.||++||++.++++
T Consensus 284 ~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 284 DLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp HHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHhcCcCcccCCCHHHHhc
Confidence 9999999999999999887754
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-37 Score=310.95 Aligned_cols=214 Identities=14% Similarity=0.083 Sum_probs=165.4
Q ss_pred cEEEEEeeeccc-CCChhHHHHHHHHHHHhc--CCCCCceEE-------EEeEeCC-----------------EEEEEEe
Q 013092 3 EILTVFSVQENV-KTKHPQLLYESKLYRILQ--GGTGIPNVR-------WFGVEGD-----------------YNVLVMD 55 (449)
Q Consensus 3 ~aikV~~k~~~~-~~~~~~~~~E~~il~~l~--~hp~Iv~l~-------~~~~~~~-----------------~~~lVmE 55 (449)
+|||++.+.... ....+.+.+|+++++.++ .||||++++ +++.+.+ ..|||||
T Consensus 101 vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E 180 (377)
T 3byv_A 101 FEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYP 180 (377)
T ss_dssp EEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTTSCSEEEC------CEEESEEEEEE
T ss_pred EEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccCCccccccccCCCceEEEEEEEEEe
Confidence 455665544322 234567889997777765 799999987 5555443 2799999
Q ss_pred cCCCCHHHHHHHcCCCCC-------HHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceee
Q 013092 56 LLGPSLEDLFNFCSRKLS-------LKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 128 (449)
Q Consensus 56 ~~g~sL~~ll~~~~~~ls-------~~~~~~i~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~ 128 (449)
|++++|.+++... ..++ +..++.|+.||+.||+|||++||+||||||+|||| +.++.+||+|||+++..
T Consensus 181 ~~~g~L~~~l~~~-~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIll---~~~~~~kL~DFG~a~~~ 256 (377)
T 3byv_A 181 RMQSNLQTFGEVL-LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVL---DQRGGVFLTGFEHLVRD 256 (377)
T ss_dssp CCSEEHHHHHHHH-HHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCGGGCEET
T ss_pred ccCCCHHHHHHhc-cccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEEechhheec
Confidence 9988999999853 2233 47888899999999999999999999999999999 57789999999999864
Q ss_pred cCCCCCcccccccCCCCccCccccchhhhhCC-----------CCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHH
Q 013092 129 RDTSTHQHIPYRENKNLTGTARYASMNTHLGI-----------EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKY 197 (449)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~-----------~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~ 197 (449)
... .....| +.|+|||++.+. .++.++|||||||++|||++|..||.+...... +
T Consensus 257 ~~~----------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~---~ 322 (377)
T 3byv_A 257 GAR----------VVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGG---S 322 (377)
T ss_dssp TCE----------EECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC------CC---S
T ss_pred CCc----------ccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCCCCCcccccccc---h
Confidence 321 134567 999999999987 899999999999999999999999976432111 0
Q ss_pred HHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 198 EKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 198 ~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
..+...+..+|+++.+||..||+.||++||++.++++
T Consensus 323 ---------~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 323 ---------EWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp ---------GGGGSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred ---------hhhhhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 1111123578999999999999999999999988864
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-36 Score=305.12 Aligned_cols=232 Identities=16% Similarity=0.140 Sum_probs=167.2
Q ss_pred EEeeecccCCChhHHHHHHHHHHHhcCCCCCceEEEEeEe--CCEEEEEEecCCCCHHHHHHHc--------CCCCCHHH
Q 013092 7 VFSVQENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVE--GDYNVLVMDLLGPSLEDLFNFC--------SRKLSLKT 76 (449)
Q Consensus 7 V~~k~~~~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~--~~~~~lVmE~~g~sL~~ll~~~--------~~~ls~~~ 76 (449)
|++|..........+.+|+.+|+.| .||||+++++++.. ....||||||++++|.+++... ...+++..
T Consensus 51 vaiK~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~ 129 (405)
T 3rgf_A 51 YALKQIEGTGISMSACREIALLREL-KHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGM 129 (405)
T ss_dssp EEEEECSSSSCCHHHHHHHHHHHHC-CCTTBCCCCEEEEETTTTEEEEEEECCSEEHHHHHHHHHHHC-------CCHHH
T ss_pred EEEEEECCCCCCHHHHHHHHHHHhc-CCCCeeeEeeEEecCCCCeEEEEEeCCCCCHHHHHHHhccccccccccCCCHHH
Confidence 3444444444556899999999999 89999999999854 7789999999988999988632 12499999
Q ss_pred HHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeec-CCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchh
Q 013092 77 VLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG-RRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMN 155 (449)
Q Consensus 77 ~~~i~~qi~~aL~yLH~~givHRDLKP~NiLl~~~-~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE 155 (449)
++.|+.||+.||+|||++||+||||||+||||... +..+.+||+|||+++.+...... ........||+.|+|||
T Consensus 130 ~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~----~~~~~~~~gt~~y~aPE 205 (405)
T 3rgf_A 130 VKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKP----LADLDPVVVTFWYRAPE 205 (405)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC--------------------CCCTTCCHH
T ss_pred HHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEECCCceecCCCCcc----cccCCCceecCcccCch
Confidence 99999999999999999999999999999999532 45689999999999876543211 12234568999999999
Q ss_pred hhhCC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCcCC------HHHHHHHHHhhcccch--------------------
Q 013092 156 THLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT------KKQKYEKISEKKVSTS-------------------- 208 (449)
Q Consensus 156 ~~~~~-~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~------~~~~~~~i~~~~~~~~-------------------- 208 (449)
++.+. .++.++||||||||+|+|++|..||.+..... ....+..+......+.
T Consensus 206 ~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~ 285 (405)
T 3rgf_A 206 LLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDF 285 (405)
T ss_dssp HHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHC
T ss_pred hhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhc
Confidence 99884 48999999999999999999999997643310 1122222221110000
Q ss_pred -------------HHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 209 -------------IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 209 -------------~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
........++++.+||..||..||.+||++.++++
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~ 333 (405)
T 3rgf_A 286 RRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 333 (405)
T ss_dssp CGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00011123678999999999999999999877754
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=288.15 Aligned_cols=223 Identities=15% Similarity=0.240 Sum_probs=176.3
Q ss_pred EEEEEeeeccc--CCChhHHHHHHHHHHHhcCCCCCceEEEEeE--eCCEEEEEEecCCCCHHHHHHHc-CCCCCHHHHH
Q 013092 4 ILTVFSVQENV--KTKHPQLLYESKLYRILQGGTGIPNVRWFGV--EGDYNVLVMDLLGPSLEDLFNFC-SRKLSLKTVL 78 (449)
Q Consensus 4 aikV~~k~~~~--~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~--~~~~~~lVmE~~g~sL~~ll~~~-~~~ls~~~~~ 78 (449)
|+|++.+.... ......+.+|+.+++.+ +|+||+++++++. +....||||||+.+.|.+++... ...+++..++
T Consensus 34 avK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~ 112 (305)
T 2wtk_C 34 AVKILKKKKLRRIPNGEANVKKEIQLLRRL-RHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAH 112 (305)
T ss_dssp EEEEECHHHHHHSTTHHHHHHHHHHHHTTC-CCTTBCCEEEEEECC---CEEEEEECCSEEHHHHHHHSTTCSCCHHHHH
T ss_pred EEEEeccccccccchhHHHHHHHHHHHHhc-CCCCeeEEEEEEEcCCCCeEEEEehhccCCHHHHHHhCcccccCHHHHH
Confidence 45554443221 23456799999999999 8999999999884 55688999999966688888754 4569999999
Q ss_pred HHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhh
Q 013092 79 MLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHL 158 (449)
Q Consensus 79 ~i~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~ 158 (449)
.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++......... .......||+.|+|||++.
T Consensus 113 ~~~~qi~~al~~LH~~~i~H~dlkp~NIl~---~~~~~~kl~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~ 184 (305)
T 2wtk_C 113 GYFCQLIDGLEYLHSQGIVHKDIKPGNLLL---TTGGTLKISALGVAEALHPFAAD-----DTCRTSQGSPAFQPPEIAN 184 (305)
T ss_dssp HHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTTCEECCTTCSS-----CEECCCCSCGGGCCHHHHT
T ss_pred HHHHHHHHHHHHHHHCCeeecCCCcccEEE---cCCCcEEeeccccccccCccccc-----cccccCCCCCCCcChhhcc
Confidence 999999999999999999999999999999 57889999999999876543221 1123457999999999998
Q ss_pred CCCC--ChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCC
Q 013092 159 GIEQ--SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKP 236 (449)
Q Consensus 159 ~~~~--s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RP 236 (449)
+... +.++|||||||++|+|++|..||.+. ...+.+..+..... .+...+++++.++|..||+.||++||
T Consensus 185 ~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~---~~~~~~~~i~~~~~-----~~~~~~~~~l~~li~~~l~~dp~~Rp 256 (305)
T 2wtk_C 185 GLDTFSGFKVDIWSAGVTLYNITTGLYPFEGD---NIYKLFENIGKGSY-----AIPGDCGPPLSDLLKGMLEYEPAKRF 256 (305)
T ss_dssp CCSCEESHHHHHHHHHHHHHHHHHSSCSCCCS---SHHHHHHHHHHCCC-----CCCSSSCHHHHHHHHHHTCSSTTTSC
T ss_pred CcccCCcchhhHHHHHHHHHHHHhCCCCCCCc---hHHHHHHHHhcCCC-----CCCCccCHHHHHHHHHHccCChhhCC
Confidence 7554 78999999999999999999999863 33444444444332 23456899999999999999999999
Q ss_pred CHHHHHH
Q 013092 237 DYAYLKR 243 (449)
Q Consensus 237 t~~~l~~ 243 (449)
++.+|++
T Consensus 257 s~~~ll~ 263 (305)
T 2wtk_C 257 SIRQIRQ 263 (305)
T ss_dssp CHHHHHH
T ss_pred CHHHHhc
Confidence 9887754
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=284.91 Aligned_cols=207 Identities=19% Similarity=0.228 Sum_probs=167.7
Q ss_pred CChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC
Q 013092 16 TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 94 (449)
Q Consensus 16 ~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~ 94 (449)
.....+.+|+.+++.+ .||||+++++++.+.+..||||||+ +++|.+++.. ...+++..++.++.||+.||+|||++
T Consensus 53 ~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~ 130 (276)
T 2h6d_A 53 DVVGKIKREIQNLKLF-RHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICK-HGRVEEMEARRLFQQILSAVDYCHRH 130 (276)
T ss_dssp TCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHhcC-CCCCEeEEEEEEecCCeEEEEEeccCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 3456789999999999 8999999999999999999999999 8999999975 35699999999999999999999999
Q ss_pred CceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCC-ChhhHHHHHHH
Q 013092 95 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQ-SRRDDLESLGY 173 (449)
Q Consensus 95 givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~-s~~~DiwSlG~ 173 (449)
||+|+||||+||++ +.++.+||+|||++........ .....||+.|+|||++.+..+ +.++||||||+
T Consensus 131 ~i~H~dl~p~Nil~---~~~~~~~l~dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ 199 (276)
T 2h6d_A 131 MVVHRDLKPENVLL---DAHMNAKIADFGLSNMMSDGEF--------LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGV 199 (276)
T ss_dssp CSSCCCCCGGGEEE---CTTSCEEECCCCGGGCCCC---------------------CCTGGGTTSCCCHHHHHHHHHHH
T ss_pred CCccCCCChhhEEE---CCCCCEEEeecccccccCCCcc--------eecccCCccccCHHHHcCCCCCCccchHHHHHH
Confidence 99999999999999 5788999999999987654321 124578999999999998765 68999999999
Q ss_pred HHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 174 VLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 174 il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
++|+|++|..||... .....+..+..... .++..++.++.++|..||+.+|++||++.+|++
T Consensus 200 ~l~~l~~g~~p~~~~---~~~~~~~~~~~~~~-----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 261 (276)
T 2h6d_A 200 ILYALLCGTLPFDDE---HVPTLFKKIRGGVF-----YIPEYLNRSVATLLMHMLQVDPLKRATIKDIRE 261 (276)
T ss_dssp HHHHHHHSSCSSCCS---SHHHHHHHHHHCCC-----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHhCCCCCCCC---cHHHHHHHhhcCcc-----cCchhcCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 999999999999763 33344444443322 123567899999999999999999999887754
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-35 Score=289.07 Aligned_cols=215 Identities=20% Similarity=0.238 Sum_probs=171.0
Q ss_pred ChhHHHHHHHHHHHhcCCCCCceEEEEe--------------EeCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHH
Q 013092 17 KHPQLLYESKLYRILQGGTGIPNVRWFG--------------VEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLAD 82 (449)
Q Consensus 17 ~~~~~~~E~~il~~l~~hp~Iv~l~~~~--------------~~~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~~~~i~~ 82 (449)
....+.+|+++++.+ +||||+++++++ .+....||||||++++|.+++. .+.+++..++.++.
T Consensus 51 ~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~--~~~~~~~~~~~~~~ 127 (320)
T 2i6l_A 51 SVKHALREIKIIRRL-DHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLE--QGPLLEEHARLFMY 127 (320)
T ss_dssp HHHHHHHHHHHHHTC-CCTTBCCEEEEECTTSCBCCC----CCSCSEEEEEEECCSEEHHHHHT--TCCCCHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhc-CCCCeeEEEEeccccccccccccccccccCceeEEeeccCCCHHHHhh--cCCccHHHHHHHHH
Confidence 345688999999999 899999999876 3457889999999779999997 46799999999999
Q ss_pred HHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhC-CC
Q 013092 83 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG-IE 161 (449)
Q Consensus 83 qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~-~~ 161 (449)
||+.||+|||++||+||||||+|||+. ..++.+||+|||+++......... .......+|..|+|||++.+ ..
T Consensus 128 qi~~~l~~lH~~~i~H~dlkp~Nil~~--~~~~~~kl~Dfg~~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~ 201 (320)
T 2i6l_A 128 QLLRGLKYIHSANVLHRDLKPANLFIN--TEDLVLKIGDFGLARIMDPHYSHK----GHLSEGLVTKWYRSPRLLLSPNN 201 (320)
T ss_dssp HHHHHHHHHHHTTCBCCCCSGGGEEEE--TTTTEEEECCCTTCBCC------------CCCGGGSCCTTCCHHHHHCTTC
T ss_pred HHHHHHHHHHhCCEecCCCCHHHEEEc--CCCCeEEEccCccccccCCCcccc----cccccccccccccCcHHhcCccc
Confidence 999999999999999999999999995 356799999999998765322111 11234567999999999876 67
Q ss_pred CChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhc-------------------------ccchHHHhhcCC
Q 013092 162 QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK-------------------------VSTSIEALCRGY 216 (449)
Q Consensus 162 ~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~-------------------------~~~~~~~l~~~~ 216 (449)
++.++|||||||++|+|++|..||.+... .+.+..+.... .......+...+
T Consensus 202 ~~~~~Di~slG~il~el~~g~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (320)
T 2i6l_A 202 YTKAIDMWAAGCIFAEMLTGKTLFAGAHE---LEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGI 278 (320)
T ss_dssp CCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTC
T ss_pred CCchhhhHhHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchh
Confidence 89999999999999999999999987543 23333332211 112233455678
Q ss_pred cHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 217 PTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 217 p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
+.++.+||..||+.||++||++.++++
T Consensus 279 ~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 279 SREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp CHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred hHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 999999999999999999999887754
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=300.14 Aligned_cols=206 Identities=19% Similarity=0.260 Sum_probs=166.7
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEE------EEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHH
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYN------VLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 91 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~------~lVmE~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yL 91 (449)
...+.+|+.+++.+ .||||+++++++...+.. ||||||++++|.+++. ..+++..++.++.||+.||+||
T Consensus 85 ~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~i~~qi~~aL~~L 160 (371)
T 4exu_A 85 AKRAYRELLLLKHM-QHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMG---MEFSEEKIQYLVYQMLKGLKYI 160 (371)
T ss_dssp HHHHHHHHHHHHHC-CCTTBCCCSEEECSCSSSTTCCCCEEEEECCCEEHHHHTT---SCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhc-CCCCchhhhhheeccCCcccceeEEEEEccccccHHHHhh---cCCCHHHHHHHHHHHHHHHHHH
Confidence 45688999999999 899999999999876654 9999999888888774 4599999999999999999999
Q ss_pred HHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhC-CCCChhhHHHH
Q 013092 92 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLES 170 (449)
Q Consensus 92 H~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~-~~~s~~~DiwS 170 (449)
|++||+||||||+|||+ +.++.+||+|||+++...... ....||+.|+|||++.+ ..++.++||||
T Consensus 161 H~~~ivH~Dikp~NIll---~~~~~~kL~Dfg~a~~~~~~~----------~~~~~t~~y~aPE~~~~~~~~~~~~Diws 227 (371)
T 4exu_A 161 HSAGVVHRDLKPGNLAV---NEDCELKILDFGLARHADAEM----------TGYVVTRWYRAPEVILSWMHYNQTVDIWS 227 (371)
T ss_dssp HHTTCCCSCCCGGGEEE---CTTCCEEECSTTCC------------------CTTCCCTTSCHHHHSCCSCCCTTHHHHH
T ss_pred HHCCCcCCCcCHHHeEE---CCCCCEEEEecCcccccccCc----------CCcccCccccCHHHhcCCCCCCcHHhHHH
Confidence 99999999999999999 678899999999998654322 34578999999999987 67899999999
Q ss_pred HHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhc--------------------------ccchHHHhhcCCcHHHHHHH
Q 013092 171 LGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK--------------------------VSTSIEALCRGYPTEFASYF 224 (449)
Q Consensus 171 lG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~--------------------------~~~~~~~l~~~~p~el~~li 224 (449)
|||++|+|++|..||.+... .+.+..+.... .......+...+++++.+||
T Consensus 228 lG~il~el~~g~~pf~~~~~---~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 304 (371)
T 4exu_A 228 VGCIMAEMLTGKTLFKGKDY---LDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLL 304 (371)
T ss_dssp HHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHH
T ss_pred HHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHH
Confidence 99999999999999987443 22333322211 11122334457799999999
Q ss_pred HHHhcCCCCCCCCHHHHHH
Q 013092 225 HYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 225 ~~cl~~~p~~RPt~~~l~~ 243 (449)
..||+.||++||++.++++
T Consensus 305 ~~~L~~dP~~Rpt~~ell~ 323 (371)
T 4exu_A 305 EKMLELDVDKRLTAAQALT 323 (371)
T ss_dssp HHHSCSCTTTSCCHHHHHT
T ss_pred HHHCCCChhhcCCHHHHhc
Confidence 9999999999999887753
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-36 Score=291.10 Aligned_cols=206 Identities=20% Similarity=0.306 Sum_probs=155.9
Q ss_pred HHHHHHH-HHHhcCCCCCceEEEEeEeCCEEEEEEecCCCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHHC-C
Q 013092 21 LLYESKL-YRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHSK-S 95 (449)
Q Consensus 21 ~~~E~~i-l~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~g~sL~~ll~~---~~~~ls~~~~~~i~~qi~~aL~yLH~~-g 95 (449)
+..|..+ ++.+ +||||+++++++.+.+..||||||++++|.+++.. ....+++..++.++.||+.||+|||++ |
T Consensus 52 ~~~~~~~~~~~~-~h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~ 130 (290)
T 3fme_A 52 LLMDLDISMRTV-DCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS 130 (290)
T ss_dssp HHHHHHHHHTTC-CCTTBCCEEEEEECSSSEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC
T ss_pred HHHHHHHHHHhC-CCCeEEEEeeeeeccCCEEEEEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Confidence 4444444 4445 99999999999999999999999997799888764 256799999999999999999999998 9
Q ss_pred ceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhh----hCCCCChhhHHHHH
Q 013092 96 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTH----LGIEQSRRDDLESL 171 (449)
Q Consensus 96 ivHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~----~~~~~s~~~DiwSl 171 (449)
|+||||||+|||+ +..+.+||+|||+++....... .....||+.|+|||++ .+..++.++|||||
T Consensus 131 i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~sl 199 (290)
T 3fme_A 131 VIHRDVKPSNVLI---NALGQVKMCDFGISGYLVDDVA--------KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSL 199 (290)
T ss_dssp CCCCCCSGGGCEE---CTTCCEEBCCC-----------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHH
T ss_pred eecCCCCHHHEEE---CCCCCEEEeecCCccccccccc--------ccccCCCccccChhhcChhhcCcCCCcHHHHHHH
Confidence 9999999999999 5788999999999987654322 1234799999999996 55678999999999
Q ss_pred HHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 172 GYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 172 G~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
||++|+|++|..||..... ....+.......... .....+++++.++|..||+.+|++||++.++++
T Consensus 200 G~il~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 200 GITMIELAILRFPYDSWGT--PFQQLKQVVEEPSPQ---LPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp HHHHHHHHHTSCSSCCCSC--HHHHHHHHHHSCCCC---CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHHHHHCCCCccccCc--hHHHHHHHhccCCCC---cccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 9999999999999975322 223333332222211 112468999999999999999999999988764
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-35 Score=289.41 Aligned_cols=213 Identities=18% Similarity=0.288 Sum_probs=168.0
Q ss_pred CCChhHHHHHHHHHHHhcCCCCCceEEEEeEe------CCEEEEEEecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHH
Q 013092 15 KTKHPQLLYESKLYRILQGGTGIPNVRWFGVE------GDYNVLVMDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMIN 86 (449)
Q Consensus 15 ~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~------~~~~~lVmE~~-g~sL~~ll~~~-~~~ls~~~~~~i~~qi~~ 86 (449)
......+.+|+.+++.+.+||||+++++++.. .+..||||||+ +++|.+++... ...+++..++.++.||+.
T Consensus 61 ~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~ 140 (326)
T 2x7f_A 61 GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILR 140 (326)
T ss_dssp SSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHH
T ss_pred cccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHH
Confidence 34567899999999999899999999999986 56899999999 88999999864 356999999999999999
Q ss_pred HHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhh-----CCC
Q 013092 87 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHL-----GIE 161 (449)
Q Consensus 87 aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~-----~~~ 161 (449)
||.|||++||+|+||||+|||+ +.++.+||+|||++........ ......||+.|+|||++. +..
T Consensus 141 ~l~~lH~~~ivH~dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~ 210 (326)
T 2x7f_A 141 GLSHLHQHKVIHRDIKGQNVLL---TENAEVKLVDFGVSAQLDRTVG-------RRNTFIGTPYWMAPEVIACDENPDAT 210 (326)
T ss_dssp HHHHHHHTTCCCCCCSGGGEEE---CTTCCEEECCCTTTC--------------------CCGGGCCHHHHC--------
T ss_pred HHHHHHHCCccccCCcHHHEEE---cCCCCEEEeeCcCceecCcCcc-------ccccccCCccccChhhhccccccCcC
Confidence 9999999999999999999999 5788999999999987643221 123457999999999997 566
Q ss_pred CChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHH
Q 013092 162 QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYL 241 (449)
Q Consensus 162 ~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l 241 (449)
++.++|||||||++|+|++|..||.+... ...+..+....... .....++.++.+||..||..+|++||++.+|
T Consensus 211 ~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l 284 (326)
T 2x7f_A 211 YDFKSDLWSLGITAIEMAEGAPPLCDMHP---MRALFLIPRNPAPR---LKSKKWSKKFQSFIESCLVKNHSQRPATEQL 284 (326)
T ss_dssp CCTTHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHHHHSCCCC---CSCSCSCHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred CCccchHHHHHHHHHHHHhCCCCCCCCcH---HHHHHHhhcCcccc---CCccccCHHHHHHHHHHhccChhhCCCHHHH
Confidence 89999999999999999999999976432 22333333222111 1235689999999999999999999998877
Q ss_pred HH
Q 013092 242 KR 243 (449)
Q Consensus 242 ~~ 243 (449)
++
T Consensus 285 l~ 286 (326)
T 2x7f_A 285 MK 286 (326)
T ss_dssp HT
T ss_pred hh
Confidence 54
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-36 Score=297.81 Aligned_cols=215 Identities=15% Similarity=0.176 Sum_probs=147.6
Q ss_pred hHHHHHHHHHHHhcCCCCCceEEEEeEe----CCEEEEEEecC-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHH
Q 013092 19 PQLLYESKLYRILQGGTGIPNVRWFGVE----GDYNVLVMDLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVH 92 (449)
Q Consensus 19 ~~~~~E~~il~~l~~hp~Iv~l~~~~~~----~~~~~lVmE~~-g~sL~~ll~~~~-~~ls~~~~~~i~~qi~~aL~yLH 92 (449)
.....|+..+..+.+||||+++++++.. +...||||||| |++|.+++.... ..+++..++.++.||+.||+|||
T Consensus 66 ~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH 145 (336)
T 3fhr_A 66 PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH 145 (336)
T ss_dssp HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 4456666666565699999999999876 55689999999 889999998542 46999999999999999999999
Q ss_pred HCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHH
Q 013092 93 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLG 172 (449)
Q Consensus 93 ~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG 172 (449)
++||+||||||+|||+..++..+.+||+|||+++....... ....||+.|+|||++.+..++.++||||||
T Consensus 146 ~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~~~---------~~~~~t~~y~aPE~~~~~~~~~~~Di~slG 216 (336)
T 3fhr_A 146 SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNAL---------QTPCYTPYYVAPEVLGPEKYDKSCDMWSLG 216 (336)
T ss_dssp HTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC-------------------------------CHHHHHHHHHHHH
T ss_pred hCCeecCCCCHHHEEEEecCCCceEEEeccccceecccccc---------ccCCCCcCccChhhhCCCCCCchhhHHHHH
Confidence 99999999999999996544567799999999987654321 345789999999999888899999999999
Q ss_pred HHHHHHHhCCCCCCCCCcCCHHHH-HHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 173 YVLMYFLRGSLPWQGLKAGTKKQK-YEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 173 ~il~elltG~~Pf~~~~~~~~~~~-~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
|++|+|++|..||........... ...+....... .......+++++.+||..||+.+|++||++.++++
T Consensus 217 ~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 217 VIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGF-PNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp HHHHHHHHSSCCC---------------------CC-CTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHCCCCCCCccchhhhhhHHHhhhcccccc-CchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 999999999999977543221111 11111111111 11123468999999999999999999999887754
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-37 Score=308.89 Aligned_cols=226 Identities=15% Similarity=0.091 Sum_probs=160.6
Q ss_pred cEEEEEeeecc-cCCChhHHHHHHHHHHHhc-CCCCCceEE-------EEeEeC-----------------CEEEEEEec
Q 013092 3 EILTVFSVQEN-VKTKHPQLLYESKLYRILQ-GGTGIPNVR-------WFGVEG-----------------DYNVLVMDL 56 (449)
Q Consensus 3 ~aikV~~k~~~-~~~~~~~~~~E~~il~~l~-~hp~Iv~l~-------~~~~~~-----------------~~~~lVmE~ 56 (449)
.|||++.+... .......+.+|+.+++.|+ .||||++++ +++... ...||||||
T Consensus 90 vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~ 169 (371)
T 3q60_A 90 FALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPA 169 (371)
T ss_dssp EEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEETTSCSSSBCSCC---CCEEEEEEEECC
T ss_pred eEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecCCCCCeeeccCCcccceeeeEEEEecC
Confidence 34555554332 1233456788988888886 599988754 333322 348999999
Q ss_pred CCCCHHHHHHHcCCCCCHHHH------HHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecC
Q 013092 57 LGPSLEDLFNFCSRKLSLKTV------LMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 130 (449)
Q Consensus 57 ~g~sL~~ll~~~~~~ls~~~~------~~i~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~ 130 (449)
|+++|.+++...+..++.... +.++.||+.||+|||++||+||||||+|||| +.++.+||+|||+++....
T Consensus 170 ~~~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDikp~NIll---~~~~~~kL~DFG~a~~~~~ 246 (371)
T 3q60_A 170 ASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFI---MPDGRLMLGDVSALWKVGT 246 (371)
T ss_dssp CSEEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEE---CTTSCEEECCGGGEEETTC
T ss_pred CCCCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCCHHHEEE---CCCCCEEEEecceeeecCC
Confidence 988999999865444555555 6788999999999999999999999999999 5788999999999987643
Q ss_pred CCCCcccccccCCCCccCccccchhhhhC--CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHH--hhccc
Q 013092 131 TSTHQHIPYRENKNLTGTARYASMNTHLG--IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKIS--EKKVS 206 (449)
Q Consensus 131 ~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~--~~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~--~~~~~ 206 (449)
.. ....+|+.|+|||++.+ ..++.++|||||||++|||++|..||.+....... .+..+. .....
T Consensus 247 ~~----------~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~-~~~~~~~~~~~~~ 315 (371)
T 3q60_A 247 RG----------PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKG-SWKRPSLRVPGTD 315 (371)
T ss_dssp EE----------EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCTT-CCCBCCTTSCCCC
T ss_pred Cc----------cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCccccc-chhhhhhhhcccc
Confidence 21 13457799999999987 67999999999999999999999999876432110 000000 00000
Q ss_pred chHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 013092 207 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 242 (449)
Q Consensus 207 ~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~ 242 (449)
......+..+++++.+||..||+.||++||++.+++
T Consensus 316 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l 351 (371)
T 3q60_A 316 SLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAM 351 (371)
T ss_dssp SCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHT
T ss_pred ccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHh
Confidence 111112357899999999999999999999988875
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-35 Score=298.12 Aligned_cols=209 Identities=16% Similarity=0.209 Sum_probs=165.9
Q ss_pred HHHHHHHHHHhcCCCCCceEEEEeEeCC------EEEEEEecCCCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHH
Q 013092 21 LLYESKLYRILQGGTGIPNVRWFGVEGD------YNVLVMDLLGPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFV 91 (449)
Q Consensus 21 ~~~E~~il~~l~~hp~Iv~l~~~~~~~~------~~~lVmE~~g~sL~~ll~~---~~~~ls~~~~~~i~~qi~~aL~yL 91 (449)
..+|+++|+.+ +||||+++++++...+ +.||||||+.++|.+.+.. ....+++..++.++.||+.||+||
T Consensus 79 ~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~L 157 (394)
T 4e7w_A 79 KNRELQIMRIV-KHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYI 157 (394)
T ss_dssp CCHHHHHHHTC-CCTTBCCEEEEEEEESSSSSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHhC-CCCCcceEEEEEEecCCCCCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHH
Confidence 34799999999 8999999999886433 4889999996676665542 256799999999999999999999
Q ss_pred HHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCC-CCChhhHHHH
Q 013092 92 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLES 170 (449)
Q Consensus 92 H~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~-~~s~~~DiwS 170 (449)
|++||+||||||+||||+ ..++.+||+|||+++.+..... .....||+.|+|||++.+. .++.++||||
T Consensus 158 H~~~ivHrDlkp~Nill~--~~~~~~kL~DFG~a~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwS 227 (394)
T 4e7w_A 158 HSIGICHRDIKPQNLLLD--PPSGVLKLIDFGSAKILIAGEP--------NVSYICSRYYRAPELIFGATNYTTNIDIWS 227 (394)
T ss_dssp HHTTEECSCCSGGGEEEE--TTTTEEEECCCTTCEECCTTCC--------CCSSCSCGGGCCHHHHTTCSSCCTHHHHHH
T ss_pred HHCCccCCCCCHHHEEEc--CCCCcEEEeeCCCcccccCCCC--------CcccccCcCccCHHHHcCCCCCCcHHHHHH
Confidence 999999999999999994 3688999999999987754332 2345789999999999875 5899999999
Q ss_pred HHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccc------------------------hHHHhhcCCcHHHHHHHHH
Q 013092 171 LGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST------------------------SIEALCRGYPTEFASYFHY 226 (449)
Q Consensus 171 lG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~------------------------~~~~l~~~~p~el~~li~~ 226 (449)
|||++|||++|..||.+... ...+..+......+ ....+...+++++.+||..
T Consensus 228 lG~il~ell~g~~pf~~~~~---~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 304 (394)
T 4e7w_A 228 TGCVMAELMQGQPLFPGESG---IDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISR 304 (394)
T ss_dssp HHHHHHHHHHSSCSSCCSSH---HHHHHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHH
T ss_pred HHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHH
Confidence 99999999999999987543 22222232211111 1112234588999999999
Q ss_pred HhcCCCCCCCCHHHHHH
Q 013092 227 CRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 227 cl~~~p~~RPt~~~l~~ 243 (449)
||+.||.+||++.++++
T Consensus 305 ~L~~dP~~R~t~~e~l~ 321 (394)
T 4e7w_A 305 LLEYTPSARLTAIEALC 321 (394)
T ss_dssp HCCSSGGGSCCHHHHHT
T ss_pred HhCCChhhCCCHHHHhc
Confidence 99999999999877753
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-35 Score=284.15 Aligned_cols=213 Identities=22% Similarity=0.237 Sum_probs=170.6
Q ss_pred CChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHH
Q 013092 16 TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCS--RKLSLKTVLMLADQMINRVEFVH 92 (449)
Q Consensus 16 ~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~--~~ls~~~~~~i~~qi~~aL~yLH 92 (449)
.....+.+|+.+++.+ +||||+++++++.+.+..+|||||+ +++|.+++.... ..+++..++.++.||+.||+|||
T Consensus 61 ~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH 139 (295)
T 2clq_A 61 RYSQPLHEEIALHKHL-KHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH 139 (295)
T ss_dssp ---HHHHHHHHHHHTC-CCTTBCCEEEEEEETTEEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhC-CCCCEeeEeeEEEeCCcEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHH
Confidence 3456789999999999 9999999999999999999999999 899999998643 24678999999999999999999
Q ss_pred HCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCC--CChhhHHHH
Q 013092 93 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIE--QSRRDDLES 170 (449)
Q Consensus 93 ~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~--~s~~~DiwS 170 (449)
++||+|+||||+|||+. ..++.+||+|||+++....... ......||+.|+|||++.+.. ++.++||||
T Consensus 140 ~~~i~H~dl~p~Nil~~--~~~~~~kl~Dfg~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~s 210 (295)
T 2clq_A 140 DNQIVHRDIKGDNVLIN--TYSGVLKISDFGTSKRLAGINP-------CTETFTGTLQYMAPEIIDKGPRGYGKAADIWS 210 (295)
T ss_dssp HTTEECCCCSGGGEEEE--TTTCCEEECCTTTCEESCC------------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHH
T ss_pred hCCEEccCCChhhEEEE--CCCCCEEEeecccccccCCCCC-------cccccCCCccccChhhhcCCCCCCCcHHHHHH
Confidence 99999999999999995 3378999999999987654221 123457899999999998654 889999999
Q ss_pred HHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 171 LGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 171 lG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
|||++|+|++|..||...... ............ ...++..+++++.++|..||+.+|++||++.++++
T Consensus 211 lG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 211 LGCTIIEMATGKPPFYELGEP--QAAMFKVGMFKV---HPEIPESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp HHHHHHHHHHTSCTTGGGSSH--HHHHHHHHHHCC---CCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred HHHHHHHHHHCCCCccCCCch--hHHHHhhccccc---cccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 999999999999999764321 111111111111 11234578999999999999999999999887753
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=299.92 Aligned_cols=217 Identities=18% Similarity=0.208 Sum_probs=168.3
Q ss_pred ChhHHHHHHHHHHHhcC-------CCCCceEEEEeE----eCCEEEEEEecCCCCHHHHHHHcC-CCCCHHHHHHHHHHH
Q 013092 17 KHPQLLYESKLYRILQG-------GTGIPNVRWFGV----EGDYNVLVMDLLGPSLEDLFNFCS-RKLSLKTVLMLADQM 84 (449)
Q Consensus 17 ~~~~~~~E~~il~~l~~-------hp~Iv~l~~~~~----~~~~~~lVmE~~g~sL~~ll~~~~-~~ls~~~~~~i~~qi 84 (449)
....+.+|+++++.+++ |+||+++++.+. ++...||||||++++|.+++.... ..+++..++.++.||
T Consensus 76 ~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi 155 (397)
T 1wak_A 76 YTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQV 155 (397)
T ss_dssp HHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHH
T ss_pred chHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHH
Confidence 34568899999999963 788999999887 566899999999888888776543 569999999999999
Q ss_pred HHHHHHHHHC-CceecCCCCCcEEEeecC----------------------------------------------CCCeE
Q 013092 85 INRVEFVHSK-SFLHRDIKPDNFLMGLGR----------------------------------------------RANQV 117 (449)
Q Consensus 85 ~~aL~yLH~~-givHRDLKP~NiLl~~~~----------------------------------------------~~~~v 117 (449)
+.||+|||++ ||+||||||+||||..+. ....+
T Consensus 156 ~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (397)
T 1wak_A 156 LQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKV 235 (397)
T ss_dssp HHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCE
T ss_pred HHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccce
Confidence 9999999998 999999999999994211 11379
Q ss_pred EEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCC---HH
Q 013092 118 YIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT---KK 194 (449)
Q Consensus 118 kL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~---~~ 194 (449)
||+|||+++...... ....||+.|+|||++.+..++.++|||||||++|+|++|..||....... ..
T Consensus 236 kl~DfG~a~~~~~~~----------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~ 305 (397)
T 1wak_A 236 KIADLGNACWVHKHF----------TEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDE 305 (397)
T ss_dssp EECCGGGCEETTBCS----------CSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHH
T ss_pred EeccccccccccccC----------ccCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchH
Confidence 999999998765432 34578999999999999999999999999999999999999998755432 12
Q ss_pred HHHHHHHhhcccchHH-------------------------------H------hhcCCcHHHHHHHHHHhcCCCCCCCC
Q 013092 195 QKYEKISEKKVSTSIE-------------------------------A------LCRGYPTEFASYFHYCRSLRFDDKPD 237 (449)
Q Consensus 195 ~~~~~i~~~~~~~~~~-------------------------------~------l~~~~p~el~~li~~cl~~~p~~RPt 237 (449)
..+..+.+.....+.. . +...++.++.+||..||+.||++||+
T Consensus 306 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 385 (397)
T 1wak_A 306 DHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRAT 385 (397)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCC
T ss_pred HHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCC
Confidence 2222222211111000 0 01123567899999999999999999
Q ss_pred HHHHHH
Q 013092 238 YAYLKR 243 (449)
Q Consensus 238 ~~~l~~ 243 (449)
+.++++
T Consensus 386 ~~e~l~ 391 (397)
T 1wak_A 386 AAECLR 391 (397)
T ss_dssp HHHHHT
T ss_pred HHHHhh
Confidence 888754
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-36 Score=295.41 Aligned_cols=228 Identities=15% Similarity=0.203 Sum_probs=165.9
Q ss_pred hhHHHHHHHHHHH-hcCCCCCceEEEEeE-----eCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHH
Q 013092 18 HPQLLYESKLYRI-LQGGTGIPNVRWFGV-----EGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEF 90 (449)
Q Consensus 18 ~~~~~~E~~il~~-l~~hp~Iv~l~~~~~-----~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~y 90 (449)
...+..|.+++.. ...|+||+++++.+. .....||||||| +++|.+++.. ..+++..++.++.||+.||+|
T Consensus 49 ~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~qi~~~L~~ 126 (336)
T 3g2f_A 49 RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL--HTSDWVSSCRLAHSVTRGLAY 126 (336)
T ss_dssp HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHH
T ss_pred hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEEecCCCCcHHHHHhh--cccchhHHHHHHHHHHHHHHH
Confidence 4456666666554 239999999987554 234679999999 9999999984 456899999999999999999
Q ss_pred HHHC---------CceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcc-cccccCCCCccCccccchhhhhC-
Q 013092 91 VHSK---------SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQH-IPYRENKNLTGTARYASMNTHLG- 159 (449)
Q Consensus 91 LH~~---------givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~-~~~~~~~~~~gT~~Y~aPE~~~~- 159 (449)
||+. ||+||||||+|||+ +.++.+||+|||+++.+........ ..........||+.|+|||++.+
T Consensus 127 LH~~~~~~~~~~~~ivH~Dikp~Nill---~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 203 (336)
T 3g2f_A 127 LHTELPRGDHYKPAISHRDLNSRNVLV---KNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGA 203 (336)
T ss_dssp HHCCBCCGGGCBCCEECSSCSGGGEEE---CTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTC
T ss_pred HHhhhccccccccceeecccccceEEE---cCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCC
Confidence 9999 99999999999999 5778999999999987754322110 00112235579999999999987
Q ss_pred ------CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCH---------------HHHHHHHHhhcccchHHHhhc---C
Q 013092 160 ------IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK---------------KQKYEKISEKKVSTSIEALCR---G 215 (449)
Q Consensus 160 ------~~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~---------------~~~~~~i~~~~~~~~~~~l~~---~ 215 (449)
..++.++|||||||++|||++|..||........ ......+........++..+. .
T Consensus 204 ~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (336)
T 3g2f_A 204 VNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSL 283 (336)
T ss_dssp CCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSH
T ss_pred cccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccc
Confidence 3466789999999999999999777644222110 000011111111111111111 1
Q ss_pred CcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 013092 216 YPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFI 250 (449)
Q Consensus 216 ~p~el~~li~~cl~~~p~~RPt~~~l~~~L~~~~~ 250 (449)
+++++.+||..||+.||++||++.++++.|++++.
T Consensus 284 ~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~ 318 (336)
T 3g2f_A 284 AVRSLKETIEDCWDQDAEARLTAQXAEERMAELMM 318 (336)
T ss_dssp HHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHH
Confidence 34589999999999999999999999999999875
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-35 Score=290.38 Aligned_cols=216 Identities=18% Similarity=0.172 Sum_probs=169.4
Q ss_pred hhHHHHHHHHHHHhcC-----CCCCceEEEEeEeCCEEEEEEecCCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHH
Q 013092 18 HPQLLYESKLYRILQG-----GTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFV 91 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~-----hp~Iv~l~~~~~~~~~~~lVmE~~g~sL~~ll~~~~-~~ls~~~~~~i~~qi~~aL~yL 91 (449)
...+.+|+++++.+.+ +++|+.+++++.+.+..||||||++++|.+++.... ..+++..++.++.||+.||+||
T Consensus 55 ~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~l 134 (339)
T 1z57_A 55 CEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFL 134 (339)
T ss_dssp HHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEEEEEcCCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHH
Confidence 4668899999999842 346999999999999999999999999999998643 3689999999999999999999
Q ss_pred HHCCceecCCCCCcEEEeecCC----------------CCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchh
Q 013092 92 HSKSFLHRDIKPDNFLMGLGRR----------------ANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMN 155 (449)
Q Consensus 92 H~~givHRDLKP~NiLl~~~~~----------------~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE 155 (449)
|++||+||||||+|||+...+. ++.+||+|||+++...... ....||+.|+|||
T Consensus 135 H~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~----------~~~~gt~~y~aPE 204 (339)
T 1z57_A 135 HSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHH----------STLVSTRHYRAPE 204 (339)
T ss_dssp HHTTEECCCCCGGGEEESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTSCC----------CSSCSCGGGCCHH
T ss_pred HHCCCcCCCCCHHHEEEeccccccccCCccccccccccCCCceEeeCcccccCcccc----------ccccCCccccChH
Confidence 9999999999999999952111 5679999999998654322 3457899999999
Q ss_pred hhhCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchH--------------------------
Q 013092 156 THLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI-------------------------- 209 (449)
Q Consensus 156 ~~~~~~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~-------------------------- 209 (449)
++.+..++.++|||||||++|||++|..||...+.......+..+.........
T Consensus 205 ~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (339)
T 1z57_A 205 VILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYV 284 (339)
T ss_dssp HHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHH
T ss_pred HhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchh
Confidence 999999999999999999999999999999875443222222222111000000
Q ss_pred -------HH---hhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 210 -------EA---LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 210 -------~~---l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
.. ....+++++.+||..||+.||++||++.++++
T Consensus 285 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 328 (339)
T 1z57_A 285 SRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALK 328 (339)
T ss_dssp HHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred hhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHhc
Confidence 00 00123578999999999999999999888753
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=287.72 Aligned_cols=212 Identities=19% Similarity=0.275 Sum_probs=171.7
Q ss_pred CChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC
Q 013092 16 TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 94 (449)
Q Consensus 16 ~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~ 94 (449)
.....+.+|+++++.+ +||||+++++++.+.+..|+||||+ +++|.+++......+++..++.++.||+.||.|||++
T Consensus 58 ~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 136 (302)
T 2j7t_A 58 EELEDYIVEIEILATC-DHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK 136 (302)
T ss_dssp CCHHHHHHHHHHHHHC-CCTTBCCEEEEEECC-CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHhcC-CCCCEeeeeeeeeeCCeEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcC
Confidence 4557799999999999 8999999999999999999999999 8999999886667899999999999999999999999
Q ss_pred CceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhh-----CCCCChhhHHH
Q 013092 95 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHL-----GIEQSRRDDLE 169 (449)
Q Consensus 95 givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~-----~~~~s~~~Diw 169 (449)
||+||||||+|||+ +.++.+||+|||++....... .......||+.|+|||++. +..++.++|||
T Consensus 137 ~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~ 206 (302)
T 2j7t_A 137 RIIHRDLKAGNVLM---TLEGDIRLADFGVSAKNLKTL-------QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIW 206 (302)
T ss_dssp TCCCCCCSGGGEEE---CTTSCEEECCCHHHHHHHHHH-------HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHH
T ss_pred CcccCCCCHHHEEE---CCCCCEEEEECCCCccccccc-------cccccccCChhhcCCeeeccccCCCCCCchhhhHH
Confidence 99999999999999 578899999999876432211 1123457899999999984 66789999999
Q ss_pred HHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 170 SLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 170 SlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
||||++|+|++|..||..... ...+..+....... ......++.++.++|..||+.+|++||++.+|++
T Consensus 207 slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 207 SLGITLIEMAQIEPPHHELNP---MRVLLKIAKSDPPT--LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp HHHHHHHHHHHSSCTTTTSCH---HHHHHHHHHSCCCC--CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred HHHHHHHHHhcCCCCCccCCH---HHHHHHHhccCCcc--cCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 999999999999999987433 23333333322211 1123457899999999999999999999888753
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-35 Score=290.98 Aligned_cols=216 Identities=17% Similarity=0.180 Sum_probs=168.2
Q ss_pred ChhHHHHHHHHHHHhcCC-----CCCceEEEEeEeCCEEEEEEecCCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHH
Q 013092 17 KHPQLLYESKLYRILQGG-----TGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEF 90 (449)
Q Consensus 17 ~~~~~~~E~~il~~l~~h-----p~Iv~l~~~~~~~~~~~lVmE~~g~sL~~ll~~~~-~~ls~~~~~~i~~qi~~aL~y 90 (449)
....+.+|+.+++.+.++ .+|+.+.+++...+..||||||++++|.+++.... ..+++..++.++.||+.||+|
T Consensus 59 ~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~ 138 (355)
T 2eu9_A 59 YREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRF 138 (355)
T ss_dssp HHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred chhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Confidence 345688999999999532 23888999999999999999999888888887543 469999999999999999999
Q ss_pred HHHCCceecCCCCCcEEEeec----------------CCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccch
Q 013092 91 VHSKSFLHRDIKPDNFLMGLG----------------RRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASM 154 (449)
Q Consensus 91 LH~~givHRDLKP~NiLl~~~----------------~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aP 154 (449)
||++||+||||||+|||+... +..+.+||+|||+++...... ....||+.|+||
T Consensus 139 lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~----------~~~~gt~~y~aP 208 (355)
T 2eu9_A 139 LHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHH----------TTIVATRHYRPP 208 (355)
T ss_dssp HHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSCC----------CSSCSCGGGCCH
T ss_pred HHHCCcccCCCCHHHEEEecccccccccccccccccccCCCcEEEeecCccccccccc----------cCCcCCCcccCC
Confidence 999999999999999999422 256789999999998654322 345799999999
Q ss_pred hhhhCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccch--------------------------
Q 013092 155 NTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS-------------------------- 208 (449)
Q Consensus 155 E~~~~~~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~-------------------------- 208 (449)
|++.+..++.++|||||||++|||++|..||...........+.++........
T Consensus 209 E~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (355)
T 2eu9_A 209 EVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRY 288 (355)
T ss_dssp HHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHH
T ss_pred eeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhcc
Confidence 999999999999999999999999999999987544322222222211100000
Q ss_pred HHHhh----------cCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 013092 209 IEALC----------RGYPTEFASYFHYCRSLRFDDKPDYAYLK 242 (449)
Q Consensus 209 ~~~l~----------~~~p~el~~li~~cl~~~p~~RPt~~~l~ 242 (449)
....+ ...+.++.+||..||+.||++||++.+++
T Consensus 289 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l 332 (355)
T 2eu9_A 289 VKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEAL 332 (355)
T ss_dssp HHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHT
T ss_pred ccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHh
Confidence 00000 11245899999999999999999988774
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-36 Score=294.96 Aligned_cols=223 Identities=16% Similarity=0.199 Sum_probs=172.0
Q ss_pred ChhHHHHHHHHHHHhcCCCCCceEEEEeE----eCCEEEEEEecC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHH
Q 013092 17 KHPQLLYESKLYRILQGGTGIPNVRWFGV----EGDYNVLVMDLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRV 88 (449)
Q Consensus 17 ~~~~~~~E~~il~~l~~hp~Iv~l~~~~~----~~~~~~lVmE~~-g~sL~~ll~~~---~~~ls~~~~~~i~~qi~~aL 88 (449)
....+.+|+++++.+ +||||+++++++. .....|+||||+ +++|.+++... ...+++..++.++.||+.||
T Consensus 69 ~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L 147 (317)
T 2buj_A 69 DREEAQREADMHRLF-NHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGL 147 (317)
T ss_dssp HHHHHHHHHHHHHTC-CCTTBCCCCEEEEEEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhhc-CCCCeeeEEEEEEeccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHH
Confidence 455688999999999 9999999999886 345789999999 88999999753 46799999999999999999
Q ss_pred HHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcc--cccccCCCCccCccccchhhhhCCC---CC
Q 013092 89 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQH--IPYRENKNLTGTARYASMNTHLGIE---QS 163 (449)
Q Consensus 89 ~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~--~~~~~~~~~~gT~~Y~aPE~~~~~~---~s 163 (449)
+|||++||+||||||+|||+ +.++.+||+|||++........... ..........||+.|+|||++.+.. ++
T Consensus 148 ~~LH~~~ivH~dlkp~NIl~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 224 (317)
T 2buj_A 148 EAIHAKGYAHRDLKPTNILL---GDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVID 224 (317)
T ss_dssp HHHHHTTEECCCCCGGGEEE---CTTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEEC
T ss_pred HHHHhCCcccCCCCHHHEEE---cCCCCEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCC
Confidence 99999999999999999999 5788999999999876532111000 0000012345799999999998654 68
Q ss_pred hhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 164 RRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 164 ~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
.++|||||||++|+|++|..||......... ....+.. ... ......++.++.++|..||+.+|++||++.+|.+
T Consensus 225 ~~~Di~slG~il~el~~g~~p~~~~~~~~~~-~~~~~~~-~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 299 (317)
T 2buj_A 225 ERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS-VALAVQN-QLS---IPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLS 299 (317)
T ss_dssp THHHHHHHHHHHHHHHHSSCTTHHHHHTTSC-HHHHHHC-C-----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred chhhHHHHHHHHHHHHhCCCChhhhhcccch-hhHHhhc-cCC---CCccccCCHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 8999999999999999999999642111100 1111111 110 1122467899999999999999999999999998
Q ss_pred HHHHH
Q 013092 244 IFRDL 248 (449)
Q Consensus 244 ~L~~~ 248 (449)
.|+.+
T Consensus 300 ~L~~~ 304 (317)
T 2buj_A 300 QLEAL 304 (317)
T ss_dssp HHHHT
T ss_pred Hhhhc
Confidence 87765
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-35 Score=287.85 Aligned_cols=207 Identities=19% Similarity=0.327 Sum_probs=158.2
Q ss_pred HHHHH-HHHHHhcCCCCCceEEEEeEeCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC-Ccee
Q 013092 21 LLYES-KLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK-SFLH 98 (449)
Q Consensus 21 ~~~E~-~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~-givH 98 (449)
+..|. .+++.+ +||||+++++++.+.+..||||||+++.+..+.......+++..++.++.||+.||.|||++ ||+|
T Consensus 70 ~~~~~~~~~~~~-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H 148 (318)
T 2dyl_A 70 ILMDLDVVLKSH-DCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIH 148 (318)
T ss_dssp HHHHHHHHHHTT-TCTTBCCEEEEEECSSEEEEEECCCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCC
T ss_pred HHHHHHHHHHhc-CCCceeeEEEEEecCCcEEEEEeccCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEe
Confidence 44444 455555 99999999999999999999999998888888776567899999999999999999999995 9999
Q ss_pred cCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhh-----CCCCChhhHHHHHHH
Q 013092 99 RDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHL-----GIEQSRRDDLESLGY 173 (449)
Q Consensus 99 RDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~-----~~~~s~~~DiwSlG~ 173 (449)
|||||+|||+ +.++.+||+|||++..+..... .....||+.|+|||++. ...++.++|||||||
T Consensus 149 ~dlkp~Nil~---~~~~~~kl~dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~ 217 (318)
T 2dyl_A 149 RDVKPSNILL---DERGQIKLCDFGISGRLVDDKA--------KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGI 217 (318)
T ss_dssp CCCCGGGEEE---CTTSCEEECCCTTC----------------------CCTTCCHHHHC--------CCTHHHHHHHHH
T ss_pred CCCCHHHEEE---CCCCCEEEEECCCchhccCCcc--------ccccCCCccccChhhcccccccccCCccccchhhHHH
Confidence 9999999999 5788999999999976654322 13456899999999994 456889999999999
Q ss_pred HHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 174 VLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 174 il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
++|+|++|..||..... ..+.+..+....... . .....+++++.++|..||+.+|.+||++.+|++
T Consensus 218 il~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~-~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 218 SLVELATGQFPYKNCKT--DFEVLTKVLQEEPPL-L-PGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp HHHHHHHSSCTTTTCCS--HHHHHHHHHHSCCCC-C-CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred HHHHHHhCCCCCCCCCc--cHHHHHHHhccCCCC-C-CccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 99999999999976432 233333333322211 0 112357899999999999999999999988864
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-36 Score=290.77 Aligned_cols=218 Identities=21% Similarity=0.257 Sum_probs=162.3
Q ss_pred ChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHc-------CCCCCHHHHHHHHHHHHHHH
Q 013092 17 KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFC-------SRKLSLKTVLMLADQMINRV 88 (449)
Q Consensus 17 ~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~-------~~~ls~~~~~~i~~qi~~aL 88 (449)
....+.+|+.+++.+ .||||+++++++...+..|+||||+ +++|.+++... ...+++..++.++.||+.||
T Consensus 56 ~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l 134 (303)
T 2vwi_A 56 SMDELLKEIQAMSQC-HHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134 (303)
T ss_dssp ----------CCCCC-CCTTBCCEEEEEESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHhhc-CCCCEeeEEEEEeecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHH
Confidence 345688999999999 8999999999999999999999999 99999998742 34589999999999999999
Q ss_pred HHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhC-CCCChhhH
Q 013092 89 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDD 167 (449)
Q Consensus 89 ~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~-~~~s~~~D 167 (449)
+|||++||+||||||+||++ +.++.+||+|||++.......... .........||+.|+|||++.+ ..++.++|
T Consensus 135 ~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~D 209 (303)
T 2vwi_A 135 EYLHKNGQIHRDVKAGNILL---GEDGSVQIADFGVSAFLATGGDIT--RNKVRKTFVGTPCWMAPEVMEQVRGYDFKAD 209 (303)
T ss_dssp HHHHHTTCCCCCCSGGGEEE---CTTCCEEECCCHHHHHCC-----------------CCCTTCCHHHHHHHHCCCTHHH
T ss_pred HHHHhCCCCCCCCChhhEEE---cCCCCEEEEeccchheeccCCCcc--chhhhcccCCCccccCHHHhccccCCCchhh
Confidence 99999999999999999999 578899999999987654322110 0111234579999999999976 56899999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccc-----hHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 013092 168 LESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST-----SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 242 (449)
Q Consensus 168 iwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~-----~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~ 242 (449)
||||||++|+|++|..||........ +.......... ........++.++.++|..||+.||++||++.+|+
T Consensus 210 i~slG~il~~l~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll 286 (303)
T 2vwi_A 210 IWSFGITAIELATGAAPYHKYPPMKV---LMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELL 286 (303)
T ss_dssp HHHHHHHHHHHHHSSCTTTTSCGGGH---HHHHHTSSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHH
T ss_pred HHHHHHHHHHHHhCCCCCccCchhhH---HHHHhccCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHh
Confidence 99999999999999999987544321 11121111111 11223457899999999999999999999988875
Q ss_pred H
Q 013092 243 R 243 (449)
Q Consensus 243 ~ 243 (449)
+
T Consensus 287 ~ 287 (303)
T 2vwi_A 287 R 287 (303)
T ss_dssp T
T ss_pred h
Confidence 4
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-34 Score=291.65 Aligned_cols=161 Identities=24% Similarity=0.319 Sum_probs=141.4
Q ss_pred hhHHHHHHHHHHHhcCCCC-----CceEEEEeEeCCEEEEEEecCCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHH
Q 013092 18 HPQLLYESKLYRILQGGTG-----IPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFV 91 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~-----Iv~l~~~~~~~~~~~lVmE~~g~sL~~ll~~~~-~~ls~~~~~~i~~qi~~aL~yL 91 (449)
..++..|+++++.+.+|++ |+.+++++...+..||||||++++|.+++.... ..+++..++.++.||+.||.||
T Consensus 94 ~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~l 173 (382)
T 2vx3_A 94 LNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFL 173 (382)
T ss_dssp HHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEEEEECCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEEEEecCCCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHh
Confidence 4567889999999977775 999999999999999999999889999998653 5699999999999999999999
Q ss_pred H--HCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHH
Q 013092 92 H--SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLE 169 (449)
Q Consensus 92 H--~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~Diw 169 (449)
| +.||+||||||+||||+. +..+.+||+|||+++...... ....||+.|+|||++.+..++.++|||
T Consensus 174 H~~~~~ivHrDlkp~NIll~~-~~~~~~kL~DFG~a~~~~~~~----------~~~~~t~~y~aPE~~~~~~~~~~~Diw 242 (382)
T 2vx3_A 174 ATPELSIIHCDLKPENILLCN-PKRSAIKIVDFGSSCQLGQRI----------YQYIQSRFYRSPEVLLGMPYDLAIDMW 242 (382)
T ss_dssp TSTTTCEECCCCSGGGEEESS-TTSCCEEECCCTTCEETTCCC----------CSSCSCGGGCCHHHHTTCCCCTHHHHH
T ss_pred ccCCCCEEcCCCCcccEEEec-CCCCcEEEEeccCceeccccc----------ccccCCccccChHHHcCCCCCcHHHHH
Confidence 9 579999999999999942 245789999999998765422 345789999999999999999999999
Q ss_pred HHHHHHHHHHhCCCCCCCCC
Q 013092 170 SLGYVLMYFLRGSLPWQGLK 189 (449)
Q Consensus 170 SlG~il~elltG~~Pf~~~~ 189 (449)
||||++|||++|..||.+..
T Consensus 243 SlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 243 SLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp HHHHHHHHHHHSSCSSCCSS
T ss_pred HHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999998743
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-35 Score=288.48 Aligned_cols=200 Identities=23% Similarity=0.314 Sum_probs=169.6
Q ss_pred hhHHHHHHHHHHHhc-CCCCCceEEEEeEeCCEEEEEEecC-C-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC
Q 013092 18 HPQLLYESKLYRILQ-GGTGIPNVRWFGVEGDYNVLVMDLL-G-PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 94 (449)
Q Consensus 18 ~~~~~~E~~il~~l~-~hp~Iv~l~~~~~~~~~~~lVmE~~-g-~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~ 94 (449)
...+.+|+.+++.+. +|+||+++++++.+.+..++|||++ + ++|.+++.. ...+++..++.++.||+.||+|||++
T Consensus 90 ~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~ 168 (320)
T 3a99_A 90 GTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNC 168 (320)
T ss_dssp CCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred hhHHHHHHHHHHhhccCCCCceEEEEEEecCCcEEEEEEcCCCCccHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 356789999999996 4799999999999999999999999 4 899999986 45799999999999999999999999
Q ss_pred CceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCC-ChhhHHHHHHH
Q 013092 95 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQ-SRRDDLESLGY 173 (449)
Q Consensus 95 givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~-s~~~DiwSlG~ 173 (449)
||+||||||+|||++ ...+.+||+|||+++...... .....||+.|+|||++.+..+ +.++|||||||
T Consensus 169 ~ivH~Dlkp~NIll~--~~~~~~kL~Dfg~~~~~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~ 237 (320)
T 3a99_A 169 GVLHRDIKDENILID--LNRGELKLIDFGSGALLKDTV---------YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGI 237 (320)
T ss_dssp TEECCCCSGGGEEEE--TTTTEEEECCCTTCEECCSSC---------BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHH
T ss_pred CcEeCCCCHHHEEEe--CCCCCEEEeeCcccccccccc---------ccCCCCCccCCChHHhccCCCCCccchHHhHHH
Confidence 999999999999994 367899999999998775432 134579999999999987765 78899999999
Q ss_pred HHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 174 VLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 174 il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
++|||++|..||.... .+..... .+...+++++.+||..||+.+|++||++.+|++
T Consensus 238 il~el~~g~~pf~~~~---------~~~~~~~-----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 238 LLYDMVCGDIPFEHDE---------EIIRGQV-----FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp HHHHHHHSSCSCCSHH---------HHHHCCC-----CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHHCCCCCCChh---------hhhcccc-----cccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 9999999999996521 1111111 133568999999999999999999999888754
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-34 Score=287.84 Aligned_cols=214 Identities=17% Similarity=0.144 Sum_probs=166.8
Q ss_pred CChhHHHHHHHHHHHhcCCCCCceEEEEeEeCC-------EEEEEEecCCCCHHHHHHH---cCCCCCHHHHHHHHHHHH
Q 013092 16 TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGD-------YNVLVMDLLGPSLEDLFNF---CSRKLSLKTVLMLADQMI 85 (449)
Q Consensus 16 ~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~-------~~~lVmE~~g~sL~~ll~~---~~~~ls~~~~~~i~~qi~ 85 (449)
.....+..|++.+..+ +||||+++++++...+ +.||||||+.++|.+.+.. ....+++..+..++.|++
T Consensus 61 ~~~~~~~~~~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~ 139 (360)
T 3e3p_A 61 RFRNRELQIMQDLAVL-HHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLI 139 (360)
T ss_dssp TCCCHHHHHHHHHHHH-CCTTBCCEEEEEEEECSSCTTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHH
T ss_pred cccHHHHHHHHHHHhc-CCCCcccHHHhhhccccccccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHH
Confidence 3445677888888888 9999999999886533 3899999997777766543 245689999999999999
Q ss_pred HHHHHHH--HCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCC-C
Q 013092 86 NRVEFVH--SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIE-Q 162 (449)
Q Consensus 86 ~aL~yLH--~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~-~ 162 (449)
.||.||| ++||+||||||+|||++ ..++.+||+|||+++.+..... .....||+.|+|||++.+.. +
T Consensus 140 ~al~~lH~~~~~ivH~Dlkp~NIll~--~~~~~~kl~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~ 209 (360)
T 3e3p_A 140 RSIGCLHLPSVNVCHRDIKPHNVLVN--EADGTLKLCDFGSAKKLSPSEP--------NVAYICSRYYRAPELIFGNQHY 209 (360)
T ss_dssp HHHHHHTSTTTCCBCSCCCGGGEEEE--TTTTEEEECCCTTCBCCCTTSC--------CCSTTSCGGGCCHHHHTTCSSC
T ss_pred HHHHHHhCCCCCeecCcCCHHHEEEe--CCCCcEEEeeCCCceecCCCCC--------cccccCCcceeCHHHHcCCCCC
Confidence 9999999 99999999999999995 3378999999999987654332 23457899999999997654 8
Q ss_pred ChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccch-----------------------HHHh----hcC
Q 013092 163 SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS-----------------------IEAL----CRG 215 (449)
Q Consensus 163 s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~-----------------------~~~l----~~~ 215 (449)
+.++|||||||++|+|++|..||.+... ...+..+........ .... ...
T Consensus 210 ~~~~Di~slG~il~ell~g~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (360)
T 3e3p_A 210 TTAVDIWSVGCIFAEMMLGEPIFRGDNS---AGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLK 286 (360)
T ss_dssp CTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCT
T ss_pred CcHHHHHHHHHHHHHHHhCCCCcCCCCh---HHHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhcc
Confidence 9999999999999999999999987443 333333332211111 1111 122
Q ss_pred CcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 216 YPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 216 ~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
+++++.+||..||+.||++||++.++++
T Consensus 287 ~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 314 (360)
T 3e3p_A 287 DAKEAYDLLSALLQYLPEERMKPYEALC 314 (360)
T ss_dssp THHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ccHHHHHHHHHHhccCccccCCHHHHhc
Confidence 5789999999999999999999887753
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-35 Score=292.18 Aligned_cols=206 Identities=19% Similarity=0.260 Sum_probs=165.2
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeCCE------EEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHH
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEGDY------NVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 91 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~------~~lVmE~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yL 91 (449)
...+.+|+.+++.+ +||||+++++++..... .|+||||++++|.+++. ..+++..++.++.||+.||+||
T Consensus 67 ~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~i~~qi~~al~~L 142 (353)
T 3coi_A 67 AKRAYRELLLLKHM-QHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMG---LKFSEEKIQYLVYQMLKGLKYI 142 (353)
T ss_dssp HHHHHHHHHHHHHC-CCTTBCCCSEEECSCSSGGGCCCCEEEEECCSEEGGGTTT---SCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhc-CCCCcccHhheEecccccccceeEEEEeccccCCHHHHhc---CCCCHHHHHHHHHHHHHHHHHH
Confidence 45688999999999 89999999999887654 49999999888887765 3599999999999999999999
Q ss_pred HHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhC-CCCChhhHHHH
Q 013092 92 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLES 170 (449)
Q Consensus 92 H~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~-~~~s~~~DiwS 170 (449)
|++||+||||||+|||+ +.++.+||+|||+++...... ....||+.|+|||++.+ ..++.++||||
T Consensus 143 H~~~ivH~dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~~~----------~~~~~t~~y~aPE~~~~~~~~~~~~Di~s 209 (353)
T 3coi_A 143 HSAGVVHRDLKPGNLAV---NEDCELKILDFGLARHADAEM----------TGYVVTRWYRAPEVILSWMHYNQTVDIWS 209 (353)
T ss_dssp HHTTCCCSSCCGGGEEE---CTTCCEEECSTTCTTC------------------CCSBCCSCHHHHSCCSCCCTTHHHHH
T ss_pred HHCCcccCCCCHHHEeE---CCCCcEEEeecccccCCCCCc----------cccccCcCcCCHHHHhCcCCCCchhhHHH
Confidence 99999999999999999 578899999999997654321 24578999999999987 67899999999
Q ss_pred HHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcc--------------------------cchHHHhhcCCcHHHHHHH
Q 013092 171 LGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV--------------------------STSIEALCRGYPTEFASYF 224 (449)
Q Consensus 171 lG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~--------------------------~~~~~~l~~~~p~el~~li 224 (449)
|||++|+|++|..||.+... .+.+..+..... ...+..+...+++++.+||
T Consensus 210 lG~il~el~~g~~pf~~~~~---~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 286 (353)
T 3coi_A 210 VGCIMAEMLTGKTLFKGKDY---LDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLL 286 (353)
T ss_dssp HHHHHHHHHHSSCSSBSSCH---HHHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHH
T ss_pred HHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHH
Confidence 99999999999999987543 222332222110 0111223356789999999
Q ss_pred HHHhcCCCCCCCCHHHHHH
Q 013092 225 HYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 225 ~~cl~~~p~~RPt~~~l~~ 243 (449)
..||+.||++||++.++++
T Consensus 287 ~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 287 EKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp HHHSCSCTTTSCCHHHHHT
T ss_pred HHHcCCCcccCCCHHHHhc
Confidence 9999999999999887753
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=281.46 Aligned_cols=217 Identities=19% Similarity=0.197 Sum_probs=163.6
Q ss_pred ChhHHHHHHHHHHHhcCCCCCceEEEEeEe-------------CCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHH
Q 013092 17 KHPQLLYESKLYRILQGGTGIPNVRWFGVE-------------GDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLAD 82 (449)
Q Consensus 17 ~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~-------------~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~ 82 (449)
....+.+|+.+++.+ +||||+++++++.+ ....||||||+ +++|.+++......+++..++.++.
T Consensus 45 ~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ 123 (303)
T 1zy4_A 45 KLSTILSEVMLLASL-NHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFR 123 (303)
T ss_dssp HHHHHHHHHHHHTTC-CCTTBCCEEEEEEECCCCCC------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhc-CchHHHHHHHHHHhhcchhhhhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHH
Confidence 346788999999999 89999999988765 45789999999 8999999986566688999999999
Q ss_pred HHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcc-------cccccCCCCccCccccchh
Q 013092 83 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQH-------IPYRENKNLTGTARYASMN 155 (449)
Q Consensus 83 qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~-------~~~~~~~~~~gT~~Y~aPE 155 (449)
||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.......... ..........||+.|+|||
T Consensus 124 qi~~~l~~LH~~~i~H~dlkp~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE 200 (303)
T 1zy4_A 124 QILEALSYIHSQGIIHRDLKPMNIFI---DESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATE 200 (303)
T ss_dssp HHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECCCCCCSCTTC-------------------------CTTSCHH
T ss_pred HHHHHHHHHHhCCeecccCCHHhEEE---cCCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcc
Confidence 99999999999999999999999999 5788999999999986643211000 0011223457999999999
Q ss_pred hhhCC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCC
Q 013092 156 THLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDD 234 (449)
Q Consensus 156 ~~~~~-~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~ 234 (449)
++.+. .++.++|||||||++|+|++ ||... ......+..+..... .....+...++.++.++|..||+.||++
T Consensus 201 ~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~--~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~dp~~ 274 (303)
T 1zy4_A 201 VLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG--MERVNILKKLRSVSI-EFPPDFDDNKMKVEKKIIRLLIDHDPNK 274 (303)
T ss_dssp HHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH--HHHHHHHHHHHSTTC-CCCTTCCTTTSHHHHHHHHHHTCSSGGG
T ss_pred cccCCCCCcchhhHHHHHHHHHHHHh---ccCCc--hhHHHHHHhcccccc-ccCccccccchHHHHHHHHHHHhcCccc
Confidence 99865 68999999999999999998 66431 112223333332221 1122344567889999999999999999
Q ss_pred CCCHHHHHH
Q 013092 235 KPDYAYLKR 243 (449)
Q Consensus 235 RPt~~~l~~ 243 (449)
||++.+|++
T Consensus 275 Rps~~~ll~ 283 (303)
T 1zy4_A 275 RPGARTLLN 283 (303)
T ss_dssp SCCHHHHHH
T ss_pred CcCHHHHhC
Confidence 999888754
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-35 Score=303.67 Aligned_cols=217 Identities=17% Similarity=0.187 Sum_probs=162.6
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFL 97 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~giv 97 (449)
...+.+|+++|+.+.+||||+++++++.+....|||||||+++|.+++......+....++.++.||+.||+|||++||+
T Consensus 61 ~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iv 140 (432)
T 3p23_A 61 FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIV 140 (432)
T ss_dssp EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCC
T ss_pred HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCCCCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCE
Confidence 34578999999999889999999999999999999999998899999986555566667889999999999999999999
Q ss_pred ecCCCCCcEEEeecC--CCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhh---CCCCChhhHHHHHH
Q 013092 98 HRDIKPDNFLMGLGR--RANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHL---GIEQSRRDDLESLG 172 (449)
Q Consensus 98 HRDLKP~NiLl~~~~--~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~---~~~~s~~~DiwSlG 172 (449)
||||||+||||...+ ....+||+|||+++.+...... +.......||+.|+|||++. ...++.++||||||
T Consensus 141 HrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~----~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG 216 (432)
T 3p23_A 141 HRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHS----FSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAG 216 (432)
T ss_dssp CCCCSTTSEEECCCBTTTBCCEEECCTTEEECC----------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHH
T ss_pred eCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcc----eeeccccCCCcCccChhhhhcccccCCCcHHHHHHHH
Confidence 999999999995322 2236889999999876543211 11224567999999999998 45678899999999
Q ss_pred HHHHHHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 173 YVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 173 ~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
|++|||++ |..||..... .+ ...+... ............+..+.+||..||+.||++||++.++++
T Consensus 217 ~il~ellt~g~~pf~~~~~---~~-~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 217 CVFYYVISEGSHPFGKSLQ---RQ-ANILLGA-CSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp HHHHHHHTTSCBTTBSTTT---HH-HHHHTTC-CCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHHcCCCCCcchhhH---HH-HHHHhcc-CCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 99999999 9999965322 11 1111111 111000011123566899999999999999999888753
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-35 Score=300.25 Aligned_cols=218 Identities=21% Similarity=0.248 Sum_probs=160.6
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecCCCCHHHHHHHcCCC------CCHHHHHHHHHHHHHHHHHH
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRK------LSLKTVLMLADQMINRVEFV 91 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~g~sL~~ll~~~~~~------ls~~~~~~i~~qi~~aL~yL 91 (449)
...+.+|+++++.+.+||||+++++++.+.+..|||||||+++|.+++...... .++..++.++.||+.||+||
T Consensus 52 ~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~L 131 (434)
T 2rio_A 52 CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHL 131 (434)
T ss_dssp HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHH
Confidence 456889999999887999999999999999999999999977999999843211 12334578999999999999
Q ss_pred HHCCceecCCCCCcEEEeec----------CCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhC--
Q 013092 92 HSKSFLHRDIKPDNFLMGLG----------RRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG-- 159 (449)
Q Consensus 92 H~~givHRDLKP~NiLl~~~----------~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~-- 159 (449)
|++||+||||||+|||++.. +....+||+|||+++.+........ .......||+.|+|||++.+
T Consensus 132 H~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~ 208 (434)
T 2rio_A 132 HSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFR---TNLNNPSGTSGWRAPELLEESN 208 (434)
T ss_dssp HHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC-----------------CCTTSCHHHHSCCC
T ss_pred HHCCccccCCChHhEEEecCcccccccccCCCceEEEEcccccceecCCCCccce---eeecCCCCCCCccCHHHhcccc
Confidence 99999999999999999632 2346899999999998765432110 11234579999999999976
Q ss_pred -----CCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCCHHHHHHHHHhhcccc-hHHHh-hcCCcHHHHHHHHHHhcCC
Q 013092 160 -----IEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVST-SIEAL-CRGYPTEFASYFHYCRSLR 231 (449)
Q Consensus 160 -----~~~s~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~-~~~~l-~~~~p~el~~li~~cl~~~ 231 (449)
..++.++|||||||++|||++ |..||...... . ..+....... ....+ ...+++++.++|..||+.|
T Consensus 209 ~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~--~---~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 283 (434)
T 2rio_A 209 NLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR--E---SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHD 283 (434)
T ss_dssp TTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH--H---HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSS
T ss_pred ccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh--H---HHHhcCCCCcccccccccccchHHHHHHHHHHhhCC
Confidence 568999999999999999998 99999764321 1 1222221111 01000 1234688999999999999
Q ss_pred CCCCCCHHHHHH
Q 013092 232 FDDKPDYAYLKR 243 (449)
Q Consensus 232 p~~RPt~~~l~~ 243 (449)
|.+||++.+|++
T Consensus 284 P~~Rps~~eil~ 295 (434)
T 2rio_A 284 PLKRPTAMKVLR 295 (434)
T ss_dssp GGGSCCHHHHHT
T ss_pred hhhCCCHHHHHh
Confidence 999999988753
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-35 Score=291.03 Aligned_cols=210 Identities=15% Similarity=0.199 Sum_probs=173.4
Q ss_pred hHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHH------HHHc-CCCCCHHHHHHHHHHHHHHHHH
Q 013092 19 PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDL------FNFC-SRKLSLKTVLMLADQMINRVEF 90 (449)
Q Consensus 19 ~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~l------l~~~-~~~ls~~~~~~i~~qi~~aL~y 90 (449)
..+.+|+.+++.+ +||||+++++++.+.+..||||||+ +++|.++ +... ...+++..++.++.||+.||.|
T Consensus 88 ~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~ 166 (348)
T 2pml_X 88 DDFKNELQIITDI-KNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSY 166 (348)
T ss_dssp HHHHHHHHHHTTC-CCTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhC-CCCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHH
Confidence 7899999999999 7999999999999999999999999 8899998 5432 4569999999999999999999
Q ss_pred HHH-CCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCC-CCCh-hhH
Q 013092 91 VHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI-EQSR-RDD 167 (449)
Q Consensus 91 LH~-~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~-~~s~-~~D 167 (449)
||+ +||+||||||+|||+ +.++.+||+|||++....... .....||+.|+|||++.+. .++. ++|
T Consensus 167 lH~~~~i~H~dl~p~Nil~---~~~~~~kl~dfg~~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~~D 234 (348)
T 2pml_X 167 IHNEKNICHRDVKPSNILM---DKNGRVKLSDFGESEYMVDKK---------IKGSRGTYEFMPPEFFSNESSYNGAKVD 234 (348)
T ss_dssp HHHTSCEECCCCCGGGEEE---CTTSCEEECCCTTCEECBTTE---------ECSSCSCGGGCCGGGGSSCCCEEHHHHH
T ss_pred HhccCCEeecCCChHhEEE---cCCCcEEEecccccccccccc---------ccCCCCCcCccCchhhcCCCCCCcchhh
Confidence 999 999999999999999 688899999999998765431 2345799999999999987 5666 999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchH--------------HHhhcCCcHHHHHHHHHHhcCCCC
Q 013092 168 LESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI--------------EALCRGYPTEFASYFHYCRSLRFD 233 (449)
Q Consensus 168 iwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~--------------~~l~~~~p~el~~li~~cl~~~p~ 233 (449)
||||||++|+|++|..||...... .+.+..+.......+. ......++.++.+||..||+.+|+
T Consensus 235 i~slG~il~~l~~g~~pf~~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~ 312 (348)
T 2pml_X 235 IWSLGICLYVMFYNVVPFSLKISL--VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPA 312 (348)
T ss_dssp HHHHHHHHHHHHHSSCSSCCSSCS--HHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGG
T ss_pred HHHHHHHHHHHHhCCCCCCCCCcH--HHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChh
Confidence 999999999999999999875431 3344444433222110 111256899999999999999999
Q ss_pred CCCCHHHHHH
Q 013092 234 DKPDYAYLKR 243 (449)
Q Consensus 234 ~RPt~~~l~~ 243 (449)
+||++.++++
T Consensus 313 ~Rps~~e~l~ 322 (348)
T 2pml_X 313 ERITSEDALK 322 (348)
T ss_dssp GSCCHHHHHT
T ss_pred hCCCHHHHhc
Confidence 9999887754
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-35 Score=291.16 Aligned_cols=213 Identities=17% Similarity=0.288 Sum_probs=149.1
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecCCCCHHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHH
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNF----CSRKLSLKTVLMLADQMINRVEFVHS 93 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~g~sL~~ll~~----~~~~ls~~~~~~i~~qi~~aL~yLH~ 93 (449)
..++..|+..+....+||||+++++++.+.+..||||||+.++|.+++.. ....+++..+..++.|++.||.|||+
T Consensus 64 ~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~ 143 (327)
T 3aln_A 64 QKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE 143 (327)
T ss_dssp HHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhc
Confidence 34566777755444499999999999999999999999997799888863 25679999999999999999999999
Q ss_pred C-CceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhh----hCCCCChhhHH
Q 013092 94 K-SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTH----LGIEQSRRDDL 168 (449)
Q Consensus 94 ~-givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~----~~~~~s~~~Di 168 (449)
. ||+||||||+|||+ +.++.+||+|||+++.+..... .....||+.|+|||++ .+..++.++||
T Consensus 144 ~~~ivH~dlkp~NIll---~~~~~~kl~Dfg~~~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di 212 (327)
T 3aln_A 144 NLKIIHRDIKPSNILL---DRSGNIKLCDFGISGQLVDSIA--------KTRDAGCRPYMAPERIDPSASRQGYDVRSDV 212 (327)
T ss_dssp HHSCCCSCCCGGGEEE---ETTTEEEECCCSSSCC--------------------------------------CCSHHHH
T ss_pred cCCEeECCCCHHHEEE---cCCCCEEEccCCCceecccccc--------cccCCCCccccCceeeccccCcCCCCchhhH
Confidence 8 99999999999999 4788999999999987654322 1234689999999998 45678999999
Q ss_pred HHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 169 ESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 169 wSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
|||||++|+|++|..||.+.... .+.+..+...............+++++.+||..||+.+|++||++.+|++
T Consensus 213 ~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 213 WSLGITLYELATGRFPYPKWNSV--FDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp HHHHHHHHHHHHSCCCSSCC---------CCCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHHHHHHHHCCCCCCCcchH--HHHHHHHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 99999999999999999764321 11111111111111111122468999999999999999999999988864
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=290.77 Aligned_cols=217 Identities=21% Similarity=0.247 Sum_probs=167.0
Q ss_pred ChhHHHHHHHHHHHhcC----------CCCCceEEEEeEeCC----EEEEEEecCCCCHHHHHHHc-CCCCCHHHHHHHH
Q 013092 17 KHPQLLYESKLYRILQG----------GTGIPNVRWFGVEGD----YNVLVMDLLGPSLEDLFNFC-SRKLSLKTVLMLA 81 (449)
Q Consensus 17 ~~~~~~~E~~il~~l~~----------hp~Iv~l~~~~~~~~----~~~lVmE~~g~sL~~ll~~~-~~~ls~~~~~~i~ 81 (449)
....+.+|+++++.+.+ |+||+++++++...+ ..+|||||++++|.+++... ...+++..++.++
T Consensus 58 ~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~ 137 (373)
T 1q8y_A 58 YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQIS 137 (373)
T ss_dssp HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHH
T ss_pred chhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccCCCCceEEEEEecCCCCHHHHHHHhhccCCcHHHHHHHH
Confidence 34568899999999853 789999999887654 88999999999999999864 3559999999999
Q ss_pred HHHHHHHHHHHHC-CceecCCCCCcEEEeec---CCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhh
Q 013092 82 DQMINRVEFVHSK-SFLHRDIKPDNFLMGLG---RRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTH 157 (449)
Q Consensus 82 ~qi~~aL~yLH~~-givHRDLKP~NiLl~~~---~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~ 157 (449)
.||+.||+|||++ ||+||||||+||||... +..+.+||+|||+++...... ....||+.|+|||++
T Consensus 138 ~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~~----------~~~~~t~~y~aPE~~ 207 (373)
T 1q8y_A 138 KQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY----------TNSIQTREYRSPEVL 207 (373)
T ss_dssp HHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBCC----------CSCCSCGGGCCHHHH
T ss_pred HHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcceEEEcccccccccCCCC----------CCCCCCccccCcHHH
Confidence 9999999999998 99999999999999532 233489999999998765432 234789999999999
Q ss_pred hCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCC---HHHHHHHHHhhcccchH-------------------------
Q 013092 158 LGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT---KKQKYEKISEKKVSTSI------------------------- 209 (449)
Q Consensus 158 ~~~~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~---~~~~~~~i~~~~~~~~~------------------------- 209 (449)
.+..++.++|||||||++|||++|..||.+..... ....+..+.+.....+.
T Consensus 208 ~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (373)
T 1q8y_A 208 LGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKL 287 (373)
T ss_dssp HTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCC
T ss_pred hCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccc
Confidence 99999999999999999999999999998654221 11222222211110000
Q ss_pred -----H-------HhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 210 -----E-------ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 210 -----~-------~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
. .+...++.++.+||..||+.||++||++.+|++
T Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 333 (373)
T 1q8y_A 288 KFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVN 333 (373)
T ss_dssp CBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHT
T ss_pred cccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhh
Confidence 0 011234678999999999999999999888753
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-34 Score=280.81 Aligned_cols=200 Identities=20% Similarity=0.259 Sum_probs=164.0
Q ss_pred hhHHHHHHHHHHHhc---CCCCCceEEEEeEeCCEEEEEEec-C-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH
Q 013092 18 HPQLLYESKLYRILQ---GGTGIPNVRWFGVEGDYNVLVMDL-L-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 92 (449)
Q Consensus 18 ~~~~~~E~~il~~l~---~hp~Iv~l~~~~~~~~~~~lVmE~-~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH 92 (449)
...+.+|+.++..+. +|+||+++++++.+.+..++|||+ + +++|.+++.. ...+++..++.++.||+.||+|||
T Consensus 78 ~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH 156 (312)
T 2iwi_A 78 SVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITE-KGPLGEGPSRCFFGQVVAAIQHCH 156 (312)
T ss_dssp -CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-----CEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHhhcccCCCCCeeeEEEEEecCCeEEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH
Confidence 345678999999986 799999999999999999999999 5 8999999986 456999999999999999999999
Q ss_pred HCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCC-ChhhHHHHH
Q 013092 93 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQ-SRRDDLESL 171 (449)
Q Consensus 93 ~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~-s~~~DiwSl 171 (449)
++||+||||||+||+++ ..++.+||+|||+++...... .....||..|+|||++.+..+ +.++|||||
T Consensus 157 ~~~i~H~dlkp~Nil~~--~~~~~~kl~dfg~~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~sl 225 (312)
T 2iwi_A 157 SRGVVHRDIKDENILID--LRRGCAKLIDFGSGALLHDEP---------YTDFDGTRVYSPPEWISRHQYHALPATVWSL 225 (312)
T ss_dssp HHTEECCCCSGGGEEEE--TTTTEEEECCCSSCEECCSSC---------BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHH
T ss_pred HCCeeecCCChhhEEEe--CCCCeEEEEEcchhhhcccCc---------ccccCCcccccCceeeecCCCCCccchHHHH
Confidence 99999999999999994 367899999999998775432 134568999999999987766 458999999
Q ss_pred HHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 172 GYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 172 G~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
||++|+|++|..||... . .+..... .+...++.++.++|..||+.+|++||++.++++
T Consensus 226 G~il~~l~~g~~pf~~~-----~----~~~~~~~-----~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 226 GILLYDMVCGDIPFERD-----Q----EILEAEL-----HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp HHHHHHHHHSSCSCCSH-----H----HHHHTCC-----CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHHCCCCCCCh-----H----HHhhhcc-----CCcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 99999999999999652 1 1222211 133568999999999999999999999888754
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-33 Score=273.08 Aligned_cols=196 Identities=17% Similarity=0.173 Sum_probs=153.2
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEe----CCEEEEEEecC-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHH
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVE----GDYNVLVMDLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFV 91 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~----~~~~~lVmE~~-g~sL~~ll~~~~-~~ls~~~~~~i~~qi~~aL~yL 91 (449)
...+.+|+.++.++.+||||+++++++.+ ....||||||+ +++|.+++.... ..+++..++.++.||+.||+||
T Consensus 54 ~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~l 133 (299)
T 3m2w_A 54 CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 133 (299)
T ss_dssp SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHH
T ss_pred cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH
Confidence 45788999999777799999999999887 77899999999 889999998643 4699999999999999999999
Q ss_pred HHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHH
Q 013092 92 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESL 171 (449)
Q Consensus 92 H~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSl 171 (449)
|++||+||||||+|||++....++.+||+|||++..... ..++.++|||||
T Consensus 134 H~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~-----------------------------~~~~~~~Diwsl 184 (299)
T 3m2w_A 134 HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTG-----------------------------EKYDKSCDMWSL 184 (299)
T ss_dssp HHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECTT-----------------------------CGGGGHHHHHHH
T ss_pred HhCCcccCCCCHHHEEEecCCCCCcEEEecccccccccc-----------------------------ccCCchhhHHHH
Confidence 999999999999999995333378999999999865321 235779999999
Q ss_pred HHHHHHHHhCCCCCCCCCcCCHHHHH-HHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 172 GYVLMYFLRGSLPWQGLKAGTKKQKY-EKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 172 G~il~elltG~~Pf~~~~~~~~~~~~-~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
||++|+|++|..||.+.......... ..+..... .........+++++.+||..||+.+|++||++.++++
T Consensus 185 G~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 185 GVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY-EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp HHHHHHHHHSSCSCCC-------CCSCCSSCTTCC-SSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccc-cCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 99999999999999764321100000 00111111 1112233578999999999999999999999887754
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-33 Score=288.70 Aligned_cols=200 Identities=15% Similarity=0.132 Sum_probs=153.3
Q ss_pred ChhHHHHHHHHHHHhcCCCCC---------------------ceEEEEeEe-----CCEEEEEEecCCCCHHHHHHHc--
Q 013092 17 KHPQLLYESKLYRILQGGTGI---------------------PNVRWFGVE-----GDYNVLVMDLLGPSLEDLFNFC-- 68 (449)
Q Consensus 17 ~~~~~~~E~~il~~l~~hp~I---------------------v~l~~~~~~-----~~~~~lVmE~~g~sL~~ll~~~-- 68 (449)
....|.+|+.+++.+.+..++ +.+..++.. ....|++|++++++|.++++..
T Consensus 121 ~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~ 200 (413)
T 3dzo_A 121 AIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLS 200 (413)
T ss_dssp CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC---------------CCSEEEEEECCSEEHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhc
Confidence 356789999999998543321 111111121 2347899999999999999533
Q ss_pred ----CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCC
Q 013092 69 ----SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKN 144 (449)
Q Consensus 69 ----~~~ls~~~~~~i~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~ 144 (449)
...+++..++.++.||+.||+|||++||+||||||+|||| +.++.+||+|||+++..... ...
T Consensus 201 ~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDiKp~NILl---~~~~~~kL~DFG~a~~~~~~----------~~~ 267 (413)
T 3dzo_A 201 HSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVL---DQRGGVFLTGFEHLVRDGAS----------AVS 267 (413)
T ss_dssp HTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCGGGCEETTEE----------ECC
T ss_pred ccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcccceEEE---ecCCeEEEEeccceeecCCc----------ccc
Confidence 3447888999999999999999999999999999999999 67888999999999875443 134
Q ss_pred CccCccccchhhh----------hCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhc
Q 013092 145 LTGTARYASMNTH----------LGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 214 (449)
Q Consensus 145 ~~gT~~Y~aPE~~----------~~~~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~ 214 (449)
..| +.|+|||++ .+..++.++|||||||++|||++|+.||.+...... +. .+...+.
T Consensus 268 ~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~---~~---------~~~~~~~ 334 (413)
T 3dzo_A 268 PIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGG---SE---------WIFRSCK 334 (413)
T ss_dssp CCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSC---SG---------GGGSSCC
T ss_pred CCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhh---HH---------HHHhhcc
Confidence 567 999999999 555688999999999999999999999977433211 11 1111234
Q ss_pred CCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 013092 215 GYPTEFASYFHYCRSLRFDDKPDYAYLK 242 (449)
Q Consensus 215 ~~p~el~~li~~cl~~~p~~RPt~~~l~ 242 (449)
.+|+++.+||..||+.+|++||++.+++
T Consensus 335 ~~~~~~~~li~~~l~~dP~~Rpt~~~~l 362 (413)
T 3dzo_A 335 NIPQPVRALLEGFLRYPKEDRLLPLQAM 362 (413)
T ss_dssp CCCHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 6899999999999999999999987764
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-32 Score=268.62 Aligned_cols=188 Identities=11% Similarity=0.072 Sum_probs=154.3
Q ss_pred hHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q 013092 19 PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFL 97 (449)
Q Consensus 19 ~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~giv 97 (449)
..+.+|+.++..+ +||||+++++++.+.+..||||||+ |++|.++++. + ....+++.++.||+.||+|||++||+
T Consensus 76 ~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~--~-~~~~~~~~i~~ql~~aL~~lH~~giv 151 (286)
T 3uqc_A 76 QETLSRTLRLSRI-DKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADT--S-PSPVGAIRAMQSLAAAADAAHRAGVA 151 (286)
T ss_dssp HHHHHHHHHHHTC-CCTTBCCEEEEEEETTEEEEEEECCCEEEHHHHHTT--C-CCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred HHHHHHHHHHhcC-CCCCcceeeEEEEECCcEEEEEEecCCCCHHHHHhc--C-CChHHHHHHHHHHHHHHHHHHHCCCc
Confidence 6789999999999 9999999999999999999999999 8999999963 3 46667899999999999999999999
Q ss_pred ecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHHHHH
Q 013092 98 HRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMY 177 (449)
Q Consensus 98 HRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il~e 177 (449)
||||||+|||+ +.++.+||+++| |++ +++.++|||||||++||
T Consensus 152 H~Dikp~NIll---~~~g~~kl~~~~---------------------------~~~-------~~~~~~Di~slG~il~e 194 (286)
T 3uqc_A 152 LSIDHPSRVRV---SIDGDVVLAYPA---------------------------TMP-------DANPQDDIRGIGASLYA 194 (286)
T ss_dssp CCCCSGGGEEE---ETTSCEEECSCC---------------------------CCT-------TCCHHHHHHHHHHHHHH
T ss_pred cCCCCcccEEE---cCCCCEEEEecc---------------------------ccC-------CCCchhHHHHHHHHHHH
Confidence 99999999999 477888887543 222 36889999999999999
Q ss_pred HHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 013092 178 FLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLF 249 (449)
Q Consensus 178 lltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~L~~~~ 249 (449)
|++|+.||.+...........+... ........+...+|+++.++|..||+.||++| ++.++.+.|+++.
T Consensus 195 lltg~~Pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~ 264 (286)
T 3uqc_A 195 LLVNRWPLPEAGVRSGLAPAERDTA-GQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQAT 264 (286)
T ss_dssp HHHSEECSCCCSBCCCSEECCBCTT-SCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHH
T ss_pred HHHCCCCCCcCCcchhhHHHHHHhc-cCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHh
Confidence 9999999987554221100000011 11233445667899999999999999999999 9999999988774
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=4.1e-33 Score=299.74 Aligned_cols=224 Identities=17% Similarity=0.212 Sum_probs=169.4
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEe------CCEEEEEEecC-CCCHHHHHHHcC--CCCCHHHHHHHHHHHHHHH
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVE------GDYNVLVMDLL-GPSLEDLFNFCS--RKLSLKTVLMLADQMINRV 88 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~------~~~~~lVmE~~-g~sL~~ll~~~~--~~ls~~~~~~i~~qi~~aL 88 (449)
...+.+|+++++.+ +||||+.+++++.. ++..||||||| |++|.+++.... ..+++..++.++.|++.||
T Consensus 56 ~~~~~~Ei~iL~~L-~HpnIV~l~~v~~~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL 134 (676)
T 3qa8_A 56 RERWCLEIQIMKKL-NHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSAL 134 (676)
T ss_dssp HHHHHHHHHHHHHC-CBTTBCCEEECCTTTCCCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhC-CCCCCCceeeeecccccccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHH
Confidence 45688999999999 89999999998765 67789999999 999999998542 2589999999999999999
Q ss_pred HHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHH
Q 013092 89 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDL 168 (449)
Q Consensus 89 ~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~Di 168 (449)
+|||++||+||||||+|||++.+.....+||+|||++........ .....||+.|+|||++.+..++.++||
T Consensus 135 ~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~~~~~~--------~~~~~gt~~Y~APE~l~~~~~s~ksDI 206 (676)
T 3qa8_A 135 RYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL--------CTEFVGTLQYLAPELLEQKKYTVTVDY 206 (676)
T ss_dssp HHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCCBTTSCCC--------CCCCCSCCTTCSSCSSCCSCCSTTHHH
T ss_pred HHHHHCCCccCCCCHHHeEeecCCCceeEEEcccccccccccccc--------cccccCCcccCChHHhccCCCCchhHH
Confidence 999999999999999999997544455699999999987654322 234679999999999999999999999
Q ss_pred HHHHHHHHHHHhCCCCCCCCCcCCH------HHHHHHHH-hh---------cccchHHHhhcCCcHHHHHHHHHHhcCCC
Q 013092 169 ESLGYVLMYFLRGSLPWQGLKAGTK------KQKYEKIS-EK---------KVSTSIEALCRGYPTEFASYFHYCRSLRF 232 (449)
Q Consensus 169 wSlG~il~elltG~~Pf~~~~~~~~------~~~~~~i~-~~---------~~~~~~~~l~~~~p~el~~li~~cl~~~p 232 (449)
|||||++|+|++|..||........ ......+. .. ........+...+++++.+||..||..||
T Consensus 207 wSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP 286 (676)
T 3qa8_A 207 WSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQ 286 (676)
T ss_dssp HHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSC
T ss_pred HHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCH
Confidence 9999999999999999975311000 00000000 00 00001112233467899999999999999
Q ss_pred CCCCCHHHH-----HHHHHHHHH
Q 013092 233 DDKPDYAYL-----KRIFRDLFI 250 (449)
Q Consensus 233 ~~RPt~~~l-----~~~L~~~~~ 250 (449)
++||++.++ .+.+.+++.
T Consensus 287 ~kRPTa~elL~hp~F~~l~~iL~ 309 (676)
T 3qa8_A 287 RQRGTDPQNPNVGCFQALDSILS 309 (676)
T ss_dssp C---CCTTCCCCTTHHHHHHHHC
T ss_pred hhCcCHHHHhcCHHHHHHHHHHh
Confidence 999998763 344555543
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-32 Score=297.98 Aligned_cols=198 Identities=14% Similarity=0.180 Sum_probs=159.5
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeCCE-----EEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHH
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEGDY-----NVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 91 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~-----~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yL 91 (449)
...+.+|++++..+ +||||+++++++.+.+. .||||||+ |++|.+++. ..+++..++.|+.||+.||+||
T Consensus 123 ~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~~~~~~lv~E~~~g~~L~~~~~---~~l~~~~~~~~~~qi~~aL~~l 198 (681)
T 2pzi_A 123 QAMAMAERQFLAEV-VHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG---QKLPVAEAIAYLLEILPALSYL 198 (681)
T ss_dssp HHHHHHHHGGGGGC-CCTTBCCEEEEEEEECTTSCEEEEEEEECCCCEECC-------CCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhc-CCCCcCeEeeeEeecCCCCCceeEEEEEeCCCCcHHHHHh---CCCCHHHHHHHHHHHHHHHHHH
Confidence 34588999999999 89999999999987654 79999999 899998876 2799999999999999999999
Q ss_pred HHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHH
Q 013092 92 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESL 171 (449)
Q Consensus 92 H~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSl 171 (449)
|++||+||||||+||||+ . +.+||+|||+++..... ....||+.|+|||++.+.. +.++|||||
T Consensus 199 H~~giiHrDlkp~NIll~---~-~~~kl~DFG~a~~~~~~-----------~~~~gt~~y~aPE~~~~~~-~~~sDi~sl 262 (681)
T 2pzi_A 199 HSIGLVYNDLKPENIMLT---E-EQLKLIDLGAVSRINSF-----------GYLYGTPGFQAPEIVRTGP-TVATDIYTV 262 (681)
T ss_dssp HHTTEECCCCSGGGEEEC---S-SCEEECCCTTCEETTCC-----------SCCCCCTTTSCTTHHHHCS-CHHHHHHHH
T ss_pred HHCCCeecccChHHeEEe---C-CcEEEEecccchhcccC-----------CccCCCccccCHHHHcCCC-CCceehhhh
Confidence 999999999999999994 3 48999999999876542 3457999999999998754 899999999
Q ss_pred HHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCC-HHHHHHHHHHHH
Q 013092 172 GYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPD-YAYLKRIFRDLF 249 (449)
Q Consensus 172 G~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt-~~~l~~~L~~~~ 249 (449)
||++|+|++|..||.+...... ..... ...+++++.+||..||+.+|++||+ .+++...|..++
T Consensus 263 G~~l~~l~~g~~~~~~~~~~~~------------~~~~~--~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 327 (681)
T 2pzi_A 263 GRTLAALTLDLPTRNGRYVDGL------------PEDDP--VLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL 327 (681)
T ss_dssp HHHHHHHHSCCCEETTEECSSC------------CTTCH--HHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred HHHHHHHHhCCCCCcccccccc------------ccccc--ccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence 9999999999999875322110 00000 0123578999999999999999995 566766666554
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.97 E-value=5.8e-32 Score=268.75 Aligned_cols=218 Identities=15% Similarity=0.118 Sum_probs=159.8
Q ss_pred cEEEEEeeecc------cCCChhHHHHHHHHHHHhc--------CCCCCceEEEEeE-----------------------
Q 013092 3 EILTVFSVQEN------VKTKHPQLLYESKLYRILQ--------GGTGIPNVRWFGV----------------------- 45 (449)
Q Consensus 3 ~aikV~~k~~~------~~~~~~~~~~E~~il~~l~--------~hp~Iv~l~~~~~----------------------- 45 (449)
+|||++.+... .......+.+|+.+++.|+ .|+||+.+.+.+.
T Consensus 46 vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~ 125 (336)
T 2vuw_A 46 VAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSA 125 (336)
T ss_dssp EEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEEEEEEESSCCHHHHHHHHHHHHHTCCS
T ss_pred EEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhcceeEecCCCcHHHHHHHHHHhhhcccc
Confidence 46666655432 1223377999999999997 5888888877643
Q ss_pred -------eCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH-HCCceecCCCCCcEEEeecC----
Q 013092 46 -------EGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH-SKSFLHRDIKPDNFLMGLGR---- 112 (449)
Q Consensus 46 -------~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH-~~givHRDLKP~NiLl~~~~---- 112 (449)
+.+..||||||| ++++.+.+. ...+++..++.++.||+.||+||| ++||+||||||+||||..+.
T Consensus 126 ~~~~~~~~~~~~~lv~E~~~~g~ll~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~ 203 (336)
T 2vuw_A 126 NDRPDFFKDDQLFIVLEFEFGGIDLEQMR--TKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKL 203 (336)
T ss_dssp SCCSCCCCTTCEEEEEEEECCCEETGGGT--TTCCCHHHHHHHHHHHHHHHHHHHHHHCCBCSCCCGGGEEEEECSCSEE
T ss_pred ccCccccccCeEEEEEEecCCCccHHHHH--hcCCCHHHHHHHHHHHHHHHHHHHHhCCEeECCCCHHHEEEeccCCcce
Confidence 267899999999 776655554 356899999999999999999999 99999999999999996321
Q ss_pred -------------CCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHH-HHHH
Q 013092 113 -------------RANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYV-LMYF 178 (449)
Q Consensus 113 -------------~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~i-l~el 178 (449)
....+||+|||+++..... ...||+.|+|||++.+.. +.++|||||+++ .+++
T Consensus 204 ~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------------~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~ 270 (336)
T 2vuw_A 204 HYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------------IVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNR 270 (336)
T ss_dssp EEEETTEEEEEECTTEEEEECCCTTCBEEETT------------EEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTC
T ss_pred eeeccCccccccCCCceEEEeeccccEecCCC------------cEEEeecccChhhhcCCC-ccceehhhhhCCCCccc
Confidence 1128999999999877542 237999999999999776 999999998777 6778
Q ss_pred HhCCCCCCCCCcCCHHHHHHHHHhh-cc-cchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 013092 179 LRGSLPWQGLKAGTKKQKYEKISEK-KV-STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 242 (449)
Q Consensus 179 ltG~~Pf~~~~~~~~~~~~~~i~~~-~~-~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~ 242 (449)
+.|..||.+... .......+... .. ..........+++++.+||..||+.+ ++.+++
T Consensus 271 ~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 271 WGEYHPYSNVLW--LHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp TTSCCTHHHHHH--HHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHH
T ss_pred ccccCCCcchhh--hhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----CHHHHH
Confidence 889999954100 01112222211 11 11112234457889999999999976 666654
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.6e-31 Score=283.17 Aligned_cols=167 Identities=17% Similarity=0.171 Sum_probs=123.0
Q ss_pred cEEEEEeeecccC--------CChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCC
Q 013092 3 EILTVFSVQENVK--------TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLS 73 (449)
Q Consensus 3 ~aikV~~k~~~~~--------~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls 73 (449)
.++|++.+..... ...++|.+|+++|+++.+|+||++++++|++++..||||||| |++|.+++.. .++++
T Consensus 262 ~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~-~~~l~ 340 (569)
T 4azs_A 262 YVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAA-GEEID 340 (569)
T ss_dssp EEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHHT-TCCCC
T ss_pred eEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHHh-CCCCC
Confidence 3677776543221 223569999999999999999999999999999999999999 9999999985 56677
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccc
Q 013092 74 LKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYAS 153 (449)
Q Consensus 74 ~~~~~~i~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~a 153 (449)
.. .|+.||+.||+|||++|||||||||+|||| +.++.+||+|||+|+........ ....+||+.|||
T Consensus 341 ~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL---~~dg~vKL~DFGlAr~~~~~~~~-------~~t~vGTp~YmA 407 (569)
T 4azs_A 341 RE---KILGSLLRSLAALEKQGFWHDDVRPWNVMV---DARQHARLIDFGSIVTTPQDCSW-------PTNLVQSFFVFV 407 (569)
T ss_dssp HH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEE---CTTSCEEECCCTTEESCC---CC-------SHHHHHHHHHHH
T ss_pred HH---HHHHHHHHHHHHHHHCCceeccCchHhEEE---CCCCCEEEeecccCeeCCCCCcc-------ccCceechhhcc
Confidence 65 478999999999999999999999999999 68899999999999876554321 245689999999
Q ss_pred hhhhhCCCCChhhHHHHHHHHHHHHHhCCCC
Q 013092 154 MNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 184 (449)
Q Consensus 154 PE~~~~~~~s~~~DiwSlG~il~elltG~~P 184 (449)
||++.+. +...+|+|++|+++++|+++..+
T Consensus 408 PE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 408 NELFAEN-KSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp HHHC------------------CCCCTTHHH
T ss_pred HHHhCCC-CCCcccccccccchhhhccccch
Confidence 9999864 56789999999998877655433
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=3.3e-24 Score=226.99 Aligned_cols=153 Identities=20% Similarity=0.212 Sum_probs=125.8
Q ss_pred hHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q 013092 19 PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFL 97 (449)
Q Consensus 19 ~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~giv 97 (449)
+.+.+|+++|+.+ +||||+.+..++...+..||||||| |++|.+++.. ++.++.|++.||+|||++||+
T Consensus 384 ~~~~~E~~il~~l-~h~nIv~~~~~~~~~~~~~lVmE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~~gIi 453 (540)
T 3en9_A 384 SRTAREARYLALV-KDFGIPAPYIFDVDLDNKRIMMSYINGKLAKDVIED---------NLDIAYKIGEIVGKLHKNDVI 453 (540)
T ss_dssp HHHHHHHHHHHHG-GGGTCCCCCEEEEETTTTEEEEECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHHHHhc-CCCCcCceEEEEEeCCccEEEEECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHHHCcCc
Confidence 3479999999999 8999997777777788889999999 8999999873 568999999999999999999
Q ss_pred ecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhC--CCCChhhHHHHHHHHH
Q 013092 98 HRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG--IEQSRRDDLESLGYVL 175 (449)
Q Consensus 98 HRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~--~~~s~~~DiwSlG~il 175 (449)
||||||+|||+. . .+||+|||+++............+.......||+.|||||++.. ..|+...|+|+..+-.
T Consensus 454 HrDiKp~NILl~---~--~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~ 528 (540)
T 3en9_A 454 HNDLTTSNFIFD---K--DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILEL 528 (540)
T ss_dssp CTTCCTTSEEES---S--SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHH
T ss_pred cCCCCHHHEEEC---C--eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHH
Confidence 999999999993 4 99999999999875432111000111235689999999999987 5577888999999999
Q ss_pred HHHHhCCCCCC
Q 013092 176 MYFLRGSLPWQ 186 (449)
Q Consensus 176 ~elltG~~Pf~ 186 (449)
.+.+.++.+|.
T Consensus 529 l~~v~~r~rY~ 539 (540)
T 3en9_A 529 MKDVERRARYV 539 (540)
T ss_dssp HHHHHTCSCCC
T ss_pred HHHHHhccccC
Confidence 88888877763
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.72 E-value=2.4e-18 Score=167.27 Aligned_cols=103 Identities=19% Similarity=0.267 Sum_probs=82.7
Q ss_pred hHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q 013092 19 PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFL 97 (449)
Q Consensus 19 ~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~giv 97 (449)
..+.+|+.+|+.+. |.+++.++ . .+..||||||+ |++|.+ +. . .....++.|++.||+|||++||+
T Consensus 149 ~~~~~E~~~l~~l~-~~~v~~~~---~-~~~~~lvmE~~~g~~L~~-l~-----~--~~~~~i~~qi~~~l~~lH~~gii 215 (282)
T 1zar_A 149 RSARNEFRALQKLQ-GLAVPKVY---A-WEGNAVLMELIDAKELYR-VR-----V--ENPDEVLDMILEEVAKFYHRGIV 215 (282)
T ss_dssp HHHHHHHHHHHHTT-TSSSCCEE---E-EETTEEEEECCCCEEGGG-CC-----C--SCHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHHHHhcc-CCCcCeEE---e-ccceEEEEEecCCCcHHH-cc-----h--hhHHHHHHHHHHHHHHHHHCCCE
Confidence 45889999999996 45554433 2 24569999999 889987 32 1 23457999999999999999999
Q ss_pred ecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhh
Q 013092 98 HRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHL 158 (449)
Q Consensus 98 HRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~ 158 (449)
||||||+|||+ + ++.+||+|||+++. +..|+|||++.
T Consensus 216 HrDlkp~NILl---~-~~~vkl~DFG~a~~--------------------~~~~~a~e~l~ 252 (282)
T 1zar_A 216 HGDLSQYNVLV---S-EEGIWIIDFPQSVE--------------------VGEEGWREILE 252 (282)
T ss_dssp CSCCSTTSEEE---E-TTEEEECCCTTCEE--------------------TTSTTHHHHHH
T ss_pred eCCCCHHHEEE---E-CCcEEEEECCCCeE--------------------CCCCCHHHHHH
Confidence 99999999999 4 78999999999863 34578899874
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.58 E-value=1.4e-15 Score=145.60 Aligned_cols=95 Identities=23% Similarity=0.293 Sum_probs=75.9
Q ss_pred HHHHHHHHHHHhcCCCC--CceEEEEeEeCCEEEEEEecCC--C----CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHH
Q 013092 20 QLLYESKLYRILQGGTG--IPNVRWFGVEGDYNVLVMDLLG--P----SLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 91 (449)
Q Consensus 20 ~~~~E~~il~~l~~hp~--Iv~l~~~~~~~~~~~lVmE~~g--~----sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yL 91 (449)
.+.+|+.+|..| .|++ ++.++.+ ...||||||+| + +|.++... +++..+..++.|++.+|.||
T Consensus 116 ~~~~E~~~l~~l-~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~l 186 (258)
T 1zth_A 116 WTEKEFRNLERA-KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRL 186 (258)
T ss_dssp HHHHHHHHHHHH-HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHH-HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHH
Confidence 578999999999 5554 4445543 35789999994 3 77776442 33556788999999999999
Q ss_pred H-HCCceecCCCCCcEEEeecCCCCeEEEeecCcceee
Q 013092 92 H-SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 128 (449)
Q Consensus 92 H-~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~ 128 (449)
| ++||+||||||+|||+. . .++|+|||+|...
T Consensus 187 H~~~givHrDlkp~NILl~---~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 187 YQEAELVHADLSEYNIMYI---D--KVYFIDMGQAVTL 219 (258)
T ss_dssp HHTSCEECSSCSTTSEEES---S--SEEECCCTTCEET
T ss_pred HHHCCEEeCCCCHHHEEEc---C--cEEEEECcccccC
Confidence 9 99999999999999993 4 8999999999754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.21 E-value=9.2e-12 Score=125.53 Aligned_cols=96 Identities=18% Similarity=0.211 Sum_probs=68.4
Q ss_pred HHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecC
Q 013092 22 LYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRD 100 (449)
Q Consensus 22 ~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~givHRD 100 (449)
.+|...|.+| .+.+|.....+.... .+|||||+ |..|.++.. ...+..++.||+.+|.+||++||||||
T Consensus 161 ~kE~~nL~rL-~~~gv~vp~p~~~~~--~~LVME~i~G~~L~~l~~-------~~~~~~l~~qll~~l~~lH~~gIVHrD 230 (397)
T 4gyi_A 161 IKEFAFMKAL-YEEGFPVPEPIAQSR--HTIVMSLVDALPMRQVSS-------VPDPASLYADLIALILRLAKHGLIHGD 230 (397)
T ss_dssp HHHHHHHHHH-HHTTCSCCCEEEEET--TEEEEECCSCEEGGGCCC-------CSCHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred HHHHHHHHHH-HhcCCCCCeeeeccC--ceEEEEecCCccHhhhcc-------cHHHHHHHHHHHHHHHHHHHCCCcCCC
Confidence 3577778887 445554333332222 47999999 777765432 223456889999999999999999999
Q ss_pred CCCCcEEEeecCCC-------CeEEEeecCccee
Q 013092 101 IKPDNFLMGLGRRA-------NQVYIIDFGLAKK 127 (449)
Q Consensus 101 LKP~NiLl~~~~~~-------~~vkL~DFGla~~ 127 (449)
|||.|||+..+... ..++|+||+-+..
T Consensus 231 LKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 231 FNEFNILIREEKDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp CSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred CCHHHEEEeCCCCcccccccccceEEEEeCCccc
Confidence 99999999643211 1489999997754
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.06 E-value=6.2e-10 Score=105.64 Aligned_cols=100 Identities=18% Similarity=0.266 Sum_probs=81.7
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH---
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS--- 93 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~--- 93 (449)
...+.+|+++++.|..+..|+.+++++.+.+..|+||||+ |.+|.+.+. +......++.+++.+|..||+
T Consensus 53 ~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~------~~~~~~~~~~~l~~~l~~LH~~~~ 126 (263)
T 3tm0_A 53 TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYE------DEQSPEKIIELYAECIRLFHSIDI 126 (263)
T ss_dssp TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHCC------TTTCHHHHHHHHHHHHHHHHHSCC
T ss_pred HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCeehhhccC------CcccHHHHHHHHHHHHHHHhCCCc
Confidence 3469999999999977788999999999999999999999 888877531 122334678899999999998
Q ss_pred --------------------------------------------------------CCceecCCCCCcEEEeecCCCCeE
Q 013092 94 --------------------------------------------------------KSFLHRDIKPDNFLMGLGRRANQV 117 (449)
Q Consensus 94 --------------------------------------------------------~givHRDLKP~NiLl~~~~~~~~v 117 (449)
..++|+|++|.|||+. .+..+
T Consensus 127 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~---~~~~~ 203 (263)
T 3tm0_A 127 SDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVK---DGKVS 203 (263)
T ss_dssp TTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEE---TTEEE
T ss_pred ccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEE---CCcEE
Confidence 4589999999999993 44456
Q ss_pred EEeecCcce
Q 013092 118 YIIDFGLAK 126 (449)
Q Consensus 118 kL~DFGla~ 126 (449)
.|+||+.+.
T Consensus 204 ~lIDwe~a~ 212 (263)
T 3tm0_A 204 GFIDLGRSG 212 (263)
T ss_dssp EECCCTTCE
T ss_pred EEEEchhcc
Confidence 799998764
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.85 E-value=3.6e-09 Score=99.52 Aligned_cols=97 Identities=18% Similarity=0.094 Sum_probs=73.0
Q ss_pred hhHHHHHHHHHHHhcCCCC-CceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 013092 18 HPQLLYESKLYRILQGGTG-IPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 95 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~-Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~g 95 (449)
...+.+|+.+++.|.++.- |+.++.++..++..|+||||+ |.+|. .. .... ..++.+++..|..||+..
T Consensus 57 ~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~--~~----~~~~---~~~~~~l~~~l~~lh~~~ 127 (264)
T 1nd4_A 57 LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL--SS----HLAP---AEKVSIMADAMRRLHTLD 127 (264)
T ss_dssp TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--TS----CCCH---HHHHHHHHHHHHHHTTSC
T ss_pred chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--cC----cCCH---hHHHHHHHHHHHHHhCCC
Confidence 3568999999999976633 677888888888899999999 77773 11 1222 245667777777777643
Q ss_pred ----------------------------------------------------------ceecCCCCCcEEEeecCCCCeE
Q 013092 96 ----------------------------------------------------------FLHRDIKPDNFLMGLGRRANQV 117 (449)
Q Consensus 96 ----------------------------------------------------------ivHRDLKP~NiLl~~~~~~~~v 117 (449)
++|+|++|.|||+. .++.+
T Consensus 128 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~---~~~~~ 204 (264)
T 1nd4_A 128 PATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVE---NGRFS 204 (264)
T ss_dssp GGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEE---TTEEE
T ss_pred CCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEE---CCcEE
Confidence 99999999999993 44456
Q ss_pred EEeecCcce
Q 013092 118 YIIDFGLAK 126 (449)
Q Consensus 118 kL~DFGla~ 126 (449)
.|+||+.+.
T Consensus 205 ~liD~~~a~ 213 (264)
T 1nd4_A 205 GFIDCGRLG 213 (264)
T ss_dssp EECCCTTCE
T ss_pred EEEcchhcc
Confidence 699999874
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.76 E-value=6.4e-09 Score=101.18 Aligned_cols=160 Identities=17% Similarity=0.224 Sum_probs=102.2
Q ss_pred hhHHHHHHHHHHHhcCCCC--CceEEEEeEeCC---EEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHH
Q 013092 18 HPQLLYESKLYRILQGGTG--IPNVRWFGVEGD---YNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 91 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~--Iv~l~~~~~~~~---~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yL 91 (449)
...+.+|.++|+.|..+.. ++.++..+...+ ..|+||+++ |..|.+... ..++.++...++.|++..|..|
T Consensus 54 ~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G~~l~~~~~---~~l~~~~~~~~~~~l~~~la~L 130 (304)
T 3sg8_A 54 STNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKGVPLTPLLL---NNLPKQSQNQAAKDLARFLSEL 130 (304)
T ss_dssp HHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCCEECCHHHH---HTSCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCCeECCcccc---ccCCHHHHHHHHHHHHHHHHHH
Confidence 4578999999999855543 556666655443 458999999 877765432 2477888888888999888888
Q ss_pred HH----------------------------------------------------------CCceecCCCCCcEEEeecCC
Q 013092 92 HS----------------------------------------------------------KSFLHRDIKPDNFLMGLGRR 113 (449)
Q Consensus 92 H~----------------------------------------------------------~givHRDLKP~NiLl~~~~~ 113 (449)
|+ ..++|+|++|.||++..+ .
T Consensus 131 H~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~-~ 209 (304)
T 3sg8_A 131 HSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTE-K 209 (304)
T ss_dssp HHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETT-T
T ss_pred HcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCC-C
Confidence 86 237999999999999511 1
Q ss_pred CCeEEEeecCcceeecCCCCCcccccccCCCCccC---------ccccc-hhhhhCCCCChhhHHHHHHHHHHHHHhCCC
Q 013092 114 ANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGT---------ARYAS-MNTHLGIEQSRRDDLESLGYVLMYFLRGSL 183 (449)
Q Consensus 114 ~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT---------~~Y~a-PE~~~~~~~s~~~DiwSlG~il~elltG~~ 183 (449)
...+.|+||+.+...... .....-.... ...+. ..+.. |+.... .....++|++++++|.+.+|..
T Consensus 210 ~~~~~~iD~~~~~~~~~~-~Dl~~~~~~~-~~~~~~~~~~~l~~Y~~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~ 285 (304)
T 3sg8_A 210 NTICGIIDFGDAAISDPD-NDFISLMEDD-EEYGMEFVSKILNHYKHKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYM 285 (304)
T ss_dssp TEEEEECCCTTCEEECTT-HHHHTTCCTT-TSCCHHHHHHHHHHHTCSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCH
T ss_pred CCEEEEEeCCCCccCChH-HHHHHHHhhc-cccCHHHHHHHHHHcCCCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCH
Confidence 456789999998754221 1000000000 00000 00111 222111 1223689999999999999988
Q ss_pred CC
Q 013092 184 PW 185 (449)
Q Consensus 184 Pf 185 (449)
+|
T Consensus 286 ~~ 287 (304)
T 3sg8_A 286 DW 287 (304)
T ss_dssp HH
T ss_pred HH
Confidence 77
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.72 E-value=3.3e-08 Score=98.34 Aligned_cols=104 Identities=17% Similarity=0.259 Sum_probs=81.4
Q ss_pred hhHHHHHHHHHHHhcC-CCCCceEEEEeEeC---CEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH
Q 013092 18 HPQLLYESKLYRILQG-GTGIPNVRWFGVEG---DYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 92 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~-hp~Iv~l~~~~~~~---~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH 92 (449)
...+.+|.++++.|.. +..|++++.++.+. +..|+||||+ |..|.+.. ...++......++.+++..|..||
T Consensus 80 ~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~v~G~~l~~~~---~~~l~~~~~~~~~~~l~~~La~LH 156 (359)
T 3dxp_A 80 AHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEFVSGRVLWDQS---LPGMSPAERTAIYDEMNRVIAAMH 156 (359)
T ss_dssp --CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEECCCCBCCCCTT---CTTCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEecCCeecCCCc---cccCCHHHHHHHHHHHHHHHHHHh
Confidence 3478999999999964 34588888888776 4589999999 76664311 224778888899999999999999
Q ss_pred H----------------------------------------------------------CCceecCCCCCcEEEeecCCC
Q 013092 93 S----------------------------------------------------------KSFLHRDIKPDNFLMGLGRRA 114 (449)
Q Consensus 93 ~----------------------------------------------------------~givHRDLKP~NiLl~~~~~~ 114 (449)
. .+++|+|++|.|||+. .+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~---~~ 233 (359)
T 3dxp_A 157 TVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFH---PT 233 (359)
T ss_dssp HSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEEC---SS
T ss_pred CCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEe---CC
Confidence 7 3699999999999994 33
Q ss_pred --CeEEEeecCccee
Q 013092 115 --NQVYIIDFGLAKK 127 (449)
Q Consensus 115 --~~vkL~DFGla~~ 127 (449)
..+.|+||+.+..
T Consensus 234 ~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 234 EPRVLAVLDWELSTL 248 (359)
T ss_dssp SSCEEEECCCTTCEE
T ss_pred CCcEEEEECcccccc
Confidence 3468999998864
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.26 E-value=5.4e-06 Score=80.65 Aligned_cols=107 Identities=26% Similarity=0.292 Sum_probs=72.8
Q ss_pred hhHHHHHHHHHHHhcCCC--CCceEEEEeE-eCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH
Q 013092 18 HPQLLYESKLYRILQGGT--GIPNVRWFGV-EGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 93 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp--~Iv~l~~~~~-~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~ 93 (449)
...+.+|.++|+.|.++. .|+.++.++. ..+..|+|||++ |..|.+..- ..++......++.++...|..||+
T Consensus 53 ~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~l~~~~~---~~l~~~~~~~~~~~lg~~La~LH~ 129 (306)
T 3tdw_A 53 ADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQILGEDGM---AVLPDDAKDRLALQLAEFMNELSA 129 (306)
T ss_dssp HHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEECHHHHH---TTSCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeECchhhh---hhCCHHHHHHHHHHHHHHHHHHhc
Confidence 456899999999997653 3677777775 456789999999 777765321 124445555555555555555553
Q ss_pred C------------------------------------------------------------CceecCCCCCcEEEeecCC
Q 013092 94 K------------------------------------------------------------SFLHRDIKPDNFLMGLGRR 113 (449)
Q Consensus 94 ~------------------------------------------------------------givHRDLKP~NiLl~~~~~ 113 (449)
. .++|+|++|.|||+..+..
T Consensus 130 ~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~ 209 (306)
T 3tdw_A 130 FPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSR 209 (306)
T ss_dssp SCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCS
T ss_pred CCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCC
Confidence 2 3599999999999942111
Q ss_pred CCe-EEEeecCccee
Q 013092 114 ANQ-VYIIDFGLAKK 127 (449)
Q Consensus 114 ~~~-vkL~DFGla~~ 127 (449)
.+. +.|+||+.+..
T Consensus 210 ~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 210 QTPLTGIIDFGDAAI 224 (306)
T ss_dssp SCCEEEECCCTTCEE
T ss_pred CCceEEEEehhhcCC
Confidence 344 58999998754
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.23 E-value=5.1e-06 Score=78.70 Aligned_cols=101 Identities=17% Similarity=0.163 Sum_probs=75.4
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC--
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK-- 94 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~-- 94 (449)
...+.+|..+|+.|..+--|++++.++.+.+..|+|||++ |.++.+..... ......++.+++..|..||..
T Consensus 63 ~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~~~~~~-----~~~~~~~~~~l~~~L~~Lh~~~~ 137 (272)
T 4gkh_A 63 ANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEY-----PDSGENIVDALAVFLRRLHSIPV 137 (272)
T ss_dssp HHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHHHHHHC-----GGGHHHHHHHHHHHHHHHHTSCG
T ss_pred HhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccccccCC-----HHHHHHHHHHHHHHHHHhcCCCc
Confidence 3468899999999977666889999999999999999999 87887765421 122234455555556666521
Q ss_pred --------------------------------------------------------CceecCCCCCcEEEeecCCCCeEE
Q 013092 95 --------------------------------------------------------SFLHRDIKPDNFLMGLGRRANQVY 118 (449)
Q Consensus 95 --------------------------------------------------------givHRDLKP~NiLl~~~~~~~~vk 118 (449)
.++|+|+.+.|||+. ..+.+-
T Consensus 138 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~---~~~~~~ 214 (272)
T 4gkh_A 138 CNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFD---EGKLIG 214 (272)
T ss_dssp GGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEE---TTEEEE
T ss_pred ccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEE---CCeEEE
Confidence 278999999999993 455567
Q ss_pred EeecCcce
Q 013092 119 IIDFGLAK 126 (449)
Q Consensus 119 L~DFGla~ 126 (449)
|+||+.+.
T Consensus 215 viDwe~a~ 222 (272)
T 4gkh_A 215 CIDVGRVG 222 (272)
T ss_dssp ECCCTTCE
T ss_pred EEECcccc
Confidence 99998774
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.80 E-value=1.9e-05 Score=78.01 Aligned_cols=43 Identities=23% Similarity=0.407 Sum_probs=33.4
Q ss_pred hHHHHHHHHHHHhcCC--CCCceEEEEeEeC---CEEEEEEecC-CCCH
Q 013092 19 PQLLYESKLYRILQGG--TGIPNVRWFGVEG---DYNVLVMDLL-GPSL 61 (449)
Q Consensus 19 ~~~~~E~~il~~l~~h--p~Iv~l~~~~~~~---~~~~lVmE~~-g~sL 61 (449)
..+.+|+.+|+.|..+ -.|++++.++.+. +..|+||||+ |..|
T Consensus 72 ~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~g~~~~v~e~l~G~~l 120 (357)
T 3ats_A 72 YRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVLGTPFFLMDYVEGVVP 120 (357)
T ss_dssp CCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTTSSCEEEEECCCCBCC
T ss_pred hHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCccCCceEEEEecCCCCh
Confidence 5689999999999765 3578888887655 4578999999 6543
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.27 E-value=0.005 Score=56.59 Aligned_cols=123 Identities=13% Similarity=0.111 Sum_probs=78.2
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCccc
Q 013092 59 PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHI 137 (449)
Q Consensus 59 ~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~-~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~ 137 (449)
-+|.+++...+.+++++++|.++.|++.+|.-+-. +.-..+=+-|..|+| ..+|.|.+.+ ..+.
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l---~~dG~V~f~~-~~s~----------- 97 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRV---WRDGAVTLAP-AADD----------- 97 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEE---ETTSCEEECC-C--------------
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEE---ecCCceeccc-cccc-----------
Confidence 47999999889999999999999999999877632 111123334577777 4667666653 1110
Q ss_pred ccccCCCCccCccccchhhhhCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCc
Q 013092 138 PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYP 217 (449)
Q Consensus 138 ~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p 217 (449)
.....+.+||... ...+.+.=|||||++||.-+-=.+|=. ....++
T Consensus 98 --------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e~-------------------------eE~eLS 143 (229)
T 2yle_A 98 --------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKEN-------------------------EERELS 143 (229)
T ss_dssp -----------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCTT-------------------------EEECCC
T ss_pred --------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCcc-------------------------cchhhC
Confidence 1122455777653 345688899999999999886333311 113467
Q ss_pred HHHHHHHHHHhcC
Q 013092 218 TEFASYFHYCRSL 230 (449)
Q Consensus 218 ~el~~li~~cl~~ 230 (449)
+.+..||..|...
T Consensus 144 ~~LE~LL~~Mt~~ 156 (229)
T 2yle_A 144 PPLEQLIDHMANT 156 (229)
T ss_dssp HHHHHHHHHHTTC
T ss_pred HHHHHHHHHHHhc
Confidence 8888888888655
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.24 E-value=0.002 Score=62.38 Aligned_cols=30 Identities=23% Similarity=0.473 Sum_probs=25.9
Q ss_pred CCceecCCCCCcEEEeecCCCCeEEEeecCcce
Q 013092 94 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 126 (449)
Q Consensus 94 ~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~ 126 (449)
.+++|+|+++.|||+ +.++.+.|+||+.+.
T Consensus 222 ~~l~HgD~~~~Nil~---~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 222 PNLCHQDYGTGNTLL---GENEQIWVIDLDTVS 251 (346)
T ss_dssp CCEECSSCSTTSEEE---CGGGCEEECCCTTCE
T ss_pred CceecCCCCcccEEE---eCCCcEEEEehhhcc
Confidence 679999999999999 456789999998764
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.06 E-value=0.0015 Score=63.73 Aligned_cols=107 Identities=21% Similarity=0.211 Sum_probs=62.2
Q ss_pred hHHHHHHHHHHHhcCCC-CCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHc-------------------C------CC
Q 013092 19 PQLLYESKLYRILQGGT-GIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFC-------------------S------RK 71 (449)
Q Consensus 19 ~~~~~E~~il~~l~~hp-~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~-------------------~------~~ 71 (449)
..+..|+.+++.|..+. .+++++.+..+.+ ++|||++ +..+.+++... . ..
T Consensus 57 ~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~ 134 (333)
T 3csv_A 57 GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELAR 134 (333)
T ss_dssp CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCB
T ss_pred ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCc
Confidence 56788999999996543 3667777644443 7899999 55665443211 0 01
Q ss_pred CCHHHHHH--------HH------------HHHHHHHHHH------HHCCceecCCCCCcEEEeecCC-CCeEEEeecCc
Q 013092 72 LSLKTVLM--------LA------------DQMINRVEFV------HSKSFLHRDIKPDNFLMGLGRR-ANQVYIIDFGL 124 (449)
Q Consensus 72 ls~~~~~~--------i~------------~qi~~aL~yL------H~~givHRDLKP~NiLl~~~~~-~~~vkL~DFGl 124 (449)
+....... +. ..+...++.+ +...++|+|+.+.|||+..+.. .+.+.|+||+.
T Consensus 135 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~ 214 (333)
T 3csv_A 135 LDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQD 214 (333)
T ss_dssp CCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTT
T ss_pred cCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCC
Confidence 22211100 00 0111222233 1347999999999999941100 25789999998
Q ss_pred cee
Q 013092 125 AKK 127 (449)
Q Consensus 125 a~~ 127 (449)
+..
T Consensus 215 a~~ 217 (333)
T 3csv_A 215 AKL 217 (333)
T ss_dssp CEE
T ss_pred cCc
Confidence 864
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.00 E-value=0.0021 Score=61.72 Aligned_cols=28 Identities=25% Similarity=0.424 Sum_probs=23.7
Q ss_pred CceecCCCCCcEEEeecCCCCeEEEeecCcce
Q 013092 95 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 126 (449)
Q Consensus 95 givHRDLKP~NiLl~~~~~~~~vkL~DFGla~ 126 (449)
.++|+|+.+.||+. .++.+.|+||..+.
T Consensus 174 ~l~HgDl~~~Nil~----~~~~~~lID~e~a~ 201 (301)
T 3dxq_A 174 AACHCDPLCENFLD----TGERMWIVDWEYSG 201 (301)
T ss_dssp EEECSCCCGGGEEE----CSSCEEECCCTTCE
T ss_pred eeeccCCCcCCEEE----CCCCEEEEeccccc
Confidence 48999999999995 45678999998775
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=96.75 E-value=0.0042 Score=62.04 Aligned_cols=38 Identities=21% Similarity=0.145 Sum_probs=27.7
Q ss_pred hHHHHHHHHHHHhcCC--CCCceEEEEeEeCCEEEEEEecCC
Q 013092 19 PQLLYESKLYRILQGG--TGIPNVRWFGVEGDYNVLVMDLLG 58 (449)
Q Consensus 19 ~~~~~E~~il~~l~~h--p~Iv~l~~~~~~~~~~~lVmE~~g 58 (449)
..+..|.++|+.+... ..++.++.+ +.+..+||||++.
T Consensus 79 ~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~lvmE~l~ 118 (397)
T 2olc_A 79 DRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTVMEDLS 118 (397)
T ss_dssp THHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEEECCCT
T ss_pred HHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEEEEEeCC
Confidence 4578899999998653 346667655 4455789999993
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=96.43 E-value=0.013 Score=59.00 Aligned_cols=32 Identities=13% Similarity=0.335 Sum_probs=26.3
Q ss_pred HHCCceecCCCCCcEEEeecCCCCeEEEeecCccee
Q 013092 92 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 127 (449)
Q Consensus 92 H~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~ 127 (449)
+...++|+|++|.|||+. .++ ++|+||+.+..
T Consensus 230 ~~~~liHGDl~~~Nil~~---~~~-~~lID~e~a~~ 261 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVT---QDS-TQVIDPEFSFY 261 (420)
T ss_dssp BCCEEECSCCSGGGEEEC---SSC-EEECCCTTCEE
T ss_pred CCCeEEecCCCCCcEEEe---CCC-CEEEeCccccc
Confidence 356799999999999993 334 99999998864
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=96.41 E-value=0.0095 Score=57.92 Aligned_cols=43 Identities=16% Similarity=0.212 Sum_probs=36.2
Q ss_pred hhHHHHHHHHHHHhcCC--CCCceEEEEeEeCCEEEEEEecC-CCC
Q 013092 18 HPQLLYESKLYRILQGG--TGIPNVRWFGVEGDYNVLVMDLL-GPS 60 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~h--p~Iv~l~~~~~~~~~~~lVmE~~-g~s 60 (449)
...+..|.++|+.|... ..|++++.++...+..|+||||+ |..
T Consensus 72 ~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~ 117 (312)
T 3jr1_A 72 RSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSK 117 (312)
T ss_dssp HHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCC
T ss_pred HHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCC
Confidence 45689999999999653 67889999998888999999999 654
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.11 E-value=0.011 Score=58.97 Aligned_cols=106 Identities=20% Similarity=0.254 Sum_probs=65.1
Q ss_pred ChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHH--------------HHHHHc-C------CCCC-
Q 013092 17 KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLE--------------DLFNFC-S------RKLS- 73 (449)
Q Consensus 17 ~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~--------------~ll~~~-~------~~ls- 73 (449)
....+.+|.++++.|..+.-.+++++++.++ +||||+ |..|. +.+.+. . +...
T Consensus 96 ~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~g----~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~ 171 (379)
T 3feg_A 96 GVDSLVLESVMFAILAERSLGPQLYGVFPEG----RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHW 171 (379)
T ss_dssp CHHHHHHHHHHHHHHHHTTSSCCEEEEETTE----EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCH
T ss_pred hHHHHHHHHHHHHHHHhcCCCCeEEEEcCCc----cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCccc
Confidence 3456779999999997766668887776542 999999 54331 112111 1 1122
Q ss_pred -HHHHHHHHHHHHH-------------------HHHHHH----H----CCceecCCCCCcEEEeec-CCCCeEEEeecCc
Q 013092 74 -LKTVLMLADQMIN-------------------RVEFVH----S----KSFLHRDIKPDNFLMGLG-RRANQVYIIDFGL 124 (449)
Q Consensus 74 -~~~~~~i~~qi~~-------------------aL~yLH----~----~givHRDLKP~NiLl~~~-~~~~~vkL~DFGl 124 (449)
+..+..+..++.. .++.|. . ..++|+|+.+.|||+..+ +..+.+.|+||..
T Consensus 172 l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~ 251 (379)
T 3feg_A 172 LFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEY 251 (379)
T ss_dssp HHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTT
T ss_pred HHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEeccc
Confidence 3455555544422 233332 2 259999999999999522 1136899999987
Q ss_pred ce
Q 013092 125 AK 126 (449)
Q Consensus 125 a~ 126 (449)
+.
T Consensus 252 a~ 253 (379)
T 3feg_A 252 SS 253 (379)
T ss_dssp CE
T ss_pred CC
Confidence 74
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=95.86 E-value=0.029 Score=53.94 Aligned_cols=106 Identities=19% Similarity=0.231 Sum_probs=60.4
Q ss_pred hhHHHHHHHHHHHhcCCC-CCceEEEE------eEeCCEEEEEEecC-CCCHH-----------HHH---HHcCCCC---
Q 013092 18 HPQLLYESKLYRILQGGT-GIPNVRWF------GVEGDYNVLVMDLL-GPSLE-----------DLF---NFCSRKL--- 72 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp-~Iv~l~~~------~~~~~~~~lVmE~~-g~sL~-----------~ll---~~~~~~l--- 72 (449)
...+..|..+++.|..+. .++.++.. ....+..+++|+|+ |..+. +.+ +.....+
T Consensus 59 ~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~ 138 (322)
T 2ppq_A 59 KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIK 138 (322)
T ss_dssp CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCC
T ss_pred HHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCc
Confidence 456888999999986442 14554422 22356789999999 64321 111 1111111
Q ss_pred -----C---HHHHHH------------HHHHHHHHHHHHHH-------CCceecCCCCCcEEEeecCCCCeEEEeecCcc
Q 013092 73 -----S---LKTVLM------------LADQMINRVEFVHS-------KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 125 (449)
Q Consensus 73 -----s---~~~~~~------------i~~qi~~aL~yLH~-------~givHRDLKP~NiLl~~~~~~~~vkL~DFGla 125 (449)
. |...+. +...+...++.+.. .+++|+|+.+.|||+. .++.+.|+||+.+
T Consensus 139 ~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~---~~~~~~lIDf~~a 215 (322)
T 2ppq_A 139 RPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFL---GDELSGLIDFYFA 215 (322)
T ss_dssp CBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEE---TTEEEEECCCTTC
T ss_pred ccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEe---CCceEEEecchhc
Confidence 1 111000 00113444555553 3699999999999994 4444579999876
Q ss_pred e
Q 013092 126 K 126 (449)
Q Consensus 126 ~ 126 (449)
.
T Consensus 216 ~ 216 (322)
T 2ppq_A 216 C 216 (322)
T ss_dssp E
T ss_pred c
Confidence 4
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=95.44 E-value=0.079 Score=50.94 Aligned_cols=29 Identities=24% Similarity=0.265 Sum_probs=24.2
Q ss_pred CCceecCCCCCcEEEeecCCCCeEEEeecCccee
Q 013092 94 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 127 (449)
Q Consensus 94 ~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~ 127 (449)
..++|+|+++.|||+. + .+.|+||+.+..
T Consensus 195 ~~l~HgD~~~~Nil~~----~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 195 VLRLHGDCHAGNILWR----D-GPMFVDLDDARN 223 (328)
T ss_dssp CEECCSSCSGGGEEES----S-SEEECCCTTCCE
T ss_pred eeeeeCCCCcccEeEc----C-CCEEEECCCCCc
Confidence 4589999999999993 2 799999987753
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=95.29 E-value=0.018 Score=56.74 Aligned_cols=28 Identities=25% Similarity=0.496 Sum_probs=23.1
Q ss_pred CceecCCCCCcEEEeecCCCCeEEEeecCcce
Q 013092 95 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 126 (449)
Q Consensus 95 givHRDLKP~NiLl~~~~~~~~vkL~DFGla~ 126 (449)
+++|+|+.+.|||+. .+.+.|+||..+.
T Consensus 213 ~l~HgDl~~~Nil~~----~~~~~lID~e~a~ 240 (369)
T 3c5i_A 213 VFCHNDLQENNIINT----NKCLRLIDFEYSG 240 (369)
T ss_dssp EEECSCCCGGGEEEC----C-CEEECCCTTCE
T ss_pred EEEeCCCCcccEEec----CCcEEEEEecCCC
Confidence 599999999999993 3458999998775
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=94.96 E-value=0.062 Score=54.41 Aligned_cols=36 Identities=14% Similarity=0.109 Sum_probs=27.3
Q ss_pred hHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-C
Q 013092 19 PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-G 58 (449)
Q Consensus 19 ~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g 58 (449)
..+..|..+++.|..+...+++++.+.+ .+||||+ |
T Consensus 120 ~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e~l~G 156 (429)
T 1nw1_A 120 SHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYIPS 156 (429)
T ss_dssp HHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCCCE
T ss_pred HHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEEEeCC
Confidence 5778999999999766556777766542 3899999 5
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=93.66 E-value=0.36 Score=49.29 Aligned_cols=34 Identities=18% Similarity=0.113 Sum_probs=25.4
Q ss_pred HHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CC
Q 013092 22 LYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GP 59 (449)
Q Consensus 22 ~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~ 59 (449)
.+|..+++.|..+.-.+++++++. + .+||||+ |.
T Consensus 152 ~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~ 186 (458)
T 2qg7_A 152 EREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGY 186 (458)
T ss_dssp HHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSE
T ss_pred HHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCc
Confidence 689999999976555677877763 2 3599999 53
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=92.73 E-value=0.78 Score=43.10 Aligned_cols=36 Identities=19% Similarity=0.226 Sum_probs=25.2
Q ss_pred hhHHHHHHHHHHHhcCCCC--CceEEEEeEeCCEEEEEEecC
Q 013092 18 HPQLLYESKLYRILQGGTG--IPNVRWFGVEGDYNVLVMDLL 57 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~--Iv~l~~~~~~~~~~~lVmE~~ 57 (449)
...|..|.+.|+.|..... +++++..+ . .++||||+
T Consensus 55 ~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~--~--~~lv~e~l 92 (288)
T 3f7w_A 55 DGLFRAEALGLDWLGRSFGSPVPQVAGWD--D--RTLAMEWV 92 (288)
T ss_dssp TTHHHHHHHHHHHHTCSTTCCSCCEEEEE--T--TEEEEECC
T ss_pred hhHHHHHHHHHHHHHhhCCCCcceEEecc--C--ceEEEEee
Confidence 3458899999999965433 45555543 3 37899998
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=89.63 E-value=1.1 Score=45.27 Aligned_cols=29 Identities=28% Similarity=0.576 Sum_probs=24.6
Q ss_pred CceecCCCCCcEEEeecCCCCeEEEeecCccee
Q 013092 95 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 127 (449)
Q Consensus 95 givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~ 127 (449)
.++|+|+.+.||+- ..+.+.|+||..+..
T Consensus 263 ~~~H~D~~~~N~l~----~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 263 VFAHNDLQENNLLQ----TQNNIRMIDYEYSAI 291 (424)
T ss_dssp EEECSCCCGGGEEE----CSSCEEECCCTTCEE
T ss_pred eEECCCCCccceec----CCCcEEEEecccCCc
Confidence 48999999999992 567899999988753
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=83.54 E-value=0.71 Score=44.82 Aligned_cols=31 Identities=29% Similarity=0.475 Sum_probs=26.1
Q ss_pred CCceecCCCCCcEEEeecCCCCeEEEeecCccee
Q 013092 94 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 127 (449)
Q Consensus 94 ~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~ 127 (449)
..++|+|+.+.||++ +.++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~---~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLV---GNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEE---CGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEE---eCCCeEEEEECCCCee
Confidence 469999999999999 4556799999987754
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 449 | ||||
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 6e-74 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 6e-74 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 5e-21 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-18 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-18 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-18 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 5e-18 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-17 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-17 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-17 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-17 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 8e-17 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-16 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 5e-16 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 7e-16 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 7e-16 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 7e-16 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 9e-16 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-15 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-15 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 4e-15 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 7e-15 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 7e-15 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-14 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-14 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 6e-14 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 6e-14 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 8e-14 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 9e-14 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 9e-14 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-13 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-13 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-13 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 4e-13 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 4e-13 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 5e-13 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 6e-13 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 6e-13 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 7e-13 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 7e-13 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-12 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-12 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-12 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-11 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-11 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-11 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 5e-11 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 5e-11 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 6e-11 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 8e-11 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 8e-11 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-10 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-10 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-10 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 4e-10 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 4e-10 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 5e-10 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 8e-10 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 9e-10 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 7e-09 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 8e-09 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-08 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 4e-08 |
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 232 bits (591), Expect = 6e-74
Identities = 154/256 (60%), Positives = 187/256 (73%), Gaps = 2/256 (0%)
Query: 12 ENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRK 71
E ++ PQL E + Y++L G TGIPNV +FG EG +NVLV+DLLGPSLEDL + C RK
Sbjct: 38 EPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRK 97
Query: 72 LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG--RRANQVYIIDFGLAKKYR 129
S+KTV M A QM+ RV+ +H KS ++RDIKPDNFL+G + AN +Y++DFG+ K YR
Sbjct: 98 FSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 157
Query: 130 DTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLK 189
D T QHIPYRE KNL+GTARY S+NTHLG EQSRRDDLE+LG+V MYFLRGSLPWQGLK
Sbjct: 158 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK 217
Query: 190 AGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLF 249
A T KQKYE+I EKK ST + LC G+P EF Y HY R+L FD PDY YL+ +F +
Sbjct: 218 AATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL 277
Query: 250 IREGFQFDYVFDWTIL 265
R D FDW +L
Sbjct: 278 ERLNTTEDENFDWNLL 293
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 232 bits (592), Expect = 6e-74
Identities = 201/261 (77%), Positives = 237/261 (90%)
Query: 11 QENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSR 70
E VKTKHPQL ESK+Y+++QGG GIP +RW G EGDYNV+VM+LLGPSLEDLFNFCSR
Sbjct: 39 LECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSR 98
Query: 71 KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 130
K SLKTVL+LADQMI+R+E++HSK+F+HRD+KPDNFLMGLG++ N VYIIDFGLAKKYRD
Sbjct: 99 KFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158
Query: 131 TSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 190
THQHIPYRENKNLTGTARYAS+NTHLGIEQSRRDDLESLGYVLMYF GSLPWQGLKA
Sbjct: 159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKA 218
Query: 191 GTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFI 250
TK+QKYE+ISEKK+ST IE LC+GYP+EFA+Y ++CRSLRFDDKPDY+YL+++FR+LF
Sbjct: 219 ATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278
Query: 251 REGFQFDYVFDWTILKYQQSQ 271
R+GF +DYVFDW +LK+ S+
Sbjct: 279 RQGFSYDYVFDWNMLKFGASR 299
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.4 bits (224), Expect = 5e-21
Identities = 42/217 (19%), Positives = 83/217 (38%), Gaps = 16/217 (7%)
Query: 38 PN-VRWFGVEGDYNV-LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 94
N + + G + +V G SL + K + ++ +A Q ++++H+K
Sbjct: 64 VNILLFMGYSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 123
Query: 95 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASM 154
S +HRD+K +N + V I DFGLA S + L+G+ + +
Sbjct: 124 SIIHRDLKSNNIFLH---EDLTVKIGDFGLATVKSRWSGSHQF-----EQLSGSILWMAP 175
Query: 155 NTHLGIEQ---SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 211
++ S + D+ + G VL + G LP+ + + Q + +S +
Sbjct: 176 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN--NRDQIIFMVGRGYLSPDLSK 233
Query: 212 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDL 248
+ P C + D++P + + L
Sbjct: 234 VRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELL 270
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 83.1 bits (205), Expect = 2e-18
Identities = 32/171 (18%), Positives = 63/171 (36%), Gaps = 13/171 (7%)
Query: 37 IPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 95
+ + + + + L ++++ +E++H K
Sbjct: 70 FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKG 128
Query: 96 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMN 155
+HRD+KP+N L+ + I DFG AK S + GTA+Y S
Sbjct: 129 IIHRDLKPENILLN---EDMHIQITDFGTAKVLSPESKQARA-----NSFVGTAQYVSPE 180
Query: 156 THLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 206
+ DL +LG ++ + G P++ G + ++KI + +
Sbjct: 181 LLTEKSACKSSDLWALGCIIYQLVAGLPPFRA---GNEYLIFQKIIKLEYD 228
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 83.6 bits (206), Expect = 2e-18
Identities = 40/252 (15%), Positives = 88/252 (34%), Gaps = 28/252 (11%)
Query: 37 IPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 95
+ N+ + + V++ + + G L + K+S + Q+ + +H +
Sbjct: 85 LVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN 144
Query: 96 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMN 155
++H D+KP+N + +R+N++ +IDFGL + + TGTA +A+
Sbjct: 145 YVHLDLKPENIMF-TTKRSNELKLIDFGLTAHLDPKQSVKVT--------TGTAEFAAPE 195
Query: 156 THLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRG 215
G D+ S+G + L G P+ G + + ++ G
Sbjct: 196 VAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE---NDDETLRNVKSCDW-NMDDSAFSG 251
Query: 216 YPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREG-----------FQFDYVFDWTI 264
+ + + + + + ++ G ++ + D
Sbjct: 252 ISEDGKDFIRKLLLADPNTRMT---IHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDSIK 308
Query: 265 LKYQQSQLATPP 276
KY PP
Sbjct: 309 TKYDAWPEPLPP 320
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 83.6 bits (206), Expect = 3e-18
Identities = 39/171 (22%), Positives = 67/171 (39%), Gaps = 13/171 (7%)
Query: 37 IPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 95
+ N+ + VL+++ L G L D K+S V+ Q ++ +H S
Sbjct: 88 LINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS 147
Query: 96 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMN 155
+H DIKP+N + ++A+ V IIDFGLA K + T TA +A+
Sbjct: 148 IVHLDIKPENIMC-ETKKASSVKIIDFGLATKLNPDEIVKVT--------TATAEFAAPE 198
Query: 156 THLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 206
D+ ++G + L G P+ G + + +
Sbjct: 199 IVDREPVGFYTDMWAIGVLGYVLLSGLSPFAG---EDDLETLQNVKRCDWE 246
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 82.4 bits (203), Expect = 5e-18
Identities = 37/210 (17%), Positives = 76/210 (36%), Gaps = 23/210 (10%)
Query: 37 IPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK- 94
I + M+ + G SL+ + + ++ + + ++ +I + ++ K
Sbjct: 66 IVGFYGAFYSDGEISICMEHMDGGSLDQVLK-KAGRIPEQILGKVSIAVIKGLTYLREKH 124
Query: 95 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASM 154
+HRD+KP N L+ ++ + DFG++ + D+ + + GT Y S
Sbjct: 125 KIMHRDVKPSNILVN---SRGEIKLCDFGVSGQLIDSMANSFV---------GTRSYMSP 172
Query: 155 NTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 214
G S + D+ S+G L+ G P A + + +E
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQ--------VEGDAA 224
Query: 215 GYPTEFASYFHYCRSLRFDDKPDYAYLKRI 244
P + S D +P A + +
Sbjct: 225 ETPPRPRTPGRPLSSYGMDSRPPMAIFELL 254
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 80.0 bits (197), Expect = 2e-17
Identities = 29/174 (16%), Positives = 65/174 (37%), Gaps = 19/174 (10%)
Query: 37 IPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 95
I + + ++++ G +++ + R L+ + ++ Q ++ + ++H
Sbjct: 71 IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK 130
Query: 96 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMN 155
+HRD+K N L + + DFG++ K T + + GT + +
Sbjct: 131 IIHRDLKAGNILFT---LDGDIKLADFGVSAKNTRTIQRRD-------SFIGTPYWMAPE 180
Query: 156 THLGIEQSRRD-----DLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 204
+ R D+ SLG L+ P L + KI++ +
Sbjct: 181 VVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHEL---NPMRVLLKIAKSE 231
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 80.5 bits (198), Expect = 2e-17
Identities = 46/274 (16%), Positives = 98/274 (35%), Gaps = 31/274 (11%)
Query: 37 IPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 95
I ++ + V++ + + G + + N + +L+ + ++ Q+ ++F+HS +
Sbjct: 63 ILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN 122
Query: 96 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMN 155
H DI+P+N + RR++ + II+FG A++ + + + Y +
Sbjct: 123 IGHFDIRPENIIYQ-TRRSSTIKIIEFGQARQLKPGDNFRLLF--------TAPEYYAPE 173
Query: 156 THLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRG 215
H S D+ SLG ++ L G P+ T +Q E I + T E +
Sbjct: 174 VHQHDVVSTATDMWSLGTLVYVLLSGINPFLA---ETNQQIIENIMNAEY-TFDEEAFKE 229
Query: 216 YPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREG--------------FQFDYVFD 261
E + + + ++++ ++ +
Sbjct: 230 ISIEAMDFVDRLLVKERKSRMT---ASEALQHPWLKQKIERVSTKVIRTLKHRRYYHTLI 286
Query: 262 WTILKYQQSQLATPPARALVPGAGTSGAPPAIAS 295
L S A+ G S A +AS
Sbjct: 287 KKDLNMVVSAARISCGGAIRSQKGVSVAKVKVAS 320
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 80.1 bits (197), Expect = 2e-17
Identities = 43/217 (19%), Positives = 85/217 (39%), Gaps = 18/217 (8%)
Query: 38 PN-VRWFGV-EGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 94
P VR GV + + +LVM++ G L ++ + V L Q+ ++++ K
Sbjct: 69 PYIVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK 128
Query: 95 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASM 154
+F+HRD+ N L+ + I DFGL+K ++ ++ +
Sbjct: 129 NFVHRDLAARNVLLV---NRHYAKISDFGLSKALGADDSYYTA----RSAGKWPLKWYAP 181
Query: 155 NTHLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 213
+ S R D+ S G + L G P++ + + I + K
Sbjct: 182 ECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM---KGPEVMAFIEQGK----RMECP 234
Query: 214 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFI 250
P E + C +++D+PD+ +++ R +
Sbjct: 235 PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 271
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 79.6 bits (196), Expect = 2e-17
Identities = 38/170 (22%), Positives = 66/170 (38%), Gaps = 15/170 (8%)
Query: 37 IPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 96
I + + + L+++ K + ++ N + + HSK
Sbjct: 68 ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 127
Query: 97 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNT 156
+HRDIKP+N L+G A ++ I DFG + + GT Y
Sbjct: 128 IHRDIKPENLLLG---SAGELKIADFGWSVHAPSSRRTTLC---------GTLDYLPPEM 175
Query: 157 HLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 206
G + DL SLG + FL G P++ T ++ Y++IS + +
Sbjct: 176 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA---NTYQETYKRISRVEFT 222
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 79.0 bits (194), Expect = 8e-17
Identities = 30/147 (20%), Positives = 59/147 (40%), Gaps = 10/147 (6%)
Query: 43 FGVEGDYNVLVMDLL-GPSLED-LFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRD 100
++VM+ L G L + + + + + + + ++++HS + HRD
Sbjct: 77 LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRD 136
Query: 101 IKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI 160
+KP+N L R + + DFG AK+ ++ Y T Y +
Sbjct: 137 VKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY--------TPYYVAPEVLGPE 188
Query: 161 EQSRRDDLESLGYVLMYFLRGSLPWQG 187
+ + D+ SLG ++ L G P+
Sbjct: 189 KYDKSCDMWSLGVIMYILLCGYPPFYS 215
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 77.1 bits (189), Expect = 1e-16
Identities = 47/215 (21%), Positives = 77/215 (35%), Gaps = 17/215 (7%)
Query: 38 PN-VRWFGV-EGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 94
N +R +GV +V +L SL D L T+ A Q+ + ++ SK
Sbjct: 71 RNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK 130
Query: 95 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASM 154
F+HRD+ N L+ + V I DFGL + H Y ++ + +
Sbjct: 131 RFIHRDLAARNLLLA---TRDLVKIGDFGLMRALPQNDDH----YVMQEHRKVPFAWCAP 183
Query: 155 NTHLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 213
+ S D G L G PW GL Q KI ++ C
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL---NGSQILHKIDKEGERLPRPEDC 240
Query: 214 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDL 248
P + + C + + +D+P + L+ +
Sbjct: 241 ---PQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 76.7 bits (188), Expect = 5e-16
Identities = 32/168 (19%), Positives = 67/168 (39%), Gaps = 15/168 (8%)
Query: 40 VRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRK--LSLKTVLMLADQMINRVEFVHSKSFL 97
++ L + + +LF SR+ + + ++++ +E++HS+ +
Sbjct: 68 TALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVV 127
Query: 98 HRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTH 157
+RDIK +N ++ + + I DFGL K+ GT Y +
Sbjct: 128 YRDIKLENLML---DKDGHIKITDFGLCKEGISDGATMK-------TFCGTPEYLAPEVL 177
Query: 158 LGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 205
+ R D LG V+ + G LP+ ++ +E I +++
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGRLPFYN---QDHERLFELILMEEI 222
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 75.5 bits (185), Expect = 7e-16
Identities = 41/217 (18%), Positives = 85/217 (39%), Gaps = 21/217 (9%)
Query: 38 PN-VRWFGVEGDYNV-LVMDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 93
VR + V + ++ + + G ++ L KL++ +L +A Q+ + F+
Sbjct: 68 QRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 127
Query: 94 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYAS 153
++++HRD++ N L+ I DFGLA+ D + ++ +
Sbjct: 128 RNYIHRDLRAANILV---SDTLSCKIADFGLARLIEDNEYTAR------EGAKFPIKWTA 178
Query: 154 MNTHLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 212
+ + D+ S G +L + G +P+ G+ T + + + +
Sbjct: 179 PEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM---TNPEVIQNLERGYRMVRPD-- 233
Query: 213 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLF 249
P E C R +D+P + YL+ + D F
Sbjct: 234 --NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 75.8 bits (186), Expect = 7e-16
Identities = 34/188 (18%), Positives = 65/188 (34%), Gaps = 25/188 (13%)
Query: 38 PN-VRWFGV--EGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 94
PN +++ G LVM+ S DL + L + + + + ++HS
Sbjct: 75 PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 134
Query: 95 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASM 154
+ +HRD+K N L+ V + DFG A ++ GT + +
Sbjct: 135 NMIHRDVKAGNILLS---EPGLVKLGDFGSASIMAPANSF-----------VGTPYWMAP 180
Query: 155 NTHLGIEQSRRD---DLESLGYVLMYFLRGSLPWQGLKAGT-----KKQKYEKISEKKVS 206
L +++ + D D+ SLG + P + A + + + + S
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWS 240
Query: 207 TSIEALCR 214
Sbjct: 241 EYFRNFVD 248
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 75.1 bits (184), Expect = 7e-16
Identities = 37/196 (18%), Positives = 69/196 (35%), Gaps = 10/196 (5%)
Query: 11 QENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCS 69
E V+ L E + R + G I ++ + LV DL+ L D
Sbjct: 46 AEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT-EK 104
Query: 70 RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 129
LS K + ++ + +H + +HRD+KP+N L+ + + DFG + +
Sbjct: 105 VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILL---DDDMNIKLTDFGFSCQLD 161
Query: 130 DTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLK 189
+ + + + + H G + D+ S G ++ L GS P+
Sbjct: 162 PGEKLREVCGTPSYLAPEIIECSMNDNHPGY--GKEVDMWSTGVIMYTLLAGSPPFWH-- 217
Query: 190 AGTKKQKYEKISEKKV 205
+ I
Sbjct: 218 -RKQMLMLRMIMSGNY 232
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 75.1 bits (184), Expect = 9e-16
Identities = 42/222 (18%), Positives = 93/222 (41%), Gaps = 20/222 (9%)
Query: 38 PN-VRWFGV-EGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 95
P VR G+ E + +LVM++ + + +R + K ++ L Q+ ++++ +
Sbjct: 68 PYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN 127
Query: 96 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMN 155
F+HRD+ N L+ + I DFGL+K R + Y+ + ++ +
Sbjct: 128 FVHRDLAARNVLLV---TQHYAKISDFGLSKALRADENY----YKAQTHGKWPVKWYAPE 180
Query: 156 THLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 214
+ S + D+ S G ++ G P++G+ + + + +
Sbjct: 181 CINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM---KGSEVTAMLEKGERMGCPA---- 233
Query: 215 GYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLF---IREG 253
G P E + C + +++P +A ++ R+ + + EG
Sbjct: 234 GCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEG 275
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 74.4 bits (182), Expect = 1e-15
Identities = 43/191 (22%), Positives = 79/191 (41%), Gaps = 18/191 (9%)
Query: 27 LYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRK--LSLKTVLMLADQM 84
L ++ G +G+ + + D VL+++ P DLF+F + + L + Q+
Sbjct: 61 LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQ-DLFDFITERGALQEELARSFFWQV 119
Query: 85 INRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKN 144
+ V H+ LHRDIK +N L + ++ +IDFG +DT
Sbjct: 120 LEAVRHCHNCGVLHRDIKDENIL--IDLNRGELKLIDFGSGALLKDTVYTDFD------- 170
Query: 145 LTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK 203
GT Y+ R + SLG +L + G +P++ + + + +
Sbjct: 171 --GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH---DEEIIRGQVFFRQ 225
Query: 204 KVSTSIEALCR 214
+VS+ + L R
Sbjct: 226 RVSSECQHLIR 236
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 73.9 bits (181), Expect = 2e-15
Identities = 41/186 (22%), Positives = 68/186 (36%), Gaps = 15/186 (8%)
Query: 37 IPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 96
+ EG+ L ++ + Q++ V ++H
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 124
Query: 97 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNT 156
HRDIKP+N L+ + + I DFGLA +R + + + + GT Y +
Sbjct: 125 THRDIKPENLLLD---ERDNLKISDFGLATVFRYNNRERLL-----NKMCGTLPYVAPEL 176
Query: 157 HLGIE-QSRRDDLESLGYVLMYFLRGSLPWQG------LKAGTKKQKYEKISEKKVSTSI 209
E + D+ S G VL L G LPW + K++K KK+ ++
Sbjct: 177 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP 236
Query: 210 EALCRG 215
AL
Sbjct: 237 LALLHK 242
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 73.2 bits (179), Expect = 4e-15
Identities = 41/158 (25%), Positives = 67/158 (42%), Gaps = 16/158 (10%)
Query: 38 PN-VRWFGV------EGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVE 89
P V + G +VM+ + G +L D+ + ++ K + + +
Sbjct: 67 PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALN 125
Query: 90 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTA 149
F H +HRD+KP N ++ N V ++DFG+A+ D+ + + GTA
Sbjct: 126 FSHQNGIIHRDVKPANIMIS---ATNAVKVMDFGIARAIADSGNSVT----QTAAVIGTA 178
Query: 150 RYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 187
+Y S G R D+ SLG VL L G P+ G
Sbjct: 179 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTG 216
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 72.8 bits (178), Expect = 7e-15
Identities = 38/152 (25%), Positives = 62/152 (40%), Gaps = 12/152 (7%)
Query: 37 IPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 95
+ ++ + VM+ L G L C K L A ++I ++F+HSK
Sbjct: 65 LTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLHSKG 123
Query: 96 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMN 155
++RD+K DN L+ + + I DFG+ K+ + GT Y +
Sbjct: 124 IVYRDLKLDNILLD---KDGHIKIADFGMCKENMLGDAKTN-------TFCGTPDYIAPE 173
Query: 156 THLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 187
LG + + D S G +L L G P+ G
Sbjct: 174 ILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG 205
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 72.3 bits (177), Expect = 7e-15
Identities = 39/185 (21%), Positives = 68/185 (36%), Gaps = 19/185 (10%)
Query: 37 IPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 95
I N + GD +VM+ L G SL D+ + + + + + +EF+HS
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLHSNQ 136
Query: 96 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMN 155
+HRDIK DN L+ V + DFG + + + + GT + +
Sbjct: 137 VIHRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQSKRS-------TMVGTPYWMAPE 186
Query: 156 THLGIEQSRRDDLESLGYVLMYFLRGSLPWQG------LKAGTKKQKYEKISEKKVSTSI 209
+ D+ SLG + + + G P+ L E + +K+S
Sbjct: 187 VVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIF 246
Query: 210 EALCR 214
Sbjct: 247 RDFLN 251
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 72.2 bits (176), Expect = 1e-14
Identities = 47/218 (21%), Positives = 73/218 (33%), Gaps = 13/218 (5%)
Query: 43 FGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIK 102
+ LV D L L + K +L + + ++N + ++H LHRD+K
Sbjct: 85 YNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMK 144
Query: 103 PDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQ 162
N L+ R + + DFGLA+ + Q Y N T Y LG
Sbjct: 145 AANVLIT---RDGVLKLADFGLARAFSLAKNSQPNRY---TNRVVTLWYRPPELLLGERD 198
Query: 163 -SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFA 221
DL G ++ S QG T++ + IS+ S + E E
Sbjct: 199 YGPPIDLWGAGCIMAEMWTRSPIMQG---NTEQHQLALISQLCGSITPEVWPNVDNYELY 255
Query: 222 SYFHYCRSLRFDDKPDYAYLKR--IFRDLFIREGFQFD 257
+ + K R DL I + D
Sbjct: 256 EKLELVKGQKRKVKDRLKAYVRDPYALDL-IDKLLVLD 292
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 71.2 bits (174), Expect = 2e-14
Identities = 47/239 (19%), Positives = 84/239 (35%), Gaps = 25/239 (10%)
Query: 37 IPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRK--LSLKTVLMLADQMINRVEFVHSK 94
I + G + L+M L+ S +LF+ K + + L Q+++ V+++H
Sbjct: 69 IVALDDIYESGGHLYLIMQLV--SGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDL 126
Query: 95 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASM 154
+HRD+KP+N L +++ I DFGL+K S GT Y +
Sbjct: 127 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTA--------CGTPGYVAP 178
Query: 155 NTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 214
S+ D S+G + L G P+ + +E+I + +
Sbjct: 179 EVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYD---ENDAKLFEQILKAEYEFDSP-YWD 234
Query: 215 GYPTEFASYFHYCRSLRFDDKPDYAYLKRI-FRDLFIREGFQFDYVFDWTILKYQQSQL 272
+ + + D P+ KR D D I + Q+
Sbjct: 235 DISDSAKDFIRHL--MEKD--PE----KRFTCEQALQHPWIAGDTALDKNIHQSVSEQI 285
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 69.9 bits (170), Expect = 6e-14
Identities = 47/259 (18%), Positives = 88/259 (33%), Gaps = 26/259 (10%)
Query: 7 VFSVQENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGV--------EGDYNVLVMDLLG 58
VQ + + E + R L+ VR F V E ++ +
Sbjct: 40 RVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ 99
Query: 59 PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVY 118
L + +T+ + Q++ ++F+HS +HRD+KP N L+ + Q+
Sbjct: 100 DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVT---SSGQIK 156
Query: 119 IIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYF 178
+ DFGLA+ Y + T Y + L + DL S+G +
Sbjct: 157 LADFGLARIYSFQMALTSV--------VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEM 208
Query: 179 LRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDY 238
R ++G + + KI + E R ++ D
Sbjct: 209 FRRKPLFRG---SSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTD- 264
Query: 239 AYLKRIFRDLFIREGFQFD 257
+ + +DL + + F+
Sbjct: 265 --IDELGKDL-LLKCLTFN 280
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 70.6 bits (172), Expect = 6e-14
Identities = 43/216 (19%), Positives = 74/216 (34%), Gaps = 25/216 (11%)
Query: 49 YNVLVMDLLGPSLEDLFNFCSRK---LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDN 105
Y LV+D + ++ + SR L + V + Q+ + ++HS HRDIKP N
Sbjct: 93 YLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQN 152
Query: 106 FLMGLGRRANQVYIIDFGLAKKYRDT----STHQHIPYRENKNLTGTARYASMNTHLGIE 161
L + + DFG AK+ S YR + + G Y
Sbjct: 153 L--LLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDY---------- 200
Query: 162 QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFA 221
+ D+ S G VL L G + G + + +I + + + E + P
Sbjct: 201 -TSSIDVWSAGCVLAELLLGQPIFPG---DSGVDQLVEIIKVLGTPTREQIREMNPNYTE 256
Query: 222 SYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFD 257
F ++ + K L ++
Sbjct: 257 FKFPQIKAHPW-TKVFRPRTPPEAIAL-CSRLLEYT 290
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 69.3 bits (169), Expect = 8e-14
Identities = 39/173 (22%), Positives = 66/173 (38%), Gaps = 22/173 (12%)
Query: 42 WFGVEGDYNVLVMDLL-GPSLEDLFNFCSRK---LSLKTVLMLADQMINRVEFVHSKS-- 95
+VM+ G L + +++ L + VL + Q+ ++ H +S
Sbjct: 72 IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 131
Query: 96 ---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 152
LHRD+KP N + V + DFGLA+ ++ K GT Y
Sbjct: 132 GHTVLHRDLKPANVFL---DGKQNVKLGDFGLARILNHDTSFA-------KAFVGTPYYM 181
Query: 153 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 205
S + + + D+ SLG +L P+ ++K+ KI E K
Sbjct: 182 SPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF---SQKELAGKIREGKF 231
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 69.0 bits (168), Expect = 9e-14
Identities = 39/215 (18%), Positives = 78/215 (36%), Gaps = 20/215 (9%)
Query: 38 PN-VRWFGV--EGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 94
P+ V+ GV E +++ L L L ++++ A Q+ + ++ SK
Sbjct: 68 PHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK 127
Query: 95 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASM 154
F+HRDI N L+ + V + DFGL++ D++ ++ ++ +
Sbjct: 128 RFVHRDIAARNVLV---SSNDCVKLGDFGLSRYMEDSTYYKA------SKGKLPIKWMAP 178
Query: 155 NTHLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 213
+ + D+ G + L G P+QG+ +I + +
Sbjct: 179 ESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV---KNNDVIGRIENGE----RLPMP 231
Query: 214 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDL 248
P S C + +P + LK +
Sbjct: 232 PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 70.1 bits (171), Expect = 9e-14
Identities = 38/170 (22%), Positives = 62/170 (36%), Gaps = 13/170 (7%)
Query: 37 IPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 96
I + + D ++DL+ S + A ++I +E +H++
Sbjct: 69 IVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFV 128
Query: 97 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNT 156
++RD+KP N L+ V I D GLA + H + GT Y +
Sbjct: 129 VYRDLKPANILLD---EHGHVRISDLGLACDFSKKKPHASV---------GTHGYMAPEV 176
Query: 157 HL-GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 205
G+ D SLG +L LRG P++ K K + V
Sbjct: 177 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV 226
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 68.5 bits (167), Expect = 1e-13
Identities = 30/170 (17%), Positives = 64/170 (37%), Gaps = 16/170 (9%)
Query: 46 EGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKP 103
VLV +L+ + + + +K + Q++ ++F+H+++ +HRD+K
Sbjct: 83 GKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKC 142
Query: 104 DNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQS 163
DN + V I D GLA R + K + GT + + + +
Sbjct: 143 DNIF--ITGPTGSVKIGDLGLATLKRASFA---------KAVIGTPEFMAPEMYEE-KYD 190
Query: 164 RRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 213
D+ + G ++ P+ Q Y +++ S + +
Sbjct: 191 ESVDVYAFGMCMLEMATSEYPYSE--CQNAAQIYRRVTSGVKPASFDKVA 238
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 68.0 bits (165), Expect = 3e-13
Identities = 43/247 (17%), Positives = 82/247 (33%), Gaps = 42/247 (17%)
Query: 29 RILQGGTGIPNVRWFGV--EGDYNVLVMDLL-GPSLEDL--------------------- 64
++ V+ GV G L+ + + L +
Sbjct: 68 ALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRA 127
Query: 65 --FNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDF 122
+ LS L +A Q+ + ++ + F+HRD+ N L+G V I DF
Sbjct: 128 RVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVG---ENMVVKIADF 184
Query: 123 GLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFL-RG 181
GL++ Y+ + N R+ + + D+ + G VL G
Sbjct: 185 GLSRNIYSADY-----YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG 239
Query: 182 SLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYL 241
P+ G+ ++ + + + E P E + C S D+P + +
Sbjct: 240 LQPYYGM---AHEEVIYYVRDGNILACPE----NCPLELYNLMRLCWSKLPADRPSFCSI 292
Query: 242 KRIFRDL 248
RI + +
Sbjct: 293 HRILQRM 299
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 67.6 bits (164), Expect = 3e-13
Identities = 41/186 (22%), Positives = 74/186 (39%), Gaps = 20/186 (10%)
Query: 7 VFSVQENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFN 66
+++ + + E + + L+ + I + VLV + L L+ L +
Sbjct: 33 KIRLEKEDEGIPSTTIREISILKELKH-SNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLD 91
Query: 67 FCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 126
C L T Q++N + + H + LHRD+KP N L+ R ++ I DFGLA+
Sbjct: 92 VCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLI---NREGELKIADFGLAR 148
Query: 127 KYRDTSTH-----QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRG 181
+ + YR L G+ +Y S D+ S+G + + G
Sbjct: 149 AFGIPVRKYTHEIVTLWYRAPDVLMGSKKY-----------STTIDIWSVGCIFAEMVNG 197
Query: 182 SLPWQG 187
+ + G
Sbjct: 198 TPLFPG 203
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 67.5 bits (164), Expect = 4e-13
Identities = 29/164 (17%), Positives = 59/164 (35%), Gaps = 9/164 (5%)
Query: 37 IPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 96
+ + + ++ + L D + + +L Q+ + ++ +
Sbjct: 73 VCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRL 132
Query: 97 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNT 156
+HRD+ N L+ V I DFGLAK H + ++ ++ +
Sbjct: 133 VHRDLAARNVLVK---TPQHVKITDFGLAKLLGAEEKEYHA-----EGGKVPIKWMALES 184
Query: 157 HLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYEK 199
L + + D+ S G + + GS P+ G+ A EK
Sbjct: 185 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK 228
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 67.0 bits (163), Expect = 4e-13
Identities = 30/172 (17%), Positives = 67/172 (38%), Gaps = 17/172 (9%)
Query: 38 PN-VRWFGV--EGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 93
V+ +GV + ++ + + L + + + +L + + +E++ S
Sbjct: 59 EKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES 118
Query: 94 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYAS 153
K FLHRD+ N L+ V + DFGL++ D + R++
Sbjct: 119 KQFLHRDLAARNCLV---NDQGVVKVSDFGLSRYVLDDEYTSSV------GSKFPVRWSP 169
Query: 154 MNTHLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYEKISEKK 204
+ + S + D+ + G ++ G +P++ T + E I++
Sbjct: 170 PEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF---TNSETAEHIAQGL 218
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 67.0 bits (163), Expect = 5e-13
Identities = 38/214 (17%), Positives = 83/214 (38%), Gaps = 20/214 (9%)
Query: 40 VRWFGV-EGDYNVLVMDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 96
V+ + V + +V + + G L+ L + L L ++ +A Q+ + + +V ++
Sbjct: 75 VQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY 134
Query: 97 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNT 156
+HRD++ N L+G + DFGLA+ D + ++ +
Sbjct: 135 VHRDLRAANILVG---ENLVCKVADFGLARLIEDNEYTAR------QGAKFPIKWTAPEA 185
Query: 157 HLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRG 215
L + + D+ S G +L +G +P+ G+ ++ +++
Sbjct: 186 ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM---VNREVLDQVERGYRMPCPP----E 238
Query: 216 YPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLF 249
P C +++P + YL+ D F
Sbjct: 239 CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 67.1 bits (163), Expect = 6e-13
Identities = 22/170 (12%), Positives = 64/170 (37%), Gaps = 10/170 (5%)
Query: 37 IPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 95
+ ++ + +++ + + SL+ + ++ ++ + + ++++ +
Sbjct: 89 VIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMN 148
Query: 96 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMN 155
++HRD+ N L+ + DFGL++ D ++ Y R+ +
Sbjct: 149 YVHRDLAARNILVN---SNLVCKVSDFGLSRFLEDDTSDPT--YTSALGGKIPIRWTAPE 203
Query: 156 THLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYEKISEKK 204
+ + D+ S G V+ + G P+ + T + I +
Sbjct: 204 AIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDM---TNQDVINAIEQDY 250
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 67.2 bits (163), Expect = 6e-13
Identities = 38/251 (15%), Positives = 86/251 (34%), Gaps = 22/251 (8%)
Query: 15 KTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSL 74
K ++ E K+ L+GG I + + + + D + L+
Sbjct: 70 PVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY-QTLTD 128
Query: 75 KTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 134
+ +++ +++ HS +HRD+KP N + + ++ +ID+GLA+ Y +
Sbjct: 129 YDIRFYMYEILKALDYCHSMGIMHRDVKPHNVM--IDHEHRKLRLIDWGLAEFYHPGQEY 186
Query: 135 QHIPYRENKNLTGTARYASMNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTK 193
+ + + + D+ SLG +L + P+
Sbjct: 187 NVR--------VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH--GHDN 236
Query: 194 KQKYEKISEKKVSTSIEALCRGYPTEFASYFH-------YCRSLRFDDKPDYAYLKRIFR 246
+ +I++ + + Y E F+ R RF + +
Sbjct: 237 YDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEAL 296
Query: 247 DLFIREGFQFD 257
D + + ++D
Sbjct: 297 DF-LDKLLRYD 306
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 67.1 bits (163), Expect = 7e-13
Identities = 40/218 (18%), Positives = 69/218 (31%), Gaps = 35/218 (16%)
Query: 20 QLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRK------- 71
L+ E K+ L I N+ L+ + L + K
Sbjct: 86 ALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIE 145
Query: 72 ---------------LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQ 116
L+ + +L A Q+ +EF+ KS +HRD+ N L+
Sbjct: 146 YENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVT---HGKV 202
Query: 117 VYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLM 176
V I DFGLA+ S Y N ++ + + + + D+ S G +L
Sbjct: 203 VKICDFGLARDIMSDSN-----YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLW 257
Query: 177 YFL-RGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 213
G P+ G+ + K+ +
Sbjct: 258 EIFSLGVNPYPGI---PVDANFYKLIQNGFKMDQPFYA 292
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 67.0 bits (163), Expect = 7e-13
Identities = 36/170 (21%), Positives = 65/170 (38%), Gaps = 16/170 (9%)
Query: 37 IPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 96
I + + ++MD + S++ A ++ +E++HSK
Sbjct: 66 IIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDI 125
Query: 97 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNT 156
++RD+KP+N L+ + + I DFG AK D + L GT Y +
Sbjct: 126 IYRDLKPENILLD---KNGHIKITDFGFAKYVPDVTY----------TLCGTPDYIAPEV 172
Query: 157 HLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 206
++ D S G ++ L G P+ + YEKI ++
Sbjct: 173 VSTKPYNKSIDWWSFGILIYEMLAGYTPFYD---SNTMKTYEKILNAELR 219
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 65.8 bits (160), Expect = 1e-12
Identities = 40/218 (18%), Positives = 76/218 (34%), Gaps = 27/218 (12%)
Query: 38 PN-VRWFGV---EGDYNVLVMDLL-GPSLED-LFNFCSRKLSLKTVLMLADQMINRVEFV 91
N V+ GV E +V + + SL D L + L +L + + +E++
Sbjct: 60 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 119
Query: 92 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY 151
+F+HRD+ N L+ N + DFGL K+ T ++
Sbjct: 120 EGNNFVHRDLAARNVLVS---EDNVAKVSDFGLTKEASSTQDTGK----------LPVKW 166
Query: 152 ASMNTHLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 210
+ + S + D+ S G +L G +P+ + K ++ + + +
Sbjct: 167 TAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI---PLKDVVPRVEKGYKMDAPD 223
Query: 211 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDL 248
G P C L +P + L+ +
Sbjct: 224 ----GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 66.0 bits (160), Expect = 1e-12
Identities = 52/257 (20%), Positives = 86/257 (33%), Gaps = 22/257 (8%)
Query: 4 ILTVFSVQENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLED 63
+ + E + L E KL + L I + LV D + LE
Sbjct: 30 KIKLGHRSEAKDGINRTALREIKLLQELSH-PNIIGLLDAFGHKSNISLVFDFMETDLEV 88
Query: 64 LFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFG 123
+ S L+ + + +E++H LHRD+KP+N L+ + + DFG
Sbjct: 89 IIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLL---DENGVLKLADFG 145
Query: 124 LAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQ-SRRDDLESLGYVLMYFLRGS 182
LAK + P R + T Y + G D+ ++G +L L
Sbjct: 146 LAKSFGS-------PNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRV 198
Query: 183 LPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 242
G + + +I E + + E + S Y F P +
Sbjct: 199 PFLPG---DSDLDQLTRIFETLGTPTEEQW-----PDMCSLPDYVTFKSFPGIPLHHIFS 250
Query: 243 RIFRDL--FIREGFQFD 257
DL I+ F F+
Sbjct: 251 AAGDDLLDLIQGLFLFN 267
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 66.4 bits (161), Expect = 1e-12
Identities = 46/245 (18%), Positives = 84/245 (34%), Gaps = 26/245 (10%)
Query: 15 KTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSL 74
+ +H ++ + I++ T + LV L+G L L ++ LS
Sbjct: 62 RFRHENII---GINDIIRAPTIEQMKDVY--------LVTHLMGADLYKLLK--TQHLSN 108
Query: 75 KTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 134
+ Q++ ++++HS + LHRD+KP N L+ + I DFGLA+ H
Sbjct: 109 DHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLN---TTCDLKICDFGLARVADPDHDH 165
Query: 135 QHIPYRENKNLTGTARYASMN-THLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK 193
T Y + ++ D+ S+G +L L + G
Sbjct: 166 TGFLTE----YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG---KHY 218
Query: 194 KQKYEKISEKKVSTSIEALCRGYPTEFASY-FHYCRSLRFDDKPDYAYLKRIFRDLFIRE 252
+ I S S E L + +Y + + DL + +
Sbjct: 219 LDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDL-LDK 277
Query: 253 GFQFD 257
F+
Sbjct: 278 MLTFN 282
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 62.4 bits (151), Expect = 1e-11
Identities = 39/216 (18%), Positives = 78/216 (36%), Gaps = 21/216 (9%)
Query: 38 PN-VRWFGV--EGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 93
P V+ +GV E LV + + L D + +T+L + + + ++
Sbjct: 60 PKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE 119
Query: 94 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYAS 153
+HRD+ N L+ + + DFG+ + D + ++AS
Sbjct: 120 ACVIHRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQYTSSTGTK------FPVKWAS 170
Query: 154 MNTHLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 212
S + D+ S G ++ G +P++ + + E IS
Sbjct: 171 PEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR---SNSEVVEDISTGFR----LYK 223
Query: 213 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDL 248
R T ++C R +D+P ++ L R ++
Sbjct: 224 PRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 62.5 bits (151), Expect = 2e-11
Identities = 36/175 (20%), Positives = 68/175 (38%), Gaps = 12/175 (6%)
Query: 37 IPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 96
+ + +L+++L+ F L+ + Q++N V ++HS
Sbjct: 75 VITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQI 134
Query: 97 LHRDIKPDNFLM-GLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMN 155
H D+KP+N ++ ++ IIDFGLA K + ++I GT + +
Sbjct: 135 AHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI--------FGTPEFVAPE 186
Query: 156 THLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 210
D+ S+G + L G+ P+ G TK++ +S E
Sbjct: 187 IVNYEPLGLEADMWSIGVITYILLSGASPFLGD---TKQETLANVSAVNYEFEDE 238
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 62.9 bits (152), Expect = 2e-11
Identities = 31/150 (20%), Positives = 61/150 (40%), Gaps = 15/150 (10%)
Query: 40 VRWFGVEGDYNVLVMDLLGPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFVHSKSFL 97
V+ D + L M + + ++F+ R + S A Q++ E++HS +
Sbjct: 104 VKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLI 163
Query: 98 HRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTH 157
+RD+KP+N L+ + + + DFG AK+ + + GT +
Sbjct: 164 YRDLKPENLLID---QQGYIQVTDFGFAKRVKGRTWTLC----------GTPEALAPEII 210
Query: 158 LGIEQSRRDDLESLGYVLMYFLRGSLPWQG 187
L ++ D +LG ++ G P+
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 61.0 bits (147), Expect = 5e-11
Identities = 40/222 (18%), Positives = 74/222 (33%), Gaps = 15/222 (6%)
Query: 37 IPNVRWFGVEGDYNVLVMDLLGPSLEDLFNF-CSRKLSLKTVLMLADQMINRVEFVHSKS 95
I + + LV + L L+ + + L + Q++ + F HS
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 122
Query: 96 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMN 155
LHRD+KP N L+ + + DFGLA+ + + A
Sbjct: 123 VLHRDLKPQNLLIN---TEGAIKLADFGLARAFGVPVRTYT------HEVVTLWYRAPEI 173
Query: 156 THLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRG 215
S D+ SLG + + + G ++ + +I + + T E + G
Sbjct: 174 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPG---DSEIDQLFRI-FRTLGTPDEVVWPG 229
Query: 216 YPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFD 257
+ + + R D L R L + + +D
Sbjct: 230 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSL-LSQMLHYD 270
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 61.4 bits (148), Expect = 5e-11
Identities = 30/170 (17%), Positives = 66/170 (38%), Gaps = 11/170 (6%)
Query: 20 QLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLM 79
E ++ ++ + + + L++D + + + V +
Sbjct: 74 HTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQI 133
Query: 80 LADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPY 139
+++ +E +H ++RDIK +N L+ V + DFGL+K++ T + +
Sbjct: 134 YVGEIVLALEHLHKLGIIYRDIKLENILL---DSNGHVVLTDFGLSKEFVADETERAYDF 190
Query: 140 RENKNLTGTARYASMNTHLGIEQ--SRRDDLESLGYVLMYFLRGSLPWQG 187
GT Y + + G + + D SLG ++ L G+ P+
Sbjct: 191 C------GTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTV 234
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 61.1 bits (147), Expect = 6e-11
Identities = 38/173 (21%), Positives = 74/173 (42%), Gaps = 17/173 (9%)
Query: 46 EGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDN 105
E LVM+L+ +L + +L + + L QM+ ++ +HS +HRD+KP N
Sbjct: 93 EFQDVYLVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSN 149
Query: 106 FLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRR 165
++ + + I+DFGLA+ + T Y + LG+
Sbjct: 150 IVV---KSDCTLKILDFGLARTAGTSFMMTPY--------VVTRYYRAPEVILGMGYKEN 198
Query: 166 DDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPT 218
D+ S+G ++ +R + + G ++ K+ E+ + E + + PT
Sbjct: 199 VDIWSVGCIMGEMVRHKILFPG---RDYIDQWNKVIEQLGTPCPEFMKKLQPT 248
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 60.6 bits (146), Expect = 8e-11
Identities = 40/209 (19%), Positives = 73/209 (34%), Gaps = 31/209 (14%)
Query: 11 QENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDL----- 64
+ K H E ++ L I N+ Y L ++ +L D
Sbjct: 47 EYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSR 106
Query: 65 ----------FNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRA 114
N + LS + +L A + ++++ K F+HRD+ N L+G
Sbjct: 107 VLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG---EN 163
Query: 115 NQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYV 174
I DFGL++ R+ ++ + + D+ S G +
Sbjct: 164 YVAKIADFGLSRGQEVYVKKTMG--------RLPVRWMAIESLNYSVYTTNSDVWSYGVL 215
Query: 175 LMYFL-RGSLPWQGLKAGTKKQKYEKISE 202
L + G P+ G+ T + YEK+ +
Sbjct: 216 LWEIVSLGGTPYCGM---TCAELYEKLPQ 241
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 60.6 bits (146), Expect = 8e-11
Identities = 30/178 (16%), Positives = 57/178 (32%), Gaps = 29/178 (16%)
Query: 29 RILQGGTGIPN-VRWFGV--EGDYNVLVMDLL-GPSLEDL-----------------FNF 67
++L N V G G +++ + L +
Sbjct: 78 KVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMED 137
Query: 68 CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 127
L L+ +L + Q+ + F+ SK+ +HRD+ N L+ I DFGLA+
Sbjct: 138 DELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL---THGRITKICDFGLARD 194
Query: 128 YRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPW 185
++ S + N ++ + + + D+ S G L
Sbjct: 195 IKNDSNYVV-----KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 59.7 bits (144), Expect = 1e-10
Identities = 41/216 (18%), Positives = 87/216 (40%), Gaps = 19/216 (8%)
Query: 37 IPNVRWFGVEGDYNVLVMDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 94
+ + ++ + + G L+ L +++S +L +A Q+ + +E++ K
Sbjct: 75 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK 134
Query: 95 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASM 154
+F+HRD+ N L+G + V + DFGL++ + H + ++ +
Sbjct: 135 NFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAHAGAK------FPIKWTAP 185
Query: 155 NTHLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 213
+ + S + D+ + G +L G P+ G+ Q YE + + E
Sbjct: 186 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI---DLSQVYELLEKDYRMERPE--- 239
Query: 214 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLF 249
G P + C D+P +A + + F +F
Sbjct: 240 -GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 59.5 bits (143), Expect = 2e-10
Identities = 22/171 (12%), Positives = 63/171 (36%), Gaps = 13/171 (7%)
Query: 38 PN-VRWFGV--EGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 93
N +R GV + +++ + + +L+ + S+ ++ + + ++++ +
Sbjct: 69 HNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLAN 128
Query: 94 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYAS 153
+++HRD+ N L+ + DFGL++ D + R+ +
Sbjct: 129 MNYVHRDLAARNILVN---SNLVCKVSDFGLSRVLEDDPEATYT----TSGGKIPIRWTA 181
Query: 154 MNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 204
+ + D+ S G V+ + + + + I++
Sbjct: 182 PEAISYRKFTSASDVWSFGIVMWEVMTYGERPYW--ELSNHEVMKAINDGF 230
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 59.0 bits (142), Expect = 3e-10
Identities = 26/155 (16%), Positives = 65/155 (41%), Gaps = 9/155 (5%)
Query: 37 IPNVRWFGVEGDYNV-LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 94
+ ++ + + + +V+ + L + + ++K ++ Q+ ++F+ SK
Sbjct: 90 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK 149
Query: 95 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASM 154
F+HRD+ N ++ V + DFGLA+ D ++ ++
Sbjct: 150 KFVHRDLAARNCMLD---EKFTVKVADFGLARDMYDKEFDSV---HNKTGAKLPVKWMAL 203
Query: 155 NTHLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGL 188
+ + + + D+ S G +L + RG+ P+ +
Sbjct: 204 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 238
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 58.7 bits (141), Expect = 4e-10
Identities = 46/245 (18%), Positives = 89/245 (36%), Gaps = 31/245 (12%)
Query: 15 KTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSL 74
KH ++ L + + E + LV L+G L ++ +KL+
Sbjct: 73 HMKHENVI---GLLDVFTPARSLE-------EFNDVYLVTHLMGADLNNIVK--CQKLTD 120
Query: 75 KTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 134
V L Q++ ++++HS +HRD+KP N + ++ I+DFGLA+ D T
Sbjct: 121 DHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARHTDDEMTG 177
Query: 135 QHIPYRENKNLTGTARYASMNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTK 193
T Y + L ++ D+ S+G ++ L G + G
Sbjct: 178 YVA----------TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG---TDH 224
Query: 194 KQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSL-RFDDKPDYAYLKRIFRDLFIRE 252
+ + I + E L + +Y + + + + + DL + +
Sbjct: 225 IDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDL-LEK 283
Query: 253 GFQFD 257
D
Sbjct: 284 MLVLD 288
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 56.7 bits (136), Expect = 4e-10
Identities = 20/119 (16%), Positives = 50/119 (42%), Gaps = 14/119 (11%)
Query: 28 YRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINR 87
+R LQ G+ + + EG+ ++M E + ++ ++ + D ++
Sbjct: 65 FRALQKLQGLAVPKVYAWEGNA--VLM-------ELIDAKELYRVRVENPDEVLDMILEE 115
Query: 88 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLT 146
V + + +H D+ N L+ ++IIDF + + + + + R+ +N+
Sbjct: 116 VAKFYHRGIVHGDLSQYNVLVS----EEGIWIIDFPQSVEVGEEGWREIL-ERDVRNII 169
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 58.3 bits (140), Expect = 5e-10
Identities = 43/245 (17%), Positives = 88/245 (35%), Gaps = 31/245 (12%)
Query: 15 KTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSL 74
+H ++ L + + + F LVM +G L L KL
Sbjct: 73 HMRHENVI---GLLDVFTPDETLDDFTDF-------YLVMPFMGTDLGKLMK--HEKLGE 120
Query: 75 KTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 134
+ L QM+ + ++H+ +HRD+KP N + ++ I+DFGLA++ T
Sbjct: 121 DRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVN---EDCELKILDFGLARQADSEMTG 177
Query: 135 Q--HIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 192
YR + + RY ++ D+ S+G ++ + G ++G
Sbjct: 178 YVVTRWYRAPEVILNWMRY-----------TQTVDIWSVGCIMAEMITGKTLFKGSDHLD 226
Query: 193 KKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIRE 252
+ ++ K++ + ++ L + F A + +L + +
Sbjct: 227 QLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNA--SPLAVNL-LEK 283
Query: 253 GFQFD 257
D
Sbjct: 284 MLVLD 288
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.3 bits (137), Expect = 8e-10
Identities = 40/183 (21%), Positives = 68/183 (37%), Gaps = 18/183 (9%)
Query: 7 VFSVQENVKTKHPQLLYESKLYRILQGGTGIPN-VRWFGV--EGDYNVLVMDLLGPSLED 63
+ ++ + L E L + L+ N VR V LV + L+
Sbjct: 34 RVRLDDDDEGVPSSALREICLLKELKH----KNIVRLHDVLHSDKKLTLVFEFCDQDLKK 89
Query: 64 LFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFG 123
F+ C+ L + V Q++ + F HS++ LHRD+KP N L+ R ++ + +FG
Sbjct: 90 YFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLIN---RNGELKLANFG 146
Query: 124 LAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQ-SRRDDLESLGYVLMYFLRGS 182
LA+ + T Y + G + S D+ S G +
Sbjct: 147 LARAFGIPVRCYS-------AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAG 199
Query: 183 LPW 185
P
Sbjct: 200 RPL 202
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.2 bits (137), Expect = 9e-10
Identities = 34/211 (16%), Positives = 78/211 (36%), Gaps = 28/211 (13%)
Query: 11 QENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFC- 68
+ + L+ E ++ +++ I N+ + ++++ +L +
Sbjct: 55 SDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARR 114
Query: 69 --------------SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRA 114
+LS K ++ A Q+ +E++ SK +HRD+ N L+
Sbjct: 115 PPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---ED 171
Query: 115 NQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYV 174
N + I DFGLA+ ++ N ++ + + + D+ S G +
Sbjct: 172 NVMKIADFGLARDIHHIDYYKK-----TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVL 226
Query: 175 LMYFL-RGSLPWQGLKAGTKKQKYEKISEKK 204
L G P+ G+ ++ ++ + E
Sbjct: 227 LWEIFTLGGSPYPGV---PVEELFKLLKEGH 254
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 55.0 bits (131), Expect = 7e-09
Identities = 30/191 (15%), Positives = 73/191 (38%), Gaps = 9/191 (4%)
Query: 61 LEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK-SFLHRDIKPDNFLMGLGRRANQVYI 119
L + + R + L V ++ Q++ ++++H + +H DIKP+N L + + +
Sbjct: 111 LALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVL--MEIVDSPENL 168
Query: 120 IDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFL 179
I +A +H T Y S LG D+ S ++ +
Sbjct: 169 IQIKIADLGNACWYDEHYTNS-----IQTREYRSPEVLLGAPWGCGADIWSTACLIFELI 223
Query: 180 RGSLPWQGLKAGTKKQKYEKISE-KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDY 238
G ++ + + + + I++ ++ + + ++F+ LR K +
Sbjct: 224 TGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKF 283
Query: 239 AYLKRIFRDLF 249
L+ + + +
Sbjct: 284 WPLEDVLTEKY 294
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.5 bits (130), Expect = 8e-09
Identities = 37/190 (19%), Positives = 75/190 (39%), Gaps = 24/190 (12%)
Query: 29 RILQGGTGIPNVRWFGV--EGDYNVLVMDLL-GPSLEDLFNFCSR---------KLSLKT 76
+++ VR GV +G +++M+L+ L+ SL
Sbjct: 75 SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSK 134
Query: 77 VLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQH 136
++ +A ++ + + ++++ F+HRD+ N ++ V I DFG+ + +T
Sbjct: 135 MIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMTRDIYETDY--- 188
Query: 137 IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQ 195
YR+ R+ S + + D+ S G VL P+QGL + +Q
Sbjct: 189 --YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL---SNEQ 243
Query: 196 KYEKISEKKV 205
+ E +
Sbjct: 244 VLRFVMEGGL 253
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.5 bits (125), Expect = 3e-08
Identities = 42/229 (18%), Positives = 73/229 (31%), Gaps = 18/229 (7%)
Query: 10 VQENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCS 69
+ + V +H +L G W + + + D L + +
Sbjct: 48 IYQTVMLRHENIL---GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGM 102
Query: 70 RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 129
KL+L T LA + V + HRD+K N L+ + I D GLA ++
Sbjct: 103 IKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK---KNGTCCIADLGLAVRHD 159
Query: 130 DTSTHQHIPYRENKNLTGTARY------ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSL 183
+ I + GT RY E +R D+ ++G V R
Sbjct: 160 SATDTIDIAP---NHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCS 216
Query: 184 PWQGLKAGTKKQKYEKISEKKVSTSIEALC-RGYPTEFASYFHYCRSLR 231
+ S+ V + +C + + + C +LR
Sbjct: 217 IGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALR 265
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.2 bits (124), Expect = 4e-08
Identities = 24/116 (20%), Positives = 46/116 (39%), Gaps = 8/116 (6%)
Query: 70 RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 129
L+L+ ++ + Q+ +EF+ S+ +HRD+ N L+ N V I DFGLA+
Sbjct: 129 DFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLARDIY 185
Query: 130 DTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPW 185
+ + ++ + T + + D+ S G +L
Sbjct: 186 KDPDYVR-----KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 236
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 449 | |||
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.97 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.68 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 97.96 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.43 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 96.58 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.0 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 93.54 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 90.04 |
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.1e-50 Score=391.71 Aligned_cols=264 Identities=76% Similarity=1.322 Sum_probs=231.2
Q ss_pred EEEeeecccCCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHH
Q 013092 6 TVFSVQENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMI 85 (449)
Q Consensus 6 kV~~k~~~~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~ 85 (449)
.|++|+.......+++..|+++++.+++|++|+.+.+++.+++..+|||||++++|.+.+....+.+++..++.++.|++
T Consensus 34 ~vAvK~~~~~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~ 113 (299)
T d1ckia_ 34 EVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMI 113 (299)
T ss_dssp EEEEEEEESCTTSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHH
T ss_pred EEEEEEEchhccCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEcCCchhhhhhhccCCCcHHHHHHHHHHHH
Confidence 45555555556677899999999999888889999999999999999999999999988887778899999999999999
Q ss_pred HHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChh
Q 013092 86 NRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRR 165 (449)
Q Consensus 86 ~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~ 165 (449)
.||+|||++||+||||||+|||++..+.+..+||+|||+|+.+.........+++......||+.|||||++.+.+++.+
T Consensus 114 ~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 193 (299)
T d1ckia_ 114 SRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRR 193 (299)
T ss_dssp HHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHH
T ss_pred HHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCCh
Confidence 99999999999999999999999766677889999999999988777666666666778899999999999999999999
Q ss_pred hHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Q 013092 166 DDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIF 245 (449)
Q Consensus 166 ~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~L 245 (449)
+|||||||++|||++|..||...........+.+........+.+.++.++|+++.+||..||+.+|++||++.+|.++|
T Consensus 194 ~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l 273 (299)
T d1ckia_ 194 DDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLF 273 (299)
T ss_dssp HHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHH
T ss_pred hhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHH
Confidence 99999999999999999999987766666666666666666777888899999999999999999999999999999999
Q ss_pred HHHHHHcCCCCCCcccchhhhhhh
Q 013092 246 RDLFIREGFQFDYVFDWTILKYQQ 269 (449)
Q Consensus 246 ~~~~~~~~~~~~~~~dw~~~~~~~ 269 (449)
++++.+.++..+..+||+.++...
T Consensus 274 ~~~~~~~~~~~~~~~Dw~~~~~~~ 297 (299)
T d1ckia_ 274 RNLFHRQGFSYDYVFDWNMLKFGA 297 (299)
T ss_dssp HHHHHHHTCCCSCCCHHHHGGGTC
T ss_pred HHHHHHcCCCCCCCcCchhhcCCC
Confidence 999999999999999999987653
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=6.9e-49 Score=383.08 Aligned_cols=259 Identities=60% Similarity=0.994 Sum_probs=232.5
Q ss_pred EEeeecccCCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHH
Q 013092 7 VFSVQENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMIN 86 (449)
Q Consensus 7 V~~k~~~~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~ 86 (449)
|++|........+++.+|+++++.|++++||+.+++++.++...|+||||++++|.+++......++..+++.++.|++.
T Consensus 33 vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~~~~l~~~~~~~~~~~~~~~~~~i~~q~~~ 112 (293)
T d1csna_ 33 VAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLA 112 (293)
T ss_dssp EEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHH
T ss_pred EEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEecCCCHHHHHHhhccchhhHHHHHHHHHHHH
Confidence 44454444556678999999999998889999999999999999999999999999999877778999999999999999
Q ss_pred HHHHHHHCCceecCCCCCcEEEeec--CCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCCh
Q 013092 87 RVEFVHSKSFLHRDIKPDNFLMGLG--RRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSR 164 (449)
Q Consensus 87 aL~yLH~~givHRDLKP~NiLl~~~--~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~ 164 (449)
||+|||++||+||||||+|||++.. ...+.+||+|||+|+.+.........+.+......||+.|||||++.+..++.
T Consensus 113 ~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~ 192 (293)
T d1csna_ 113 RVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSR 192 (293)
T ss_dssp HHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCH
T ss_pred HHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCCh
Confidence 9999999999999999999999632 23578999999999998876665555666667789999999999999999999
Q ss_pred hhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHH
Q 013092 165 RDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRI 244 (449)
Q Consensus 165 ~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~ 244 (449)
++|||||||++|||++|..||.+.........+.++...+.....+.+++++|+++.+++..||..+|++||+|+.|.++
T Consensus 193 ~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~ 272 (293)
T d1csna_ 193 RDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGL 272 (293)
T ss_dssp HHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred HHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 99999999999999999999998887777778888887777778888999999999999999999999999999999999
Q ss_pred HHHHHHHcCCCCCCcccchhh
Q 013092 245 FRDLFIREGFQFDYVFDWTIL 265 (449)
Q Consensus 245 L~~~~~~~~~~~~~~~dw~~~ 265 (449)
|++++.+.+...+..+||+.+
T Consensus 273 l~~~~~~~~~~~~~~~Dw~~~ 293 (293)
T d1csna_ 273 FSKVLERLNTTEDENFDWNLL 293 (293)
T ss_dssp HHHHHHHTTCCSCSCCGGGCC
T ss_pred HHHHHHHcCCCCCCCCCCCcC
Confidence 999999999999999999853
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-47 Score=367.79 Aligned_cols=236 Identities=19% Similarity=0.270 Sum_probs=190.7
Q ss_pred cEEEEEeeecccCCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHH
Q 013092 3 EILTVFSVQENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLA 81 (449)
Q Consensus 3 ~aikV~~k~~~~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~ 81 (449)
+|||++.+........+.|.+|+++|+.+ +||||+++++++.+ +..||||||| |++|.+++...+..+++..++.|+
T Consensus 33 vAvK~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~-~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~ 110 (276)
T d1uwha_ 33 VAVKMLNVTAPTPQQLQAFKNEVGVLRKT-RHVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIA 110 (276)
T ss_dssp EEEEECCCSSCCTTHHHHHHHHHHHHTTC-CCTTBCCEEEEECS-SSCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHH
T ss_pred EEEEEEEcccCCHHHHHHHHHHHHHHHhC-CCCCEeeeeEEEec-cEEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHH
Confidence 35666555444455567799999999999 99999999988754 5689999999 899999998666779999999999
Q ss_pred HHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCC-
Q 013092 82 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI- 160 (449)
Q Consensus 82 ~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~- 160 (449)
.||+.||+|||++|||||||||+|||| +.++.+||+|||+++........ .......||+.|||||++.+.
T Consensus 111 ~qi~~gl~yLH~~~ivHrDlKp~NiLl---~~~~~~Kl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~APE~l~~~~ 182 (276)
T d1uwha_ 111 RQTAQGMDYLHAKSIIHRDLKSNNIFL---HEDLTVKIGDFGLATVKSRWSGS-----HQFEQLSGSILWMAPEVIRMQD 182 (276)
T ss_dssp HHHHHHHHHHHHTTCCCSCCCGGGEEE---ETTSSEEECCCCCSCC-----------------CCCCGGGCCHHHHTTCS
T ss_pred HHHHHHHHHHhcCCEeccccCHHHEEE---cCCCCEEEccccceeeccccCCc-----ccccccccCcccCCHHHHhccc
Confidence 999999999999999999999999999 57889999999999876543221 122456899999999999753
Q ss_pred --CCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCH
Q 013092 161 --EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDY 238 (449)
Q Consensus 161 --~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~ 238 (449)
.++.++|||||||+||||++|+.||.+.+. ..+....+......+.+..+...+|+++.+||..||+.+|++||++
T Consensus 183 ~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~--~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~ 260 (276)
T d1uwha_ 183 KNPYSFQSDVYAFGIVLYELMTGQLPYSNINN--RDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLF 260 (276)
T ss_dssp SCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC--HHHHHHHHHHTSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred CCCCCchhhhhhhHHHHHHHHHCCCCCCCCCh--HHHHHHHHhcCCCCCcchhccccchHHHHHHHHHHcCCCHhHCcCH
Confidence 479999999999999999999999987543 2334444445444555666778899999999999999999999999
Q ss_pred HHHHHHHHHHHH
Q 013092 239 AYLKRIFRDLFI 250 (449)
Q Consensus 239 ~~l~~~L~~~~~ 250 (449)
.+|.+.|+.+..
T Consensus 261 ~~il~~Le~l~~ 272 (276)
T d1uwha_ 261 PQILASIELLAR 272 (276)
T ss_dssp HHHHHHHHHHHH
T ss_pred HHHHHHHHHHHH
Confidence 999999887643
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-46 Score=358.09 Aligned_cols=219 Identities=21% Similarity=0.235 Sum_probs=187.6
Q ss_pred cEEEEEeeeccc-CCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHH
Q 013092 3 EILTVFSVQENV-KTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLML 80 (449)
Q Consensus 3 ~aikV~~k~~~~-~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i 80 (449)
.|+|++.+.... ......+.+|+++++.+ +||||+++++++.+.+..||||||| |++|.+++.. ...+++..+..|
T Consensus 34 vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~ivmEy~~~g~L~~~l~~-~~~l~e~~~~~i 111 (263)
T d2j4za1 34 LALKVLFKAQLEKAGVEHQLRREVEIQSHL-RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK-LSKFDEQRTATY 111 (263)
T ss_dssp EEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHH
T ss_pred EEEEEEchHHccChHHHHHHHHHHHHHHhc-CCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHhh-cCCCCHHHHHHH
Confidence 466666654433 34556789999999999 9999999999999999999999999 9999999985 457999999999
Q ss_pred HHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCC
Q 013092 81 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI 160 (449)
Q Consensus 81 ~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~ 160 (449)
+.||+.||+|||++||+||||||+|||| +.++.+||+|||+++....... ....||+.|||||++.+.
T Consensus 112 ~~qi~~al~~lH~~~ivHrDiKp~Nill---~~~~~~kl~DFG~a~~~~~~~~---------~~~~Gt~~Y~APE~~~~~ 179 (263)
T d2j4za1 112 ITELANALSYCHSKRVIHRDIKPENLLL---GSAGELKIADFGWSVHAPSSRR---------TTLCGTLDYLPPEMIEGR 179 (263)
T ss_dssp HHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCCSCSCCCCCCC---------EETTEEGGGCCHHHHTTC
T ss_pred HHHHHHHHHHHHHCCeeeeeecccccee---cCCCCEeecccceeeecCCCcc---------cccCCCCcccCHHHHcCC
Confidence 9999999999999999999999999999 6788999999999986654322 345799999999999999
Q ss_pred CCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHH
Q 013092 161 EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAY 240 (449)
Q Consensus 161 ~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~ 240 (449)
.++.++|||||||+||||++|+.||.+. +..+.+.++...... ++..+++++.+||..||+.||++||++.+
T Consensus 180 ~~~~~~DiwSlGvilyell~G~~Pf~~~---~~~~~~~~i~~~~~~-----~p~~~s~~~~~li~~~L~~dp~~R~t~~e 251 (263)
T d2j4za1 180 MHDEKVDLWSLGVLCYEFLVGKPPFEAN---TYQETYKRISRVEFT-----FPDFVTEGARDLISRLLKHNPSQRPMLRE 251 (263)
T ss_dssp CCCTTHHHHHHHHHHHHHHHSSCTTCCS---SHHHHHHHHHTTCCC-----CCTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CCCchhhhhhHhHHHHHHhcCCCCCCCC---CHHHHHHHHHcCCCC-----CCccCCHHHHHHHHHHccCCHhHCcCHHH
Confidence 9999999999999999999999999763 445556666554432 34568999999999999999999999888
Q ss_pred HHH
Q 013092 241 LKR 243 (449)
Q Consensus 241 l~~ 243 (449)
+++
T Consensus 252 il~ 254 (263)
T d2j4za1 252 VLE 254 (263)
T ss_dssp HHT
T ss_pred HHc
Confidence 754
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-46 Score=364.02 Aligned_cols=244 Identities=17% Similarity=0.245 Sum_probs=198.7
Q ss_pred cEEEEEeeecc-cCCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHH
Q 013092 3 EILTVFSVQEN-VKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLML 80 (449)
Q Consensus 3 ~aikV~~k~~~-~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i 80 (449)
.|||++.+... .......+.+|+++|+.| +||||+++++++.+.+..||||||| |++|.+++.. .+.+++..++.+
T Consensus 36 vAvK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~~~~-~~~l~e~~~~~~ 113 (288)
T d1uu3a_ 36 YAIKILEKRHIIKENKVPYVTRERDVMSRL-DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK-IGSFDETCTRFY 113 (288)
T ss_dssp EEEEEEEHHHHHHTTCHHHHHHHHHHHHHC-CSTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHH-HSSCCHHHHHHH
T ss_pred EEEEEEehHHccCHHHHHHHHHHHHHHHHc-CCCCeeEEEEEEEECCEEEEEEEccCCCCHHHhhhc-cCCCCHHHHHHH
Confidence 46666655442 234556799999999999 9999999999999999999999999 8999999875 467999999999
Q ss_pred HHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCC
Q 013092 81 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI 160 (449)
Q Consensus 81 ~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~ 160 (449)
+.|++.||+|||++||+||||||+|||+ +.++.+||+|||+|+.+...... ......+||+.|||||++.+.
T Consensus 114 ~~qi~~al~ylH~~~iiHrDiKp~NIll---~~~~~vkl~DFG~a~~~~~~~~~-----~~~~~~~GT~~Y~APE~~~~~ 185 (288)
T d1uu3a_ 114 TAEIVSALEYLHGKGIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQ-----ARANSFVGTAQYVSPELLTEK 185 (288)
T ss_dssp HHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCTTCEECC---------------CCCCGGGCCHHHHHTC
T ss_pred HHHHHHHHHhhccccEEcCcCCcccccc---CCCceEEecccccceecccCCcc-----cccccccCCccccCceeeccC
Confidence 9999999999999999999999999999 68889999999999977543221 112356799999999999999
Q ss_pred CCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHH
Q 013092 161 EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAY 240 (449)
Q Consensus 161 ~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~ 240 (449)
.++.++|||||||++|||++|..||.+. +..+.+.++...... ++..+++++.+||..||+.||++||++++
T Consensus 186 ~~~~~~DiwSlGvilyell~g~~Pf~~~---~~~~~~~~i~~~~~~-----~p~~~s~~~~~li~~~L~~dP~~R~t~~e 257 (288)
T d1uu3a_ 186 SACKSSDLWALGCIIYQLVAGLPPFRAG---NEYLIFQKIIKLEYD-----FPEKFFPKARDLVEKLLVLDATKRLGCEE 257 (288)
T ss_dssp CCCHHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHTTCCC-----CCTTCCHHHHHHHHTTSCSSGGGSTTSGG
T ss_pred CCCcccceehhhHHHHHHhhCCCCCCCc---CHHHHHHHHHcCCCC-----CCccCCHHHHHHHHHHccCCHhHCcCHHH
Confidence 9999999999999999999999999873 445666666655432 34578999999999999999999999888
Q ss_pred HHHHHHHHHHHcCCCCCCcccchhhhhh
Q 013092 241 LKRIFRDLFIREGFQFDYVFDWTILKYQ 268 (449)
Q Consensus 241 l~~~L~~~~~~~~~~~~~~~dw~~~~~~ 268 (449)
+... ..+ ..++|...+||+.+..+
T Consensus 258 ~~~~-~~i---~~Hpff~~i~w~~l~~~ 281 (288)
T d1uu3a_ 258 MEGY-GPL---KAHPFFESVTWENLHQQ 281 (288)
T ss_dssp GTCH-HHH---HTSGGGTTCCCTTGGGS
T ss_pred HcCC-HHH---HcCCccCCCCHHHhhcC
Confidence 6442 111 23567778899987543
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-45 Score=356.99 Aligned_cols=220 Identities=20% Similarity=0.281 Sum_probs=183.0
Q ss_pred cEEEEEeeecccCCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHH
Q 013092 3 EILTVFSVQENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLA 81 (449)
Q Consensus 3 ~aikV~~k~~~~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~ 81 (449)
.|||++.+.. ....+.+.+|+++|+.+ +||||+++++++.+.+..||||||| |++|.+++.. +.+++..++.|+
T Consensus 48 vAvK~~~~~~--~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~~~~--~~l~~~~~~~i~ 122 (293)
T d1yhwa1 48 VAIRQMNLQQ--QPKKELIINEILVMREN-KNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVC 122 (293)
T ss_dssp EEEEEEEGGG--CSCHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHH--SCCCHHHHHHHH
T ss_pred EEEEEEeccc--ChHHHHHHHHHHHHHhC-CCCCEeeEeEEEEECCEEEEEEEecCCCcHHHHhhc--cCCCHHHHHHHH
Confidence 4566554332 33456799999999999 9999999999999999999999999 9999999874 569999999999
Q ss_pred HHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCC
Q 013092 82 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIE 161 (449)
Q Consensus 82 ~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~ 161 (449)
.||+.||+|||++||+||||||+|||| +.++.+||+|||+++.+...... ....+||+.|||||++.+..
T Consensus 123 ~qi~~aL~yLH~~~iiHrDiKp~NILl---~~~~~vkl~DFG~a~~~~~~~~~-------~~~~~gt~~Y~aPE~~~~~~ 192 (293)
T d1yhwa1 123 RECLQALEFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQSK-------RSTMVGTPYWMAPEVVTRKA 192 (293)
T ss_dssp HHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECCSTTCC-------BCCCCSCGGGCCHHHHSSSC
T ss_pred HHHHHHHHHHHHCCCcccCCcHHHeEE---CCCCcEeeccchhheeecccccc-------ccccccCCCccChhhhcCCC
Confidence 999999999999999999999999999 57889999999999987543321 24568999999999999999
Q ss_pred CChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHH
Q 013092 162 QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYL 241 (449)
Q Consensus 162 ~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l 241 (449)
++.++|||||||++|+|++|..||.+.+ ..+.+..+....... ...+..+++++.+||..||+.||++||++.++
T Consensus 193 ~~~~~DiwSlGvilyemltG~~Pf~~~~---~~~~~~~~~~~~~~~--~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ei 267 (293)
T d1yhwa1 193 YGPKVDIWSLGIMAIEMIEGEPPYLNEN---PLRALYLIATNGTPE--LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKEL 267 (293)
T ss_dssp BCTHHHHHHHHHHHHHHHHSSCTTTTSC---HHHHHHHHHHHCSCC--CSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred CCchhceehHhHHHHHHhhCCCCCCCCC---HHHHHHHHHhCCCCC--CCCcccCCHHHHHHHHHHccCChhHCcCHHHH
Confidence 9999999999999999999999998743 233333333322111 12345689999999999999999999998887
Q ss_pred H
Q 013092 242 K 242 (449)
Q Consensus 242 ~ 242 (449)
+
T Consensus 268 l 268 (293)
T d1yhwa1 268 L 268 (293)
T ss_dssp T
T ss_pred h
Confidence 4
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-45 Score=357.21 Aligned_cols=216 Identities=19% Similarity=0.314 Sum_probs=181.8
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 96 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gi 96 (449)
...|.+|+++|++| +||||+++++++.++ ..||||||| +++|.+++.. ...+++..++.|+.||+.||+|||++||
T Consensus 52 ~~~~~~E~~il~~l-~HpnIv~~~g~~~~~-~~~lvmE~~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~gl~ylH~~~i 128 (277)
T d1xbba_ 52 KDELLAEANVMQQL-DNPYIVRMIGICEAE-SWMLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESNF 128 (277)
T ss_dssp HHHHHHHHHHHHTC-CCTTBCCEEEEEESS-SEEEEEECCTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred HHHHHHHHHHHHhC-CCCCCceEEEEeccC-CEEEEEEcCCCCcHHHHHhh-ccCCCHHHHHHHHHHHHHHHhhHHhCCc
Confidence 45699999999999 899999999998654 578999999 9999999986 5679999999999999999999999999
Q ss_pred eecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHHHH
Q 013092 97 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLM 176 (449)
Q Consensus 97 vHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il~ 176 (449)
+||||||+|||+ +.++.+||+|||+++.+....... .......||+.|||||++.+..++.++|||||||++|
T Consensus 129 iHrDlKp~Nill---~~~~~~kl~DFGla~~~~~~~~~~----~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ 201 (277)
T d1xbba_ 129 VHRDLAARNVLL---VTQHYAKISDFGLSKALRADENYY----KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMW 201 (277)
T ss_dssp ECSCCSGGGEEE---EETTEEEECCCTTCEECCTTCSEE----EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHH
T ss_pred ccCCCcchhhcc---cccCcccccchhhhhhcccccccc----ccccccCCCceecCchhhcCCCCCchhhhccchhhhh
Confidence 999999999999 578999999999998875543321 2234467999999999999999999999999999999
Q ss_pred HHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 013092 177 YFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFI 250 (449)
Q Consensus 177 ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~L~~~~~ 250 (449)
||++ |..||.+.+. .+....+..... ..++..+|+++.+||..||+.||++||++.+|.+.|++.+.
T Consensus 202 ellt~g~~Pf~~~~~---~~~~~~i~~~~~----~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 202 EAFSYGQKPYRGMKG---SEVTAMLEKGER----MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp HHHTTTCCSSTTCCH---HHHHHHHHTTCC----CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHhhCCCCCCCCCCH---HHHHHHHHcCCC----CCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence 9997 9999987543 344444444322 12346789999999999999999999999999998888764
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-45 Score=358.41 Aligned_cols=220 Identities=19% Similarity=0.276 Sum_probs=186.4
Q ss_pred ChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 013092 17 KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 95 (449)
Q Consensus 17 ~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~g 95 (449)
..+.|.+|+++|+.| +||||+++++++.+ +..||||||| +++|.+++...+..+++..++.++.||+.||+|||++|
T Consensus 52 ~~~~~~~E~~il~~l-~HpnIv~l~g~~~~-~~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~ 129 (285)
T d1u59a_ 52 DTEEMMREAQIMHQL-DNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN 129 (285)
T ss_dssp HHHHHHHHHHHHHHC-CCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHhC-CCCCEeeEeeeecc-CeEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 345699999999999 89999999999865 4579999999 89999998755667999999999999999999999999
Q ss_pred ceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHHH
Q 013092 96 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVL 175 (449)
Q Consensus 96 ivHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il 175 (449)
|+||||||+|||| +.++.+||+|||+++.+....... .......||+.|||||++.+..++.++|||||||++
T Consensus 130 iiHrDlKp~Nill---~~~~~~Kl~DFGla~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l 202 (285)
T d1u59a_ 130 FVHRDLAARNVLL---VNRHYAKISDFGLSKALGADDSYY----TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTM 202 (285)
T ss_dssp EECCCCSGGGEEE---EETTEEEECCCTTCEECTTCSCEE----CCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHH
T ss_pred eecCcCchhheee---ccCCceeeccchhhhccccccccc----ccccccccCccccChHHHhCCCCCccchhhcchHHH
Confidence 9999999999999 478899999999999876543221 123456789999999999999999999999999999
Q ss_pred HHHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 013092 176 MYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIRE 252 (449)
Q Consensus 176 ~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~L~~~~~~~ 252 (449)
|||++ |..||.+... .+.+..+...... .+++.+|+++.+||..||+.+|++||++.+|.+.|++.+...
T Consensus 203 ~E~lt~G~~Pf~~~~~---~~~~~~i~~~~~~----~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~ 273 (285)
T d1u59a_ 203 WEALSYGQKPYKKMKG---PEVMAFIEQGKRM----ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 273 (285)
T ss_dssp HHHHTTSCCTTTTCCT---HHHHHHHHTTCCC----CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHhCCCCCCCCCCH---HHHHHHHHcCCCC----CCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 99998 9999987643 3444445443321 245679999999999999999999999999999999887543
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.8e-45 Score=356.83 Aligned_cols=220 Identities=12% Similarity=0.236 Sum_probs=176.0
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 96 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gi 96 (449)
.+.|.+|+++|+.| +|||||++++++.+.+..||||||| +++|.+++......+++.+++.++.||+.||+|||++||
T Consensus 71 ~~~~~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~i 149 (299)
T d1jpaa_ 71 RRDFLSEASIMGQF-DHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNY 149 (299)
T ss_dssp HHHHHHHHHHHTTC-CCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred HHHHHHHHHHHHhC-CCCCCccEEEEEeeCCEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCC
Confidence 34689999999999 8999999999999999999999999 999999988656679999999999999999999999999
Q ss_pred eecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHHHH
Q 013092 97 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLM 176 (449)
Q Consensus 97 vHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il~ 176 (449)
+||||||+|||| +.++.+||+|||+++.+........ +.......||+.|||||++.+..++.++|||||||++|
T Consensus 150 iHrDlKp~NILl---~~~~~~Kl~DFGla~~~~~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ 224 (299)
T d1jpaa_ 150 VHRDLAARNILV---NSNLVCKVSDFGLSRFLEDDTSDPT--YTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMW 224 (299)
T ss_dssp CCSCCCGGGEEE---CTTCCEEECCC-------------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHH
T ss_pred ccCccccceEEE---CCCCcEEECCcccceEccCCCCcce--eeecccccCCccccCHHHHhcCCCCcccccccchHHHH
Confidence 999999999999 6889999999999987755332111 11223356899999999999999999999999999999
Q ss_pred HHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 013092 177 YFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFI 250 (449)
Q Consensus 177 ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~L~~~~~ 250 (449)
||++ |..||.+... .+.+..+...... ..+..+|+++.+||..||+.+|++||++.+|.+.|+.++.
T Consensus 225 el~t~g~~Pf~~~~~---~~~~~~i~~~~~~----~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 225 EVMSYGERPYWDMTN---QDVINAIEQDYRL----PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp HHHTTSCCTTTTCCH---HHHHHHHHTTCCC----CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHHhCCCCCCCCCCH---HHHHHHHHcCCCC----CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 9998 8999987543 3444555443221 1345689999999999999999999999999999988865
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-45 Score=356.29 Aligned_cols=224 Identities=21% Similarity=0.280 Sum_probs=179.9
Q ss_pred cEEEEEeeecccCCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHH
Q 013092 3 EILTVFSVQENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLA 81 (449)
Q Consensus 3 ~aikV~~k~~~~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~ 81 (449)
.|||++.+.. .....+.+.+|+++|+.| +||||+++++++.+++..||||||| |++|.+++.. ...+++..++.++
T Consensus 33 vAiK~i~~~~-~~~~~~~~~~Ei~~l~~l-~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~l~~-~~~l~e~~~~~i~ 109 (271)
T d1nvra_ 33 VAVKIVDMKR-AVDCPENIKKEICINKML-NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFF 109 (271)
T ss_dssp EEEEEEECC--------CHHHHHHHHHTC-CCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBT-TTBCCHHHHHHHH
T ss_pred EEEEEEehhh-cchHHHHHHHHHHHHHhC-CCCCEeeEeeeeccCceeEEEEeccCCCcHHHHHhc-CCCCCHHHHHHHH
Confidence 4566655433 223445799999999999 8999999999999999999999999 8999999874 5679999999999
Q ss_pred HHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCC
Q 013092 82 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIE 161 (449)
Q Consensus 82 ~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~ 161 (449)
.||+.||+|||++||+||||||+|||+ +.++.+||+|||+|+.+...... ......+||+.|||||++.+.+
T Consensus 110 ~qi~~al~ylH~~~IiHrDiKp~NILl---~~~~~~KL~DFG~a~~~~~~~~~-----~~~~~~~GT~~Y~APE~~~~~~ 181 (271)
T d1nvra_ 110 HQLMAGVVYLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRE-----RLLNKMCGTLPYVAPELLKRRE 181 (271)
T ss_dssp HHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCCTTCEECEETTEE-----CCBCCCCSCGGGSCTHHHHCSS
T ss_pred HHHHHHHHHHHHcCCccCcccHHHEEE---CCCCCEEEccchhheeeccCCcc-----ccccceeeCcCccCHhHhcCCC
Confidence 999999999999999999999999999 57789999999999977543221 1234568999999999999888
Q ss_pred C-ChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHH
Q 013092 162 Q-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAY 240 (449)
Q Consensus 162 ~-s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~ 240 (449)
+ +.++|||||||++|||++|+.||....... +.+..+..... .......+++++.+||..||+.||++||++.+
T Consensus 182 ~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~--~~~~~~~~~~~---~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e 256 (271)
T d1nvra_ 182 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC--QEYSDWKEKKT---YLNPWKKIDSAPLALLHKILVENPSARITIPD 256 (271)
T ss_dssp BCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTS--HHHHHHHTTCT---TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred CCCCceeeeHhHHHHHHHHhCCCCCCCCChHH--HHHHHHhcCCC---CCCccccCCHHHHHHHHHHcCCChhHCcCHHH
Confidence 6 578999999999999999999998754332 22333322221 11223568899999999999999999999887
Q ss_pred HH
Q 013092 241 LK 242 (449)
Q Consensus 241 l~ 242 (449)
++
T Consensus 257 il 258 (271)
T d1nvra_ 257 IK 258 (271)
T ss_dssp HT
T ss_pred Hh
Confidence 74
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.7e-45 Score=359.95 Aligned_cols=226 Identities=18% Similarity=0.186 Sum_probs=173.8
Q ss_pred cEEEEEeeecccCCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHH
Q 013092 3 EILTVFSVQENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLA 81 (449)
Q Consensus 3 ~aikV~~k~~~~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~ 81 (449)
.|||++.+.... .....+.+|+++|+.| +||||+++++++.+++..||||||| |++|.+++.. .+.+++..+..++
T Consensus 37 vAvK~i~~~~~~-~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lvmE~~~gg~L~~~l~~-~~~l~e~~~~~~~ 113 (307)
T d1a06a_ 37 VAIKCIAKKALE-GKEGSMENEIAVLHKI-KHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVE-KGFYTERDASRLI 113 (307)
T ss_dssp EEEEEEEC-----------CHHHHHHHTC-CCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHT-CSCCCHHHHHHHH
T ss_pred EEEEEEchHHhh-hHHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCEEEEEEeccCCCcHHHhhhc-ccCCCHHHHHHHH
Confidence 466666544322 2345688999999999 8999999999999999999999999 8999999975 5679999999999
Q ss_pred HHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCC
Q 013092 82 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIE 161 (449)
Q Consensus 82 ~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~ 161 (449)
.||+.||+|||++||+||||||+|||+...+.++.+||+|||+++....... ....+||+.|||||++.+..
T Consensus 114 ~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~--------~~~~~GT~~y~APE~~~~~~ 185 (307)
T d1a06a_ 114 FQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV--------LSTACGTPGYVAPEVLAQKP 185 (307)
T ss_dssp HHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC--------------------------CTTSCHHHHTTCC
T ss_pred HHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCCe--------eeeeeeCccccCcHHHcCCC
Confidence 9999999999999999999999999996555678999999999987654322 23567999999999999999
Q ss_pred CChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHH
Q 013092 162 QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYL 241 (449)
Q Consensus 162 ~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l 241 (449)
++.++|||||||+||||++|..||.+. ...+.+..+........ ......+|+++.+||..||+.||++||++.++
T Consensus 186 ~~~~~DiwSlGvilyell~g~~Pf~~~---~~~~~~~~i~~~~~~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ei 261 (307)
T d1a06a_ 186 YSKAVDCWSIGVIAYILLCGYPPFYDE---NDAKLFEQILKAEYEFD-SPYWDDISDSAKDFIRHLMEKDPEKRFTCEQA 261 (307)
T ss_dssp CCTHHHHHHHHHHHHHHHHSSCSCCCS---SHHHHHHHHHTTCCCCC-TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred CCcHHHhhhhhHHHHHHHhCCCCCCCC---CHHHHHHHHhccCCCCC-CccccCCCHHHHHHHHHHccCCHhHCcCHHHH
Confidence 999999999999999999999999873 34455566665544322 22446789999999999999999999998877
Q ss_pred HH
Q 013092 242 KR 243 (449)
Q Consensus 242 ~~ 243 (449)
++
T Consensus 262 l~ 263 (307)
T d1a06a_ 262 LQ 263 (307)
T ss_dssp HH
T ss_pred hc
Confidence 53
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-44 Score=359.76 Aligned_cols=239 Identities=18% Similarity=0.242 Sum_probs=200.0
Q ss_pred cEEEEEeeecc-cCCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHH
Q 013092 3 EILTVFSVQEN-VKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLML 80 (449)
Q Consensus 3 ~aikV~~k~~~-~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i 80 (449)
.|||++.|... ......++.+|+++|+.+ +||||+++++++.+.+..||||||| |++|.+++.. .+.+++..++.+
T Consensus 33 ~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~iv~ey~~gg~L~~~~~~-~~~~~e~~~~~~ 110 (337)
T d1o6la_ 33 YAMKILRKEVIIAKDEVAHTVTESRVLQNT-RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSR-ERVFTEERARFY 110 (337)
T ss_dssp EEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH-HSCCCHHHHHHH
T ss_pred EEEEEEchhhccCHHHHHHHHHHHHHHHhC-CCCCEEEEEeeeccccccccceeccCCCchhhhhhc-ccCCcHHHHHHH
Confidence 46777766543 244567799999999999 8999999999999999999999999 9999999986 467999999999
Q ss_pred HHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCC
Q 013092 81 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI 160 (449)
Q Consensus 81 ~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~ 160 (449)
+.||+.||+|||++||+||||||+|||| +.++.+||+|||+|+....... .....+||+.|||||++.+.
T Consensus 111 ~~qil~al~ylH~~~iiHRDlKP~NILl---~~~g~vkl~DFG~a~~~~~~~~-------~~~~~~GT~~Y~aPE~~~~~ 180 (337)
T d1o6la_ 111 GAEIVSALEYLHSRDVVYRDIKLENLML---DKDGHIKITDFGLCKEGISDGA-------TMKTFCGTPEYLAPEVLEDN 180 (337)
T ss_dssp HHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCSCCTTC-------CBCCCEECGGGCCGGGGSSS
T ss_pred HHHHhhhhhhhhhcCccccccCHHHeEe---cCCCCEEEeecccccccccCCc-------ccccceeCHHHhhhhhccCC
Confidence 9999999999999999999999999999 6889999999999987644322 12457899999999999999
Q ss_pred CCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCC---
Q 013092 161 EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPD--- 237 (449)
Q Consensus 161 ~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt--- 237 (449)
.|+.++|||||||++|||++|+.||.+. +..+.+.++...... ++..+++++.+||..||+.||.+|++
T Consensus 181 ~y~~~~DiwSlGvilyeml~G~~pf~~~---~~~~~~~~i~~~~~~-----~p~~~s~~~~dli~~~L~~dP~~R~~~~~ 252 (337)
T d1o6la_ 181 DYGRAVDWWGLGVVMYEMMCGRLPFYNQ---DHERLFELILMEEIR-----FPRTLSPEAKSLLAGLLKKDPKQRLGGGP 252 (337)
T ss_dssp CBCTTHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHCCCC-----CCTTSCHHHHHHHHHHTCSSTTTSTTCST
T ss_pred CCChhhcccchhhHHHHHHHCCCCCCCc---CHHHHHHHHhcCCCC-----CCccCCHHHHHHHHhhccCCchhhccccc
Confidence 9999999999999999999999999874 445556666554432 34678999999999999999999995
Q ss_pred --HHHHHHHHHHHHHHcCCCCCCcccchhhhhhhcc
Q 013092 238 --YAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQ 271 (449)
Q Consensus 238 --~~~l~~~L~~~~~~~~~~~~~~~dw~~~~~~~~~ 271 (449)
+++|+ .+++...++|..+...+..
T Consensus 253 ~~~~eil----------~Hp~f~~i~~~~l~~~~~~ 278 (337)
T d1o6la_ 253 SDAKEVM----------EHRFFLSINWQDVVQKKLL 278 (337)
T ss_dssp TTHHHHH----------TSGGGTTCCHHHHHTTCSC
T ss_pred ccHHHHH----------cCcccccCCHHHHHhCCCC
Confidence 45443 2456667899887665543
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-45 Score=351.11 Aligned_cols=222 Identities=17% Similarity=0.240 Sum_probs=181.0
Q ss_pred cEEEEEeeecccCCChhHHHHHHHHHHHhcCCCCCceEEEEeEe----CCEEEEEEecC-CCCHHHHHHHcCCCCCHHHH
Q 013092 3 EILTVFSVQENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVE----GDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTV 77 (449)
Q Consensus 3 ~aikV~~k~~~~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~----~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~ 77 (449)
+|+|++.+....+...+.|.+|+++|+.| +||||+++++++.+ ....||||||| |++|.+++.. ...+++..+
T Consensus 37 va~K~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~-~~~~~~~~~ 114 (270)
T d1t4ha_ 37 VAWCELQDRKLTKSERQRFKEEAEMLKGL-QHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR-FKVMKIKVL 114 (270)
T ss_dssp EEEEEEEGGGSCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHH-HSSCCHHHH
T ss_pred EEEEEEchhhCCHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEeeccccCCEEEEEEeCCCCCcHHHHHhc-cccccHHHH
Confidence 35555544443444456789999999999 89999999999865 45689999999 9999999976 457999999
Q ss_pred HHHHHHHHHHHHHHHHCC--ceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchh
Q 013092 78 LMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMN 155 (449)
Q Consensus 78 ~~i~~qi~~aL~yLH~~g--ivHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE 155 (449)
+.++.||+.||+|||+++ |+||||||+||||. +.++.+||+|||+++...... ....+||+.|||||
T Consensus 115 ~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~--~~~~~~Kl~DFGla~~~~~~~---------~~~~~GT~~Y~aPE 183 (270)
T d1t4ha_ 115 RSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT--GPTGSVKIGDLGLATLKRASF---------AKAVIGTPEFMAPE 183 (270)
T ss_dssp HHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEES--STTSCEEECCTTGGGGCCTTS---------BEESCSSCCCCCGG
T ss_pred HHHHHHHHHHHHHHHHCCCCEEeCCcChhhceee--CCCCCEEEeecCcceeccCCc---------cCCcccCccccCHH
Confidence 999999999999999999 99999999999994 356899999999997543321 23568999999999
Q ss_pred hhhCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCC
Q 013092 156 THLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDK 235 (449)
Q Consensus 156 ~~~~~~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~R 235 (449)
++.+ .++.++|||||||++|||++|+.||.+.. ...+.+..+...... ..+...+++++.+||..||+.||++|
T Consensus 184 ~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~--~~~~~~~~i~~~~~~---~~~~~~~~~~~~~li~~~l~~dp~~R 257 (270)
T d1t4ha_ 184 MYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ--NAAQIYRRVTSGVKP---ASFDKVAIPEVKEIIEGCIRQNKDER 257 (270)
T ss_dssp GGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS--SHHHHHHHHTTTCCC---GGGGGCCCHHHHHHHHHHSCSSGGGS
T ss_pred HhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcc--cHHHHHHHHHcCCCC---cccCccCCHHHHHHHHHHccCCHhHC
Confidence 9876 59999999999999999999999997643 334455555543322 23456788999999999999999999
Q ss_pred CCHHHHHH
Q 013092 236 PDYAYLKR 243 (449)
Q Consensus 236 Pt~~~l~~ 243 (449)
|++.+|++
T Consensus 258 ~s~~ell~ 265 (270)
T d1t4ha_ 258 YSIKDLLN 265 (270)
T ss_dssp CCHHHHHT
T ss_pred cCHHHHhC
Confidence 99888754
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-45 Score=355.32 Aligned_cols=223 Identities=16% Similarity=0.251 Sum_probs=183.0
Q ss_pred cEEEEEeeecccCCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHH
Q 013092 3 EILTVFSVQENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLA 81 (449)
Q Consensus 3 ~aikV~~k~~~~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~ 81 (449)
.|+|++.+. .....+.+.+|+++|+.| +||||+++++++.+.+..||||||| |++|.+++....+.+++..+..++
T Consensus 40 vAvK~i~~~--~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~ 116 (288)
T d2jfla1 40 AAAKVIDTK--SEEELEDYMVEIDILASC-DHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVC 116 (288)
T ss_dssp EEEEEEECS--SSGGGGGTHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHH
T ss_pred EEEEEECcC--CHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEeeCCeEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHH
Confidence 355554432 234456799999999999 8999999999999999999999999 999999987656779999999999
Q ss_pred HHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhh---
Q 013092 82 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHL--- 158 (449)
Q Consensus 82 ~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~--- 158 (449)
.||+.||+|||++||+||||||+|||| +.++.+||+|||+++....... ......||+.|||||++.
T Consensus 117 ~qi~~gL~ylH~~~ivHrDiKp~NIll---~~~~~~Kl~DFG~a~~~~~~~~-------~~~~~~Gt~~y~APE~l~~~~ 186 (288)
T d2jfla1 117 KQTLDALNYLHDNKIIHRDLKAGNILF---TLDGDIKLADFGVSAKNTRTIQ-------RRDSFIGTPYWMAPEVVMCET 186 (288)
T ss_dssp HHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECHHHHH-------HHTCCCSCCTTCCHHHHTTCS
T ss_pred HHHHHHHHHHHHCCEEEeecChhheeE---CCCCCEEEEechhhhccCCCcc-------cccccccccccCCHHHHhhcc
Confidence 999999999999999999999999999 5788999999999986543211 123568999999999985
Q ss_pred --CCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCC
Q 013092 159 --GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKP 236 (449)
Q Consensus 159 --~~~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RP 236 (449)
+..|+.++|||||||++|||++|..||.+.+. .+.+.++....... ...+..+++++.+||..||+.||++||
T Consensus 187 ~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~---~~~~~~i~~~~~~~--~~~~~~~s~~~~~li~~~L~~dp~~R~ 261 (288)
T d2jfla1 187 SKDRPYDYKADVWSLGITLIEMAEIEPPHHELNP---MRVLLKIAKSEPPT--LAQPSRWSSNFKDFLKKCLEKNVDARW 261 (288)
T ss_dssp TTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCG---GGHHHHHHHSCCCC--CSSGGGSCHHHHHHHHHHSCSSTTTSC
T ss_pred cCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCH---HHHHHHHHcCCCCC--CCccccCCHHHHHHHHHHccCChhHCc
Confidence 45688999999999999999999999987544 33444444433211 122356899999999999999999999
Q ss_pred CHHHHHH
Q 013092 237 DYAYLKR 243 (449)
Q Consensus 237 t~~~l~~ 243 (449)
++.+|++
T Consensus 262 t~~ell~ 268 (288)
T d2jfla1 262 TTSQLLQ 268 (288)
T ss_dssp CHHHHTT
T ss_pred CHHHHhc
Confidence 9888743
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-45 Score=354.79 Aligned_cols=223 Identities=22% Similarity=0.267 Sum_probs=174.3
Q ss_pred cEEEEEeeecccCCChhHHHHHHHHHHHhcCCCCCceEEEEeEe--CCEEEEEEecC-CCCHHHHHHHc---CCCCCHHH
Q 013092 3 EILTVFSVQENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVE--GDYNVLVMDLL-GPSLEDLFNFC---SRKLSLKT 76 (449)
Q Consensus 3 ~aikV~~k~~~~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~--~~~~~lVmE~~-g~sL~~ll~~~---~~~ls~~~ 76 (449)
.|+|++.+........+.+.+|+++|+.+ +||||+++++++.+ .+..||||||| |++|.+++... +..+++..
T Consensus 32 vAvK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~ 110 (269)
T d2java1 32 LVWKELDYGSMTEAEKQMLVSEVNLLREL-KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEF 110 (269)
T ss_dssp EEEEEECCTTSCHHHHHHHHHHHHHTTSC-CCTTBCCEEEEEEC----CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHH
T ss_pred EEEEEEChhhCCHHHHHHHHHHHHHHHHC-CCCCEeeEEEEEEeCCCCEEEEEEecCCCCcHHHHHHhccccCCCCCHHH
Confidence 35555544433333455689999999999 99999999998864 45689999999 99999998642 56799999
Q ss_pred HHHHHHHHHHHHHHHHHCC-----ceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccc
Q 013092 77 VLMLADQMINRVEFVHSKS-----FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY 151 (449)
Q Consensus 77 ~~~i~~qi~~aL~yLH~~g-----ivHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y 151 (449)
++.++.||+.||+|||++| |+||||||+|||| +.++.+||+|||+++.+..... ......||+.|
T Consensus 111 ~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll---~~~~~vkl~DFG~a~~~~~~~~-------~~~~~~gt~~Y 180 (269)
T d2java1 111 VLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL---DGKQNVKLGDFGLARILNHDTS-------FAKAFVGTPYY 180 (269)
T ss_dssp HHHHHHHHHHHHHHHHHHCC---------CCGGGEEE---CTTSCEEECCHHHHHHC------------------CCCSC
T ss_pred HHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCc---CCCCcEEEeeccceeecccCCC-------ccccCCCCccc
Confidence 9999999999999999976 9999999999999 6789999999999987654322 12356899999
Q ss_pred cchhhhhCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCC
Q 013092 152 ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLR 231 (449)
Q Consensus 152 ~aPE~~~~~~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~ 231 (449)
||||++.+..++.++|||||||++|||++|..||.+. +..+.+.++...... .++..+++++.+||..||+.|
T Consensus 181 ~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~---~~~~~~~~i~~~~~~----~~~~~~s~~l~~li~~~L~~d 253 (269)
T d2java1 181 MSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF---SQKELAGKIREGKFR----RIPYRYSDELNEIITRMLNLK 253 (269)
T ss_dssp CCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS---SHHHHHHHHHHTCCC----CCCTTSCHHHHHHHHHHTCSS
T ss_pred CCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCC---CHHHHHHHHHcCCCC----CCCcccCHHHHHHHHHHcCCC
Confidence 9999999999999999999999999999999999874 345556666654432 244678999999999999999
Q ss_pred CCCCCCHHHHHH
Q 013092 232 FDDKPDYAYLKR 243 (449)
Q Consensus 232 p~~RPt~~~l~~ 243 (449)
|++||++.+|++
T Consensus 254 p~~Rps~~ell~ 265 (269)
T d2java1 254 DYHRPSVEEILE 265 (269)
T ss_dssp GGGSCCHHHHHT
T ss_pred hhHCcCHHHHHh
Confidence 999999988753
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-44 Score=346.12 Aligned_cols=220 Identities=17% Similarity=0.229 Sum_probs=177.0
Q ss_pred cCCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH
Q 013092 14 VKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 92 (449)
Q Consensus 14 ~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH 92 (449)
.....++|.+|+++++.+ +||||+++++++.+.+..||||||| +++|.+++......+++..++.++.||+.||+|||
T Consensus 40 ~~~~~~~~~~E~~~l~~l-~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH 118 (263)
T d1sm2a_ 40 GAMSEEDFIEEAEVMMKL-SHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE 118 (263)
T ss_dssp SSSCHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH
T ss_pred CcCcHHHHHHHHHHHHhc-CCCCcccccceeccCCceEEEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhh
Confidence 345567899999999999 8999999999999999999999999 99999998865677999999999999999999999
Q ss_pred HCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHH
Q 013092 93 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLG 172 (449)
Q Consensus 93 ~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG 172 (449)
+++|+||||||+|||| +.++.+||+|||+++.+...... ......||+.|+|||++.+..++.++||||||
T Consensus 119 ~~~iiHrDlKp~Nill---~~~~~~Kl~DFGla~~~~~~~~~------~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~G 189 (263)
T d1sm2a_ 119 EACVIHRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQYT------SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFG 189 (263)
T ss_dssp HTTCCCTTCSGGGEEE---CGGGCEEECSCC------------------------CTTSCCHHHHTTCCCCHHHHHHHHH
T ss_pred ccceeecccchhheee---cCCCCeEecccchheeccCCCce------eecceecCcccCChHHhcCCCCCchhhhcchH
Confidence 9999999999999999 68889999999999876554321 12345789999999999999999999999999
Q ss_pred HHHHHHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 013092 173 YVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFI 250 (449)
Q Consensus 173 ~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~L~~~~~ 250 (449)
|++|||++ |.+||... ...+.+..+...... ..+..+++++.+||..||+.||++||++++|++.|+++.+
T Consensus 190 vil~el~t~~~~~~~~~---~~~~~~~~i~~~~~~----~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 190 VLMWEVFSEGKIPYENR---SNSEVVEDISTGFRL----YKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp HHHHHHHTTSCCTTCSC---CHHHHHHHHHHTCCC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHCCCCCCCCC---CHHHHHHHHHhcCCC----CCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 99999999 56666542 334455555443221 1235689999999999999999999999999999998754
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-44 Score=358.46 Aligned_cols=228 Identities=19% Similarity=0.228 Sum_probs=186.7
Q ss_pred EEEEeeeccc---CCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcC-----------
Q 013092 5 LTVFSVQENV---KTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCS----------- 69 (449)
Q Consensus 5 ikV~~k~~~~---~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~----------- 69 (449)
++|++|.... ......+.+|+.+|..+.+|||||++++++.+.+..||||||| +|+|.+++....
T Consensus 68 ~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~ 147 (325)
T d1rjba_ 68 IQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYE 147 (325)
T ss_dssp EEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC--------
T ss_pred eEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhc
Confidence 4566665432 2345568999999999989999999999999999999999999 999999997432
Q ss_pred -----------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccc
Q 013092 70 -----------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIP 138 (449)
Q Consensus 70 -----------~~ls~~~~~~i~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~ 138 (449)
..+++..++.|+.||+.||+|||+++||||||||+|||+ +.++.+||+|||+|+........
T Consensus 148 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~Nill---~~~~~~Kl~DFGla~~~~~~~~~---- 220 (325)
T d1rjba_ 148 NQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLV---THGKVVKICDFGLARDIMSDSNY---- 220 (325)
T ss_dssp -------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEE---ETTTEEEECCCGGGSCGGGCTTS----
T ss_pred cccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhcccc---ccCCeEEEeeccccccccCCCce----
Confidence 248999999999999999999999999999999999999 57899999999999876654332
Q ss_pred cccCCCCccCccccchhhhhCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCc
Q 013092 139 YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYP 217 (449)
Q Consensus 139 ~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p 217 (449)
.......||+.|||||++.+..++.++|||||||+||||++ |..||.+.... +.+.++....... ..+..+|
T Consensus 221 -~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~---~~~~~~~~~~~~~---~~p~~~~ 293 (325)
T d1rjba_ 221 -VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD---ANFYKLIQNGFKM---DQPFYAT 293 (325)
T ss_dssp -EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS---HHHHHHHHTTCCC---CCCTTCC
T ss_pred -eeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHH---HHHHHHHhcCCCC---CCCCcCC
Confidence 12235678999999999999999999999999999999997 89999875443 2233333332222 2345689
Q ss_pred HHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 013092 218 TEFASYFHYCRSLRFDDKPDYAYLKRIFR 246 (449)
Q Consensus 218 ~el~~li~~cl~~~p~~RPt~~~l~~~L~ 246 (449)
+++.+||..||+.+|++||++++|++.|.
T Consensus 294 ~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 294 EEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 99999999999999999999999998875
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.4e-44 Score=352.64 Aligned_cols=236 Identities=19% Similarity=0.245 Sum_probs=198.0
Q ss_pred cEEEEEeeecc-cCCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHH
Q 013092 3 EILTVFSVQEN-VKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLML 80 (449)
Q Consensus 3 ~aikV~~k~~~-~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i 80 (449)
.|||++.+... .....+.+.+|+.+|+.+ +||||+++++++.+.+..||||||| |++|.+++.. ...+++..+..+
T Consensus 32 vAvK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~ivmE~~~gg~l~~~~~~-~~~~~~~~~~~~ 109 (316)
T d1fota_ 32 YAMKVLKKEIVVRLKQVEHTNDERLMLSIV-THPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRK-SQRFPNPVAKFY 109 (316)
T ss_dssp EEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH-TSSCCHHHHHHH
T ss_pred EEEEEEchHHccCHHHHHHHHHHHHHHHhc-cCcChhheeeeEeeCCeeeeEeeecCCccccccccc-cccccccHHHHH
Confidence 46676655432 234566799999999999 9999999999999999999999999 9999999885 567899999999
Q ss_pred HHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCC
Q 013092 81 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI 160 (449)
Q Consensus 81 ~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~ 160 (449)
+.||+.||+|||++||+||||||+|||| +.++.+||+|||+|+...... ...+||+.|||||++.+.
T Consensus 110 ~~qi~~al~~lH~~~iiHrDiKp~NILl---~~~g~vkL~DFG~a~~~~~~~----------~~~~Gt~~Y~APE~l~~~ 176 (316)
T d1fota_ 110 AAEVCLALEYLHSKDIIYRDLKPENILL---DKNGHIKITDFGFAKYVPDVT----------YTLCGTPDYIAPEVVSTK 176 (316)
T ss_dssp HHHHHHHHHHHHTTTEECCCCCGGGEEE---CTTSCEEECCCSSCEECSSCB----------CCCCSCTTTCCHHHHTTC
T ss_pred HHHHHHhhhhhccCcEEccccCchheeE---cCCCCEEEecCccceEecccc----------ccccCcccccCHHHHcCC
Confidence 9999999999999999999999999999 688999999999998875432 356899999999999999
Q ss_pred CCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCC----
Q 013092 161 EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKP---- 236 (449)
Q Consensus 161 ~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RP---- 236 (449)
.++.++|||||||++|+|++|+.||.+. +..+.+.++...... ++..+++++.+++..||..+|.+|+
T Consensus 177 ~y~~~~DiwSlGvilyemltG~~Pf~~~---~~~~~~~~i~~~~~~-----~p~~~s~~~~~li~~~L~~dp~~R~~~~r 248 (316)
T d1fota_ 177 PYNKSIDWWSFGILIYEMLAGYTPFYDS---NTMKTYEKILNAELR-----FPPFFNEDVKDLLSRLITRDLSQRLGNLQ 248 (316)
T ss_dssp CBCTTHHHHHHHHHHHHHHHSSCTTCCS---SHHHHHHHHHHCCCC-----CCTTSCHHHHHHHHHHTCSCTTTCTTSST
T ss_pred CCCchhhccccchhHHHHHhCCCCCCCc---CHHHHHHHHHcCCCC-----CCCCCCHHHHHHHHHHhhhCHHhccccch
Confidence 9999999999999999999999999873 445556666654432 3456899999999999999999996
Q ss_pred -CHHHHHHHHHHHHHHcCCCCCCcccchhhhhhhcc
Q 013092 237 -DYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQ 271 (449)
Q Consensus 237 -t~~~l~~~L~~~~~~~~~~~~~~~dw~~~~~~~~~ 271 (449)
++++|+ .++|...++|+.+.....+
T Consensus 249 ~t~~~il----------~Hp~f~~i~~~~l~~~~~~ 274 (316)
T d1fota_ 249 NGTEDVK----------NHPWFKEVVWEKLLSRNIE 274 (316)
T ss_dssp TTTHHHH----------TSGGGSSCCHHHHHTTCSC
T ss_pred hhHHHHH----------cCcccccCCHHHHHhCCCC
Confidence 666653 2466677899977655443
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-43 Score=345.22 Aligned_cols=227 Identities=17% Similarity=0.208 Sum_probs=189.4
Q ss_pred cEEEEEeeecccCC----ChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHH
Q 013092 3 EILTVFSVQENVKT----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTV 77 (449)
Q Consensus 3 ~aikV~~k~~~~~~----~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~ 77 (449)
.|||++.+...... ..+.+.+|+++|+.| +||||+++++++.+.+..||||||| |++|.+++.. .+.+++..+
T Consensus 38 ~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~iv~E~~~gg~L~~~i~~-~~~l~~~~~ 115 (293)
T d1jksa_ 38 YAAKFIKKRRTKSSRRGVSREDIEREVSILKEI-QHPNVITLHEVYENKTDVILILELVAGGELFDFLAE-KESLTEEEA 115 (293)
T ss_dssp EEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH-HSSCCHHHH
T ss_pred EEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCEEEEEEEcCCCccccchhcc-ccccchhHH
Confidence 46777765543322 356799999999999 8999999999999999999999999 9999999976 457999999
Q ss_pred HHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecC-CCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhh
Q 013092 78 LMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR-RANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNT 156 (449)
Q Consensus 78 ~~i~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~-~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~ 156 (449)
+.++.||+.||+|||++||+||||||+|||+...+ ....+||+|||+++....... .....||+.|+|||+
T Consensus 116 ~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~~~~--------~~~~~~t~~y~APE~ 187 (293)
T d1jksa_ 116 TEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE--------FKNIFGTPEFVAPEI 187 (293)
T ss_dssp HHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTTSCB--------CSCCCCCGGGCCHHH
T ss_pred HHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcCCCcc--------ccccCCCCcccCHHH
Confidence 99999999999999999999999999999995221 223699999999988754322 235679999999999
Q ss_pred hhCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCC
Q 013092 157 HLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKP 236 (449)
Q Consensus 157 ~~~~~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RP 236 (449)
+.+..++.++|||||||++|||++|..||.+. +..+.+..+....... .......+++++.+||..||+.||++||
T Consensus 188 ~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~---~~~~~~~~i~~~~~~~-~~~~~~~~s~~~~~li~~~L~~dP~~R~ 263 (293)
T d1jksa_ 188 VNYEPLGLEADMWSIGVITYILLSGASPFLGD---TKQETLANVSAVNYEF-EDEYFSNTSALAKDFIRRLLVKDPKKRM 263 (293)
T ss_dssp HTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHTTCCCC-CHHHHTTSCHHHHHHHHTTSCSSGGGSC
T ss_pred HcCCCCCCcccchhhhHHHHHHHcCCCCCCCC---CHHHHHHHHHhcCCCC-CchhcCCCCHHHHHHHHHHccCChhHCc
Confidence 99999999999999999999999999999874 4455566666654432 2345577899999999999999999999
Q ss_pred CHHHHHH
Q 013092 237 DYAYLKR 243 (449)
Q Consensus 237 t~~~l~~ 243 (449)
+++++++
T Consensus 264 s~~eil~ 270 (293)
T d1jksa_ 264 TIQDSLQ 270 (293)
T ss_dssp CHHHHHH
T ss_pred CHHHHhc
Confidence 9888753
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-43 Score=342.75 Aligned_cols=218 Identities=12% Similarity=0.150 Sum_probs=176.3
Q ss_pred hHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q 013092 19 PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFL 97 (449)
Q Consensus 19 ~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~giv 97 (449)
.+|.+|+++|+.| +|||||++++++.+.+..++||||| +++|.+++......+++..++.++.||+.||+|||+++|+
T Consensus 54 ~~~~~E~~il~~l-~H~nIv~~~g~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~ii 132 (283)
T d1mqba_ 54 VDFLGEAGIMGQF-SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYV 132 (283)
T ss_dssp HHHHHHHHHHHTC-CCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred HHHHHHHHHHHhc-CCCCEeeeeEEEecCCceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccc
Confidence 4688999999999 8999999999999999999999999 9999998887667899999999999999999999999999
Q ss_pred ecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHHHHH
Q 013092 98 HRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMY 177 (449)
Q Consensus 98 HRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il~e 177 (449)
||||||+|||| +.++.+||+|||+++.+....... .......||+.|||||++.+..++.++|||||||++||
T Consensus 133 HrDlKp~NILl---~~~~~~Kl~DFGla~~~~~~~~~~----~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~e 205 (283)
T d1mqba_ 133 HRDLAARNILV---NSNLVCKVSDFGLSRVLEDDPEAT----YTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWE 205 (283)
T ss_dssp CSCCCGGGEEE---CTTCCEEECCCCC---------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHH
T ss_pred cCccccceEEE---CCCCeEEEcccchhhcccCCCccc----eEeccCCCCccccCHHHHccCCCCCcccccccHHHHHH
Confidence 99999999999 688999999999998765543211 11234568999999999999999999999999999999
Q ss_pred HHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 013092 178 FLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFI 250 (449)
Q Consensus 178 lltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~L~~~~~ 250 (449)
|++|..||... ....+.+..+...... ..+..+|.++.+||..||+.+|++||++.+|.+.|+.++.
T Consensus 206 l~t~~~~~~~~--~~~~~~~~~i~~~~~~----~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~ 272 (283)
T d1mqba_ 206 VMTYGERPYWE--LSNHEVMKAINDGFRL----PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272 (283)
T ss_dssp HHTTSCCTTTT--CCHHHHHHHHHTTCCC----CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHhCCCCcccc--CCHHHHHHHHhccCCC----CCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence 99965555432 2334445555443222 2345689999999999999999999999999999988765
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-44 Score=357.70 Aligned_cols=226 Identities=17% Similarity=0.249 Sum_probs=177.0
Q ss_pred cEEEEEeeecccCCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHH
Q 013092 3 EILTVFSVQENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLA 81 (449)
Q Consensus 3 ~aikV~~k~~~~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~ 81 (449)
.|+|++.+. .......++.+|+.+|+.+ +||||+++++++.+.+..||||||| |++|.+++.+ .+.+++..+..++
T Consensus 34 vAiK~i~~~-~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~iVmEy~~gg~L~~~l~~-~~~l~~~~~~~~~ 110 (322)
T d1s9ja_ 34 MARKLIHLE-IKPAIRNQIIRELQVLHEC-NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK-AGRIPEQILGKVS 110 (322)
T ss_dssp EEEEEEECC-CCTTHHHHHHHHGGGGGGC-CCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHH-HSSCCHHHHHHHH
T ss_pred EEEEEEChh-hCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHhh-cCCCCHHHHHHHH
Confidence 456665432 2233356789999999999 8999999999999999999999999 8999999976 4579999999999
Q ss_pred HHHHHHHHHHHH-CCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCC
Q 013092 82 DQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI 160 (449)
Q Consensus 82 ~qi~~aL~yLH~-~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~ 160 (449)
.|++.||.|||+ +||+||||||+|||| +.++.+||+|||+|+.+.+.. ....+||+.|+|||++.+.
T Consensus 111 ~qil~aL~yLH~~~~IiHRDiKP~NILl---~~~~~vkl~DFGla~~~~~~~---------~~~~~GT~~Y~APEvl~~~ 178 (322)
T d1s9ja_ 111 IAVIKGLTYLREKHKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLIDSM---------ANSFVGTRSYMSPERLQGT 178 (322)
T ss_dssp HHHHHHHHHHHHHHCCCCSCCSGGGEEE---CTTCCEEECCCCCCHHHHHHT---------C---CCSSCCCCHHHHHCS
T ss_pred HHHHHHHHHHHHhCCEEccccCHHHeeE---CCCCCEEEeeCCCccccCCCc---------cccccCCccccCchHHcCC
Confidence 999999999997 499999999999999 678899999999998765432 2356899999999999999
Q ss_pred CCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhh-----------------------cccc----hHHH--
Q 013092 161 EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK-----------------------KVST----SIEA-- 211 (449)
Q Consensus 161 ~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~-----------------------~~~~----~~~~-- 211 (449)
.|+.++|||||||++|||++|+.||.+.+.............. .... ....
T Consensus 179 ~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (322)
T d1s9ja_ 179 HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIV 258 (322)
T ss_dssp CCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------------------CCCCHHHHHHHHH
T ss_pred CCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccccccccccchhHHHHHhhhh
Confidence 9999999999999999999999999875432111100000000 0000 0000
Q ss_pred ------hh-cCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 212 ------LC-RGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 212 ------l~-~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
+. ..++.++.+||..||..||++|||++++++
T Consensus 259 ~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~ 297 (322)
T d1s9ja_ 259 NEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297 (322)
T ss_dssp TSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 00 125789999999999999999999988765
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1e-43 Score=354.85 Aligned_cols=237 Identities=18% Similarity=0.273 Sum_probs=198.5
Q ss_pred cEEEEEeeeccc-CCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHH
Q 013092 3 EILTVFSVQENV-KTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLML 80 (449)
Q Consensus 3 ~aikV~~k~~~~-~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i 80 (449)
.|||++.+.... ......+.+|+++|+.+ +||||+++++++.+....|+||||+ |++|.+++.. .+.+++..++.|
T Consensus 69 ~AvK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~l~~-~~~l~e~~~~~i 146 (350)
T d1rdqe_ 69 YAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR-IGRFSEPHARFY 146 (350)
T ss_dssp EEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH-HCCCCHHHHHHH
T ss_pred EEEEEEchHHccCHHHHHHHHHHHHHHHHc-CCCcEeecccccccccccccccccccccchhhhHhh-cCCCCHHHHHHH
Confidence 456665543322 34456789999999999 9999999999999999999999999 9999999875 457999999999
Q ss_pred HHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCC
Q 013092 81 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI 160 (449)
Q Consensus 81 ~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~ 160 (449)
+.||+.||.|||++|||||||||+|||| +.++.+||+|||+|+.+.... ....||+.|||||++.+.
T Consensus 147 ~~qi~~aL~yLH~~~iiHRDIKP~NILl---~~~g~ikL~DFG~a~~~~~~~----------~~~~Gt~~Y~APE~~~~~ 213 (350)
T d1rdqe_ 147 AAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKGRT----------WTLCGTPEALAPEIILSK 213 (350)
T ss_dssp HHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECSSCB----------CCCEECGGGCCHHHHTTC
T ss_pred HHHHHHHHHHHHhCCEecCcCCHHHccc---CCCCCEEeeeceeeeeccccc----------ccccCccccCCHHHHcCC
Confidence 9999999999999999999999999999 678899999999999775432 346899999999999999
Q ss_pred CCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCC----
Q 013092 161 EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKP---- 236 (449)
Q Consensus 161 ~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RP---- 236 (449)
.++.++|||||||++|||++|..||.+. +..+.+.++...... .+..+++++.+||..||..||.+|+
T Consensus 214 ~~~~~~DiwSlGvilyemltG~~Pf~~~---~~~~~~~~i~~~~~~-----~p~~~s~~~~~li~~~L~~dP~kR~~~~r 285 (350)
T d1rdqe_ 214 GYNKAVDWWALGVLIYEMAAGYPPFFAD---QPIQIYEKIVSGKVR-----FPSHFSSDLKDLLRNLLQVDLTKRFGNLK 285 (350)
T ss_dssp CBCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHCCCC-----CCTTCCHHHHHHHHHHSCSCTTTCTTSST
T ss_pred CCCccccccchhHHHHHHHhCCCCCCCc---CHHHHHHHHhcCCCC-----CCccCCHHHHHHHHHHhhhCHHhcccccc
Confidence 9999999999999999999999999873 445566666655432 2456899999999999999999995
Q ss_pred -CHHHHHHHHHHHHHHcCCCCCCcccchhhhhhhccC
Q 013092 237 -DYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQL 272 (449)
Q Consensus 237 -t~~~l~~~L~~~~~~~~~~~~~~~dw~~~~~~~~~~ 272 (449)
++++|++ ++|...+||..+..++.++
T Consensus 286 ~t~~ell~----------Hp~f~~~~~~~~~~~~~~~ 312 (350)
T d1rdqe_ 286 NGVNDIKN----------HKWFATTDWIAIYQRKVEA 312 (350)
T ss_dssp TTTHHHHT----------SGGGTTCCHHHHHTTCSCC
T ss_pred ccHHHHHc----------CccccCCCHHHHHhcCCCc
Confidence 6666642 5677778999876654433
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.2e-44 Score=348.14 Aligned_cols=221 Identities=17% Similarity=0.253 Sum_probs=183.9
Q ss_pred cCCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHH
Q 013092 14 VKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFV 91 (449)
Q Consensus 14 ~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~-~~~ls~~~~~~i~~qi~~aL~yL 91 (449)
.....++|.+|+++|+.| +||||+++++++.+++..||||||| +|+|.+++... ...+++..++.++.||+.||+||
T Consensus 53 ~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yL 131 (287)
T d1opja_ 53 DTMEVEEFLKEAAVMKEI-KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL 131 (287)
T ss_dssp TCSCHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHH
T ss_pred ccchHHHHHHHHHHHHhC-CCCCEecCCccEeeCCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHH
Confidence 344567899999999999 8999999999999999999999999 99999998754 45689999999999999999999
Q ss_pred HHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHH
Q 013092 92 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESL 171 (449)
Q Consensus 92 H~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSl 171 (449)
|++||+||||||+|||| +.++.+||+|||+++........ ......||+.|+|||++.+..++.++|||||
T Consensus 132 H~~~iiHrDlKp~NILl---~~~~~~Kl~DFG~a~~~~~~~~~------~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~ 202 (287)
T d1opja_ 132 EKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLMTGDTYT------AHAGAKFPIKWTAPESLAYNKFSIKSDVWAF 202 (287)
T ss_dssp HHTTCCCSCCSGGGEEE---CGGGCEEECCCCCTTTCCSSSSE------EETTEEECGGGCCHHHHHHCCCSHHHHHHHH
T ss_pred HHCCcccCccccCeEEE---CCCCcEEEccccceeecCCCCce------eeccccccccccChHHHcCCCCCchhhhhhH
Confidence 99999999999999999 67889999999999876543321 1234468999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 013092 172 GYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFI 250 (449)
Q Consensus 172 G~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~L~~~~~ 250 (449)
||++|||++|..||... .+..+.+..+.... . ...+..+|+++.+||..||+.||++||++.+|.+.|+.++.
T Consensus 203 Gv~l~ell~~~~p~~~~--~~~~~~~~~i~~~~-~---~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 203 GVLLWEIATYGMSPYPG--IDLSQVYELLEKDY-R---MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp HHHHHHHHTTSCCSSTT--CCHHHHHHHHHTTC-C---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred HHHHHHHHhCCCCCCCc--chHHHHHHHHhcCC-C---CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 99999999976666442 22333333333322 1 12446789999999999999999999999999988877643
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.8e-43 Score=354.77 Aligned_cols=243 Identities=20% Similarity=0.240 Sum_probs=193.2
Q ss_pred cEEEEEeeeccc-CCChhHHHHHHHHHHHhc--CCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHH
Q 013092 3 EILTVFSVQENV-KTKHPQLLYESKLYRILQ--GGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVL 78 (449)
Q Consensus 3 ~aikV~~k~~~~-~~~~~~~~~E~~il~~l~--~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~ 78 (449)
.|||++.+.... ......+.+|..++..++ +||||+++++++.+.+..||||||| |++|.+++.. ...+++..++
T Consensus 32 vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ivmE~~~gg~L~~~l~~-~~~~~e~~~~ 110 (364)
T d1omwa3 32 YAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ-HGVFSEADMR 110 (364)
T ss_dssp EEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH-HCSCCHHHHH
T ss_pred EEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEEEEEecCCCcHHHHHHh-cccccHHHHH
Confidence 466666544322 234445667766666554 7999999999999999999999999 9999999976 4678999999
Q ss_pred HHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhh
Q 013092 79 MLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHL 158 (449)
Q Consensus 79 ~i~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~ 158 (449)
.++.||+.||+|||++|||||||||+|||| +..+.+||+|||+|+.+..... ....||+.|||||++.
T Consensus 111 ~~~~qi~~aL~ylH~~~iiHrDlKP~NILl---~~~g~iKl~DFGla~~~~~~~~---------~~~~GT~~y~APE~~~ 178 (364)
T d1omwa3 111 FYAAEIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSKKKP---------HASVGTHGYMAPEVLQ 178 (364)
T ss_dssp HHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CSSSCEEECCCTTCEECSSSCC---------CSCCSCGGGCCHHHHS
T ss_pred HHHHHHHHHHHHHHHCCccceeeccceeEE---cCCCcEEEeeeceeeecCCCcc---------cccccccccchhHHhh
Confidence 999999999999999999999999999999 6889999999999987765432 3457999999999997
Q ss_pred C-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCC
Q 013092 159 G-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPD 237 (449)
Q Consensus 159 ~-~~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt 237 (449)
. ..++.++|||||||+||||++|+.||.+............+... ...++..+++++.+||..||+.||++||+
T Consensus 179 ~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~-----~~~~~~~~s~~~~~li~~~L~~dP~~R~t 253 (364)
T d1omwa3 179 KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM-----AVELPDSFSPELRSLLEGLLQRDVNRRLG 253 (364)
T ss_dssp TTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSC-----CCCCCSSSCHHHHHHHHHHTCSSTTTSTT
T ss_pred cCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC-----CCCCCCCCCHHHHHHHHHHcccCHHHhCC
Confidence 4 56899999999999999999999999886554443333222221 12234578999999999999999999998
Q ss_pred -----HHHHHHHHHHHHHHcCCCCCCcccchhhhhhhccCC
Q 013092 238 -----YAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQLA 273 (449)
Q Consensus 238 -----~~~l~~~L~~~~~~~~~~~~~~~dw~~~~~~~~~~~ 273 (449)
+++|+ .++|...+||..+..++.+++
T Consensus 254 ~~~~~a~eil----------~Hp~f~~i~~~~~~~~~~~~p 284 (364)
T d1omwa3 254 CLGRGAQEVK----------ESPFFRSLDWQMVFLQKYPPP 284 (364)
T ss_dssp TSSSTHHHHH----------TSGGGTTCCHHHHHTTCSCCS
T ss_pred CcccCHHHHH----------cCccccCCCHHHHhcCCCCcC
Confidence 45553 256777889998766654433
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1e-43 Score=354.72 Aligned_cols=213 Identities=17% Similarity=0.248 Sum_probs=182.4
Q ss_pred ChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 013092 17 KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 95 (449)
Q Consensus 17 ~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~g 95 (449)
..+.+.+|+.+|+.| .||||+++++++.+++..||||||| |++|.+++....+.+++..++.|+.||+.||+|||++|
T Consensus 66 ~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~ 144 (350)
T d1koaa2 66 DKETVRKEIQTMSVL-RHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN 144 (350)
T ss_dssp HHHHHHHHHHHHHHT-CCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred hHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCEEEEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcC
Confidence 345688999999999 8999999999999999999999999 99999999654567999999999999999999999999
Q ss_pred ceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHHH
Q 013092 96 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVL 175 (449)
Q Consensus 96 ivHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il 175 (449)
||||||||+|||+.. +.++.+||+|||+++.+..... .....||+.|||||++.+..++.++|||||||++
T Consensus 145 iiHrDiKp~NIll~~-~~~~~vkL~DFG~a~~~~~~~~--------~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvil 215 (350)
T d1koaa2 145 YVHLDLKPENIMFTT-KRSNELKLIDFGLTAHLDPKQS--------VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLS 215 (350)
T ss_dssp EECCCCCGGGEEESS-TTSCCEEECCCTTCEECCTTSC--------EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHH
T ss_pred CeeeeechhHeeecc-CCCCeEEEeecchheecccccc--------cceecCcccccCHHHHcCCCCChhHhhhhhhHHH
Confidence 999999999999942 2357899999999988765432 2346899999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 176 MYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 176 ~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
|+|++|..||.+. +..+.+..+........ ......+++++.+||..||..||++||++.+|++
T Consensus 216 yell~G~~Pf~~~---~~~~~~~~i~~~~~~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 216 YILLSGLSPFGGE---NDDETLRNVKSCDWNMD-DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 279 (350)
T ss_dssp HHHHHSSCSSCCS---SHHHHHHHHHHTCCCSC-CGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred HHHHhCCCCCCCC---CHHHHHHHHHhCCCCCC-cccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 9999999999864 44555666665544322 2344678999999999999999999999887754
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=4.9e-44 Score=357.29 Aligned_cols=225 Identities=20% Similarity=0.180 Sum_probs=186.3
Q ss_pred cEEEEEeeecccCCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHH
Q 013092 3 EILTVFSVQENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLA 81 (449)
Q Consensus 3 ~aikV~~k~~~~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~ 81 (449)
+|||++.+.. ......+.+|+++|+.| +||||+++++++.+++..||||||| |++|.+++.....++++..++.|+
T Consensus 57 vAiK~i~~~~--~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~ 133 (352)
T d1koba_ 57 FVAKFINTPY--PLDKYTVKNEISIMNQL-HHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYM 133 (352)
T ss_dssp EEEEEEECCS--HHHHHHHHHHHHHHTTC-CSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHH
T ss_pred EEEEEECCcc--hhHHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCEEEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHH
Confidence 3555544322 12345688999999999 8999999999999999999999999 999999887555679999999999
Q ss_pred HHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCC
Q 013092 82 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIE 161 (449)
Q Consensus 82 ~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~ 161 (449)
.||+.||+|||++||+||||||+||||.. ...+.+||+|||+|+.+..... .....||+.|||||++.+..
T Consensus 134 ~qi~~aL~ylH~~~iiHRDiKp~NILl~~-~~~~~vkL~DFGla~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~ 204 (352)
T d1koba_ 134 RQACEGLKHMHEHSIVHLDIKPENIMCET-KKASSVKIIDFGLATKLNPDEI--------VKVTTATAEFAAPEIVDREP 204 (352)
T ss_dssp HHHHHHHHHHHHTTEECCCCCGGGEEESS-TTCCCEEECCCTTCEECCTTSC--------EEEECSSGGGCCHHHHTTCC
T ss_pred HHHHHHHHHHHHCCeeecccccccccccc-cCCCeEEEeecccceecCCCCc--------eeeccCcccccCHHHHcCCC
Confidence 99999999999999999999999999931 2567899999999998765432 23457999999999999999
Q ss_pred CChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHH
Q 013092 162 QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYL 241 (449)
Q Consensus 162 ~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l 241 (449)
++.++|||||||++|+|++|..||.+. +..+.+..+....... .......+++++.+||..||+.||++||++.++
T Consensus 205 ~~~~~DiwSlGvilyelltG~~Pf~~~---~~~~~~~~i~~~~~~~-~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ei 280 (352)
T d1koba_ 205 VGFYTDMWAIGVLGYVLLSGLSPFAGE---DDLETLQNVKRCDWEF-DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDA 280 (352)
T ss_dssp BCHHHHHHHHHHHHHHHHHSCCSSCCS---SHHHHHHHHHHCCCCC-CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHH
T ss_pred CCCccchHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHHhCCCCC-CcccccCCCHHHHHHHHHHccCChhHCcCHHHH
Confidence 999999999999999999999999874 3345555565544322 223456789999999999999999999998877
Q ss_pred HH
Q 013092 242 KR 243 (449)
Q Consensus 242 ~~ 243 (449)
++
T Consensus 281 l~ 282 (352)
T d1koba_ 281 LE 282 (352)
T ss_dssp HT
T ss_pred hc
Confidence 43
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-43 Score=338.84 Aligned_cols=216 Identities=16% Similarity=0.254 Sum_probs=185.8
Q ss_pred CCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH
Q 013092 15 KTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 93 (449)
Q Consensus 15 ~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~ 93 (449)
.....+|++|+.++..+ +||||+++++++.+.+..|+||||+ +++|.+++......+++..++.++.||+.||+|||+
T Consensus 40 ~~~~~~~~~Ev~~~~~l-~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~ 118 (258)
T d1k2pa_ 40 SMSEDEFIEEAKVMMNL-SHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES 118 (258)
T ss_dssp SSCHHHHHHHHHHHHTC-CCTTBCCEEEEECCSSSEEEEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred cCCHHHHHHHHHHHHhc-CCCceeeEEEEEeeCCceEEEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhh
Confidence 44567899999999999 8999999999999999999999999 899999987556679999999999999999999999
Q ss_pred CCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHH
Q 013092 94 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGY 173 (449)
Q Consensus 94 ~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~ 173 (449)
+||+||||||+|||+ +.++.+||+|||+++.+...... ......||+.|+|||++.+..++.++|||||||
T Consensus 119 ~~iiH~dlk~~Nill---~~~~~~kl~DfG~a~~~~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~ 189 (258)
T d1k2pa_ 119 KQFLHRDLAARNCLV---NDQGVVKVSDFGLSRYVLDDEYT------SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGV 189 (258)
T ss_dssp TTBCCSCCSGGGEEE---CTTCCEEECCCSSCCBCSSSSCC------CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHH
T ss_pred cCcccccccceeEEE---cCCCcEEECcchhheeccCCCce------eecccCCCCCcCCcHHhcCCCCCcceeecccch
Confidence 999999999999999 68899999999999876554321 233467999999999999999999999999999
Q ss_pred HHHHHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Q 013092 174 VLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRD 247 (449)
Q Consensus 174 il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~L~~ 247 (449)
++|||++ |+.||.+.. ..+...++...... ..+..+|+++.+||..||+.+|++||++++|++.|.+
T Consensus 190 ~l~el~t~g~~Pf~~~~---~~~~~~~i~~~~~~----~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 190 LMWEIYSLGKMPYERFT---NSETAEHIAQGLRL----YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp HHHHHHTTSCCTTTTSC---HHHHHHHHHTTCCC----CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred hhHhHHhcCCCCCCCCC---HHHHHHHHHhCCCC----CCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 9999998 899998754 34455555543221 2345689999999999999999999999999887754
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.5e-44 Score=349.85 Aligned_cols=219 Identities=17% Similarity=0.243 Sum_probs=178.7
Q ss_pred cEEEEEeeeccc-CCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHH
Q 013092 3 EILTVFSVQENV-KTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLML 80 (449)
Q Consensus 3 ~aikV~~k~~~~-~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i 80 (449)
+|||++.+.... ....+.+.+|+++|+.| +||||+++++++.+.+..||||||| +++|..++.. ...+++..++.+
T Consensus 43 vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~~~~-~~~l~e~~~~~i 120 (309)
T d1u5ra_ 43 VAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVH-KKPLQEVEIAAV 120 (309)
T ss_dssp EEEEEEECCSSCHHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHH-TSCCCHHHHHHH
T ss_pred EEEEEEchhhccCHHHHHHHHHHHHHHHHC-CCCCEeeEEEEEEECCEEEEEEEecCCCchHHHHHh-CCCCCHHHHHHH
Confidence 355555443322 12335688999999999 8999999999999999999999999 7777665553 678999999999
Q ss_pred HHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhC-
Q 013092 81 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG- 159 (449)
Q Consensus 81 ~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~- 159 (449)
+.||+.||+|||++||+||||||+|||| +.++.+||+|||+++..... ....||+.|||||++.+
T Consensus 121 ~~qi~~aL~yLH~~~iiHrDiKp~NILl---~~~~~~Kl~DFG~a~~~~~~-----------~~~~GT~~Y~APE~~~~~ 186 (309)
T d1u5ra_ 121 THGALQGLAYLHSHNMIHRDVKAGNILL---SEPGLVKLGDFGSASIMAPA-----------NSFVGTPYWMAPEVILAM 186 (309)
T ss_dssp HHHHHHHHHHHHHTTCBCCCCSGGGEEE---ETTTEEEECCCTTCBSSSSB-----------CCCCSCGGGCCHHHHTTT
T ss_pred HHHHHHHHHHHHhCCEeccCCCcceEEE---CCCCCEEEeecccccccCCC-----------CccccCccccCHHHHhcc
Confidence 9999999999999999999999999999 57899999999999765432 34579999999999975
Q ss_pred --CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCC
Q 013092 160 --IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPD 237 (449)
Q Consensus 160 --~~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt 237 (449)
..|+.++|||||||++|||++|..||.+.. ..+.+.++........ ....+++++.+||..||+.||++||+
T Consensus 187 ~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~---~~~~~~~i~~~~~~~~---~~~~~s~~~~~li~~~L~~dP~~Rpt 260 (309)
T d1u5ra_ 187 DEGQYDGKVDVWSLGITCIELAERKPPLFNMN---AMSALYHIAQNESPAL---QSGHWSEYFRNFVDSCLQKIPQDRPT 260 (309)
T ss_dssp TSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC---HHHHHHHHHHSCCCCC---SCTTSCHHHHHHHHHHTCSSGGGSCC
T ss_pred CCCCcCchhhhhhHHHHHHHHHHCCCCCCCCC---HHHHHHHHHhCCCCCC---CCCCCCHHHHHHHHHHCcCChhHCcC
Confidence 358999999999999999999999998743 3444555554433221 13468999999999999999999999
Q ss_pred HHHHHH
Q 013092 238 YAYLKR 243 (449)
Q Consensus 238 ~~~l~~ 243 (449)
+.+|++
T Consensus 261 ~~ell~ 266 (309)
T d1u5ra_ 261 SEVLLK 266 (309)
T ss_dssp HHHHTT
T ss_pred HHHHHh
Confidence 988754
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-43 Score=341.50 Aligned_cols=220 Identities=19% Similarity=0.332 Sum_probs=181.8
Q ss_pred cCCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHH
Q 013092 14 VKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFV 91 (449)
Q Consensus 14 ~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~-~~~ls~~~~~~i~~qi~~aL~yL 91 (449)
.......|.+|+++|+.+ +||||+++++++.+ +..||||||| +|+|.+++... ..++++..++.|+.||+.||.||
T Consensus 48 ~~~~~~~~~~E~~~l~~l-~HpnIv~~~g~~~~-~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~l 125 (272)
T d1qpca_ 48 GSMSPDAFLAEANLMKQL-QHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI 125 (272)
T ss_dssp TSSCHHHHHHHHHHHHHC-CCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHH
T ss_pred CcCCHHHHHHHHHHHHhC-CCCCEeEEEeeecc-CCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHH
Confidence 344566799999999999 89999999998754 5679999999 99999987532 33699999999999999999999
Q ss_pred HHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHH
Q 013092 92 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESL 171 (449)
Q Consensus 92 H~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSl 171 (449)
|+++|+||||||+|||| +.++.+||+|||+|+.+..... .......||+.|||||++.+..++.++|||||
T Consensus 126 H~~~ivHrDiKp~NIll---~~~~~~Kl~DFGla~~~~~~~~------~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~ 196 (272)
T d1qpca_ 126 EERNYIHRDLRAANILV---SDTLSCKIADFGLARLIEDNEY------TAREGAKFPIKWTAPEAINYGTFTIKSDVWSF 196 (272)
T ss_dssp HHTTEECSCCSGGGEEE---CTTSCEEECCCTTCEECSSSCE------ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHH
T ss_pred HhCCcccCccchhheee---ecccceeeccccceEEccCCcc------ccccccCCcccccChHHHhCCCCCchhhhhhh
Confidence 99999999999999999 6889999999999998765432 12345678999999999999899999999999
Q ss_pred HHHHHHHHhCCC-CCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 013092 172 GYVLMYFLRGSL-PWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFI 250 (449)
Q Consensus 172 G~il~elltG~~-Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~L~~~~~ 250 (449)
||++|||++|.. ||... ...+.+..+...... ..+..+|+++.+||..||+.+|++||++.+|.+.|++++.
T Consensus 197 Gvvl~ellt~~~~~~~~~---~~~~~~~~i~~~~~~----~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 197 GILLTEIVTHGRIPYPGM---TNPEVIQNLERGYRM----VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp HHHHHHHHTTTCCSSTTC---CHHHHHHHHHTTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHhCCCCCCCCC---CHHHHHHHHHhcCCC----CCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 999999999554 45442 334444444443221 2345789999999999999999999999999999999876
Q ss_pred H
Q 013092 251 R 251 (449)
Q Consensus 251 ~ 251 (449)
.
T Consensus 270 s 270 (272)
T d1qpca_ 270 A 270 (272)
T ss_dssp H
T ss_pred c
Confidence 4
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-43 Score=340.57 Aligned_cols=217 Identities=19% Similarity=0.275 Sum_probs=174.8
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 96 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gi 96 (449)
...|.+|+++|+.+ +||||+++++++. .+..||||||| +++|.+++......+++..++.++.||+.||+|||+++|
T Consensus 52 ~~~~~~E~~~l~~l-~HpnIv~l~~~~~-~~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~i 129 (273)
T d1mp8a_ 52 REKFLQEALTMRQF-DHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRF 129 (273)
T ss_dssp HHHHHHHHHHHHTC-CCTTBCCEEEEEC-SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred HHHHHHHHHHHHhC-CCCCEeeEEEEEe-cCeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCe
Confidence 35689999999999 8999999999985 46789999999 999999987667789999999999999999999999999
Q ss_pred eecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHHHH
Q 013092 97 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLM 176 (449)
Q Consensus 97 vHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il~ 176 (449)
+||||||+|||+ +..+.+||+|||+++.+...... ......||+.|+|||++.+..++.++|||||||++|
T Consensus 130 iHrDlKp~NIll---~~~~~~Kl~DfG~a~~~~~~~~~------~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~ 200 (273)
T d1mp8a_ 130 VHRDIAARNVLV---SSNDCVKLGDFGLSRYMEDSTYY------KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMW 200 (273)
T ss_dssp CCSCCSGGGEEE---EETTEEEECC-------------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHH
T ss_pred eccccchhheee---cCCCcEEEccchhheeccCCcce------eccceecCcccchhhHhccCCCCCccccccchHHHH
Confidence 999999999999 47789999999999876543221 123457899999999999999999999999999999
Q ss_pred HHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 013092 177 YFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIRE 252 (449)
Q Consensus 177 ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~L~~~~~~~ 252 (449)
||++ |.+||.+.... +.+.++...... .+++++|+++.+||..||+.||++||++.+|++.|+.+++.+
T Consensus 201 e~lt~g~~P~~~~~~~---~~~~~i~~~~~~----~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 270 (273)
T d1mp8a_ 201 EILMHGVKPFQGVKNN---DVIGRIENGERL----PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 270 (273)
T ss_dssp HHHTTSCCTTTTCCGG---GHHHHHHTTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHhcCCCCCCCCCHH---HHHHHHHcCCCC----CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 9998 89999876543 344445443322 245679999999999999999999999999999999887654
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-43 Score=348.01 Aligned_cols=240 Identities=18% Similarity=0.242 Sum_probs=196.6
Q ss_pred cEEEEEeeecc-cCCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHH
Q 013092 3 EILTVFSVQEN-VKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLML 80 (449)
Q Consensus 3 ~aikV~~k~~~-~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i 80 (449)
.|||++.|... .......+..|+.++.+..+||||+++++++.+++..||||||| ||+|.+++.. ...+++..++.+
T Consensus 30 vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmEy~~~g~L~~~i~~-~~~~~e~~~~~~ 108 (320)
T d1xjda_ 30 FAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQS-CHKFDLSRATFY 108 (320)
T ss_dssp EEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHH
T ss_pred EEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEeecCCCcHHHHhhc-cCCCCHHHHHHH
Confidence 36666655432 23455678888888775449999999999999999999999999 9999999986 457999999999
Q ss_pred HHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCC
Q 013092 81 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI 160 (449)
Q Consensus 81 ~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~ 160 (449)
+.||+.||+|||++||+||||||+|||+ +..+.+||+|||+++....... ......||+.|+|||++.+.
T Consensus 109 ~~qi~~al~ylH~~~iiHrDikp~NiL~---~~~~~~kl~DFG~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~ 178 (320)
T d1xjda_ 109 AAEIILGLQFLHSKGIVYRDLKLDNILL---DKDGHIKIADFGMCKENMLGDA-------KTNTFCGTPDYIAPEILLGQ 178 (320)
T ss_dssp HHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCCCCTTC-------CBCCCCSCGGGCCHHHHTTC
T ss_pred HHHHHHHHHHHHhCCeeeccCcccceee---cCCCceeccccchhhhcccccc-------cccccCCCCCcCCHHHHcCC
Confidence 9999999999999999999999999999 6889999999999986654332 12456899999999999999
Q ss_pred CCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHH-
Q 013092 161 EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYA- 239 (449)
Q Consensus 161 ~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~- 239 (449)
.++.++|||||||++|+|++|+.||.+. +..+.+.++..... .++..+++++.+||..||+.||++||++.
T Consensus 179 ~~~~~~DiwSlGvilyemltG~~PF~~~---~~~~~~~~i~~~~~-----~~p~~~s~~~~dli~~~L~~dP~~R~s~~~ 250 (320)
T d1xjda_ 179 KYNHSVDWWSFGVLLYEMLIGQSPFHGQ---DEEELFHSIRMDNP-----FYPRWLEKEAKDLLVKLFVREPEKRLGVRG 250 (320)
T ss_dssp CBCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHCCC-----CCCTTSCHHHHHHHHHHSCSSGGGSBTTBS
T ss_pred CCCchhhhhhhhHHHHHHHhCCCCCCCC---CHHHHHHHHHcCCC-----CCCccCCHHHHHHHHHhcccCCCCCcCHHH
Confidence 9999999999999999999999999874 44555666655433 23456899999999999999999999974
Q ss_pred HHHHHHHHHHHHcCCCCCCcccchhhhhhhcc
Q 013092 240 YLKRIFRDLFIREGFQFDYVFDWTILKYQQSQ 271 (449)
Q Consensus 240 ~l~~~L~~~~~~~~~~~~~~~dw~~~~~~~~~ 271 (449)
+|++ ++|...++|+.+...+..
T Consensus 251 ~l~~----------hpff~~~~~~~l~~~~~~ 272 (320)
T d1xjda_ 251 DIRQ----------HPLFREINWEELERKEID 272 (320)
T ss_dssp CGGG----------SGGGTTCCHHHHHTTCSC
T ss_pred HHHh----------CchhccCCHHHHHhcCCC
Confidence 4532 355566789877655443
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-43 Score=351.18 Aligned_cols=217 Identities=16% Similarity=0.150 Sum_probs=174.8
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEe----CCEEEEEEecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHH
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVE----GDYNVLVMDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFV 91 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~----~~~~~lVmE~~-g~sL~~ll~~~-~~~ls~~~~~~i~~qi~~aL~yL 91 (449)
...+.+|+.++.++.+||||+++++++.+ ..+.||||||| ||+|.+++... ...|++..+..|+.||+.||+||
T Consensus 48 ~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~yl 127 (335)
T d2ozaa1 48 CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 127 (335)
T ss_dssp SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHH
T ss_pred cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHH
Confidence 35788999998877799999999999875 46789999999 89999999753 34699999999999999999999
Q ss_pred HHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHH
Q 013092 92 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESL 171 (449)
Q Consensus 92 H~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSl 171 (449)
|++||+||||||+|||+......+.+||+|||+++....... .....||+.|||||++.+..|+.++|||||
T Consensus 128 H~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~y~~~~DiwSl 199 (335)
T d2ozaa1 128 HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS--------LTTPCYTPYYVAPEVLGPEKYDKSCDMWSL 199 (335)
T ss_dssp HHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCCC--------CCCCSCCCSSCCCCCCCGGGGSHHHHHHHH
T ss_pred HHcCCccccccccccccccccccccccccccceeeeccCCCc--------cccccCCcccCCcHHHcCCCCCHHHHHHhh
Confidence 999999999999999996555567899999999987765432 235689999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCCcCCHHH-HHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 172 GYVLMYFLRGSLPWQGLKAGTKKQ-KYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 172 G~il~elltG~~Pf~~~~~~~~~~-~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
||+||+|++|+.||.+........ ....+.......+ ......+++++.+||..||+.||++||++.+++.
T Consensus 200 Gvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 200 GVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP-NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp HHHHHHHTTSSCSCEETTCC--------CCCSCSSSCC-TTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred chhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCC-CcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 999999999999998754432211 1112221111111 1123457899999999999999999999887754
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.8e-42 Score=333.52 Aligned_cols=224 Identities=17% Similarity=0.200 Sum_probs=185.2
Q ss_pred cEEEEEeeecccCC-------ChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCH
Q 013092 3 EILTVFSVQENVKT-------KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSL 74 (449)
Q Consensus 3 ~aikV~~k~~~~~~-------~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~ 74 (449)
.|||++.+...... ....+.+|+.+++.|..||||+++++++.++++.||||||| |++|.+++.. .+.+++
T Consensus 31 ~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~-~~~l~e 109 (277)
T d1phka_ 31 YAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE-KVTLSE 109 (277)
T ss_dssp EEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH-HSSCCH
T ss_pred EEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCcceEEEEEcCCCchHHHHHHh-cCCCCH
Confidence 45666555433222 22358899999999977999999999999999999999999 9999999975 567999
Q ss_pred HHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccch
Q 013092 75 KTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASM 154 (449)
Q Consensus 75 ~~~~~i~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aP 154 (449)
..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++....... .....||+.|+||
T Consensus 110 ~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill---~~~~~~kl~DFG~a~~~~~~~~--------~~~~~gt~~y~~P 178 (277)
T d1phka_ 110 KETRKIMRALLEVICALHKLNIVHRDLKPENILL---DDDMNIKLTDFGFSCQLDPGEK--------LREVCGTPSYLAP 178 (277)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTTCEECCTTCC--------BCCCCSCGGGCCH
T ss_pred HHHHHHHHHHHHHHHHHHHcCCcccccccceEEE---cCCCCeEEccchheeEccCCCc--------eeeeeccCCCCCH
Confidence 9999999999999999999999999999999999 6889999999999988755322 2346899999999
Q ss_pred hhhhC------CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHh
Q 013092 155 NTHLG------IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCR 228 (449)
Q Consensus 155 E~~~~------~~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl 228 (449)
|.+.+ ..++.++||||+||+||+|++|+.||.+.+ ....+..+......... ....++++++.+||..||
T Consensus 179 E~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~---~~~~~~~i~~~~~~~~~-~~~~~~s~~~~~li~~~L 254 (277)
T d1phka_ 179 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK---QMLMLRMIMSGNYQFGS-PEWDDYSDTVKDLVSRFL 254 (277)
T ss_dssp HHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHTCCCCCT-TTGGGSCHHHHHHHHHHC
T ss_pred HHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCC---HHHHHHHHHhCCCCCCC-cccccCCHHHHHHHHHHc
Confidence 99863 346889999999999999999999998743 34455556655443222 233568999999999999
Q ss_pred cCCCCCCCCHHHHH
Q 013092 229 SLRFDDKPDYAYLK 242 (449)
Q Consensus 229 ~~~p~~RPt~~~l~ 242 (449)
+.+|++||++.+++
T Consensus 255 ~~~p~~R~s~~eil 268 (277)
T d1phka_ 255 VVQPQKRYTAEEAL 268 (277)
T ss_dssp CSSGGGSCCHHHHT
T ss_pred cCChhHCcCHHHHH
Confidence 99999999988774
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.1e-42 Score=335.93 Aligned_cols=233 Identities=20% Similarity=0.277 Sum_probs=178.8
Q ss_pred cEEEEEeeecccC-CChhHHHHHHHHHHHhcCCCCCceEEEEeEeCC----EEEEEEecC-CCCHHHHHHHcCCCCCHHH
Q 013092 3 EILTVFSVQENVK-TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGD----YNVLVMDLL-GPSLEDLFNFCSRKLSLKT 76 (449)
Q Consensus 3 ~aikV~~k~~~~~-~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~----~~~lVmE~~-g~sL~~ll~~~~~~ls~~~ 76 (449)
.|||++.+..... .....+.+|+++++.+ +||||+++++++.+.+ ..||||||| |++|.+++.. .+.+++.+
T Consensus 35 vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~-~hpniv~~~~~~~~~~~~~~~~~lvmE~~~g~~L~~~~~~-~~~l~~~~ 112 (277)
T d1o6ya_ 35 VAVKVLRADLARDPSFYLRFRREAQNAAAL-NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT-EGPMTPKR 112 (277)
T ss_dssp EEEEEECSTTTTCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEEECSSSEEEEEEEECCCEEEHHHHHHH-HCSCCHHH
T ss_pred EEEEEEchhhccCHHHHHHHHHHHHHHHhc-CCCCCCcccceeeeccCCCceEEEEEECCCCCEehhhhcc-cCCCCHHH
Confidence 3555554432221 2334689999999999 9999999999887543 489999999 8999998875 45799999
Q ss_pred HHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhh
Q 013092 77 VLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNT 156 (449)
Q Consensus 77 ~~~i~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~ 156 (449)
++.++.||+.||+|||++||+||||||+|||+ +..+.++|+|||+++......... ......+||+.|||||+
T Consensus 113 ~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll---~~~~~~~l~d~~~~~~~~~~~~~~----~~~~~~~Gt~~Y~aPE~ 185 (277)
T d1o6ya_ 113 AIEVIADACQALNFSHQNGIIHRDVKPANIMI---SATNAVKVMDFGIARAIADSGNSV----TQTAAVIGTAQYLSPEQ 185 (277)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---ETTSCEEECCCTTCEECC--------------------TTCCHHH
T ss_pred HHHHHHHHHHHHHHHHhCCccCccccCccccc---Cccccceeehhhhhhhhccccccc----cccccccCcccccCHHH
Confidence 99999999999999999999999999999999 578899999999987664432211 12345689999999999
Q ss_pred hhCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCC
Q 013092 157 HLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKP 236 (449)
Q Consensus 157 ~~~~~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RP 236 (449)
+.+..++.++|||||||++|||++|..||.+.+ ..+.+.++...... ........+|+++.++|.+||+.||++||
T Consensus 186 ~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~---~~~~~~~~~~~~~~-~~~~~~~~~s~~l~~li~~~L~~dp~~R~ 261 (277)
T d1o6ya_ 186 ARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS---PVSVAYQHVREDPI-PPSARHEGLSADLDAVVLKALAKNPENRY 261 (277)
T ss_dssp HTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHHCCCC-CGGGTSSSCCHHHHHHHHHHTCSSGGGSC
T ss_pred HcCCCCCcceecccchHHHHHHHhCCCCCCCcC---HHHHHHHHHhcCCC-CCchhccCCCHHHHHHHHHHccCCHhHCH
Confidence 999999999999999999999999999998743 33444444443322 22344578999999999999999999999
Q ss_pred -CHHHHHHHHHHH
Q 013092 237 -DYAYLKRIFRDL 248 (449)
Q Consensus 237 -t~~~l~~~L~~~ 248 (449)
++++|+..|..+
T Consensus 262 ~sa~~l~~~l~r~ 274 (277)
T d1o6ya_ 262 QTAAEMRADLVRV 274 (277)
T ss_dssp SSHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHH
Confidence 788887776654
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-43 Score=336.53 Aligned_cols=216 Identities=20% Similarity=0.262 Sum_probs=180.1
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 96 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gi 96 (449)
.+.|.+|+++|+.+ +||||+++++++.+ +..+|||||| +++|.+++......+++..++.++.||+.||.|||++||
T Consensus 55 ~~~~~~Ei~~l~~l-~H~nIv~~~g~~~~-~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~i 132 (273)
T d1u46a_ 55 MDDFIREVNAMHSL-DHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRF 132 (273)
T ss_dssp HHHHHHHHHHHHHC-CCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred HHHHHHHHHHHHhC-CCCCEEEEEEEEee-cchheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCE
Confidence 45689999999999 99999999999976 4678999999 999999887656679999999999999999999999999
Q ss_pred eecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHHHH
Q 013092 97 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLM 176 (449)
Q Consensus 97 vHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il~ 176 (449)
+||||||+|||| +.++.+||+|||+++.+....... .......||..|+|||++.+..++.++|||||||++|
T Consensus 133 iHrDikp~NIll---~~~~~vkl~DfGl~~~~~~~~~~~----~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~ 205 (273)
T d1u46a_ 133 IHRDLAARNLLL---ATRDLVKIGDFGLMRALPQNDDHY----VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLW 205 (273)
T ss_dssp ECSCCCGGGEEE---EETTEEEECCCTTCEECCC-CCEE----EC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHH
T ss_pred eeeeecHHHhcc---ccccceeeccchhhhhcccCCCcc----eecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHH
Confidence 999999999999 467899999999999876544322 1223456788999999999999999999999999999
Q ss_pred HHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 013092 177 YFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDL 248 (449)
Q Consensus 177 ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~L~~~ 248 (449)
||++ |..||.+.+ ..+.+.++....... .....+|+++.+||..||+.||++||++.+|.+.|++.
T Consensus 206 emlt~G~~Pf~~~~---~~~~~~~i~~~~~~~---~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 206 EMFTYGQEPWIGLN---GSQILHKIDKEGERL---PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp HHHTTSCCTTTTCC---HHHHHHHHHTSCCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHhCCCCCCCCcC---HHHHHHHHHhCCCCC---CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 9998 899998753 344455555443322 23467899999999999999999999999999888764
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-42 Score=336.63 Aligned_cols=221 Identities=18% Similarity=0.232 Sum_probs=175.9
Q ss_pred ChhHHHHHHHHHHHhcCCCCCceEEEEeEe-CCEEEEEEecC-CCCHHHHHHHc---------------CCCCCHHHHHH
Q 013092 17 KHPQLLYESKLYRILQGGTGIPNVRWFGVE-GDYNVLVMDLL-GPSLEDLFNFC---------------SRKLSLKTVLM 79 (449)
Q Consensus 17 ~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~-~~~~~lVmE~~-g~sL~~ll~~~---------------~~~ls~~~~~~ 79 (449)
....+..|..++.++.+|+||+.+++++.+ +...|+||||| +++|.+++... ...+++..++.
T Consensus 59 ~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 138 (299)
T d1ywna1 59 EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 138 (299)
T ss_dssp HHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHH
T ss_pred HHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHH
Confidence 345688899999999899999999988765 45689999999 99999999743 23489999999
Q ss_pred HHHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhC
Q 013092 80 LADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG 159 (449)
Q Consensus 80 i~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~ 159 (449)
++.||+.||+|||++|||||||||+|||| +.++.+||+|||+++........ .......||+.|||||++.+
T Consensus 139 ~~~qi~~gl~ylH~~~ivHrDlKp~NILl---~~~~~~Kl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~APE~l~~ 210 (299)
T d1ywna1 139 YSFQVAKGMEFLASRKCIHRDLAARNILL---SEKNVVKICDFGLARDIYKDPDY-----VRKGDARLPLKWMAPETIFD 210 (299)
T ss_dssp HHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CGGGCEEECC------CCSCTTS-----CCTTSCCCGGGGCCHHHHHH
T ss_pred HHHHHHHHHHHHHhCCCcCCcCCccceeE---CCCCcEEEccCcchhhccccccc-----cccCceeeCccccchhHhhc
Confidence 99999999999999999999999999999 57889999999999876544321 12345689999999999999
Q ss_pred CCCChhhHHHHHHHHHHHHHhC-CCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCH
Q 013092 160 IEQSRRDDLESLGYVLMYFLRG-SLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDY 238 (449)
Q Consensus 160 ~~~s~~~DiwSlG~il~elltG-~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~ 238 (449)
..++.++|||||||++|||++| ..||.+.... ......+..... ...+..+++++.++|..||+.||++||++
T Consensus 211 ~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~--~~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~Rpt~ 284 (299)
T d1ywna1 211 RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--EEFCRRLKEGTR----MRAPDYTTPEMYQTMLDCWHGEPSQRPTF 284 (299)
T ss_dssp CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS--HHHHHHHHHTCC----CCCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred CCCCcccceeehHHHHHHHHhCCCCCCCCCCHH--HHHHHHHhcCCC----CCCCccCCHHHHHHHHHHcCCChhHCcCH
Confidence 9999999999999999999986 5688765432 222233333221 12345689999999999999999999999
Q ss_pred HHHHHHHHHHHHH
Q 013092 239 AYLKRIFRDLFIR 251 (449)
Q Consensus 239 ~~l~~~L~~~~~~ 251 (449)
.+|.+.|+++++.
T Consensus 285 ~eil~~L~~ilq~ 297 (299)
T d1ywna1 285 SELVEHLGNLLQA 297 (299)
T ss_dssp HHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhC
Confidence 9999999988754
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-42 Score=338.32 Aligned_cols=229 Identities=16% Similarity=0.215 Sum_probs=183.3
Q ss_pred EEEEEeeecc---cCCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHH
Q 013092 4 ILTVFSVQEN---VKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLM 79 (449)
Q Consensus 4 aikV~~k~~~---~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~ 79 (449)
+++|++|... .....++|.+|+++|+.| +|||||++++++.++. .+++|||+ +++|.+++......+++..++.
T Consensus 38 ~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~~~-~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~ 115 (317)
T d1xkka_ 38 KIPVAIKELREATSPKANKEILDEAYVMASV-DNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLN 115 (317)
T ss_dssp CEEEEEEEECC----CTHHHHHHHHHHHHHC-CCTTBCCEEEEEESSS-EEEEEECCTTCBHHHHHHHTSSSCCHHHHHH
T ss_pred EEEEEEEEeccccCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEecCC-eeEEEEeccCCcccccccccccCCCHHHHHH
Confidence 3466665432 223456799999999999 8999999999998765 55666777 9999999887677899999999
Q ss_pred HHHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhC
Q 013092 80 LADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG 159 (449)
Q Consensus 80 i~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~ 159 (449)
|+.||+.||+|||++|||||||||+|||| +.++.+||+|||+++.+...... .......||+.|||||++.+
T Consensus 116 i~~qi~~gl~yLH~~~iiHrDlKp~NIll---~~~~~~kl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~APE~l~~ 187 (317)
T d1xkka_ 116 WCVQIAKGMNYLEDRRLVHRDLAARNVLV---KTPQHVKITDFGLAKLLGAEEKE-----YHAEGGKVPIKWMALESILH 187 (317)
T ss_dssp HHHHHHHHHHHHHHTTCCCSCCCGGGEEE---EETTEEEECCCSHHHHTTTTCC-------------CCTTTSCHHHHHH
T ss_pred HHHHHHHHHHHHHHcCcccCcchhhccee---CCCCCeEeeccccceeccccccc-----ccccccccCccccChHHHhc
Confidence 99999999999999999999999999999 57889999999999876543321 11234568999999999999
Q ss_pred CCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCH
Q 013092 160 IEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDY 238 (449)
Q Consensus 160 ~~~s~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~ 238 (449)
..++.++|||||||++|||++ |..||.+.+... ....+...... ..+..+|+++.+||..||+.+|++||++
T Consensus 188 ~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~---~~~~i~~~~~~----~~p~~~~~~~~~li~~cl~~dP~~RPs~ 260 (317)
T d1xkka_ 188 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISSILEKGERL----PQPPICTIDVYMIMVKCWMIDADSRPKF 260 (317)
T ss_dssp CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG---HHHHHHHTCCC----CCCTTBCHHHHHHHHHHTCSSGGGSCCH
T ss_pred CCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH---HHHHHHcCCCC----CCCcccCHHHHHHHHHhCCCChhhCcCH
Confidence 999999999999999999998 899998765433 33333332211 2335689999999999999999999999
Q ss_pred HHHHHHHHHHH
Q 013092 239 AYLKRIFRDLF 249 (449)
Q Consensus 239 ~~l~~~L~~~~ 249 (449)
.+|.+.|..+.
T Consensus 261 ~eil~~l~~~~ 271 (317)
T d1xkka_ 261 RELIIEFSKMA 271 (317)
T ss_dssp HHHHHHHHHHH
T ss_pred HHHHHHHHHHH
Confidence 99988877664
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-42 Score=340.04 Aligned_cols=213 Identities=19% Similarity=0.241 Sum_probs=182.7
Q ss_pred ChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 013092 17 KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 95 (449)
Q Consensus 17 ~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~g 95 (449)
....+.+|+++|+.+ +||||+++++++.+.+..||||||| |++|.+++......+++.+++.|+.||+.||+|||++|
T Consensus 44 ~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~~~~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~ 122 (321)
T d1tkia_ 44 DQVLVKKEISILNIA-RHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN 122 (321)
T ss_dssp HHHHHHHHHHHHHHS-CCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred cHHHHHHHHHHHHhC-CCCCCCeEEEEEEECCEEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC
Confidence 345688999999999 8999999999999999999999999 89999999865557999999999999999999999999
Q ss_pred ceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHHH
Q 013092 96 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVL 175 (449)
Q Consensus 96 ivHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~il 175 (449)
|+||||||+|||+.. +....+||+|||+++....... .....||+.|+|||.+.+..++.++|||||||++
T Consensus 123 iiHrDlKp~NIll~~-~~~~~ikl~DFG~~~~~~~~~~--------~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvil 193 (321)
T d1tkia_ 123 IGHFDIRPENIIYQT-RRSSTIKIIEFGQARQLKPGDN--------FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLV 193 (321)
T ss_dssp EECCCCCGGGEEESS-SSCCCEEECCCTTCEECCTTCE--------EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHH
T ss_pred CCcccccccceeecC-CCceEEEEcccchhhccccCCc--------ccccccccccccchhccCCCCCchhhcccHHHHH
Confidence 999999999999942 2445899999999987654322 2345789999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 176 MYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 176 ~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
|+|++|..||.+. +..+.+..|.......+ ....+.+++++.+||..||..||++||++.++++
T Consensus 194 y~ll~G~~Pf~~~---~~~~~~~~i~~~~~~~~-~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 194 YVLLSGINPFLAE---TNQQIIENIMNAEYTFD-EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HHHHHSSCTTCCS---SHHHHHHHHHHTCCCCC-HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHhCCCCCCCC---CHHHHHHHHHhCCCCCC-hhhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 9999999999874 44566677766554432 3445678999999999999999999999888754
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-42 Score=333.62 Aligned_cols=227 Identities=17% Similarity=0.164 Sum_probs=177.1
Q ss_pred cEEEEEeeecccCC---ChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHH
Q 013092 3 EILTVFSVQENVKT---KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLM 79 (449)
Q Consensus 3 ~aikV~~k~~~~~~---~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~~~~ 79 (449)
.|||++.+...... ....+.+|+.+|+.+ +||||+++++++.++++.|||||||.+.+...+......+++..+..
T Consensus 26 vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~~~~~~~~~~~~~ivmE~~~~~~~~~~~~~~~~l~~~~~~~ 104 (299)
T d1ua2a_ 26 VAIKKIKLGHRSEAKDGINRTALREIKLLQEL-SHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKA 104 (299)
T ss_dssp EEEEEC------------CTHHHHHHHHHHHC-CCTTBCCEEEEECCTTCCEEEEECCSEEHHHHHTTCCSSCCSSHHHH
T ss_pred EEEEEEehhhhhhhhHHHHHHHHHHHHHHHhC-CCCCEeEEEeeeccCCceeehhhhhcchHHhhhhhcccCCCHHHHHH
Confidence 46666554433222 245689999999999 89999999999999999999999994444444443466799999999
Q ss_pred HHHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhC
Q 013092 80 LADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG 159 (449)
Q Consensus 80 i~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~ 159 (449)
++.||+.||+|||++||+||||||+|||+ +..+.+||+|||+++....... .....+||+.|+|||++.+
T Consensus 105 ~~~qil~aL~~lH~~~iiHrDiKp~NIli---~~~~~~KL~DFG~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~ 174 (299)
T d1ua2a_ 105 YMLMTLQGLEYLHQHWILHRDLKPNNLLL---DENGVLKLADFGLAKSFGSPNR-------AYTHQVVTRWYRAPELLFG 174 (299)
T ss_dssp HHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECCCGGGSTTTSCCC-------CCCCSCCCCTTCCHHHHTT
T ss_pred HHHHHHHHHHHhhccceecccCCcceEEe---cCCCccccccCccccccCCCcc-------cccceecChhhccHHHHcc
Confidence 99999999999999999999999999999 6889999999999987655332 1235689999999999875
Q ss_pred C-CCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcc-----------------------cchHHHhhcC
Q 013092 160 I-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV-----------------------STSIEALCRG 215 (449)
Q Consensus 160 ~-~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~-----------------------~~~~~~l~~~ 215 (449)
. .++.++|||||||++|||++|..||.+... .+.+.++.+... ...+..+...
T Consensus 175 ~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~---~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (299)
T d1ua2a_ 175 ARMYGVGVDMWAVGCILAELLLRVPFLPGDSD---LDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSA 251 (299)
T ss_dssp CSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTT
T ss_pred CCCCChhhhhhhcchHHHHHHhCcCCCCCCCH---HHHHHHHHHhcCCCChhhccchhccchhhhhccCCCCChHHhccc
Confidence 4 579999999999999999999999987443 333333332211 1223344567
Q ss_pred CcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 216 YPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 216 ~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
+++++.+||..||+.||++|||+.++++
T Consensus 252 ~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 252 AGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp CCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 7899999999999999999999888743
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-41 Score=330.91 Aligned_cols=230 Identities=17% Similarity=0.247 Sum_probs=191.5
Q ss_pred EEEeeecccCC---ChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcC------------
Q 013092 6 TVFSVQENVKT---KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCS------------ 69 (449)
Q Consensus 6 kV~~k~~~~~~---~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~------------ 69 (449)
.|++|...... ...++.+|..++.++.+||||+.+++++.+++..|+||||| +|+|.+++....
T Consensus 47 ~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~ 126 (299)
T d1fgka_ 47 KVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSH 126 (299)
T ss_dssp EEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC----------
T ss_pred EEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCCeEEEEEEccCCCcHHHHHHhhcCCcccccccccc
Confidence 34555443322 34568889999999989999999999999999999999999 999999997432
Q ss_pred ---CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCc
Q 013092 70 ---RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLT 146 (449)
Q Consensus 70 ---~~ls~~~~~~i~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~ 146 (449)
..+++.+++.++.||+.||+|||+++||||||||+|||+ +.++.+||+|||+++........ .......
T Consensus 127 ~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl---~~~~~~kl~dfg~~~~~~~~~~~-----~~~~~~~ 198 (299)
T d1fgka_ 127 NPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV---TEDNVMKIADFGLARDIHHIDYY-----KKTTNGR 198 (299)
T ss_dssp --CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTCCEEECSTTCCCCGGGCCTT-----CCCTTSC
T ss_pred CccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceee---cCCCCeEeccchhhccccccccc-----cccccCC
Confidence 358999999999999999999999999999999999999 68899999999999877654332 1234567
Q ss_pred cCccccchhhhhCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHH
Q 013092 147 GTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFH 225 (449)
Q Consensus 147 gT~~Y~aPE~~~~~~~s~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~ 225 (449)
||+.|+|||++.+..|+.++|||||||++|||++ |.+||.+.+. .+.+..+...... ..+..+++++.+||.
T Consensus 199 ~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~---~~~~~~i~~~~~~----~~p~~~~~~l~~li~ 271 (299)
T d1fgka_ 199 LPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV---EELFKLLKEGHRM----DKPSNCTNELYMMMR 271 (299)
T ss_dssp CGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---HHHHHHHHTTCCC----CCCSSCCHHHHHHHH
T ss_pred CChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH---HHHHHHHHcCCCC----CCCccchHHHHHHHH
Confidence 8999999999999999999999999999999998 7999977443 3444444443221 234678999999999
Q ss_pred HHhcCCCCCCCCHHHHHHHHHHHHH
Q 013092 226 YCRSLRFDDKPDYAYLKRIFRDLFI 250 (449)
Q Consensus 226 ~cl~~~p~~RPt~~~l~~~L~~~~~ 250 (449)
.||+.+|++||++.+|++.|+.++.
T Consensus 272 ~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 272 DCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp HHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHccCCHhHCcCHHHHHHHHHHHhh
Confidence 9999999999999999999988864
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1e-41 Score=333.30 Aligned_cols=216 Identities=19% Similarity=0.292 Sum_probs=182.3
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcC-----------------------CCCC
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCS-----------------------RKLS 73 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~-----------------------~~ls 73 (449)
..+|.+|+.+|+.+ .||||+++++++.+.+..++||||+ +++|.+++.... ..++
T Consensus 60 ~~~~~~E~~il~~l-~h~niv~~~~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 138 (301)
T d1lufa_ 60 QADFQREAALMAEF-DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 138 (301)
T ss_dssp HHHHHHHHHHHHTC-CCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCC
T ss_pred HHHHHHHHHHHHhc-CCCCcccceeeeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCC
Confidence 45689999999999 9999999999999999999999999 999999986421 2488
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccc
Q 013092 74 LKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYAS 153 (449)
Q Consensus 74 ~~~~~~i~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~a 153 (449)
+..++.|+.|++.||+|||+++||||||||+|||| +.++.+||+|||+++.+...... .......||+.|+|
T Consensus 139 ~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~NILl---d~~~~~Kl~DFGls~~~~~~~~~-----~~~~~~~~~~~y~a 210 (301)
T d1lufa_ 139 CAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLV---GENMVVKIADFGLSRNIYSADYY-----KADGNDAIPIRWMP 210 (301)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCSCHHHHTGGGCB-----C----CCBCGGGCC
T ss_pred HHHHHHHHHHHHHHhhhcccCCeEeeEEcccceEE---CCCCcEEEccchhheeccCCccc-----cccCCCCcCcCcCC
Confidence 99999999999999999999999999999999999 67889999999999866443221 12345678999999
Q ss_pred hhhhhCCCCChhhHHHHHHHHHHHHHhCC-CCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCC
Q 013092 154 MNTHLGIEQSRRDDLESLGYVLMYFLRGS-LPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRF 232 (449)
Q Consensus 154 PE~~~~~~~s~~~DiwSlG~il~elltG~-~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p 232 (449)
||.+.+..++.++|||||||++|||++|. .||.+. +..+.+..+...... ..+..+|+++.+||..||+.+|
T Consensus 211 PE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~---~~~e~~~~v~~~~~~----~~p~~~~~~~~~li~~cl~~~P 283 (301)
T d1lufa_ 211 PESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM---AHEEVIYYVRDGNIL----ACPENCPLELYNLMRLCWSKLP 283 (301)
T ss_dssp HHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS---CHHHHHHHHHTTCCC----CCCTTCCHHHHHHHHHHTCSSG
T ss_pred HHHHccCCCChhhhhccchhhHHHHHccCCCCCCCC---CHHHHHHHHHcCCCC----CCCccchHHHHHHHHHHcCCCh
Confidence 99999999999999999999999999985 678764 334555555554432 3456789999999999999999
Q ss_pred CCCCCHHHHHHHHHHHH
Q 013092 233 DDKPDYAYLKRIFRDLF 249 (449)
Q Consensus 233 ~~RPt~~~l~~~L~~~~ 249 (449)
++||++.+|.+.|+++.
T Consensus 284 ~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 284 ADRPSFCSIHRILQRMC 300 (301)
T ss_dssp GGSCCHHHHHHHHHHTT
T ss_pred hHCcCHHHHHHHHHHhc
Confidence 99999999999988763
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-41 Score=333.34 Aligned_cols=219 Identities=18% Similarity=0.227 Sum_probs=183.0
Q ss_pred CChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHc---------------CCCCCHHHHHH
Q 013092 16 TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFC---------------SRKLSLKTVLM 79 (449)
Q Consensus 16 ~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~---------------~~~ls~~~~~~ 79 (449)
...+.|.+|+++|..+.+||||+++++++.+.+..||||||| +|+|.+++... ...+++..++.
T Consensus 52 ~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 131 (309)
T d1fvra_ 52 DDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 131 (309)
T ss_dssp ---CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHH
T ss_pred HHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHH
Confidence 345679999999999978999999999999999999999999 99999998632 25699999999
Q ss_pred HHHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhC
Q 013092 80 LADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG 159 (449)
Q Consensus 80 i~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~ 159 (449)
++.||+.||.|||+++|+||||||+|||+ +.++.+||+|||+++....... .....||..|+|||.+.+
T Consensus 132 ~~~qia~gl~~lH~~~iiHrDlkp~NIL~---~~~~~~kl~DfG~a~~~~~~~~--------~~~~~gt~~y~aPE~l~~ 200 (309)
T d1fvra_ 132 FAADVARGMDYLSQKQFIHRDLAARNILV---GENYVAKIADFGLSRGQEVYVK--------KTMGRLPVRWMAIESLNY 200 (309)
T ss_dssp HHHHHHHHHHHHHHTTEECSCCSGGGEEE---CGGGCEEECCTTCEESSCEECC--------C----CCTTTCCHHHHHH
T ss_pred HHHHHHHHHHhhhcCCccccccccceEEE---cCCCceEEcccccccccccccc--------ccceecCCcccchHHhcc
Confidence 99999999999999999999999999999 6788999999999986544322 234568999999999999
Q ss_pred CCCChhhHHHHHHHHHHHHHhCC-CCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCH
Q 013092 160 IEQSRRDDLESLGYVLMYFLRGS-LPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDY 238 (449)
Q Consensus 160 ~~~s~~~DiwSlG~il~elltG~-~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~ 238 (449)
..++.++|||||||++|||++|. +||.+. +..+.+..+..... ...+..+|+++.+||..||+.||++||++
T Consensus 201 ~~~~~~sDvwSfGvil~ell~~~~~p~~~~---~~~~~~~~i~~~~~----~~~~~~~~~~~~~li~~cl~~dP~~RPs~ 273 (309)
T d1fvra_ 201 SVYTTNSDVWSYGVLLWEIVSLGGTPYCGM---TCAELYEKLPQGYR----LEKPLNCDDEVYDLMRQCWREKPYERPSF 273 (309)
T ss_dssp CEECHHHHHHHHHHHHHHHHTTSCCTTTTC---CHHHHHHHGGGTCC----CCCCTTBCHHHHHHHHHHTCSSGGGSCCH
T ss_pred CCCCccceeehhHHHHHHHHhcCCCCCCCC---CHHHHHHHHHhcCC----CCCCccCCHHHHHHHHHHcCCChhHCcCH
Confidence 99999999999999999999965 577664 34455555544322 12345689999999999999999999999
Q ss_pred HHHHHHHHHHHHHc
Q 013092 239 AYLKRIFRDLFIRE 252 (449)
Q Consensus 239 ~~l~~~L~~~~~~~ 252 (449)
.+|.+.|.++++..
T Consensus 274 ~eil~~L~~i~~~~ 287 (309)
T d1fvra_ 274 AQILVSLNRMLEER 287 (309)
T ss_dssp HHHHHHHHHHHHSS
T ss_pred HHHHHHHHHHHhcC
Confidence 99999999987643
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-42 Score=328.30 Aligned_cols=224 Identities=18% Similarity=0.240 Sum_probs=178.6
Q ss_pred EEEeeecccCCChhHHHHHHHHHHHhcCCCCCceEEEEeEe-CCEEEEEEecC-CCCHHHHHHHc-CCCCCHHHHHHHHH
Q 013092 6 TVFSVQENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVE-GDYNVLVMDLL-GPSLEDLFNFC-SRKLSLKTVLMLAD 82 (449)
Q Consensus 6 kV~~k~~~~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~-~~~~~lVmE~~-g~sL~~ll~~~-~~~ls~~~~~~i~~ 82 (449)
+|++|........+.|.+|+++++++ +||||+++++++.+ .+..||||||+ +|+|.+++... ...+++..++.++.
T Consensus 32 ~vAvK~i~~~~~~~~~~~E~~~l~~l-~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~ 110 (262)
T d1byga_ 32 KVAVKCIKNDATAQAFLAEASVMTQL-RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSL 110 (262)
T ss_dssp EEEEEECCCCC--HHHHHTHHHHTTC-CCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHH
T ss_pred EEEEEEECcHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEecCCcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHH
Confidence 34444444445567899999999999 89999999998865 45689999999 99999998643 23589999999999
Q ss_pred HHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCC
Q 013092 83 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQ 162 (449)
Q Consensus 83 qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~ 162 (449)
||+.||.|||+++|+||||||+|||+ +.++.+||+|||+++...... ....+|..|+|||++.+..+
T Consensus 111 ~i~~al~ylH~~~ivH~dlkp~Nil~---~~~~~~kl~dfg~s~~~~~~~----------~~~~~~~~y~aPE~l~~~~~ 177 (262)
T d1byga_ 111 DVCEAMEYLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLTKEASSTQ----------DTGKLPVKWTAPEALREKKF 177 (262)
T ss_dssp HHHHHHHHHHHTTCCCSCCSGGGEEE---CTTSCEEECCCCC----------------------CCTTTSCHHHHHHCCC
T ss_pred HHHhhccccccCceeccccchHhhee---cCCCCEeecccccceecCCCC----------ccccccccCCChHHHhCCCC
Confidence 99999999999999999999999999 688999999999998654322 23468899999999999999
Q ss_pred ChhhHHHHHHHHHHHHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHH
Q 013092 163 SRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYL 241 (449)
Q Consensus 163 s~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l 241 (449)
+.++|||||||++|||++ |++||...+. .+.+..+...... .++..+++++.+||..||+.||++||++.+|
T Consensus 178 t~~sDIwSfG~il~el~t~~~~p~~~~~~---~~~~~~i~~~~~~----~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l 250 (262)
T d1byga_ 178 STKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVPRVEKGYKM----DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQL 250 (262)
T ss_dssp CHHHHHHHHHHHHHHHHTTSCCSCTTSCG---GGHHHHHTTTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred ChHHHHHhHHHHHHHHHHCCCCCCCCCCH---HHHHHHHHcCCCC----CCCccCCHHHHHHHHHHcccCHhHCcCHHHH
Confidence 999999999999999998 7999987544 3445555443322 2445789999999999999999999999999
Q ss_pred HHHHHHHHH
Q 013092 242 KRIFRDLFI 250 (449)
Q Consensus 242 ~~~L~~~~~ 250 (449)
.+.|+++.+
T Consensus 251 ~~~L~~i~~ 259 (262)
T d1byga_ 251 REQLEHIKT 259 (262)
T ss_dssp HHHHHHHHH
T ss_pred HHHHHHHHh
Confidence 999988754
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-41 Score=330.62 Aligned_cols=227 Identities=16% Similarity=0.219 Sum_probs=177.0
Q ss_pred EEEeeec-ccCCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHc-CCCCCHHHHHHHHH
Q 013092 6 TVFSVQE-NVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFC-SRKLSLKTVLMLAD 82 (449)
Q Consensus 6 kV~~k~~-~~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~-~~~ls~~~~~~i~~ 82 (449)
+|++|.. ......+.|.+|+.+|+++ +|||||++++++.+ +..||||||| +|+|.+++... ...+++..++.++.
T Consensus 43 ~vAiK~l~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~g~~~~-~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~ 120 (285)
T d1fmka3 43 RVAIKTLKPGTMSPEAFLQEAQVMKKL-RHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAA 120 (285)
T ss_dssp EEEEEECCTTSSCHHHHHHHHHHHHHC-CCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHH
T ss_pred EEEEEEECcccCCHHHHHHHHHHHHhc-ccCCEeEEEEEEec-CCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHH
Confidence 3444432 3344567799999999999 99999999999855 4579999999 99999887532 45699999999999
Q ss_pred HHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCC
Q 013092 83 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQ 162 (449)
Q Consensus 83 qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~ 162 (449)
||+.||+|||++||+||||||+|||| +.++.+||+|||+++....... .......||+.|+|||++....+
T Consensus 121 ~i~~gl~~LH~~~ivH~DlKp~NIll---~~~~~~kl~DfGla~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~ 191 (285)
T d1fmka3 121 QIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLARLIEDNEY------TARQGAKFPIKWTAPEAALYGRF 191 (285)
T ss_dssp HHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCCTTC--------------------CCGGGSCHHHHHHCCC
T ss_pred HHHHHHHHHhhhheecccccceEEEE---CCCCcEEEcccchhhhccCCCc------eeeccccccccccChHHHhCCCC
Confidence 99999999999999999999999999 5778999999999987654332 11234578999999999999999
Q ss_pred ChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 013092 163 SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 242 (449)
Q Consensus 163 s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~ 242 (449)
+.++|||||||+||||++|..||... ....+.+..+...... .....+|+++.+||..||+.||++||++++|.
T Consensus 192 ~~ksDI~S~Giil~el~t~~~p~~~~--~~~~~~~~~i~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~ 265 (285)
T d1fmka3 192 TIKSDVWSFGILLTELTTKGRVPYPG--MVNREVLDQVERGYRM----PCPPECPESLHDLMCQCWRKEPEERPTFEYLQ 265 (285)
T ss_dssp CHHHHHHHHHHHHHHHHTTTCCSSTT--CCHHHHHHHHHTTCCC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CcHHhhhcchHHHHHHHhCCCCCCCC--CCHHHHHHHHHhcCCC----CCCcccCHHHHHHHHHHcccCHhHCcCHHHHH
Confidence 99999999999999999965555432 2334445555443221 23467899999999999999999999999998
Q ss_pred HHHHHHH
Q 013092 243 RIFRDLF 249 (449)
Q Consensus 243 ~~L~~~~ 249 (449)
+.|++.+
T Consensus 266 ~~L~~~~ 272 (285)
T d1fmka3 266 AFLEDYF 272 (285)
T ss_dssp HHHHTTT
T ss_pred HHHhhhh
Confidence 8877653
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-41 Score=329.27 Aligned_cols=228 Identities=19% Similarity=0.215 Sum_probs=181.7
Q ss_pred ccEEEEEeeecccCCChhHHHHHHHHHHHhc--CCCCCceEEEEeEe-----CCEEEEEEecCCCCHHH-HHHHcCCCCC
Q 013092 2 YEILTVFSVQENVKTKHPQLLYESKLYRILQ--GGTGIPNVRWFGVE-----GDYNVLVMDLLGPSLED-LFNFCSRKLS 73 (449)
Q Consensus 2 ~~aikV~~k~~~~~~~~~~~~~E~~il~~l~--~hp~Iv~l~~~~~~-----~~~~~lVmE~~g~sL~~-ll~~~~~~ls 73 (449)
++|||++.+..........+.+|+.+|+.|+ +||||+++++++.. ..+.||+||||.+.+.. ........++
T Consensus 35 ~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~ 114 (305)
T d1blxa_ 35 FVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVP 114 (305)
T ss_dssp EEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCSCBHHHHHHHSCTTCSC
T ss_pred EEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCceEEEEEEeccCCchhhhhhccCCCCC
Confidence 3577877766555556667889999999886 79999999998853 35789999999444444 4443356799
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccc
Q 013092 74 LKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYAS 153 (449)
Q Consensus 74 ~~~~~~i~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~a 153 (449)
+..++.++.|++.||+|||++||+||||||+|||+ +..+.+||+|||+++...... ......||+.|+|
T Consensus 115 ~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi---~~~~~~kl~dfg~~~~~~~~~--------~~~~~~gT~~Y~A 183 (305)
T d1blxa_ 115 TETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILV---TSSGQIKLADFGLARIYSFQM--------ALTSVVVTLWYRA 183 (305)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECSCCSCCCCCGGG--------GGCCCCCCCTTCC
T ss_pred HHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEE---cCCCCeeecchhhhhhhcccc--------cCCCcccChhhcC
Confidence 99999999999999999999999999999999999 688899999999987654322 2346789999999
Q ss_pred hhhhhCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhc----------------------ccchHHH
Q 013092 154 MNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK----------------------VSTSIEA 211 (449)
Q Consensus 154 PE~~~~~~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~----------------------~~~~~~~ 211 (449)
||++.+.+|+.++|||||||++|||++|+.||.+.+. .+.+.++.... .....+.
T Consensus 184 PE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~---~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (305)
T d1blxa_ 184 PEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD---VDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEK 260 (305)
T ss_dssp HHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGG
T ss_pred cchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCH---HHHHHHHHHhhCCCchhcccccccchhhhhccccccchhh
Confidence 9999999999999999999999999999999987543 33333333211 1122334
Q ss_pred hhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 212 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 212 l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
+...+++++.+||..||+.||++||++.++++
T Consensus 261 ~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 261 FVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp TCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 45667899999999999999999999887743
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-41 Score=328.07 Aligned_cols=227 Identities=17% Similarity=0.195 Sum_probs=179.1
Q ss_pred cEEEEEeeecccCCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecCCCCHHHHHHHc-CCCCCHHHHHHHH
Q 013092 3 EILTVFSVQENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFC-SRKLSLKTVLMLA 81 (449)
Q Consensus 3 ~aikV~~k~~~~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~g~sL~~ll~~~-~~~ls~~~~~~i~ 81 (449)
.|||++.+.........++.+|+++|+.+ +||||+++++++.+++..|||||||++++.+++... ...+++..+..++
T Consensus 30 vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~Hp~Iv~~~~~~~~~~~~~iv~e~~~~~~~~~~~~~~~~~l~e~~~~~~~ 108 (298)
T d1gz8a_ 30 VALKKIRLDTETEGVPSTAIREISLLKEL-NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL 108 (298)
T ss_dssp EEEEEEC-------CCHHHHHHHHHHTTC-CCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHTTTTCCCHHHHHHHH
T ss_pred EEEEEEehhhcChHHHHHHHHHHHHHHhC-CCCcEEEeccccccccceeEEEeecCCchhhhhhhhcccCCCHHHHHHHH
Confidence 46676655444444567899999999999 899999999999999999999999977777766543 4569999999999
Q ss_pred HHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCC
Q 013092 82 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIE 161 (449)
Q Consensus 82 ~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~ 161 (449)
.||+.||+|||++|||||||||+|||+ +.++.+||+|||+++....... ......||+.|+|||++....
T Consensus 109 ~qil~~L~yLH~~~IiHrDiKpeNIl~---~~~~~~kl~DFG~a~~~~~~~~-------~~~~~~gt~~y~apE~~~~~~ 178 (298)
T d1gz8a_ 109 FQLLQGLAFCHSHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVR-------TYTHEVVTLWYRAPEILLGCK 178 (298)
T ss_dssp HHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECSTTHHHHHCCCSB-------CTTCCBCCCTTCCHHHHTTCS
T ss_pred HHHHHHHHHhhcCCEEccccCchheee---cccCcceeccCCcceeccCCcc-------cceeecccceeeehhhhcccc
Confidence 999999999999999999999999999 6788999999999987654322 234568999999999988766
Q ss_pred -CChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhh------------------------cccchHHHhhcCC
Q 013092 162 -QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK------------------------KVSTSIEALCRGY 216 (449)
Q Consensus 162 -~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~------------------------~~~~~~~~l~~~~ 216 (449)
++.++|||||||++|+|++|+.||.+.+. ...+.++... ............+
T Consensus 179 ~~~~~~DiwSlGvily~m~~G~~Pf~~~~~---~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (298)
T d1gz8a_ 179 YYSTAVDIWSLGCIFAEMVTRRALFPGDSE---IDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPL 255 (298)
T ss_dssp SCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTC
T ss_pred CCCccccccccchhhhHHhhCCCCCCCCCH---HHHHHHHHHhcCCCchhhccccccccccccccccccccchhhhccCC
Confidence 48899999999999999999999987432 2222222211 0111223344567
Q ss_pred cHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 217 PTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 217 p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
++++.+||..||..||++||++.+|++
T Consensus 256 s~~~~dll~~mL~~dP~~R~t~~ell~ 282 (298)
T d1gz8a_ 256 DEDGRSLLSQMLHYDPNKRISAKAALA 282 (298)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 899999999999999999999988754
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-41 Score=330.75 Aligned_cols=221 Identities=19% Similarity=0.274 Sum_probs=184.5
Q ss_pred ChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcC-----------------CCCCHHHHH
Q 013092 17 KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCS-----------------RKLSLKTVL 78 (449)
Q Consensus 17 ~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~-----------------~~ls~~~~~ 78 (449)
....|.+|+.++..+.+||||+++++++.+.+..||||||| +++|.+++.... ..+++..++
T Consensus 69 ~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 148 (311)
T d1t46a_ 69 EREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148 (311)
T ss_dssp HHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHH
T ss_pred HHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHH
Confidence 34468899999999988999999999999999999999999 999999987532 258999999
Q ss_pred HHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhh
Q 013092 79 MLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHL 158 (449)
Q Consensus 79 ~i~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~ 158 (449)
.++.||+.||+|||+++||||||||+|||+ +..+.+||+|||+++........ .......||+.|+|||++.
T Consensus 149 ~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~---~~~~~~ki~DfG~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~ 220 (311)
T d1t46a_ 149 SFSYQVAKGMAFLASKNCIHRDLAARNILL---THGRITKICDFGLARDIKNDSNY-----VVKGNARLPVKWMAPESIF 220 (311)
T ss_dssp HHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---ETTTEEEECCCGGGSCTTSCTTS-----EECSSSEECGGGCCHHHHH
T ss_pred HHHHHHHHHHHHHHhCCeeecccccccccc---cccCcccccccchheeccCCCcc-----eEeeecccChHHcCHHHhc
Confidence 999999999999999999999999999999 57899999999999877654332 2234568999999999999
Q ss_pred CCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCC
Q 013092 159 GIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPD 237 (449)
Q Consensus 159 ~~~~s~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt 237 (449)
+..++.++|||||||++|||++ |.+||...... ..+.++....... .....+|+++.+||..||+.||++||+
T Consensus 221 ~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~---~~~~~~i~~~~~~---~~~~~~~~~l~~Li~~cl~~dP~~RPs 294 (311)
T d1t46a_ 221 NCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD---SKFYKMIKEGFRM---LSPEHAPAEMYDIMKTCWDADPLKRPT 294 (311)
T ss_dssp HCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS---HHHHHHHHHTCCC---CCCTTSCHHHHHHHHHHTCSSGGGSCC
T ss_pred CCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH---HHHHHHHhcCCCC---CCcccccHHHHHHHHHHcCCChhHCcC
Confidence 9999999999999999999998 66666664432 2233333332222 123468899999999999999999999
Q ss_pred HHHHHHHHHHHHHH
Q 013092 238 YAYLKRIFRDLFIR 251 (449)
Q Consensus 238 ~~~l~~~L~~~~~~ 251 (449)
+.+|++.|+.++..
T Consensus 295 ~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 295 FKQIVQLIEKQISE 308 (311)
T ss_dssp HHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHhhcc
Confidence 99999999887654
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-41 Score=330.26 Aligned_cols=222 Identities=14% Similarity=0.211 Sum_probs=182.8
Q ss_pred ChhHHHHHHHHHHHhcCCCCCceEEEEeEe-CCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC
Q 013092 17 KHPQLLYESKLYRILQGGTGIPNVRWFGVE-GDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 94 (449)
Q Consensus 17 ~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~-~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~ 94 (449)
....|.+|+++|.+| +||||+++++++.+ ++..|+||||| +++|.+++......+++..++.++.|++.||.|||+.
T Consensus 71 ~~~~~~~E~~~l~~l-~HpnIv~~~g~~~~~~~~~~lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~ 149 (311)
T d1r0pa_ 71 EVSQFLTEGIIMKDF-SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK 149 (311)
T ss_dssp HHHHHHHHHHHHHTC-CCTTBCCCCEEEEETTTEEEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHhC-CCCCEeEEeEEEEecCCceEEEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhccc
Confidence 346699999999999 89999999999876 56899999999 9999999986566788999999999999999999999
Q ss_pred CceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHHHHHHHH
Q 013092 95 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYV 174 (449)
Q Consensus 95 givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~DiwSlG~i 174 (449)
+|+||||||+|||| +.++.+||+|||+++......... ........||+.|+|||.+....++.++||||||++
T Consensus 150 ~iiHrDLK~~NILl---~~~~~~kL~DFG~~~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGiv 223 (311)
T d1r0pa_ 150 KFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEFDS---VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVL 223 (311)
T ss_dssp TCCCSCCSGGGEEE---CTTCCEEECSSGGGCCTTTTTCCC---TTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHH
T ss_pred CcccCCccHHhEeE---CCCCCEEEecccchhhcccccccc---ceecccccccccccChHHHhcCCCCChhHhhhhHHH
Confidence 99999999999999 688999999999998775543322 122344679999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 013092 175 LMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIR 251 (449)
Q Consensus 175 l~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~L~~~~~~ 251 (449)
+|||++|..||..... ..+....+...... ..++.+|+++.+||..||+.||++||++.+|.+.|+.++..
T Consensus 224 l~El~t~~~p~~~~~~--~~~~~~~i~~g~~~----~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 224 LWELMTRGAPPYPDVN--TFDITVYLLQGRRL----LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294 (311)
T ss_dssp HHHHHTTSCCSCC--------CHHHHHTTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HHHHHHCCCCCCCCCC--HHHHHHHHHcCCCC----CCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 9999998777765322 22233333333221 23456899999999999999999999999999999988753
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-41 Score=325.82 Aligned_cols=215 Identities=21% Similarity=0.289 Sum_probs=175.5
Q ss_pred cEEEEEeeecccC----CChhHHHHHHHHHHHhc-CCCCCceEEEEeEeCCEEEEEEecC-C-CCHHHHHHHcCCCCCHH
Q 013092 3 EILTVFSVQENVK----TKHPQLLYESKLYRILQ-GGTGIPNVRWFGVEGDYNVLVMDLL-G-PSLEDLFNFCSRKLSLK 75 (449)
Q Consensus 3 ~aikV~~k~~~~~----~~~~~~~~E~~il~~l~-~hp~Iv~l~~~~~~~~~~~lVmE~~-g-~sL~~ll~~~~~~ls~~ 75 (449)
+|||++.+..... ....++.+|+.+|+.++ .||||+++++++.+.+..|+||||+ + +++.+++.. ...+++.
T Consensus 32 vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~lv~e~~~~~~~l~~~~~~-~~~l~e~ 110 (273)
T d1xwsa_ 32 VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE-RGALQEE 110 (273)
T ss_dssp EEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHH-HCSCCHH
T ss_pred EEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeEEEEEEeccCcchHHHHHhc-cCCCCHH
Confidence 4566665433221 22345789999999995 4899999999999999999999999 4 588888875 4579999
Q ss_pred HHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchh
Q 013092 76 TVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMN 155 (449)
Q Consensus 76 ~~~~i~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE 155 (449)
+++.++.||+.||+|||++||+||||||+|||+. .+.+.+||+|||+++...... .....||+.|+|||
T Consensus 111 ~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~--~~~~~vkl~DFG~a~~~~~~~---------~~~~~GT~~y~aPE 179 (273)
T d1xwsa_ 111 LARSFFWQVLEAVRHCHNCGVLHRDIKDENILID--LNRGELKLIDFGSGALLKDTV---------YTDFDGTRVYSPPE 179 (273)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE--TTTTEEEECCCTTCEECCSSC---------BCCCCSCGGGSCHH
T ss_pred HHHHHHHHHHHHHHHHHHCCCccccCcccceEEe--cCCCeEEECccccceeccccc---------ccccccCCCcCCHH
Confidence 9999999999999999999999999999999994 345799999999998764432 24568999999999
Q ss_pred hhhCCCC-ChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCC
Q 013092 156 THLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDD 234 (449)
Q Consensus 156 ~~~~~~~-s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~ 234 (449)
++.+..+ +.++|||||||++|||++|..||.+. ..+..... .+...+|+++.+||..||+.||++
T Consensus 180 ~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~---------~~i~~~~~-----~~~~~~s~~~~~li~~~L~~dp~~ 245 (273)
T d1xwsa_ 180 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD---------EEIIRGQV-----FFRQRVSSECQHLIRWCLALRPSD 245 (273)
T ss_dssp HHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH---------HHHHHCCC-----CCSSCCCHHHHHHHHHHTCSSGGG
T ss_pred HHcCCCCCCcccccccceeeehhHhhCCCCCCCc---------hHHhhccc-----CCCCCCCHHHHHHHHHHccCCHhH
Confidence 9987765 67799999999999999999999752 12222222 234678999999999999999999
Q ss_pred CCCHHHHHH
Q 013092 235 KPDYAYLKR 243 (449)
Q Consensus 235 RPt~~~l~~ 243 (449)
||+++++++
T Consensus 246 R~s~~eil~ 254 (273)
T d1xwsa_ 246 RPTFEEIQN 254 (273)
T ss_dssp SCCHHHHHT
T ss_pred CcCHHHHhc
Confidence 999888753
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-40 Score=323.06 Aligned_cols=214 Identities=17% Similarity=0.260 Sum_probs=181.6
Q ss_pred hHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcC---------CCCCHHHHHHHHHHHHHHH
Q 013092 19 PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCS---------RKLSLKTVLMLADQMINRV 88 (449)
Q Consensus 19 ~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~---------~~ls~~~~~~i~~qi~~aL 88 (449)
..|.+|+.+++++ +||||+++++++...+..+|||||| +|+|.+++.... ..+++..++.++.|++.||
T Consensus 68 ~~~~~E~~il~~l-~h~nIv~~~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl 146 (308)
T d1p4oa_ 68 IEFLNEASVMKEF-NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGM 146 (308)
T ss_dssp HHHHHHHHHGGGC-CCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHc-CCCCEeeeeeEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHH
Confidence 3588999999999 8999999999999999999999999 999999986321 2478999999999999999
Q ss_pred HHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCCCChhhHH
Q 013092 89 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDL 168 (449)
Q Consensus 89 ~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~s~~~Di 168 (449)
.|||+++|+||||||+|||| +.++.+||+|||+++.+...... .......||+.|+|||.+.+..++.++||
T Consensus 147 ~~LH~~~ivHrDlk~~NiLl---d~~~~~Kl~DFGla~~~~~~~~~-----~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv 218 (308)
T d1p4oa_ 147 AYLNANKFVHRDLAARNCMV---AEDFTVKIGDFGMTRDIYETDYY-----RKGGKGLLPVRWMSPESLKDGVFTTYSDV 218 (308)
T ss_dssp HHHHHTTCBCSCCSGGGEEE---CTTCCEEECCTTCCCGGGGGGCE-----EGGGSSEECGGGCCHHHHHHCCCCHHHHH
T ss_pred HHHhhCCeeeceEcCCceee---cCCceEEEeecccceeccCCcce-----eeccceecccccCCHHHHccCCCCccccc
Confidence 99999999999999999999 68899999999999876554321 12344578999999999999999999999
Q ss_pred HHHHHHHHHHHhC-CCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Q 013092 169 ESLGYVLMYFLRG-SLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRD 247 (449)
Q Consensus 169 wSlG~il~elltG-~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~~L~~ 247 (449)
|||||++|||++| ..||.+. +..+.+..+...... ..+..+|+++.++|..||+.+|++||++.+|++.|++
T Consensus 219 ~S~G~il~El~t~~~~p~~~~---~~~~~~~~i~~~~~~----~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~ 291 (308)
T d1p4oa_ 219 WSFGVVLWEIATLAEQPYQGL---SNEQVLRFVMEGGLL----DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 291 (308)
T ss_dssp HHHHHHHHHHHHTSCCTTTTS---CHHHHHHHHHTTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGG
T ss_pred ccHHHHHHHHHhCCCCCCCCC---CHHHHHHHHHhCCCC----CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 9999999999997 5888764 344555555554332 2345789999999999999999999999999988765
Q ss_pred H
Q 013092 248 L 248 (449)
Q Consensus 248 ~ 248 (449)
.
T Consensus 292 ~ 292 (308)
T d1p4oa_ 292 E 292 (308)
T ss_dssp G
T ss_pred h
Confidence 5
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-40 Score=324.23 Aligned_cols=249 Identities=16% Similarity=0.212 Sum_probs=195.3
Q ss_pred EEEEEeeeccc--CCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHH
Q 013092 4 ILTVFSVQENV--KTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLML 80 (449)
Q Consensus 4 aikV~~k~~~~--~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i 80 (449)
|||++.+.... ......+.+|+++|+++.+||||+++++++.+....|+||||+ +++|.+++.. .+.+++..+..+
T Consensus 56 AvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~-~~~~~e~~~~~~ 134 (322)
T d1vzoa_ 56 AMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQ-RERFTEHEVQIY 134 (322)
T ss_dssp EEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHH-HSCCCHHHHHHH
T ss_pred EEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCceeeeeecccccHHHHHHHh-cccccHHHHHHH
Confidence 55555443322 2345678899999999988899999999999999999999999 9999999986 456889999999
Q ss_pred HHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCC
Q 013092 81 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI 160 (449)
Q Consensus 81 ~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~ 160 (449)
+.||+.||+|||++||+||||||+|||| +.++.+||+|||+++.+...... ......|++.|++||.+.+.
T Consensus 135 ~~Qi~~al~~lH~~~ivHrDiKp~Nill---~~~~~vkL~DFG~a~~~~~~~~~------~~~~~~g~~~~~~pe~~~~~ 205 (322)
T d1vzoa_ 135 VGEIVLALEHLHKLGIIYRDIKLENILL---DSNGHVVLTDFGLSKEFVADETE------RAYDFCGTIEYMAPDIVRGG 205 (322)
T ss_dssp HHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEESCSSEEEECCGGGGG------GGCGGGSCCTTCCHHHHTTC
T ss_pred HHHHHHHHHHhhcCCEEeccCCccceee---cCCCCEEEeeccchhhhcccccc------cccccccccccchhHHhhcC
Confidence 9999999999999999999999999999 67889999999999877543321 22456799999999999865
Q ss_pred C--CChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchHHHhhcCCcHHHHHHHHHHhcCCCCCCCC-
Q 013092 161 E--QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPD- 237 (449)
Q Consensus 161 ~--~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~el~~li~~cl~~~p~~RPt- 237 (449)
. ++.++|||||||+||+|++|..||.+.........+........ ..++..+++++.+||..||+.||++||+
T Consensus 206 ~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~----~~~~~~~s~~~~~li~~~l~~dP~~R~s~ 281 (322)
T d1vzoa_ 206 DSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE----PPYPQEMSALAKDLIQRLLMKDPKKRLGC 281 (322)
T ss_dssp C---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCC----CCCCTTSCHHHHHHHHHHTCSSGGGSTTS
T ss_pred CcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCC----CCCcccCCHHHHHHHHHHcccCHHHcCCC
Confidence 4 68899999999999999999999988655444333322221111 1234568999999999999999999995
Q ss_pred ----HHHHHHHHHHHHHHcCCCCCCcccchhhhhhhccCCCCC
Q 013092 238 ----YAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQLATPP 276 (449)
Q Consensus 238 ----~~~l~~~L~~~~~~~~~~~~~~~dw~~~~~~~~~~~~~p 276 (449)
+++++ .++|...++|..+..++.++|..|
T Consensus 282 ~~~t~~eil----------~Hpff~~i~~~~l~~~~~~~p~~p 314 (322)
T d1vzoa_ 282 GPRDADEIK----------EHLFFQKINWDDLAAKKVPAPFKP 314 (322)
T ss_dssp STTTHHHHH----------TSGGGTTCCHHHHHTTCSCCSCCC
T ss_pred CcccHHHHH----------cCHhhcCCCHHHHHhCCCCcCCCC
Confidence 55553 245556678988777665544443
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=5e-40 Score=318.46 Aligned_cols=226 Identities=19% Similarity=0.260 Sum_probs=178.9
Q ss_pred cEEEEEeeecccCCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHH
Q 013092 3 EILTVFSVQENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLAD 82 (449)
Q Consensus 3 ~aikV~~k~~~~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~~~~i~~ 82 (449)
.|||++.+.........++.+|+.+|+.+ +||||+++++.+.+.+..||+|||+++.+...+....+.+++..+..++.
T Consensus 29 vAvK~i~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~i~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~ 107 (286)
T d1ob3a_ 29 FALKKIRLEKEDEGIPSTTIREISILKEL-KHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLL 107 (286)
T ss_dssp EEEEEECCSSGGGCCCHHHHHHHHGGGGC-CCTTBCCEEEEEECSSCEEEEEECCSEEHHHHHHTSTTCCCHHHHHHHHH
T ss_pred EEEEEEehhhcChHHHHHHHHHHHHHHhC-CCCcEEeeeeecccCCceeEEEEeehhhhHHHHHhhcCCcchhhhHHHHH
Confidence 46777655554455567899999999999 89999999999999999999999996666666655567899999999999
Q ss_pred HHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCC-C
Q 013092 83 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI-E 161 (449)
Q Consensus 83 qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~-~ 161 (449)
||+.||+|||++|||||||||+|||| +.++.+||+|||++........ ......|++.|+|||.+.+. .
T Consensus 108 qi~~~L~~LH~~~IvHrDiKp~NIll---~~~~~~kl~DfG~a~~~~~~~~-------~~~~~~~~~~y~~pE~~~~~~~ 177 (286)
T d1ob3a_ 108 QLLNGIAYCHDRRVLHRDLKPQNLLI---NREGELKIADFGLARAFGIPVR-------KYTHEIVTLWYRAPDVLMGSKK 177 (286)
T ss_dssp HHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECCTTHHHHHCC----------------CCCTTCCHHHHTTCCS
T ss_pred HHHHHHHHhccCcEEecCCCCceeeE---cCCCCEEecccccceecccCcc-------ccceecccchhhhHHHHhCCCC
Confidence 99999999999999999999999999 6889999999999987654322 12345689999999999865 4
Q ss_pred CChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcc------------------------cchHHHhhcCCc
Q 013092 162 QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV------------------------STSIEALCRGYP 217 (449)
Q Consensus 162 ~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~------------------------~~~~~~l~~~~p 217 (449)
++.++|||||||++|||++|+.||.+... .+.+.++..... ..........++
T Consensus 178 ~~~~~DiwslGv~l~el~~G~~pf~~~~~---~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s 254 (286)
T d1ob3a_ 178 YSTTIDIWSVGCIFAEMVNGTPLFPGVSE---ADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLD 254 (286)
T ss_dssp CCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCC
T ss_pred CCcceeehhcCcHHHHHHHCCCCCCCCCH---HHHHHHHHHhhCCCChhhccchhhhhhcccccccccCcchhhhcccCC
Confidence 68999999999999999999999987433 233333322110 111123345678
Q ss_pred HHHHHHHHHHhcCCCCCCCCHHHHH
Q 013092 218 TEFASYFHYCRSLRFDDKPDYAYLK 242 (449)
Q Consensus 218 ~el~~li~~cl~~~p~~RPt~~~l~ 242 (449)
+++.+||..||+.||++||++.+|+
T Consensus 255 ~~~~dli~~~L~~dP~~R~s~~ell 279 (286)
T d1ob3a_ 255 ESGIDLLSKMLKLDPNQRITAKQAL 279 (286)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred HHHHHHHHHHccCChhHCcCHHHHh
Confidence 9999999999999999999988875
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-40 Score=321.02 Aligned_cols=240 Identities=18% Similarity=0.192 Sum_probs=180.0
Q ss_pred EEEeeecccCCChhHHHHHHHHHH--HhcCCCCCceEEEEeEeCC----EEEEEEecC-CCCHHHHHHHcCCCCCHHHHH
Q 013092 6 TVFSVQENVKTKHPQLLYESKLYR--ILQGGTGIPNVRWFGVEGD----YNVLVMDLL-GPSLEDLFNFCSRKLSLKTVL 78 (449)
Q Consensus 6 kV~~k~~~~~~~~~~~~~E~~il~--~l~~hp~Iv~l~~~~~~~~----~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~ 78 (449)
+|++|..... ....+..|.+++. .+ +||||+++++++.+.+ ..||||||| +++|.++++. .++++...+
T Consensus 28 ~vAvK~~~~~-~~~~~~~e~ei~~~~~~-~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~--~~l~~~~~~ 103 (303)
T d1vjya_ 28 EVAVKIFSSR-EERSWFREAEIYQTVML-RHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR--YTVTVEGMI 103 (303)
T ss_dssp EEEEEEECGG-GHHHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHH--CCBCHHHHH
T ss_pred EEEEEEECcc-chhHHHHHHHHHHHhhC-CCCcCcceEEEEEeCCCcceEEEEEEecccCCCHHHHHhc--CCCCHHHHH
Confidence 4555544332 3345666666654 45 8999999999998654 689999999 9999999985 469999999
Q ss_pred HHHHHHHHHHHHHHH--------CCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCcc
Q 013092 79 MLADQMINRVEFVHS--------KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTAR 150 (449)
Q Consensus 79 ~i~~qi~~aL~yLH~--------~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~ 150 (449)
.++.|++.||+|||+ +||+||||||+|||| +.++.+||+|||+++.+........ .......||+.
T Consensus 104 ~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl---~~~~~~Kl~DFGl~~~~~~~~~~~~---~~~~~~~gt~~ 177 (303)
T d1vjya_ 104 KLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVRHDSATDTID---IAPNHRVGTKR 177 (303)
T ss_dssp HHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEE---CTTSCEEECCCTTCEEEETTTTEEC---C----CCSCGG
T ss_pred HHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEE---cCCCCeEEEecCccccccCCCccee---ccccceecccC
Confidence 999999999999996 599999999999999 6889999999999998866443221 12245689999
Q ss_pred ccchhhhhCCC------CChhhHHHHHHHHHHHHHhCCCCCCCCCcC------------CHHHHHHHHHhhcccchHHHh
Q 013092 151 YASMNTHLGIE------QSRRDDLESLGYVLMYFLRGSLPWQGLKAG------------TKKQKYEKISEKKVSTSIEAL 212 (449)
Q Consensus 151 Y~aPE~~~~~~------~s~~~DiwSlG~il~elltG~~Pf~~~~~~------------~~~~~~~~i~~~~~~~~~~~l 212 (449)
|+|||++.+.. ++.++|||||||+||||++|..||...... ........+......+.++..
T Consensus 178 y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~ 257 (303)
T d1vjya_ 178 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNR 257 (303)
T ss_dssp GCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGG
T ss_pred cCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHHHHHHHHhccccCCCCCcc
Confidence 99999988653 567899999999999999998887542211 112222222232322222111
Q ss_pred h--cCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCC
Q 013092 213 C--RGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQ 255 (449)
Q Consensus 213 ~--~~~p~el~~li~~cl~~~p~~RPt~~~l~~~L~~~~~~~~~~ 255 (449)
. ..++.++.+|+..||+.||++||++.+|.+.|+++...++.+
T Consensus 258 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~~~~ 302 (303)
T d1vjya_ 258 WQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGIK 302 (303)
T ss_dssp GGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHHCCC
T ss_pred cCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhcCCC
Confidence 1 223467999999999999999999999999999998887754
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-39 Score=324.13 Aligned_cols=222 Identities=16% Similarity=0.228 Sum_probs=178.9
Q ss_pred cEEEEEeeecccCCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCC------EEEEEEecCCCCHHHHHHHcCCCCCHHH
Q 013092 3 EILTVFSVQENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGD------YNVLVMDLLGPSLEDLFNFCSRKLSLKT 76 (449)
Q Consensus 3 ~aikV~~k~~~~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~------~~~lVmE~~g~sL~~ll~~~~~~ls~~~ 76 (449)
.|||++.+........+.+.+|+++|+.+ +||||+++++++...+ +.|||||||+.+|.++++. ..+++..
T Consensus 46 vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~--~~l~~~~ 122 (346)
T d1cm8a_ 46 VAIKKLYRPFQSELFAKRAYRELRLLKHM-RHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH--EKLGEDR 122 (346)
T ss_dssp EEEEECSSTTSSHHHHHHHHHHHHHHHHC-CBTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHHH--CCCCHHH
T ss_pred EEEEEEchhhcChHHHHHHHHHHHHHHhc-CCCCeeEEEEEeccCccccccceEEEEEecccccHHHHHHh--ccccHHH
Confidence 46666554333333455788999999999 8999999999987654 5799999999999998874 5799999
Q ss_pred HHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhh
Q 013092 77 VLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNT 156 (449)
Q Consensus 77 ~~~i~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~ 156 (449)
++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++...... ....||+.|+|||+
T Consensus 123 ~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~---~~~~~~kl~Dfg~a~~~~~~~----------~~~~~t~~y~aPE~ 189 (346)
T d1cm8a_ 123 IQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAV---NEDCELKILDFGLARQADSEM----------TGYVVTRWYRAPEV 189 (346)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEECCSSC----------CSSCSCGGGCCTHH
T ss_pred HHHHHHHHHHHHHHHHhCCCcccccCcchhhc---ccccccccccccceeccCCcc----------ccccccccccCHHH
Confidence 99999999999999999999999999999999 688999999999998765432 34579999999999
Q ss_pred hhCC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhc--------------------------ccchH
Q 013092 157 HLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK--------------------------VSTSI 209 (449)
Q Consensus 157 ~~~~-~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~--------------------------~~~~~ 209 (449)
+.+. .++.++|||||||++|+|++|..||.+.+.. ..+..+.... ....+
T Consensus 190 ~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (346)
T d1cm8a_ 190 ILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL---DQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDF 266 (346)
T ss_dssp HHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCG
T ss_pred HcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChH---HHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccch
Confidence 9874 4689999999999999999999999875432 2222222111 11122
Q ss_pred HHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 210 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 210 ~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
..+...+++++.+||..||..||++|||+.+|++
T Consensus 267 ~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~ 300 (346)
T d1cm8a_ 267 ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300 (346)
T ss_dssp GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 2334567899999999999999999999888754
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-38 Score=312.99 Aligned_cols=235 Identities=18% Similarity=0.164 Sum_probs=174.8
Q ss_pred ccEEEEEeeecccCCChhHHHHHHHHHHHhcCCCCCceEEEEeEe--------CCEEEEEEecCCCCHHHHHHHcCCCCC
Q 013092 2 YEILTVFSVQENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVE--------GDYNVLVMDLLGPSLEDLFNFCSRKLS 73 (449)
Q Consensus 2 ~~aikV~~k~~~~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~--------~~~~~lVmE~~g~sL~~ll~~~~~~ls 73 (449)
++|||++.+.........++.+|+++|+.+ +|+||+.+++.+.. .+..|||||||++.+...+......++
T Consensus 37 ~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-~h~nii~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~~~~~~~~~~~~~ 115 (318)
T d3blha1 37 KVALKKVLMENEKEGFPITALREIKILQLL-KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFT 115 (318)
T ss_dssp EEEEEEC----CTTSSCHHHHHHHHHHHHC-CCTTBCCEEEEEEC----------CEEEEEECCCEEHHHHHTCTTCCCC
T ss_pred EEEEEEEehhhcchHHHHHHHHHHHHHHHh-cCCCccceEeeeecccccccccCceEEEEEeccCCCccchhhhcccccc
Confidence 356777666555556667899999999999 89999999988754 456899999996666666655566799
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccc
Q 013092 74 LKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYAS 153 (449)
Q Consensus 74 ~~~~~~i~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~a 153 (449)
+..+..++.|++.||+|||++||+||||||+|||+ +.++.+||+|||+++.+....... .......+||+.|+|
T Consensus 116 ~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl---~~~~~~kl~dfg~~~~~~~~~~~~---~~~~~~~~gT~~Y~a 189 (318)
T d3blha1 116 LSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLI---TRDGVLKLADFGLARAFSLAKNSQ---PNRYTNRVVTLWYRP 189 (318)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTSCEEECCCTTCEECCC--------CCCCCSCCSCGGGCC
T ss_pred cHHHHHHHHHHHHHHHHhccCCEEecCcCchheee---cCCCcEEeeecceeeecccccccc---cccccceecCHHHhh
Confidence 99999999999999999999999999999999999 688999999999998766433221 122345689999999
Q ss_pred hhhhhCC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccc----------------------hHH
Q 013092 154 MNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST----------------------SIE 210 (449)
Q Consensus 154 PE~~~~~-~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~----------------------~~~ 210 (449)
||++.+. .++.++|||||||++|||++|+.||.+.+.......+..+....... ...
T Consensus 190 PE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (318)
T d3blha1 190 PELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVK 269 (318)
T ss_dssp HHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHH
T ss_pred HHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccccchhhhhhhhcccccccccch
Confidence 9999865 68999999999999999999999998754432222222221110000 000
Q ss_pred Hh--hcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 211 AL--CRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 211 ~l--~~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
.. ....++++.+||..||+.||++||++.++++
T Consensus 270 ~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 270 DRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp HHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence 00 0113567889999999999999999887753
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-39 Score=318.72 Aligned_cols=230 Identities=20% Similarity=0.203 Sum_probs=176.4
Q ss_pred cEEEEEeeecccCCChhHHHHHHHHHHHhcCCCCCceEEEEeEeC-----CEEEEEEecCCCCHHHHHHHcCCCCCHHHH
Q 013092 3 EILTVFSVQENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEG-----DYNVLVMDLLGPSLEDLFNFCSRKLSLKTV 77 (449)
Q Consensus 3 ~aikV~~k~~~~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~-----~~~~lVmE~~g~sL~~ll~~~~~~ls~~~~ 77 (449)
.|||++.+.. .......+.+|+.+|+.| +||||+++++++... .+.||+|+++|++|.+++.. +.+++..+
T Consensus 36 vAvK~i~~~~-~~~~~~~~~~Ei~il~~l-~hp~iv~~~~~~~~~~~~~~~~~~l~~~~~~g~L~~~l~~--~~l~~~~i 111 (345)
T d1pmea_ 36 VAIKKISPFE-HQTYCQRTLREIKILLRF-RHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT--QHLSNDHI 111 (345)
T ss_dssp EEEEEECCTT-CHHHHHHHHHHHHHHHHC-CCTTBCCCCEEECCSSTTTCCCEEEEEECCCEEHHHHHHH--CCCCHHHH
T ss_pred EEEEEEehhc-ChHHHHHHHHHHHHHHHc-CCCCCCcEEEEEeeccccccceEEEEEeecCCchhhhhhc--CCCCHHHH
Confidence 4556554332 223345688999999999 999999999988654 34677776669999999984 57999999
Q ss_pred HHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhh
Q 013092 78 LMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTH 157 (449)
Q Consensus 78 ~~i~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~ 157 (449)
..++.||+.||+|||++|||||||||+|||| +.++.+||+|||+++......... ......+||+.|+|||++
T Consensus 112 ~~i~~qil~al~yLH~~~iiHRDIKp~NILl---~~~~~~kl~DfG~a~~~~~~~~~~----~~~~~~~gt~~y~aPE~l 184 (345)
T d1pmea_ 112 CYFLYQILRGLKYIHSANVLHRDLKPSNLLL---NTTCDLKICDFGLARVADPDHDHT----GFLTEYVATRWYRAPEIM 184 (345)
T ss_dssp HHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEECCGGGCBC----CTTCCCCSCGGGCCGGGT
T ss_pred HHHHHHHHHHHHHHHHCCCcCCCCCcceEEE---CCCCCEEEcccCceeeccCCCccc----eeeccccccceechHHHh
Confidence 9999999999999999999999999999999 578899999999998765543221 123456799999999998
Q ss_pred hC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHh-----------------------hcccchHHHhh
Q 013092 158 LG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE-----------------------KKVSTSIEALC 213 (449)
Q Consensus 158 ~~-~~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~-----------------------~~~~~~~~~l~ 213 (449)
.. ..++.++||||+||++|+|++|+.||.+............+.. .........+.
T Consensus 185 ~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (345)
T d1pmea_ 185 LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLF 264 (345)
T ss_dssp TTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHC
T ss_pred hcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhC
Confidence 54 5678999999999999999999999987543221111111100 01112233455
Q ss_pred cCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 214 RGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 214 ~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
..+++++.+|+..||+.||++||++.++++
T Consensus 265 ~~~s~~~~~li~~~L~~dP~~R~ta~e~L~ 294 (345)
T d1pmea_ 265 PNADSKALDLLDKMLTFNPHKRIEVEQALA 294 (345)
T ss_dssp TTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 677889999999999999999999888753
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-38 Score=314.82 Aligned_cols=209 Identities=20% Similarity=0.219 Sum_probs=163.9
Q ss_pred HHHHHHHHHHhcCCCCCceEEEEeEe------CCEEEEEEecCCCCHHHHHH---HcCCCCCHHHHHHHHHHHHHHHHHH
Q 013092 21 LLYESKLYRILQGGTGIPNVRWFGVE------GDYNVLVMDLLGPSLEDLFN---FCSRKLSLKTVLMLADQMINRVEFV 91 (449)
Q Consensus 21 ~~~E~~il~~l~~hp~Iv~l~~~~~~------~~~~~lVmE~~g~sL~~ll~---~~~~~ls~~~~~~i~~qi~~aL~yL 91 (449)
+.+|+++|+.| +|+||+++++++.. ..+.|||||||++++.+.+. .....+++..++.|+.||+.||+||
T Consensus 60 ~~~Ei~il~~l-~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yL 138 (350)
T d1q5ka_ 60 KNRELQIMRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 138 (350)
T ss_dssp CCHHHHHHHHC-CCTTBCCEEEEEEEC--CCSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHhc-CCCCCCcEEEEEEecCccCCceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHH
Confidence 45799999999 99999999988853 34689999999666655543 2355799999999999999999999
Q ss_pred HHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhC-CCCChhhHHHH
Q 013092 92 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLES 170 (449)
Q Consensus 92 H~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~-~~~s~~~DiwS 170 (449)
|++||+||||||+||||. .+...+||+|||+++.+..... .....||+.|+|||.+.+ ..++.++||||
T Consensus 139 H~~~IiHrDiKp~NILl~--~~~~~~kl~DFG~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DIwS 208 (350)
T d1q5ka_ 139 HSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLVRGEP--------NVSYICSRYYRAPELIFGATDYTSSIDVWS 208 (350)
T ss_dssp HTTTEECCCCCGGGEEEC--TTTCCEEECCCTTCEECCTTSC--------CCSCCSCTTSCCHHHHTTCSSCCTHHHHHH
T ss_pred HhcCCcccCCCcceEEEe--cCCCceeEecccchhhccCCcc--------cccccccccccChHHhhcccCCCcceeecc
Confidence 999999999999999993 2335899999999987754332 235689999999999876 46899999999
Q ss_pred HHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccch------------------------HHHhhcCCcHHHHHHHHH
Q 013092 171 LGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS------------------------IEALCRGYPTEFASYFHY 226 (449)
Q Consensus 171 lG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~------------------------~~~l~~~~p~el~~li~~ 226 (449)
|||++|||++|+.||..... .+.+..+........ .......+++++.+||..
T Consensus 209 lG~il~el~~g~~pf~~~~~---~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~ 285 (350)
T d1q5ka_ 209 AGCVLAELLLGQPIFPGDSG---VDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSR 285 (350)
T ss_dssp HHHHHHHHHHTSCSSCCSSH---HHHHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHH
T ss_pred cceEEEehhhCCCCCCCCCH---HHHHHHHHHHhCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHH
Confidence 99999999999999987443 233333322111100 111124578899999999
Q ss_pred HhcCCCCCCCCHHHHHH
Q 013092 227 CRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 227 cl~~~p~~RPt~~~l~~ 243 (449)
||..||++||++.++++
T Consensus 286 mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 286 LLEYTPTARLTPLEACA 302 (350)
T ss_dssp HSCSSGGGSCCHHHHHT
T ss_pred HccCChhHCcCHHHHhc
Confidence 99999999999887653
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.3e-38 Score=312.54 Aligned_cols=212 Identities=16% Similarity=0.229 Sum_probs=167.8
Q ss_pred CChhHHHHHHHHHHHhcCCCCCceEEEEeEe--CCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH
Q 013092 16 TKHPQLLYESKLYRILQGGTGIPNVRWFGVE--GDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 92 (449)
Q Consensus 16 ~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~--~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH 92 (449)
....++.+|+.+|+.+++||||+++++++.. ....|+||||| +++|.++. +.+++..+..++.||+.||+|||
T Consensus 71 ~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH 146 (328)
T d3bqca1 71 VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCH 146 (328)
T ss_dssp SCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECCCSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeecCCCcHHHHh----cCCCHHHHHHHHHHHHHHHHHHh
Confidence 3457899999999999889999999999874 45799999999 88887653 46999999999999999999999
Q ss_pred HCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCCC-CChhhHHHHH
Q 013092 93 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESL 171 (449)
Q Consensus 93 ~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~-~s~~~DiwSl 171 (449)
++||+||||||+||||+ ..++.+||+|||+++....... .....||+.|+|||.+.+.. ++.++|||||
T Consensus 147 ~~gIvHrDiKp~NILi~--~~~~~vkl~DFG~a~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~Diwsl 216 (328)
T d3bqca1 147 SMGIMHRDVKPHNVMID--HEHRKLRLIDWGLAEFYHPGQE--------YNVRVASRYFKGPELLVDYQMYDYSLDMWSL 216 (328)
T ss_dssp HTTEECCCCSGGGEEEE--TTTTEEEECCGGGCEECCTTCC--------CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHH
T ss_pred hcccccccccccceEEc--CCCCeeeecccccceeccCCCc--------ccccccCccccCcccccCCCCCCcccchhhh
Confidence 99999999999999995 3456799999999987765432 24567999999999988754 7999999999
Q ss_pred HHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcc---------------cch-----------------HHHhhcCCcHH
Q 013092 172 GYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV---------------STS-----------------IEALCRGYPTE 219 (449)
Q Consensus 172 G~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~---------------~~~-----------------~~~l~~~~p~e 219 (449)
||++|+|++|..||...... ......+..... ... .......++++
T Consensus 217 G~~l~e~~~g~~pf~~~~~~--~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 294 (328)
T d3bqca1 217 GCMLASMIFRKEPFFHGHDN--YDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPE 294 (328)
T ss_dssp HHHHHHHHHTCSSSSCCSSH--HHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHH
T ss_pred hhhhHHhccCCCCCCCCchh--HHHHHHHHHHHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHH
Confidence 99999999999999764332 111111111100 000 00011336789
Q ss_pred HHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 220 FASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 220 l~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
+.+||..||..||++|||++++++
T Consensus 295 ~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 295 ALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHccCChhHCcCHHHHhc
Confidence 999999999999999999888743
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-38 Score=302.99 Aligned_cols=228 Identities=17% Similarity=0.169 Sum_probs=183.0
Q ss_pred ccEEEEEeeecccCCChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHH
Q 013092 2 YEILTVFSVQENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLML 80 (449)
Q Consensus 2 ~~aikV~~k~~~~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i 80 (449)
++|||++++.........++.+|+.+|+.+ +||||+++++++.+....+|||+++ +++|..++. ..+.+++..+..+
T Consensus 29 ~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~~~~~iv~~~~~~~~l~~~~~-~~~~~~~~~~~~~ 106 (292)
T d1unla_ 29 IVALKRVRLDDDDEGVPSSALREICLLKEL-KHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDS-CNGDLDPEIVKSF 106 (292)
T ss_dssp EEEEEEEESSCSSTTHHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEEEECCSEEHHHHHHH-TTTCCCHHHHHHH
T ss_pred EEEEEEEehhhCChHHHHHHHHHHHHHHhc-CcCCEEeeccccccccceeEEeeeccccccccccc-cccccchhHHHHH
Confidence 457888766554445567899999999999 8999999999999999999999999 777776665 4678999999999
Q ss_pred HHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhhCC
Q 013092 81 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI 160 (449)
Q Consensus 81 ~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~ 160 (449)
+.|++.||+|||++||+||||||+|||+ +..+.+||+|||+++........ .....+++.|+|||.+.+.
T Consensus 107 ~~q~~~aL~~lH~~~IvHrDiKP~NIli---~~~~~~kl~DFG~a~~~~~~~~~-------~~~~~~~~~~~~pe~~~~~ 176 (292)
T d1unla_ 107 LFQLLKGLGFCHSRNVLHRDLKPQNLLI---NRNGELKLANFGLARAFGIPVRC-------YSAEVVTLWYRPPDVLFGA 176 (292)
T ss_dssp HHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECCSCCSC-------CCSCCSCGGGCCHHHHTTC
T ss_pred HHHHHHHHHHhhcCCEeeecccCccccc---ccCCceeeeecchhhcccCCCcc-------ceeeccccchhhhhHhccC
Confidence 9999999999999999999999999999 57889999999999987654321 2344678899999999876
Q ss_pred C-CChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhccc------------------------chHHHhhcC
Q 013092 161 E-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS------------------------TSIEALCRG 215 (449)
Q Consensus 161 ~-~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~------------------------~~~~~l~~~ 215 (449)
. ++.++|||||||++|||++|..||.... +..+.+.++...... .........
T Consensus 177 ~~~~~~~DiwSlG~il~ell~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (292)
T d1unla_ 177 KLYSTSIDMWSAGCIFAELANAGRPLFPGN--DVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPK 254 (292)
T ss_dssp SCCCTHHHHHHHHHHHHHHTTTSCCSCCCS--SHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTT
T ss_pred CCCCchhhccccchHHHHHhhCCCCCCCCC--CHHHHHHHHHhhcCCCChhhhhhhhhcccccccccccccchhhhcccc
Confidence 5 6899999999999999999999975532 333444444322111 111223345
Q ss_pred CcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 216 YPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 216 ~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
+++++.+|+..||+.||.+||+++++++
T Consensus 255 ~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 255 LNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 6889999999999999999999887743
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-37 Score=309.00 Aligned_cols=223 Identities=18% Similarity=0.200 Sum_probs=166.7
Q ss_pred ccEEEEEeeecccCCChhHHHHHHHHHHHhcCCCCCceEEEEeE------eCCEEEEEEecCCCCHHHHHHHcCCCCCHH
Q 013092 2 YEILTVFSVQENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGV------EGDYNVLVMDLLGPSLEDLFNFCSRKLSLK 75 (449)
Q Consensus 2 ~~aikV~~k~~~~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~------~~~~~~lVmE~~g~sL~~ll~~~~~~ls~~ 75 (449)
+.|||++.+..........+.+|+.+|+.+ +||||+++++++. ...+.|||||||.++|.+.+. ..+++.
T Consensus 44 ~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~~~~~f~~~~~~~~~~~~~iv~Ey~~~~l~~~~~---~~~~~~ 119 (355)
T d2b1pa1 44 NVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ---MELDHE 119 (355)
T ss_dssp EEEEEEEESTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCCSTTTCCEEEEEEECCSEEHHHHHT---SCCCHH
T ss_pred EEEEEEEChhhcCHHHHHHHHHHHHHHHhc-CCCCeeEEEEEEecccccccCceeEEEEeccchHHHHhhh---cCCCHH
Confidence 356777665444334445688999999999 8999999999886 347899999999767766654 469999
Q ss_pred HHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchh
Q 013092 76 TVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMN 155 (449)
Q Consensus 76 ~~~~i~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE 155 (449)
.++.++.||+.||+|||++||+||||||+|||+ +.++.+|++|||+++....... .....||+.|+|||
T Consensus 120 ~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~---~~~~~~kl~df~~~~~~~~~~~--------~~~~~~t~~y~aPE 188 (355)
T d2b1pa1 120 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFM--------MTPYVVTRYYRAPE 188 (355)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCCCC-----------------------CCTTCCHH
T ss_pred HHHHHHHHHHHHHHHhhhcccccccCCcccccc---ccccceeeechhhhhccccccc--------cccccccccccChh
Confidence 999999999999999999999999999999999 5788999999999886654322 24567999999999
Q ss_pred hhhCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhcccchH-------------------------H
Q 013092 156 THLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI-------------------------E 210 (449)
Q Consensus 156 ~~~~~~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~-------------------------~ 210 (449)
++.+..++.++||||+||++|+|++|+.||.+.+. ...+.++......... .
T Consensus 189 ~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~---~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (355)
T d2b1pa1 189 VILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY---IDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFP 265 (355)
T ss_dssp HHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHH
T ss_pred hhcCCCCCCCcccccccchHHHHhhCCCCCCCCCH---HHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCccccccccc
Confidence 99999999999999999999999999999987433 2222222211110000 0
Q ss_pred H------------hhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 013092 211 A------------LCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 242 (449)
Q Consensus 211 ~------------l~~~~p~el~~li~~cl~~~p~~RPt~~~l~ 242 (449)
. .....++++.+||..||..||++|||+++|+
T Consensus 266 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL 309 (355)
T d2b1pa1 266 KLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL 309 (355)
T ss_dssp HHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred cccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHh
Confidence 0 0112367899999999999999999988875
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-37 Score=309.04 Aligned_cols=222 Identities=19% Similarity=0.240 Sum_probs=169.6
Q ss_pred cEEEEEeeecccCCChhHHHHHHHHHHHhcCCCCCceEEEEeEeC------CEEEEEEecCCCCHHHHHHHcCCCCCHHH
Q 013092 3 EILTVFSVQENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEG------DYNVLVMDLLGPSLEDLFNFCSRKLSLKT 76 (449)
Q Consensus 3 ~aikV~~k~~~~~~~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~------~~~~lVmE~~g~sL~~ll~~~~~~ls~~~ 76 (449)
+|||++.+..........+.+|+.+|+.| +||||+++++++... ...||+|+++|++|.+++. .+++++..
T Consensus 46 vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~h~~iv~~~~~~~~~~~~~~~~~~~i~~~~~gg~L~~~~~--~~~l~e~~ 122 (348)
T d2gfsa1 46 VAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDH 122 (348)
T ss_dssp EEEEECSCTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHT--TCCCCHHH
T ss_pred EEEEEECchhcChHHHHHHHHHHHHHHhc-CCCCeeeEEEEEeeccccccCceEEEEEeecCCchhhhcc--cccccHHH
Confidence 45555544333333445688999999999 899999999988532 3345555544999999997 46799999
Q ss_pred HHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhh
Q 013092 77 VLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNT 156 (449)
Q Consensus 77 ~~~i~~qi~~aL~yLH~~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~ 156 (449)
+..++.||+.||+|||++||+||||||+|||+ +.++.+|++|||++...... .....||+.|+|||.
T Consensus 123 ~~~i~~qil~aL~~LH~~giiHrDiKp~NILi---~~~~~~kl~dfg~a~~~~~~----------~~~~~g~~~y~apE~ 189 (348)
T d2gfsa1 123 VQFLIYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARHTDDE----------MTGYVATRWYRAPEI 189 (348)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECCC----CCTGG----------GSSSCHHHHTSCHHH
T ss_pred HHHHHHHHHHHHHHHHhCCCcccccCCccccc---cccccccccccchhcccCcc----------cccccccccccCchh
Confidence 99999999999999999999999999999999 68899999999999765432 235679999999999
Q ss_pred hhCCC-CChhhHHHHHHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHhhccc--------------------------chH
Q 013092 157 HLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS--------------------------TSI 209 (449)
Q Consensus 157 ~~~~~-~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~--------------------------~~~ 209 (449)
+.+.. ++.++|||||||++|+|++|..||.+.+. ......+...... ..+
T Consensus 190 ~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~---~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (348)
T d2gfsa1 190 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH---IDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNF 266 (348)
T ss_dssp HTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCH
T ss_pred hcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCH---HHHHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcch
Confidence 88765 58999999999999999999999987543 2233333222111 122
Q ss_pred HHhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 013092 210 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 243 (449)
Q Consensus 210 ~~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~~ 243 (449)
.....++++++.+||..||..||++|||+.++++
T Consensus 267 ~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 267 ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp HHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence 2334567899999999999999999999887753
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.97 E-value=6.3e-32 Score=269.03 Aligned_cols=215 Identities=21% Similarity=0.231 Sum_probs=154.8
Q ss_pred hhHHHHHHHHHHHhc----------CCCCCceEEEEeE--eCCEEEEEEecC--CCCHHHHHHHc-CCCCCHHHHHHHHH
Q 013092 18 HPQLLYESKLYRILQ----------GGTGIPNVRWFGV--EGDYNVLVMDLL--GPSLEDLFNFC-SRKLSLKTVLMLAD 82 (449)
Q Consensus 18 ~~~~~~E~~il~~l~----------~hp~Iv~l~~~~~--~~~~~~lVmE~~--g~sL~~ll~~~-~~~ls~~~~~~i~~ 82 (449)
...+.+|+++++.+. +|+||+++++++. .....+++|+++ ++......... ...+++..+..++.
T Consensus 53 ~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~ 132 (362)
T d1q8ya_ 53 TEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISK 132 (362)
T ss_dssp HHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHH
T ss_pred hHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHH
Confidence 456789999999885 3688999987775 345667777766 44444444432 45789999999999
Q ss_pred HHHHHHHHHHH-CCceecCCCCCcEEEeecCCC---CeEEEeecCcceeecCCCCCcccccccCCCCccCccccchhhhh
Q 013092 83 QMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRA---NQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHL 158 (449)
Q Consensus 83 qi~~aL~yLH~-~givHRDLKP~NiLl~~~~~~---~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~ 158 (449)
||+.||+|||+ .||+||||||+||||...+.. ..++|+|||.+....... ....||+.|+|||++.
T Consensus 133 qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~~~----------~~~~gt~~y~aPE~~~ 202 (362)
T d1q8ya_ 133 QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY----------TNSIQTREYRSPEVLL 202 (362)
T ss_dssp HHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBCC----------CSCCSCGGGCCHHHHH
T ss_pred HHHHHHHHHhhhcCcccccCChhHeeeeccCcccccceeeEeeccccccccccc----------ccccccccccChhhcc
Confidence 99999999998 899999999999999643222 258999999998654422 3457999999999999
Q ss_pred CCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCCH---HHHHHHHHhhcccc----------------------------
Q 013092 159 GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK---KQKYEKISEKKVST---------------------------- 207 (449)
Q Consensus 159 ~~~~s~~~DiwSlG~il~elltG~~Pf~~~~~~~~---~~~~~~i~~~~~~~---------------------------- 207 (449)
+..++.++|||||||++++|++|+.||........ ......+.......
T Consensus 203 ~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (362)
T d1q8ya_ 203 GAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLK 282 (362)
T ss_dssp TCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCC
T ss_pred ccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhcccccc
Confidence 99999999999999999999999999976432111 11111111100000
Q ss_pred --hHH-------HhhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 013092 208 --SIE-------ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 242 (449)
Q Consensus 208 --~~~-------~l~~~~p~el~~li~~cl~~~p~~RPt~~~l~ 242 (449)
... ......++++.+|+..||..||.+|||+.+++
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L 326 (362)
T d1q8ya_ 283 FWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLV 326 (362)
T ss_dssp BCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHH
T ss_pred CCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 000 00122367899999999999999999988764
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.68 E-value=1e-17 Score=150.92 Aligned_cols=124 Identities=19% Similarity=0.274 Sum_probs=89.5
Q ss_pred HHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q 013092 21 LLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHR 99 (449)
Q Consensus 21 ~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~givHR 99 (449)
...|..++.++ .|.+++..+++. . .+|+|||+ +..+. .++...+..++.|++.+|.|||++||+||
T Consensus 61 ~~~e~~~l~~l-~~~~v~~~~~~~--~--~~lvme~~~~~~~~--------~l~~~~~~~i~~ql~~~l~~lH~~giiHr 127 (191)
T d1zara2 61 ARNEFRALQKL-QGLAVPKVYAWE--G--NAVLMELIDAKELY--------RVRVENPDEVLDMILEEVAKFYHRGIVHG 127 (191)
T ss_dssp HHHHHHHHHHT-TTSSSCCEEEEE--T--TEEEEECCCCEEGG--------GCCCSCHHHHHHHHHHHHHHHHHTTEECS
T ss_pred HHHHHHHHHHc-cCCCcceEEEec--C--CEEEEEeecccccc--------chhhHHHHHHHHHHHHHHHHHhhCCEEEc
Confidence 45688888888 788888877653 2 37999999 44332 24556677899999999999999999999
Q ss_pred CCCCCcEEEeecCCCCeEEEeecCcceeecCCCCCcccccccCCCCccCccccch-----hhhhCCCCChhhHHHHHHHH
Q 013092 100 DIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASM-----NTHLGIEQSRRDDLESLGYV 174 (449)
Q Consensus 100 DLKP~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gT~~Y~aP-----E~~~~~~~s~~~DiwSlG~i 174 (449)
||||+|||+. .+.++|+|||+|+....+.. ..|... -.+....|+.++|+||+.--
T Consensus 128 DiKP~NILv~----~~~~~liDFG~a~~~~~~~~---------------~~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 128 DLSQYNVLVS----EEGIWIIDFPQSVEVGEEGW---------------REILERDVRNIITYFSRTYRTEKDINSAIDR 188 (191)
T ss_dssp CCSTTSEEEE----TTEEEECCCTTCEETTSTTH---------------HHHHHHHHHHHHHHHHHHHCCCCCHHHHHHH
T ss_pred cCChhheeee----CCCEEEEECCCcccCCCCCc---------------HHHHHHHHHHHHHHHcCCCCCcccHHHHHHH
Confidence 9999999994 35699999999976543221 111111 01223567788999998655
Q ss_pred HH
Q 013092 175 LM 176 (449)
Q Consensus 175 l~ 176 (449)
+.
T Consensus 189 ~~ 190 (191)
T d1zara2 189 IL 190 (191)
T ss_dssp HH
T ss_pred Hh
Confidence 43
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=97.96 E-value=2e-05 Score=71.89 Aligned_cols=48 Identities=19% Similarity=0.233 Sum_probs=39.8
Q ss_pred ChhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CCCHHHH
Q 013092 17 KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDL 64 (449)
Q Consensus 17 ~~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~sL~~l 64 (449)
....+.+|..++..|..+--|+.+++++.+++..|+||+++ |..+.+.
T Consensus 52 ~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~ 100 (263)
T d1j7la_ 52 TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEE 100 (263)
T ss_dssp STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHH
T ss_pred chhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEeccccccccc
Confidence 34458899999999977666899999999999999999999 7676544
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.43 E-value=9.8e-05 Score=66.70 Aligned_cols=45 Identities=18% Similarity=0.072 Sum_probs=35.6
Q ss_pred ChhHHHHHHHHHHHhcCCC-CCceEEEEeEeCCEEEEEEecC-CCCH
Q 013092 17 KHPQLLYESKLYRILQGGT-GIPNVRWFGVEGDYNVLVMDLL-GPSL 61 (449)
Q Consensus 17 ~~~~~~~E~~il~~l~~hp-~Iv~l~~~~~~~~~~~lVmE~~-g~sL 61 (449)
....+..|..+|+.|..+. .+++++.++.+++..|+||+++ |.++
T Consensus 47 ~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 47 ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred CHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 3456899999999986543 3777888888888999999999 6544
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=96.58 E-value=0.0014 Score=63.53 Aligned_cols=36 Identities=22% Similarity=0.156 Sum_probs=26.5
Q ss_pred HHHHHHHHHHHhcCC--CCCceEEEEeEeCCEEEEEEecC
Q 013092 20 QLLYESKLYRILQGG--TGIPNVRWFGVEGDYNVLVMDLL 57 (449)
Q Consensus 20 ~~~~E~~il~~l~~h--p~Iv~l~~~~~~~~~~~lVmE~~ 57 (449)
....|.++|+.+..+ ..+|+++.+ +....++|||++
T Consensus 76 R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lvmE~L 113 (392)
T d2pula1 76 RARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTVMEDL 113 (392)
T ss_dssp HHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEEECCC
T ss_pred HHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEEEecc
Confidence 456799999988654 346666655 455678999999
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.00 E-value=0.0044 Score=59.72 Aligned_cols=38 Identities=13% Similarity=0.100 Sum_probs=29.7
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEEEeEeCCEEEEEEecC-CC
Q 013092 18 HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GP 59 (449)
Q Consensus 18 ~~~~~~E~~il~~l~~hp~Iv~l~~~~~~~~~~~lVmE~~-g~ 59 (449)
.-...+|..+++.+..+.-.+++++++.+ ++||||+ |.
T Consensus 88 ~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~efi~g~ 126 (395)
T d1nw1a_ 88 ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYIPSR 126 (395)
T ss_dssp HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCCCEE
T ss_pred hhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEEeccc
Confidence 34567899999999877777888888753 6899999 53
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=93.54 E-value=0.11 Score=48.04 Aligned_cols=28 Identities=29% Similarity=0.349 Sum_probs=22.5
Q ss_pred CCceecCCCCCcEEEeecCCCCeEEEeecCcce
Q 013092 94 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 126 (449)
Q Consensus 94 ~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~ 126 (449)
.++||+|+.+.|||+ + ++ ..++||+.+.
T Consensus 192 ~~liHgDlh~~NvL~---~-~~-~~~IDFdd~~ 219 (325)
T d1zyla1 192 VLRLHGDCHAGNILW---R-DG-PMFVDLDDAR 219 (325)
T ss_dssp CEECCSSCSGGGEEE---S-SS-EEECCCTTCC
T ss_pred ceeecCCCCcccEEE---e-CC-ceEEechhcc
Confidence 369999999999998 2 33 4589999775
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=90.04 E-value=0.047 Score=50.07 Aligned_cols=30 Identities=27% Similarity=0.350 Sum_probs=24.8
Q ss_pred CCceecCCCCCcEEEeecCCCCeEEEeecCcce
Q 013092 94 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 126 (449)
Q Consensus 94 ~givHRDLKP~NiLl~~~~~~~~vkL~DFGla~ 126 (449)
.|+||+|+.++||++ +.+...-|+||+.+.
T Consensus 183 ~giIHgDl~~dNvl~---~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFF---LGDELSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEE---ETTEEEEECCCTTCE
T ss_pred cccccCCcchhhhhc---ccccceeEecccccc
Confidence 479999999999999 355556899999774
|